{
  "timestamp": "2025-10-31T21:03:30.109069",
  "summary": {
    "total": 75,
    "successful": 73,
    "failed": 0,
    "timeout": 1,
    "skipped": 1
  },
  "results": [
    {
      "adapter": "pubchem",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Invalid SMILES string"
      },
      "metadata": {
        "name": "pubchem",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.2,
          "timeout": 30
        }
      }
    },
    {
      "adapter": "chembl",
      "status": "success",
      "error": null,
      "execution_time": 2.016927,
      "data": {
        "success": true,
        "data": {
          "num_activities": 100,
          "num_targets": 15,
          "assay_types": [
            "P",
            "A",
            "T",
            "B",
            "F"
          ],
          "best_ic50_nm": 5000.0,
          "best_ki_nm": null,
          "targets": [
            "CHEMBL2362975",
            "CHEMBL3253",
            "CHEMBL369",
            "CHEMBL2093869",
            "CHEMBL2096674",
            "CHEMBL612884",
            "CHEMBL2949",
            "CHEMBL376",
            "CHEMBL372",
            "CHEMBL374"
          ],
          "bioactivities": [
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 42173,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL702885",
              "assay_description": "Binding constant against human serum albumin (HSA)",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000357",
              "bao_label": "single protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1134302",
              "document_journal": "J Med Chem",
              "document_year": 2001,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 264421,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Log K'",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.39",
              "target_chembl_id": "CHEMBL3253",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Albumin",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Log K'",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.39"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 81965,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL771355",
              "assay_description": "Antiedema efficacy was measured in male Sprague-Dawley rats relative to aspirin; activity expressed as percent of aspirin",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0001103",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121620",
              "document_journal": "J Med Chem",
              "document_year": 1980,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 329936,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Activity",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "100.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Activity",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 81966,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL780106",
              "assay_description": "Effective dose of compound to produce 25% inhibition in rat; Value ranges from 326-499",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121620",
              "document_journal": "J Med Chem",
              "document_year": 1980,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 329936,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED25",
              "standard_units": "uM kg-1",
              "standard_upper_value": null,
              "standard_value": "402.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED25",
              "units": "uM kg-1",
              "uo_units": null,
              "upper_value": null,
              "value": "402.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 88326,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL762032",
              "assay_description": "Inhibitory concentration required against Arachidonic acid (100 uM) induced platelet aggregatory activity",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1146621",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.46",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 174376,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "34600.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "34.6"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 88327,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL762033",
              "assay_description": "In vitro inhibition of Collagen (10 ug/mL) induced platelet aggregatory activity.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1146621",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.46",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 174376,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "34900.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "34.9"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 88328,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL765149",
              "assay_description": "Percentage inhibition against thrombin induced platelet aggregatory activity",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1146621",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 174376,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "81.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "81.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 88329,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL765148",
              "assay_description": "Percentage inhibition against platelet activating factor (2 ng/mL) induced platelet aggregatory activity",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1146621",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 174376,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "2.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "2.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 91852,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL760085",
              "assay_description": "Inhibitory concentration in DMSO with purified human Prostaglandin G/H synthase 2 (COX-2)",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000357",
              "bao_label": "single protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1131194",
              "document_journal": "J Med Chem",
              "document_year": 1998,
              "ligand_efficiency": {
                "bei": "23.34",
                "le": "0.44",
                "lle": "2.89",
                "sei": "6.61"
              },
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.20",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 280370,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "62500.0",
              "target_chembl_id": "CHEMBL230",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Prostaglandin G/H synthase 2",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "62.5"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 91853,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL764258",
              "assay_description": "Inhibitory concentration in DMSO with purified ovine Prostaglandin G/H synthase 1 (COX-1).",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000357",
              "bao_label": "single protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1131194",
              "document_journal": "J Med Chem",
              "document_year": 1998,
              "ligand_efficiency": {
                "bei": "27.22",
                "le": "0.52",
                "lle": "3.59",
                "sei": "7.71"
              },
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.90",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 280370,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "12500.0",
              "target_chembl_id": "CHEMBL2949",
              "target_organism": "Ovis aries",
              "target_pref_name": "Prostaglandin G/H synthase 1",
              "target_tax_id": "9940",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "12.5"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 98177,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767504",
              "assay_description": "Evaluated for dose to inhibit Prostaglandin G/H synthase of platelets by about 90% in human",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121444",
              "document_journal": "J Med Chem",
              "document_year": 1980,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 303968,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Dose",
              "standard_units": "mg",
              "standard_upper_value": null,
              "standard_value": "325.0",
              "target_chembl_id": "CHEMBL2094253",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Cyclooxygenase",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Dose",
              "units": "mg",
              "uo_units": "UO_0000022",
              "upper_value": null,
              "value": "325.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 98892,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL733962",
              "assay_description": "Analgesic activity was assessed from the ability to inhibit phenylquinone-induced writhing in mouse at a dose of 70 mg/kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124641",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 23967,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "70.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "70.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 110238,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL735173",
              "assay_description": "Effective dose required for writhing response in mouse after 20 minutes on ig administration",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1126943",
              "document_journal": "J Med Chem",
              "document_year": 1993,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 210558,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "42.3",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "42.3"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 122608,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL840552",
              "assay_description": "In vitro inhibition of collagen-induced human platelet aggregation.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000188",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1122226",
              "document_journal": "J Med Chem",
              "document_year": 1983,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/MicrogramPerMilliliter",
              "record_id": 328384,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "EC50",
              "standard_units": "ug.mL-1",
              "standard_upper_value": null,
              "standard_value": "494.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "EC50",
              "units": "mg l-1",
              "uo_units": "UO_0000274",
              "upper_value": null,
              "value": "494.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 122609,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL841426",
              "assay_description": "Relative activity (compared to acetylsalicylic acid) for in vitro inhibition of collagen-induced human platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122226",
              "document_journal": "J Med Chem",
              "document_year": 1983,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 328384,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Relative activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Relative activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 122610,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL847716",
              "assay_description": "Ex vivo inhibition of collagen-induced rat platelet aggregation after peroral administration",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122226",
              "document_journal": "J Med Chem",
              "document_year": 1983,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 328384,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED33",
              "standard_units": "mg kg-1",
              "standard_upper_value": null,
              "standard_value": "233.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED33",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "233.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 122611,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL849664",
              "assay_description": "Activity relative to dihydralazine for in vitro hypotensive activity in anesthetized rats",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122226",
              "document_journal": "J Med Chem",
              "document_year": 1983,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 328384,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Relative activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Relative activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 122612,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL848423",
              "assay_description": "In vitro inhibition of collagen induced aggregation of human plateles and the ratio of ED33 to EC50 was reported",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122226",
              "document_journal": "J Med Chem",
              "document_year": 1983,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 328384,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "0.47",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "0.47"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 129040,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL724465",
              "assay_description": "Analgesic activity was measured on phenylquinone writhing in mice at 50 mg/kg subcutaneous dose",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121818",
              "document_journal": "J Med Chem",
              "document_year": 1981,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 274988,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "50.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "50.0"
            },
            {
              "action_type": null,
              "activity_comment": "Not Determined",
              "activity_id": 129041,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL812595",
              "assay_description": "Compound was measured as concentration of compound required for 90% growth inhibition of Trichomonas vaginalis; ND=No data",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0002146",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121818",
              "document_journal": "J Med Chem",
              "document_year": 1981,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/MicrogramPerMilliliter",
              "record_id": 274988,
              "relation": null,
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": null,
              "standard_text_value": null,
              "standard_type": "MIC",
              "standard_units": "ug.mL-1",
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL612884",
              "target_organism": "Trichomonas vaginalis",
              "target_pref_name": "Trichomonas vaginalis",
              "target_tax_id": "5722",
              "text_value": null,
              "toid": null,
              "type": "MIC",
              "units": "ug ml-1",
              "uo_units": "UO_0000274",
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 164569,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL782421",
              "assay_description": "Antiinflammatory activity against adjuvant induced arthritis in male charles river rats",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127690",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 349770,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "305.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "305.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 209449,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL771612",
              "assay_description": "In vitro inhibitory activity against Adenosine diphosphate (ADP) induced rabbit platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1130834",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 54521,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "1000000.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "1000.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 209450,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL771613",
              "assay_description": "In vitro inhibitory activity against collagen induced rabbit platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1130834",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 54521,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "1000000.0",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "1000.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 209451,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL738536",
              "assay_description": "In vivo anti-thrombotic activity was evaluated by the inhibition of pulmonary thromboembolism model in mice at a dose of 30 mg/kg (p.o.)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1130834",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 54521,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "33.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "33.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 209452,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL787143",
              "assay_description": "In vivo anti-hyperplastic activity was evaluated by the inhibition of balloon injury model in rats at a dose of 30 mg/kg (p.o.)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1130834",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 54521,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "16.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "16.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 223619,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL628746",
              "assay_description": "Human absorption A (%)",
              "assay_type": "A",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1131302",
              "document_journal": "J Med Chem",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 1179,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Absorption",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "100.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Absorption",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 223620,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL631372",
              "assay_description": "Partition coefficient (logD7.4)",
              "assay_type": "P",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0002129",
              "bao_format": "BAO_0000100",
              "bao_label": "small-molecule physicochemical format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1131302",
              "document_journal": "J Med Chem",
              "document_year": 1998,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 1179,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "LogD",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "-2.57",
              "target_chembl_id": "CHEMBL2362975",
              "target_organism": null,
              "target_pref_name": "No relevant target",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "logD",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "-2.57"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 278684,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL789981",
              "assay_description": "Relative Oral Anti inflammatory activity in the 5-h Evans Blue-Carrageenan pleural assay using indomethacin as reference compound",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122614",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 36871,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Relative potency",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "0.01",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Relative potency",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "0.01"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 278685,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767951",
              "assay_description": "Inhibition of PG synthetase activity obtained from bovine seminal vesicles",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000224",
              "bao_label": "protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1122614",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 36871,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "1500000.0",
              "target_chembl_id": "CHEMBL2096674",
              "target_organism": "Bos taurus",
              "target_pref_name": "Cyclooxygenase",
              "target_tax_id": "9913",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "1500.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 285781,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL702047",
              "assay_description": "In vitro inhibition of arachidonic acid induced platelet aggregation of human platelet-rich plasma",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1123449",
              "document_journal": "J Med Chem",
              "document_year": 1986,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 136719,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "185000.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "I50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "185.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 297357,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL631962",
              "assay_description": "Aqueous solubility",
              "assay_type": "P",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000100",
              "bao_label": "small-molecule physicochemical format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1132890",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 17511,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Log S",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "-1.72",
              "target_chembl_id": "CHEMBL2362975",
              "target_organism": null,
              "target_pref_name": "No relevant target",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "Log S",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "-1.72"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 308369,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699334",
              "assay_description": "Inhibition of collagen induced platelet aggregation in platelet-rich human plasma (PRP)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1123971",
              "document_journal": "J Med Chem",
              "document_year": 1988,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 94961,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "70000000000.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "M",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "70.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 308370,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL734113",
              "assay_description": "Effective dose of the compound required to protect 50% tested mice against experimental antithrombosis",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1123971",
              "document_journal": "J Med Chem",
              "document_year": 1988,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 94961,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED30",
              "standard_units": "uM kg-1",
              "standard_upper_value": null,
              "standard_value": "166.66",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "ED30",
              "units": "uM kg-1",
              "uo_units": null,
              "upper_value": null,
              "value": "166.66"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 308371,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL734113",
              "assay_description": "Effective dose of the compound required to protect 50% tested mice against experimental antithrombosis",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1123971",
              "document_journal": "J Med Chem",
              "document_year": 1988,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 94961,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED30",
              "standard_units": "mg kg-1",
              "standard_upper_value": null,
              "standard_value": "30.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "ED30",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "30.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337502,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL877804",
              "assay_description": "Lethal dose in mouse was determined by administering perorally",
              "assay_type": "T",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0002117",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 131321,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "LD50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "1000.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "LD50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "1000.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337503,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL740447",
              "assay_description": "divya_inp96 Lethal dose in mouse by administering compound intraperitoneally",
              "assay_type": "T",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0002117",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "LD50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "6495.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "LD50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "6495.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337504,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL740190",
              "assay_description": "Antithrombotic activity in mouse when administered a dose of 20 mg/kg perorally",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Protection",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "44.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Protection",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "44.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337505,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL872780",
              "assay_description": "In vitro reversible inhibitory activity of adenosine diphosphate (0.5 uM)-induced platelet aggregation in guinea pig platelet rich plasma",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "0.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "0.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337506,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL763786",
              "assay_description": "In vitro irreversible inhibitory activity of adenosine diphosphate (0.5 uM)-induced platelet aggregation in guinea pig platelet rich plasma",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "100.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337507,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL763789",
              "assay_description": "Inhibitory activity of thrombin (0.625 IU/mL)-induced platelet aggregation in guinea pig platelet rich plasma after 2 min",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "0.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "0.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337508,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL763785",
              "assay_description": "In vitro inhibitory activity of thrombin (0.625 IU/mL)-induced platelet aggregation in guinea pig platelet rich plasma after 4 min",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "0.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "0.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 337509,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL763784",
              "assay_description": "In vitro inhibitory activity of collagen (0.8 ug/mL)-induced platelet aggregation in guinea pig platelet rich plasma at a dose of 0.8 ug/mL",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124348",
              "document_journal": "J Med Chem",
              "document_year": 1989,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 131321,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "75.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "75.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346256,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699899",
              "assay_description": "In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 100 uM",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "31.2",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "31.2"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346257,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699900",
              "assay_description": "In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 150 uM",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "37.1",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "37.1"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346258,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699901",
              "assay_description": "In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 200 uM",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "48.5",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "48.5"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346259,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699902",
              "assay_description": "In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 250 uM",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "56.4",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "56.4"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346260,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL842349",
              "assay_description": "Effect on acute pulmonary thromboembolism in mice at 25 mg/kg expressed as no. of killed or paralyzed to no. of tested observed after 10 min",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "No. of killed or paralyzed",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "28.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "No. of killed or paralyzed",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "28.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 346261,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL842582",
              "assay_description": "Effect on acute pulmonary thromboembolism in mice at 25 mg/kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1133676",
              "document_journal": "J Med Chem",
              "document_year": 2000,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 231328,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Protected",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "45.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Protected",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "45.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 363803,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL761638",
              "assay_description": "In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122973",
              "document_journal": "J Med Chem",
              "document_year": 1985,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/MicrogramPerMilliliter",
              "record_id": 267950,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "ug.mL-1",
              "standard_upper_value": null,
              "standard_value": "10.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "ug ml-1",
              "uo_units": "UO_0000274",
              "upper_value": null,
              "value": "10.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 363804,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL761642",
              "assay_description": "Potency relative to flurbiprofen in inhibiting collagen-induced platelet aggregation in human platelet-rich plasma (PRP)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122973",
              "document_journal": "J Med Chem",
              "document_year": 1985,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 267950,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Relative potency",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "0.01",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Relative potency",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "0.01"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392578,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL768981",
              "assay_description": "In vitro antiplatelet activity against arachidonic acid induced malondialdehyde production",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.80",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "16000.0",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "16.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392579,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL776420",
              "assay_description": "In vitro vasodilatory activity in isolated rat aorta",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Micromolar",
              "record_id": 22653,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "uM",
              "standard_upper_value": null,
              "standard_value": "600.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "uM",
              "uo_units": "UO_0000064",
              "upper_value": null,
              "value": "600.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392580,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL680150",
              "assay_description": "Inhibitory effect on platelet aggregation induced by Arachidonic acid (AA) in guinea pigs ex vivo at a dose of 3.2 mg/Kg after 1 hr of oral administration",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "DOSE",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "64.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Dose",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "64.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392581,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL680155",
              "assay_description": "Inhibitory effect on platelet aggregation induced by Collagen in guinea pigs ex vivo at a dose of 3.2 mg/Kg after 1 hr of oral administration",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "DOSE",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "9.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "Dose",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "9.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392582,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL804161",
              "assay_description": "Induction of acute stomach lesion at a dose of 10 mg/Kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ulcer index",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "0.6",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ulcer index",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "0.6"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392583,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL804164",
              "assay_description": "Induction of acute stomach lesion at a dose of 32 mg/Kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ulcer index",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "2.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ulcer index",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "2.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392584,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL804162",
              "assay_description": "Induction of acute stomach lesion at a dose of 100 mg/Kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ulcer index",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "2.2",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ulcer index",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "2.2"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392585,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL804166",
              "assay_description": "Induction of acute stomach lesion at a dose of 320 mg/Kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ulcer index",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "3.8",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ulcer index",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "3.8"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392586,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL791096",
              "assay_description": "Induction of acute stomach lesion at a dose of 10 mg/Kg to determine the number of rats with ulceration; 1/5",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392587,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL878818",
              "assay_description": "Induction of acute stomach lesion at a dose of 32 mg/Kg to determine the number of rats with ulceration; 3/5",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392588,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL791097",
              "assay_description": "Induction of acute stomach lesion at a dose of 100 mg/Kg to determine the number of rats with ulceration; 4/5",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392589,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL791098",
              "assay_description": "Induction of acute stomach lesion at a dose of 320 mg/Kg to determine the number of rats with ulceration; 5/5",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 392590,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL783761",
              "assay_description": "Compound was evaluated for collagen-induced platelet aggregation in rat ex vivo at the dose of 32 mg/Kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1127637",
              "document_journal": "J Med Chem",
              "document_year": 1994,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 22653,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "8.4",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "8.4"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 399466,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL787541",
              "assay_description": "Compound was evaluated for its antiinflammatory activity in the cotton pellet induced granuloma(CPG) in normal rats at the dose 50 mg/kg p.o.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122649",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 306550,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "24.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "24.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 399467,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL774773",
              "assay_description": "Compound was evaluated for its analgesic activity by Randall-Selitto test in comparison with that of Aspirine",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000375",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122649",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 306550,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 399468,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL774774",
              "assay_description": "Compound was evaluated for its antipyretic activity by antipyresis effect in comparison with that of Aspirin.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000375",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122649",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 306550,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 399469,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL804169",
              "assay_description": "Compound was evaluated for its gastroulcerogenic effect in rats at a peroral dose of 200 mg/kg, P<0.05.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122649",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 306550,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ulcerogenic index",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "1.6",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Ulcerogenic index",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "1.6"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 428894,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL699491",
              "assay_description": "In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1121768",
              "document_journal": "J Med Chem",
              "document_year": 1981,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/MicrogramPerMilliliter",
              "record_id": 58380,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "ug.mL-1",
              "standard_upper_value": null,
              "standard_value": "10.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "ug ml-1",
              "uo_units": "UO_0000274",
              "upper_value": null,
              "value": "10.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 513632,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL761741",
              "assay_description": "In vitro inhibitory activity on platelet aggregation induced by arachidonic acid (AA)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1134765",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2001,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.70",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 176504,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "20000.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "20.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 515157,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL696981",
              "assay_description": "In vitro inhibition of thrombin-induced platelet aggregation.",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128342",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 252486,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "100000.0",
              "target_chembl_id": "CHEMBL612545",
              "target_organism": null,
              "target_pref_name": "Unchecked",
              "target_tax_id": null,
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 515158,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL696980",
              "assay_description": "Inhibition of collagen-induced platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128342",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 252486,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "100000.0",
              "target_chembl_id": "CHEMBL2093869",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Integrin alpha-IIb/beta-3",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 515159,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL696979",
              "assay_description": "Inhibition of arachidonic acid-induced platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000019",
              "bao_label": "assay format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128342",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "5.30",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 252486,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "5000.0",
              "target_chembl_id": "CHEMBL2093869",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Integrin alpha-IIb/beta-3",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "5.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 558549,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL721200",
              "assay_description": "In vivo antithrombotic activity in Swiss mice was determined when the compound was administered at 30 umol/kg orally 1 hour prior to challenge",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1135176",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2002,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 96697,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Protection",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "40.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Protection",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "40.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 558550,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL721473",
              "assay_description": "In vivo increase in the bleeding time was determined when administered at 30 umol/kg orally 1 hour prior to challenge",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1135176",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2002,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 96697,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Increase",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "110.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "Increase",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "110.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 579271,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL779638",
              "assay_description": "In vivo effective dose required for antiinflammatory activity in rat adjuvant arthritis model",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128445",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Micromolar",
              "record_id": 242897,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "uM",
              "standard_upper_value": null,
              "standard_value": "1942.7",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "uM",
              "uo_units": "UO_0000064",
              "upper_value": null,
              "value": "1942.7"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 579272,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL764147",
              "assay_description": "Tested for inhibitory activity against Prostaglandin G/H synthase 1 from ovine",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000357",
              "bao_label": "single protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1128445",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 242897,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "1280000.0",
              "target_chembl_id": "CHEMBL2949",
              "target_organism": "Ovis aries",
              "target_pref_name": "Prostaglandin G/H synthase 1",
              "target_tax_id": "9940",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "1280.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 579273,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL769654",
              "assay_description": "Tested for inhibitory activity against Prostaglandin G/H synthase 2 from human",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000357",
              "bao_label": "single protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": "Outside typical range",
              "data_validity_description": "Values for this activity type are unusually large/small, so may not be accurate",
              "document_chembl_id": "CHEMBL1128445",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 242897,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "18000000.0",
              "target_chembl_id": "CHEMBL230",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Prostaglandin G/H synthase 2",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "18000.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 579274,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL849098",
              "assay_description": "IC50 ratio measured as the IC50 values of COX-1 to that of COX-2.",
              "assay_type": "B",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000193",
              "bao_format": "BAO_0000224",
              "bao_label": "protein format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128445",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 242897,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Ratio",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "0.1",
              "target_chembl_id": "CHEMBL2094253",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Cyclooxygenase",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "Ratio",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "0.1"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 597862,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL760548",
              "assay_description": "In vitro antiplatelet activity against guinea pig platelet rich plasma aggregated by collagen",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1134079",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2001,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.32",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 45619,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "48000.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "48.0"
            },
            {
              "action_type": null,
              "activity_comment": "Not Determined",
              "activity_id": 597863,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL760547",
              "assay_description": "In vitro antiplatelet activity against guinea pig platelet rich plasma aggregated by ADP; Not calculable because maximum inhibition of aggregation is lower than 50%",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1134079",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2001,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 45619,
              "relation": null,
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": null,
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": null,
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": null
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 597864,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL760545",
              "assay_description": "Evaluated for in vitro antiplatelet activity against guinea pig platelet rich plasma aggregated by arachidonic acid (AA)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1134079",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2001,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.21",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 45619,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "61000.0",
              "target_chembl_id": "CHEMBL369",
              "target_organism": "Cavia porcellus",
              "target_pref_name": "Cavia porcellus",
              "target_tax_id": "10141",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "61.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 613450,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL718282",
              "assay_description": "Antianalgesic activity by phenylquinone writhing method in mice after peroral administration",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122640",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 295647,
              "relation": ">",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": ">",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "100.0",
              "target_chembl_id": "CHEMBL613490",
              "target_organism": "Mus sp.",
              "target_pref_name": "Mus sp.",
              "target_tax_id": "10095",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "100.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 613451,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL786415",
              "assay_description": "Compound was tested for antiinflammatory activity and the % inhibition was reported 3 hr after carrageenan injection in the hind paw edema test in rats: dose=80 mg/kg",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1122640",
              "document_journal": "J Med Chem",
              "document_year": 1984,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 295647,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "25.8",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "25.8"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619257,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767916",
              "assay_description": "Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-7 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "53.42",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "53.42"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619258,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767915",
              "assay_description": "Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-6 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "36.98",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "36.98"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619259,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767914",
              "assay_description": "Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-5 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "29.99",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "29.99"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619260,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767913",
              "assay_description": "Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-7 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "54.89",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "54.89"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619261,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767912",
              "assay_description": "Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-6 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "42.58",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "42.58"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619262,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL767911",
              "assay_description": "Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-5 mol/L (in vitro)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000179",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Am",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "30.01",
              "target_chembl_id": "CHEMBL374",
              "target_organism": "Oryctolagus cuniculus",
              "target_pref_name": "Oryctolagus cuniculus",
              "target_tax_id": "9986",
              "text_value": null,
              "toid": null,
              "type": "Am",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "30.01"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619263,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL775277",
              "assay_description": "Effect on the wet thrombus weight in male wistar rat was determined(in vivo)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000375",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "28.11",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "28.11"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 619264,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL774676",
              "assay_description": "Effect on the dry thrombus weight in male wistar rat was determined(in vivo)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000375",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1136439",
              "document_journal": "Bioorg Med Chem Lett",
              "document_year": 2003,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 251140,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 0,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Activity",
              "standard_units": null,
              "standard_upper_value": null,
              "standard_value": "3.99",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Activity",
              "units": null,
              "uo_units": null,
              "upper_value": null,
              "value": "3.99"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625655,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL879115",
              "assay_description": "Antinociceptive potency against phenylquinone (PBQ)-induced writhing in mice (8 mice/dose)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "63.0",
              "target_chembl_id": "CHEMBL375",
              "target_organism": "Mus musculus",
              "target_pref_name": "Mus musculus",
              "target_tax_id": "10090",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "63.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625656,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL784656",
              "assay_description": "Antinociceptive potency against acetic acid -induced writhing in rat (8 rats/dose)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0003036",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": null,
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "ED50",
              "standard_units": "mg.kg-1",
              "standard_upper_value": null,
              "standard_value": "32.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "ED50",
              "units": "mg kg-1",
              "uo_units": "UO_0000308",
              "upper_value": null,
              "value": "32.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625657,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL785132",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 15 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "53.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "53.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625658,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL785134",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 30 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "37.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "37.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625659,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL784466",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 60 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "60.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "60.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625660,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL872540",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 120 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "26.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "26.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625661,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL785133",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 180 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "18.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "18.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 625662,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL784465",
              "assay_description": "% inhibition of acetic acid-induced writhing in rat at 30 mg/kg peroral dose, 360 min postdose(5 rats per compound at each time)",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000201",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1128726",
              "document_journal": "J Med Chem",
              "document_year": 1995,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": null,
              "potential_duplicate": 0,
              "qudt_units": "http://qudt.org/vocab/unit#Percent",
              "record_id": 32799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "Inhibition",
              "standard_units": "%",
              "standard_upper_value": null,
              "standard_value": "0.0",
              "target_chembl_id": "CHEMBL376",
              "target_organism": "Rattus norvegicus",
              "target_pref_name": "Rattus norvegicus",
              "target_tax_id": "10116",
              "text_value": null,
              "toid": null,
              "type": "Inhibition",
              "units": "%",
              "uo_units": "UO_0000187",
              "upper_value": null,
              "value": "0.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 634989,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL700472",
              "assay_description": "Inhibition of adenosine diphosphate (ADP) induced human platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124160",
              "document_journal": "J Med Chem",
              "document_year": 1988,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.23",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 50799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "59000.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "59.0"
            },
            {
              "action_type": null,
              "activity_comment": null,
              "activity_id": 634990,
              "activity_properties": [],
              "assay_chembl_id": "CHEMBL700475",
              "assay_description": "Inhibition of arachidonic acid (AA) induced human platelet aggregation",
              "assay_type": "F",
              "assay_variant_accession": null,
              "assay_variant_mutation": null,
              "bao_endpoint": "BAO_0000190",
              "bao_format": "BAO_0000218",
              "bao_label": "organism-based format",
              "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "data_validity_comment": null,
              "data_validity_description": null,
              "document_chembl_id": "CHEMBL1124160",
              "document_journal": "J Med Chem",
              "document_year": 1988,
              "ligand_efficiency": null,
              "molecule_chembl_id": "CHEMBL25",
              "molecule_pref_name": "ASPIRIN",
              "parent_molecule_chembl_id": "CHEMBL25",
              "pchembl_value": "4.05",
              "potential_duplicate": 0,
              "qudt_units": "http://www.openphacts.org/units/Nanomolar",
              "record_id": 50799,
              "relation": "=",
              "src_id": 1,
              "standard_flag": 1,
              "standard_relation": "=",
              "standard_text_value": null,
              "standard_type": "IC50",
              "standard_units": "nM",
              "standard_upper_value": null,
              "standard_value": "89000.0",
              "target_chembl_id": "CHEMBL372",
              "target_organism": "Homo sapiens",
              "target_pref_name": "Homo sapiens",
              "target_tax_id": "9606",
              "text_value": null,
              "toid": null,
              "type": "IC50",
              "units": "uM",
              "uo_units": "UO_0000065",
              "upper_value": null,
              "value": "89.0"
            }
          ]
        },
        "error": null
      },
      "metadata": {
        "name": "chembl",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "max_activities": 100
        }
      }
    },
    {
      "adapter": "chemspider",
      "status": "success",
      "error": null,
      "execution_time": 0.997269,
      "data": {
        "success": false,
        "data": null,
        "error": "Failed to search ChemSpider for smiles: CC(=O)Oc1ccccc1C(=O)O"
      },
      "metadata": {
        "name": "chemspider",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "max_results": 10
        }
      }
    },
    {
      "adapter": "drugcentral",
      "status": "success",
      "error": null,
      "execution_time": 15.236699,
      "data": {
        "success": true,
        "data": {
          "drugs": [
            {
              "drug_id": "CHEMBL25",
              "name": "ASPIRIN",
              "generic_name": "ASPIRIN",
              "synonyms": [
                "8-hour bayer",
                "Acetosalic acid",
                "Acetylsalic acid",
                "Acetyl salicylate",
                "Acetylsalicylic acid",
                "Acetylsalicylic acid",
                "Acetylsalicylic acid (who-ip)",
                "Acetylsalicylicum acidum",
                "Acidum acetylsalicylicum",
                "Acidum acetylsalicylicum (who-ip)"
              ],
              "smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "inchikey": "BSYNRYMUTXBXSQ-UHFFFAOYSA-N",
              "max_phase": "4.0",
              "first_approval": 1950,
              "therapeutic_flag": true,
              "source": "chembl/drugcentral",
              "targets": [
                {
                  "target_chembl_id": "CHEMBL3253",
                  "target_name": "Albumin",
                  "organism": "Homo sapiens",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL376",
                  "target_name": "Rattus norvegicus",
                  "organism": "Rattus norvegicus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL612545",
                  "target_name": "Unchecked",
                  "organism": null,
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL230",
                  "target_name": "Prostaglandin G/H synthase 2",
                  "organism": "Homo sapiens",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL2949",
                  "target_name": "Prostaglandin G/H synthase 1",
                  "organism": "Ovis aries",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL2094253",
                  "target_name": "Cyclooxygenase",
                  "organism": "Homo sapiens",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL375",
                  "target_name": "Mus musculus",
                  "organism": "Mus musculus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL372",
                  "target_name": "Homo sapiens",
                  "organism": "Homo sapiens",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL612884",
                  "target_name": "Trichomonas vaginalis",
                  "organism": "Trichomonas vaginalis",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL374",
                  "target_name": "Oryctolagus cuniculus",
                  "organism": "Oryctolagus cuniculus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL2362975",
                  "target_name": "No relevant target",
                  "organism": null,
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL2096674",
                  "target_name": "Cyclooxygenase",
                  "organism": "Bos taurus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL369",
                  "target_name": "Cavia porcellus",
                  "organism": "Cavia porcellus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL2093869",
                  "target_name": "Integrin alpha-IIb/beta-3",
                  "organism": "Homo sapiens",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL613490",
                  "target_name": "Mus sp.",
                  "organism": "Mus sp.",
                  "target_type": null
                }
              ],
              "num_targets": 15,
              "indications": [
                {
                  "disease": "Atrial Fibrillation",
                  "mesh_id": "D001281",
                  "efo_id": "EFO:0000275",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Duodenal Ulcer",
                  "mesh_id": "D004381",
                  "efo_id": "EFO:0004607",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Fever",
                  "mesh_id": "D005334",
                  "efo_id": "HP:0001945",
                  "max_phase": "4.0"
                },
                {
                  "disease": "Hypertension",
                  "mesh_id": "D006973",
                  "efo_id": "EFO:0000537",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Peripheral Arterial Disease",
                  "mesh_id": "D058729",
                  "efo_id": "EFO:0004265",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Infertility",
                  "mesh_id": "D007246",
                  "efo_id": "EFO:0000545",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Stroke",
                  "mesh_id": "D020521",
                  "efo_id": "EFO:0000712",
                  "max_phase": "4.0"
                },
                {
                  "disease": "Pain",
                  "mesh_id": "D010146",
                  "efo_id": "EFO:0003843",
                  "max_phase": "4.0"
                },
                {
                  "disease": "Pre-Eclampsia",
                  "mesh_id": "D011225",
                  "efo_id": "EFO:0000668",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Carcinoma, Squamous Cell",
                  "mesh_id": "D002294",
                  "efo_id": "EFO:0000707",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Cardiovascular Diseases",
                  "mesh_id": "D002318",
                  "efo_id": "EFO:0000319",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Psychotic Disorders",
                  "mesh_id": "D011618",
                  "efo_id": "EFO:0005407",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Heart Failure",
                  "mesh_id": "D006333",
                  "efo_id": "EFO:0003144",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Hypertension, Pulmonary",
                  "mesh_id": "D006976",
                  "efo_id": "EFO:0001361",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Acute Lung Injury",
                  "mesh_id": "D055371",
                  "efo_id": "EFO:0004610",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Glioblastoma",
                  "mesh_id": "D005909",
                  "efo_id": "EFO:0000519",
                  "max_phase": "2.0"
                },
                {
                  "disease": "HIV Infections",
                  "mesh_id": "D015658",
                  "efo_id": "EFO:0000764",
                  "max_phase": "2.0"
                },
                {
                  "disease": "HIV Infections",
                  "mesh_id": "D015658",
                  "efo_id": "EFO:0000180",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Atherosclerosis",
                  "mesh_id": "D050197",
                  "efo_id": "EFO:0003914",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Venous Thromboembolism",
                  "mesh_id": "D054556",
                  "efo_id": "EFO:0004286",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Pulmonary Disease, Chronic Obstructive",
                  "mesh_id": "D029424",
                  "efo_id": "EFO:0000341",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Respiratory Distress Syndrome",
                  "mesh_id": "D012128",
                  "efo_id": "EFO:1000637",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Thrombosis",
                  "mesh_id": "D013927",
                  "efo_id": "HP:0004419",
                  "max_phase": "4.0"
                },
                {
                  "disease": "Breast Neoplasms",
                  "mesh_id": "D001943",
                  "efo_id": "EFO:0003869",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Prostatic Neoplasms",
                  "mesh_id": "D011471",
                  "efo_id": "EFO:0001663",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Carcinoma, Non-Small-Cell Lung",
                  "mesh_id": "D002289",
                  "efo_id": "EFO:0003060",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Pneumonia",
                  "mesh_id": "D011014",
                  "efo_id": "EFO:0003106",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Wounds and Injuries",
                  "mesh_id": "D014947",
                  "efo_id": "EFO:0000546",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Renal Insufficiency, Chronic",
                  "mesh_id": "D051436",
                  "efo_id": "EFO:0003884",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Ischemia",
                  "mesh_id": "D007511",
                  "efo_id": "EFO:0000556",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Acute Coronary Syndrome",
                  "mesh_id": "D054058",
                  "efo_id": "EFO:0005672",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Venous Thrombosis",
                  "mesh_id": "D020246",
                  "efo_id": "HP:0004936",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Heart Diseases",
                  "mesh_id": "D006331",
                  "efo_id": "EFO:0003777",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Sleep Initiation and Maintenance Disorders",
                  "mesh_id": "D007319",
                  "efo_id": "EFO:0004698",
                  "max_phase": "0.5"
                },
                {
                  "disease": "Diabetes Mellitus",
                  "mesh_id": "D003920",
                  "efo_id": "EFO:0000400",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Cardiomyopathy, Hypertrophic",
                  "mesh_id": "D002312",
                  "efo_id": "EFO:0000538",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Polycythemia Vera",
                  "mesh_id": "D011087",
                  "efo_id": "EFO:0002429",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Neoplasms",
                  "mesh_id": "D009369",
                  "efo_id": "EFO:0000616",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Barrett Esophagus",
                  "mesh_id": "D001471",
                  "efo_id": "EFO:0000280",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Vascular Diseases",
                  "mesh_id": "D014652",
                  "efo_id": "EFO:0004264",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Myocardial Infarction",
                  "mesh_id": "D009203",
                  "efo_id": "EFO:0000612",
                  "max_phase": "4.0"
                },
                {
                  "disease": "Abortion, Habitual",
                  "mesh_id": "D000026",
                  "efo_id": "EFO:1000954",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Pregnancy",
                  "mesh_id": "D011247",
                  "efo_id": "EFO:0002950",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Retinal Vein Occlusion",
                  "mesh_id": "D012170",
                  "efo_id": "EFO:1001157",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Adenoma",
                  "mesh_id": "D000236",
                  "efo_id": "EFO:0005406",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Tobacco Use Disorder",
                  "mesh_id": "D014029",
                  "efo_id": "EFO:0003768",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Angina, Stable",
                  "mesh_id": "D060050",
                  "efo_id": "EFO:0003913",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Carcinoma, Hepatocellular",
                  "mesh_id": "D006528",
                  "efo_id": "EFO:0000182",
                  "max_phase": "3.0"
                },
                {
                  "disease": "Metabolic Syndrome",
                  "mesh_id": "D024821",
                  "efo_id": "EFO:0000195",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Aortic Valve Stenosis",
                  "mesh_id": "D001024",
                  "efo_id": "EFO:0000266",
                  "max_phase": "3.0"
                }
              ],
              "num_indications": 50,
              "pharmacology": {
                "mechanism_of_action": "Cyclooxygenase inhibitor",
                "action_type": "INHIBITOR",
                "mechanisms": [
                  {
                    "action_type": "INHIBITOR",
                    "binding_site_comment": null,
                    "direct_interaction": 1,
                    "disease_efficacy": 1,
                    "max_phase": 4,
                    "mec_id": 1187,
                    "mechanism_comment": null,
                    "mechanism_of_action": "Cyclooxygenase inhibitor",
                    "mechanism_refs": [
                      {
                        "ref_id": "17131625",
                        "ref_type": "PubMed",
                        "ref_url": "http://europepmc.org/abstract/MED/17131625"
                      },
                      {
                        "ref_id": "17258197",
                        "ref_type": "PubMed",
                        "ref_url": "http://europepmc.org/abstract/MED/17258197"
                      },
                      {
                        "ref_id": "Aspirin#Mechanism_of_action",
                        "ref_type": "Wikipedia",
                        "ref_url": "http://en.wikipedia.org/wiki/Aspirin#Mechanism_of_action"
                      }
                    ],
                    "molecular_mechanism": 1,
                    "molecule_chembl_id": "CHEMBL25",
                    "parent_molecule_chembl_id": "CHEMBL25",
                    "record_id": 1343081,
                    "selectivity_comment": null,
                    "site_id": null,
                    "target_chembl_id": "CHEMBL2094253",
                    "variant_sequence": null
                  }
                ]
              },
              "properties": {
                "molecular_weight": "180.16",
                "alogp": "1.31",
                "psa": "63.60",
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "aromatic_rings": 1,
                "qed_weighted": "0.55",
                "ro5_violations": 0
              }
            },
            {
              "drug_id": "CHEMBL5314595",
              "name": "ASPIRIN TRELAMINE",
              "generic_name": "ASPIRIN TRELAMINE",
              "synonyms": [
                "Aspirin trelamine",
                "Aspirin trelamine",
                "Edan",
                "TF-0023",
                "TF0023",
                "X-0023",
                "X0023"
              ],
              "smiles": "CCN(CC)CCOC(=O)c1ccccc1OC(C)=O",
              "inchikey": "GHIVDTCFLFLOBV-UHFFFAOYSA-N",
              "max_phase": "2.0",
              "first_approval": null,
              "therapeutic_flag": false,
              "source": "chembl/drugcentral",
              "targets": [],
              "num_targets": 0,
              "indications": [
                {
                  "disease": "Cardiovascular Diseases",
                  "mesh_id": "D002318",
                  "efo_id": "EFO:0000319",
                  "max_phase": "1.0"
                },
                {
                  "disease": "Fever",
                  "mesh_id": "D005334",
                  "efo_id": "HP:0001945",
                  "max_phase": "1.0"
                },
                {
                  "disease": "Inflammation",
                  "mesh_id": "D007249",
                  "efo_id": "MP:0001845",
                  "max_phase": "1.0"
                },
                {
                  "disease": "Analgesia",
                  "mesh_id": "D000698",
                  "efo_id": "EFO:1001484",
                  "max_phase": "1.0"
                },
                {
                  "disease": "Ischemic Stroke",
                  "mesh_id": "D000083242",
                  "efo_id": "HP:0002140",
                  "max_phase": "2.0"
                },
                {
                  "disease": "Severe Acute Respiratory Syndrome",
                  "mesh_id": "D045169",
                  "efo_id": "MONDO:0100096",
                  "max_phase": "2.0"
                }
              ],
              "num_indications": 6,
              "pharmacology": {
                "mechanism_of_action": null,
                "action_type": null,
                "mechanisms": []
              },
              "properties": {
                "molecular_weight": "279.34",
                "alogp": "2.11",
                "psa": "55.84",
                "hbd": 0,
                "hba": 5,
                "rotatable_bonds": 7,
                "aromatic_rings": 1,
                "qed_weighted": "0.56",
                "ro5_violations": 0
              }
            },
            {
              "drug_id": "CHEMBL5282669",
              "name": null,
              "generic_name": null,
              "synonyms": [],
              "smiles": "CC(=O)Oc1ccccc1C(C)=O",
              "inchikey": "WWEDAIJJBDFOOK-UHFFFAOYSA-N",
              "max_phase": null,
              "first_approval": null,
              "therapeutic_flag": false,
              "source": "chembl/drugcentral",
              "targets": [
                {
                  "target_chembl_id": "CHEMBL375",
                  "target_name": "Mus musculus",
                  "organism": "Mus musculus",
                  "target_type": null
                }
              ],
              "num_targets": 1,
              "indications": [],
              "num_indications": 0,
              "pharmacology": {
                "mechanism_of_action": null,
                "action_type": null,
                "mechanisms": []
              },
              "properties": {
                "molecular_weight": "178.19",
                "alogp": "1.81",
                "psa": "43.37",
                "hbd": 0,
                "hba": 3,
                "rotatable_bonds": 2,
                "aromatic_rings": 1,
                "qed_weighted": "0.39",
                "ro5_violations": 0
              }
            },
            {
              "drug_id": "CHEMBL1697753",
              "name": "ASPIRIN DL-LYSINE",
              "generic_name": "ASPIRIN DL-LYSINE",
              "synonyms": [
                "Acetylsalicylate lysine",
                "Acetylsalicylic acid lysinate",
                "Aspegic",
                "Aspidol",
                "Aspirin dl-lysine",
                "Aspirin lysine",
                "Aspirisine",
                "Dl-lysine acetylsalicylate",
                "Dl-lysine-acetylsalicylate",
                "Egicalm"
              ],
              "smiles": "CC(=O)Oc1ccccc1C(=O)O.NCCCCC(N)C(=O)O",
              "inchikey": "JJBCTCGUOQYZHK-UHFFFAOYSA-N",
              "max_phase": "3.0",
              "first_approval": null,
              "therapeutic_flag": false,
              "source": "chembl/drugcentral",
              "targets": [
                {
                  "target_chembl_id": "CHEMBL1697861",
                  "target_name": "Hepatotoxicity",
                  "organism": null,
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL375",
                  "target_name": "Mus musculus",
                  "organism": "Mus musculus",
                  "target_type": null
                }
              ],
              "num_targets": 2,
              "indications": [
                {
                  "disease": "Aortic Valve Stenosis",
                  "mesh_id": "D001024",
                  "efo_id": "EFO:0000266",
                  "max_phase": "3.0"
                }
              ],
              "num_indications": 1,
              "pharmacology": {
                "mechanism_of_action": null,
                "action_type": null,
                "mechanisms": []
              },
              "properties": {
                "molecular_weight": "326.35",
                "alogp": "1.31",
                "psa": "63.60",
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "aromatic_rings": 1,
                "qed_weighted": "0.55",
                "ro5_violations": 0
              }
            },
            {
              "drug_id": "CHEMBL2260549",
              "name": "ASPIRIN EUGENOL ESTER",
              "generic_name": "ASPIRIN EUGENOL ESTER",
              "synonyms": [],
              "smiles": "C=CCc1ccc(OC(=O)c2ccccc2OC(C)=O)c(OC)c1",
              "inchikey": "PVMKDHNAJBHURS-UHFFFAOYSA-N",
              "max_phase": null,
              "first_approval": null,
              "therapeutic_flag": false,
              "source": "chembl/drugcentral",
              "targets": [
                {
                  "target_chembl_id": "CHEMBL375",
                  "target_name": "Mus musculus",
                  "organism": "Mus musculus",
                  "target_type": null
                },
                {
                  "target_chembl_id": "CHEMBL376",
                  "target_name": "Rattus norvegicus",
                  "organism": "Rattus norvegicus",
                  "target_type": null
                }
              ],
              "num_targets": 2,
              "indications": [],
              "num_indications": 0,
              "pharmacology": {
                "mechanism_of_action": null,
                "action_type": null,
                "mechanisms": []
              },
              "properties": {
                "molecular_weight": "326.35",
                "alogp": "3.57",
                "psa": "61.83",
                "hbd": 0,
                "hba": 5,
                "rotatable_bonds": 6,
                "aromatic_rings": 2,
                "qed_weighted": "0.46",
                "ro5_violations": 0
              }
            }
          ],
          "total_found": 10
        },
        "error": null
      },
      "metadata": {
        "name": "drugcentral",
        "type": "api",
        "version": "3.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "max_retries": 3
        }
      }
    },
    {
      "adapter": "zinc_fragments",
      "status": "success",
      "error": null,
      "execution_time": 1.492643,
      "data": {
        "success": true,
        "data": {
          "query_smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "search_type": "similarity",
          "num_results": 4,
          "num_total": 9,
          "fragments": [
            {
              "atc_classifications": [
                "B01AC06",
                "N02BA01",
                "N02BA51",
                "A01AD05",
                "N02BA71"
              ],
              "availability_type": 2,
              "biotherapeutic": null,
              "black_box_warning": 0,
              "chemical_probe": 0,
              "chirality": 2,
              "cross_references": [
                {
                  "xref_id": "aspirin",
                  "xref_name": "aspirin",
                  "xref_src": "DailyMed"
                }
              ],
              "dosed_ingredient": true,
              "first_approval": 1950,
              "first_in_class": 0,
              "helm_notation": null,
              "inorganic_flag": 0,
              "max_phase": "4.0",
              "molecule_chembl_id": "CHEMBL25",
              "molecule_hierarchy": {
                "active_chembl_id": "CHEMBL25",
                "molecule_chembl_id": "CHEMBL25",
                "parent_chembl_id": "CHEMBL25"
              },
              "molecule_properties": {
                "alogp": "1.31",
                "aromatic_rings": 1,
                "full_molformula": "C9H8O4",
                "full_mwt": "180.16",
                "hba": 3,
                "hbd": 1,
                "heavy_atoms": 13,
                "mw_freebase": "180.16",
                "np_likeness_score": "0.12",
                "num_ro5_violations": 0,
                "psa": "63.60",
                "qed_weighted": "0.55",
                "ro3_pass": "N",
                "rtb": 2
              },
              "molecule_structures": {
                "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
                "molfile": "\n     RDKit          2D\n\n 13 13  0  0  0  0  0  0  0  0999 V2000\n   19.8052   -4.2758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.8040   -5.0953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.5121   -5.5043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2217   -5.0948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2189   -4.2722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.5103   -3.8669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.5078   -3.0497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2143   -2.6390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.7989   -2.6432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   21.9250   -3.8609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   22.6343   -4.2668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   23.3405   -3.8556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   22.6374   -5.0840    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  2  0\n  2  3  1  0\n  3  4  2  0\n  4  5  1  0\n  5  6  2  0\n  6  1  1  0\n  6  7  1  0\n  7  8  1  0\n  7  9  2  0\n  5 10  1  0\n 10 11  1  0\n 11 12  1  0\n 11 13  2  0\nM  END\n> <chembl_id>\nCHEMBL25\n\n> <chembl_pref_name>\nASPIRIN",
                "standard_inchi": "InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",
                "standard_inchi_key": "BSYNRYMUTXBXSQ-UHFFFAOYSA-N"
              },
              "molecule_type": "Small molecule",
              "natural_product": 1,
              "oral": true,
              "orphan": 0,
              "parenteral": false,
              "polymer_flag": 0,
              "pref_name": "ASPIRIN",
              "prodrug": 0,
              "similarity": "100",
              "structure_type": "MOL",
              "therapeutic_flag": true,
              "topical": false,
              "usan_stem": null,
              "usan_stem_definition": null,
              "usan_substem": null,
              "usan_year": null,
              "veterinary": 0,
              "withdrawn_flag": false
            },
            {
              "atc_classifications": [],
              "availability_type": -1,
              "biotherapeutic": null,
              "black_box_warning": 0,
              "chemical_probe": 0,
              "chirality": -1,
              "cross_references": [],
              "dosed_ingredient": false,
              "first_approval": null,
              "first_in_class": -1,
              "helm_notation": null,
              "inorganic_flag": -1,
              "max_phase": null,
              "molecule_chembl_id": "CHEMBL5282669",
              "molecule_hierarchy": {
                "active_chembl_id": "CHEMBL5282669",
                "molecule_chembl_id": "CHEMBL5282669",
                "parent_chembl_id": "CHEMBL5282669"
              },
              "molecule_properties": {
                "alogp": "1.81",
                "aromatic_rings": 1,
                "full_molformula": "C10H10O3",
                "full_mwt": "178.19",
                "hba": 3,
                "hbd": 0,
                "heavy_atoms": 13,
                "mw_freebase": "178.19",
                "np_likeness_score": "-0.10",
                "num_ro5_violations": 0,
                "psa": "43.37",
                "qed_weighted": "0.39",
                "ro3_pass": "Y",
                "rtb": 2
              },
              "molecule_structures": {
                "canonical_smiles": "CC(=O)Oc1ccccc1C(C)=O",
                "molfile": " \n     RDKit          2D\n\n 13 13  0  0  0  0  0  0  0  0999 V2000\n    1.0026   -0.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2876    0.1650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.4296   -0.2451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.1423    0.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7153    0.1650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2876    0.9900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7153    0.9900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0026    1.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.8582   -0.2403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.1395    0.9945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.0031   -1.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.2889   -1.4854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.7179   -1.4845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0\n  3  2  1  0\n  4  3  1  0\n  5  1  1  0\n  6  2  1  0\n  7  5  2  0\n  8  7  1  0\n  6  8  2  0\n  4 10  1  0\n  4  9  2  0\n  1 11  1  0\n 11 12  1  0\n 11 13  2  0\nM  END\n> <chembl_id>\nCHEMBL5282669\n\n> <chembl_pref_name>\nNone",
                "standard_inchi": "InChI=1S/C10H10O3/c1-7(11)9-5-3-4-6-10(9)13-8(2)12/h3-6H,1-2H3",
                "standard_inchi_key": "WWEDAIJJBDFOOK-UHFFFAOYSA-N"
              },
              "molecule_type": null,
              "natural_product": 0,
              "oral": false,
              "orphan": -1,
              "parenteral": false,
              "polymer_flag": 0,
              "pref_name": null,
              "prodrug": -1,
              "similarity": "74.0740716457366943359375",
              "structure_type": "MOL",
              "therapeutic_flag": false,
              "topical": false,
              "usan_stem": null,
              "usan_stem_definition": null,
              "usan_substem": null,
              "usan_year": null,
              "veterinary": -1,
              "withdrawn_flag": false
            },
            {
              "atc_classifications": [],
              "availability_type": -1,
              "biotherapeutic": null,
              "black_box_warning": 0,
              "chemical_probe": 0,
              "chirality": -1,
              "cross_references": [],
              "dosed_ingredient": false,
              "first_approval": null,
              "first_in_class": -1,
              "helm_notation": null,
              "inorganic_flag": -1,
              "max_phase": null,
              "molecule_chembl_id": "CHEMBL4515737",
              "molecule_hierarchy": {
                "active_chembl_id": "CHEMBL4515737",
                "molecule_chembl_id": "CHEMBL4515737",
                "parent_chembl_id": "CHEMBL4515737"
              },
              "molecule_properties": {
                "alogp": "1.44",
                "aromatic_rings": 1,
                "full_molformula": "C8H6O5",
                "full_mwt": "182.13",
                "hba": 3,
                "hbd": 2,
                "heavy_atoms": 13,
                "mw_freebase": "182.13",
                "np_likeness_score": "0.05",
                "num_ro5_violations": 0,
                "psa": "83.83",
                "qed_weighted": "0.53",
                "ro3_pass": "N",
                "rtb": 2
              },
              "molecule_structures": {
                "canonical_smiles": "O=C(O)Oc1ccccc1C(=O)O",
                "molfile": " \n     RDKit          2D\n\n 13 13  0  0  0  0  0  0  0  0999 V2000\n   34.4754   -5.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.1932   -4.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.9028   -5.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.9028   -6.0608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.1916   -6.4705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   34.4754   -6.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.1932   -3.9991    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   35.9067   -3.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   35.9067   -2.7582    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   36.6204   -3.9991    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   33.7619   -4.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   33.7619   -3.9987    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   33.0482   -5.2354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0\n  3  2  1  0\n  4  3  2  0\n  5  4  1  0\n  6  5  2  0\n  1  6  1  0\n  2  7  1  0\n  7  8  1  0\n  8  9  2  0\n  8 10  1  0\n 11  1  1  0\n 11 12  1  0\n 11 13  2  0\nM  END\n> <chembl_id>\nCHEMBL4515737\n\n> <chembl_pref_name>\nNone",
                "standard_inchi": "InChI=1S/C8H6O5/c9-7(10)5-3-1-2-4-6(5)13-8(11)12/h1-4H,(H,9,10)(H,11,12)",
                "standard_inchi_key": "CLTAZWADHDXZQR-UHFFFAOYSA-N"
              },
              "molecule_type": "Unknown",
              "natural_product": 0,
              "oral": false,
              "orphan": -1,
              "parenteral": false,
              "polymer_flag": 0,
              "pref_name": null,
              "prodrug": -1,
              "similarity": "70.3703701496124267578125",
              "structure_type": "MOL",
              "therapeutic_flag": false,
              "topical": false,
              "usan_stem": null,
              "usan_stem_definition": null,
              "usan_substem": null,
              "usan_year": null,
              "veterinary": -1,
              "withdrawn_flag": false
            },
            {
              "atc_classifications": [
                "N02BA09",
                "N02BA59",
                "N02BA79"
              ],
              "availability_type": null,
              "biotherapeutic": null,
              "black_box_warning": 0,
              "chemical_probe": 0,
              "chirality": 2,
              "cross_references": [],
              "dosed_ingredient": false,
              "first_approval": null,
              "first_in_class": 0,
              "helm_notation": null,
              "inorganic_flag": 0,
              "max_phase": "2.0",
              "molecule_chembl_id": "CHEMBL1451173",
              "molecule_hierarchy": {
                "active_chembl_id": "CHEMBL1451173",
                "molecule_chembl_id": "CHEMBL1451173",
                "parent_chembl_id": "CHEMBL1451173"
              },
              "molecule_properties": {
                "alogp": "1.24",
                "aromatic_rings": 1,
                "full_molformula": "C11H10O6",
                "full_mwt": "238.19",
                "hba": 5,
                "hbd": 1,
                "heavy_atoms": 17,
                "mw_freebase": "238.19",
                "np_likeness_score": "0.42",
                "num_ro5_violations": 0,
                "psa": "89.90",
                "qed_weighted": "0.63",
                "ro3_pass": "N",
                "rtb": 3
              },
              "molecule_structures": {
                "canonical_smiles": "CC(=O)Oc1cccc(C(=O)O)c1OC(C)=O",
                "molfile": "\n     RDKit          2D\n\n 17 17  0  0  0  0  0  0  0  0999 V2000\n    1.8167   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6375   -0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0000   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.5083   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6375    0.9000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.6875   -0.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.5000    1.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.8625   -1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.1917   -1.1000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.6000    2.9458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -4.0833   -0.5292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0000    0.9250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8292   -2.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.5083   -2.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.6542   -3.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.9458   -2.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.7208    0.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0\n  3  1  1  0\n  4  2  1  0\n  5  2  1  0\n  6  4  1  0\n  7  5  1  0\n  8  6  1  0\n  9  3  2  0\n 10  7  2  0\n 11  8  2  0\n 12  3  1  0\n 13  1  1  0\n 14 15  1  0\n 15 13  2  0\n 16  8  1  0\n 17  7  1  0\n  4 14  2  0\nM  END\n> <chembl_id>\nCHEMBL1451173\n\n> <chembl_pref_name>\nDIPYROCETYL",
                "standard_inchi": "InChI=1S/C11H10O6/c1-6(12)16-9-5-3-4-8(11(14)15)10(9)17-7(2)13/h3-5H,1-2H3,(H,14,15)",
                "standard_inchi_key": "NYIZXMGNIUSNKL-UHFFFAOYSA-N"
              },
              "molecule_type": "Small molecule",
              "natural_product": 1,
              "oral": false,
              "orphan": 0,
              "parenteral": false,
              "polymer_flag": 0,
              "pref_name": "DIPYROCETYL",
              "prodrug": 0,
              "similarity": "69.9999988079071044921875",
              "structure_type": "MOL",
              "therapeutic_flag": false,
              "topical": false,
              "usan_stem": null,
              "usan_stem_definition": null,
              "usan_substem": null,
              "usan_year": null,
              "veterinary": 0,
              "withdrawn_flag": false
            }
          ],
          "filters_applied": {
            "mw_max": 300,
            "logp_max": null,
            "hbd_max": null,
            "hba_max": null
          }
        },
        "error": null
      },
      "metadata": {
        "name": "zinc_fragments",
        "type": "api",
        "version": "3.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "default_similarity": 70,
          "max_results": 100,
          "fragment_mw_max": 300,
          "max_retries": 3,
          "backoff_base": 2
        }
      }
    },
    {
      "adapter": "surechembl",
      "status": "success",
      "error": null,
      "execution_time": 1.588261,
      "data": {
        "success": true,
        "data": {
          "query_smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "search_type": "similarity",
          "mode": "structure_search",
          "num_patents": 0,
          "num_compounds": 0,
          "patent_families": [],
          "date_range": null,
          "top_applicants": [],
          "patents": []
        },
        "error": null
      },
      "metadata": {
        "name": "surechembl",
        "type": "api",
        "version": "2.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 90,
          "default_similarity": 0.8,
          "max_results": 50,
          "max_retries": 3,
          "use_chembl_fallback": true
        }
      }
    },
    {
      "adapter": "coconut",
      "status": "success",
      "error": null,
      "execution_time": 1.420709,
      "data": {
        "success": true,
        "data": {
          "results": [],
          "num_results": 0,
          "query_type": "smiles",
          "query": "CC(=O)Oc1ccccc1C(=O)O",
          "warnings": [
            "No natural products found for smiles: CC(=O)Oc1ccccc1C(=O)O"
          ]
        },
        "error": null
      },
      "metadata": {
        "name": "coconut",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "max_results": 50,
          "default_similarity_threshold": 0.8
        }
      }
    },
    {
      "adapter": "opentargets",
      "status": "timeout",
      "error": "Execution timed out after 30 seconds",
      "execution_time": 30.002137,
      "data": null,
      "metadata": {
        "name": "opentargets",
        "type": "api",
        "version": "1.2.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.1,
          "timeout": 60,
          "max_results": 50,
          "max_retries": 3,
          "retry_delay": 1.0
        }
      }
    },
    {
      "adapter": "disgenet",
      "status": "success",
      "error": null,
      "execution_time": 2.418527,
      "data": {
        "success": false,
        "data": null,
        "error": "Failed to fetch data from DisGeNET (may require API key)"
      },
      "metadata": {
        "name": "disgenet",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 60,
          "max_results": 100
        }
      }
    },
    {
      "adapter": "uniprot",
      "status": "success",
      "error": null,
      "execution_time": 0.859667,
      "data": {
        "success": true,
        "data": {
          "accession": "P00533",
          "entry_name": "EGFR_HUMAN",
          "gene_names": [
            "EGFR"
          ],
          "protein_name": "Epidermal growth factor receptor",
          "organism": "Homo sapiens",
          "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
          "sequence_length": 1210,
          "molecular_weight": 134277,
          "function": [
            "Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). Plays a role in mammalian pain signaling (long-lasting hypersensitivity) (By similarity)",
            "Isoform 2 may act as an antagonist of EGF action",
            "(Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins"
          ],
          "subcellular_location": [
            "Cell membrane",
            "Endoplasmic reticulum membrane",
            "Golgi apparatus membrane",
            "Nucleus membrane",
            "Endosome",
            "Endosome membrane",
            "Nucleus",
            "Secreted"
          ],
          "disease_associations": [
            "Lung cancer",
            "Neonatal nephrocutaneous inflammatory syndrome"
          ],
          "post_translational_modifications": [
            "Phosphorylated on Tyr residues in response to EGF (PubMed:20462955, PubMed:27153536). Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2",
            "Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting (PubMed:27153536). Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126 (By similarity). Ubiquitinated by ZNRF1 or CBL at different lysines in response to EGF stimulation; leading to recruitment of the ESCRT machinery and subsequent degradation in the lysosomes (PubMed:33996800). Deubiquitinated by UCHL1 leading to the inhibition of its degradation (By similarity)",
            "Palmitoylated on Cys residues by ZDHHC20. Palmitoylation inhibits internalization after ligand binding, and increases the persistence of tyrosine-phosphorylated EGFR at the cell membrane. Palmitoylation increases the amplitude and duration of EGFR signaling",
            "Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197"
          ],
          "domains": [
            "Protein kinase"
          ],
          "active_sites": [
            "Proton acceptor"
          ],
          "binding_sites": [],
          "modifications": [
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphothreonine; by PKC and PKD/PRKD1",
            "Modified residue: Phosphothreonine; by PKD/PRKD1",
            "Modified residue: Phosphoserine",
            "Modified residue: N6-(2-hydroxyisobutyryl)lysine",
            "Modified residue: Phosphotyrosine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphothreonine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphotyrosine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Phosphoserine",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Phosphotyrosine; by autocatalysis",
            "Modified residue: Omega-N-methylarginine",
            "Glycosylation: N-linked (GlcNAc...) (complex) asparagine; atypical; partial",
            "Glycosylation: N-linked (GlcNAc...) asparagine; atypical",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine",
            "Glycosylation: N-linked (GlcNAc...) asparagine; partial",
            "Glycosylation: N-linked (GlcNAc...) asparagine; partial",
            "Glycosylation: N-linked (GlcNAc...) (high mannose) asparagine"
          ],
          "pdb_structures": [
            "1IVO",
            "1M14",
            "1M17",
            "1MOX",
            "1NQL",
            "1XKK",
            "1YY9",
            "1Z9I",
            "2EB2",
            "2EB3",
            "2GS2",
            "2GS6",
            "2GS7",
            "2ITN",
            "2ITO",
            "2ITP",
            "2ITQ",
            "2ITT",
            "2ITU",
            "2ITV",
            "2ITW",
            "2ITX",
            "2ITY",
            "2ITZ",
            "2J5E",
            "2J5F",
            "2J6M",
            "2JIT",
            "2JIU",
            "2JIV",
            "2KS1",
            "2M0B",
            "2M20",
            "2N5S",
            "2RF9",
            "2RFD",
            "2RFE",
            "2RGP",
            "3B2U",
            "3B2V",
            "3BEL",
            "3BUO",
            "3C09",
            "3G5V",
            "3G5Y",
            "3GOP",
            "3GT8",
            "3IKA",
            "3LZB",
            "3NJP",
            "3OB2",
            "3OP0",
            "3P0Y",
            "3PFV",
            "3POZ",
            "3QWQ",
            "3UG1",
            "3UG2",
            "3VJN",
            "3VJO",
            "3VRP",
            "3VRR",
            "3W2O",
            "3W2P",
            "3W2Q",
            "3W2R",
            "3W2S",
            "3W32",
            "3W33",
            "4G5J",
            "4G5P",
            "4HJO",
            "4I1Z",
            "4I20",
            "4I21",
            "4I22",
            "4I23",
            "4I24",
            "4JQ7",
            "4JQ8",
            "4JR3",
            "4JRV",
            "4KRL",
            "4KRM",
            "4KRO",
            "4KRP",
            "4LI5",
            "4LL0",
            "4LQM",
            "4LRM",
            "4R3P",
            "4R3R",
            "4R5S",
            "4RIW",
            "4RIX",
            "4RIY",
            "4RJ4",
            "4RJ5",
            "4RJ6",
            "4RJ7",
            "4RJ8",
            "4TKS",
            "4UIP",
            "4UV7",
            "4WD5",
            "4WKQ",
            "4WRG",
            "4ZAU",
            "4ZJV",
            "4ZSE",
            "5C8K",
            "5C8M",
            "5C8N",
            "5CAL",
            "5CAN",
            "5CAO",
            "5CAP",
            "5CAQ",
            "5CAS",
            "5CAU",
            "5CAV",
            "5CNN",
            "5CNO",
            "5CZH",
            "5CZI",
            "5D41",
            "5EDP",
            "5EDQ",
            "5EDR",
            "5EM5",
            "5EM6",
            "5EM7",
            "5EM8",
            "5FED",
            "5FEE",
            "5FEQ",
            "5GMP",
            "5GNK",
            "5GTY",
            "5GTZ",
            "5HCX",
            "5HCY",
            "5HCZ",
            "5HG5",
            "5HG7",
            "5HG8",
            "5HG9",
            "5HIB",
            "5HIC",
            "5J9Y",
            "5J9Z",
            "5JEB",
            "5LV6",
            "5SX4",
            "5SX5",
            "5U8L",
            "5UG8",
            "5UG9",
            "5UGA",
            "5UGB",
            "5UGC",
            "5UWD",
            "5WB7",
            "5WB8",
            "5X26",
            "5X27",
            "5X28",
            "5X2A",
            "5X2C",
            "5X2F",
            "5X2K",
            "5XDK",
            "5XDL",
            "5XGM",
            "5XGN",
            "5XWD",
            "5Y25",
            "5Y9T",
            "5YU9",
            "5ZTO",
            "5ZWJ",
            "6ARU",
            "6B3S",
            "6D8E",
            "6DUK",
            "6JRJ",
            "6JRK",
            "6JRX",
            "6JWL",
            "6JX0",
            "6JX4",
            "6JXT",
            "6JZ0",
            "6LUB",
            "6LUD",
            "6P1D",
            "6P1L",
            "6P8Q",
            "6S89",
            "6S8A",
            "6S9B",
            "6S9C",
            "6S9D",
            "6TFU",
            "6TFV",
            "6TFW",
            "6TFY",
            "6TFZ",
            "6TG0",
            "6TG1",
            "6V5N",
            "6V5P",
            "6V66",
            "6V6K",
            "6V6O",
            "6VH4",
            "6VHN",
            "6VHP",
            "6WA2",
            "6WAK",
            "6WXN",
            "6XL4",
            "6Z4B",
            "6Z4D",
            "7A2A",
            "7A6I",
            "7A6J",
            "7A6K",
            "7AEI",
            "7AEM",
            "7B85",
            "7ER2",
            "7JXI",
            "7JXK",
            "7JXL",
            "7JXM",
            "7JXP",
            "7JXQ",
            "7JXW",
            "7K1H",
            "7K1I",
            "7KXZ",
            "7KY0",
            "7LEN",
            "7LFR",
            "7LFS",
            "7LG8",
            "7LGS",
            "7LTX",
            "7OM4",
            "7OXB",
            "7SI1",
            "7SYD",
            "7SYE",
            "7SZ0",
            "7SZ1",
            "7SZ5",
            "7SZ7",
            "7T4I",
            "7T4J",
            "7TVD",
            "7U98",
            "7U99",
            "7U9A",
            "7UKV",
            "7UKW",
            "7VRA",
            "7VRE",
            "7ZYM",
            "7ZYN",
            "7ZYP",
            "7ZYQ",
            "8A27",
            "8A2A",
            "8A2B",
            "8A2D",
            "8D73",
            "8D76",
            "8DSW",
            "8EME",
            "8F1H",
            "8F1W",
            "8F1X",
            "8F1Y",
            "8F1Z",
            "8FV3",
            "8FV4",
            "8G63",
            "8GB4",
            "8GK5",
            "8H7X",
            "8HGO",
            "8HGP",
            "8HGS",
            "8HV1",
            "8HV2",
            "8HV3",
            "8HV4",
            "8HV5",
            "8HV6",
            "8HV7",
            "8HV8",
            "8HV9",
            "8HVA",
            "8HY7",
            "8KFQ",
            "8PNZ",
            "8PO0",
            "8PO1",
            "8PO2",
            "8PO3",
            "8PO4",
            "8S1M",
            "8SC7",
            "8TJL",
            "8TO3",
            "8TO4",
            "8UKV",
            "8UKW",
            "8UKX",
            "8WD4",
            "9D3V",
            "9D3W",
            "9EWS",
            "9EWT",
            "9FQP",
            "9FQS",
            "9FRD",
            "9GC4",
            "9GC5",
            "9GC6",
            "9GDV",
            "9H46",
            "9HBO"
          ],
          "alphafold_structures": [
            "P00533"
          ],
          "keywords": [
            "3D-structure",
            "Alternative splicing",
            "ATP-binding",
            "Cell membrane",
            "Developmental protein",
            "Direct protein sequencing",
            "Disease variant",
            "Disulfide bond",
            "Endoplasmic reticulum",
            "Endosome",
            "Glycoprotein",
            "Golgi apparatus",
            "Host cell receptor for virus entry",
            "Host-virus interaction",
            "Hydroxylation",
            "Isopeptide bond",
            "Kinase",
            "Lipoprotein",
            "Membrane",
            "Methylation",
            "Nucleotide-binding",
            "Nucleus",
            "Palmitate",
            "Phosphoprotein",
            "Proteomics identification",
            "Proto-oncogene",
            "Receptor",
            "Reference proteome",
            "Repeat",
            "Secreted",
            "Signal",
            "Transferase",
            "Transmembrane",
            "Transmembrane helix",
            "Tyrosine-protein kinase",
            "Ubl conjugation"
          ]
        },
        "error": null
      },
      "metadata": {
        "name": "uniprot",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.1,
          "timeout": 60,
          "format": "json"
        }
      }
    },
    {
      "adapter": "string_db",
      "status": "success",
      "error": null,
      "execution_time": 2.941498,
      "data": {
        "success": true,
        "data": {
          "interactions": [
            {
              "protein_a": "DCN",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000052754",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 8.3e-05,
                "experimental": 0.000537,
                "database": 0.0009,
                "textmining": 0.000986
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.000812,
                "database": 0.0009,
                "textmining": 0.000998
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.2000000000000004e-05,
                "experimental": 0.000966,
                "database": 0.0009,
                "textmining": 0.000996
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 5.5e-05,
                "experimental": 0.000815,
                "database": 0.0,
                "textmining": 0.000995
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.4e-05,
                "experimental": 0.000877,
                "database": 0.0009,
                "textmining": 0.000986
              }
            },
            {
              "protein_a": "PIK3CA",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000263967",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.00079,
                "database": 0.0009,
                "textmining": 0.000976
              }
            },
            {
              "protein_a": "CBL",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000264033",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.2000000000000004e-05,
                "experimental": 0.000996,
                "database": 0.0009,
                "textmining": 0.000994
              }
            },
            {
              "protein_a": "EGF",
              "protein_b": "ERBB2",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000265171",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.000128,
                "experimental": 0.000314,
                "database": 0.0009,
                "textmining": 0.000998
              }
            },
            {
              "protein_a": "EGF",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000265171",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.000128,
                "experimental": 0.000999,
                "database": 0.0009,
                "textmining": 0.000999
              }
            },
            {
              "protein_a": "EGF",
              "protein_b": "ERBB3",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000265171",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.000128,
                "experimental": 0.000314,
                "database": 0.0009,
                "textmining": 0.000998
              }
            },
            {
              "protein_a": "ERBB3",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000267101",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 6.1e-05,
                "coexpression": 4.2000000000000004e-05,
                "experimental": 0.000986,
                "database": 0.0008,
                "textmining": 0.000984
              }
            },
            {
              "protein_a": "ERBB3",
              "protein_b": "ERBB2",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000267101",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 8.1e-05,
                "coexpression": 8.599999999999999e-05,
                "experimental": 0.000997,
                "database": 0.0009,
                "textmining": 0.000984
              }
            },
            {
              "protein_a": "ERBB2",
              "protein_b": "EGFR",
              "combined_score": 0.000999,
              "string_id_a": "9606.ENSP00000269571",
              "string_id_b": "9606.ENSP00000275493",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 6.4e-05,
                "coexpression": 8e-05,
                "experimental": 0.000998,
                "database": 0.0009,
                "textmining": 0.000983
              }
            },
            {
              "protein_a": "PIK3CA",
              "protein_b": "ERBB3",
              "combined_score": 0.000993,
              "string_id_a": "9606.ENSP00000263967",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.000597,
                "database": 0.0009,
                "textmining": 0.000856
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "EGF",
              "combined_score": 0.000992,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000988
              }
            },
            {
              "protein_a": "PIK3CA",
              "protein_b": "ERBB2",
              "combined_score": 0.000992,
              "string_id_a": "9606.ENSP00000263967",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.000115,
                "database": 0.0009,
                "textmining": 0.0009270000000000001
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "ERBB3",
              "combined_score": 0.000991,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000986
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "ERBB3",
              "combined_score": 0.000982,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.00065,
                "textmining": 0.0009519999999999999
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "ERBB2",
              "combined_score": 0.0009699999999999999,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.00013900000000000002,
                "experimental": 0.000108,
                "database": 0.0,
                "textmining": 0.000964
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "EREG",
              "combined_score": 0.000959,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000244869",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.000127,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000928
              }
            },
            {
              "protein_a": "DCN",
              "protein_b": "ERBB2",
              "combined_score": 0.000958,
              "string_id_a": "9606.ENSP00000052754",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.2000000000000004e-05,
                "experimental": 9.4e-05,
                "database": 0.0009,
                "textmining": 0.000578
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "EGF",
              "combined_score": 0.000958,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.00040500000000000003,
                "database": 0.0004,
                "textmining": 0.000893
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "ERBB2",
              "combined_score": 0.000948,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.9000000000000005e-05,
                "experimental": 0.000314,
                "database": 0.0009,
                "textmining": 0.0003
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "ERBB2",
              "combined_score": 0.000944,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000911
              }
            },
            {
              "protein_a": "CBL",
              "protein_b": "ERBB2",
              "combined_score": 0.000944,
              "string_id_a": "9606.ENSP00000264033",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0008,
                "database": 0.0,
                "textmining": 0.000734
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "ERBB3",
              "combined_score": 0.0009320000000000001,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.9000000000000005e-05,
                "experimental": 7.099999999999999e-05,
                "database": 0.0009,
                "textmining": 0.00032700000000000003
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "PIK3CA",
              "combined_score": 0.00092,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000263967",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 5.9999999999999995e-05,
                "experimental": 4.1e-05,
                "database": 0.0009,
                "textmining": 0.000224
              }
            },
            {
              "protein_a": "DCN",
              "protein_b": "EGF",
              "combined_score": 0.0009170000000000001,
              "string_id_a": "9606.ENSP00000052754",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 4.2000000000000004e-05,
                "database": 0.0,
                "textmining": 0.000916
              }
            },
            {
              "protein_a": "DCN",
              "protein_b": "ERBB3",
              "combined_score": 0.0009130000000000001,
              "string_id_a": "9606.ENSP00000052754",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 9.4e-05,
                "database": 0.0009,
                "textmining": 0.000126
              }
            },
            {
              "protein_a": "PIK3CA",
              "protein_b": "CBL",
              "combined_score": 0.000887,
              "string_id_a": "9606.ENSP00000263967",
              "string_id_b": "9606.ENSP00000264033",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 5.9999999999999995e-05,
                "experimental": 0.000629,
                "database": 0.00065,
                "textmining": 0.000186
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "ERBB2",
              "combined_score": 0.00086,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000269571",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.00065,
                "textmining": 0.000616
              }
            },
            {
              "protein_a": "CBL",
              "protein_b": "EGF",
              "combined_score": 0.000859,
              "string_id_a": "9606.ENSP00000264033",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0005,
                "textmining": 0.000731
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "ERBB3",
              "combined_score": 0.000856,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.000204,
                "experimental": 0.000108,
                "database": 0.0,
                "textmining": 0.0008129999999999999
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "EGF",
              "combined_score": 0.000852,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.2999999999999995e-05,
                "experimental": 0.0,
                "database": 0.0,
                "textmining": 0.000851
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "EGF",
              "combined_score": 0.0008259999999999999,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.4e-05,
                "experimental": 4.6e-05,
                "database": 0.0004,
                "textmining": 0.0007199999999999999
              }
            },
            {
              "protein_a": "PIK3CA",
              "protein_b": "EGF",
              "combined_score": 0.000746,
              "string_id_a": "9606.ENSP00000263967",
              "string_id_b": "9606.ENSP00000265171",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.0005949999999999999
              }
            },
            {
              "protein_a": "CBL",
              "protein_b": "ERBB3",
              "combined_score": 0.000732,
              "string_id_a": "9606.ENSP00000264033",
              "string_id_b": "9606.ENSP00000267101",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.000489,
                "database": 0.0,
                "textmining": 0.000498
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "CBL",
              "combined_score": 0.0006879999999999999,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000264033",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 8e-05,
                "database": 0.00054,
                "textmining": 0.000322
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "CBL",
              "combined_score": 0.000606,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000264033",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 4.2000000000000004e-05,
                "experimental": 0.0,
                "database": 0.0005,
                "textmining": 0.000245
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "PIK3CA",
              "combined_score": 0.000605,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000263967",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.00037
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "CBL",
              "combined_score": 0.0005949999999999999,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000264033",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0005,
                "textmining": 0.000225
              }
            },
            {
              "protein_a": "CDH1",
              "protein_b": "PIK3CA",
              "combined_score": 0.000575,
              "string_id_a": "9606.ENSP00000261769",
              "string_id_b": "9606.ENSP00000263967",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0,
                "textmining": 0.000575
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "PIK3CA",
              "combined_score": 0.000513,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000263967",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000223
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "GAB1",
              "combined_score": 0.00047299999999999995,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000262995",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000157
              }
            },
            {
              "protein_a": "EREG",
              "protein_b": "GAB1",
              "combined_score": 0.000472,
              "string_id_a": "9606.ENSP00000244869",
              "string_id_b": "9606.ENSP00000262995",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0004,
                "textmining": 0.000157
              }
            },
            {
              "protein_a": "HBEGF",
              "protein_b": "CDH1",
              "combined_score": 0.000435,
              "string_id_a": "9606.ENSP00000230990",
              "string_id_b": "9606.ENSP00000261769",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 0.0,
                "experimental": 0.0,
                "database": 0.0,
                "textmining": 0.000435
              }
            },
            {
              "protein_a": "GAB1",
              "protein_b": "CBL",
              "combined_score": 0.00041299999999999996,
              "string_id_a": "9606.ENSP00000262995",
              "string_id_b": "9606.ENSP00000264033",
              "evidence_scores": {
                "neighborhood": 0.0,
                "fusion": 0.0,
                "cooccurrence": 0.0,
                "coexpression": 5.4e-05,
                "experimental": 0.0,
                "database": 0.0,
                "textmining": 0.00040500000000000003
              }
            }
          ],
          "num_interactions": 47,
          "protein_mapping": {
            "P00533": {
              "string_id": "9606.ENSP00000275493",
              "preferred_name": "EGFR",
              "annotation": "Epidermal growth factor receptor; Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin- binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at leas [...] "
            }
          },
          "query_proteins": [
            "P00533"
          ],
          "string_ids": [
            "9606.ENSP00000275493"
          ],
          "parameters": {
            "species": "9606",
            "required_score": 400,
            "network_type": "functional"
          }
        },
        "error": null
      },
      "metadata": {
        "name": "string_db",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 60,
          "format": "json",
          "default_organism": "9606",
          "default_score": 400,
          "network_type": "functional"
        }
      }
    },
    {
      "adapter": "biogrid",
      "status": "success",
      "error": null,
      "execution_time": 0.206867,
      "data": {
        "success": false,
        "data": null,
        "error": "Failed to fetch interactions from BioGRID API"
      },
      "metadata": {
        "name": "biogrid",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.2,
          "timeout": 120,
          "max_results": 10000,
          "access_key": null
        }
      }
    },
    {
      "adapter": "intact",
      "status": "success",
      "error": null,
      "execution_time": 0.973636,
      "data": {
        "success": false,
        "data": null,
        "error": "Failed to search IntAct database"
      },
      "metadata": {
        "name": "intact",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "format": "json",
          "default_organism": "9606",
          "min_mi_score": 0.4,
          "max_results": 200,
          "negative_interactions": false
        }
      }
    },
    {
      "adapter": "alphafold",
      "status": "success",
      "error": null,
      "execution_time": 0.726146,
      "data": {
        "success": true,
        "data": {
          "uniprot_id": "P00533",
          "metadata": {
            "toolUsed": "AlphaFold Monomer v2.0 pipeline",
            "providerId": "GDM",
            "entityType": "protein",
            "isUniProt": true,
            "modelEntityId": "AF-P00533-F1",
            "modelCreatedDate": "2025-08-01T00:00:00Z",
            "sequenceVersionDate": "1997-11-01T00:00:00Z",
            "globalMetricValue": 75.94,
            "fractionPlddtVeryLow": 0.228,
            "fractionPlddtLow": 0.065,
            "fractionPlddtConfident": 0.233,
            "fractionPlddtVeryHigh": 0.474,
            "latestVersion": 6,
            "allVersions": [
              1,
              2,
              3,
              4,
              5,
              6
            ],
            "sequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
            "sequenceStart": 1,
            "sequenceEnd": 1210,
            "sequenceChecksum": "D8A2A50B4EFB6ED2",
            "isUniProtReviewed": true,
            "gene": "EGFR",
            "uniprotAccession": "P00533",
            "uniprotId": "EGFR_HUMAN",
            "uniprotDescription": "Epidermal growth factor receptor",
            "taxId": 9606,
            "organismScientificName": "Homo sapiens",
            "isUniProtReferenceProteome": true,
            "bcifUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-model_v6.bcif",
            "cifUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-model_v6.cif",
            "pdbUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-model_v6.pdb",
            "paeImageUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-predicted_aligned_error_v6.png",
            "msaUrl": "https://alphafold.ebi.ac.uk/files/msa/AF-P00533-F1-msa_v6.a3m",
            "plddtDocUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-confidence_v6.json",
            "paeDocUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-predicted_aligned_error_v6.json",
            "amAnnotationsUrl": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-aa-substitutions.csv",
            "amAnnotationsHg19Url": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-hg19.csv",
            "amAnnotationsHg38Url": "https://alphafold.ebi.ac.uk/files/AF-P00533-F1-hg38.csv",
            "entryId": "AF-P00533-F1",
            "uniprotSequence": "MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA",
            "uniprotStart": 1,
            "uniprotEnd": 1210,
            "isReferenceProteome": true,
            "isReviewed": true
          },
          "structure_files": {
            "pdb": "HEADER                                            01-AUG-25                     \nTITLE     ALPHAFOLD MONOMER V2.0 PREDICTION FOR EPIDERMAL GROWTH FACTOR         \nTITLE    2 RECEPTOR (P00533)                                                    \nCOMPND    MOL_ID: 1;                                                            \nCOMPND   2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR;                          \nCOMPND   3 CHAIN: A                                                             \nSOURCE    MOL_ID: 1;                                                            \nSOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   \nSOURCE   3 ORGANISM_TAXID: 9606                                                 \nREMARK   1                                                                      \nREMARK   1 REFERENCE 1                                                          \nREMARK   1  AUTH   JOHN JUMPER, RICHARD EVANS, ALEXANDER PRITZEL, TIM GREEN,    \nREMARK   1  AUTH 2 MICHAEL FIGURNOV, OLAF RONNEBERGER, KATHRYN TUNYASUVUNAKOOL, \nREMARK   1  AUTH 3 RUSS BATES, AUGUSTIN ZIDEK, ANNA POTAPENKO, ALEX BRIDGLAND,  \nREMARK   1  AUTH 4 CLEMENS MEYER, SIMON A A KOHL, ANDREW J BALLARD,             \nREMARK   1  AUTH 5 ANDREW COWIE, BERNARDINO ROMERA-PAREDES, STANISLAV NIKOLOV,  \nREMARK   1  AUTH 6 RISHUB JAIN, JONAS ADLER, TREVOR BACK, STIG PETERSEN,        \nREMARK   1  AUTH 7 DAVID REIMAN, ELLEN CLANCY, MICHAL ZIELINSKI,                \nREMARK   1  AUTH 8 MARTIN STEINEGGER, MICHALINA PACHOLSKA, TAMAS BERGHAMMER,    \nREMARK   1  AUTH 9 DAVID SILVER, ORIOL VINYALS, ANDREW W SENIOR,                \nREMARK   1  AUTH10 KORAY KAVUKCUOGLU, PUSHMEET KOHLI, DEMIS HASSABIS            \nREMARK   1  TITL   HIGHLY ACCURATE PROTEIN STRUCTURE PREDICTION WITH ALPHAFOLD  \nREMARK   1  REF    NATURE                        V. 596   583 2021              \nREMARK   1  REFN                   ISSN 0028-0836                               \nREMARK   1  PMID   34265844                                                     \nREMARK   1  DOI    10.1038/s41586-021-03819-2                                   \nREMARK   1                                                                      \nREMARK   1 DISCLAIMERS                                                          \nREMARK   1 ALPHAFOLD DATA, COPYRIGHT (2021) DEEPMIND TECHNOLOGIES LIMITED. THE  \nREMARK   1 INFORMATION PROVIDED IS THEORETICAL MODELLING ONLY AND CAUTION SHOULD\nREMARK   1 BE EXERCISED IN ITS USE. IT IS PROVIDED \"AS-IS\" WITHOUT ANY WARRANTY \nREMARK   1 OF ANY KIND, WHETHER EXPRESSED OR IMPLIED. NO WARRANTY IS GIVEN THAT \nREMARK   1 USE OF THE INFORMATION SHALL NOT INFRINGE THE RIGHTS OF ANY THIRD    \nREMARK   1 PARTY. THE INFORMATION IS NOT INTENDED TO BE A SUBSTITUTE FOR        \nREMARK   1 PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT, AND DOES NOT   \nREMARK   1 CONSTITUTE MEDICAL OR OTHER PROFESSIONAL ADVICE. IT IS AVAILABLE FOR \nREMARK   1 ACADEMIC AND COMMERCIAL PURPOSES, UNDER CC-BY 4.0 LICENCE.           \nDBREF  XXXX A    1  1210  UNP    P00533   EGFR_HUMAN       1   1210             \nSEQRES   1 A 1210  MET ARG PRO SER GLY THR ALA GLY ALA ALA LEU LEU ALA          \nSEQRES   2 A 1210  LEU LEU ALA ALA LEU CYS PRO ALA SER ARG ALA LEU GLU          \nSEQRES   3 A 1210  GLU LYS LYS VAL CYS GLN GLY THR SER ASN LYS LEU THR          \nSEQRES   4 A 1210  GLN LEU GLY THR PHE GLU ASP HIS PHE LEU SER LEU GLN          \nSEQRES   5 A 1210  ARG MET PHE ASN ASN CYS GLU VAL VAL LEU GLY ASN LEU          \nSEQRES   6 A 1210  GLU ILE THR TYR VAL GLN ARG ASN TYR ASP LEU SER PHE          \nSEQRES   7 A 1210  LEU LYS THR ILE GLN GLU VAL ALA GLY TYR VAL LEU ILE          \nSEQRES   8 A 1210  ALA LEU ASN THR VAL GLU ARG ILE PRO LEU GLU ASN LEU          \nSEQRES   9 A 1210  GLN ILE ILE ARG GLY ASN MET TYR TYR GLU ASN SER TYR          \nSEQRES  10 A 1210  ALA LEU ALA VAL LEU SER ASN TYR ASP ALA ASN LYS THR          \nSEQRES  11 A 1210  GLY LEU LYS GLU LEU PRO MET ARG ASN LEU GLN GLU ILE          \nSEQRES  12 A 1210  LEU HIS GLY ALA VAL ARG PHE SER ASN ASN PRO ALA LEU          \nSEQRES  13 A 1210  CYS ASN VAL GLU SER ILE GLN TRP ARG ASP ILE VAL SER          \nSEQRES  14 A 1210  SER ASP PHE LEU SER ASN MET SER MET ASP PHE GLN ASN          \nSEQRES  15 A 1210  HIS LEU GLY SER CYS GLN LYS CYS ASP PRO SER CYS PRO          \nSEQRES  16 A 1210  ASN GLY SER CYS TRP GLY ALA GLY GLU GLU ASN CYS GLN          \nSEQRES  17 A 1210  LYS LEU THR LYS ILE ILE CYS ALA GLN GLN CYS SER GLY          \nSEQRES  18 A 1210  ARG CYS ARG GLY LYS SER PRO SER ASP CYS CYS HIS ASN          \nSEQRES  19 A 1210  GLN CYS ALA ALA GLY CYS THR GLY PRO ARG GLU SER ASP          \nSEQRES  20 A 1210  CYS LEU VAL CYS ARG LYS PHE ARG ASP GLU ALA THR CYS          \nSEQRES  21 A 1210  LYS ASP THR CYS PRO PRO LEU MET LEU TYR ASN PRO THR          \nSEQRES  22 A 1210  THR TYR GLN MET ASP VAL ASN PRO GLU GLY LYS TYR SER          \nSEQRES  23 A 1210  PHE GLY ALA THR CYS VAL LYS LYS CYS PRO ARG ASN TYR          \nSEQRES  24 A 1210  VAL VAL THR ASP HIS GLY SER CYS VAL ARG ALA CYS GLY          \nSEQRES  25 A 1210  ALA ASP SER TYR GLU MET GLU GLU ASP GLY VAL ARG LYS          \nSEQRES  26 A 1210  CYS LYS LYS CYS GLU GLY PRO CYS ARG LYS VAL CYS ASN          \nSEQRES  27 A 1210  GLY ILE GLY ILE GLY GLU PHE LYS ASP SER LEU SER ILE          \nSEQRES  28 A 1210  ASN ALA THR ASN ILE LYS HIS PHE LYS ASN CYS THR SER          \nSEQRES  29 A 1210  ILE SER GLY ASP LEU HIS ILE LEU PRO VAL ALA PHE ARG          \nSEQRES  30 A 1210  GLY ASP SER PHE THR HIS THR PRO PRO LEU ASP PRO GLN          \nSEQRES  31 A 1210  GLU LEU ASP ILE LEU LYS THR VAL LYS GLU ILE THR GLY          \nSEQRES  32 A 1210  PHE LEU LEU ILE GLN ALA TRP PRO GLU ASN ARG THR ASP          \nSEQRES  33 A 1210  LEU HIS ALA PHE GLU ASN LEU GLU ILE ILE ARG GLY ARG          \nSEQRES  34 A 1210  THR LYS GLN HIS GLY GLN PHE SER LEU ALA VAL VAL SER          \nSEQRES  35 A 1210  LEU ASN ILE THR SER LEU GLY LEU ARG SER LEU LYS GLU          \nSEQRES  36 A 1210  ILE SER ASP GLY ASP VAL ILE ILE SER GLY ASN LYS ASN          \nSEQRES  37 A 1210  LEU CYS TYR ALA ASN THR ILE ASN TRP LYS LYS LEU PHE          \nSEQRES  38 A 1210  GLY THR SER GLY GLN LYS THR LYS ILE ILE SER ASN ARG          \nSEQRES  39 A 1210  GLY GLU ASN SER CYS LYS ALA THR GLY GLN VAL CYS HIS          \nSEQRES  40 A 1210  ALA LEU CYS SER PRO GLU GLY CYS TRP GLY PRO GLU PRO          \nSEQRES  41 A 1210  ARG ASP CYS VAL SER CYS ARG ASN VAL SER ARG GLY ARG          \nSEQRES  42 A 1210  GLU CYS VAL ASP LYS CYS ASN LEU LEU GLU GLY GLU PRO          \nSEQRES  43 A 1210  ARG GLU PHE VAL GLU ASN SER GLU CYS ILE GLN CYS HIS          \nSEQRES  44 A 1210  PRO GLU CYS LEU PRO GLN ALA MET ASN ILE THR CYS THR          \nSEQRES  45 A 1210  GLY ARG GLY PRO ASP ASN CYS ILE GLN CYS ALA HIS TYR          \nSEQRES  46 A 1210  ILE ASP GLY PRO HIS CYS VAL LYS THR CYS PRO ALA GLY          \nSEQRES  47 A 1210  VAL MET GLY GLU ASN ASN THR LEU VAL TRP LYS TYR ALA          \nSEQRES  48 A 1210  ASP ALA GLY HIS VAL CYS HIS LEU CYS HIS PRO ASN CYS          \nSEQRES  49 A 1210  THR TYR GLY CYS THR GLY PRO GLY LEU GLU GLY CYS PRO          \nSEQRES  50 A 1210  THR ASN GLY PRO LYS ILE PRO SER ILE ALA THR GLY MET          \nSEQRES  51 A 1210  VAL GLY ALA LEU LEU LEU LEU LEU VAL VAL ALA LEU GLY          \nSEQRES  52 A 1210  ILE GLY LEU PHE MET ARG ARG ARG HIS ILE VAL ARG LYS          \nSEQRES  53 A 1210  ARG THR LEU ARG ARG LEU LEU GLN GLU ARG GLU LEU VAL          \nSEQRES  54 A 1210  GLU PRO LEU THR PRO SER GLY GLU ALA PRO ASN GLN ALA          \nSEQRES  55 A 1210  LEU LEU ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE          \nSEQRES  56 A 1210  LYS VAL LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS          \nSEQRES  57 A 1210  GLY LEU TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO          \nSEQRES  58 A 1210  VAL ALA ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS          \nSEQRES  59 A 1210  ALA ASN LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA          \nSEQRES  60 A 1210  SER VAL ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE          \nSEQRES  61 A 1210  CYS LEU THR SER THR VAL GLN LEU ILE THR GLN LEU MET          \nSEQRES  62 A 1210  PRO PHE GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS          \nSEQRES  63 A 1210  ASP ASN ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL          \nSEQRES  64 A 1210  GLN ILE ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG          \nSEQRES  65 A 1210  LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL          \nSEQRES  66 A 1210  LYS THR PRO GLN HIS VAL LYS ILE THR ASP PHE GLY LEU          \nSEQRES  67 A 1210  ALA LYS LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA          \nSEQRES  68 A 1210  GLU GLY GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU          \nSEQRES  69 A 1210  SER ILE LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL          \nSEQRES  70 A 1210  TRP SER TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE          \nSEQRES  71 A 1210  GLY SER LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE          \nSEQRES  72 A 1210  SER SER ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO          \nSEQRES  73 A 1210  PRO ILE CYS THR ILE ASP VAL TYR MET ILE MET VAL LYS          \nSEQRES  74 A 1210  CYS TRP MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG          \nSEQRES  75 A 1210  GLU LEU ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO          \nSEQRES  76 A 1210  GLN ARG TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS          \nSEQRES  77 A 1210  LEU PRO SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU          \nSEQRES  78 A 1210  MET ASP GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP          \nSEQRES  79 A 1210  GLU TYR LEU ILE PRO GLN GLN GLY PHE PHE SER SER PRO          \nSEQRES  80 A 1210  SER THR SER ARG THR PRO LEU LEU SER SER LEU SER ALA          \nSEQRES  81 A 1210  THR SER ASN ASN SER THR VAL ALA CYS ILE ASP ARG ASN          \nSEQRES  82 A 1210  GLY LEU GLN SER CYS PRO ILE LYS GLU ASP SER PHE LEU          \nSEQRES  83 A 1210  GLN ARG TYR SER SER ASP PRO THR GLY ALA LEU THR GLU          \nSEQRES  84 A 1210  ASP SER ILE ASP ASP THR PHE LEU PRO VAL PRO GLU TYR          \nSEQRES  85 A 1210  ILE ASN GLN SER VAL PRO LYS ARG PRO ALA GLY SER VAL          \nSEQRES  86 A 1210  GLN ASN PRO VAL TYR HIS ASN GLN PRO LEU ASN PRO ALA          \nSEQRES  87 A 1210  PRO SER ARG ASP PRO HIS TYR GLN ASP PRO HIS SER THR          \nSEQRES  88 A 1210  ALA VAL GLY ASN PRO GLU TYR LEU ASN THR VAL GLN PRO          \nSEQRES  89 A 1210  THR CYS VAL ASN SER THR PHE ASP SER PRO ALA HIS TRP          \nSEQRES  90 A 1210  ALA GLN LYS GLY SER HIS GLN ILE SER LEU ASP ASN PRO          \nSEQRES  91 A 1210  ASP TYR GLN GLN ASP PHE PHE PRO LYS GLU ALA LYS PRO          \nSEQRES  92 A 1210  ASN GLY ILE PHE LYS GLY SER THR ALA GLU ASN ALA GLU          \nSEQRES  93 A 1210  TYR LEU ARG VAL ALA PRO GLN SER SER GLU PHE ILE GLY          \nSEQRES  94 A 1210  ALA                                                          \nCRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          \nORIGX1      1.000000  0.000000  0.000000        0.00000                         \nORIGX2      0.000000  1.000000  0.000000        0.00000                         \nORIGX3      0.000000  0.000000  1.000000        0.00000                         \nSCALE1      1.000000  0.000000  0.000000        0.00000                         \nSCALE2      0.000000  1.000000  0.000000        0.00000                         \nSCALE3      0.000000  0.000000  1.000000        0.00000                         \nMODEL        1                                                                  \nATOM      1  N   MET A   1     -84.651  11.107  23.716  1.00 39.94           N  \nATOM      2  CA  MET A   1     -84.119  10.653  22.409  1.00 39.94           C  \nATOM      3  C   MET A   1     -82.675  11.127  22.277  1.00 39.94           C  \nATOM      4  CB  MET A   1     -84.980  11.213  21.267  1.00 39.94           C  \nATOM      5  O   MET A   1     -82.408  12.258  22.660  1.00 39.94           O  \nATOM      6  CG  MET A   1     -86.367  10.552  21.217  1.00 39.94           C  \nATOM      7  SD  MET A   1     -87.680  11.674  20.686  1.00 39.94           S  \nATOM      8  CE  MET A   1     -89.035  10.498  20.413  1.00 39.94           C  \nATOM      9  N   ARG A   2     -81.750  10.274  21.815  1.00 38.81           N  \nATOM     10  CA  ARG A   2     -80.326  10.591  21.567  1.00 38.81           C  \nATOM     11  C   ARG A   2     -79.810   9.679  20.437  1.00 38.81           C  \nATOM     12  CB  ARG A   2     -79.457  10.299  22.816  1.00 38.81           C  \nATOM     13  O   ARG A   2     -79.929   8.469  20.612  1.00 38.81           O  \nATOM     14  CG  ARG A   2     -79.568  11.285  23.991  1.00 38.81           C  \nATOM     15  CD  ARG A   2     -78.615  10.843  25.118  1.00 38.81           C  \nATOM     16  NE  ARG A   2     -78.581  11.795  26.249  1.00 38.81           N  \nATOM     17  NH1 ARG A   2     -77.457  10.461  27.757  1.00 38.81           N  \nATOM     18  NH2 ARG A   2     -78.009  12.538  28.331  1.00 38.81           N  \nATOM     19  CZ  ARG A   2     -78.020  11.593  27.433  1.00 38.81           C  \nATOM     20  N   PRO A   3     -79.248  10.194  19.330  1.00 48.25           N  \nATOM     21  CA  PRO A   3     -78.543   9.369  18.352  1.00 48.25           C  \nATOM     22  C   PRO A   3     -77.069   9.181  18.755  1.00 48.25           C  \nATOM     23  CB  PRO A   3     -78.713  10.101  17.021  1.00 48.25           C  \nATOM     24  O   PRO A   3     -76.377  10.135  19.106  1.00 48.25           O  \nATOM     25  CG  PRO A   3     -78.762  11.574  17.433  1.00 48.25           C  \nATOM     26  CD  PRO A   3     -79.355  11.563  18.847  1.00 48.25           C  \nATOM     27  N   SER A   4     -76.588   7.941  18.713  1.00 42.94           N  \nATOM     28  CA  SER A   4     -75.188   7.561  18.951  1.00 42.94           C  \nATOM     29  C   SER A   4     -74.309   7.850  17.728  1.00 42.94           C  \nATOM     30  CB  SER A   4     -75.141   6.061  19.265  1.00 42.94           C  \nATOM     31  O   SER A   4     -74.679   7.457  16.624  1.00 42.94           O  \nATOM     32  OG  SER A   4     -75.881   5.342  18.293  1.00 42.94           O  \nATOM     33  N   GLY A   5     -73.130   8.462  17.910  1.00 41.34           N  \nATOM     34  CA  GLY A   5     -72.294   8.908  16.780  1.00 41.34           C  \nATOM     35  C   GLY A   5     -70.784   9.025  17.032  1.00 41.34           C  \nATOM     36  O   GLY A   5     -70.126   9.789  16.339  1.00 41.34           O  \nATOM     37  N   THR A   6     -70.219   8.315  18.016  1.00 49.47           N  \nATOM     38  CA  THR A   6     -68.810   8.495  18.446  1.00 49.47           C  \nATOM     39  C   THR A   6     -67.891   7.280  18.254  1.00 49.47           C  \nATOM     40  CB  THR A   6     -68.751   8.971  19.906  1.00 49.47           C  \nATOM     41  O   THR A   6     -66.683   7.408  18.428  1.00 49.47           O  \nATOM     42  CG2 THR A   6     -69.208  10.423  20.045  1.00 49.47           C  \nATOM     43  OG1 THR A   6     -69.612   8.185  20.705  1.00 49.47           O  \nATOM     44  N   ALA A   7     -68.409   6.112  17.858  1.00 48.50           N  \nATOM     45  CA  ALA A   7     -67.609   4.880  17.762  1.00 48.50           C  \nATOM     46  C   ALA A   7     -66.721   4.778  16.499  1.00 48.50           C  \nATOM     47  CB  ALA A   7     -68.566   3.686  17.874  1.00 48.50           C  \nATOM     48  O   ALA A   7     -65.669   4.143  16.536  1.00 48.50           O  \nATOM     49  N   GLY A   8     -67.118   5.396  15.379  1.00 46.78           N  \nATOM     50  CA  GLY A   8     -66.455   5.189  14.080  1.00 46.78           C  \nATOM     51  C   GLY A   8     -65.050   5.795  13.961  1.00 46.78           C  \nATOM     52  O   GLY A   8     -64.161   5.182  13.374  1.00 46.78           O  \nATOM     53  N   ALA A   9     -64.823   6.976  14.546  1.00 49.91           N  \nATOM     54  CA  ALA A   9     -63.551   7.694  14.414  1.00 49.91           C  \nATOM     55  C   ALA A   9     -62.387   6.991  15.139  1.00 49.91           C  \nATOM     56  CB  ALA A   9     -63.756   9.128  14.919  1.00 49.91           C  \nATOM     57  O   ALA A   9     -61.276   6.930  14.615  1.00 49.91           O  \nATOM     58  N   ALA A  10     -62.649   6.408  16.315  1.00 51.81           N  \nATOM     59  CA  ALA A  10     -61.639   5.683  17.087  1.00 51.81           C  \nATOM     60  C   ALA A  10     -61.157   4.409  16.370  1.00 51.81           C  \nATOM     61  CB  ALA A  10     -62.230   5.366  18.466  1.00 51.81           C  \nATOM     62  O   ALA A  10     -59.968   4.093  16.401  1.00 51.81           O  \nATOM     63  N   LEU A  11     -62.061   3.703  15.679  1.00 50.09           N  \nATOM     64  CA  LEU A  11     -61.722   2.471  14.962  1.00 50.09           C  \nATOM     65  C   LEU A  11     -60.826   2.741  13.741  1.00 50.09           C  \nATOM     66  CB  LEU A  11     -63.022   1.736  14.579  1.00 50.09           C  \nATOM     67  O   LEU A  11     -59.886   1.990  13.490  1.00 50.09           O  \nATOM     68  CG  LEU A  11     -62.871   0.206  14.662  1.00 50.09           C  \nATOM     69  CD1 LEU A  11     -62.915  -0.272  16.118  1.00 50.09           C  \nATOM     70  CD2 LEU A  11     -64.009  -0.481  13.911  1.00 50.09           C  \nATOM     71  N   LEU A  12     -61.063   3.846  13.025  1.00 52.34           N  \nATOM     72  CA  LEU A  12     -60.211   4.283  11.913  1.00 52.34           C  \nATOM     73  C   LEU A  12     -58.815   4.726  12.380  1.00 52.34           C  \nATOM     74  CB  LEU A  12     -60.933   5.396  11.132  1.00 52.34           C  \nATOM     75  O   LEU A  12     -57.831   4.405  11.716  1.00 52.34           O  \nATOM     76  CG  LEU A  12     -61.966   4.842  10.133  1.00 52.34           C  \nATOM     77  CD1 LEU A  12     -62.940   5.940   9.711  1.00 52.34           C  \nATOM     78  CD2 LEU A  12     -61.287   4.300   8.870  1.00 52.34           C  \nATOM     79  N   ALA A  13     -58.707   5.391  13.535  1.00 51.25           N  \nATOM     80  CA  ALA A  13     -57.411   5.737  14.125  1.00 51.25           C  \nATOM     81  C   ALA A  13     -56.607   4.488  14.545  1.00 51.25           C  \nATOM     82  CB  ALA A  13     -57.653   6.689  15.302  1.00 51.25           C  \nATOM     83  O   ALA A  13     -55.405   4.414  14.293  1.00 51.25           O  \nATOM     84  N   LEU A  14     -57.271   3.477  15.120  1.00 51.88           N  \nATOM     85  CA  LEU A  14     -56.652   2.190  15.463  1.00 51.88           C  \nATOM     86  C   LEU A  14     -56.202   1.401  14.224  1.00 51.88           C  \nATOM     87  CB  LEU A  14     -57.633   1.378  16.330  1.00 51.88           C  \nATOM     88  O   LEU A  14     -55.099   0.861  14.217  1.00 51.88           O  \nATOM     89  CG  LEU A  14     -57.457   1.682  17.829  1.00 51.88           C  \nATOM     90  CD1 LEU A  14     -58.721   1.321  18.607  1.00 51.88           C  \nATOM     91  CD2 LEU A  14     -56.292   0.877  18.412  1.00 51.88           C  \nATOM     92  N   LEU A  15     -57.003   1.377  13.155  1.00 52.34           N  \nATOM     93  CA  LEU A  15     -56.614   0.738  11.892  1.00 52.34           C  \nATOM     94  C   LEU A  15     -55.441   1.465  11.213  1.00 52.34           C  \nATOM     95  CB  LEU A  15     -57.844   0.636  10.974  1.00 52.34           C  \nATOM     96  O   LEU A  15     -54.538   0.809  10.697  1.00 52.34           O  \nATOM     97  CG  LEU A  15     -58.851  -0.441  11.424  1.00 52.34           C  \nATOM     98  CD1 LEU A  15     -60.173  -0.263  10.675  1.00 52.34           C  \nATOM     99  CD2 LEU A  15     -58.338  -1.858  11.147  1.00 52.34           C  \nATOM    100  N   ALA A  16     -55.389   2.800  11.278  1.00 47.47           N  \nATOM    101  CA  ALA A  16     -54.247   3.574  10.787  1.00 47.47           C  \nATOM    102  C   ALA A  16     -52.948   3.289  11.571  1.00 47.47           C  \nATOM    103  CB  ALA A  16     -54.616   5.062  10.821  1.00 47.47           C  \nATOM    104  O   ALA A  16     -51.873   3.285  10.975  1.00 47.47           O  \nATOM    105  N   ALA A  17     -53.043   2.998  12.874  1.00 48.75           N  \nATOM    106  CA  ALA A  17     -51.909   2.590  13.708  1.00 48.75           C  \nATOM    107  C   ALA A  17     -51.466   1.124  13.493  1.00 48.75           C  \nATOM    108  CB  ALA A  17     -52.281   2.856  15.172  1.00 48.75           C  \nATOM    109  O   ALA A  17     -50.349   0.767  13.864  1.00 48.75           O  \nATOM    110  N   LEU A  18     -52.320   0.281  12.898  1.00 44.38           N  \nATOM    111  CA  LEU A  18     -52.044  -1.136  12.616  1.00 44.38           C  \nATOM    112  C   LEU A  18     -51.528  -1.398  11.191  1.00 44.38           C  \nATOM    113  CB  LEU A  18     -53.305  -1.960  12.934  1.00 44.38           C  \nATOM    114  O   LEU A  18     -51.016  -2.484  10.918  1.00 44.38           O  \nATOM    115  CG  LEU A  18     -53.540  -2.150  14.445  1.00 44.38           C  \nATOM    116  CD1 LEU A  18     -54.961  -2.658  14.691  1.00 44.38           C  \nATOM    117  CD2 LEU A  18     -52.569  -3.171  15.047  1.00 44.38           C  \nATOM    118  N   CYS A  19     -51.600  -0.418  10.288  1.00 36.91           N  \nATOM    119  CA  CYS A  19     -50.887  -0.481   9.014  1.00 36.91           C  \nATOM    120  C   CYS A  19     -49.368  -0.370   9.255  1.00 36.91           C  \nATOM    121  CB  CYS A  19     -51.377   0.648   8.097  1.00 36.91           C  \nATOM    122  O   CYS A  19     -48.914   0.667   9.744  1.00 36.91           O  \nATOM    123  SG  CYS A  19     -52.951   0.169   7.330  1.00 36.91           S  \nATOM    124  N   PRO A  20     -48.543  -1.371   8.878  1.00 37.09           N  \nATOM    125  CA  PRO A  20     -47.096  -1.259   9.011  1.00 37.09           C  \nATOM    126  C   PRO A  20     -46.591  -0.137   8.100  1.00 37.09           C  \nATOM    127  CB  PRO A  20     -46.536  -2.637   8.640  1.00 37.09           C  \nATOM    128  O   PRO A  20     -46.654  -0.242   6.872  1.00 37.09           O  \nATOM    129  CG  PRO A  20     -47.598  -3.218   7.707  1.00 37.09           C  \nATOM    130  CD  PRO A  20     -48.901  -2.639   8.258  1.00 37.09           C  \nATOM    131  N   ALA A  21     -46.099   0.948   8.707  1.00 33.31           N  \nATOM    132  CA  ALA A  21     -45.603   2.119   7.993  1.00 33.31           C  \nATOM    133  C   ALA A  21     -44.597   1.692   6.914  1.00 33.31           C  \nATOM    134  CB  ALA A  21     -44.980   3.091   9.004  1.00 33.31           C  \nATOM    135  O   ALA A  21     -43.595   1.045   7.226  1.00 33.31           O  \nATOM    136  N   SER A  22     -44.884   2.026   5.648  1.00 32.91           N  \nATOM    137  CA  SER A  22     -44.205   1.467   4.472  1.00 32.91           C  \nATOM    138  C   SER A  22     -42.690   1.608   4.611  1.00 32.91           C  \nATOM    139  CB  SER A  22     -44.669   2.170   3.185  1.00 32.91           C  \nATOM    140  O   SER A  22     -42.172   2.726   4.479  1.00 32.91           O  \nATOM    141  OG  SER A  22     -46.059   2.428   3.189  1.00 32.91           O  \nATOM    142  N   ARG A  23     -42.006   0.494   4.924  1.00 31.64           N  \nATOM    143  CA  ARG A  23     -40.597   0.478   5.345  1.00 31.64           C  \nATOM    144  C   ARG A  23     -39.764   1.295   4.361  1.00 31.64           C  \nATOM    145  CB  ARG A  23     -40.065  -0.969   5.455  1.00 31.64           C  \nATOM    146  O   ARG A  23     -39.668   0.945   3.188  1.00 31.64           O  \nATOM    147  CG  ARG A  23     -40.545  -1.713   6.716  1.00 31.64           C  \nATOM    148  CD  ARG A  23     -39.977  -3.144   6.763  1.00 31.64           C  \nATOM    149  NE  ARG A  23     -40.261  -3.821   8.049  1.00 31.64           N  \nATOM    150  NH1 ARG A  23     -39.701  -5.967   7.424  1.00 31.64           N  \nATOM    151  NH2 ARG A  23     -40.308  -5.560   9.526  1.00 31.64           N  \nATOM    152  CZ  ARG A  23     -40.091  -5.106   8.323  1.00 31.64           C  \nATOM    153  N   ALA A  24     -39.186   2.401   4.834  1.00 32.12           N  \nATOM    154  CA  ALA A  24     -38.101   3.035   4.098  1.00 32.12           C  \nATOM    155  C   ALA A  24     -36.961   2.019   4.114  1.00 32.12           C  \nATOM    156  CB  ALA A  24     -37.717   4.362   4.767  1.00 32.12           C  \nATOM    157  O   ALA A  24     -36.511   1.663   5.200  1.00 32.12           O  \nATOM    158  N   LEU A  25     -36.604   1.479   2.948  1.00 45.75           N  \nATOM    159  CA  LEU A  25     -35.718   0.323   2.870  1.00 45.75           C  \nATOM    160  C   LEU A  25     -34.387   0.649   3.557  1.00 45.75           C  \nATOM    161  CB  LEU A  25     -35.536  -0.077   1.398  1.00 45.75           C  \nATOM    162  O   LEU A  25     -33.699   1.589   3.159  1.00 45.75           O  \nATOM    163  CG  LEU A  25     -34.992  -1.508   1.257  1.00 45.75           C  \nATOM    164  CD1 LEU A  25     -36.106  -2.546   1.419  1.00 45.75           C  \nATOM    165  CD2 LEU A  25     -34.372  -1.686  -0.120  1.00 45.75           C  \nATOM    166  N   GLU A  26     -34.071  -0.086   4.624  1.00 50.81           N  \nATOM    167  CA  GLU A  26     -32.912   0.215   5.455  1.00 50.81           C  \nATOM    168  C   GLU A  26     -31.635  -0.212   4.715  1.00 50.81           C  \nATOM    169  CB  GLU A  26     -33.058  -0.402   6.860  1.00 50.81           C  \nATOM    170  O   GLU A  26     -31.460  -1.350   4.262  1.00 50.81           O  \nATOM    171  CG  GLU A  26     -32.145   0.243   7.930  1.00 50.81           C  \nATOM    172  CD  GLU A  26     -32.856   1.271   8.833  1.00 50.81           C  \nATOM    173  OE1 GLU A  26     -32.382   2.443   8.883  1.00 50.81           O  \nATOM    174  OE2 GLU A  26     -33.885   0.905   9.444  1.00 50.81           O  \nATOM    175  N   GLU A  27     -30.745   0.753   4.538  1.00 69.94           N  \nATOM    176  CA  GLU A  27     -29.420   0.553   3.976  1.00 69.94           C  \nATOM    177  C   GLU A  27     -28.530  -0.025   5.082  1.00 69.94           C  \nATOM    178  CB  GLU A  27     -28.971   1.907   3.411  1.00 69.94           C  \nATOM    179  O   GLU A  27     -28.132   0.709   5.986  1.00 69.94           O  \nATOM    180  CG  GLU A  27     -27.678   1.875   2.588  1.00 69.94           C  \nATOM    181  CD  GLU A  27     -27.500   3.176   1.777  1.00 69.94           C  \nATOM    182  OE1 GLU A  27     -26.728   3.140   0.797  1.00 69.94           O  \nATOM    183  OE2 GLU A  27     -28.187   4.186   2.086  1.00 69.94           O  \nATOM    184  N   LYS A  28     -28.315  -1.353   5.043  1.00 81.94           N  \nATOM    185  CA  LYS A  28     -27.540  -2.100   6.047  1.00 81.94           C  \nATOM    186  C   LYS A  28     -26.179  -1.443   6.308  1.00 81.94           C  \nATOM    187  CB  LYS A  28     -27.299  -3.566   5.624  1.00 81.94           C  \nATOM    188  O   LYS A  28     -25.473  -1.100   5.358  1.00 81.94           O  \nATOM    189  CG  LYS A  28     -28.541  -4.473   5.555  1.00 81.94           C  \nATOM    190  CD  LYS A  28     -28.109  -5.945   5.389  1.00 81.94           C  \nATOM    191  CE  LYS A  28     -29.299  -6.903   5.249  1.00 81.94           C  \nATOM    192  NZ  LYS A  28     -28.853  -8.320   5.250  1.00 81.94           N  \nATOM    193  N   LYS A  29     -25.783  -1.332   7.577  1.00 86.25           N  \nATOM    194  CA  LYS A  29     -24.463  -0.825   7.981  1.00 86.25           C  \nATOM    195  C   LYS A  29     -23.340  -1.754   7.511  1.00 86.25           C  \nATOM    196  CB  LYS A  29     -24.406  -0.656   9.505  1.00 86.25           C  \nATOM    197  O   LYS A  29     -23.314  -2.933   7.862  1.00 86.25           O  \nATOM    198  CG  LYS A  29     -25.143   0.600   9.995  1.00 86.25           C  \nATOM    199  CD  LYS A  29     -24.889   0.774  11.498  1.00 86.25           C  \nATOM    200  CE  LYS A  29     -25.266   2.170  11.998  1.00 86.25           C  \nATOM    201  NZ  LYS A  29     -24.630   2.445  13.313  1.00 86.25           N  \nATOM    202  N   VAL A  30     -22.388  -1.207   6.758  1.00 84.31           N  \nATOM    203  CA  VAL A  30     -21.189  -1.918   6.288  1.00 84.31           C  \nATOM    204  C   VAL A  30     -19.994  -1.676   7.215  1.00 84.31           C  \nATOM    205  CB  VAL A  30     -20.832  -1.553   4.832  1.00 84.31           C  \nATOM    206  O   VAL A  30     -19.864  -0.586   7.766  1.00 84.31           O  \nATOM    207  CG1 VAL A  30     -21.919  -2.010   3.852  1.00 84.31           C  \nATOM    208  CG2 VAL A  30     -20.595  -0.052   4.611  1.00 84.31           C  \nATOM    209  N   CYS A  31     -19.097  -2.654   7.343  1.00 85.44           N  \nATOM    210  CA  CYS A  31     -17.779  -2.481   7.965  1.00 85.44           C  \nATOM    211  C   CYS A  31     -16.665  -3.156   7.147  1.00 85.44           C  \nATOM    212  CB  CYS A  31     -17.784  -2.959   9.424  1.00 85.44           C  \nATOM    213  O   CYS A  31     -16.921  -4.002   6.284  1.00 85.44           O  \nATOM    214  SG  CYS A  31     -18.083  -4.726   9.680  1.00 85.44           S  \nATOM    215  N   GLN A  32     -15.417  -2.756   7.405  1.00 76.06           N  \nATOM    216  CA  GLN A  32     -14.244  -3.145   6.616  1.00 76.06           C  \nATOM    217  C   GLN A  32     -13.930  -4.648   6.702  1.00 76.06           C  \nATOM    218  CB  GLN A  32     -13.066  -2.244   7.046  1.00 76.06           C  \nATOM    219  O   GLN A  32     -13.641  -5.253   5.665  1.00 76.06           O  \nATOM    220  CG  GLN A  32     -11.667  -2.636   6.530  1.00 76.06           C  \nATOM    221  CD  GLN A  32     -10.918  -1.461   5.906  1.00 76.06           C  \nATOM    222  NE2 GLN A  32      -9.751  -1.096   6.385  1.00 76.06           N  \nATOM    223  OE1 GLN A  32     -11.382  -0.869   4.942  1.00 76.06           O  \nATOM    224  N   GLY A  33     -14.035  -5.243   7.895  1.00 83.19           N  \nATOM    225  CA  GLY A  33     -13.499  -6.576   8.187  1.00 83.19           C  \nATOM    226  C   GLY A  33     -11.974  -6.566   8.352  1.00 83.19           C  \nATOM    227  O   GLY A  33     -11.329  -5.537   8.171  1.00 83.19           O  \nATOM    228  N   THR A  34     -11.390  -7.712   8.696  1.00 80.75           N  \nATOM    229  CA  THR A  34      -9.952  -7.845   9.002  1.00 80.75           C  \nATOM    230  C   THR A  34      -9.257  -8.871   8.092  1.00 80.75           C  \nATOM    231  CB  THR A  34      -9.747  -8.162  10.493  1.00 80.75           C  \nATOM    232  O   THR A  34      -9.889  -9.506   7.241  1.00 80.75           O  \nATOM    233  CG2 THR A  34     -10.290  -7.071  11.417  1.00 80.75           C  \nATOM    234  OG1 THR A  34     -10.408  -9.353  10.824  1.00 80.75           O  \nATOM    235  N   SER A  35      -7.928  -8.990   8.190  1.00 85.12           N  \nATOM    236  CA  SER A  35      -7.113 -10.007   7.484  1.00 85.12           C  \nATOM    237  C   SER A  35      -5.862 -10.418   8.285  1.00 85.12           C  \nATOM    238  CB  SER A  35      -6.746  -9.520   6.075  1.00 85.12           C  \nATOM    239  O   SER A  35      -4.821 -10.764   7.724  1.00 85.12           O  \nATOM    240  OG  SER A  35      -7.906  -9.493   5.267  1.00 85.12           O  \nATOM    241  N   ASN A  36      -5.970 -10.372   9.613  1.00 80.06           N  \nATOM    242  CA  ASN A  36      -4.903 -10.626  10.584  1.00 80.06           C  \nATOM    243  C   ASN A  36      -4.669 -12.126  10.831  1.00 80.06           C  \nATOM    244  CB  ASN A  36      -5.279  -9.901  11.889  1.00 80.06           C  \nATOM    245  O   ASN A  36      -3.629 -12.510  11.365  1.00 80.06           O  \nATOM    246  CG  ASN A  36      -5.413  -8.401  11.698  1.00 80.06           C  \nATOM    247  ND2 ASN A  36      -6.398  -7.780  12.304  1.00 80.06           N  \nATOM    248  OD1 ASN A  36      -4.664  -7.771  10.977  1.00 80.06           O  \nATOM    249  N   LYS A  37      -5.611 -12.994  10.438  1.00 88.38           N  \nATOM    250  CA  LYS A  37      -5.571 -14.455  10.613  1.00 88.38           C  \nATOM    251  C   LYS A  37      -5.400 -14.856  12.082  1.00 88.38           C  \nATOM    252  CB  LYS A  37      -4.558 -15.097   9.639  1.00 88.38           C  \nATOM    253  O   LYS A  37      -6.372 -14.864  12.827  1.00 88.38           O  \nATOM    254  CG  LYS A  37      -4.910 -14.806   8.173  1.00 88.38           C  \nATOM    255  CD  LYS A  37      -3.813 -15.299   7.225  1.00 88.38           C  \nATOM    256  CE  LYS A  37      -4.196 -14.869   5.806  1.00 88.38           C  \nATOM    257  NZ  LYS A  37      -3.159 -15.240   4.815  1.00 88.38           N  \nATOM    258  N   LEU A  38      -4.181 -15.203  12.494  1.00 89.12           N  \nATOM    259  CA  LEU A  38      -3.834 -15.598  13.866  1.00 89.12           C  \nATOM    260  C   LEU A  38      -2.846 -14.613  14.520  1.00 89.12           C  \nATOM    261  CB  LEU A  38      -3.325 -17.056  13.894  1.00 89.12           C  \nATOM    262  O   LEU A  38      -2.198 -14.953  15.500  1.00 89.12           O  \nATOM    263  CG  LEU A  38      -4.299 -18.126  13.364  1.00 89.12           C  \nATOM    264  CD1 LEU A  38      -3.628 -19.499  13.444  1.00 89.12           C  \nATOM    265  CD2 LEU A  38      -5.609 -18.198  14.151  1.00 89.12           C  \nATOM    266  N   THR A  39      -2.698 -13.400  13.987  1.00 74.75           N  \nATOM    267  CA  THR A  39      -1.874 -12.354  14.603  1.00 74.75           C  \nATOM    268  C   THR A  39      -2.658 -11.651  15.711  1.00 74.75           C  \nATOM    269  CB  THR A  39      -1.383 -11.355  13.545  1.00 74.75           C  \nATOM    270  O   THR A  39      -3.715 -11.073  15.457  1.00 74.75           O  \nATOM    271  CG2 THR A  39      -0.460 -10.281  14.117  1.00 74.75           C  \nATOM    272  OG1 THR A  39      -0.609 -12.040  12.585  1.00 74.75           O  \nATOM    273  N   GLN A  40      -2.137 -11.688  16.939  1.00 79.69           N  \nATOM    274  CA  GLN A  40      -2.653 -10.909  18.067  1.00 79.69           C  \nATOM    275  C   GLN A  40      -2.235  -9.434  17.933  1.00 79.69           C  \nATOM    276  CB  GLN A  40      -2.145 -11.533  19.379  1.00 79.69           C  \nATOM    277  O   GLN A  40      -1.078  -9.149  17.616  1.00 79.69           O  \nATOM    278  CG  GLN A  40      -2.761 -10.877  20.625  1.00 79.69           C  \nATOM    279  CD  GLN A  40      -2.260 -11.502  21.924  1.00 79.69           C  \nATOM    280  NE2 GLN A  40      -1.949 -10.705  22.920  1.00 79.69           N  \nATOM    281  OE1 GLN A  40      -2.137 -12.708  22.074  1.00 79.69           O  \nATOM    282  N   LEU A  41      -3.155  -8.502  18.194  1.00 67.25           N  \nATOM    283  CA  LEU A  41      -2.901  -7.060  18.169  1.00 67.25           C  \nATOM    284  C   LEU A  41      -2.782  -6.511  19.599  1.00 67.25           C  \nATOM    285  CB  LEU A  41      -4.027  -6.347  17.395  1.00 67.25           C  \nATOM    286  O   LEU A  41      -3.789  -6.298  20.265  1.00 67.25           O  \nATOM    287  CG  LEU A  41      -4.254  -6.810  15.945  1.00 67.25           C  \nATOM    288  CD1 LEU A  41      -5.393  -5.984  15.347  1.00 67.25           C  \nATOM    289  CD2 LEU A  41      -3.015  -6.638  15.063  1.00 67.25           C  \nATOM    290  N   GLY A  42      -1.556  -6.270  20.070  1.00 78.69           N  \nATOM    291  CA  GLY A  42      -1.314  -5.744  21.420  1.00 78.69           C  \nATOM    292  C   GLY A  42      -1.681  -6.740  22.528  1.00 78.69           C  \nATOM    293  O   GLY A  42      -1.478  -7.951  22.389  1.00 78.69           O  \nATOM    294  N   THR A  43      -2.197  -6.243  23.653  1.00 84.19           N  \nATOM    295  CA  THR A  43      -2.742  -7.090  24.727  1.00 84.19           C  \nATOM    296  C   THR A  43      -4.087  -7.713  24.326  1.00 84.19           C  \nATOM    297  CB  THR A  43      -2.905  -6.311  26.043  1.00 84.19           C  \nATOM    298  O   THR A  43      -4.690  -7.348  23.319  1.00 84.19           O  \nATOM    299  CG2 THR A  43      -1.638  -5.594  26.506  1.00 84.19           C  \nATOM    300  OG1 THR A  43      -3.950  -5.381  25.938  1.00 84.19           O  \nATOM    301  N   PHE A  44      -4.610  -8.647  25.130  1.00 89.12           N  \nATOM    302  CA  PHE A  44      -5.964  -9.176  24.911  1.00 89.12           C  \nATOM    303  C   PHE A  44      -7.054  -8.093  24.995  1.00 89.12           C  \nATOM    304  CB  PHE A  44      -6.260 -10.298  25.918  1.00 89.12           C  \nATOM    305  O   PHE A  44      -8.082  -8.222  24.333  1.00 89.12           O  \nATOM    306  CG  PHE A  44      -5.355 -11.514  25.826  1.00 89.12           C  \nATOM    307  CD1 PHE A  44      -5.150 -12.148  24.587  1.00 89.12           C  \nATOM    308  CD2 PHE A  44      -4.727 -12.025  26.979  1.00 89.12           C  \nATOM    309  CE1 PHE A  44      -4.313 -13.272  24.494  1.00 89.12           C  \nATOM    310  CE2 PHE A  44      -3.896 -13.157  26.888  1.00 89.12           C  \nATOM    311  CZ  PHE A  44      -3.686 -13.779  25.645  1.00 89.12           C  \nATOM    312  N   GLU A  45      -6.826  -7.030  25.773  1.00 88.44           N  \nATOM    313  CA  GLU A  45      -7.754  -5.903  25.890  1.00 88.44           C  \nATOM    314  C   GLU A  45      -7.680  -4.998  24.651  1.00 88.44           C  \nATOM    315  CB  GLU A  45      -7.477  -5.155  27.204  1.00 88.44           C  \nATOM    316  O   GLU A  45      -8.718  -4.693  24.067  1.00 88.44           O  \nATOM    317  CG  GLU A  45      -8.580  -4.134  27.526  1.00 88.44           C  \nATOM    318  CD  GLU A  45      -8.465  -3.510  28.930  1.00 88.44           C  \nATOM    319  OE1 GLU A  45      -9.249  -2.569  29.192  1.00 88.44           O  \nATOM    320  OE2 GLU A  45      -7.642  -3.989  29.745  1.00 88.44           O  \nATOM    321  N   ASP A  46      -6.477  -4.665  24.165  1.00 82.12           N  \nATOM    322  CA  ASP A  46      -6.289  -3.905  22.915  1.00 82.12           C  \nATOM    323  C   ASP A  46      -6.910  -4.628  21.711  1.00 82.12           C  \nATOM    324  CB  ASP A  46      -4.798  -3.696  22.614  1.00 82.12           C  \nATOM    325  O   ASP A  46      -7.598  -4.019  20.883  1.00 82.12           O  \nATOM    326  CG  ASP A  46      -4.048  -2.971  23.722  1.00 82.12           C  \nATOM    327  OD1 ASP A  46      -4.439  -1.832  24.046  1.00 82.12           O  \nATOM    328  OD2 ASP A  46      -3.088  -3.592  24.241  1.00 82.12           O  \nATOM    329  N   HIS A  47      -6.707  -5.948  21.634  1.00 84.00           N  \nATOM    330  CA  HIS A  47      -7.253  -6.799  20.578  1.00 84.00           C  \nATOM    331  C   HIS A  47      -8.786  -6.845  20.632  1.00 84.00           C  \nATOM    332  CB  HIS A  47      -6.631  -8.196  20.695  1.00 84.00           C  \nATOM    333  O   HIS A  47      -9.446  -6.676  19.604  1.00 84.00           O  \nATOM    334  CG  HIS A  47      -6.887  -9.057  19.488  1.00 84.00           C  \nATOM    335  CD2 HIS A  47      -7.814 -10.050  19.402  1.00 84.00           C  \nATOM    336  ND1 HIS A  47      -6.186  -8.990  18.282  1.00 84.00           N  \nATOM    337  CE1 HIS A  47      -6.715  -9.936  17.494  1.00 84.00           C  \nATOM    338  NE2 HIS A  47      -7.688 -10.594  18.144  1.00 84.00           N  \nATOM    339  N   PHE A  48      -9.372  -6.989  21.827  1.00 93.06           N  \nATOM    340  CA  PHE A  48     -10.825  -6.924  22.013  1.00 93.06           C  \nATOM    341  C   PHE A  48     -11.397  -5.536  21.687  1.00 93.06           C  \nATOM    342  CB  PHE A  48     -11.197  -7.336  23.443  1.00 93.06           C  \nATOM    343  O   PHE A  48     -12.412  -5.446  20.998  1.00 93.06           O  \nATOM    344  CG  PHE A  48     -12.661  -7.087  23.755  1.00 93.06           C  \nATOM    345  CD1 PHE A  48     -13.054  -5.861  24.328  1.00 93.06           C  \nATOM    346  CD2 PHE A  48     -13.636  -8.048  23.422  1.00 93.06           C  \nATOM    347  CE1 PHE A  48     -14.413  -5.593  24.565  1.00 93.06           C  \nATOM    348  CE2 PHE A  48     -14.995  -7.787  23.682  1.00 93.06           C  \nATOM    349  CZ  PHE A  48     -15.382  -6.559  24.248  1.00 93.06           C  \nATOM    350  N   LEU A  49     -10.759  -4.450  22.130  1.00 88.38           N  \nATOM    351  CA  LEU A  49     -11.206  -3.085  21.835  1.00 88.38           C  \nATOM    352  C   LEU A  49     -11.119  -2.780  20.332  1.00 88.38           C  \nATOM    353  CB  LEU A  49     -10.375  -2.084  22.660  1.00 88.38           C  \nATOM    354  O   LEU A  49     -11.988  -2.094  19.793  1.00 88.38           O  \nATOM    355  CG  LEU A  49     -10.694  -2.081  24.169  1.00 88.38           C  \nATOM    356  CD1 LEU A  49      -9.679  -1.203  24.900  1.00 88.38           C  \nATOM    357  CD2 LEU A  49     -12.092  -1.524  24.462  1.00 88.38           C  \nATOM    358  N   SER A  50     -10.124  -3.333  19.637  1.00 83.69           N  \nATOM    359  CA  SER A  50     -10.003  -3.255  18.175  1.00 83.69           C  \nATOM    360  C   SER A  50     -11.117  -4.040  17.470  1.00 83.69           C  \nATOM    361  CB  SER A  50      -8.623  -3.752  17.731  1.00 83.69           C  \nATOM    362  O   SER A  50     -11.783  -3.502  16.583  1.00 83.69           O  \nATOM    363  OG  SER A  50      -7.614  -2.983  18.356  1.00 83.69           O  \nATOM    364  N   LEU A  51     -11.394  -5.272  17.919  1.00 89.81           N  \nATOM    365  CA  LEU A  51     -12.515  -6.096  17.448  1.00 89.81           C  \nATOM    366  C   LEU A  51     -13.863  -5.379  17.648  1.00 89.81           C  \nATOM    367  CB  LEU A  51     -12.476  -7.439  18.212  1.00 89.81           C  \nATOM    368  O   LEU A  51     -14.686  -5.321  16.732  1.00 89.81           O  \nATOM    369  CG  LEU A  51     -13.526  -8.467  17.757  1.00 89.81           C  \nATOM    370  CD1 LEU A  51     -13.111  -9.125  16.446  1.00 89.81           C  \nATOM    371  CD2 LEU A  51     -13.690  -9.572  18.800  1.00 89.81           C  \nATOM    372  N   GLN A  52     -14.074  -4.794  18.829  1.00 92.12           N  \nATOM    373  CA  GLN A  52     -15.284  -4.050  19.159  1.00 92.12           C  \nATOM    374  C   GLN A  52     -15.432  -2.817  18.261  1.00 92.12           C  \nATOM    375  CB  GLN A  52     -15.279  -3.700  20.656  1.00 92.12           C  \nATOM    376  O   GLN A  52     -16.491  -2.637  17.668  1.00 92.12           O  \nATOM    377  CG  GLN A  52     -16.623  -3.108  21.106  1.00 92.12           C  \nATOM    378  CD  GLN A  52     -16.641  -2.795  22.599  1.00 92.12           C  \nATOM    379  NE2 GLN A  52     -17.627  -3.255  23.338  1.00 92.12           N  \nATOM    380  OE1 GLN A  52     -15.786  -2.108  23.128  1.00 92.12           O  \nATOM    381  N   ARG A  53     -14.381  -2.003  18.086  1.00 85.94           N  \nATOM    382  CA  ARG A  53     -14.412  -0.827  17.193  1.00 85.94           C  \nATOM    383  C   ARG A  53     -14.750  -1.198  15.745  1.00 85.94           C  \nATOM    384  CB  ARG A  53     -13.071  -0.080  17.255  1.00 85.94           C  \nATOM    385  O   ARG A  53     -15.582  -0.526  15.146  1.00 85.94           O  \nATOM    386  CG  ARG A  53     -12.896   0.711  18.560  1.00 85.94           C  \nATOM    387  CD  ARG A  53     -11.444   1.185  18.683  1.00 85.94           C  \nATOM    388  NE  ARG A  53     -11.167   1.778  20.005  1.00 85.94           N  \nATOM    389  NH1 ARG A  53      -8.956   2.285  19.633  1.00 85.94           N  \nATOM    390  NH2 ARG A  53      -9.838   2.634  21.648  1.00 85.94           N  \nATOM    391  CZ  ARG A  53      -9.997   2.234  20.418  1.00 85.94           C  \nATOM    392  N   MET A  54     -14.161  -2.271  15.211  1.00 88.25           N  \nATOM    393  CA  MET A  54     -14.370  -2.715  13.824  1.00 88.25           C  \nATOM    394  C   MET A  54     -15.795  -3.232  13.553  1.00 88.25           C  \nATOM    395  CB  MET A  54     -13.317  -3.793  13.506  1.00 88.25           C  \nATOM    396  O   MET A  54     -16.340  -3.003  12.473  1.00 88.25           O  \nATOM    397  CG  MET A  54     -13.406  -4.370  12.085  1.00 88.25           C  \nATOM    398  SD  MET A  54     -13.289  -3.189  10.711  1.00 88.25           S  \nATOM    399  CE  MET A  54     -11.576  -2.601  10.895  1.00 88.25           C  \nATOM    400  N   PHE A  55     -16.406  -3.938  14.513  1.00 94.38           N  \nATOM    401  CA  PHE A  55     -17.672  -4.654  14.294  1.00 94.38           C  \nATOM    402  C   PHE A  55     -18.894  -4.063  15.024  1.00 94.38           C  \nATOM    403  CB  PHE A  55     -17.450  -6.150  14.577  1.00 94.38           C  \nATOM    404  O   PHE A  55     -20.013  -4.535  14.811  1.00 94.38           O  \nATOM    405  CG  PHE A  55     -16.466  -6.817  13.625  1.00 94.38           C  \nATOM    406  CD1 PHE A  55     -16.791  -6.948  12.262  1.00 94.38           C  \nATOM    407  CD2 PHE A  55     -15.217  -7.283  14.080  1.00 94.38           C  \nATOM    408  CE1 PHE A  55     -15.869  -7.512  11.362  1.00 94.38           C  \nATOM    409  CE2 PHE A  55     -14.296  -7.853  13.179  1.00 94.38           C  \nATOM    410  CZ  PHE A  55     -14.619  -7.962  11.818  1.00 94.38           C  \nATOM    411  N   ASN A  56     -18.736  -3.018  15.845  1.00 91.56           N  \nATOM    412  CA  ASN A  56     -19.842  -2.366  16.556  1.00 91.56           C  \nATOM    413  C   ASN A  56     -20.905  -1.797  15.595  1.00 91.56           C  \nATOM    414  CB  ASN A  56     -19.271  -1.277  17.481  1.00 91.56           C  \nATOM    415  O   ASN A  56     -20.640  -0.886  14.814  1.00 91.56           O  \nATOM    416  CG  ASN A  56     -20.323  -0.544  18.284  1.00 91.56           C  \nATOM    417  ND2 ASN A  56     -20.051   0.678  18.676  1.00 91.56           N  \nATOM    418  OD1 ASN A  56     -21.390  -1.051  18.582  1.00 91.56           O  \nATOM    419  N   ASN A  57     -22.144  -2.287  15.701  1.00 92.38           N  \nATOM    420  CA  ASN A  57     -23.261  -1.999  14.790  1.00 92.38           C  \nATOM    421  C   ASN A  57     -23.051  -2.431  13.323  1.00 92.38           C  \nATOM    422  CB  ASN A  57     -23.712  -0.524  14.862  1.00 92.38           C  \nATOM    423  O   ASN A  57     -23.805  -1.978  12.461  1.00 92.38           O  \nATOM    424  CG  ASN A  57     -23.967   0.009  16.250  1.00 92.38           C  \nATOM    425  ND2 ASN A  57     -23.006   0.681  16.827  1.00 92.38           N  \nATOM    426  OD1 ASN A  57     -25.061  -0.082  16.772  1.00 92.38           O  \nATOM    427  N   CYS A  58     -22.065  -3.272  13.004  1.00 92.19           N  \nATOM    428  CA  CYS A  58     -21.886  -3.762  11.638  1.00 92.19           C  \nATOM    429  C   CYS A  58     -22.952  -4.810  11.284  1.00 92.19           C  \nATOM    430  CB  CYS A  58     -20.469  -4.309  11.469  1.00 92.19           C  \nATOM    431  O   CYS A  58     -23.188  -5.741  12.054  1.00 92.19           O  \nATOM    432  SG  CYS A  58     -20.107  -4.840   9.776  1.00 92.19           S  \nATOM    433  N   GLU A  59     -23.581  -4.680  10.114  1.00 96.00           N  \nATOM    434  CA  GLU A  59     -24.543  -5.651   9.572  1.00 96.00           C  \nATOM    435  C   GLU A  59     -23.968  -6.433   8.378  1.00 96.00           C  \nATOM    436  CB  GLU A  59     -25.838  -4.936   9.159  1.00 96.00           C  \nATOM    437  O   GLU A  59     -24.346  -7.584   8.157  1.00 96.00           O  \nATOM    438  CG  GLU A  59     -26.599  -4.286  10.323  1.00 96.00           C  \nATOM    439  CD  GLU A  59     -27.850  -3.586   9.789  1.00 96.00           C  \nATOM    440  OE1 GLU A  59     -28.938  -4.208   9.816  1.00 96.00           O  \nATOM    441  OE2 GLU A  59     -27.700  -2.450   9.284  1.00 96.00           O  \nATOM    442  N   VAL A  60     -23.045  -5.834   7.619  1.00 92.00           N  \nATOM    443  CA  VAL A  60     -22.401  -6.431   6.439  1.00 92.00           C  \nATOM    444  C   VAL A  60     -20.886  -6.230   6.512  1.00 92.00           C  \nATOM    445  CB  VAL A  60     -22.977  -5.830   5.141  1.00 92.00           C  \nATOM    446  O   VAL A  60     -20.391  -5.112   6.374  1.00 92.00           O  \nATOM    447  CG1 VAL A  60     -22.288  -6.390   3.888  1.00 92.00           C  \nATOM    448  CG2 VAL A  60     -24.483  -6.096   5.008  1.00 92.00           C  \nATOM    449  N   VAL A  61     -20.140  -7.318   6.696  1.00 90.94           N  \nATOM    450  CA  VAL A  61     -18.672  -7.309   6.670  1.00 90.94           C  \nATOM    451  C   VAL A  61     -18.200  -7.436   5.221  1.00 90.94           C  \nATOM    452  CB  VAL A  61     -18.078  -8.431   7.544  1.00 90.94           C  \nATOM    453  O   VAL A  61     -18.451  -8.454   4.575  1.00 90.94           O  \nATOM    454  CG1 VAL A  61     -16.562  -8.264   7.654  1.00 90.94           C  \nATOM    455  CG2 VAL A  61     -18.663  -8.458   8.964  1.00 90.94           C  \nATOM    456  N   LEU A  62     -17.520  -6.406   4.709  1.00 83.88           N  \nATOM    457  CA  LEU A  62     -17.015  -6.363   3.328  1.00 83.88           C  \nATOM    458  C   LEU A  62     -15.749  -7.212   3.117  1.00 83.88           C  \nATOM    459  CB  LEU A  62     -16.741  -4.898   2.941  1.00 83.88           C  \nATOM    460  O   LEU A  62     -15.473  -7.629   1.999  1.00 83.88           O  \nATOM    461  CG  LEU A  62     -17.978  -3.980   2.912  1.00 83.88           C  \nATOM    462  CD1 LEU A  62     -17.525  -2.545   2.634  1.00 83.88           C  \nATOM    463  CD2 LEU A  62     -18.986  -4.382   1.832  1.00 83.88           C  \nATOM    464  N   GLY A  63     -14.982  -7.455   4.181  1.00 84.44           N  \nATOM    465  CA  GLY A  63     -13.842  -8.371   4.211  1.00 84.44           C  \nATOM    466  C   GLY A  63     -14.158  -9.646   4.994  1.00 84.44           C  \nATOM    467  O   GLY A  63     -15.250 -10.208   4.882  1.00 84.44           O  \nATOM    468  N   ASN A  64     -13.206 -10.088   5.815  1.00 92.62           N  \nATOM    469  CA  ASN A  64     -13.350 -11.263   6.677  1.00 92.62           C  \nATOM    470  C   ASN A  64     -13.797 -10.864   8.092  1.00 92.62           C  \nATOM    471  CB  ASN A  64     -12.039 -12.070   6.698  1.00 92.62           C  \nATOM    472  O   ASN A  64     -13.499  -9.764   8.565  1.00 92.62           O  \nATOM    473  CG  ASN A  64     -11.418 -12.193   5.322  1.00 92.62           C  \nATOM    474  ND2 ASN A  64     -10.363 -11.459   5.064  1.00 92.62           N  \nATOM    475  OD1 ASN A  64     -11.918 -12.881   4.447  1.00 92.62           O  \nATOM    476  N   LEU A  65     -14.477 -11.780   8.780  1.00 97.81           N  \nATOM    477  CA  LEU A  65     -14.811 -11.672  10.199  1.00 97.81           C  \nATOM    478  C   LEU A  65     -13.867 -12.579  10.993  1.00 97.81           C  \nATOM    479  CB  LEU A  65     -16.293 -12.042  10.382  1.00 97.81           C  \nATOM    480  O   LEU A  65     -14.027 -13.798  10.980  1.00 97.81           O  \nATOM    481  CG  LEU A  65     -16.758 -12.167  11.845  1.00 97.81           C  \nATOM    482  CD1 LEU A  65     -16.607 -10.863  12.629  1.00 97.81           C  \nATOM    483  CD2 LEU A  65     -18.229 -12.578  11.869  1.00 97.81           C  \nATOM    484  N   GLU A  66     -12.888 -11.996  11.679  1.00 97.56           N  \nATOM    485  CA  GLU A  66     -11.914 -12.741  12.481  1.00 97.56           C  \nATOM    486  C   GLU A  66     -12.122 -12.426  13.963  1.00 97.56           C  \nATOM    487  CB  GLU A  66     -10.477 -12.444  12.026  1.00 97.56           C  \nATOM    488  O   GLU A  66     -11.914 -11.301  14.409  1.00 97.56           O  \nATOM    489  CG  GLU A  66     -10.276 -12.672  10.517  1.00 97.56           C  \nATOM    490  CD  GLU A  66      -8.887 -12.245  10.046  1.00 97.56           C  \nATOM    491  OE1 GLU A  66      -8.229 -13.019   9.311  1.00 97.56           O  \nATOM    492  OE2 GLU A  66      -8.477 -11.111  10.381  1.00 97.56           O  \nATOM    493  N   ILE A  67     -12.552 -13.429  14.724  1.00 97.94           N  \nATOM    494  CA  ILE A  67     -12.763 -13.357  16.169  1.00 97.94           C  \nATOM    495  C   ILE A  67     -11.695 -14.244  16.795  1.00 97.94           C  \nATOM    496  CB  ILE A  67     -14.199 -13.792  16.534  1.00 97.94           C  \nATOM    497  O   ILE A  67     -11.781 -15.475  16.741  1.00 97.94           O  \nATOM    498  CG1 ILE A  67     -15.256 -12.896  15.844  1.00 97.94           C  \nATOM    499  CG2 ILE A  67     -14.396 -13.752  18.063  1.00 97.94           C  \nATOM    500  CD1 ILE A  67     -16.625 -13.574  15.750  1.00 97.94           C  \nATOM    501  N   THR A  68     -10.652 -13.625  17.336  1.00 96.50           N  \nATOM    502  CA  THR A  68      -9.498 -14.337  17.891  1.00 96.50           C  \nATOM    503  C   THR A  68      -9.097 -13.811  19.256  1.00 96.50           C  \nATOM    504  CB  THR A  68      -8.297 -14.339  16.929  1.00 96.50           C  \nATOM    505  O   THR A  68      -9.355 -12.654  19.572  1.00 96.50           O  \nATOM    506  CG2 THR A  68      -8.582 -15.109  15.642  1.00 96.50           C  \nATOM    507  OG1 THR A  68      -7.953 -13.028  16.542  1.00 96.50           O  \nATOM    508  N   TYR A  69      -8.460 -14.664  20.064  1.00 95.62           N  \nATOM    509  CA  TYR A  69      -7.874 -14.319  21.367  1.00 95.62           C  \nATOM    510  C   TYR A  69      -8.828 -13.707  22.418  1.00 95.62           C  \nATOM    511  CB  TYR A  69      -6.610 -13.469  21.149  1.00 95.62           C  \nATOM    512  O   TYR A  69      -8.363 -13.261  23.471  1.00 95.62           O  \nATOM    513  CG  TYR A  69      -5.534 -14.150  20.329  1.00 95.62           C  \nATOM    514  CD1 TYR A  69      -4.765 -15.168  20.924  1.00 95.62           C  \nATOM    515  CD2 TYR A  69      -5.289 -13.765  18.995  1.00 95.62           C  \nATOM    516  CE1 TYR A  69      -3.738 -15.793  20.198  1.00 95.62           C  \nATOM    517  CE2 TYR A  69      -4.275 -14.407  18.257  1.00 95.62           C  \nATOM    518  OH  TYR A  69      -2.499 -16.025  18.175  1.00 95.62           O  \nATOM    519  CZ  TYR A  69      -3.492 -15.412  18.864  1.00 95.62           C  \nATOM    520  N   VAL A  70     -10.149 -13.709  22.190  1.00 96.69           N  \nATOM    521  CA  VAL A  70     -11.130 -13.130  23.121  1.00 96.69           C  \nATOM    522  C   VAL A  70     -11.228 -13.994  24.373  1.00 96.69           C  \nATOM    523  CB  VAL A  70     -12.523 -12.938  22.490  1.00 96.69           C  \nATOM    524  O   VAL A  70     -11.530 -15.190  24.302  1.00 96.69           O  \nATOM    525  CG1 VAL A  70     -13.452 -12.219  23.481  1.00 96.69           C  \nATOM    526  CG2 VAL A  70     -12.463 -12.089  21.214  1.00 96.69           C  \nATOM    527  N   GLN A  71     -10.974 -13.384  25.529  1.00 95.12           N  \nATOM    528  CA  GLN A  71     -10.907 -14.099  26.799  1.00 95.12           C  \nATOM    529  C   GLN A  71     -12.285 -14.308  27.446  1.00 95.12           C  \nATOM    530  CB  GLN A  71      -9.903 -13.415  27.746  1.00 95.12           C  \nATOM    531  O   GLN A  71     -13.275 -13.671  27.077  1.00 95.12           O  \nATOM    532  CG  GLN A  71      -8.475 -13.359  27.175  1.00 95.12           C  \nATOM    533  CD  GLN A  71      -7.937 -14.739  26.801  1.00 95.12           C  \nATOM    534  NE2 GLN A  71      -7.321 -14.879  25.652  1.00 95.12           N  \nATOM    535  OE1 GLN A  71      -8.115 -15.725  27.506  1.00 95.12           O  \nATOM    536  N   ARG A  72     -12.348 -15.189  28.453  1.00 93.44           N  \nATOM    537  CA  ARG A  72     -13.512 -15.337  29.346  1.00 93.44           C  \nATOM    538  C   ARG A  72     -14.016 -13.969  29.836  1.00 93.44           C  \nATOM    539  CB  ARG A  72     -13.166 -16.207  30.567  1.00 93.44           C  \nATOM    540  O   ARG A  72     -13.226 -13.067  30.097  1.00 93.44           O  \nATOM    541  CG  ARG A  72     -12.737 -17.653  30.259  1.00 93.44           C  \nATOM    542  CD  ARG A  72     -12.603 -18.410  31.586  1.00 93.44           C  \nATOM    543  NE  ARG A  72     -11.884 -19.699  31.488  1.00 93.44           N  \nATOM    544  NH1 ARG A  72     -12.264 -20.348  33.659  1.00 93.44           N  \nATOM    545  NH2 ARG A  72     -10.871 -21.522  32.408  1.00 93.44           N  \nATOM    546  CZ  ARG A  72     -11.678 -20.516  32.505  1.00 93.44           C  \nATOM    547  N   ASN A  73     -15.330 -13.862  30.032  1.00 90.62           N  \nATOM    548  CA  ASN A  73     -16.048 -12.696  30.576  1.00 90.62           C  \nATOM    549  C   ASN A  73     -16.086 -11.423  29.700  1.00 90.62           C  \nATOM    550  CB  ASN A  73     -15.575 -12.392  32.014  1.00 90.62           C  \nATOM    551  O   ASN A  73     -16.746 -10.465  30.096  1.00 90.62           O  \nATOM    552  CG  ASN A  73     -15.505 -13.595  32.940  1.00 90.62           C  \nATOM    553  ND2 ASN A  73     -14.720 -13.505  33.987  1.00 90.62           N  \nATOM    554  OD1 ASN A  73     -16.128 -14.626  32.752  1.00 90.62           O  \nATOM    555  N   TYR A  74     -15.453 -11.394  28.523  1.00 94.12           N  \nATOM    556  CA  TYR A  74     -15.603 -10.285  27.572  1.00 94.12           C  \nATOM    557  C   TYR A  74     -16.968 -10.322  26.863  1.00 94.12           C  \nATOM    558  CB  TYR A  74     -14.452 -10.307  26.561  1.00 94.12           C  \nATOM    559  O   TYR A  74     -17.419 -11.383  26.429  1.00 94.12           O  \nATOM    560  CG  TYR A  74     -13.178  -9.657  27.067  1.00 94.12           C  \nATOM    561  CD1 TYR A  74     -12.934  -8.303  26.776  1.00 94.12           C  \nATOM    562  CD2 TYR A  74     -12.248 -10.382  27.837  1.00 94.12           C  \nATOM    563  CE1 TYR A  74     -11.738  -7.688  27.187  1.00 94.12           C  \nATOM    564  CE2 TYR A  74     -11.059  -9.762  28.277  1.00 94.12           C  \nATOM    565  OH  TYR A  74      -9.645  -7.813  28.322  1.00 94.12           O  \nATOM    566  CZ  TYR A  74     -10.794  -8.419  27.931  1.00 94.12           C  \nATOM    567  N   ASP A  75     -17.620  -9.162  26.715  1.00 95.31           N  \nATOM    568  CA  ASP A  75     -18.930  -9.068  26.060  1.00 95.31           C  \nATOM    569  C   ASP A  75     -18.816  -8.923  24.535  1.00 95.31           C  \nATOM    570  CB  ASP A  75     -19.791  -7.941  26.654  1.00 95.31           C  \nATOM    571  O   ASP A  75     -18.370  -7.902  24.015  1.00 95.31           O  \nATOM    572  CG  ASP A  75     -21.156  -7.883  25.952  1.00 95.31           C  \nATOM    573  OD1 ASP A  75     -21.636  -8.948  25.496  1.00 95.31           O  \nATOM    574  OD2 ASP A  75     -21.718  -6.781  25.784  1.00 95.31           O  \nATOM    575  N   LEU A  76     -19.293  -9.937  23.813  1.00 97.31           N  \nATOM    576  CA  LEU A  76     -19.389  -9.954  22.351  1.00 97.31           C  \nATOM    577  C   LEU A  76     -20.801  -9.631  21.826  1.00 97.31           C  \nATOM    578  CB  LEU A  76     -18.834 -11.292  21.833  1.00 97.31           C  \nATOM    579  O   LEU A  76     -21.103  -9.915  20.665  1.00 97.31           O  \nATOM    580  CG  LEU A  76     -17.316 -11.480  22.007  1.00 97.31           C  \nATOM    581  CD1 LEU A  76     -16.955 -12.877  21.510  1.00 97.31           C  \nATOM    582  CD2 LEU A  76     -16.501 -10.473  21.192  1.00 97.31           C  \nATOM    583  N   SER A  77     -21.683  -9.043  22.644  1.00 96.25           N  \nATOM    584  CA  SER A  77     -23.067  -8.696  22.273  1.00 96.25           C  \nATOM    585  C   SER A  77     -23.191  -7.894  20.973  1.00 96.25           C  \nATOM    586  CB  SER A  77     -23.739  -7.898  23.399  1.00 96.25           C  \nATOM    587  O   SER A  77     -24.144  -8.104  20.219  1.00 96.25           O  \nATOM    588  OG  SER A  77     -23.107  -6.649  23.587  1.00 96.25           O  \nATOM    589  N   PHE A  78     -22.209  -7.041  20.664  1.00 95.94           N  \nATOM    590  CA  PHE A  78     -22.155  -6.242  19.437  1.00 95.94           C  \nATOM    591  C   PHE A  78     -22.149  -7.089  18.153  1.00 95.94           C  \nATOM    592  CB  PHE A  78     -20.943  -5.299  19.497  1.00 95.94           C  \nATOM    593  O   PHE A  78     -22.699  -6.657  17.143  1.00 95.94           O  \nATOM    594  CG  PHE A  78     -19.582  -5.970  19.604  1.00 95.94           C  \nATOM    595  CD1 PHE A  78     -19.011  -6.212  20.869  1.00 95.94           C  \nATOM    596  CD2 PHE A  78     -18.868  -6.321  18.440  1.00 95.94           C  \nATOM    597  CE1 PHE A  78     -17.731  -6.784  20.967  1.00 95.94           C  \nATOM    598  CE2 PHE A  78     -17.596  -6.914  18.544  1.00 95.94           C  \nATOM    599  CZ  PHE A  78     -17.025  -7.141  19.807  1.00 95.94           C  \nATOM    600  N   LEU A  79     -21.632  -8.325  18.189  1.00 98.00           N  \nATOM    601  CA  LEU A  79     -21.643  -9.237  17.037  1.00 98.00           C  \nATOM    602  C   LEU A  79     -23.060  -9.650  16.600  1.00 98.00           C  \nATOM    603  CB  LEU A  79     -20.813 -10.491  17.355  1.00 98.00           C  \nATOM    604  O   LEU A  79     -23.238 -10.119  15.475  1.00 98.00           O  \nATOM    605  CG  LEU A  79     -19.314 -10.264  17.624  1.00 98.00           C  \nATOM    606  CD1 LEU A  79     -18.671 -11.631  17.855  1.00 98.00           C  \nATOM    607  CD2 LEU A  79     -18.589  -9.606  16.448  1.00 98.00           C  \nATOM    608  N   LYS A  80     -24.084  -9.443  17.445  1.00 97.12           N  \nATOM    609  CA  LYS A  80     -25.486  -9.743  17.111  1.00 97.12           C  \nATOM    610  C   LYS A  80     -26.034  -8.920  15.941  1.00 97.12           C  \nATOM    611  CB  LYS A  80     -26.398  -9.546  18.335  1.00 97.12           C  \nATOM    612  O   LYS A  80     -27.078  -9.297  15.413  1.00 97.12           O  \nATOM    613  CG  LYS A  80     -26.194 -10.608  19.424  1.00 97.12           C  \nATOM    614  CD  LYS A  80     -27.227 -10.428  20.544  1.00 97.12           C  \nATOM    615  CE  LYS A  80     -27.034 -11.488  21.636  1.00 97.12           C  \nATOM    616  NZ  LYS A  80     -28.298 -12.174  21.991  1.00 97.12           N  \nATOM    617  N   THR A  81     -25.403  -7.815  15.535  1.00 97.06           N  \nATOM    618  CA  THR A  81     -25.881  -7.029  14.381  1.00 97.06           C  \nATOM    619  C   THR A  81     -25.489  -7.633  13.032  1.00 97.06           C  \nATOM    620  CB  THR A  81     -25.455  -5.554  14.465  1.00 97.06           C  \nATOM    621  O   THR A  81     -26.187  -7.391  12.046  1.00 97.06           O  \nATOM    622  CG2 THR A  81     -26.074  -4.882  15.693  1.00 97.06           C  \nATOM    623  OG1 THR A  81     -24.062  -5.409  14.584  1.00 97.06           O  \nATOM    624  N   ILE A  82     -24.429  -8.452  12.982  1.00 97.94           N  \nATOM    625  CA  ILE A  82     -23.870  -8.988  11.734  1.00 97.94           C  \nATOM    626  C   ILE A  82     -24.861  -9.956  11.073  1.00 97.94           C  \nATOM    627  CB  ILE A  82     -22.480  -9.633  11.964  1.00 97.94           C  \nATOM    628  O   ILE A  82     -25.366 -10.881  11.708  1.00 97.94           O  \nATOM    629  CG1 ILE A  82     -21.493  -8.617  12.594  1.00 97.94           C  \nATOM    630  CG2 ILE A  82     -21.921 -10.168  10.628  1.00 97.94           C  \nATOM    631  CD1 ILE A  82     -20.117  -9.200  12.937  1.00 97.94           C  \nATOM    632  N   GLN A  83     -25.112  -9.743   9.779  1.00 97.25           N  \nATOM    633  CA  GLN A  83     -26.015 -10.530   8.932  1.00 97.25           C  \nATOM    634  C   GLN A  83     -25.308 -11.136   7.716  1.00 97.25           C  \nATOM    635  CB  GLN A  83     -27.164  -9.641   8.443  1.00 97.25           C  \nATOM    636  O   GLN A  83     -25.675 -12.227   7.286  1.00 97.25           O  \nATOM    637  CG  GLN A  83     -28.138  -9.244   9.558  1.00 97.25           C  \nATOM    638  CD  GLN A  83     -28.910  -7.993   9.163  1.00 97.25           C  \nATOM    639  NE2 GLN A  83     -28.834  -6.966   9.977  1.00 97.25           N  \nATOM    640  OE1 GLN A  83     -29.523  -7.931   8.101  1.00 97.25           O  \nATOM    641  N   GLU A  84     -24.306 -10.465   7.150  1.00 96.75           N  \nATOM    642  CA  GLU A  84     -23.586 -10.947   5.965  1.00 96.75           C  \nATOM    643  C   GLU A  84     -22.073 -10.783   6.144  1.00 96.75           C  \nATOM    644  CB  GLU A  84     -24.066 -10.222   4.686  1.00 96.75           C  \nATOM    645  O   GLU A  84     -21.616  -9.754   6.642  1.00 96.75           O  \nATOM    646  CG  GLU A  84     -25.599 -10.152   4.531  1.00 96.75           C  \nATOM    647  CD  GLU A  84     -26.079  -9.598   3.181  1.00 96.75           C  \nATOM    648  OE1 GLU A  84     -27.106  -8.873   3.216  1.00 96.75           O  \nATOM    649  OE2 GLU A  84     -25.492  -9.940   2.123  1.00 96.75           O  \nATOM    650  N   VAL A  85     -21.295 -11.774   5.704  1.00 97.00           N  \nATOM    651  CA  VAL A  85     -19.828 -11.690   5.594  1.00 97.00           C  \nATOM    652  C   VAL A  85     -19.431 -12.025   4.159  1.00 97.00           C  \nATOM    653  CB  VAL A  85     -19.131 -12.616   6.615  1.00 97.00           C  \nATOM    654  O   VAL A  85     -19.848 -13.058   3.633  1.00 97.00           O  \nATOM    655  CG1 VAL A  85     -17.602 -12.573   6.482  1.00 97.00           C  \nATOM    656  CG2 VAL A  85     -19.484 -12.220   8.057  1.00 97.00           C  \nATOM    657  N   ALA A  86     -18.664 -11.152   3.505  1.00 92.38           N  \nATOM    658  CA  ALA A  86     -18.248 -11.348   2.117  1.00 92.38           C  \nATOM    659  C   ALA A  86     -17.040 -12.296   1.990  1.00 92.38           C  \nATOM    660  CB  ALA A  86     -17.983  -9.979   1.488  1.00 92.38           C  \nATOM    661  O   ALA A  86     -17.040 -13.189   1.145  1.00 92.38           O  \nATOM    662  N   GLY A  87     -16.032 -12.137   2.850  1.00 91.88           N  \nATOM    663  CA  GLY A  87     -14.872 -13.026   2.939  1.00 91.88           C  \nATOM    664  C   GLY A  87     -15.159 -14.318   3.714  1.00 91.88           C  \nATOM    665  O   GLY A  87     -16.236 -14.905   3.588  1.00 91.88           O  \nATOM    666  N   TYR A  88     -14.197 -14.748   4.534  1.00 97.62           N  \nATOM    667  CA  TYR A  88     -14.352 -15.872   5.465  1.00 97.62           C  \nATOM    668  C   TYR A  88     -14.737 -15.427   6.887  1.00 97.62           C  \nATOM    669  CB  TYR A  88     -13.087 -16.753   5.461  1.00 97.62           C  \nATOM    670  O   TYR A  88     -14.568 -14.270   7.277  1.00 97.62           O  \nATOM    671  CG  TYR A  88     -11.789 -16.076   5.880  1.00 97.62           C  \nATOM    672  CD1 TYR A  88     -10.861 -15.683   4.897  1.00 97.62           C  \nATOM    673  CD2 TYR A  88     -11.487 -15.864   7.241  1.00 97.62           C  \nATOM    674  CE1 TYR A  88      -9.645 -15.075   5.264  1.00 97.62           C  \nATOM    675  CE2 TYR A  88     -10.280 -15.234   7.609  1.00 97.62           C  \nATOM    676  OH  TYR A  88      -8.203 -14.193   6.963  1.00 97.62           O  \nATOM    677  CZ  TYR A  88      -9.359 -14.826   6.622  1.00 97.62           C  \nATOM    678  N   VAL A  89     -15.207 -16.384   7.689  1.00 98.56           N  \nATOM    679  CA  VAL A  89     -15.380 -16.279   9.143  1.00 98.56           C  \nATOM    680  C   VAL A  89     -14.348 -17.173   9.832  1.00 98.56           C  \nATOM    681  CB  VAL A  89     -16.813 -16.653   9.565  1.00 98.56           C  \nATOM    682  O   VAL A  89     -14.328 -18.387   9.622  1.00 98.56           O  \nATOM    683  CG1 VAL A  89     -17.001 -16.555  11.086  1.00 98.56           C  \nATOM    684  CG2 VAL A  89     -17.851 -15.733   8.914  1.00 98.56           C  \nATOM    685  N   LEU A  90     -13.501 -16.582  10.672  1.00 98.38           N  \nATOM    686  CA  LEU A  90     -12.498 -17.270  11.484  1.00 98.38           C  \nATOM    687  C   LEU A  90     -12.804 -17.045  12.965  1.00 98.38           C  \nATOM    688  CB  LEU A  90     -11.105 -16.751  11.096  1.00 98.38           C  \nATOM    689  O   LEU A  90     -12.910 -15.907  13.414  1.00 98.38           O  \nATOM    690  CG  LEU A  90      -9.941 -17.309  11.936  1.00 98.38           C  \nATOM    691  CD1 LEU A  90      -9.744 -18.814  11.740  1.00 98.38           C  \nATOM    692  CD2 LEU A  90      -8.660 -16.592  11.523  1.00 98.38           C  \nATOM    693  N   ILE A  91     -12.917 -18.127  13.728  1.00 98.50           N  \nATOM    694  CA  ILE A  91     -13.158 -18.107  15.172  1.00 98.50           C  \nATOM    695  C   ILE A  91     -12.099 -18.994  15.819  1.00 98.50           C  \nATOM    696  CB  ILE A  91     -14.602 -18.559  15.490  1.00 98.50           C  \nATOM    697  O   ILE A  91     -12.238 -20.219  15.812  1.00 98.50           O  \nATOM    698  CG1 ILE A  91     -15.629 -17.654  14.770  1.00 98.50           C  \nATOM    699  CG2 ILE A  91     -14.823 -18.548  17.011  1.00 98.50           C  \nATOM    700  CD1 ILE A  91     -17.096 -18.019  15.016  1.00 98.50           C  \nATOM    701  N   ALA A  92     -11.013 -18.409  16.326  1.00 97.62           N  \nATOM    702  CA  ALA A  92      -9.872 -19.195  16.796  1.00 97.62           C  \nATOM    703  C   ALA A  92      -9.213 -18.680  18.080  1.00 97.62           C  \nATOM    704  CB  ALA A  92      -8.859 -19.336  15.651  1.00 97.62           C  \nATOM    705  O   ALA A  92      -9.068 -17.478  18.277  1.00 97.62           O  \nATOM    706  N   LEU A  93      -8.738 -19.603  18.923  1.00 96.62           N  \nATOM    707  CA  LEU A  93      -7.977 -19.295  20.147  1.00 96.62           C  \nATOM    708  C   LEU A  93      -8.742 -18.426  21.173  1.00 96.62           C  \nATOM    709  CB  LEU A  93      -6.582 -18.726  19.779  1.00 96.62           C  \nATOM    710  O   LEU A  93      -8.130 -17.729  21.982  1.00 96.62           O  \nATOM    711  CG  LEU A  93      -5.776 -19.561  18.764  1.00 96.62           C  \nATOM    712  CD1 LEU A  93      -4.506 -18.819  18.352  1.00 96.62           C  \nATOM    713  CD2 LEU A  93      -5.367 -20.919  19.337  1.00 96.62           C  \nATOM    714  N   ASN A  94     -10.079 -18.454  21.152  1.00 97.44           N  \nATOM    715  CA  ASN A  94     -10.920 -17.747  22.123  1.00 97.44           C  \nATOM    716  C   ASN A  94     -11.214 -18.624  23.351  1.00 97.44           C  \nATOM    717  CB  ASN A  94     -12.228 -17.287  21.462  1.00 97.44           C  \nATOM    718  O   ASN A  94     -11.406 -19.834  23.223  1.00 97.44           O  \nATOM    719  CG  ASN A  94     -12.008 -16.472  20.206  1.00 97.44           C  \nATOM    720  ND2 ASN A  94     -12.198 -17.060  19.053  1.00 97.44           N  \nATOM    721  OD1 ASN A  94     -11.659 -15.306  20.249  1.00 97.44           O  \nATOM    722  N   THR A  95     -11.330 -18.007  24.530  1.00 96.44           N  \nATOM    723  CA  THR A  95     -11.718 -18.683  25.785  1.00 96.44           C  \nATOM    724  C   THR A  95     -13.096 -18.242  26.305  1.00 96.44           C  \nATOM    725  CB  THR A  95     -10.619 -18.583  26.864  1.00 96.44           C  \nATOM    726  O   THR A  95     -13.592 -18.801  27.280  1.00 96.44           O  \nATOM    727  CG2 THR A  95      -9.230 -18.945  26.336  1.00 96.44           C  \nATOM    728  OG1 THR A  95     -10.511 -17.286  27.397  1.00 96.44           O  \nATOM    729  N   VAL A  96     -13.750 -17.280  25.638  1.00 96.69           N  \nATOM    730  CA  VAL A  96     -15.135 -16.843  25.907  1.00 96.69           C  \nATOM    731  C   VAL A  96     -16.164 -17.968  25.687  1.00 96.69           C  \nATOM    732  CB  VAL A  96     -15.455 -15.587  25.067  1.00 96.69           C  \nATOM    733  O   VAL A  96     -16.073 -18.715  24.718  1.00 96.69           O  \nATOM    734  CG1 VAL A  96     -15.614 -15.876  23.570  1.00 96.69           C  \nATOM    735  CG2 VAL A  96     -16.705 -14.857  25.566  1.00 96.69           C  \nATOM    736  N   GLU A  97     -17.169 -18.080  26.566  1.00 94.75           N  \nATOM    737  CA  GLU A  97     -18.140 -19.194  26.549  1.00 94.75           C  \nATOM    738  C   GLU A  97     -19.148 -19.114  25.384  1.00 94.75           C  \nATOM    739  CB  GLU A  97     -18.849 -19.265  27.921  1.00 94.75           C  \nATOM    740  O   GLU A  97     -19.545 -20.149  24.842  1.00 94.75           O  \nATOM    741  CG  GLU A  97     -19.713 -20.530  28.110  1.00 94.75           C  \nATOM    742  CD  GLU A  97     -20.339 -20.685  29.513  1.00 94.75           C  \nATOM    743  OE1 GLU A  97     -21.111 -21.661  29.704  1.00 94.75           O  \nATOM    744  OE2 GLU A  97     -20.058 -19.851  30.398  1.00 94.75           O  \nATOM    745  N   ARG A  98     -19.542 -17.902  24.961  1.00 96.69           N  \nATOM    746  CA  ARG A  98     -20.567 -17.667  23.927  1.00 96.69           C  \nATOM    747  C   ARG A  98     -20.132 -16.614  22.907  1.00 96.69           C  \nATOM    748  CB  ARG A  98     -21.896 -17.294  24.614  1.00 96.69           C  \nATOM    749  O   ARG A  98     -19.752 -15.510  23.288  1.00 96.69           O  \nATOM    750  CG  ARG A  98     -23.075 -17.109  23.641  1.00 96.69           C  \nATOM    751  CD  ARG A  98     -24.370 -16.852  24.425  1.00 96.69           C  \nATOM    752  NE  ARG A  98     -25.539 -16.638  23.541  1.00 96.69           N  \nATOM    753  NH1 ARG A  98     -26.964 -18.237  24.420  1.00 96.69           N  \nATOM    754  NH2 ARG A  98     -27.697 -16.844  22.858  1.00 96.69           N  \nATOM    755  CZ  ARG A  98     -26.714 -17.242  23.618  1.00 96.69           C  \nATOM    756  N   ILE A  99     -20.274 -16.921  21.615  1.00 98.12           N  \nATOM    757  CA  ILE A  99     -20.025 -15.983  20.501  1.00 98.12           C  \nATOM    758  C   ILE A  99     -21.349 -15.756  19.748  1.00 98.12           C  \nATOM    759  CB  ILE A  99     -18.872 -16.483  19.602  1.00 98.12           C  \nATOM    760  O   ILE A  99     -21.777 -16.616  18.975  1.00 98.12           O  \nATOM    761  CG1 ILE A  99     -17.554 -16.440  20.410  1.00 98.12           C  \nATOM    762  CG2 ILE A  99     -18.740 -15.623  18.329  1.00 98.12           C  \nATOM    763  CD1 ILE A  99     -16.341 -17.036  19.694  1.00 98.12           C  \nATOM    764  N   PRO A 100     -22.057 -14.635  19.983  1.00 97.56           N  \nATOM    765  CA  PRO A 100     -23.467 -14.507  19.629  1.00 97.56           C  \nATOM    766  C   PRO A 100     -23.699 -14.009  18.189  1.00 97.56           C  \nATOM    767  CB  PRO A 100     -24.038 -13.587  20.707  1.00 97.56           C  \nATOM    768  O   PRO A 100     -24.342 -12.983  17.972  1.00 97.56           O  \nATOM    769  CG  PRO A 100     -22.890 -12.611  20.950  1.00 97.56           C  \nATOM    770  CD  PRO A 100     -21.666 -13.521  20.844  1.00 97.56           C  \nATOM    771  N   LEU A 101     -23.237 -14.764  17.188  1.00 98.12           N  \nATOM    772  CA  LEU A 101     -23.487 -14.505  15.756  1.00 98.12           C  \nATOM    773  C   LEU A 101     -24.917 -14.904  15.331  1.00 98.12           C  \nATOM    774  CB  LEU A 101     -22.366 -15.149  14.915  1.00 98.12           C  \nATOM    775  O   LEU A 101     -25.147 -15.581  14.331  1.00 98.12           O  \nATOM    776  CG  LEU A 101     -21.016 -14.423  15.069  1.00 98.12           C  \nATOM    777  CD1 LEU A 101     -19.894 -15.275  14.483  1.00 98.12           C  \nATOM    778  CD2 LEU A 101     -21.005 -13.071  14.350  1.00 98.12           C  \nATOM    779  N   GLU A 102     -25.897 -14.475  16.127  1.00 97.25           N  \nATOM    780  CA  GLU A 102     -27.289 -14.936  16.101  1.00 97.25           C  \nATOM    781  C   GLU A 102     -28.061 -14.530  14.840  1.00 97.25           C  \nATOM    782  CB  GLU A 102     -28.010 -14.422  17.362  1.00 97.25           C  \nATOM    783  O   GLU A 102     -29.052 -15.181  14.508  1.00 97.25           O  \nATOM    784  CG  GLU A 102     -27.533 -15.115  18.654  1.00 97.25           C  \nATOM    785  CD  GLU A 102     -28.148 -14.523  19.932  1.00 97.25           C  \nATOM    786  OE1 GLU A 102     -27.594 -14.733  21.039  1.00 97.25           O  \nATOM    787  OE2 GLU A 102     -29.182 -13.814  19.862  1.00 97.25           O  \nATOM    788  N   ASN A 103     -27.627 -13.480  14.137  1.00 97.50           N  \nATOM    789  CA  ASN A 103     -28.294 -12.946  12.947  1.00 97.50           C  \nATOM    790  C   ASN A 103     -27.513 -13.154  11.642  1.00 97.50           C  \nATOM    791  CB  ASN A 103     -28.661 -11.476  13.197  1.00 97.50           C  \nATOM    792  O   ASN A 103     -28.022 -12.770  10.591  1.00 97.50           O  \nATOM    793  CG  ASN A 103     -29.756 -11.334  14.238  1.00 97.50           C  \nATOM    794  ND2 ASN A 103     -29.624 -10.405  15.150  1.00 97.50           N  \nATOM    795  OD1 ASN A 103     -30.746 -12.051  14.253  1.00 97.50           O  \nATOM    796  N   LEU A 104     -26.342 -13.802  11.683  1.00 98.12           N  \nATOM    797  CA  LEU A 104     -25.559 -14.128  10.490  1.00 98.12           C  \nATOM    798  C   LEU A 104     -26.387 -15.042   9.573  1.00 98.12           C  \nATOM    799  CB  LEU A 104     -24.231 -14.774  10.934  1.00 98.12           C  \nATOM    800  O   LEU A 104     -26.799 -16.117   9.993  1.00 98.12           O  \nATOM    801  CG  LEU A 104     -23.284 -15.152   9.779  1.00 98.12           C  \nATOM    802  CD1 LEU A 104     -22.776 -13.929   9.015  1.00 98.12           C  \nATOM    803  CD2 LEU A 104     -22.069 -15.898  10.331  1.00 98.12           C  \nATOM    804  N   GLN A 105     -26.651 -14.603   8.342  1.00 97.44           N  \nATOM    805  CA  GLN A 105     -27.483 -15.290   7.346  1.00 97.44           C  \nATOM    806  C   GLN A 105     -26.650 -15.990   6.268  1.00 97.44           C  \nATOM    807  CB  GLN A 105     -28.437 -14.273   6.690  1.00 97.44           C  \nATOM    808  O   GLN A 105     -27.022 -17.076   5.813  1.00 97.44           O  \nATOM    809  CG  GLN A 105     -29.581 -13.858   7.629  1.00 97.44           C  \nATOM    810  CD  GLN A 105     -30.368 -12.633   7.162  1.00 97.44           C  \nATOM    811  NE2 GLN A 105     -31.548 -12.417   7.701  1.00 97.44           N  \nATOM    812  OE1 GLN A 105     -29.965 -11.832   6.335  1.00 97.44           O  \nATOM    813  N   ILE A 106     -25.542 -15.362   5.862  1.00 97.50           N  \nATOM    814  CA  ILE A 106     -24.695 -15.788   4.745  1.00 97.50           C  \nATOM    815  C   ILE A 106     -23.208 -15.576   5.043  1.00 97.50           C  \nATOM    816  CB  ILE A 106     -25.115 -15.053   3.447  1.00 97.50           C  \nATOM    817  O   ILE A 106     -22.821 -14.563   5.634  1.00 97.50           O  \nATOM    818  CG1 ILE A 106     -24.502 -15.691   2.183  1.00 97.50           C  \nATOM    819  CG2 ILE A 106     -24.765 -13.556   3.505  1.00 97.50           C  \nATOM    820  CD1 ILE A 106     -25.131 -15.141   0.898  1.00 97.50           C  \nATOM    821  N   ILE A 107     -22.380 -16.486   4.535  1.00 98.19           N  \nATOM    822  CA  ILE A 107     -20.957 -16.240   4.279  1.00 98.19           C  \nATOM    823  C   ILE A 107     -20.749 -16.419   2.771  1.00 98.19           C  \nATOM    824  CB  ILE A 107     -20.052 -17.170   5.117  1.00 98.19           C  \nATOM    825  O   ILE A 107     -21.096 -17.464   2.219  1.00 98.19           O  \nATOM    826  CG1 ILE A 107     -20.423 -17.165   6.623  1.00 98.19           C  \nATOM    827  CG2 ILE A 107     -18.589 -16.740   4.919  1.00 98.19           C  \nATOM    828  CD1 ILE A 107     -19.749 -18.281   7.433  1.00 98.19           C  \nATOM    829  N   ARG A 108     -20.258 -15.395   2.067  1.00 96.12           N  \nATOM    830  CA  ARG A 108     -20.132 -15.454   0.599  1.00 96.12           C  \nATOM    831  C   ARG A 108     -18.885 -16.227   0.171  1.00 96.12           C  \nATOM    832  CB  ARG A 108     -20.211 -14.056  -0.038  1.00 96.12           C  \nATOM    833  O   ARG A 108     -18.954 -16.973  -0.799  1.00 96.12           O  \nATOM    834  CG  ARG A 108     -21.520 -13.335   0.325  1.00 96.12           C  \nATOM    835  CD  ARG A 108     -21.628 -11.942  -0.308  1.00 96.12           C  \nATOM    836  NE  ARG A 108     -22.966 -11.362  -0.051  1.00 96.12           N  \nATOM    837  NH1 ARG A 108     -24.049 -12.210  -1.898  1.00 96.12           N  \nATOM    838  NH2 ARG A 108     -25.202 -11.098  -0.372  1.00 96.12           N  \nATOM    839  CZ  ARG A 108     -24.055 -11.553  -0.773  1.00 96.12           C  \nATOM    840  N   GLY A 109     -17.792 -16.134   0.930  1.00 94.44           N  \nATOM    841  CA  GLY A 109     -16.563 -16.866   0.630  1.00 94.44           C  \nATOM    842  C   GLY A 109     -15.800 -16.293  -0.565  1.00 94.44           C  \nATOM    843  O   GLY A 109     -15.148 -17.041  -1.288  1.00 94.44           O  \nATOM    844  N   ASN A 110     -15.848 -14.973  -0.776  1.00 86.88           N  \nATOM    845  CA  ASN A 110     -15.008 -14.277  -1.761  1.00 86.88           C  \nATOM    846  C   ASN A 110     -13.502 -14.421  -1.431  1.00 86.88           C  \nATOM    847  CB  ASN A 110     -15.392 -12.785  -1.799  1.00 86.88           C  \nATOM    848  O   ASN A 110     -12.642 -14.279  -2.297  1.00 86.88           O  \nATOM    849  CG  ASN A 110     -16.779 -12.452  -2.335  1.00 86.88           C  \nATOM    850  ND2 ASN A 110     -16.896 -11.275  -2.902  1.00 86.88           N  \nATOM    851  OD1 ASN A 110     -17.743 -13.197  -2.218  1.00 86.88           O  \nATOM    852  N   MET A 111     -13.180 -14.723  -0.169  1.00 84.50           N  \nATOM    853  CA  MET A 111     -11.850 -15.085   0.323  1.00 84.50           C  \nATOM    854  C   MET A 111     -11.946 -16.345   1.192  1.00 84.50           C  \nATOM    855  CB  MET A 111     -11.253 -13.931   1.143  1.00 84.50           C  \nATOM    856  O   MET A 111     -12.960 -16.562   1.855  1.00 84.50           O  \nATOM    857  CG  MET A 111     -10.909 -12.702   0.294  1.00 84.50           C  \nATOM    858  SD  MET A 111     -10.226 -11.306   1.234  1.00 84.50           S  \nATOM    859  CE  MET A 111      -8.699 -12.024   1.890  1.00 84.50           C  \nATOM    860  N   TYR A 112     -10.870 -17.139   1.243  1.00 93.25           N  \nATOM    861  CA  TYR A 112     -10.797 -18.368   2.043  1.00 93.25           C  \nATOM    862  C   TYR A 112      -9.673 -18.326   3.082  1.00 93.25           C  \nATOM    863  CB  TYR A 112     -10.587 -19.598   1.148  1.00 93.25           C  \nATOM    864  O   TYR A 112      -8.535 -17.961   2.771  1.00 93.25           O  \nATOM    865  CG  TYR A 112     -11.529 -19.778  -0.025  1.00 93.25           C  \nATOM    866  CD1 TYR A 112     -12.912 -19.555   0.121  1.00 93.25           C  \nATOM    867  CD2 TYR A 112     -11.011 -20.182  -1.273  1.00 93.25           C  \nATOM    868  CE1 TYR A 112     -13.764 -19.682  -0.991  1.00 93.25           C  \nATOM    869  CE2 TYR A 112     -11.863 -20.313  -2.384  1.00 93.25           C  \nATOM    870  OH  TYR A 112     -14.037 -20.078  -3.344  1.00 93.25           O  \nATOM    871  CZ  TYR A 112     -13.236 -20.033  -2.251  1.00 93.25           C  \nATOM    872  N   TYR A 113      -9.964 -18.811   4.286  1.00 91.81           N  \nATOM    873  CA  TYR A 113      -8.955 -19.200   5.265  1.00 91.81           C  \nATOM    874  C   TYR A 113      -8.289 -20.518   4.828  1.00 91.81           C  \nATOM    875  CB  TYR A 113      -9.605 -19.306   6.647  1.00 91.81           C  \nATOM    876  O   TYR A 113      -8.959 -21.409   4.300  1.00 91.81           O  \nATOM    877  CG  TYR A 113      -8.599 -19.530   7.754  1.00 91.81           C  \nATOM    878  CD1 TYR A 113      -8.358 -20.829   8.239  1.00 91.81           C  \nATOM    879  CD2 TYR A 113      -7.881 -18.435   8.275  1.00 91.81           C  \nATOM    880  CE1 TYR A 113      -7.412 -21.032   9.261  1.00 91.81           C  \nATOM    881  CE2 TYR A 113      -6.933 -18.637   9.297  1.00 91.81           C  \nATOM    882  OH  TYR A 113      -5.820 -20.137  10.805  1.00 91.81           O  \nATOM    883  CZ  TYR A 113      -6.708 -19.937   9.799  1.00 91.81           C  \nATOM    884  N   GLU A 114      -6.963 -20.623   4.992  1.00 89.25           N  \nATOM    885  CA  GLU A 114      -6.132 -21.747   4.495  1.00 89.25           C  \nATOM    886  C   GLU A 114      -6.491 -22.186   3.058  1.00 89.25           C  \nATOM    887  CB  GLU A 114      -6.137 -22.917   5.487  1.00 89.25           C  \nATOM    888  O   GLU A 114      -6.514 -23.370   2.718  1.00 89.25           O  \nATOM    889  CG  GLU A 114      -5.412 -22.616   6.808  1.00 89.25           C  \nATOM    890  CD  GLU A 114      -5.663 -23.727   7.842  1.00 89.25           C  \nATOM    891  OE1 GLU A 114      -4.797 -23.974   8.711  1.00 89.25           O  \nATOM    892  OE2 GLU A 114      -6.751 -24.350   7.797  1.00 89.25           O  \nATOM    893  N   ASN A 115      -6.810 -21.207   2.204  1.00 87.25           N  \nATOM    894  CA  ASN A 115      -7.123 -21.372   0.782  1.00 87.25           C  \nATOM    895  C   ASN A 115      -8.349 -22.258   0.471  1.00 87.25           C  \nATOM    896  CB  ASN A 115      -5.849 -21.828   0.042  1.00 87.25           C  \nATOM    897  O   ASN A 115      -8.626 -22.500  -0.701  1.00 87.25           O  \nATOM    898  CG  ASN A 115      -4.615 -20.978   0.317  1.00 87.25           C  \nATOM    899  ND2 ASN A 115      -3.454 -21.477  -0.034  1.00 87.25           N  \nATOM    900  OD1 ASN A 115      -4.654 -19.883   0.864  1.00 87.25           O  \nATOM    901  N   SER A 116      -9.085 -22.720   1.490  1.00 93.31           N  \nATOM    902  CA  SER A 116     -10.121 -23.757   1.350  1.00 93.31           C  \nATOM    903  C   SER A 116     -11.418 -23.465   2.108  1.00 93.31           C  \nATOM    904  CB  SER A 116      -9.579 -25.101   1.859  1.00 93.31           C  \nATOM    905  O   SER A 116     -12.478 -23.925   1.684  1.00 93.31           O  \nATOM    906  OG  SER A 116      -8.322 -25.409   1.287  1.00 93.31           O  \nATOM    907  N   TYR A 117     -11.363 -22.733   3.227  1.00 96.50           N  \nATOM    908  CA  TYR A 117     -12.478 -22.627   4.174  1.00 96.50           C  \nATOM    909  C   TYR A 117     -13.092 -21.225   4.207  1.00 96.50           C  \nATOM    910  CB  TYR A 117     -12.018 -23.060   5.574  1.00 96.50           C  \nATOM    911  O   TYR A 117     -12.383 -20.234   4.371  1.00 96.50           O  \nATOM    912  CG  TYR A 117     -11.276 -24.384   5.602  1.00 96.50           C  \nATOM    913  CD1 TYR A 117     -11.965 -25.591   5.383  1.00 96.50           C  \nATOM    914  CD2 TYR A 117      -9.885 -24.401   5.816  1.00 96.50           C  \nATOM    915  CE1 TYR A 117     -11.265 -26.813   5.390  1.00 96.50           C  \nATOM    916  CE2 TYR A 117      -9.179 -25.617   5.811  1.00 96.50           C  \nATOM    917  OH  TYR A 117      -9.200 -28.008   5.632  1.00 96.50           O  \nATOM    918  CZ  TYR A 117      -9.871 -26.829   5.601  1.00 96.50           C  \nATOM    919  N   ALA A 118     -14.419 -21.145   4.120  1.00 97.56           N  \nATOM    920  CA  ALA A 118     -15.176 -19.918   4.370  1.00 97.56           C  \nATOM    921  C   ALA A 118     -15.653 -19.807   5.829  1.00 97.56           C  \nATOM    922  CB  ALA A 118     -16.329 -19.847   3.373  1.00 97.56           C  \nATOM    923  O   ALA A 118     -15.916 -18.704   6.298  1.00 97.56           O  \nATOM    924  N   LEU A 119     -15.708 -20.917   6.572  1.00 98.31           N  \nATOM    925  CA  LEU A 119     -15.910 -20.927   8.024  1.00 98.31           C  \nATOM    926  C   LEU A 119     -14.856 -21.823   8.682  1.00 98.31           C  \nATOM    927  CB  LEU A 119     -17.350 -21.379   8.332  1.00 98.31           C  \nATOM    928  O   LEU A 119     -14.775 -23.007   8.357  1.00 98.31           O  \nATOM    929  CG  LEU A 119     -17.679 -21.543   9.829  1.00 98.31           C  \nATOM    930  CD1 LEU A 119     -17.524 -20.250  10.632  1.00 98.31           C  \nATOM    931  CD2 LEU A 119     -19.126 -22.009   9.980  1.00 98.31           C  \nATOM    932  N   ALA A 120     -14.073 -21.277   9.612  1.00 98.06           N  \nATOM    933  CA  ALA A 120     -13.057 -22.008  10.366  1.00 98.06           C  \nATOM    934  C   ALA A 120     -13.178 -21.721  11.873  1.00 98.06           C  \nATOM    935  CB  ALA A 120     -11.676 -21.645   9.804  1.00 98.06           C  \nATOM    936  O   ALA A 120     -12.989 -20.588  12.310  1.00 98.06           O  \nATOM    937  N   VAL A 121     -13.477 -22.750  12.672  1.00 97.81           N  \nATOM    938  CA  VAL A 121     -13.643 -22.665  14.133  1.00 97.81           C  \nATOM    939  C   VAL A 121     -12.611 -23.570  14.811  1.00 97.81           C  \nATOM    940  CB  VAL A 121     -15.088 -22.994  14.554  1.00 97.81           C  \nATOM    941  O   VAL A 121     -12.745 -24.798  14.796  1.00 97.81           O  \nATOM    942  CG1 VAL A 121     -15.302 -22.724  16.049  1.00 97.81           C  \nATOM    943  CG2 VAL A 121     -16.117 -22.160  13.774  1.00 97.81           C  \nATOM    944  N   LEU A 122     -11.542 -22.976  15.350  1.00 96.50           N  \nATOM    945  CA  LEU A 122     -10.278 -23.665  15.648  1.00 96.50           C  \nATOM    946  C   LEU A 122      -9.765 -23.402  17.074  1.00 96.50           C  \nATOM    947  CB  LEU A 122      -9.204 -23.222  14.630  1.00 96.50           C  \nATOM    948  O   LEU A 122      -9.460 -22.267  17.431  1.00 96.50           O  \nATOM    949  CG  LEU A 122      -9.570 -23.346  13.140  1.00 96.50           C  \nATOM    950  CD1 LEU A 122      -8.431 -22.805  12.278  1.00 96.50           C  \nATOM    951  CD2 LEU A 122      -9.825 -24.790  12.713  1.00 96.50           C  \nATOM    952  N   SER A 123      -9.551 -24.457  17.860  1.00 95.38           N  \nATOM    953  CA  SER A 123      -8.801 -24.386  19.127  1.00 95.38           C  \nATOM    954  C   SER A 123      -9.337 -23.356  20.136  1.00 95.38           C  \nATOM    955  CB  SER A 123      -7.299 -24.207  18.862  1.00 95.38           C  \nATOM    956  O   SER A 123      -8.563 -22.663  20.794  1.00 95.38           O  \nATOM    957  OG  SER A 123      -6.801 -25.279  18.081  1.00 95.38           O  \nATOM    958  N   ASN A 124     -10.661 -23.228  20.267  1.00 95.88           N  \nATOM    959  CA  ASN A 124     -11.285 -22.275  21.194  1.00 95.88           C  \nATOM    960  C   ASN A 124     -11.390 -22.850  22.619  1.00 95.88           C  \nATOM    961  CB  ASN A 124     -12.625 -21.791  20.626  1.00 95.88           C  \nATOM    962  O   ASN A 124     -12.486 -23.142  23.107  1.00 95.88           O  \nATOM    963  CG  ASN A 124     -12.464 -21.057  19.315  1.00 95.88           C  \nATOM    964  ND2 ASN A 124     -12.701 -21.716  18.209  1.00 95.88           N  \nATOM    965  OD1 ASN A 124     -12.107 -19.890  19.270  1.00 95.88           O  \nATOM    966  N   TYR A 125     -10.237 -23.067  23.261  1.00 93.25           N  \nATOM    967  CA  TYR A 125     -10.128 -23.571  24.631  1.00 93.25           C  \nATOM    968  C   TYR A 125      -8.869 -23.074  25.355  1.00 93.25           C  \nATOM    969  CB  TYR A 125     -10.192 -25.108  24.652  1.00 93.25           C  \nATOM    970  O   TYR A 125      -7.860 -22.743  24.735  1.00 93.25           O  \nATOM    971  CG  TYR A 125      -8.993 -25.822  24.040  1.00 93.25           C  \nATOM    972  CD1 TYR A 125      -8.823 -25.863  22.644  1.00 93.25           C  \nATOM    973  CD2 TYR A 125      -8.019 -26.413  24.868  1.00 93.25           C  \nATOM    974  CE1 TYR A 125      -7.668 -26.443  22.083  1.00 93.25           C  \nATOM    975  CE2 TYR A 125      -6.857 -26.986  24.318  1.00 93.25           C  \nATOM    976  OH  TYR A 125      -5.552 -27.525  22.374  1.00 93.25           O  \nATOM    977  CZ  TYR A 125      -6.676 -26.989  22.919  1.00 93.25           C  \nATOM    978  N   ASP A 126      -8.931 -23.062  26.685  1.00 90.38           N  \nATOM    979  CA  ASP A 126      -7.808 -22.813  27.591  1.00 90.38           C  \nATOM    980  C   ASP A 126      -7.220 -24.114  28.173  1.00 90.38           C  \nATOM    981  CB  ASP A 126      -8.241 -21.815  28.679  1.00 90.38           C  \nATOM    982  O   ASP A 126      -7.708 -25.215  27.917  1.00 90.38           O  \nATOM    983  CG  ASP A 126      -9.282 -22.351  29.663  1.00 90.38           C  \nATOM    984  OD1 ASP A 126      -8.956 -23.262  30.458  1.00 90.38           O  \nATOM    985  OD2 ASP A 126     -10.388 -21.773  29.763  1.00 90.38           O  \nATOM    986  N   ALA A 127      -6.169 -24.003  28.992  1.00 89.69           N  \nATOM    987  CA  ALA A 127      -5.458 -25.148  29.573  1.00 89.69           C  \nATOM    988  C   ALA A 127      -6.353 -26.149  30.345  1.00 89.69           C  \nATOM    989  CB  ALA A 127      -4.347 -24.599  30.476  1.00 89.69           C  \nATOM    990  O   ALA A 127      -5.990 -27.319  30.458  1.00 89.69           O  \nATOM    991  N   ASN A 128      -7.531 -25.733  30.829  1.00 88.75           N  \nATOM    992  CA  ASN A 128      -8.489 -26.598  31.528  1.00 88.75           C  \nATOM    993  C   ASN A 128      -9.496 -27.289  30.585  1.00 88.75           C  \nATOM    994  CB  ASN A 128      -9.216 -25.792  32.617  1.00 88.75           C  \nATOM    995  O   ASN A 128     -10.450 -27.904  31.058  1.00 88.75           O  \nATOM    996  CG  ASN A 128      -8.271 -25.032  33.521  1.00 88.75           C  \nATOM    997  ND2 ASN A 128      -8.178 -23.737  33.334  1.00 88.75           N  \nATOM    998  OD1 ASN A 128      -7.596 -25.584  34.370  1.00 88.75           O  \nATOM    999  N   LYS A 129      -9.327 -27.164  29.259  1.00 88.25           N  \nATOM   1000  CA  LYS A 129     -10.291 -27.563  28.210  1.00 88.25           C  \nATOM   1001  C   LYS A 129     -11.659 -26.855  28.272  1.00 88.25           C  \nATOM   1002  CB  LYS A 129     -10.431 -29.097  28.107  1.00 88.25           C  \nATOM   1003  O   LYS A 129     -12.588 -27.265  27.580  1.00 88.25           O  \nATOM   1004  CG  LYS A 129      -9.141 -29.835  27.714  1.00 88.25           C  \nATOM   1005  CD  LYS A 129      -9.478 -31.309  27.432  1.00 88.25           C  \nATOM   1006  CE  LYS A 129      -8.286 -32.087  26.864  1.00 88.25           C  \nATOM   1007  NZ  LYS A 129      -8.692 -33.448  26.411  1.00 88.25           N  \nATOM   1008  N   THR A 130     -11.785 -25.773  29.036  1.00 90.00           N  \nATOM   1009  CA  THR A 130     -12.930 -24.849  28.969  1.00 90.00           C  \nATOM   1010  C   THR A 130     -12.715 -23.795  27.884  1.00 90.00           C  \nATOM   1011  CB  THR A 130     -13.184 -24.181  30.325  1.00 90.00           C  \nATOM   1012  O   THR A 130     -11.575 -23.514  27.526  1.00 90.00           O  \nATOM   1013  CG2 THR A 130     -13.782 -25.176  31.318  1.00 90.00           C  \nATOM   1014  OG1 THR A 130     -11.989 -23.720  30.910  1.00 90.00           O  \nATOM   1015  N   GLY A 131     -13.787 -23.217  27.341  1.00 92.81           N  \nATOM   1016  CA  GLY A 131     -13.709 -22.246  26.248  1.00 92.81           C  \nATOM   1017  C   GLY A 131     -15.053 -22.061  25.553  1.00 92.81           C  \nATOM   1018  O   GLY A 131     -16.090 -22.074  26.217  1.00 92.81           O  \nATOM   1019  N   LEU A 132     -15.037 -21.934  24.223  1.00 95.31           N  \nATOM   1020  CA  LEU A 132     -16.248 -21.741  23.424  1.00 95.31           C  \nATOM   1021  C   LEU A 132     -17.188 -22.945  23.532  1.00 95.31           C  \nATOM   1022  CB  LEU A 132     -15.871 -21.459  21.963  1.00 95.31           C  \nATOM   1023  O   LEU A 132     -16.840 -24.062  23.147  1.00 95.31           O  \nATOM   1024  CG  LEU A 132     -17.071 -21.225  21.025  1.00 95.31           C  \nATOM   1025  CD1 LEU A 132     -17.876 -19.988  21.424  1.00 95.31           C  \nATOM   1026  CD2 LEU A 132     -16.559 -21.055  19.593  1.00 95.31           C  \nATOM   1027  N   LYS A 133     -18.401 -22.671  24.008  1.00 93.56           N  \nATOM   1028  CA  LYS A 133     -19.459 -23.646  24.277  1.00 93.56           C  \nATOM   1029  C   LYS A 133     -20.705 -23.384  23.437  1.00 93.56           C  \nATOM   1030  CB  LYS A 133     -19.736 -23.562  25.777  1.00 93.56           C  \nATOM   1031  O   LYS A 133     -21.295 -24.320  22.905  1.00 93.56           O  \nATOM   1032  CG  LYS A 133     -20.858 -24.466  26.317  1.00 93.56           C  \nATOM   1033  CD  LYS A 133     -21.283 -23.824  27.634  1.00 93.56           C  \nATOM   1034  CE  LYS A 133     -22.482 -24.447  28.335  1.00 93.56           C  \nATOM   1035  NZ  LYS A 133     -23.134 -23.373  29.122  1.00 93.56           N  \nATOM   1036  N   GLU A 134     -21.079 -22.115  23.279  1.00 94.81           N  \nATOM   1037  CA  GLU A 134     -22.288 -21.691  22.568  1.00 94.81           C  \nATOM   1038  C   GLU A 134     -21.939 -20.831  21.341  1.00 94.81           C  \nATOM   1039  CB  GLU A 134     -23.226 -20.951  23.539  1.00 94.81           C  \nATOM   1040  O   GLU A 134     -21.489 -19.688  21.459  1.00 94.81           O  \nATOM   1041  CG  GLU A 134     -23.818 -21.888  24.608  1.00 94.81           C  \nATOM   1042  CD  GLU A 134     -24.690 -21.166  25.648  1.00 94.81           C  \nATOM   1043  OE1 GLU A 134     -24.854 -21.744  26.752  1.00 94.81           O  \nATOM   1044  OE2 GLU A 134     -25.190 -20.052  25.345  1.00 94.81           O  \nATOM   1045  N   LEU A 135     -22.206 -21.366  20.145  1.00 97.06           N  \nATOM   1046  CA  LEU A 135     -22.051 -20.665  18.864  1.00 97.06           C  \nATOM   1047  C   LEU A 135     -23.404 -20.609  18.117  1.00 97.06           C  \nATOM   1048  CB  LEU A 135     -20.910 -21.343  18.077  1.00 97.06           C  \nATOM   1049  O   LEU A 135     -23.587 -21.309  17.119  1.00 97.06           O  \nATOM   1050  CG  LEU A 135     -20.489 -20.607  16.789  1.00 97.06           C  \nATOM   1051  CD1 LEU A 135     -19.901 -19.226  17.083  1.00 97.06           C  \nATOM   1052  CD2 LEU A 135     -19.432 -21.424  16.045  1.00 97.06           C  \nATOM   1053  N   PRO A 136     -24.383 -19.813  18.599  1.00 96.94           N  \nATOM   1054  CA  PRO A 136     -25.770 -19.848  18.133  1.00 96.94           C  \nATOM   1055  C   PRO A 136     -25.978 -19.175  16.760  1.00 96.94           C  \nATOM   1056  CB  PRO A 136     -26.584 -19.213  19.271  1.00 96.94           C  \nATOM   1057  O   PRO A 136     -26.697 -18.183  16.653  1.00 96.94           O  \nATOM   1058  CG  PRO A 136     -25.607 -18.184  19.835  1.00 96.94           C  \nATOM   1059  CD  PRO A 136     -24.290 -18.951  19.772  1.00 96.94           C  \nATOM   1060  N   MET A 137     -25.398 -19.711  15.681  1.00 97.94           N  \nATOM   1061  CA  MET A 137     -25.559 -19.224  14.294  1.00 97.94           C  \nATOM   1062  C   MET A 137     -26.930 -19.587  13.674  1.00 97.94           C  \nATOM   1063  CB  MET A 137     -24.385 -19.697  13.419  1.00 97.94           C  \nATOM   1064  O   MET A 137     -27.037 -19.956  12.508  1.00 97.94           O  \nATOM   1065  CG  MET A 137     -23.035 -19.078  13.787  1.00 97.94           C  \nATOM   1066  SD  MET A 137     -21.674 -19.772  12.806  1.00 97.94           S  \nATOM   1067  CE  MET A 137     -20.416 -18.495  13.032  1.00 97.94           C  \nATOM   1068  N   ARG A 138     -28.015 -19.448  14.445  1.00 96.75           N  \nATOM   1069  CA  ARG A 138     -29.402 -19.873  14.143  1.00 96.75           C  \nATOM   1070  C   ARG A 138     -30.057 -19.319  12.869  1.00 96.75           C  \nATOM   1071  CB  ARG A 138     -30.274 -19.552  15.363  1.00 96.75           C  \nATOM   1072  O   ARG A 138     -31.168 -19.723  12.523  1.00 96.75           O  \nATOM   1073  CG  ARG A 138     -30.259 -18.051  15.699  1.00 96.75           C  \nATOM   1074  CD  ARG A 138     -31.354 -17.752  16.709  1.00 96.75           C  \nATOM   1075  NE  ARG A 138     -31.166 -16.458  17.387  1.00 96.75           N  \nATOM   1076  NH1 ARG A 138     -32.938 -16.763  18.774  1.00 96.75           N  \nATOM   1077  NH2 ARG A 138     -31.599 -15.024  19.130  1.00 96.75           N  \nATOM   1078  CZ  ARG A 138     -31.891 -16.077  18.419  1.00 96.75           C  \nATOM   1079  N   ASN A 139     -29.418 -18.368  12.194  1.00 97.56           N  \nATOM   1080  CA  ASN A 139     -29.871 -17.823  10.917  1.00 97.56           C  \nATOM   1081  C   ASN A 139     -28.951 -18.185   9.737  1.00 97.56           C  \nATOM   1082  CB  ASN A 139     -30.100 -16.309  11.077  1.00 97.56           C  \nATOM   1083  O   ASN A 139     -29.334 -17.893   8.603  1.00 97.56           O  \nATOM   1084  CG  ASN A 139     -31.390 -15.997  11.817  1.00 97.56           C  \nATOM   1085  ND2 ASN A 139     -31.335 -15.316  12.933  1.00 97.56           N  \nATOM   1086  OD1 ASN A 139     -32.482 -16.376  11.409  1.00 97.56           O  \nATOM   1087  N   LEU A 140     -27.807 -18.843   9.961  1.00 98.00           N  \nATOM   1088  CA  LEU A 140     -26.844 -19.172   8.911  1.00 98.00           C  \nATOM   1089  C   LEU A 140     -27.415 -20.286   8.031  1.00 98.00           C  \nATOM   1090  CB  LEU A 140     -25.487 -19.531   9.545  1.00 98.00           C  \nATOM   1091  O   LEU A 140     -27.534 -21.435   8.453  1.00 98.00           O  \nATOM   1092  CG  LEU A 140     -24.391 -19.934   8.537  1.00 98.00           C  \nATOM   1093  CD1 LEU A 140     -24.070 -18.830   7.525  1.00 98.00           C  \nATOM   1094  CD2 LEU A 140     -23.103 -20.271   9.290  1.00 98.00           C  \nATOM   1095  N   GLN A 141     -27.803 -19.909   6.814  1.00 97.06           N  \nATOM   1096  CA  GLN A 141     -28.505 -20.775   5.863  1.00 97.06           C  \nATOM   1097  C   GLN A 141     -27.743 -20.930   4.541  1.00 97.06           C  \nATOM   1098  CB  GLN A 141     -29.918 -20.209   5.630  1.00 97.06           C  \nATOM   1099  O   GLN A 141     -28.037 -21.856   3.796  1.00 97.06           O  \nATOM   1100  CG  GLN A 141     -30.890 -20.505   6.785  1.00 97.06           C  \nATOM   1101  CD  GLN A 141     -32.034 -19.497   6.853  1.00 97.06           C  \nATOM   1102  NE2 GLN A 141     -31.864 -18.395   7.544  1.00 97.06           N  \nATOM   1103  OE1 GLN A 141     -33.107 -19.646   6.296  1.00 97.06           O  \nATOM   1104  N   GLU A 142     -26.760 -20.074   4.240  1.00 97.44           N  \nATOM   1105  CA  GLU A 142     -25.993 -20.139   2.989  1.00 97.44           C  \nATOM   1106  C   GLU A 142     -24.487 -19.921   3.213  1.00 97.44           C  \nATOM   1107  CB  GLU A 142     -26.580 -19.119   1.994  1.00 97.44           C  \nATOM   1108  O   GLU A 142     -24.071 -18.955   3.858  1.00 97.44           O  \nATOM   1109  CG  GLU A 142     -25.965 -19.170   0.587  1.00 97.44           C  \nATOM   1110  CD  GLU A 142     -26.353 -20.462  -0.140  1.00 97.44           C  \nATOM   1111  OE1 GLU A 142     -25.661 -21.483   0.031  1.00 97.44           O  \nATOM   1112  OE2 GLU A 142     -27.441 -20.527  -0.752  1.00 97.44           O  \nATOM   1113  N   ILE A 143     -23.678 -20.799   2.620  1.00 97.69           N  \nATOM   1114  CA  ILE A 143     -22.247 -20.601   2.372  1.00 97.69           C  \nATOM   1115  C   ILE A 143     -22.037 -20.836   0.872  1.00 97.69           C  \nATOM   1116  CB  ILE A 143     -21.365 -21.493   3.282  1.00 97.69           C  \nATOM   1117  O   ILE A 143     -21.995 -21.984   0.420  1.00 97.69           O  \nATOM   1118  CG1 ILE A 143     -21.553 -21.099   4.768  1.00 97.69           C  \nATOM   1119  CG2 ILE A 143     -19.880 -21.362   2.886  1.00 97.69           C  \nATOM   1120  CD1 ILE A 143     -20.797 -21.974   5.779  1.00 97.69           C  \nATOM   1121  N   LEU A 144     -21.960 -19.739   0.104  1.00 94.44           N  \nATOM   1122  CA  LEU A 144     -21.939 -19.784  -1.368  1.00 94.44           C  \nATOM   1123  C   LEU A 144     -20.678 -20.483  -1.889  1.00 94.44           C  \nATOM   1124  CB  LEU A 144     -22.008 -18.360  -1.964  1.00 94.44           C  \nATOM   1125  O   LEU A 144     -20.756 -21.355  -2.755  1.00 94.44           O  \nATOM   1126  CG  LEU A 144     -23.313 -17.578  -1.752  1.00 94.44           C  \nATOM   1127  CD1 LEU A 144     -23.142 -16.150  -2.280  1.00 94.44           C  \nATOM   1128  CD2 LEU A 144     -24.497 -18.202  -2.493  1.00 94.44           C  \nATOM   1129  N   HIS A 145     -19.523 -20.108  -1.339  1.00 95.25           N  \nATOM   1130  CA  HIS A 145     -18.220 -20.621  -1.734  1.00 95.25           C  \nATOM   1131  C   HIS A 145     -17.371 -20.996  -0.516  1.00 95.25           C  \nATOM   1132  CB  HIS A 145     -17.504 -19.587  -2.615  1.00 95.25           C  \nATOM   1133  O   HIS A 145     -17.469 -20.360   0.530  1.00 95.25           O  \nATOM   1134  CG  HIS A 145     -18.303 -19.132  -3.811  1.00 95.25           C  \nATOM   1135  CD2 HIS A 145     -18.845 -17.890  -4.007  1.00 95.25           C  \nATOM   1136  ND1 HIS A 145     -18.655 -19.902  -4.897  1.00 95.25           N  \nATOM   1137  CE1 HIS A 145     -19.388 -19.141  -5.725  1.00 95.25           C  \nATOM   1138  NE2 HIS A 145     -19.541 -17.908  -5.222  1.00 95.25           N  \nATOM   1139  N   GLY A 146     -16.492 -21.988  -0.677  1.00 94.19           N  \nATOM   1140  CA  GLY A 146     -15.576 -22.449   0.367  1.00 94.19           C  \nATOM   1141  C   GLY A 146     -16.176 -23.502   1.306  1.00 94.19           C  \nATOM   1142  O   GLY A 146     -17.389 -23.649   1.447  1.00 94.19           O  \nATOM   1143  N   ALA A 147     -15.294 -24.269   1.943  1.00 96.44           N  \nATOM   1144  CA  ALA A 147     -15.645 -25.351   2.857  1.00 96.44           C  \nATOM   1145  C   ALA A 147     -15.755 -24.880   4.321  1.00 96.44           C  \nATOM   1146  CB  ALA A 147     -14.616 -26.473   2.662  1.00 96.44           C  \nATOM   1147  O   ALA A 147     -15.549 -23.708   4.650  1.00 96.44           O  \nATOM   1148  N   VAL A 148     -16.052 -25.822   5.218  1.00 97.38           N  \nATOM   1149  CA  VAL A 148     -16.222 -25.594   6.659  1.00 97.38           C  \nATOM   1150  C   VAL A 148     -15.209 -26.432   7.446  1.00 97.38           C  \nATOM   1151  CB  VAL A 148     -17.671 -25.910   7.079  1.00 97.38           C  \nATOM   1152  O   VAL A 148     -15.086 -27.635   7.202  1.00 97.38           O  \nATOM   1153  CG1 VAL A 148     -17.880 -25.708   8.581  1.00 97.38           C  \nATOM   1154  CG2 VAL A 148     -18.676 -25.019   6.337  1.00 97.38           C  \nATOM   1155  N   ARG A 149     -14.509 -25.810   8.404  1.00 97.06           N  \nATOM   1156  CA  ARG A 149     -13.562 -26.467   9.317  1.00 97.06           C  \nATOM   1157  C   ARG A 149     -13.952 -26.264  10.783  1.00 97.06           C  \nATOM   1158  CB  ARG A 149     -12.120 -26.009   9.018  1.00 97.06           C  \nATOM   1159  O   ARG A 149     -14.027 -25.131  11.247  1.00 97.06           O  \nATOM   1160  CG  ARG A 149     -11.075 -26.841   9.780  1.00 97.06           C  \nATOM   1161  CD  ARG A 149      -9.630 -26.503   9.372  1.00 97.06           C  \nATOM   1162  NE  ARG A 149      -8.670 -27.256  10.204  1.00 97.06           N  \nATOM   1163  NH1 ARG A 149      -6.766 -25.983   9.872  1.00 97.06           N  \nATOM   1164  NH2 ARG A 149      -6.734 -27.667  11.309  1.00 97.06           N  \nATOM   1165  CZ  ARG A 149      -7.403 -26.960  10.443  1.00 97.06           C  \nATOM   1166  N   PHE A 150     -14.112 -27.356  11.525  1.00 96.38           N  \nATOM   1167  CA  PHE A 150     -14.190 -27.379  12.990  1.00 96.38           C  \nATOM   1168  C   PHE A 150     -13.067 -28.272  13.524  1.00 96.38           C  \nATOM   1169  CB  PHE A 150     -15.572 -27.861  13.466  1.00 96.38           C  \nATOM   1170  O   PHE A 150     -12.910 -29.400  13.062  1.00 96.38           O  \nATOM   1171  CG  PHE A 150     -16.646 -26.789  13.409  1.00 96.38           C  \nATOM   1172  CD1 PHE A 150     -17.014 -26.089  14.575  1.00 96.38           C  \nATOM   1173  CD2 PHE A 150     -17.260 -26.470  12.186  1.00 96.38           C  \nATOM   1174  CE1 PHE A 150     -17.972 -25.061  14.509  1.00 96.38           C  \nATOM   1175  CE2 PHE A 150     -18.212 -25.437  12.120  1.00 96.38           C  \nATOM   1176  CZ  PHE A 150     -18.566 -24.730  13.280  1.00 96.38           C  \nATOM   1177  N   SER A 151     -12.267 -27.760  14.461  1.00 94.44           N  \nATOM   1178  CA  SER A 151     -11.115 -28.472  15.032  1.00 94.44           C  \nATOM   1179  C   SER A 151     -10.899 -28.047  16.483  1.00 94.44           C  \nATOM   1180  CB  SER A 151      -9.861 -28.141  14.206  1.00 94.44           C  \nATOM   1181  O   SER A 151     -10.848 -26.850  16.764  1.00 94.44           O  \nATOM   1182  OG  SER A 151      -8.858 -29.139  14.263  1.00 94.44           O  \nATOM   1183  N   ASN A 152     -10.711 -29.005  17.394  1.00 92.19           N  \nATOM   1184  CA  ASN A 152     -10.237 -28.754  18.763  1.00 92.19           C  \nATOM   1185  C   ASN A 152     -11.114 -27.772  19.579  1.00 92.19           C  \nATOM   1186  CB  ASN A 152      -8.748 -28.334  18.736  1.00 92.19           C  \nATOM   1187  O   ASN A 152     -10.589 -26.879  20.237  1.00 92.19           O  \nATOM   1188  CG  ASN A 152      -7.824 -29.288  18.003  1.00 92.19           C  \nATOM   1189  ND2 ASN A 152      -6.879 -29.887  18.690  1.00 92.19           N  \nATOM   1190  OD1 ASN A 152      -7.922 -29.496  16.804  1.00 92.19           O  \nATOM   1191  N   ASN A 153     -12.442 -27.924  19.574  1.00 92.69           N  \nATOM   1192  CA  ASN A 153     -13.350 -27.099  20.395  1.00 92.69           C  \nATOM   1193  C   ASN A 153     -14.010 -27.950  21.509  1.00 92.69           C  \nATOM   1194  CB  ASN A 153     -14.357 -26.370  19.486  1.00 92.69           C  \nATOM   1195  O   ASN A 153     -15.188 -28.284  21.394  1.00 92.69           O  \nATOM   1196  CG  ASN A 153     -13.691 -25.570  18.381  1.00 92.69           C  \nATOM   1197  ND2 ASN A 153     -13.816 -26.021  17.155  1.00 92.69           N  \nATOM   1198  OD1 ASN A 153     -13.060 -24.546  18.600  1.00 92.69           O  \nATOM   1199  N   PRO A 154     -13.272 -28.355  22.565  1.00 91.38           N  \nATOM   1200  CA  PRO A 154     -13.676 -29.415  23.503  1.00 91.38           C  \nATOM   1201  C   PRO A 154     -14.907 -29.134  24.382  1.00 91.38           C  \nATOM   1202  CB  PRO A 154     -12.439 -29.683  24.371  1.00 91.38           C  \nATOM   1203  O   PRO A 154     -15.408 -30.053  25.034  1.00 91.38           O  \nATOM   1204  CG  PRO A 154     -11.675 -28.362  24.314  1.00 91.38           C  \nATOM   1205  CD  PRO A 154     -11.914 -27.937  22.871  1.00 91.38           C  \nATOM   1206  N   ALA A 155     -15.369 -27.881  24.423  1.00 92.38           N  \nATOM   1207  CA  ALA A 155     -16.546 -27.440  25.171  1.00 92.38           C  \nATOM   1208  C   ALA A 155     -17.764 -27.128  24.276  1.00 92.38           C  \nATOM   1209  CB  ALA A 155     -16.130 -26.227  26.017  1.00 92.38           C  \nATOM   1210  O   ALA A 155     -18.836 -26.849  24.810  1.00 92.38           O  \nATOM   1211  N   LEU A 156     -17.611 -27.155  22.944  1.00 94.12           N  \nATOM   1212  CA  LEU A 156     -18.639 -26.732  21.988  1.00 94.12           C  \nATOM   1213  C   LEU A 156     -19.821 -27.709  21.974  1.00 94.12           C  \nATOM   1214  CB  LEU A 156     -17.993 -26.567  20.600  1.00 94.12           C  \nATOM   1215  O   LEU A 156     -19.632 -28.912  21.802  1.00 94.12           O  \nATOM   1216  CG  LEU A 156     -18.927 -26.022  19.503  1.00 94.12           C  \nATOM   1217  CD1 LEU A 156     -19.338 -24.570  19.754  1.00 94.12           C  \nATOM   1218  CD2 LEU A 156     -18.207 -26.066  18.153  1.00 94.12           C  \nATOM   1219  N   CYS A 157     -21.032 -27.170  22.115  1.00 93.25           N  \nATOM   1220  CA  CYS A 157     -22.279 -27.928  22.137  1.00 93.25           C  \nATOM   1221  C   CYS A 157     -23.131 -27.683  20.883  1.00 93.25           C  \nATOM   1222  CB  CYS A 157     -23.076 -27.521  23.384  1.00 93.25           C  \nATOM   1223  O   CYS A 157     -23.104 -26.596  20.300  1.00 93.25           O  \nATOM   1224  SG  CYS A 157     -22.304 -27.853  24.992  1.00 93.25           S  \nATOM   1225  N   ASN A 158     -23.974 -28.663  20.549  1.00 93.88           N  \nATOM   1226  CA  ASN A 158     -25.058 -28.628  19.562  1.00 93.88           C  \nATOM   1227  C   ASN A 158     -24.647 -28.479  18.084  1.00 93.88           C  \nATOM   1228  CB  ASN A 158     -26.122 -27.596  19.993  1.00 93.88           C  \nATOM   1229  O   ASN A 158     -25.327 -29.045  17.226  1.00 93.88           O  \nATOM   1230  CG  ASN A 158     -26.641 -27.826  21.401  1.00 93.88           C  \nATOM   1231  ND2 ASN A 158     -27.451 -28.838  21.600  1.00 93.88           N  \nATOM   1232  OD1 ASN A 158     -26.323 -27.115  22.341  1.00 93.88           O  \nATOM   1233  N   VAL A 159     -23.550 -27.791  17.753  1.00 94.19           N  \nATOM   1234  CA  VAL A 159     -23.095 -27.564  16.363  1.00 94.19           C  \nATOM   1235  C   VAL A 159     -22.799 -28.875  15.610  1.00 94.19           C  \nATOM   1236  CB  VAL A 159     -21.874 -26.621  16.334  1.00 94.19           C  \nATOM   1237  O   VAL A 159     -22.965 -28.946  14.391  1.00 94.19           O  \nATOM   1238  CG1 VAL A 159     -21.460 -26.270  14.899  1.00 94.19           C  \nATOM   1239  CG2 VAL A 159     -22.167 -25.288  17.041  1.00 94.19           C  \nATOM   1240  N   GLU A 160     -22.456 -29.944  16.329  1.00 91.81           N  \nATOM   1241  CA  GLU A 160     -22.314 -31.309  15.809  1.00 91.81           C  \nATOM   1242  C   GLU A 160     -23.612 -31.892  15.210  1.00 91.81           C  \nATOM   1243  CB  GLU A 160     -21.739 -32.232  16.909  1.00 91.81           C  \nATOM   1244  O   GLU A 160     -23.558 -32.840  14.427  1.00 91.81           O  \nATOM   1245  CG  GLU A 160     -22.655 -32.572  18.111  1.00 91.81           C  \nATOM   1246  CD  GLU A 160     -22.828 -31.463  19.169  1.00 91.81           C  \nATOM   1247  OE1 GLU A 160     -23.600 -31.676  20.133  1.00 91.81           O  \nATOM   1248  OE2 GLU A 160     -22.223 -30.380  19.024  1.00 91.81           O  \nATOM   1249  N   SER A 161     -24.778 -31.321  15.538  1.00 94.19           N  \nATOM   1250  CA  SER A 161     -26.088 -31.748  15.023  1.00 94.19           C  \nATOM   1251  C   SER A 161     -26.472 -31.122  13.673  1.00 94.19           C  \nATOM   1252  CB  SER A 161     -27.179 -31.469  16.068  1.00 94.19           C  \nATOM   1253  O   SER A 161     -27.468 -31.532  13.070  1.00 94.19           O  \nATOM   1254  OG  SER A 161     -27.506 -30.092  16.129  1.00 94.19           O  \nATOM   1255  N   ILE A 162     -25.726 -30.121  13.191  1.00 96.88           N  \nATOM   1256  CA  ILE A 162     -26.120 -29.282  12.049  1.00 96.88           C  \nATOM   1257  C   ILE A 162     -26.018 -30.026  10.708  1.00 96.88           C  \nATOM   1258  CB  ILE A 162     -25.326 -27.954  12.067  1.00 96.88           C  \nATOM   1259  O   ILE A 162     -24.991 -30.597  10.336  1.00 96.88           O  \nATOM   1260  CG1 ILE A 162     -25.666 -27.099  13.312  1.00 96.88           C  \nATOM   1261  CG2 ILE A 162     -25.517 -27.120  10.787  1.00 96.88           C  \nATOM   1262  CD1 ILE A 162     -27.135 -26.675  13.452  1.00 96.88           C  \nATOM   1263  N   GLN A 163     -27.091 -29.960   9.918  1.00 96.56           N  \nATOM   1264  CA  GLN A 163     -27.173 -30.523   8.572  1.00 96.56           C  \nATOM   1265  C   GLN A 163     -26.498 -29.585   7.559  1.00 96.56           C  \nATOM   1266  CB  GLN A 163     -28.631 -30.867   8.196  1.00 96.56           C  \nATOM   1267  O   GLN A 163     -27.160 -28.908   6.771  1.00 96.56           O  \nATOM   1268  CG  GLN A 163     -29.386 -31.603   9.312  1.00 96.56           C  \nATOM   1269  CD  GLN A 163     -30.511 -32.486   8.791  1.00 96.56           C  \nATOM   1270  NE2 GLN A 163     -30.309 -33.784   8.708  1.00 96.56           N  \nATOM   1271  OE1 GLN A 163     -31.592 -32.051   8.430  1.00 96.56           O  \nATOM   1272  N   TRP A 164     -25.162 -29.556   7.556  1.00 95.75           N  \nATOM   1273  CA  TRP A 164     -24.341 -28.675   6.704  1.00 95.75           C  \nATOM   1274  C   TRP A 164     -24.628 -28.773   5.193  1.00 95.75           C  \nATOM   1275  CB  TRP A 164     -22.861 -28.957   6.990  1.00 95.75           C  \nATOM   1276  O   TRP A 164     -24.361 -27.823   4.463  1.00 95.75           O  \nATOM   1277  CG  TRP A 164     -22.423 -28.537   8.358  1.00 95.75           C  \nATOM   1278  CD1 TRP A 164     -22.319 -29.331   9.449  1.00 95.75           C  \nATOM   1279  CD2 TRP A 164     -22.068 -27.194   8.810  1.00 95.75           C  \nATOM   1280  CE2 TRP A 164     -21.763 -27.253  10.203  1.00 95.75           C  \nATOM   1281  CE3 TRP A 164     -21.998 -25.928   8.186  1.00 95.75           C  \nATOM   1282  NE1 TRP A 164     -21.934 -28.577  10.540  1.00 95.75           N  \nATOM   1283  CH2 TRP A 164     -21.348 -24.872  10.291  1.00 95.75           C  \nATOM   1284  CZ2 TRP A 164     -21.408 -26.116  10.940  1.00 95.75           C  \nATOM   1285  CZ3 TRP A 164     -21.643 -24.778   8.919  1.00 95.75           C  \nATOM   1286  N   ARG A 165     -25.239 -29.871   4.722  1.00 95.56           N  \nATOM   1287  CA  ARG A 165     -25.701 -30.040   3.327  1.00 95.56           C  \nATOM   1288  C   ARG A 165     -26.801 -29.054   2.906  1.00 95.56           C  \nATOM   1289  CB  ARG A 165     -26.197 -31.476   3.095  1.00 95.56           C  \nATOM   1290  O   ARG A 165     -26.984 -28.844   1.711  1.00 95.56           O  \nATOM   1291  CG  ARG A 165     -25.101 -32.536   3.267  1.00 95.56           C  \nATOM   1292  CD  ARG A 165     -25.646 -33.913   2.868  1.00 95.56           C  \nATOM   1293  NE  ARG A 165     -24.637 -34.975   3.046  1.00 95.56           N  \nATOM   1294  NH1 ARG A 165     -25.846 -36.701   2.127  1.00 95.56           N  \nATOM   1295  NH2 ARG A 165     -23.798 -37.089   2.921  1.00 95.56           N  \nATOM   1296  CZ  ARG A 165     -24.765 -36.244   2.698  1.00 95.56           C  \nATOM   1297  N   ASP A 166     -27.531 -28.467   3.856  1.00 96.62           N  \nATOM   1298  CA  ASP A 166     -28.483 -27.383   3.578  1.00 96.62           C  \nATOM   1299  C   ASP A 166     -27.778 -26.025   3.434  1.00 96.62           C  \nATOM   1300  CB  ASP A 166     -29.546 -27.354   4.687  1.00 96.62           C  \nATOM   1301  O   ASP A 166     -28.233 -25.161   2.691  1.00 96.62           O  \nATOM   1302  CG  ASP A 166     -30.797 -26.583   4.256  1.00 96.62           C  \nATOM   1303  OD1 ASP A 166     -31.689 -27.204   3.637  1.00 96.62           O  \nATOM   1304  OD2 ASP A 166     -30.897 -25.373   4.527  1.00 96.62           O  \nATOM   1305  N   ILE A 167     -26.630 -25.857   4.094  1.00 97.19           N  \nATOM   1306  CA  ILE A 167     -25.923 -24.578   4.206  1.00 97.19           C  \nATOM   1307  C   ILE A 167     -24.900 -24.398   3.079  1.00 97.19           C  \nATOM   1308  CB  ILE A 167     -25.306 -24.438   5.618  1.00 97.19           C  \nATOM   1309  O   ILE A 167     -24.909 -23.371   2.414  1.00 97.19           O  \nATOM   1310  CG1 ILE A 167     -26.410 -24.503   6.703  1.00 97.19           C  \nATOM   1311  CG2 ILE A 167     -24.509 -23.127   5.735  1.00 97.19           C  \nATOM   1312  CD1 ILE A 167     -25.873 -24.535   8.138  1.00 97.19           C  \nATOM   1313  N   VAL A 168     -24.030 -25.383   2.848  1.00 95.62           N  \nATOM   1314  CA  VAL A 168     -22.872 -25.280   1.935  1.00 95.62           C  \nATOM   1315  C   VAL A 168     -23.258 -25.688   0.502  1.00 95.62           C  \nATOM   1316  CB  VAL A 168     -21.692 -26.122   2.483  1.00 95.62           C  \nATOM   1317  O   VAL A 168     -24.172 -26.501   0.310  1.00 95.62           O  \nATOM   1318  CG1 VAL A 168     -20.367 -25.835   1.765  1.00 95.62           C  \nATOM   1319  CG2 VAL A 168     -21.421 -25.861   3.976  1.00 95.62           C  \nATOM   1320  N   SER A 169     -22.588 -25.158  -0.533  1.00 90.81           N  \nATOM   1321  CA  SER A 169     -22.686 -25.736  -1.890  1.00 90.81           C  \nATOM   1322  C   SER A 169     -22.167 -27.182  -1.935  1.00 90.81           C  \nATOM   1323  CB  SER A 169     -21.984 -24.906  -2.976  1.00 90.81           C  \nATOM   1324  O   SER A 169     -21.260 -27.553  -1.187  1.00 90.81           O  \nATOM   1325  OG  SER A 169     -22.469 -25.386  -4.220  1.00 90.81           O  \nATOM   1326  N   SER A 170     -22.715 -27.995  -2.844  1.00 89.75           N  \nATOM   1327  CA  SER A 170     -22.301 -29.387  -3.091  1.00 89.75           C  \nATOM   1328  C   SER A 170     -20.794 -29.535  -3.289  1.00 89.75           C  \nATOM   1329  CB  SER A 170     -23.000 -29.916  -4.355  1.00 89.75           C  \nATOM   1330  O   SER A 170     -20.190 -30.507  -2.840  1.00 89.75           O  \nATOM   1331  OG  SER A 170     -23.157 -28.919  -5.355  1.00 89.75           O  \nATOM   1332  N   ASP A 171     -20.204 -28.536  -3.932  1.00 89.94           N  \nATOM   1333  CA  ASP A 171     -18.881 -28.584  -4.555  1.00 89.94           C  \nATOM   1334  C   ASP A 171     -17.746 -28.448  -3.526  1.00 89.94           C  \nATOM   1335  CB  ASP A 171     -18.819 -27.500  -5.652  1.00 89.94           C  \nATOM   1336  O   ASP A 171     -16.598 -28.774  -3.817  1.00 89.94           O  \nATOM   1337  CG  ASP A 171     -20.190 -27.251  -6.303  1.00 89.94           C  \nATOM   1338  OD1 ASP A 171     -20.845 -28.244  -6.705  1.00 89.94           O  \nATOM   1339  OD2 ASP A 171     -20.677 -26.106  -6.183  1.00 89.94           O  \nATOM   1340  N   PHE A 172     -18.080 -28.017  -2.303  1.00 92.50           N  \nATOM   1341  CA  PHE A 172     -17.155 -27.895  -1.173  1.00 92.50           C  \nATOM   1342  C   PHE A 172     -17.405 -28.939  -0.071  1.00 92.50           C  \nATOM   1343  CB  PHE A 172     -17.200 -26.459  -0.627  1.00 92.50           C  \nATOM   1344  O   PHE A 172     -16.623 -29.016   0.878  1.00 92.50           O  \nATOM   1345  CG  PHE A 172     -16.931 -25.390  -1.672  1.00 92.50           C  \nATOM   1346  CD1 PHE A 172     -15.614 -25.102  -2.078  1.00 92.50           C  \nATOM   1347  CD2 PHE A 172     -18.006 -24.712  -2.272  1.00 92.50           C  \nATOM   1348  CE1 PHE A 172     -15.379 -24.145  -3.083  1.00 92.50           C  \nATOM   1349  CE2 PHE A 172     -17.776 -23.785  -3.302  1.00 92.50           C  \nATOM   1350  CZ  PHE A 172     -16.460 -23.493  -3.703  1.00 92.50           C  \nATOM   1351  N   LEU A 173     -18.448 -29.779  -0.186  1.00 90.38           N  \nATOM   1352  CA  LEU A 173     -18.768 -30.805   0.822  1.00 90.38           C  \nATOM   1353  C   LEU A 173     -17.645 -31.842   0.994  1.00 90.38           C  \nATOM   1354  CB  LEU A 173     -20.078 -31.534   0.465  1.00 90.38           C  \nATOM   1355  O   LEU A 173     -17.462 -32.356   2.095  1.00 90.38           O  \nATOM   1356  CG  LEU A 173     -21.365 -30.693   0.537  1.00 90.38           C  \nATOM   1357  CD1 LEU A 173     -22.555 -31.559   0.112  1.00 90.38           C  \nATOM   1358  CD2 LEU A 173     -21.665 -30.170   1.944  1.00 90.38           C  \nATOM   1359  N   SER A 174     -16.880 -32.127  -0.065  1.00 89.19           N  \nATOM   1360  CA  SER A 174     -15.705 -33.013  -0.038  1.00 89.19           C  \nATOM   1361  C   SER A 174     -14.520 -32.449   0.746  1.00 89.19           C  \nATOM   1362  CB  SER A 174     -15.236 -33.280  -1.473  1.00 89.19           C  \nATOM   1363  O   SER A 174     -13.641 -33.206   1.146  1.00 89.19           O  \nATOM   1364  OG  SER A 174     -15.077 -32.067  -2.188  1.00 89.19           O  \nATOM   1365  N   ASN A 175     -14.485 -31.130   0.949  1.00 89.12           N  \nATOM   1366  CA  ASN A 175     -13.356 -30.410   1.534  1.00 89.12           C  \nATOM   1367  C   ASN A 175     -13.648 -29.959   2.976  1.00 89.12           C  \nATOM   1368  CB  ASN A 175     -12.975 -29.239   0.605  1.00 89.12           C  \nATOM   1369  O   ASN A 175     -12.857 -29.227   3.565  1.00 89.12           O  \nATOM   1370  CG  ASN A 175     -12.410 -29.666  -0.742  1.00 89.12           C  \nATOM   1371  ND2 ASN A 175     -11.433 -28.949  -1.248  1.00 89.12           N  \nATOM   1372  OD1 ASN A 175     -12.840 -30.618  -1.377  1.00 89.12           O  \nATOM   1373  N   MET A 176     -14.786 -30.362   3.552  1.00 90.44           N  \nATOM   1374  CA  MET A 176     -15.114 -30.070   4.947  1.00 90.44           C  \nATOM   1375  C   MET A 176     -14.297 -30.945   5.903  1.00 90.44           C  \nATOM   1376  CB  MET A 176     -16.613 -30.254   5.211  1.00 90.44           C  \nATOM   1377  O   MET A 176     -14.112 -32.136   5.665  1.00 90.44           O  \nATOM   1378  CG  MET A 176     -17.482 -29.322   4.359  1.00 90.44           C  \nATOM   1379  SD  MET A 176     -19.227 -29.226   4.855  1.00 90.44           S  \nATOM   1380  CE  MET A 176     -19.683 -30.980   4.834  1.00 90.44           C  \nATOM   1381  N   SER A 177     -13.860 -30.365   7.021  1.00 87.81           N  \nATOM   1382  CA  SER A 177     -13.071 -31.052   8.050  1.00 87.81           C  \nATOM   1383  C   SER A 177     -13.679 -30.776   9.421  1.00 87.81           C  \nATOM   1384  CB  SER A 177     -11.616 -30.577   7.969  1.00 87.81           C  \nATOM   1385  O   SER A 177     -13.603 -29.654   9.911  1.00 87.81           O  \nATOM   1386  OG  SER A 177     -10.848 -31.111   9.032  1.00 87.81           O  \nATOM   1387  N   MET A 178     -14.292 -31.779  10.047  1.00 86.12           N  \nATOM   1388  CA  MET A 178     -15.064 -31.613  11.283  1.00 86.12           C  \nATOM   1389  C   MET A 178     -14.609 -32.608  12.353  1.00 86.12           C  \nATOM   1390  CB  MET A 178     -16.562 -31.780  10.975  1.00 86.12           C  \nATOM   1391  O   MET A 178     -14.926 -33.792  12.267  1.00 86.12           O  \nATOM   1392  CG  MET A 178     -17.123 -30.647  10.107  1.00 86.12           C  \nATOM   1393  SD  MET A 178     -18.825 -30.927   9.549  1.00 86.12           S  \nATOM   1394  CE  MET A 178     -19.043 -29.451   8.523  1.00 86.12           C  \nATOM   1395  N   ASP A 179     -13.897 -32.112  13.364  1.00 84.62           N  \nATOM   1396  CA  ASP A 179     -13.578 -32.838  14.596  1.00 84.62           C  \nATOM   1397  C   ASP A 179     -14.319 -32.208  15.789  1.00 84.62           C  \nATOM   1398  CB  ASP A 179     -12.056 -32.882  14.807  1.00 84.62           C  \nATOM   1399  O   ASP A 179     -14.038 -31.074  16.196  1.00 84.62           O  \nATOM   1400  CG  ASP A 179     -11.679 -33.594  16.111  1.00 84.62           C  \nATOM   1401  OD1 ASP A 179     -12.433 -34.493  16.542  1.00 84.62           O  \nATOM   1402  OD2 ASP A 179     -10.645 -33.218  16.708  1.00 84.62           O  \nATOM   1403  N   PHE A 180     -15.282 -32.954  16.337  1.00 80.19           N  \nATOM   1404  CA  PHE A 180     -16.117 -32.565  17.475  1.00 80.19           C  \nATOM   1405  C   PHE A 180     -15.823 -33.474  18.679  1.00 80.19           C  \nATOM   1406  CB  PHE A 180     -17.606 -32.595  17.081  1.00 80.19           C  \nATOM   1407  O   PHE A 180     -16.441 -34.523  18.862  1.00 80.19           O  \nATOM   1408  CG  PHE A 180     -18.046 -31.559  16.058  1.00 80.19           C  \nATOM   1409  CD1 PHE A 180     -18.147 -30.202  16.424  1.00 80.19           C  \nATOM   1410  CD2 PHE A 180     -18.431 -31.957  14.763  1.00 80.19           C  \nATOM   1411  CE1 PHE A 180     -18.616 -29.251  15.499  1.00 80.19           C  \nATOM   1412  CE2 PHE A 180     -18.913 -31.007  13.843  1.00 80.19           C  \nATOM   1413  CZ  PHE A 180     -18.998 -29.653  14.208  1.00 80.19           C  \nATOM   1414  N   GLN A 181     -14.879 -33.059  19.527  1.00 69.19           N  \nATOM   1415  CA  GLN A 181     -14.504 -33.780  20.749  1.00 69.19           C  \nATOM   1416  C   GLN A 181     -15.313 -33.276  21.950  1.00 69.19           C  \nATOM   1417  CB  GLN A 181     -12.995 -33.636  21.016  1.00 69.19           C  \nATOM   1418  O   GLN A 181     -14.855 -32.396  22.674  1.00 69.19           O  \nATOM   1419  CG  GLN A 181     -12.123 -34.171  19.876  1.00 69.19           C  \nATOM   1420  CD  GLN A 181     -10.630 -34.084  20.177  1.00 69.19           C  \nATOM   1421  NE2 GLN A 181      -9.799 -34.133  19.167  1.00 69.19           N  \nATOM   1422  OE1 GLN A 181     -10.178 -33.952  21.309  1.00 69.19           O  \nATOM   1423  N   ASN A 182     -16.508 -33.817  22.192  1.00 64.62           N  \nATOM   1424  CA  ASN A 182     -17.308 -33.380  23.338  1.00 64.62           C  \nATOM   1425  C   ASN A 182     -16.798 -34.010  24.652  1.00 64.62           C  \nATOM   1426  CB  ASN A 182     -18.800 -33.608  23.056  1.00 64.62           C  \nATOM   1427  O   ASN A 182     -17.068 -35.176  24.949  1.00 64.62           O  \nATOM   1428  CG  ASN A 182     -19.662 -32.839  24.043  1.00 64.62           C  \nATOM   1429  ND2 ASN A 182     -20.869 -32.493  23.668  1.00 64.62           N  \nATOM   1430  OD1 ASN A 182     -19.255 -32.525  25.149  1.00 64.62           O  \nATOM   1431  N   HIS A 183     -16.043 -33.234  25.435  1.00 59.84           N  \nATOM   1432  CA  HIS A 183     -15.525 -33.645  26.746  1.00 59.84           C  \nATOM   1433  C   HIS A 183     -16.363 -33.136  27.931  1.00 59.84           C  \nATOM   1434  CB  HIS A 183     -14.061 -33.193  26.876  1.00 59.84           C  \nATOM   1435  O   HIS A 183     -16.095 -33.528  29.069  1.00 59.84           O  \nATOM   1436  CG  HIS A 183     -13.051 -34.099  26.217  1.00 59.84           C  \nATOM   1437  CD2 HIS A 183     -11.990 -33.696  25.455  1.00 59.84           C  \nATOM   1438  ND1 HIS A 183     -12.920 -35.457  26.404  1.00 59.84           N  \nATOM   1439  CE1 HIS A 183     -11.802 -35.858  25.777  1.00 59.84           C  \nATOM   1440  NE2 HIS A 183     -11.161 -34.805  25.237  1.00 59.84           N  \nATOM   1441  N   LEU A 184     -17.361 -32.277  27.697  1.00 60.78           N  \nATOM   1442  CA  LEU A 184     -18.132 -31.615  28.747  1.00 60.78           C  \nATOM   1443  C   LEU A 184     -19.587 -32.106  28.729  1.00 60.78           C  \nATOM   1444  CB  LEU A 184     -17.973 -30.081  28.611  1.00 60.78           C  \nATOM   1445  O   LEU A 184     -20.419 -31.645  27.952  1.00 60.78           O  \nATOM   1446  CG  LEU A 184     -17.677 -29.390  29.955  1.00 60.78           C  \nATOM   1447  CD1 LEU A 184     -16.242 -29.658  30.425  1.00 60.78           C  \nATOM   1448  CD2 LEU A 184     -17.845 -27.876  29.826  1.00 60.78           C  \nATOM   1449  N   GLY A 185     -19.918 -33.028  29.639  1.00 62.22           N  \nATOM   1450  CA  GLY A 185     -21.250 -33.644  29.770  1.00 62.22           C  \nATOM   1451  C   GLY A 185     -22.382 -32.711  30.241  1.00 62.22           C  \nATOM   1452  O   GLY A 185     -23.325 -33.178  30.872  1.00 62.22           O  \nATOM   1453  N   SER A 186     -22.275 -31.406  29.984  1.00 76.44           N  \nATOM   1454  CA  SER A 186     -23.208 -30.344  30.381  1.00 76.44           C  \nATOM   1455  C   SER A 186     -23.963 -29.704  29.205  1.00 76.44           C  \nATOM   1456  CB  SER A 186     -22.453 -29.282  31.189  1.00 76.44           C  \nATOM   1457  O   SER A 186     -24.769 -28.797  29.425  1.00 76.44           O  \nATOM   1458  OG  SER A 186     -21.366 -28.764  30.442  1.00 76.44           O  \nATOM   1459  N   CYS A 187     -23.745 -30.168  27.968  1.00 87.25           N  \nATOM   1460  CA  CYS A 187     -24.511 -29.719  26.804  1.00 87.25           C  \nATOM   1461  C   CYS A 187     -26.008 -30.037  26.946  1.00 87.25           C  \nATOM   1462  CB  CYS A 187     -23.950 -30.350  25.524  1.00 87.25           C  \nATOM   1463  O   CYS A 187     -26.399 -31.168  27.244  1.00 87.25           O  \nATOM   1464  SG  CYS A 187     -22.249 -29.884  25.118  1.00 87.25           S  \nATOM   1465  N   GLN A 188     -26.857 -29.041  26.690  1.00 90.31           N  \nATOM   1466  CA  GLN A 188     -28.307 -29.228  26.647  1.00 90.31           C  \nATOM   1467  C   GLN A 188     -28.722 -29.864  25.313  1.00 90.31           C  \nATOM   1468  CB  GLN A 188     -29.033 -27.900  26.907  1.00 90.31           C  \nATOM   1469  O   GLN A 188     -28.088 -29.652  24.280  1.00 90.31           O  \nATOM   1470  CG  GLN A 188     -28.730 -27.346  28.312  1.00 90.31           C  \nATOM   1471  CD  GLN A 188     -29.562 -26.120  28.681  1.00 90.31           C  \nATOM   1472  NE2 GLN A 188     -29.258 -25.464  29.779  1.00 90.31           N  \nATOM   1473  OE1 GLN A 188     -30.507 -25.732  28.022  1.00 90.31           O  \nATOM   1474  N   LYS A 189     -29.798 -30.657  25.322  1.00 92.00           N  \nATOM   1475  CA  LYS A 189     -30.349 -31.244  24.093  1.00 92.00           C  \nATOM   1476  C   LYS A 189     -31.100 -30.189  23.277  1.00 92.00           C  \nATOM   1477  CB  LYS A 189     -31.249 -32.447  24.411  1.00 92.00           C  \nATOM   1478  O   LYS A 189     -31.683 -29.269  23.844  1.00 92.00           O  \nATOM   1479  CG  LYS A 189     -30.428 -33.633  24.937  1.00 92.00           C  \nATOM   1480  CD  LYS A 189     -31.308 -34.873  25.122  1.00 92.00           C  \nATOM   1481  CE  LYS A 189     -30.430 -36.052  25.553  1.00 92.00           C  \nATOM   1482  NZ  LYS A 189     -31.222 -37.298  25.683  1.00 92.00           N  \nATOM   1483  N   CYS A 190     -31.115 -30.375  21.959  1.00 94.12           N  \nATOM   1484  CA  CYS A 190     -31.999 -29.639  21.061  1.00 94.12           C  \nATOM   1485  C   CYS A 190     -33.473 -29.851  21.437  1.00 94.12           C  \nATOM   1486  CB  CYS A 190     -31.736 -30.094  19.620  1.00 94.12           C  \nATOM   1487  O   CYS A 190     -33.839 -30.904  21.970  1.00 94.12           O  \nATOM   1488  SG  CYS A 190     -30.043 -29.812  19.040  1.00 94.12           S  \nATOM   1489  N   ASP A 191     -34.310 -28.860  21.136  1.00 96.19           N  \nATOM   1490  CA  ASP A 191     -35.749 -28.951  21.368  1.00 96.19           C  \nATOM   1491  C   ASP A 191     -36.390 -30.053  20.487  1.00 96.19           C  \nATOM   1492  CB  ASP A 191     -36.390 -27.578  21.131  1.00 96.19           C  \nATOM   1493  O   ASP A 191     -35.969 -30.230  19.338  1.00 96.19           O  \nATOM   1494  CG  ASP A 191     -37.836 -27.613  21.604  1.00 96.19           C  \nATOM   1495  OD1 ASP A 191     -38.691 -28.014  20.781  1.00 96.19           O  \nATOM   1496  OD2 ASP A 191     -38.049 -27.377  22.811  1.00 96.19           O  \nATOM   1497  N   PRO A 192     -37.406 -30.803  20.969  1.00 95.31           N  \nATOM   1498  CA  PRO A 192     -38.097 -31.825  20.175  1.00 95.31           C  \nATOM   1499  C   PRO A 192     -38.746 -31.321  18.875  1.00 95.31           C  \nATOM   1500  CB  PRO A 192     -39.156 -32.420  21.109  1.00 95.31           C  \nATOM   1501  O   PRO A 192     -39.028 -32.135  17.996  1.00 95.31           O  \nATOM   1502  CG  PRO A 192     -38.574 -32.187  22.500  1.00 95.31           C  \nATOM   1503  CD  PRO A 192     -37.889 -30.835  22.344  1.00 95.31           C  \nATOM   1504  N   SER A 193     -38.988 -30.013  18.739  1.00 96.06           N  \nATOM   1505  CA  SER A 193     -39.464 -29.382  17.500  1.00 96.06           C  \nATOM   1506  C   SER A 193     -38.402 -29.303  16.392  1.00 96.06           C  \nATOM   1507  CB  SER A 193     -39.971 -27.968  17.806  1.00 96.06           C  \nATOM   1508  O   SER A 193     -38.755 -29.179  15.215  1.00 96.06           O  \nATOM   1509  OG  SER A 193     -38.928 -27.187  18.345  1.00 96.06           O  \nATOM   1510  N   CYS A 194     -37.108 -29.389  16.727  1.00 95.94           N  \nATOM   1511  CA  CYS A 194     -36.032 -29.177  15.764  1.00 95.94           C  \nATOM   1512  C   CYS A 194     -36.001 -30.272  14.677  1.00 95.94           C  \nATOM   1513  CB  CYS A 194     -34.678 -29.090  16.477  1.00 95.94           C  \nATOM   1514  O   CYS A 194     -35.983 -31.467  15.001  1.00 95.94           O  \nATOM   1515  SG  CYS A 194     -34.424 -27.742  17.669  1.00 95.94           S  \nATOM   1516  N   PRO A 195     -35.924 -29.914  13.378  1.00 94.12           N  \nATOM   1517  CA  PRO A 195     -35.938 -30.894  12.298  1.00 94.12           C  \nATOM   1518  C   PRO A 195     -34.725 -31.821  12.410  1.00 94.12           C  \nATOM   1519  CB  PRO A 195     -35.942 -30.087  10.997  1.00 94.12           C  \nATOM   1520  O   PRO A 195     -33.591 -31.363  12.509  1.00 94.12           O  \nATOM   1521  CG  PRO A 195     -35.275 -28.771  11.393  1.00 94.12           C  \nATOM   1522  CD  PRO A 195     -35.720 -28.575  12.843  1.00 94.12           C  \nATOM   1523  N   ASN A 196     -34.976 -33.134  12.419  1.00 94.44           N  \nATOM   1524  CA  ASN A 196     -33.965 -34.182  12.623  1.00 94.44           C  \nATOM   1525  C   ASN A 196     -33.142 -34.052  13.928  1.00 94.44           C  \nATOM   1526  CB  ASN A 196     -33.098 -34.308  11.353  1.00 94.44           C  \nATOM   1527  O   ASN A 196     -32.111 -34.706  14.061  1.00 94.44           O  \nATOM   1528  CG  ASN A 196     -33.922 -34.562  10.104  1.00 94.44           C  \nATOM   1529  ND2 ASN A 196     -33.641 -33.891   9.013  1.00 94.44           N  \nATOM   1530  OD1 ASN A 196     -34.844 -35.362  10.080  1.00 94.44           O  \nATOM   1531  N   GLY A 197     -33.590 -33.238  14.894  1.00 94.50           N  \nATOM   1532  CA  GLY A 197     -32.836 -32.920  16.109  1.00 94.50           C  \nATOM   1533  C   GLY A 197     -31.682 -31.930  15.903  1.00 94.50           C  \nATOM   1534  O   GLY A 197     -30.815 -31.852  16.767  1.00 94.50           O  \nATOM   1535  N   SER A 198     -31.648 -31.191  14.788  1.00 96.81           N  \nATOM   1536  CA  SER A 198     -30.570 -30.249  14.454  1.00 96.81           C  \nATOM   1537  C   SER A 198     -30.808 -28.850  15.036  1.00 96.81           C  \nATOM   1538  CB  SER A 198     -30.405 -30.175  12.934  1.00 96.81           C  \nATOM   1539  O   SER A 198     -31.793 -28.189  14.697  1.00 96.81           O  \nATOM   1540  OG  SER A 198     -30.044 -31.447  12.429  1.00 96.81           O  \nATOM   1541  N   CYS A 199     -29.893 -28.364  15.878  1.00 97.31           N  \nATOM   1542  CA  CYS A 199     -29.952 -27.033  16.491  1.00 97.31           C  \nATOM   1543  C   CYS A 199     -28.566 -26.411  16.723  1.00 97.31           C  \nATOM   1544  CB  CYS A 199     -30.730 -27.098  17.814  1.00 97.31           C  \nATOM   1545  O   CYS A 199     -27.558 -27.103  16.811  1.00 97.31           O  \nATOM   1546  SG  CYS A 199     -29.843 -27.806  19.229  1.00 97.31           S  \nATOM   1547  N   TRP A 200     -28.529 -25.087  16.873  1.00 96.88           N  \nATOM   1548  CA  TRP A 200     -27.322 -24.303  17.175  1.00 96.88           C  \nATOM   1549  C   TRP A 200     -27.128 -24.011  18.677  1.00 96.88           C  \nATOM   1550  CB  TRP A 200     -27.382 -23.004  16.367  1.00 96.88           C  \nATOM   1551  O   TRP A 200     -26.224 -23.269  19.057  1.00 96.88           O  \nATOM   1552  CG  TRP A 200     -27.304 -23.154  14.884  1.00 96.88           C  \nATOM   1553  CD1 TRP A 200     -28.347 -23.225  14.026  1.00 96.88           C  \nATOM   1554  CD2 TRP A 200     -26.099 -23.245  14.067  1.00 96.88           C  \nATOM   1555  CE2 TRP A 200     -26.490 -23.262  12.697  1.00 96.88           C  \nATOM   1556  CE3 TRP A 200     -24.716 -23.306  14.347  1.00 96.88           C  \nATOM   1557  NE1 TRP A 200     -27.868 -23.242  12.728  1.00 96.88           N  \nATOM   1558  CH2 TRP A 200     -24.189 -23.354  11.962  1.00 96.88           C  \nATOM   1559  CZ2 TRP A 200     -25.558 -23.289  11.654  1.00 96.88           C  \nATOM   1560  CZ3 TRP A 200     -23.770 -23.377  13.305  1.00 96.88           C  \nATOM   1561  N   GLY A 201     -28.010 -24.539  19.526  1.00 93.81           N  \nATOM   1562  CA  GLY A 201     -28.074 -24.276  20.963  1.00 93.81           C  \nATOM   1563  C   GLY A 201     -29.434 -24.683  21.536  1.00 93.81           C  \nATOM   1564  O   GLY A 201     -30.306 -25.142  20.800  1.00 93.81           O  \nATOM   1565  N   ALA A 202     -29.626 -24.503  22.842  1.00 92.62           N  \nATOM   1566  CA  ALA A 202     -30.894 -24.802  23.512  1.00 92.62           C  \nATOM   1567  C   ALA A 202     -32.054 -23.902  23.036  1.00 92.62           C  \nATOM   1568  CB  ALA A 202     -30.675 -24.665  25.022  1.00 92.62           C  \nATOM   1569  O   ALA A 202     -31.828 -22.751  22.669  1.00 92.62           O  \nATOM   1570  N   GLY A 203     -33.289 -24.409  23.109  1.00 93.12           N  \nATOM   1571  CA  GLY A 203     -34.515 -23.675  22.763  1.00 93.12           C  \nATOM   1572  C   GLY A 203     -34.950 -23.802  21.296  1.00 93.12           C  \nATOM   1573  O   GLY A 203     -34.126 -23.943  20.389  1.00 93.12           O  \nATOM   1574  N   GLU A 204     -36.267 -23.749  21.063  1.00 95.62           N  \nATOM   1575  CA  GLU A 204     -36.901 -23.794  19.731  1.00 95.62           C  \nATOM   1576  C   GLU A 204     -36.336 -22.711  18.793  1.00 95.62           C  \nATOM   1577  CB  GLU A 204     -38.425 -23.624  19.917  1.00 95.62           C  \nATOM   1578  O   GLU A 204     -36.129 -22.933  17.597  1.00 95.62           O  \nATOM   1579  CG  GLU A 204     -39.221 -23.592  18.596  1.00 95.62           C  \nATOM   1580  CD  GLU A 204     -40.747 -23.458  18.774  1.00 95.62           C  \nATOM   1581  OE1 GLU A 204     -41.459 -23.632  17.756  1.00 95.62           O  \nATOM   1582  OE2 GLU A 204     -41.204 -23.110  19.888  1.00 95.62           O  \nATOM   1583  N   GLU A 205     -35.987 -21.541  19.335  1.00 95.50           N  \nATOM   1584  CA  GLU A 205     -35.475 -20.411  18.564  1.00 95.50           C  \nATOM   1585  C   GLU A 205     -34.056 -20.617  18.000  1.00 95.50           C  \nATOM   1586  CB  GLU A 205     -35.599 -19.116  19.387  1.00 95.50           C  \nATOM   1587  O   GLU A 205     -33.577 -19.758  17.250  1.00 95.50           O  \nATOM   1588  CG  GLU A 205     -34.488 -18.842  20.418  1.00 95.50           C  \nATOM   1589  CD  GLU A 205     -34.501 -19.660  21.712  1.00 95.50           C  \nATOM   1590  OE1 GLU A 205     -33.607 -19.346  22.530  1.00 95.50           O  \nATOM   1591  OE2 GLU A 205     -35.371 -20.543  21.870  1.00 95.50           O  \nATOM   1592  N   ASN A 206     -33.393 -21.724  18.361  1.00 96.56           N  \nATOM   1593  CA  ASN A 206     -32.080 -22.142  17.866  1.00 96.56           C  \nATOM   1594  C   ASN A 206     -32.127 -23.412  16.990  1.00 96.56           C  \nATOM   1595  CB  ASN A 206     -31.104 -22.257  19.053  1.00 96.56           C  \nATOM   1596  O   ASN A 206     -31.074 -23.857  16.524  1.00 96.56           O  \nATOM   1597  CG  ASN A 206     -30.827 -20.903  19.681  1.00 96.56           C  \nATOM   1598  ND2 ASN A 206     -31.207 -20.703  20.918  1.00 96.56           N  \nATOM   1599  OD1 ASN A 206     -30.295 -19.999  19.051  1.00 96.56           O  \nATOM   1600  N   CYS A 207     -33.308 -23.979  16.706  1.00 97.56           N  \nATOM   1601  CA  CYS A 207     -33.456 -25.061  15.727  1.00 97.56           C  \nATOM   1602  C   CYS A 207     -32.942 -24.650  14.332  1.00 97.56           C  \nATOM   1603  CB  CYS A 207     -34.927 -25.484  15.633  1.00 97.56           C  \nATOM   1604  O   CYS A 207     -33.117 -23.506  13.897  1.00 97.56           O  \nATOM   1605  SG  CYS A 207     -35.660 -26.219  17.117  1.00 97.56           S  \nATOM   1606  N   GLN A 208     -32.327 -25.583  13.597  1.00 97.75           N  \nATOM   1607  CA  GLN A 208     -31.835 -25.304  12.248  1.00 97.75           C  \nATOM   1608  C   GLN A 208     -33.003 -25.086  11.274  1.00 97.75           C  \nATOM   1609  CB  GLN A 208     -30.891 -26.411  11.752  1.00 97.75           C  \nATOM   1610  O   GLN A 208     -33.849 -25.957  11.074  1.00 97.75           O  \nATOM   1611  CG  GLN A 208     -30.236 -26.009  10.413  1.00 97.75           C  \nATOM   1612  CD  GLN A 208     -29.371 -27.098   9.792  1.00 97.75           C  \nATOM   1613  NE2 GLN A 208     -28.867 -26.882   8.594  1.00 97.75           N  \nATOM   1614  OE1 GLN A 208     -29.136 -28.151  10.358  1.00 97.75           O  \nATOM   1615  N   LYS A 209     -33.003 -23.931  10.608  1.00 96.69           N  \nATOM   1616  CA  LYS A 209     -33.928 -23.605   9.517  1.00 96.69           C  \nATOM   1617  C   LYS A 209     -33.385 -24.225   8.231  1.00 96.69           C  \nATOM   1618  CB  LYS A 209     -34.076 -22.078   9.406  1.00 96.69           C  \nATOM   1619  O   LYS A 209     -32.277 -23.889   7.827  1.00 96.69           O  \nATOM   1620  CG  LYS A 209     -34.595 -21.469  10.719  1.00 96.69           C  \nATOM   1621  CD  LYS A 209     -34.496 -19.943  10.725  1.00 96.69           C  \nATOM   1622  CE  LYS A 209     -34.668 -19.481  12.174  1.00 96.69           C  \nATOM   1623  NZ  LYS A 209     -34.506 -18.018  12.304  1.00 96.69           N  \nATOM   1624  N   LEU A 210     -34.143 -25.139   7.627  1.00 97.06           N  \nATOM   1625  CA  LEU A 210     -33.767 -25.821   6.386  1.00 97.06           C  \nATOM   1626  C   LEU A 210     -34.443 -25.134   5.195  1.00 97.06           C  \nATOM   1627  CB  LEU A 210     -34.153 -27.311   6.463  1.00 97.06           C  \nATOM   1628  O   LEU A 210     -35.667 -24.997   5.192  1.00 97.06           O  \nATOM   1629  CG  LEU A 210     -33.517 -28.106   7.621  1.00 97.06           C  \nATOM   1630  CD1 LEU A 210     -34.086 -29.526   7.633  1.00 97.06           C  \nATOM   1631  CD2 LEU A 210     -31.997 -28.198   7.497  1.00 97.06           C  \nATOM   1632  N   THR A 211     -33.672 -24.725   4.186  1.00 96.62           N  \nATOM   1633  CA  THR A 211     -34.185 -23.993   3.009  1.00 96.62           C  \nATOM   1634  C   THR A 211     -33.713 -24.552   1.665  1.00 96.62           C  \nATOM   1635  CB  THR A 211     -33.894 -22.481   3.092  1.00 96.62           C  \nATOM   1636  O   THR A 211     -33.982 -23.931   0.636  1.00 96.62           O  \nATOM   1637  CG2 THR A 211     -34.486 -21.832   4.340  1.00 96.62           C  \nATOM   1638  OG1 THR A 211     -32.509 -22.225   3.094  1.00 96.62           O  \nATOM   1639  N   LYS A 212     -33.036 -25.713   1.644  1.00 95.75           N  \nATOM   1640  CA  LYS A 212     -32.458 -26.351   0.441  1.00 95.75           C  \nATOM   1641  C   LYS A 212     -32.764 -27.851   0.353  1.00 95.75           C  \nATOM   1642  CB  LYS A 212     -30.953 -26.048   0.472  1.00 95.75           C  \nATOM   1643  O   LYS A 212     -33.314 -28.305  -0.646  1.00 95.75           O  \nATOM   1644  CG  LYS A 212     -30.076 -26.515  -0.702  1.00 95.75           C  \nATOM   1645  CD  LYS A 212     -28.629 -26.105  -0.363  1.00 95.75           C  \nATOM   1646  CE  LYS A 212     -27.634 -26.156  -1.522  1.00 95.75           C  \nATOM   1647  NZ  LYS A 212     -26.356 -25.502  -1.126  1.00 95.75           N  \nATOM   1648  N   ILE A 213     -32.491 -28.634   1.402  1.00 95.19           N  \nATOM   1649  CA  ILE A 213     -32.665 -30.105   1.383  1.00 95.19           C  \nATOM   1650  C   ILE A 213     -34.125 -30.560   1.511  1.00 95.19           C  \nATOM   1651  CB  ILE A 213     -31.773 -30.822   2.425  1.00 95.19           C  \nATOM   1652  O   ILE A 213     -34.422 -31.732   1.295  1.00 95.19           O  \nATOM   1653  CG1 ILE A 213     -32.252 -30.603   3.881  1.00 95.19           C  \nATOM   1654  CG2 ILE A 213     -30.300 -30.436   2.213  1.00 95.19           C  \nATOM   1655  CD1 ILE A 213     -31.393 -31.304   4.940  1.00 95.19           C  \nATOM   1656  N   ILE A 214     -35.035 -29.652   1.878  1.00 95.44           N  \nATOM   1657  CA  ILE A 214     -36.473 -29.935   2.024  1.00 95.44           C  \nATOM   1658  C   ILE A 214     -37.303 -29.552   0.788  1.00 95.44           C  \nATOM   1659  CB  ILE A 214     -37.044 -29.289   3.307  1.00 95.44           C  \nATOM   1660  O   ILE A 214     -38.513 -29.773   0.786  1.00 95.44           O  \nATOM   1661  CG1 ILE A 214     -37.016 -27.744   3.260  1.00 95.44           C  \nATOM   1662  CG2 ILE A 214     -36.324 -29.838   4.552  1.00 95.44           C  \nATOM   1663  CD1 ILE A 214     -37.931 -27.101   4.308  1.00 95.44           C  \nATOM   1664  N   CYS A 215     -36.685 -28.944  -0.225  1.00 95.56           N  \nATOM   1665  CA  CYS A 215     -37.394 -28.329  -1.342  1.00 95.56           C  \nATOM   1666  C   CYS A 215     -37.964 -29.349  -2.334  1.00 95.56           C  \nATOM   1667  CB  CYS A 215     -36.457 -27.333  -2.038  1.00 95.56           C  \nATOM   1668  O   CYS A 215     -37.443 -30.453  -2.505  1.00 95.56           O  \nATOM   1669  SG  CYS A 215     -35.762 -26.067  -0.947  1.00 95.56           S  \nATOM   1670  N   ALA A 216     -39.022 -28.953  -3.045  1.00 95.06           N  \nATOM   1671  CA  ALA A 216     -39.505 -29.707  -4.194  1.00 95.06           C  \nATOM   1672  C   ALA A 216     -38.441 -29.740  -5.308  1.00 95.06           C  \nATOM   1673  CB  ALA A 216     -40.817 -29.081  -4.682  1.00 95.06           C  \nATOM   1674  O   ALA A 216     -37.767 -28.742  -5.553  1.00 95.06           O  \nATOM   1675  N   GLN A 217     -38.360 -30.848  -6.054  1.00 91.81           N  \nATOM   1676  CA  GLN A 217     -37.403 -31.043  -7.165  1.00 91.81           C  \nATOM   1677  C   GLN A 217     -37.521 -30.010  -8.308  1.00 91.81           C  \nATOM   1678  CB  GLN A 217     -37.594 -32.455  -7.748  1.00 91.81           C  \nATOM   1679  O   GLN A 217     -36.676 -29.977  -9.195  1.00 91.81           O  \nATOM   1680  CG  GLN A 217     -37.165 -33.581  -6.794  1.00 91.81           C  \nATOM   1681  CD  GLN A 217     -37.373 -34.970  -7.398  1.00 91.81           C  \nATOM   1682  NE2 GLN A 217     -36.718 -35.986  -6.882  1.00 91.81           N  \nATOM   1683  OE1 GLN A 217     -38.136 -35.185  -8.322  1.00 91.81           O  \nATOM   1684  N   GLN A 218     -38.573 -29.186  -8.304  1.00 90.81           N  \nATOM   1685  CA  GLN A 218     -38.810 -28.110  -9.271  1.00 90.81           C  \nATOM   1686  C   GLN A 218     -38.186 -26.764  -8.853  1.00 90.81           C  \nATOM   1687  CB  GLN A 218     -40.328 -27.968  -9.478  1.00 90.81           C  \nATOM   1688  O   GLN A 218     -38.130 -25.849  -9.672  1.00 90.81           O  \nATOM   1689  CG  GLN A 218     -40.949 -29.211 -10.142  1.00 90.81           C  \nATOM   1690  CD  GLN A 218     -42.470 -29.141 -10.258  1.00 90.81           C  \nATOM   1691  NE2 GLN A 218     -43.083 -30.067 -10.962  1.00 90.81           N  \nATOM   1692  OE1 GLN A 218     -43.148 -28.294  -9.706  1.00 90.81           O  \nATOM   1693  N   CYS A 219     -37.725 -26.610  -7.606  1.00 92.94           N  \nATOM   1694  CA  CYS A 219     -37.067 -25.381  -7.159  1.00 92.94           C  \nATOM   1695  C   CYS A 219     -35.631 -25.314  -7.707  1.00 92.94           C  \nATOM   1696  CB  CYS A 219     -37.064 -25.296  -5.623  1.00 92.94           C  \nATOM   1697  O   CYS A 219     -34.858 -26.249  -7.521  1.00 92.94           O  \nATOM   1698  SG  CYS A 219     -38.653 -25.446  -4.750  1.00 92.94           S  \nATOM   1699  N   SER A 220     -35.228 -24.186  -8.304  1.00 90.06           N  \nATOM   1700  CA  SER A 220     -33.871 -24.005  -8.856  1.00 90.06           C  \nATOM   1701  C   SER A 220     -32.778 -23.750  -7.803  1.00 90.06           C  \nATOM   1702  CB  SER A 220     -33.877 -22.883  -9.899  1.00 90.06           C  \nATOM   1703  O   SER A 220     -31.626 -23.510  -8.154  1.00 90.06           O  \nATOM   1704  OG  SER A 220     -34.072 -21.623  -9.286  1.00 90.06           O  \nATOM   1705  N   GLY A 221     -33.133 -23.763  -6.517  1.00 92.00           N  \nATOM   1706  CA  GLY A 221     -32.245 -23.437  -5.405  1.00 92.00           C  \nATOM   1707  C   GLY A 221     -32.968 -23.540  -4.065  1.00 92.00           C  \nATOM   1708  O   GLY A 221     -33.166 -24.635  -3.547  1.00 92.00           O  \nATOM   1709  N   ARG A 222     -33.353 -22.394  -3.497  1.00 95.88           N  \nATOM   1710  CA  ARG A 222     -33.933 -22.291  -2.147  1.00 95.88           C  \nATOM   1711  C   ARG A 222     -35.463 -22.389  -2.132  1.00 95.88           C  \nATOM   1712  CB  ARG A 222     -33.445 -20.991  -1.486  1.00 95.88           C  \nATOM   1713  O   ARG A 222     -36.125 -22.149  -3.143  1.00 95.88           O  \nATOM   1714  CG  ARG A 222     -31.922 -20.933  -1.277  1.00 95.88           C  \nATOM   1715  CD  ARG A 222     -31.484 -21.682  -0.010  1.00 95.88           C  \nATOM   1716  NE  ARG A 222     -30.018 -21.768   0.140  1.00 95.88           N  \nATOM   1717  NH1 ARG A 222     -30.005 -23.100   2.015  1.00 95.88           N  \nATOM   1718  NH2 ARG A 222     -28.105 -22.652   0.987  1.00 95.88           N  \nATOM   1719  CZ  ARG A 222     -29.389 -22.491   1.045  1.00 95.88           C  \nATOM   1720  N   CYS A 223     -36.033 -22.666  -0.963  1.00 97.31           N  \nATOM   1721  CA  CYS A 223     -37.476 -22.672  -0.710  1.00 97.31           C  \nATOM   1722  C   CYS A 223     -37.832 -22.248   0.729  1.00 97.31           C  \nATOM   1723  CB  CYS A 223     -38.027 -24.073  -1.004  1.00 97.31           C  \nATOM   1724  O   CYS A 223     -36.971 -22.140   1.601  1.00 97.31           O  \nATOM   1725  SG  CYS A 223     -37.361 -25.355   0.084  1.00 97.31           S  \nATOM   1726  N   ARG A 224     -39.131 -22.032   0.973  1.00 95.62           N  \nATOM   1727  CA  ARG A 224     -39.746 -21.743   2.288  1.00 95.62           C  \nATOM   1728  C   ARG A 224     -40.394 -22.969   2.943  1.00 95.62           C  \nATOM   1729  CB  ARG A 224     -40.813 -20.643   2.126  1.00 95.62           C  \nATOM   1730  O   ARG A 224     -40.897 -22.876   4.057  1.00 95.62           O  \nATOM   1731  CG  ARG A 224     -40.258 -19.374   1.474  1.00 95.62           C  \nATOM   1732  CD  ARG A 224     -41.331 -18.300   1.258  1.00 95.62           C  \nATOM   1733  NE  ARG A 224     -42.312 -18.730   0.239  1.00 95.62           N  \nATOM   1734  NH1 ARG A 224     -44.133 -17.517   0.952  1.00 95.62           N  \nATOM   1735  NH2 ARG A 224     -44.393 -19.058  -0.634  1.00 95.62           N  \nATOM   1736  CZ  ARG A 224     -43.599 -18.438   0.196  1.00 95.62           C  \nATOM   1737  N   GLY A 225     -40.458 -24.084   2.220  1.00 93.69           N  \nATOM   1738  CA  GLY A 225     -41.301 -25.233   2.528  1.00 93.69           C  \nATOM   1739  C   GLY A 225     -41.212 -26.300   1.436  1.00 93.69           C  \nATOM   1740  O   GLY A 225     -40.424 -26.181   0.498  1.00 93.69           O  \nATOM   1741  N   LYS A 226     -41.994 -27.372   1.584  1.00 94.56           N  \nATOM   1742  CA  LYS A 226     -41.875 -28.589   0.758  1.00 94.56           C  \nATOM   1743  C   LYS A 226     -42.694 -28.555  -0.538  1.00 94.56           C  \nATOM   1744  CB  LYS A 226     -42.212 -29.834   1.596  1.00 94.56           C  \nATOM   1745  O   LYS A 226     -42.545 -29.454  -1.363  1.00 94.56           O  \nATOM   1746  CG  LYS A 226     -41.327 -29.965   2.846  1.00 94.56           C  \nATOM   1747  CD  LYS A 226     -41.504 -31.324   3.533  1.00 94.56           C  \nATOM   1748  CE  LYS A 226     -40.526 -31.416   4.712  1.00 94.56           C  \nATOM   1749  NZ  LYS A 226     -40.657 -32.700   5.444  1.00 94.56           N  \nATOM   1750  N   SER A 227     -43.577 -27.574  -0.719  1.00 94.12           N  \nATOM   1751  CA  SER A 227     -44.419 -27.464  -1.915  1.00 94.12           C  \nATOM   1752  C   SER A 227     -43.690 -26.721  -3.046  1.00 94.12           C  \nATOM   1753  CB  SER A 227     -45.718 -26.744  -1.548  1.00 94.12           C  \nATOM   1754  O   SER A 227     -42.925 -25.797  -2.768  1.00 94.12           O  \nATOM   1755  OG  SER A 227     -46.548 -26.560  -2.675  1.00 94.12           O  \nATOM   1756  N   PRO A 228     -43.964 -27.016  -4.333  1.00 92.06           N  \nATOM   1757  CA  PRO A 228     -43.529 -26.168  -5.447  1.00 92.06           C  \nATOM   1758  C   PRO A 228     -43.981 -24.696  -5.333  1.00 92.06           C  \nATOM   1759  CB  PRO A 228     -44.100 -26.830  -6.706  1.00 92.06           C  \nATOM   1760  O   PRO A 228     -43.322 -23.810  -5.867  1.00 92.06           O  \nATOM   1761  CG  PRO A 228     -44.254 -28.297  -6.308  1.00 92.06           C  \nATOM   1762  CD  PRO A 228     -44.639 -28.205  -4.832  1.00 92.06           C  \nATOM   1763  N   SER A 229     -45.057 -24.405  -4.586  1.00 93.19           N  \nATOM   1764  CA  SER A 229     -45.482 -23.030  -4.244  1.00 93.19           C  \nATOM   1765  C   SER A 229     -44.514 -22.276  -3.321  1.00 93.19           C  \nATOM   1766  CB  SER A 229     -46.851 -23.058  -3.556  1.00 93.19           C  \nATOM   1767  O   SER A 229     -44.654 -21.067  -3.108  1.00 93.19           O  \nATOM   1768  OG  SER A 229     -46.840 -23.856  -2.379  1.00 93.19           O  \nATOM   1769  N   ASP A 230     -43.562 -22.991  -2.727  1.00 95.06           N  \nATOM   1770  CA  ASP A 230     -42.683 -22.478  -1.682  1.00 95.06           C  \nATOM   1771  C   ASP A 230     -41.280 -22.175  -2.216  1.00 95.06           C  \nATOM   1772  CB  ASP A 230     -42.641 -23.449  -0.491  1.00 95.06           C  \nATOM   1773  O   ASP A 230     -40.471 -21.618  -1.472  1.00 95.06           O  \nATOM   1774  CG  ASP A 230     -44.013 -23.913   0.016  1.00 95.06           C  \nATOM   1775  OD1 ASP A 230     -45.031 -23.228  -0.260  1.00 95.06           O  \nATOM   1776  OD2 ASP A 230     -44.030 -24.989   0.660  1.00 95.06           O  \nATOM   1777  N   CYS A 231     -40.993 -22.505  -3.483  1.00 96.12           N  \nATOM   1778  CA  CYS A 231     -39.733 -22.182  -4.146  1.00 96.12           C  \nATOM   1779  C   CYS A 231     -39.456 -20.669  -4.118  1.00 96.12           C  \nATOM   1780  CB  CYS A 231     -39.747 -22.682  -5.598  1.00 96.12           C  \nATOM   1781  O   CYS A 231     -40.347 -19.842  -4.334  1.00 96.12           O  \nATOM   1782  SG  CYS A 231     -40.030 -24.454  -5.878  1.00 96.12           S  \nATOM   1783  N   CYS A 232     -38.199 -20.315  -3.869  1.00 96.81           N  \nATOM   1784  CA  CYS A 232     -37.709 -18.945  -3.920  1.00 96.81           C  \nATOM   1785  C   CYS A 232     -37.283 -18.551  -5.339  1.00 96.81           C  \nATOM   1786  CB  CYS A 232     -36.540 -18.814  -2.937  1.00 96.81           C  \nATOM   1787  O   CYS A 232     -37.041 -19.408  -6.191  1.00 96.81           O  \nATOM   1788  SG  CYS A 232     -36.975 -19.086  -1.201  1.00 96.81           S  \nATOM   1789  N   HIS A 233     -37.122 -17.247  -5.580  1.00 96.19           N  \nATOM   1790  CA  HIS A 233     -36.498 -16.771  -6.812  1.00 96.19           C  \nATOM   1791  C   HIS A 233     -35.042 -17.253  -6.926  1.00 96.19           C  \nATOM   1792  CB  HIS A 233     -36.577 -15.242  -6.891  1.00 96.19           C  \nATOM   1793  O   HIS A 233     -34.336 -17.367  -5.922  1.00 96.19           O  \nATOM   1794  CG  HIS A 233     -36.230 -14.735  -8.265  1.00 96.19           C  \nATOM   1795  CD2 HIS A 233     -36.914 -15.032  -9.412  1.00 96.19           C  \nATOM   1796  ND1 HIS A 233     -35.173 -13.921  -8.617  1.00 96.19           N  \nATOM   1797  CE1 HIS A 233     -35.245 -13.707  -9.944  1.00 96.19           C  \nATOM   1798  NE2 HIS A 233     -36.268 -14.396 -10.471  1.00 96.19           N  \nATOM   1799  N   ASN A 234     -34.554 -17.450  -8.155  1.00 94.94           N  \nATOM   1800  CA  ASN A 234     -33.210 -17.980  -8.427  1.00 94.94           C  \nATOM   1801  C   ASN A 234     -32.056 -17.080  -7.924  1.00 94.94           C  \nATOM   1802  CB  ASN A 234     -33.108 -18.232  -9.943  1.00 94.94           C  \nATOM   1803  O   ASN A 234     -30.907 -17.508  -7.873  1.00 94.94           O  \nATOM   1804  CG  ASN A 234     -31.971 -19.174 -10.296  1.00 94.94           C  \nATOM   1805  ND2 ASN A 234     -31.252 -18.925 -11.365  1.00 94.94           N  \nATOM   1806  OD1 ASN A 234     -31.757 -20.184  -9.650  1.00 94.94           O  \nATOM   1807  N   GLN A 235     -32.359 -15.831  -7.547  1.00 95.75           N  \nATOM   1808  CA  GLN A 235     -31.409 -14.881  -6.953  1.00 95.75           C  \nATOM   1809  C   GLN A 235     -31.504 -14.765  -5.424  1.00 95.75           C  \nATOM   1810  CB  GLN A 235     -31.520 -13.507  -7.636  1.00 95.75           C  \nATOM   1811  O   GLN A 235     -30.852 -13.898  -4.840  1.00 95.75           O  \nATOM   1812  CG  GLN A 235     -31.272 -13.549  -9.150  1.00 95.75           C  \nATOM   1813  CD  GLN A 235     -29.901 -14.094  -9.545  1.00 95.75           C  \nATOM   1814  NE2 GLN A 235     -29.745 -14.417 -10.805  1.00 95.75           N  \nATOM   1815  OE1 GLN A 235     -28.971 -14.250  -8.760  1.00 95.75           O  \nATOM   1816  N   CYS A 236     -32.278 -15.621  -4.755  1.00 96.38           N  \nATOM   1817  CA  CYS A 236     -32.310 -15.691  -3.296  1.00 96.38           C  \nATOM   1818  C   CYS A 236     -31.201 -16.613  -2.761  1.00 96.38           C  \nATOM   1819  CB  CYS A 236     -33.689 -16.170  -2.829  1.00 96.38           C  \nATOM   1820  O   CYS A 236     -31.058 -17.738  -3.233  1.00 96.38           O  \nATOM   1821  SG  CYS A 236     -35.142 -15.212  -3.360  1.00 96.38           S  \nATOM   1822  N   ALA A 237     -30.449 -16.149  -1.758  1.00 94.06           N  \nATOM   1823  CA  ALA A 237     -29.326 -16.874  -1.157  1.00 94.06           C  \nATOM   1824  C   ALA A 237     -29.734 -17.721   0.060  1.00 94.06           C  \nATOM   1825  CB  ALA A 237     -28.226 -15.869  -0.815  1.00 94.06           C  \nATOM   1826  O   ALA A 237     -29.835 -18.929  -0.035  1.00 94.06           O  \nATOM   1827  N   ALA A 238     -30.027 -17.105   1.209  1.00 94.25           N  \nATOM   1828  CA  ALA A 238     -30.393 -17.838   2.430  1.00 94.25           C  \nATOM   1829  C   ALA A 238     -31.794 -18.489   2.368  1.00 94.25           C  \nATOM   1830  CB  ALA A 238     -30.286 -16.845   3.595  1.00 94.25           C  \nATOM   1831  O   ALA A 238     -32.064 -19.488   3.029  1.00 94.25           O  \nATOM   1832  N   GLY A 239     -32.704 -17.898   1.593  1.00 95.44           N  \nATOM   1833  CA  GLY A 239     -34.132 -18.212   1.575  1.00 95.44           C  \nATOM   1834  C   GLY A 239     -34.944 -16.990   1.144  1.00 95.44           C  \nATOM   1835  O   GLY A 239     -34.382 -16.002   0.658  1.00 95.44           O  \nATOM   1836  N   CYS A 240     -36.262 -17.026   1.329  1.00 96.62           N  \nATOM   1837  CA  CYS A 240     -37.165 -15.952   0.912  1.00 96.62           C  \nATOM   1838  C   CYS A 240     -38.423 -15.856   1.789  1.00 96.62           C  \nATOM   1839  CB  CYS A 240     -37.537 -16.167  -0.561  1.00 96.62           C  \nATOM   1840  O   CYS A 240     -38.705 -16.716   2.618  1.00 96.62           O  \nATOM   1841  SG  CYS A 240     -38.432 -17.701  -0.903  1.00 96.62           S  \nATOM   1842  N   THR A 241     -39.203 -14.800   1.574  1.00 95.81           N  \nATOM   1843  CA  THR A 241     -40.532 -14.564   2.161  1.00 95.81           C  \nATOM   1844  C   THR A 241     -41.665 -14.830   1.159  1.00 95.81           C  \nATOM   1845  CB  THR A 241     -40.625 -13.138   2.724  1.00 95.81           C  \nATOM   1846  O   THR A 241     -42.791 -15.118   1.562  1.00 95.81           O  \nATOM   1847  CG2 THR A 241     -39.618 -12.889   3.847  1.00 95.81           C  \nATOM   1848  OG1 THR A 241     -40.382 -12.173   1.728  1.00 95.81           O  \nATOM   1849  N   GLY A 242     -41.345 -14.858  -0.138  1.00 93.81           N  \nATOM   1850  CA  GLY A 242     -42.229 -15.087  -1.283  1.00 93.81           C  \nATOM   1851  C   GLY A 242     -41.421 -15.467  -2.540  1.00 93.81           C  \nATOM   1852  O   GLY A 242     -40.199 -15.594  -2.456  1.00 93.81           O  \nATOM   1853  N   PRO A 243     -42.072 -15.699  -3.693  1.00 94.00           N  \nATOM   1854  CA  PRO A 243     -41.424 -16.263  -4.881  1.00 94.00           C  \nATOM   1855  C   PRO A 243     -40.690 -15.242  -5.775  1.00 94.00           C  \nATOM   1856  CB  PRO A 243     -42.567 -16.957  -5.631  1.00 94.00           C  \nATOM   1857  O   PRO A 243     -40.103 -15.646  -6.778  1.00 94.00           O  \nATOM   1858  CG  PRO A 243     -43.765 -16.056  -5.328  1.00 94.00           C  \nATOM   1859  CD  PRO A 243     -43.513 -15.622  -3.884  1.00 94.00           C  \nATOM   1860  N   ARG A 244     -40.739 -13.933  -5.485  1.00 94.31           N  \nATOM   1861  CA  ARG A 244     -40.162 -12.881  -6.352  1.00 94.31           C  \nATOM   1862  C   ARG A 244     -38.733 -12.512  -5.953  1.00 94.31           C  \nATOM   1863  CB  ARG A 244     -41.045 -11.624  -6.330  1.00 94.31           C  \nATOM   1864  O   ARG A 244     -38.314 -12.715  -4.817  1.00 94.31           O  \nATOM   1865  CG  ARG A 244     -42.514 -11.878  -6.684  1.00 94.31           C  \nATOM   1866  CD  ARG A 244     -43.312 -10.595  -6.453  1.00 94.31           C  \nATOM   1867  NE  ARG A 244     -44.700 -10.737  -6.933  1.00 94.31           N  \nATOM   1868  NH1 ARG A 244     -45.438  -8.693  -6.220  1.00 94.31           N  \nATOM   1869  NH2 ARG A 244     -46.831 -10.044  -7.333  1.00 94.31           N  \nATOM   1870  CZ  ARG A 244     -45.648  -9.828  -6.826  1.00 94.31           C  \nATOM   1871  N   GLU A 245     -38.009 -11.865  -6.866  1.00 93.12           N  \nATOM   1872  CA  GLU A 245     -36.680 -11.288  -6.598  1.00 93.12           C  \nATOM   1873  C   GLU A 245     -36.668 -10.199  -5.512  1.00 93.12           C  \nATOM   1874  CB  GLU A 245     -36.087 -10.724  -7.896  1.00 93.12           C  \nATOM   1875  O   GLU A 245     -35.615  -9.913  -4.948  1.00 93.12           O  \nATOM   1876  CG  GLU A 245     -36.843  -9.520  -8.476  1.00 93.12           C  \nATOM   1877  CD  GLU A 245     -36.163  -8.961  -9.734  1.00 93.12           C  \nATOM   1878  OE1 GLU A 245     -36.342  -7.747  -9.975  1.00 93.12           O  \nATOM   1879  OE2 GLU A 245     -35.478  -9.741 -10.432  1.00 93.12           O  \nATOM   1880  N   SER A 246     -37.829  -9.608  -5.214  1.00 94.50           N  \nATOM   1881  CA  SER A 246     -38.042  -8.659  -4.117  1.00 94.50           C  \nATOM   1882  C   SER A 246     -38.183  -9.312  -2.744  1.00 94.50           C  \nATOM   1883  CB  SER A 246     -39.306  -7.837  -4.394  1.00 94.50           C  \nATOM   1884  O   SER A 246     -38.135  -8.630  -1.724  1.00 94.50           O  \nATOM   1885  OG  SER A 246     -40.428  -8.661  -4.706  1.00 94.50           O  \nATOM   1886  N   ASP A 247     -38.410 -10.625  -2.712  1.00 95.62           N  \nATOM   1887  CA  ASP A 247     -38.894 -11.320  -1.522  1.00 95.62           C  \nATOM   1888  C   ASP A 247     -37.776 -12.119  -0.823  1.00 95.62           C  \nATOM   1889  CB  ASP A 247     -40.072 -12.233  -1.898  1.00 95.62           C  \nATOM   1890  O   ASP A 247     -38.011 -12.731   0.222  1.00 95.62           O  \nATOM   1891  CG  ASP A 247     -41.218 -11.626  -2.726  1.00 95.62           C  \nATOM   1892  OD1 ASP A 247     -41.323 -10.383  -2.860  1.00 95.62           O  \nATOM   1893  OD2 ASP A 247     -41.999 -12.446  -3.272  1.00 95.62           O  \nATOM   1894  N   CYS A 248     -36.570 -12.151  -1.397  1.00 95.75           N  \nATOM   1895  CA  CYS A 248     -35.404 -12.856  -0.866  1.00 95.75           C  \nATOM   1896  C   CYS A 248     -34.968 -12.323   0.511  1.00 95.75           C  \nATOM   1897  CB  CYS A 248     -34.244 -12.711  -1.854  1.00 95.75           C  \nATOM   1898  O   CYS A 248     -35.004 -11.122   0.762  1.00 95.75           O  \nATOM   1899  SG  CYS A 248     -34.529 -13.280  -3.552  1.00 95.75           S  \nATOM   1900  N   LEU A 249     -34.471 -13.207   1.385  1.00 94.25           N  \nATOM   1901  CA  LEU A 249     -33.862 -12.801   2.662  1.00 94.25           C  \nATOM   1902  C   LEU A 249     -32.508 -12.104   2.447  1.00 94.25           C  \nATOM   1903  CB  LEU A 249     -33.687 -14.033   3.572  1.00 94.25           C  \nATOM   1904  O   LEU A 249     -32.202 -11.114   3.104  1.00 94.25           O  \nATOM   1905  CG  LEU A 249     -34.994 -14.708   4.023  1.00 94.25           C  \nATOM   1906  CD1 LEU A 249     -34.666 -15.957   4.841  1.00 94.25           C  \nATOM   1907  CD2 LEU A 249     -35.871 -13.791   4.876  1.00 94.25           C  \nATOM   1908  N   VAL A 250     -31.718 -12.631   1.507  1.00 93.50           N  \nATOM   1909  CA  VAL A 250     -30.421 -12.104   1.064  1.00 93.50           C  \nATOM   1910  C   VAL A 250     -30.277 -12.375  -0.434  1.00 93.50           C  \nATOM   1911  CB  VAL A 250     -29.251 -12.754   1.835  1.00 93.50           C  \nATOM   1912  O   VAL A 250     -30.720 -13.424  -0.911  1.00 93.50           O  \nATOM   1913  CG1 VAL A 250     -27.909 -12.190   1.368  1.00 93.50           C  \nATOM   1914  CG2 VAL A 250     -29.330 -12.538   3.348  1.00 93.50           C  \nATOM   1915  N   CYS A 251     -29.646 -11.461  -1.173  1.00 95.44           N  \nATOM   1916  CA  CYS A 251     -29.376 -11.627  -2.601  1.00 95.44           C  \nATOM   1917  C   CYS A 251     -28.139 -12.499  -2.859  1.00 95.44           C  \nATOM   1918  CB  CYS A 251     -29.236 -10.254  -3.268  1.00 95.44           C  \nATOM   1919  O   CYS A 251     -27.087 -12.297  -2.245  1.00 95.44           O  \nATOM   1920  SG  CYS A 251     -30.663  -9.157  -3.060  1.00 95.44           S  \nATOM   1921  N   ARG A 252     -28.270 -13.441  -3.800  1.00 94.62           N  \nATOM   1922  CA  ARG A 252     -27.232 -14.390  -4.235  1.00 94.62           C  \nATOM   1923  C   ARG A 252     -26.028 -13.672  -4.833  1.00 94.62           C  \nATOM   1924  CB  ARG A 252     -27.876 -15.400  -5.196  1.00 94.62           C  \nATOM   1925  O   ARG A 252     -24.936 -13.795  -4.291  1.00 94.62           O  \nATOM   1926  CG  ARG A 252     -26.944 -16.561  -5.558  1.00 94.62           C  \nATOM   1927  CD  ARG A 252     -27.610 -17.492  -6.577  1.00 94.62           C  \nATOM   1928  NE  ARG A 252     -27.657 -16.899  -7.935  1.00 94.62           N  \nATOM   1929  NH1 ARG A 252     -27.478 -18.859  -9.112  1.00 94.62           N  \nATOM   1930  NH2 ARG A 252     -27.394 -16.921 -10.204  1.00 94.62           N  \nATOM   1931  CZ  ARG A 252     -27.519 -17.554  -9.072  1.00 94.62           C  \nATOM   1932  N   LYS A 253     -26.256 -12.875  -5.879  1.00 92.06           N  \nATOM   1933  CA  LYS A 253     -25.271 -11.933  -6.419  1.00 92.06           C  \nATOM   1934  C   LYS A 253     -25.516 -10.526  -5.864  1.00 92.06           C  \nATOM   1935  CB  LYS A 253     -25.161 -12.059  -7.946  1.00 92.06           C  \nATOM   1936  O   LYS A 253     -25.075 -10.263  -4.749  1.00 92.06           O  \nATOM   1937  CG  LYS A 253     -24.534 -13.397  -8.394  1.00 92.06           C  \nATOM   1938  CD  LYS A 253     -24.178 -13.316  -9.883  1.00 92.06           C  \nATOM   1939  CE  LYS A 253     -23.595 -14.597 -10.489  1.00 92.06           C  \nATOM   1940  NZ  LYS A 253     -23.362 -14.424 -11.947  1.00 92.06           N  \nATOM   1941  N   PHE A 254     -26.271  -9.660  -6.547  1.00 92.75           N  \nATOM   1942  CA  PHE A 254     -26.371  -8.239  -6.176  1.00 92.75           C  \nATOM   1943  C   PHE A 254     -27.761  -7.818  -5.703  1.00 92.75           C  \nATOM   1944  CB  PHE A 254     -25.865  -7.354  -7.323  1.00 92.75           C  \nATOM   1945  O   PHE A 254     -28.782  -8.231  -6.253  1.00 92.75           O  \nATOM   1946  CG  PHE A 254     -24.442  -7.712  -7.688  1.00 92.75           C  \nATOM   1947  CD1 PHE A 254     -23.378  -7.264  -6.885  1.00 92.75           C  \nATOM   1948  CD2 PHE A 254     -24.203  -8.645  -8.712  1.00 92.75           C  \nATOM   1949  CE1 PHE A 254     -22.097  -7.819  -7.045  1.00 92.75           C  \nATOM   1950  CE2 PHE A 254     -22.922  -9.195  -8.876  1.00 92.75           C  \nATOM   1951  CZ  PHE A 254     -21.878  -8.808  -8.017  1.00 92.75           C  \nATOM   1952  N   ARG A 255     -27.799  -6.948  -4.690  1.00 93.38           N  \nATOM   1953  CA  ARG A 255     -28.993  -6.211  -4.269  1.00 93.38           C  \nATOM   1954  C   ARG A 255     -29.058  -4.875  -5.005  1.00 93.38           C  \nATOM   1955  CB  ARG A 255     -28.984  -6.040  -2.741  1.00 93.38           C  \nATOM   1956  O   ARG A 255     -28.321  -3.944  -4.673  1.00 93.38           O  \nATOM   1957  CG  ARG A 255     -30.279  -5.370  -2.253  1.00 93.38           C  \nATOM   1958  CD  ARG A 255     -30.360  -5.255  -0.725  1.00 93.38           C  \nATOM   1959  NE  ARG A 255     -29.283  -4.401  -0.175  1.00 93.38           N  \nATOM   1960  NH1 ARG A 255     -30.470  -3.332   1.485  1.00 93.38           N  \nATOM   1961  NH2 ARG A 255     -28.308  -2.847   1.163  1.00 93.38           N  \nATOM   1962  CZ  ARG A 255     -29.363  -3.534   0.820  1.00 93.38           C  \nATOM   1963  N   ASP A 256     -29.973  -4.775  -5.960  1.00 93.19           N  \nATOM   1964  CA  ASP A 256     -30.348  -3.516  -6.591  1.00 93.19           C  \nATOM   1965  C   ASP A 256     -31.582  -2.933  -5.887  1.00 93.19           C  \nATOM   1966  CB  ASP A 256     -30.547  -3.707  -8.101  1.00 93.19           C  \nATOM   1967  O   ASP A 256     -32.718  -3.361  -6.106  1.00 93.19           O  \nATOM   1968  CG  ASP A 256     -30.741  -2.361  -8.800  1.00 93.19           C  \nATOM   1969  OD1 ASP A 256     -30.372  -1.328  -8.197  1.00 93.19           O  \nATOM   1970  OD2 ASP A 256     -31.246  -2.335  -9.945  1.00 93.19           O  \nATOM   1971  N   GLU A 257     -31.335  -1.984  -4.981  1.00 89.88           N  \nATOM   1972  CA  GLU A 257     -32.322  -1.394  -4.067  1.00 89.88           C  \nATOM   1973  C   GLU A 257     -33.131  -2.465  -3.306  1.00 89.88           C  \nATOM   1974  CB  GLU A 257     -33.163  -0.303  -4.773  1.00 89.88           C  \nATOM   1975  O   GLU A 257     -32.633  -3.017  -2.322  1.00 89.88           O  \nATOM   1976  CG  GLU A 257     -32.282   0.885  -5.208  1.00 89.88           C  \nATOM   1977  CD  GLU A 257     -33.038   1.997  -5.954  1.00 89.88           C  \nATOM   1978  OE1 GLU A 257     -32.454   2.524  -6.938  1.00 89.88           O  \nATOM   1979  OE2 GLU A 257     -34.145   2.373  -5.510  1.00 89.88           O  \nATOM   1980  N   ALA A 258     -34.356  -2.767  -3.749  1.00 90.12           N  \nATOM   1981  CA  ALA A 258     -35.258  -3.753  -3.145  1.00 90.12           C  \nATOM   1982  C   ALA A 258     -35.324  -5.097  -3.903  1.00 90.12           C  \nATOM   1983  CB  ALA A 258     -36.647  -3.111  -3.002  1.00 90.12           C  \nATOM   1984  O   ALA A 258     -36.188  -5.911  -3.593  1.00 90.12           O  \nATOM   1985  N   THR A 259     -34.469  -5.320  -4.906  1.00 93.94           N  \nATOM   1986  CA  THR A 259     -34.511  -6.488  -5.810  1.00 93.94           C  \nATOM   1987  C   THR A 259     -33.168  -7.211  -5.876  1.00 93.94           C  \nATOM   1988  CB  THR A 259     -34.949  -6.092  -7.234  1.00 93.94           C  \nATOM   1989  O   THR A 259     -32.115  -6.578  -5.797  1.00 93.94           O  \nATOM   1990  CG2 THR A 259     -36.382  -5.560  -7.257  1.00 93.94           C  \nATOM   1991  OG1 THR A 259     -34.112  -5.100  -7.799  1.00 93.94           O  \nATOM   1992  N   CYS A 260     -33.186  -8.536  -6.026  1.00 94.88           N  \nATOM   1993  CA  CYS A 260     -31.978  -9.348  -6.179  1.00 94.88           C  \nATOM   1994  C   CYS A 260     -31.706  -9.694  -7.650  1.00 94.88           C  \nATOM   1995  CB  CYS A 260     -32.111 -10.606  -5.319  1.00 94.88           C  \nATOM   1996  O   CYS A 260     -32.439 -10.488  -8.239  1.00 94.88           O  \nATOM   1997  SG  CYS A 260     -32.267 -10.310  -3.540  1.00 94.88           S  \nATOM   1998  N   LYS A 261     -30.625  -9.147  -8.217  1.00 92.69           N  \nATOM   1999  CA  LYS A 261     -30.232  -9.280  -9.631  1.00 92.69           C  \nATOM   2000  C   LYS A 261     -28.918 -10.055  -9.789  1.00 92.69           C  \nATOM   2001  CB  LYS A 261     -30.150  -7.884 -10.280  1.00 92.69           C  \nATOM   2002  O   LYS A 261     -28.114 -10.132  -8.860  1.00 92.69           O  \nATOM   2003  CG  LYS A 261     -31.506  -7.157 -10.265  1.00 92.69           C  \nATOM   2004  CD  LYS A 261     -31.451  -5.838 -11.043  1.00 92.69           C  \nATOM   2005  CE  LYS A 261     -32.829  -5.170 -10.987  1.00 92.69           C  \nATOM   2006  NZ  LYS A 261     -32.801  -3.821 -11.597  1.00 92.69           N  \nATOM   2007  N   ASP A 262     -28.700 -10.633 -10.974  1.00 90.62           N  \nATOM   2008  CA  ASP A 262     -27.457 -11.366 -11.282  1.00 90.62           C  \nATOM   2009  C   ASP A 262     -26.272 -10.417 -11.553  1.00 90.62           C  \nATOM   2010  CB  ASP A 262     -27.677 -12.338 -12.455  1.00 90.62           C  \nATOM   2011  O   ASP A 262     -25.137 -10.723 -11.201  1.00 90.62           O  \nATOM   2012  CG  ASP A 262     -26.781 -13.578 -12.321  1.00 90.62           C  \nATOM   2013  OD1 ASP A 262     -27.104 -14.463 -11.489  1.00 90.62           O  \nATOM   2014  OD2 ASP A 262     -25.733 -13.651 -12.990  1.00 90.62           O  \nATOM   2015  N   THR A 263     -26.547  -9.231 -12.100  1.00 89.88           N  \nATOM   2016  CA  THR A 263     -25.594  -8.129 -12.299  1.00 89.88           C  \nATOM   2017  C   THR A 263     -26.246  -6.801 -11.912  1.00 89.88           C  \nATOM   2018  CB  THR A 263     -25.106  -8.045 -13.758  1.00 89.88           C  \nATOM   2019  O   THR A 263     -27.475  -6.684 -11.885  1.00 89.88           O  \nATOM   2020  CG2 THR A 263     -24.416  -9.324 -14.231  1.00 89.88           C  \nATOM   2021  OG1 THR A 263     -26.183  -7.788 -14.632  1.00 89.88           O  \nATOM   2022  N   CYS A 264     -25.439  -5.774 -11.644  1.00 91.50           N  \nATOM   2023  CA  CYS A 264     -25.948  -4.404 -11.569  1.00 91.50           C  \nATOM   2024  C   CYS A 264     -26.326  -3.864 -12.966  1.00 91.50           C  \nATOM   2025  CB  CYS A 264     -24.922  -3.518 -10.848  1.00 91.50           C  \nATOM   2026  O   CYS A 264     -25.806  -4.362 -13.969  1.00 91.50           O  \nATOM   2027  SG  CYS A 264     -24.683  -3.974  -9.109  1.00 91.50           S  \nATOM   2028  N   PRO A 265     -27.221  -2.857 -13.057  1.00 91.50           N  \nATOM   2029  CA  PRO A 265     -27.462  -2.112 -14.294  1.00 91.50           C  \nATOM   2030  C   PRO A 265     -26.141  -1.592 -14.896  1.00 91.50           C  \nATOM   2031  CB  PRO A 265     -28.400  -0.963 -13.900  1.00 91.50           C  \nATOM   2032  O   PRO A 265     -25.447  -0.827 -14.220  1.00 91.50           O  \nATOM   2033  CG  PRO A 265     -29.175  -1.542 -12.719  1.00 91.50           C  \nATOM   2034  CD  PRO A 265     -28.132  -2.408 -12.013  1.00 91.50           C  \nATOM   2035  N   PRO A 266     -25.766  -1.995 -16.126  1.00 90.19           N  \nATOM   2036  CA  PRO A 266     -24.444  -1.707 -16.680  1.00 90.19           C  \nATOM   2037  C   PRO A 266     -24.246  -0.205 -16.897  1.00 90.19           C  \nATOM   2038  CB  PRO A 266     -24.362  -2.498 -17.990  1.00 90.19           C  \nATOM   2039  O   PRO A 266     -25.204   0.514 -17.167  1.00 90.19           O  \nATOM   2040  CG  PRO A 266     -25.822  -2.626 -18.418  1.00 90.19           C  \nATOM   2041  CD  PRO A 266     -26.558  -2.754 -17.085  1.00 90.19           C  \nATOM   2042  N   LEU A 267     -23.005   0.275 -16.794  1.00 89.81           N  \nATOM   2043  CA  LEU A 267     -22.683   1.702 -16.946  1.00 89.81           C  \nATOM   2044  C   LEU A 267     -22.824   2.211 -18.390  1.00 89.81           C  \nATOM   2045  CB  LEU A 267     -21.260   1.966 -16.424  1.00 89.81           C  \nATOM   2046  O   LEU A 267     -22.994   3.410 -18.590  1.00 89.81           O  \nATOM   2047  CG  LEU A 267     -21.047   1.658 -14.931  1.00 89.81           C  \nATOM   2048  CD1 LEU A 267     -19.580   1.893 -14.581  1.00 89.81           C  \nATOM   2049  CD2 LEU A 267     -21.907   2.532 -14.013  1.00 89.81           C  \nATOM   2050  N   MET A 268     -22.797   1.307 -19.370  1.00 88.31           N  \nATOM   2051  CA  MET A 268     -22.971   1.596 -20.794  1.00 88.31           C  \nATOM   2052  C   MET A 268     -24.108   0.740 -21.370  1.00 88.31           C  \nATOM   2053  CB  MET A 268     -21.665   1.341 -21.567  1.00 88.31           C  \nATOM   2054  O   MET A 268     -24.296  -0.402 -20.941  1.00 88.31           O  \nATOM   2055  CG  MET A 268     -20.411   2.017 -20.988  1.00 88.31           C  \nATOM   2056  SD  MET A 268     -20.428   3.827 -20.890  1.00 88.31           S  \nATOM   2057  CE  MET A 268     -20.325   4.242 -22.651  1.00 88.31           C  \nATOM   2058  N   LEU A 269     -24.835   1.275 -22.350  1.00 91.00           N  \nATOM   2059  CA  LEU A 269     -25.852   0.589 -23.148  1.00 91.00           C  \nATOM   2060  C   LEU A 269     -25.406   0.529 -24.607  1.00 91.00           C  \nATOM   2061  CB  LEU A 269     -27.199   1.333 -23.074  1.00 91.00           C  \nATOM   2062  O   LEU A 269     -24.837   1.485 -25.118  1.00 91.00           O  \nATOM   2063  CG  LEU A 269     -27.811   1.445 -21.673  1.00 91.00           C  \nATOM   2064  CD1 LEU A 269     -29.158   2.162 -21.733  1.00 91.00           C  \nATOM   2065  CD2 LEU A 269     -28.020   0.077 -21.025  1.00 91.00           C  \nATOM   2066  N   TYR A 270     -25.716  -0.561 -25.296  1.00 90.12           N  \nATOM   2067  CA  TYR A 270     -25.562  -0.627 -26.744  1.00 90.12           C  \nATOM   2068  C   TYR A 270     -26.727   0.106 -27.423  1.00 90.12           C  \nATOM   2069  CB  TYR A 270     -25.473  -2.097 -27.157  1.00 90.12           C  \nATOM   2070  O   TYR A 270     -27.886  -0.288 -27.254  1.00 90.12           O  \nATOM   2071  CG  TYR A 270     -25.284  -2.285 -28.642  1.00 90.12           C  \nATOM   2072  CD1 TYR A 270     -26.407  -2.283 -29.487  1.00 90.12           C  \nATOM   2073  CD2 TYR A 270     -23.989  -2.416 -29.180  1.00 90.12           C  \nATOM   2074  CE1 TYR A 270     -26.240  -2.421 -30.872  1.00 90.12           C  \nATOM   2075  CE2 TYR A 270     -23.818  -2.561 -30.568  1.00 90.12           C  \nATOM   2076  OH  TYR A 270     -24.812  -2.702 -32.743  1.00 90.12           O  \nATOM   2077  CZ  TYR A 270     -24.946  -2.552 -31.409  1.00 90.12           C  \nATOM   2078  N   ASN A 271     -26.437   1.149 -28.200  1.00 91.62           N  \nATOM   2079  CA  ASN A 271     -27.438   1.900 -28.956  1.00 91.62           C  \nATOM   2080  C   ASN A 271     -27.637   1.258 -30.346  1.00 91.62           C  \nATOM   2081  CB  ASN A 271     -27.009   3.371 -29.005  1.00 91.62           C  \nATOM   2082  O   ASN A 271     -26.727   1.299 -31.177  1.00 91.62           O  \nATOM   2083  CG  ASN A 271     -27.946   4.275 -29.796  1.00 91.62           C  \nATOM   2084  ND2 ASN A 271     -27.988   5.537 -29.463  1.00 91.62           N  \nATOM   2085  OD1 ASN A 271     -28.646   3.873 -30.721  1.00 91.62           O  \nATOM   2086  N   PRO A 272     -28.821   0.691 -30.659  1.00 88.31           N  \nATOM   2087  CA  PRO A 272     -29.044   0.001 -31.931  1.00 88.31           C  \nATOM   2088  C   PRO A 272     -29.040   0.893 -33.178  1.00 88.31           C  \nATOM   2089  CB  PRO A 272     -30.389  -0.714 -31.780  1.00 88.31           C  \nATOM   2090  O   PRO A 272     -29.035   0.358 -34.285  1.00 88.31           O  \nATOM   2091  CG  PRO A 272     -30.599  -0.814 -30.273  1.00 88.31           C  \nATOM   2092  CD  PRO A 272     -29.969   0.483 -29.785  1.00 88.31           C  \nATOM   2093  N   THR A 273     -29.073   2.217 -33.005  1.00 88.62           N  \nATOM   2094  CA  THR A 273     -29.111   3.212 -34.086  1.00 88.62           C  \nATOM   2095  C   THR A 273     -27.711   3.697 -34.457  1.00 88.62           C  \nATOM   2096  CB  THR A 273     -29.966   4.428 -33.681  1.00 88.62           C  \nATOM   2097  O   THR A 273     -27.408   3.848 -35.638  1.00 88.62           O  \nATOM   2098  CG2 THR A 273     -30.341   5.296 -34.881  1.00 88.62           C  \nATOM   2099  OG1 THR A 273     -31.177   4.030 -33.077  1.00 88.62           O  \nATOM   2100  N   THR A 274     -26.852   3.942 -33.460  1.00 90.56           N  \nATOM   2101  CA  THR A 274     -25.458   4.380 -33.666  1.00 90.56           C  \nATOM   2102  C   THR A 274     -24.475   3.215 -33.750  1.00 90.56           C  \nATOM   2103  CB  THR A 274     -24.988   5.333 -32.555  1.00 90.56           C  \nATOM   2104  O   THR A 274     -23.372   3.407 -34.249  1.00 90.56           O  \nATOM   2105  CG2 THR A 274     -25.869   6.575 -32.431  1.00 90.56           C  \nATOM   2106  OG1 THR A 274     -25.022   4.657 -31.326  1.00 90.56           O  \nATOM   2107  N   TYR A 275     -24.881   2.020 -33.296  1.00 89.06           N  \nATOM   2108  CA  TYR A 275     -24.055   0.815 -33.115  1.00 89.06           C  \nATOM   2109  C   TYR A 275     -22.958   0.962 -32.038  1.00 89.06           C  \nATOM   2110  CB  TYR A 275     -23.544   0.278 -34.468  1.00 89.06           C  \nATOM   2111  O   TYR A 275     -22.179   0.037 -31.815  1.00 89.06           O  \nATOM   2112  CG  TYR A 275     -24.622  -0.078 -35.486  1.00 89.06           C  \nATOM   2113  CD1 TYR A 275     -24.861  -1.428 -35.804  1.00 89.06           C  \nATOM   2114  CD2 TYR A 275     -25.346   0.926 -36.162  1.00 89.06           C  \nATOM   2115  CE1 TYR A 275     -25.820  -1.778 -36.777  1.00 89.06           C  \nATOM   2116  CE2 TYR A 275     -26.342   0.584 -37.095  1.00 89.06           C  \nATOM   2117  OH  TYR A 275     -27.514  -1.102 -38.335  1.00 89.06           O  \nATOM   2118  CZ  TYR A 275     -26.580  -0.769 -37.407  1.00 89.06           C  \nATOM   2119  N   GLN A 276     -22.939   2.093 -31.325  1.00 89.62           N  \nATOM   2120  CA  GLN A 276     -21.954   2.431 -30.300  1.00 89.62           C  \nATOM   2121  C   GLN A 276     -22.456   2.115 -28.881  1.00 89.62           C  \nATOM   2122  CB  GLN A 276     -21.535   3.907 -30.457  1.00 89.62           C  \nATOM   2123  O   GLN A 276     -23.626   1.795 -28.652  1.00 89.62           O  \nATOM   2124  CG  GLN A 276     -20.785   4.136 -31.781  1.00 89.62           C  \nATOM   2125  CD  GLN A 276     -20.279   5.562 -31.980  1.00 89.62           C  \nATOM   2126  NE2 GLN A 276     -19.520   5.801 -33.025  1.00 89.62           N  \nATOM   2127  OE1 GLN A 276     -20.536   6.485 -31.226  1.00 89.62           O  \nATOM   2128  N   MET A 277     -21.539   2.203 -27.915  1.00 87.25           N  \nATOM   2129  CA  MET A 277     -21.836   2.081 -26.488  1.00 87.25           C  \nATOM   2130  C   MET A 277     -22.056   3.474 -25.881  1.00 87.25           C  \nATOM   2131  CB  MET A 277     -20.700   1.329 -25.775  1.00 87.25           C  \nATOM   2132  O   MET A 277     -21.094   4.208 -25.659  1.00 87.25           O  \nATOM   2133  CG  MET A 277     -20.525  -0.125 -26.238  1.00 87.25           C  \nATOM   2134  SD  MET A 277     -21.938  -1.251 -26.020  1.00 87.25           S  \nATOM   2135  CE  MET A 277     -22.222  -1.148 -24.236  1.00 87.25           C  \nATOM   2136  N   ASP A 278     -23.305   3.806 -25.566  1.00 89.88           N  \nATOM   2137  CA  ASP A 278     -23.711   5.070 -24.941  1.00 89.88           C  \nATOM   2138  C   ASP A 278     -23.741   4.945 -23.405  1.00 89.88           C  \nATOM   2139  CB  ASP A 278     -25.089   5.506 -25.472  1.00 89.88           C  \nATOM   2140  O   ASP A 278     -23.924   3.858 -22.856  1.00 89.88           O  \nATOM   2141  CG  ASP A 278     -25.108   5.971 -26.936  1.00 89.88           C  \nATOM   2142  OD1 ASP A 278     -24.032   6.171 -27.535  1.00 89.88           O  \nATOM   2143  OD2 ASP A 278     -26.232   6.160 -27.450  1.00 89.88           O  \nATOM   2144  N   VAL A 279     -23.587   6.053 -22.673  1.00 89.06           N  \nATOM   2145  CA  VAL A 279     -23.614   6.048 -21.195  1.00 89.06           C  \nATOM   2146  C   VAL A 279     -25.031   5.780 -20.674  1.00 89.06           C  \nATOM   2147  CB  VAL A 279     -23.067   7.367 -20.613  1.00 89.06           C  \nATOM   2148  O   VAL A 279     -25.968   6.493 -21.025  1.00 89.06           O  \nATOM   2149  CG1 VAL A 279     -23.075   7.356 -19.076  1.00 89.06           C  \nATOM   2150  CG2 VAL A 279     -21.623   7.626 -21.061  1.00 89.06           C  \nATOM   2151  N   ASN A 280     -25.193   4.803 -19.777  1.00 89.81           N  \nATOM   2152  CA  ASN A 280     -26.486   4.446 -19.189  1.00 89.81           C  \nATOM   2153  C   ASN A 280     -26.926   5.444 -18.092  1.00 89.81           C  \nATOM   2154  CB  ASN A 280     -26.401   3.028 -18.597  1.00 89.81           C  \nATOM   2155  O   ASN A 280     -26.312   5.462 -17.020  1.00 89.81           O  \nATOM   2156  CG  ASN A 280     -27.760   2.492 -18.167  1.00 89.81           C  \nATOM   2157  ND2 ASN A 280     -27.816   1.281 -17.678  1.00 89.81           N  \nATOM   2158  OD1 ASN A 280     -28.784   3.154 -18.221  1.00 89.81           O  \nATOM   2159  N   PRO A 281     -28.044   6.184 -18.242  1.00 88.38           N  \nATOM   2160  CA  PRO A 281     -28.560   7.061 -17.183  1.00 88.38           C  \nATOM   2161  C   PRO A 281     -29.070   6.305 -15.940  1.00 88.38           C  \nATOM   2162  CB  PRO A 281     -29.687   7.873 -17.839  1.00 88.38           C  \nATOM   2163  O   PRO A 281     -29.184   6.885 -14.855  1.00 88.38           O  \nATOM   2164  CG  PRO A 281     -29.416   7.753 -19.339  1.00 88.38           C  \nATOM   2165  CD  PRO A 281     -28.844   6.345 -19.447  1.00 88.38           C  \nATOM   2166  N   GLU A 282     -29.384   5.012 -16.078  1.00 90.19           N  \nATOM   2167  CA  GLU A 282     -29.755   4.117 -14.974  1.00 90.19           C  \nATOM   2168  C   GLU A 282     -28.588   3.256 -14.458  1.00 90.19           C  \nATOM   2169  CB  GLU A 282     -30.963   3.240 -15.348  1.00 90.19           C  \nATOM   2170  O   GLU A 282     -28.792   2.456 -13.540  1.00 90.19           O  \nATOM   2171  CG  GLU A 282     -32.212   4.056 -15.718  1.00 90.19           C  \nATOM   2172  CD  GLU A 282     -33.504   3.310 -15.349  1.00 90.19           C  \nATOM   2173  OE1 GLU A 282     -34.343   3.944 -14.666  1.00 90.19           O  \nATOM   2174  OE2 GLU A 282     -33.621   2.103 -15.672  1.00 90.19           O  \nATOM   2175  N   GLY A 283     -27.379   3.431 -15.006  1.00 90.31           N  \nATOM   2176  CA  GLY A 283     -26.190   2.658 -14.649  1.00 90.31           C  \nATOM   2177  C   GLY A 283     -25.856   2.728 -13.156  1.00 90.31           C  \nATOM   2178  O   GLY A 283     -26.020   3.765 -12.502  1.00 90.31           O  \nATOM   2179  N   LYS A 284     -25.399   1.604 -12.595  1.00 93.56           N  \nATOM   2180  CA  LYS A 284     -25.013   1.488 -11.183  1.00 93.56           C  \nATOM   2181  C   LYS A 284     -23.712   0.711 -11.043  1.00 93.56           C  \nATOM   2182  CB  LYS A 284     -26.119   0.806 -10.365  1.00 93.56           C  \nATOM   2183  O   LYS A 284     -23.563  -0.373 -11.595  1.00 93.56           O  \nATOM   2184  CG  LYS A 284     -27.376   1.672 -10.227  1.00 93.56           C  \nATOM   2185  CD  LYS A 284     -28.478   0.956  -9.440  1.00 93.56           C  \nATOM   2186  CE  LYS A 284     -29.692   1.880  -9.294  1.00 93.56           C  \nATOM   2187  NZ  LYS A 284     -30.838   1.175  -8.682  1.00 93.56           N  \nATOM   2188  N   TYR A 285     -22.819   1.253 -10.229  1.00 91.75           N  \nATOM   2189  CA  TYR A 285     -21.582   0.603  -9.830  1.00 91.75           C  \nATOM   2190  C   TYR A 285     -21.866  -0.517  -8.824  1.00 91.75           C  \nATOM   2191  CB  TYR A 285     -20.631   1.641  -9.216  1.00 91.75           C  \nATOM   2192  O   TYR A 285     -22.782  -0.401  -8.004  1.00 91.75           O  \nATOM   2193  CG  TYR A 285     -20.322   2.832 -10.102  1.00 91.75           C  \nATOM   2194  CD1 TYR A 285     -19.214   2.792 -10.968  1.00 91.75           C  \nATOM   2195  CD2 TYR A 285     -21.157   3.968 -10.080  1.00 91.75           C  \nATOM   2196  CE1 TYR A 285     -18.953   3.870 -11.834  1.00 91.75           C  \nATOM   2197  CE2 TYR A 285     -20.896   5.051 -10.941  1.00 91.75           C  \nATOM   2198  OH  TYR A 285     -19.560   6.041 -12.663  1.00 91.75           O  \nATOM   2199  CZ  TYR A 285     -19.798   4.999 -11.825  1.00 91.75           C  \nATOM   2200  N   SER A 286     -21.058  -1.573  -8.835  1.00 91.75           N  \nATOM   2201  CA  SER A 286     -21.087  -2.608  -7.795  1.00 91.75           C  \nATOM   2202  C   SER A 286     -20.291  -2.160  -6.572  1.00 91.75           C  \nATOM   2203  CB  SER A 286     -20.538  -3.957  -8.279  1.00 91.75           C  \nATOM   2204  O   SER A 286     -19.113  -1.835  -6.687  1.00 91.75           O  \nATOM   2205  OG  SER A 286     -20.206  -3.977  -9.656  1.00 91.75           O  \nATOM   2206  N   PHE A 287     -20.896  -2.187  -5.390  1.00 87.62           N  \nATOM   2207  CA  PHE A 287     -20.225  -1.960  -4.111  1.00 87.62           C  \nATOM   2208  C   PHE A 287     -20.517  -3.146  -3.188  1.00 87.62           C  \nATOM   2209  CB  PHE A 287     -20.674  -0.614  -3.533  1.00 87.62           C  \nATOM   2210  O   PHE A 287     -21.607  -3.255  -2.614  1.00 87.62           O  \nATOM   2211  CG  PHE A 287     -20.167  -0.351  -2.129  1.00 87.62           C  \nATOM   2212  CD1 PHE A 287     -21.081  -0.122  -1.083  1.00 87.62           C  \nATOM   2213  CD2 PHE A 287     -18.786  -0.384  -1.854  1.00 87.62           C  \nATOM   2214  CE1 PHE A 287     -20.620   0.083   0.229  1.00 87.62           C  \nATOM   2215  CE2 PHE A 287     -18.330  -0.200  -0.539  1.00 87.62           C  \nATOM   2216  CZ  PHE A 287     -19.242   0.044   0.501  1.00 87.62           C  \nATOM   2217  N   GLY A 288     -19.568  -4.085  -3.123  1.00 84.38           N  \nATOM   2218  CA  GLY A 288     -19.841  -5.431  -2.624  1.00 84.38           C  \nATOM   2219  C   GLY A 288     -21.031  -6.057  -3.365  1.00 84.38           C  \nATOM   2220  O   GLY A 288     -21.313  -5.751  -4.525  1.00 84.38           O  \nATOM   2221  N   ALA A 289     -21.843  -6.819  -2.634  1.00 88.56           N  \nATOM   2222  CA  ALA A 289     -23.106  -7.386  -3.112  1.00 88.56           C  \nATOM   2223  C   ALA A 289     -24.262  -6.359  -3.288  1.00 88.56           C  \nATOM   2224  CB  ALA A 289     -23.467  -8.546  -2.177  1.00 88.56           C  \nATOM   2225  O   ALA A 289     -25.434  -6.717  -3.141  1.00 88.56           O  \nATOM   2226  N   THR A 290     -23.988  -5.079  -3.580  1.00 90.88           N  \nATOM   2227  CA  THR A 290     -25.017  -4.030  -3.766  1.00 90.88           C  \nATOM   2228  C   THR A 290     -24.763  -3.148  -4.991  1.00 90.88           C  \nATOM   2229  CB  THR A 290     -25.195  -3.138  -2.523  1.00 90.88           C  \nATOM   2230  O   THR A 290     -23.617  -2.937  -5.375  1.00 90.88           O  \nATOM   2231  CG2 THR A 290     -25.436  -3.906  -1.221  1.00 90.88           C  \nATOM   2232  OG1 THR A 290     -24.118  -2.264  -2.296  1.00 90.88           O  \nATOM   2233  N   CYS A 291     -25.829  -2.608  -5.592  1.00 93.38           N  \nATOM   2234  CA  CYS A 291     -25.741  -1.703  -6.744  1.00 93.38           C  \nATOM   2235  C   CYS A 291     -25.980  -0.244  -6.329  1.00 93.38           C  \nATOM   2236  CB  CYS A 291     -26.735  -2.150  -7.822  1.00 93.38           C  \nATOM   2237  O   CYS A 291     -27.063   0.102  -5.849  1.00 93.38           O  \nATOM   2238  SG  CYS A 291     -26.565  -3.879  -8.322  1.00 93.38           S  \nATOM   2239  N   VAL A 292     -24.993   0.629  -6.547  1.00 90.75           N  \nATOM   2240  CA  VAL A 292     -24.992   2.032  -6.098  1.00 90.75           C  \nATOM   2241  C   VAL A 292     -24.838   3.014  -7.266  1.00 90.75           C  \nATOM   2242  CB  VAL A 292     -23.926   2.278  -5.006  1.00 90.75           C  \nATOM   2243  O   VAL A 292     -24.072   2.788  -8.196  1.00 90.75           O  \nATOM   2244  CG1 VAL A 292     -24.226   1.454  -3.747  1.00 90.75           C  \nATOM   2245  CG2 VAL A 292     -22.488   1.978  -5.448  1.00 90.75           C  \nATOM   2246  N   LYS A 293     -25.551   4.150  -7.230  1.00 90.88           N  \nATOM   2247  CA  LYS A 293     -25.499   5.163  -8.315  1.00 90.88           C  \nATOM   2248  C   LYS A 293     -24.188   5.964  -8.371  1.00 90.88           C  \nATOM   2249  CB  LYS A 293     -26.709   6.113  -8.250  1.00 90.88           C  \nATOM   2250  O   LYS A 293     -23.917   6.615  -9.372  1.00 90.88           O  \nATOM   2251  CG  LYS A 293     -28.036   5.392  -8.543  1.00 90.88           C  \nATOM   2252  CD  LYS A 293     -29.140   6.363  -8.989  1.00 90.88           C  \nATOM   2253  CE  LYS A 293     -30.390   5.568  -9.402  1.00 90.88           C  \nATOM   2254  NZ  LYS A 293     -31.143   6.219 -10.508  1.00 90.88           N  \nATOM   2255  N   LYS A 294     -23.403   5.950  -7.292  1.00 88.94           N  \nATOM   2256  CA  LYS A 294     -22.025   6.455  -7.191  1.00 88.94           C  \nATOM   2257  C   LYS A 294     -21.305   5.619  -6.135  1.00 88.94           C  \nATOM   2258  CB  LYS A 294     -21.978   7.945  -6.780  1.00 88.94           C  \nATOM   2259  O   LYS A 294     -21.947   5.225  -5.160  1.00 88.94           O  \nATOM   2260  CG  LYS A 294     -22.530   8.906  -7.848  1.00 88.94           C  \nATOM   2261  CD  LYS A 294     -22.074  10.357  -7.625  1.00 88.94           C  \nATOM   2262  CE  LYS A 294     -22.542  11.240  -8.794  1.00 88.94           C  \nATOM   2263  NZ  LYS A 294     -21.725  12.478  -8.933  1.00 88.94           N  \nATOM   2264  N   CYS A 295     -20.006   5.389  -6.297  1.00 85.19           N  \nATOM   2265  CA  CYS A 295     -19.196   4.781  -5.243  1.00 85.19           C  \nATOM   2266  C   CYS A 295     -19.143   5.670  -3.981  1.00 85.19           C  \nATOM   2267  CB  CYS A 295     -17.791   4.485  -5.782  1.00 85.19           C  \nATOM   2268  O   CYS A 295     -19.313   6.891  -4.089  1.00 85.19           O  \nATOM   2269  SG  CYS A 295     -17.771   3.297  -7.146  1.00 85.19           S  \nATOM   2270  N   PRO A 296     -18.909   5.094  -2.785  1.00 78.19           N  \nATOM   2271  CA  PRO A 296     -18.659   5.875  -1.574  1.00 78.19           C  \nATOM   2272  C   PRO A 296     -17.413   6.769  -1.703  1.00 78.19           C  \nATOM   2273  CB  PRO A 296     -18.505   4.850  -0.441  1.00 78.19           C  \nATOM   2274  O   PRO A 296     -16.523   6.494  -2.511  1.00 78.19           O  \nATOM   2275  CG  PRO A 296     -19.177   3.588  -0.980  1.00 78.19           C  \nATOM   2276  CD  PRO A 296     -18.902   3.670  -2.478  1.00 78.19           C  \nATOM   2277  N   ARG A 297     -17.310   7.816  -0.867  1.00 73.62           N  \nATOM   2278  CA  ARG A 297     -16.053   8.578  -0.722  1.00 73.62           C  \nATOM   2279  C   ARG A 297     -14.914   7.622  -0.321  1.00 73.62           C  \nATOM   2280  CB  ARG A 297     -16.206   9.770   0.257  1.00 73.62           C  \nATOM   2281  O   ARG A 297     -15.153   6.610   0.334  1.00 73.62           O  \nATOM   2282  CG  ARG A 297     -16.940  10.969  -0.381  1.00 73.62           C  \nATOM   2283  CD  ARG A 297     -17.031  12.217   0.527  1.00 73.62           C  \nATOM   2284  NE  ARG A 297     -17.490  13.407  -0.236  1.00 73.62           N  \nATOM   2285  NH1 ARG A 297     -18.445  14.642   1.467  1.00 73.62           N  \nATOM   2286  NH2 ARG A 297     -18.465  15.445  -0.589  1.00 73.62           N  \nATOM   2287  CZ  ARG A 297     -18.125  14.479   0.222  1.00 73.62           C  \nATOM   2288  N   ASN A 298     -13.698   7.938  -0.759  1.00 69.62           N  \nATOM   2289  CA  ASN A 298     -12.468   7.146  -0.605  1.00 69.62           C  \nATOM   2290  C   ASN A 298     -12.411   5.799  -1.363  1.00 69.62           C  \nATOM   2291  CB  ASN A 298     -12.059   7.048   0.881  1.00 69.62           C  \nATOM   2292  O   ASN A 298     -11.369   5.153  -1.333  1.00 69.62           O  \nATOM   2293  CG  ASN A 298     -11.912   8.396   1.574  1.00 69.62           C  \nATOM   2294  ND2 ASN A 298     -11.656   8.402   2.860  1.00 69.62           N  \nATOM   2295  OD1 ASN A 298     -12.045   9.457   0.986  1.00 69.62           O  \nATOM   2296  N   TYR A 299     -13.437   5.414  -2.134  1.00 80.56           N  \nATOM   2297  CA  TYR A 299     -13.355   4.299  -3.095  1.00 80.56           C  \nATOM   2298  C   TYR A 299     -12.928   4.789  -4.492  1.00 80.56           C  \nATOM   2299  CB  TYR A 299     -14.675   3.503  -3.113  1.00 80.56           C  \nATOM   2300  O   TYR A 299     -13.008   5.986  -4.791  1.00 80.56           O  \nATOM   2301  CG  TYR A 299     -14.855   2.597  -1.903  1.00 80.56           C  \nATOM   2302  CD1 TYR A 299     -14.756   1.199  -2.041  1.00 80.56           C  \nATOM   2303  CD2 TYR A 299     -15.058   3.151  -0.624  1.00 80.56           C  \nATOM   2304  CE1 TYR A 299     -14.800   0.365  -0.907  1.00 80.56           C  \nATOM   2305  CE2 TYR A 299     -15.108   2.325   0.514  1.00 80.56           C  \nATOM   2306  OH  TYR A 299     -14.954   0.135   1.484  1.00 80.56           O  \nATOM   2307  CZ  TYR A 299     -14.958   0.929   0.377  1.00 80.56           C  \nATOM   2308  N   VAL A 300     -12.458   3.866  -5.330  1.00 80.69           N  \nATOM   2309  CA  VAL A 300     -12.045   4.065  -6.730  1.00 80.69           C  \nATOM   2310  C   VAL A 300     -12.818   3.117  -7.656  1.00 80.69           C  \nATOM   2311  CB  VAL A 300     -10.518   3.913  -6.913  1.00 80.69           C  \nATOM   2312  O   VAL A 300     -13.328   2.083  -7.219  1.00 80.69           O  \nATOM   2313  CG1 VAL A 300      -9.744   4.900  -6.044  1.00 80.69           C  \nATOM   2314  CG2 VAL A 300      -9.993   2.522  -6.560  1.00 80.69           C  \nATOM   2315  N   VAL A 301     -12.945   3.480  -8.932  1.00 89.50           N  \nATOM   2316  CA  VAL A 301     -13.741   2.761  -9.941  1.00 89.50           C  \nATOM   2317  C   VAL A 301     -12.842   1.902 -10.830  1.00 89.50           C  \nATOM   2318  CB  VAL A 301     -14.559   3.763 -10.781  1.00 89.50           C  \nATOM   2319  O   VAL A 301     -11.929   2.409 -11.470  1.00 89.50           O  \nATOM   2320  CG1 VAL A 301     -15.284   3.111 -11.964  1.00 89.50           C  \nATOM   2321  CG2 VAL A 301     -15.630   4.438  -9.915  1.00 89.50           C  \nATOM   2322  N   THR A 302     -13.124   0.606 -10.919  1.00 86.69           N  \nATOM   2323  CA  THR A 302     -12.478  -0.299 -11.892  1.00 86.69           C  \nATOM   2324  C   THR A 302     -13.089  -0.181 -13.291  1.00 86.69           C  \nATOM   2325  CB  THR A 302     -12.572  -1.762 -11.434  1.00 86.69           C  \nATOM   2326  O   THR A 302     -14.259   0.181 -13.417  1.00 86.69           O  \nATOM   2327  CG2 THR A 302     -11.681  -2.029 -10.225  1.00 86.69           C  \nATOM   2328  OG1 THR A 302     -13.897  -2.095 -11.075  1.00 86.69           O  \nATOM   2329  N   ASP A 303     -12.345  -0.597 -14.327  1.00 80.81           N  \nATOM   2330  CA  ASP A 303     -12.821  -0.737 -15.722  1.00 80.81           C  \nATOM   2331  C   ASP A 303     -14.170  -1.484 -15.843  1.00 80.81           C  \nATOM   2332  CB  ASP A 303     -11.789  -1.548 -16.536  1.00 80.81           C  \nATOM   2333  O   ASP A 303     -14.948  -1.256 -16.766  1.00 80.81           O  \nATOM   2334  CG  ASP A 303     -10.415  -0.893 -16.717  1.00 80.81           C  \nATOM   2335  OD1 ASP A 303     -10.370   0.349 -16.825  1.00 80.81           O  \nATOM   2336  OD2 ASP A 303      -9.426  -1.666 -16.769  1.00 80.81           O  \nATOM   2337  N   HIS A 304     -14.462  -2.389 -14.903  1.00 79.44           N  \nATOM   2338  CA  HIS A 304     -15.680  -3.208 -14.867  1.00 79.44           C  \nATOM   2339  C   HIS A 304     -16.852  -2.560 -14.106  1.00 79.44           C  \nATOM   2340  CB  HIS A 304     -15.320  -4.593 -14.308  1.00 79.44           C  \nATOM   2341  O   HIS A 304     -17.906  -3.177 -13.960  1.00 79.44           O  \nATOM   2342  CG  HIS A 304     -14.192  -5.267 -15.055  1.00 79.44           C  \nATOM   2343  CD2 HIS A 304     -13.140  -5.953 -14.508  1.00 79.44           C  \nATOM   2344  ND1 HIS A 304     -14.000  -5.257 -16.418  1.00 79.44           N  \nATOM   2345  CE1 HIS A 304     -12.861  -5.917 -16.683  1.00 79.44           C  \nATOM   2346  NE2 HIS A 304     -12.298  -6.363 -15.549  1.00 79.44           N  \nATOM   2347  N   GLY A 305     -16.690  -1.335 -13.598  1.00 85.88           N  \nATOM   2348  CA  GLY A 305     -17.729  -0.612 -12.862  1.00 85.88           C  \nATOM   2349  C   GLY A 305     -17.887  -1.012 -11.390  1.00 85.88           C  \nATOM   2350  O   GLY A 305     -18.880  -0.641 -10.769  1.00 85.88           O  \nATOM   2351  N   SER A 306     -16.931  -1.731 -10.800  1.00 87.62           N  \nATOM   2352  CA  SER A 306     -16.933  -2.031  -9.360  1.00 87.62           C  \nATOM   2353  C   SER A 306     -16.161  -0.982  -8.555  1.00 87.62           C  \nATOM   2354  CB  SER A 306     -16.408  -3.442  -9.086  1.00 87.62           C  \nATOM   2355  O   SER A 306     -15.077  -0.550  -8.957  1.00 87.62           O  \nATOM   2356  OG  SER A 306     -17.348  -4.380  -9.576  1.00 87.62           O  \nATOM   2357  N   CYS A 307     -16.722  -0.612  -7.403  1.00 87.50           N  \nATOM   2358  CA  CYS A 307     -16.144   0.255  -6.383  1.00 87.50           C  \nATOM   2359  C   CYS A 307     -15.165  -0.540  -5.510  1.00 87.50           C  \nATOM   2360  CB  CYS A 307     -17.275   0.803  -5.497  1.00 87.50           C  \nATOM   2361  O   CYS A 307     -15.580  -1.423  -4.756  1.00 87.50           O  \nATOM   2362  SG  CYS A 307     -18.635   1.644  -6.342  1.00 87.50           S  \nATOM   2363  N   VAL A 308     -13.880  -0.204  -5.566  1.00 80.06           N  \nATOM   2364  CA  VAL A 308     -12.805  -0.876  -4.813  1.00 80.06           C  \nATOM   2365  C   VAL A 308     -12.059   0.140  -3.934  1.00 80.06           C  \nATOM   2366  CB  VAL A 308     -11.895  -1.678  -5.771  1.00 80.06           C  \nATOM   2367  O   VAL A 308     -12.219   1.342  -4.133  1.00 80.06           O  \nATOM   2368  CG1 VAL A 308     -12.707  -2.525  -6.769  1.00 80.06           C  \nATOM   2369  CG2 VAL A 308     -10.972  -0.799  -6.610  1.00 80.06           C  \nATOM   2370  N   ARG A 309     -11.297  -0.289  -2.917  1.00 71.44           N  \nATOM   2371  CA  ARG A 309     -10.587   0.655  -2.016  1.00 71.44           C  \nATOM   2372  C   ARG A 309      -9.285   1.183  -2.619  1.00 71.44           C  \nATOM   2373  CB  ARG A 309     -10.302   0.023  -0.645  1.00 71.44           C  \nATOM   2374  O   ARG A 309      -8.982   2.359  -2.476  1.00 71.44           O  \nATOM   2375  CG  ARG A 309     -11.586  -0.283   0.132  1.00 71.44           C  \nATOM   2376  CD  ARG A 309     -11.254  -0.861   1.510  1.00 71.44           C  \nATOM   2377  NE  ARG A 309     -12.410  -1.589   2.070  1.00 71.44           N  \nATOM   2378  NH1 ARG A 309     -11.234  -3.313   3.050  1.00 71.44           N  \nATOM   2379  NH2 ARG A 309     -13.451  -3.302   3.161  1.00 71.44           N  \nATOM   2380  CZ  ARG A 309     -12.357  -2.718   2.759  1.00 71.44           C  \nATOM   2381  N   ALA A 310      -8.554   0.306  -3.298  1.00 72.06           N  \nATOM   2382  CA  ALA A 310      -7.315   0.586  -4.006  1.00 72.06           C  \nATOM   2383  C   ALA A 310      -7.289  -0.218  -5.314  1.00 72.06           C  \nATOM   2384  CB  ALA A 310      -6.133   0.223  -3.097  1.00 72.06           C  \nATOM   2385  O   ALA A 310      -8.013  -1.207  -5.455  1.00 72.06           O  \nATOM   2386  N   CYS A 311      -6.465   0.209  -6.266  1.00 80.31           N  \nATOM   2387  CA  CYS A 311      -6.276  -0.497  -7.529  1.00 80.31           C  \nATOM   2388  C   CYS A 311      -5.394  -1.745  -7.361  1.00 80.31           C  \nATOM   2389  CB  CYS A 311      -5.715   0.487  -8.561  1.00 80.31           C  \nATOM   2390  O   CYS A 311      -4.564  -1.814  -6.455  1.00 80.31           O  \nATOM   2391  SG  CYS A 311      -6.756   1.954  -8.788  1.00 80.31           S  \nATOM   2392  N   GLY A 312      -5.563  -2.729  -8.250  1.00 73.44           N  \nATOM   2393  CA  GLY A 312      -4.693  -3.907  -8.302  1.00 73.44           C  \nATOM   2394  C   GLY A 312      -3.247  -3.543  -8.656  1.00 73.44           C  \nATOM   2395  O   GLY A 312      -2.992  -2.511  -9.266  1.00 73.44           O  \nATOM   2396  N   ALA A 313      -2.289  -4.407  -8.310  1.00 73.94           N  \nATOM   2397  CA  ALA A 313      -0.851  -4.146  -8.483  1.00 73.94           C  \nATOM   2398  C   ALA A 313      -0.354  -4.078  -9.953  1.00 73.94           C  \nATOM   2399  CB  ALA A 313      -0.087  -5.198  -7.667  1.00 73.94           C  \nATOM   2400  O   ALA A 313       0.836  -3.865 -10.187  1.00 73.94           O  \nATOM   2401  N   ASP A 314      -1.243  -4.280 -10.931  1.00 82.06           N  \nATOM   2402  CA  ASP A 314      -1.041  -4.076 -12.375  1.00 82.06           C  \nATOM   2403  C   ASP A 314      -1.610  -2.731 -12.881  1.00 82.06           C  \nATOM   2404  CB  ASP A 314      -1.681  -5.255 -13.134  1.00 82.06           C  \nATOM   2405  O   ASP A 314      -1.549  -2.429 -14.076  1.00 82.06           O  \nATOM   2406  CG  ASP A 314      -3.222  -5.233 -13.144  1.00 82.06           C  \nATOM   2407  OD1 ASP A 314      -3.819  -4.640 -12.210  1.00 82.06           O  \nATOM   2408  OD2 ASP A 314      -3.806  -5.823 -14.084  1.00 82.06           O  \nATOM   2409  N   SER A 315      -2.178  -1.934 -11.974  1.00 82.38           N  \nATOM   2410  CA  SER A 315      -2.964  -0.737 -12.248  1.00 82.38           C  \nATOM   2411  C   SER A 315      -2.561   0.423 -11.331  1.00 82.38           C  \nATOM   2412  CB  SER A 315      -4.451  -1.063 -12.062  1.00 82.38           C  \nATOM   2413  O   SER A 315      -2.036   0.226 -10.238  1.00 82.38           O  \nATOM   2414  OG  SER A 315      -4.874  -2.132 -12.892  1.00 82.38           O  \nATOM   2415  N   TYR A 316      -2.835   1.652 -11.762  1.00 81.50           N  \nATOM   2416  CA  TYR A 316      -2.634   2.870 -10.978  1.00 81.50           C  \nATOM   2417  C   TYR A 316      -3.942   3.657 -10.842  1.00 81.50           C  \nATOM   2418  CB  TYR A 316      -1.484   3.704 -11.567  1.00 81.50           C  \nATOM   2419  O   TYR A 316      -4.853   3.530 -11.663  1.00 81.50           O  \nATOM   2420  CG  TYR A 316      -1.773   4.404 -12.884  1.00 81.50           C  \nATOM   2421  CD1 TYR A 316      -1.730   3.692 -14.100  1.00 81.50           C  \nATOM   2422  CD2 TYR A 316      -2.078   5.779 -12.892  1.00 81.50           C  \nATOM   2423  CE1 TYR A 316      -2.008   4.345 -15.318  1.00 81.50           C  \nATOM   2424  CE2 TYR A 316      -2.348   6.438 -14.106  1.00 81.50           C  \nATOM   2425  OH  TYR A 316      -2.624   6.356 -16.483  1.00 81.50           O  \nATOM   2426  CZ  TYR A 316      -2.325   5.720 -15.320  1.00 81.50           C  \nATOM   2427  N   GLU A 317      -4.040   4.455  -9.780  1.00 83.31           N  \nATOM   2428  CA  GLU A 317      -5.165   5.364  -9.569  1.00 83.31           C  \nATOM   2429  C   GLU A 317      -4.982   6.635 -10.412  1.00 83.31           C  \nATOM   2430  CB  GLU A 317      -5.306   5.676  -8.069  1.00 83.31           C  \nATOM   2431  O   GLU A 317      -3.914   7.249 -10.403  1.00 83.31           O  \nATOM   2432  CG  GLU A 317      -6.622   6.405  -7.777  1.00 83.31           C  \nATOM   2433  CD  GLU A 317      -6.759   6.816  -6.307  1.00 83.31           C  \nATOM   2434  OE1 GLU A 317      -7.122   7.989  -6.074  1.00 83.31           O  \nATOM   2435  OE2 GLU A 317      -6.621   5.967  -5.398  1.00 83.31           O  \nATOM   2436  N   MET A 318      -6.027   7.034 -11.136  1.00 84.88           N  \nATOM   2437  CA  MET A 318      -6.058   8.245 -11.953  1.00 84.88           C  \nATOM   2438  C   MET A 318      -7.415   8.932 -11.801  1.00 84.88           C  \nATOM   2439  CB  MET A 318      -5.773   7.861 -13.414  1.00 84.88           C  \nATOM   2440  O   MET A 318      -8.451   8.284 -11.940  1.00 84.88           O  \nATOM   2441  CG  MET A 318      -5.508   9.085 -14.296  1.00 84.88           C  \nATOM   2442  SD  MET A 318      -4.833   8.684 -15.934  1.00 84.88           S  \nATOM   2443  CE  MET A 318      -4.541  10.369 -16.532  1.00 84.88           C  \nATOM   2444  N   GLU A 319      -7.439  10.235 -11.524  1.00 81.38           N  \nATOM   2445  CA  GLU A 319      -8.691  10.996 -11.520  1.00 81.38           C  \nATOM   2446  C   GLU A 319      -9.030  11.478 -12.934  1.00 81.38           C  \nATOM   2447  CB  GLU A 319      -8.660  12.123 -10.476  1.00 81.38           C  \nATOM   2448  O   GLU A 319      -8.229  12.141 -13.590  1.00 81.38           O  \nATOM   2449  CG  GLU A 319     -10.083  12.655 -10.225  1.00 81.38           C  \nATOM   2450  CD  GLU A 319     -10.173  13.629  -9.041  1.00 81.38           C  \nATOM   2451  OE1 GLU A 319     -10.945  14.607  -9.166  1.00 81.38           O  \nATOM   2452  OE2 GLU A 319      -9.551  13.345  -7.994  1.00 81.38           O  \nATOM   2453  N   GLU A 320     -10.224  11.125 -13.402  1.00 77.69           N  \nATOM   2454  CA  GLU A 320     -10.747  11.470 -14.723  1.00 77.69           C  \nATOM   2455  C   GLU A 320     -12.236  11.820 -14.554  1.00 77.69           C  \nATOM   2456  CB  GLU A 320     -10.477  10.288 -15.671  1.00 77.69           C  \nATOM   2457  O   GLU A 320     -12.997  11.061 -13.948  1.00 77.69           O  \nATOM   2458  CG  GLU A 320     -10.772  10.567 -17.152  1.00 77.69           C  \nATOM   2459  CD  GLU A 320     -10.478   9.325 -18.012  1.00 77.69           C  \nATOM   2460  OE1 GLU A 320      -9.598   9.384 -18.897  1.00 77.69           O  \nATOM   2461  OE2 GLU A 320     -11.135   8.287 -17.747  1.00 77.69           O  \nATOM   2462  N   ASP A 321     -12.644  13.005 -15.014  1.00 76.88           N  \nATOM   2463  CA  ASP A 321     -13.999  13.571 -14.844  1.00 76.88           C  \nATOM   2464  C   ASP A 321     -14.480  13.703 -13.379  1.00 76.88           C  \nATOM   2465  CB  ASP A 321     -15.013  12.836 -15.735  1.00 76.88           C  \nATOM   2466  O   ASP A 321     -15.676  13.617 -13.084  1.00 76.88           O  \nATOM   2467  CG  ASP A 321     -14.473  12.593 -17.139  1.00 76.88           C  \nATOM   2468  OD1 ASP A 321     -14.081  13.597 -17.775  1.00 76.88           O  \nATOM   2469  OD2 ASP A 321     -14.436  11.395 -17.521  1.00 76.88           O  \nATOM   2470  N   GLY A 322     -13.555  13.886 -12.428  1.00 74.19           N  \nATOM   2471  CA  GLY A 322     -13.868  13.915 -10.991  1.00 74.19           C  \nATOM   2472  C   GLY A 322     -14.209  12.539 -10.402  1.00 74.19           C  \nATOM   2473  O   GLY A 322     -14.782  12.442  -9.313  1.00 74.19           O  \nATOM   2474  N   VAL A 323     -13.894  11.461 -11.127  1.00 78.94           N  \nATOM   2475  CA  VAL A 323     -13.991  10.075 -10.665  1.00 78.94           C  \nATOM   2476  C   VAL A 323     -12.587   9.486 -10.631  1.00 78.94           C  \nATOM   2477  CB  VAL A 323     -14.932   9.245 -11.563  1.00 78.94           C  \nATOM   2478  O   VAL A 323     -11.893   9.439 -11.643  1.00 78.94           O  \nATOM   2479  CG1 VAL A 323     -15.055   7.799 -11.060  1.00 78.94           C  \nATOM   2480  CG2 VAL A 323     -16.347   9.841 -11.592  1.00 78.94           C  \nATOM   2481  N   ARG A 324     -12.166   8.997  -9.464  1.00 82.25           N  \nATOM   2482  CA  ARG A 324     -10.903   8.266  -9.312  1.00 82.25           C  \nATOM   2483  C   ARG A 324     -11.089   6.858  -9.881  1.00 82.25           C  \nATOM   2484  CB  ARG A 324     -10.449   8.281  -7.843  1.00 82.25           C  \nATOM   2485  O   ARG A 324     -11.865   6.071  -9.332  1.00 82.25           O  \nATOM   2486  CG  ARG A 324     -10.339   9.710  -7.263  1.00 82.25           C  \nATOM   2487  CD  ARG A 324      -9.826   9.757  -5.816  1.00 82.25           C  \nATOM   2488  NE  ARG A 324     -10.490   8.752  -4.953  1.00 82.25           N  \nATOM   2489  NH1 ARG A 324      -8.637   7.840  -3.906  1.00 82.25           N  \nATOM   2490  NH2 ARG A 324     -10.647   6.980  -3.567  1.00 82.25           N  \nATOM   2491  CZ  ARG A 324      -9.909   7.881  -4.144  1.00 82.25           C  \nATOM   2492  N   LYS A 325     -10.443   6.568 -11.008  1.00 88.88           N  \nATOM   2493  CA  LYS A 325     -10.521   5.313 -11.770  1.00 88.88           C  \nATOM   2494  C   LYS A 325      -9.213   4.524 -11.614  1.00 88.88           C  \nATOM   2495  CB  LYS A 325     -10.836   5.606 -13.260  1.00 88.88           C  \nATOM   2496  O   LYS A 325      -8.155   5.104 -11.380  1.00 88.88           O  \nATOM   2497  CG  LYS A 325     -12.155   6.379 -13.504  1.00 88.88           C  \nATOM   2498  CD  LYS A 325     -12.375   6.769 -14.982  1.00 88.88           C  \nATOM   2499  CE  LYS A 325     -13.392   7.928 -15.119  1.00 88.88           C  \nATOM   2500  NZ  LYS A 325     -13.494   8.462 -16.508  1.00 88.88           N  \nATOM   2501  N   CYS A 326      -9.276   3.205 -11.760  1.00 87.19           N  \nATOM   2502  CA  CYS A 326      -8.106   2.337 -11.862  1.00 87.19           C  \nATOM   2503  C   CYS A 326      -7.790   2.076 -13.328  1.00 87.19           C  \nATOM   2504  CB  CYS A 326      -8.369   1.014 -11.140  1.00 87.19           C  \nATOM   2505  O   CYS A 326      -8.590   1.436 -14.005  1.00 87.19           O  \nATOM   2506  SG  CYS A 326      -8.554   1.179  -9.357  1.00 87.19           S  \nATOM   2507  N   LYS A 327      -6.624   2.525 -13.793  1.00 87.25           N  \nATOM   2508  CA  LYS A 327      -6.150   2.307 -15.164  1.00 87.25           C  \nATOM   2509  C   LYS A 327      -4.924   1.400 -15.152  1.00 87.25           C  \nATOM   2510  CB  LYS A 327      -5.900   3.675 -15.816  1.00 87.25           C  \nATOM   2511  O   LYS A 327      -4.037   1.566 -14.316  1.00 87.25           O  \nATOM   2512  CG  LYS A 327      -5.511   3.567 -17.297  1.00 87.25           C  \nATOM   2513  CD  LYS A 327      -5.569   4.950 -17.956  1.00 87.25           C  \nATOM   2514  CE  LYS A 327      -5.051   4.885 -19.395  1.00 87.25           C  \nATOM   2515  NZ  LYS A 327      -5.079   6.226 -20.028  1.00 87.25           N  \nATOM   2516  N   LYS A 328      -4.858   0.436 -16.070  1.00 86.31           N  \nATOM   2517  CA  LYS A 328      -3.718  -0.492 -16.165  1.00 86.31           C  \nATOM   2518  C   LYS A 328      -2.428   0.236 -16.537  1.00 86.31           C  \nATOM   2519  CB  LYS A 328      -4.034  -1.649 -17.118  1.00 86.31           C  \nATOM   2520  O   LYS A 328      -2.438   1.168 -17.341  1.00 86.31           O  \nATOM   2521  CG  LYS A 328      -5.071  -2.547 -16.437  1.00 86.31           C  \nATOM   2522  CD  LYS A 328      -5.469  -3.747 -17.288  1.00 86.31           C  \nATOM   2523  CE  LYS A 328      -6.480  -4.516 -16.439  1.00 86.31           C  \nATOM   2524  NZ  LYS A 328      -7.016  -5.688 -17.158  1.00 86.31           N  \nATOM   2525  N   CYS A 329      -1.321  -0.191 -15.942  1.00 82.25           N  \nATOM   2526  CA  CYS A 329      -0.009   0.409 -16.155  1.00 82.25           C  \nATOM   2527  C   CYS A 329       0.555   0.065 -17.545  1.00 82.25           C  \nATOM   2528  CB  CYS A 329       0.921  -0.063 -15.032  1.00 82.25           C  \nATOM   2529  O   CYS A 329       0.479  -1.077 -18.001  1.00 82.25           O  \nATOM   2530  SG  CYS A 329       0.377   0.437 -13.375  1.00 82.25           S  \nATOM   2531  N   GLU A 330       1.186   1.039 -18.209  1.00 81.44           N  \nATOM   2532  CA  GLU A 330       1.887   0.824 -19.484  1.00 81.44           C  \nATOM   2533  C   GLU A 330       3.254   0.155 -19.249  1.00 81.44           C  \nATOM   2534  CB  GLU A 330       1.971   2.124 -20.297  1.00 81.44           C  \nATOM   2535  O   GLU A 330       4.319   0.780 -19.270  1.00 81.44           O  \nATOM   2536  CG  GLU A 330       0.584   2.535 -20.825  1.00 81.44           C  \nATOM   2537  CD  GLU A 330       0.615   3.752 -21.763  1.00 81.44           C  \nATOM   2538  OE1 GLU A 330      -0.493   4.200 -22.138  1.00 81.44           O  \nATOM   2539  OE2 GLU A 330       1.728   4.221 -22.094  1.00 81.44           O  \nATOM   2540  N   GLY A 331       3.204  -1.152 -18.980  1.00 78.81           N  \nATOM   2541  CA  GLY A 331       4.334  -1.944 -18.497  1.00 78.81           C  \nATOM   2542  C   GLY A 331       4.332  -2.056 -16.966  1.00 78.81           C  \nATOM   2543  O   GLY A 331       3.266  -2.025 -16.352  1.00 78.81           O  \nATOM   2544  N   PRO A 332       5.500  -2.219 -16.317  1.00 78.94           N  \nATOM   2545  CA  PRO A 332       5.584  -2.255 -14.859  1.00 78.94           C  \nATOM   2546  C   PRO A 332       5.034  -0.965 -14.237  1.00 78.94           C  \nATOM   2547  CB  PRO A 332       7.071  -2.452 -14.528  1.00 78.94           C  \nATOM   2548  O   PRO A 332       5.439   0.131 -14.630  1.00 78.94           O  \nATOM   2549  CG  PRO A 332       7.655  -3.048 -15.809  1.00 78.94           C  \nATOM   2550  CD  PRO A 332       6.814  -2.401 -16.907  1.00 78.94           C  \nATOM   2551  N   CYS A 333       4.143  -1.090 -13.249  1.00 77.19           N  \nATOM   2552  CA  CYS A 333       3.649   0.061 -12.497  1.00 77.19           C  \nATOM   2553  C   CYS A 333       4.786   0.829 -11.821  1.00 77.19           C  \nATOM   2554  CB  CYS A 333       2.612  -0.374 -11.462  1.00 77.19           C  \nATOM   2555  O   CYS A 333       5.797   0.255 -11.408  1.00 77.19           O  \nATOM   2556  SG  CYS A 333       1.091  -1.037 -12.162  1.00 77.19           S  \nATOM   2557  N   ARG A 334       4.612   2.149 -11.709  1.00 85.44           N  \nATOM   2558  CA  ARG A 334       5.672   3.047 -11.258  1.00 85.44           C  \nATOM   2559  C   ARG A 334       6.026   2.801  -9.788  1.00 85.44           C  \nATOM   2560  CB  ARG A 334       5.269   4.498 -11.551  1.00 85.44           C  \nATOM   2561  O   ARG A 334       5.237   3.099  -8.900  1.00 85.44           O  \nATOM   2562  CG  ARG A 334       6.397   5.482 -11.214  1.00 85.44           C  \nATOM   2563  CD  ARG A 334       6.019   6.884 -11.691  1.00 85.44           C  \nATOM   2564  NE  ARG A 334       6.970   7.895 -11.190  1.00 85.44           N  \nATOM   2565  NH1 ARG A 334       5.468   9.612 -11.062  1.00 85.44           N  \nATOM   2566  NH2 ARG A 334       7.433   9.828 -10.070  1.00 85.44           N  \nATOM   2567  CZ  ARG A 334       6.628   9.105 -10.787  1.00 85.44           C  \nATOM   2568  N   LYS A 335       7.252   2.336  -9.543  1.00 87.81           N  \nATOM   2569  CA  LYS A 335       7.863   2.199  -8.213  1.00 87.81           C  \nATOM   2570  C   LYS A 335       9.117   3.073  -8.146  1.00 87.81           C  \nATOM   2571  CB  LYS A 335       8.150   0.711  -7.935  1.00 87.81           C  \nATOM   2572  O   LYS A 335      10.022   2.926  -8.976  1.00 87.81           O  \nATOM   2573  CG  LYS A 335       8.678   0.446  -6.512  1.00 87.81           C  \nATOM   2574  CD  LYS A 335       9.217  -0.986  -6.345  1.00 87.81           C  \nATOM   2575  CE  LYS A 335       9.933  -1.134  -4.991  1.00 87.81           C  \nATOM   2576  NZ  LYS A 335      10.805  -2.338  -4.939  1.00 87.81           N  \nATOM   2577  N   VAL A 336       9.162   3.977  -7.170  1.00 86.88           N  \nATOM   2578  CA  VAL A 336      10.347   4.789  -6.849  1.00 86.88           C  \nATOM   2579  C   VAL A 336      11.176   4.053  -5.797  1.00 86.88           C  \nATOM   2580  CB  VAL A 336       9.967   6.209  -6.379  1.00 86.88           C  \nATOM   2581  O   VAL A 336      10.612   3.474  -4.872  1.00 86.88           O  \nATOM   2582  CG1 VAL A 336      11.214   7.075  -6.153  1.00 86.88           C  \nATOM   2583  CG2 VAL A 336       9.095   6.927  -7.422  1.00 86.88           C  \nATOM   2584  N   CYS A 337      12.499   4.043  -5.954  1.00 93.00           N  \nATOM   2585  CA  CYS A 337      13.429   3.341  -5.064  1.00 93.00           C  \nATOM   2586  C   CYS A 337      14.678   4.189  -4.801  1.00 93.00           C  \nATOM   2587  CB  CYS A 337      13.801   1.999  -5.705  1.00 93.00           C  \nATOM   2588  O   CYS A 337      15.052   5.000  -5.648  1.00 93.00           O  \nATOM   2589  SG  CYS A 337      12.359   0.971  -6.081  1.00 93.00           S  \nATOM   2590  N   ASN A 338      15.336   4.003  -3.655  1.00 92.81           N  \nATOM   2591  CA  ASN A 338      16.554   4.743  -3.317  1.00 92.81           C  \nATOM   2592  C   ASN A 338      17.724   4.370  -4.242  1.00 92.81           C  \nATOM   2593  CB  ASN A 338      16.907   4.502  -1.840  1.00 92.81           C  \nATOM   2594  O   ASN A 338      17.871   3.217  -4.649  1.00 92.81           O  \nATOM   2595  CG  ASN A 338      15.859   5.074  -0.911  1.00 92.81           C  \nATOM   2596  ND2 ASN A 338      15.236   4.252  -0.097  1.00 92.81           N  \nATOM   2597  OD1 ASN A 338      15.570   6.261  -0.940  1.00 92.81           O  \nATOM   2598  N   GLY A 339      18.571   5.349  -4.560  1.00 91.81           N  \nATOM   2599  CA  GLY A 339      19.875   5.106  -5.178  1.00 91.81           C  \nATOM   2600  C   GLY A 339      20.955   4.740  -4.158  1.00 91.81           C  \nATOM   2601  O   GLY A 339      20.792   4.915  -2.951  1.00 91.81           O  \nATOM   2602  N   ILE A 340      22.089   4.258  -4.659  1.00 93.44           N  \nATOM   2603  CA  ILE A 340      23.303   4.029  -3.872  1.00 93.44           C  \nATOM   2604  C   ILE A 340      23.751   5.355  -3.234  1.00 93.44           C  \nATOM   2605  CB  ILE A 340      24.395   3.396  -4.767  1.00 93.44           C  \nATOM   2606  O   ILE A 340      23.689   6.402  -3.875  1.00 93.44           O  \nATOM   2607  CG1 ILE A 340      23.944   2.078  -5.447  1.00 93.44           C  \nATOM   2608  CG2 ILE A 340      25.671   3.128  -3.960  1.00 93.44           C  \nATOM   2609  CD1 ILE A 340      23.504   0.953  -4.494  1.00 93.44           C  \nATOM   2610  N   GLY A 341      24.171   5.322  -1.966  1.00 83.56           N  \nATOM   2611  CA  GLY A 341      24.500   6.522  -1.189  1.00 83.56           C  \nATOM   2612  C   GLY A 341      23.300   7.230  -0.542  1.00 83.56           C  \nATOM   2613  O   GLY A 341      23.502   8.213   0.171  1.00 83.56           O  \nATOM   2614  N   ILE A 342      22.065   6.738  -0.721  1.00 81.50           N  \nATOM   2615  CA  ILE A 342      20.841   7.335  -0.156  1.00 81.50           C  \nATOM   2616  C   ILE A 342      20.040   6.299   0.651  1.00 81.50           C  \nATOM   2617  CB  ILE A 342      20.007   8.019  -1.272  1.00 81.50           C  \nATOM   2618  O   ILE A 342      19.934   5.135   0.269  1.00 81.50           O  \nATOM   2619  CG1 ILE A 342      20.865   9.111  -1.963  1.00 81.50           C  \nATOM   2620  CG2 ILE A 342      18.695   8.611  -0.716  1.00 81.50           C  \nATOM   2621  CD1 ILE A 342      20.126  10.010  -2.961  1.00 81.50           C  \nATOM   2622  N   GLY A 343      19.460   6.735   1.776  1.00 84.25           N  \nATOM   2623  CA  GLY A 343      18.558   5.929   2.607  1.00 84.25           C  \nATOM   2624  C   GLY A 343      19.196   4.625   3.098  1.00 84.25           C  \nATOM   2625  O   GLY A 343      20.308   4.622   3.620  1.00 84.25           O  \nATOM   2626  N   GLU A 344      18.499   3.513   2.876  1.00 85.19           N  \nATOM   2627  CA  GLU A 344      18.959   2.132   3.107  1.00 85.19           C  \nATOM   2628  C   GLU A 344      20.315   1.786   2.447  1.00 85.19           C  \nATOM   2629  CB  GLU A 344      17.849   1.175   2.616  1.00 85.19           C  \nATOM   2630  O   GLU A 344      21.011   0.880   2.904  1.00 85.19           O  \nATOM   2631  CG  GLU A 344      17.519   1.394   1.127  1.00 85.19           C  \nATOM   2632  CD  GLU A 344      16.341   0.572   0.590  1.00 85.19           C  \nATOM   2633  OE1 GLU A 344      15.543   1.197  -0.153  1.00 85.19           O  \nATOM   2634  OE2 GLU A 344      16.260  -0.645   0.876  1.00 85.19           O  \nATOM   2635  N   PHE A 345      20.735   2.520   1.407  1.00 91.06           N  \nATOM   2636  CA  PHE A 345      22.005   2.307   0.701  1.00 91.06           C  \nATOM   2637  C   PHE A 345      23.061   3.380   0.998  1.00 91.06           C  \nATOM   2638  CB  PHE A 345      21.759   2.155  -0.808  1.00 91.06           C  \nATOM   2639  O   PHE A 345      24.067   3.432   0.288  1.00 91.06           O  \nATOM   2640  CG  PHE A 345      20.657   1.188  -1.191  1.00 91.06           C  \nATOM   2641  CD1 PHE A 345      20.572  -0.084  -0.586  1.00 91.06           C  \nATOM   2642  CD2 PHE A 345      19.663   1.601  -2.097  1.00 91.06           C  \nATOM   2643  CE1 PHE A 345      19.459  -0.905  -0.838  1.00 91.06           C  \nATOM   2644  CE2 PHE A 345      18.565   0.770  -2.364  1.00 91.06           C  \nATOM   2645  CZ  PHE A 345      18.456  -0.469  -1.718  1.00 91.06           C  \nATOM   2646  N   LYS A 346      22.870   4.215   2.031  1.00 86.62           N  \nATOM   2647  CA  LYS A 346      23.790   5.303   2.417  1.00 86.62           C  \nATOM   2648  C   LYS A 346      25.255   4.863   2.509  1.00 86.62           C  \nATOM   2649  CB  LYS A 346      23.299   5.908   3.738  1.00 86.62           C  \nATOM   2650  O   LYS A 346      26.120   5.508   1.927  1.00 86.62           O  \nATOM   2651  CG  LYS A 346      24.142   7.106   4.190  1.00 86.62           C  \nATOM   2652  CD  LYS A 346      23.616   7.613   5.532  1.00 86.62           C  \nATOM   2653  CE  LYS A 346      24.508   8.744   6.042  1.00 86.62           C  \nATOM   2654  NZ  LYS A 346      24.123   9.124   7.422  1.00 86.62           N  \nATOM   2655  N   ASP A 347      25.505   3.736   3.172  1.00 87.31           N  \nATOM   2656  CA  ASP A 347      26.855   3.196   3.388  1.00 87.31           C  \nATOM   2657  C   ASP A 347      27.222   2.074   2.387  1.00 87.31           C  \nATOM   2658  CB  ASP A 347      26.996   2.788   4.865  1.00 87.31           C  \nATOM   2659  O   ASP A 347      28.291   1.466   2.470  1.00 87.31           O  \nATOM   2660  CG  ASP A 347      26.620   3.936   5.818  1.00 87.31           C  \nATOM   2661  OD1 ASP A 347      27.175   5.048   5.662  1.00 87.31           O  \nATOM   2662  OD2 ASP A 347      25.730   3.718   6.667  1.00 87.31           O  \nATOM   2663  N   SER A 348      26.359   1.794   1.398  1.00 89.75           N  \nATOM   2664  CA  SER A 348      26.670   0.870   0.299  1.00 89.75           C  \nATOM   2665  C   SER A 348      27.551   1.553  -0.748  1.00 89.75           C  \nATOM   2666  CB  SER A 348      25.398   0.355  -0.388  1.00 89.75           C  \nATOM   2667  O   SER A 348      27.172   2.562  -1.329  1.00 89.75           O  \nATOM   2668  OG  SER A 348      24.742  -0.622   0.398  1.00 89.75           O  \nATOM   2669  N   LEU A 349      28.700   0.958  -1.079  1.00 90.31           N  \nATOM   2670  CA  LEU A 349      29.585   1.483  -2.132  1.00 90.31           C  \nATOM   2671  C   LEU A 349      29.077   1.201  -3.561  1.00 90.31           C  \nATOM   2672  CB  LEU A 349      30.995   0.891  -1.944  1.00 90.31           C  \nATOM   2673  O   LEU A 349      29.419   1.921  -4.497  1.00 90.31           O  \nATOM   2674  CG  LEU A 349      31.694   1.269  -0.623  1.00 90.31           C  \nATOM   2675  CD1 LEU A 349      33.030   0.531  -0.536  1.00 90.31           C  \nATOM   2676  CD2 LEU A 349      31.970   2.770  -0.523  1.00 90.31           C  \nATOM   2677  N   SER A 350      28.307   0.124  -3.741  1.00 95.81           N  \nATOM   2678  CA  SER A 350      27.903  -0.434  -5.038  1.00 95.81           C  \nATOM   2679  C   SER A 350      26.591  -1.209  -4.911  1.00 95.81           C  \nATOM   2680  CB  SER A 350      29.014  -1.372  -5.542  1.00 95.81           C  \nATOM   2681  O   SER A 350      26.293  -1.750  -3.842  1.00 95.81           O  \nATOM   2682  OG  SER A 350      28.785  -1.883  -6.845  1.00 95.81           O  \nATOM   2683  N   ILE A 351      25.870  -1.363  -6.023  1.00 96.50           N  \nATOM   2684  CA  ILE A 351      24.933  -2.481  -6.202  1.00 96.50           C  \nATOM   2685  C   ILE A 351      25.715  -3.790  -5.992  1.00 96.50           C  \nATOM   2686  CB  ILE A 351      24.282  -2.443  -7.604  1.00 96.50           C  \nATOM   2687  O   ILE A 351      26.846  -3.910  -6.476  1.00 96.50           O  \nATOM   2688  CG1 ILE A 351      23.468  -1.149  -7.848  1.00 96.50           C  \nATOM   2689  CG2 ILE A 351      23.347  -3.654  -7.779  1.00 96.50           C  \nATOM   2690  CD1 ILE A 351      23.113  -0.916  -9.327  1.00 96.50           C  \nATOM   2691  N   ASN A 352      25.151  -4.741  -5.248  1.00 95.94           N  \nATOM   2692  CA  ASN A 352      25.770  -6.008  -4.858  1.00 95.94           C  \nATOM   2693  C   ASN A 352      24.711  -7.101  -4.576  1.00 95.94           C  \nATOM   2694  CB  ASN A 352      26.692  -5.735  -3.651  1.00 95.94           C  \nATOM   2695  O   ASN A 352      23.512  -6.827  -4.590  1.00 95.94           O  \nATOM   2696  CG  ASN A 352      25.966  -5.346  -2.365  1.00 95.94           C  \nATOM   2697  ND2 ASN A 352      26.491  -4.411  -1.611  1.00 95.94           N  \nATOM   2698  OD1 ASN A 352      24.946  -5.900  -1.998  1.00 95.94           O  \nATOM   2699  N   ALA A 353      25.147  -8.336  -4.302  1.00 96.12           N  \nATOM   2700  CA  ALA A 353      24.270  -9.497  -4.077  1.00 96.12           C  \nATOM   2701  C   ALA A 353      23.285  -9.357  -2.892  1.00 96.12           C  \nATOM   2702  CB  ALA A 353      25.187 -10.697  -3.828  1.00 96.12           C  \nATOM   2703  O   ALA A 353      22.247 -10.026  -2.853  1.00 96.12           O  \nATOM   2704  N   THR A 354      23.609  -8.499  -1.919  1.00 94.44           N  \nATOM   2705  CA  THR A 354      22.790  -8.242  -0.728  1.00 94.44           C  \nATOM   2706  C   THR A 354      21.698  -7.213  -1.028  1.00 94.44           C  \nATOM   2707  CB  THR A 354      23.674  -7.770   0.444  1.00 94.44           C  \nATOM   2708  O   THR A 354      20.539  -7.424  -0.671  1.00 94.44           O  \nATOM   2709  CG2 THR A 354      22.925  -7.756   1.775  1.00 94.44           C  \nATOM   2710  OG1 THR A 354      24.778  -8.636   0.607  1.00 94.44           O  \nATOM   2711  N   ASN A 355      22.032  -6.112  -1.715  1.00 95.75           N  \nATOM   2712  CA  ASN A 355      21.098  -5.005  -1.942  1.00 95.75           C  \nATOM   2713  C   ASN A 355      20.271  -5.113  -3.243  1.00 95.75           C  \nATOM   2714  CB  ASN A 355      21.802  -3.648  -1.725  1.00 95.75           C  \nATOM   2715  O   ASN A 355      19.138  -4.630  -3.247  1.00 95.75           O  \nATOM   2716  CG  ASN A 355      22.898  -3.294  -2.712  1.00 95.75           C  \nATOM   2717  ND2 ASN A 355      23.819  -2.436  -2.329  1.00 95.75           N  \nATOM   2718  OD1 ASN A 355      22.939  -3.772  -3.833  1.00 95.75           O  \nATOM   2719  N   ILE A 356      20.736  -5.817  -4.289  1.00 96.75           N  \nATOM   2720  CA  ILE A 356      20.077  -5.902  -5.616  1.00 96.75           C  \nATOM   2721  C   ILE A 356      18.581  -6.279  -5.567  1.00 96.75           C  \nATOM   2722  CB  ILE A 356      20.869  -6.859  -6.548  1.00 96.75           C  \nATOM   2723  O   ILE A 356      17.790  -5.817  -6.387  1.00 96.75           O  \nATOM   2724  CG1 ILE A 356      20.343  -6.915  -8.001  1.00 96.75           C  \nATOM   2725  CG2 ILE A 356      20.896  -8.302  -6.010  1.00 96.75           C  \nATOM   2726  CD1 ILE A 356      20.423  -5.603  -8.785  1.00 96.75           C  \nATOM   2727  N   LYS A 357      18.154  -7.069  -4.576  1.00 94.12           N  \nATOM   2728  CA  LYS A 357      16.766  -7.558  -4.444  1.00 94.12           C  \nATOM   2729  C   LYS A 357      15.751  -6.456  -4.124  1.00 94.12           C  \nATOM   2730  CB  LYS A 357      16.742  -8.706  -3.418  1.00 94.12           C  \nATOM   2731  O   LYS A 357      14.606  -6.549  -4.560  1.00 94.12           O  \nATOM   2732  CG  LYS A 357      17.394  -9.932  -4.072  1.00 94.12           C  \nATOM   2733  CD  LYS A 357      17.878 -11.030  -3.120  1.00 94.12           C  \nATOM   2734  CE  LYS A 357      18.533 -12.037  -4.071  1.00 94.12           C  \nATOM   2735  NZ  LYS A 357      19.743 -12.714  -3.566  1.00 94.12           N  \nATOM   2736  N   HIS A 358      16.172  -5.380  -3.463  1.00 94.19           N  \nATOM   2737  CA  HIS A 358      15.327  -4.217  -3.165  1.00 94.19           C  \nATOM   2738  C   HIS A 358      14.947  -3.451  -4.447  1.00 94.19           C  \nATOM   2739  CB  HIS A 358      16.073  -3.319  -2.169  1.00 94.19           C  \nATOM   2740  O   HIS A 358      13.830  -2.935  -4.564  1.00 94.19           O  \nATOM   2741  CG  HIS A 358      16.473  -4.045  -0.907  1.00 94.19           C  \nATOM   2742  CD2 HIS A 358      15.770  -4.127   0.265  1.00 94.19           C  \nATOM   2743  ND1 HIS A 358      17.603  -4.814  -0.755  1.00 94.19           N  \nATOM   2744  CE1 HIS A 358      17.572  -5.371   0.467  1.00 94.19           C  \nATOM   2745  NE2 HIS A 358      16.456  -5.007   1.114  1.00 94.19           N  \nATOM   2746  N   PHE A 359      15.823  -3.496  -5.463  1.00 95.25           N  \nATOM   2747  CA  PHE A 359      15.606  -2.903  -6.786  1.00 95.25           C  \nATOM   2748  C   PHE A 359      14.532  -3.627  -7.625  1.00 95.25           C  \nATOM   2749  CB  PHE A 359      16.936  -2.746  -7.541  1.00 95.25           C  \nATOM   2750  O   PHE A 359      14.231  -3.214  -8.748  1.00 95.25           O  \nATOM   2751  CG  PHE A 359      17.898  -1.783  -6.870  1.00 95.25           C  \nATOM   2752  CD1 PHE A 359      17.862  -0.415  -7.198  1.00 95.25           C  \nATOM   2753  CD2 PHE A 359      18.785  -2.234  -5.874  1.00 95.25           C  \nATOM   2754  CE1 PHE A 359      18.700   0.496  -6.531  1.00 95.25           C  \nATOM   2755  CE2 PHE A 359      19.631  -1.327  -5.212  1.00 95.25           C  \nATOM   2756  CZ  PHE A 359      19.585   0.039  -5.539  1.00 95.25           C  \nATOM   2757  N   LYS A 360      13.904  -4.692  -7.102  1.00 91.94           N  \nATOM   2758  CA  LYS A 360      12.861  -5.432  -7.817  1.00 91.94           C  \nATOM   2759  C   LYS A 360      11.658  -4.544  -8.147  1.00 91.94           C  \nATOM   2760  CB  LYS A 360      12.487  -6.710  -7.044  1.00 91.94           C  \nATOM   2761  O   LYS A 360      11.093  -3.882  -7.274  1.00 91.94           O  \nATOM   2762  CG  LYS A 360      11.584  -7.679  -7.826  1.00 91.94           C  \nATOM   2763  CD  LYS A 360      12.260  -8.229  -9.093  1.00 91.94           C  \nATOM   2764  CE  LYS A 360      11.332  -9.207  -9.816  1.00 91.94           C  \nATOM   2765  NZ  LYS A 360      11.966  -9.727 -11.053  1.00 91.94           N  \nATOM   2766  N   ASN A 361      11.279  -4.565  -9.426  1.00 90.50           N  \nATOM   2767  CA  ASN A 361      10.208  -3.779 -10.044  1.00 90.50           C  \nATOM   2768  C   ASN A 361      10.395  -2.250  -9.951  1.00 90.50           C  \nATOM   2769  CB  ASN A 361       8.823  -4.259  -9.555  1.00 90.50           C  \nATOM   2770  O   ASN A 361       9.452  -1.513 -10.218  1.00 90.50           O  \nATOM   2771  CG  ASN A 361       8.520  -5.737  -9.753  1.00 90.50           C  \nATOM   2772  ND2 ASN A 361       7.373  -6.170  -9.286  1.00 90.50           N  \nATOM   2773  OD1 ASN A 361       9.283  -6.524 -10.302  1.00 90.50           O  \nATOM   2774  N   CYS A 362      11.580  -1.751  -9.583  1.00 93.81           N  \nATOM   2775  CA  CYS A 362      11.848  -0.314  -9.528  1.00 93.81           C  \nATOM   2776  C   CYS A 362      11.873   0.287 -10.936  1.00 93.81           C  \nATOM   2777  CB  CYS A 362      13.168  -0.079  -8.795  1.00 93.81           C  \nATOM   2778  O   CYS A 362      12.574  -0.215 -11.815  1.00 93.81           O  \nATOM   2779  SG  CYS A 362      13.102  -0.614  -7.071  1.00 93.81           S  \nATOM   2780  N   THR A 363      11.124   1.370 -11.141  1.00 93.56           N  \nATOM   2781  CA  THR A 363      11.031   2.073 -12.431  1.00 93.56           C  \nATOM   2782  C   THR A 363      11.771   3.406 -12.434  1.00 93.56           C  \nATOM   2783  CB  THR A 363       9.573   2.307 -12.840  1.00 93.56           C  \nATOM   2784  O   THR A 363      12.199   3.862 -13.491  1.00 93.56           O  \nATOM   2785  CG2 THR A 363       8.787   1.008 -13.008  1.00 93.56           C  \nATOM   2786  OG1 THR A 363       8.931   3.077 -11.849  1.00 93.56           O  \nATOM   2787  N   SER A 364      11.923   4.033 -11.265  1.00 93.56           N  \nATOM   2788  CA  SER A 364      12.639   5.300 -11.091  1.00 93.56           C  \nATOM   2789  C   SER A 364      13.554   5.209  -9.871  1.00 93.56           C  \nATOM   2790  CB  SER A 364      11.637   6.452 -10.966  1.00 93.56           C  \nATOM   2791  O   SER A 364      13.114   4.793  -8.796  1.00 93.56           O  \nATOM   2792  OG  SER A 364      12.291   7.692 -10.816  1.00 93.56           O  \nATOM   2793  N   ILE A 365      14.829   5.554 -10.045  1.00 96.12           N  \nATOM   2794  CA  ILE A 365      15.832   5.552  -8.979  1.00 96.12           C  \nATOM   2795  C   ILE A 365      16.048   6.979  -8.480  1.00 96.12           C  \nATOM   2796  CB  ILE A 365      17.146   4.887  -9.438  1.00 96.12           C  \nATOM   2797  O   ILE A 365      16.597   7.824  -9.189  1.00 96.12           O  \nATOM   2798  CG1 ILE A 365      16.934   3.457  -9.987  1.00 96.12           C  \nATOM   2799  CG2 ILE A 365      18.164   4.878  -8.284  1.00 96.12           C  \nATOM   2800  CD1 ILE A 365      16.204   2.477  -9.056  1.00 96.12           C  \nATOM   2801  N   SER A 366      15.641   7.220  -7.236  1.00 92.06           N  \nATOM   2802  CA  SER A 366      15.880   8.450  -6.487  1.00 92.06           C  \nATOM   2803  C   SER A 366      17.288   8.426  -5.888  1.00 92.06           C  \nATOM   2804  CB  SER A 366      14.795   8.627  -5.422  1.00 92.06           C  \nATOM   2805  O   SER A 366      17.484   8.092  -4.719  1.00 92.06           O  \nATOM   2806  OG  SER A 366      15.008   9.837  -4.726  1.00 92.06           O  \nATOM   2807  N   GLY A 367      18.278   8.735  -6.723  1.00 90.56           N  \nATOM   2808  CA  GLY A 367      19.697   8.780  -6.372  1.00 90.56           C  \nATOM   2809  C   GLY A 367      20.594   8.290  -7.504  1.00 90.56           C  \nATOM   2810  O   GLY A 367      20.212   8.340  -8.676  1.00 90.56           O  \nATOM   2811  N   ASP A 368      21.779   7.818  -7.129  1.00 94.44           N  \nATOM   2812  CA  ASP A 368      22.827   7.350  -8.037  1.00 94.44           C  \nATOM   2813  C   ASP A 368      22.818   5.817  -8.177  1.00 94.44           C  \nATOM   2814  CB  ASP A 368      24.182   7.875  -7.524  1.00 94.44           C  \nATOM   2815  O   ASP A 368      22.329   5.102  -7.301  1.00 94.44           O  \nATOM   2816  CG  ASP A 368      24.181   9.402  -7.379  1.00 94.44           C  \nATOM   2817  OD1 ASP A 368      23.704  10.076  -8.319  1.00 94.44           O  \nATOM   2818  OD2 ASP A 368      24.601   9.942  -6.336  1.00 94.44           O  \nATOM   2819  N   LEU A 369      23.386   5.281  -9.261  1.00 97.50           N  \nATOM   2820  CA  LEU A 369      23.664   3.845  -9.400  1.00 97.50           C  \nATOM   2821  C   LEU A 369      25.158   3.607  -9.624  1.00 97.50           C  \nATOM   2822  CB  LEU A 369      22.836   3.213 -10.533  1.00 97.50           C  \nATOM   2823  O   LEU A 369      25.724   4.026 -10.634  1.00 97.50           O  \nATOM   2824  CG  LEU A 369      21.321   3.065 -10.294  1.00 97.50           C  \nATOM   2825  CD1 LEU A 369      20.753   2.205 -11.427  1.00 97.50           C  \nATOM   2826  CD2 LEU A 369      20.964   2.371  -8.976  1.00 97.50           C  \nATOM   2827  N   HIS A 370      25.787   2.879  -8.700  1.00 96.56           N  \nATOM   2828  CA  HIS A 370      27.189   2.470  -8.785  1.00 96.56           C  \nATOM   2829  C   HIS A 370      27.298   0.964  -9.044  1.00 96.56           C  \nATOM   2830  CB  HIS A 370      27.925   2.806  -7.482  1.00 96.56           C  \nATOM   2831  O   HIS A 370      26.741   0.163  -8.292  1.00 96.56           O  \nATOM   2832  CG  HIS A 370      27.897   4.234  -7.016  1.00 96.56           C  \nATOM   2833  CD2 HIS A 370      27.532   5.352  -7.717  1.00 96.56           C  \nATOM   2834  ND1 HIS A 370      28.214   4.636  -5.739  1.00 96.56           N  \nATOM   2835  CE1 HIS A 370      28.020   5.962  -5.661  1.00 96.56           C  \nATOM   2836  NE2 HIS A 370      27.635   6.439  -6.852  1.00 96.56           N  \nATOM   2837  N   ILE A 371      28.066   0.575 -10.061  1.00 97.31           N  \nATOM   2838  CA  ILE A 371      28.406  -0.819 -10.365  1.00 97.31           C  \nATOM   2839  C   ILE A 371      29.930  -0.922 -10.455  1.00 97.31           C  \nATOM   2840  CB  ILE A 371      27.659  -1.313 -11.625  1.00 97.31           C  \nATOM   2841  O   ILE A 371      30.554  -0.551 -11.455  1.00 97.31           O  \nATOM   2842  CG1 ILE A 371      26.134  -1.167 -11.406  1.00 97.31           C  \nATOM   2843  CG2 ILE A 371      28.038  -2.778 -11.912  1.00 97.31           C  \nATOM   2844  CD1 ILE A 371      25.253  -1.692 -12.539  1.00 97.31           C  \nATOM   2845  N   LEU A 372      30.535  -1.370  -9.354  1.00 95.62           N  \nATOM   2846  CA  LEU A 372      31.980  -1.329  -9.126  1.00 95.62           C  \nATOM   2847  C   LEU A 372      32.613  -2.735  -9.143  1.00 95.62           C  \nATOM   2848  CB  LEU A 372      32.253  -0.612  -7.789  1.00 95.62           C  \nATOM   2849  O   LEU A 372      31.934  -3.716  -8.834  1.00 95.62           O  \nATOM   2850  CG  LEU A 372      31.675   0.810  -7.649  1.00 95.62           C  \nATOM   2851  CD1 LEU A 372      32.116   1.394  -6.308  1.00 95.62           C  \nATOM   2852  CD2 LEU A 372      32.144   1.755  -8.757  1.00 95.62           C  \nATOM   2853  N   PRO A 373      33.937  -2.865  -9.387  1.00 95.56           N  \nATOM   2854  CA  PRO A 373      34.655  -4.148  -9.371  1.00 95.56           C  \nATOM   2855  C   PRO A 373      34.594  -4.959  -8.068  1.00 95.56           C  \nATOM   2856  CB  PRO A 373      36.114  -3.799  -9.686  1.00 95.56           C  \nATOM   2857  O   PRO A 373      35.144  -6.057  -8.026  1.00 95.56           O  \nATOM   2858  CG  PRO A 373      36.043  -2.493 -10.467  1.00 95.56           C  \nATOM   2859  CD  PRO A 373      34.816  -1.806  -9.874  1.00 95.56           C  \nATOM   2860  N   VAL A 374      34.016  -4.424  -6.990  1.00 93.50           N  \nATOM   2861  CA  VAL A 374      33.766  -5.160  -5.741  1.00 93.50           C  \nATOM   2862  C   VAL A 374      32.497  -6.019  -5.833  1.00 93.50           C  \nATOM   2863  CB  VAL A 374      33.766  -4.192  -4.540  1.00 93.50           C  \nATOM   2864  O   VAL A 374      32.487  -7.133  -5.328  1.00 93.50           O  \nATOM   2865  CG1 VAL A 374      32.583  -3.215  -4.529  1.00 93.50           C  \nATOM   2866  CG2 VAL A 374      33.802  -4.948  -3.217  1.00 93.50           C  \nATOM   2867  N   ALA A 375      31.470  -5.584  -6.576  1.00 94.81           N  \nATOM   2868  CA  ALA A 375      30.196  -6.300  -6.697  1.00 94.81           C  \nATOM   2869  C   ALA A 375      30.373  -7.741  -7.203  1.00 94.81           C  \nATOM   2870  CB  ALA A 375      29.296  -5.500  -7.645  1.00 94.81           C  \nATOM   2871  O   ALA A 375      29.866  -8.684  -6.607  1.00 94.81           O  \nATOM   2872  N   PHE A 376      31.157  -7.917  -8.269  1.00 96.38           N  \nATOM   2873  CA  PHE A 376      31.401  -9.217  -8.907  1.00 96.38           C  \nATOM   2874  C   PHE A 376      32.528 -10.035  -8.255  1.00 96.38           C  \nATOM   2875  CB  PHE A 376      31.679  -8.991 -10.399  1.00 96.38           C  \nATOM   2876  O   PHE A 376      32.746 -11.181  -8.636  1.00 96.38           O  \nATOM   2877  CG  PHE A 376      30.613  -8.167 -11.094  1.00 96.38           C  \nATOM   2878  CD1 PHE A 376      29.335  -8.716 -11.312  1.00 96.38           C  \nATOM   2879  CD2 PHE A 376      30.876  -6.835 -11.464  1.00 96.38           C  \nATOM   2880  CE1 PHE A 376      28.326  -7.933 -11.899  1.00 96.38           C  \nATOM   2881  CE2 PHE A 376      29.868  -6.055 -12.057  1.00 96.38           C  \nATOM   2882  CZ  PHE A 376      28.592  -6.602 -12.271  1.00 96.38           C  \nATOM   2883  N   ARG A 377      33.260  -9.462  -7.289  1.00 94.56           N  \nATOM   2884  CA  ARG A 377      34.286 -10.173  -6.501  1.00 94.56           C  \nATOM   2885  C   ARG A 377      33.816 -10.531  -5.089  1.00 94.56           C  \nATOM   2886  CB  ARG A 377      35.594  -9.366  -6.473  1.00 94.56           C  \nATOM   2887  O   ARG A 377      34.456 -11.359  -4.448  1.00 94.56           O  \nATOM   2888  CG  ARG A 377      36.312  -9.433  -7.831  1.00 94.56           C  \nATOM   2889  CD  ARG A 377      37.706  -8.795  -7.785  1.00 94.56           C  \nATOM   2890  NE  ARG A 377      37.625  -7.330  -7.667  1.00 94.56           N  \nATOM   2891  NH1 ARG A 377      39.839  -6.886  -7.253  1.00 94.56           N  \nATOM   2892  NH2 ARG A 377      38.360  -5.215  -7.342  1.00 94.56           N  \nATOM   2893  CZ  ARG A 377      38.609  -6.489  -7.424  1.00 94.56           C  \nATOM   2894  N   GLY A 378      32.710  -9.941  -4.636  1.00 92.56           N  \nATOM   2895  CA  GLY A 378      32.315  -9.934  -3.233  1.00 92.56           C  \nATOM   2896  C   GLY A 378      33.182  -8.986  -2.398  1.00 92.56           C  \nATOM   2897  O   GLY A 378      34.199  -8.458  -2.857  1.00 92.56           O  \nATOM   2898  N   ASP A 379      32.770  -8.787  -1.152  1.00 93.38           N  \nATOM   2899  CA  ASP A 379      33.528  -8.069  -0.132  1.00 93.38           C  \nATOM   2900  C   ASP A 379      33.484  -8.825   1.199  1.00 93.38           C  \nATOM   2901  CB  ASP A 379      33.002  -6.640   0.033  1.00 93.38           C  \nATOM   2902  O   ASP A 379      32.445  -8.918   1.854  1.00 93.38           O  \nATOM   2903  CG  ASP A 379      33.654  -5.951   1.232  1.00 93.38           C  \nATOM   2904  OD1 ASP A 379      34.839  -6.240   1.515  1.00 93.38           O  \nATOM   2905  OD2 ASP A 379      32.936  -5.199   1.922  1.00 93.38           O  \nATOM   2906  N   SER A 380      34.644  -9.327   1.620  1.00 91.50           N  \nATOM   2907  CA  SER A 380      34.812 -10.029   2.892  1.00 91.50           C  \nATOM   2908  C   SER A 380      34.626  -9.130   4.118  1.00 91.50           C  \nATOM   2909  CB  SER A 380      36.205 -10.662   2.968  1.00 91.50           C  \nATOM   2910  O   SER A 380      34.398  -9.658   5.201  1.00 91.50           O  \nATOM   2911  OG  SER A 380      36.504 -11.404   1.797  1.00 91.50           O  \nATOM   2912  N   PHE A 381      34.731  -7.800   3.989  1.00 90.81           N  \nATOM   2913  CA  PHE A 381      34.553  -6.877   5.114  1.00 90.81           C  \nATOM   2914  C   PHE A 381      33.067  -6.713   5.464  1.00 90.81           C  \nATOM   2915  CB  PHE A 381      35.246  -5.546   4.790  1.00 90.81           C  \nATOM   2916  O   PHE A 381      32.655  -6.996   6.589  1.00 90.81           O  \nATOM   2917  CG  PHE A 381      35.226  -4.547   5.928  1.00 90.81           C  \nATOM   2918  CD1 PHE A 381      34.274  -3.511   5.941  1.00 90.81           C  \nATOM   2919  CD2 PHE A 381      36.148  -4.662   6.985  1.00 90.81           C  \nATOM   2920  CE1 PHE A 381      34.240  -2.596   7.009  1.00 90.81           C  \nATOM   2921  CE2 PHE A 381      36.117  -3.746   8.052  1.00 90.81           C  \nATOM   2922  CZ  PHE A 381      35.162  -2.714   8.065  1.00 90.81           C  \nATOM   2923  N   THR A 382      32.231  -6.369   4.481  1.00 89.00           N  \nATOM   2924  CA  THR A 382      30.762  -6.313   4.638  1.00 89.00           C  \nATOM   2925  C   THR A 382      30.071  -7.683   4.590  1.00 89.00           C  \nATOM   2926  CB  THR A 382      30.107  -5.366   3.619  1.00 89.00           C  \nATOM   2927  O   THR A 382      28.846  -7.744   4.644  1.00 89.00           O  \nATOM   2928  CG2 THR A 382      30.550  -3.914   3.798  1.00 89.00           C  \nATOM   2929  OG1 THR A 382      30.409  -5.760   2.300  1.00 89.00           O  \nATOM   2930  N   HIS A 383      30.828  -8.785   4.495  1.00 93.00           N  \nATOM   2931  CA  HIS A 383      30.315 -10.156   4.328  1.00 93.00           C  \nATOM   2932  C   HIS A 383      29.401 -10.326   3.092  1.00 93.00           C  \nATOM   2933  CB  HIS A 383      29.701 -10.671   5.644  1.00 93.00           C  \nATOM   2934  O   HIS A 383      28.537 -11.202   3.043  1.00 93.00           O  \nATOM   2935  CG  HIS A 383      30.682 -10.760   6.789  1.00 93.00           C  \nATOM   2936  CD2 HIS A 383      31.108 -11.911   7.397  1.00 93.00           C  \nATOM   2937  ND1 HIS A 383      31.323  -9.715   7.420  1.00 93.00           N  \nATOM   2938  CE1 HIS A 383      32.113 -10.229   8.375  1.00 93.00           C  \nATOM   2939  NE2 HIS A 383      32.016 -11.568   8.403  1.00 93.00           N  \nATOM   2940  N   THR A 384      29.609  -9.495   2.068  1.00 93.38           N  \nATOM   2941  CA  THR A 384      28.802  -9.450   0.846  1.00 93.38           C  \nATOM   2942  C   THR A 384      29.316 -10.480  -0.170  1.00 93.38           C  \nATOM   2943  CB  THR A 384      28.843  -8.039   0.247  1.00 93.38           C  \nATOM   2944  O   THR A 384      30.465 -10.367  -0.610  1.00 93.38           O  \nATOM   2945  CG2 THR A 384      28.079  -7.913  -1.065  1.00 93.38           C  \nATOM   2946  OG1 THR A 384      28.234  -7.118   1.120  1.00 93.38           O  \nATOM   2947  N   PRO A 385      28.509 -11.469  -0.599  1.00 96.44           N  \nATOM   2948  CA  PRO A 385      28.937 -12.438  -1.606  1.00 96.44           C  \nATOM   2949  C   PRO A 385      29.021 -11.814  -3.017  1.00 96.44           C  \nATOM   2950  CB  PRO A 385      27.926 -13.586  -1.517  1.00 96.44           C  \nATOM   2951  O   PRO A 385      28.452 -10.744  -3.257  1.00 96.44           O  \nATOM   2952  CG  PRO A 385      26.651 -12.910  -1.018  1.00 96.44           C  \nATOM   2953  CD  PRO A 385      27.155 -11.760  -0.146  1.00 96.44           C  \nATOM   2954  N   PRO A 386      29.710 -12.466  -3.974  1.00 96.69           N  \nATOM   2955  CA  PRO A 386      29.730 -12.034  -5.370  1.00 96.69           C  \nATOM   2956  C   PRO A 386      28.322 -11.962  -5.982  1.00 96.69           C  \nATOM   2957  CB  PRO A 386      30.610 -13.049  -6.112  1.00 96.69           C  \nATOM   2958  O   PRO A 386      27.525 -12.886  -5.827  1.00 96.69           O  \nATOM   2959  CG  PRO A 386      31.483 -13.649  -5.012  1.00 96.69           C  \nATOM   2960  CD  PRO A 386      30.559 -13.635  -3.797  1.00 96.69           C  \nATOM   2961  N   LEU A 387      28.034 -10.876  -6.702  1.00 96.69           N  \nATOM   2962  CA  LEU A 387      26.791 -10.668  -7.450  1.00 96.69           C  \nATOM   2963  C   LEU A 387      26.704 -11.607  -8.663  1.00 96.69           C  \nATOM   2964  CB  LEU A 387      26.731  -9.182  -7.861  1.00 96.69           C  \nATOM   2965  O   LEU A 387      27.608 -11.615  -9.502  1.00 96.69           O  \nATOM   2966  CG  LEU A 387      25.513  -8.780  -8.715  1.00 96.69           C  \nATOM   2967  CD1 LEU A 387      24.187  -8.954  -7.979  1.00 96.69           C  \nATOM   2968  CD2 LEU A 387      25.636  -7.304  -9.102  1.00 96.69           C  \nATOM   2969  N   ASP A 388      25.592 -12.335  -8.789  1.00 96.31           N  \nATOM   2970  CA  ASP A 388      25.289 -13.142  -9.976  1.00 96.31           C  \nATOM   2971  C   ASP A 388      25.012 -12.222 -11.189  1.00 96.31           C  \nATOM   2972  CB  ASP A 388      24.102 -14.084  -9.684  1.00 96.31           C  \nATOM   2973  O   ASP A 388      24.126 -11.363 -11.119  1.00 96.31           O  \nATOM   2974  CG  ASP A 388      23.793 -15.093 -10.808  1.00 96.31           C  \nATOM   2975  OD1 ASP A 388      24.158 -14.834 -11.978  1.00 96.31           O  \nATOM   2976  OD2 ASP A 388      23.167 -16.130 -10.511  1.00 96.31           O  \nATOM   2977  N   PRO A 389      25.708 -12.396 -12.333  1.00 94.94           N  \nATOM   2978  CA  PRO A 389      25.402 -11.720 -13.598  1.00 94.94           C  \nATOM   2979  C   PRO A 389      23.955 -11.844 -14.113  1.00 94.94           C  \nATOM   2980  CB  PRO A 389      26.366 -12.346 -14.611  1.00 94.94           C  \nATOM   2981  O   PRO A 389      23.600 -11.121 -15.048  1.00 94.94           O  \nATOM   2982  CG  PRO A 389      27.577 -12.714 -13.760  1.00 94.94           C  \nATOM   2983  CD  PRO A 389      26.912 -13.203 -12.479  1.00 94.94           C  \nATOM   2984  N   GLN A 390      23.137 -12.751 -13.570  1.00 94.62           N  \nATOM   2985  CA  GLN A 390      21.697 -12.857 -13.838  1.00 94.62           C  \nATOM   2986  C   GLN A 390      20.852 -11.921 -12.960  1.00 94.62           C  \nATOM   2987  CB  GLN A 390      21.230 -14.308 -13.641  1.00 94.62           C  \nATOM   2988  O   GLN A 390      19.826 -11.428 -13.421  1.00 94.62           O  \nATOM   2989  CG  GLN A 390      21.902 -15.276 -14.623  1.00 94.62           C  \nATOM   2990  CD  GLN A 390      21.369 -16.698 -14.484  1.00 94.62           C  \nATOM   2991  NE2 GLN A 390      22.222 -17.663 -14.233  1.00 94.62           N  \nATOM   2992  OE1 GLN A 390      20.190 -16.978 -14.619  1.00 94.62           O  \nATOM   2993  N   GLU A 391      21.272 -11.597 -11.731  1.00 96.38           N  \nATOM   2994  CA  GLU A 391      20.516 -10.670 -10.869  1.00 96.38           C  \nATOM   2995  C   GLU A 391      20.527  -9.229 -11.420  1.00 96.38           C  \nATOM   2996  CB  GLU A 391      20.987 -10.745  -9.400  1.00 96.38           C  \nATOM   2997  O   GLU A 391      19.629  -8.451 -11.112  1.00 96.38           O  \nATOM   2998  CG  GLU A 391      20.530 -12.037  -8.693  1.00 96.38           C  \nATOM   2999  CD  GLU A 391      20.846 -12.068  -7.181  1.00 96.38           C  \nATOM   3000  OE1 GLU A 391      20.020 -12.613  -6.405  1.00 96.38           O  \nATOM   3001  OE2 GLU A 391      21.901 -11.547  -6.760  1.00 96.38           O  \nATOM   3002  N   LEU A 392      21.453  -8.886 -12.327  1.00 97.12           N  \nATOM   3003  CA  LEU A 392      21.423  -7.623 -13.081  1.00 97.12           C  \nATOM   3004  C   LEU A 392      20.171  -7.462 -13.963  1.00 97.12           C  \nATOM   3005  CB  LEU A 392      22.680  -7.507 -13.960  1.00 97.12           C  \nATOM   3006  O   LEU A 392      19.727  -6.331 -14.161  1.00 97.12           O  \nATOM   3007  CG  LEU A 392      24.001  -7.301 -13.200  1.00 97.12           C  \nATOM   3008  CD1 LEU A 392      25.145  -7.328 -14.214  1.00 97.12           C  \nATOM   3009  CD2 LEU A 392      24.055  -5.961 -12.459  1.00 97.12           C  \nATOM   3010  N   ASP A 393      19.550  -8.550 -14.442  1.00 96.06           N  \nATOM   3011  CA  ASP A 393      18.294  -8.478 -15.209  1.00 96.06           C  \nATOM   3012  C   ASP A 393      17.123  -7.904 -14.368  1.00 96.06           C  \nATOM   3013  CB  ASP A 393      17.946  -9.852 -15.830  1.00 96.06           C  \nATOM   3014  O   ASP A 393      16.098  -7.516 -14.929  1.00 96.06           O  \nATOM   3015  CG  ASP A 393      18.732 -10.186 -17.114  1.00 96.06           C  \nATOM   3016  OD1 ASP A 393      18.391  -9.615 -18.178  1.00 96.06           O  \nATOM   3017  OD2 ASP A 393      19.643 -11.046 -17.099  1.00 96.06           O  \nATOM   3018  N   ILE A 394      17.274  -7.762 -13.038  1.00 96.44           N  \nATOM   3019  CA  ILE A 394      16.330  -7.033 -12.169  1.00 96.44           C  \nATOM   3020  C   ILE A 394      16.221  -5.551 -12.559  1.00 96.44           C  \nATOM   3021  CB  ILE A 394      16.725  -7.202 -10.675  1.00 96.44           C  \nATOM   3022  O   ILE A 394      15.126  -4.993 -12.499  1.00 96.44           O  \nATOM   3023  CG1 ILE A 394      16.473  -8.670 -10.250  1.00 96.44           C  \nATOM   3024  CG2 ILE A 394      15.940  -6.245  -9.762  1.00 96.44           C  \nATOM   3025  CD1 ILE A 394      17.013  -9.066  -8.868  1.00 96.44           C  \nATOM   3026  N   LEU A 395      17.317  -4.920 -12.995  1.00 97.62           N  \nATOM   3027  CA  LEU A 395      17.349  -3.482 -13.297  1.00 97.62           C  \nATOM   3028  C   LEU A 395      16.617  -3.120 -14.600  1.00 97.62           C  \nATOM   3029  CB  LEU A 395      18.803  -2.975 -13.306  1.00 97.62           C  \nATOM   3030  O   LEU A 395      16.368  -1.943 -14.843  1.00 97.62           O  \nATOM   3031  CG  LEU A 395      19.593  -3.215 -12.004  1.00 97.62           C  \nATOM   3032  CD1 LEU A 395      21.046  -2.779 -12.185  1.00 97.62           C  \nATOM   3033  CD2 LEU A 395      19.006  -2.444 -10.819  1.00 97.62           C  \nATOM   3034  N   LYS A 396      16.180  -4.108 -15.396  1.00 96.44           N  \nATOM   3035  CA  LYS A 396      15.457  -3.887 -16.661  1.00 96.44           C  \nATOM   3036  C   LYS A 396      14.136  -3.138 -16.523  1.00 96.44           C  \nATOM   3037  CB  LYS A 396      15.215  -5.226 -17.364  1.00 96.44           C  \nATOM   3038  O   LYS A 396      13.622  -2.667 -17.534  1.00 96.44           O  \nATOM   3039  CG  LYS A 396      16.500  -5.715 -18.027  1.00 96.44           C  \nATOM   3040  CD  LYS A 396      16.245  -7.030 -18.755  1.00 96.44           C  \nATOM   3041  CE  LYS A 396      17.386  -7.245 -19.741  1.00 96.44           C  \nATOM   3042  NZ  LYS A 396      17.259  -8.561 -20.386  1.00 96.44           N  \nATOM   3043  N   THR A 397      13.570  -3.024 -15.321  1.00 94.88           N  \nATOM   3044  CA  THR A 397      12.381  -2.189 -15.089  1.00 94.88           C  \nATOM   3045  C   THR A 397      12.704  -0.698 -14.959  1.00 94.88           C  \nATOM   3046  CB  THR A 397      11.567  -2.682 -13.881  1.00 94.88           C  \nATOM   3047  O   THR A 397      11.788   0.113 -15.076  1.00 94.88           O  \nATOM   3048  CG2 THR A 397      11.024  -4.092 -14.128  1.00 94.88           C  \nATOM   3049  OG1 THR A 397      12.345  -2.759 -12.709  1.00 94.88           O  \nATOM   3050  N   VAL A 398      13.973  -0.319 -14.751  1.00 96.88           N  \nATOM   3051  CA  VAL A 398      14.396   1.072 -14.543  1.00 96.88           C  \nATOM   3052  C   VAL A 398      14.309   1.867 -15.847  1.00 96.88           C  \nATOM   3053  CB  VAL A 398      15.814   1.158 -13.934  1.00 96.88           C  \nATOM   3054  O   VAL A 398      15.014   1.583 -16.815  1.00 96.88           O  \nATOM   3055  CG1 VAL A 398      16.243   2.617 -13.718  1.00 96.88           C  \nATOM   3056  CG2 VAL A 398      15.878   0.464 -12.564  1.00 96.88           C  \nATOM   3057  N   LYS A 399      13.466   2.903 -15.830  1.00 95.94           N  \nATOM   3058  CA  LYS A 399      13.285   3.902 -16.893  1.00 95.94           C  \nATOM   3059  C   LYS A 399      13.926   5.253 -16.568  1.00 95.94           C  \nATOM   3060  CB  LYS A 399      11.784   4.105 -17.141  1.00 95.94           C  \nATOM   3061  O   LYS A 399      14.246   6.007 -17.480  1.00 95.94           O  \nATOM   3062  CG  LYS A 399      11.101   2.920 -17.841  1.00 95.94           C  \nATOM   3063  CD  LYS A 399       9.625   3.269 -18.081  1.00 95.94           C  \nATOM   3064  CE  LYS A 399       8.996   2.394 -19.172  1.00 95.94           C  \nATOM   3065  NZ  LYS A 399       8.197   3.226 -20.105  1.00 95.94           N  \nATOM   3066  N   GLU A 400      14.113   5.577 -15.292  1.00 95.69           N  \nATOM   3067  CA  GLU A 400      14.610   6.883 -14.841  1.00 95.69           C  \nATOM   3068  C   GLU A 400      15.666   6.725 -13.737  1.00 95.69           C  \nATOM   3069  CB  GLU A 400      13.407   7.727 -14.373  1.00 95.69           C  \nATOM   3070  O   GLU A 400      15.487   5.942 -12.803  1.00 95.69           O  \nATOM   3071  CG  GLU A 400      13.764   9.144 -13.888  1.00 95.69           C  \nATOM   3072  CD  GLU A 400      12.529   9.928 -13.406  1.00 95.69           C  \nATOM   3073  OE1 GLU A 400      12.486  11.165 -13.625  1.00 95.69           O  \nATOM   3074  OE2 GLU A 400      11.635   9.319 -12.773  1.00 95.69           O  \nATOM   3075  N   ILE A 401      16.745   7.505 -13.816  1.00 96.81           N  \nATOM   3076  CA  ILE A 401      17.723   7.700 -12.734  1.00 96.81           C  \nATOM   3077  C   ILE A 401      17.806   9.204 -12.459  1.00 96.81           C  \nATOM   3078  CB  ILE A 401      19.096   7.089 -13.114  1.00 96.81           C  \nATOM   3079  O   ILE A 401      18.098   9.984 -13.367  1.00 96.81           O  \nATOM   3080  CG1 ILE A 401      18.990   5.559 -13.326  1.00 96.81           C  \nATOM   3081  CG2 ILE A 401      20.154   7.403 -12.037  1.00 96.81           C  \nATOM   3082  CD1 ILE A 401      20.241   4.932 -13.957  1.00 96.81           C  \nATOM   3083  N   THR A 402      17.535   9.652 -11.229  1.00 90.38           N  \nATOM   3084  CA  THR A 402      17.548  11.095 -10.916  1.00 90.38           C  \nATOM   3085  C   THR A 402      18.956  11.656 -10.708  1.00 90.38           C  \nATOM   3086  CB  THR A 402      16.687  11.452  -9.699  1.00 90.38           C  \nATOM   3087  O   THR A 402      19.167  12.858 -10.873  1.00 90.38           O  \nATOM   3088  CG2 THR A 402      15.231  11.009  -9.847  1.00 90.38           C  \nATOM   3089  OG1 THR A 402      17.202  10.899  -8.513  1.00 90.38           O  \nATOM   3090  N   GLY A 403      19.895  10.804 -10.304  1.00 90.88           N  \nATOM   3091  CA  GLY A 403      21.307  11.118 -10.131  1.00 90.88           C  \nATOM   3092  C   GLY A 403      22.153  10.715 -11.338  1.00 90.88           C  \nATOM   3093  O   GLY A 403      21.759  10.973 -12.479  1.00 90.88           O  \nATOM   3094  N   PHE A 404      23.295  10.075 -11.088  1.00 94.75           N  \nATOM   3095  CA  PHE A 404      24.221   9.577 -12.109  1.00 94.75           C  \nATOM   3096  C   PHE A 404      24.303   8.044 -12.186  1.00 94.75           C  \nATOM   3097  CB  PHE A 404      25.606  10.217 -11.919  1.00 94.75           C  \nATOM   3098  O   PHE A 404      24.014   7.324 -11.230  1.00 94.75           O  \nATOM   3099  CG  PHE A 404      26.385   9.826 -10.680  1.00 94.75           C  \nATOM   3100  CD1 PHE A 404      26.311  10.628  -9.531  1.00 94.75           C  \nATOM   3101  CD2 PHE A 404      27.212   8.688 -10.678  1.00 94.75           C  \nATOM   3102  CE1 PHE A 404      27.073  10.324  -8.393  1.00 94.75           C  \nATOM   3103  CE2 PHE A 404      27.963   8.371  -9.531  1.00 94.75           C  \nATOM   3104  CZ  PHE A 404      27.907   9.198  -8.397  1.00 94.75           C  \nATOM   3105  N   LEU A 405      24.752   7.543 -13.341  1.00 97.88           N  \nATOM   3106  CA  LEU A 405      25.041   6.128 -13.587  1.00 97.88           C  \nATOM   3107  C   LEU A 405      26.553   5.913 -13.759  1.00 97.88           C  \nATOM   3108  CB  LEU A 405      24.214   5.661 -14.801  1.00 97.88           C  \nATOM   3109  O   LEU A 405      27.163   6.418 -14.706  1.00 97.88           O  \nATOM   3110  CG  LEU A 405      24.450   4.198 -15.229  1.00 97.88           C  \nATOM   3111  CD1 LEU A 405      24.166   3.189 -14.115  1.00 97.88           C  \nATOM   3112  CD2 LEU A 405      23.538   3.855 -16.408  1.00 97.88           C  \nATOM   3113  N   LEU A 406      27.154   5.142 -12.851  1.00 97.19           N  \nATOM   3114  CA  LEU A 406      28.584   4.832 -12.809  1.00 97.19           C  \nATOM   3115  C   LEU A 406      28.823   3.325 -12.942  1.00 97.19           C  \nATOM   3116  CB  LEU A 406      29.161   5.393 -11.496  1.00 97.19           C  \nATOM   3117  O   LEU A 406      28.544   2.558 -12.022  1.00 97.19           O  \nATOM   3118  CG  LEU A 406      30.631   5.028 -11.218  1.00 97.19           C  \nATOM   3119  CD1 LEU A 406      31.568   5.628 -12.269  1.00 97.19           C  \nATOM   3120  CD2 LEU A 406      31.046   5.555  -9.847  1.00 97.19           C  \nATOM   3121  N   ILE A 407      29.420   2.910 -14.059  1.00 97.81           N  \nATOM   3122  CA  ILE A 407      29.764   1.516 -14.350  1.00 97.81           C  \nATOM   3123  C   ILE A 407      31.282   1.410 -14.551  1.00 97.81           C  \nATOM   3124  CB  ILE A 407      28.950   0.977 -15.552  1.00 97.81           C  \nATOM   3125  O   ILE A 407      31.832   1.866 -15.556  1.00 97.81           O  \nATOM   3126  CG1 ILE A 407      27.439   1.298 -15.415  1.00 97.81           C  \nATOM   3127  CG2 ILE A 407      29.167  -0.543 -15.660  1.00 97.81           C  \nATOM   3128  CD1 ILE A 407      26.577   0.779 -16.570  1.00 97.81           C  \nATOM   3129  N   GLN A 408      31.956   0.810 -13.567  1.00 95.56           N  \nATOM   3130  CA  GLN A 408      33.401   0.523 -13.565  1.00 95.56           C  \nATOM   3131  C   GLN A 408      33.714  -0.982 -13.624  1.00 95.56           C  \nATOM   3132  CB  GLN A 408      34.054   1.137 -12.318  1.00 95.56           C  \nATOM   3133  O   GLN A 408      34.879  -1.373 -13.677  1.00 95.56           O  \nATOM   3134  CG  GLN A 408      34.011   2.670 -12.277  1.00 95.56           C  \nATOM   3135  CD  GLN A 408      34.816   3.235 -11.107  1.00 95.56           C  \nATOM   3136  NE2 GLN A 408      34.952   4.539 -11.007  1.00 95.56           N  \nATOM   3137  OE1 GLN A 408      35.356   2.539 -10.265  1.00 95.56           O  \nATOM   3138  N   ALA A 409      32.690  -1.836 -13.583  1.00 95.75           N  \nATOM   3139  CA  ALA A 409      32.796  -3.262 -13.865  1.00 95.75           C  \nATOM   3140  C   ALA A 409      31.515  -3.776 -14.521  1.00 95.75           C  \nATOM   3141  CB  ALA A 409      33.079  -4.026 -12.573  1.00 95.75           C  \nATOM   3142  O   ALA A 409      30.432  -3.239 -14.298  1.00 95.75           O  \nATOM   3143  N   TRP A 410      31.645  -4.842 -15.306  1.00 97.44           N  \nATOM   3144  CA  TRP A 410      30.536  -5.527 -15.960  1.00 97.44           C  \nATOM   3145  C   TRP A 410      30.911  -6.997 -16.193  1.00 97.44           C  \nATOM   3146  CB  TRP A 410      30.229  -4.825 -17.288  1.00 97.44           C  \nATOM   3147  O   TRP A 410      32.103  -7.268 -16.372  1.00 97.44           O  \nATOM   3148  CG  TRP A 410      28.856  -5.071 -17.806  1.00 97.44           C  \nATOM   3149  CD1 TRP A 410      28.523  -5.735 -18.935  1.00 97.44           C  \nATOM   3150  CD2 TRP A 410      27.601  -4.635 -17.206  1.00 97.44           C  \nATOM   3151  CE2 TRP A 410      26.528  -5.080 -18.031  1.00 97.44           C  \nATOM   3152  CE3 TRP A 410      27.271  -3.903 -16.047  1.00 97.44           C  \nATOM   3153  NE1 TRP A 410      27.151  -5.709 -19.085  1.00 97.44           N  \nATOM   3154  CH2 TRP A 410      24.893  -4.094 -16.552  1.00 97.44           C  \nATOM   3155  CZ2 TRP A 410      25.186  -4.816 -17.720  1.00 97.44           C  \nATOM   3156  CZ3 TRP A 410      25.930  -3.639 -15.724  1.00 97.44           C  \nATOM   3157  N   PRO A 411      29.960  -7.949 -16.212  1.00 95.88           N  \nATOM   3158  CA  PRO A 411      30.266  -9.346 -16.509  1.00 95.88           C  \nATOM   3159  C   PRO A 411      30.886  -9.496 -17.905  1.00 95.88           C  \nATOM   3160  CB  PRO A 411      28.935 -10.096 -16.383  1.00 95.88           C  \nATOM   3161  O   PRO A 411      30.294  -9.079 -18.899  1.00 95.88           O  \nATOM   3162  CG  PRO A 411      28.104  -9.204 -15.464  1.00 95.88           C  \nATOM   3163  CD  PRO A 411      28.554  -7.805 -15.866  1.00 95.88           C  \nATOM   3164  N   GLU A 412      32.072 -10.107 -18.003  1.00 92.31           N  \nATOM   3165  CA  GLU A 412      32.821 -10.180 -19.271  1.00 92.31           C  \nATOM   3166  C   GLU A 412      32.116 -10.993 -20.371  1.00 92.31           C  \nATOM   3167  CB  GLU A 412      34.230 -10.754 -19.045  1.00 92.31           C  \nATOM   3168  O   GLU A 412      32.451 -10.839 -21.546  1.00 92.31           O  \nATOM   3169  CG  GLU A 412      35.127  -9.862 -18.175  1.00 92.31           C  \nATOM   3170  CD  GLU A 412      36.612 -10.213 -18.367  1.00 92.31           C  \nATOM   3171  OE1 GLU A 412      37.400  -9.273 -18.638  1.00 92.31           O  \nATOM   3172  OE2 GLU A 412      36.944 -11.416 -18.301  1.00 92.31           O  \nATOM   3173  N   ASN A 413      31.135 -11.821 -19.995  1.00 92.62           N  \nATOM   3174  CA  ASN A 413      30.286 -12.617 -20.883  1.00 92.62           C  \nATOM   3175  C   ASN A 413      29.050 -11.864 -21.423  1.00 92.62           C  \nATOM   3176  CB  ASN A 413      29.882 -13.916 -20.154  1.00 92.62           C  \nATOM   3177  O   ASN A 413      28.302 -12.438 -22.213  1.00 92.62           O  \nATOM   3178  CG  ASN A 413      28.951 -13.708 -18.966  1.00 92.62           C  \nATOM   3179  ND2 ASN A 413      28.254 -14.735 -18.543  1.00 92.62           N  \nATOM   3180  OD1 ASN A 413      28.853 -12.643 -18.380  1.00 92.62           O  \nATOM   3181  N   ARG A 414      28.813 -10.610 -21.013  1.00 93.69           N  \nATOM   3182  CA  ARG A 414      27.744  -9.749 -21.544  1.00 93.69           C  \nATOM   3183  C   ARG A 414      28.363  -8.703 -22.479  1.00 93.69           C  \nATOM   3184  CB  ARG A 414      26.959  -9.098 -20.389  1.00 93.69           C  \nATOM   3185  O   ARG A 414      29.260  -7.957 -22.091  1.00 93.69           O  \nATOM   3186  CG  ARG A 414      26.252 -10.070 -19.419  1.00 93.69           C  \nATOM   3187  CD  ARG A 414      24.951 -10.717 -19.935  1.00 93.69           C  \nATOM   3188  NE  ARG A 414      24.145 -11.222 -18.797  1.00 93.69           N  \nATOM   3189  NH1 ARG A 414      22.025 -11.297 -19.729  1.00 93.69           N  \nATOM   3190  NH2 ARG A 414      22.279 -11.572 -17.550  1.00 93.69           N  \nATOM   3191  CZ  ARG A 414      22.829 -11.365 -18.708  1.00 93.69           C  \nATOM   3192  N   THR A 415      27.890  -8.652 -23.721  1.00 95.00           N  \nATOM   3193  CA  THR A 415      28.433  -7.798 -24.797  1.00 95.00           C  \nATOM   3194  C   THR A 415      27.991  -6.334 -24.727  1.00 95.00           C  \nATOM   3195  CB  THR A 415      28.042  -8.379 -26.165  1.00 95.00           C  \nATOM   3196  O   THR A 415      28.592  -5.487 -25.389  1.00 95.00           O  \nATOM   3197  CG2 THR A 415      28.903  -9.595 -26.506  1.00 95.00           C  \nATOM   3198  OG1 THR A 415      26.700  -8.820 -26.153  1.00 95.00           O  \nATOM   3199  N   ASP A 416      26.960  -6.042 -23.938  1.00 96.00           N  \nATOM   3200  CA  ASP A 416      26.269  -4.758 -23.826  1.00 96.00           C  \nATOM   3201  C   ASP A 416      25.786  -4.492 -22.385  1.00 96.00           C  \nATOM   3202  CB  ASP A 416      25.071  -4.775 -24.795  1.00 96.00           C  \nATOM   3203  O   ASP A 416      25.889  -5.350 -21.499  1.00 96.00           O  \nATOM   3204  CG  ASP A 416      23.943  -5.743 -24.394  1.00 96.00           C  \nATOM   3205  OD1 ASP A 416      24.142  -6.565 -23.466  1.00 96.00           O  \nATOM   3206  OD2 ASP A 416      22.867  -5.638 -25.013  1.00 96.00           O  \nATOM   3207  N   LEU A 417      25.200  -3.315 -22.150  1.00 97.62           N  \nATOM   3208  CA  LEU A 417      24.588  -2.941 -20.873  1.00 97.62           C  \nATOM   3209  C   LEU A 417      23.096  -3.344 -20.799  1.00 97.62           C  \nATOM   3210  CB  LEU A 417      24.834  -1.444 -20.580  1.00 97.62           C  \nATOM   3211  O   LEU A 417      22.283  -2.560 -20.318  1.00 97.62           O  \nATOM   3212  CG  LEU A 417      26.298  -0.971 -20.687  1.00 97.62           C  \nATOM   3213  CD1 LEU A 417      26.362   0.547 -20.510  1.00 97.62           C  \nATOM   3214  CD2 LEU A 417      27.190  -1.632 -19.632  1.00 97.62           C  \nATOM   3215  N   HIS A 418      22.729  -4.553 -21.257  1.00 95.88           N  \nATOM   3216  CA  HIS A 418      21.347  -5.090 -21.332  1.00 95.88           C  \nATOM   3217  C   HIS A 418      20.420  -4.783 -20.137  1.00 95.88           C  \nATOM   3218  CB  HIS A 418      21.396  -6.625 -21.480  1.00 95.88           C  \nATOM   3219  O   HIS A 418      19.212  -4.657 -20.316  1.00 95.88           O  \nATOM   3220  CG  HIS A 418      22.037  -7.319 -20.299  1.00 95.88           C  \nATOM   3221  CD2 HIS A 418      21.398  -7.920 -19.243  1.00 95.88           C  \nATOM   3222  ND1 HIS A 418      23.380  -7.299 -20.003  1.00 95.88           N  \nATOM   3223  CE1 HIS A 418      23.542  -7.829 -18.779  1.00 95.88           C  \nATOM   3224  NE2 HIS A 418      22.366  -8.240 -18.287  1.00 95.88           N  \nATOM   3225  N   ALA A 419      20.955  -4.674 -18.917  1.00 97.19           N  \nATOM   3226  CA  ALA A 419      20.192  -4.337 -17.716  1.00 97.19           C  \nATOM   3227  C   ALA A 419      19.531  -2.943 -17.781  1.00 97.19           C  \nATOM   3228  CB  ALA A 419      21.152  -4.416 -16.532  1.00 97.19           C  \nATOM   3229  O   ALA A 419      18.523  -2.713 -17.126  1.00 97.19           O  \nATOM   3230  N   PHE A 420      20.081  -2.032 -18.588  1.00 97.94           N  \nATOM   3231  CA  PHE A 420      19.615  -0.657 -18.782  1.00 97.94           C  \nATOM   3232  C   PHE A 420      18.988  -0.436 -20.171  1.00 97.94           C  \nATOM   3233  CB  PHE A 420      20.773   0.308 -18.481  1.00 97.94           C  \nATOM   3234  O   PHE A 420      18.867   0.698 -20.628  1.00 97.94           O  \nATOM   3235  CG  PHE A 420      21.321   0.196 -17.070  1.00 97.94           C  \nATOM   3236  CD1 PHE A 420      20.521   0.576 -15.976  1.00 97.94           C  \nATOM   3237  CD2 PHE A 420      22.618  -0.306 -16.845  1.00 97.94           C  \nATOM   3238  CE1 PHE A 420      21.017   0.461 -14.667  1.00 97.94           C  \nATOM   3239  CE2 PHE A 420      23.116  -0.415 -15.534  1.00 97.94           C  \nATOM   3240  CZ  PHE A 420      22.317  -0.024 -14.445  1.00 97.94           C  \nATOM   3241  N   GLU A 421      18.551  -1.501 -20.855  1.00 96.25           N  \nATOM   3242  CA  GLU A 421      17.940  -1.413 -22.194  1.00 96.25           C  \nATOM   3243  C   GLU A 421      16.669  -0.538 -22.247  1.00 96.25           C  \nATOM   3244  CB  GLU A 421      17.635  -2.830 -22.717  1.00 96.25           C  \nATOM   3245  O   GLU A 421      16.335  -0.001 -23.305  1.00 96.25           O  \nATOM   3246  CG  GLU A 421      16.487  -3.536 -21.964  1.00 96.25           C  \nATOM   3247  CD  GLU A 421      16.210  -4.963 -22.456  1.00 96.25           C  \nATOM   3248  OE1 GLU A 421      15.617  -5.751 -21.684  1.00 96.25           O  \nATOM   3249  OE2 GLU A 421      16.550  -5.265 -23.624  1.00 96.25           O  \nATOM   3250  N   ASN A 422      15.971  -0.397 -21.111  1.00 95.81           N  \nATOM   3251  CA  ASN A 422      14.745   0.390 -20.933  1.00 95.81           C  \nATOM   3252  C   ASN A 422      14.981   1.753 -20.251  1.00 95.81           C  \nATOM   3253  CB  ASN A 422      13.701  -0.444 -20.164  1.00 95.81           C  \nATOM   3254  O   ASN A 422      14.011   2.465 -20.008  1.00 95.81           O  \nATOM   3255  CG  ASN A 422      13.256  -1.688 -20.910  1.00 95.81           C  \nATOM   3256  ND2 ASN A 422      13.440  -2.850 -20.335  1.00 95.81           N  \nATOM   3257  OD1 ASN A 422      12.720  -1.633 -22.009  1.00 95.81           O  \nATOM   3258  N   LEU A 423      16.231   2.128 -19.947  1.00 97.69           N  \nATOM   3259  CA  LEU A 423      16.555   3.410 -19.318  1.00 97.69           C  \nATOM   3260  C   LEU A 423      16.280   4.555 -20.303  1.00 97.69           C  \nATOM   3261  CB  LEU A 423      18.022   3.367 -18.848  1.00 97.69           C  \nATOM   3262  O   LEU A 423      16.936   4.644 -21.336  1.00 97.69           O  \nATOM   3263  CG  LEU A 423      18.544   4.658 -18.190  1.00 97.69           C  \nATOM   3264  CD1 LEU A 423      17.782   5.029 -16.918  1.00 97.69           C  \nATOM   3265  CD2 LEU A 423      20.014   4.460 -17.813  1.00 97.69           C  \nATOM   3266  N   GLU A 424      15.316   5.419 -19.984  1.00 96.31           N  \nATOM   3267  CA  GLU A 424      14.862   6.518 -20.844  1.00 96.31           C  \nATOM   3268  C   GLU A 424      15.533   7.857 -20.497  1.00 96.31           C  \nATOM   3269  CB  GLU A 424      13.319   6.640 -20.815  1.00 96.31           C  \nATOM   3270  O   GLU A 424      15.859   8.624 -21.406  1.00 96.31           O  \nATOM   3271  CG  GLU A 424      12.583   5.323 -21.139  1.00 96.31           C  \nATOM   3272  CD  GLU A 424      11.101   5.503 -21.515  1.00 96.31           C  \nATOM   3273  OE1 GLU A 424      10.232   4.811 -20.926  1.00 96.31           O  \nATOM   3274  OE2 GLU A 424      10.816   6.274 -22.461  1.00 96.31           O  \nATOM   3275  N   ILE A 425      15.756   8.136 -19.202  1.00 96.06           N  \nATOM   3276  CA  ILE A 425      16.258   9.431 -18.699  1.00 96.06           C  \nATOM   3277  C   ILE A 425      17.306   9.249 -17.585  1.00 96.06           C  \nATOM   3278  CB  ILE A 425      15.087  10.322 -18.198  1.00 96.06           C  \nATOM   3279  O   ILE A 425      17.068   8.534 -16.607  1.00 96.06           O  \nATOM   3280  CG1 ILE A 425      14.016  10.533 -19.300  1.00 96.06           C  \nATOM   3281  CG2 ILE A 425      15.611  11.678 -17.672  1.00 96.06           C  \nATOM   3282  CD1 ILE A 425      12.826  11.417 -18.902  1.00 96.06           C  \nATOM   3283  N   ILE A 426      18.421   9.985 -17.675  1.00 97.00           N  \nATOM   3284  CA  ILE A 426      19.369  10.228 -16.569  1.00 97.00           C  \nATOM   3285  C   ILE A 426      19.345  11.726 -16.235  1.00 97.00           C  \nATOM   3286  CB  ILE A 426      20.800   9.766 -16.941  1.00 97.00           C  \nATOM   3287  O   ILE A 426      19.767  12.539 -17.052  1.00 97.00           O  \nATOM   3288  CG1 ILE A 426      20.844   8.264 -17.306  1.00 97.00           C  \nATOM   3289  CG2 ILE A 426      21.770  10.061 -15.778  1.00 97.00           C  \nATOM   3290  CD1 ILE A 426      22.206   7.796 -17.843  1.00 97.00           C  \nATOM   3291  N   ARG A 427      18.879  12.133 -15.048  1.00 89.50           N  \nATOM   3292  CA  ARG A 427      18.735  13.573 -14.739  1.00 89.50           C  \nATOM   3293  C   ARG A 427      20.003  14.267 -14.254  1.00 89.50           C  \nATOM   3294  CB  ARG A 427      17.566  13.865 -13.795  1.00 89.50           C  \nATOM   3295  O   ARG A 427      20.051  15.492 -14.294  1.00 89.50           O  \nATOM   3296  CG  ARG A 427      16.224  13.388 -14.349  1.00 89.50           C  \nATOM   3297  CD  ARG A 427      15.090  14.024 -13.540  1.00 89.50           C  \nATOM   3298  NE  ARG A 427      13.783  13.549 -14.006  1.00 89.50           N  \nATOM   3299  NH1 ARG A 427      13.550  14.817 -15.930  1.00 89.50           N  \nATOM   3300  NH2 ARG A 427      12.067  13.221 -15.396  1.00 89.50           N  \nATOM   3301  CZ  ARG A 427      13.141  13.887 -15.107  1.00 89.50           C  \nATOM   3302  N   GLY A 428      21.002  13.532 -13.765  1.00 87.88           N  \nATOM   3303  CA  GLY A 428      22.284  14.110 -13.356  1.00 87.88           C  \nATOM   3304  C   GLY A 428      22.187  15.159 -12.242  1.00 87.88           C  \nATOM   3305  O   GLY A 428      23.024  16.061 -12.200  1.00 87.88           O  \nATOM   3306  N   ARG A 429      21.177  15.096 -11.355  1.00 80.50           N  \nATOM   3307  CA  ARG A 429      21.032  16.055 -10.237  1.00 80.50           C  \nATOM   3308  C   ARG A 429      22.268  16.001  -9.334  1.00 80.50           C  \nATOM   3309  CB  ARG A 429      19.747  15.781  -9.436  1.00 80.50           C  \nATOM   3310  O   ARG A 429      22.944  17.008  -9.137  1.00 80.50           O  \nATOM   3311  CG  ARG A 429      18.466  16.084 -10.229  1.00 80.50           C  \nATOM   3312  CD  ARG A 429      17.239  15.736  -9.377  1.00 80.50           C  \nATOM   3313  NE  ARG A 429      15.977  16.136 -10.030  1.00 80.50           N  \nATOM   3314  NH1 ARG A 429      14.535  15.055  -8.598  1.00 80.50           N  \nATOM   3315  NH2 ARG A 429      13.715  16.305 -10.251  1.00 80.50           N  \nATOM   3316  CZ  ARG A 429      14.755  15.830  -9.625  1.00 80.50           C  \nATOM   3317  N   THR A 430      22.598  14.798  -8.879  1.00 78.12           N  \nATOM   3318  CA  THR A 430      23.921  14.393  -8.391  1.00 78.12           C  \nATOM   3319  C   THR A 430      24.805  13.961  -9.567  1.00 78.12           C  \nATOM   3320  CB  THR A 430      23.784  13.262  -7.353  1.00 78.12           C  \nATOM   3321  O   THR A 430      24.308  13.527 -10.609  1.00 78.12           O  \nATOM   3322  CG2 THR A 430      23.420  13.827  -5.982  1.00 78.12           C  \nATOM   3323  OG1 THR A 430      22.733  12.399  -7.712  1.00 78.12           O  \nATOM   3324  N   LYS A 431      26.129  14.111  -9.427  1.00 82.75           N  \nATOM   3325  CA  LYS A 431      27.124  13.846 -10.485  1.00 82.75           C  \nATOM   3326  C   LYS A 431      28.403  13.253  -9.892  1.00 82.75           C  \nATOM   3327  CB  LYS A 431      27.475  15.150 -11.224  1.00 82.75           C  \nATOM   3328  O   LYS A 431      28.886  13.744  -8.870  1.00 82.75           O  \nATOM   3329  CG  LYS A 431      26.302  15.830 -11.943  1.00 82.75           C  \nATOM   3330  CD  LYS A 431      26.750  17.176 -12.530  1.00 82.75           C  \nATOM   3331  CE  LYS A 431      25.609  17.935 -13.212  1.00 82.75           C  \nATOM   3332  NZ  LYS A 431      24.542  18.341 -12.269  1.00 82.75           N  \nATOM   3333  N   GLN A 432      29.017  12.285 -10.569  1.00 72.44           N  \nATOM   3334  CA  GLN A 432      30.274  11.686 -10.124  1.00 72.44           C  \nATOM   3335  C   GLN A 432      31.408  12.718 -10.166  1.00 72.44           C  \nATOM   3336  CB  GLN A 432      30.595  10.424 -10.946  1.00 72.44           C  \nATOM   3337  O   GLN A 432      31.661  13.342 -11.202  1.00 72.44           O  \nATOM   3338  CG  GLN A 432      31.896   9.687 -10.566  1.00 72.44           C  \nATOM   3339  CD  GLN A 432      31.999   9.207  -9.114  1.00 72.44           C  \nATOM   3340  NE2 GLN A 432      32.974   8.393  -8.782  1.00 72.44           N  \nATOM   3341  OE1 GLN A 432      31.257   9.573  -8.230  1.00 72.44           O  \nATOM   3342  N   HIS A 433      32.077  12.904  -9.024  1.00 75.06           N  \nATOM   3343  CA  HIS A 433      33.013  14.011  -8.761  1.00 75.06           C  \nATOM   3344  C   HIS A 433      32.443  15.412  -9.086  1.00 75.06           C  \nATOM   3345  CB  HIS A 433      34.373  13.761  -9.440  1.00 75.06           C  \nATOM   3346  O   HIS A 433      33.189  16.311  -9.464  1.00 75.06           O  \nATOM   3347  CG  HIS A 433      35.008  12.432  -9.124  1.00 75.06           C  \nATOM   3348  CD2 HIS A 433      35.571  12.050  -7.936  1.00 75.06           C  \nATOM   3349  ND1 HIS A 433      35.188  11.398 -10.012  1.00 75.06           N  \nATOM   3350  CE1 HIS A 433      35.843  10.414  -9.374  1.00 75.06           C  \nATOM   3351  NE2 HIS A 433      36.103  10.766  -8.108  1.00 75.06           N  \nATOM   3352  N   GLY A 434      31.120  15.595  -9.003  1.00 68.12           N  \nATOM   3353  CA  GLY A 434      30.441  16.842  -9.372  1.00 68.12           C  \nATOM   3354  C   GLY A 434      30.348  17.115 -10.881  1.00 68.12           C  \nATOM   3355  O   GLY A 434      29.736  18.106 -11.264  1.00 68.12           O  \nATOM   3356  N   GLN A 435      30.904  16.249 -11.741  1.00 82.44           N  \nATOM   3357  CA  GLN A 435      31.001  16.488 -13.187  1.00 82.44           C  \nATOM   3358  C   GLN A 435      30.164  15.518 -14.034  1.00 82.44           C  \nATOM   3359  CB  GLN A 435      32.487  16.493 -13.598  1.00 82.44           C  \nATOM   3360  O   GLN A 435      29.410  15.971 -14.892  1.00 82.44           O  \nATOM   3361  CG  GLN A 435      32.657  16.786 -15.099  1.00 82.44           C  \nATOM   3362  CD  GLN A 435      34.097  16.999 -15.557  1.00 82.44           C  \nATOM   3363  NE2 GLN A 435      34.289  17.418 -16.786  1.00 82.44           N  \nATOM   3364  OE1 GLN A 435      35.079  16.782 -14.862  1.00 82.44           O  \nATOM   3365  N   PHE A 436      30.289  14.202 -13.832  1.00 86.25           N  \nATOM   3366  CA  PHE A 436      29.762  13.214 -14.787  1.00 86.25           C  \nATOM   3367  C   PHE A 436      28.411  12.630 -14.361  1.00 86.25           C  \nATOM   3368  CB  PHE A 436      30.800  12.110 -15.041  1.00 86.25           C  \nATOM   3369  O   PHE A 436      28.288  12.114 -13.252  1.00 86.25           O  \nATOM   3370  CG  PHE A 436      32.128  12.632 -15.556  1.00 86.25           C  \nATOM   3371  CD1 PHE A 436      32.262  12.984 -16.911  1.00 86.25           C  \nATOM   3372  CD2 PHE A 436      33.201  12.845 -14.670  1.00 86.25           C  \nATOM   3373  CE1 PHE A 436      33.453  13.569 -17.377  1.00 86.25           C  \nATOM   3374  CE2 PHE A 436      34.397  13.420 -15.137  1.00 86.25           C  \nATOM   3375  CZ  PHE A 436      34.520  13.787 -16.488  1.00 86.25           C  \nATOM   3376  N   SER A 437      27.418  12.652 -15.251  1.00 93.69           N  \nATOM   3377  CA  SER A 437      26.114  11.995 -15.052  1.00 93.69           C  \nATOM   3378  C   SER A 437      26.048  10.587 -15.657  1.00 93.69           C  \nATOM   3379  CB  SER A 437      24.991  12.875 -15.592  1.00 93.69           C  \nATOM   3380  O   SER A 437      25.284   9.749 -15.180  1.00 93.69           O  \nATOM   3381  OG  SER A 437      25.273  13.266 -16.916  1.00 93.69           O  \nATOM   3382  N   LEU A 438      26.902  10.283 -16.640  1.00 97.56           N  \nATOM   3383  CA  LEU A 438      27.091   8.932 -17.177  1.00 97.56           C  \nATOM   3384  C   LEU A 438      28.585   8.605 -17.295  1.00 97.56           C  \nATOM   3385  CB  LEU A 438      26.352   8.820 -18.523  1.00 97.56           C  \nATOM   3386  O   LEU A 438      29.335   9.303 -17.982  1.00 97.56           O  \nATOM   3387  CG  LEU A 438      26.510   7.468 -19.245  1.00 97.56           C  \nATOM   3388  CD1 LEU A 438      25.942   6.298 -18.440  1.00 97.56           C  \nATOM   3389  CD2 LEU A 438      25.789   7.518 -20.593  1.00 97.56           C  \nATOM   3390  N   ALA A 439      29.012   7.520 -16.651  1.00 96.06           N  \nATOM   3391  CA  ALA A 439      30.397   7.062 -16.645  1.00 96.06           C  \nATOM   3392  C   ALA A 439      30.496   5.555 -16.937  1.00 96.06           C  \nATOM   3393  CB  ALA A 439      31.018   7.452 -15.299  1.00 96.06           C  \nATOM   3394  O   ALA A 439      30.070   4.734 -16.128  1.00 96.06           O  \nATOM   3395  N   VAL A 440      31.095   5.197 -18.078  1.00 97.50           N  \nATOM   3396  CA  VAL A 440      31.252   3.812 -18.565  1.00 97.50           C  \nATOM   3397  C   VAL A 440      32.738   3.534 -18.812  1.00 97.50           C  \nATOM   3398  CB  VAL A 440      30.408   3.585 -19.838  1.00 97.50           C  \nATOM   3399  O   VAL A 440      33.314   3.987 -19.809  1.00 97.50           O  \nATOM   3400  CG1 VAL A 440      30.454   2.123 -20.293  1.00 97.50           C  \nATOM   3401  CG2 VAL A 440      28.929   3.944 -19.625  1.00 97.50           C  \nATOM   3402  N   VAL A 441      33.395   2.850 -17.870  1.00 95.06           N  \nATOM   3403  CA  VAL A 441      34.865   2.829 -17.782  1.00 95.06           C  \nATOM   3404  C   VAL A 441      35.433   1.410 -17.680  1.00 95.06           C  \nATOM   3405  CB  VAL A 441      35.355   3.726 -16.623  1.00 95.06           C  \nATOM   3406  O   VAL A 441      35.031   0.636 -16.817  1.00 95.06           O  \nATOM   3407  CG1 VAL A 441      36.886   3.821 -16.575  1.00 95.06           C  \nATOM   3408  CG2 VAL A 441      34.828   5.166 -16.750  1.00 95.06           C  \nATOM   3409  N   SER A 442      36.434   1.112 -18.517  1.00 94.19           N  \nATOM   3410  CA  SER A 442      37.256  -0.115 -18.493  1.00 94.19           C  \nATOM   3411  C   SER A 442      36.501  -1.445 -18.667  1.00 94.19           C  \nATOM   3412  CB  SER A 442      38.171  -0.131 -17.259  1.00 94.19           C  \nATOM   3413  O   SER A 442      36.904  -2.467 -18.110  1.00 94.19           O  \nATOM   3414  OG  SER A 442      39.036   0.994 -17.254  1.00 94.19           O  \nATOM   3415  N   LEU A 443      35.419  -1.463 -19.452  1.00 96.69           N  \nATOM   3416  CA  LEU A 443      34.567  -2.642 -19.647  1.00 96.69           C  \nATOM   3417  C   LEU A 443      34.957  -3.489 -20.878  1.00 96.69           C  \nATOM   3418  CB  LEU A 443      33.092  -2.200 -19.705  1.00 96.69           C  \nATOM   3419  O   LEU A 443      35.595  -3.014 -21.822  1.00 96.69           O  \nATOM   3420  CG  LEU A 443      32.627  -1.268 -18.568  1.00 96.69           C  \nATOM   3421  CD1 LEU A 443      31.130  -1.015 -18.719  1.00 96.69           C  \nATOM   3422  CD2 LEU A 443      32.881  -1.851 -17.180  1.00 96.69           C  \nATOM   3423  N   ASN A 444      34.521  -4.755 -20.893  1.00 96.25           N  \nATOM   3424  CA  ASN A 444      34.748  -5.709 -21.994  1.00 96.25           C  \nATOM   3425  C   ASN A 444      33.723  -5.590 -23.153  1.00 96.25           C  \nATOM   3426  CB  ASN A 444      34.793  -7.134 -21.394  1.00 96.25           C  \nATOM   3427  O   ASN A 444      33.861  -6.285 -24.159  1.00 96.25           O  \nATOM   3428  CG  ASN A 444      35.466  -8.158 -22.299  1.00 96.25           C  \nATOM   3429  ND2 ASN A 444      34.865  -9.301 -22.532  1.00 96.25           N  \nATOM   3430  OD1 ASN A 444      36.569  -7.950 -22.788  1.00 96.25           O  \nATOM   3431  N   ILE A 445      32.707  -4.729 -23.012  1.00 97.25           N  \nATOM   3432  CA  ILE A 445      31.553  -4.589 -23.922  1.00 97.25           C  \nATOM   3433  C   ILE A 445      31.932  -4.163 -25.352  1.00 97.25           C  \nATOM   3434  CB  ILE A 445      30.494  -3.625 -23.327  1.00 97.25           C  \nATOM   3435  O   ILE A 445      32.881  -3.405 -25.564  1.00 97.25           O  \nATOM   3436  CG1 ILE A 445      31.034  -2.181 -23.183  1.00 97.25           C  \nATOM   3437  CG2 ILE A 445      29.952  -4.191 -22.000  1.00 97.25           C  \nATOM   3438  CD1 ILE A 445      30.041  -1.176 -22.585  1.00 97.25           C  \nATOM   3439  N   THR A 446      31.148  -4.612 -26.334  1.00 96.69           N  \nATOM   3440  CA  THR A 446      31.252  -4.239 -27.760  1.00 96.69           C  \nATOM   3441  C   THR A 446      30.315  -3.094 -28.147  1.00 96.69           C  \nATOM   3442  CB  THR A 446      30.924  -5.441 -28.661  1.00 96.69           C  \nATOM   3443  O   THR A 446      30.613  -2.318 -29.059  1.00 96.69           O  \nATOM   3444  CG2 THR A 446      32.029  -6.495 -28.624  1.00 96.69           C  \nATOM   3445  OG1 THR A 446      29.737  -6.089 -28.256  1.00 96.69           O  \nATOM   3446  N   SER A 447      29.185  -2.986 -27.451  1.00 97.44           N  \nATOM   3447  CA  SER A 447      28.087  -2.039 -27.680  1.00 97.44           C  \nATOM   3448  C   SER A 447      27.605  -1.457 -26.351  1.00 97.44           C  \nATOM   3449  CB  SER A 447      26.938  -2.720 -28.450  1.00 97.44           C  \nATOM   3450  O   SER A 447      27.914  -1.989 -25.288  1.00 97.44           O  \nATOM   3451  OG  SER A 447      26.760  -4.066 -28.052  1.00 97.44           O  \nATOM   3452  N   LEU A 448      26.881  -0.335 -26.396  1.00 97.50           N  \nATOM   3453  CA  LEU A 448      26.298   0.256 -25.186  1.00 97.50           C  \nATOM   3454  C   LEU A 448      24.954  -0.400 -24.851  1.00 97.50           C  \nATOM   3455  CB  LEU A 448      26.169   1.784 -25.343  1.00 97.50           C  \nATOM   3456  O   LEU A 448      24.714  -0.708 -23.691  1.00 97.50           O  \nATOM   3457  CG  LEU A 448      27.501   2.559 -25.327  1.00 97.50           C  \nATOM   3458  CD1 LEU A 448      27.244   4.045 -25.576  1.00 97.50           C  \nATOM   3459  CD2 LEU A 448      28.257   2.430 -24.000  1.00 97.50           C  \nATOM   3460  N   GLY A 449      24.090  -0.635 -25.844  1.00 96.06           N  \nATOM   3461  CA  GLY A 449      22.767  -1.247 -25.633  1.00 96.06           C  \nATOM   3462  C   GLY A 449      21.733  -0.356 -24.921  1.00 96.06           C  \nATOM   3463  O   GLY A 449      20.632  -0.817 -24.630  1.00 96.06           O  \nATOM   3464  N   LEU A 450      22.045   0.923 -24.674  1.00 97.25           N  \nATOM   3465  CA  LEU A 450      21.171   1.913 -24.017  1.00 97.25           C  \nATOM   3466  C   LEU A 450      20.053   2.428 -24.952  1.00 97.25           C  \nATOM   3467  CB  LEU A 450      22.029   3.060 -23.431  1.00 97.25           C  \nATOM   3468  O   LEU A 450      19.814   3.626 -25.055  1.00 97.25           O  \nATOM   3469  CG  LEU A 450      23.107   2.639 -22.415  1.00 97.25           C  \nATOM   3470  CD1 LEU A 450      23.893   3.866 -21.947  1.00 97.25           C  \nATOM   3471  CD2 LEU A 450      22.518   1.949 -21.185  1.00 97.25           C  \nATOM   3472  N   ARG A 451      19.382   1.517 -25.667  1.00 94.62           N  \nATOM   3473  CA  ARG A 451      18.494   1.822 -26.805  1.00 94.62           C  \nATOM   3474  C   ARG A 451      17.295   2.718 -26.494  1.00 94.62           C  \nATOM   3475  CB  ARG A 451      18.068   0.532 -27.524  1.00 94.62           C  \nATOM   3476  O   ARG A 451      16.806   3.383 -27.399  1.00 94.62           O  \nATOM   3477  CG  ARG A 451      17.373  -0.497 -26.618  1.00 94.62           C  \nATOM   3478  CD  ARG A 451      16.890  -1.691 -27.452  1.00 94.62           C  \nATOM   3479  NE  ARG A 451      16.912  -2.946 -26.671  1.00 94.62           N  \nATOM   3480  NH1 ARG A 451      18.714  -3.952 -27.734  1.00 94.62           N  \nATOM   3481  NH2 ARG A 451      17.740  -4.968 -26.030  1.00 94.62           N  \nATOM   3482  CZ  ARG A 451      17.778  -3.935 -26.821  1.00 94.62           C  \nATOM   3483  N   SER A 452      16.842   2.764 -25.243  1.00 95.50           N  \nATOM   3484  CA  SER A 452      15.724   3.629 -24.839  1.00 95.50           C  \nATOM   3485  C   SER A 452      16.148   5.036 -24.394  1.00 95.50           C  \nATOM   3486  CB  SER A 452      14.875   2.953 -23.759  1.00 95.50           C  \nATOM   3487  O   SER A 452      15.266   5.858 -24.150  1.00 95.50           O  \nATOM   3488  OG  SER A 452      14.458   1.664 -24.185  1.00 95.50           O  \nATOM   3489  N   LEU A 453      17.453   5.330 -24.286  1.00 97.25           N  \nATOM   3490  CA  LEU A 453      17.962   6.565 -23.681  1.00 97.25           C  \nATOM   3491  C   LEU A 453      17.710   7.778 -24.586  1.00 97.25           C  \nATOM   3492  CB  LEU A 453      19.451   6.384 -23.327  1.00 97.25           C  \nATOM   3493  O   LEU A 453      18.315   7.912 -25.651  1.00 97.25           O  \nATOM   3494  CG  LEU A 453      20.086   7.579 -22.589  1.00 97.25           C  \nATOM   3495  CD1 LEU A 453      19.479   7.817 -21.205  1.00 97.25           C  \nATOM   3496  CD2 LEU A 453      21.580   7.319 -22.389  1.00 97.25           C  \nATOM   3497  N   LYS A 454      16.832   8.672 -24.124  1.00 94.06           N  \nATOM   3498  CA  LYS A 454      16.384   9.884 -24.829  1.00 94.06           C  \nATOM   3499  C   LYS A 454      16.992  11.160 -24.251  1.00 94.06           C  \nATOM   3500  CB  LYS A 454      14.850   9.963 -24.750  1.00 94.06           C  \nATOM   3501  O   LYS A 454      17.193  12.115 -24.991  1.00 94.06           O  \nATOM   3502  CG  LYS A 454      14.136   8.852 -25.538  1.00 94.06           C  \nATOM   3503  CD  LYS A 454      12.721   8.634 -24.988  1.00 94.06           C  \nATOM   3504  CE  LYS A 454      12.067   7.418 -25.646  1.00 94.06           C  \nATOM   3505  NZ  LYS A 454      10.764   7.108 -25.009  1.00 94.06           N  \nATOM   3506  N   GLU A 455      17.282  11.182 -22.949  1.00 96.06           N  \nATOM   3507  CA  GLU A 455      17.683  12.401 -22.239  1.00 96.06           C  \nATOM   3508  C   GLU A 455      18.764  12.129 -21.176  1.00 96.06           C  \nATOM   3509  CB  GLU A 455      16.430  13.038 -21.611  1.00 96.06           C  \nATOM   3510  O   GLU A 455      18.662  11.209 -20.361  1.00 96.06           O  \nATOM   3511  CG  GLU A 455      16.625  14.495 -21.162  1.00 96.06           C  \nATOM   3512  CD  GLU A 455      15.473  14.993 -20.270  1.00 96.06           C  \nATOM   3513  OE1 GLU A 455      15.770  15.742 -19.311  1.00 96.06           O  \nATOM   3514  OE2 GLU A 455      14.310  14.578 -20.465  1.00 96.06           O  \nATOM   3515  N   ILE A 456      19.786  12.982 -21.161  1.00 95.94           N  \nATOM   3516  CA  ILE A 456      20.737  13.180 -20.070  1.00 95.94           C  \nATOM   3517  C   ILE A 456      20.599  14.651 -19.654  1.00 95.94           C  \nATOM   3518  CB  ILE A 456      22.179  12.795 -20.478  1.00 95.94           C  \nATOM   3519  O   ILE A 456      21.259  15.520 -20.229  1.00 95.94           O  \nATOM   3520  CG1 ILE A 456      22.246  11.329 -20.966  1.00 95.94           C  \nATOM   3521  CG2 ILE A 456      23.125  13.011 -19.280  1.00 95.94           C  \nATOM   3522  CD1 ILE A 456      23.649  10.870 -21.380  1.00 95.94           C  \nATOM   3523  N   SER A 457      19.705  14.936 -18.700  1.00 91.38           N  \nATOM   3524  CA  SER A 457      19.224  16.302 -18.425  1.00 91.38           C  \nATOM   3525  C   SER A 457      20.348  17.274 -18.060  1.00 91.38           C  \nATOM   3526  CB  SER A 457      18.214  16.342 -17.269  1.00 91.38           C  \nATOM   3527  O   SER A 457      20.266  18.445 -18.409  1.00 91.38           O  \nATOM   3528  OG  SER A 457      17.242  15.315 -17.317  1.00 91.38           O  \nATOM   3529  N   ASP A 458      21.377  16.799 -17.352  1.00 89.19           N  \nATOM   3530  CA  ASP A 458      22.541  17.585 -16.941  1.00 89.19           C  \nATOM   3531  C   ASP A 458      23.778  16.686 -16.711  1.00 89.19           C  \nATOM   3532  CB  ASP A 458      22.170  18.386 -15.676  1.00 89.19           C  \nATOM   3533  O   ASP A 458      23.664  15.463 -16.578  1.00 89.19           O  \nATOM   3534  CG  ASP A 458      23.198  19.456 -15.305  1.00 89.19           C  \nATOM   3535  OD1 ASP A 458      23.974  19.885 -16.189  1.00 89.19           O  \nATOM   3536  OD2 ASP A 458      23.275  19.787 -14.101  1.00 89.19           O  \nATOM   3537  N   GLY A 459      24.972  17.284 -16.637  1.00 82.50           N  \nATOM   3538  CA  GLY A 459      26.255  16.607 -16.388  1.00 82.50           C  \nATOM   3539  C   GLY A 459      26.946  16.012 -17.625  1.00 82.50           C  \nATOM   3540  O   GLY A 459      26.327  15.752 -18.655  1.00 82.50           O  \nATOM   3541  N   ASP A 460      28.260  15.808 -17.519  1.00 92.81           N  \nATOM   3542  CA  ASP A 460      29.111  15.301 -18.603  1.00 92.81           C  \nATOM   3543  C   ASP A 460      29.018  13.771 -18.770  1.00 92.81           C  \nATOM   3544  CB  ASP A 460      30.580  15.707 -18.361  1.00 92.81           C  \nATOM   3545  O   ASP A 460      28.717  13.022 -17.836  1.00 92.81           O  \nATOM   3546  CG  ASP A 460      30.947  17.156 -18.706  1.00 92.81           C  \nATOM   3547  OD1 ASP A 460      30.103  17.891 -19.259  1.00 92.81           O  \nATOM   3548  OD2 ASP A 460      32.132  17.512 -18.487  1.00 92.81           O  \nATOM   3549  N   VAL A 461      29.394  13.291 -19.958  1.00 96.44           N  \nATOM   3550  CA  VAL A 461      29.486  11.863 -20.301  1.00 96.44           C  \nATOM   3551  C   VAL A 461      30.949  11.448 -20.441  1.00 96.44           C  \nATOM   3552  CB  VAL A 461      28.705  11.572 -21.597  1.00 96.44           C  \nATOM   3553  O   VAL A 461      31.692  12.048 -21.220  1.00 96.44           O  \nATOM   3554  CG1 VAL A 461      28.854  10.116 -22.058  1.00 96.44           C  \nATOM   3555  CG2 VAL A 461      27.213  11.861 -21.414  1.00 96.44           C  \nATOM   3556  N   ILE A 462      31.371  10.382 -19.755  1.00 95.19           N  \nATOM   3557  CA  ILE A 462      32.705   9.777 -19.913  1.00 95.19           C  \nATOM   3558  C   ILE A 462      32.608   8.296 -20.292  1.00 95.19           C  \nATOM   3559  CB  ILE A 462      33.609  10.055 -18.690  1.00 95.19           C  \nATOM   3560  O   ILE A 462      32.030   7.484 -19.575  1.00 95.19           O  \nATOM   3561  CG1 ILE A 462      35.038   9.524 -18.947  1.00 95.19           C  \nATOM   3562  CG2 ILE A 462      33.042   9.517 -17.364  1.00 95.19           C  \nATOM   3563  CD1 ILE A 462      36.051   9.910 -17.862  1.00 95.19           C  \nATOM   3564  N   ILE A 463      33.214   7.935 -21.425  1.00 96.75           N  \nATOM   3565  CA  ILE A 463      33.241   6.563 -21.947  1.00 96.75           C  \nATOM   3566  C   ILE A 463      34.691   6.246 -22.309  1.00 96.75           C  \nATOM   3567  CB  ILE A 463      32.265   6.394 -23.135  1.00 96.75           C  \nATOM   3568  O   ILE A 463      35.192   6.708 -23.335  1.00 96.75           O  \nATOM   3569  CG1 ILE A 463      30.818   6.752 -22.718  1.00 96.75           C  \nATOM   3570  CG2 ILE A 463      32.330   4.953 -23.672  1.00 96.75           C  \nATOM   3571  CD1 ILE A 463      29.794   6.703 -23.854  1.00 96.75           C  \nATOM   3572  N   SER A 464      35.395   5.517 -21.440  1.00 95.19           N  \nATOM   3573  CA  SER A 464      36.859   5.422 -21.505  1.00 95.19           C  \nATOM   3574  C   SER A 464      37.417   4.035 -21.198  1.00 95.19           C  \nATOM   3575  CB  SER A 464      37.473   6.473 -20.574  1.00 95.19           C  \nATOM   3576  O   SER A 464      37.051   3.421 -20.202  1.00 95.19           O  \nATOM   3577  OG  SER A 464      38.889   6.456 -20.618  1.00 95.19           O  \nATOM   3578  N   GLY A 465      38.388   3.579 -21.993  1.00 93.38           N  \nATOM   3579  CA  GLY A 465      39.121   2.328 -21.740  1.00 93.38           C  \nATOM   3580  C   GLY A 465      38.380   1.051 -22.152  1.00 93.38           C  \nATOM   3581  O   GLY A 465      38.829  -0.050 -21.835  1.00 93.38           O  \nATOM   3582  N   ASN A 466      37.246   1.170 -22.846  1.00 96.31           N  \nATOM   3583  CA  ASN A 466      36.417   0.034 -23.240  1.00 96.31           C  \nATOM   3584  C   ASN A 466      36.984  -0.583 -24.530  1.00 96.31           C  \nATOM   3585  CB  ASN A 466      34.949   0.482 -23.339  1.00 96.31           C  \nATOM   3586  O   ASN A 466      36.587  -0.232 -25.643  1.00 96.31           O  \nATOM   3587  CG  ASN A 466      34.471   1.209 -22.096  1.00 96.31           C  \nATOM   3588  ND2 ASN A 466      34.389   2.516 -22.140  1.00 96.31           N  \nATOM   3589  OD1 ASN A 466      34.206   0.619 -21.066  1.00 96.31           O  \nATOM   3590  N   LYS A 467      37.971  -1.473 -24.371  1.00 94.19           N  \nATOM   3591  CA  LYS A 467      38.848  -2.020 -25.433  1.00 94.19           C  \nATOM   3592  C   LYS A 467      38.134  -2.590 -26.675  1.00 94.19           C  \nATOM   3593  CB  LYS A 467      39.794  -3.067 -24.799  1.00 94.19           C  \nATOM   3594  O   LYS A 467      38.717  -2.578 -27.756  1.00 94.19           O  \nATOM   3595  CG  LYS A 467      39.035  -4.286 -24.243  1.00 94.19           C  \nATOM   3596  CD  LYS A 467      39.892  -5.307 -23.477  1.00 94.19           C  \nATOM   3597  CE  LYS A 467      38.904  -6.398 -23.045  1.00 94.19           C  \nATOM   3598  NZ  LYS A 467      39.431  -7.433 -22.119  1.00 94.19           N  \nATOM   3599  N   ASN A 468      36.891  -3.056 -26.529  1.00 96.25           N  \nATOM   3600  CA  ASN A 468      36.093  -3.670 -27.598  1.00 96.25           C  \nATOM   3601  C   ASN A 468      34.977  -2.754 -28.148  1.00 96.25           C  \nATOM   3602  CB  ASN A 468      35.499  -4.984 -27.059  1.00 96.25           C  \nATOM   3603  O   ASN A 468      34.365  -3.093 -29.160  1.00 96.25           O  \nATOM   3604  CG  ASN A 468      36.517  -6.037 -26.662  1.00 96.25           C  \nATOM   3605  ND2 ASN A 468      36.152  -6.901 -25.746  1.00 96.25           N  \nATOM   3606  OD1 ASN A 468      37.636  -6.097 -27.144  1.00 96.25           O  \nATOM   3607  N   LEU A 469      34.697  -1.619 -27.498  1.00 97.12           N  \nATOM   3608  CA  LEU A 469      33.508  -0.797 -27.738  1.00 97.12           C  \nATOM   3609  C   LEU A 469      33.638   0.054 -29.006  1.00 97.12           C  \nATOM   3610  CB  LEU A 469      33.273   0.077 -26.493  1.00 97.12           C  \nATOM   3611  O   LEU A 469      34.571   0.852 -29.108  1.00 97.12           O  \nATOM   3612  CG  LEU A 469      32.100   1.069 -26.584  1.00 97.12           C  \nATOM   3613  CD1 LEU A 469      30.753   0.377 -26.776  1.00 97.12           C  \nATOM   3614  CD2 LEU A 469      32.035   1.897 -25.303  1.00 97.12           C  \nATOM   3615  N   CYS A 470      32.667  -0.065 -29.918  1.00 96.62           N  \nATOM   3616  CA  CYS A 470      32.707   0.595 -31.231  1.00 96.62           C  \nATOM   3617  C   CYS A 470      31.682   1.721 -31.453  1.00 96.62           C  \nATOM   3618  CB  CYS A 470      32.572  -0.490 -32.305  1.00 96.62           C  \nATOM   3619  O   CYS A 470      32.001   2.726 -32.083  1.00 96.62           O  \nATOM   3620  SG  CYS A 470      34.146  -1.300 -32.655  1.00 96.62           S  \nATOM   3621  N   TYR A 471      30.454   1.585 -30.949  1.00 96.94           N  \nATOM   3622  CA  TYR A 471      29.325   2.406 -31.422  1.00 96.94           C  \nATOM   3623  C   TYR A 471      29.204   3.789 -30.753  1.00 96.94           C  \nATOM   3624  CB  TYR A 471      28.033   1.581 -31.319  1.00 96.94           C  \nATOM   3625  O   TYR A 471      28.505   4.661 -31.265  1.00 96.94           O  \nATOM   3626  CG  TYR A 471      28.135   0.234 -32.014  1.00 96.94           C  \nATOM   3627  CD1 TYR A 471      27.827   0.113 -33.382  1.00 96.94           C  \nATOM   3628  CD2 TYR A 471      28.609  -0.888 -31.308  1.00 96.94           C  \nATOM   3629  CE1 TYR A 471      28.000  -1.121 -34.038  1.00 96.94           C  \nATOM   3630  CE2 TYR A 471      28.793  -2.120 -31.959  1.00 96.94           C  \nATOM   3631  OH  TYR A 471      28.716  -3.409 -33.973  1.00 96.94           O  \nATOM   3632  CZ  TYR A 471      28.498  -2.233 -33.333  1.00 96.94           C  \nATOM   3633  N   ALA A 472      29.925   4.033 -29.651  1.00 95.25           N  \nATOM   3634  CA  ALA A 472      29.798   5.248 -28.830  1.00 95.25           C  \nATOM   3635  C   ALA A 472      30.117   6.570 -29.567  1.00 95.25           C  \nATOM   3636  CB  ALA A 472      30.696   5.078 -27.597  1.00 95.25           C  \nATOM   3637  O   ALA A 472      29.584   7.614 -29.191  1.00 95.25           O  \nATOM   3638  N   ASN A 473      30.943   6.527 -30.621  1.00 93.56           N  \nATOM   3639  CA  ASN A 473      31.246   7.685 -31.474  1.00 93.56           C  \nATOM   3640  C   ASN A 473      30.127   8.016 -32.481  1.00 93.56           C  \nATOM   3641  CB  ASN A 473      32.560   7.435 -32.244  1.00 93.56           C  \nATOM   3642  O   ASN A 473      30.168   9.082 -33.086  1.00 93.56           O  \nATOM   3643  CG  ASN A 473      33.831   7.609 -31.436  1.00 93.56           C  \nATOM   3644  ND2 ASN A 473      34.949   7.748 -32.113  1.00 93.56           N  \nATOM   3645  OD1 ASN A 473      33.855   7.610 -30.215  1.00 93.56           O  \nATOM   3646  N   THR A 474      29.165   7.112 -32.709  1.00 95.31           N  \nATOM   3647  CA  THR A 474      28.102   7.315 -33.713  1.00 95.31           C  \nATOM   3648  C   THR A 474      26.948   8.167 -33.190  1.00 95.31           C  \nATOM   3649  CB  THR A 474      27.543   5.989 -34.259  1.00 95.31           C  \nATOM   3650  O   THR A 474      26.285   8.833 -33.976  1.00 95.31           O  \nATOM   3651  CG2 THR A 474      28.629   5.016 -34.727  1.00 95.31           C  \nATOM   3652  OG1 THR A 474      26.736   5.323 -33.314  1.00 95.31           O  \nATOM   3653  N   ILE A 475      26.721   8.149 -31.873  1.00 96.06           N  \nATOM   3654  CA  ILE A 475      25.610   8.826 -31.200  1.00 96.06           C  \nATOM   3655  C   ILE A 475      25.777  10.347 -31.282  1.00 96.06           C  \nATOM   3656  CB  ILE A 475      25.534   8.360 -29.726  1.00 96.06           C  \nATOM   3657  O   ILE A 475      26.793  10.901 -30.850  1.00 96.06           O  \nATOM   3658  CG1 ILE A 475      25.336   6.837 -29.556  1.00 96.06           C  \nATOM   3659  CG2 ILE A 475      24.465   9.126 -28.923  1.00 96.06           C  \nATOM   3660  CD1 ILE A 475      23.996   6.303 -30.065  1.00 96.06           C  \nATOM   3661  N   ASN A 476      24.738  11.048 -31.737  1.00 95.25           N  \nATOM   3662  CA  ASN A 476      24.660  12.506 -31.661  1.00 95.25           C  \nATOM   3663  C   ASN A 476      24.337  12.982 -30.227  1.00 95.25           C  \nATOM   3664  CB  ASN A 476      23.664  13.009 -32.715  1.00 95.25           C  \nATOM   3665  O   ASN A 476      23.243  13.469 -29.944  1.00 95.25           O  \nATOM   3666  CG  ASN A 476      23.663  14.521 -32.862  1.00 95.25           C  \nATOM   3667  ND2 ASN A 476      22.800  15.028 -33.704  1.00 95.25           N  \nATOM   3668  OD1 ASN A 476      24.439  15.259 -32.261  1.00 95.25           O  \nATOM   3669  N   TRP A 477      25.303  12.852 -29.308  1.00 95.44           N  \nATOM   3670  CA  TRP A 477      25.146  13.140 -27.870  1.00 95.44           C  \nATOM   3671  C   TRP A 477      24.536  14.515 -27.554  1.00 95.44           C  \nATOM   3672  CB  TRP A 477      26.515  13.018 -27.187  1.00 95.44           C  \nATOM   3673  O   TRP A 477      23.827  14.653 -26.563  1.00 95.44           O  \nATOM   3674  CG  TRP A 477      27.068  11.626 -27.122  1.00 95.44           C  \nATOM   3675  CD1 TRP A 477      27.921  11.059 -28.007  1.00 95.44           C  \nATOM   3676  CD2 TRP A 477      26.770  10.589 -26.140  1.00 95.44           C  \nATOM   3677  CE2 TRP A 477      27.456   9.396 -26.518  1.00 95.44           C  \nATOM   3678  CE3 TRP A 477      25.958  10.526 -24.986  1.00 95.44           C  \nATOM   3679  NE1 TRP A 477      28.156   9.745 -27.653  1.00 95.44           N  \nATOM   3680  CH2 TRP A 477      26.500   8.164 -24.668  1.00 95.44           C  \nATOM   3681  CZ2 TRP A 477      27.327   8.196 -25.805  1.00 95.44           C  \nATOM   3682  CZ3 TRP A 477      25.822   9.326 -24.261  1.00 95.44           C  \nATOM   3683  N   LYS A 478      24.731  15.516 -28.424  1.00 93.44           N  \nATOM   3684  CA  LYS A 478      24.129  16.852 -28.278  1.00 93.44           C  \nATOM   3685  C   LYS A 478      22.597  16.853 -28.295  1.00 93.44           C  \nATOM   3686  CB  LYS A 478      24.630  17.785 -29.386  1.00 93.44           C  \nATOM   3687  O   LYS A 478      22.021  17.796 -27.773  1.00 93.44           O  \nATOM   3688  CG  LYS A 478      26.108  18.159 -29.233  1.00 93.44           C  \nATOM   3689  CD  LYS A 478      26.470  19.178 -30.318  1.00 93.44           C  \nATOM   3690  CE  LYS A 478      27.919  19.640 -30.163  1.00 93.44           C  \nATOM   3691  NZ  LYS A 478      28.253  20.661 -31.185  1.00 93.44           N  \nATOM   3692  N   LYS A 479      21.943  15.840 -28.879  1.00 93.25           N  \nATOM   3693  CA  LYS A 479      20.477  15.688 -28.834  1.00 93.25           C  \nATOM   3694  C   LYS A 479      19.958  15.088 -27.528  1.00 93.25           C  \nATOM   3695  CB  LYS A 479      19.980  14.852 -30.023  1.00 93.25           C  \nATOM   3696  O   LYS A 479      18.772  15.211 -27.260  1.00 93.25           O  \nATOM   3697  CG  LYS A 479      20.008  15.660 -31.323  1.00 93.25           C  \nATOM   3698  CD  LYS A 479      19.237  14.928 -32.424  1.00 93.25           C  \nATOM   3699  CE  LYS A 479      19.152  15.836 -33.652  1.00 93.25           C  \nATOM   3700  NZ  LYS A 479      18.365  15.220 -34.741  1.00 93.25           N  \nATOM   3701  N   LEU A 480      20.828  14.455 -26.740  1.00 94.19           N  \nATOM   3702  CA  LEU A 480      20.481  13.898 -25.430  1.00 94.19           C  \nATOM   3703  C   LEU A 480      20.674  14.930 -24.306  1.00 94.19           C  \nATOM   3704  CB  LEU A 480      21.325  12.632 -25.172  1.00 94.19           C  \nATOM   3705  O   LEU A 480      20.121  14.763 -23.228  1.00 94.19           O  \nATOM   3706  CG  LEU A 480      21.279  11.558 -26.279  1.00 94.19           C  \nATOM   3707  CD1 LEU A 480      22.210  10.402 -25.919  1.00 94.19           C  \nATOM   3708  CD2 LEU A 480      19.882  10.982 -26.495  1.00 94.19           C  \nATOM   3709  N   PHE A 481      21.481  15.970 -24.529  1.00 95.69           N  \nATOM   3710  CA  PHE A 481      21.871  16.956 -23.519  1.00 95.69           C  \nATOM   3711  C   PHE A 481      20.790  18.016 -23.265  1.00 95.69           C  \nATOM   3712  CB  PHE A 481      23.210  17.579 -23.951  1.00 95.69           C  \nATOM   3713  O   PHE A 481      20.386  18.728 -24.183  1.00 95.69           O  \nATOM   3714  CG  PHE A 481      24.440  16.678 -23.890  1.00 95.69           C  \nATOM   3715  CD1 PHE A 481      24.448  15.476 -23.151  1.00 95.69           C  \nATOM   3716  CD2 PHE A 481      25.622  17.085 -24.539  1.00 95.69           C  \nATOM   3717  CE1 PHE A 481      25.613  14.703 -23.062  1.00 95.69           C  \nATOM   3718  CE2 PHE A 481      26.796  16.315 -24.440  1.00 95.69           C  \nATOM   3719  CZ  PHE A 481      26.793  15.123 -23.695  1.00 95.69           C  \nATOM   3720  N   GLY A 482      20.358  18.135 -22.004  1.00 83.06           N  \nATOM   3721  CA  GLY A 482      19.377  19.124 -21.551  1.00 83.06           C  \nATOM   3722  C   GLY A 482      19.963  20.490 -21.164  1.00 83.06           C  \nATOM   3723  O   GLY A 482      19.258  21.494 -21.264  1.00 83.06           O  \nATOM   3724  N   THR A 483      21.240  20.572 -20.765  1.00 77.94           N  \nATOM   3725  CA  THR A 483      21.896  21.828 -20.353  1.00 77.94           C  \nATOM   3726  C   THR A 483      22.987  22.289 -21.324  1.00 77.94           C  \nATOM   3727  CB  THR A 483      22.429  21.799 -18.905  1.00 77.94           C  \nATOM   3728  O   THR A 483      23.839  21.537 -21.808  1.00 77.94           O  \nATOM   3729  CG2 THR A 483      21.307  21.739 -17.873  1.00 77.94           C  \nATOM   3730  OG1 THR A 483      23.311  20.727 -18.686  1.00 77.94           O  \nATOM   3731  N   SER A 484      23.000  23.599 -21.594  1.00 77.00           N  \nATOM   3732  CA  SER A 484      23.975  24.254 -22.469  1.00 77.00           C  \nATOM   3733  C   SER A 484      25.366  24.317 -21.822  1.00 77.00           C  \nATOM   3734  CB  SER A 484      23.465  25.646 -22.860  1.00 77.00           C  \nATOM   3735  O   SER A 484      25.745  25.320 -21.218  1.00 77.00           O  \nATOM   3736  OG  SER A 484      23.251  26.435 -21.708  1.00 77.00           O  \nATOM   3737  N   GLY A 485      26.140  23.241 -21.956  1.00 81.12           N  \nATOM   3738  CA  GLY A 485      27.505  23.154 -21.426  1.00 81.12           C  \nATOM   3739  C   GLY A 485      28.071  21.738 -21.311  1.00 81.12           C  \nATOM   3740  O   GLY A 485      29.295  21.604 -21.235  1.00 81.12           O  \nATOM   3741  N   GLN A 486      27.205  20.715 -21.340  1.00 91.06           N  \nATOM   3742  CA  GLN A 486      27.563  19.293 -21.241  1.00 91.06           C  \nATOM   3743  C   GLN A 486      28.554  18.853 -22.330  1.00 91.06           C  \nATOM   3744  CB  GLN A 486      26.294  18.424 -21.322  1.00 91.06           C  \nATOM   3745  O   GLN A 486      28.481  19.274 -23.492  1.00 91.06           O  \nATOM   3746  CG  GLN A 486      25.329  18.646 -20.152  1.00 91.06           C  \nATOM   3747  CD  GLN A 486      24.028  17.864 -20.320  1.00 91.06           C  \nATOM   3748  NE2 GLN A 486      23.959  16.616 -19.925  1.00 91.06           N  \nATOM   3749  OE1 GLN A 486      23.045  18.349 -20.844  1.00 91.06           O  \nATOM   3750  N   LYS A 487      29.495  17.983 -21.953  1.00 90.44           N  \nATOM   3751  CA  LYS A 487      30.600  17.503 -22.795  1.00 90.44           C  \nATOM   3752  C   LYS A 487      30.710  15.983 -22.786  1.00 90.44           C  \nATOM   3753  CB  LYS A 487      31.921  18.134 -22.320  1.00 90.44           C  \nATOM   3754  O   LYS A 487      30.399  15.300 -21.814  1.00 90.44           O  \nATOM   3755  CG  LYS A 487      31.959  19.646 -22.581  1.00 90.44           C  \nATOM   3756  CD  LYS A 487      33.000  20.347 -21.706  1.00 90.44           C  \nATOM   3757  CE  LYS A 487      32.736  21.853 -21.775  1.00 90.44           C  \nATOM   3758  NZ  LYS A 487      33.459  22.579 -20.707  1.00 90.44           N  \nATOM   3759  N   THR A 488      31.246  15.461 -23.883  1.00 94.62           N  \nATOM   3760  CA  THR A 488      31.582  14.046 -24.070  1.00 94.62           C  \nATOM   3761  C   THR A 488      33.090  13.827 -23.979  1.00 94.62           C  \nATOM   3762  CB  THR A 488      31.104  13.564 -25.446  1.00 94.62           C  \nATOM   3763  O   THR A 488      33.852  14.423 -24.744  1.00 94.62           O  \nATOM   3764  CG2 THR A 488      29.588  13.537 -25.574  1.00 94.62           C  \nATOM   3765  OG1 THR A 488      31.601  14.423 -26.450  1.00 94.62           O  \nATOM   3766  N   LYS A 489      33.535  12.912 -23.116  1.00 91.62           N  \nATOM   3767  CA  LYS A 489      34.921  12.433 -23.032  1.00 91.62           C  \nATOM   3768  C   LYS A 489      34.981  10.959 -23.441  1.00 91.62           C  \nATOM   3769  CB  LYS A 489      35.468  12.732 -21.627  1.00 91.62           C  \nATOM   3770  O   LYS A 489      34.965  10.064 -22.597  1.00 91.62           O  \nATOM   3771  CG  LYS A 489      36.968  12.420 -21.520  1.00 91.62           C  \nATOM   3772  CD  LYS A 489      37.510  12.879 -20.163  1.00 91.62           C  \nATOM   3773  CE  LYS A 489      38.997  12.534 -20.039  1.00 91.62           C  \nATOM   3774  NZ  LYS A 489      39.541  12.982 -18.733  1.00 91.62           N  \nATOM   3775  N   ILE A 490      35.022  10.727 -24.753  1.00 94.75           N  \nATOM   3776  CA  ILE A 490      35.032   9.392 -25.366  1.00 94.75           C  \nATOM   3777  C   ILE A 490      36.434   9.130 -25.926  1.00 94.75           C  \nATOM   3778  CB  ILE A 490      33.905   9.245 -26.418  1.00 94.75           C  \nATOM   3779  O   ILE A 490      36.814   9.695 -26.947  1.00 94.75           O  \nATOM   3780  CG1 ILE A 490      32.542   9.674 -25.823  1.00 94.75           C  \nATOM   3781  CG2 ILE A 490      33.854   7.788 -26.909  1.00 94.75           C  \nATOM   3782  CD1 ILE A 490      31.360   9.593 -26.791  1.00 94.75           C  \nATOM   3783  N   ILE A 491      37.236   8.339 -25.208  1.00 92.56           N  \nATOM   3784  CA  ILE A 491      38.670   8.125 -25.485  1.00 92.56           C  \nATOM   3785  C   ILE A 491      39.097   6.695 -25.134  1.00 92.56           C  \nATOM   3786  CB  ILE A 491      39.560   9.148 -24.730  1.00 92.56           C  \nATOM   3787  O   ILE A 491      38.450   6.031 -24.333  1.00 92.56           O  \nATOM   3788  CG1 ILE A 491      39.336   9.113 -23.199  1.00 92.56           C  \nATOM   3789  CG2 ILE A 491      39.374  10.567 -25.295  1.00 92.56           C  \nATOM   3790  CD1 ILE A 491      40.314   9.993 -22.409  1.00 92.56           C  \nATOM   3791  N   SER A 492      40.204   6.208 -25.700  1.00 92.69           N  \nATOM   3792  CA  SER A 492      40.791   4.898 -25.348  1.00 92.69           C  \nATOM   3793  C   SER A 492      39.829   3.696 -25.456  1.00 92.69           C  \nATOM   3794  CB  SER A 492      41.470   4.961 -23.971  1.00 92.69           C  \nATOM   3795  O   SER A 492      40.005   2.694 -24.767  1.00 92.69           O  \nATOM   3796  OG  SER A 492      42.370   6.054 -23.911  1.00 92.69           O  \nATOM   3797  N   ASN A 493      38.806   3.799 -26.307  1.00 94.31           N  \nATOM   3798  CA  ASN A 493      37.943   2.687 -26.715  1.00 94.31           C  \nATOM   3799  C   ASN A 493      38.485   2.081 -28.026  1.00 94.31           C  \nATOM   3800  CB  ASN A 493      36.490   3.192 -26.817  1.00 94.31           C  \nATOM   3801  O   ASN A 493      39.568   2.465 -28.484  1.00 94.31           O  \nATOM   3802  CG  ASN A 493      36.023   3.910 -25.558  1.00 94.31           C  \nATOM   3803  ND2 ASN A 493      35.560   5.128 -25.694  1.00 94.31           N  \nATOM   3804  OD1 ASN A 493      36.076   3.404 -24.445  1.00 94.31           O  \nATOM   3805  N   ARG A 494      37.761   1.149 -28.660  1.00 93.50           N  \nATOM   3806  CA  ARG A 494      38.211   0.576 -29.937  1.00 93.50           C  \nATOM   3807  C   ARG A 494      38.245   1.654 -31.029  1.00 93.50           C  \nATOM   3808  CB  ARG A 494      37.344  -0.635 -30.309  1.00 93.50           C  \nATOM   3809  O   ARG A 494      37.307   2.428 -31.189  1.00 93.50           O  \nATOM   3810  CG  ARG A 494      38.001  -1.448 -31.429  1.00 93.50           C  \nATOM   3811  CD  ARG A 494      37.355  -2.825 -31.582  1.00 93.50           C  \nATOM   3812  NE  ARG A 494      37.936  -3.522 -32.741  1.00 93.50           N  \nATOM   3813  NH1 ARG A 494      36.160  -4.890 -33.290  1.00 93.50           N  \nATOM   3814  NH2 ARG A 494      37.951  -4.810 -34.584  1.00 93.50           N  \nATOM   3815  CZ  ARG A 494      37.347  -4.414 -33.508  1.00 93.50           C  \nATOM   3816  N   GLY A 495      39.348   1.721 -31.778  1.00 88.25           N  \nATOM   3817  CA  GLY A 495      39.540   2.749 -32.803  1.00 88.25           C  \nATOM   3818  C   GLY A 495      38.518   2.634 -33.937  1.00 88.25           C  \nATOM   3819  O   GLY A 495      38.354   1.560 -34.513  1.00 88.25           O  \nATOM   3820  N   GLU A 496      37.884   3.749 -34.301  1.00 89.50           N  \nATOM   3821  CA  GLU A 496      36.762   3.816 -35.253  1.00 89.50           C  \nATOM   3822  C   GLU A 496      37.046   3.126 -36.601  1.00 89.50           C  \nATOM   3823  CB  GLU A 496      36.451   5.303 -35.462  1.00 89.50           C  \nATOM   3824  O   GLU A 496      36.208   2.393 -37.126  1.00 89.50           O  \nATOM   3825  CG  GLU A 496      35.154   5.550 -36.235  1.00 89.50           C  \nATOM   3826  CD  GLU A 496      34.963   7.045 -36.499  1.00 89.50           C  \nATOM   3827  OE1 GLU A 496      34.640   7.363 -37.668  1.00 89.50           O  \nATOM   3828  OE2 GLU A 496      35.163   7.835 -35.551  1.00 89.50           O  \nATOM   3829  N   ASN A 497      38.264   3.274 -37.130  1.00 91.38           N  \nATOM   3830  CA  ASN A 497      38.682   2.606 -38.366  1.00 91.38           C  \nATOM   3831  C   ASN A 497      38.756   1.072 -38.219  1.00 91.38           C  \nATOM   3832  CB  ASN A 497      40.021   3.208 -38.835  1.00 91.38           C  \nATOM   3833  O   ASN A 497      38.474   0.362 -39.178  1.00 91.38           O  \nATOM   3834  CG  ASN A 497      39.899   4.653 -39.297  1.00 91.38           C  \nATOM   3835  ND2 ASN A 497      40.997   5.364 -39.400  1.00 91.38           N  \nATOM   3836  OD1 ASN A 497      38.829   5.165 -39.570  1.00 91.38           O  \nATOM   3837  N   SER A 498      39.072   0.542 -37.029  1.00 94.38           N  \nATOM   3838  CA  SER A 498      39.035  -0.905 -36.739  1.00 94.38           C  \nATOM   3839  C   SER A 498      37.598  -1.425 -36.634  1.00 94.38           C  \nATOM   3840  CB  SER A 498      39.782  -1.210 -35.432  1.00 94.38           C  \nATOM   3841  O   SER A 498      37.310  -2.535 -37.082  1.00 94.38           O  \nATOM   3842  OG  SER A 498      39.934  -2.610 -35.237  1.00 94.38           O  \nATOM   3843  N   CYS A 499      36.687  -0.614 -36.092  1.00 94.81           N  \nATOM   3844  CA  CYS A 499      35.257  -0.916 -36.050  1.00 94.81           C  \nATOM   3845  C   CYS A 499      34.679  -1.008 -37.469  1.00 94.81           C  \nATOM   3846  CB  CYS A 499      34.565   0.155 -35.206  1.00 94.81           C  \nATOM   3847  O   CYS A 499      34.170  -2.059 -37.859  1.00 94.81           O  \nATOM   3848  SG  CYS A 499      35.189   0.213 -33.512  1.00 94.81           S  \nATOM   3849  N   LYS A 500      34.897   0.030 -38.291  1.00 93.62           N  \nATOM   3850  CA  LYS A 500      34.522   0.053 -39.716  1.00 93.62           C  \nATOM   3851  C   LYS A 500      35.127  -1.125 -40.494  1.00 93.62           C  \nATOM   3852  CB  LYS A 500      34.914   1.413 -40.326  1.00 93.62           C  \nATOM   3853  O   LYS A 500      34.401  -1.822 -41.194  1.00 93.62           O  \nATOM   3854  CG  LYS A 500      34.000   2.546 -39.825  1.00 93.62           C  \nATOM   3855  CD  LYS A 500      34.501   3.937 -40.240  1.00 93.62           C  \nATOM   3856  CE  LYS A 500      33.469   4.992 -39.816  1.00 93.62           C  \nATOM   3857  NZ  LYS A 500      33.960   6.380 -39.995  1.00 93.62           N  \nATOM   3858  N   ALA A 501      36.417  -1.416 -40.302  1.00 93.81           N  \nATOM   3859  CA  ALA A 501      37.099  -2.544 -40.947  1.00 93.81           C  \nATOM   3860  C   ALA A 501      36.627  -3.940 -40.484  1.00 93.81           C  \nATOM   3861  CB  ALA A 501      38.609  -2.383 -40.736  1.00 93.81           C  \nATOM   3862  O   ALA A 501      36.962  -4.929 -41.127  1.00 93.81           O  \nATOM   3863  N   THR A 502      35.859  -4.041 -39.391  1.00 93.25           N  \nATOM   3864  CA  THR A 502      35.252  -5.305 -38.924  1.00 93.25           C  \nATOM   3865  C   THR A 502      33.725  -5.321 -39.037  1.00 93.25           C  \nATOM   3866  CB  THR A 502      35.757  -5.734 -37.530  1.00 93.25           C  \nATOM   3867  O   THR A 502      33.077  -6.164 -38.424  1.00 93.25           O  \nATOM   3868  CG2 THR A 502      37.226  -6.149 -37.590  1.00 93.25           C  \nATOM   3869  OG1 THR A 502      35.686  -4.720 -36.547  1.00 93.25           O  \nATOM   3870  N   GLY A 503      33.139  -4.402 -39.815  1.00 93.12           N  \nATOM   3871  CA  GLY A 503      31.687  -4.315 -40.014  1.00 93.12           C  \nATOM   3872  C   GLY A 503      30.901  -3.864 -38.777  1.00 93.12           C  \nATOM   3873  O   GLY A 503      29.677  -3.908 -38.786  1.00 93.12           O  \nATOM   3874  N   GLN A 504      31.581  -3.411 -37.719  1.00 94.75           N  \nATOM   3875  CA  GLN A 504      30.965  -2.937 -36.478  1.00 94.75           C  \nATOM   3876  C   GLN A 504      30.545  -1.472 -36.644  1.00 94.75           C  \nATOM   3877  CB  GLN A 504      31.894  -3.218 -35.283  1.00 94.75           C  \nATOM   3878  O   GLN A 504      31.207  -0.545 -36.172  1.00 94.75           O  \nATOM   3879  CG  GLN A 504      32.055  -4.738 -35.092  1.00 94.75           C  \nATOM   3880  CD  GLN A 504      32.794  -5.147 -33.824  1.00 94.75           C  \nATOM   3881  NE2 GLN A 504      32.743  -6.409 -33.459  1.00 94.75           N  \nATOM   3882  OE1 GLN A 504      33.453  -4.379 -33.144  1.00 94.75           O  \nATOM   3883  N   VAL A 505      29.464  -1.291 -37.404  1.00 95.38           N  \nATOM   3884  CA  VAL A 505      28.840  -0.017 -37.792  1.00 95.38           C  \nATOM   3885  C   VAL A 505      27.321  -0.102 -37.605  1.00 95.38           C  \nATOM   3886  CB  VAL A 505      29.187   0.363 -39.249  1.00 95.38           C  \nATOM   3887  O   VAL A 505      26.780  -1.191 -37.429  1.00 95.38           O  \nATOM   3888  CG1 VAL A 505      30.700   0.533 -39.438  1.00 95.38           C  \nATOM   3889  CG2 VAL A 505      28.682  -0.644 -40.292  1.00 95.38           C  \nATOM   3890  N   CYS A 506      26.626   1.036 -37.631  1.00 96.56           N  \nATOM   3891  CA  CYS A 506      25.168   1.060 -37.499  1.00 96.56           C  \nATOM   3892  C   CYS A 506      24.457   0.325 -38.639  1.00 96.56           C  \nATOM   3893  CB  CYS A 506      24.678   2.511 -37.416  1.00 96.56           C  \nATOM   3894  O   CYS A 506      24.917   0.343 -39.784  1.00 96.56           O  \nATOM   3895  SG  CYS A 506      25.371   3.451 -36.037  1.00 96.56           S  \nATOM   3896  N   HIS A 507      23.301  -0.268 -38.328  1.00 97.06           N  \nATOM   3897  CA  HIS A 507      22.465  -0.938 -39.316  1.00 97.06           C  \nATOM   3898  C   HIS A 507      22.038   0.015 -40.447  1.00 97.06           C  \nATOM   3899  CB  HIS A 507      21.239  -1.559 -38.626  1.00 97.06           C  \nATOM   3900  O   HIS A 507      21.791   1.199 -40.218  1.00 97.06           O  \nATOM   3901  CG  HIS A 507      20.578  -2.579 -39.511  1.00 97.06           C  \nATOM   3902  CD2 HIS A 507      21.145  -3.752 -39.933  1.00 97.06           C  \nATOM   3903  ND1 HIS A 507      19.354  -2.469 -40.131  1.00 97.06           N  \nATOM   3904  CE1 HIS A 507      19.196  -3.546 -40.921  1.00 97.06           C  \nATOM   3905  NE2 HIS A 507      20.273  -4.339 -40.851  1.00 97.06           N  \nATOM   3906  N   ALA A 508      21.868  -0.503 -41.668  1.00 96.69           N  \nATOM   3907  CA  ALA A 508      21.517   0.297 -42.852  1.00 96.69           C  \nATOM   3908  C   ALA A 508      20.136   0.995 -42.777  1.00 96.69           C  \nATOM   3909  CB  ALA A 508      21.614  -0.624 -44.076  1.00 96.69           C  \nATOM   3910  O   ALA A 508      19.835   1.865 -43.599  1.00 96.69           O  \nATOM   3911  N   LEU A 509      19.313   0.612 -41.792  1.00 97.38           N  \nATOM   3912  CA  LEU A 509      18.004   1.199 -41.482  1.00 97.38           C  \nATOM   3913  C   LEU A 509      18.058   2.289 -40.395  1.00 97.38           C  \nATOM   3914  CB  LEU A 509      17.020   0.078 -41.094  1.00 97.38           C  \nATOM   3915  O   LEU A 509      17.037   2.929 -40.145  1.00 97.38           O  \nATOM   3916  CG  LEU A 509      16.798  -0.993 -42.181  1.00 97.38           C  \nATOM   3917  CD1 LEU A 509      15.916  -2.104 -41.628  1.00 97.38           C  \nATOM   3918  CD2 LEU A 509      16.117  -0.419 -43.424  1.00 97.38           C  \nATOM   3919  N   CYS A 510      19.212   2.524 -39.762  1.00 96.75           N  \nATOM   3920  CA  CYS A 510      19.387   3.636 -38.829  1.00 96.75           C  \nATOM   3921  C   CYS A 510      19.471   4.979 -39.571  1.00 96.75           C  \nATOM   3922  CB  CYS A 510      20.635   3.431 -37.955  1.00 96.75           C  \nATOM   3923  O   CYS A 510      19.957   5.065 -40.703  1.00 96.75           O  \nATOM   3924  SG  CYS A 510      20.740   1.912 -36.961  1.00 96.75           S  \nATOM   3925  N   SER A 511      19.022   6.044 -38.912  1.00 95.50           N  \nATOM   3926  CA  SER A 511      19.230   7.423 -39.351  1.00 95.50           C  \nATOM   3927  C   SER A 511      20.689   7.884 -39.124  1.00 95.50           C  \nATOM   3928  CB  SER A 511      18.247   8.327 -38.596  1.00 95.50           C  \nATOM   3929  O   SER A 511      21.466   7.198 -38.451  1.00 95.50           O  \nATOM   3930  OG  SER A 511      18.745   8.572 -37.298  1.00 95.50           O  \nATOM   3931  N   PRO A 512      21.080   9.077 -39.619  1.00 95.06           N  \nATOM   3932  CA  PRO A 512      22.385   9.679 -39.327  1.00 95.06           C  \nATOM   3933  C   PRO A 512      22.649  10.037 -37.850  1.00 95.06           C  \nATOM   3934  CB  PRO A 512      22.464  10.931 -40.211  1.00 95.06           C  \nATOM   3935  O   PRO A 512      23.745  10.498 -37.545  1.00 95.06           O  \nATOM   3936  CG  PRO A 512      21.486  10.639 -41.346  1.00 95.06           C  \nATOM   3937  CD  PRO A 512      20.386   9.866 -40.626  1.00 95.06           C  \nATOM   3938  N   GLU A 513      21.687   9.855 -36.937  1.00 94.25           N  \nATOM   3939  CA  GLU A 513      21.833  10.185 -35.505  1.00 94.25           C  \nATOM   3940  C   GLU A 513      22.619   9.134 -34.697  1.00 94.25           C  \nATOM   3941  CB  GLU A 513      20.448  10.390 -34.873  1.00 94.25           C  \nATOM   3942  O   GLU A 513      22.961   9.376 -33.535  1.00 94.25           O  \nATOM   3943  CG  GLU A 513      19.578  11.433 -35.588  1.00 94.25           C  \nATOM   3944  CD  GLU A 513      20.180  12.841 -35.626  1.00 94.25           C  \nATOM   3945  OE1 GLU A 513      19.695  13.650 -36.446  1.00 94.25           O  \nATOM   3946  OE2 GLU A 513      20.950  13.239 -34.725  1.00 94.25           O  \nATOM   3947  N   GLY A 514      22.907   7.980 -35.309  1.00 95.19           N  \nATOM   3948  CA  GLY A 514      23.739   6.920 -34.744  1.00 95.19           C  \nATOM   3949  C   GLY A 514      22.971   5.711 -34.213  1.00 95.19           C  \nATOM   3950  O   GLY A 514      21.779   5.514 -34.473  1.00 95.19           O  \nATOM   3951  N   CYS A 515      23.690   4.866 -33.477  1.00 97.12           N  \nATOM   3952  CA  CYS A 515      23.182   3.618 -32.923  1.00 97.12           C  \nATOM   3953  C   CYS A 515      23.923   3.206 -31.642  1.00 97.12           C  \nATOM   3954  CB  CYS A 515      23.319   2.516 -33.978  1.00 97.12           C  \nATOM   3955  O   CYS A 515      25.103   3.498 -31.440  1.00 97.12           O  \nATOM   3956  SG  CYS A 515      25.036   2.202 -34.467  1.00 97.12           S  \nATOM   3957  N   TRP A 516      23.232   2.466 -30.782  1.00 97.25           N  \nATOM   3958  CA  TRP A 516      23.747   1.934 -29.519  1.00 97.25           C  \nATOM   3959  C   TRP A 516      24.452   0.572 -29.672  1.00 97.25           C  \nATOM   3960  CB  TRP A 516      22.571   1.881 -28.538  1.00 97.25           C  \nATOM   3961  O   TRP A 516      25.107   0.109 -28.729  1.00 97.25           O  \nATOM   3962  CG  TRP A 516      21.928   3.212 -28.279  1.00 97.25           C  \nATOM   3963  CD1 TRP A 516      20.756   3.651 -28.794  1.00 97.25           C  \nATOM   3964  CD2 TRP A 516      22.440   4.319 -27.475  1.00 97.25           C  \nATOM   3965  CE2 TRP A 516      21.478   5.372 -27.480  1.00 97.25           C  \nATOM   3966  CE3 TRP A 516      23.635   4.542 -26.759  1.00 97.25           C  \nATOM   3967  NE1 TRP A 516      20.458   4.897 -28.276  1.00 97.25           N  \nATOM   3968  CH2 TRP A 516      22.880   6.762 -26.081  1.00 97.25           C  \nATOM   3969  CZ2 TRP A 516      21.678   6.573 -26.784  1.00 97.25           C  \nATOM   3970  CZ3 TRP A 516      23.857   5.752 -26.073  1.00 97.25           C  \nATOM   3971  N   GLY A 517      24.336  -0.041 -30.854  1.00 96.56           N  \nATOM   3972  CA  GLY A 517      24.792  -1.378 -31.235  1.00 96.56           C  \nATOM   3973  C   GLY A 517      24.517  -1.665 -32.727  1.00 96.56           C  \nATOM   3974  O   GLY A 517      24.105  -0.754 -33.448  1.00 96.56           O  \nATOM   3975  N   PRO A 518      24.778  -2.892 -33.215  1.00 95.69           N  \nATOM   3976  CA  PRO A 518      24.668  -3.244 -34.637  1.00 95.69           C  \nATOM   3977  C   PRO A 518      23.238  -3.520 -35.124  1.00 95.69           C  \nATOM   3978  CB  PRO A 518      25.510  -4.514 -34.789  1.00 95.69           C  \nATOM   3979  O   PRO A 518      23.006  -3.560 -36.330  1.00 95.69           O  \nATOM   3980  CG  PRO A 518      25.382  -5.191 -33.423  1.00 95.69           C  \nATOM   3981  CD  PRO A 518      25.282  -4.020 -32.444  1.00 95.69           C  \nATOM   3982  N   GLU A 519      22.296  -3.771 -34.215  1.00 96.25           N  \nATOM   3983  CA  GLU A 519      20.966  -4.283 -34.550  1.00 96.25           C  \nATOM   3984  C   GLU A 519      20.021  -3.175 -35.064  1.00 96.25           C  \nATOM   3985  CB  GLU A 519      20.358  -4.920 -33.296  1.00 96.25           C  \nATOM   3986  O   GLU A 519      20.143  -2.020 -34.645  1.00 96.25           O  \nATOM   3987  CG  GLU A 519      21.068  -6.180 -32.784  1.00 96.25           C  \nATOM   3988  CD  GLU A 519      20.642  -7.409 -33.585  1.00 96.25           C  \nATOM   3989  OE1 GLU A 519      21.483  -7.958 -34.324  1.00 96.25           O  \nATOM   3990  OE2 GLU A 519      19.445  -7.765 -33.448  1.00 96.25           O  \nATOM   3991  N   PRO A 520      18.980  -3.499 -35.859  1.00 96.69           N  \nATOM   3992  CA  PRO A 520      17.955  -2.519 -36.238  1.00 96.69           C  \nATOM   3993  C   PRO A 520      17.143  -2.003 -35.034  1.00 96.69           C  \nATOM   3994  CB  PRO A 520      17.055  -3.218 -37.265  1.00 96.69           C  \nATOM   3995  O   PRO A 520      16.501  -0.959 -35.125  1.00 96.69           O  \nATOM   3996  CG  PRO A 520      17.731  -4.553 -37.584  1.00 96.69           C  \nATOM   3997  CD  PRO A 520      18.665  -4.810 -36.407  1.00 96.69           C  \nATOM   3998  N   ARG A 521      17.189  -2.717 -33.898  1.00 95.88           N  \nATOM   3999  CA  ARG A 521      16.596  -2.341 -32.599  1.00 95.88           C  \nATOM   4000  C   ARG A 521      17.454  -1.376 -31.765  1.00 95.88           C  \nATOM   4001  CB  ARG A 521      16.236  -3.628 -31.823  1.00 95.88           C  \nATOM   4002  O   ARG A 521      17.025  -0.959 -30.693  1.00 95.88           O  \nATOM   4003  CG  ARG A 521      17.448  -4.218 -31.071  1.00 95.88           C  \nATOM   4004  CD  ARG A 521      17.321  -5.673 -30.583  1.00 95.88           C  \nATOM   4005  NE  ARG A 521      17.433  -6.665 -31.675  1.00 95.88           N  \nATOM   4006  NH1 ARG A 521      15.206  -7.023 -32.066  1.00 95.88           N  \nATOM   4007  NH2 ARG A 521      16.727  -7.918 -33.417  1.00 95.88           N  \nATOM   4008  CZ  ARG A 521      16.454  -7.212 -32.369  1.00 95.88           C  \nATOM   4009  N   ASP A 522      18.671  -1.073 -32.222  1.00 96.56           N  \nATOM   4010  CA  ASP A 522      19.642  -0.238 -31.503  1.00 96.56           C  \nATOM   4011  C   ASP A 522      19.845   1.143 -32.158  1.00 96.56           C  \nATOM   4012  CB  ASP A 522      20.987  -0.975 -31.376  1.00 96.56           C  \nATOM   4013  O   ASP A 522      20.651   1.939 -31.675  1.00 96.56           O  \nATOM   4014  CG  ASP A 522      20.976  -2.279 -30.569  1.00 96.56           C  \nATOM   4015  OD1 ASP A 522      20.071  -2.482 -29.718  1.00 96.56           O  \nATOM   4016  OD2 ASP A 522      21.940  -3.053 -30.775  1.00 96.56           O  \nATOM   4017  N   CYS A 523      19.151   1.453 -33.256  1.00 96.31           N  \nATOM   4018  CA  CYS A 523      19.202   2.769 -33.899  1.00 96.31           C  \nATOM   4019  C   CYS A 523      18.650   3.873 -32.977  1.00 96.31           C  \nATOM   4020  CB  CYS A 523      18.378   2.724 -35.189  1.00 96.31           C  \nATOM   4021  O   CYS A 523      17.631   3.673 -32.322  1.00 96.31           O  \nATOM   4022  SG  CYS A 523      18.828   1.467 -36.420  1.00 96.31           S  \nATOM   4023  N   VAL A 524      19.259   5.067 -32.979  1.00 94.56           N  \nATOM   4024  CA  VAL A 524      18.728   6.243 -32.246  1.00 94.56           C  \nATOM   4025  C   VAL A 524      17.402   6.723 -32.847  1.00 94.56           C  \nATOM   4026  CB  VAL A 524      19.766   7.385 -32.243  1.00 94.56           C  \nATOM   4027  O   VAL A 524      16.506   7.169 -32.136  1.00 94.56           O  \nATOM   4028  CG1 VAL A 524      19.241   8.700 -31.652  1.00 94.56           C  \nATOM   4029  CG2 VAL A 524      20.994   6.988 -31.418  1.00 94.56           C  \nATOM   4030  N   SER A 525      17.268   6.615 -34.168  1.00 94.19           N  \nATOM   4031  CA  SER A 525      16.005   6.754 -34.891  1.00 94.19           C  \nATOM   4032  C   SER A 525      16.084   6.011 -36.225  1.00 94.19           C  \nATOM   4033  CB  SER A 525      15.629   8.233 -35.075  1.00 94.19           C  \nATOM   4034  O   SER A 525      17.174   5.746 -36.742  1.00 94.19           O  \nATOM   4035  OG  SER A 525      16.685   9.009 -35.616  1.00 94.19           O  \nATOM   4036  N   CYS A 526      14.931   5.644 -36.778  1.00 95.31           N  \nATOM   4037  CA  CYS A 526      14.849   4.902 -38.032  1.00 95.31           C  \nATOM   4038  C   CYS A 526      14.961   5.825 -39.249  1.00 95.31           C  \nATOM   4039  CB  CYS A 526      13.560   4.072 -38.048  1.00 95.31           C  \nATOM   4040  O   CYS A 526      14.568   6.989 -39.209  1.00 95.31           O  \nATOM   4041  SG  CYS A 526      13.366   3.007 -36.597  1.00 95.31           S  \nATOM   4042  N   ARG A 527      15.486   5.291 -40.354  1.00 93.94           N  \nATOM   4043  CA  ARG A 527      15.575   5.992 -41.643  1.00 93.94           C  \nATOM   4044  C   ARG A 527      14.235   6.055 -42.384  1.00 93.94           C  \nATOM   4045  CB  ARG A 527      16.653   5.293 -42.480  1.00 93.94           C  \nATOM   4046  O   ARG A 527      13.978   7.044 -43.062  1.00 93.94           O  \nATOM   4047  CG  ARG A 527      16.897   6.004 -43.812  1.00 93.94           C  \nATOM   4048  CD  ARG A 527      17.991   5.277 -44.584  1.00 93.94           C  \nATOM   4049  NE  ARG A 527      18.186   5.900 -45.903  1.00 93.94           N  \nATOM   4050  NH1 ARG A 527      19.846   4.496 -46.612  1.00 93.94           N  \nATOM   4051  NH2 ARG A 527      19.126   6.139 -47.955  1.00 93.94           N  \nATOM   4052  CZ  ARG A 527      19.050   5.510 -46.815  1.00 93.94           C  \nATOM   4053  N   ASN A 528      13.427   5.000 -42.256  1.00 92.88           N  \nATOM   4054  CA  ASN A 528      12.116   4.863 -42.893  1.00 92.88           C  \nATOM   4055  C   ASN A 528      11.016   4.764 -41.823  1.00 92.88           C  \nATOM   4056  CB  ASN A 528      12.091   3.643 -43.844  1.00 92.88           C  \nATOM   4057  O   ASN A 528      10.365   5.757 -41.516  1.00 92.88           O  \nATOM   4058  CG  ASN A 528      12.932   3.736 -45.104  1.00 92.88           C  \nATOM   4059  ND2 ASN A 528      12.746   2.787 -45.992  1.00 92.88           N  \nATOM   4060  OD1 ASN A 528      13.772   4.600 -45.307  1.00 92.88           O  \nATOM   4061  N   VAL A 529      10.830   3.563 -41.264  1.00 95.25           N  \nATOM   4062  CA  VAL A 529       9.736   3.205 -40.351  1.00 95.25           C  \nATOM   4063  C   VAL A 529      10.215   2.271 -39.231  1.00 95.25           C  \nATOM   4064  CB  VAL A 529       8.552   2.561 -41.113  1.00 95.25           C  \nATOM   4065  O   VAL A 529      11.261   1.625 -39.355  1.00 95.25           O  \nATOM   4066  CG1 VAL A 529       7.806   3.571 -41.994  1.00 95.25           C  \nATOM   4067  CG2 VAL A 529       8.988   1.392 -42.009  1.00 95.25           C  \nATOM   4068  N   SER A 530       9.454   2.190 -38.140  1.00 95.44           N  \nATOM   4069  CA  SER A 530       9.688   1.285 -37.005  1.00 95.44           C  \nATOM   4070  C   SER A 530       8.548   0.278 -36.836  1.00 95.44           C  \nATOM   4071  CB  SER A 530       9.857   2.081 -35.702  1.00 95.44           C  \nATOM   4072  O   SER A 530       7.381   0.612 -36.999  1.00 95.44           O  \nATOM   4073  OG  SER A 530       8.730   2.907 -35.493  1.00 95.44           O  \nATOM   4074  N   ARG A 531       8.859  -0.958 -36.436  1.00 94.31           N  \nATOM   4075  CA  ARG A 531       7.885  -1.921 -35.903  1.00 94.31           C  \nATOM   4076  C   ARG A 531       8.091  -2.012 -34.395  1.00 94.31           C  \nATOM   4077  CB  ARG A 531       8.002  -3.251 -36.660  1.00 94.31           C  \nATOM   4078  O   ARG A 531       8.929  -2.771 -33.903  1.00 94.31           O  \nATOM   4079  CG  ARG A 531       6.920  -4.253 -36.219  1.00 94.31           C  \nATOM   4080  CD  ARG A 531       6.899  -5.501 -37.112  1.00 94.31           C  \nATOM   4081  NE  ARG A 531       6.349  -5.191 -38.443  1.00 94.31           N  \nATOM   4082  NH1 ARG A 531       8.183  -5.551 -39.792  1.00 94.31           N  \nATOM   4083  NH2 ARG A 531       6.321  -4.740 -40.658  1.00 94.31           N  \nATOM   4084  CZ  ARG A 531       6.951  -5.166 -39.615  1.00 94.31           C  \nATOM   4085  N   GLY A 532       7.383  -1.159 -33.656  1.00 90.50           N  \nATOM   4086  CA  GLY A 532       7.628  -0.939 -32.231  1.00 90.50           C  \nATOM   4087  C   GLY A 532       9.043  -0.404 -31.985  1.00 90.50           C  \nATOM   4088  O   GLY A 532       9.329   0.754 -32.261  1.00 90.50           O  \nATOM   4089  N   ARG A 533       9.943  -1.253 -31.472  1.00 89.88           N  \nATOM   4090  CA  ARG A 533      11.324  -0.871 -31.107  1.00 89.88           C  \nATOM   4091  C   ARG A 533      12.370  -1.131 -32.195  1.00 89.88           C  \nATOM   4092  CB  ARG A 533      11.752  -1.581 -29.814  1.00 89.88           C  \nATOM   4093  O   ARG A 533      13.542  -0.850 -31.974  1.00 89.88           O  \nATOM   4094  CG  ARG A 533      10.793  -1.385 -28.633  1.00 89.88           C  \nATOM   4095  CD  ARG A 533      11.422  -2.052 -27.408  1.00 89.88           C  \nATOM   4096  NE  ARG A 533      10.506  -2.092 -26.251  1.00 89.88           N  \nATOM   4097  NH1 ARG A 533      12.001  -1.396 -24.652  1.00 89.88           N  \nATOM   4098  NH2 ARG A 533      10.047  -2.212 -24.015  1.00 89.88           N  \nATOM   4099  CZ  ARG A 533      10.850  -1.897 -24.990  1.00 89.88           C  \nATOM   4100  N   GLU A 534      11.990  -1.739 -33.315  1.00 95.06           N  \nATOM   4101  CA  GLU A 534      12.928  -2.212 -34.338  1.00 95.06           C  \nATOM   4102  C   GLU A 534      12.723  -1.453 -35.651  1.00 95.06           C  \nATOM   4103  CB  GLU A 534      12.779  -3.739 -34.466  1.00 95.06           C  \nATOM   4104  O   GLU A 534      11.605  -1.382 -36.156  1.00 95.06           O  \nATOM   4105  CG  GLU A 534      13.905  -4.377 -35.294  1.00 95.06           C  \nATOM   4106  CD  GLU A 534      14.006  -5.906 -35.144  1.00 95.06           C  \nATOM   4107  OE1 GLU A 534      14.634  -6.542 -36.014  1.00 95.06           O  \nATOM   4108  OE2 GLU A 534      13.591  -6.451 -34.094  1.00 95.06           O  \nATOM   4109  N   CYS A 535      13.785  -0.869 -36.209  1.00 96.75           N  \nATOM   4110  CA  CYS A 535      13.716  -0.202 -37.506  1.00 96.75           C  \nATOM   4111  C   CYS A 535      13.582  -1.228 -38.632  1.00 96.75           C  \nATOM   4112  CB  CYS A 535      14.952   0.676 -37.708  1.00 96.75           C  \nATOM   4113  O   CYS A 535      14.401  -2.142 -38.735  1.00 96.75           O  \nATOM   4114  SG  CYS A 535      15.128   1.995 -36.486  1.00 96.75           S  \nATOM   4115  N   VAL A 536      12.586  -1.049 -39.500  1.00 96.44           N  \nATOM   4116  CA  VAL A 536      12.273  -1.976 -40.599  1.00 96.44           C  \nATOM   4117  C   VAL A 536      12.279  -1.252 -41.948  1.00 96.44           C  \nATOM   4118  CB  VAL A 536      10.987  -2.786 -40.325  1.00 96.44           C  \nATOM   4119  O   VAL A 536      12.230  -0.023 -42.022  1.00 96.44           O  \nATOM   4120  CG1 VAL A 536      11.130  -3.589 -39.023  1.00 96.44           C  \nATOM   4121  CG2 VAL A 536       9.716  -1.937 -40.245  1.00 96.44           C  \nATOM   4122  N   ASP A 537      12.414  -2.011 -43.032  1.00 94.31           N  \nATOM   4123  CA  ASP A 537      12.427  -1.484 -44.399  1.00 94.31           C  \nATOM   4124  C   ASP A 537      11.032  -1.011 -44.841  1.00 94.31           C  \nATOM   4125  CB  ASP A 537      13.008  -2.551 -45.353  1.00 94.31           C  \nATOM   4126  O   ASP A 537      10.916   0.048 -45.469  1.00 94.31           O  \nATOM   4127  CG  ASP A 537      12.156  -3.828 -45.467  1.00 94.31           C  \nATOM   4128  OD1 ASP A 537      11.660  -4.288 -44.413  1.00 94.31           O  \nATOM   4129  OD2 ASP A 537      11.982  -4.320 -46.604  1.00 94.31           O  \nATOM   4130  N   LYS A 538       9.993  -1.775 -44.468  1.00 94.62           N  \nATOM   4131  CA  LYS A 538       8.574  -1.539 -44.779  1.00 94.62           C  \nATOM   4132  C   LYS A 538       7.622  -2.082 -43.699  1.00 94.62           C  \nATOM   4133  CB  LYS A 538       8.250  -2.163 -46.154  1.00 94.62           C  \nATOM   4134  O   LYS A 538       7.928  -3.047 -42.994  1.00 94.62           O  \nATOM   4135  CG  LYS A 538       8.391  -3.697 -46.161  1.00 94.62           C  \nATOM   4136  CD  LYS A 538       8.262  -4.296 -47.563  1.00 94.62           C  \nATOM   4137  CE  LYS A 538       8.649  -5.774 -47.475  1.00 94.62           C  \nATOM   4138  NZ  LYS A 538       8.467  -6.471 -48.769  1.00 94.62           N  \nATOM   4139  N   CYS A 539       6.430  -1.492 -43.636  1.00 95.25           N  \nATOM   4140  CA  CYS A 539       5.287  -2.028 -42.892  1.00 95.25           C  \nATOM   4141  C   CYS A 539       4.493  -3.041 -43.739  1.00 95.25           C  \nATOM   4142  CB  CYS A 539       4.395  -0.876 -42.413  1.00 95.25           C  \nATOM   4143  O   CYS A 539       4.551  -3.013 -44.972  1.00 95.25           O  \nATOM   4144  SG  CYS A 539       5.238   0.462 -41.529  1.00 95.25           S  \nATOM   4145  N   ASN A 540       3.711  -3.901 -43.086  1.00 95.81           N  \nATOM   4146  CA  ASN A 540       2.922  -4.978 -43.693  1.00 95.81           C  \nATOM   4147  C   ASN A 540       1.602  -4.460 -44.305  1.00 95.81           C  \nATOM   4148  CB  ASN A 540       2.685  -6.077 -42.643  1.00 95.81           C  \nATOM   4149  O   ASN A 540       0.504  -4.840 -43.890  1.00 95.81           O  \nATOM   4150  CG  ASN A 540       3.926  -6.814 -42.176  1.00 95.81           C  \nATOM   4151  ND2 ASN A 540       3.767  -7.619 -41.155  1.00 95.81           N  \nATOM   4152  OD1 ASN A 540       5.022  -6.710 -42.710  1.00 95.81           O  \nATOM   4153  N   LEU A 541       1.707  -3.534 -45.264  1.00 94.88           N  \nATOM   4154  CA  LEU A 541       0.555  -2.829 -45.840  1.00 94.88           C  \nATOM   4155  C   LEU A 541      -0.222  -3.719 -46.826  1.00 94.88           C  \nATOM   4156  CB  LEU A 541       1.016  -1.510 -46.501  1.00 94.88           C  \nATOM   4157  O   LEU A 541      -1.407  -3.991 -46.634  1.00 94.88           O  \nATOM   4158  CG  LEU A 541       1.863  -0.571 -45.620  1.00 94.88           C  \nATOM   4159  CD1 LEU A 541       2.164   0.725 -46.374  1.00 94.88           C  \nATOM   4160  CD2 LEU A 541       1.175  -0.220 -44.306  1.00 94.88           C  \nATOM   4161  N   LEU A 542       0.466  -4.189 -47.874  1.00 94.00           N  \nATOM   4162  CA  LEU A 542      -0.098  -4.960 -48.999  1.00 94.00           C  \nATOM   4163  C   LEU A 542       0.157  -6.475 -48.886  1.00 94.00           C  \nATOM   4164  CB  LEU A 542       0.507  -4.443 -50.321  1.00 94.00           C  \nATOM   4165  O   LEU A 542      -0.486  -7.277 -49.564  1.00 94.00           O  \nATOM   4166  CG  LEU A 542       0.471  -2.920 -50.553  1.00 94.00           C  \nATOM   4167  CD1 LEU A 542       1.076  -2.600 -51.920  1.00 94.00           C  \nATOM   4168  CD2 LEU A 542      -0.943  -2.347 -50.514  1.00 94.00           C  \nATOM   4169  N   GLU A 543       1.119  -6.846 -48.044  1.00 91.44           N  \nATOM   4170  CA  GLU A 543       1.660  -8.187 -47.827  1.00 91.44           C  \nATOM   4171  C   GLU A 543       2.238  -8.276 -46.403  1.00 91.44           C  \nATOM   4172  CB  GLU A 543       2.749  -8.504 -48.877  1.00 91.44           C  \nATOM   4173  O   GLU A 543       2.474  -7.247 -45.770  1.00 91.44           O  \nATOM   4174  CG  GLU A 543       3.941  -7.525 -48.854  1.00 91.44           C  \nATOM   4175  CD  GLU A 543       5.096  -7.903 -49.796  1.00 91.44           C  \nATOM   4176  OE1 GLU A 543       6.117  -7.171 -49.755  1.00 91.44           O  \nATOM   4177  OE2 GLU A 543       5.008  -8.919 -50.516  1.00 91.44           O  \nATOM   4178  N   GLY A 544       2.501  -9.493 -45.921  1.00 89.31           N  \nATOM   4179  CA  GLY A 544       3.003  -9.742 -44.565  1.00 89.31           C  \nATOM   4180  C   GLY A 544       1.893  -9.912 -43.524  1.00 89.31           C  \nATOM   4181  O   GLY A 544       0.760  -9.482 -43.728  1.00 89.31           O  \nATOM   4182  N   GLU A 545       2.236 -10.566 -42.414  1.00 89.19           N  \nATOM   4183  CA  GLU A 545       1.342 -10.830 -41.282  1.00 89.19           C  \nATOM   4184  C   GLU A 545       2.057 -10.517 -39.952  1.00 89.19           C  \nATOM   4185  CB  GLU A 545       0.859 -12.293 -41.290  1.00 89.19           C  \nATOM   4186  O   GLU A 545       3.243 -10.844 -39.821  1.00 89.19           O  \nATOM   4187  CG  GLU A 545      -0.140 -12.618 -42.415  1.00 89.19           C  \nATOM   4188  CD  GLU A 545      -1.415 -11.753 -42.380  1.00 89.19           C  \nATOM   4189  OE1 GLU A 545      -2.025 -11.571 -43.461  1.00 89.19           O  \nATOM   4190  OE2 GLU A 545      -1.767 -11.261 -41.282  1.00 89.19           O  \nATOM   4191  N   PRO A 546       1.381  -9.907 -38.957  1.00 94.00           N  \nATOM   4192  CA  PRO A 546       0.044  -9.312 -39.056  1.00 94.00           C  \nATOM   4193  C   PRO A 546       0.034  -8.116 -40.019  1.00 94.00           C  \nATOM   4194  CB  PRO A 546      -0.308  -8.866 -37.634  1.00 94.00           C  \nATOM   4195  O   PRO A 546       1.073  -7.493 -40.250  1.00 94.00           O  \nATOM   4196  CG  PRO A 546       1.059  -8.542 -37.034  1.00 94.00           C  \nATOM   4197  CD  PRO A 546       1.975  -9.584 -37.670  1.00 94.00           C  \nATOM   4198  N   ARG A 547      -1.134  -7.792 -40.578  1.00 95.94           N  \nATOM   4199  CA  ARG A 547      -1.320  -6.592 -41.407  1.00 95.94           C  \nATOM   4200  C   ARG A 547      -1.240  -5.305 -40.599  1.00 95.94           C  \nATOM   4201  CB  ARG A 547      -2.642  -6.675 -42.174  1.00 95.94           C  \nATOM   4202  O   ARG A 547      -1.622  -5.268 -39.431  1.00 95.94           O  \nATOM   4203  CG  ARG A 547      -2.561  -7.689 -43.315  1.00 95.94           C  \nATOM   4204  CD  ARG A 547      -1.603  -7.220 -44.420  1.00 95.94           C  \nATOM   4205  NE  ARG A 547      -1.742  -8.101 -45.579  1.00 95.94           N  \nATOM   4206  NH1 ARG A 547      -2.558  -6.579 -47.127  1.00 95.94           N  \nATOM   4207  NH2 ARG A 547      -2.586  -8.752 -47.559  1.00 95.94           N  \nATOM   4208  CZ  ARG A 547      -2.279  -7.795 -46.743  1.00 95.94           C  \nATOM   4209  N   GLU A 548      -0.757  -4.250 -41.242  1.00 97.00           N  \nATOM   4210  CA  GLU A 548      -0.418  -2.976 -40.603  1.00 97.00           C  \nATOM   4211  C   GLU A 548      -0.872  -1.769 -41.440  1.00 97.00           C  \nATOM   4212  CB  GLU A 548       1.107  -2.924 -40.371  1.00 97.00           C  \nATOM   4213  O   GLU A 548      -1.110  -1.878 -42.645  1.00 97.00           O  \nATOM   4214  CG  GLU A 548       1.606  -3.933 -39.315  1.00 97.00           C  \nATOM   4215  CD  GLU A 548       3.130  -4.101 -39.298  1.00 97.00           C  \nATOM   4216  OE1 GLU A 548       3.682  -4.567 -38.278  1.00 97.00           O  \nATOM   4217  OE2 GLU A 548       3.803  -3.808 -40.316  1.00 97.00           O  \nATOM   4218  N   PHE A 549      -0.927  -0.604 -40.796  1.00 96.44           N  \nATOM   4219  CA  PHE A 549      -0.954   0.722 -41.418  1.00 96.44           C  \nATOM   4220  C   PHE A 549       0.228   1.564 -40.892  1.00 96.44           C  \nATOM   4221  CB  PHE A 549      -2.328   1.382 -41.204  1.00 96.44           C  \nATOM   4222  O   PHE A 549       0.973   1.111 -40.017  1.00 96.44           O  \nATOM   4223  CG  PHE A 549      -2.589   1.864 -39.790  1.00 96.44           C  \nATOM   4224  CD1 PHE A 549      -2.915   0.944 -38.775  1.00 96.44           C  \nATOM   4225  CD2 PHE A 549      -2.484   3.234 -39.483  1.00 96.44           C  \nATOM   4226  CE1 PHE A 549      -3.085   1.382 -37.452  1.00 96.44           C  \nATOM   4227  CE2 PHE A 549      -2.662   3.670 -38.160  1.00 96.44           C  \nATOM   4228  CZ  PHE A 549      -2.926   2.744 -37.142  1.00 96.44           C  \nATOM   4229  N   VAL A 550       0.434   2.769 -41.441  1.00 95.69           N  \nATOM   4230  CA  VAL A 550       1.501   3.690 -41.000  1.00 95.69           C  \nATOM   4231  C   VAL A 550       0.900   4.913 -40.318  1.00 95.69           C  \nATOM   4232  CB  VAL A 550       2.433   4.149 -42.142  1.00 95.69           C  \nATOM   4233  O   VAL A 550       0.088   5.615 -40.916  1.00 95.69           O  \nATOM   4234  CG1 VAL A 550       3.717   4.771 -41.572  1.00 95.69           C  \nATOM   4235  CG2 VAL A 550       2.838   3.008 -43.078  1.00 95.69           C  \nATOM   4236  N   GLU A 551       1.360   5.211 -39.107  1.00 93.50           N  \nATOM   4237  CA  GLU A 551       1.025   6.423 -38.352  1.00 93.50           C  \nATOM   4238  C   GLU A 551       2.304   6.915 -37.661  1.00 93.50           C  \nATOM   4239  CB  GLU A 551      -0.159   6.108 -37.416  1.00 93.50           C  \nATOM   4240  O   GLU A 551       2.997   6.142 -37.011  1.00 93.50           O  \nATOM   4241  CG  GLU A 551      -0.367   6.986 -36.175  1.00 93.50           C  \nATOM   4242  CD  GLU A 551      -1.574   6.467 -35.369  1.00 93.50           C  \nATOM   4243  OE1 GLU A 551      -1.369   5.739 -34.367  1.00 93.50           O  \nATOM   4244  OE2 GLU A 551      -2.724   6.750 -35.759  1.00 93.50           O  \nATOM   4245  N   ASN A 552       2.681   8.183 -37.870  1.00 91.81           N  \nATOM   4246  CA  ASN A 552       3.929   8.781 -37.358  1.00 91.81           C  \nATOM   4247  C   ASN A 552       5.224   7.994 -37.685  1.00 91.81           C  \nATOM   4248  CB  ASN A 552       3.751   9.108 -35.864  1.00 91.81           C  \nATOM   4249  O   ASN A 552       6.176   7.997 -36.910  1.00 91.81           O  \nATOM   4250  CG  ASN A 552       2.571  10.030 -35.627  1.00 91.81           C  \nATOM   4251  ND2 ASN A 552       1.774   9.771 -34.619  1.00 91.81           N  \nATOM   4252  OD1 ASN A 552       2.336  10.977 -36.360  1.00 91.81           O  \nATOM   4253  N   SER A 553       5.262   7.335 -38.850  1.00 93.00           N  \nATOM   4254  CA  SER A 553       6.311   6.386 -39.278  1.00 93.00           C  \nATOM   4255  C   SER A 553       6.433   5.103 -38.437  1.00 93.00           C  \nATOM   4256  CB  SER A 553       7.674   7.065 -39.483  1.00 93.00           C  \nATOM   4257  O   SER A 553       7.380   4.339 -38.624  1.00 93.00           O  \nATOM   4258  OG  SER A 553       7.606   8.045 -40.503  1.00 93.00           O  \nATOM   4259  N   GLU A 554       5.462   4.805 -37.576  1.00 94.62           N  \nATOM   4260  CA  GLU A 554       5.346   3.511 -36.903  1.00 94.62           C  \nATOM   4261  C   GLU A 554       4.425   2.570 -37.697  1.00 94.62           C  \nATOM   4262  CB  GLU A 554       4.870   3.670 -35.449  1.00 94.62           C  \nATOM   4263  O   GLU A 554       3.362   2.962 -38.184  1.00 94.62           O  \nATOM   4264  CG  GLU A 554       5.697   4.693 -34.649  1.00 94.62           C  \nATOM   4265  CD  GLU A 554       5.583   4.503 -33.128  1.00 94.62           C  \nATOM   4266  OE1 GLU A 554       6.611   4.731 -32.447  1.00 94.62           O  \nATOM   4267  OE2 GLU A 554       4.496   4.106 -32.645  1.00 94.62           O  \nATOM   4268  N   CYS A 555       4.838   1.310 -37.817  1.00 96.38           N  \nATOM   4269  CA  CYS A 555       4.047   0.208 -38.345  1.00 96.38           C  \nATOM   4270  C   CYS A 555       3.122  -0.311 -37.239  1.00 96.38           C  \nATOM   4271  CB  CYS A 555       4.980  -0.910 -38.832  1.00 96.38           C  \nATOM   4272  O   CYS A 555       3.574  -0.992 -36.312  1.00 96.38           O  \nATOM   4273  SG  CYS A 555       6.258  -0.473 -40.040  1.00 96.38           S  \nATOM   4274  N   ILE A 556       1.834   0.018 -37.324  1.00 95.81           N  \nATOM   4275  CA  ILE A 556       0.843  -0.308 -36.293  1.00 95.81           C  \nATOM   4276  C   ILE A 556      -0.146  -1.325 -36.855  1.00 95.81           C  \nATOM   4277  CB  ILE A 556       0.190   0.980 -35.750  1.00 95.81           C  \nATOM   4278  O   ILE A 556      -0.608  -1.207 -37.988  1.00 95.81           O  \nATOM   4279  CG1 ILE A 556       1.253   1.848 -35.029  1.00 95.81           C  \nATOM   4280  CG2 ILE A 556      -0.939   0.658 -34.747  1.00 95.81           C  \nATOM   4281  CD1 ILE A 556       0.893   3.332 -34.989  1.00 95.81           C  \nATOM   4282  N   GLN A 557      -0.444  -2.356 -36.067  1.00 96.12           N  \nATOM   4283  CA  GLN A 557      -1.255  -3.491 -36.505  1.00 96.12           C  \nATOM   4284  C   GLN A 557      -2.714  -3.087 -36.748  1.00 96.12           C  \nATOM   4285  CB  GLN A 557      -1.145  -4.647 -35.496  1.00 96.12           C  \nATOM   4286  O   GLN A 557      -3.310  -2.343 -35.965  1.00 96.12           O  \nATOM   4287  CG  GLN A 557       0.302  -5.160 -35.389  1.00 96.12           C  \nATOM   4288  CD  GLN A 557       0.493  -6.296 -34.387  1.00 96.12           C  \nATOM   4289  NE2 GLN A 557       1.724  -6.683 -34.134  1.00 96.12           N  \nATOM   4290  OE1 GLN A 557      -0.419  -6.859 -33.810  1.00 96.12           O  \nATOM   4291  N   CYS A 558      -3.296  -3.624 -37.820  1.00 96.06           N  \nATOM   4292  CA  CYS A 558      -4.734  -3.592 -38.051  1.00 96.06           C  \nATOM   4293  C   CYS A 558      -5.473  -4.363 -36.945  1.00 96.06           C  \nATOM   4294  CB  CYS A 558      -5.049  -4.187 -39.433  1.00 96.06           C  \nATOM   4295  O   CYS A 558      -4.915  -5.249 -36.295  1.00 96.06           O  \nATOM   4296  SG  CYS A 558      -4.405  -3.263 -40.856  1.00 96.06           S  \nATOM   4297  N   HIS A 559      -6.755  -4.055 -36.744  1.00 96.31           N  \nATOM   4298  CA  HIS A 559      -7.581  -4.812 -35.807  1.00 96.31           C  \nATOM   4299  C   HIS A 559      -7.723  -6.285 -36.262  1.00 96.31           C  \nATOM   4300  CB  HIS A 559      -8.933  -4.108 -35.670  1.00 96.31           C  \nATOM   4301  O   HIS A 559      -7.854  -6.516 -37.466  1.00 96.31           O  \nATOM   4302  CG  HIS A 559      -9.781  -4.663 -34.561  1.00 96.31           C  \nATOM   4303  CD2 HIS A 559      -9.576  -4.490 -33.219  1.00 96.31           C  \nATOM   4304  ND1 HIS A 559     -10.905  -5.442 -34.702  1.00 96.31           N  \nATOM   4305  CE1 HIS A 559     -11.368  -5.730 -33.474  1.00 96.31           C  \nATOM   4306  NE2 HIS A 559     -10.580  -5.180 -32.537  1.00 96.31           N  \nATOM   4307  N   PRO A 560      -7.757  -7.286 -35.355  1.00 96.44           N  \nATOM   4308  CA  PRO A 560      -7.840  -8.706 -35.734  1.00 96.44           C  \nATOM   4309  C   PRO A 560      -9.080  -9.101 -36.552  1.00 96.44           C  \nATOM   4310  CB  PRO A 560      -7.803  -9.484 -34.415  1.00 96.44           C  \nATOM   4311  O   PRO A 560      -9.097 -10.162 -37.167  1.00 96.44           O  \nATOM   4312  CG  PRO A 560      -7.020  -8.560 -33.488  1.00 96.44           C  \nATOM   4313  CD  PRO A 560      -7.500  -7.179 -33.924  1.00 96.44           C  \nATOM   4314  N   GLU A 561     -10.111  -8.254 -36.563  1.00 96.81           N  \nATOM   4315  CA  GLU A 561     -11.329  -8.438 -37.362  1.00 96.81           C  \nATOM   4316  C   GLU A 561     -11.232  -7.829 -38.779  1.00 96.81           C  \nATOM   4317  CB  GLU A 561     -12.549  -7.905 -36.586  1.00 96.81           C  \nATOM   4318  O   GLU A 561     -12.208  -7.892 -39.523  1.00 96.81           O  \nATOM   4319  CG  GLU A 561     -12.762  -8.590 -35.220  1.00 96.81           C  \nATOM   4320  CD  GLU A 561     -13.043 -10.093 -35.348  1.00 96.81           C  \nATOM   4321  OE1 GLU A 561     -12.545 -10.884 -34.513  1.00 96.81           O  \nATOM   4322  OE2 GLU A 561     -13.789 -10.467 -36.278  1.00 96.81           O  \nATOM   4323  N   CYS A 562     -10.087  -7.258 -39.180  1.00 96.75           N  \nATOM   4324  CA  CYS A 562      -9.847  -6.802 -40.554  1.00 96.75           C  \nATOM   4325  C   CYS A 562      -9.335  -7.957 -41.431  1.00 96.75           C  \nATOM   4326  CB  CYS A 562      -8.829  -5.649 -40.583  1.00 96.75           C  \nATOM   4327  O   CYS A 562      -8.280  -8.527 -41.153  1.00 96.75           O  \nATOM   4328  SG  CYS A 562      -9.141  -4.165 -39.586  1.00 96.75           S  \nATOM   4329  N   LEU A 563     -10.032  -8.276 -42.524  1.00 96.00           N  \nATOM   4330  CA  LEU A 563      -9.647  -9.353 -43.442  1.00 96.00           C  \nATOM   4331  C   LEU A 563      -8.448  -8.936 -44.326  1.00 96.00           C  \nATOM   4332  CB  LEU A 563     -10.866  -9.735 -44.301  1.00 96.00           C  \nATOM   4333  O   LEU A 563      -8.595  -7.974 -45.087  1.00 96.00           O  \nATOM   4334  CG  LEU A 563     -10.635 -10.968 -45.194  1.00 96.00           C  \nATOM   4335  CD1 LEU A 563     -10.510 -12.263 -44.387  1.00 96.00           C  \nATOM   4336  CD2 LEU A 563     -11.807 -11.133 -46.158  1.00 96.00           C  \nATOM   4337  N   PRO A 564      -7.299  -9.648 -44.302  1.00 95.56           N  \nATOM   4338  CA  PRO A 564      -6.112  -9.289 -45.084  1.00 95.56           C  \nATOM   4339  C   PRO A 564      -6.372  -9.155 -46.592  1.00 95.56           C  \nATOM   4340  CB  PRO A 564      -5.063 -10.363 -44.768  1.00 95.56           C  \nATOM   4341  O   PRO A 564      -6.715 -10.123 -47.271  1.00 95.56           O  \nATOM   4342  CG  PRO A 564      -5.430 -10.782 -43.348  1.00 95.56           C  \nATOM   4343  CD  PRO A 564      -6.957 -10.729 -43.383  1.00 95.56           C  \nATOM   4344  N   GLN A 565      -6.170  -7.952 -47.134  1.00 94.69           N  \nATOM   4345  CA  GLN A 565      -6.502  -7.630 -48.525  1.00 94.69           C  \nATOM   4346  C   GLN A 565      -5.343  -7.951 -49.479  1.00 94.69           C  \nATOM   4347  CB  GLN A 565      -6.915  -6.155 -48.624  1.00 94.69           C  \nATOM   4348  O   GLN A 565      -4.236  -7.426 -49.343  1.00 94.69           O  \nATOM   4349  CG  GLN A 565      -8.211  -5.828 -47.866  1.00 94.69           C  \nATOM   4350  CD  GLN A 565      -9.407  -6.592 -48.419  1.00 94.69           C  \nATOM   4351  NE2 GLN A 565     -10.016  -7.463 -47.647  1.00 94.69           N  \nATOM   4352  OE1 GLN A 565      -9.774  -6.441 -49.572  1.00 94.69           O  \nATOM   4353  N   ALA A 566      -5.564  -8.819 -50.467  1.00 90.69           N  \nATOM   4354  CA  ALA A 566      -4.529  -9.185 -51.434  1.00 90.69           C  \nATOM   4355  C   ALA A 566      -4.162  -7.991 -52.339  1.00 90.69           C  \nATOM   4356  CB  ALA A 566      -5.008 -10.400 -52.238  1.00 90.69           C  \nATOM   4357  O   ALA A 566      -5.022  -7.456 -53.034  1.00 90.69           O  \nATOM   4358  N   MET A 567      -2.882  -7.592 -52.347  1.00 88.38           N  \nATOM   4359  CA  MET A 567      -2.351  -6.456 -53.127  1.00 88.38           C  \nATOM   4360  C   MET A 567      -3.006  -5.087 -52.838  1.00 88.38           C  \nATOM   4361  CB  MET A 567      -2.316  -6.785 -54.636  1.00 88.38           C  \nATOM   4362  O   MET A 567      -2.861  -4.156 -53.628  1.00 88.38           O  \nATOM   4363  CG  MET A 567      -1.427  -7.984 -54.980  1.00 88.38           C  \nATOM   4364  SD  MET A 567       0.336  -7.716 -54.647  1.00 88.38           S  \nATOM   4365  CE  MET A 567       1.022  -9.247 -55.326  1.00 88.38           C  \nATOM   4366  N   ASN A 568      -3.689  -4.935 -51.700  1.00 93.56           N  \nATOM   4367  CA  ASN A 568      -4.282  -3.673 -51.252  1.00 93.56           C  \nATOM   4368  C   ASN A 568      -4.079  -3.493 -49.735  1.00 93.56           C  \nATOM   4369  CB  ASN A 568      -5.763  -3.644 -51.683  1.00 93.56           C  \nATOM   4370  O   ASN A 568      -3.705  -4.443 -49.041  1.00 93.56           O  \nATOM   4371  CG  ASN A 568      -6.379  -2.255 -51.653  1.00 93.56           C  \nATOM   4372  ND2 ASN A 568      -7.677  -2.159 -51.818  1.00 93.56           N  \nATOM   4373  OD1 ASN A 568      -5.716  -1.244 -51.490  1.00 93.56           O  \nATOM   4374  N   ILE A 569      -4.303  -2.281 -49.221  1.00 95.44           N  \nATOM   4375  CA  ILE A 569      -4.271  -2.010 -47.778  1.00 95.44           C  \nATOM   4376  C   ILE A 569      -5.399  -2.763 -47.059  1.00 95.44           C  \nATOM   4377  CB  ILE A 569      -4.294  -0.493 -47.466  1.00 95.44           C  \nATOM   4378  O   ILE A 569      -6.482  -2.944 -47.611  1.00 95.44           O  \nATOM   4379  CG1 ILE A 569      -5.567   0.216 -47.985  1.00 95.44           C  \nATOM   4380  CG2 ILE A 569      -3.014   0.161 -48.019  1.00 95.44           C  \nATOM   4381  CD1 ILE A 569      -5.706   1.670 -47.516  1.00 95.44           C  \nATOM   4382  N   THR A 570      -5.150  -3.199 -45.823  1.00 96.38           N  \nATOM   4383  CA  THR A 570      -6.126  -3.963 -45.017  1.00 96.38           C  \nATOM   4384  C   THR A 570      -6.930  -3.082 -44.058  1.00 96.38           C  \nATOM   4385  CB  THR A 570      -5.396  -5.077 -44.257  1.00 96.38           C  \nATOM   4386  O   THR A 570      -8.097  -3.370 -43.787  1.00 96.38           O  \nATOM   4387  CG2 THR A 570      -6.267  -5.879 -43.293  1.00 96.38           C  \nATOM   4388  OG1 THR A 570      -4.875  -5.994 -45.191  1.00 96.38           O  \nATOM   4389  N   CYS A 571      -6.331  -1.997 -43.565  1.00 96.75           N  \nATOM   4390  CA  CYS A 571      -6.987  -1.017 -42.708  1.00 96.75           C  \nATOM   4391  C   CYS A 571      -6.439   0.401 -42.941  1.00 96.75           C  \nATOM   4392  CB  CYS A 571      -6.837  -1.433 -41.235  1.00 96.75           C  \nATOM   4393  O   CYS A 571      -5.357   0.574 -43.505  1.00 96.75           O  \nATOM   4394  SG  CYS A 571      -5.148  -1.387 -40.575  1.00 96.75           S  \nATOM   4395  N   THR A 572      -7.187   1.406 -42.486  1.00 95.75           N  \nATOM   4396  CA  THR A 572      -6.833   2.838 -42.524  1.00 95.75           C  \nATOM   4397  C   THR A 572      -6.400   3.405 -41.169  1.00 95.75           C  \nATOM   4398  CB  THR A 572      -8.015   3.664 -43.064  1.00 95.75           C  \nATOM   4399  O   THR A 572      -6.045   4.577 -41.089  1.00 95.75           O  \nATOM   4400  CG2 THR A 572      -8.239   3.383 -44.550  1.00 95.75           C  \nATOM   4401  OG1 THR A 572      -9.212   3.317 -42.400  1.00 95.75           O  \nATOM   4402  N   GLY A 573      -6.443   2.604 -40.102  1.00 94.31           N  \nATOM   4403  CA  GLY A 573      -6.241   3.058 -38.728  1.00 94.31           C  \nATOM   4404  C   GLY A 573      -6.455   1.949 -37.696  1.00 94.31           C  \nATOM   4405  O   GLY A 573      -6.673   0.785 -38.041  1.00 94.31           O  \nATOM   4406  N   ARG A 574      -6.418   2.321 -36.411  1.00 94.50           N  \nATOM   4407  CA  ARG A 574      -6.671   1.414 -35.276  1.00 94.50           C  \nATOM   4408  C   ARG A 574      -8.173   1.086 -35.154  1.00 94.50           C  \nATOM   4409  CB  ARG A 574      -6.116   2.017 -33.961  1.00 94.50           C  \nATOM   4410  O   ARG A 574      -9.016   1.910 -35.497  1.00 94.50           O  \nATOM   4411  CG  ARG A 574      -4.668   2.542 -34.054  1.00 94.50           C  \nATOM   4412  CD  ARG A 574      -4.105   3.000 -32.698  1.00 94.50           C  \nATOM   4413  NE  ARG A 574      -2.783   3.664 -32.823  1.00 94.50           N  \nATOM   4414  NH1 ARG A 574      -1.715   2.778 -30.976  1.00 94.50           N  \nATOM   4415  NH2 ARG A 574      -0.681   4.278 -32.242  1.00 94.50           N  \nATOM   4416  CZ  ARG A 574      -1.739   3.565 -32.017  1.00 94.50           C  \nATOM   4417  N   GLY A 575      -8.501  -0.077 -34.586  1.00 92.44           N  \nATOM   4418  CA  GLY A 575      -9.882  -0.482 -34.268  1.00 92.44           C  \nATOM   4419  C   GLY A 575     -10.668  -1.130 -35.428  1.00 92.44           C  \nATOM   4420  O   GLY A 575     -10.215  -1.092 -36.572  1.00 92.44           O  \nATOM   4421  N   PRO A 576     -11.818  -1.775 -35.135  1.00 95.19           N  \nATOM   4422  CA  PRO A 576     -12.601  -2.543 -36.113  1.00 95.19           C  \nATOM   4423  C   PRO A 576     -13.280  -1.686 -37.192  1.00 95.19           C  \nATOM   4424  CB  PRO A 576     -13.644  -3.303 -35.288  1.00 95.19           C  \nATOM   4425  O   PRO A 576     -13.618  -2.201 -38.252  1.00 95.19           O  \nATOM   4426  CG  PRO A 576     -13.804  -2.490 -34.008  1.00 95.19           C  \nATOM   4427  CD  PRO A 576     -12.430  -1.854 -33.813  1.00 95.19           C  \nATOM   4428  N   ASP A 577     -13.469  -0.398 -36.922  1.00 94.56           N  \nATOM   4429  CA  ASP A 577     -14.134   0.595 -37.775  1.00 94.56           C  \nATOM   4430  C   ASP A 577     -13.299   0.968 -39.013  1.00 94.56           C  \nATOM   4431  CB  ASP A 577     -14.354   1.878 -36.943  1.00 94.56           C  \nATOM   4432  O   ASP A 577     -13.820   1.441 -40.018  1.00 94.56           O  \nATOM   4433  CG  ASP A 577     -15.082   1.706 -35.601  1.00 94.56           C  \nATOM   4434  OD1 ASP A 577     -14.878   0.674 -34.915  1.00 94.56           O  \nATOM   4435  OD2 ASP A 577     -15.824   2.632 -35.218  1.00 94.56           O  \nATOM   4436  N   ASN A 578     -11.978   0.775 -38.930  1.00 96.44           N  \nATOM   4437  CA  ASN A 578     -11.008   1.179 -39.947  1.00 96.44           C  \nATOM   4438  C   ASN A 578     -10.605   0.033 -40.892  1.00 96.44           C  \nATOM   4439  CB  ASN A 578      -9.807   1.828 -39.237  1.00 96.44           C  \nATOM   4440  O   ASN A 578      -9.620   0.155 -41.621  1.00 96.44           O  \nATOM   4441  CG  ASN A 578     -10.094   3.258 -38.829  1.00 96.44           C  \nATOM   4442  ND2 ASN A 578     -10.110   3.553 -37.551  1.00 96.44           N  \nATOM   4443  OD1 ASN A 578     -10.245   4.137 -39.662  1.00 96.44           O  \nATOM   4444  N   CYS A 579     -11.302  -1.103 -40.865  1.00 96.50           N  \nATOM   4445  CA  CYS A 579     -11.034  -2.223 -41.762  1.00 96.50           C  \nATOM   4446  C   CYS A 579     -11.592  -1.961 -43.172  1.00 96.50           C  \nATOM   4447  CB  CYS A 579     -11.667  -3.488 -41.181  1.00 96.50           C  \nATOM   4448  O   CYS A 579     -12.723  -1.511 -43.320  1.00 96.50           O  \nATOM   4449  SG  CYS A 579     -11.163  -3.978 -39.508  1.00 96.50           S  \nATOM   4450  N   ILE A 580     -10.850  -2.336 -44.221  1.00 96.38           N  \nATOM   4451  CA  ILE A 580     -11.369  -2.300 -45.605  1.00 96.38           C  \nATOM   4452  C   ILE A 580     -12.449  -3.375 -45.832  1.00 96.38           C  \nATOM   4453  CB  ILE A 580     -10.194  -2.426 -46.603  1.00 96.38           C  \nATOM   4454  O   ILE A 580     -13.364  -3.188 -46.631  1.00 96.38           O  \nATOM   4455  CG1 ILE A 580      -9.196  -1.250 -46.486  1.00 96.38           C  \nATOM   4456  CG2 ILE A 580     -10.665  -2.559 -48.063  1.00 96.38           C  \nATOM   4457  CD1 ILE A 580      -9.775   0.158 -46.679  1.00 96.38           C  \nATOM   4458  N   GLN A 581     -12.354  -4.497 -45.115  1.00 95.31           N  \nATOM   4459  CA  GLN A 581     -13.344  -5.572 -45.105  1.00 95.31           C  \nATOM   4460  C   GLN A 581     -13.262  -6.330 -43.774  1.00 95.31           C  \nATOM   4461  CB  GLN A 581     -13.061  -6.510 -46.288  1.00 95.31           C  \nATOM   4462  O   GLN A 581     -12.169  -6.522 -43.239  1.00 95.31           O  \nATOM   4463  CG  GLN A 581     -14.156  -7.562 -46.516  1.00 95.31           C  \nATOM   4464  CD  GLN A 581     -13.853  -8.478 -47.698  1.00 95.31           C  \nATOM   4465  NE2 GLN A 581     -14.748  -9.385 -48.021  1.00 95.31           N  \nATOM   4466  OE1 GLN A 581     -12.813  -8.429 -48.336  1.00 95.31           O  \nATOM   4467  N   CYS A 582     -14.400  -6.790 -43.257  1.00 96.62           N  \nATOM   4468  CA  CYS A 582     -14.463  -7.567 -42.020  1.00 96.62           C  \nATOM   4469  C   CYS A 582     -14.128  -9.051 -42.238  1.00 96.62           C  \nATOM   4470  CB  CYS A 582     -15.846  -7.395 -41.386  1.00 96.62           C  \nATOM   4471  O   CYS A 582     -14.462  -9.625 -43.274  1.00 96.62           O  \nATOM   4472  SG  CYS A 582     -16.365  -5.674 -41.158  1.00 96.62           S  \nATOM   4473  N   ALA A 583     -13.497  -9.680 -41.244  1.00 95.81           N  \nATOM   4474  CA  ALA A 583     -13.101 -11.088 -41.270  1.00 95.81           C  \nATOM   4475  C   ALA A 583     -14.232 -12.066 -40.897  1.00 95.81           C  \nATOM   4476  CB  ALA A 583     -11.887 -11.254 -40.347  1.00 95.81           C  \nATOM   4477  O   ALA A 583     -14.224 -13.200 -41.373  1.00 95.81           O  \nATOM   4478  N   HIS A 584     -15.197 -11.641 -40.069  1.00 96.50           N  \nATOM   4479  CA  HIS A 584     -16.309 -12.486 -39.609  1.00 96.50           C  \nATOM   4480  C   HIS A 584     -17.689 -11.876 -39.902  1.00 96.50           C  \nATOM   4481  CB  HIS A 584     -16.138 -12.833 -38.122  1.00 96.50           C  \nATOM   4482  O   HIS A 584     -18.400 -12.405 -40.755  1.00 96.50           O  \nATOM   4483  CG  HIS A 584     -14.864 -13.567 -37.786  1.00 96.50           C  \nATOM   4484  CD2 HIS A 584     -14.592 -14.896 -37.968  1.00 96.50           C  \nATOM   4485  ND1 HIS A 584     -13.765 -13.017 -37.181  1.00 96.50           N  \nATOM   4486  CE1 HIS A 584     -12.847 -13.975 -37.011  1.00 96.50           C  \nATOM   4487  NE2 HIS A 584     -13.315 -15.158 -37.448  1.00 96.50           N  \nATOM   4488  N   TYR A 585     -18.078 -10.794 -39.214  1.00 96.81           N  \nATOM   4489  CA  TYR A 585     -19.388 -10.143 -39.365  1.00 96.81           C  \nATOM   4490  C   TYR A 585     -19.289  -8.613 -39.315  1.00 96.81           C  \nATOM   4491  CB  TYR A 585     -20.374 -10.652 -38.298  1.00 96.81           C  \nATOM   4492  O   TYR A 585     -18.290  -8.056 -38.854  1.00 96.81           O  \nATOM   4493  CG  TYR A 585     -20.554 -12.157 -38.255  1.00 96.81           C  \nATOM   4494  CD1 TYR A 585     -21.482 -12.790 -39.102  1.00 96.81           C  \nATOM   4495  CD2 TYR A 585     -19.762 -12.925 -37.386  1.00 96.81           C  \nATOM   4496  CE1 TYR A 585     -21.611 -14.193 -39.086  1.00 96.81           C  \nATOM   4497  CE2 TYR A 585     -19.886 -14.326 -37.359  1.00 96.81           C  \nATOM   4498  OH  TYR A 585     -20.924 -16.315 -38.204  1.00 96.81           O  \nATOM   4499  CZ  TYR A 585     -20.811 -14.962 -38.215  1.00 96.81           C  \nATOM   4500  N   ILE A 586     -20.339  -7.940 -39.792  1.00 96.38           N  \nATOM   4501  CA  ILE A 586     -20.436  -6.478 -39.889  1.00 96.38           C  \nATOM   4502  C   ILE A 586     -21.592  -5.986 -39.016  1.00 96.38           C  \nATOM   4503  CB  ILE A 586     -20.625  -6.014 -41.357  1.00 96.38           C  \nATOM   4504  O   ILE A 586     -22.756  -6.261 -39.310  1.00 96.38           O  \nATOM   4505  CG1 ILE A 586     -19.759  -6.817 -42.357  1.00 96.38           C  \nATOM   4506  CG2 ILE A 586     -20.341  -4.502 -41.423  1.00 96.38           C  \nATOM   4507  CD1 ILE A 586     -19.786  -6.305 -43.802  1.00 96.38           C  \nATOM   4508  N   ASP A 587     -21.289  -5.237 -37.961  1.00 94.75           N  \nATOM   4509  CA  ASP A 587     -22.279  -4.629 -37.075  1.00 94.75           C  \nATOM   4510  C   ASP A 587     -22.268  -3.104 -37.225  1.00 94.75           C  \nATOM   4511  CB  ASP A 587     -22.068  -5.129 -35.641  1.00 94.75           C  \nATOM   4512  O   ASP A 587     -21.594  -2.377 -36.497  1.00 94.75           O  \nATOM   4513  CG  ASP A 587     -23.223  -4.713 -34.738  1.00 94.75           C  \nATOM   4514  OD1 ASP A 587     -24.395  -4.829 -35.172  1.00 94.75           O  \nATOM   4515  OD2 ASP A 587     -22.978  -4.298 -33.588  1.00 94.75           O  \nATOM   4516  N   GLY A 588     -23.000  -2.621 -38.233  1.00 92.25           N  \nATOM   4517  CA  GLY A 588     -23.003  -1.208 -38.614  1.00 92.25           C  \nATOM   4518  C   GLY A 588     -21.646  -0.811 -39.200  1.00 92.25           C  \nATOM   4519  O   GLY A 588     -21.275  -1.372 -40.231  1.00 92.25           O  \nATOM   4520  N   PRO A 589     -20.898   0.125 -38.587  1.00 92.69           N  \nATOM   4521  CA  PRO A 589     -19.535   0.445 -39.002  1.00 92.69           C  \nATOM   4522  C   PRO A 589     -18.483  -0.539 -38.452  1.00 92.69           C  \nATOM   4523  CB  PRO A 589     -19.308   1.864 -38.473  1.00 92.69           C  \nATOM   4524  O   PRO A 589     -17.343  -0.509 -38.903  1.00 92.69           O  \nATOM   4525  CG  PRO A 589     -20.087   1.863 -37.158  1.00 92.69           C  \nATOM   4526  CD  PRO A 589     -21.276   0.942 -37.439  1.00 92.69           C  \nATOM   4527  N   HIS A 590     -18.824  -1.395 -37.481  1.00 95.00           N  \nATOM   4528  CA  HIS A 590     -17.844  -2.190 -36.738  1.00 95.00           C  \nATOM   4529  C   HIS A 590     -17.682  -3.609 -37.308  1.00 95.00           C  \nATOM   4530  CB  HIS A 590     -18.240  -2.239 -35.251  1.00 95.00           C  \nATOM   4531  O   HIS A 590     -18.645  -4.375 -37.389  1.00 95.00           O  \nATOM   4532  CG  HIS A 590     -18.494  -0.887 -34.623  1.00 95.00           C  \nATOM   4533  CD2 HIS A 590     -19.694  -0.423 -34.148  1.00 95.00           C  \nATOM   4534  ND1 HIS A 590     -17.578   0.124 -34.435  1.00 95.00           N  \nATOM   4535  CE1 HIS A 590     -18.211   1.171 -33.889  1.00 95.00           C  \nATOM   4536  NE2 HIS A 590     -19.509   0.889 -33.690  1.00 95.00           N  \nATOM   4537  N   CYS A 591     -16.450  -4.019 -37.614  1.00 96.75           N  \nATOM   4538  CA  CYS A 591     -16.128  -5.429 -37.845  1.00 96.75           C  \nATOM   4539  C   CYS A 591     -16.108  -6.222 -36.529  1.00 96.75           C  \nATOM   4540  CB  CYS A 591     -14.788  -5.533 -38.575  1.00 96.75           C  \nATOM   4541  O   CYS A 591     -15.287  -5.954 -35.648  1.00 96.75           O  \nATOM   4542  SG  CYS A 591     -14.781  -4.807 -40.229  1.00 96.75           S  \nATOM   4543  N   VAL A 592     -16.987  -7.220 -36.397  1.00 95.31           N  \nATOM   4544  CA  VAL A 592     -17.173  -7.992 -35.158  1.00 95.31           C  \nATOM   4545  C   VAL A 592     -17.071  -9.500 -35.380  1.00 95.31           C  \nATOM   4546  CB  VAL A 592     -18.487  -7.635 -34.429  1.00 95.31           C  \nATOM   4547  O   VAL A 592     -17.553 -10.047 -36.371  1.00 95.31           O  \nATOM   4548  CG1 VAL A 592     -18.539  -6.152 -34.046  1.00 95.31           C  \nATOM   4549  CG2 VAL A 592     -19.756  -7.985 -35.214  1.00 95.31           C  \nATOM   4550  N   LYS A 593     -16.509 -10.197 -34.388  1.00 96.19           N  \nATOM   4551  CA  LYS A 593     -16.345 -11.659 -34.398  1.00 96.19           C  \nATOM   4552  C   LYS A 593     -17.668 -12.431 -34.372  1.00 96.19           C  \nATOM   4553  CB  LYS A 593     -15.474 -12.043 -33.201  1.00 96.19           C  \nATOM   4554  O   LYS A 593     -17.755 -13.552 -34.869  1.00 96.19           O  \nATOM   4555  CG  LYS A 593     -14.978 -13.484 -33.346  1.00 96.19           C  \nATOM   4556  CD  LYS A 593     -13.883 -13.764 -32.324  1.00 96.19           C  \nATOM   4557  CE  LYS A 593     -13.365 -15.179 -32.566  1.00 96.19           C  \nATOM   4558  NZ  LYS A 593     -12.148 -15.423 -31.764  1.00 96.19           N  \nATOM   4559  N   THR A 594     -18.685 -11.833 -33.759  1.00 95.31           N  \nATOM   4560  CA  THR A 594     -20.054 -12.340 -33.598  1.00 95.31           C  \nATOM   4561  C   THR A 594     -20.991 -11.152 -33.407  1.00 95.31           C  \nATOM   4562  CB  THR A 594     -20.207 -13.233 -32.350  1.00 95.31           C  \nATOM   4563  O   THR A 594     -20.624 -10.212 -32.702  1.00 95.31           O  \nATOM   4564  CG2 THR A 594     -19.523 -14.592 -32.481  1.00 95.31           C  \nATOM   4565  OG1 THR A 594     -19.660 -12.606 -31.210  1.00 95.31           O  \nATOM   4566  N   CYS A 595     -22.203 -11.205 -33.960  1.00 94.56           N  \nATOM   4567  CA  CYS A 595     -23.211 -10.165 -33.743  1.00 94.56           C  \nATOM   4568  C   CYS A 595     -23.588 -10.000 -32.251  1.00 94.56           C  \nATOM   4569  CB  CYS A 595     -24.457 -10.494 -34.574  1.00 94.56           C  \nATOM   4570  O   CYS A 595     -23.580 -10.995 -31.518  1.00 94.56           O  \nATOM   4571  SG  CYS A 595     -24.169 -10.628 -36.356  1.00 94.56           S  \nATOM   4572  N   PRO A 596     -23.963  -8.786 -31.791  1.00 92.31           N  \nATOM   4573  CA  PRO A 596     -24.406  -8.547 -30.415  1.00 92.31           C  \nATOM   4574  C   PRO A 596     -25.565  -9.458 -29.983  1.00 92.31           C  \nATOM   4575  CB  PRO A 596     -24.808  -7.068 -30.357  1.00 92.31           C  \nATOM   4576  O   PRO A 596     -26.631  -9.463 -30.598  1.00 92.31           O  \nATOM   4577  CG  PRO A 596     -23.929  -6.430 -31.426  1.00 92.31           C  \nATOM   4578  CD  PRO A 596     -23.835  -7.515 -32.498  1.00 92.31           C  \nATOM   4579  N   ALA A 597     -25.372 -10.212 -28.901  1.00 90.88           N  \nATOM   4580  CA  ALA A 597     -26.330 -11.203 -28.421  1.00 90.88           C  \nATOM   4581  C   ALA A 597     -26.490 -11.114 -26.894  1.00 90.88           C  \nATOM   4582  CB  ALA A 597     -25.852 -12.583 -28.898  1.00 90.88           C  \nATOM   4583  O   ALA A 597     -25.630 -11.572 -26.145  1.00 90.88           O  \nATOM   4584  N   GLY A 598     -27.586 -10.502 -26.437  1.00 86.75           N  \nATOM   4585  CA  GLY A 598     -27.887 -10.329 -25.012  1.00 86.75           C  \nATOM   4586  C   GLY A 598     -27.207  -9.117 -24.368  1.00 86.75           C  \nATOM   4587  O   GLY A 598     -27.125  -9.044 -23.144  1.00 86.75           O  \nATOM   4588  N   VAL A 599     -26.724  -8.162 -25.168  1.00 87.19           N  \nATOM   4589  CA  VAL A 599     -26.161  -6.896 -24.668  1.00 87.19           C  \nATOM   4590  C   VAL A 599     -27.309  -5.992 -24.211  1.00 87.19           C  \nATOM   4591  CB  VAL A 599     -25.288  -6.196 -25.733  1.00 87.19           C  \nATOM   4592  O   VAL A 599     -28.334  -5.922 -24.883  1.00 87.19           O  \nATOM   4593  CG1 VAL A 599     -24.527  -5.013 -25.121  1.00 87.19           C  \nATOM   4594  CG2 VAL A 599     -24.246  -7.150 -26.337  1.00 87.19           C  \nATOM   4595  N   MET A 600     -27.177  -5.292 -23.082  1.00 84.44           N  \nATOM   4596  CA  MET A 600     -28.214  -4.345 -22.653  1.00 84.44           C  \nATOM   4597  C   MET A 600     -28.217  -3.116 -23.568  1.00 84.44           C  \nATOM   4598  CB  MET A 600     -28.011  -3.937 -21.187  1.00 84.44           C  \nATOM   4599  O   MET A 600     -27.178  -2.480 -23.742  1.00 84.44           O  \nATOM   4600  CG  MET A 600     -29.253  -3.232 -20.621  1.00 84.44           C  \nATOM   4601  SD  MET A 600     -30.691  -4.302 -20.343  1.00 84.44           S  \nATOM   4602  CE  MET A 600     -30.215  -5.075 -18.776  1.00 84.44           C  \nATOM   4603  N   GLY A 601     -29.377  -2.774 -24.120  1.00 85.50           N  \nATOM   4604  CA  GLY A 601     -29.605  -1.547 -24.875  1.00 85.50           C  \nATOM   4605  C   GLY A 601     -30.594  -0.613 -24.186  1.00 85.50           C  \nATOM   4606  O   GLY A 601     -30.923  -0.760 -23.005  1.00 85.50           O  \nATOM   4607  N   GLU A 602     -31.070   0.371 -24.943  1.00 84.75           N  \nATOM   4608  CA  GLU A 602     -32.009   1.384 -24.461  1.00 84.75           C  \nATOM   4609  C   GLU A 602     -33.295   0.784 -23.859  1.00 84.75           C  \nATOM   4610  CB  GLU A 602     -32.345   2.370 -25.586  1.00 84.75           C  \nATOM   4611  O   GLU A 602     -33.735  -0.322 -24.191  1.00 84.75           O  \nATOM   4612  CG  GLU A 602     -31.114   3.139 -26.085  1.00 84.75           C  \nATOM   4613  CD  GLU A 602     -31.564   4.221 -27.068  1.00 84.75           C  \nATOM   4614  OE1 GLU A 602     -31.644   5.392 -26.638  1.00 84.75           O  \nATOM   4615  OE2 GLU A 602     -31.929   3.838 -28.203  1.00 84.75           O  \nATOM   4616  N   ASN A 603     -33.924   1.545 -22.958  1.00 81.38           N  \nATOM   4617  CA  ASN A 603     -35.186   1.192 -22.296  1.00 81.38           C  \nATOM   4618  C   ASN A 603     -35.169  -0.153 -21.529  1.00 81.38           C  \nATOM   4619  CB  ASN A 603     -36.350   1.337 -23.299  1.00 81.38           C  \nATOM   4620  O   ASN A 603     -36.213  -0.787 -21.381  1.00 81.38           O  \nATOM   4621  CG  ASN A 603     -36.411   2.731 -23.894  1.00 81.38           C  \nATOM   4622  ND2 ASN A 603     -36.136   2.885 -25.168  1.00 81.38           N  \nATOM   4623  OD1 ASN A 603     -36.673   3.700 -23.204  1.00 81.38           O  \nATOM   4624  N   ASN A 604     -34.003  -0.578 -21.013  1.00 75.94           N  \nATOM   4625  CA  ASN A 604     -33.812  -1.862 -20.311  1.00 75.94           C  \nATOM   4626  C   ASN A 604     -34.158  -3.094 -21.184  1.00 75.94           C  \nATOM   4627  CB  ASN A 604     -34.501  -1.820 -18.917  1.00 75.94           C  \nATOM   4628  O   ASN A 604     -34.587  -4.135 -20.681  1.00 75.94           O  \nATOM   4629  CG  ASN A 604     -33.531  -1.678 -17.755  1.00 75.94           C  \nATOM   4630  ND2 ASN A 604     -33.728  -0.707 -16.891  1.00 75.94           N  \nATOM   4631  OD1 ASN A 604     -32.595  -2.442 -17.585  1.00 75.94           O  \nATOM   4632  N   THR A 605     -33.983  -2.983 -22.506  1.00 83.31           N  \nATOM   4633  CA  THR A 605     -34.206  -4.089 -23.449  1.00 83.31           C  \nATOM   4634  C   THR A 605     -32.896  -4.798 -23.799  1.00 83.31           C  \nATOM   4635  CB  THR A 605     -34.968  -3.648 -24.711  1.00 83.31           C  \nATOM   4636  O   THR A 605     -31.853  -4.164 -23.948  1.00 83.31           O  \nATOM   4637  CG2 THR A 605     -36.338  -3.052 -24.384  1.00 83.31           C  \nATOM   4638  OG1 THR A 605     -34.268  -2.705 -25.484  1.00 83.31           O  \nATOM   4639  N   LEU A 606     -32.931  -6.129 -23.929  1.00 87.19           N  \nATOM   4640  CA  LEU A 606     -31.778  -6.895 -24.407  1.00 87.19           C  \nATOM   4641  C   LEU A 606     -31.708  -6.834 -25.933  1.00 87.19           C  \nATOM   4642  CB  LEU A 606     -31.826  -8.353 -23.919  1.00 87.19           C  \nATOM   4643  O   LEU A 606     -32.637  -7.255 -26.626  1.00 87.19           O  \nATOM   4644  CG  LEU A 606     -31.703  -8.546 -22.398  1.00 87.19           C  \nATOM   4645  CD1 LEU A 606     -31.746 -10.044 -22.089  1.00 87.19           C  \nATOM   4646  CD2 LEU A 606     -30.404  -7.977 -21.825  1.00 87.19           C  \nATOM   4647  N   VAL A 607     -30.582  -6.351 -26.444  1.00 90.88           N  \nATOM   4648  CA  VAL A 607     -30.262  -6.318 -27.866  1.00 90.88           C  \nATOM   4649  C   VAL A 607     -29.780  -7.697 -28.291  1.00 90.88           C  \nATOM   4650  CB  VAL A 607     -29.232  -5.223 -28.195  1.00 90.88           C  \nATOM   4651  O   VAL A 607     -28.775  -8.223 -27.803  1.00 90.88           O  \nATOM   4652  CG1 VAL A 607     -28.913  -5.193 -29.697  1.00 90.88           C  \nATOM   4653  CG2 VAL A 607     -29.791  -3.851 -27.798  1.00 90.88           C  \nATOM   4654  N   TRP A 608     -30.512  -8.268 -29.238  1.00 92.69           N  \nATOM   4655  CA  TRP A 608     -30.153  -9.490 -29.936  1.00 92.69           C  \nATOM   4656  C   TRP A 608     -30.094  -9.192 -31.429  1.00 92.69           C  \nATOM   4657  CB  TRP A 608     -31.175 -10.586 -29.623  1.00 92.69           C  \nATOM   4658  O   TRP A 608     -31.026  -8.604 -31.985  1.00 92.69           O  \nATOM   4659  CG  TRP A 608     -31.298 -10.986 -28.183  1.00 92.69           C  \nATOM   4660  CD1 TRP A 608     -32.206 -10.503 -27.304  1.00 92.69           C  \nATOM   4661  CD2 TRP A 608     -30.518 -11.975 -27.444  1.00 92.69           C  \nATOM   4662  CE2 TRP A 608     -31.011 -12.031 -26.106  1.00 92.69           C  \nATOM   4663  CE3 TRP A 608     -29.459 -12.849 -27.774  1.00 92.69           C  \nATOM   4664  NE1 TRP A 608     -32.051 -11.131 -26.084  1.00 92.69           N  \nATOM   4665  CH2 TRP A 608     -29.402 -13.725 -25.490  1.00 92.69           C  \nATOM   4666  CZ2 TRP A 608     -30.470 -12.885 -25.136  1.00 92.69           C  \nATOM   4667  CZ3 TRP A 608     -28.906 -13.713 -26.806  1.00 92.69           C  \nATOM   4668  N   LYS A 609     -29.006  -9.607 -32.073  1.00 94.25           N  \nATOM   4669  CA  LYS A 609     -28.796  -9.509 -33.513  1.00 94.25           C  \nATOM   4670  C   LYS A 609     -28.457 -10.872 -34.105  1.00 94.25           C  \nATOM   4671  CB  LYS A 609     -27.709  -8.464 -33.822  1.00 94.25           C  \nATOM   4672  O   LYS A 609     -27.777 -11.678 -33.472  1.00 94.25           O  \nATOM   4673  CG  LYS A 609     -28.212  -7.027 -33.615  1.00 94.25           C  \nATOM   4674  CD  LYS A 609     -27.135  -5.993 -33.944  1.00 94.25           C  \nATOM   4675  CE  LYS A 609     -27.754  -4.622 -34.224  1.00 94.25           C  \nATOM   4676  NZ  LYS A 609     -26.691  -3.647 -34.531  1.00 94.25           N  \nATOM   4677  N   TYR A 610     -28.913 -11.105 -35.329  1.00 94.12           N  \nATOM   4678  CA  TYR A 610     -28.572 -12.271 -36.141  1.00 94.12           C  \nATOM   4679  C   TYR A 610     -27.765 -11.824 -37.366  1.00 94.12           C  \nATOM   4680  CB  TYR A 610     -29.846 -13.041 -36.530  1.00 94.12           C  \nATOM   4681  O   TYR A 610     -27.911 -10.692 -37.826  1.00 94.12           O  \nATOM   4682  CG  TYR A 610     -30.708 -12.339 -37.564  1.00 94.12           C  \nATOM   4683  CD1 TYR A 610     -31.623 -11.339 -37.180  1.00 94.12           C  \nATOM   4684  CD2 TYR A 610     -30.535 -12.638 -38.929  1.00 94.12           C  \nATOM   4685  CE1 TYR A 610     -32.354 -10.636 -38.156  1.00 94.12           C  \nATOM   4686  CE2 TYR A 610     -31.236 -11.916 -39.911  1.00 94.12           C  \nATOM   4687  OH  TYR A 610     -32.780 -10.169 -40.467  1.00 94.12           O  \nATOM   4688  CZ  TYR A 610     -32.142 -10.907 -39.523  1.00 94.12           C  \nATOM   4689  N   ALA A 611     -26.924 -12.709 -37.898  1.00 95.31           N  \nATOM   4690  CA  ALA A 611     -26.218 -12.472 -39.154  1.00 95.31           C  \nATOM   4691  C   ALA A 611     -27.090 -12.878 -40.351  1.00 95.31           C  \nATOM   4692  CB  ALA A 611     -24.898 -13.244 -39.136  1.00 95.31           C  \nATOM   4693  O   ALA A 611     -27.688 -13.956 -40.338  1.00 95.31           O  \nATOM   4694  N   ASP A 612     -27.138 -12.051 -41.395  1.00 93.31           N  \nATOM   4695  CA  ASP A 612     -27.675 -12.457 -42.696  1.00 93.31           C  \nATOM   4696  C   ASP A 612     -26.638 -13.218 -43.552  1.00 93.31           C  \nATOM   4697  CB  ASP A 612     -28.314 -11.253 -43.418  1.00 93.31           C  \nATOM   4698  O   ASP A 612     -25.505 -13.471 -43.139  1.00 93.31           O  \nATOM   4699  CG  ASP A 612     -27.341 -10.209 -43.983  1.00 93.31           C  \nATOM   4700  OD1 ASP A 612     -26.118 -10.463 -44.000  1.00 93.31           O  \nATOM   4701  OD2 ASP A 612     -27.842  -9.172 -44.465  1.00 93.31           O  \nATOM   4702  N   ALA A 613     -27.026 -13.588 -44.777  1.00 92.69           N  \nATOM   4703  CA  ALA A 613     -26.148 -14.271 -45.732  1.00 92.69           C  \nATOM   4704  C   ALA A 613     -25.001 -13.392 -46.284  1.00 92.69           C  \nATOM   4705  CB  ALA A 613     -27.026 -14.827 -46.861  1.00 92.69           C  \nATOM   4706  O   ALA A 613     -24.110 -13.912 -46.953  1.00 92.69           O  \nATOM   4707  N   GLY A 614     -25.020 -12.080 -46.024  1.00 92.69           N  \nATOM   4708  CA  GLY A 614     -23.922 -11.144 -46.272  1.00 92.69           C  \nATOM   4709  C   GLY A 614     -23.053 -10.895 -45.034  1.00 92.69           C  \nATOM   4710  O   GLY A 614     -22.196 -10.017 -45.073  1.00 92.69           O  \nATOM   4711  N   HIS A 615     -23.264 -11.655 -43.952  1.00 94.56           N  \nATOM   4712  CA  HIS A 615     -22.617 -11.499 -42.648  1.00 94.56           C  \nATOM   4713  C   HIS A 615     -22.927 -10.169 -41.928  1.00 94.56           C  \nATOM   4714  CB  HIS A 615     -21.116 -11.826 -42.744  1.00 94.56           C  \nATOM   4715  O   HIS A 615     -22.208  -9.784 -41.004  1.00 94.56           O  \nATOM   4716  CG  HIS A 615     -20.813 -13.226 -43.212  1.00 94.56           C  \nATOM   4717  CD2 HIS A 615     -20.831 -13.701 -44.496  1.00 94.56           C  \nATOM   4718  ND1 HIS A 615     -20.404 -14.256 -42.403  1.00 94.56           N  \nATOM   4719  CE1 HIS A 615     -20.195 -15.333 -43.178  1.00 94.56           C  \nATOM   4720  NE2 HIS A 615     -20.443 -15.047 -44.466  1.00 94.56           N  \nATOM   4721  N   VAL A 616     -24.009  -9.476 -42.297  1.00 96.25           N  \nATOM   4722  CA  VAL A 616     -24.438  -8.224 -41.652  1.00 96.25           C  \nATOM   4723  C   VAL A 616     -25.340  -8.525 -40.451  1.00 96.25           C  \nATOM   4724  CB  VAL A 616     -25.121  -7.277 -42.657  1.00 96.25           C  \nATOM   4725  O   VAL A 616     -26.237  -9.366 -40.527  1.00 96.25           O  \nATOM   4726  CG1 VAL A 616     -25.473  -5.929 -42.011  1.00 96.25           C  \nATOM   4727  CG2 VAL A 616     -24.214  -6.985 -43.862  1.00 96.25           C  \nATOM   4728  N   CYS A 617     -25.099  -7.839 -39.333  1.00 95.94           N  \nATOM   4729  CA  CYS A 617     -25.788  -8.036 -38.060  1.00 95.94           C  \nATOM   4730  C   CYS A 617     -27.076  -7.199 -37.954  1.00 95.94           C  \nATOM   4731  CB  CYS A 617     -24.808  -7.723 -36.925  1.00 95.94           C  \nATOM   4732  O   CYS A 617     -27.050  -6.006 -37.634  1.00 95.94           O  \nATOM   4733  SG  CYS A 617     -23.369  -8.818 -36.835  1.00 95.94           S  \nATOM   4734  N   HIS A 618     -28.223  -7.845 -38.160  1.00 94.88           N  \nATOM   4735  CA  HIS A 618     -29.555  -7.228 -38.100  1.00 94.88           C  \nATOM   4736  C   HIS A 618     -30.262  -7.522 -36.779  1.00 94.88           C  \nATOM   4737  CB  HIS A 618     -30.410  -7.722 -39.264  1.00 94.88           C  \nATOM   4738  O   HIS A 618     -30.061  -8.575 -36.178  1.00 94.88           O  \nATOM   4739  CG  HIS A 618     -29.844  -7.359 -40.605  1.00 94.88           C  \nATOM   4740  CD2 HIS A 618     -29.086  -8.184 -41.375  1.00 94.88           C  \nATOM   4741  ND1 HIS A 618     -29.997  -6.131 -41.251  1.00 94.88           N  \nATOM   4742  CE1 HIS A 618     -29.324  -6.255 -42.409  1.00 94.88           C  \nATOM   4743  NE2 HIS A 618     -28.782  -7.480 -42.513  1.00 94.88           N  \nATOM   4744  N   LEU A 619     -31.120  -6.605 -36.329  1.00 93.25           N  \nATOM   4745  CA  LEU A 619     -31.892  -6.771 -35.094  1.00 93.25           C  \nATOM   4746  C   LEU A 619     -32.897  -7.925 -35.187  1.00 93.25           C  \nATOM   4747  CB  LEU A 619     -32.608  -5.456 -34.738  1.00 93.25           C  \nATOM   4748  O   LEU A 619     -33.673  -8.024 -36.137  1.00 93.25           O  \nATOM   4749  CG  LEU A 619     -31.665  -4.354 -34.225  1.00 93.25           C  \nATOM   4750  CD1 LEU A 619     -32.394  -3.011 -34.233  1.00 93.25           C  \nATOM   4751  CD2 LEU A 619     -31.186  -4.647 -32.800  1.00 93.25           C  \nATOM   4752  N   CYS A 620     -32.931  -8.750 -34.142  1.00 92.56           N  \nATOM   4753  CA  CYS A 620     -34.023  -9.683 -33.902  1.00 92.56           C  \nATOM   4754  C   CYS A 620     -35.352  -8.940 -33.704  1.00 92.56           C  \nATOM   4755  CB  CYS A 620     -33.699 -10.534 -32.667  1.00 92.56           C  \nATOM   4756  O   CYS A 620     -35.393  -7.800 -33.238  1.00 92.56           O  \nATOM   4757  SG  CYS A 620     -32.322 -11.687 -32.885  1.00 92.56           S  \nATOM   4758  N   HIS A 621     -36.466  -9.611 -34.001  1.00 90.62           N  \nATOM   4759  CA  HIS A 621     -37.792  -9.057 -33.739  1.00 90.62           C  \nATOM   4760  C   HIS A 621     -37.992  -8.794 -32.225  1.00 90.62           C  \nATOM   4761  CB  HIS A 621     -38.831 -10.022 -34.310  1.00 90.62           C  \nATOM   4762  O   HIS A 621     -37.638  -9.664 -31.426  1.00 90.62           O  \nATOM   4763  CG  HIS A 621     -40.249  -9.572 -34.118  1.00 90.62           C  \nATOM   4764  CD2 HIS A 621     -40.998  -8.827 -34.987  1.00 90.62           C  \nATOM   4765  ND1 HIS A 621     -41.029  -9.824 -33.016  1.00 90.62           N  \nATOM   4766  CE1 HIS A 621     -42.220  -9.232 -33.210  1.00 90.62           C  \nATOM   4767  NE2 HIS A 621     -42.250  -8.621 -34.402  1.00 90.62           N  \nATOM   4768  N   PRO A 622     -38.598  -7.664 -31.791  1.00 87.25           N  \nATOM   4769  CA  PRO A 622     -38.600  -7.239 -30.379  1.00 87.25           C  \nATOM   4770  C   PRO A 622     -39.137  -8.254 -29.356  1.00 87.25           C  \nATOM   4771  CB  PRO A 622     -39.433  -5.954 -30.351  1.00 87.25           C  \nATOM   4772  O   PRO A 622     -38.715  -8.261 -28.204  1.00 87.25           O  \nATOM   4773  CG  PRO A 622     -39.170  -5.348 -31.726  1.00 87.25           C  \nATOM   4774  CD  PRO A 622     -39.094  -6.576 -32.628  1.00 87.25           C  \nATOM   4775  N   ASN A 623     -40.048  -9.143 -29.761  1.00 88.50           N  \nATOM   4776  CA  ASN A 623     -40.584 -10.199 -28.892  1.00 88.50           C  \nATOM   4777  C   ASN A 623     -39.589 -11.347 -28.611  1.00 88.50           C  \nATOM   4778  CB  ASN A 623     -41.879 -10.770 -29.498  1.00 88.50           C  \nATOM   4779  O   ASN A 623     -39.897 -12.226 -27.806  1.00 88.50           O  \nATOM   4780  CG  ASN A 623     -43.011  -9.768 -29.641  1.00 88.50           C  \nATOM   4781  ND2 ASN A 623     -44.213 -10.130 -29.260  1.00 88.50           N  \nATOM   4782  OD1 ASN A 623     -42.861  -8.673 -30.142  1.00 88.50           O  \nATOM   4783  N   CYS A 624     -38.436 -11.392 -29.279  1.00 86.88           N  \nATOM   4784  CA  CYS A 624     -37.480 -12.498 -29.208  1.00 86.88           C  \nATOM   4785  C   CYS A 624     -36.449 -12.269 -28.093  1.00 86.88           C  \nATOM   4786  CB  CYS A 624     -36.894 -12.744 -30.599  1.00 86.88           C  \nATOM   4787  O   CYS A 624     -35.249 -12.142 -28.325  1.00 86.88           O  \nATOM   4788  SG  CYS A 624     -38.181 -13.007 -31.851  1.00 86.88           S  \nATOM   4789  N   THR A 625     -36.946 -12.221 -26.854  1.00 84.06           N  \nATOM   4790  CA  THR A 625     -36.204 -11.847 -25.633  1.00 84.06           C  \nATOM   4791  C   THR A 625     -35.018 -12.751 -25.283  1.00 84.06           C  \nATOM   4792  CB  THR A 625     -37.160 -11.830 -24.429  1.00 84.06           C  \nATOM   4793  O   THR A 625     -34.207 -12.381 -24.437  1.00 84.06           O  \nATOM   4794  CG2 THR A 625     -38.231 -10.748 -24.568  1.00 84.06           C  \nATOM   4795  OG1 THR A 625     -37.838 -13.066 -24.314  1.00 84.06           O  \nATOM   4796  N   TYR A 626     -34.919 -13.921 -25.919  1.00 84.81           N  \nATOM   4797  CA  TYR A 626     -33.862 -14.924 -25.738  1.00 84.81           C  \nATOM   4798  C   TYR A 626     -33.011 -15.122 -27.008  1.00 84.81           C  \nATOM   4799  CB  TYR A 626     -34.495 -16.240 -25.255  1.00 84.81           C  \nATOM   4800  O   TYR A 626     -32.352 -16.149 -27.156  1.00 84.81           O  \nATOM   4801  CG  TYR A 626     -35.388 -16.105 -24.034  1.00 84.81           C  \nATOM   4802  CD1 TYR A 626     -34.818 -15.812 -22.780  1.00 84.81           C  \nATOM   4803  CD2 TYR A 626     -36.784 -16.264 -24.151  1.00 84.81           C  \nATOM   4804  CE1 TYR A 626     -35.636 -15.690 -21.640  1.00 84.81           C  \nATOM   4805  CE2 TYR A 626     -37.605 -16.143 -23.014  1.00 84.81           C  \nATOM   4806  OH  TYR A 626     -37.828 -15.750 -20.660  1.00 84.81           O  \nATOM   4807  CZ  TYR A 626     -37.033 -15.863 -21.756  1.00 84.81           C  \nATOM   4808  N   GLY A 627     -33.058 -14.164 -27.938  1.00 88.12           N  \nATOM   4809  CA  GLY A 627     -32.360 -14.220 -29.219  1.00 88.12           C  \nATOM   4810  C   GLY A 627     -33.179 -14.806 -30.369  1.00 88.12           C  \nATOM   4811  O   GLY A 627     -34.316 -15.258 -30.212  1.00 88.12           O  \nATOM   4812  N   CYS A 628     -32.577 -14.761 -31.555  1.00 91.12           N  \nATOM   4813  CA  CYS A 628     -33.120 -15.285 -32.802  1.00 91.12           C  \nATOM   4814  C   CYS A 628     -31.986 -15.779 -33.717  1.00 91.12           C  \nATOM   4815  CB  CYS A 628     -33.956 -14.200 -33.497  1.00 91.12           C  \nATOM   4816  O   CYS A 628     -30.811 -15.509 -33.483  1.00 91.12           O  \nATOM   4817  SG  CYS A 628     -33.011 -12.913 -34.348  1.00 91.12           S  \nATOM   4818  N   THR A 629     -32.361 -16.490 -34.776  1.00 90.50           N  \nATOM   4819  CA  THR A 629     -31.476 -17.025 -35.828  1.00 90.50           C  \nATOM   4820  C   THR A 629     -31.773 -16.431 -37.210  1.00 90.50           C  \nATOM   4821  CB  THR A 629     -31.575 -18.559 -35.885  1.00 90.50           C  \nATOM   4822  O   THR A 629     -31.170 -16.831 -38.200  1.00 90.50           O  \nATOM   4823  CG2 THR A 629     -31.072 -19.220 -34.602  1.00 90.50           C  \nATOM   4824  OG1 THR A 629     -32.913 -18.975 -36.068  1.00 90.50           O  \nATOM   4825  N   GLY A 630     -32.713 -15.486 -37.288  1.00 88.81           N  \nATOM   4826  CA  GLY A 630     -33.230 -14.916 -38.529  1.00 88.81           C  \nATOM   4827  C   GLY A 630     -34.278 -13.827 -38.266  1.00 88.81           C  \nATOM   4828  O   GLY A 630     -34.611 -13.568 -37.105  1.00 88.81           O  \nATOM   4829  N   PRO A 631     -34.821 -13.200 -39.324  1.00 90.06           N  \nATOM   4830  CA  PRO A 631     -35.800 -12.122 -39.208  1.00 90.06           C  \nATOM   4831  C   PRO A 631     -37.144 -12.569 -38.609  1.00 90.06           C  \nATOM   4832  CB  PRO A 631     -35.982 -11.582 -40.633  1.00 90.06           C  \nATOM   4833  O   PRO A 631     -37.515 -13.746 -38.615  1.00 90.06           O  \nATOM   4834  CG  PRO A 631     -35.637 -12.780 -41.516  1.00 90.06           C  \nATOM   4835  CD  PRO A 631     -34.540 -13.486 -40.723  1.00 90.06           C  \nATOM   4836  N   GLY A 632     -37.917 -11.579 -38.153  1.00 87.50           N  \nATOM   4837  CA  GLY A 632     -39.302 -11.762 -37.715  1.00 87.50           C  \nATOM   4838  C   GLY A 632     -39.451 -12.650 -36.477  1.00 87.50           C  \nATOM   4839  O   GLY A 632     -38.516 -12.843 -35.706  1.00 87.50           O  \nATOM   4840  N   LEU A 633     -40.658 -13.182 -36.276  1.00 85.75           N  \nATOM   4841  CA  LEU A 633     -40.927 -14.201 -35.251  1.00 85.75           C  \nATOM   4842  C   LEU A 633     -40.483 -15.606 -35.695  1.00 85.75           C  \nATOM   4843  CB  LEU A 633     -42.432 -14.190 -34.921  1.00 85.75           C  \nATOM   4844  O   LEU A 633     -40.347 -16.495 -34.862  1.00 85.75           O  \nATOM   4845  CG  LEU A 633     -42.912 -12.929 -34.181  1.00 85.75           C  \nATOM   4846  CD1 LEU A 633     -44.441 -12.913 -34.123  1.00 85.75           C  \nATOM   4847  CD2 LEU A 633     -42.398 -12.884 -32.740  1.00 85.75           C  \nATOM   4848  N   GLU A 634     -40.268 -15.800 -36.996  1.00 82.75           N  \nATOM   4849  CA  GLU A 634     -39.918 -17.078 -37.627  1.00 82.75           C  \nATOM   4850  C   GLU A 634     -38.495 -17.526 -37.272  1.00 82.75           C  \nATOM   4851  CB  GLU A 634     -40.082 -16.909 -39.146  1.00 82.75           C  \nATOM   4852  O   GLU A 634     -38.266 -18.710 -37.034  1.00 82.75           O  \nATOM   4853  CG  GLU A 634     -41.568 -16.804 -39.547  1.00 82.75           C  \nATOM   4854  CD  GLU A 634     -41.829 -15.894 -40.758  1.00 82.75           C  \nATOM   4855  OE1 GLU A 634     -42.963 -15.366 -40.820  1.00 82.75           O  \nATOM   4856  OE2 GLU A 634     -40.911 -15.708 -41.586  1.00 82.75           O  \nATOM   4857  N   GLY A 635     -37.555 -16.584 -37.139  1.00 81.06           N  \nATOM   4858  CA  GLY A 635     -36.203 -16.860 -36.651  1.00 81.06           C  \nATOM   4859  C   GLY A 635     -36.103 -17.157 -35.148  1.00 81.06           C  \nATOM   4860  O   GLY A 635     -34.993 -17.380 -34.659  1.00 81.06           O  \nATOM   4861  N   CYS A 636     -37.205 -17.137 -34.392  1.00 80.94           N  \nATOM   4862  CA  CYS A 636     -37.190 -17.189 -32.929  1.00 80.94           C  \nATOM   4863  C   CYS A 636     -37.787 -18.509 -32.398  1.00 80.94           C  \nATOM   4864  CB  CYS A 636     -37.933 -15.968 -32.381  1.00 80.94           C  \nATOM   4865  O   CYS A 636     -38.959 -18.790 -32.655  1.00 80.94           O  \nATOM   4866  SG  CYS A 636     -37.371 -14.394 -33.078  1.00 80.94           S  \nATOM   4867  N   PRO A 637     -37.043 -19.323 -31.621  1.00 68.69           N  \nATOM   4868  CA  PRO A 637     -37.539 -20.612 -31.135  1.00 68.69           C  \nATOM   4869  C   PRO A 637     -38.706 -20.424 -30.153  1.00 68.69           C  \nATOM   4870  CB  PRO A 637     -36.323 -21.308 -30.512  1.00 68.69           C  \nATOM   4871  O   PRO A 637     -38.533 -19.982 -29.016  1.00 68.69           O  \nATOM   4872  CG  PRO A 637     -35.412 -20.151 -30.098  1.00 68.69           C  \nATOM   4873  CD  PRO A 637     -35.673 -19.101 -31.176  1.00 68.69           C  \nATOM   4874  N   THR A 638     -39.922 -20.765 -30.587  1.00 54.84           N  \nATOM   4875  CA  THR A 638     -41.163 -20.469 -29.857  1.00 54.84           C  \nATOM   4876  C   THR A 638     -41.382 -21.380 -28.644  1.00 54.84           C  \nATOM   4877  CB  THR A 638     -42.388 -20.519 -30.789  1.00 54.84           C  \nATOM   4878  O   THR A 638     -42.141 -22.344 -28.716  1.00 54.84           O  \nATOM   4879  CG2 THR A 638     -42.366 -19.438 -31.866  1.00 54.84           C  \nATOM   4880  OG1 THR A 638     -42.472 -21.769 -31.431  1.00 54.84           O  \nATOM   4881  N   ASN A 639     -40.770 -21.043 -27.506  1.00 47.25           N  \nATOM   4882  CA  ASN A 639     -41.061 -21.636 -26.195  1.00 47.25           C  \nATOM   4883  C   ASN A 639     -41.165 -20.545 -25.112  1.00 47.25           C  \nATOM   4884  CB  ASN A 639     -40.018 -22.726 -25.873  1.00 47.25           C  \nATOM   4885  O   ASN A 639     -40.232 -20.301 -24.353  1.00 47.25           O  \nATOM   4886  CG  ASN A 639     -40.414 -24.089 -26.416  1.00 47.25           C  \nATOM   4887  ND2 ASN A 639     -39.488 -24.831 -26.976  1.00 47.25           N  \nATOM   4888  OD1 ASN A 639     -41.545 -24.528 -26.301  1.00 47.25           O  \nATOM   4889  N   GLY A 640     -42.324 -19.883 -25.044  1.00 42.06           N  \nATOM   4890  CA  GLY A 640     -42.640 -18.858 -24.043  1.00 42.06           C  \nATOM   4891  C   GLY A 640     -44.159 -18.737 -23.821  1.00 42.06           C  \nATOM   4892  O   GLY A 640     -44.894 -18.677 -24.812  1.00 42.06           O  \nATOM   4893  N   PRO A 641     -44.675 -18.724 -22.572  1.00 38.94           N  \nATOM   4894  CA  PRO A 641     -46.118 -18.675 -22.323  1.00 38.94           C  \nATOM   4895  C   PRO A 641     -46.750 -17.331 -22.714  1.00 38.94           C  \nATOM   4896  CB  PRO A 641     -46.309 -18.960 -20.827  1.00 38.94           C  \nATOM   4897  O   PRO A 641     -46.262 -16.268 -22.336  1.00 38.94           O  \nATOM   4898  CG  PRO A 641     -45.007 -19.643 -20.414  1.00 38.94           C  \nATOM   4899  CD  PRO A 641     -43.975 -18.978 -21.320  1.00 38.94           C  \nATOM   4900  N   LYS A 642     -47.895 -17.369 -23.408  1.00 32.31           N  \nATOM   4901  CA  LYS A 642     -48.711 -16.174 -23.683  1.00 32.31           C  \nATOM   4902  C   LYS A 642     -49.681 -15.922 -22.526  1.00 32.31           C  \nATOM   4903  CB  LYS A 642     -49.472 -16.324 -25.014  1.00 32.31           C  \nATOM   4904  O   LYS A 642     -50.531 -16.766 -22.257  1.00 32.31           O  \nATOM   4905  CG  LYS A 642     -48.539 -16.406 -26.234  1.00 32.31           C  \nATOM   4906  CD  LYS A 642     -49.336 -16.504 -27.544  1.00 32.31           C  \nATOM   4907  CE  LYS A 642     -48.368 -16.622 -28.729  1.00 32.31           C  \nATOM   4908  NZ  LYS A 642     -49.076 -16.738 -30.030  1.00 32.31           N  \nATOM   4909  N   ILE A 643     -49.601 -14.749 -21.897  1.00 37.66           N  \nATOM   4910  CA  ILE A 643     -50.589 -14.271 -20.915  1.00 37.66           C  \nATOM   4911  C   ILE A 643     -51.436 -13.168 -21.573  1.00 37.66           C  \nATOM   4912  CB  ILE A 643     -49.910 -13.766 -19.618  1.00 37.66           C  \nATOM   4913  O   ILE A 643     -50.875 -12.139 -21.954  1.00 37.66           O  \nATOM   4914  CG1 ILE A 643     -49.051 -14.880 -18.970  1.00 37.66           C  \nATOM   4915  CG2 ILE A 643     -50.981 -13.263 -18.626  1.00 37.66           C  \nATOM   4916  CD1 ILE A 643     -48.269 -14.433 -17.727  1.00 37.66           C  \nATOM   4917  N   PRO A 644     -52.764 -13.333 -21.715  1.00 35.25           N  \nATOM   4918  CA  PRO A 644     -53.653 -12.250 -22.120  1.00 35.25           C  \nATOM   4919  C   PRO A 644     -54.031 -11.377 -20.913  1.00 35.25           C  \nATOM   4920  CB  PRO A 644     -54.868 -12.954 -22.729  1.00 35.25           C  \nATOM   4921  O   PRO A 644     -54.283 -11.888 -19.824  1.00 35.25           O  \nATOM   4922  CG  PRO A 644     -54.971 -14.238 -21.902  1.00 35.25           C  \nATOM   4923  CD  PRO A 644     -53.520 -14.567 -21.540  1.00 35.25           C  \nATOM   4924  N   SER A 645     -54.136 -10.063 -21.117  1.00 36.75           N  \nATOM   4925  CA  SER A 645     -54.683  -9.120 -20.133  1.00 36.75           C  \nATOM   4926  C   SER A 645     -55.691  -8.203 -20.823  1.00 36.75           C  \nATOM   4927  CB  SER A 645     -53.555  -8.322 -19.476  1.00 36.75           C  \nATOM   4928  O   SER A 645     -55.360  -7.566 -21.823  1.00 36.75           O  \nATOM   4929  OG  SER A 645     -54.078  -7.557 -18.410  1.00 36.75           O  \nATOM   4930  N   ILE A 646     -56.937  -8.190 -20.341  1.00 38.66           N  \nATOM   4931  CA  ILE A 646     -58.078  -7.495 -20.958  1.00 38.66           C  \nATOM   4932  C   ILE A 646     -58.947  -6.882 -19.852  1.00 38.66           C  \nATOM   4933  CB  ILE A 646     -58.914  -8.475 -21.834  1.00 38.66           C  \nATOM   4934  O   ILE A 646     -59.405  -7.618 -18.984  1.00 38.66           O  \nATOM   4935  CG1 ILE A 646     -58.102  -8.973 -23.056  1.00 38.66           C  \nATOM   4936  CG2 ILE A 646     -60.235  -7.827 -22.301  1.00 38.66           C  \nATOM   4937  CD1 ILE A 646     -58.818 -10.005 -23.939  1.00 38.66           C  \nATOM   4938  N   ALA A 647     -59.245  -5.577 -19.980  1.00 44.69           N  \nATOM   4939  CA  ALA A 647     -60.228  -4.804 -19.195  1.00 44.69           C  \nATOM   4940  C   ALA A 647     -59.946  -4.701 -17.668  1.00 44.69           C  \nATOM   4941  CB  ALA A 647     -61.620  -5.355 -19.544  1.00 44.69           C  \nATOM   4942  O   ALA A 647     -59.274  -5.535 -17.081  1.00 44.69           O  \nATOM   4943  N   THR A 648     -60.377  -3.684 -16.913  1.00 49.34           N  \nATOM   4944  CA  THR A 648     -61.014  -2.368 -17.180  1.00 49.34           C  \nATOM   4945  C   THR A 648     -60.511  -1.437 -16.049  1.00 49.34           C  \nATOM   4946  CB  THR A 648     -62.562  -2.426 -17.159  1.00 49.34           C  \nATOM   4947  O   THR A 648     -60.229  -1.913 -14.956  1.00 49.34           O  \nATOM   4948  CG2 THR A 648     -63.172  -1.943 -18.477  1.00 49.34           C  \nATOM   4949  OG1 THR A 648     -63.067  -3.724 -16.943  1.00 49.34           O  \nATOM   4950  N   GLY A 649     -60.256  -0.134 -16.202  1.00 44.56           N  \nATOM   4951  CA  GLY A 649     -61.197   0.904 -16.629  1.00 44.56           C  \nATOM   4952  C   GLY A 649     -62.183   1.259 -15.502  1.00 44.56           C  \nATOM   4953  O   GLY A 649     -63.135   0.513 -15.339  1.00 44.56           O  \nATOM   4954  N   MET A 650     -61.930   2.348 -14.736  1.00 54.16           N  \nATOM   4955  CA  MET A 650     -62.897   3.197 -13.967  1.00 54.16           C  \nATOM   4956  C   MET A 650     -62.261   4.031 -12.819  1.00 54.16           C  \nATOM   4957  CB  MET A 650     -64.086   2.404 -13.369  1.00 54.16           C  \nATOM   4958  O   MET A 650     -62.796   5.072 -12.456  1.00 54.16           O  \nATOM   4959  CG  MET A 650     -65.225   2.202 -14.389  1.00 54.16           C  \nATOM   4960  SD  MET A 650     -66.694   3.238 -14.165  1.00 54.16           S  \nATOM   4961  CE  MET A 650     -67.541   2.276 -12.884  1.00 54.16           C  \nATOM   4962  N   VAL A 651     -61.123   3.629 -12.233  1.00 56.09           N  \nATOM   4963  CA  VAL A 651     -60.657   4.140 -10.908  1.00 56.09           C  \nATOM   4964  C   VAL A 651     -60.003   5.549 -10.922  1.00 56.09           C  \nATOM   4965  CB  VAL A 651     -59.744   3.085 -10.222  1.00 56.09           C  \nATOM   4966  O   VAL A 651     -59.731   6.127  -9.870  1.00 56.09           O  \nATOM   4967  CG1 VAL A 651     -59.464   3.361  -8.736  1.00 56.09           C  \nATOM   4968  CG2 VAL A 651     -60.368   1.677 -10.272  1.00 56.09           C  \nATOM   4969  N   GLY A 652     -59.748   6.136 -12.096  1.00 57.22           N  \nATOM   4970  CA  GLY A 652     -58.787   7.240 -12.276  1.00 57.22           C  \nATOM   4971  C   GLY A 652     -58.992   8.512 -11.433  1.00 57.22           C  \nATOM   4972  O   GLY A 652     -58.011   9.092 -10.975  1.00 57.22           O  \nATOM   4973  N   ALA A 653     -60.233   8.947 -11.185  1.00 57.12           N  \nATOM   4974  CA  ALA A 653     -60.499  10.243 -10.542  1.00 57.12           C  \nATOM   4975  C   ALA A 653     -60.112  10.289  -9.047  1.00 57.12           C  \nATOM   4976  CB  ALA A 653     -61.974  10.600 -10.760  1.00 57.12           C  \nATOM   4977  O   ALA A 653     -59.467  11.237  -8.601  1.00 57.12           O  \nATOM   4978  N   LEU A 654     -60.448   9.245  -8.277  1.00 62.91           N  \nATOM   4979  CA  LEU A 654     -60.030   9.124  -6.871  1.00 62.91           C  \nATOM   4980  C   LEU A 654     -58.522   8.872  -6.751  1.00 62.91           C  \nATOM   4981  CB  LEU A 654     -60.826   7.993  -6.192  1.00 62.91           C  \nATOM   4982  O   LEU A 654     -57.879   9.374  -5.828  1.00 62.91           O  \nATOM   4983  CG  LEU A 654     -62.244   8.412  -5.764  1.00 62.91           C  \nATOM   4984  CD1 LEU A 654     -63.067   7.172  -5.415  1.00 62.91           C  \nATOM   4985  CD2 LEU A 654     -62.218   9.321  -4.531  1.00 62.91           C  \nATOM   4986  N   LEU A 655     -57.955   8.147  -7.720  1.00 66.31           N  \nATOM   4987  CA  LEU A 655     -56.515   7.945  -7.845  1.00 66.31           C  \nATOM   4988  C   LEU A 655     -55.764   9.276  -7.979  1.00 66.31           C  \nATOM   4989  CB  LEU A 655     -56.240   7.009  -9.042  1.00 66.31           C  \nATOM   4990  O   LEU A 655     -54.714   9.428  -7.370  1.00 66.31           O  \nATOM   4991  CG  LEU A 655     -55.598   5.678  -8.622  1.00 66.31           C  \nATOM   4992  CD1 LEU A 655     -55.656   4.684  -9.783  1.00 66.31           C  \nATOM   4993  CD2 LEU A 655     -54.136   5.863  -8.209  1.00 66.31           C  \nATOM   4994  N   LEU A 656     -56.308  10.257  -8.705  1.00 68.88           N  \nATOM   4995  CA  LEU A 656     -55.651  11.547  -8.939  1.00 68.88           C  \nATOM   4996  C   LEU A 656     -55.533  12.384  -7.648  1.00 68.88           C  \nATOM   4997  CB  LEU A 656     -56.387  12.254 -10.097  1.00 68.88           C  \nATOM   4998  O   LEU A 656     -54.457  12.901  -7.350  1.00 68.88           O  \nATOM   4999  CG  LEU A 656     -55.480  13.134 -10.979  1.00 68.88           C  \nATOM   5000  CD1 LEU A 656     -56.136  13.344 -12.345  1.00 68.88           C  \nATOM   5001  CD2 LEU A 656     -55.214  14.510 -10.368  1.00 68.88           C  \nATOM   5002  N   LEU A 657     -56.583  12.437  -6.818  1.00 72.06           N  \nATOM   5003  CA  LEU A 657     -56.514  13.084  -5.496  1.00 72.06           C  \nATOM   5004  C   LEU A 657     -55.582  12.337  -4.528  1.00 72.06           C  \nATOM   5005  CB  LEU A 657     -57.927  13.223  -4.900  1.00 72.06           C  \nATOM   5006  O   LEU A 657     -54.806  12.974  -3.813  1.00 72.06           O  \nATOM   5007  CG  LEU A 657     -58.765  14.353  -5.526  1.00 72.06           C  \nATOM   5008  CD1 LEU A 657     -60.201  14.265  -5.009  1.00 72.06           C  \nATOM   5009  CD2 LEU A 657     -58.225  15.743  -5.170  1.00 72.06           C  \nATOM   5010  N   LEU A 658     -55.596  10.998  -4.544  1.00 73.50           N  \nATOM   5011  CA  LEU A 658     -54.629  10.195  -3.790  1.00 73.50           C  \nATOM   5012  C   LEU A 658     -53.190  10.443  -4.258  1.00 73.50           C  \nATOM   5013  CB  LEU A 658     -54.993   8.700  -3.878  1.00 73.50           C  \nATOM   5014  O   LEU A 658     -52.308  10.547  -3.415  1.00 73.50           O  \nATOM   5015  CG  LEU A 658     -55.951   8.248  -2.763  1.00 73.50           C  \nATOM   5016  CD1 LEU A 658     -56.531   6.875  -3.101  1.00 73.50           C  \nATOM   5017  CD2 LEU A 658     -55.230   8.131  -1.414  1.00 73.50           C  \nATOM   5018  N   VAL A 659     -52.948  10.602  -5.562  1.00 75.62           N  \nATOM   5019  CA  VAL A 659     -51.632  10.921  -6.139  1.00 75.62           C  \nATOM   5020  C   VAL A 659     -51.166  12.326  -5.757  1.00 75.62           C  \nATOM   5021  CB  VAL A 659     -51.639  10.698  -7.668  1.00 75.62           C  \nATOM   5022  O   VAL A 659     -49.979  12.494  -5.496  1.00 75.62           O  \nATOM   5023  CG1 VAL A 659     -50.471  11.363  -8.409  1.00 75.62           C  \nATOM   5024  CG2 VAL A 659     -51.551   9.194  -7.971  1.00 75.62           C  \nATOM   5025  N   VAL A 660     -52.053  13.319  -5.630  1.00 77.62           N  \nATOM   5026  CA  VAL A 660     -51.680  14.650  -5.103  1.00 77.62           C  \nATOM   5027  C   VAL A 660     -51.345  14.582  -3.608  1.00 77.62           C  \nATOM   5028  CB  VAL A 660     -52.771  15.698  -5.403  1.00 77.62           C  \nATOM   5029  O   VAL A 660     -50.321  15.123  -3.186  1.00 77.62           O  \nATOM   5030  CG1 VAL A 660     -52.496  17.048  -4.724  1.00 77.62           C  \nATOM   5031  CG2 VAL A 660     -52.853  15.964  -6.912  1.00 77.62           C  \nATOM   5032  N   ALA A 661     -52.137  13.862  -2.806  1.00 77.06           N  \nATOM   5033  CA  ALA A 661     -51.856  13.663  -1.382  1.00 77.06           C  \nATOM   5034  C   ALA A 661     -50.554  12.867  -1.150  1.00 77.06           C  \nATOM   5035  CB  ALA A 661     -53.070  12.983  -0.738  1.00 77.06           C  \nATOM   5036  O   ALA A 661     -49.727  13.259  -0.323  1.00 77.06           O  \nATOM   5037  N   LEU A 662     -50.318  11.805  -1.931  1.00 77.62           N  \nATOM   5038  CA  LEU A 662     -49.032  11.109  -1.990  1.00 77.62           C  \nATOM   5039  C   LEU A 662     -47.926  12.018  -2.522  1.00 77.62           C  \nATOM   5040  CB  LEU A 662     -49.118   9.828  -2.849  1.00 77.62           C  \nATOM   5041  O   LEU A 662     -46.817  11.915  -2.030  1.00 77.62           O  \nATOM   5042  CG  LEU A 662     -49.302   8.538  -2.019  1.00 77.62           C  \nATOM   5043  CD1 LEU A 662     -50.568   7.780  -2.410  1.00 77.62           C  \nATOM   5044  CD2 LEU A 662     -48.106   7.601  -2.215  1.00 77.62           C  \nATOM   5045  N   GLY A 663     -48.189  12.919  -3.466  1.00 79.88           N  \nATOM   5046  CA  GLY A 663     -47.211  13.875  -3.984  1.00 79.88           C  \nATOM   5047  C   GLY A 663     -46.699  14.815  -2.894  1.00 79.88           C  \nATOM   5048  O   GLY A 663     -45.490  14.940  -2.710  1.00 79.88           O  \nATOM   5049  N   ILE A 664     -47.605  15.393  -2.100  1.00 79.69           N  \nATOM   5050  CA  ILE A 664     -47.264  16.231  -0.938  1.00 79.69           C  \nATOM   5051  C   ILE A 664     -46.574  15.388   0.145  1.00 79.69           C  \nATOM   5052  CB  ILE A 664     -48.528  16.951  -0.410  1.00 79.69           C  \nATOM   5053  O   ILE A 664     -45.509  15.765   0.638  1.00 79.69           O  \nATOM   5054  CG1 ILE A 664     -49.086  17.921  -1.481  1.00 79.69           C  \nATOM   5055  CG2 ILE A 664     -48.219  17.722   0.889  1.00 79.69           C  \nATOM   5056  CD1 ILE A 664     -50.505  18.422  -1.187  1.00 79.69           C  \nATOM   5057  N   GLY A 665     -47.114  14.208   0.467  1.00 78.19           N  \nATOM   5058  CA  GLY A 665     -46.519  13.284   1.436  1.00 78.19           C  \nATOM   5059  C   GLY A 665     -45.119  12.808   1.034  1.00 78.19           C  \nATOM   5060  O   GLY A 665     -44.223  12.756   1.872  1.00 78.19           O  \nATOM   5061  N   LEU A 666     -44.888  12.532  -0.251  1.00 77.38           N  \nATOM   5062  CA  LEU A 666     -43.592  12.173  -0.830  1.00 77.38           C  \nATOM   5063  C   LEU A 666     -42.670  13.383  -0.965  1.00 77.38           C  \nATOM   5064  CB  LEU A 666     -43.769  11.495  -2.203  1.00 77.38           C  \nATOM   5065  O   LEU A 666     -41.464  13.198  -0.863  1.00 77.38           O  \nATOM   5066  CG  LEU A 666     -44.338  10.063  -2.156  1.00 77.38           C  \nATOM   5067  CD1 LEU A 666     -44.707   9.610  -3.569  1.00 77.38           C  \nATOM   5068  CD2 LEU A 666     -43.323   9.065  -1.589  1.00 77.38           C  \nATOM   5069  N   PHE A 667     -43.180  14.604  -1.138  1.00 76.50           N  \nATOM   5070  CA  PHE A 667     -42.371  15.823  -1.095  1.00 76.50           C  \nATOM   5071  C   PHE A 667     -41.863  16.092   0.327  1.00 76.50           C  \nATOM   5072  CB  PHE A 667     -43.167  17.008  -1.656  1.00 76.50           C  \nATOM   5073  O   PHE A 667     -40.659  16.255   0.525  1.00 76.50           O  \nATOM   5074  CG  PHE A 667     -42.368  18.295  -1.707  1.00 76.50           C  \nATOM   5075  CD1 PHE A 667     -42.518  19.267  -0.699  1.00 76.50           C  \nATOM   5076  CD2 PHE A 667     -41.469  18.520  -2.767  1.00 76.50           C  \nATOM   5077  CE1 PHE A 667     -41.776  20.460  -0.755  1.00 76.50           C  \nATOM   5078  CE2 PHE A 667     -40.725  19.712  -2.820  1.00 76.50           C  \nATOM   5079  CZ  PHE A 667     -40.880  20.683  -1.815  1.00 76.50           C  \nATOM   5080  N   MET A 668     -42.738  16.021   1.337  1.00 76.06           N  \nATOM   5081  CA  MET A 668     -42.345  16.110   2.749  1.00 76.06           C  \nATOM   5082  C   MET A 668     -41.413  14.957   3.143  1.00 76.06           C  \nATOM   5083  CB  MET A 668     -43.585  16.139   3.654  1.00 76.06           C  \nATOM   5084  O   MET A 668     -40.360  15.194   3.735  1.00 76.06           O  \nATOM   5085  CG  MET A 668     -44.406  17.420   3.468  1.00 76.06           C  \nATOM   5086  SD  MET A 668     -45.816  17.571   4.598  1.00 76.06           S  \nATOM   5087  CE  MET A 668     -44.983  18.081   6.127  1.00 76.06           C  \nATOM   5088  N   ARG A 669     -41.727  13.716   2.743  1.00 74.00           N  \nATOM   5089  CA  ARG A 669     -40.872  12.542   2.979  1.00 74.00           C  \nATOM   5090  C   ARG A 669     -39.542  12.645   2.228  1.00 74.00           C  \nATOM   5091  CB  ARG A 669     -41.648  11.249   2.661  1.00 74.00           C  \nATOM   5092  O   ARG A 669     -38.534  12.254   2.799  1.00 74.00           O  \nATOM   5093  CG  ARG A 669     -40.974   9.976   3.195  1.00 74.00           C  \nATOM   5094  CD  ARG A 669     -41.810   8.725   2.871  1.00 74.00           C  \nATOM   5095  NE  ARG A 669     -41.286   7.523   3.554  1.00 74.00           N  \nATOM   5096  NH1 ARG A 669     -42.710   5.943   2.656  1.00 74.00           N  \nATOM   5097  NH2 ARG A 669     -41.248   5.347   4.216  1.00 74.00           N  \nATOM   5098  CZ  ARG A 669     -41.749   6.284   3.466  1.00 74.00           C  \nATOM   5099  N   ARG A 670     -39.485  13.230   1.022  1.00 72.00           N  \nATOM   5100  CA  ARG A 670     -38.227  13.574   0.328  1.00 72.00           C  \nATOM   5101  C   ARG A 670     -37.445  14.616   1.120  1.00 72.00           C  \nATOM   5102  CB  ARG A 670     -38.459  14.061  -1.120  1.00 72.00           C  \nATOM   5103  O   ARG A 670     -36.286  14.356   1.405  1.00 72.00           O  \nATOM   5104  CG  ARG A 670     -38.539  12.923  -2.154  1.00 72.00           C  \nATOM   5105  CD  ARG A 670     -38.806  13.492  -3.559  1.00 72.00           C  \nATOM   5106  NE  ARG A 670     -38.717  12.458  -4.615  1.00 72.00           N  \nATOM   5107  NH1 ARG A 670     -38.654  13.863  -6.442  1.00 72.00           N  \nATOM   5108  NH2 ARG A 670     -38.540  11.665  -6.751  1.00 72.00           N  \nATOM   5109  CZ  ARG A 670     -38.638  12.667  -5.923  1.00 72.00           C  \nATOM   5110  N   ARG A 671     -38.051  15.730   1.547  1.00 70.19           N  \nATOM   5111  CA  ARG A 671     -37.373  16.775   2.347  1.00 70.19           C  \nATOM   5112  C   ARG A 671     -36.815  16.200   3.663  1.00 70.19           C  \nATOM   5113  CB  ARG A 671     -38.336  17.975   2.546  1.00 70.19           C  \nATOM   5114  O   ARG A 671     -35.681  16.495   4.033  1.00 70.19           O  \nATOM   5115  CG  ARG A 671     -37.634  19.347   2.478  1.00 70.19           C  \nATOM   5116  CD  ARG A 671     -38.637  20.520   2.522  1.00 70.19           C  \nATOM   5117  NE  ARG A 671     -37.964  21.839   2.426  1.00 70.19           N  \nATOM   5118  NH1 ARG A 671     -39.810  23.213   2.614  1.00 70.19           N  \nATOM   5119  NH2 ARG A 671     -37.789  24.121   2.445  1.00 70.19           N  \nATOM   5120  CZ  ARG A 671     -38.522  23.044   2.491  1.00 70.19           C  \nATOM   5121  N   HIS A 672     -37.557  15.297   4.308  1.00 69.19           N  \nATOM   5122  CA  HIS A 672     -37.158  14.643   5.559  1.00 69.19           C  \nATOM   5123  C   HIS A 672     -36.139  13.496   5.374  1.00 69.19           C  \nATOM   5124  CB  HIS A 672     -38.426  14.168   6.287  1.00 69.19           C  \nATOM   5125  O   HIS A 672     -35.262  13.322   6.224  1.00 69.19           O  \nATOM   5126  CG  HIS A 672     -38.253  14.036   7.780  1.00 69.19           C  \nATOM   5127  CD2 HIS A 672     -39.200  14.327   8.725  1.00 69.19           C  \nATOM   5128  ND1 HIS A 672     -37.094  13.712   8.452  1.00 69.19           N  \nATOM   5129  CE1 HIS A 672     -37.335  13.822   9.770  1.00 69.19           C  \nATOM   5130  NE2 HIS A 672     -38.611  14.172   9.981  1.00 69.19           N  \nATOM   5131  N   ILE A 673     -36.209  12.734   4.274  1.00 65.62           N  \nATOM   5132  CA  ILE A 673     -35.195  11.732   3.893  1.00 65.62           C  \nATOM   5133  C   ILE A 673     -33.910  12.420   3.429  1.00 65.62           C  \nATOM   5134  CB  ILE A 673     -35.738  10.731   2.836  1.00 65.62           C  \nATOM   5135  O   ILE A 673     -32.839  11.935   3.765  1.00 65.62           O  \nATOM   5136  CG1 ILE A 673     -36.708   9.740   3.525  1.00 65.62           C  \nATOM   5137  CG2 ILE A 673     -34.615   9.948   2.122  1.00 65.62           C  \nATOM   5138  CD1 ILE A 673     -37.434   8.788   2.564  1.00 65.62           C  \nATOM   5139  N   VAL A 674     -33.991  13.550   2.719  1.00 65.56           N  \nATOM   5140  CA  VAL A 674     -32.827  14.373   2.363  1.00 65.56           C  \nATOM   5141  C   VAL A 674     -32.146  14.866   3.634  1.00 65.56           C  \nATOM   5142  CB  VAL A 674     -33.188  15.513   1.388  1.00 65.56           C  \nATOM   5143  O   VAL A 674     -30.992  14.506   3.822  1.00 65.56           O  \nATOM   5144  CG1 VAL A 674     -32.072  16.554   1.243  1.00 65.56           C  \nATOM   5145  CG2 VAL A 674     -33.446  14.939  -0.014  1.00 65.56           C  \nATOM   5146  N   ARG A 675     -32.855  15.535   4.564  1.00 59.41           N  \nATOM   5147  CA  ARG A 675     -32.265  15.943   5.859  1.00 59.41           C  \nATOM   5148  C   ARG A 675     -31.667  14.758   6.646  1.00 59.41           C  \nATOM   5149  CB  ARG A 675     -33.258  16.785   6.702  1.00 59.41           C  \nATOM   5150  O   ARG A 675     -30.576  14.891   7.185  1.00 59.41           O  \nATOM   5151  CG  ARG A 675     -33.321  18.266   6.257  1.00 59.41           C  \nATOM   5152  CD  ARG A 675     -34.153  19.174   7.193  1.00 59.41           C  \nATOM   5153  NE  ARG A 675     -33.970  20.620   6.887  1.00 59.41           N  \nATOM   5154  NH1 ARG A 675     -35.425  21.535   8.423  1.00 59.41           N  \nATOM   5155  NH2 ARG A 675     -34.196  22.893   7.143  1.00 59.41           N  \nATOM   5156  CZ  ARG A 675     -34.528  21.672   7.480  1.00 59.41           C  \nATOM   5157  N   LYS A 676     -32.295  13.569   6.653  1.00 59.88           N  \nATOM   5158  CA  LYS A 676     -31.683  12.356   7.249  1.00 59.88           C  \nATOM   5159  C   LYS A 676     -30.480  11.805   6.462  1.00 59.88           C  \nATOM   5160  CB  LYS A 676     -32.724  11.240   7.489  1.00 59.88           C  \nATOM   5161  O   LYS A 676     -29.629  11.163   7.071  1.00 59.88           O  \nATOM   5162  CG  LYS A 676     -33.487  11.407   8.817  1.00 59.88           C  \nATOM   5163  CD  LYS A 676     -34.225  10.118   9.229  1.00 59.88           C  \nATOM   5164  CE  LYS A 676     -34.844  10.283  10.629  1.00 59.88           C  \nATOM   5165  NZ  LYS A 676     -35.386   9.009  11.178  1.00 59.88           N  \nATOM   5166  N   ARG A 677     -30.394  12.012   5.143  1.00 59.28           N  \nATOM   5167  CA  ARG A 677     -29.292  11.536   4.286  1.00 59.28           C  \nATOM   5168  C   ARG A 677     -28.085  12.474   4.288  1.00 59.28           C  \nATOM   5169  CB  ARG A 677     -29.775  11.253   2.852  1.00 59.28           C  \nATOM   5170  O   ARG A 677     -26.979  11.948   4.282  1.00 59.28           O  \nATOM   5171  CG  ARG A 677     -30.446   9.875   2.729  1.00 59.28           C  \nATOM   5172  CD  ARG A 677     -30.904   9.617   1.286  1.00 59.28           C  \nATOM   5173  NE  ARG A 677     -31.336   8.217   1.089  1.00 59.28           N  \nATOM   5174  NH1 ARG A 677     -32.265   8.436  -1.004  1.00 59.28           N  \nATOM   5175  NH2 ARG A 677     -32.143   6.421  -0.053  1.00 59.28           N  \nATOM   5176  CZ  ARG A 677     -31.916   7.702   0.018  1.00 59.28           C  \nATOM   5177  N   THR A 678     -28.254  13.797   4.362  1.00 55.97           N  \nATOM   5178  CA  THR A 678     -27.128  14.698   4.677  1.00 55.97           C  \nATOM   5179  C   THR A 678     -26.596  14.396   6.073  1.00 55.97           C  \nATOM   5180  CB  THR A 678     -27.453  16.197   4.532  1.00 55.97           C  \nATOM   5181  O   THR A 678     -25.418  14.094   6.204  1.00 55.97           O  \nATOM   5182  CG2 THR A 678     -27.036  16.715   3.163  1.00 55.97           C  \nATOM   5183  OG1 THR A 678     -28.833  16.477   4.639  1.00 55.97           O  \nATOM   5184  N   LEU A 679     -27.460  14.285   7.090  1.00 52.38           N  \nATOM   5185  CA  LEU A 679     -27.019  13.933   8.448  1.00 52.38           C  \nATOM   5186  C   LEU A 679     -26.285  12.573   8.521  1.00 52.38           C  \nATOM   5187  CB  LEU A 679     -28.235  13.979   9.389  1.00 52.38           C  \nATOM   5188  O   LEU A 679     -25.267  12.467   9.200  1.00 52.38           O  \nATOM   5189  CG  LEU A 679     -27.864  14.057  10.882  1.00 52.38           C  \nATOM   5190  CD1 LEU A 679     -27.299  15.431  11.245  1.00 52.38           C  \nATOM   5191  CD2 LEU A 679     -29.119  13.822  11.724  1.00 52.38           C  \nATOM   5192  N   ARG A 680     -26.747  11.538   7.792  1.00 52.25           N  \nATOM   5193  CA  ARG A 680     -26.015  10.257   7.679  1.00 52.25           C  \nATOM   5194  C   ARG A 680     -24.678  10.401   6.935  1.00 52.25           C  \nATOM   5195  CB  ARG A 680     -26.872   9.129   7.061  1.00 52.25           C  \nATOM   5196  O   ARG A 680     -23.723   9.761   7.351  1.00 52.25           O  \nATOM   5197  CG  ARG A 680     -27.821   8.430   8.061  1.00 52.25           C  \nATOM   5198  CD  ARG A 680     -28.475   7.172   7.441  1.00 52.25           C  \nATOM   5199  NE  ARG A 680     -29.421   6.487   8.362  1.00 52.25           N  \nATOM   5200  NH1 ARG A 680     -29.802   4.561   7.135  1.00 52.25           N  \nATOM   5201  NH2 ARG A 680     -30.870   4.831   9.049  1.00 52.25           N  \nATOM   5202  CZ  ARG A 680     -30.021   5.308   8.177  1.00 52.25           C  \nATOM   5203  N   ARG A 681     -24.574  11.238   5.893  1.00 52.41           N  \nATOM   5204  CA  ARG A 681     -23.291  11.508   5.209  1.00 52.41           C  \nATOM   5205  C   ARG A 681     -22.283  12.187   6.136  1.00 52.41           C  \nATOM   5206  CB  ARG A 681     -23.499  12.353   3.943  1.00 52.41           C  \nATOM   5207  O   ARG A 681     -21.154  11.723   6.211  1.00 52.41           O  \nATOM   5208  CG  ARG A 681     -23.992  11.510   2.765  1.00 52.41           C  \nATOM   5209  CD  ARG A 681     -24.256  12.426   1.568  1.00 52.41           C  \nATOM   5210  NE  ARG A 681     -24.553  11.650   0.350  1.00 52.41           N  \nATOM   5211  NH1 ARG A 681     -24.741  13.446  -1.063  1.00 52.41           N  \nATOM   5212  NH2 ARG A 681     -24.899  11.368  -1.880  1.00 52.41           N  \nATOM   5213  CZ  ARG A 681     -24.732  12.158  -0.855  1.00 52.41           C  \nATOM   5214  N   LEU A 682     -22.708  13.214   6.873  1.00 48.38           N  \nATOM   5215  CA  LEU A 682     -21.857  13.951   7.817  1.00 48.38           C  \nATOM   5216  C   LEU A 682     -21.361  13.066   8.972  1.00 48.38           C  \nATOM   5217  CB  LEU A 682     -22.631  15.179   8.336  1.00 48.38           C  \nATOM   5218  O   LEU A 682     -20.205  13.172   9.369  1.00 48.38           O  \nATOM   5219  CG  LEU A 682     -22.988  16.202   7.241  1.00 48.38           C  \nATOM   5220  CD1 LEU A 682     -23.940  17.260   7.798  1.00 48.38           C  \nATOM   5221  CD2 LEU A 682     -21.756  16.890   6.667  1.00 48.38           C  \nATOM   5222  N   LEU A 683     -22.194  12.135   9.455  1.00 46.44           N  \nATOM   5223  CA  LEU A 683     -21.759  11.074  10.374  1.00 46.44           C  \nATOM   5224  C   LEU A 683     -20.697  10.164   9.736  1.00 46.44           C  \nATOM   5225  CB  LEU A 683     -22.982  10.237  10.804  1.00 46.44           C  \nATOM   5226  O   LEU A 683     -19.636   9.935  10.314  1.00 46.44           O  \nATOM   5227  CG  LEU A 683     -23.824  10.881  11.915  1.00 46.44           C  \nATOM   5228  CD1 LEU A 683     -25.171  10.164  12.049  1.00 46.44           C  \nATOM   5229  CD2 LEU A 683     -23.106  10.790  13.264  1.00 46.44           C  \nATOM   5230  N   GLN A 684     -20.979   9.658   8.534  1.00 44.56           N  \nATOM   5231  CA  GLN A 684     -20.177   8.623   7.880  1.00 44.56           C  \nATOM   5232  C   GLN A 684     -18.815   9.129   7.364  1.00 44.56           C  \nATOM   5233  CB  GLN A 684     -21.057   7.978   6.796  1.00 44.56           C  \nATOM   5234  O   GLN A 684     -17.921   8.320   7.129  1.00 44.56           O  \nATOM   5235  CG  GLN A 684     -20.541   6.617   6.310  1.00 44.56           C  \nATOM   5236  CD  GLN A 684     -21.564   5.860   5.462  1.00 44.56           C  \nATOM   5237  NE2 GLN A 684     -21.273   4.629   5.102  1.00 44.56           N  \nATOM   5238  OE1 GLN A 684     -22.633   6.333   5.101  1.00 44.56           O  \nATOM   5239  N   GLU A 685     -18.608  10.447   7.251  1.00 47.59           N  \nATOM   5240  CA  GLU A 685     -17.281  11.030   6.990  1.00 47.59           C  \nATOM   5241  C   GLU A 685     -16.294  10.897   8.162  1.00 47.59           C  \nATOM   5242  CB  GLU A 685     -17.389  12.520   6.632  1.00 47.59           C  \nATOM   5243  O   GLU A 685     -15.087  10.918   7.925  1.00 47.59           O  \nATOM   5244  CG  GLU A 685     -18.003  12.778   5.253  1.00 47.59           C  \nATOM   5245  CD  GLU A 685     -17.411  14.041   4.628  1.00 47.59           C  \nATOM   5246  OE1 GLU A 685     -16.888  13.918   3.497  1.00 47.59           O  \nATOM   5247  OE2 GLU A 685     -17.486  15.127   5.250  1.00 47.59           O  \nATOM   5248  N   ARG A 686     -16.762  10.766   9.414  1.00 40.22           N  \nATOM   5249  CA  ARG A 686     -15.869  10.620  10.583  1.00 40.22           C  \nATOM   5250  C   ARG A 686     -15.467   9.172  10.887  1.00 40.22           C  \nATOM   5251  CB  ARG A 686     -16.461  11.308  11.831  1.00 40.22           C  \nATOM   5252  O   ARG A 686     -14.475   8.972  11.578  1.00 40.22           O  \nATOM   5253  CG  ARG A 686     -16.155  12.818  11.917  1.00 40.22           C  \nATOM   5254  CD  ARG A 686     -16.370  13.313  13.362  1.00 40.22           C  \nATOM   5255  NE  ARG A 686     -16.022  14.740  13.553  1.00 40.22           N  \nATOM   5256  NH1 ARG A 686     -14.510  14.574  15.300  1.00 40.22           N  \nATOM   5257  NH2 ARG A 686     -15.043  16.569  14.521  1.00 40.22           N  \nATOM   5258  CZ  ARG A 686     -15.200  15.280  14.447  1.00 40.22           C  \nATOM   5259  N   GLU A 687     -16.188   8.172  10.378  1.00 42.16           N  \nATOM   5260  CA  GLU A 687     -15.963   6.749  10.706  1.00 42.16           C  \nATOM   5261  C   GLU A 687     -14.970   6.028   9.760  1.00 42.16           C  \nATOM   5262  CB  GLU A 687     -17.318   6.009  10.845  1.00 42.16           C  \nATOM   5263  O   GLU A 687     -14.805   4.816   9.867  1.00 42.16           O  \nATOM   5264  CG  GLU A 687     -18.137   6.487  12.064  1.00 42.16           C  \nATOM   5265  CD  GLU A 687     -19.452   5.707  12.296  1.00 42.16           C  \nATOM   5266  OE1 GLU A 687     -19.799   5.466  13.478  1.00 42.16           O  \nATOM   5267  OE2 GLU A 687     -20.165   5.406  11.308  1.00 42.16           O  \nATOM   5268  N   LEU A 688     -14.293   6.741   8.842  1.00 37.22           N  \nATOM   5269  CA  LEU A 688     -13.439   6.143   7.793  1.00 37.22           C  \nATOM   5270  C   LEU A 688     -11.949   6.560   7.804  1.00 37.22           C  \nATOM   5271  CB  LEU A 688     -14.106   6.319   6.405  1.00 37.22           C  \nATOM   5272  O   LEU A 688     -11.264   6.396   6.794  1.00 37.22           O  \nATOM   5273  CG  LEU A 688     -14.387   4.965   5.720  1.00 37.22           C  \nATOM   5274  CD1 LEU A 688     -15.777   4.449   6.105  1.00 37.22           C  \nATOM   5275  CD2 LEU A 688     -14.326   5.080   4.196  1.00 37.22           C  \nATOM   5276  N   VAL A 689     -11.431   7.087   8.921  1.00 36.41           N  \nATOM   5277  CA  VAL A 689     -10.003   7.448   9.078  1.00 36.41           C  \nATOM   5278  C   VAL A 689      -9.320   6.518  10.087  1.00 36.41           C  \nATOM   5279  CB  VAL A 689      -9.813   8.945   9.410  1.00 36.41           C  \nATOM   5280  O   VAL A 689      -9.248   6.806  11.281  1.00 36.41           O  \nATOM   5281  CG1 VAL A 689      -8.322   9.313   9.484  1.00 36.41           C  \nATOM   5282  CG2 VAL A 689     -10.449   9.836   8.332  1.00 36.41           C  \nATOM   5283  N   GLU A 690      -8.824   5.384   9.594  1.00 34.66           N  \nATOM   5284  CA  GLU A 690      -8.037   4.409  10.362  1.00 34.66           C  \nATOM   5285  C   GLU A 690      -6.550   4.855  10.415  1.00 34.66           C  \nATOM   5286  CB  GLU A 690      -8.264   3.014   9.738  1.00 34.66           C  \nATOM   5287  O   GLU A 690      -6.014   5.288   9.389  1.00 34.66           O  \nATOM   5288  CG  GLU A 690      -7.868   1.828  10.633  1.00 34.66           C  \nATOM   5289  CD  GLU A 690      -8.483   0.493  10.152  1.00 34.66           C  \nATOM   5290  OE1 GLU A 690      -9.000  -0.252  11.016  1.00 34.66           O  \nATOM   5291  OE2 GLU A 690      -8.465   0.214   8.927  1.00 34.66           O  \nATOM   5292  N   PRO A 691      -5.866   4.827  11.579  1.00 29.34           N  \nATOM   5293  CA  PRO A 691      -4.520   5.392  11.731  1.00 29.34           C  \nATOM   5294  C   PRO A 691      -3.430   4.460  11.169  1.00 29.34           C  \nATOM   5295  CB  PRO A 691      -4.370   5.659  13.234  1.00 29.34           C  \nATOM   5296  O   PRO A 691      -2.895   3.605  11.872  1.00 29.34           O  \nATOM   5297  CG  PRO A 691      -5.230   4.567  13.868  1.00 29.34           C  \nATOM   5298  CD  PRO A 691      -6.387   4.421  12.878  1.00 29.34           C  \nATOM   5299  N   LEU A 692      -3.087   4.636   9.891  1.00 30.58           N  \nATOM   5300  CA  LEU A 692      -2.131   3.791   9.164  1.00 30.58           C  \nATOM   5301  C   LEU A 692      -0.655   4.239   9.265  1.00 30.58           C  \nATOM   5302  CB  LEU A 692      -2.616   3.587   7.710  1.00 30.58           C  \nATOM   5303  O   LEU A 692       0.021   4.348   8.248  1.00 30.58           O  \nATOM   5304  CG  LEU A 692      -3.863   2.697   7.557  1.00 30.58           C  \nATOM   5305  CD1 LEU A 692      -4.292   2.682   6.088  1.00 30.58           C  \nATOM   5306  CD2 LEU A 692      -3.602   1.246   7.976  1.00 30.58           C  \nATOM   5307  N   THR A 693      -0.124   4.398  10.482  1.00 36.44           N  \nATOM   5308  CA  THR A 693       1.315   4.187  10.773  1.00 36.44           C  \nATOM   5309  C   THR A 693       1.498   3.629  12.197  1.00 36.44           C  \nATOM   5310  CB  THR A 693       2.212   5.436  10.628  1.00 36.44           C  \nATOM   5311  O   THR A 693       0.980   4.212  13.149  1.00 36.44           O  \nATOM   5312  CG2 THR A 693       2.502   5.848   9.187  1.00 36.44           C  \nATOM   5313  OG1 THR A 693       1.669   6.555  11.279  1.00 36.44           O  \nATOM   5314  N   PRO A 694       2.252   2.527  12.403  1.00 35.31           N  \nATOM   5315  CA  PRO A 694       2.499   1.989  13.748  1.00 35.31           C  \nATOM   5316  C   PRO A 694       3.419   2.833  14.646  1.00 35.31           C  \nATOM   5317  CB  PRO A 694       3.094   0.590  13.540  1.00 35.31           C  \nATOM   5318  O   PRO A 694       3.549   2.513  15.824  1.00 35.31           O  \nATOM   5319  CG  PRO A 694       2.620   0.200  12.144  1.00 35.31           C  \nATOM   5320  CD  PRO A 694       2.641   1.537  11.408  1.00 35.31           C  \nATOM   5321  N   SER A 695       4.090   3.862  14.114  1.00 38.53           N  \nATOM   5322  CA  SER A 695       5.073   4.663  14.859  1.00 38.53           C  \nATOM   5323  C   SER A 695       4.480   5.870  15.594  1.00 38.53           C  \nATOM   5324  CB  SER A 695       6.188   5.126  13.919  1.00 38.53           C  \nATOM   5325  O   SER A 695       4.997   6.260  16.635  1.00 38.53           O  \nATOM   5326  OG  SER A 695       5.673   5.857  12.820  1.00 38.53           O  \nATOM   5327  N   GLY A 696       3.399   6.472  15.082  1.00 43.44           N  \nATOM   5328  CA  GLY A 696       2.804   7.686  15.665  1.00 43.44           C  \nATOM   5329  C   GLY A 696       3.662   8.958  15.541  1.00 43.44           C  \nATOM   5330  O   GLY A 696       3.345   9.966  16.166  1.00 43.44           O  \nATOM   5331  N   GLU A 697       4.730   8.922  14.739  1.00 42.41           N  \nATOM   5332  CA  GLU A 697       5.720  10.005  14.575  1.00 42.41           C  \nATOM   5333  C   GLU A 697       5.321  11.063  13.530  1.00 42.41           C  \nATOM   5334  CB  GLU A 697       7.081   9.384  14.229  1.00 42.41           C  \nATOM   5335  O   GLU A 697       6.031  12.045  13.323  1.00 42.41           O  \nATOM   5336  CG  GLU A 697       7.648   8.584  15.411  1.00 42.41           C  \nATOM   5337  CD  GLU A 697       8.893   7.785  15.018  1.00 42.41           C  \nATOM   5338  OE1 GLU A 697       9.880   7.851  15.782  1.00 42.41           O  \nATOM   5339  OE2 GLU A 697       8.823   7.087  13.978  1.00 42.41           O  \nATOM   5340  N   ALA A 698       4.166  10.889  12.889  1.00 40.53           N  \nATOM   5341  CA  ALA A 698       3.536  11.876  12.021  1.00 40.53           C  \nATOM   5342  C   ALA A 698       2.055  12.051  12.415  1.00 40.53           C  \nATOM   5343  CB  ALA A 698       3.696  11.430  10.561  1.00 40.53           C  \nATOM   5344  O   ALA A 698       1.447  11.116  12.944  1.00 40.53           O  \nATOM   5345  N   PRO A 699       1.430  13.211  12.133  1.00 40.19           N  \nATOM   5346  CA  PRO A 699      -0.031  13.332  12.134  1.00 40.19           C  \nATOM   5347  C   PRO A 699      -0.681  12.432  11.047  1.00 40.19           C  \nATOM   5348  CB  PRO A 699      -0.313  14.837  11.978  1.00 40.19           C  \nATOM   5349  O   PRO A 699       0.014  11.689  10.356  1.00 40.19           O  \nATOM   5350  CG  PRO A 699       1.019  15.533  12.277  1.00 40.19           C  \nATOM   5351  CD  PRO A 699       2.060  14.495  11.867  1.00 40.19           C  \nATOM   5352  N   ASN A 700      -2.010  12.489  10.865  1.00 38.94           N  \nATOM   5353  CA  ASN A 700      -2.751  11.629   9.914  1.00 38.94           C  \nATOM   5354  C   ASN A 700      -3.236  12.393   8.664  1.00 38.94           C  \nATOM   5355  CB  ASN A 700      -3.963  11.000  10.637  1.00 38.94           C  \nATOM   5356  O   ASN A 700      -4.185  13.175   8.770  1.00 38.94           O  \nATOM   5357  CG  ASN A 700      -3.641   9.804  11.510  1.00 38.94           C  \nATOM   5358  ND2 ASN A 700      -4.561   9.396  12.352  1.00 38.94           N  \nATOM   5359  OD1 ASN A 700      -2.601   9.189  11.437  1.00 38.94           O  \nATOM   5360  N   GLN A 701      -2.648  12.143   7.480  1.00 42.03           N  \nATOM   5361  CA  GLN A 701      -2.851  12.954   6.252  1.00 42.03           C  \nATOM   5362  C   GLN A 701      -4.325  13.119   5.845  1.00 42.03           C  \nATOM   5363  CB  GLN A 701      -2.005  12.410   5.081  1.00 42.03           C  \nATOM   5364  O   GLN A 701      -4.729  14.188   5.397  1.00 42.03           O  \nATOM   5365  CG  GLN A 701      -0.499  12.677   5.281  1.00 42.03           C  \nATOM   5366  CD  GLN A 701       0.364  12.439   4.045  1.00 42.03           C  \nATOM   5367  NE2 GLN A 701       1.607  12.870   4.059  1.00 42.03           N  \nATOM   5368  OE1 GLN A 701      -0.043  11.862   3.055  1.00 42.03           O  \nATOM   5369  N   ALA A 702      -5.157  12.107   6.101  1.00 41.75           N  \nATOM   5370  CA  ALA A 702      -6.586  12.101   5.783  1.00 41.75           C  \nATOM   5371  C   ALA A 702      -7.466  13.093   6.587  1.00 41.75           C  \nATOM   5372  CB  ALA A 702      -7.070  10.655   5.945  1.00 41.75           C  \nATOM   5373  O   ALA A 702      -8.671  13.156   6.346  1.00 41.75           O  \nATOM   5374  N   LEU A 703      -6.918  13.853   7.548  1.00 56.72           N  \nATOM   5375  CA  LEU A 703      -7.683  14.834   8.341  1.00 56.72           C  \nATOM   5376  C   LEU A 703      -7.689  16.258   7.755  1.00 56.72           C  \nATOM   5377  CB  LEU A 703      -7.172  14.837   9.796  1.00 56.72           C  \nATOM   5378  O   LEU A 703      -8.560  17.047   8.129  1.00 56.72           O  \nATOM   5379  CG  LEU A 703      -7.514  13.554  10.578  1.00 56.72           C  \nATOM   5380  CD1 LEU A 703      -6.744  13.524  11.898  1.00 56.72           C  \nATOM   5381  CD2 LEU A 703      -9.001  13.455  10.939  1.00 56.72           C  \nATOM   5382  N   LEU A 704      -6.754  16.597   6.859  1.00 64.69           N  \nATOM   5383  CA  LEU A 704      -6.664  17.926   6.246  1.00 64.69           C  \nATOM   5384  C   LEU A 704      -7.578  18.012   5.014  1.00 64.69           C  \nATOM   5385  CB  LEU A 704      -5.190  18.240   5.920  1.00 64.69           C  \nATOM   5386  O   LEU A 704      -7.360  17.338   4.011  1.00 64.69           O  \nATOM   5387  CG  LEU A 704      -4.947  19.634   5.303  1.00 64.69           C  \nATOM   5388  CD1 LEU A 704      -5.322  20.772   6.256  1.00 64.69           C  \nATOM   5389  CD2 LEU A 704      -3.469  19.794   4.951  1.00 64.69           C  \nATOM   5390  N   ARG A 705      -8.604  18.866   5.076  1.00 75.12           N  \nATOM   5391  CA  ARG A 705      -9.527  19.098   3.956  1.00 75.12           C  \nATOM   5392  C   ARG A 705      -8.990  20.198   3.046  1.00 75.12           C  \nATOM   5393  CB  ARG A 705     -10.927  19.448   4.484  1.00 75.12           C  \nATOM   5394  O   ARG A 705      -8.879  21.337   3.488  1.00 75.12           O  \nATOM   5395  CG  ARG A 705     -11.563  18.271   5.236  1.00 75.12           C  \nATOM   5396  CD  ARG A 705     -12.932  18.641   5.815  1.00 75.12           C  \nATOM   5397  NE  ARG A 705     -13.618  17.430   6.301  1.00 75.12           N  \nATOM   5398  NH1 ARG A 705     -15.728  18.298   6.545  1.00 75.12           N  \nATOM   5399  NH2 ARG A 705     -15.413  16.100   6.665  1.00 75.12           N  \nATOM   5400  CZ  ARG A 705     -14.912  17.286   6.508  1.00 75.12           C  \nATOM   5401  N   ILE A 706      -8.707  19.877   1.785  1.00 80.19           N  \nATOM   5402  CA  ILE A 706      -8.500  20.890   0.741  1.00 80.19           C  \nATOM   5403  C   ILE A 706      -9.885  21.334   0.261  1.00 80.19           C  \nATOM   5404  CB  ILE A 706      -7.605  20.374  -0.409  1.00 80.19           C  \nATOM   5405  O   ILE A 706     -10.675  20.511  -0.199  1.00 80.19           O  \nATOM   5406  CG1 ILE A 706      -6.242  19.884   0.138  1.00 80.19           C  \nATOM   5407  CG2 ILE A 706      -7.401  21.498  -1.446  1.00 80.19           C  \nATOM   5408  CD1 ILE A 706      -5.316  19.273  -0.922  1.00 80.19           C  \nATOM   5409  N   LEU A 707     -10.189  22.621   0.413  1.00 81.31           N  \nATOM   5410  CA  LEU A 707     -11.495  23.215   0.125  1.00 81.31           C  \nATOM   5411  C   LEU A 707     -11.359  24.196  -1.050  1.00 81.31           C  \nATOM   5412  CB  LEU A 707     -12.055  23.861   1.411  1.00 81.31           C  \nATOM   5413  O   LEU A 707     -10.363  24.912  -1.154  1.00 81.31           O  \nATOM   5414  CG  LEU A 707     -12.215  22.897   2.611  1.00 81.31           C  \nATOM   5415  CD1 LEU A 707     -12.684  23.628   3.871  1.00 81.31           C  \nATOM   5416  CD2 LEU A 707     -13.222  21.778   2.344  1.00 81.31           C  \nATOM   5417  N   LYS A 708     -12.338  24.206  -1.961  1.00 81.75           N  \nATOM   5418  CA  LYS A 708     -12.308  25.040  -3.178  1.00 81.75           C  \nATOM   5419  C   LYS A 708     -12.709  26.478  -2.852  1.00 81.75           C  \nATOM   5420  CB  LYS A 708     -13.268  24.483  -4.245  1.00 81.75           C  \nATOM   5421  O   LYS A 708     -13.625  26.689  -2.066  1.00 81.75           O  \nATOM   5422  CG  LYS A 708     -12.954  23.069  -4.758  1.00 81.75           C  \nATOM   5423  CD  LYS A 708     -14.161  22.545  -5.553  1.00 81.75           C  \nATOM   5424  CE  LYS A 708     -13.861  21.207  -6.233  1.00 81.75           C  \nATOM   5425  NZ  LYS A 708     -15.102  20.593  -6.764  1.00 81.75           N  \nATOM   5426  N   GLU A 709     -12.144  27.462  -3.554  1.00 81.31           N  \nATOM   5427  CA  GLU A 709     -12.557  28.872  -3.417  1.00 81.31           C  \nATOM   5428  C   GLU A 709     -14.059  29.077  -3.698  1.00 81.31           C  \nATOM   5429  CB  GLU A 709     -11.678  29.739  -4.330  1.00 81.31           C  \nATOM   5430  O   GLU A 709     -14.717  29.880  -3.043  1.00 81.31           O  \nATOM   5431  CG  GLU A 709     -11.875  31.245  -4.086  1.00 81.31           C  \nATOM   5432  CD  GLU A 709     -10.677  32.073  -4.575  1.00 81.31           C  \nATOM   5433  OE1 GLU A 709     -10.226  32.951  -3.798  1.00 81.31           O  \nATOM   5434  OE2 GLU A 709     -10.182  31.787  -5.688  1.00 81.31           O  \nATOM   5435  N   THR A 710     -14.635  28.264  -4.591  1.00 82.88           N  \nATOM   5436  CA  THR A 710     -16.072  28.239  -4.909  1.00 82.88           C  \nATOM   5437  C   THR A 710     -16.980  27.799  -3.755  1.00 82.88           C  \nATOM   5438  CB  THR A 710     -16.341  27.313  -6.105  1.00 82.88           C  \nATOM   5439  O   THR A 710     -18.187  28.012  -3.840  1.00 82.88           O  \nATOM   5440  CG2 THR A 710     -15.689  27.823  -7.390  1.00 82.88           C  \nATOM   5441  OG1 THR A 710     -15.824  26.021  -5.859  1.00 82.88           O  \nATOM   5442  N   GLU A 711     -16.447  27.185  -2.693  1.00 82.94           N  \nATOM   5443  CA  GLU A 711     -17.214  26.859  -1.482  1.00 82.94           C  \nATOM   5444  C   GLU A 711     -17.282  28.030  -0.484  1.00 82.94           C  \nATOM   5445  CB  GLU A 711     -16.648  25.617  -0.773  1.00 82.94           C  \nATOM   5446  O   GLU A 711     -17.922  27.897   0.559  1.00 82.94           O  \nATOM   5447  CG  GLU A 711     -16.689  24.318  -1.588  1.00 82.94           C  \nATOM   5448  CD  GLU A 711     -16.413  23.098  -0.693  1.00 82.94           C  \nATOM   5449  OE1 GLU A 711     -17.018  22.032  -0.941  1.00 82.94           O  \nATOM   5450  OE2 GLU A 711     -15.631  23.227   0.276  1.00 82.94           O  \nATOM   5451  N   PHE A 712     -16.636  29.174  -0.750  1.00 82.31           N  \nATOM   5452  CA  PHE A 712     -16.529  30.269   0.218  1.00 82.31           C  \nATOM   5453  C   PHE A 712     -17.117  31.592  -0.264  1.00 82.31           C  \nATOM   5454  CB  PHE A 712     -15.073  30.465   0.646  1.00 82.31           C  \nATOM   5455  O   PHE A 712     -16.909  32.040  -1.388  1.00 82.31           O  \nATOM   5456  CG  PHE A 712     -14.467  29.244   1.296  1.00 82.31           C  \nATOM   5457  CD1 PHE A 712     -14.893  28.838   2.575  1.00 82.31           C  \nATOM   5458  CD2 PHE A 712     -13.502  28.495   0.603  1.00 82.31           C  \nATOM   5459  CE1 PHE A 712     -14.340  27.687   3.158  1.00 82.31           C  \nATOM   5460  CE2 PHE A 712     -12.947  27.349   1.187  1.00 82.31           C  \nATOM   5461  CZ  PHE A 712     -13.364  26.953   2.467  1.00 82.31           C  \nATOM   5462  N   LYS A 713     -17.767  32.298   0.666  1.00 85.19           N  \nATOM   5463  CA  LYS A 713     -18.113  33.717   0.531  1.00 85.19           C  \nATOM   5464  C   LYS A 713     -17.415  34.504   1.640  1.00 85.19           C  \nATOM   5465  CB  LYS A 713     -19.649  33.852   0.536  1.00 85.19           C  \nATOM   5466  O   LYS A 713     -17.868  34.469   2.784  1.00 85.19           O  \nATOM   5467  CG  LYS A 713     -20.132  35.267   0.175  1.00 85.19           C  \nATOM   5468  CD  LYS A 713     -21.668  35.350   0.219  1.00 85.19           C  \nATOM   5469  CE  LYS A 713     -22.163  36.744  -0.199  1.00 85.19           C  \nATOM   5470  NZ  LYS A 713     -23.635  36.892  -0.024  1.00 85.19           N  \nATOM   5471  N   LYS A 714     -16.327  35.220   1.322  1.00 88.00           N  \nATOM   5472  CA  LYS A 714     -15.752  36.256   2.210  1.00 88.00           C  \nATOM   5473  C   LYS A 714     -16.795  37.384   2.362  1.00 88.00           C  \nATOM   5474  CB  LYS A 714     -14.399  36.782   1.654  1.00 88.00           C  \nATOM   5475  O   LYS A 714     -17.366  37.814   1.364  1.00 88.00           O  \nATOM   5476  CG  LYS A 714     -13.248  35.743   1.607  1.00 88.00           C  \nATOM   5477  CD  LYS A 714     -11.936  36.308   1.008  1.00 88.00           C  \nATOM   5478  CE  LYS A 714     -10.842  35.227   0.873  1.00 88.00           C  \nATOM   5479  NZ  LYS A 714      -9.609  35.697   0.179  1.00 88.00           N  \nATOM   5480  N   ILE A 715     -17.081  37.830   3.591  1.00 85.50           N  \nATOM   5481  CA  ILE A 715     -18.123  38.838   3.898  1.00 85.50           C  \nATOM   5482  C   ILE A 715     -17.514  40.150   4.402  1.00 85.50           C  \nATOM   5483  CB  ILE A 715     -19.179  38.281   4.894  1.00 85.50           C  \nATOM   5484  O   ILE A 715     -17.768  41.206   3.833  1.00 85.50           O  \nATOM   5485  CG1 ILE A 715     -19.976  37.131   4.240  1.00 85.50           C  \nATOM   5486  CG2 ILE A 715     -20.149  39.387   5.365  1.00 85.50           C  \nATOM   5487  CD1 ILE A 715     -20.886  36.357   5.200  1.00 85.50           C  \nATOM   5488  N   LYS A 716     -16.729  40.107   5.486  1.00 86.69           N  \nATOM   5489  CA  LYS A 716     -16.170  41.305   6.142  1.00 86.69           C  \nATOM   5490  C   LYS A 716     -14.813  40.984   6.763  1.00 86.69           C  \nATOM   5491  CB  LYS A 716     -17.171  41.827   7.203  1.00 86.69           C  \nATOM   5492  O   LYS A 716     -14.663  39.923   7.361  1.00 86.69           O  \nATOM   5493  CG  LYS A 716     -16.698  43.126   7.883  1.00 86.69           C  \nATOM   5494  CD  LYS A 716     -17.586  43.602   9.044  1.00 86.69           C  \nATOM   5495  CE  LYS A 716     -16.827  44.690   9.826  1.00 86.69           C  \nATOM   5496  NZ  LYS A 716     -17.587  45.206  10.994  1.00 86.69           N  \nATOM   5497  N   VAL A 717     -13.851  41.904   6.688  1.00 85.94           N  \nATOM   5498  CA  VAL A 717     -12.588  41.802   7.442  1.00 85.94           C  \nATOM   5499  C   VAL A 717     -12.864  41.878   8.952  1.00 85.94           C  \nATOM   5500  CB  VAL A 717     -11.579  42.881   6.999  1.00 85.94           C  \nATOM   5501  O   VAL A 717     -13.548  42.783   9.430  1.00 85.94           O  \nATOM   5502  CG1 VAL A 717     -10.276  42.811   7.806  1.00 85.94           C  \nATOM   5503  CG2 VAL A 717     -11.212  42.708   5.519  1.00 85.94           C  \nATOM   5504  N   LEU A 718     -12.329  40.915   9.701  1.00 79.69           N  \nATOM   5505  CA  LEU A 718     -12.388  40.820  11.164  1.00 79.69           C  \nATOM   5506  C   LEU A 718     -11.131  41.385  11.845  1.00 79.69           C  \nATOM   5507  CB  LEU A 718     -12.548  39.337  11.543  1.00 79.69           C  \nATOM   5508  O   LEU A 718     -11.204  41.864  12.978  1.00 79.69           O  \nATOM   5509  CG  LEU A 718     -13.933  38.738  11.262  1.00 79.69           C  \nATOM   5510  CD1 LEU A 718     -13.881  37.221  11.443  1.00 79.69           C  \nATOM   5511  CD2 LEU A 718     -15.000  39.293  12.209  1.00 79.69           C  \nATOM   5512  N   GLY A 719      -9.989  41.309  11.159  1.00 73.31           N  \nATOM   5513  CA  GLY A 719      -8.690  41.762  11.649  1.00 73.31           C  \nATOM   5514  C   GLY A 719      -7.588  41.603  10.601  1.00 73.31           C  \nATOM   5515  O   GLY A 719      -7.785  40.991   9.548  1.00 73.31           O  \nATOM   5516  N   SER A 720      -6.419  42.178  10.865  1.00 72.31           N  \nATOM   5517  CA  SER A 720      -5.211  42.024  10.045  1.00 72.31           C  \nATOM   5518  C   SER A 720      -3.969  42.209  10.908  1.00 72.31           C  \nATOM   5519  CB  SER A 720      -5.182  43.042   8.902  1.00 72.31           C  \nATOM   5520  O   SER A 720      -3.928  43.102  11.751  1.00 72.31           O  \nATOM   5521  OG  SER A 720      -6.150  42.686   7.936  1.00 72.31           O  \nATOM   5522  N   GLY A 721      -2.953  41.385  10.675  1.00 64.19           N  \nATOM   5523  CA  GLY A 721      -1.699  41.399  11.425  1.00 64.19           C  \nATOM   5524  C   GLY A 721      -0.542  40.842  10.600  1.00 64.19           C  \nATOM   5525  O   GLY A 721      -0.669  40.638   9.393  1.00 64.19           O  \nATOM   5526  N   ALA A 722       0.591  40.576  11.256  1.00 57.78           N  \nATOM   5527  CA  ALA A 722       1.817  40.124  10.590  1.00 57.78           C  \nATOM   5528  C   ALA A 722       1.617  38.862   9.726  1.00 57.78           C  \nATOM   5529  CB  ALA A 722       2.883  39.894  11.671  1.00 57.78           C  \nATOM   5530  O   ALA A 722       2.153  38.782   8.627  1.00 57.78           O  \nATOM   5531  N   PHE A 723       0.802  37.913  10.195  1.00 62.38           N  \nATOM   5532  CA  PHE A 723       0.565  36.634   9.520  1.00 62.38           C  \nATOM   5533  C   PHE A 723      -0.467  36.689   8.383  1.00 62.38           C  \nATOM   5534  CB  PHE A 723       0.156  35.593  10.573  1.00 62.38           C  \nATOM   5535  O   PHE A 723      -0.614  35.701   7.670  1.00 62.38           O  \nATOM   5536  CG  PHE A 723       1.167  35.439  11.692  1.00 62.38           C  \nATOM   5537  CD1 PHE A 723       2.383  34.775  11.444  1.00 62.38           C  \nATOM   5538  CD2 PHE A 723       0.912  35.980  12.968  1.00 62.38           C  \nATOM   5539  CE1 PHE A 723       3.341  34.653  12.466  1.00 62.38           C  \nATOM   5540  CE2 PHE A 723       1.873  35.859  13.988  1.00 62.38           C  \nATOM   5541  CZ  PHE A 723       3.087  35.196  13.737  1.00 62.38           C  \nATOM   5542  N   GLY A 724      -1.213  37.788   8.213  1.00 72.69           N  \nATOM   5543  CA  GLY A 724      -2.286  37.840   7.219  1.00 72.69           C  \nATOM   5544  C   GLY A 724      -3.506  38.677   7.593  1.00 72.69           C  \nATOM   5545  O   GLY A 724      -3.494  39.459   8.547  1.00 72.69           O  \nATOM   5546  N   THR A 725      -4.580  38.484   6.829  1.00 82.56           N  \nATOM   5547  CA  THR A 725      -5.881  39.145   7.008  1.00 82.56           C  \nATOM   5548  C   THR A 725      -6.962  38.098   7.278  1.00 82.56           C  \nATOM   5549  CB  THR A 725      -6.195  40.032   5.790  1.00 82.56           C  \nATOM   5550  O   THR A 725      -7.038  37.081   6.595  1.00 82.56           O  \nATOM   5551  CG2 THR A 725      -7.613  40.606   5.801  1.00 82.56           C  \nATOM   5552  OG1 THR A 725      -5.303  41.138   5.796  1.00 82.56           O  \nATOM   5553  N   VAL A 726      -7.798  38.331   8.295  1.00 86.25           N  \nATOM   5554  CA  VAL A 726      -8.869  37.406   8.700  1.00 86.25           C  \nATOM   5555  C   VAL A 726     -10.223  37.963   8.272  1.00 86.25           C  \nATOM   5556  CB  VAL A 726      -8.843  37.101  10.212  1.00 86.25           C  \nATOM   5557  O   VAL A 726     -10.540  39.114   8.575  1.00 86.25           O  \nATOM   5558  CG1 VAL A 726      -9.869  36.016  10.571  1.00 86.25           C  \nATOM   5559  CG2 VAL A 726      -7.470  36.590  10.670  1.00 86.25           C  \nATOM   5560  N   TYR A 727     -11.049  37.143   7.623  1.00 89.56           N  \nATOM   5561  CA  TYR A 727     -12.399  37.488   7.170  1.00 89.56           C  \nATOM   5562  C   TYR A 727     -13.469  36.662   7.898  1.00 89.56           C  \nATOM   5563  CB  TYR A 727     -12.529  37.271   5.651  1.00 89.56           C  \nATOM   5564  O   TYR A 727     -13.312  35.453   8.062  1.00 89.56           O  \nATOM   5565  CG  TYR A 727     -11.536  38.018   4.779  1.00 89.56           C  \nATOM   5566  CD1 TYR A 727     -11.917  39.205   4.120  1.00 89.56           C  \nATOM   5567  CD2 TYR A 727     -10.240  37.500   4.591  1.00 89.56           C  \nATOM   5568  CE1 TYR A 727     -11.005  39.870   3.274  1.00 89.56           C  \nATOM   5569  CE2 TYR A 727      -9.324  38.178   3.770  1.00 89.56           C  \nATOM   5570  OH  TYR A 727      -8.804  40.009   2.319  1.00 89.56           O  \nATOM   5571  CZ  TYR A 727      -9.700  39.359   3.104  1.00 89.56           C  \nATOM   5572  N   LYS A 728     -14.602  37.289   8.244  1.00 87.00           N  \nATOM   5573  CA  LYS A 728     -15.895  36.606   8.426  1.00 87.00           C  \nATOM   5574  C   LYS A 728     -16.273  36.062   7.057  1.00 87.00           C  \nATOM   5575  CB  LYS A 728     -16.981  37.592   8.939  1.00 87.00           C  \nATOM   5576  O   LYS A 728     -16.308  36.836   6.096  1.00 87.00           O  \nATOM   5577  CG  LYS A 728     -18.405  36.986   9.072  1.00 87.00           C  \nATOM   5578  CD  LYS A 728     -19.523  38.038   9.294  1.00 87.00           C  \nATOM   5579  CE  LYS A 728     -20.936  37.401   9.287  1.00 87.00           C  \nATOM   5580  NZ  LYS A 728     -22.072  38.381   9.186  1.00 87.00           N  \nATOM   5581  N   GLY A 729     -16.597  34.782   6.971  1.00 88.44           N  \nATOM   5582  CA  GLY A 729     -17.125  34.181   5.756  1.00 88.44           C  \nATOM   5583  C   GLY A 729     -18.212  33.152   6.026  1.00 88.44           C  \nATOM   5584  O   GLY A 729     -18.497  32.799   7.173  1.00 88.44           O  \nATOM   5585  N   LEU A 730     -18.808  32.672   4.941  1.00 87.69           N  \nATOM   5586  CA  LEU A 730     -19.630  31.468   4.928  1.00 87.69           C  \nATOM   5587  C   LEU A 730     -18.912  30.395   4.115  1.00 87.69           C  \nATOM   5588  CB  LEU A 730     -21.021  31.768   4.347  1.00 87.69           C  \nATOM   5589  O   LEU A 730     -18.475  30.669   2.997  1.00 87.69           O  \nATOM   5590  CG  LEU A 730     -21.882  32.686   5.231  1.00 87.69           C  \nATOM   5591  CD1 LEU A 730     -23.128  33.113   4.454  1.00 87.69           C  \nATOM   5592  CD2 LEU A 730     -22.317  32.012   6.532  1.00 87.69           C  \nATOM   5593  N   TRP A 731     -18.822  29.194   4.677  1.00 86.31           N  \nATOM   5594  CA  TRP A 731     -18.521  27.971   3.943  1.00 86.31           C  \nATOM   5595  C   TRP A 731     -19.849  27.341   3.507  1.00 86.31           C  \nATOM   5596  CB  TRP A 731     -17.656  27.051   4.816  1.00 86.31           C  \nATOM   5597  O   TRP A 731     -20.790  27.239   4.302  1.00 86.31           O  \nATOM   5598  CG  TRP A 731     -17.236  25.738   4.222  1.00 86.31           C  \nATOM   5599  CD1 TRP A 731     -16.835  25.528   2.946  1.00 86.31           C  \nATOM   5600  CD2 TRP A 731     -17.135  24.435   4.880  1.00 86.31           C  \nATOM   5601  CE2 TRP A 731     -16.725  23.468   3.912  1.00 86.31           C  \nATOM   5602  CE3 TRP A 731     -17.355  23.971   6.197  1.00 86.31           C  \nATOM   5603  NE1 TRP A 731     -16.536  24.193   2.757  1.00 86.31           N  \nATOM   5604  CH2 TRP A 731     -16.874  21.672   5.528  1.00 86.31           C  \nATOM   5605  CZ2 TRP A 731     -16.598  22.107   4.220  1.00 86.31           C  \nATOM   5606  CZ3 TRP A 731     -17.235  22.604   6.519  1.00 86.31           C  \nATOM   5607  N   ILE A 732     -19.936  26.989   2.227  1.00 85.31           N  \nATOM   5608  CA  ILE A 732     -21.104  26.429   1.545  1.00 85.31           C  \nATOM   5609  C   ILE A 732     -20.617  25.144   0.849  1.00 85.31           C  \nATOM   5610  CB  ILE A 732     -21.726  27.452   0.561  1.00 85.31           C  \nATOM   5611  O   ILE A 732     -20.146  25.209  -0.288  1.00 85.31           O  \nATOM   5612  CG1 ILE A 732     -21.978  28.822   1.242  1.00 85.31           C  \nATOM   5613  CG2 ILE A 732     -23.035  26.858   0.005  1.00 85.31           C  \nATOM   5614  CD1 ILE A 732     -22.622  29.883   0.340  1.00 85.31           C  \nATOM   5615  N   PRO A 733     -20.657  23.990   1.540  1.00 78.06           N  \nATOM   5616  CA  PRO A 733     -20.043  22.750   1.063  1.00 78.06           C  \nATOM   5617  C   PRO A 733     -20.647  22.259  -0.261  1.00 78.06           C  \nATOM   5618  CB  PRO A 733     -20.223  21.739   2.203  1.00 78.06           C  \nATOM   5619  O   PRO A 733     -21.867  22.296  -0.451  1.00 78.06           O  \nATOM   5620  CG  PRO A 733     -20.361  22.627   3.441  1.00 78.06           C  \nATOM   5621  CD  PRO A 733     -21.117  23.830   2.911  1.00 78.06           C  \nATOM   5622  N   GLU A 734     -19.811  21.773  -1.180  1.00 71.06           N  \nATOM   5623  CA  GLU A 734     -20.214  21.471  -2.556  1.00 71.06           C  \nATOM   5624  C   GLU A 734     -21.308  20.385  -2.625  1.00 71.06           C  \nATOM   5625  CB  GLU A 734     -18.975  21.121  -3.399  1.00 71.06           C  \nATOM   5626  O   GLU A 734     -21.109  19.211  -2.297  1.00 71.06           O  \nATOM   5627  CG  GLU A 734     -19.277  20.998  -4.901  1.00 71.06           C  \nATOM   5628  CD  GLU A 734     -17.994  20.739  -5.707  1.00 71.06           C  \nATOM   5629  OE1 GLU A 734     -17.692  21.482  -6.668  1.00 71.06           O  \nATOM   5630  OE2 GLU A 734     -17.257  19.776  -5.394  1.00 71.06           O  \nATOM   5631  N   GLY A 735     -22.497  20.792  -3.083  1.00 68.69           N  \nATOM   5632  CA  GLY A 735     -23.684  19.937  -3.182  1.00 68.69           C  \nATOM   5633  C   GLY A 735     -24.594  19.930  -1.945  1.00 68.69           C  \nATOM   5634  O   GLY A 735     -25.614  19.235  -1.960  1.00 68.69           O  \nATOM   5635  N   GLU A 736     -24.277  20.704  -0.905  1.00 70.38           N  \nATOM   5636  CA  GLU A 736     -25.134  20.910   0.267  1.00 70.38           C  \nATOM   5637  C   GLU A 736     -25.866  22.266   0.206  1.00 70.38           C  \nATOM   5638  CB  GLU A 736     -24.335  20.704   1.572  1.00 70.38           C  \nATOM   5639  O   GLU A 736     -25.593  23.115  -0.640  1.00 70.38           O  \nATOM   5640  CG  GLU A 736     -23.688  19.296   1.636  1.00 70.38           C  \nATOM   5641  CD  GLU A 736     -23.926  18.478   2.920  1.00 70.38           C  \nATOM   5642  OE1 GLU A 736     -23.429  17.325   2.941  1.00 70.38           O  \nATOM   5643  OE2 GLU A 736     -24.746  18.890   3.776  1.00 70.38           O  \nATOM   5644  N   LYS A 737     -26.862  22.459   1.082  1.00 68.00           N  \nATOM   5645  CA  LYS A 737     -27.576  23.744   1.248  1.00 68.00           C  \nATOM   5646  C   LYS A 737     -27.242  24.468   2.554  1.00 68.00           C  \nATOM   5647  CB  LYS A 737     -29.094  23.555   1.092  1.00 68.00           C  \nATOM   5648  O   LYS A 737     -27.779  25.540   2.806  1.00 68.00           O  \nATOM   5649  CG  LYS A 737     -29.480  23.284  -0.368  1.00 68.00           C  \nATOM   5650  CD  LYS A 737     -30.946  23.662  -0.607  1.00 68.00           C  \nATOM   5651  CE  LYS A 737     -31.244  23.655  -2.109  1.00 68.00           C  \nATOM   5652  NZ  LYS A 737     -32.251  24.690  -2.449  1.00 68.00           N  \nATOM   5653  N   VAL A 738     -26.390  23.865   3.377  1.00 71.12           N  \nATOM   5654  CA  VAL A 738     -26.022  24.384   4.692  1.00 71.12           C  \nATOM   5655  C   VAL A 738     -25.049  25.551   4.531  1.00 71.12           C  \nATOM   5656  CB  VAL A 738     -25.420  23.267   5.566  1.00 71.12           C  \nATOM   5657  O   VAL A 738     -24.082  25.449   3.778  1.00 71.12           O  \nATOM   5658  CG1 VAL A 738     -25.134  23.785   6.975  1.00 71.12           C  \nATOM   5659  CG2 VAL A 738     -26.382  22.074   5.696  1.00 71.12           C  \nATOM   5660  N   LYS A 739     -25.295  26.645   5.255  1.00 77.00           N  \nATOM   5661  CA  LYS A 739     -24.382  27.793   5.364  1.00 77.00           C  \nATOM   5662  C   LYS A 739     -23.669  27.729   6.720  1.00 77.00           C  \nATOM   5663  CB  LYS A 739     -25.182  29.098   5.161  1.00 77.00           C  \nATOM   5664  O   LYS A 739     -24.326  27.745   7.758  1.00 77.00           O  \nATOM   5665  CG  LYS A 739     -25.728  29.256   3.727  1.00 77.00           C  \nATOM   5666  CD  LYS A 739     -26.538  30.554   3.537  1.00 77.00           C  \nATOM   5667  CE  LYS A 739     -27.075  30.638   2.096  1.00 77.00           C  \nATOM   5668  NZ  LYS A 739     -27.889  31.856   1.860  1.00 77.00           N  \nATOM   5669  N   ILE A 740     -22.339  27.647   6.727  1.00 82.12           N  \nATOM   5670  CA  ILE A 740     -21.539  27.466   7.953  1.00 82.12           C  \nATOM   5671  C   ILE A 740     -20.708  28.734   8.210  1.00 82.12           C  \nATOM   5672  CB  ILE A 740     -20.644  26.210   7.848  1.00 82.12           C  \nATOM   5673  O   ILE A 740     -19.934  29.125   7.332  1.00 82.12           O  \nATOM   5674  CG1 ILE A 740     -21.482  24.947   7.546  1.00 82.12           C  \nATOM   5675  CG2 ILE A 740     -19.837  26.013   9.148  1.00 82.12           C  \nATOM   5676  CD1 ILE A 740     -20.642  23.773   7.048  1.00 82.12           C  \nATOM   5677  N   PRO A 741     -20.825  29.394   9.377  1.00 86.19           N  \nATOM   5678  CA  PRO A 741     -20.062  30.599   9.683  1.00 86.19           C  \nATOM   5679  C   PRO A 741     -18.601  30.259  10.010  1.00 86.19           C  \nATOM   5680  CB  PRO A 741     -20.810  31.257  10.844  1.00 86.19           C  \nATOM   5681  O   PRO A 741     -18.302  29.540  10.967  1.00 86.19           O  \nATOM   5682  CG  PRO A 741     -21.431  30.075  11.589  1.00 86.19           C  \nATOM   5683  CD  PRO A 741     -21.720  29.066  10.478  1.00 86.19           C  \nATOM   5684  N   VAL A 742     -17.678  30.812   9.223  1.00 90.38           N  \nATOM   5685  CA  VAL A 742     -16.237  30.533   9.312  1.00 90.38           C  \nATOM   5686  C   VAL A 742     -15.401  31.804   9.450  1.00 90.38           C  \nATOM   5687  CB  VAL A 742     -15.741  29.676   8.128  1.00 90.38           C  \nATOM   5688  O   VAL A 742     -15.803  32.889   9.017  1.00 90.38           O  \nATOM   5689  CG1 VAL A 742     -16.347  28.268   8.176  1.00 90.38           C  \nATOM   5690  CG2 VAL A 742     -16.039  30.297   6.757  1.00 90.38           C  \nATOM   5691  N   ALA A 743     -14.220  31.656  10.043  1.00 89.44           N  \nATOM   5692  CA  ALA A 743     -13.133  32.617   9.948  1.00 89.44           C  \nATOM   5693  C   ALA A 743     -12.130  32.122   8.891  1.00 89.44           C  \nATOM   5694  CB  ALA A 743     -12.510  32.816  11.334  1.00 89.44           C  \nATOM   5695  O   ALA A 743     -11.704  30.968   8.924  1.00 89.44           O  \nATOM   5696  N   ILE A 744     -11.778  32.988   7.941  1.00 88.94           N  \nATOM   5697  CA  ILE A 744     -10.870  32.685   6.825  1.00 88.94           C  \nATOM   5698  C   ILE A 744      -9.617  33.547   7.004  1.00 88.94           C  \nATOM   5699  CB  ILE A 744     -11.576  32.933   5.466  1.00 88.94           C  \nATOM   5700  O   ILE A 744      -9.694  34.765   6.844  1.00 88.94           O  \nATOM   5701  CG1 ILE A 744     -12.887  32.115   5.338  1.00 88.94           C  \nATOM   5702  CG2 ILE A 744     -10.615  32.603   4.309  1.00 88.94           C  \nATOM   5703  CD1 ILE A 744     -13.733  32.458   4.103  1.00 88.94           C  \nATOM   5704  N   LYS A 745      -8.486  32.941   7.375  1.00 86.38           N  \nATOM   5705  CA  LYS A 745      -7.185  33.600   7.590  1.00 86.38           C  \nATOM   5706  C   LYS A 745      -6.338  33.469   6.323  1.00 86.38           C  \nATOM   5707  CB  LYS A 745      -6.524  32.987   8.843  1.00 86.38           C  \nATOM   5708  O   LYS A 745      -5.783  32.410   6.051  1.00 86.38           O  \nATOM   5709  CG  LYS A 745      -5.127  33.542   9.188  1.00 86.38           C  \nATOM   5710  CD  LYS A 745      -4.546  32.820  10.420  1.00 86.38           C  \nATOM   5711  CE  LYS A 745      -3.130  33.304  10.766  1.00 86.38           C  \nATOM   5712  NZ  LYS A 745      -2.509  32.478  11.836  1.00 86.38           N  \nATOM   5713  N   GLU A 746      -6.270  34.543   5.548  1.00 85.31           N  \nATOM   5714  CA  GLU A 746      -5.518  34.650   4.295  1.00 85.31           C  \nATOM   5715  C   GLU A 746      -4.078  35.098   4.573  1.00 85.31           C  \nATOM   5716  CB  GLU A 746      -6.286  35.621   3.390  1.00 85.31           C  \nATOM   5717  O   GLU A 746      -3.856  36.194   5.098  1.00 85.31           O  \nATOM   5718  CG  GLU A 746      -5.627  35.899   2.034  1.00 85.31           C  \nATOM   5719  CD  GLU A 746      -6.656  36.419   1.019  1.00 85.31           C  \nATOM   5720  OE1 GLU A 746      -6.578  36.021  -0.160  1.00 85.31           O  \nATOM   5721  OE2 GLU A 746      -7.647  37.075   1.410  1.00 85.31           O  \nATOM   5722  N   LEU A 747      -3.110  34.233   4.258  1.00 77.50           N  \nATOM   5723  CA  LEU A 747      -1.688  34.434   4.545  1.00 77.50           C  \nATOM   5724  C   LEU A 747      -1.037  35.375   3.518  1.00 77.50           C  \nATOM   5725  CB  LEU A 747      -0.964  33.074   4.620  1.00 77.50           C  \nATOM   5726  O   LEU A 747      -1.375  35.352   2.334  1.00 77.50           O  \nATOM   5727  CG  LEU A 747      -1.550  32.056   5.624  1.00 77.50           C  \nATOM   5728  CD1 LEU A 747      -0.700  30.786   5.630  1.00 77.50           C  \nATOM   5729  CD2 LEU A 747      -1.605  32.586   7.060  1.00 77.50           C  \nATOM   5730  N   ARG A 748      -0.095  36.212   3.974  1.00 63.78           N  \nATOM   5731  CA  ARG A 748       0.501  37.297   3.162  1.00 63.78           C  \nATOM   5732  C   ARG A 748       1.680  36.896   2.272  1.00 63.78           C  \nATOM   5733  CB  ARG A 748       0.853  38.496   4.063  1.00 63.78           C  \nATOM   5734  O   ARG A 748       1.989  37.643   1.350  1.00 63.78           O  \nATOM   5735  CG  ARG A 748      -0.340  39.454   4.155  1.00 63.78           C  \nATOM   5736  CD  ARG A 748      -0.119  40.536   5.217  1.00 63.78           C  \nATOM   5737  NE  ARG A 748      -1.321  41.382   5.358  1.00 63.78           N  \nATOM   5738  NH1 ARG A 748      -0.305  43.303   6.108  1.00 63.78           N  \nATOM   5739  NH2 ARG A 748      -2.525  43.247   5.810  1.00 63.78           N  \nATOM   5740  CZ  ARG A 748      -1.373  42.637   5.760  1.00 63.78           C  \nATOM   5741  N   GLU A 749       2.316  35.750   2.508  1.00 57.41           N  \nATOM   5742  CA  GLU A 749       3.483  35.289   1.742  1.00 57.41           C  \nATOM   5743  C   GLU A 749       3.351  33.791   1.413  1.00 57.41           C  \nATOM   5744  CB  GLU A 749       4.785  35.581   2.517  1.00 57.41           C  \nATOM   5745  O   GLU A 749       3.218  32.966   2.312  1.00 57.41           O  \nATOM   5746  CG  GLU A 749       5.043  37.091   2.694  1.00 57.41           C  \nATOM   5747  CD  GLU A 749       6.366  37.423   3.405  1.00 57.41           C  \nATOM   5748  OE1 GLU A 749       6.806  38.587   3.267  1.00 57.41           O  \nATOM   5749  OE2 GLU A 749       6.913  36.539   4.101  1.00 57.41           O  \nATOM   5750  N   ALA A 750       3.368  33.443   0.120  1.00 50.12           N  \nATOM   5751  CA  ALA A 750       3.214  32.064  -0.386  1.00 50.12           C  \nATOM   5752  C   ALA A 750       4.095  31.767  -1.626  1.00 50.12           C  \nATOM   5753  CB  ALA A 750       1.723  31.814  -0.658  1.00 50.12           C  \nATOM   5754  O   ALA A 750       3.882  30.806  -2.367  1.00 50.12           O  \nATOM   5755  N   THR A 751       5.087  32.621  -1.895  1.00 46.34           N  \nATOM   5756  CA  THR A 751       5.926  32.592  -3.110  1.00 46.34           C  \nATOM   5757  C   THR A 751       7.182  31.722  -2.983  1.00 46.34           C  \nATOM   5758  CB  THR A 751       6.323  34.022  -3.510  1.00 46.34           C  \nATOM   5759  O   THR A 751       7.868  31.490  -3.977  1.00 46.34           O  \nATOM   5760  CG2 THR A 751       5.136  34.805  -4.069  1.00 46.34           C  \nATOM   5761  OG1 THR A 751       6.779  34.717  -2.370  1.00 46.34           O  \nATOM   5762  N   SER A 752       7.489  31.214  -1.785  1.00 44.81           N  \nATOM   5763  CA  SER A 752       8.640  30.343  -1.525  1.00 44.81           C  \nATOM   5764  C   SER A 752       8.218  28.869  -1.452  1.00 44.81           C  \nATOM   5765  CB  SER A 752       9.334  30.770  -0.229  1.00 44.81           C  \nATOM   5766  O   SER A 752       7.406  28.517  -0.594  1.00 44.81           O  \nATOM   5767  OG  SER A 752      10.337  29.839   0.147  1.00 44.81           O  \nATOM   5768  N   PRO A 753       8.813  27.961  -2.255  1.00 47.84           N  \nATOM   5769  CA  PRO A 753       8.570  26.522  -2.133  1.00 47.84           C  \nATOM   5770  C   PRO A 753       8.926  25.940  -0.756  1.00 47.84           C  \nATOM   5771  CB  PRO A 753       9.406  25.871  -3.242  1.00 47.84           C  \nATOM   5772  O   PRO A 753       8.346  24.930  -0.363  1.00 47.84           O  \nATOM   5773  CG  PRO A 753       9.528  26.975  -4.291  1.00 47.84           C  \nATOM   5774  CD  PRO A 753       9.618  28.237  -3.436  1.00 47.84           C  \nATOM   5775  N   LYS A 754       9.847  26.573  -0.007  1.00 43.41           N  \nATOM   5776  CA  LYS A 754      10.170  26.182   1.376  1.00 43.41           C  \nATOM   5777  C   LYS A 754       9.023  26.553   2.323  1.00 43.41           C  \nATOM   5778  CB  LYS A 754      11.519  26.792   1.815  1.00 43.41           C  \nATOM   5779  O   LYS A 754       8.531  25.686   3.040  1.00 43.41           O  \nATOM   5780  CG  LYS A 754      12.028  26.152   3.121  1.00 43.41           C  \nATOM   5781  CD  LYS A 754      13.252  26.868   3.720  1.00 43.41           C  \nATOM   5782  CE  LYS A 754      13.701  26.127   4.993  1.00 43.41           C  \nATOM   5783  NZ  LYS A 754      14.410  27.000   5.966  1.00 43.41           N  \nATOM   5784  N   ALA A 755       8.540  27.797   2.240  1.00 54.50           N  \nATOM   5785  CA  ALA A 755       7.418  28.277   3.048  1.00 54.50           C  \nATOM   5786  C   ALA A 755       6.138  27.470   2.779  1.00 54.50           C  \nATOM   5787  CB  ALA A 755       7.195  29.768   2.768  1.00 54.50           C  \nATOM   5788  O   ALA A 755       5.446  27.092   3.715  1.00 54.50           O  \nATOM   5789  N   ASN A 756       5.858  27.117   1.520  1.00 62.50           N  \nATOM   5790  CA  ASN A 756       4.671  26.327   1.183  1.00 62.50           C  \nATOM   5791  C   ASN A 756       4.701  24.907   1.775  1.00 62.50           C  \nATOM   5792  CB  ASN A 756       4.474  26.326  -0.344  1.00 62.50           C  \nATOM   5793  O   ASN A 756       3.637  24.362   2.056  1.00 62.50           O  \nATOM   5794  CG  ASN A 756       4.064  27.692  -0.875  1.00 62.50           C  \nATOM   5795  ND2 ASN A 756       4.095  27.898  -2.169  1.00 62.50           N  \nATOM   5796  OD1 ASN A 756       3.714  28.601  -0.146  1.00 62.50           O  \nATOM   5797  N   LYS A 757       5.883  24.317   2.022  1.00 61.81           N  \nATOM   5798  CA  LYS A 757       5.976  23.083   2.816  1.00 61.81           C  \nATOM   5799  C   LYS A 757       5.693  23.363   4.295  1.00 61.81           C  \nATOM   5800  CB  LYS A 757       7.333  22.381   2.623  1.00 61.81           C  \nATOM   5801  O   LYS A 757       4.863  22.684   4.885  1.00 61.81           O  \nATOM   5802  CG  LYS A 757       7.281  21.028   3.349  1.00 61.81           C  \nATOM   5803  CD  LYS A 757       8.607  20.273   3.434  1.00 61.81           C  \nATOM   5804  CE  LYS A 757       8.298  19.069   4.334  1.00 61.81           C  \nATOM   5805  NZ  LYS A 757       9.504  18.383   4.838  1.00 61.81           N  \nATOM   5806  N   GLU A 758       6.359  24.360   4.872  1.00 63.53           N  \nATOM   5807  CA  GLU A 758       6.243  24.700   6.298  1.00 63.53           C  \nATOM   5808  C   GLU A 758       4.788  25.050   6.683  1.00 63.53           C  \nATOM   5809  CB  GLU A 758       7.254  25.826   6.621  1.00 63.53           C  \nATOM   5810  O   GLU A 758       4.282  24.540   7.679  1.00 63.53           O  \nATOM   5811  CG  GLU A 758       8.715  25.317   6.536  1.00 63.53           C  \nATOM   5812  CD  GLU A 758       9.814  26.401   6.507  1.00 63.53           C  \nATOM   5813  OE1 GLU A 758      11.011  26.012   6.537  1.00 63.53           O  \nATOM   5814  OE2 GLU A 758       9.508  27.606   6.389  1.00 63.53           O  \nATOM   5815  N   ILE A 759       4.073  25.795   5.831  1.00 66.56           N  \nATOM   5816  CA  ILE A 759       2.642  26.126   5.975  1.00 66.56           C  \nATOM   5817  C   ILE A 759       1.743  24.880   5.872  1.00 66.56           C  \nATOM   5818  CB  ILE A 759       2.251  27.184   4.910  1.00 66.56           C  \nATOM   5819  O   ILE A 759       0.721  24.802   6.556  1.00 66.56           O  \nATOM   5820  CG1 ILE A 759       2.951  28.538   5.180  1.00 66.56           C  \nATOM   5821  CG2 ILE A 759       0.728  27.412   4.851  1.00 66.56           C  \nATOM   5822  CD1 ILE A 759       2.941  29.493   3.976  1.00 66.56           C  \nATOM   5823  N   LEU A 760       2.088  23.900   5.027  1.00 69.00           N  \nATOM   5824  CA  LEU A 760       1.332  22.646   4.928  1.00 69.00           C  \nATOM   5825  C   LEU A 760       1.562  21.756   6.154  1.00 69.00           C  \nATOM   5826  CB  LEU A 760       1.665  21.913   3.614  1.00 69.00           C  \nATOM   5827  O   LEU A 760       0.585  21.245   6.696  1.00 69.00           O  \nATOM   5828  CG  LEU A 760       0.984  22.513   2.369  1.00 69.00           C  \nATOM   5829  CD1 LEU A 760       1.561  21.874   1.103  1.00 69.00           C  \nATOM   5830  CD2 LEU A 760      -0.529  22.263   2.354  1.00 69.00           C  \nATOM   5831  N   ASP A 761       2.805  21.626   6.626  1.00 63.91           N  \nATOM   5832  CA  ASP A 761       3.146  20.896   7.856  1.00 63.91           C  \nATOM   5833  C   ASP A 761       2.460  21.538   9.096  1.00 63.91           C  \nATOM   5834  CB  ASP A 761       4.685  20.828   8.022  1.00 63.91           C  \nATOM   5835  O   ASP A 761       1.947  20.825   9.962  1.00 63.91           O  \nATOM   5836  CG  ASP A 761       5.454  19.945   7.011  1.00 63.91           C  \nATOM   5837  OD1 ASP A 761       4.860  19.023   6.408  1.00 63.91           O  \nATOM   5838  OD2 ASP A 761       6.691  20.136   6.881  1.00 63.91           O  \nATOM   5839  N   GLU A 762       2.359  22.874   9.146  1.00 67.44           N  \nATOM   5840  CA  GLU A 762       1.595  23.650  10.145  1.00 67.44           C  \nATOM   5841  C   GLU A 762       0.079  23.381  10.064  1.00 67.44           C  \nATOM   5842  CB  GLU A 762       1.918  25.154   9.962  1.00 67.44           C  \nATOM   5843  O   GLU A 762      -0.542  22.929  11.034  1.00 67.44           O  \nATOM   5844  CG  GLU A 762       0.941  26.112  10.673  1.00 67.44           C  \nATOM   5845  CD  GLU A 762       1.315  27.608  10.591  1.00 67.44           C  \nATOM   5846  OE1 GLU A 762       0.450  28.437  10.976  1.00 67.44           O  \nATOM   5847  OE2 GLU A 762       2.429  27.953  10.138  1.00 67.44           O  \nATOM   5848  N   ALA A 763      -0.535  23.616   8.898  1.00 74.69           N  \nATOM   5849  CA  ALA A 763      -1.975  23.438   8.689  1.00 74.69           C  \nATOM   5850  C   ALA A 763      -2.422  21.997   8.987  1.00 74.69           C  \nATOM   5851  CB  ALA A 763      -2.289  23.812   7.237  1.00 74.69           C  \nATOM   5852  O   ALA A 763      -3.522  21.749   9.488  1.00 74.69           O  \nATOM   5853  N   TYR A 764      -1.537  21.044   8.716  1.00 73.12           N  \nATOM   5854  CA  TYR A 764      -1.704  19.631   8.993  1.00 73.12           C  \nATOM   5855  C   TYR A 764      -1.765  19.312  10.495  1.00 73.12           C  \nATOM   5856  CB  TYR A 764      -0.528  18.948   8.303  1.00 73.12           C  \nATOM   5857  O   TYR A 764      -2.690  18.621  10.939  1.00 73.12           O  \nATOM   5858  CG  TYR A 764      -0.423  17.469   8.481  1.00 73.12           C  \nATOM   5859  CD1 TYR A 764       0.846  16.871   8.591  1.00 73.12           C  \nATOM   5860  CD2 TYR A 764      -1.585  16.692   8.404  1.00 73.12           C  \nATOM   5861  CE1 TYR A 764       0.964  15.472   8.545  1.00 73.12           C  \nATOM   5862  CE2 TYR A 764      -1.469  15.306   8.383  1.00 73.12           C  \nATOM   5863  OH  TYR A 764      -0.111  13.358   8.258  1.00 73.12           O  \nATOM   5864  CZ  TYR A 764      -0.200  14.696   8.397  1.00 73.12           C  \nATOM   5865  N   VAL A 765      -0.857  19.880  11.298  1.00 71.44           N  \nATOM   5866  CA  VAL A 765      -0.939  19.827  12.767  1.00 71.44           C  \nATOM   5867  C   VAL A 765      -2.267  20.429  13.243  1.00 71.44           C  \nATOM   5868  CB  VAL A 765       0.287  20.517  13.407  1.00 71.44           C  \nATOM   5869  O   VAL A 765      -2.982  19.779  14.012  1.00 71.44           O  \nATOM   5870  CG1 VAL A 765       0.123  20.748  14.914  1.00 71.44           C  \nATOM   5871  CG2 VAL A 765       1.539  19.649  13.217  1.00 71.44           C  \nATOM   5872  N   MET A 766      -2.665  21.594  12.716  1.00 76.81           N  \nATOM   5873  CA  MET A 766      -3.929  22.264  13.069  1.00 76.81           C  \nATOM   5874  C   MET A 766      -5.201  21.499  12.651  1.00 76.81           C  \nATOM   5875  CB  MET A 766      -3.974  23.677  12.473  1.00 76.81           C  \nATOM   5876  O   MET A 766      -6.244  21.652  13.291  1.00 76.81           O  \nATOM   5877  CG  MET A 766      -2.875  24.627  12.960  1.00 76.81           C  \nATOM   5878  SD  MET A 766      -3.036  26.308  12.293  1.00 76.81           S  \nATOM   5879  CE  MET A 766      -4.494  26.898  13.194  1.00 76.81           C  \nATOM   5880  N   ALA A 767      -5.150  20.663  11.611  1.00 79.12           N  \nATOM   5881  CA  ALA A 767      -6.262  19.792  11.209  1.00 79.12           C  \nATOM   5882  C   ALA A 767      -6.367  18.512  12.060  1.00 79.12           C  \nATOM   5883  CB  ALA A 767      -6.096  19.460   9.724  1.00 79.12           C  \nATOM   5884  O   ALA A 767      -7.437  17.898  12.129  1.00 79.12           O  \nATOM   5885  N   SER A 768      -5.268  18.115  12.713  1.00 74.56           N  \nATOM   5886  CA  SER A 768      -5.158  16.874  13.492  1.00 74.56           C  \nATOM   5887  C   SER A 768      -5.688  16.956  14.932  1.00 74.56           C  \nATOM   5888  CB  SER A 768      -3.706  16.381  13.482  1.00 74.56           C  \nATOM   5889  O   SER A 768      -5.774  15.928  15.606  1.00 74.56           O  \nATOM   5890  OG  SER A 768      -2.908  17.063  14.434  1.00 74.56           O  \nATOM   5891  N   VAL A 769      -6.027  18.154  15.427  1.00 78.75           N  \nATOM   5892  CA  VAL A 769      -6.524  18.345  16.800  1.00 78.75           C  \nATOM   5893  C   VAL A 769      -8.027  18.068  16.913  1.00 78.75           C  \nATOM   5894  CB  VAL A 769      -6.143  19.717  17.399  1.00 78.75           C  \nATOM   5895  O   VAL A 769      -8.811  18.531  16.090  1.00 78.75           O  \nATOM   5896  CG1 VAL A 769      -4.623  19.929  17.391  1.00 78.75           C  \nATOM   5897  CG2 VAL A 769      -6.806  20.906  16.702  1.00 78.75           C  \nATOM   5898  N   ASP A 770      -8.450  17.349  17.956  1.00 81.44           N  \nATOM   5899  CA  ASP A 770      -9.867  17.114  18.273  1.00 81.44           C  \nATOM   5900  C   ASP A 770     -10.058  17.248  19.797  1.00 81.44           C  \nATOM   5901  CB  ASP A 770     -10.332  15.762  17.671  1.00 81.44           C  \nATOM   5902  O   ASP A 770      -9.990  16.282  20.555  1.00 81.44           O  \nATOM   5903  CG  ASP A 770     -11.807  15.731  17.217  1.00 81.44           C  \nATOM   5904  OD1 ASP A 770     -12.288  16.717  16.604  1.00 81.44           O  \nATOM   5905  OD2 ASP A 770     -12.460  14.669  17.285  1.00 81.44           O  \nATOM   5906  N   ASN A 771     -10.218  18.489  20.269  1.00 88.38           N  \nATOM   5907  CA  ASN A 771     -10.390  18.819  21.686  1.00 88.38           C  \nATOM   5908  C   ASN A 771     -11.373  19.994  21.843  1.00 88.38           C  \nATOM   5909  CB  ASN A 771      -9.016  19.163  22.285  1.00 88.38           C  \nATOM   5910  O   ASN A 771     -11.272  20.959  21.085  1.00 88.38           O  \nATOM   5911  CG  ASN A 771      -9.079  19.408  23.782  1.00 88.38           C  \nATOM   5912  ND2 ASN A 771      -8.740  18.428  24.579  1.00 88.38           N  \nATOM   5913  OD1 ASN A 771      -9.506  20.450  24.254  1.00 88.38           O  \nATOM   5914  N   PRO A 772     -12.294  19.982  22.828  1.00 90.88           N  \nATOM   5915  CA  PRO A 772     -13.269  21.060  23.003  1.00 90.88           C  \nATOM   5916  C   PRO A 772     -12.647  22.442  23.254  1.00 90.88           C  \nATOM   5917  CB  PRO A 772     -14.153  20.627  24.180  1.00 90.88           C  \nATOM   5918  O   PRO A 772     -13.300  23.438  22.951  1.00 90.88           O  \nATOM   5919  CG  PRO A 772     -13.276  19.644  24.955  1.00 90.88           C  \nATOM   5920  CD  PRO A 772     -12.496  18.955  23.840  1.00 90.88           C  \nATOM   5921  N   HIS A 773     -11.418  22.518  23.776  1.00 94.44           N  \nATOM   5922  CA  HIS A 773     -10.720  23.759  24.130  1.00 94.44           C  \nATOM   5923  C   HIS A 773      -9.542  24.096  23.201  1.00 94.44           C  \nATOM   5924  CB  HIS A 773     -10.312  23.715  25.611  1.00 94.44           C  \nATOM   5925  O   HIS A 773      -8.754  24.984  23.521  1.00 94.44           O  \nATOM   5926  CG  HIS A 773     -11.491  23.491  26.520  1.00 94.44           C  \nATOM   5927  CD2 HIS A 773     -11.675  22.435  27.370  1.00 94.44           C  \nATOM   5928  ND1 HIS A 773     -12.633  24.256  26.563  1.00 94.44           N  \nATOM   5929  CE1 HIS A 773     -13.495  23.661  27.403  1.00 94.44           C  \nATOM   5930  NE2 HIS A 773     -12.948  22.554  27.945  1.00 94.44           N  \nATOM   5931  N   VAL A 774      -9.432  23.454  22.033  1.00 91.12           N  \nATOM   5932  CA  VAL A 774      -8.457  23.808  20.986  1.00 91.12           C  \nATOM   5933  C   VAL A 774      -9.200  24.061  19.672  1.00 91.12           C  \nATOM   5934  CB  VAL A 774      -7.351  22.741  20.839  1.00 91.12           C  \nATOM   5935  O   VAL A 774     -10.135  23.343  19.319  1.00 91.12           O  \nATOM   5936  CG1 VAL A 774      -6.256  23.203  19.871  1.00 91.12           C  \nATOM   5937  CG2 VAL A 774      -6.665  22.441  22.182  1.00 91.12           C  \nATOM   5938  N   CYS A 775      -8.835  25.123  18.959  1.00 88.50           N  \nATOM   5939  CA  CYS A 775      -9.453  25.510  17.699  1.00 88.50           C  \nATOM   5940  C   CYS A 775      -8.908  24.634  16.566  1.00 88.50           C  \nATOM   5941  CB  CYS A 775      -9.214  27.005  17.457  1.00 88.50           C  \nATOM   5942  O   CYS A 775      -7.724  24.683  16.238  1.00 88.50           O  \nATOM   5943  SG  CYS A 775     -10.366  27.599  16.187  1.00 88.50           S  \nATOM   5944  N   ARG A 776      -9.780  23.814  15.978  1.00 85.75           N  \nATOM   5945  CA  ARG A 776      -9.444  22.907  14.879  1.00 85.75           C  \nATOM   5946  C   ARG A 776      -9.520  23.626  13.529  1.00 85.75           C  \nATOM   5947  CB  ARG A 776     -10.381  21.692  14.967  1.00 85.75           C  \nATOM   5948  O   ARG A 776     -10.472  24.369  13.277  1.00 85.75           O  \nATOM   5949  CG  ARG A 776     -10.056  20.642  13.906  1.00 85.75           C  \nATOM   5950  CD  ARG A 776     -11.015  19.457  13.983  1.00 85.75           C  \nATOM   5951  NE  ARG A 776     -10.703  18.522  12.896  1.00 85.75           N  \nATOM   5952  NH1 ARG A 776     -11.381  16.552  13.895  1.00 85.75           N  \nATOM   5953  NH2 ARG A 776     -10.508  16.556  11.831  1.00 85.75           N  \nATOM   5954  CZ  ARG A 776     -10.866  17.218  12.894  1.00 85.75           C  \nATOM   5955  N   LEU A 777      -8.571  23.343  12.637  1.00 85.50           N  \nATOM   5956  CA  LEU A 777      -8.663  23.731  11.228  1.00 85.50           C  \nATOM   5957  C   LEU A 777      -9.751  22.901  10.527  1.00 85.50           C  \nATOM   5958  CB  LEU A 777      -7.283  23.565  10.566  1.00 85.50           C  \nATOM   5959  O   LEU A 777      -9.707  21.669  10.535  1.00 85.50           O  \nATOM   5960  CG  LEU A 777      -7.178  24.200   9.171  1.00 85.50           C  \nATOM   5961  CD1 LEU A 777      -7.104  25.723   9.250  1.00 85.50           C  \nATOM   5962  CD2 LEU A 777      -5.914  23.729   8.461  1.00 85.50           C  \nATOM   5963  N   LEU A 778     -10.730  23.573   9.919  1.00 85.50           N  \nATOM   5964  CA  LEU A 778     -11.805  22.930   9.154  1.00 85.50           C  \nATOM   5965  C   LEU A 778     -11.330  22.531   7.752  1.00 85.50           C  \nATOM   5966  CB  LEU A 778     -13.034  23.854   9.050  1.00 85.50           C  \nATOM   5967  O   LEU A 778     -11.817  21.551   7.192  1.00 85.50           O  \nATOM   5968  CG  LEU A 778     -13.539  24.493  10.356  1.00 85.50           C  \nATOM   5969  CD1 LEU A 778     -14.925  25.091  10.119  1.00 85.50           C  \nATOM   5970  CD2 LEU A 778     -13.599  23.531  11.543  1.00 85.50           C  \nATOM   5971  N   GLY A 779     -10.370  23.282   7.209  1.00 84.44           N  \nATOM   5972  CA  GLY A 779      -9.675  22.991   5.964  1.00 84.44           C  \nATOM   5973  C   GLY A 779      -8.745  24.122   5.525  1.00 84.44           C  \nATOM   5974  O   GLY A 779      -8.593  25.134   6.214  1.00 84.44           O  \nATOM   5975  N   ILE A 780      -8.133  23.929   4.363  1.00 85.31           N  \nATOM   5976  CA  ILE A 780      -7.206  24.847   3.703  1.00 85.31           C  \nATOM   5977  C   ILE A 780      -7.681  25.102   2.270  1.00 85.31           C  \nATOM   5978  CB  ILE A 780      -5.765  24.286   3.786  1.00 85.31           C  \nATOM   5979  O   ILE A 780      -8.067  24.169   1.566  1.00 85.31           O  \nATOM   5980  CG1 ILE A 780      -4.736  25.319   3.283  1.00 85.31           C  \nATOM   5981  CG2 ILE A 780      -5.603  22.936   3.053  1.00 85.31           C  \nATOM   5982  CD1 ILE A 780      -3.292  24.927   3.628  1.00 85.31           C  \nATOM   5983  N   CYS A 781      -7.654  26.356   1.830  1.00 83.62           N  \nATOM   5984  CA  CYS A 781      -7.893  26.737   0.442  1.00 83.62           C  \nATOM   5985  C   CYS A 781      -6.562  27.191  -0.169  1.00 83.62           C  \nATOM   5986  CB  CYS A 781      -9.018  27.777   0.396  1.00 83.62           C  \nATOM   5987  O   CYS A 781      -5.868  28.041   0.394  1.00 83.62           O  \nATOM   5988  SG  CYS A 781      -9.446  28.222  -1.308  1.00 83.62           S  \nATOM   5989  N   LEU A 782      -6.188  26.576  -1.292  1.00 78.31           N  \nATOM   5990  CA  LEU A 782      -4.901  26.758  -1.965  1.00 78.31           C  \nATOM   5991  C   LEU A 782      -5.133  27.475  -3.302  1.00 78.31           C  \nATOM   5992  CB  LEU A 782      -4.224  25.378  -2.144  1.00 78.31           C  \nATOM   5993  O   LEU A 782      -5.409  26.827  -4.311  1.00 78.31           O  \nATOM   5994  CG  LEU A 782      -3.848  24.642  -0.842  1.00 78.31           C  \nATOM   5995  CD1 LEU A 782      -3.319  23.242  -1.164  1.00 78.31           C  \nATOM   5996  CD2 LEU A 782      -2.769  25.386  -0.054  1.00 78.31           C  \nATOM   5997  N   THR A 783      -5.072  28.809  -3.298  1.00 73.31           N  \nATOM   5998  CA  THR A 783      -5.231  29.647  -4.503  1.00 73.31           C  \nATOM   5999  C   THR A 783      -3.953  30.463  -4.740  1.00 73.31           C  \nATOM   6000  CB  THR A 783      -6.508  30.515  -4.431  1.00 73.31           C  \nATOM   6001  O   THR A 783      -2.859  30.011  -4.402  1.00 73.31           O  \nATOM   6002  CG2 THR A 783      -7.776  29.704  -4.189  1.00 73.31           C  \nATOM   6003  OG1 THR A 783      -6.439  31.497  -3.427  1.00 73.31           O  \nATOM   6004  N   SER A 784      -4.049  31.672  -5.305  1.00 69.50           N  \nATOM   6005  CA  SER A 784      -2.945  32.646  -5.321  1.00 69.50           C  \nATOM   6006  C   SER A 784      -2.480  33.055  -3.916  1.00 69.50           C  \nATOM   6007  CB  SER A 784      -3.389  33.897  -6.084  1.00 69.50           C  \nATOM   6008  O   SER A 784      -1.367  33.550  -3.755  1.00 69.50           O  \nATOM   6009  OG  SER A 784      -4.640  34.365  -5.607  1.00 69.50           O  \nATOM   6010  N   THR A 785      -3.329  32.853  -2.907  1.00 73.25           N  \nATOM   6011  CA  THR A 785      -3.021  32.993  -1.483  1.00 73.25           C  \nATOM   6012  C   THR A 785      -3.382  31.694  -0.767  1.00 73.25           C  \nATOM   6013  CB  THR A 785      -3.781  34.175  -0.853  1.00 73.25           C  \nATOM   6014  O   THR A 785      -4.351  31.017  -1.119  1.00 73.25           O  \nATOM   6015  CG2 THR A 785      -3.267  35.519  -1.367  1.00 73.25           C  \nATOM   6016  OG1 THR A 785      -5.161  34.089  -1.150  1.00 73.25           O  \nATOM   6017  N   VAL A 786      -2.616  31.325   0.261  1.00 80.00           N  \nATOM   6018  CA  VAL A 786      -3.014  30.227   1.151  1.00 80.00           C  \nATOM   6019  C   VAL A 786      -3.993  30.777   2.181  1.00 80.00           C  \nATOM   6020  CB  VAL A 786      -1.810  29.535   1.808  1.00 80.00           C  \nATOM   6021  O   VAL A 786      -3.713  31.783   2.837  1.00 80.00           O  \nATOM   6022  CG1 VAL A 786      -2.295  28.425   2.748  1.00 80.00           C  \nATOM   6023  CG2 VAL A 786      -0.892  28.906   0.752  1.00 80.00           C  \nATOM   6024  N   GLN A 787      -5.147  30.129   2.326  1.00 85.06           N  \nATOM   6025  CA  GLN A 787      -6.198  30.552   3.249  1.00 85.06           C  \nATOM   6026  C   GLN A 787      -6.530  29.405   4.213  1.00 85.06           C  \nATOM   6027  CB  GLN A 787      -7.430  31.070   2.479  1.00 85.06           C  \nATOM   6028  O   GLN A 787      -6.866  28.301   3.785  1.00 85.06           O  \nATOM   6029  CG  GLN A 787      -7.106  32.079   1.354  1.00 85.06           C  \nATOM   6030  CD  GLN A 787      -8.324  32.532   0.548  1.00 85.06           C  \nATOM   6031  NE2 GLN A 787      -8.126  33.032  -0.654  1.00 85.06           N  \nATOM   6032  OE1 GLN A 787      -9.462  32.503   0.995  1.00 85.06           O  \nATOM   6033  N   LEU A 788      -6.433  29.664   5.517  1.00 85.56           N  \nATOM   6034  CA  LEU A 788      -6.749  28.718   6.592  1.00 85.56           C  \nATOM   6035  C   LEU A 788      -8.176  28.969   7.097  1.00 85.56           C  \nATOM   6036  CB  LEU A 788      -5.713  28.872   7.723  1.00 85.56           C  \nATOM   6037  O   LEU A 788      -8.523  30.111   7.407  1.00 85.56           O  \nATOM   6038  CG  LEU A 788      -4.251  28.571   7.337  1.00 85.56           C  \nATOM   6039  CD1 LEU A 788      -3.347  28.845   8.539  1.00 85.56           C  \nATOM   6040  CD2 LEU A 788      -4.047  27.121   6.902  1.00 85.56           C  \nATOM   6041  N   ILE A 789      -9.003  27.924   7.190  1.00 87.69           N  \nATOM   6042  CA  ILE A 789     -10.424  28.043   7.542  1.00 87.69           C  \nATOM   6043  C   ILE A 789     -10.694  27.425   8.916  1.00 87.69           C  \nATOM   6044  CB  ILE A 789     -11.323  27.447   6.432  1.00 87.69           C  \nATOM   6045  O   ILE A 789     -10.499  26.226   9.117  1.00 87.69           O  \nATOM   6046  CG1 ILE A 789     -11.085  28.146   5.070  1.00 87.69           C  \nATOM   6047  CG2 ILE A 789     -12.806  27.617   6.807  1.00 87.69           C  \nATOM   6048  CD1 ILE A 789     -10.100  27.408   4.156  1.00 87.69           C  \nATOM   6049  N   THR A 790     -11.192  28.230   9.854  1.00 88.38           N  \nATOM   6050  CA  THR A 790     -11.599  27.815  11.208  1.00 88.38           C  \nATOM   6051  C   THR A 790     -13.069  28.164  11.480  1.00 88.38           C  \nATOM   6052  CB  THR A 790     -10.677  28.403  12.291  1.00 88.38           C  \nATOM   6053  O   THR A 790     -13.705  28.915  10.739  1.00 88.38           O  \nATOM   6054  CG2 THR A 790      -9.247  27.875  12.189  1.00 88.38           C  \nATOM   6055  OG1 THR A 790     -10.610  29.803  12.201  1.00 88.38           O  \nATOM   6056  N   GLN A 791     -13.647  27.605  12.546  1.00 86.00           N  \nATOM   6057  CA  GLN A 791     -14.975  27.996  13.037  1.00 86.00           C  \nATOM   6058  C   GLN A 791     -14.981  29.478  13.445  1.00 86.00           C  \nATOM   6059  CB  GLN A 791     -15.323  27.091  14.226  1.00 86.00           C  \nATOM   6060  O   GLN A 791     -14.085  29.922  14.164  1.00 86.00           O  \nATOM   6061  CG  GLN A 791     -16.614  27.454  14.985  1.00 86.00           C  \nATOM   6062  CD  GLN A 791     -16.828  26.492  16.148  1.00 86.00           C  \nATOM   6063  NE2 GLN A 791     -18.023  26.034  16.425  1.00 86.00           N  \nATOM   6064  OE1 GLN A 791     -15.898  26.115  16.851  1.00 86.00           O  \nATOM   6065  N   LEU A 792     -16.006  30.238  13.040  1.00 85.44           N  \nATOM   6066  CA  LEU A 792     -16.146  31.632  13.465  1.00 85.44           C  \nATOM   6067  C   LEU A 792     -16.400  31.714  14.979  1.00 85.44           C  \nATOM   6068  CB  LEU A 792     -17.287  32.301  12.677  1.00 85.44           C  \nATOM   6069  O   LEU A 792     -17.381  31.164  15.476  1.00 85.44           O  \nATOM   6070  CG  LEU A 792     -17.471  33.800  12.979  1.00 85.44           C  \nATOM   6071  CD1 LEU A 792     -16.286  34.633  12.487  1.00 85.44           C  \nATOM   6072  CD2 LEU A 792     -18.728  34.324  12.285  1.00 85.44           C  \nATOM   6073  N   MET A 793     -15.560  32.460  15.698  1.00 86.75           N  \nATOM   6074  CA  MET A 793     -15.737  32.732  17.128  1.00 86.75           C  \nATOM   6075  C   MET A 793     -16.376  34.122  17.297  1.00 86.75           C  \nATOM   6076  CB  MET A 793     -14.396  32.587  17.861  1.00 86.75           C  \nATOM   6077  O   MET A 793     -15.712  35.131  17.032  1.00 86.75           O  \nATOM   6078  CG  MET A 793     -13.864  31.153  17.738  1.00 86.75           C  \nATOM   6079  SD  MET A 793     -14.862  29.883  18.555  1.00 86.75           S  \nATOM   6080  CE  MET A 793     -13.994  28.451  17.882  1.00 86.75           C  \nATOM   6081  N   PRO A 794     -17.670  34.217  17.664  1.00 77.44           N  \nATOM   6082  CA  PRO A 794     -18.432  35.463  17.537  1.00 77.44           C  \nATOM   6083  C   PRO A 794     -18.007  36.559  18.525  1.00 77.44           C  \nATOM   6084  CB  PRO A 794     -19.901  35.060  17.715  1.00 77.44           C  \nATOM   6085  O   PRO A 794     -18.190  37.740  18.236  1.00 77.44           O  \nATOM   6086  CG  PRO A 794     -19.846  33.765  18.523  1.00 77.44           C  \nATOM   6087  CD  PRO A 794     -18.547  33.120  18.054  1.00 77.44           C  \nATOM   6088  N   PHE A 795     -17.409  36.184  19.659  1.00 84.50           N  \nATOM   6089  CA  PHE A 795     -16.977  37.109  20.711  1.00 84.50           C  \nATOM   6090  C   PHE A 795     -15.494  37.526  20.602  1.00 84.50           C  \nATOM   6091  CB  PHE A 795     -17.329  36.498  22.075  1.00 84.50           C  \nATOM   6092  O   PHE A 795     -15.006  38.248  21.465  1.00 84.50           O  \nATOM   6093  CG  PHE A 795     -18.805  36.242  22.308  1.00 84.50           C  \nATOM   6094  CD1 PHE A 795     -19.643  37.279  22.757  1.00 84.50           C  \nATOM   6095  CD2 PHE A 795     -19.341  34.959  22.086  1.00 84.50           C  \nATOM   6096  CE1 PHE A 795     -21.010  37.033  22.981  1.00 84.50           C  \nATOM   6097  CE2 PHE A 795     -20.711  34.718  22.290  1.00 84.50           C  \nATOM   6098  CZ  PHE A 795     -21.546  35.755  22.743  1.00 84.50           C  \nATOM   6099  N   GLY A 796     -14.783  37.121  19.540  1.00 85.12           N  \nATOM   6100  CA  GLY A 796     -13.385  37.510  19.303  1.00 85.12           C  \nATOM   6101  C   GLY A 796     -12.381  36.823  20.237  1.00 85.12           C  \nATOM   6102  O   GLY A 796     -12.604  35.689  20.680  1.00 85.12           O  \nATOM   6103  N   CYS A 797     -11.254  37.494  20.500  1.00 89.56           N  \nATOM   6104  CA  CYS A 797     -10.228  36.997  21.417  1.00 89.56           C  \nATOM   6105  C   CYS A 797     -10.528  37.332  22.888  1.00 89.56           C  \nATOM   6106  CB  CYS A 797      -8.821  37.415  20.956  1.00 89.56           C  \nATOM   6107  O   CYS A 797     -11.170  38.333  23.209  1.00 89.56           O  \nATOM   6108  SG  CYS A 797      -8.283  39.015  21.632  1.00 89.56           S  \nATOM   6109  N   LEU A 798     -10.040  36.487  23.797  1.00 94.44           N  \nATOM   6110  CA  LEU A 798     -10.310  36.589  25.227  1.00 94.44           C  \nATOM   6111  C   LEU A 798      -9.670  37.841  25.844  1.00 94.44           C  \nATOM   6112  CB  LEU A 798      -9.864  35.274  25.893  1.00 94.44           C  \nATOM   6113  O   LEU A 798     -10.274  38.434  26.731  1.00 94.44           O  \nATOM   6114  CG  LEU A 798     -10.150  35.163  27.402  1.00 94.44           C  \nATOM   6115  CD1 LEU A 798     -11.629  35.310  27.761  1.00 94.44           C  \nATOM   6116  CD2 LEU A 798      -9.694  33.783  27.884  1.00 94.44           C  \nATOM   6117  N   LEU A 799      -8.511  38.288  25.342  1.00 93.50           N  \nATOM   6118  CA  LEU A 799      -7.868  39.539  25.768  1.00 93.50           C  \nATOM   6119  C   LEU A 799      -8.771  40.766  25.562  1.00 93.50           C  \nATOM   6120  CB  LEU A 799      -6.537  39.710  25.009  1.00 93.50           C  \nATOM   6121  O   LEU A 799      -8.893  41.594  26.463  1.00 93.50           O  \nATOM   6122  CG  LEU A 799      -5.773  41.007  25.337  1.00 93.50           C  \nATOM   6123  CD1 LEU A 799      -5.345  41.053  26.802  1.00 93.50           C  \nATOM   6124  CD2 LEU A 799      -4.516  41.114  24.475  1.00 93.50           C  \nATOM   6125  N   ASP A 800      -9.409  40.878  24.397  1.00 89.44           N  \nATOM   6126  CA  ASP A 800     -10.331  41.981  24.109  1.00 89.44           C  \nATOM   6127  C   ASP A 800     -11.639  41.797  24.888  1.00 89.44           C  \nATOM   6128  CB  ASP A 800     -10.565  42.097  22.595  1.00 89.44           C  \nATOM   6129  O   ASP A 800     -12.139  42.744  25.494  1.00 89.44           O  \nATOM   6130  CG  ASP A 800      -9.276  42.380  21.809  1.00 89.44           C  \nATOM   6131  OD1 ASP A 800      -8.394  43.099  22.345  1.00 89.44           O  \nATOM   6132  OD2 ASP A 800      -9.173  41.835  20.683  1.00 89.44           O  \nATOM   6133  N   TYR A 801     -12.137  40.558  24.984  1.00 91.75           N  \nATOM   6134  CA  TYR A 801     -13.348  40.233  25.736  1.00 91.75           C  \nATOM   6135  C   TYR A 801     -13.254  40.619  27.225  1.00 91.75           C  \nATOM   6136  CB  TYR A 801     -13.664  38.742  25.563  1.00 91.75           C  \nATOM   6137  O   TYR A 801     -14.192  41.227  27.747  1.00 91.75           O  \nATOM   6138  CG  TYR A 801     -15.022  38.352  26.107  1.00 91.75           C  \nATOM   6139  CD1 TYR A 801     -15.150  37.877  27.428  1.00 91.75           C  \nATOM   6140  CD2 TYR A 801     -16.163  38.517  25.300  1.00 91.75           C  \nATOM   6141  CE1 TYR A 801     -16.425  37.592  27.952  1.00 91.75           C  \nATOM   6142  CE2 TYR A 801     -17.438  38.219  25.817  1.00 91.75           C  \nATOM   6143  OH  TYR A 801     -18.802  37.526  27.662  1.00 91.75           O  \nATOM   6144  CZ  TYR A 801     -17.570  37.772  27.146  1.00 91.75           C  \nATOM   6145  N   VAL A 802     -12.132  40.333  27.910  1.00 93.06           N  \nATOM   6146  CA  VAL A 802     -11.955  40.707  29.332  1.00 93.06           C  \nATOM   6147  C   VAL A 802     -11.781  42.209  29.556  1.00 93.06           C  \nATOM   6148  CB  VAL A 802     -10.834  39.939  30.064  1.00 93.06           C  \nATOM   6149  O   VAL A 802     -12.071  42.687  30.652  1.00 93.06           O  \nATOM   6150  CG1 VAL A 802     -11.091  38.429  30.071  1.00 93.06           C  \nATOM   6151  CG2 VAL A 802      -9.423  40.219  29.536  1.00 93.06           C  \nATOM   6152  N   ARG A 803     -11.356  42.957  28.530  1.00 91.69           N  \nATOM   6153  CA  ARG A 803     -11.298  44.426  28.552  1.00 91.69           C  \nATOM   6154  C   ARG A 803     -12.680  45.038  28.331  1.00 91.69           C  \nATOM   6155  CB  ARG A 803     -10.314  44.929  27.489  1.00 91.69           C  \nATOM   6156  O   ARG A 803     -13.097  45.865  29.134  1.00 91.69           O  \nATOM   6157  CG  ARG A 803      -8.850  44.617  27.817  1.00 91.69           C  \nATOM   6158  CD  ARG A 803      -8.026  44.853  26.551  1.00 91.69           C  \nATOM   6159  NE  ARG A 803      -6.584  44.736  26.802  1.00 91.69           N  \nATOM   6160  NH1 ARG A 803      -5.919  44.633  24.601  1.00 91.69           N  \nATOM   6161  NH2 ARG A 803      -4.406  44.612  26.263  1.00 91.69           N  \nATOM   6162  CZ  ARG A 803      -5.649  44.666  25.880  1.00 91.69           C  \nATOM   6163  N   GLU A 804     -13.393  44.604  27.285  1.00 88.62           N  \nATOM   6164  CA  GLU A 804     -14.751  45.067  26.950  1.00 88.62           C  \nATOM   6165  C   GLU A 804     -15.753  44.794  28.093  1.00 88.62           C  \nATOM   6166  CB  GLU A 804     -15.266  44.381  25.656  1.00 88.62           C  \nATOM   6167  O   GLU A 804     -16.626  45.619  28.355  1.00 88.62           O  \nATOM   6168  CG  GLU A 804     -14.724  44.882  24.293  1.00 88.62           C  \nATOM   6169  CD  GLU A 804     -15.456  44.244  23.071  1.00 88.62           C  \nATOM   6170  OE1 GLU A 804     -15.353  44.738  21.919  1.00 88.62           O  \nATOM   6171  OE2 GLU A 804     -16.206  43.257  23.240  1.00 88.62           O  \nATOM   6172  N   HIS A 805     -15.632  43.656  28.792  1.00 87.62           N  \nATOM   6173  CA  HIS A 805     -16.641  43.178  29.751  1.00 87.62           C  \nATOM   6174  C   HIS A 805     -16.184  43.197  31.219  1.00 87.62           C  \nATOM   6175  CB  HIS A 805     -17.153  41.791  29.323  1.00 87.62           C  \nATOM   6176  O   HIS A 805     -16.862  42.609  32.063  1.00 87.62           O  \nATOM   6177  CG  HIS A 805     -17.713  41.764  27.927  1.00 87.62           C  \nATOM   6178  CD2 HIS A 805     -19.024  41.902  27.559  1.00 87.62           C  \nATOM   6179  ND1 HIS A 805     -16.978  41.656  26.774  1.00 87.62           N  \nATOM   6180  CE1 HIS A 805     -17.816  41.764  25.731  1.00 87.62           C  \nATOM   6181  NE2 HIS A 805     -19.086  41.887  26.161  1.00 87.62           N  \nATOM   6182  N   LYS A 806     -15.065  43.867  31.535  1.00 87.94           N  \nATOM   6183  CA  LYS A 806     -14.416  43.897  32.861  1.00 87.94           C  \nATOM   6184  C   LYS A 806     -15.391  43.979  34.041  1.00 87.94           C  \nATOM   6185  CB  LYS A 806     -13.431  45.078  32.874  1.00 87.94           C  \nATOM   6186  O   LYS A 806     -15.335  43.144  34.938  1.00 87.94           O  \nATOM   6187  CG  LYS A 806     -12.800  45.296  34.255  1.00 87.94           C  \nATOM   6188  CD  LYS A 806     -11.737  46.386  34.190  1.00 87.94           C  \nATOM   6189  CE  LYS A 806     -11.204  46.610  35.602  1.00 87.94           C  \nATOM   6190  NZ  LYS A 806     -10.243  47.733  35.620  1.00 87.94           N  \nATOM   6191  N   ASP A 807     -16.309  44.942  34.011  1.00 84.62           N  \nATOM   6192  CA  ASP A 807     -17.218  45.238  35.129  1.00 84.62           C  \nATOM   6193  C   ASP A 807     -18.370  44.217  35.290  1.00 84.62           C  \nATOM   6194  CB  ASP A 807     -17.732  46.681  34.988  1.00 84.62           C  \nATOM   6195  O   ASP A 807     -19.188  44.338  36.198  1.00 84.62           O  \nATOM   6196  CG  ASP A 807     -16.598  47.708  34.843  1.00 84.62           C  \nATOM   6197  OD1 ASP A 807     -15.587  47.597  35.578  1.00 84.62           O  \nATOM   6198  OD2 ASP A 807     -16.727  48.578  33.957  1.00 84.62           O  \nATOM   6199  N   ASN A 808     -18.434  43.196  34.423  1.00 84.69           N  \nATOM   6200  CA  ASN A 808     -19.437  42.125  34.435  1.00 84.69           C  \nATOM   6201  C   ASN A 808     -18.828  40.715  34.608  1.00 84.69           C  \nATOM   6202  CB  ASN A 808     -20.270  42.212  33.143  1.00 84.69           C  \nATOM   6203  O   ASN A 808     -19.568  39.727  34.610  1.00 84.69           O  \nATOM   6204  CG  ASN A 808     -21.023  43.521  33.004  1.00 84.69           C  \nATOM   6205  ND2 ASN A 808     -20.576  44.411  32.147  1.00 84.69           N  \nATOM   6206  OD1 ASN A 808     -22.032  43.755  33.642  1.00 84.69           O  \nATOM   6207  N   ILE A 809     -17.500  40.591  34.726  1.00 87.81           N  \nATOM   6208  CA  ILE A 809     -16.793  39.303  34.808  1.00 87.81           C  \nATOM   6209  C   ILE A 809     -16.535  38.929  36.272  1.00 87.81           C  \nATOM   6210  CB  ILE A 809     -15.505  39.337  33.952  1.00 87.81           C  \nATOM   6211  O   ILE A 809     -15.605  39.423  36.906  1.00 87.81           O  \nATOM   6212  CG1 ILE A 809     -15.872  39.369  32.453  1.00 87.81           C  \nATOM   6213  CG2 ILE A 809     -14.603  38.111  34.217  1.00 87.81           C  \nATOM   6214  CD1 ILE A 809     -14.707  39.778  31.548  1.00 87.81           C  \nATOM   6215  N   GLY A 810     -17.346  38.001  36.783  1.00 88.50           N  \nATOM   6216  CA  GLY A 810     -17.155  37.409  38.106  1.00 88.50           C  \nATOM   6217  C   GLY A 810     -16.021  36.374  38.171  1.00 88.50           C  \nATOM   6218  O   GLY A 810     -15.607  35.782  37.167  1.00 88.50           O  \nATOM   6219  N   SER A 811     -15.569  36.103  39.392  1.00 91.88           N  \nATOM   6220  CA  SER A 811     -14.490  35.187  39.785  1.00 91.88           C  \nATOM   6221  C   SER A 811     -14.603  33.792  39.153  1.00 91.88           C  \nATOM   6222  CB  SER A 811     -14.531  35.057  41.317  1.00 91.88           C  \nATOM   6223  O   SER A 811     -13.620  33.229  38.661  1.00 91.88           O  \nATOM   6224  OG  SER A 811     -15.771  34.513  41.731  1.00 91.88           O  \nATOM   6225  N   GLN A 812     -15.826  33.257  39.106  1.00 90.69           N  \nATOM   6226  CA  GLN A 812     -16.150  31.957  38.524  1.00 90.69           C  \nATOM   6227  C   GLN A 812     -15.771  31.872  37.038  1.00 90.69           C  \nATOM   6228  CB  GLN A 812     -17.655  31.706  38.722  1.00 90.69           C  \nATOM   6229  O   GLN A 812     -15.297  30.824  36.602  1.00 90.69           O  \nATOM   6230  CG  GLN A 812     -18.144  30.328  38.246  1.00 90.69           C  \nATOM   6231  CD  GLN A 812     -17.661  29.182  39.129  1.00 90.69           C  \nATOM   6232  NE2 GLN A 812     -16.555  28.537  38.828  1.00 90.69           N  \nATOM   6233  OE1 GLN A 812     -18.288  28.839  40.112  1.00 90.69           O  \nATOM   6234  N   TYR A 813     -15.953  32.949  36.262  1.00 92.44           N  \nATOM   6235  CA  TYR A 813     -15.612  32.969  34.835  1.00 92.44           C  \nATOM   6236  C   TYR A 813     -14.097  32.930  34.627  1.00 92.44           C  \nATOM   6237  CB  TYR A 813     -16.246  34.182  34.139  1.00 92.44           C  \nATOM   6238  O   TYR A 813     -13.617  32.087  33.870  1.00 92.44           O  \nATOM   6239  CG  TYR A 813     -17.724  34.009  33.845  1.00 92.44           C  \nATOM   6240  CD1 TYR A 813     -18.116  33.265  32.716  1.00 92.44           C  \nATOM   6241  CD2 TYR A 813     -18.701  34.581  34.685  1.00 92.44           C  \nATOM   6242  CE1 TYR A 813     -19.481  33.078  32.432  1.00 92.44           C  \nATOM   6243  CE2 TYR A 813     -20.071  34.398  34.403  1.00 92.44           C  \nATOM   6244  OH  TYR A 813     -21.778  33.440  32.990  1.00 92.44           O  \nATOM   6245  CZ  TYR A 813     -20.463  33.638  33.277  1.00 92.44           C  \nATOM   6246  N   LEU A 814     -13.344  33.754  35.364  1.00 94.88           N  \nATOM   6247  CA  LEU A 814     -11.878  33.793  35.299  1.00 94.88           C  \nATOM   6248  C   LEU A 814     -11.262  32.418  35.597  1.00 94.88           C  \nATOM   6249  CB  LEU A 814     -11.348  34.861  36.277  1.00 94.88           C  \nATOM   6250  O   LEU A 814     -10.492  31.897  34.790  1.00 94.88           O  \nATOM   6251  CG  LEU A 814     -11.728  36.308  35.910  1.00 94.88           C  \nATOM   6252  CD1 LEU A 814     -11.393  37.241  37.069  1.00 94.88           C  \nATOM   6253  CD2 LEU A 814     -10.978  36.803  34.673  1.00 94.88           C  \nATOM   6254  N   LEU A 815     -11.652  31.784  36.711  1.00 95.31           N  \nATOM   6255  CA  LEU A 815     -11.143  30.455  37.075  1.00 95.31           C  \nATOM   6256  C   LEU A 815     -11.597  29.367  36.089  1.00 95.31           C  \nATOM   6257  CB  LEU A 815     -11.556  30.110  38.517  1.00 95.31           C  \nATOM   6258  O   LEU A 815     -10.808  28.479  35.759  1.00 95.31           O  \nATOM   6259  CG  LEU A 815     -10.945  31.030  39.591  1.00 95.31           C  \nATOM   6260  CD1 LEU A 815     -11.546  30.693  40.950  1.00 95.31           C  \nATOM   6261  CD2 LEU A 815      -9.424  30.885  39.707  1.00 95.31           C  \nATOM   6262  N   ASN A 816     -12.825  29.446  35.563  1.00 95.12           N  \nATOM   6263  CA  ASN A 816     -13.299  28.512  34.540  1.00 95.12           C  \nATOM   6264  C   ASN A 816     -12.501  28.633  33.234  1.00 95.12           C  \nATOM   6265  CB  ASN A 816     -14.806  28.711  34.292  1.00 95.12           C  \nATOM   6266  O   ASN A 816     -12.184  27.604  32.637  1.00 95.12           O  \nATOM   6267  CG  ASN A 816     -15.686  28.120  35.381  1.00 95.12           C  \nATOM   6268  ND2 ASN A 816     -16.976  28.354  35.323  1.00 95.12           N  \nATOM   6269  OD1 ASN A 816     -15.256  27.406  36.270  1.00 95.12           O  \nATOM   6270  N   TRP A 817     -12.138  29.842  32.796  1.00 97.25           N  \nATOM   6271  CA  TRP A 817     -11.291  30.027  31.615  1.00 97.25           C  \nATOM   6272  C   TRP A 817      -9.872  29.492  31.846  1.00 97.25           C  \nATOM   6273  CB  TRP A 817     -11.295  31.496  31.176  1.00 97.25           C  \nATOM   6274  O   TRP A 817      -9.369  28.777  30.980  1.00 97.25           O  \nATOM   6275  CG  TRP A 817     -12.625  32.074  30.775  1.00 97.25           C  \nATOM   6276  CD1 TRP A 817     -13.648  31.422  30.168  1.00 97.25           C  \nATOM   6277  CD2 TRP A 817     -13.089  33.449  30.949  1.00 97.25           C  \nATOM   6278  CE2 TRP A 817     -14.401  33.562  30.402  1.00 97.25           C  \nATOM   6279  CE3 TRP A 817     -12.530  34.616  31.514  1.00 97.25           C  \nATOM   6280  NE1 TRP A 817     -14.701  32.295  29.959  1.00 97.25           N  \nATOM   6281  CH2 TRP A 817     -14.526  35.911  30.953  1.00 97.25           C  \nATOM   6282  CZ2 TRP A 817     -15.116  34.766  30.393  1.00 97.25           C  \nATOM   6283  CZ3 TRP A 817     -13.243  35.829  31.523  1.00 97.25           C  \nATOM   6284  N   CYS A 818      -9.273  29.700  33.027  1.00 97.81           N  \nATOM   6285  CA  CYS A 818      -7.996  29.067  33.393  1.00 97.81           C  \nATOM   6286  C   CYS A 818      -8.058  27.533  33.273  1.00 97.81           C  \nATOM   6287  CB  CYS A 818      -7.598  29.471  34.821  1.00 97.81           C  \nATOM   6288  O   CYS A 818      -7.214  26.929  32.612  1.00 97.81           O  \nATOM   6289  SG  CYS A 818      -7.303  31.256  34.914  1.00 97.81           S  \nATOM   6290  N   VAL A 819      -9.100  26.896  33.830  1.00 97.81           N  \nATOM   6291  CA  VAL A 819      -9.314  25.438  33.714  1.00 97.81           C  \nATOM   6292  C   VAL A 819      -9.455  24.990  32.255  1.00 97.81           C  \nATOM   6293  CB  VAL A 819     -10.547  24.992  34.532  1.00 97.81           C  \nATOM   6294  O   VAL A 819      -8.941  23.933  31.891  1.00 97.81           O  \nATOM   6295  CG1 VAL A 819     -10.938  23.526  34.288  1.00 97.81           C  \nATOM   6296  CG2 VAL A 819     -10.287  25.123  36.033  1.00 97.81           C  \nATOM   6297  N   GLN A 820     -10.151  25.756  31.411  1.00 97.56           N  \nATOM   6298  CA  GLN A 820     -10.343  25.412  29.997  1.00 97.56           C  \nATOM   6299  C   GLN A 820      -9.048  25.535  29.187  1.00 97.56           C  \nATOM   6300  CB  GLN A 820     -11.458  26.276  29.399  1.00 97.56           C  \nATOM   6301  O   GLN A 820      -8.724  24.624  28.426  1.00 97.56           O  \nATOM   6302  CG  GLN A 820     -12.826  25.848  29.945  1.00 97.56           C  \nATOM   6303  CD  GLN A 820     -13.968  26.660  29.351  1.00 97.56           C  \nATOM   6304  NE2 GLN A 820     -14.859  27.166  30.171  1.00 97.56           N  \nATOM   6305  OE1 GLN A 820     -14.096  26.820  28.148  1.00 97.56           O  \nATOM   6306  N   ILE A 821      -8.268  26.598  29.404  1.00 98.00           N  \nATOM   6307  CA  ILE A 821      -6.957  26.781  28.767  1.00 98.00           C  \nATOM   6308  C   ILE A 821      -5.997  25.669  29.221  1.00 98.00           C  \nATOM   6309  CB  ILE A 821      -6.413  28.201  29.051  1.00 98.00           C  \nATOM   6310  O   ILE A 821      -5.377  25.022  28.382  1.00 98.00           O  \nATOM   6311  CG1 ILE A 821      -7.336  29.286  28.442  1.00 98.00           C  \nATOM   6312  CG2 ILE A 821      -4.994  28.370  28.475  1.00 98.00           C  \nATOM   6313  CD1 ILE A 821      -7.103  30.682  29.035  1.00 98.00           C  \nATOM   6314  N   ALA A 822      -5.939  25.354  30.520  1.00 98.06           N  \nATOM   6315  CA  ALA A 822      -5.101  24.265  31.028  1.00 98.06           C  \nATOM   6316  C   ALA A 822      -5.492  22.893  30.434  1.00 98.06           C  \nATOM   6317  CB  ALA A 822      -5.160  24.274  32.560  1.00 98.06           C  \nATOM   6318  O   ALA A 822      -4.615  22.102  30.095  1.00 98.06           O  \nATOM   6319  N   LYS A 823      -6.793  22.625  30.226  1.00 97.81           N  \nATOM   6320  CA  LYS A 823      -7.285  21.421  29.520  1.00 97.81           C  \nATOM   6321  C   LYS A 823      -6.893  21.380  28.042  1.00 97.81           C  \nATOM   6322  CB  LYS A 823      -8.810  21.319  29.645  1.00 97.81           C  \nATOM   6323  O   LYS A 823      -6.552  20.307  27.549  1.00 97.81           O  \nATOM   6324  CG  LYS A 823      -9.256  20.819  31.022  1.00 97.81           C  \nATOM   6325  CD  LYS A 823     -10.775  20.968  31.139  1.00 97.81           C  \nATOM   6326  CE  LYS A 823     -11.245  20.472  32.505  1.00 97.81           C  \nATOM   6327  NZ  LYS A 823     -12.701  20.692  32.666  1.00 97.81           N  \nATOM   6328  N   GLY A 824      -6.942  22.516  27.346  1.00 95.38           N  \nATOM   6329  CA  GLY A 824      -6.478  22.618  25.960  1.00 95.38           C  \nATOM   6330  C   GLY A 824      -4.971  22.370  25.845  1.00 95.38           C  \nATOM   6331  O   GLY A 824      -4.539  21.609  24.984  1.00 95.38           O  \nATOM   6332  N   MET A 825      -4.181  22.926  26.766  1.00 96.88           N  \nATOM   6333  CA  MET A 825      -2.726  22.750  26.790  1.00 96.88           C  \nATOM   6334  C   MET A 825      -2.279  21.346  27.211  1.00 96.88           C  \nATOM   6335  CB  MET A 825      -2.087  23.796  27.702  1.00 96.88           C  \nATOM   6336  O   MET A 825      -1.374  20.808  26.584  1.00 96.88           O  \nATOM   6337  CG  MET A 825      -2.178  25.220  27.149  1.00 96.88           C  \nATOM   6338  SD  MET A 825      -1.512  25.473  25.477  1.00 96.88           S  \nATOM   6339  CE  MET A 825       0.183  24.863  25.673  1.00 96.88           C  \nATOM   6340  N   ASN A 826      -2.940  20.703  28.183  1.00 96.94           N  \nATOM   6341  CA  ASN A 826      -2.681  19.292  28.512  1.00 96.94           C  \nATOM   6342  C   ASN A 826      -2.906  18.391  27.292  1.00 96.94           C  \nATOM   6343  CB  ASN A 826      -3.603  18.868  29.667  1.00 96.94           C  \nATOM   6344  O   ASN A 826      -2.152  17.455  27.073  1.00 96.94           O  \nATOM   6345  CG  ASN A 826      -3.262  17.523  30.301  1.00 96.94           C  \nATOM   6346  ND2 ASN A 826      -3.346  16.413  29.613  1.00 96.94           N  \nATOM   6347  OD1 ASN A 826      -2.987  17.451  31.486  1.00 96.94           O  \nATOM   6348  N   TYR A 827      -3.916  18.685  26.470  1.00 94.38           N  \nATOM   6349  CA  TYR A 827      -4.138  17.946  25.229  1.00 94.38           C  \nATOM   6350  C   TYR A 827      -3.021  18.176  24.195  1.00 94.38           C  \nATOM   6351  CB  TYR A 827      -5.525  18.304  24.690  1.00 94.38           C  \nATOM   6352  O   TYR A 827      -2.697  17.259  23.448  1.00 94.38           O  \nATOM   6353  CG  TYR A 827      -5.786  17.785  23.293  1.00 94.38           C  \nATOM   6354  CD1 TYR A 827      -5.399  18.563  22.184  1.00 94.38           C  \nATOM   6355  CD2 TYR A 827      -6.326  16.498  23.103  1.00 94.38           C  \nATOM   6356  CE1 TYR A 827      -5.493  18.035  20.885  1.00 94.38           C  \nATOM   6357  CE2 TYR A 827      -6.462  15.984  21.799  1.00 94.38           C  \nATOM   6358  OH  TYR A 827      -6.026  16.183  19.456  1.00 94.38           O  \nATOM   6359  CZ  TYR A 827      -6.014  16.737  20.695  1.00 94.38           C  \nATOM   6360  N   LEU A 828      -2.405  19.363  24.144  1.00 90.75           N  \nATOM   6361  CA  LEU A 828      -1.222  19.591  23.304  1.00 90.75           C  \nATOM   6362  C   LEU A 828       0.021  18.867  23.870  1.00 90.75           C  \nATOM   6363  CB  LEU A 828      -1.009  21.103  23.085  1.00 90.75           C  \nATOM   6364  O   LEU A 828       0.742  18.239  23.095  1.00 90.75           O  \nATOM   6365  CG  LEU A 828      -2.142  21.828  22.324  1.00 90.75           C  \nATOM   6366  CD1 LEU A 828      -1.809  23.313  22.181  1.00 90.75           C  \nATOM   6367  CD2 LEU A 828      -2.384  21.275  20.916  1.00 90.75           C  \nATOM   6368  N   GLU A 829       0.207  18.845  25.199  1.00 91.56           N  \nATOM   6369  CA  GLU A 829       1.234  18.046  25.903  1.00 91.56           C  \nATOM   6370  C   GLU A 829       1.088  16.542  25.584  1.00 91.56           C  \nATOM   6371  CB  GLU A 829       1.198  18.349  27.428  1.00 91.56           C  \nATOM   6372  O   GLU A 829       2.021  15.927  25.066  1.00 91.56           O  \nATOM   6373  CG  GLU A 829       2.367  17.726  28.227  1.00 91.56           C  \nATOM   6374  CD  GLU A 829       2.358  17.965  29.763  1.00 91.56           C  \nATOM   6375  OE1 GLU A 829       3.230  17.363  30.449  1.00 91.56           O  \nATOM   6376  OE2 GLU A 829       1.502  18.729  30.279  1.00 91.56           O  \nATOM   6377  N   ASP A 830      -0.111  15.968  25.757  1.00 89.62           N  \nATOM   6378  CA  ASP A 830      -0.430  14.563  25.432  1.00 89.62           C  \nATOM   6379  C   ASP A 830      -0.206  14.216  23.942  1.00 89.62           C  \nATOM   6380  CB  ASP A 830      -1.906  14.260  25.760  1.00 89.62           C  \nATOM   6381  O   ASP A 830      -0.048  13.047  23.579  1.00 89.62           O  \nATOM   6382  CG  ASP A 830      -2.303  14.275  27.242  1.00 89.62           C  \nATOM   6383  OD1 ASP A 830      -1.494  13.878  28.110  1.00 89.62           O  \nATOM   6384  OD2 ASP A 830      -3.479  14.629  27.501  1.00 89.62           O  \nATOM   6385  N   ARG A 831      -0.210  15.222  23.056  1.00 82.38           N  \nATOM   6386  CA  ARG A 831      -0.011  15.084  21.602  1.00 82.38           C  \nATOM   6387  C   ARG A 831       1.402  15.469  21.136  1.00 82.38           C  \nATOM   6388  CB  ARG A 831      -1.118  15.856  20.853  1.00 82.38           C  \nATOM   6389  O   ARG A 831       1.627  15.491  19.928  1.00 82.38           O  \nATOM   6390  CG  ARG A 831      -2.537  15.299  21.088  1.00 82.38           C  \nATOM   6391  CD  ARG A 831      -2.807  13.939  20.435  1.00 82.38           C  \nATOM   6392  NE  ARG A 831      -2.867  14.028  18.962  1.00 82.38           N  \nATOM   6393  NH1 ARG A 831      -2.582  11.798  18.505  1.00 82.38           N  \nATOM   6394  NH2 ARG A 831      -2.861  13.245  16.827  1.00 82.38           N  \nATOM   6395  CZ  ARG A 831      -2.772  13.026  18.109  1.00 82.38           C  \nATOM   6396  N   ARG A 832       2.345  15.738  22.054  1.00 84.50           N  \nATOM   6397  CA  ARG A 832       3.728  16.198  21.774  1.00 84.50           C  \nATOM   6398  C   ARG A 832       3.809  17.490  20.940  1.00 84.50           C  \nATOM   6399  CB  ARG A 832       4.596  15.075  21.172  1.00 84.50           C  \nATOM   6400  O   ARG A 832       4.745  17.682  20.163  1.00 84.50           O  \nATOM   6401  CG  ARG A 832       4.689  13.798  22.014  1.00 84.50           C  \nATOM   6402  CD  ARG A 832       5.715  12.870  21.349  1.00 84.50           C  \nATOM   6403  NE  ARG A 832       5.888  11.600  22.083  1.00 84.50           N  \nATOM   6404  NH1 ARG A 832       8.189  11.420  21.894  1.00 84.50           N  \nATOM   6405  NH2 ARG A 832       7.026   9.793  22.867  1.00 84.50           N  \nATOM   6406  CZ  ARG A 832       7.029  10.955  22.274  1.00 84.50           C  \nATOM   6407  N   LEU A 833       2.830  18.382  21.101  1.00 83.25           N  \nATOM   6408  CA  LEU A 833       2.776  19.692  20.448  1.00 83.25           C  \nATOM   6409  C   LEU A 833       3.128  20.802  21.448  1.00 83.25           C  \nATOM   6410  CB  LEU A 833       1.377  19.905  19.840  1.00 83.25           C  \nATOM   6411  O   LEU A 833       2.485  20.933  22.488  1.00 83.25           O  \nATOM   6412  CG  LEU A 833       0.978  18.891  18.751  1.00 83.25           C  \nATOM   6413  CD1 LEU A 833      -0.452  19.176  18.286  1.00 83.25           C  \nATOM   6414  CD2 LEU A 833       1.915  18.940  17.542  1.00 83.25           C  \nATOM   6415  N   VAL A 834       4.134  21.615  21.126  1.00 87.38           N  \nATOM   6416  CA  VAL A 834       4.485  22.827  21.892  1.00 87.38           C  \nATOM   6417  C   VAL A 834       3.838  24.035  21.210  1.00 87.38           C  \nATOM   6418  CB  VAL A 834       6.015  23.002  22.005  1.00 87.38           C  \nATOM   6419  O   VAL A 834       4.052  24.221  20.014  1.00 87.38           O  \nATOM   6420  CG1 VAL A 834       6.366  24.084  23.031  1.00 87.38           C  \nATOM   6421  CG2 VAL A 834       6.737  21.721  22.449  1.00 87.38           C  \nATOM   6422  N   HIS A 835       3.064  24.857  21.922  1.00 89.12           N  \nATOM   6423  CA  HIS A 835       2.291  25.973  21.348  1.00 89.12           C  \nATOM   6424  C   HIS A 835       3.162  27.187  20.998  1.00 89.12           C  \nATOM   6425  CB  HIS A 835       1.176  26.365  22.331  1.00 89.12           C  \nATOM   6426  O   HIS A 835       2.953  27.808  19.953  1.00 89.12           O  \nATOM   6427  CG  HIS A 835       0.211  27.438  21.870  1.00 89.12           C  \nATOM   6428  CD2 HIS A 835      -1.012  27.681  22.429  1.00 89.12           C  \nATOM   6429  ND1 HIS A 835       0.382  28.387  20.881  1.00 89.12           N  \nATOM   6430  CE1 HIS A 835      -0.709  29.172  20.847  1.00 89.12           C  \nATOM   6431  NE2 HIS A 835      -1.585  28.779  21.784  1.00 89.12           N  \nATOM   6432  N   ARG A 836       4.134  27.532  21.853  1.00 87.62           N  \nATOM   6433  CA  ARG A 836       5.192  28.546  21.634  1.00 87.62           C  \nATOM   6434  C   ARG A 836       4.732  30.013  21.549  1.00 87.62           C  \nATOM   6435  CB  ARG A 836       6.075  28.131  20.435  1.00 87.62           C  \nATOM   6436  O   ARG A 836       5.581  30.902  21.545  1.00 87.62           O  \nATOM   6437  CG  ARG A 836       6.570  26.675  20.533  1.00 87.62           C  \nATOM   6438  CD  ARG A 836       7.263  26.173  19.267  1.00 87.62           C  \nATOM   6439  NE  ARG A 836       8.521  26.893  19.018  1.00 87.62           N  \nATOM   6440  NH1 ARG A 836       8.348  27.194  16.733  1.00 87.62           N  \nATOM   6441  NH2 ARG A 836      10.080  28.021  17.850  1.00 87.62           N  \nATOM   6442  CZ  ARG A 836       8.965  27.354  17.868  1.00 87.62           C  \nATOM   6443  N   ASP A 837       3.423  30.273  21.535  1.00 88.12           N  \nATOM   6444  CA  ASP A 837       2.816  31.605  21.679  1.00 88.12           C  \nATOM   6445  C   ASP A 837       1.460  31.541  22.413  1.00 88.12           C  \nATOM   6446  CB  ASP A 837       2.712  32.333  20.320  1.00 88.12           C  \nATOM   6447  O   ASP A 837       0.426  31.968  21.899  1.00 88.12           O  \nATOM   6448  CG  ASP A 837       2.325  33.810  20.506  1.00 88.12           C  \nATOM   6449  OD1 ASP A 837       2.599  34.369  21.596  1.00 88.12           O  \nATOM   6450  OD2 ASP A 837       1.781  34.447  19.569  1.00 88.12           O  \nATOM   6451  N   LEU A 838       1.435  30.961  23.616  1.00 94.38           N  \nATOM   6452  CA  LEU A 838       0.231  30.974  24.450  1.00 94.38           C  \nATOM   6453  C   LEU A 838       0.065  32.347  25.130  1.00 94.38           C  \nATOM   6454  CB  LEU A 838       0.282  29.806  25.445  1.00 94.38           C  \nATOM   6455  O   LEU A 838       0.906  32.770  25.922  1.00 94.38           O  \nATOM   6456  CG  LEU A 838      -0.945  29.736  26.371  1.00 94.38           C  \nATOM   6457  CD1 LEU A 838      -2.252  29.445  25.630  1.00 94.38           C  \nATOM   6458  CD2 LEU A 838      -0.714  28.631  27.394  1.00 94.38           C  \nATOM   6459  N   ALA A 839      -1.035  33.031  24.824  1.00 93.88           N  \nATOM   6460  CA  ALA A 839      -1.378  34.354  25.348  1.00 93.88           C  \nATOM   6461  C   ALA A 839      -2.899  34.567  25.310  1.00 93.88           C  \nATOM   6462  CB  ALA A 839      -0.667  35.401  24.483  1.00 93.88           C  \nATOM   6463  O   ALA A 839      -3.585  33.946  24.495  1.00 93.88           O  \nATOM   6464  N   ALA A 840      -3.442  35.510  26.087  1.00 94.69           N  \nATOM   6465  CA  ALA A 840      -4.887  35.786  26.103  1.00 94.69           C  \nATOM   6466  C   ALA A 840      -5.447  36.250  24.737  1.00 94.69           C  \nATOM   6467  CB  ALA A 840      -5.170  36.806  27.213  1.00 94.69           C  \nATOM   6468  O   ALA A 840      -6.633  36.072  24.455  1.00 94.69           O  \nATOM   6469  N   ARG A 841      -4.596  36.805  23.860  1.00 91.25           N  \nATOM   6470  CA  ARG A 841      -4.934  37.146  22.461  1.00 91.25           C  \nATOM   6471  C   ARG A 841      -5.094  35.924  21.540  1.00 91.25           C  \nATOM   6472  CB  ARG A 841      -3.906  38.141  21.892  1.00 91.25           C  \nATOM   6473  O   ARG A 841      -5.826  36.001  20.561  1.00 91.25           O  \nATOM   6474  CG  ARG A 841      -2.494  37.547  21.784  1.00 91.25           C  \nATOM   6475  CD  ARG A 841      -1.509  38.509  21.118  1.00 91.25           C  \nATOM   6476  NE  ARG A 841      -0.275  37.802  20.741  1.00 91.25           N  \nATOM   6477  NH1 ARG A 841       0.831  37.770  22.775  1.00 91.25           N  \nATOM   6478  NH2 ARG A 841       1.697  36.760  21.007  1.00 91.25           N  \nATOM   6479  CZ  ARG A 841       0.736  37.453  21.513  1.00 91.25           C  \nATOM   6480  N   ASN A 842      -4.456  34.804  21.887  1.00 91.88           N  \nATOM   6481  CA  ASN A 842      -4.491  33.532  21.155  1.00 91.88           C  \nATOM   6482  C   ASN A 842      -5.462  32.529  21.818  1.00 91.88           C  \nATOM   6483  CB  ASN A 842      -3.057  32.996  20.976  1.00 91.88           C  \nATOM   6484  O   ASN A 842      -5.385  31.319  21.618  1.00 91.88           O  \nATOM   6485  CG  ASN A 842      -2.165  33.852  20.085  1.00 91.88           C  \nATOM   6486  ND2 ASN A 842      -0.893  33.550  20.068  1.00 91.88           N  \nATOM   6487  OD1 ASN A 842      -2.575  34.807  19.444  1.00 91.88           O  \nATOM   6488  N   VAL A 843      -6.423  33.033  22.597  1.00 94.62           N  \nATOM   6489  CA  VAL A 843      -7.581  32.283  23.092  1.00 94.62           C  \nATOM   6490  C   VAL A 843      -8.834  32.966  22.553  1.00 94.62           C  \nATOM   6491  CB  VAL A 843      -7.573  32.201  24.631  1.00 94.62           C  \nATOM   6492  O   VAL A 843      -8.972  34.180  22.673  1.00 94.62           O  \nATOM   6493  CG1 VAL A 843      -8.783  31.414  25.149  1.00 94.62           C  \nATOM   6494  CG2 VAL A 843      -6.311  31.502  25.155  1.00 94.62           C  \nATOM   6495  N   LEU A 844      -9.746  32.209  21.946  1.00 92.62           N  \nATOM   6496  CA  LEU A 844     -10.989  32.711  21.356  1.00 92.62           C  \nATOM   6497  C   LEU A 844     -12.207  32.316  22.191  1.00 92.62           C  \nATOM   6498  CB  LEU A 844     -11.152  32.212  19.912  1.00 92.62           C  \nATOM   6499  O   LEU A 844     -12.259  31.233  22.780  1.00 92.62           O  \nATOM   6500  CG  LEU A 844     -10.010  32.564  18.948  1.00 92.62           C  \nATOM   6501  CD1 LEU A 844     -10.279  31.962  17.567  1.00 92.62           C  \nATOM   6502  CD2 LEU A 844      -9.819  34.072  18.785  1.00 92.62           C  \nATOM   6503  N   VAL A 845     -13.216  33.184  22.194  1.00 91.56           N  \nATOM   6504  CA  VAL A 845     -14.447  33.020  22.974  1.00 91.56           C  \nATOM   6505  C   VAL A 845     -15.581  32.537  22.057  1.00 91.56           C  \nATOM   6506  CB  VAL A 845     -14.765  34.341  23.710  1.00 91.56           C  \nATOM   6507  O   VAL A 845     -16.067  33.280  21.200  1.00 91.56           O  \nATOM   6508  CG1 VAL A 845     -16.011  34.208  24.596  1.00 91.56           C  \nATOM   6509  CG2 VAL A 845     -13.609  34.798  24.608  1.00 91.56           C  \nATOM   6510  N   LYS A 846     -16.026  31.280  22.233  1.00 86.19           N  \nATOM   6511  CA  LYS A 846     -17.198  30.732  21.515  1.00 86.19           C  \nATOM   6512  C   LYS A 846     -18.500  31.190  22.177  1.00 86.19           C  \nATOM   6513  CB  LYS A 846     -17.131  29.191  21.413  1.00 86.19           C  \nATOM   6514  O   LYS A 846     -19.442  31.592  21.502  1.00 86.19           O  \nATOM   6515  CG  LYS A 846     -18.219  28.684  20.444  1.00 86.19           C  \nATOM   6516  CD  LYS A 846     -18.336  27.159  20.321  1.00 86.19           C  \nATOM   6517  CE  LYS A 846     -19.468  26.867  19.321  1.00 86.19           C  \nATOM   6518  NZ  LYS A 846     -19.791  25.428  19.207  1.00 86.19           N  \nATOM   6519  N   THR A 847     -18.533  31.130  23.505  1.00 86.81           N  \nATOM   6520  CA  THR A 847     -19.586  31.673  24.381  1.00 86.81           C  \nATOM   6521  C   THR A 847     -18.921  32.177  25.666  1.00 86.81           C  \nATOM   6522  CB  THR A 847     -20.653  30.620  24.745  1.00 86.81           C  \nATOM   6523  O   THR A 847     -17.789  31.768  25.935  1.00 86.81           O  \nATOM   6524  CG2 THR A 847     -21.339  29.977  23.542  1.00 86.81           C  \nATOM   6525  OG1 THR A 847     -20.087  29.579  25.502  1.00 86.81           O  \nATOM   6526  N   PRO A 848     -19.582  32.990  26.512  1.00 86.06           N  \nATOM   6527  CA  PRO A 848     -19.000  33.419  27.788  1.00 86.06           C  \nATOM   6528  C   PRO A 848     -18.533  32.248  28.674  1.00 86.06           C  \nATOM   6529  CB  PRO A 848     -20.102  34.239  28.467  1.00 86.06           C  \nATOM   6530  O   PRO A 848     -17.583  32.378  29.442  1.00 86.06           O  \nATOM   6531  CG  PRO A 848     -20.949  34.757  27.304  1.00 86.06           C  \nATOM   6532  CD  PRO A 848     -20.884  33.608  26.304  1.00 86.06           C  \nATOM   6533  N   GLN A 849     -19.168  31.079  28.540  1.00 87.44           N  \nATOM   6534  CA  GLN A 849     -18.848  29.857  29.277  1.00 87.44           C  \nATOM   6535  C   GLN A 849     -17.841  28.933  28.557  1.00 87.44           C  \nATOM   6536  CB  GLN A 849     -20.156  29.109  29.610  1.00 87.44           C  \nATOM   6537  O   GLN A 849     -17.393  27.965  29.172  1.00 87.44           O  \nATOM   6538  CG  GLN A 849     -21.151  29.908  30.482  1.00 87.44           C  \nATOM   6539  CD  GLN A 849     -21.922  31.009  29.745  1.00 87.44           C  \nATOM   6540  NE2 GLN A 849     -22.436  32.003  30.435  1.00 87.44           N  \nATOM   6541  OE1 GLN A 849     -22.066  31.011  28.532  1.00 87.44           O  \nATOM   6542  N   HIS A 850     -17.460  29.196  27.296  1.00 89.81           N  \nATOM   6543  CA  HIS A 850     -16.632  28.289  26.479  1.00 89.81           C  \nATOM   6544  C   HIS A 850     -15.555  29.014  25.659  1.00 89.81           C  \nATOM   6545  CB  HIS A 850     -17.531  27.456  25.550  1.00 89.81           C  \nATOM   6546  O   HIS A 850     -15.871  29.775  24.739  1.00 89.81           O  \nATOM   6547  CG  HIS A 850     -16.819  26.277  24.932  1.00 89.81           C  \nATOM   6548  CD2 HIS A 850     -15.753  26.323  24.077  1.00 89.81           C  \nATOM   6549  ND1 HIS A 850     -17.103  24.944  25.224  1.00 89.81           N  \nATOM   6550  CE1 HIS A 850     -16.191  24.219  24.565  1.00 89.81           C  \nATOM   6551  NE2 HIS A 850     -15.366  25.020  23.875  1.00 89.81           N  \nATOM   6552  N   VAL A 851     -14.286  28.673  25.906  1.00 95.06           N  \nATOM   6553  CA  VAL A 851     -13.114  29.182  25.169  1.00 95.06           C  \nATOM   6554  C   VAL A 851     -12.349  28.074  24.429  1.00 95.06           C  \nATOM   6555  CB  VAL A 851     -12.183  30.010  26.080  1.00 95.06           C  \nATOM   6556  O   VAL A 851     -12.375  26.910  24.844  1.00 95.06           O  \nATOM   6557  CG1 VAL A 851     -12.922  31.229  26.642  1.00 95.06           C  \nATOM   6558  CG2 VAL A 851     -11.587  29.221  27.254  1.00 95.06           C  \nATOM   6559  N   LYS A 852     -11.673  28.436  23.327  1.00 94.25           N  \nATOM   6560  CA  LYS A 852     -10.763  27.566  22.554  1.00 94.25           C  \nATOM   6561  C   LYS A 852      -9.428  28.272  22.270  1.00 94.25           C  \nATOM   6562  CB  LYS A 852     -11.393  27.099  21.218  1.00 94.25           C  \nATOM   6563  O   LYS A 852      -9.425  29.432  21.875  1.00 94.25           O  \nATOM   6564  CG  LYS A 852     -12.747  26.369  21.326  1.00 94.25           C  \nATOM   6565  CD  LYS A 852     -13.068  25.553  20.053  1.00 94.25           C  \nATOM   6566  CE  LYS A 852     -14.500  24.976  20.055  1.00 94.25           C  \nATOM   6567  NZ  LYS A 852     -14.901  24.386  18.744  1.00 94.25           N  \nATOM   6568  N   ILE A 853      -8.308  27.572  22.425  1.00 93.69           N  \nATOM   6569  CA  ILE A 853      -6.953  28.039  22.075  1.00 93.69           C  \nATOM   6570  C   ILE A 853      -6.794  28.093  20.544  1.00 93.69           C  \nATOM   6571  CB  ILE A 853      -5.913  27.100  22.733  1.00 93.69           C  \nATOM   6572  O   ILE A 853      -7.254  27.181  19.861  1.00 93.69           O  \nATOM   6573  CG1 ILE A 853      -6.076  27.097  24.274  1.00 93.69           C  \nATOM   6574  CG2 ILE A 853      -4.481  27.497  22.347  1.00 93.69           C  \nATOM   6575  CD1 ILE A 853      -5.151  26.112  24.992  1.00 93.69           C  \nATOM   6576  N   THR A 854      -6.160  29.129  19.994  1.00 87.88           N  \nATOM   6577  CA  THR A 854      -5.925  29.338  18.548  1.00 87.88           C  \nATOM   6578  C   THR A 854      -4.454  29.659  18.265  1.00 87.88           C  \nATOM   6579  CB  THR A 854      -6.853  30.442  17.995  1.00 87.88           C  \nATOM   6580  O   THR A 854      -3.661  29.812  19.185  1.00 87.88           O  \nATOM   6581  CG2 THR A 854      -6.558  31.840  18.534  1.00 87.88           C  \nATOM   6582  OG1 THR A 854      -6.797  30.527  16.588  1.00 87.88           O  \nATOM   6583  N   ASP A 855      -4.089  29.762  16.985  1.00 76.75           N  \nATOM   6584  CA  ASP A 855      -2.805  30.307  16.515  1.00 76.75           C  \nATOM   6585  C   ASP A 855      -1.547  29.630  17.096  1.00 76.75           C  \nATOM   6586  CB  ASP A 855      -2.826  31.846  16.560  1.00 76.75           C  \nATOM   6587  O   ASP A 855      -0.443  30.167  17.048  1.00 76.75           O  \nATOM   6588  CG  ASP A 855      -3.833  32.379  15.535  1.00 76.75           C  \nATOM   6589  OD1 ASP A 855      -3.483  32.403  14.329  1.00 76.75           O  \nATOM   6590  OD2 ASP A 855      -4.993  32.659  15.914  1.00 76.75           O  \nATOM   6591  N   PHE A 856      -1.680  28.359  17.484  1.00 65.38           N  \nATOM   6592  CA  PHE A 856      -0.582  27.402  17.657  1.00 65.38           C  \nATOM   6593  C   PHE A 856       0.071  27.008  16.312  1.00 65.38           C  \nATOM   6594  CB  PHE A 856      -1.077  26.197  18.486  1.00 65.38           C  \nATOM   6595  O   PHE A 856       0.578  25.905  16.162  1.00 65.38           O  \nATOM   6596  CG  PHE A 856      -2.182  25.372  17.842  1.00 65.38           C  \nATOM   6597  CD1 PHE A 856      -3.527  25.764  17.983  1.00 65.38           C  \nATOM   6598  CD2 PHE A 856      -1.871  24.211  17.107  1.00 65.38           C  \nATOM   6599  CE1 PHE A 856      -4.547  25.030  17.353  1.00 65.38           C  \nATOM   6600  CE2 PHE A 856      -2.893  23.462  16.499  1.00 65.38           C  \nATOM   6601  CZ  PHE A 856      -4.231  23.883  16.605  1.00 65.38           C  \nATOM   6602  N   GLY A 857       0.067  27.901  15.317  1.00 51.94           N  \nATOM   6603  CA  GLY A 857       0.621  27.652  13.984  1.00 51.94           C  \nATOM   6604  C   GLY A 857       2.140  27.466  14.000  1.00 51.94           C  \nATOM   6605  O   GLY A 857       2.683  26.573  13.362  1.00 51.94           O  \nATOM   6606  N   LEU A 858       2.829  28.208  14.873  1.00 51.22           N  \nATOM   6607  CA  LEU A 858       4.259  28.022  15.134  1.00 51.22           C  \nATOM   6608  C   LEU A 858       4.575  26.719  15.899  1.00 51.22           C  \nATOM   6609  CB  LEU A 858       4.807  29.263  15.868  1.00 51.22           C  \nATOM   6610  O   LEU A 858       5.744  26.492  16.232  1.00 51.22           O  \nATOM   6611  CG  LEU A 858       4.673  30.589  15.092  1.00 51.22           C  \nATOM   6612  CD1 LEU A 858       5.163  31.742  15.970  1.00 51.22           C  \nATOM   6613  CD2 LEU A 858       5.492  30.595  13.798  1.00 51.22           C  \nATOM   6614  N   ALA A 859       3.581  25.884  16.224  1.00 50.81           N  \nATOM   6615  CA  ALA A 859       3.805  24.618  16.906  1.00 50.81           C  \nATOM   6616  C   ALA A 859       4.578  23.632  16.032  1.00 50.81           C  \nATOM   6617  CB  ALA A 859       2.487  24.000  17.387  1.00 50.81           C  \nATOM   6618  O   ALA A 859       4.426  23.570  14.815  1.00 50.81           O  \nATOM   6619  N   LYS A 860       5.406  22.822  16.686  1.00 53.34           N  \nATOM   6620  CA  LYS A 860       6.211  21.796  16.031  1.00 53.34           C  \nATOM   6621  C   LYS A 860       6.155  20.515  16.847  1.00 53.34           C  \nATOM   6622  CB  LYS A 860       7.623  22.353  15.806  1.00 53.34           C  \nATOM   6623  O   LYS A 860       6.147  20.566  18.077  1.00 53.34           O  \nATOM   6624  CG  LYS A 860       8.486  21.466  14.896  1.00 53.34           C  \nATOM   6625  CD  LYS A 860       9.546  22.334  14.210  1.00 53.34           C  \nATOM   6626  CE  LYS A 860      10.581  21.482  13.470  1.00 53.34           C  \nATOM   6627  NZ  LYS A 860      11.486  22.330  12.653  1.00 53.34           N  \nATOM   6628  N   LEU A 861       6.071  19.393  16.141  1.00 43.41           N  \nATOM   6629  CA  LEU A 861       6.116  18.063  16.731  1.00 43.41           C  \nATOM   6630  C   LEU A 861       7.543  17.791  17.225  1.00 43.41           C  \nATOM   6631  CB  LEU A 861       5.664  17.051  15.658  1.00 43.41           C  \nATOM   6632  O   LEU A 861       8.494  18.001  16.471  1.00 43.41           O  \nATOM   6633  CG  LEU A 861       5.321  15.654  16.206  1.00 43.41           C  \nATOM   6634  CD1 LEU A 861       3.998  15.669  16.978  1.00 43.41           C  \nATOM   6635  CD2 LEU A 861       5.165  14.675  15.044  1.00 43.41           C  \nATOM   6636  N   LEU A 862       7.685  17.344  18.471  1.00 40.22           N  \nATOM   6637  CA  LEU A 862       8.963  16.865  19.008  1.00 40.22           C  \nATOM   6638  C   LEU A 862       9.186  15.402  18.597  1.00 40.22           C  \nATOM   6639  CB  LEU A 862       8.980  17.033  20.540  1.00 40.22           C  \nATOM   6640  O   LEU A 862       8.269  14.582  18.728  1.00 40.22           O  \nATOM   6641  CG  LEU A 862       9.003  18.492  21.038  1.00 40.22           C  \nATOM   6642  CD1 LEU A 862       8.831  18.522  22.558  1.00 40.22           C  \nATOM   6643  CD2 LEU A 862      10.317  19.204  20.705  1.00 40.22           C  \nATOM   6644  N   GLY A 863      10.389  15.074  18.113  1.00 36.69           N  \nATOM   6645  CA  GLY A 863      10.765  13.711  17.730  1.00 36.69           C  \nATOM   6646  C   GLY A 863      10.696  12.698  18.883  1.00 36.69           C  \nATOM   6647  O   GLY A 863      10.555  13.051  20.055  1.00 36.69           O  \nATOM   6648  N   ALA A 864      10.809  11.403  18.568  1.00 39.84           N  \nATOM   6649  CA  ALA A 864      10.720  10.340  19.574  1.00 39.84           C  \nATOM   6650  C   ALA A 864      11.772  10.472  20.697  1.00 39.84           C  \nATOM   6651  CB  ALA A 864      10.808   8.985  18.867  1.00 39.84           C  \nATOM   6652  O   ALA A 864      11.441  10.224  21.860  1.00 39.84           O  \nATOM   6653  N   GLU A 865      12.987  10.912  20.346  1.00 41.00           N  \nATOM   6654  CA  GLU A 865      14.133  11.115  21.249  1.00 41.00           C  \nATOM   6655  C   GLU A 865      14.379  12.596  21.622  1.00 41.00           C  \nATOM   6656  CB  GLU A 865      15.400  10.505  20.613  1.00 41.00           C  \nATOM   6657  O   GLU A 865      15.158  12.885  22.532  1.00 41.00           O  \nATOM   6658  CG  GLU A 865      15.246   9.013  20.259  1.00 41.00           C  \nATOM   6659  CD  GLU A 865      16.566   8.331  19.853  1.00 41.00           C  \nATOM   6660  OE1 GLU A 865      16.628   7.089  19.995  1.00 41.00           O  \nATOM   6661  OE2 GLU A 865      17.504   9.039  19.420  1.00 41.00           O  \nATOM   6662  N   GLU A 866      13.715  13.548  20.957  1.00 46.16           N  \nATOM   6663  CA  GLU A 866      13.930  14.987  21.160  1.00 46.16           C  \nATOM   6664  C   GLU A 866      13.055  15.533  22.298  1.00 46.16           C  \nATOM   6665  CB  GLU A 866      13.658  15.780  19.872  1.00 46.16           C  \nATOM   6666  O   GLU A 866      11.827  15.465  22.255  1.00 46.16           O  \nATOM   6667  CG  GLU A 866      14.619  15.452  18.717  1.00 46.16           C  \nATOM   6668  CD  GLU A 866      14.328  16.304  17.469  1.00 46.16           C  \nATOM   6669  OE1 GLU A 866      15.297  16.646  16.752  1.00 46.16           O  \nATOM   6670  OE2 GLU A 866      13.130  16.590  17.223  1.00 46.16           O  \nATOM   6671  N   LYS A 867      13.681  16.135  23.315  1.00 50.31           N  \nATOM   6672  CA  LYS A 867      12.973  16.832  24.407  1.00 50.31           C  \nATOM   6673  C   LYS A 867      12.741  18.321  24.142  1.00 50.31           C  \nATOM   6674  CB  LYS A 867      13.763  16.678  25.712  1.00 50.31           C  \nATOM   6675  O   LYS A 867      11.917  18.939  24.811  1.00 50.31           O  \nATOM   6676  CG  LYS A 867      13.792  15.235  26.229  1.00 50.31           C  \nATOM   6677  CD  LYS A 867      14.554  15.224  27.555  1.00 50.31           C  \nATOM   6678  CE  LYS A 867      14.579  13.827  28.169  1.00 50.31           C  \nATOM   6679  NZ  LYS A 867      15.288  13.865  29.470  1.00 50.31           N  \nATOM   6680  N   GLU A 868      13.507  18.896  23.222  1.00 45.66           N  \nATOM   6681  CA  GLU A 868      13.719  20.334  23.072  1.00 45.66           C  \nATOM   6682  C   GLU A 868      13.792  20.700  21.589  1.00 45.66           C  \nATOM   6683  CB  GLU A 868      15.045  20.731  23.754  1.00 45.66           C  \nATOM   6684  O   GLU A 868      14.433  19.998  20.809  1.00 45.66           O  \nATOM   6685  CG  GLU A 868      14.997  20.630  25.286  1.00 45.66           C  \nATOM   6686  CD  GLU A 868      16.379  20.827  25.917  1.00 45.66           C  \nATOM   6687  OE1 GLU A 868      16.796  19.920  26.675  1.00 45.66           O  \nATOM   6688  OE2 GLU A 868      16.989  21.887  25.652  1.00 45.66           O  \nATOM   6689  N   TYR A 869      13.174  21.817  21.201  1.00 40.28           N  \nATOM   6690  CA  TYR A 869      13.299  22.366  19.849  1.00 40.28           C  \nATOM   6691  C   TYR A 869      14.097  23.675  19.836  1.00 40.28           C  \nATOM   6692  CB  TYR A 869      11.907  22.558  19.234  1.00 40.28           C  \nATOM   6693  O   TYR A 869      13.756  24.596  20.579  1.00 40.28           O  \nATOM   6694  CG  TYR A 869      11.966  23.172  17.850  1.00 40.28           C  \nATOM   6695  CD1 TYR A 869      11.467  24.469  17.611  1.00 40.28           C  \nATOM   6696  CD2 TYR A 869      12.608  22.462  16.819  1.00 40.28           C  \nATOM   6697  CE1 TYR A 869      11.594  25.048  16.332  1.00 40.28           C  \nATOM   6698  CE2 TYR A 869      12.768  23.049  15.554  1.00 40.28           C  \nATOM   6699  OH  TYR A 869      12.312  24.840  14.040  1.00 40.28           O  \nATOM   6700  CZ  TYR A 869      12.251  24.337  15.303  1.00 40.28           C  \nATOM   6701  N   HIS A 870      15.085  23.789  18.939  1.00 50.81           N  \nATOM   6702  CA  HIS A 870      15.826  25.025  18.646  1.00 50.81           C  \nATOM   6703  C   HIS A 870      15.344  25.671  17.334  1.00 50.81           C  \nATOM   6704  CB  HIS A 870      17.335  24.751  18.582  1.00 50.81           C  \nATOM   6705  O   HIS A 870      15.110  24.974  16.349  1.00 50.81           O  \nATOM   6706  CG  HIS A 870      17.929  24.209  19.857  1.00 50.81           C  \nATOM   6707  CD2 HIS A 870      18.296  22.909  20.080  1.00 50.81           C  \nATOM   6708  ND1 HIS A 870      18.263  24.927  20.989  1.00 50.81           N  \nATOM   6709  CE1 HIS A 870      18.815  24.070  21.866  1.00 50.81           C  \nATOM   6710  NE2 HIS A 870      18.869  22.836  21.348  1.00 50.81           N  \nATOM   6711  N   ALA A 871      15.214  27.003  17.292  1.00 50.16           N  \nATOM   6712  CA  ALA A 871      14.584  27.715  16.170  1.00 50.16           C  \nATOM   6713  C   ALA A 871      15.498  28.717  15.430  1.00 50.16           C  \nATOM   6714  CB  ALA A 871      13.321  28.405  16.697  1.00 50.16           C  \nATOM   6715  O   ALA A 871      16.060  29.627  16.043  1.00 50.16           O  \nATOM   6716  N   GLU A 872      15.540  28.615  14.096  1.00 43.59           N  \nATOM   6717  CA  GLU A 872      16.246  29.528  13.179  1.00 43.59           C  \nATOM   6718  C   GLU A 872      15.492  30.861  12.949  1.00 43.59           C  \nATOM   6719  CB  GLU A 872      16.545  28.823  11.837  1.00 43.59           C  \nATOM   6720  O   GLU A 872      14.985  31.142  11.866  1.00 43.59           O  \nATOM   6721  CG  GLU A 872      17.488  27.616  11.951  1.00 43.59           C  \nATOM   6722  CD  GLU A 872      17.904  27.073  10.569  1.00 43.59           C  \nATOM   6723  OE1 GLU A 872      19.081  26.674  10.441  1.00 43.59           O  \nATOM   6724  OE2 GLU A 872      17.044  27.044   9.652  1.00 43.59           O  \nATOM   6725  N   GLY A 873      15.437  31.718  13.973  1.00 40.78           N  \nATOM   6726  CA  GLY A 873      14.988  33.115  13.839  1.00 40.78           C  \nATOM   6727  C   GLY A 873      13.467  33.350  13.771  1.00 40.78           C  \nATOM   6728  O   GLY A 873      12.665  32.451  14.013  1.00 40.78           O  \nATOM   6729  N   GLY A 874      13.082  34.607  13.505  1.00 47.78           N  \nATOM   6730  CA  GLY A 874      11.686  35.076  13.421  1.00 47.78           C  \nATOM   6731  C   GLY A 874      11.296  36.151  14.454  1.00 47.78           C  \nATOM   6732  O   GLY A 874      12.009  36.390  15.432  1.00 47.78           O  \nATOM   6733  N   LYS A 875      10.141  36.807  14.243  1.00 57.78           N  \nATOM   6734  CA  LYS A 875       9.488  37.654  15.264  1.00 57.78           C  \nATOM   6735  C   LYS A 875       8.921  36.756  16.369  1.00 57.78           C  \nATOM   6736  CB  LYS A 875       8.356  38.510  14.661  1.00 57.78           C  \nATOM   6737  O   LYS A 875       8.294  35.748  16.062  1.00 57.78           O  \nATOM   6738  CG  LYS A 875       8.836  39.687  13.794  1.00 57.78           C  \nATOM   6739  CD  LYS A 875       7.639  40.554  13.364  1.00 57.78           C  \nATOM   6740  CE  LYS A 875       8.087  41.789  12.572  1.00 57.78           C  \nATOM   6741  NZ  LYS A 875       6.935  42.665  12.231  1.00 57.78           N  \nATOM   6742  N   VAL A 876       9.123  37.121  17.637  1.00 71.81           N  \nATOM   6743  CA  VAL A 876       8.781  36.271  18.794  1.00 71.81           C  \nATOM   6744  C   VAL A 876       8.131  37.055  19.951  1.00 71.81           C  \nATOM   6745  CB  VAL A 876      10.011  35.490  19.299  1.00 71.81           C  \nATOM   6746  O   VAL A 876       8.452  38.230  20.147  1.00 71.81           O  \nATOM   6747  CG1 VAL A 876      10.425  34.367  18.343  1.00 71.81           C  \nATOM   6748  CG2 VAL A 876      11.235  36.377  19.560  1.00 71.81           C  \nATOM   6749  N   PRO A 877       7.240  36.431  20.747  1.00 85.31           N  \nATOM   6750  CA  PRO A 877       6.402  37.100  21.748  1.00 85.31           C  \nATOM   6751  C   PRO A 877       7.122  37.297  23.097  1.00 85.31           C  \nATOM   6752  CB  PRO A 877       5.159  36.200  21.843  1.00 85.31           C  \nATOM   6753  O   PRO A 877       6.633  36.857  24.133  1.00 85.31           O  \nATOM   6754  CG  PRO A 877       5.771  34.806  21.703  1.00 85.31           C  \nATOM   6755  CD  PRO A 877       6.818  35.037  20.621  1.00 85.31           C  \nATOM   6756  N   ILE A 878       8.288  37.959  23.107  1.00 88.44           N  \nATOM   6757  CA  ILE A 878       9.274  37.951  24.220  1.00 88.44           C  \nATOM   6758  C   ILE A 878       8.665  38.087  25.630  1.00 88.44           C  \nATOM   6759  CB  ILE A 878      10.372  39.024  23.979  1.00 88.44           C  \nATOM   6760  O   ILE A 878       9.073  37.371  26.537  1.00 88.44           O  \nATOM   6761  CG1 ILE A 878      11.165  38.694  22.692  1.00 88.44           C  \nATOM   6762  CG2 ILE A 878      11.337  39.116  25.178  1.00 88.44           C  \nATOM   6763  CD1 ILE A 878      12.149  39.775  22.222  1.00 88.44           C  \nATOM   6764  N   LYS A 879       7.661  38.951  25.829  1.00 92.56           N  \nATOM   6765  CA  LYS A 879       7.039  39.188  27.148  1.00 92.56           C  \nATOM   6766  C   LYS A 879       6.187  38.031  27.703  1.00 92.56           C  \nATOM   6767  CB  LYS A 879       6.231  40.492  27.122  1.00 92.56           C  \nATOM   6768  O   LYS A 879       5.815  38.078  28.872  1.00 92.56           O  \nATOM   6769  CG  LYS A 879       7.098  41.706  26.754  1.00 92.56           C  \nATOM   6770  CD  LYS A 879       6.400  42.985  27.209  1.00 92.56           C  \nATOM   6771  CE  LYS A 879       7.282  44.213  27.002  1.00 92.56           C  \nATOM   6772  NZ  LYS A 879       6.760  45.370  27.761  1.00 92.56           N  \nATOM   6773  N   TRP A 880       5.898  37.014  26.891  1.00 94.31           N  \nATOM   6774  CA  TRP A 880       5.214  35.770  27.273  1.00 94.31           C  \nATOM   6775  C   TRP A 880       6.162  34.561  27.322  1.00 94.31           C  \nATOM   6776  CB  TRP A 880       4.059  35.500  26.292  1.00 94.31           C  \nATOM   6777  O   TRP A 880       5.759  33.493  27.779  1.00 94.31           O  \nATOM   6778  CG  TRP A 880       2.900  36.446  26.379  1.00 94.31           C  \nATOM   6779  CD1 TRP A 880       1.718  36.168  26.973  1.00 94.31           C  \nATOM   6780  CD2 TRP A 880       2.761  37.797  25.837  1.00 94.31           C  \nATOM   6781  CE2 TRP A 880       1.472  38.296  26.196  1.00 94.31           C  \nATOM   6782  CE3 TRP A 880       3.577  38.641  25.049  1.00 94.31           C  \nATOM   6783  NE1 TRP A 880       0.878  37.257  26.877  1.00 94.31           N  \nATOM   6784  CH2 TRP A 880       1.881  40.399  25.062  1.00 94.31           C  \nATOM   6785  CZ2 TRP A 880       1.035  39.576  25.825  1.00 94.31           C  \nATOM   6786  CZ3 TRP A 880       3.146  39.927  24.666  1.00 94.31           C  \nATOM   6787  N   MET A 881       7.402  34.699  26.843  1.00 93.06           N  \nATOM   6788  CA  MET A 881       8.343  33.587  26.682  1.00 93.06           C  \nATOM   6789  C   MET A 881       9.076  33.243  27.980  1.00 93.06           C  \nATOM   6790  CB  MET A 881       9.373  33.921  25.595  1.00 93.06           C  \nATOM   6791  O   MET A 881       9.387  34.123  28.784  1.00 93.06           O  \nATOM   6792  CG  MET A 881       8.752  34.018  24.201  1.00 93.06           C  \nATOM   6793  SD  MET A 881       9.908  34.556  22.911  1.00 93.06           S  \nATOM   6794  CE  MET A 881      10.993  33.112  22.838  1.00 93.06           C  \nATOM   6795  N   ALA A 882       9.415  31.963  28.133  1.00 94.88           N  \nATOM   6796  CA  ALA A 882      10.317  31.492  29.176  1.00 94.88           C  \nATOM   6797  C   ALA A 882      11.770  31.930  28.922  1.00 94.88           C  \nATOM   6798  CB  ALA A 882      10.182  29.975  29.279  1.00 94.88           C  \nATOM   6799  O   ALA A 882      12.170  32.185  27.780  1.00 94.88           O  \nATOM   6800  N   LEU A 883      12.576  32.003  29.985  1.00 94.06           N  \nATOM   6801  CA  LEU A 883      13.946  32.523  29.915  1.00 94.06           C  \nATOM   6802  C   LEU A 883      14.840  31.697  28.970  1.00 94.06           C  \nATOM   6803  CB  LEU A 883      14.504  32.618  31.348  1.00 94.06           C  \nATOM   6804  O   LEU A 883      15.571  32.269  28.163  1.00 94.06           O  \nATOM   6805  CG  LEU A 883      15.915  33.232  31.450  1.00 94.06           C  \nATOM   6806  CD1 LEU A 883      15.985  34.642  30.856  1.00 94.06           C  \nATOM   6807  CD2 LEU A 883      16.330  33.314  32.920  1.00 94.06           C  \nATOM   6808  N   GLU A 884      14.716  30.369  28.982  1.00 92.75           N  \nATOM   6809  CA  GLU A 884      15.428  29.463  28.072  1.00 92.75           C  \nATOM   6810  C   GLU A 884      15.030  29.652  26.594  1.00 92.75           C  \nATOM   6811  CB  GLU A 884      15.261  28.002  28.544  1.00 92.75           C  \nATOM   6812  O   GLU A 884      15.866  29.546  25.692  1.00 92.75           O  \nATOM   6813  CG  GLU A 884      13.862  27.356  28.418  1.00 92.75           C  \nATOM   6814  CD  GLU A 884      12.820  27.753  29.481  1.00 92.75           C  \nATOM   6815  OE1 GLU A 884      11.707  27.186  29.457  1.00 92.75           O  \nATOM   6816  OE2 GLU A 884      13.068  28.633  30.340  1.00 92.75           O  \nATOM   6817  N   SER A 885      13.776  30.029  26.327  1.00 91.56           N  \nATOM   6818  CA  SER A 885      13.281  30.334  24.978  1.00 91.56           C  \nATOM   6819  C   SER A 885      13.778  31.691  24.469  1.00 91.56           C  \nATOM   6820  CB  SER A 885      11.749  30.307  24.958  1.00 91.56           C  \nATOM   6821  O   SER A 885      13.968  31.877  23.260  1.00 91.56           O  \nATOM   6822  OG  SER A 885      11.247  29.150  25.587  1.00 91.56           O  \nATOM   6823  N   ILE A 886      14.011  32.642  25.380  1.00 90.00           N  \nATOM   6824  CA  ILE A 886      14.607  33.949  25.074  1.00 90.00           C  \nATOM   6825  C   ILE A 886      16.108  33.788  24.792  1.00 90.00           C  \nATOM   6826  CB  ILE A 886      14.307  34.970  26.202  1.00 90.00           C  \nATOM   6827  O   ILE A 886      16.563  34.216  23.732  1.00 90.00           O  \nATOM   6828  CG1 ILE A 886      12.785  35.230  26.314  1.00 90.00           C  \nATOM   6829  CG2 ILE A 886      15.040  36.302  25.946  1.00 90.00           C  \nATOM   6830  CD1 ILE A 886      12.368  35.990  27.582  1.00 90.00           C  \nATOM   6831  N   LEU A 887      16.854  33.142  25.698  1.00 88.12           N  \nATOM   6832  CA  LEU A 887      18.321  33.048  25.648  1.00 88.12           C  \nATOM   6833  C   LEU A 887      18.855  32.003  24.656  1.00 88.12           C  \nATOM   6834  CB  LEU A 887      18.859  32.720  27.055  1.00 88.12           C  \nATOM   6835  O   LEU A 887      19.854  32.250  23.982  1.00 88.12           O  \nATOM   6836  CG  LEU A 887      18.641  33.789  28.141  1.00 88.12           C  \nATOM   6837  CD1 LEU A 887      19.212  33.271  29.460  1.00 88.12           C  \nATOM   6838  CD2 LEU A 887      19.325  35.114  27.800  1.00 88.12           C  \nATOM   6839  N   HIS A 888      18.225  30.828  24.573  1.00 86.75           N  \nATOM   6840  CA  HIS A 888      18.777  29.653  23.875  1.00 86.75           C  \nATOM   6841  C   HIS A 888      17.879  29.140  22.740  1.00 86.75           C  \nATOM   6842  CB  HIS A 888      19.067  28.556  24.909  1.00 86.75           C  \nATOM   6843  O   HIS A 888      18.188  28.136  22.095  1.00 86.75           O  \nATOM   6844  CG  HIS A 888      19.924  29.018  26.062  1.00 86.75           C  \nATOM   6845  CD2 HIS A 888      19.716  28.747  27.387  1.00 86.75           C  \nATOM   6846  ND1 HIS A 888      21.024  29.845  25.984  1.00 86.75           N  \nATOM   6847  CE1 HIS A 888      21.466  30.065  27.233  1.00 86.75           C  \nATOM   6848  NE2 HIS A 888      20.696  29.422  28.122  1.00 86.75           N  \nATOM   6849  N   ARG A 889      16.755  29.829  22.493  1.00 84.06           N  \nATOM   6850  CA  ARG A 889      15.707  29.428  21.539  1.00 84.06           C  \nATOM   6851  C   ARG A 889      15.159  28.018  21.788  1.00 84.06           C  \nATOM   6852  CB  ARG A 889      16.177  29.626  20.078  1.00 84.06           C  \nATOM   6853  O   ARG A 889      14.665  27.416  20.842  1.00 84.06           O  \nATOM   6854  CG  ARG A 889      16.673  31.035  19.732  1.00 84.06           C  \nATOM   6855  CD  ARG A 889      15.641  32.088  20.142  1.00 84.06           C  \nATOM   6856  NE  ARG A 889      15.875  33.381  19.481  1.00 84.06           N  \nATOM   6857  NH1 ARG A 889      14.248  34.512  20.620  1.00 84.06           N  \nATOM   6858  NH2 ARG A 889      15.375  35.546  18.987  1.00 84.06           N  \nATOM   6859  CZ  ARG A 889      15.169  34.472  19.698  1.00 84.06           C  \nATOM   6860  N   ILE A 890      15.231  27.529  23.028  1.00 84.88           N  \nATOM   6861  CA  ILE A 890      14.691  26.232  23.456  1.00 84.88           C  \nATOM   6862  C   ILE A 890      13.178  26.357  23.654  1.00 84.88           C  \nATOM   6863  CB  ILE A 890      15.408  25.755  24.743  1.00 84.88           C  \nATOM   6864  O   ILE A 890      12.712  27.262  24.348  1.00 84.88           O  \nATOM   6865  CG1 ILE A 890      16.879  25.396  24.431  1.00 84.88           C  \nATOM   6866  CG2 ILE A 890      14.691  24.547  25.372  1.00 84.88           C  \nATOM   6867  CD1 ILE A 890      17.766  25.252  25.675  1.00 84.88           C  \nATOM   6868  N   TYR A 891      12.408  25.443  23.066  1.00 86.69           N  \nATOM   6869  CA  TYR A 891      10.958  25.353  23.248  1.00 86.69           C  \nATOM   6870  C   TYR A 891      10.557  23.942  23.697  1.00 86.69           C  \nATOM   6871  CB  TYR A 891      10.232  25.763  21.960  1.00 86.69           C  \nATOM   6872  O   TYR A 891      10.949  22.953  23.078  1.00 86.69           O  \nATOM   6873  CG  TYR A 891      10.500  27.184  21.493  1.00 86.69           C  \nATOM   6874  CD1 TYR A 891       9.646  28.240  21.868  1.00 86.69           C  \nATOM   6875  CD2 TYR A 891      11.610  27.449  20.669  1.00 86.69           C  \nATOM   6876  CE1 TYR A 891       9.901  29.552  21.416  1.00 86.69           C  \nATOM   6877  CE2 TYR A 891      11.893  28.762  20.251  1.00 86.69           C  \nATOM   6878  OH  TYR A 891      11.300  31.080  20.193  1.00 86.69           O  \nATOM   6879  CZ  TYR A 891      11.037  29.820  20.625  1.00 86.69           C  \nATOM   6880  N   THR A 892       9.766  23.876  24.770  1.00 91.94           N  \nATOM   6881  CA  THR A 892       9.276  22.656  25.442  1.00 91.94           C  \nATOM   6882  C   THR A 892       7.881  22.895  26.036  1.00 91.94           C  \nATOM   6883  CB  THR A 892      10.204  22.242  26.604  1.00 91.94           C  \nATOM   6884  O   THR A 892       7.469  24.046  26.210  1.00 91.94           O  \nATOM   6885  CG2 THR A 892      11.675  22.118  26.231  1.00 91.94           C  \nATOM   6886  OG1 THR A 892      10.128  23.183  27.652  1.00 91.94           O  \nATOM   6887  N   HIS A 893       7.170  21.846  26.460  1.00 93.44           N  \nATOM   6888  CA  HIS A 893       5.909  22.013  27.205  1.00 93.44           C  \nATOM   6889  C   HIS A 893       6.083  22.840  28.500  1.00 93.44           C  \nATOM   6890  CB  HIS A 893       5.308  20.634  27.509  1.00 93.44           C  \nATOM   6891  O   HIS A 893       5.204  23.618  28.858  1.00 93.44           O  \nATOM   6892  CG  HIS A 893       5.113  19.787  26.275  1.00 93.44           C  \nATOM   6893  CD2 HIS A 893       5.688  18.568  26.024  1.00 93.44           C  \nATOM   6894  ND1 HIS A 893       4.345  20.104  25.176  1.00 93.44           N  \nATOM   6895  CE1 HIS A 893       4.458  19.101  24.293  1.00 93.44           C  \nATOM   6896  NE2 HIS A 893       5.274  18.144  24.758  1.00 93.44           N  \nATOM   6897  N   GLN A 894       7.252  22.774  29.151  1.00 96.12           N  \nATOM   6898  CA  GLN A 894       7.564  23.594  30.331  1.00 96.12           C  \nATOM   6899  C   GLN A 894       7.776  25.082  29.980  1.00 96.12           C  \nATOM   6900  CB  GLN A 894       8.796  23.027  31.057  1.00 96.12           C  \nATOM   6901  O   GLN A 894       7.574  25.948  30.836  1.00 96.12           O  \nATOM   6902  CG  GLN A 894       8.664  21.555  31.490  1.00 96.12           C  \nATOM   6903  CD  GLN A 894       7.520  21.312  32.471  1.00 96.12           C  \nATOM   6904  NE2 GLN A 894       7.758  21.468  33.750  1.00 96.12           N  \nATOM   6905  OE1 GLN A 894       6.408  20.985  32.089  1.00 96.12           O  \nATOM   6906  N   SER A 895       8.137  25.404  28.731  1.00 94.62           N  \nATOM   6907  CA  SER A 895       8.132  26.788  28.232  1.00 94.62           C  \nATOM   6908  C   SER A 895       6.707  27.300  27.967  1.00 94.62           C  \nATOM   6909  CB  SER A 895       9.067  26.966  27.025  1.00 94.62           C  \nATOM   6910  O   SER A 895       6.407  28.445  28.297  1.00 94.62           O  \nATOM   6911  OG  SER A 895       8.567  26.399  25.823  1.00 94.62           O  \nATOM   6912  N   ASP A 896       5.784  26.440  27.509  1.00 95.81           N  \nATOM   6913  CA  ASP A 896       4.359  26.795  27.410  1.00 95.81           C  \nATOM   6914  C   ASP A 896       3.717  27.008  28.795  1.00 95.81           C  \nATOM   6915  CB  ASP A 896       3.555  25.715  26.670  1.00 95.81           C  \nATOM   6916  O   ASP A 896       2.848  27.867  28.940  1.00 95.81           O  \nATOM   6917  CG  ASP A 896       3.786  25.609  25.163  1.00 95.81           C  \nATOM   6918  OD1 ASP A 896       4.075  26.628  24.498  1.00 95.81           O  \nATOM   6919  OD2 ASP A 896       3.573  24.496  24.636  1.00 95.81           O  \nATOM   6920  N   VAL A 897       4.143  26.270  29.832  1.00 98.12           N  \nATOM   6921  CA  VAL A 897       3.688  26.476  31.226  1.00 98.12           C  \nATOM   6922  C   VAL A 897       4.020  27.891  31.720  1.00 98.12           C  \nATOM   6923  CB  VAL A 897       4.280  25.404  32.168  1.00 98.12           C  \nATOM   6924  O   VAL A 897       3.195  28.526  32.380  1.00 98.12           O  \nATOM   6925  CG1 VAL A 897       4.112  25.748  33.654  1.00 98.12           C  \nATOM   6926  CG2 VAL A 897       3.613  24.045  31.928  1.00 98.12           C  \nATOM   6927  N   TRP A 898       5.182  28.436  31.353  1.00 97.75           N  \nATOM   6928  CA  TRP A 898       5.536  29.825  31.661  1.00 97.75           C  \nATOM   6929  C   TRP A 898       4.574  30.813  30.984  1.00 97.75           C  \nATOM   6930  CB  TRP A 898       6.983  30.065  31.229  1.00 97.75           C  \nATOM   6931  O   TRP A 898       4.033  31.713  31.639  1.00 97.75           O  \nATOM   6932  CG  TRP A 898       7.528  31.429  31.496  1.00 97.75           C  \nATOM   6933  CD1 TRP A 898       7.142  32.566  30.873  1.00 97.75           C  \nATOM   6934  CD2 TRP A 898       8.628  31.809  32.376  1.00 97.75           C  \nATOM   6935  CE2 TRP A 898       8.816  33.216  32.266  1.00 97.75           C  \nATOM   6936  CE3 TRP A 898       9.521  31.107  33.215  1.00 97.75           C  \nATOM   6937  NE1 TRP A 898       7.888  33.626  31.339  1.00 97.75           N  \nATOM   6938  CH2 TRP A 898      10.692  33.171  33.795  1.00 97.75           C  \nATOM   6939  CZ2 TRP A 898       9.816  33.892  32.967  1.00 97.75           C  \nATOM   6940  CZ3 TRP A 898      10.543  31.778  33.916  1.00 97.75           C  \nATOM   6941  N   SER A 899       4.312  30.616  29.688  1.00 97.06           N  \nATOM   6942  CA  SER A 899       3.366  31.423  28.906  1.00 97.06           C  \nATOM   6943  C   SER A 899       1.922  31.296  29.415  1.00 97.06           C  \nATOM   6944  CB  SER A 899       3.454  31.023  27.430  1.00 97.06           C  \nATOM   6945  O   SER A 899       1.183  32.283  29.434  1.00 97.06           O  \nATOM   6946  OG  SER A 899       4.782  31.134  26.960  1.00 97.06           O  \nATOM   6947  N   TYR A 900       1.533  30.129  29.939  1.00 98.19           N  \nATOM   6948  CA  TYR A 900       0.276  29.940  30.668  1.00 98.19           C  \nATOM   6949  C   TYR A 900       0.237  30.795  31.940  1.00 98.19           C  \nATOM   6950  CB  TYR A 900       0.062  28.455  30.991  1.00 98.19           C  \nATOM   6951  O   TYR A 900      -0.748  31.493  32.164  1.00 98.19           O  \nATOM   6952  CG  TYR A 900      -1.144  28.191  31.873  1.00 98.19           C  \nATOM   6953  CD1 TYR A 900      -0.992  28.165  33.273  1.00 98.19           C  \nATOM   6954  CD2 TYR A 900      -2.419  28.018  31.302  1.00 98.19           C  \nATOM   6955  CE1 TYR A 900      -2.115  27.989  34.102  1.00 98.19           C  \nATOM   6956  CE2 TYR A 900      -3.545  27.831  32.129  1.00 98.19           C  \nATOM   6957  OH  TYR A 900      -4.489  27.684  34.327  1.00 98.19           O  \nATOM   6958  CZ  TYR A 900      -3.396  27.827  33.532  1.00 98.19           C  \nATOM   6959  N   GLY A 901       1.315  30.823  32.732  1.00 97.94           N  \nATOM   6960  CA  GLY A 901       1.424  31.707  33.898  1.00 97.94           C  \nATOM   6961  C   GLY A 901       1.195  33.183  33.542  1.00 97.94           C  \nATOM   6962  O   GLY A 901       0.422  33.867  34.215  1.00 97.94           O  \nATOM   6963  N   VAL A 902       1.792  33.657  32.438  1.00 97.88           N  \nATOM   6964  CA  VAL A 902       1.559  35.020  31.915  1.00 97.88           C  \nATOM   6965  C   VAL A 902       0.113  35.199  31.435  1.00 97.88           C  \nATOM   6966  CB  VAL A 902       2.568  35.394  30.807  1.00 97.88           C  \nATOM   6967  O   VAL A 902      -0.505  36.213  31.745  1.00 97.88           O  \nATOM   6968  CG1 VAL A 902       2.354  36.833  30.318  1.00 97.88           C  \nATOM   6969  CG2 VAL A 902       4.014  35.299  31.318  1.00 97.88           C  \nATOM   6970  N   THR A 903      -0.471  34.200  30.768  1.00 97.62           N  \nATOM   6971  CA  THR A 903      -1.876  34.227  30.319  1.00 97.62           C  \nATOM   6972  C   THR A 903      -2.853  34.329  31.496  1.00 97.62           C  \nATOM   6973  CB  THR A 903      -2.205  32.984  29.476  1.00 97.62           C  \nATOM   6974  O   THR A 903      -3.794  35.119  31.448  1.00 97.62           O  \nATOM   6975  CG2 THR A 903      -3.628  33.001  28.916  1.00 97.62           C  \nATOM   6976  OG1 THR A 903      -1.354  32.904  28.358  1.00 97.62           O  \nATOM   6977  N   VAL A 904      -2.626  33.597  32.595  1.00 98.00           N  \nATOM   6978  CA  VAL A 904      -3.439  33.740  33.817  1.00 98.00           C  \nATOM   6979  C   VAL A 904      -3.269  35.142  34.411  1.00 98.00           C  \nATOM   6980  CB  VAL A 904      -3.122  32.647  34.860  1.00 98.00           C  \nATOM   6981  O   VAL A 904      -4.252  35.736  34.848  1.00 98.00           O  \nATOM   6982  CG1 VAL A 904      -3.996  32.787  36.115  1.00 98.00           C  \nATOM   6983  CG2 VAL A 904      -3.407  31.239  34.321  1.00 98.00           C  \nATOM   6984  N   TRP A 905      -2.062  35.717  34.387  1.00 97.88           N  \nATOM   6985  CA  TRP A 905      -1.846  37.102  34.820  1.00 97.88           C  \nATOM   6986  C   TRP A 905      -2.601  38.122  33.947  1.00 97.88           C  \nATOM   6987  CB  TRP A 905      -0.343  37.393  34.892  1.00 97.88           C  \nATOM   6988  O   TRP A 905      -3.213  39.041  34.493  1.00 97.88           O  \nATOM   6989  CG  TRP A 905      -0.005  38.719  35.492  1.00 97.88           C  \nATOM   6990  CD1 TRP A 905       0.295  38.936  36.790  1.00 97.88           C  \nATOM   6991  CD2 TRP A 905       0.062  40.028  34.842  1.00 97.88           C  \nATOM   6992  CE2 TRP A 905       0.427  41.000  35.822  1.00 97.88           C  \nATOM   6993  CE3 TRP A 905      -0.141  40.490  33.523  1.00 97.88           C  \nATOM   6994  NE1 TRP A 905       0.529  40.279  36.992  1.00 97.88           N  \nATOM   6995  CH2 TRP A 905       0.392  42.783  34.183  1.00 97.88           C  \nATOM   6996  CZ2 TRP A 905       0.605  42.356  35.506  1.00 97.88           C  \nATOM   6997  CZ3 TRP A 905       0.011  41.851  33.201  1.00 97.88           C  \nATOM   6998  N   GLU A 906      -2.651  37.941  32.620  1.00 97.38           N  \nATOM   6999  CA  GLU A 906      -3.484  38.767  31.726  1.00 97.38           C  \nATOM   7000  C   GLU A 906      -4.970  38.698  32.119  1.00 97.38           C  \nATOM   7001  CB  GLU A 906      -3.332  38.350  30.248  1.00 97.38           C  \nATOM   7002  O   GLU A 906      -5.619  39.738  32.237  1.00 97.38           O  \nATOM   7003  CG  GLU A 906      -1.971  38.680  29.622  1.00 97.38           C  \nATOM   7004  CD  GLU A 906      -1.939  38.282  28.137  1.00 97.38           C  \nATOM   7005  OE1 GLU A 906      -2.046  39.176  27.270  1.00 97.38           O  \nATOM   7006  OE2 GLU A 906      -1.775  37.077  27.830  1.00 97.38           O  \nATOM   7007  N   LEU A 907      -5.512  37.503  32.391  1.00 96.50           N  \nATOM   7008  CA  LEU A 907      -6.912  37.345  32.816  1.00 96.50           C  \nATOM   7009  C   LEU A 907      -7.188  38.040  34.155  1.00 96.50           C  \nATOM   7010  CB  LEU A 907      -7.290  35.852  32.896  1.00 96.50           C  \nATOM   7011  O   LEU A 907      -8.125  38.830  34.262  1.00 96.50           O  \nATOM   7012  CG  LEU A 907      -7.243  35.094  31.560  1.00 96.50           C  \nATOM   7013  CD1 LEU A 907      -7.613  33.627  31.788  1.00 96.50           C  \nATOM   7014  CD2 LEU A 907      -8.195  35.673  30.516  1.00 96.50           C  \nATOM   7015  N   MET A 908      -6.344  37.802  35.160  1.00 95.38           N  \nATOM   7016  CA  MET A 908      -6.527  38.351  36.511  1.00 95.38           C  \nATOM   7017  C   MET A 908      -6.248  39.863  36.609  1.00 95.38           C  \nATOM   7018  CB  MET A 908      -5.669  37.569  37.513  1.00 95.38           C  \nATOM   7019  O   MET A 908      -6.522  40.480  37.638  1.00 95.38           O  \nATOM   7020  CG  MET A 908      -6.001  36.072  37.576  1.00 95.38           C  \nATOM   7021  SD  MET A 908      -7.715  35.645  37.955  1.00 95.38           S  \nATOM   7022  CE  MET A 908      -7.601  33.857  37.687  1.00 95.38           C  \nATOM   7023  N   THR A 909      -5.722  40.474  35.546  1.00 94.81           N  \nATOM   7024  CA  THR A 909      -5.538  41.928  35.409  1.00 94.81           C  \nATOM   7025  C   THR A 909      -6.470  42.552  34.361  1.00 94.81           C  \nATOM   7026  CB  THR A 909      -4.074  42.282  35.122  1.00 94.81           C  \nATOM   7027  O   THR A 909      -6.267  43.705  33.973  1.00 94.81           O  \nATOM   7028  CG2 THR A 909      -3.128  41.872  36.247  1.00 94.81           C  \nATOM   7029  OG1 THR A 909      -3.653  41.678  33.924  1.00 94.81           O  \nATOM   7030  N   PHE A 910      -7.495  41.811  33.911  1.00 93.69           N  \nATOM   7031  CA  PHE A 910      -8.472  42.223  32.892  1.00 93.69           C  \nATOM   7032  C   PHE A 910      -7.818  42.748  31.600  1.00 93.69           C  \nATOM   7033  CB  PHE A 910      -9.527  43.161  33.498  1.00 93.69           C  \nATOM   7034  O   PHE A 910      -8.210  43.769  31.037  1.00 93.69           O  \nATOM   7035  CG  PHE A 910     -10.298  42.556  34.658  1.00 93.69           C  \nATOM   7036  CD1 PHE A 910     -11.458  41.797  34.412  1.00 93.69           C  \nATOM   7037  CD2 PHE A 910      -9.866  42.762  35.983  1.00 93.69           C  \nATOM   7038  CE1 PHE A 910     -12.192  41.268  35.488  1.00 93.69           C  \nATOM   7039  CE2 PHE A 910     -10.600  42.228  37.057  1.00 93.69           C  \nATOM   7040  CZ  PHE A 910     -11.767  41.484  36.809  1.00 93.69           C  \nATOM   7041  N   GLY A 911      -6.785  42.040  31.140  1.00 91.81           N  \nATOM   7042  CA  GLY A 911      -6.064  42.330  29.906  1.00 91.81           C  \nATOM   7043  C   GLY A 911      -5.024  43.445  30.018  1.00 91.81           C  \nATOM   7044  O   GLY A 911      -4.783  44.150  29.030  1.00 91.81           O  \nATOM   7045  N   SER A 912      -4.409  43.628  31.191  1.00 93.38           N  \nATOM   7046  CA  SER A 912      -3.249  44.520  31.328  1.00 93.38           C  \nATOM   7047  C   SER A 912      -2.035  43.955  30.581  1.00 93.38           C  \nATOM   7048  CB  SER A 912      -2.907  44.786  32.795  1.00 93.38           C  \nATOM   7049  O   SER A 912      -1.917  42.749  30.374  1.00 93.38           O  \nATOM   7050  OG  SER A 912      -4.015  45.389  33.437  1.00 93.38           O  \nATOM   7051  N   LYS A 913      -1.125  44.827  30.140  1.00 89.81           N  \nATOM   7052  CA  LYS A 913       0.035  44.432  29.329  1.00 89.81           C  \nATOM   7053  C   LYS A 913       1.144  43.854  30.228  1.00 89.81           C  \nATOM   7054  CB  LYS A 913       0.469  45.659  28.513  1.00 89.81           C  \nATOM   7055  O   LYS A 913       1.561  44.541  31.162  1.00 89.81           O  \nATOM   7056  CG  LYS A 913       1.513  45.383  27.420  1.00 89.81           C  \nATOM   7057  CD  LYS A 913       1.595  46.625  26.517  1.00 89.81           C  \nATOM   7058  CE  LYS A 913       2.679  46.537  25.439  1.00 89.81           C  \nATOM   7059  NZ  LYS A 913       2.801  47.835  24.726  1.00 89.81           N  \nATOM   7060  N   PRO A 914       1.652  42.630  29.979  1.00 93.00           N  \nATOM   7061  CA  PRO A 914       2.780  42.090  30.738  1.00 93.00           C  \nATOM   7062  C   PRO A 914       4.004  43.010  30.649  1.00 93.00           C  \nATOM   7063  CB  PRO A 914       3.049  40.696  30.159  1.00 93.00           C  \nATOM   7064  O   PRO A 914       4.311  43.535  29.574  1.00 93.00           O  \nATOM   7065  CG  PRO A 914       1.682  40.283  29.616  1.00 93.00           C  \nATOM   7066  CD  PRO A 914       1.121  41.604  29.090  1.00 93.00           C  \nATOM   7067  N   TYR A 915       4.699  43.197  31.776  1.00 92.19           N  \nATOM   7068  CA  TYR A 915       5.898  44.038  31.903  1.00 92.19           C  \nATOM   7069  C   TYR A 915       5.738  45.416  31.234  1.00 92.19           C  \nATOM   7070  CB  TYR A 915       7.136  43.269  31.398  1.00 92.19           C  \nATOM   7071  O   TYR A 915       6.572  45.800  30.411  1.00 92.19           O  \nATOM   7072  CG  TYR A 915       7.383  41.940  32.079  1.00 92.19           C  \nATOM   7073  CD1 TYR A 915       8.088  41.903  33.297  1.00 92.19           C  \nATOM   7074  CD2 TYR A 915       6.912  40.744  31.498  1.00 92.19           C  \nATOM   7075  CE1 TYR A 915       8.316  40.675  33.944  1.00 92.19           C  \nATOM   7076  CE2 TYR A 915       7.122  39.515  32.152  1.00 92.19           C  \nATOM   7077  OH  TYR A 915       8.015  38.304  34.022  1.00 92.19           O  \nATOM   7078  CZ  TYR A 915       7.823  39.481  33.376  1.00 92.19           C  \nATOM   7079  N   ASP A 916       4.625  46.122  31.466  1.00 88.06           N  \nATOM   7080  CA  ASP A 916       4.356  47.368  30.737  1.00 88.06           C  \nATOM   7081  C   ASP A 916       5.403  48.462  31.010  1.00 88.06           C  \nATOM   7082  CB  ASP A 916       2.923  47.878  30.954  1.00 88.06           C  \nATOM   7083  O   ASP A 916       6.078  48.462  32.038  1.00 88.06           O  \nATOM   7084  CG  ASP A 916       2.415  48.699  29.756  1.00 88.06           C  \nATOM   7085  OD1 ASP A 916       3.144  48.789  28.732  1.00 88.06           O  \nATOM   7086  OD2 ASP A 916       1.259  49.160  29.822  1.00 88.06           O  \nATOM   7087  N   GLY A 917       5.604  49.353  30.039  1.00 84.38           N  \nATOM   7088  CA  GLY A 917       6.701  50.330  30.019  1.00 84.38           C  \nATOM   7089  C   GLY A 917       8.096  49.746  29.731  1.00 84.38           C  \nATOM   7090  O   GLY A 917       8.936  50.451  29.183  1.00 84.38           O  \nATOM   7091  N   ILE A 918       8.343  48.464  30.020  1.00 86.56           N  \nATOM   7092  CA  ILE A 918       9.667  47.831  29.868  1.00 86.56           C  \nATOM   7093  C   ILE A 918       9.929  47.431  28.398  1.00 86.56           C  \nATOM   7094  CB  ILE A 918       9.812  46.632  30.836  1.00 86.56           C  \nATOM   7095  O   ILE A 918       9.081  46.755  27.798  1.00 86.56           O  \nATOM   7096  CG1 ILE A 918       9.460  47.067  32.282  1.00 86.56           C  \nATOM   7097  CG2 ILE A 918      11.225  46.036  30.756  1.00 86.56           C  \nATOM   7098  CD1 ILE A 918       9.691  46.026  33.381  1.00 86.56           C  \nATOM   7099  N   PRO A 919      11.078  47.784  27.788  1.00 80.94           N  \nATOM   7100  CA  PRO A 919      11.454  47.324  26.449  1.00 80.94           C  \nATOM   7101  C   PRO A 919      11.637  45.803  26.364  1.00 80.94           C  \nATOM   7102  CB  PRO A 919      12.751  48.065  26.102  1.00 80.94           C  \nATOM   7103  O   PRO A 919      12.127  45.162  27.290  1.00 80.94           O  \nATOM   7104  CG  PRO A 919      12.646  49.335  26.941  1.00 80.94           C  \nATOM   7105  CD  PRO A 919      12.016  48.808  28.227  1.00 80.94           C  \nATOM   7106  N   ALA A 920      11.288  45.201  25.222  1.00 77.88           N  \nATOM   7107  CA  ALA A 920      11.413  43.750  25.033  1.00 77.88           C  \nATOM   7108  C   ALA A 920      12.871  43.245  25.128  1.00 77.88           C  \nATOM   7109  CB  ALA A 920      10.770  43.377  23.693  1.00 77.88           C  \nATOM   7110  O   ALA A 920      13.100  42.103  25.514  1.00 77.88           O  \nATOM   7111  N   SER A 921      13.846  44.107  24.828  1.00 82.50           N  \nATOM   7112  CA  SER A 921      15.288  43.855  24.942  1.00 82.50           C  \nATOM   7113  C   SER A 921      15.803  43.709  26.378  1.00 82.50           C  \nATOM   7114  CB  SER A 921      16.032  45.014  24.265  1.00 82.50           C  \nATOM   7115  O   SER A 921      16.871  43.141  26.568  1.00 82.50           O  \nATOM   7116  OG  SER A 921      15.474  46.262  24.652  1.00 82.50           O  \nATOM   7117  N   GLU A 922      15.075  44.207  27.381  1.00 88.25           N  \nATOM   7118  CA  GLU A 922      15.512  44.204  28.790  1.00 88.25           C  \nATOM   7119  C   GLU A 922      14.928  43.032  29.598  1.00 88.25           C  \nATOM   7120  CB  GLU A 922      15.147  45.552  29.429  1.00 88.25           C  \nATOM   7121  O   GLU A 922      15.364  42.763  30.718  1.00 88.25           O  \nATOM   7122  CG  GLU A 922      15.984  46.698  28.839  1.00 88.25           C  \nATOM   7123  CD  GLU A 922      15.535  48.074  29.345  1.00 88.25           C  \nATOM   7124  OE1 GLU A 922      15.579  49.015  28.524  1.00 88.25           O  \nATOM   7125  OE2 GLU A 922      15.133  48.172  30.526  1.00 88.25           O  \nATOM   7126  N   ILE A 923      13.956  42.309  29.027  1.00 89.62           N  \nATOM   7127  CA  ILE A 923      13.192  41.260  29.716  1.00 89.62           C  \nATOM   7128  C   ILE A 923      14.099  40.132  30.230  1.00 89.62           C  \nATOM   7129  CB  ILE A 923      12.066  40.735  28.792  1.00 89.62           C  \nATOM   7130  O   ILE A 923      13.923  39.703  31.367  1.00 89.62           O  \nATOM   7131  CG1 ILE A 923      11.058  41.840  28.394  1.00 89.62           C  \nATOM   7132  CG2 ILE A 923      11.311  39.540  29.402  1.00 89.62           C  \nATOM   7133  CD1 ILE A 923      10.214  42.436  29.532  1.00 89.62           C  \nATOM   7134  N   SER A 924      15.101  39.686  29.462  1.00 89.38           N  \nATOM   7135  CA  SER A 924      16.067  38.669  29.917  1.00 89.38           C  \nATOM   7136  C   SER A 924      16.780  39.099  31.202  1.00 89.38           C  \nATOM   7137  CB  SER A 924      17.106  38.367  28.829  1.00 89.38           C  \nATOM   7138  O   SER A 924      16.693  38.406  32.212  1.00 89.38           O  \nATOM   7139  OG  SER A 924      17.571  39.570  28.243  1.00 89.38           O  \nATOM   7140  N   SER A 925      17.379  40.292  31.205  1.00 89.62           N  \nATOM   7141  CA  SER A 925      18.129  40.845  32.343  1.00 89.62           C  \nATOM   7142  C   SER A 925      17.274  41.170  33.574  1.00 89.62           C  \nATOM   7143  CB  SER A 925      18.849  42.120  31.903  1.00 89.62           C  \nATOM   7144  O   SER A 925      17.817  41.458  34.639  1.00 89.62           O  \nATOM   7145  OG  SER A 925      19.662  41.858  30.778  1.00 89.62           O  \nATOM   7146  N   ILE A 926      15.948  41.166  33.446  1.00 91.56           N  \nATOM   7147  CA  ILE A 926      14.985  41.305  34.550  1.00 91.56           C  \nATOM   7148  C   ILE A 926      14.616  39.914  35.085  1.00 91.56           C  \nATOM   7149  CB  ILE A 926      13.790  42.138  34.033  1.00 91.56           C  \nATOM   7150  O   ILE A 926      14.674  39.665  36.290  1.00 91.56           O  \nATOM   7151  CG1 ILE A 926      14.259  43.604  33.873  1.00 91.56           C  \nATOM   7152  CG2 ILE A 926      12.544  42.075  34.933  1.00 91.56           C  \nATOM   7153  CD1 ILE A 926      13.325  44.437  32.998  1.00 91.56           C  \nATOM   7154  N   LEU A 927      14.335  38.963  34.191  1.00 93.31           N  \nATOM   7155  CA  LEU A 927      14.027  37.580  34.553  1.00 93.31           C  \nATOM   7156  C   LEU A 927      15.205  36.855  35.226  1.00 93.31           C  \nATOM   7157  CB  LEU A 927      13.578  36.829  33.292  1.00 93.31           C  \nATOM   7158  O   LEU A 927      14.974  36.094  36.172  1.00 93.31           O  \nATOM   7159  CG  LEU A 927      12.220  37.274  32.724  1.00 93.31           C  \nATOM   7160  CD1 LEU A 927      11.919  36.443  31.476  1.00 93.31           C  \nATOM   7161  CD2 LEU A 927      11.098  37.127  33.750  1.00 93.31           C  \nATOM   7162  N   GLU A 928      16.438  37.128  34.788  1.00 90.81           N  \nATOM   7163  CA  GLU A 928      17.696  36.633  35.374  1.00 90.81           C  \nATOM   7164  C   GLU A 928      17.907  37.107  36.820  1.00 90.81           C  \nATOM   7165  CB  GLU A 928      18.878  37.121  34.516  1.00 90.81           C  \nATOM   7166  O   GLU A 928      18.400  36.346  37.650  1.00 90.81           O  \nATOM   7167  CG  GLU A 928      19.025  36.330  33.206  1.00 90.81           C  \nATOM   7168  CD  GLU A 928      20.008  36.965  32.205  1.00 90.81           C  \nATOM   7169  OE1 GLU A 928      20.238  36.322  31.157  1.00 90.81           O  \nATOM   7170  OE2 GLU A 928      20.486  38.099  32.449  1.00 90.81           O  \nATOM   7171  N   LYS A 929      17.470  38.328  37.163  1.00 90.88           N  \nATOM   7172  CA  LYS A 929      17.501  38.855  38.544  1.00 90.88           C  \nATOM   7173  C   LYS A 929      16.454  38.213  39.462  1.00 90.88           C  \nATOM   7174  CB  LYS A 929      17.288  40.375  38.532  1.00 90.88           C  \nATOM   7175  O   LYS A 929      16.419  38.515  40.651  1.00 90.88           O  \nATOM   7176  CG  LYS A 929      18.422  41.159  37.860  1.00 90.88           C  \nATOM   7177  CD  LYS A 929      17.911  42.580  37.613  1.00 90.88           C  \nATOM   7178  CE  LYS A 929      18.865  43.401  36.750  1.00 90.88           C  \nATOM   7179  NZ  LYS A 929      18.102  44.510  36.135  1.00 90.88           N  \nATOM   7180  N   GLY A 930      15.579  37.363  38.921  1.00 89.56           N  \nATOM   7181  CA  GLY A 930      14.452  36.777  39.647  1.00 89.56           C  \nATOM   7182  C   GLY A 930      13.205  37.666  39.709  1.00 89.56           C  \nATOM   7183  O   GLY A 930      12.230  37.278  40.347  1.00 89.56           O  \nATOM   7184  N   GLU A 931      13.183  38.822  39.036  1.00 91.56           N  \nATOM   7185  CA  GLU A 931      11.993  39.681  38.977  1.00 91.56           C  \nATOM   7186  C   GLU A 931      10.872  39.009  38.159  1.00 91.56           C  \nATOM   7187  CB  GLU A 931      12.337  41.066  38.407  1.00 91.56           C  \nATOM   7188  O   GLU A 931      11.125  38.295  37.182  1.00 91.56           O  \nATOM   7189  CG  GLU A 931      13.304  41.886  39.279  1.00 91.56           C  \nATOM   7190  CD  GLU A 931      13.640  43.244  38.635  1.00 91.56           C  \nATOM   7191  OE1 GLU A 931      14.849  43.541  38.460  1.00 91.56           O  \nATOM   7192  OE2 GLU A 931      12.681  43.978  38.307  1.00 91.56           O  \nATOM   7193  N   ARG A 932       9.613  39.204  38.569  1.00 94.19           N  \nATOM   7194  CA  ARG A 932       8.411  38.566  37.997  1.00 94.19           C  \nATOM   7195  C   ARG A 932       7.246  39.556  37.945  1.00 94.19           C  \nATOM   7196  CB  ARG A 932       8.032  37.315  38.823  1.00 94.19           C  \nATOM   7197  O   ARG A 932       7.308  40.619  38.558  1.00 94.19           O  \nATOM   7198  CG  ARG A 932       9.074  36.180  38.805  1.00 94.19           C  \nATOM   7199  CD  ARG A 932       9.320  35.629  37.393  1.00 94.19           C  \nATOM   7200  NE  ARG A 932      10.300  34.529  37.389  1.00 94.19           N  \nATOM   7201  NH1 ARG A 932      12.256  35.726  37.061  1.00 94.19           N  \nATOM   7202  NH2 ARG A 932      12.267  33.500  37.071  1.00 94.19           N  \nATOM   7203  CZ  ARG A 932      11.600  34.607  37.184  1.00 94.19           C  \nATOM   7204  N   LEU A 933       6.188  39.212  37.209  1.00 95.88           N  \nATOM   7205  CA  LEU A 933       4.964  40.017  37.168  1.00 95.88           C  \nATOM   7206  C   LEU A 933       4.337  40.112  38.577  1.00 95.88           C  \nATOM   7207  CB  LEU A 933       3.964  39.408  36.170  1.00 95.88           C  \nATOM   7208  O   LEU A 933       4.279  39.098  39.274  1.00 95.88           O  \nATOM   7209  CG  LEU A 933       4.401  39.445  34.698  1.00 95.88           C  \nATOM   7210  CD1 LEU A 933       3.485  38.581  33.836  1.00 95.88           C  \nATOM   7211  CD2 LEU A 933       4.368  40.866  34.135  1.00 95.88           C  \nATOM   7212  N   PRO A 934       3.861  41.295  39.009  1.00 94.94           N  \nATOM   7213  CA  PRO A 934       3.355  41.504  40.365  1.00 94.94           C  \nATOM   7214  C   PRO A 934       2.014  40.796  40.597  1.00 94.94           C  \nATOM   7215  CB  PRO A 934       3.222  43.023  40.510  1.00 94.94           C  \nATOM   7216  O   PRO A 934       1.239  40.605  39.660  1.00 94.94           O  \nATOM   7217  CG  PRO A 934       2.928  43.481  39.081  1.00 94.94           C  \nATOM   7218  CD  PRO A 934       3.783  42.531  38.244  1.00 94.94           C  \nATOM   7219  N   GLN A 935       1.701  40.471  41.854  1.00 96.38           N  \nATOM   7220  CA  GLN A 935       0.414  39.882  42.240  1.00 96.38           C  \nATOM   7221  C   GLN A 935      -0.770  40.756  41.771  1.00 96.38           C  \nATOM   7222  CB  GLN A 935       0.396  39.667  43.763  1.00 96.38           C  \nATOM   7223  O   GLN A 935      -0.854  41.920  42.173  1.00 96.38           O  \nATOM   7224  CG  GLN A 935      -0.932  39.078  44.277  1.00 96.38           C  \nATOM   7225  CD  GLN A 935      -0.874  38.641  45.741  1.00 96.38           C  \nATOM   7226  NE2 GLN A 935      -1.985  38.291  46.346  1.00 96.38           N  \nATOM   7227  OE1 GLN A 935       0.161  38.593  46.386  1.00 96.38           O  \nATOM   7228  N   PRO A 936      -1.705  40.227  40.954  1.00 95.44           N  \nATOM   7229  CA  PRO A 936      -2.891  40.973  40.541  1.00 95.44           C  \nATOM   7230  C   PRO A 936      -3.770  41.344  41.747  1.00 95.44           C  \nATOM   7231  CB  PRO A 936      -3.637  40.069  39.555  1.00 95.44           C  \nATOM   7232  O   PRO A 936      -3.988  40.479  42.599  1.00 95.44           O  \nATOM   7233  CG  PRO A 936      -2.520  39.195  38.994  1.00 95.44           C  \nATOM   7234  CD  PRO A 936      -1.629  38.977  40.212  1.00 95.44           C  \nATOM   7235  N   PRO A 937      -4.340  42.566  41.826  1.00 91.56           N  \nATOM   7236  CA  PRO A 937      -5.051  43.036  43.023  1.00 91.56           C  \nATOM   7237  C   PRO A 937      -6.252  42.190  43.467  1.00 91.56           C  \nATOM   7238  CB  PRO A 937      -5.502  44.463  42.695  1.00 91.56           C  \nATOM   7239  O   PRO A 937      -6.628  42.245  44.633  1.00 91.56           O  \nATOM   7240  CG  PRO A 937      -4.452  44.941  41.698  1.00 91.56           C  \nATOM   7241  CD  PRO A 937      -4.142  43.676  40.901  1.00 91.56           C  \nATOM   7242  N   ILE A 938      -6.855  41.419  42.555  1.00 93.31           N  \nATOM   7243  CA  ILE A 938      -7.977  40.521  42.866  1.00 93.31           C  \nATOM   7244  C   ILE A 938      -7.531  39.147  43.389  1.00 93.31           C  \nATOM   7245  CB  ILE A 938      -8.925  40.365  41.654  1.00 93.31           C  \nATOM   7246  O   ILE A 938      -8.357  38.414  43.912  1.00 93.31           O  \nATOM   7247  CG1 ILE A 938      -8.245  39.641  40.469  1.00 93.31           C  \nATOM   7248  CG2 ILE A 938      -9.487  41.736  41.232  1.00 93.31           C  \nATOM   7249  CD1 ILE A 938      -9.220  39.250  39.354  1.00 93.31           C  \nATOM   7250  N   CYS A 939      -6.267  38.748  43.230  1.00 94.00           N  \nATOM   7251  CA  CYS A 939      -5.812  37.393  43.562  1.00 94.00           C  \nATOM   7252  C   CYS A 939      -5.458  37.243  45.044  1.00 94.00           C  \nATOM   7253  CB  CYS A 939      -4.589  37.046  42.702  1.00 94.00           C  \nATOM   7254  O   CYS A 939      -4.688  38.049  45.573  1.00 94.00           O  \nATOM   7255  SG  CYS A 939      -5.102  36.713  40.998  1.00 94.00           S  \nATOM   7256  N   THR A 940      -5.881  36.146  45.685  1.00 94.69           N  \nATOM   7257  CA  THR A 940      -5.197  35.696  46.908  1.00 94.69           C  \nATOM   7258  C   THR A 940      -3.799  35.165  46.594  1.00 94.69           C  \nATOM   7259  CB  THR A 940      -5.966  34.651  47.735  1.00 94.69           C  \nATOM   7260  O   THR A 940      -3.443  34.878  45.444  1.00 94.69           O  \nATOM   7261  CG2 THR A 940      -7.368  35.127  48.093  1.00 94.69           C  \nATOM   7262  OG1 THR A 940      -6.001  33.389  47.106  1.00 94.69           O  \nATOM   7263  N   ILE A 941      -2.991  35.011  47.646  1.00 93.25           N  \nATOM   7264  CA  ILE A 941      -1.639  34.469  47.524  1.00 93.25           C  \nATOM   7265  C   ILE A 941      -1.632  33.031  46.979  1.00 93.25           C  \nATOM   7266  CB  ILE A 941      -0.883  34.631  48.860  1.00 93.25           C  \nATOM   7267  O   ILE A 941      -0.687  32.669  46.291  1.00 93.25           O  \nATOM   7268  CG1 ILE A 941       0.629  34.403  48.650  1.00 93.25           C  \nATOM   7269  CG2 ILE A 941      -1.456  33.728  49.970  1.00 93.25           C  \nATOM   7270  CD1 ILE A 941       1.490  34.970  49.784  1.00 93.25           C  \nATOM   7271  N   ASP A 942      -2.687  32.233  47.186  1.00 94.19           N  \nATOM   7272  CA  ASP A 942      -2.796  30.878  46.626  1.00 94.19           C  \nATOM   7273  C   ASP A 942      -2.743  30.881  45.089  1.00 94.19           C  \nATOM   7274  CB  ASP A 942      -4.115  30.224  47.061  1.00 94.19           C  \nATOM   7275  O   ASP A 942      -2.013  30.092  44.489  1.00 94.19           O  \nATOM   7276  CG  ASP A 942      -4.390  30.322  48.557  1.00 94.19           C  \nATOM   7277  OD1 ASP A 942      -4.108  29.331  49.268  1.00 94.19           O  \nATOM   7278  OD2 ASP A 942      -4.922  31.387  48.954  1.00 94.19           O  \nATOM   7279  N   VAL A 943      -3.486  31.794  44.448  1.00 95.31           N  \nATOM   7280  CA  VAL A 943      -3.523  31.935  42.981  1.00 95.31           C  \nATOM   7281  C   VAL A 943      -2.180  32.456  42.468  1.00 95.31           C  \nATOM   7282  CB  VAL A 943      -4.663  32.877  42.535  1.00 95.31           C  \nATOM   7283  O   VAL A 943      -1.627  31.930  41.500  1.00 95.31           O  \nATOM   7284  CG1 VAL A 943      -4.805  32.898  41.007  1.00 95.31           C  \nATOM   7285  CG2 VAL A 943      -6.020  32.463  43.115  1.00 95.31           C  \nATOM   7286  N   TYR A 944      -1.612  33.452  43.154  1.00 97.19           N  \nATOM   7287  CA  TYR A 944      -0.316  34.025  42.793  1.00 97.19           C  \nATOM   7288  C   TYR A 944       0.838  33.021  42.945  1.00 97.19           C  \nATOM   7289  CB  TYR A 944      -0.085  35.286  43.628  1.00 97.19           C  \nATOM   7290  O   TYR A 944       1.712  32.955  42.086  1.00 97.19           O  \nATOM   7291  CG  TYR A 944       1.208  36.007  43.302  1.00 97.19           C  \nATOM   7292  CD1 TYR A 944       2.186  36.185  44.299  1.00 97.19           C  \nATOM   7293  CD2 TYR A 944       1.441  36.485  41.996  1.00 97.19           C  \nATOM   7294  CE1 TYR A 944       3.394  36.843  43.996  1.00 97.19           C  \nATOM   7295  CE2 TYR A 944       2.645  37.148  41.691  1.00 97.19           C  \nATOM   7296  OH  TYR A 944       4.778  37.978  42.399  1.00 97.19           O  \nATOM   7297  CZ  TYR A 944       3.622  37.328  42.690  1.00 97.19           C  \nATOM   7298  N   MET A 945       0.811  32.158  43.963  1.00 96.19           N  \nATOM   7299  CA  MET A 945       1.809  31.097  44.141  1.00 96.19           C  \nATOM   7300  C   MET A 945       1.768  30.051  43.014  1.00 96.19           C  \nATOM   7301  CB  MET A 945       1.635  30.443  45.521  1.00 96.19           C  \nATOM   7302  O   MET A 945       2.798  29.442  42.725  1.00 96.19           O  \nATOM   7303  CG  MET A 945       2.138  31.356  46.649  1.00 96.19           C  \nATOM   7304  SD  MET A 945       3.936  31.583  46.731  1.00 96.19           S  \nATOM   7305  CE  MET A 945       4.428  30.051  47.565  1.00 96.19           C  \nATOM   7306  N   ILE A 946       0.632  29.864  42.327  1.00 96.50           N  \nATOM   7307  CA  ILE A 946       0.583  29.053  41.098  1.00 96.50           C  \nATOM   7308  C   ILE A 946       1.237  29.796  39.924  1.00 96.50           C  \nATOM   7309  CB  ILE A 946      -0.852  28.577  40.773  1.00 96.50           C  \nATOM   7310  O   ILE A 946       2.015  29.183  39.195  1.00 96.50           O  \nATOM   7311  CG1 ILE A 946      -1.381  27.676  41.912  1.00 96.50           C  \nATOM   7312  CG2 ILE A 946      -0.859  27.801  39.442  1.00 96.50           C  \nATOM   7313  CD1 ILE A 946      -2.841  27.244  41.741  1.00 96.50           C  \nATOM   7314  N   MET A 947       1.003  31.105  39.766  1.00 97.25           N  \nATOM   7315  CA  MET A 947       1.701  31.915  38.752  1.00 97.25           C  \nATOM   7316  C   MET A 947       3.224  31.871  38.957  1.00 97.25           C  \nATOM   7317  CB  MET A 947       1.234  33.379  38.784  1.00 97.25           C  \nATOM   7318  O   MET A 947       3.965  31.571  38.026  1.00 97.25           O  \nATOM   7319  CG  MET A 947      -0.256  33.607  38.522  1.00 97.25           C  \nATOM   7320  SD  MET A 947      -0.750  35.313  38.900  1.00 97.25           S  \nATOM   7321  CE  MET A 947      -2.481  35.257  38.389  1.00 97.25           C  \nATOM   7322  N   VAL A 948       3.694  32.064  40.195  1.00 96.50           N  \nATOM   7323  CA  VAL A 948       5.123  32.005  40.552  1.00 96.50           C  \nATOM   7324  C   VAL A 948       5.725  30.625  40.263  1.00 96.50           C  \nATOM   7325  CB  VAL A 948       5.329  32.428  42.022  1.00 96.50           C  \nATOM   7326  O   VAL A 948       6.814  30.555  39.696  1.00 96.50           O  \nATOM   7327  CG1 VAL A 948       6.773  32.236  42.503  1.00 96.50           C  \nATOM   7328  CG2 VAL A 948       4.989  33.914  42.211  1.00 96.50           C  \nATOM   7329  N   LYS A 949       5.007  29.527  40.550  1.00 97.06           N  \nATOM   7330  CA  LYS A 949       5.417  28.163  40.158  1.00 97.06           C  \nATOM   7331  C   LYS A 949       5.567  27.989  38.641  1.00 97.06           C  \nATOM   7332  CB  LYS A 949       4.402  27.140  40.682  1.00 97.06           C  \nATOM   7333  O   LYS A 949       6.451  27.258  38.206  1.00 97.06           O  \nATOM   7334  CG  LYS A 949       4.608  26.759  42.151  1.00 97.06           C  \nATOM   7335  CD  LYS A 949       3.479  25.803  42.553  1.00 97.06           C  \nATOM   7336  CE  LYS A 949       3.679  25.277  43.974  1.00 97.06           C  \nATOM   7337  NZ  LYS A 949       2.700  24.203  44.272  1.00 97.06           N  \nATOM   7338  N   CYS A 950       4.745  28.662  37.835  1.00 97.88           N  \nATOM   7339  CA  CYS A 950       4.881  28.646  36.374  1.00 97.88           C  \nATOM   7340  C   CYS A 950       6.130  29.407  35.886  1.00 97.88           C  \nATOM   7341  CB  CYS A 950       3.611  29.218  35.729  1.00 97.88           C  \nATOM   7342  O   CYS A 950       6.604  29.147  34.783  1.00 97.88           O  \nATOM   7343  SG  CYS A 950       2.139  28.249  36.177  1.00 97.88           S  \nATOM   7344  N   TRP A 951       6.682  30.317  36.698  1.00 97.25           N  \nATOM   7345  CA  TRP A 951       7.839  31.157  36.359  1.00 97.25           C  \nATOM   7346  C   TRP A 951       9.134  30.790  37.109  1.00 97.25           C  \nATOM   7347  CB  TRP A 951       7.486  32.638  36.521  1.00 97.25           C  \nATOM   7348  O   TRP A 951      10.037  31.629  37.259  1.00 97.25           O  \nATOM   7349  CG  TRP A 951       6.232  33.128  35.868  1.00 97.25           C  \nATOM   7350  CD1 TRP A 951       5.808  32.809  34.624  1.00 97.25           C  \nATOM   7351  CD2 TRP A 951       5.252  34.075  36.395  1.00 97.25           C  \nATOM   7352  CE2 TRP A 951       4.253  34.289  35.399  1.00 97.25           C  \nATOM   7353  CE3 TRP A 951       5.123  34.790  37.608  1.00 97.25           C  \nATOM   7354  NE1 TRP A 951       4.639  33.484  34.344  1.00 97.25           N  \nATOM   7355  CH2 TRP A 951       3.081  35.866  36.820  1.00 97.25           C  \nATOM   7356  CZ2 TRP A 951       3.182  35.172  35.603  1.00 97.25           C  \nATOM   7357  CZ3 TRP A 951       4.052  35.679  37.819  1.00 97.25           C  \nATOM   7358  N   MET A 952       9.244  29.546  37.586  1.00 95.56           N  \nATOM   7359  CA  MET A 952      10.509  28.992  38.083  1.00 95.56           C  \nATOM   7360  C   MET A 952      11.573  29.043  36.977  1.00 95.56           C  \nATOM   7361  CB  MET A 952      10.310  27.551  38.584  1.00 95.56           C  \nATOM   7362  O   MET A 952      11.266  28.800  35.811  1.00 95.56           O  \nATOM   7363  CG  MET A 952       9.442  27.489  39.848  1.00 95.56           C  \nATOM   7364  SD  MET A 952      10.156  28.263  41.330  1.00 95.56           S  \nATOM   7365  CE  MET A 952      11.464  27.068  41.720  1.00 95.56           C  \nATOM   7366  N   ILE A 953      12.818  29.394  37.329  1.00 91.75           N  \nATOM   7367  CA  ILE A 953      13.923  29.463  36.352  1.00 91.75           C  \nATOM   7368  C   ILE A 953      14.176  28.069  35.777  1.00 91.75           C  \nATOM   7369  CB  ILE A 953      15.201  30.089  36.966  1.00 91.75           C  \nATOM   7370  O   ILE A 953      14.065  27.883  34.569  1.00 91.75           O  \nATOM   7371  CG1 ILE A 953      14.923  31.563  37.340  1.00 91.75           C  \nATOM   7372  CG2 ILE A 953      16.388  29.993  35.987  1.00 91.75           C  \nATOM   7373  CD1 ILE A 953      16.089  32.300  38.010  1.00 91.75           C  \nATOM   7374  N   ASP A 954      14.424  27.096  36.654  1.00 92.56           N  \nATOM   7375  CA  ASP A 954      14.432  25.681  36.295  1.00 92.56           C  \nATOM   7376  C   ASP A 954      13.081  25.269  35.685  1.00 92.56           C  \nATOM   7377  CB  ASP A 954      14.781  24.850  37.537  1.00 92.56           C  \nATOM   7378  O   ASP A 954      12.017  25.573  36.232  1.00 92.56           O  \nATOM   7379  CG  ASP A 954      14.579  23.355  37.293  1.00 92.56           C  \nATOM   7380  OD1 ASP A 954      14.833  22.912  36.154  1.00 92.56           O  \nATOM   7381  OD2 ASP A 954      14.073  22.697  38.225  1.00 92.56           O  \nATOM   7382  N   ALA A 955      13.149  24.589  34.542  1.00 92.94           N  \nATOM   7383  CA  ALA A 955      11.998  24.107  33.799  1.00 92.94           C  \nATOM   7384  C   ALA A 955      11.376  22.856  34.439  1.00 92.94           C  \nATOM   7385  CB  ALA A 955      12.435  23.867  32.349  1.00 92.94           C  \nATOM   7386  O   ALA A 955      10.151  22.737  34.429  1.00 92.94           O  \nATOM   7387  N   ASP A 956      12.171  21.968  35.044  1.00 92.12           N  \nATOM   7388  CA  ASP A 956      11.658  20.743  35.681  1.00 92.12           C  \nATOM   7389  C   ASP A 956      10.929  21.047  37.007  1.00 92.12           C  \nATOM   7390  CB  ASP A 956      12.797  19.718  35.854  1.00 92.12           C  \nATOM   7391  O   ASP A 956      10.013  20.324  37.398  1.00 92.12           O  \nATOM   7392  CG  ASP A 956      13.190  18.983  34.558  1.00 92.12           C  \nATOM   7393  OD1 ASP A 956      12.354  18.913  33.625  1.00 92.12           O  \nATOM   7394  OD2 ASP A 956      14.304  18.411  34.528  1.00 92.12           O  \nATOM   7395  N   SER A 957      11.241  22.178  37.652  1.00 95.44           N  \nATOM   7396  CA  SER A 957      10.507  22.722  38.808  1.00 95.44           C  \nATOM   7397  C   SER A 957       9.132  23.338  38.480  1.00 95.44           C  \nATOM   7398  CB  SER A 957      11.359  23.782  39.517  1.00 95.44           C  \nATOM   7399  O   SER A 957       8.433  23.775  39.402  1.00 95.44           O  \nATOM   7400  OG  SER A 957      12.468  23.209  40.176  1.00 95.44           O  \nATOM   7401  N   ARG A 958       8.725  23.428  37.203  1.00 97.38           N  \nATOM   7402  CA  ARG A 958       7.420  23.997  36.797  1.00 97.38           C  \nATOM   7403  C   ARG A 958       6.322  22.913  36.784  1.00 97.38           C  \nATOM   7404  CB  ARG A 958       7.517  24.713  35.436  1.00 97.38           C  \nATOM   7405  O   ARG A 958       6.574  21.801  36.323  1.00 97.38           O  \nATOM   7406  CG  ARG A 958       8.562  25.838  35.403  1.00 97.38           C  \nATOM   7407  CD  ARG A 958       8.686  26.436  33.997  1.00 97.38           C  \nATOM   7408  NE  ARG A 958       9.936  27.206  33.848  1.00 97.38           N  \nATOM   7409  NH1 ARG A 958      10.003  27.248  31.560  1.00 97.38           N  \nATOM   7410  NH2 ARG A 958      11.753  27.973  32.708  1.00 97.38           N  \nATOM   7411  CZ  ARG A 958      10.554  27.476  32.713  1.00 97.38           C  \nATOM   7412  N   PRO A 959       5.092  23.208  37.246  1.00 97.19           N  \nATOM   7413  CA  PRO A 959       4.009  22.225  37.318  1.00 97.19           C  \nATOM   7414  C   PRO A 959       3.498  21.847  35.924  1.00 97.19           C  \nATOM   7415  CB  PRO A 959       2.908  22.903  38.139  1.00 97.19           C  \nATOM   7416  O   PRO A 959       3.340  22.717  35.067  1.00 97.19           O  \nATOM   7417  CG  PRO A 959       3.105  24.386  37.813  1.00 97.19           C  \nATOM   7418  CD  PRO A 959       4.623  24.509  37.689  1.00 97.19           C  \nATOM   7419  N   LYS A 960       3.158  20.573  35.707  1.00 96.38           N  \nATOM   7420  CA  LYS A 960       2.579  20.126  34.427  1.00 96.38           C  \nATOM   7421  C   LYS A 960       1.149  20.627  34.233  1.00 96.38           C  \nATOM   7422  CB  LYS A 960       2.650  18.601  34.323  1.00 96.38           C  \nATOM   7423  O   LYS A 960       0.443  20.907  35.209  1.00 96.38           O  \nATOM   7424  CG  LYS A 960       4.113  18.148  34.326  1.00 96.38           C  \nATOM   7425  CD  LYS A 960       4.215  16.684  33.909  1.00 96.38           C  \nATOM   7426  CE  LYS A 960       5.683  16.373  33.620  1.00 96.38           C  \nATOM   7427  NZ  LYS A 960       5.796  15.636  32.342  1.00 96.38           N  \nATOM   7428  N   PHE A 961       0.652  20.648  32.992  1.00 97.88           N  \nATOM   7429  CA  PHE A 961      -0.728  21.082  32.735  1.00 97.88           C  \nATOM   7430  C   PHE A 961      -1.764  20.227  33.476  1.00 97.88           C  \nATOM   7431  CB  PHE A 961      -1.000  21.154  31.230  1.00 97.88           C  \nATOM   7432  O   PHE A 961      -2.753  20.763  33.981  1.00 97.88           O  \nATOM   7433  CG  PHE A 961      -0.329  22.344  30.579  1.00 97.88           C  \nATOM   7434  CD1 PHE A 961      -0.793  23.638  30.878  1.00 97.88           C  \nATOM   7435  CD2 PHE A 961       0.770  22.174  29.716  1.00 97.88           C  \nATOM   7436  CE1 PHE A 961      -0.161  24.760  30.321  1.00 97.88           C  \nATOM   7437  CE2 PHE A 961       1.402  23.300  29.156  1.00 97.88           C  \nATOM   7438  CZ  PHE A 961       0.936  24.593  29.460  1.00 97.88           C  \nATOM   7439  N   ARG A 962      -1.486  18.934  33.676  1.00 96.62           N  \nATOM   7440  CA  ARG A 962      -2.310  18.031  34.495  1.00 96.62           C  \nATOM   7441  C   ARG A 962      -2.474  18.499  35.946  1.00 96.62           C  \nATOM   7442  CB  ARG A 962      -1.701  16.624  34.418  1.00 96.62           C  \nATOM   7443  O   ARG A 962      -3.556  18.359  36.514  1.00 96.62           O  \nATOM   7444  CG  ARG A 962      -2.628  15.572  35.038  1.00 96.62           C  \nATOM   7445  CD  ARG A 962      -2.067  14.171  34.792  1.00 96.62           C  \nATOM   7446  NE  ARG A 962      -2.884  13.142  35.464  1.00 96.62           N  \nATOM   7447  NH1 ARG A 962      -1.741  11.318  34.672  1.00 96.62           N  \nATOM   7448  NH2 ARG A 962      -3.466  11.019  36.055  1.00 96.62           N  \nATOM   7449  CZ  ARG A 962      -2.694  11.837  35.394  1.00 96.62           C  \nATOM   7450  N   GLU A 963      -1.427  19.060  36.545  1.00 97.38           N  \nATOM   7451  CA  GLU A 963      -1.447  19.592  37.916  1.00 97.38           C  \nATOM   7452  C   GLU A 963      -2.171  20.941  37.974  1.00 97.38           C  \nATOM   7453  CB  GLU A 963      -0.012  19.763  38.425  1.00 97.38           C  \nATOM   7454  O   GLU A 963      -2.991  21.173  38.865  1.00 97.38           O  \nATOM   7455  CG  GLU A 963       0.746  18.438  38.575  1.00 97.38           C  \nATOM   7456  CD  GLU A 963       2.253  18.703  38.611  1.00 97.38           C  \nATOM   7457  OE1 GLU A 963       2.962  18.049  37.816  1.00 97.38           O  \nATOM   7458  OE2 GLU A 963       2.666  19.603  39.377  1.00 97.38           O  \nATOM   7459  N   LEU A 964      -1.934  21.800  36.977  1.00 97.94           N  \nATOM   7460  CA  LEU A 964      -2.624  23.082  36.826  1.00 97.94           C  \nATOM   7461  C   LEU A 964      -4.143  22.886  36.685  1.00 97.94           C  \nATOM   7462  CB  LEU A 964      -2.023  23.842  35.626  1.00 97.94           C  \nATOM   7463  O   LEU A 964      -4.911  23.581  37.352  1.00 97.94           O  \nATOM   7464  CG  LEU A 964      -0.558  24.283  35.831  1.00 97.94           C  \nATOM   7465  CD1 LEU A 964       0.026  24.800  34.518  1.00 97.94           C  \nATOM   7466  CD2 LEU A 964      -0.459  25.400  36.873  1.00 97.94           C  \nATOM   7467  N   ILE A 965      -4.592  21.889  35.911  1.00 97.69           N  \nATOM   7468  CA  ILE A 965      -6.012  21.510  35.834  1.00 97.69           C  \nATOM   7469  C   ILE A 965      -6.561  21.163  37.222  1.00 97.69           C  \nATOM   7470  CB  ILE A 965      -6.232  20.331  34.854  1.00 97.69           C  \nATOM   7471  O   ILE A 965      -7.663  21.602  37.548  1.00 97.69           O  \nATOM   7472  CG1 ILE A 965      -5.967  20.774  33.401  1.00 97.69           C  \nATOM   7473  CG2 ILE A 965      -7.668  19.765  34.944  1.00 97.69           C  \nATOM   7474  CD1 ILE A 965      -5.800  19.591  32.443  1.00 97.69           C  \nATOM   7475  N   ILE A 966      -5.831  20.392  38.035  1.00 96.81           N  \nATOM   7476  CA  ILE A 966      -6.291  19.951  39.362  1.00 96.81           C  \nATOM   7477  C   ILE A 966      -6.452  21.145  40.310  1.00 96.81           C  \nATOM   7478  CB  ILE A 966      -5.354  18.855  39.930  1.00 96.81           C  \nATOM   7479  O   ILE A 966      -7.520  21.297  40.908  1.00 96.81           O  \nATOM   7480  CG1 ILE A 966      -5.518  17.554  39.109  1.00 96.81           C  \nATOM   7481  CG2 ILE A 966      -5.640  18.572  41.419  1.00 96.81           C  \nATOM   7482  CD1 ILE A 966      -4.390  16.536  39.327  1.00 96.81           C  \nATOM   7483  N   GLU A 967      -5.444  22.012  40.420  1.00 96.19           N  \nATOM   7484  CA  GLU A 967      -5.493  23.158  41.336  1.00 96.19           C  \nATOM   7485  C   GLU A 967      -6.515  24.219  40.892  1.00 96.19           C  \nATOM   7486  CB  GLU A 967      -4.087  23.744  41.543  1.00 96.19           C  \nATOM   7487  O   GLU A 967      -7.362  24.616  41.697  1.00 96.19           O  \nATOM   7488  CG  GLU A 967      -3.197  22.869  42.452  1.00 96.19           C  \nATOM   7489  CD  GLU A 967      -3.740  22.746  43.889  1.00 96.19           C  \nATOM   7490  OE1 GLU A 967      -3.659  21.671  44.527  1.00 96.19           O  \nATOM   7491  OE2 GLU A 967      -4.310  23.724  44.422  1.00 96.19           O  \nATOM   7492  N   PHE A 968      -6.565  24.601  39.608  1.00 96.56           N  \nATOM   7493  CA  PHE A 968      -7.597  25.538  39.142  1.00 96.56           C  \nATOM   7494  C   PHE A 968      -9.015  24.933  39.209  1.00 96.56           C  \nATOM   7495  CB  PHE A 968      -7.251  26.104  37.754  1.00 96.56           C  \nATOM   7496  O   PHE A 968      -9.954  25.644  39.560  1.00 96.56           O  \nATOM   7497  CG  PHE A 968      -6.196  27.197  37.774  1.00 96.56           C  \nATOM   7498  CD1 PHE A 968      -6.549  28.498  38.185  1.00 96.56           C  \nATOM   7499  CD2 PHE A 968      -4.867  26.931  37.394  1.00 96.56           C  \nATOM   7500  CE1 PHE A 968      -5.579  29.516  38.235  1.00 96.56           C  \nATOM   7501  CE2 PHE A 968      -3.897  27.945  37.450  1.00 96.56           C  \nATOM   7502  CZ  PHE A 968      -4.249  29.236  37.876  1.00 96.56           C  \nATOM   7503  N   SER A 969      -9.199  23.620  38.992  1.00 95.62           N  \nATOM   7504  CA  SER A 969     -10.514  22.950  39.156  1.00 95.62           C  \nATOM   7505  C   SER A 969     -10.935  22.751  40.618  1.00 95.62           C  \nATOM   7506  CB  SER A 969     -10.552  21.570  38.490  1.00 95.62           C  \nATOM   7507  O   SER A 969     -12.083  22.388  40.890  1.00 95.62           O  \nATOM   7508  OG  SER A 969     -10.269  21.638  37.111  1.00 95.62           O  \nATOM   7509  N   LYS A 970     -10.010  22.936  41.562  1.00 94.94           N  \nATOM   7510  CA  LYS A 970     -10.251  22.986  43.009  1.00 94.94           C  \nATOM   7511  C   LYS A 970     -10.625  24.411  43.425  1.00 94.94           C  \nATOM   7512  CB  LYS A 970      -8.994  22.411  43.683  1.00 94.94           C  \nATOM   7513  O   LYS A 970     -11.619  24.573  44.125  1.00 94.94           O  \nATOM   7514  CG  LYS A 970      -8.732  22.731  45.163  1.00 94.94           C  \nATOM   7515  CD  LYS A 970      -7.336  22.168  45.486  1.00 94.94           C  \nATOM   7516  CE  LYS A 970      -6.721  22.681  46.789  1.00 94.94           C  \nATOM   7517  NZ  LYS A 970      -5.239  22.643  46.679  1.00 94.94           N  \nATOM   7518  N   MET A 971      -9.923  25.424  42.909  1.00 95.06           N  \nATOM   7519  CA  MET A 971     -10.258  26.841  43.115  1.00 95.06           C  \nATOM   7520  C   MET A 971     -11.622  27.219  42.519  1.00 95.06           C  \nATOM   7521  CB  MET A 971      -9.150  27.731  42.530  1.00 95.06           C  \nATOM   7522  O   MET A 971     -12.421  27.877  43.176  1.00 95.06           O  \nATOM   7523  CG  MET A 971      -7.834  27.583  43.298  1.00 95.06           C  \nATOM   7524  SD  MET A 971      -6.464  28.530  42.593  1.00 95.06           S  \nATOM   7525  CE  MET A 971      -5.269  28.316  43.938  1.00 95.06           C  \nATOM   7526  N   ALA A 972     -11.947  26.728  41.319  1.00 91.44           N  \nATOM   7527  CA  ALA A 972     -13.215  26.997  40.629  1.00 91.44           C  \nATOM   7528  C   ALA A 972     -14.476  26.429  41.326  1.00 91.44           C  \nATOM   7529  CB  ALA A 972     -13.089  26.477  39.189  1.00 91.44           C  \nATOM   7530  O   ALA A 972     -15.578  26.620  40.815  1.00 91.44           O  \nATOM   7531  N   ARG A 973     -14.333  25.731  42.465  1.00 91.31           N  \nATOM   7532  CA  ARG A 973     -15.444  25.257  43.320  1.00 91.31           C  \nATOM   7533  C   ARG A 973     -15.806  26.234  44.440  1.00 91.31           C  \nATOM   7534  CB  ARG A 973     -15.080  23.916  43.972  1.00 91.31           C  \nATOM   7535  O   ARG A 973     -16.877  26.100  45.018  1.00 91.31           O  \nATOM   7536  CG  ARG A 973     -14.758  22.815  42.962  1.00 91.31           C  \nATOM   7537  CD  ARG A 973     -14.243  21.582  43.707  1.00 91.31           C  \nATOM   7538  NE  ARG A 973     -13.661  20.611  42.767  1.00 91.31           N  \nATOM   7539  NH1 ARG A 973     -13.485  18.849  44.225  1.00 91.31           N  \nATOM   7540  NH2 ARG A 973     -12.865  18.592  42.096  1.00 91.31           N  \nATOM   7541  CZ  ARG A 973     -13.344  19.359  43.032  1.00 91.31           C  \nATOM   7542  N   ASP A 974     -14.903  27.157  44.761  1.00 91.38           N  \nATOM   7543  CA  ASP A 974     -15.035  28.151  45.832  1.00 91.38           C  \nATOM   7544  C   ASP A 974     -14.414  29.489  45.360  1.00 91.38           C  \nATOM   7545  CB  ASP A 974     -14.372  27.555  47.091  1.00 91.38           C  \nATOM   7546  O   ASP A 974     -13.399  29.932  45.900  1.00 91.38           O  \nATOM   7547  CG  ASP A 974     -14.479  28.407  48.360  1.00 91.38           C  \nATOM   7548  OD1 ASP A 974     -15.248  29.393  48.357  1.00 91.38           O  \nATOM   7549  OD2 ASP A 974     -13.786  28.032  49.341  1.00 91.38           O  \nATOM   7550  N   PRO A 975     -14.926  30.110  44.273  1.00 90.31           N  \nATOM   7551  CA  PRO A 975     -14.187  31.151  43.548  1.00 90.31           C  \nATOM   7552  C   PRO A 975     -13.857  32.397  44.379  1.00 90.31           C  \nATOM   7553  CB  PRO A 975     -15.084  31.509  42.362  1.00 90.31           C  \nATOM   7554  O   PRO A 975     -12.746  32.921  44.296  1.00 90.31           O  \nATOM   7555  CG  PRO A 975     -15.857  30.229  42.093  1.00 90.31           C  \nATOM   7556  CD  PRO A 975     -16.127  29.758  43.517  1.00 90.31           C  \nATOM   7557  N   GLN A 976     -14.801  32.831  45.219  1.00 87.81           N  \nATOM   7558  CA  GLN A 976     -14.705  34.031  46.060  1.00 87.81           C  \nATOM   7559  C   GLN A 976     -13.600  33.944  47.117  1.00 87.81           C  \nATOM   7560  CB  GLN A 976     -16.052  34.234  46.766  1.00 87.81           C  \nATOM   7561  O   GLN A 976     -13.059  34.964  47.541  1.00 87.81           O  \nATOM   7562  CG  GLN A 976     -17.135  34.682  45.778  1.00 87.81           C  \nATOM   7563  CD  GLN A 976     -18.520  34.775  46.401  1.00 87.81           C  \nATOM   7564  NE2 GLN A 976     -19.496  35.194  45.630  1.00 87.81           N  \nATOM   7565  OE1 GLN A 976     -18.748  34.475  47.561  1.00 87.81           O  \nATOM   7566  N   ARG A 977     -13.226  32.726  47.526  1.00 91.50           N  \nATOM   7567  CA  ARG A 977     -12.094  32.495  48.427  1.00 91.50           C  \nATOM   7568  C   ARG A 977     -10.745  32.781  47.764  1.00 91.50           C  \nATOM   7569  CB  ARG A 977     -12.187  31.048  48.916  1.00 91.50           C  \nATOM   7570  O   ARG A 977      -9.786  33.075  48.471  1.00 91.50           O  \nATOM   7571  CG  ARG A 977     -11.030  30.680  49.841  1.00 91.50           C  \nATOM   7572  CD  ARG A 977     -11.212  29.251  50.309  1.00 91.50           C  \nATOM   7573  NE  ARG A 977     -10.035  28.809  51.067  1.00 91.50           N  \nATOM   7574  NH1 ARG A 977     -10.842  26.718  51.447  1.00 91.50           N  \nATOM   7575  NH2 ARG A 977      -8.802  27.292  52.211  1.00 91.50           N  \nATOM   7576  CZ  ARG A 977      -9.896  27.608  51.573  1.00 91.50           C  \nATOM   7577  N   TYR A 978     -10.664  32.665  46.440  1.00 94.00           N  \nATOM   7578  CA  TYR A 978      -9.421  32.768  45.671  1.00 94.00           C  \nATOM   7579  C   TYR A 978      -9.309  34.077  44.878  1.00 94.00           C  \nATOM   7580  CB  TYR A 978      -9.315  31.527  44.776  1.00 94.00           C  \nATOM   7581  O   TYR A 978      -8.193  34.543  44.634  1.00 94.00           O  \nATOM   7582  CG  TYR A 978      -9.125  30.248  45.572  1.00 94.00           C  \nATOM   7583  CD1 TYR A 978      -7.903  30.025  46.229  1.00 94.00           C  \nATOM   7584  CD2 TYR A 978     -10.174  29.319  45.712  1.00 94.00           C  \nATOM   7585  CE1 TYR A 978      -7.716  28.873  47.016  1.00 94.00           C  \nATOM   7586  CE2 TYR A 978     -10.002  28.170  46.511  1.00 94.00           C  \nATOM   7587  OH  TYR A 978      -8.573  26.834  47.920  1.00 94.00           O  \nATOM   7588  CZ  TYR A 978      -8.768  27.942  47.156  1.00 94.00           C  \nATOM   7589  N   LEU A 979     -10.441  34.690  44.513  1.00 92.81           N  \nATOM   7590  CA  LEU A 979     -10.508  35.974  43.817  1.00 92.81           C  \nATOM   7591  C   LEU A 979     -11.452  36.954  44.531  1.00 92.81           C  \nATOM   7592  CB  LEU A 979     -10.939  35.769  42.357  1.00 92.81           C  \nATOM   7593  O   LEU A 979     -12.657  36.729  44.621  1.00 92.81           O  \nATOM   7594  CG  LEU A 979     -10.024  34.872  41.506  1.00 92.81           C  \nATOM   7595  CD1 LEU A 979     -10.626  34.739  40.110  1.00 92.81           C  \nATOM   7596  CD2 LEU A 979      -8.613  35.436  41.345  1.00 92.81           C  \nATOM   7597  N   VAL A 980     -10.902  38.078  44.988  1.00 90.31           N  \nATOM   7598  CA  VAL A 980     -11.615  39.153  45.687  1.00 90.31           C  \nATOM   7599  C   VAL A 980     -12.072  40.206  44.675  1.00 90.31           C  \nATOM   7600  CB  VAL A 980     -10.739  39.760  46.803  1.00 90.31           C  \nATOM   7601  O   VAL A 980     -11.324  41.117  44.320  1.00 90.31           O  \nATOM   7602  CG1 VAL A 980     -11.520  40.807  47.612  1.00 90.31           C  \nATOM   7603  CG2 VAL A 980     -10.254  38.685  47.788  1.00 90.31           C  \nATOM   7604  N   ILE A 981     -13.315  40.083  44.206  1.00 86.62           N  \nATOM   7605  CA  ILE A 981     -13.942  41.014  43.255  1.00 86.62           C  \nATOM   7606  C   ILE A 981     -15.129  41.715  43.930  1.00 86.62           C  \nATOM   7607  CB  ILE A 981     -14.313  40.283  41.943  1.00 86.62           C  \nATOM   7608  O   ILE A 981     -15.975  41.084  44.564  1.00 86.62           O  \nATOM   7609  CG1 ILE A 981     -13.037  39.760  41.237  1.00 86.62           C  \nATOM   7610  CG2 ILE A 981     -15.076  41.230  41.000  1.00 86.62           C  \nATOM   7611  CD1 ILE A 981     -13.316  38.791  40.085  1.00 86.62           C  \nATOM   7612  N   GLN A 982     -15.201  43.045  43.816  1.00 75.88           N  \nATOM   7613  CA  GLN A 982     -16.289  43.818  44.419  1.00 75.88           C  \nATOM   7614  C   GLN A 982     -17.599  43.592  43.656  1.00 75.88           C  \nATOM   7615  CB  GLN A 982     -15.948  45.315  44.480  1.00 75.88           C  \nATOM   7616  O   GLN A 982     -17.708  43.942  42.486  1.00 75.88           O  \nATOM   7617  CG  GLN A 982     -14.800  45.620  45.455  1.00 75.88           C  \nATOM   7618  CD  GLN A 982     -14.592  47.116  45.693  1.00 75.88           C  \nATOM   7619  NE2 GLN A 982     -13.602  47.491  46.472  1.00 75.88           N  \nATOM   7620  OE1 GLN A 982     -15.306  47.978  45.215  1.00 75.88           O  \nATOM   7621  N   GLY A 983     -18.609  43.044  44.337  1.00 74.25           N  \nATOM   7622  CA  GLY A 983     -19.925  42.786  43.744  1.00 74.25           C  \nATOM   7623  C   GLY A 983     -20.036  41.476  42.958  1.00 74.25           C  \nATOM   7624  O   GLY A 983     -20.993  41.330  42.207  1.00 74.25           O  \nATOM   7625  N   ASP A 984     -19.110  40.532  43.154  1.00 79.06           N  \nATOM   7626  CA  ASP A 984     -19.022  39.247  42.438  1.00 79.06           C  \nATOM   7627  C   ASP A 984     -20.358  38.480  42.325  1.00 79.06           C  \nATOM   7628  CB  ASP A 984     -17.974  38.402  43.177  1.00 79.06           C  \nATOM   7629  O   ASP A 984     -20.735  38.041  41.242  1.00 79.06           O  \nATOM   7630  CG  ASP A 984     -17.556  37.166  42.389  1.00 79.06           C  \nATOM   7631  OD1 ASP A 984     -17.200  37.317  41.206  1.00 79.06           O  \nATOM   7632  OD2 ASP A 984     -17.510  36.064  42.973  1.00 79.06           O  \nATOM   7633  N   GLU A 985     -21.150  38.414  43.404  1.00 64.44           N  \nATOM   7634  CA  GLU A 985     -22.486  37.781  43.418  1.00 64.44           C  \nATOM   7635  C   GLU A 985     -23.501  38.400  42.437  1.00 64.44           C  \nATOM   7636  CB  GLU A 985     -23.098  37.887  44.823  1.00 64.44           C  \nATOM   7637  O   GLU A 985     -24.530  37.795  42.149  1.00 64.44           O  \nATOM   7638  CG  GLU A 985     -22.316  37.142  45.910  1.00 64.44           C  \nATOM   7639  CD  GLU A 985     -23.067  37.160  47.251  1.00 64.44           C  \nATOM   7640  OE1 GLU A 985     -22.955  36.154  47.982  1.00 64.44           O  \nATOM   7641  OE2 GLU A 985     -23.738  38.182  47.538  1.00 64.44           O  \nATOM   7642  N   ARG A 986     -23.239  39.614  41.939  1.00 59.88           N  \nATOM   7643  CA  ARG A 986     -24.086  40.350  40.984  1.00 59.88           C  \nATOM   7644  C   ARG A 986     -23.515  40.338  39.564  1.00 59.88           C  \nATOM   7645  CB  ARG A 986     -24.293  41.793  41.472  1.00 59.88           C  \nATOM   7646  O   ARG A 986     -24.186  40.798  38.643  1.00 59.88           O  \nATOM   7647  CG  ARG A 986     -24.843  41.868  42.902  1.00 59.88           C  \nATOM   7648  CD  ARG A 986     -25.007  43.327  43.334  1.00 59.88           C  \nATOM   7649  NE  ARG A 986     -25.368  43.406  44.761  1.00 59.88           N  \nATOM   7650  NH1 ARG A 986     -24.974  45.646  45.060  1.00 59.88           N  \nATOM   7651  NH2 ARG A 986     -25.595  44.383  46.798  1.00 59.88           N  \nATOM   7652  CZ  ARG A 986     -25.313  44.476  45.529  1.00 59.88           C  \nATOM   7653  N   MET A 987     -22.292  39.838  39.376  1.00 63.22           N  \nATOM   7654  CA  MET A 987     -21.628  39.779  38.075  1.00 63.22           C  \nATOM   7655  C   MET A 987     -22.121  38.561  37.295  1.00 63.22           C  \nATOM   7656  CB  MET A 987     -20.106  39.805  38.246  1.00 63.22           C  \nATOM   7657  O   MET A 987     -21.601  37.447  37.398  1.00 63.22           O  \nATOM   7658  CG  MET A 987     -19.644  41.198  38.677  1.00 63.22           C  \nATOM   7659  SD  MET A 987     -17.857  41.321  38.889  1.00 63.22           S  \nATOM   7660  CE  MET A 987     -17.717  43.098  39.205  1.00 63.22           C  \nATOM   7661  N   HIS A 988     -23.182  38.771  36.523  1.00 57.53           N  \nATOM   7662  CA  HIS A 988     -23.761  37.764  35.643  1.00 57.53           C  \nATOM   7663  C   HIS A 988     -23.680  38.245  34.194  1.00 57.53           C  \nATOM   7664  CB  HIS A 988     -25.199  37.449  36.083  1.00 57.53           C  \nATOM   7665  O   HIS A 988     -24.506  39.037  33.743  1.00 57.53           O  \nATOM   7666  CG  HIS A 988     -25.327  36.808  37.446  1.00 57.53           C  \nATOM   7667  CD2 HIS A 988     -26.504  36.592  38.109  1.00 57.53           C  \nATOM   7668  ND1 HIS A 988     -24.314  36.356  38.269  1.00 57.53           N  \nATOM   7669  CE1 HIS A 988     -24.874  35.898  39.402  1.00 57.53           C  \nATOM   7670  NE2 HIS A 988     -26.212  36.000  39.339  1.00 57.53           N  \nATOM   7671  N   LEU A 989     -22.696  37.730  33.451  1.00 57.69           N  \nATOM   7672  CA  LEU A 989     -22.687  37.836  31.991  1.00 57.69           C  \nATOM   7673  C   LEU A 989     -24.013  37.270  31.437  1.00 57.69           C  \nATOM   7674  CB  LEU A 989     -21.475  37.087  31.403  1.00 57.69           C  \nATOM   7675  O   LEU A 989     -24.445  36.215  31.919  1.00 57.69           O  \nATOM   7676  CG  LEU A 989     -20.115  37.714  31.763  1.00 57.69           C  \nATOM   7677  CD1 LEU A 989     -18.974  36.783  31.359  1.00 57.69           C  \nATOM   7678  CD2 LEU A 989     -19.894  39.053  31.054  1.00 57.69           C  \nATOM   7679  N   PRO A 990     -24.662  37.931  30.455  1.00 45.69           N  \nATOM   7680  CA  PRO A 990     -25.971  37.518  29.957  1.00 45.69           C  \nATOM   7681  C   PRO A 990     -26.037  36.047  29.532  1.00 45.69           C  \nATOM   7682  CB  PRO A 990     -26.291  38.457  28.790  1.00 45.69           C  \nATOM   7683  O   PRO A 990     -25.096  35.498  28.953  1.00 45.69           O  \nATOM   7684  CG  PRO A 990     -25.559  39.737  29.183  1.00 45.69           C  \nATOM   7685  CD  PRO A 990     -24.297  39.214  29.867  1.00 45.69           C  \nATOM   7686  N   SER A 991     -27.184  35.416  29.798  1.00 38.66           N  \nATOM   7687  CA  SER A 991     -27.465  34.050  29.348  1.00 38.66           C  \nATOM   7688  C   SER A 991     -27.318  33.946  27.821  1.00 38.66           C  \nATOM   7689  CB  SER A 991     -28.891  33.648  29.736  1.00 38.66           C  \nATOM   7690  O   SER A 991     -27.854  34.807  27.118  1.00 38.66           O  \nATOM   7691  OG  SER A 991     -29.204  32.369  29.218  1.00 38.66           O  \nATOM   7692  N   PRO A 992     -26.708  32.873  27.273  1.00 44.09           N  \nATOM   7693  CA  PRO A 992     -26.613  32.650  25.824  1.00 44.09           C  \nATOM   7694  C   PRO A 992     -27.957  32.652  25.071  1.00 44.09           C  \nATOM   7695  CB  PRO A 992     -25.908  31.297  25.671  1.00 44.09           C  \nATOM   7696  O   PRO A 992     -27.971  32.726  23.846  1.00 44.09           O  \nATOM   7697  CG  PRO A 992     -25.063  31.192  26.938  1.00 44.09           C  \nATOM   7698  CD  PRO A 992     -25.953  31.852  27.987  1.00 44.09           C  \nATOM   7699  N   THR A 993     -29.082  32.575  25.788  1.00 41.03           N  \nATOM   7700  CA  THR A 993     -30.444  32.671  25.243  1.00 41.03           C  \nATOM   7701  C   THR A 993     -30.872  34.079  24.825  1.00 41.03           C  \nATOM   7702  CB  THR A 993     -31.470  32.153  26.264  1.00 41.03           C  \nATOM   7703  O   THR A 993     -31.872  34.192  24.120  1.00 41.03           O  \nATOM   7704  CG2 THR A 993     -31.296  30.661  26.541  1.00 41.03           C  \nATOM   7705  OG1 THR A 993     -31.338  32.830  27.501  1.00 41.03           O  \nATOM   7706  N   ASP A 994     -30.184  35.142  25.258  1.00 37.09           N  \nATOM   7707  CA  ASP A 994     -30.586  36.521  24.951  1.00 37.09           C  \nATOM   7708  C   ASP A 994     -29.411  37.355  24.429  1.00 37.09           C  \nATOM   7709  CB  ASP A 994     -31.309  37.157  26.148  1.00 37.09           C  \nATOM   7710  O   ASP A 994     -28.644  37.970  25.169  1.00 37.09           O  \nATOM   7711  CG  ASP A 994     -32.191  38.349  25.739  1.00 37.09           C  \nATOM   7712  OD1 ASP A 994     -32.357  38.597  24.512  1.00 37.09           O  \nATOM   7713  OD2 ASP A 994     -32.747  38.971  26.667  1.00 37.09           O  \nATOM   7714  N   SER A 995     -29.246  37.333  23.105  1.00 40.44           N  \nATOM   7715  CA  SER A 995     -28.205  38.078  22.408  1.00 40.44           C  \nATOM   7716  C   SER A 995     -28.756  38.723  21.142  1.00 40.44           C  \nATOM   7717  CB  SER A 995     -27.026  37.160  22.095  1.00 40.44           C  \nATOM   7718  O   SER A 995     -29.016  38.061  20.134  1.00 40.44           O  \nATOM   7719  OG  SER A 995     -25.984  37.925  21.519  1.00 40.44           O  \nATOM   7720  N   ASN A 996     -28.869  40.052  21.171  1.00 39.81           N  \nATOM   7721  CA  ASN A 996     -29.220  40.862  20.001  1.00 39.81           C  \nATOM   7722  C   ASN A 996     -28.212  40.680  18.847  1.00 39.81           C  \nATOM   7723  CB  ASN A 996     -29.322  42.337  20.435  1.00 39.81           C  \nATOM   7724  O   ASN A 996     -28.569  40.888  17.694  1.00 39.81           O  \nATOM   7725  CG  ASN A 996     -30.407  42.597  21.470  1.00 39.81           C  \nATOM   7726  ND2 ASN A 996     -30.256  43.607  22.291  1.00 39.81           N  \nATOM   7727  OD1 ASN A 996     -31.403  41.901  21.564  1.00 39.81           O  \nATOM   7728  N   PHE A 997     -26.982  40.234  19.140  1.00 40.44           N  \nATOM   7729  CA  PHE A 997     -25.961  39.917  18.140  1.00 40.44           C  \nATOM   7730  C   PHE A 997     -26.315  38.678  17.305  1.00 40.44           C  \nATOM   7731  CB  PHE A 997     -24.613  39.740  18.853  1.00 40.44           C  \nATOM   7732  O   PHE A 997     -26.066  38.679  16.106  1.00 40.44           O  \nATOM   7733  CG  PHE A 997     -23.424  39.563  17.929  1.00 40.44           C  \nATOM   7734  CD1 PHE A 997     -22.977  38.272  17.586  1.00 40.44           C  \nATOM   7735  CD2 PHE A 997     -22.756  40.692  17.419  1.00 40.44           C  \nATOM   7736  CE1 PHE A 997     -21.861  38.114  16.745  1.00 40.44           C  \nATOM   7737  CE2 PHE A 997     -21.635  40.533  16.585  1.00 40.44           C  \nATOM   7738  CZ  PHE A 997     -21.184  39.243  16.253  1.00 40.44           C  \nATOM   7739  N   TYR A 998     -26.948  37.651  17.891  1.00 44.50           N  \nATOM   7740  CA  TYR A 998     -27.462  36.516  17.110  1.00 44.50           C  \nATOM   7741  C   TYR A 998     -28.633  36.930  16.211  1.00 44.50           C  \nATOM   7742  CB  TYR A 998     -27.857  35.342  18.021  1.00 44.50           C  \nATOM   7743  O   TYR A 998     -28.702  36.462  15.082  1.00 44.50           O  \nATOM   7744  CG  TYR A 998     -26.772  34.293  18.174  1.00 44.50           C  \nATOM   7745  CD1 TYR A 998     -26.649  33.269  17.212  1.00 44.50           C  \nATOM   7746  CD2 TYR A 998     -25.894  34.330  19.274  1.00 44.50           C  \nATOM   7747  CE1 TYR A 998     -25.661  32.276  17.358  1.00 44.50           C  \nATOM   7748  CE2 TYR A 998     -24.904  33.338  19.425  1.00 44.50           C  \nATOM   7749  OH  TYR A 998     -23.838  31.347  18.608  1.00 44.50           O  \nATOM   7750  CZ  TYR A 998     -24.790  32.306  18.467  1.00 44.50           C  \nATOM   7751  N   ARG A 999     -29.509  37.841  16.666  1.00 42.91           N  \nATOM   7752  CA  ARG A 999     -30.566  38.426  15.818  1.00 42.91           C  \nATOM   7753  C   ARG A 999     -29.964  39.213  14.645  1.00 42.91           C  \nATOM   7754  CB  ARG A 999     -31.572  39.233  16.667  1.00 42.91           C  \nATOM   7755  O   ARG A 999     -30.191  38.835  13.505  1.00 42.91           O  \nATOM   7756  CG  ARG A 999     -32.878  38.437  16.848  1.00 42.91           C  \nATOM   7757  CD  ARG A 999     -33.852  39.054  17.868  1.00 42.91           C  \nATOM   7758  NE  ARG A 999     -33.618  38.560  19.251  1.00 42.91           N  \nATOM   7759  NH1 ARG A 999     -33.420  40.565  20.329  1.00 42.91           N  \nATOM   7760  NH2 ARG A 999     -33.187  38.684  21.503  1.00 42.91           N  \nATOM   7761  CZ  ARG A 999     -33.416  39.268  20.355  1.00 42.91           C  \nATOM   7762  N   ALA A1000     -29.033  40.130  14.911  1.00 45.03           N  \nATOM   7763  CA  ALA A1000     -28.311  40.870  13.869  1.00 45.03           C  \nATOM   7764  C   ALA A1000     -27.435  39.997  12.935  1.00 45.03           C  \nATOM   7765  CB  ALA A1000     -27.472  41.950  14.563  1.00 45.03           C  \nATOM   7766  O   ALA A1000     -27.004  40.470  11.887  1.00 45.03           O  \nATOM   7767  N   LEU A1001     -27.153  38.735  13.290  1.00 43.97           N  \nATOM   7768  CA  LEU A1001     -26.494  37.756  12.411  1.00 43.97           C  \nATOM   7769  C   LEU A1001     -27.487  36.963  11.534  1.00 43.97           C  \nATOM   7770  CB  LEU A1001     -25.636  36.804  13.272  1.00 43.97           C  \nATOM   7771  O   LEU A1001     -27.059  36.292  10.597  1.00 43.97           O  \nATOM   7772  CG  LEU A1001     -24.395  36.263  12.538  1.00 43.97           C  \nATOM   7773  CD1 LEU A1001     -23.268  37.304  12.522  1.00 43.97           C  \nATOM   7774  CD2 LEU A1001     -23.859  35.015  13.240  1.00 43.97           C  \nATOM   7775  N   MET A1002     -28.781  37.023  11.858  1.00 43.03           N  \nATOM   7776  CA  MET A1002     -29.901  36.364  11.171  1.00 43.03           C  \nATOM   7777  C   MET A1002     -30.758  37.354  10.357  1.00 43.03           C  \nATOM   7778  CB  MET A1002     -30.785  35.656  12.214  1.00 43.03           C  \nATOM   7779  O   MET A1002     -31.489  36.921   9.475  1.00 43.03           O  \nATOM   7780  CG  MET A1002     -30.082  34.531  12.987  1.00 43.03           C  \nATOM   7781  SD  MET A1002     -29.904  32.960  12.103  1.00 43.03           S  \nATOM   7782  CE  MET A1002     -29.182  31.955  13.425  1.00 43.03           C  \nATOM   7783  N   ASP A1003     -30.652  38.661  10.627  1.00 44.62           N  \nATOM   7784  CA  ASP A1003     -31.403  39.736   9.955  1.00 44.62           C  \nATOM   7785  C   ASP A1003     -30.876  40.086   8.531  1.00 44.62           C  \nATOM   7786  CB  ASP A1003     -31.456  40.983  10.874  1.00 44.62           C  \nATOM   7787  O   ASP A1003     -31.428  40.962   7.869  1.00 44.62           O  \nATOM   7788  CG  ASP A1003     -32.281  40.824  12.169  1.00 44.62           C  \nATOM   7789  OD1 ASP A1003     -33.363  40.194  12.131  1.00 44.62           O  \nATOM   7790  OD2 ASP A1003     -31.845  41.371  13.214  1.00 44.62           O  \nATOM   7791  N   GLU A1004     -29.833  39.410   8.021  1.00 47.16           N  \nATOM   7792  CA  GLU A1004     -29.469  39.445   6.588  1.00 47.16           C  \nATOM   7793  C   GLU A1004     -30.393  38.480   5.799  1.00 47.16           C  \nATOM   7794  CB  GLU A1004     -27.966  39.119   6.365  1.00 47.16           C  \nATOM   7795  O   GLU A1004     -30.488  37.302   6.140  1.00 47.16           O  \nATOM   7796  CG  GLU A1004     -26.967  40.231   6.781  1.00 47.16           C  \nATOM   7797  CD  GLU A1004     -25.473  39.871   6.533  1.00 47.16           C  \nATOM   7798  OE1 GLU A1004     -24.598  40.196   7.381  1.00 47.16           O  \nATOM   7799  OE2 GLU A1004     -25.158  39.238   5.497  1.00 47.16           O  \nATOM   7800  N   GLU A1005     -31.057  38.963   4.736  1.00 46.91           N  \nATOM   7801  CA  GLU A1005     -32.291  38.415   4.105  1.00 46.91           C  \nATOM   7802  C   GLU A1005     -32.224  37.007   3.433  1.00 46.91           C  \nATOM   7803  CB  GLU A1005     -32.839  39.449   3.088  1.00 46.91           C  \nATOM   7804  O   GLU A1005     -33.047  36.683   2.577  1.00 46.91           O  \nATOM   7805  CG  GLU A1005     -33.102  40.861   3.641  1.00 46.91           C  \nATOM   7806  CD  GLU A1005     -33.726  41.777   2.571  1.00 46.91           C  \nATOM   7807  OE1 GLU A1005     -34.858  42.266   2.795  1.00 46.91           O  \nATOM   7808  OE2 GLU A1005     -33.067  41.987   1.525  1.00 46.91           O  \nATOM   7809  N   ASP A1006     -31.253  36.153   3.770  1.00 46.66           N  \nATOM   7810  CA  ASP A1006     -30.887  34.945   3.002  1.00 46.66           C  \nATOM   7811  C   ASP A1006     -30.506  33.733   3.904  1.00 46.66           C  \nATOM   7812  CB  ASP A1006     -29.783  35.382   2.007  1.00 46.66           C  \nATOM   7813  O   ASP A1006     -29.767  32.839   3.490  1.00 46.66           O  \nATOM   7814  CG  ASP A1006     -29.359  34.343   0.960  1.00 46.66           C  \nATOM   7815  OD1 ASP A1006     -30.191  33.539   0.487  1.00 46.66           O  \nATOM   7816  OD2 ASP A1006     -28.134  34.254   0.686  1.00 46.66           O  \nATOM   7817  N   MET A1007     -30.946  33.684   5.170  1.00 50.16           N  \nATOM   7818  CA  MET A1007     -30.286  32.886   6.236  1.00 50.16           C  \nATOM   7819  C   MET A1007     -31.044  31.645   6.786  1.00 50.16           C  \nATOM   7820  CB  MET A1007     -29.791  33.854   7.332  1.00 50.16           C  \nATOM   7821  O   MET A1007     -30.682  31.114   7.832  1.00 50.16           O  \nATOM   7822  CG  MET A1007     -28.647  34.747   6.817  1.00 50.16           C  \nATOM   7823  SD  MET A1007     -27.052  33.901   6.576  1.00 50.16           S  \nATOM   7824  CE  MET A1007     -26.343  34.214   8.214  1.00 50.16           C  \nATOM   7825  N   ASP A1008     -32.032  31.105   6.064  1.00 48.31           N  \nATOM   7826  CA  ASP A1008     -32.935  30.010   6.514  1.00 48.31           C  \nATOM   7827  C   ASP A1008     -32.296  28.607   6.772  1.00 48.31           C  \nATOM   7828  CB  ASP A1008     -34.076  29.873   5.469  1.00 48.31           C  \nATOM   7829  O   ASP A1008     -32.965  27.713   7.295  1.00 48.31           O  \nATOM   7830  CG  ASP A1008     -35.481  30.319   5.910  1.00 48.31           C  \nATOM   7831  OD1 ASP A1008     -35.678  30.697   7.085  1.00 48.31           O  \nATOM   7832  OD2 ASP A1008     -36.385  30.219   5.044  1.00 48.31           O  \nATOM   7833  N   ASP A1009     -31.030  28.366   6.397  1.00 56.00           N  \nATOM   7834  CA  ASP A1009     -30.339  27.053   6.493  1.00 56.00           C  \nATOM   7835  C   ASP A1009     -28.897  27.181   7.093  1.00 56.00           C  \nATOM   7836  CB  ASP A1009     -30.382  26.295   5.128  1.00 56.00           C  \nATOM   7837  O   ASP A1009     -27.938  26.574   6.605  1.00 56.00           O  \nATOM   7838  CG  ASP A1009     -31.674  25.513   4.754  1.00 56.00           C  \nATOM   7839  OD1 ASP A1009     -32.133  24.623   5.530  1.00 56.00           O  \nATOM   7840  OD2 ASP A1009     -32.129  25.638   3.588  1.00 56.00           O  \nATOM   7841  N   VAL A1010     -28.710  27.991   8.149  1.00 56.75           N  \nATOM   7842  CA  VAL A1010     -27.412  28.172   8.859  1.00 56.75           C  \nATOM   7843  C   VAL A1010     -27.197  27.134   9.978  1.00 56.75           C  \nATOM   7844  CB  VAL A1010     -27.270  29.609   9.412  1.00 56.75           C  \nATOM   7845  O   VAL A1010     -28.126  26.847  10.731  1.00 56.75           O  \nATOM   7846  CG1 VAL A1010     -25.955  29.849  10.175  1.00 56.75           C  \nATOM   7847  CG2 VAL A1010     -27.302  30.647   8.284  1.00 56.75           C  \nATOM   7848  N   VAL A1011     -25.976  26.590  10.123  1.00 60.75           N  \nATOM   7849  CA  VAL A1011     -25.607  25.579  11.152  1.00 60.75           C  \nATOM   7850  C   VAL A1011     -24.216  25.867  11.747  1.00 60.75           C  \nATOM   7851  CB  VAL A1011     -25.659  24.148  10.561  1.00 60.75           C  \nATOM   7852  O   VAL A1011     -23.324  26.325  11.034  1.00 60.75           O  \nATOM   7853  CG1 VAL A1011     -25.313  23.048  11.574  1.00 60.75           C  \nATOM   7854  CG2 VAL A1011     -27.055  23.791  10.021  1.00 60.75           C  \nATOM   7855  N   ASP A1012     -24.005  25.593  13.043  1.00 65.31           N  \nATOM   7856  CA  ASP A1012     -22.690  25.737  13.697  1.00 65.31           C  \nATOM   7857  C   ASP A1012     -21.669  24.711  13.171  1.00 65.31           C  \nATOM   7858  CB  ASP A1012     -22.826  25.637  15.229  1.00 65.31           C  \nATOM   7859  O   ASP A1012     -21.997  23.552  12.924  1.00 65.31           O  \nATOM   7860  CG  ASP A1012     -21.481  25.762  15.963  1.00 65.31           C  \nATOM   7861  OD1 ASP A1012     -21.279  25.080  16.992  1.00 65.31           O  \nATOM   7862  OD2 ASP A1012     -20.589  26.514  15.506  1.00 65.31           O  \nATOM   7863  N   ALA A1013     -20.400  25.107  13.052  1.00 62.44           N  \nATOM   7864  CA  ALA A1013     -19.349  24.233  12.535  1.00 62.44           C  \nATOM   7865  C   ALA A1013     -19.110  22.997  13.423  1.00 62.44           C  \nATOM   7866  CB  ALA A1013     -18.066  25.046  12.352  1.00 62.44           C  \nATOM   7867  O   ALA A1013     -18.921  21.908  12.885  1.00 62.44           O  \nATOM   7868  N   ASP A1014     -19.160  23.123  14.758  1.00 62.59           N  \nATOM   7869  CA  ASP A1014     -19.043  21.947  15.640  1.00 62.59           C  \nATOM   7870  C   ASP A1014     -20.254  21.003  15.480  1.00 62.59           C  \nATOM   7871  CB  ASP A1014     -18.904  22.333  17.125  1.00 62.59           C  \nATOM   7872  O   ASP A1014     -20.083  19.793  15.558  1.00 62.59           O  \nATOM   7873  CG  ASP A1014     -17.594  23.011  17.549  1.00 62.59           C  \nATOM   7874  OD1 ASP A1014     -16.483  22.597  17.166  1.00 62.59           O  \nATOM   7875  OD2 ASP A1014     -17.668  23.965  18.365  1.00 62.59           O  \nATOM   7876  N   GLU A1015     -21.463  21.519  15.227  1.00 62.78           N  \nATOM   7877  CA  GLU A1015     -22.679  20.708  15.034  1.00 62.78           C  \nATOM   7878  C   GLU A1015     -22.688  20.002  13.669  1.00 62.78           C  \nATOM   7879  CB  GLU A1015     -23.913  21.611  15.213  1.00 62.78           C  \nATOM   7880  O   GLU A1015     -22.954  18.801  13.587  1.00 62.78           O  \nATOM   7881  CG  GLU A1015     -25.241  20.839  15.113  1.00 62.78           C  \nATOM   7882  CD  GLU A1015     -26.484  21.720  15.330  1.00 62.78           C  \nATOM   7883  OE1 GLU A1015     -27.572  21.124  15.511  1.00 62.78           O  \nATOM   7884  OE2 GLU A1015     -26.354  22.966  15.301  1.00 62.78           O  \nATOM   7885  N   TYR A1016     -22.326  20.722  12.603  1.00 59.19           N  \nATOM   7886  CA  TYR A1016     -22.182  20.178  11.250  1.00 59.19           C  \nATOM   7887  C   TYR A1016     -21.106  19.083  11.182  1.00 59.19           C  \nATOM   7888  CB  TYR A1016     -21.849  21.337  10.297  1.00 59.19           C  \nATOM   7889  O   TYR A1016     -21.278  18.077  10.492  1.00 59.19           O  \nATOM   7890  CG  TYR A1016     -21.685  20.923   8.847  1.00 59.19           C  \nATOM   7891  CD1 TYR A1016     -20.401  20.673   8.324  1.00 59.19           C  \nATOM   7892  CD2 TYR A1016     -22.818  20.786   8.021  1.00 59.19           C  \nATOM   7893  CE1 TYR A1016     -20.244  20.293   6.978  1.00 59.19           C  \nATOM   7894  CE2 TYR A1016     -22.666  20.407   6.672  1.00 59.19           C  \nATOM   7895  OH  TYR A1016     -21.241  19.769   4.857  1.00 59.19           O  \nATOM   7896  CZ  TYR A1016     -21.381  20.158   6.151  1.00 59.19           C  \nATOM   7897  N   LEU A1017     -20.001  19.259  11.917  1.00 58.22           N  \nATOM   7898  CA  LEU A1017     -18.875  18.321  11.940  1.00 58.22           C  \nATOM   7899  C   LEU A1017     -18.983  17.245  13.029  1.00 58.22           C  \nATOM   7900  CB  LEU A1017     -17.560  19.106  12.078  1.00 58.22           C  \nATOM   7901  O   LEU A1017     -18.231  16.273  12.962  1.00 58.22           O  \nATOM   7902  CG  LEU A1017     -17.281  20.072  10.912  1.00 58.22           C  \nATOM   7903  CD1 LEU A1017     -16.085  20.951  11.248  1.00 58.22           C  \nATOM   7904  CD2 LEU A1017     -16.968  19.339   9.605  1.00 58.22           C  \nATOM   7905  N   ILE A1018     -19.862  17.396  14.025  1.00 50.03           N  \nATOM   7906  CA  ILE A1018     -20.099  16.418  15.102  1.00 50.03           C  \nATOM   7907  C   ILE A1018     -21.614  16.217  15.293  1.00 50.03           C  \nATOM   7908  CB  ILE A1018     -19.402  16.815  16.435  1.00 50.03           C  \nATOM   7909  O   ILE A1018     -22.199  16.728  16.254  1.00 50.03           O  \nATOM   7910  CG1 ILE A1018     -17.931  17.255  16.251  1.00 50.03           C  \nATOM   7911  CG2 ILE A1018     -19.460  15.613  17.405  1.00 50.03           C  \nATOM   7912  CD1 ILE A1018     -17.275  17.824  17.516  1.00 50.03           C  \nATOM   7913  N   PRO A1019     -22.277  15.422  14.429  1.00 33.62           N  \nATOM   7914  CA  PRO A1019     -23.689  15.111  14.607  1.00 33.62           C  \nATOM   7915  C   PRO A1019     -23.883  14.228  15.851  1.00 33.62           C  \nATOM   7916  CB  PRO A1019     -24.143  14.454  13.295  1.00 33.62           C  \nATOM   7917  O   PRO A1019     -23.641  13.020  15.829  1.00 33.62           O  \nATOM   7918  CG  PRO A1019     -23.047  14.811  12.289  1.00 33.62           C  \nATOM   7919  CD  PRO A1019     -21.802  14.883  13.163  1.00 33.62           C  \nATOM   7920  N   GLN A1020     -24.287  14.832  16.971  1.00 33.88           N  \nATOM   7921  CA  GLN A1020     -24.403  14.125  18.247  1.00 33.88           C  \nATOM   7922  C   GLN A1020     -25.419  12.975  18.175  1.00 33.88           C  \nATOM   7923  CB  GLN A1020     -24.793  15.081  19.384  1.00 33.88           C  \nATOM   7924  O   GLN A1020     -26.559  13.145  17.735  1.00 33.88           O  \nATOM   7925  CG  GLN A1020     -23.720  16.131  19.713  1.00 33.88           C  \nATOM   7926  CD  GLN A1020     -24.056  16.928  20.974  1.00 33.88           C  \nATOM   7927  NE2 GLN A1020     -23.233  17.881  21.350  1.00 33.88           N  \nATOM   7928  OE1 GLN A1020     -25.043  16.704  21.656  1.00 33.88           O  \nATOM   7929  N   GLN A1021     -25.047  11.811  18.718  1.00 33.88           N  \nATOM   7930  CA  GLN A1021     -25.881  10.598  18.714  1.00 33.88           C  \nATOM   7931  C   GLN A1021     -27.208  10.731  19.505  1.00 33.88           C  \nATOM   7932  CB  GLN A1021     -25.037   9.402  19.201  1.00 33.88           C  \nATOM   7933  O   GLN A1021     -28.055   9.844  19.429  1.00 33.88           O  \nATOM   7934  CG  GLN A1021     -23.915   9.015  18.213  1.00 33.88           C  \nATOM   7935  CD  GLN A1021     -23.082   7.818  18.677  1.00 33.88           C  \nATOM   7936  NE2 GLN A1021     -22.287   7.224  17.813  1.00 33.88           N  \nATOM   7937  OE1 GLN A1021     -23.122   7.394  19.818  1.00 33.88           O  \nATOM   7938  N   GLY A1022     -27.439  11.841  20.222  1.00 31.30           N  \nATOM   7939  CA  GLY A1022     -28.665  12.093  20.992  1.00 31.30           C  \nATOM   7940  C   GLY A1022     -29.909  12.481  20.173  1.00 31.30           C  \nATOM   7941  O   GLY A1022     -31.032  12.287  20.645  1.00 31.30           O  \nATOM   7942  N   PHE A1023     -29.757  12.985  18.941  1.00 29.11           N  \nATOM   7943  CA  PHE A1023     -30.861  13.615  18.187  1.00 29.11           C  \nATOM   7944  C   PHE A1023     -31.898  12.650  17.565  1.00 29.11           C  \nATOM   7945  CB  PHE A1023     -30.297  14.626  17.169  1.00 29.11           C  \nATOM   7946  O   PHE A1023     -32.797  13.079  16.842  1.00 29.11           O  \nATOM   7947  CG  PHE A1023     -30.732  16.053  17.453  1.00 29.11           C  \nATOM   7948  CD1 PHE A1023     -32.008  16.500  17.058  1.00 29.11           C  \nATOM   7949  CD2 PHE A1023     -29.866  16.930  18.134  1.00 29.11           C  \nATOM   7950  CE1 PHE A1023     -32.411  17.820  17.332  1.00 29.11           C  \nATOM   7951  CE2 PHE A1023     -30.268  18.249  18.405  1.00 29.11           C  \nATOM   7952  CZ  PHE A1023     -31.538  18.696  18.003  1.00 29.11           C  \nATOM   7953  N   PHE A1024     -31.812  11.344  17.841  1.00 28.83           N  \nATOM   7954  CA  PHE A1024     -32.736  10.328  17.310  1.00 28.83           C  \nATOM   7955  C   PHE A1024     -33.905   9.954  18.244  1.00 28.83           C  \nATOM   7956  CB  PHE A1024     -31.935   9.130  16.773  1.00 28.83           C  \nATOM   7957  O   PHE A1024     -34.732   9.111  17.888  1.00 28.83           O  \nATOM   7958  CG  PHE A1024     -31.376   9.401  15.387  1.00 28.83           C  \nATOM   7959  CD1 PHE A1024     -32.199   9.220  14.259  1.00 28.83           C  \nATOM   7960  CD2 PHE A1024     -30.066   9.888  15.222  1.00 28.83           C  \nATOM   7961  CE1 PHE A1024     -31.716   9.522  12.971  1.00 28.83           C  \nATOM   7962  CE2 PHE A1024     -29.584  10.193  13.936  1.00 28.83           C  \nATOM   7963  CZ  PHE A1024     -30.408  10.013  12.811  1.00 28.83           C  \nATOM   7964  N   SER A1025     -34.039  10.623  19.393  1.00 27.42           N  \nATOM   7965  CA  SER A1025     -35.168  10.445  20.319  1.00 27.42           C  \nATOM   7966  C   SER A1025     -36.436  11.146  19.811  1.00 27.42           C  \nATOM   7967  CB  SER A1025     -34.797  10.968  21.711  1.00 27.42           C  \nATOM   7968  O   SER A1025     -36.573  12.361  19.927  1.00 27.42           O  \nATOM   7969  OG  SER A1025     -33.678  10.264  22.210  1.00 27.42           O  \nATOM   7970  N   SER A1026     -37.392  10.392  19.256  1.00 28.67           N  \nATOM   7971  CA  SER A1026     -38.711  10.942  18.890  1.00 28.67           C  \nATOM   7972  C   SER A1026     -39.593  11.157  20.138  1.00 28.67           C  \nATOM   7973  CB  SER A1026     -39.414  10.051  17.864  1.00 28.67           C  \nATOM   7974  O   SER A1026     -39.538  10.343  21.062  1.00 28.67           O  \nATOM   7975  OG  SER A1026     -38.652  10.043  16.670  1.00 28.67           O  \nATOM   7976  N   PRO A1027     -40.414  12.224  20.202  1.00 27.05           N  \nATOM   7977  CA  PRO A1027     -41.058  12.666  21.444  1.00 27.05           C  \nATOM   7978  C   PRO A1027     -42.317  11.849  21.797  1.00 27.05           C  \nATOM   7979  CB  PRO A1027     -41.331  14.162  21.221  1.00 27.05           C  \nATOM   7980  O   PRO A1027     -43.439  12.336  21.657  1.00 27.05           O  \nATOM   7981  CG  PRO A1027     -41.603  14.239  19.720  1.00 27.05           C  \nATOM   7982  CD  PRO A1027     -40.605  13.227  19.159  1.00 27.05           C  \nATOM   7983  N   SER A1028     -42.156  10.596  22.245  1.00 29.48           N  \nATOM   7984  CA  SER A1028     -43.306   9.714  22.524  1.00 29.48           C  \nATOM   7985  C   SER A1028     -43.141   8.653  23.631  1.00 29.48           C  \nATOM   7986  CB  SER A1028     -43.823   9.097  21.215  1.00 29.48           C  \nATOM   7987  O   SER A1028     -43.873   7.667  23.619  1.00 29.48           O  \nATOM   7988  OG  SER A1028     -42.873   8.215  20.654  1.00 29.48           O  \nATOM   7989  N   THR A1029     -42.261   8.842  24.622  1.00 32.19           N  \nATOM   7990  CA  THR A1029     -42.303   8.076  25.894  1.00 32.19           C  \nATOM   7991  C   THR A1029     -41.870   8.928  27.084  1.00 32.19           C  \nATOM   7992  CB  THR A1029     -41.431   6.804  25.894  1.00 32.19           C  \nATOM   7993  O   THR A1029     -40.698   9.271  27.216  1.00 32.19           O  \nATOM   7994  CG2 THR A1029     -42.034   5.642  25.110  1.00 32.19           C  \nATOM   7995  OG1 THR A1029     -40.155   7.066  25.367  1.00 32.19           O  \nATOM   7996  N   SER A1030     -42.801   9.239  27.985  1.00 26.06           N  \nATOM   7997  CA  SER A1030     -42.537   9.966  29.227  1.00 26.06           C  \nATOM   7998  C   SER A1030     -42.402   9.019  30.425  1.00 26.06           C  \nATOM   7999  CB  SER A1030     -43.661  10.989  29.463  1.00 26.06           C  \nATOM   8000  O   SER A1030     -43.347   8.292  30.734  1.00 26.06           O  \nATOM   8001  OG  SER A1030     -44.947  10.419  29.270  1.00 26.06           O  \nATOM   8002  N   ARG A1031     -41.269   9.080  31.153  1.00 32.16           N  \nATOM   8003  CA  ARG A1031     -41.216   8.860  32.619  1.00 32.16           C  \nATOM   8004  C   ARG A1031     -39.858   9.181  33.277  1.00 32.16           C  \nATOM   8005  CB  ARG A1031     -41.671   7.425  32.993  1.00 32.16           C  \nATOM   8006  O   ARG A1031     -38.860   8.534  33.004  1.00 32.16           O  \nATOM   8007  CG  ARG A1031     -43.049   7.475  33.684  1.00 32.16           C  \nATOM   8008  CD  ARG A1031     -43.837   6.169  33.552  1.00 32.16           C  \nATOM   8009  NE  ARG A1031     -45.181   6.312  34.153  1.00 32.16           N  \nATOM   8010  NH1 ARG A1031     -46.184   4.506  33.155  1.00 32.16           N  \nATOM   8011  NH2 ARG A1031     -47.375   5.816  34.512  1.00 32.16           N  \nATOM   8012  CZ  ARG A1031     -46.235   5.547  33.936  1.00 32.16           C  \nATOM   8013  N   THR A1032     -39.915  10.131  34.220  1.00 29.72           N  \nATOM   8014  CA  THR A1032     -39.170  10.205  35.503  1.00 29.72           C  \nATOM   8015  C   THR A1032     -37.630  10.123  35.525  1.00 29.72           C  \nATOM   8016  CB  THR A1032     -39.724   9.175  36.508  1.00 29.72           C  \nATOM   8017  O   THR A1032     -37.085   9.021  35.526  1.00 29.72           O  \nATOM   8018  CG2 THR A1032     -41.148   9.518  36.950  1.00 29.72           C  \nATOM   8019  OG1 THR A1032     -39.769   7.885  35.946  1.00 29.72           O  \nATOM   8020  N   PRO A1033     -36.940  11.261  35.753  1.00 29.48           N  \nATOM   8021  CA  PRO A1033     -35.593  11.311  36.324  1.00 29.48           C  \nATOM   8022  C   PRO A1033     -35.612  11.466  37.862  1.00 29.48           C  \nATOM   8023  CB  PRO A1033     -34.952  12.528  35.652  1.00 29.48           C  \nATOM   8024  O   PRO A1033     -36.409  12.229  38.405  1.00 29.48           O  \nATOM   8025  CG  PRO A1033     -36.124  13.506  35.522  1.00 29.48           C  \nATOM   8026  CD  PRO A1033     -37.357  12.606  35.372  1.00 29.48           C  \nATOM   8027  N   LEU A1034     -34.697  10.776  38.550  1.00 32.34           N  \nATOM   8028  CA  LEU A1034     -34.310  10.904  39.970  1.00 32.34           C  \nATOM   8029  C   LEU A1034     -32.826  10.451  40.057  1.00 32.34           C  \nATOM   8030  CB  LEU A1034     -35.201   9.992  40.851  1.00 32.34           C  \nATOM   8031  O   LEU A1034     -32.419   9.634  39.236  1.00 32.34           O  \nATOM   8032  CG  LEU A1034     -36.702  10.331  40.974  1.00 32.34           C  \nATOM   8033  CD1 LEU A1034     -37.376   9.290  41.872  1.00 32.34           C  \nATOM   8034  CD2 LEU A1034     -36.978  11.701  41.598  1.00 32.34           C  \nATOM   8035  N   LEU A1035     -31.960  10.882  40.981  1.00 30.72           N  \nATOM   8036  CA  LEU A1035     -32.112  11.762  42.149  1.00 30.72           C  \nATOM   8037  C   LEU A1035     -30.733  12.367  42.513  1.00 30.72           C  \nATOM   8038  CB  LEU A1035     -32.592  10.894  43.343  1.00 30.72           C  \nATOM   8039  O   LEU A1035     -29.742  11.645  42.424  1.00 30.72           O  \nATOM   8040  CG  LEU A1035     -33.755  11.481  44.158  1.00 30.72           C  \nATOM   8041  CD1 LEU A1035     -34.342  10.404  45.072  1.00 30.72           C  \nATOM   8042  CD2 LEU A1035     -33.331  12.672  45.016  1.00 30.72           C  \nATOM   8043  N   SER A1036     -30.701  13.625  42.985  1.00 32.66           N  \nATOM   8044  CA  SER A1036     -29.763  14.243  43.967  1.00 32.66           C  \nATOM   8045  C   SER A1036     -29.387  15.687  43.578  1.00 32.66           C  \nATOM   8046  CB  SER A1036     -28.436  13.494  44.191  1.00 32.66           C  \nATOM   8047  O   SER A1036     -29.015  15.922  42.437  1.00 32.66           O  \nATOM   8048  OG  SER A1036     -28.679  12.242  44.799  1.00 32.66           O  \nATOM   8049  N   SER A1037     -29.419  16.689  44.466  1.00 32.41           N  \nATOM   8050  CA  SER A1037     -30.013  16.742  45.816  1.00 32.41           C  \nATOM   8051  C   SER A1037     -30.072  18.189  46.340  1.00 32.41           C  \nATOM   8052  CB  SER A1037     -29.164  15.952  46.836  1.00 32.41           C  \nATOM   8053  O   SER A1037     -29.017  18.806  46.412  1.00 32.41           O  \nATOM   8054  OG  SER A1037     -27.805  16.328  46.775  1.00 32.41           O  \nATOM   8055  N   LEU A1038     -31.242  18.622  46.852  1.00 30.55           N  \nATOM   8056  CA  LEU A1038     -31.424  19.726  47.831  1.00 30.55           C  \nATOM   8057  C   LEU A1038     -31.075  21.162  47.335  1.00 30.55           C  \nATOM   8058  CB  LEU A1038     -30.668  19.317  49.122  1.00 30.55           C  \nATOM   8059  O   LEU A1038     -30.222  21.335  46.480  1.00 30.55           O  \nATOM   8060  CG  LEU A1038     -31.150  17.996  49.763  1.00 30.55           C  \nATOM   8061  CD1 LEU A1038     -30.169  17.532  50.836  1.00 30.55           C  \nATOM   8062  CD2 LEU A1038     -32.535  18.127  50.402  1.00 30.55           C  \nATOM   8063  N   SER A1039     -31.695  22.254  47.808  1.00 28.98           N  \nATOM   8064  CA  SER A1039     -32.865  22.466  48.692  1.00 28.98           C  \nATOM   8065  C   SER A1039     -33.409  23.913  48.528  1.00 28.98           C  \nATOM   8066  CB  SER A1039     -32.499  22.206  50.170  1.00 28.98           C  \nATOM   8067  O   SER A1039     -32.913  24.660  47.695  1.00 28.98           O  \nATOM   8068  OG  SER A1039     -31.254  22.773  50.515  1.00 28.98           O  \nATOM   8069  N   ALA A1040     -34.405  24.301  49.346  1.00 34.38           N  \nATOM   8070  CA  ALA A1040     -35.031  25.634  49.479  1.00 34.38           C  \nATOM   8071  C   ALA A1040     -36.189  25.996  48.512  1.00 34.38           C  \nATOM   8072  CB  ALA A1040     -33.982  26.743  49.646  1.00 34.38           C  \nATOM   8073  O   ALA A1040     -36.027  26.475  47.396  1.00 34.38           O  \nATOM   8074  N   THR A1041     -37.402  25.821  49.043  1.00 30.02           N  \nATOM   8075  CA  THR A1041     -38.690  26.417  48.632  1.00 30.02           C  \nATOM   8076  C   THR A1041     -38.648  27.964  48.644  1.00 30.02           C  \nATOM   8077  CB  THR A1041     -39.727  25.924  49.656  1.00 30.02           C  \nATOM   8078  O   THR A1041     -37.901  28.531  49.431  1.00 30.02           O  \nATOM   8079  CG2 THR A1041     -39.991  24.421  49.566  1.00 30.02           C  \nATOM   8080  OG1 THR A1041     -39.255  26.173  50.967  1.00 30.02           O  \nATOM   8081  N   SER A1042     -39.494  28.722  47.929  1.00 32.47           N  \nATOM   8082  CA  SER A1042     -40.967  28.627  47.960  1.00 32.47           C  \nATOM   8083  C   SER A1042     -41.701  29.490  46.904  1.00 32.47           C  \nATOM   8084  CB  SER A1042     -41.464  29.080  49.354  1.00 32.47           C  \nATOM   8085  O   SER A1042     -41.133  30.412  46.334  1.00 32.47           O  \nATOM   8086  OG  SER A1042     -40.876  30.292  49.778  1.00 32.47           O  \nATOM   8087  N   ASN A1043     -42.978  29.136  46.688  1.00 32.12           N  \nATOM   8088  CA  ASN A1043     -44.144  29.840  46.102  1.00 32.12           C  \nATOM   8089  C   ASN A1043     -44.044  31.395  45.951  1.00 32.12           C  \nATOM   8090  CB  ASN A1043     -45.335  29.484  47.036  1.00 32.12           C  \nATOM   8091  O   ASN A1043     -43.444  32.047  46.793  1.00 32.12           O  \nATOM   8092  CG  ASN A1043     -45.448  28.041  47.514  1.00 32.12           C  \nATOM   8093  ND2 ASN A1043     -46.176  27.804  48.580  1.00 32.12           N  \nATOM   8094  OD1 ASN A1043     -44.884  27.109  46.970  1.00 32.12           O  \nATOM   8095  N   ASN A1044     -44.736  32.096  45.031  1.00 32.53           N  \nATOM   8096  CA  ASN A1044     -46.012  31.774  44.370  1.00 32.53           C  \nATOM   8097  C   ASN A1044     -46.374  32.720  43.184  1.00 32.53           C  \nATOM   8098  CB  ASN A1044     -47.123  31.956  45.438  1.00 32.53           C  \nATOM   8099  O   ASN A1044     -45.787  33.783  43.027  1.00 32.53           O  \nATOM   8100  CG  ASN A1044     -48.288  31.000  45.276  1.00 32.53           C  \nATOM   8101  ND2 ASN A1044     -49.223  31.018  46.195  1.00 32.53           N  \nATOM   8102  OD1 ASN A1044     -48.365  30.210  44.351  1.00 32.53           O  \nATOM   8103  N   SER A1045     -47.450  32.373  42.461  1.00 31.23           N  \nATOM   8104  CA  SER A1045     -48.407  33.263  41.753  1.00 31.23           C  \nATOM   8105  C   SER A1045     -47.926  34.340  40.753  1.00 31.23           C  \nATOM   8106  CB  SER A1045     -49.399  33.887  42.744  1.00 31.23           C  \nATOM   8107  O   SER A1045     -47.626  35.480  41.096  1.00 31.23           O  \nATOM   8108  OG  SER A1045     -48.728  34.643  43.727  1.00 31.23           O  \nATOM   8109  N   THR A1046     -48.099  33.988  39.479  1.00 28.28           N  \nATOM   8110  CA  THR A1046     -48.416  34.827  38.305  1.00 28.28           C  \nATOM   8111  C   THR A1046     -49.229  36.119  38.537  1.00 28.28           C  \nATOM   8112  CB  THR A1046     -49.335  33.974  37.401  1.00 28.28           C  \nATOM   8113  O   THR A1046     -50.332  36.052  39.080  1.00 28.28           O  \nATOM   8114  CG2 THR A1046     -48.637  32.763  36.786  1.00 28.28           C  \nATOM   8115  OG1 THR A1046     -50.409  33.461  38.168  1.00 28.28           O  \nATOM   8116  N   VAL A1047     -48.800  37.227  37.914  1.00 31.73           N  \nATOM   8117  CA  VAL A1047     -49.652  38.323  37.389  1.00 31.73           C  \nATOM   8118  C   VAL A1047     -49.027  38.827  36.075  1.00 31.73           C  \nATOM   8119  CB  VAL A1047     -49.826  39.496  38.390  1.00 31.73           C  \nATOM   8120  O   VAL A1047     -47.809  38.787  35.926  1.00 31.73           O  \nATOM   8121  CG1 VAL A1047     -50.699  40.630  37.821  1.00 31.73           C  \nATOM   8122  CG2 VAL A1047     -50.502  39.057  39.695  1.00 31.73           C  \nATOM   8123  N   ALA A1048     -49.838  39.295  35.124  1.00 28.84           N  \nATOM   8124  CA  ALA A1048     -49.389  39.964  33.898  1.00 28.84           C  \nATOM   8125  C   ALA A1048     -50.003  41.370  33.802  1.00 28.84           C  \nATOM   8126  CB  ALA A1048     -49.815  39.110  32.694  1.00 28.84           C  \nATOM   8127  O   ALA A1048     -51.131  41.539  34.263  1.00 28.84           O  \nATOM   8128  N   CYS A1049     -49.323  42.332  33.159  1.00 25.92           N  \nATOM   8129  CA  CYS A1049     -49.961  43.397  32.362  1.00 25.92           C  \nATOM   8130  C   CYS A1049     -48.962  44.255  31.564  1.00 25.92           C  \nATOM   8131  CB  CYS A1049     -50.883  44.296  33.206  1.00 25.92           C  \nATOM   8132  O   CYS A1049     -47.756  44.225  31.792  1.00 25.92           O  \nATOM   8133  SG  CYS A1049     -52.598  43.784  32.874  1.00 25.92           S  \nATOM   8134  N   ILE A1050     -49.523  44.988  30.601  1.00 30.06           N  \nATOM   8135  CA  ILE A1050     -48.878  45.828  29.583  1.00 30.06           C  \nATOM   8136  C   ILE A1050     -48.944  47.306  30.004  1.00 30.06           C  \nATOM   8137  CB  ILE A1050     -49.674  45.641  28.261  1.00 30.06           C  \nATOM   8138  O   ILE A1050     -50.007  47.740  30.427  1.00 30.06           O  \nATOM   8139  CG1 ILE A1050     -49.575  44.199  27.708  1.00 30.06           C  \nATOM   8140  CG2 ILE A1050     -49.278  46.649  27.164  1.00 30.06           C  \nATOM   8141  CD1 ILE A1050     -50.773  43.815  26.826  1.00 30.06           C  \nATOM   8142  N   ASP A1051     -47.878  48.076  29.762  1.00 34.06           N  \nATOM   8143  CA  ASP A1051     -47.916  49.467  29.255  1.00 34.06           C  \nATOM   8144  C   ASP A1051     -46.508  49.816  28.695  1.00 34.06           C  \nATOM   8145  CB  ASP A1051     -48.360  50.480  30.335  1.00 34.06           C  \nATOM   8146  O   ASP A1051     -45.529  49.283  29.210  1.00 34.06           O  \nATOM   8147  CG  ASP A1051     -49.827  50.938  30.208  1.00 34.06           C  \nATOM   8148  OD1 ASP A1051     -50.389  50.872  29.083  1.00 34.06           O  \nATOM   8149  OD2 ASP A1051     -50.363  51.433  31.224  1.00 34.06           O  \nATOM   8150  N   ARG A1052     -46.212  50.600  27.639  1.00 28.23           N  \nATOM   8151  CA  ARG A1052     -46.910  51.403  26.600  1.00 28.23           C  \nATOM   8152  C   ARG A1052     -46.562  52.914  26.638  1.00 28.23           C  \nATOM   8153  CB  ARG A1052     -48.420  51.118  26.475  1.00 28.23           C  \nATOM   8154  O   ARG A1052     -47.101  53.669  27.430  1.00 28.23           O  \nATOM   8155  CG  ARG A1052     -49.027  51.574  25.142  1.00 28.23           C  \nATOM   8156  CD  ARG A1052     -50.514  51.200  25.044  1.00 28.23           C  \nATOM   8157  NE  ARG A1052     -50.968  51.157  23.635  1.00 28.23           N  \nATOM   8158  NH1 ARG A1052     -53.212  51.446  24.007  1.00 28.23           N  \nATOM   8159  NH2 ARG A1052     -52.481  51.056  21.933  1.00 28.23           N  \nATOM   8160  CZ  ARG A1052     -52.214  51.221  23.200  1.00 28.23           C  \nATOM   8161  N   ASN A1053     -45.773  53.327  25.632  1.00 30.55           N  \nATOM   8162  CA  ASN A1053     -45.576  54.679  25.053  1.00 30.55           C  \nATOM   8163  C   ASN A1053     -44.699  55.762  25.741  1.00 30.55           C  \nATOM   8164  CB  ASN A1053     -46.935  55.297  24.667  1.00 30.55           C  \nATOM   8165  O   ASN A1053     -45.005  56.240  26.825  1.00 30.55           O  \nATOM   8166  CG  ASN A1053     -47.708  54.551  23.599  1.00 30.55           C  \nATOM   8167  ND2 ASN A1053     -48.896  55.016  23.292  1.00 30.55           N  \nATOM   8168  OD1 ASN A1053     -47.282  53.567  23.017  1.00 30.55           O  \nATOM   8169  N   GLY A1054     -43.768  56.321  24.940  1.00 27.64           N  \nATOM   8170  CA  GLY A1054     -43.234  57.703  25.021  1.00 27.64           C  \nATOM   8171  C   GLY A1054     -41.865  57.836  25.712  1.00 27.64           C  \nATOM   8172  O   GLY A1054     -41.722  57.397  26.840  1.00 27.64           O  \nATOM   8173  N   LEU A1055     -40.811  58.434  25.132  1.00 29.69           N  \nATOM   8174  CA  LEU A1055     -40.763  59.593  24.218  1.00 29.69           C  \nATOM   8175  C   LEU A1055     -39.640  59.490  23.140  1.00 29.69           C  \nATOM   8176  CB  LEU A1055     -40.590  60.846  25.115  1.00 29.69           C  \nATOM   8177  O   LEU A1055     -39.139  58.404  22.868  1.00 29.69           O  \nATOM   8178  CG  LEU A1055     -41.474  62.033  24.699  1.00 29.69           C  \nATOM   8179  CD1 LEU A1055     -42.939  61.792  25.073  1.00 29.69           C  \nATOM   8180  CD2 LEU A1055     -41.006  63.306  25.402  1.00 29.69           C  \nATOM   8181  N   GLN A1056     -39.292  60.600  22.470  1.00 26.11           N  \nATOM   8182  CA  GLN A1056     -38.511  60.634  21.216  1.00 26.11           C  \nATOM   8183  C   GLN A1056     -37.012  60.992  21.343  1.00 26.11           C  \nATOM   8184  CB  GLN A1056     -39.182  61.636  20.251  1.00 26.11           C  \nATOM   8185  O   GLN A1056     -36.593  61.695  22.256  1.00 26.11           O  \nATOM   8186  CG  GLN A1056     -40.504  61.114  19.670  1.00 26.11           C  \nATOM   8187  CD  GLN A1056     -41.335  62.241  19.069  1.00 26.11           C  \nATOM   8188  NE2 GLN A1056     -41.271  62.488  17.779  1.00 26.11           N  \nATOM   8189  OE1 GLN A1056     -42.063  62.928  19.761  1.00 26.11           O  \nATOM   8190  N   SER A1057     -36.271  60.592  20.296  1.00 23.81           N  \nATOM   8191  CA  SER A1057     -35.046  61.194  19.724  1.00 23.81           C  \nATOM   8192  C   SER A1057     -33.770  61.341  20.571  1.00 23.81           C  \nATOM   8193  CB  SER A1057     -35.364  62.546  19.061  1.00 23.81           C  \nATOM   8194  O   SER A1057     -33.652  62.261  21.373  1.00 23.81           O  \nATOM   8195  OG  SER A1057     -35.854  63.487  19.992  1.00 23.81           O  \nATOM   8196  N   CYS A1058     -32.722  60.608  20.170  1.00 24.50           N  \nATOM   8197  CA  CYS A1058     -31.548  61.227  19.525  1.00 24.50           C  \nATOM   8198  C   CYS A1058     -30.740  60.180  18.716  1.00 24.50           C  \nATOM   8199  CB  CYS A1058     -30.657  61.924  20.567  1.00 24.50           C  \nATOM   8200  O   CYS A1058     -30.604  59.053  19.189  1.00 24.50           O  \nATOM   8201  SG  CYS A1058     -30.485  63.671  20.095  1.00 24.50           S  \nATOM   8202  N   PRO A1059     -30.214  60.498  17.515  1.00 25.98           N  \nATOM   8203  CA  PRO A1059     -29.405  59.566  16.727  1.00 25.98           C  \nATOM   8204  C   PRO A1059     -27.923  59.641  17.125  1.00 25.98           C  \nATOM   8205  CB  PRO A1059     -29.624  59.996  15.275  1.00 25.98           C  \nATOM   8206  O   PRO A1059     -27.336  60.724  17.124  1.00 25.98           O  \nATOM   8207  CG  PRO A1059     -29.793  61.514  15.381  1.00 25.98           C  \nATOM   8208  CD  PRO A1059     -30.447  61.720  16.753  1.00 25.98           C  \nATOM   8209  N   ILE A1060     -27.290  58.499  17.414  1.00 26.58           N  \nATOM   8210  CA  ILE A1060     -25.842  58.426  17.661  1.00 26.58           C  \nATOM   8211  C   ILE A1060     -25.227  57.317  16.806  1.00 26.58           C  \nATOM   8212  CB  ILE A1060     -25.498  58.300  19.167  1.00 26.58           C  \nATOM   8213  O   ILE A1060     -25.332  56.140  17.127  1.00 26.58           O  \nATOM   8214  CG1 ILE A1060     -26.081  59.507  19.944  1.00 26.58           C  \nATOM   8215  CG2 ILE A1060     -23.967  58.227  19.350  1.00 26.58           C  \nATOM   8216  CD1 ILE A1060     -25.750  59.547  21.441  1.00 26.58           C  \nATOM   8217  N   LYS A1061     -24.593  57.774  15.723  1.00 25.14           N  \nATOM   8218  CA  LYS A1061     -23.431  57.211  15.023  1.00 25.14           C  \nATOM   8219  C   LYS A1061     -23.235  55.686  14.989  1.00 25.14           C  \nATOM   8220  CB  LYS A1061     -22.168  57.908  15.558  1.00 25.14           C  \nATOM   8221  O   LYS A1061     -22.812  55.054  15.953  1.00 25.14           O  \nATOM   8222  CG  LYS A1061     -21.931  59.230  14.816  1.00 25.14           C  \nATOM   8223  CD  LYS A1061     -20.546  59.789  15.150  1.00 25.14           C  \nATOM   8224  CE  LYS A1061     -20.205  60.915  14.170  1.00 25.14           C  \nATOM   8225  NZ  LYS A1061     -18.759  61.234  14.224  1.00 25.14           N  \nATOM   8226  N   GLU A1062     -23.340  55.179  13.764  1.00 23.86           N  \nATOM   8227  CA  GLU A1062     -22.485  54.117  13.222  1.00 23.86           C  \nATOM   8228  C   GLU A1062     -20.978  54.498  13.335  1.00 23.86           C  \nATOM   8229  CB  GLU A1062     -22.926  53.895  11.757  1.00 23.86           C  \nATOM   8230  O   GLU A1062     -20.644  55.607  13.750  1.00 23.86           O  \nATOM   8231  CG  GLU A1062     -24.384  53.387  11.652  1.00 23.86           C  \nATOM   8232  CD  GLU A1062     -25.053  53.689  10.302  1.00 23.86           C  \nATOM   8233  OE1 GLU A1062     -25.636  52.744   9.726  1.00 23.86           O  \nATOM   8234  OE2 GLU A1062     -25.040  54.876   9.902  1.00 23.86           O  \nATOM   8235  N   ASP A1063     -20.065  53.591  12.962  1.00 24.47           N  \nATOM   8236  CA  ASP A1063     -18.589  53.711  13.075  1.00 24.47           C  \nATOM   8237  C   ASP A1063     -17.940  53.443  14.457  1.00 24.47           C  \nATOM   8238  CB  ASP A1063     -18.018  54.988  12.412  1.00 24.47           C  \nATOM   8239  O   ASP A1063     -17.195  54.273  14.975  1.00 24.47           O  \nATOM   8240  CG  ASP A1063     -18.415  55.175  10.951  1.00 24.47           C  \nATOM   8241  OD1 ASP A1063     -18.562  54.136  10.264  1.00 24.47           O  \nATOM   8242  OD2 ASP A1063     -18.494  56.353  10.530  1.00 24.47           O  \nATOM   8243  N   SER A1064     -18.107  52.231  15.017  1.00 26.12           N  \nATOM   8244  CA  SER A1064     -17.058  51.593  15.856  1.00 26.12           C  \nATOM   8245  C   SER A1064     -17.241  50.069  16.044  1.00 26.12           C  \nATOM   8246  CB  SER A1064     -16.908  52.264  17.232  1.00 26.12           C  \nATOM   8247  O   SER A1064     -17.605  49.595  17.115  1.00 26.12           O  \nATOM   8248  OG  SER A1064     -15.657  51.877  17.773  1.00 26.12           O  \nATOM   8249  N   PHE A1065     -17.005  49.266  14.994  1.00 28.64           N  \nATOM   8250  CA  PHE A1065     -17.070  47.787  15.063  1.00 28.64           C  \nATOM   8251  C   PHE A1065     -16.027  47.103  14.148  1.00 28.64           C  \nATOM   8252  CB  PHE A1065     -18.513  47.295  14.800  1.00 28.64           C  \nATOM   8253  O   PHE A1065     -16.371  46.284  13.284  1.00 28.64           O  \nATOM   8254  CG  PHE A1065     -19.480  47.486  15.957  1.00 28.64           C  \nATOM   8255  CD1 PHE A1065     -19.386  46.657  17.093  1.00 28.64           C  \nATOM   8256  CD2 PHE A1065     -20.469  48.488  15.909  1.00 28.64           C  \nATOM   8257  CE1 PHE A1065     -20.269  46.831  18.174  1.00 28.64           C  \nATOM   8258  CE2 PHE A1065     -21.351  48.663  16.991  1.00 28.64           C  \nATOM   8259  CZ  PHE A1065     -21.251  47.836  18.123  1.00 28.64           C  \nATOM   8260  N   LEU A1066     -14.748  47.475  14.293  1.00 27.47           N  \nATOM   8261  CA  LEU A1066     -13.641  47.058  13.408  1.00 27.47           C  \nATOM   8262  C   LEU A1066     -12.314  46.731  14.141  1.00 27.47           C  \nATOM   8263  CB  LEU A1066     -13.477  48.101  12.269  1.00 27.47           C  \nATOM   8264  O   LEU A1066     -11.244  47.080  13.661  1.00 27.47           O  \nATOM   8265  CG  LEU A1066     -14.383  47.872  11.045  1.00 27.47           C  \nATOM   8266  CD1 LEU A1066     -14.269  49.057  10.089  1.00 27.47           C  \nATOM   8267  CD2 LEU A1066     -13.993  46.610  10.264  1.00 27.47           C  \nATOM   8268  N   GLN A1067     -12.366  46.023  15.274  1.00 30.78           N  \nATOM   8269  CA  GLN A1067     -11.187  45.431  15.941  1.00 30.78           C  \nATOM   8270  C   GLN A1067     -11.634  44.283  16.866  1.00 30.78           C  \nATOM   8271  CB  GLN A1067     -10.436  46.530  16.739  1.00 30.78           C  \nATOM   8272  O   GLN A1067     -12.110  44.548  17.963  1.00 30.78           O  \nATOM   8273  CG  GLN A1067      -9.111  46.963  16.083  1.00 30.78           C  \nATOM   8274  CD  GLN A1067      -8.610  48.326  16.562  1.00 30.78           C  \nATOM   8275  NE2 GLN A1067      -7.592  48.869  15.931  1.00 30.78           N  \nATOM   8276  OE1 GLN A1067      -9.106  48.938  17.490  1.00 30.78           O  \nATOM   8277  N   ARG A1068     -11.554  43.014  16.418  1.00 35.94           N  \nATOM   8278  CA  ARG A1068     -11.853  41.822  17.265  1.00 35.94           C  \nATOM   8279  C   ARG A1068     -11.002  40.573  16.998  1.00 35.94           C  \nATOM   8280  CB  ARG A1068     -13.353  41.454  17.198  1.00 35.94           C  \nATOM   8281  O   ARG A1068     -11.154  39.573  17.696  1.00 35.94           O  \nATOM   8282  CG  ARG A1068     -14.204  42.435  18.009  1.00 35.94           C  \nATOM   8283  CD  ARG A1068     -15.605  41.910  18.304  1.00 35.94           C  \nATOM   8284  NE  ARG A1068     -16.271  42.838  19.227  1.00 35.94           N  \nATOM   8285  NH1 ARG A1068     -18.455  42.186  18.925  1.00 35.94           N  \nATOM   8286  NH2 ARG A1068     -17.901  43.803  20.403  1.00 35.94           N  \nATOM   8287  CZ  ARG A1068     -17.549  42.938  19.502  1.00 35.94           C  \nATOM   8288  N   TYR A1069     -10.153  40.599  15.971  1.00 28.78           N  \nATOM   8289  CA  TYR A1069      -9.210  39.525  15.654  1.00 28.78           C  \nATOM   8290  C   TYR A1069      -7.801  40.127  15.584  1.00 28.78           C  \nATOM   8291  CB  TYR A1069      -9.631  38.794  14.365  1.00 28.78           C  \nATOM   8292  O   TYR A1069      -7.588  41.118  14.886  1.00 28.78           O  \nATOM   8293  CG  TYR A1069     -10.742  37.763  14.549  1.00 28.78           C  \nATOM   8294  CD1 TYR A1069     -10.468  36.396  14.343  1.00 28.78           C  \nATOM   8295  CD2 TYR A1069     -12.041  38.151  14.943  1.00 28.78           C  \nATOM   8296  CE1 TYR A1069     -11.478  35.431  14.526  1.00 28.78           C  \nATOM   8297  CE2 TYR A1069     -13.043  37.187  15.169  1.00 28.78           C  \nATOM   8298  OH  TYR A1069     -13.716  34.880  15.176  1.00 28.78           O  \nATOM   8299  CZ  TYR A1069     -12.761  35.821  14.957  1.00 28.78           C  \nATOM   8300  N   SER A1070      -6.887  39.533  16.360  1.00 33.25           N  \nATOM   8301  CA  SER A1070      -5.522  39.973  16.694  1.00 33.25           C  \nATOM   8302  C   SER A1070      -4.929  41.107  15.840  1.00 33.25           C  \nATOM   8303  CB  SER A1070      -4.595  38.752  16.657  1.00 33.25           C  \nATOM   8304  O   SER A1070      -4.424  40.882  14.738  1.00 33.25           O  \nATOM   8305  OG  SER A1070      -3.317  39.103  17.147  1.00 33.25           O  \nATOM   8306  N   SER A1071      -4.902  42.315  16.410  1.00 26.88           N  \nATOM   8307  CA  SER A1071      -4.048  43.420  15.954  1.00 26.88           C  \nATOM   8308  C   SER A1071      -2.772  43.445  16.802  1.00 26.88           C  \nATOM   8309  CB  SER A1071      -4.800  44.749  16.054  1.00 26.88           C  \nATOM   8310  O   SER A1071      -2.849  43.492  18.027  1.00 26.88           O  \nATOM   8311  OG  SER A1071      -5.950  44.691  15.229  1.00 26.88           O  \nATOM   8312  N   ASP A1072      -1.604  43.386  16.161  1.00 31.84           N  \nATOM   8313  CA  ASP A1072      -0.296  43.373  16.835  1.00 31.84           C  \nATOM   8314  C   ASP A1072      -0.047  44.709  17.583  1.00 31.84           C  \nATOM   8315  CB  ASP A1072       0.791  43.078  15.780  1.00 31.84           C  \nATOM   8316  O   ASP A1072       0.012  45.755  16.929  1.00 31.84           O  \nATOM   8317  CG  ASP A1072       2.231  43.008  16.314  1.00 31.84           C  \nATOM   8318  OD1 ASP A1072       2.469  43.392  17.483  1.00 31.84           O  \nATOM   8319  OD2 ASP A1072       3.109  42.602  15.521  1.00 31.84           O  \nATOM   8320  N   PRO A1073       0.149  44.718  18.923  1.00 29.45           N  \nATOM   8321  CA  PRO A1073       0.393  45.939  19.706  1.00 29.45           C  \nATOM   8322  C   PRO A1073       1.721  46.671  19.423  1.00 29.45           C  \nATOM   8323  CB  PRO A1073       0.303  45.517  21.180  1.00 29.45           C  \nATOM   8324  O   PRO A1073       2.086  47.569  20.185  1.00 29.45           O  \nATOM   8325  CG  PRO A1073      -0.499  44.220  21.147  1.00 29.45           C  \nATOM   8326  CD  PRO A1073      -0.043  43.596  19.834  1.00 29.45           C  \nATOM   8327  N   THR A1074       2.462  46.278  18.383  1.00 33.53           N  \nATOM   8328  CA  THR A1074       3.807  46.780  18.044  1.00 33.53           C  \nATOM   8329  C   THR A1074       3.814  47.746  16.841  1.00 33.53           C  \nATOM   8330  CB  THR A1074       4.777  45.594  17.832  1.00 33.53           C  \nATOM   8331  O   THR A1074       4.866  48.254  16.468  1.00 33.53           O  \nATOM   8332  CG2 THR A1074       6.240  45.945  18.108  1.00 33.53           C  \nATOM   8333  OG1 THR A1074       4.487  44.533  18.721  1.00 33.53           O  \nATOM   8334  N   GLY A1075       2.661  48.029  16.221  1.00 27.36           N  \nATOM   8335  CA  GLY A1075       2.567  48.781  14.953  1.00 27.36           C  \nATOM   8336  C   GLY A1075       2.520  50.319  15.024  1.00 27.36           C  \nATOM   8337  O   GLY A1075       2.186  50.943  14.024  1.00 27.36           O  \nATOM   8338  N   ALA A1076       2.786  50.946  16.174  1.00 26.08           N  \nATOM   8339  CA  ALA A1076       2.515  52.374  16.403  1.00 26.08           C  \nATOM   8340  C   ALA A1076       3.734  53.307  16.205  1.00 26.08           C  \nATOM   8341  CB  ALA A1076       1.828  52.527  17.769  1.00 26.08           C  \nATOM   8342  O   ALA A1076       4.101  54.046  17.118  1.00 26.08           O  \nATOM   8343  N   LEU A1077       4.341  53.295  15.014  1.00 27.31           N  \nATOM   8344  CA  LEU A1077       5.241  54.354  14.528  1.00 27.31           C  \nATOM   8345  C   LEU A1077       4.913  54.659  13.058  1.00 27.31           C  \nATOM   8346  CB  LEU A1077       6.725  53.971  14.710  1.00 27.31           C  \nATOM   8347  O   LEU A1077       4.689  53.740  12.273  1.00 27.31           O  \nATOM   8348  CG  LEU A1077       7.254  54.039  16.157  1.00 27.31           C  \nATOM   8349  CD1 LEU A1077       8.710  53.569  16.197  1.00 27.31           C  \nATOM   8350  CD2 LEU A1077       7.217  55.456  16.740  1.00 27.31           C  \nATOM   8351  N   THR A1078       4.822  55.945  12.720  1.00 26.27           N  \nATOM   8352  CA  THR A1078       4.289  56.456  11.445  1.00 26.27           C  \nATOM   8353  C   THR A1078       5.359  56.701  10.377  1.00 26.27           C  \nATOM   8354  CB  THR A1078       3.470  57.738  11.686  1.00 26.27           C  \nATOM   8355  O   THR A1078       6.555  56.660  10.651  1.00 26.27           O  \nATOM   8356  CG2 THR A1078       2.140  57.428  12.375  1.00 26.27           C  \nATOM   8357  OG1 THR A1078       4.179  58.628  12.521  1.00 26.27           O  \nATOM   8358  N   GLU A1079       4.884  56.952   9.158  1.00 25.97           N  \nATOM   8359  CA  GLU A1079       5.630  57.198   7.917  1.00 25.97           C  \nATOM   8360  C   GLU A1079       6.660  58.344   8.019  1.00 25.97           C  \nATOM   8361  CB  GLU A1079       4.585  57.568   6.836  1.00 25.97           C  \nATOM   8362  O   GLU A1079       6.328  59.407   8.538  1.00 25.97           O  \nATOM   8363  CG  GLU A1079       3.523  56.474   6.581  1.00 25.97           C  \nATOM   8364  CD  GLU A1079       2.212  57.011   5.977  1.00 25.97           C  \nATOM   8365  OE1 GLU A1079       1.773  56.448   4.948  1.00 25.97           O  \nATOM   8366  OE2 GLU A1079       1.595  57.899   6.611  1.00 25.97           O  \nATOM   8367  N   ASP A1080       7.887  58.130   7.511  1.00 26.53           N  \nATOM   8368  CA  ASP A1080       8.557  58.941   6.461  1.00 26.53           C  \nATOM   8369  C   ASP A1080      10.046  58.542   6.266  1.00 26.53           C  \nATOM   8370  CB  ASP A1080       8.458  60.470   6.705  1.00 26.53           C  \nATOM   8371  O   ASP A1080      10.647  57.945   7.155  1.00 26.53           O  \nATOM   8372  CG  ASP A1080       7.318  61.145   5.920  1.00 26.53           C  \nATOM   8373  OD1 ASP A1080       6.972  60.620   4.835  1.00 26.53           O  \nATOM   8374  OD2 ASP A1080       6.908  62.258   6.323  1.00 26.53           O  \nATOM   8375  N   SER A1081      10.651  58.930   5.124  1.00 26.45           N  \nATOM   8376  CA  SER A1081      12.093  58.805   4.761  1.00 26.45           C  \nATOM   8377  C   SER A1081      12.630  57.363   4.580  1.00 26.45           C  \nATOM   8378  CB  SER A1081      12.935  59.600   5.768  1.00 26.45           C  \nATOM   8379  O   SER A1081      12.734  56.603   5.533  1.00 26.45           O  \nATOM   8380  OG  SER A1081      14.243  59.828   5.283  1.00 26.45           O  \nATOM   8381  N   ILE A1082      12.880  56.874   3.354  1.00 27.28           N  \nATOM   8382  CA  ILE A1082      14.090  57.081   2.507  1.00 27.28           C  \nATOM   8383  C   ILE A1082      15.374  56.495   3.134  1.00 27.28           C  \nATOM   8384  CB  ILE A1082      14.285  58.538   2.009  1.00 27.28           C  \nATOM   8385  O   ILE A1082      15.723  56.897   4.237  1.00 27.28           O  \nATOM   8386  CG1 ILE A1082      13.089  59.004   1.147  1.00 27.28           C  \nATOM   8387  CG2 ILE A1082      15.592  58.687   1.201  1.00 27.28           C  \nATOM   8388  CD1 ILE A1082      13.029  60.526   0.955  1.00 27.28           C  \nATOM   8389  N   ASP A1083      16.030  55.590   2.380  1.00 26.45           N  \nATOM   8390  CA  ASP A1083      17.395  55.015   2.482  1.00 26.45           C  \nATOM   8391  C   ASP A1083      18.084  55.065   3.871  1.00 26.45           C  \nATOM   8392  CB  ASP A1083      18.282  55.660   1.390  1.00 26.45           C  \nATOM   8393  O   ASP A1083      18.419  56.133   4.369  1.00 26.45           O  \nATOM   8394  CG  ASP A1083      17.719  55.522  -0.037  1.00 26.45           C  \nATOM   8395  OD1 ASP A1083      16.998  54.529  -0.294  1.00 26.45           O  \nATOM   8396  OD2 ASP A1083      17.978  56.425  -0.867  1.00 26.45           O  \nATOM   8397  N   ASP A1084      18.412  53.932   4.514  1.00 27.81           N  \nATOM   8398  CA  ASP A1084      19.708  53.292   4.220  1.00 27.81           C  \nATOM   8399  C   ASP A1084      19.868  51.809   4.659  1.00 27.81           C  \nATOM   8400  CB  ASP A1084      20.856  54.100   4.883  1.00 27.81           C  \nATOM   8401  O   ASP A1084      19.343  51.334   5.667  1.00 27.81           O  \nATOM   8402  CG  ASP A1084      22.060  54.305   3.956  1.00 27.81           C  \nATOM   8403  OD1 ASP A1084      22.325  53.396   3.130  1.00 27.81           O  \nATOM   8404  OD2 ASP A1084      22.747  55.339   4.110  1.00 27.81           O  \nATOM   8405  N   THR A1085      20.708  51.123   3.887  1.00 26.36           N  \nATOM   8406  CA  THR A1085      21.557  49.946   4.150  1.00 26.36           C  \nATOM   8407  C   THR A1085      21.676  49.398   5.589  1.00 26.36           C  \nATOM   8408  CB  THR A1085      22.984  50.356   3.714  1.00 26.36           C  \nATOM   8409  O   THR A1085      22.310  50.010   6.444  1.00 26.36           O  \nATOM   8410  CG2 THR A1085      23.960  49.182   3.621  1.00 26.36           C  \nATOM   8411  OG1 THR A1085      22.970  50.948   2.434  1.00 26.36           O  \nATOM   8412  N   PHE A1086      21.314  48.119   5.793  1.00 26.03           N  \nATOM   8413  CA  PHE A1086      21.987  47.239   6.770  1.00 26.03           C  \nATOM   8414  C   PHE A1086      22.195  45.819   6.211  1.00 26.03           C  \nATOM   8415  CB  PHE A1086      21.283  47.236   8.141  1.00 26.03           C  \nATOM   8416  O   PHE A1086      21.267  45.182   5.718  1.00 26.03           O  \nATOM   8417  CG  PHE A1086      22.044  48.039   9.185  1.00 26.03           C  \nATOM   8418  CD1 PHE A1086      23.092  47.442   9.916  1.00 26.03           C  \nATOM   8419  CD2 PHE A1086      21.759  49.404   9.371  1.00 26.03           C  \nATOM   8420  CE1 PHE A1086      23.852  48.209  10.819  1.00 26.03           C  \nATOM   8421  CE2 PHE A1086      22.521  50.172  10.269  1.00 26.03           C  \nATOM   8422  CZ  PHE A1086      23.569  49.576  10.992  1.00 26.03           C  \nATOM   8423  N   LEU A1087      23.441  45.337   6.264  1.00 26.56           N  \nATOM   8424  CA  LEU A1087      23.902  44.097   5.622  1.00 26.56           C  \nATOM   8425  C   LEU A1087      23.809  42.870   6.554  1.00 26.56           C  \nATOM   8426  CB  LEU A1087      25.366  44.296   5.176  1.00 26.56           C  \nATOM   8427  O   LEU A1087      24.031  43.009   7.759  1.00 26.56           O  \nATOM   8428  CG  LEU A1087      25.540  45.230   3.963  1.00 26.56           C  \nATOM   8429  CD1 LEU A1087      26.957  45.802   3.935  1.00 26.56           C  \nATOM   8430  CD2 LEU A1087      25.302  44.478   2.652  1.00 26.56           C  \nATOM   8431  N   PRO A1088      23.587  41.651   6.018  1.00 28.02           N  \nATOM   8432  CA  PRO A1088      23.842  40.416   6.757  1.00 28.02           C  \nATOM   8433  C   PRO A1088      25.353  40.215   6.975  1.00 28.02           C  \nATOM   8434  CB  PRO A1088      23.224  39.302   5.908  1.00 28.02           C  \nATOM   8435  O   PRO A1088      26.171  40.555   6.119  1.00 28.02           O  \nATOM   8436  CG  PRO A1088      23.382  39.831   4.482  1.00 28.02           C  \nATOM   8437  CD  PRO A1088      23.223  41.345   4.640  1.00 28.02           C  \nATOM   8438  N   VAL A1089      25.732  39.650   8.125  1.00 29.02           N  \nATOM   8439  CA  VAL A1089      27.143  39.416   8.486  1.00 29.02           C  \nATOM   8440  C   VAL A1089      27.739  38.268   7.641  1.00 29.02           C  \nATOM   8441  CB  VAL A1089      27.292  39.160   9.999  1.00 29.02           C  \nATOM   8442  O   VAL A1089      27.053  37.258   7.475  1.00 29.02           O  \nATOM   8443  CG1 VAL A1089      28.736  38.851  10.416  1.00 29.02           C  \nATOM   8444  CG2 VAL A1089      26.844  40.396  10.796  1.00 29.02           C  \nATOM   8445  N   PRO A1090      28.981  38.373   7.111  1.00 29.39           N  \nATOM   8446  CA  PRO A1090      29.491  37.423   6.113  1.00 29.39           C  \nATOM   8447  C   PRO A1090      30.100  36.131   6.680  1.00 29.39           C  \nATOM   8448  CB  PRO A1090      30.537  38.187   5.284  1.00 29.39           C  \nATOM   8449  O   PRO A1090      30.389  36.002   7.869  1.00 29.39           O  \nATOM   8450  CG  PRO A1090      30.361  39.647   5.687  1.00 29.39           C  \nATOM   8451  CD  PRO A1090      29.873  39.525   7.123  1.00 29.39           C  \nATOM   8452  N   GLU A1091      30.361  35.194   5.766  1.00 26.55           N  \nATOM   8453  CA  GLU A1091      31.051  33.921   5.995  1.00 26.55           C  \nATOM   8454  C   GLU A1091      32.500  34.088   6.493  1.00 26.55           C  \nATOM   8455  CB  GLU A1091      31.124  33.142   4.667  1.00 26.55           C  \nATOM   8456  O   GLU A1091      33.218  34.996   6.075  1.00 26.55           O  \nATOM   8457  CG  GLU A1091      29.778  32.887   3.972  1.00 26.55           C  \nATOM   8458  CD  GLU A1091      30.014  32.354   2.552  1.00 26.55           C  \nATOM   8459  OE1 GLU A1091      29.736  31.157   2.319  1.00 26.55           O  \nATOM   8460  OE2 GLU A1091      30.504  33.149   1.717  1.00 26.55           O  \nATOM   8461  N   TYR A1092      32.983  33.114   7.274  1.00 31.11           N  \nATOM   8462  CA  TYR A1092      34.418  32.884   7.482  1.00 31.11           C  \nATOM   8463  C   TYR A1092      34.879  31.637   6.715  1.00 31.11           C  \nATOM   8464  CB  TYR A1092      34.774  32.856   8.980  1.00 31.11           C  \nATOM   8465  O   TYR A1092      34.896  30.523   7.237  1.00 31.11           O  \nATOM   8466  CG  TYR A1092      35.487  34.113   9.439  1.00 31.11           C  \nATOM   8467  CD1 TYR A1092      36.882  34.233   9.266  1.00 31.11           C  \nATOM   8468  CD2 TYR A1092      34.755  35.173  10.006  1.00 31.11           C  \nATOM   8469  CE1 TYR A1092      37.545  35.407   9.673  1.00 31.11           C  \nATOM   8470  CE2 TYR A1092      35.415  36.347  10.418  1.00 31.11           C  \nATOM   8471  OH  TYR A1092      37.453  37.597  10.643  1.00 31.11           O  \nATOM   8472  CZ  TYR A1092      36.812  36.465  10.251  1.00 31.11           C  \nATOM   8473  N   ILE A1093      35.291  31.840   5.463  1.00 28.25           N  \nATOM   8474  CA  ILE A1093      36.055  30.857   4.684  1.00 28.25           C  \nATOM   8475  C   ILE A1093      37.549  31.114   4.898  1.00 28.25           C  \nATOM   8476  CB  ILE A1093      35.668  30.926   3.183  1.00 28.25           C  \nATOM   8477  O   ILE A1093      37.999  32.255   4.806  1.00 28.25           O  \nATOM   8478  CG1 ILE A1093      34.214  30.432   2.996  1.00 28.25           C  \nATOM   8479  CG2 ILE A1093      36.638  30.115   2.295  1.00 28.25           C  \nATOM   8480  CD1 ILE A1093      33.668  30.574   1.569  1.00 28.25           C  \nATOM   8481  N   ASN A1094      38.346  30.055   5.072  1.00 33.56           N  \nATOM   8482  CA  ASN A1094      39.708  30.053   4.536  1.00 33.56           C  \nATOM   8483  C   ASN A1094      40.239  28.639   4.248  1.00 33.56           C  \nATOM   8484  CB  ASN A1094      40.666  30.888   5.414  1.00 33.56           C  \nATOM   8485  O   ASN A1094      39.979  27.687   4.979  1.00 33.56           O  \nATOM   8486  CG  ASN A1094      41.148  32.126   4.669  1.00 33.56           C  \nATOM   8487  ND2 ASN A1094      41.279  33.249   5.334  1.00 33.56           N  \nATOM   8488  OD1 ASN A1094      41.428  32.095   3.482  1.00 33.56           O  \nATOM   8489  N   GLN A1095      40.983  28.521   3.151  1.00 26.69           N  \nATOM   8490  CA  GLN A1095      41.666  27.304   2.682  1.00 26.69           C  \nATOM   8491  C   GLN A1095      43.139  27.378   3.176  1.00 26.69           C  \nATOM   8492  CB  GLN A1095      41.471  27.235   1.149  1.00 26.69           C  \nATOM   8493  O   GLN A1095      43.613  28.470   3.462  1.00 26.69           O  \nATOM   8494  CG  GLN A1095      39.976  27.159   0.732  1.00 26.69           C  \nATOM   8495  CD  GLN A1095      39.712  27.415  -0.754  1.00 26.69           C  \nATOM   8496  NE2 GLN A1095      38.471  27.377  -1.188  1.00 26.69           N  \nATOM   8497  OE1 GLN A1095      40.600  27.649  -1.554  1.00 26.69           O  \nATOM   8498  N   SER A1096      43.929  26.309   3.375  1.00 34.25           N  \nATOM   8499  CA  SER A1096      44.475  25.464   2.298  1.00 34.25           C  \nATOM   8500  C   SER A1096      45.377  24.287   2.778  1.00 34.25           C  \nATOM   8501  CB  SER A1096      45.373  26.355   1.415  1.00 34.25           C  \nATOM   8502  O   SER A1096      46.275  24.485   3.588  1.00 34.25           O  \nATOM   8503  OG  SER A1096      46.335  27.044   2.192  1.00 34.25           O  \nATOM   8504  N   VAL A1097      45.166  23.084   2.212  1.00 31.22           N  \nATOM   8505  CA  VAL A1097      46.113  22.150   1.512  1.00 31.22           C  \nATOM   8506  C   VAL A1097      47.661  22.284   1.764  1.00 31.22           C  \nATOM   8507  CB  VAL A1097      45.816  22.280  -0.029  1.00 31.22           C  \nATOM   8508  O   VAL A1097      48.155  23.403   1.688  1.00 31.22           O  \nATOM   8509  CG1 VAL A1097      45.802  20.933  -0.772  1.00 31.22           C  \nATOM   8510  CG2 VAL A1097      44.458  22.917  -0.411  1.00 31.22           C  \nATOM   8511  N   PRO A1098      48.515  21.213   1.710  1.00 38.16           N  \nATOM   8512  CA  PRO A1098      48.556  19.912   2.446  1.00 38.16           C  \nATOM   8513  C   PRO A1098      49.995  19.391   2.860  1.00 38.16           C  \nATOM   8514  CB  PRO A1098      48.057  18.948   1.367  1.00 38.16           C  \nATOM   8515  O   PRO A1098      50.977  19.809   2.249  1.00 38.16           O  \nATOM   8516  CG  PRO A1098      48.831  19.435   0.129  1.00 38.16           C  \nATOM   8517  CD  PRO A1098      49.075  20.934   0.389  1.00 38.16           C  \nATOM   8518  N   LYS A1099      50.135  18.361   3.747  1.00 30.77           N  \nATOM   8519  CA  LYS A1099      51.045  17.143   3.661  1.00 30.77           C  \nATOM   8520  C   LYS A1099      51.435  16.450   5.006  1.00 30.77           C  \nATOM   8521  CB  LYS A1099      52.338  17.356   2.823  1.00 30.77           C  \nATOM   8522  O   LYS A1099      51.318  17.013   6.082  1.00 30.77           O  \nATOM   8523  CG  LYS A1099      52.085  17.074   1.328  1.00 30.77           C  \nATOM   8524  CD  LYS A1099      53.225  17.576   0.432  1.00 30.77           C  \nATOM   8525  CE  LYS A1099      52.839  17.445  -1.049  1.00 30.77           C  \nATOM   8526  NZ  LYS A1099      53.911  17.960  -1.938  1.00 30.77           N  \nATOM   8527  N   ARG A1100      51.882  15.183   4.877  1.00 28.67           N  \nATOM   8528  CA  ARG A1100      52.389  14.153   5.845  1.00 28.67           C  \nATOM   8529  C   ARG A1100      53.928  14.254   6.101  1.00 28.67           C  \nATOM   8530  CB  ARG A1100      52.117  12.805   5.125  1.00 28.67           C  \nATOM   8531  O   ARG A1100      54.549  14.939   5.289  1.00 28.67           O  \nATOM   8532  CG  ARG A1100      50.768  12.123   5.399  1.00 28.67           C  \nATOM   8533  CD  ARG A1100      50.737  10.795   4.618  1.00 28.67           C  \nATOM   8534  NE  ARG A1100      49.475  10.047   4.791  1.00 28.67           N  \nATOM   8535  NH1 ARG A1100      49.985   8.266   3.418  1.00 28.67           N  \nATOM   8536  NH2 ARG A1100      48.014   8.326   4.451  1.00 28.67           N  \nATOM   8537  CZ  ARG A1100      49.167   8.890   4.222  1.00 28.67           C  \nATOM   8538  N   PRO A1101      54.599  13.425   6.964  1.00 36.16           N  \nATOM   8539  CA  PRO A1101      54.192  12.665   8.186  1.00 36.16           C  \nATOM   8540  C   PRO A1101      55.246  12.607   9.363  1.00 36.16           C  \nATOM   8541  CB  PRO A1101      54.087  11.226   7.655  1.00 36.16           C  \nATOM   8542  O   PRO A1101      56.375  13.053   9.208  1.00 36.16           O  \nATOM   8543  CG  PRO A1101      55.259  11.141   6.663  1.00 36.16           C  \nATOM   8544  CD  PRO A1101      55.635  12.597   6.347  1.00 36.16           C  \nATOM   8545  N   ALA A1102      54.911  11.858  10.439  1.00 26.83           N  \nATOM   8546  CA  ALA A1102      55.789  11.056  11.347  1.00 26.83           C  \nATOM   8547  C   ALA A1102      56.475  11.677  12.608  1.00 26.83           C  \nATOM   8548  CB  ALA A1102      56.757  10.196  10.514  1.00 26.83           C  \nATOM   8549  O   ALA A1102      56.849  12.842  12.627  1.00 26.83           O  \nATOM   8550  N   GLY A1103      56.665  10.827  13.647  1.00 30.48           N  \nATOM   8551  CA  GLY A1103      57.158  11.121  15.024  1.00 30.48           C  \nATOM   8552  C   GLY A1103      56.000  11.168  16.051  1.00 30.48           C  \nATOM   8553  O   GLY A1103      55.053  11.901  15.810  1.00 30.48           O  \nATOM   8554  N   SER A1104      55.864  10.343  17.112  1.00 25.72           N  \nATOM   8555  CA  SER A1104      56.778   9.907  18.205  1.00 25.72           C  \nATOM   8556  C   SER A1104      57.185  11.089  19.105  1.00 25.72           C  \nATOM   8557  CB  SER A1104      57.970   9.095  17.686  1.00 25.72           C  \nATOM   8558  O   SER A1104      57.823  12.002  18.599  1.00 25.72           O  \nATOM   8559  OG  SER A1104      58.502   8.288  18.716  1.00 25.72           O  \nATOM   8560  N   VAL A1105      56.808  11.186  20.397  1.00 29.39           N  \nATOM   8561  CA  VAL A1105      57.234  10.367  21.574  1.00 29.39           C  \nATOM   8562  C   VAL A1105      56.206  10.437  22.755  1.00 29.39           C  \nATOM   8563  CB  VAL A1105      58.648  10.881  21.990  1.00 29.39           C  \nATOM   8564  O   VAL A1105      55.243  11.194  22.690  1.00 29.39           O  \nATOM   8565  CG1 VAL A1105      59.108  10.693  23.443  1.00 29.39           C  \nATOM   8566  CG2 VAL A1105      59.725  10.210  21.120  1.00 29.39           C  \nATOM   8567  N   GLN A1106      56.373   9.607  23.803  1.00 28.38           N  \nATOM   8568  CA  GLN A1106      55.422   9.269  24.897  1.00 28.38           C  \nATOM   8569  C   GLN A1106      54.989  10.343  25.940  1.00 28.38           C  \nATOM   8570  CB  GLN A1106      56.036   8.119  25.728  1.00 28.38           C  \nATOM   8571  O   GLN A1106      55.783  11.172  26.368  1.00 28.38           O  \nATOM   8572  CG  GLN A1106      56.300   6.811  24.966  1.00 28.38           C  \nATOM   8573  CD  GLN A1106      57.783   6.586  24.693  1.00 28.38           C  \nATOM   8574  NE2 GLN A1106      58.426   5.651  25.360  1.00 28.38           N  \nATOM   8575  OE1 GLN A1106      58.389   7.257  23.877  1.00 28.38           O  \nATOM   8576  N   ASN A1107      53.737  10.187  26.423  1.00 33.69           N  \nATOM   8577  CA  ASN A1107      53.244   9.958  27.819  1.00 33.69           C  \nATOM   8578  C   ASN A1107      54.180  10.204  29.040  1.00 33.69           C  \nATOM   8579  CB  ASN A1107      52.729   8.492  27.856  1.00 33.69           C  \nATOM   8580  O   ASN A1107      55.362   9.868  28.961  1.00 33.69           O  \nATOM   8581  CG  ASN A1107      51.221   8.347  27.952  1.00 33.69           C  \nATOM   8582  ND2 ASN A1107      50.718   7.140  27.842  1.00 33.69           N  \nATOM   8583  OD1 ASN A1107      50.473   9.284  28.133  1.00 33.69           O  \nATOM   8584  N   PRO A1108      53.652  10.644  30.215  1.00 35.66           N  \nATOM   8585  CA  PRO A1108      52.910   9.758  31.158  1.00 35.66           C  \nATOM   8586  C   PRO A1108      51.643  10.407  31.799  1.00 35.66           C  \nATOM   8587  CB  PRO A1108      53.969   9.439  32.216  1.00 35.66           C  \nATOM   8588  O   PRO A1108      51.513  11.624  31.775  1.00 35.66           O  \nATOM   8589  CG  PRO A1108      54.684  10.776  32.401  1.00 35.66           C  \nATOM   8590  CD  PRO A1108      54.487  11.499  31.065  1.00 35.66           C  \nATOM   8591  N   VAL A1109      50.603   9.727  32.324  1.00 31.11           N  \nATOM   8592  CA  VAL A1109      50.433   8.484  33.135  1.00 31.11           C  \nATOM   8593  C   VAL A1109      50.738   8.640  34.641  1.00 31.11           C  \nATOM   8594  CB  VAL A1109      51.077   7.218  32.526  1.00 31.11           C  \nATOM   8595  O   VAL A1109      51.858   8.971  35.010  1.00 31.11           O  \nATOM   8596  CG1 VAL A1109      50.946   5.992  33.433  1.00 31.11           C  \nATOM   8597  CG2 VAL A1109      50.410   6.855  31.198  1.00 31.11           C  \nATOM   8598  N   TYR A1110      49.765   8.306  35.510  1.00 33.34           N  \nATOM   8599  CA  TYR A1110      49.951   8.102  36.963  1.00 33.34           C  \nATOM   8600  C   TYR A1110      49.082   6.955  37.527  1.00 33.34           C  \nATOM   8601  CB  TYR A1110      49.734   9.406  37.755  1.00 33.34           C  \nATOM   8602  O   TYR A1110      48.016   6.653  36.997  1.00 33.34           O  \nATOM   8603  CG  TYR A1110      51.029   9.955  38.322  1.00 33.34           C  \nATOM   8604  CD1 TYR A1110      51.573   9.407  39.503  1.00 33.34           C  \nATOM   8605  CD2 TYR A1110      51.722  10.969  37.635  1.00 33.34           C  \nATOM   8606  CE1 TYR A1110      52.816   9.861  39.984  1.00 33.34           C  \nATOM   8607  CE2 TYR A1110      52.959  11.434  38.119  1.00 33.34           C  \nATOM   8608  OH  TYR A1110      54.717  11.311  39.743  1.00 33.34           O  \nATOM   8609  CZ  TYR A1110      53.513  10.875  39.289  1.00 33.34           C  \nATOM   8610  N   HIS A1111      49.573   6.314  38.599  1.00 32.56           N  \nATOM   8611  CA  HIS A1111      49.160   5.009  39.159  1.00 32.56           C  \nATOM   8612  C   HIS A1111      49.375   4.989  40.708  1.00 32.56           C  \nATOM   8613  CB  HIS A1111      50.015   3.952  38.429  1.00 32.56           C  \nATOM   8614  O   HIS A1111      50.022   5.900  41.218  1.00 32.56           O  \nATOM   8615  CG  HIS A1111      49.465   3.485  37.109  1.00 32.56           C  \nATOM   8616  CD2 HIS A1111      49.838   3.936  35.877  1.00 32.56           C  \nATOM   8617  ND1 HIS A1111      48.609   2.427  36.907  1.00 32.56           N  \nATOM   8618  CE1 HIS A1111      48.452   2.267  35.582  1.00 32.56           C  \nATOM   8619  NE2 HIS A1111      49.190   3.163  34.910  1.00 32.56           N  \nATOM   8620  N   ASN A1112      48.912   4.020  41.528  1.00 33.19           N  \nATOM   8621  CA  ASN A1112      48.325   2.704  41.221  1.00 33.19           C  \nATOM   8622  C   ASN A1112      47.401   2.117  42.331  1.00 33.19           C  \nATOM   8623  CB  ASN A1112      49.487   1.685  41.070  1.00 33.19           C  \nATOM   8624  O   ASN A1112      47.794   2.139  43.490  1.00 33.19           O  \nATOM   8625  CG  ASN A1112      49.216   0.631  40.015  1.00 33.19           C  \nATOM   8626  ND2 ASN A1112      49.972  -0.436  40.022  1.00 33.19           N  \nATOM   8627  OD1 ASN A1112      48.315   0.746  39.197  1.00 33.19           O  \nATOM   8628  N   GLN A1113      46.320   1.427  41.923  1.00 29.94           N  \nATOM   8629  CA  GLN A1113      45.797   0.142  42.473  1.00 29.94           C  \nATOM   8630  C   GLN A1113      45.374  -0.006  43.981  1.00 29.94           C  \nATOM   8631  CB  GLN A1113      46.704  -0.986  41.916  1.00 29.94           C  \nATOM   8632  O   GLN A1113      45.515   0.935  44.755  1.00 29.94           O  \nATOM   8633  CG  GLN A1113      46.222  -1.403  40.507  1.00 29.94           C  \nATOM   8634  CD  GLN A1113      47.036  -2.532  39.880  1.00 29.94           C  \nATOM   8635  NE2 GLN A1113      46.412  -3.418  39.135  1.00 29.94           N  \nATOM   8636  OE1 GLN A1113      48.240  -2.645  40.024  1.00 29.94           O  \nATOM   8637  N   PRO A1114      44.708  -1.129  44.389  1.00 39.97           N  \nATOM   8638  CA  PRO A1114      43.729  -1.132  45.500  1.00 39.97           C  \nATOM   8639  C   PRO A1114      44.003  -2.125  46.659  1.00 39.97           C  \nATOM   8640  CB  PRO A1114      42.453  -1.585  44.782  1.00 39.97           C  \nATOM   8641  O   PRO A1114      44.872  -2.988  46.543  1.00 39.97           O  \nATOM   8642  CG  PRO A1114      42.973  -2.750  43.938  1.00 39.97           C  \nATOM   8643  CD  PRO A1114      44.378  -2.290  43.554  1.00 39.97           C  \nATOM   8644  N   LEU A1115      43.162  -2.108  47.714  1.00 31.77           N  \nATOM   8645  CA  LEU A1115      42.918  -3.274  48.592  1.00 31.77           C  \nATOM   8646  C   LEU A1115      41.553  -3.234  49.346  1.00 31.77           C  \nATOM   8647  CB  LEU A1115      44.122  -3.486  49.550  1.00 31.77           C  \nATOM   8648  O   LEU A1115      40.899  -2.200  49.420  1.00 31.77           O  \nATOM   8649  CG  LEU A1115      44.760  -4.895  49.432  1.00 31.77           C  \nATOM   8650  CD1 LEU A1115      46.239  -4.844  49.043  1.00 31.77           C  \nATOM   8651  CD2 LEU A1115      44.664  -5.655  50.756  1.00 31.77           C  \nATOM   8652  N   ASN A1116      41.139  -4.402  49.857  1.00 30.75           N  \nATOM   8653  CA  ASN A1116      39.860  -4.803  50.508  1.00 30.75           C  \nATOM   8654  C   ASN A1116      39.770  -4.466  52.036  1.00 30.75           C  \nATOM   8655  CB  ASN A1116      39.863  -6.342  50.295  1.00 30.75           C  \nATOM   8656  O   ASN A1116      40.801  -4.068  52.577  1.00 30.75           O  \nATOM   8657  CG  ASN A1116      39.322  -6.806  48.954  1.00 30.75           C  \nATOM   8658  ND2 ASN A1116      39.662  -8.003  48.538  1.00 30.75           N  \nATOM   8659  OD1 ASN A1116      38.572  -6.132  48.279  1.00 30.75           O  \nATOM   8660  N   PRO A1117      38.702  -4.818  52.822  1.00 36.44           N  \nATOM   8661  CA  PRO A1117      37.233  -4.909  52.567  1.00 36.44           C  \nATOM   8662  C   PRO A1117      36.267  -4.468  53.736  1.00 36.44           C  \nATOM   8663  CB  PRO A1117      37.001  -6.418  52.432  1.00 36.44           C  \nATOM   8664  O   PRO A1117      36.593  -4.625  54.907  1.00 36.44           O  \nATOM   8665  CG  PRO A1117      37.976  -7.011  53.466  1.00 36.44           C  \nATOM   8666  CD  PRO A1117      38.990  -5.895  53.766  1.00 36.44           C  \nATOM   8667  N   ALA A1118      34.987  -4.174  53.410  1.00 31.47           N  \nATOM   8668  CA  ALA A1118      33.761  -4.442  54.229  1.00 31.47           C  \nATOM   8669  C   ALA A1118      33.578  -3.738  55.630  1.00 31.47           C  \nATOM   8670  CB  ALA A1118      33.614  -5.977  54.245  1.00 31.47           C  \nATOM   8671  O   ALA A1118      34.410  -2.924  56.012  1.00 31.47           O  \nATOM   8672  N   PRO A1119      32.482  -3.980  56.408  1.00 39.16           N  \nATOM   8673  CA  PRO A1119      31.089  -3.562  56.121  1.00 39.16           C  \nATOM   8674  C   PRO A1119      30.327  -2.888  57.317  1.00 39.16           C  \nATOM   8675  CB  PRO A1119      30.418  -4.898  55.772  1.00 39.16           C  \nATOM   8676  O   PRO A1119      30.895  -2.643  58.378  1.00 39.16           O  \nATOM   8677  CG  PRO A1119      31.014  -5.842  56.823  1.00 39.16           C  \nATOM   8678  CD  PRO A1119      32.378  -5.225  57.164  1.00 39.16           C  \nATOM   8679  N   SER A1120      28.992  -2.723  57.176  1.00 28.12           N  \nATOM   8680  CA  SER A1120      27.967  -2.212  58.138  1.00 28.12           C  \nATOM   8681  C   SER A1120      27.762  -0.674  58.170  1.00 28.12           C  \nATOM   8682  CB  SER A1120      28.102  -2.869  59.523  1.00 28.12           C  \nATOM   8683  O   SER A1120      28.691   0.059  57.859  1.00 28.12           O  \nATOM   8684  OG  SER A1120      29.087  -2.255  60.324  1.00 28.12           O  \nATOM   8685  N   ARG A1121      26.568  -0.117  58.477  1.00 33.91           N  \nATOM   8686  CA  ARG A1121      25.377  -0.671  59.178  1.00 33.91           C  \nATOM   8687  C   ARG A1121      24.032  -0.020  58.732  1.00 33.91           C  \nATOM   8688  CB  ARG A1121      25.611  -0.427  60.686  1.00 33.91           C  \nATOM   8689  O   ARG A1121      24.018   1.125  58.306  1.00 33.91           O  \nATOM   8690  CG  ARG A1121      25.065  -1.501  61.640  1.00 33.91           C  \nATOM   8691  CD  ARG A1121      25.625  -1.223  63.046  1.00 33.91           C  \nATOM   8692  NE  ARG A1121      25.545  -2.395  63.942  1.00 33.91           N  \nATOM   8693  NH1 ARG A1121      26.677  -1.461  65.710  1.00 33.91           N  \nATOM   8694  NH2 ARG A1121      26.019  -3.589  65.826  1.00 33.91           N  \nATOM   8695  CZ  ARG A1121      26.078  -2.476  65.150  1.00 33.91           C  \nATOM   8696  N   ASP A1122      22.948  -0.789  58.877  1.00 34.53           N  \nATOM   8697  CA  ASP A1122      21.492  -0.548  58.633  1.00 34.53           C  \nATOM   8698  C   ASP A1122      20.805   0.351  59.723  1.00 34.53           C  \nATOM   8699  CB  ASP A1122      20.912  -1.987  58.677  1.00 34.53           C  \nATOM   8700  O   ASP A1122      21.539   0.720  60.651  1.00 34.53           O  \nATOM   8701  CG  ASP A1122      20.241  -2.477  57.392  1.00 34.53           C  \nATOM   8702  OD1 ASP A1122      19.599  -1.660  56.702  1.00 34.53           O  \nATOM   8703  OD2 ASP A1122      20.366  -3.695  57.145  1.00 34.53           O  \nATOM   8704  N   PRO A1123      19.454   0.615  59.788  1.00 38.75           N  \nATOM   8705  CA  PRO A1123      18.313   0.290  58.878  1.00 38.75           C  \nATOM   8706  C   PRO A1123      17.143   1.339  58.736  1.00 38.75           C  \nATOM   8707  CB  PRO A1123      17.713  -0.958  59.562  1.00 38.75           C  \nATOM   8708  O   PRO A1123      17.170   2.405  59.344  1.00 38.75           O  \nATOM   8709  CG  PRO A1123      18.023  -0.761  61.055  1.00 38.75           C  \nATOM   8710  CD  PRO A1123      18.849   0.523  61.113  1.00 38.75           C  \nATOM   8711  N   HIS A1124      16.048   0.926  58.044  1.00 37.84           N  \nATOM   8712  CA  HIS A1124      14.622   1.392  58.098  1.00 37.84           C  \nATOM   8713  C   HIS A1124      14.179   2.570  57.169  1.00 37.84           C  \nATOM   8714  CB  HIS A1124      14.191   1.626  59.567  1.00 37.84           C  \nATOM   8715  O   HIS A1124      14.896   3.554  57.064  1.00 37.84           O  \nATOM   8716  CG  HIS A1124      14.323   0.447  60.513  1.00 37.84           C  \nATOM   8717  CD2 HIS A1124      14.557   0.526  61.860  1.00 37.84           C  \nATOM   8718  ND1 HIS A1124      14.147  -0.891  60.221  1.00 37.84           N  \nATOM   8719  CE1 HIS A1124      14.273  -1.591  61.360  1.00 37.84           C  \nATOM   8720  NE2 HIS A1124      14.521  -0.771  62.389  1.00 37.84           N  \nATOM   8721  N   TYR A1125      13.000   2.583  56.496  1.00 35.41           N  \nATOM   8722  CA  TYR A1125      11.868   1.619  56.400  1.00 35.41           C  \nATOM   8723  C   TYR A1125      11.067   1.720  55.056  1.00 35.41           C  \nATOM   8724  CB  TYR A1125      10.876   1.877  57.565  1.00 35.41           C  \nATOM   8725  O   TYR A1125      10.638   2.806  54.691  1.00 35.41           O  \nATOM   8726  CG  TYR A1125      10.226   0.649  58.188  1.00 35.41           C  \nATOM   8727  CD1 TYR A1125       8.850   0.388  58.035  1.00 35.41           C  \nATOM   8728  CD2 TYR A1125      10.994  -0.191  59.013  1.00 35.41           C  \nATOM   8729  CE1 TYR A1125       8.259  -0.699  58.712  1.00 35.41           C  \nATOM   8730  CE2 TYR A1125      10.415  -1.282  59.686  1.00 35.41           C  \nATOM   8731  OH  TYR A1125       8.467  -2.586  60.188  1.00 35.41           O  \nATOM   8732  CZ  TYR A1125       9.037  -1.539  59.535  1.00 35.41           C  \nATOM   8733  N   GLN A1126      10.842   0.571  54.392  1.00 35.44           N  \nATOM   8734  CA  GLN A1126       9.754   0.147  53.457  1.00 35.44           C  \nATOM   8735  C   GLN A1126       9.218   1.039  52.290  1.00 35.44           C  \nATOM   8736  CB  GLN A1126       8.579  -0.403  54.291  1.00 35.44           C  \nATOM   8737  O   GLN A1126       8.483   1.988  52.526  1.00 35.44           O  \nATOM   8738  CG  GLN A1126       8.986  -1.670  55.067  1.00 35.44           C  \nATOM   8739  CD  GLN A1126       7.862  -2.295  55.889  1.00 35.44           C  \nATOM   8740  NE2 GLN A1126       8.049  -3.507  56.366  1.00 35.44           N  \nATOM   8741  OE1 GLN A1126       6.818  -1.729  56.155  1.00 35.44           O  \nATOM   8742  N   ASP A1127       9.536   0.645  51.033  1.00 35.91           N  \nATOM   8743  CA  ASP A1127       8.714  -0.172  50.071  1.00 35.91           C  \nATOM   8744  C   ASP A1127       7.219   0.209  49.822  1.00 35.91           C  \nATOM   8745  CB  ASP A1127       8.857  -1.647  50.532  1.00 35.91           C  \nATOM   8746  O   ASP A1127       6.612   0.770  50.733  1.00 35.91           O  \nATOM   8747  CG  ASP A1127       8.949  -2.702  49.426  1.00 35.91           C  \nATOM   8748  OD1 ASP A1127       9.547  -2.412  48.365  1.00 35.91           O  \nATOM   8749  OD2 ASP A1127       8.465  -3.827  49.663  1.00 35.91           O  \nATOM   8750  N   PRO A1128       6.535  -0.138  48.689  1.00 36.56           N  \nATOM   8751  CA  PRO A1128       6.911  -0.877  47.451  1.00 36.56           C  \nATOM   8752  C   PRO A1128       6.623  -0.085  46.134  1.00 36.56           C  \nATOM   8753  CB  PRO A1128       6.022  -2.133  47.567  1.00 36.56           C  \nATOM   8754  O   PRO A1128       6.161   1.048  46.219  1.00 36.56           O  \nATOM   8755  CG  PRO A1128       4.856  -1.766  48.489  1.00 36.56           C  \nATOM   8756  CD  PRO A1128       5.084  -0.291  48.773  1.00 36.56           C  \nATOM   8757  N   HIS A1129       6.766  -0.518  44.860  1.00 38.59           N  \nATOM   8758  CA  HIS A1129       7.424  -1.576  44.027  1.00 38.59           C  \nATOM   8759  C   HIS A1129       7.143  -1.162  42.533  1.00 38.59           C  \nATOM   8760  CB  HIS A1129       6.766  -2.959  44.230  1.00 38.59           C  \nATOM   8761  O   HIS A1129       6.264  -0.331  42.320  1.00 38.59           O  \nATOM   8762  CG  HIS A1129       7.517  -3.986  45.056  1.00 38.59           C  \nATOM   8763  CD2 HIS A1129       7.439  -5.338  44.846  1.00 38.59           C  \nATOM   8764  ND1 HIS A1129       8.357  -3.811  46.142  1.00 38.59           N  \nATOM   8765  CE1 HIS A1129       8.733  -5.023  46.581  1.00 38.59           C  \nATOM   8766  NE2 HIS A1129       8.219  -5.990  45.802  1.00 38.59           N  \nATOM   8767  N   SER A1130       7.689  -1.690  41.419  1.00 31.53           N  \nATOM   8768  CA  SER A1130       8.914  -2.445  41.060  1.00 31.53           C  \nATOM   8769  C   SER A1130       9.128  -2.353  39.516  1.00 31.53           C  \nATOM   8770  CB  SER A1130       8.809  -3.918  41.467  1.00 31.53           C  \nATOM   8771  O   SER A1130       8.185  -2.019  38.796  1.00 31.53           O  \nATOM   8772  OG  SER A1130      10.020  -4.582  41.177  1.00 31.53           O  \nATOM   8773  N   THR A1131      10.335  -2.620  38.987  1.00 34.41           N  \nATOM   8774  CA  THR A1131      10.751  -2.364  37.579  1.00 34.41           C  \nATOM   8775  C   THR A1131      11.674  -3.446  36.974  1.00 34.41           C  \nATOM   8776  CB  THR A1131      11.516  -1.026  37.475  1.00 34.41           C  \nATOM   8777  O   THR A1131      12.419  -4.091  37.704  1.00 34.41           O  \nATOM   8778  CG2 THR A1131      10.626   0.202  37.642  1.00 34.41           C  \nATOM   8779  OG1 THR A1131      12.515  -0.933  38.465  1.00 34.41           O  \nATOM   8780  N   ALA A1132      11.655  -3.608  35.635  1.00 33.56           N  \nATOM   8781  CA  ALA A1132      12.681  -4.215  34.740  1.00 33.56           C  \nATOM   8782  C   ALA A1132      12.159  -4.143  33.274  1.00 33.56           C  \nATOM   8783  CB  ALA A1132      12.922  -5.684  35.118  1.00 33.56           C  \nATOM   8784  O   ALA A1132      10.956  -4.294  33.092  1.00 33.56           O  \nATOM   8785  N   VAL A1133      12.875  -3.868  32.167  1.00 32.53           N  \nATOM   8786  CA  VAL A1133      14.309  -3.734  31.790  1.00 32.53           C  \nATOM   8787  C   VAL A1133      15.090  -5.051  31.611  1.00 32.53           C  \nATOM   8788  CB  VAL A1133      15.096  -2.687  32.614  1.00 32.53           C  \nATOM   8789  O   VAL A1133      15.425  -5.702  32.593  1.00 32.53           O  \nATOM   8790  CG1 VAL A1133      16.457  -2.386  31.969  1.00 32.53           C  \nATOM   8791  CG2 VAL A1133      14.345  -1.352  32.725  1.00 32.53           C  \nATOM   8792  N   GLY A1134      15.461  -5.391  30.361  1.00 32.28           N  \nATOM   8793  CA  GLY A1134      16.391  -6.493  30.044  1.00 32.28           C  \nATOM   8794  C   GLY A1134      16.499  -6.895  28.555  1.00 32.28           C  \nATOM   8795  O   GLY A1134      15.650  -7.619  28.051  1.00 32.28           O  \nATOM   8796  N   ASN A1135      17.582  -6.477  27.886  1.00 33.03           N  \nATOM   8797  CA  ASN A1135      18.125  -7.054  26.630  1.00 33.03           C  \nATOM   8798  C   ASN A1135      18.845  -8.407  26.936  1.00 33.03           C  \nATOM   8799  CB  ASN A1135      19.044  -5.952  26.030  1.00 33.03           C  \nATOM   8800  O   ASN A1135      19.138  -8.609  28.120  1.00 33.03           O  \nATOM   8801  CG  ASN A1135      18.361  -5.066  24.996  1.00 33.03           C  \nATOM   8802  ND2 ASN A1135      19.079  -4.139  24.408  1.00 33.03           N  \nATOM   8803  OD1 ASN A1135      17.188  -5.179  24.700  1.00 33.03           O  \nATOM   8804  N   PRO A1136      19.181  -9.326  25.979  1.00 36.53           N  \nATOM   8805  CA  PRO A1136      19.964  -9.021  24.762  1.00 36.53           C  \nATOM   8806  C   PRO A1136      19.766  -9.940  23.515  1.00 36.53           C  \nATOM   8807  CB  PRO A1136      21.388  -9.206  25.318  1.00 36.53           C  \nATOM   8808  O   PRO A1136      18.809 -10.698  23.397  1.00 36.53           O  \nATOM   8809  CG  PRO A1136      21.254 -10.505  26.122  1.00 36.53           C  \nATOM   8810  CD  PRO A1136      19.750 -10.607  26.408  1.00 36.53           C  \nATOM   8811  N   GLU A1137      20.707  -9.824  22.570  1.00 29.39           N  \nATOM   8812  CA  GLU A1137      20.812 -10.492  21.260  1.00 29.39           C  \nATOM   8813  C   GLU A1137      21.497 -11.896  21.272  1.00 29.39           C  \nATOM   8814  CB  GLU A1137      21.665  -9.562  20.368  1.00 29.39           C  \nATOM   8815  O   GLU A1137      22.016 -12.349  22.289  1.00 29.39           O  \nATOM   8816  CG  GLU A1137      21.204  -8.113  20.167  1.00 29.39           C  \nATOM   8817  CD  GLU A1137      22.239  -7.363  19.307  1.00 29.39           C  \nATOM   8818  OE1 GLU A1137      21.939  -7.119  18.121  1.00 29.39           O  \nATOM   8819  OE2 GLU A1137      23.351  -7.090  19.820  1.00 29.39           O  \nATOM   8820  N   TYR A1138      21.601 -12.493  20.068  1.00 27.72           N  \nATOM   8821  CA  TYR A1138      22.519 -13.559  19.589  1.00 27.72           C  \nATOM   8822  C   TYR A1138      22.176 -15.070  19.711  1.00 27.72           C  \nATOM   8823  CB  TYR A1138      23.997 -13.280  19.932  1.00 27.72           C  \nATOM   8824  O   TYR A1138      22.444 -15.732  20.704  1.00 27.72           O  \nATOM   8825  CG  TYR A1138      24.519 -11.974  19.366  1.00 27.72           C  \nATOM   8826  CD1 TYR A1138      24.683 -11.809  17.974  1.00 27.72           C  \nATOM   8827  CD2 TYR A1138      24.758 -10.893  20.230  1.00 27.72           C  \nATOM   8828  CE1 TYR A1138      24.991 -10.542  17.443  1.00 27.72           C  \nATOM   8829  CE2 TYR A1138      25.047  -9.623  19.700  1.00 27.72           C  \nATOM   8830  OH  TYR A1138      25.217  -8.181  17.800  1.00 27.72           O  \nATOM   8831  CZ  TYR A1138      25.116  -9.434  18.306  1.00 27.72           C  \nATOM   8832  N   LEU A1139      21.821 -15.614  18.533  1.00 28.48           N  \nATOM   8833  CA  LEU A1139      22.421 -16.778  17.836  1.00 28.48           C  \nATOM   8834  C   LEU A1139      22.228 -18.252  18.286  1.00 28.48           C  \nATOM   8835  CB  LEU A1139      23.918 -16.511  17.548  1.00 28.48           C  \nATOM   8836  O   LEU A1139      22.528 -18.672  19.393  1.00 28.48           O  \nATOM   8837  CG  LEU A1139      24.206 -15.463  16.459  1.00 28.48           C  \nATOM   8838  CD1 LEU A1139      25.691 -15.101  16.467  1.00 28.48           C  \nATOM   8839  CD2 LEU A1139      23.866 -15.970  15.054  1.00 28.48           C  \nATOM   8840  N   ASN A1140      21.978 -19.053  17.235  1.00 27.64           N  \nATOM   8841  CA  ASN A1140      22.463 -20.417  16.955  1.00 27.64           C  \nATOM   8842  C   ASN A1140      21.858 -21.670  17.635  1.00 27.64           C  \nATOM   8843  CB  ASN A1140      24.004 -20.430  16.906  1.00 27.64           C  \nATOM   8844  O   ASN A1140      22.254 -22.100  18.708  1.00 27.64           O  \nATOM   8845  CG  ASN A1140      24.567 -19.803  15.642  1.00 27.64           C  \nATOM   8846  ND2 ASN A1140      25.861 -19.600  15.583  1.00 27.64           N  \nATOM   8847  OD1 ASN A1140      23.869 -19.484  14.693  1.00 27.64           O  \nATOM   8848  N   THR A1141      21.042 -22.363  16.823  1.00 26.42           N  \nATOM   8849  CA  THR A1141      21.136 -23.800  16.455  1.00 26.42           C  \nATOM   8850  C   THR A1141      21.343 -24.881  17.529  1.00 26.42           C  \nATOM   8851  CB  THR A1141      22.251 -24.034  15.410  1.00 26.42           C  \nATOM   8852  O   THR A1141      22.417 -24.975  18.112  1.00 26.42           O  \nATOM   8853  CG2 THR A1141      22.066 -23.251  14.111  1.00 26.42           C  \nATOM   8854  OG1 THR A1141      23.511 -23.682  15.927  1.00 26.42           O  \nATOM   8855  N   VAL A1142      20.442 -25.877  17.544  1.00 31.11           N  \nATOM   8856  CA  VAL A1142      20.752 -27.299  17.234  1.00 31.11           C  \nATOM   8857  C   VAL A1142      19.443 -28.102  17.057  1.00 31.11           C  \nATOM   8858  CB  VAL A1142      21.737 -27.932  18.260  1.00 31.11           C  \nATOM   8859  O   VAL A1142      18.409 -27.743  17.614  1.00 31.11           O  \nATOM   8860  CG1 VAL A1142      21.429 -29.360  18.726  1.00 31.11           C  \nATOM   8861  CG2 VAL A1142      23.146 -28.005  17.643  1.00 31.11           C  \nATOM   8862  N   GLN A1143      19.462 -29.162  16.238  1.00 27.09           N  \nATOM   8863  CA  GLN A1143      18.328 -30.084  16.035  1.00 27.09           C  \nATOM   8864  C   GLN A1143      18.239 -31.154  17.138  1.00 27.09           C  \nATOM   8865  CB  GLN A1143      18.494 -30.848  14.708  1.00 27.09           C  \nATOM   8866  O   GLN A1143      19.259 -31.517  17.721  1.00 27.09           O  \nATOM   8867  CG  GLN A1143      18.519 -29.999  13.434  1.00 27.09           C  \nATOM   8868  CD  GLN A1143      18.816 -30.893  12.232  1.00 27.09           C  \nATOM   8869  NE2 GLN A1143      17.834 -31.255  11.436  1.00 27.09           N  \nATOM   8870  OE1 GLN A1143      19.934 -31.315  12.008  1.00 27.09           O  \nATOM   8871  N   PRO A1144      17.070 -31.800  17.278  1.00 34.44           N  \nATOM   8872  CA  PRO A1144      17.038 -33.247  17.508  1.00 34.44           C  \nATOM   8873  C   PRO A1144      16.585 -34.023  16.259  1.00 34.44           C  \nATOM   8874  CB  PRO A1144      16.119 -33.489  18.715  1.00 34.44           C  \nATOM   8875  O   PRO A1144      15.439 -33.939  15.821  1.00 34.44           O  \nATOM   8876  CG  PRO A1144      15.868 -32.090  19.280  1.00 34.44           C  \nATOM   8877  CD  PRO A1144      15.989 -31.205  18.041  1.00 34.44           C  \nATOM   8878  N   THR A1145      17.492 -34.830  15.715  1.00 30.11           N  \nATOM   8879  CA  THR A1145      17.178 -36.100  15.034  1.00 30.11           C  \nATOM   8880  C   THR A1145      16.802 -37.154  16.103  1.00 30.11           C  \nATOM   8881  CB  THR A1145      18.423 -36.522  14.230  1.00 30.11           C  \nATOM   8882  O   THR A1145      17.046 -36.931  17.285  1.00 30.11           O  \nATOM   8883  CG2 THR A1145      18.621 -35.672  12.976  1.00 30.11           C  \nATOM   8884  OG1 THR A1145      19.597 -36.387  15.001  1.00 30.11           O  \nATOM   8885  N   CYS A1146      16.218 -38.328  15.842  1.00 25.44           N  \nATOM   8886  CA  CYS A1146      15.689 -38.978  14.634  1.00 25.44           C  \nATOM   8887  C   CYS A1146      14.758 -40.127  15.080  1.00 25.44           C  \nATOM   8888  CB  CYS A1146      16.846 -39.658  13.868  1.00 25.44           C  \nATOM   8889  O   CYS A1146      15.100 -40.796  16.050  1.00 25.44           O  \nATOM   8890  SG  CYS A1146      16.913 -39.070  12.155  1.00 25.44           S  \nATOM   8891  N   VAL A1147      13.720 -40.478  14.308  1.00 30.31           N  \nATOM   8892  CA  VAL A1147      13.287 -41.887  14.140  1.00 30.31           C  \nATOM   8893  C   VAL A1147      12.760 -42.065  12.714  1.00 30.31           C  \nATOM   8894  CB  VAL A1147      12.206 -42.377  15.140  1.00 30.31           C  \nATOM   8895  O   VAL A1147      11.815 -41.392  12.313  1.00 30.31           O  \nATOM   8896  CG1 VAL A1147      11.896 -43.867  14.902  1.00 30.31           C  \nATOM   8897  CG2 VAL A1147      12.606 -42.272  16.616  1.00 30.31           C  \nATOM   8898  N   ASN A1148      13.348 -42.992  11.956  1.00 26.09           N  \nATOM   8899  CA  ASN A1148      12.822 -43.401  10.654  1.00 26.09           C  \nATOM   8900  C   ASN A1148      11.708 -44.441  10.831  1.00 26.09           C  \nATOM   8901  CB  ASN A1148      13.948 -44.017   9.800  1.00 26.09           C  \nATOM   8902  O   ASN A1148      11.874 -45.398  11.584  1.00 26.09           O  \nATOM   8903  CG  ASN A1148      14.995 -43.029   9.324  1.00 26.09           C  \nATOM   8904  ND2 ASN A1148      16.175 -43.501   8.994  1.00 26.09           N  \nATOM   8905  OD1 ASN A1148      14.779 -41.839   9.221  1.00 26.09           O  \nATOM   8906  N   SER A1149      10.653 -44.352  10.022  1.00 30.42           N  \nATOM   8907  CA  SER A1149       9.993 -45.558   9.511  1.00 30.42           C  \nATOM   8908  C   SER A1149       9.660 -45.355   8.033  1.00 30.42           C  \nATOM   8909  CB  SER A1149       8.798 -46.001  10.367  1.00 30.42           C  \nATOM   8910  O   SER A1149       8.917 -44.456   7.653  1.00 30.42           O  \nATOM   8911  OG  SER A1149       7.867 -44.967  10.588  1.00 30.42           O  \nATOM   8912  N   THR A1150      10.321 -46.144   7.194  1.00 26.50           N  \nATOM   8913  CA  THR A1150      10.178 -46.163   5.737  1.00 26.50           C  \nATOM   8914  C   THR A1150       8.958 -46.977   5.331  1.00 26.50           C  \nATOM   8915  CB  THR A1150      11.408 -46.846   5.109  1.00 26.50           C  \nATOM   8916  O   THR A1150       8.776 -48.074   5.855  1.00 26.50           O  \nATOM   8917  CG2 THR A1150      12.647 -45.956   5.149  1.00 26.50           C  \nATOM   8918  OG1 THR A1150      11.723 -48.016   5.840  1.00 26.50           O  \nATOM   8919  N   PHE A1151       8.212 -46.516   4.328  1.00 31.14           N  \nATOM   8920  CA  PHE A1151       7.547 -47.415   3.383  1.00 31.14           C  \nATOM   8921  C   PHE A1151       7.549 -46.807   1.978  1.00 31.14           C  \nATOM   8922  CB  PHE A1151       6.153 -47.854   3.863  1.00 31.14           C  \nATOM   8923  O   PHE A1151       7.579 -45.588   1.813  1.00 31.14           O  \nATOM   8924  CG  PHE A1151       6.144 -49.324   4.247  1.00 31.14           C  \nATOM   8925  CD1 PHE A1151       6.138 -50.309   3.241  1.00 31.14           C  \nATOM   8926  CD2 PHE A1151       6.250 -49.711   5.597  1.00 31.14           C  \nATOM   8927  CE1 PHE A1151       6.255 -51.669   3.580  1.00 31.14           C  \nATOM   8928  CE2 PHE A1151       6.366 -51.071   5.937  1.00 31.14           C  \nATOM   8929  CZ  PHE A1151       6.375 -52.050   4.928  1.00 31.14           C  \nATOM   8930  N   ASP A1152       7.612 -47.684   0.981  1.00 30.28           N  \nATOM   8931  CA  ASP A1152       8.183 -47.383  -0.330  1.00 30.28           C  \nATOM   8932  C   ASP A1152       7.182 -47.089  -1.455  1.00 30.28           C  \nATOM   8933  CB  ASP A1152       9.059 -48.579  -0.747  1.00 30.28           C  \nATOM   8934  O   ASP A1152       6.045 -47.554  -1.466  1.00 30.28           O  \nATOM   8935  CG  ASP A1152      10.394 -48.571  -0.020  1.00 30.28           C  \nATOM   8936  OD1 ASP A1152      11.237 -47.745  -0.431  1.00 30.28           O  \nATOM   8937  OD2 ASP A1152      10.538 -49.371   0.928  1.00 30.28           O  \nATOM   8938  N   SER A1153       7.760 -46.504  -2.509  1.00 27.70           N  \nATOM   8939  CA  SER A1153       7.402 -46.702  -3.921  1.00 27.70           C  \nATOM   8940  C   SER A1153       6.191 -45.948  -4.506  1.00 27.70           C  \nATOM   8941  CB  SER A1153       7.417 -48.197  -4.275  1.00 27.70           C  \nATOM   8942  O   SER A1153       5.329 -45.460  -3.776  1.00 27.70           O  \nATOM   8943  OG  SER A1153       8.764 -48.610  -4.409  1.00 27.70           O  \nATOM   8944  N   PRO A1154       6.189 -45.713  -5.842  1.00 32.94           N  \nATOM   8945  CA  PRO A1154       5.738 -44.417  -6.345  1.00 32.94           C  \nATOM   8946  C   PRO A1154       4.726 -44.474  -7.504  1.00 32.94           C  \nATOM   8947  CB  PRO A1154       7.060 -43.803  -6.822  1.00 32.94           C  \nATOM   8948  O   PRO A1154       4.423 -45.525  -8.054  1.00 32.94           O  \nATOM   8949  CG  PRO A1154       7.745 -44.981  -7.521  1.00 32.94           C  \nATOM   8950  CD  PRO A1154       7.155 -46.213  -6.830  1.00 32.94           C  \nATOM   8951  N   ALA A1155       4.332 -43.271  -7.939  1.00 27.05           N  \nATOM   8952  CA  ALA A1155       3.781 -42.937  -9.254  1.00 27.05           C  \nATOM   8953  C   ALA A1155       2.469 -43.630  -9.684  1.00 27.05           C  \nATOM   8954  CB  ALA A1155       4.890 -43.114 -10.308  1.00 27.05           C  \nATOM   8955  O   ALA A1155       2.476 -44.769 -10.129  1.00 27.05           O  \nATOM   8956  N   HIS A1156       1.389 -42.839  -9.801  1.00 26.81           N  \nATOM   8957  CA  HIS A1156       0.904 -42.438 -11.134  1.00 26.81           C  \nATOM   8958  C   HIS A1156      -0.247 -41.394 -11.129  1.00 26.81           C  \nATOM   8959  CB  HIS A1156       0.521 -43.673 -11.988  1.00 26.81           C  \nATOM   8960  O   HIS A1156      -1.277 -41.594 -10.507  1.00 26.81           O  \nATOM   8961  CG  HIS A1156       1.610 -44.153 -12.944  1.00 26.81           C  \nATOM   8962  CD2 HIS A1156       1.677 -45.394 -13.519  1.00 26.81           C  \nATOM   8963  ND1 HIS A1156       2.683 -43.434 -13.449  1.00 26.81           N  \nATOM   8964  CE1 HIS A1156       3.361 -44.222 -14.298  1.00 26.81           C  \nATOM   8965  NE2 HIS A1156       2.771 -45.417 -14.393  1.00 26.81           N  \nATOM   8966  N   TRP A1157      -0.056 -40.333 -11.933  1.00 26.02           N  \nATOM   8967  CA  TRP A1157      -1.047 -39.486 -12.636  1.00 26.02           C  \nATOM   8968  C   TRP A1157      -2.102 -38.632 -11.871  1.00 26.02           C  \nATOM   8969  CB  TRP A1157      -1.711 -40.293 -13.772  1.00 26.02           C  \nATOM   8970  O   TRP A1157      -2.991 -39.126 -11.196  1.00 26.02           O  \nATOM   8971  CG  TRP A1157      -0.822 -40.739 -14.907  1.00 26.02           C  \nATOM   8972  CD1 TRP A1157       0.237 -41.565 -14.789  1.00 26.02           C  \nATOM   8973  CD2 TRP A1157      -0.924 -40.470 -16.345  1.00 26.02           C  \nATOM   8974  CE2 TRP A1157       0.122 -41.179 -17.016  1.00 26.02           C  \nATOM   8975  CE3 TRP A1157      -1.801 -39.719 -17.158  1.00 26.02           C  \nATOM   8976  NE1 TRP A1157       0.791 -41.840 -16.017  1.00 26.02           N  \nATOM   8977  CH2 TRP A1157      -0.587 -40.377 -19.180  1.00 26.02           C  \nATOM   8978  CZ2 TRP A1157       0.298 -41.142 -18.405  1.00 26.02           C  \nATOM   8979  CZ3 TRP A1157      -1.633 -39.672 -18.557  1.00 26.02           C  \nATOM   8980  N   ALA A1158      -2.106 -37.342 -12.257  1.00 26.19           N  \nATOM   8981  CA  ALA A1158      -3.272 -36.500 -12.595  1.00 26.19           C  \nATOM   8982  C   ALA A1158      -3.982 -35.571 -11.562  1.00 26.19           C  \nATOM   8983  CB  ALA A1158      -4.274 -37.301 -13.444  1.00 26.19           C  \nATOM   8984  O   ALA A1158      -4.658 -35.994 -10.638  1.00 26.19           O  \nATOM   8985  N   GLN A1159      -4.003 -34.285 -11.967  1.00 26.16           N  \nATOM   8986  CA  GLN A1159      -5.018 -33.222 -11.777  1.00 26.16           C  \nATOM   8987  C   GLN A1159      -5.049 -32.290 -10.535  1.00 26.16           C  \nATOM   8988  CB  GLN A1159      -6.438 -33.689 -12.173  1.00 26.16           C  \nATOM   8989  O   GLN A1159      -5.240 -32.698  -9.401  1.00 26.16           O  \nATOM   8990  CG  GLN A1159      -6.604 -33.816 -13.698  1.00 26.16           C  \nATOM   8991  CD  GLN A1159      -8.047 -34.031 -14.157  1.00 26.16           C  \nATOM   8992  NE2 GLN A1159      -8.245 -34.701 -15.272  1.00 26.16           N  \nATOM   8993  OE1 GLN A1159      -9.014 -33.537 -13.588  1.00 26.16           O  \nATOM   8994  N   LYS A1160      -5.072 -30.983 -10.876  1.00 26.78           N  \nATOM   8995  CA  LYS A1160      -5.734 -29.834 -10.209  1.00 26.78           C  \nATOM   8996  C   LYS A1160      -5.222 -29.369  -8.831  1.00 26.78           C  \nATOM   8997  CB  LYS A1160      -7.259 -30.061 -10.193  1.00 26.78           C  \nATOM   8998  O   LYS A1160      -5.807 -29.671  -7.801  1.00 26.78           O  \nATOM   8999  CG  LYS A1160      -7.904 -30.057 -11.590  1.00 26.78           C  \nATOM   9000  CD  LYS A1160      -9.315 -30.650 -11.500  1.00 26.78           C  \nATOM   9001  CE  LYS A1160     -10.020 -30.638 -12.859  1.00 26.78           C  \nATOM   9002  NZ  LYS A1160     -11.105 -31.647 -12.888  1.00 26.78           N  \nATOM   9003  N   GLY A1161      -4.258 -28.444  -8.862  1.00 27.98           N  \nATOM   9004  CA  GLY A1161      -4.177 -27.334  -7.899  1.00 27.98           C  \nATOM   9005  C   GLY A1161      -4.671 -26.042  -8.566  1.00 27.98           C  \nATOM   9006  O   GLY A1161      -4.314 -25.790  -9.718  1.00 27.98           O  \nATOM   9007  N   SER A1162      -5.530 -25.269  -7.898  1.00 27.89           N  \nATOM   9008  CA  SER A1162      -6.196 -24.078  -8.454  1.00 27.89           C  \nATOM   9009  C   SER A1162      -5.411 -22.778  -8.243  1.00 27.89           C  \nATOM   9010  CB  SER A1162      -7.615 -23.956  -7.882  1.00 27.89           C  \nATOM   9011  O   SER A1162      -4.572 -22.670  -7.353  1.00 27.89           O  \nATOM   9012  OG  SER A1162      -7.601 -24.089  -6.476  1.00 27.89           O  \nATOM   9013  N   HIS A1163      -5.705 -21.772  -9.070  1.00 27.08           N  \nATOM   9014  CA  HIS A1163      -5.093 -20.448  -8.983  1.00 27.08           C  \nATOM   9015  C   HIS A1163      -5.589 -19.676  -7.750  1.00 27.08           C  \nATOM   9016  CB  HIS A1163      -5.412 -19.643 -10.256  1.00 27.08           C  \nATOM   9017  O   HIS A1163      -6.788 -19.619  -7.494  1.00 27.08           O  \nATOM   9018  CG  HIS A1163      -4.811 -20.192 -11.527  1.00 27.08           C  \nATOM   9019  CD2 HIS A1163      -5.226 -21.292 -12.231  1.00 27.08           C  \nATOM   9020  ND1 HIS A1163      -3.783 -19.624 -12.244  1.00 27.08           N  \nATOM   9021  CE1 HIS A1163      -3.582 -20.367 -13.346  1.00 27.08           C  \nATOM   9022  NE2 HIS A1163      -4.428 -21.409 -13.375  1.00 27.08           N  \nATOM   9023  N   GLN A1164      -4.670 -18.998  -7.065  1.00 29.09           N  \nATOM   9024  CA  GLN A1164      -4.953 -17.833  -6.227  1.00 29.09           C  \nATOM   9025  C   GLN A1164      -3.896 -16.773  -6.537  1.00 29.09           C  \nATOM   9026  CB  GLN A1164      -4.921 -18.188  -4.735  1.00 29.09           C  \nATOM   9027  O   GLN A1164      -2.700 -17.060  -6.492  1.00 29.09           O  \nATOM   9028  CG  GLN A1164      -6.198 -18.884  -4.243  1.00 29.09           C  \nATOM   9029  CD  GLN A1164      -6.086 -19.175  -2.754  1.00 29.09           C  \nATOM   9030  NE2 GLN A1164      -7.009 -18.734  -1.927  1.00 29.09           N  \nATOM   9031  OE1 GLN A1164      -5.131 -19.778  -2.302  1.00 29.09           O  \nATOM   9032  N   ILE A1165      -4.339 -15.562  -6.867  1.00 30.81           N  \nATOM   9033  CA  ILE A1165      -3.481 -14.386  -7.039  1.00 30.81           C  \nATOM   9034  C   ILE A1165      -3.912 -13.341  -6.006  1.00 30.81           C  \nATOM   9035  CB  ILE A1165      -3.453 -13.908  -8.512  1.00 30.81           C  \nATOM   9036  O   ILE A1165      -5.069 -13.287  -5.595  1.00 30.81           O  \nATOM   9037  CG1 ILE A1165      -2.758 -15.000  -9.367  1.00 30.81           C  \nATOM   9038  CG2 ILE A1165      -2.728 -12.557  -8.662  1.00 30.81           C  \nATOM   9039  CD1 ILE A1165      -2.628 -14.685 -10.863  1.00 30.81           C  \nATOM   9040  N   SER A1166      -2.925 -12.603  -5.509  1.00 31.78           N  \nATOM   9041  CA  SER A1166      -3.001 -11.783  -4.304  1.00 31.78           C  \nATOM   9042  C   SER A1166      -4.004 -10.629  -4.403  1.00 31.78           C  \nATOM   9043  CB  SER A1166      -1.597 -11.226  -4.047  1.00 31.78           C  \nATOM   9044  O   SER A1166      -3.844  -9.772  -5.264  1.00 31.78           O  \nATOM   9045  OG  SER A1166      -1.507 -10.592  -2.795  1.00 31.78           O  \nATOM   9046  N   LEU A1167      -4.946 -10.596  -3.449  1.00 30.61           N  \nATOM   9047  CA  LEU A1167      -5.262  -9.446  -2.576  1.00 30.61           C  \nATOM   9048  C   LEU A1167      -4.959  -8.078  -3.234  1.00 30.61           C  \nATOM   9049  CB  LEU A1167      -4.442  -9.615  -1.269  1.00 30.61           C  \nATOM   9050  O   LEU A1167      -3.815  -7.635  -3.207  1.00 30.61           O  \nATOM   9051  CG  LEU A1167      -4.587 -10.959  -0.521  1.00 30.61           C  \nATOM   9052  CD1 LEU A1167      -3.327 -11.300   0.280  1.00 30.61           C  \nATOM   9053  CD2 LEU A1167      -5.763 -10.923   0.449  1.00 30.61           C  \nATOM   9054  N   ASP A1168      -5.924  -7.409  -3.863  1.00 32.00           N  \nATOM   9055  CA  ASP A1168      -7.053  -6.813  -3.140  1.00 32.00           C  \nATOM   9056  C   ASP A1168      -8.413  -6.903  -3.873  1.00 32.00           C  \nATOM   9057  CB  ASP A1168      -6.698  -5.336  -2.833  1.00 32.00           C  \nATOM   9058  O   ASP A1168      -8.489  -6.863  -5.097  1.00 32.00           O  \nATOM   9059  CG  ASP A1168      -6.774  -5.017  -1.339  1.00 32.00           C  \nATOM   9060  OD1 ASP A1168      -7.699  -5.565  -0.692  1.00 32.00           O  \nATOM   9061  OD2 ASP A1168      -5.927  -4.235  -0.861  1.00 32.00           O  \nATOM   9062  N   ASN A1169      -9.492  -6.993  -3.088  1.00 34.84           N  \nATOM   9063  CA  ASN A1169     -10.915  -6.987  -3.480  1.00 34.84           C  \nATOM   9064  C   ASN A1169     -11.392  -7.915  -4.643  1.00 34.84           C  \nATOM   9065  CB  ASN A1169     -11.362  -5.529  -3.680  1.00 34.84           C  \nATOM   9066  O   ASN A1169     -11.665  -7.441  -5.749  1.00 34.84           O  \nATOM   9067  CG  ASN A1169     -12.872  -5.409  -3.588  1.00 34.84           C  \nATOM   9068  ND2 ASN A1169     -13.463  -4.455  -4.257  1.00 34.84           N  \nATOM   9069  OD1 ASN A1169     -13.543  -6.132  -2.877  1.00 34.84           O  \nATOM   9070  N   PRO A1170     -11.612  -9.222  -4.390  1.00 29.72           N  \nATOM   9071  CA  PRO A1170     -12.180 -10.159  -5.363  1.00 29.72           C  \nATOM   9072  C   PRO A1170     -13.725 -10.136  -5.400  1.00 29.72           C  \nATOM   9073  CB  PRO A1170     -11.598 -11.518  -4.958  1.00 29.72           C  \nATOM   9074  O   PRO A1170     -14.390 -11.035  -4.885  1.00 29.72           O  \nATOM   9075  CG  PRO A1170     -11.539 -11.412  -3.434  1.00 29.72           C  \nATOM   9076  CD  PRO A1170     -11.213  -9.938  -3.186  1.00 29.72           C  \nATOM   9077  N   ASP A1171     -14.299  -9.139  -6.076  1.00 33.09           N  \nATOM   9078  CA  ASP A1171     -15.631  -9.234  -6.697  1.00 33.09           C  \nATOM   9079  C   ASP A1171     -15.448  -9.269  -8.233  1.00 33.09           C  \nATOM   9080  CB  ASP A1171     -16.553  -8.070  -6.258  1.00 33.09           C  \nATOM   9081  O   ASP A1171     -14.696  -8.471  -8.786  1.00 33.09           O  \nATOM   9082  CG  ASP A1171     -17.401  -8.321  -5.000  1.00 33.09           C  \nATOM   9083  OD1 ASP A1171     -17.885  -9.464  -4.820  1.00 33.09           O  \nATOM   9084  OD2 ASP A1171     -17.667  -7.335  -4.276  1.00 33.09           O  \nATOM   9085  N   TYR A1172     -16.156 -10.168  -8.930  1.00 36.75           N  \nATOM   9086  CA  TYR A1172     -16.150 -10.352 -10.402  1.00 36.75           C  \nATOM   9087  C   TYR A1172     -14.836 -10.806 -11.090  1.00 36.75           C  \nATOM   9088  CB  TYR A1172     -16.724  -9.130 -11.138  1.00 36.75           C  \nATOM   9089  O   TYR A1172     -14.373 -10.170 -12.035  1.00 36.75           O  \nATOM   9090  CG  TYR A1172     -18.097  -8.648 -10.745  1.00 36.75           C  \nATOM   9091  CD1 TYR A1172     -19.227  -9.036 -11.491  1.00 36.75           C  \nATOM   9092  CD2 TYR A1172     -18.210  -7.675  -9.743  1.00 36.75           C  \nATOM   9093  CE1 TYR A1172     -20.454  -8.373 -11.298  1.00 36.75           C  \nATOM   9094  CE2 TYR A1172     -19.437  -7.031  -9.531  1.00 36.75           C  \nATOM   9095  OH  TYR A1172     -21.671  -6.568 -10.295  1.00 36.75           O  \nATOM   9096  CZ  TYR A1172     -20.543  -7.324 -10.359  1.00 36.75           C  \nATOM   9097  N   GLN A1173     -14.314 -11.994 -10.762  1.00 28.00           N  \nATOM   9098  CA  GLN A1173     -13.535 -12.790 -11.736  1.00 28.00           C  \nATOM   9099  C   GLN A1173     -13.948 -14.269 -11.734  1.00 28.00           C  \nATOM   9100  CB  GLN A1173     -12.009 -12.603 -11.596  1.00 28.00           C  \nATOM   9101  O   GLN A1173     -13.216 -15.147 -11.275  1.00 28.00           O  \nATOM   9102  CG  GLN A1173     -11.526 -11.271 -12.195  1.00 28.00           C  \nATOM   9103  CD  GLN A1173     -10.033 -11.233 -12.514  1.00 28.00           C  \nATOM   9104  NE2 GLN A1173      -9.565 -10.170 -13.129  1.00 28.00           N  \nATOM   9105  OE1 GLN A1173      -9.263 -12.142 -12.249  1.00 28.00           O  \nATOM   9106  N   GLN A1174     -15.148 -14.547 -12.254  1.00 28.41           N  \nATOM   9107  CA  GLN A1174     -15.575 -15.912 -12.575  1.00 28.41           C  \nATOM   9108  C   GLN A1174     -16.713 -15.931 -13.611  1.00 28.41           C  \nATOM   9109  CB  GLN A1174     -15.889 -16.694 -11.273  1.00 28.41           C  \nATOM   9110  O   GLN A1174     -17.875 -16.100 -13.267  1.00 28.41           O  \nATOM   9111  CG  GLN A1174     -15.168 -18.051 -11.268  1.00 28.41           C  \nATOM   9112  CD  GLN A1174     -15.101 -18.645  -9.869  1.00 28.41           C  \nATOM   9113  NE2 GLN A1174     -14.117 -18.273  -9.078  1.00 28.41           N  \nATOM   9114  OE1 GLN A1174     -15.918 -19.446  -9.455  1.00 28.41           O  \nATOM   9115  N   ASP A1175     -16.359 -15.676 -14.874  1.00 27.62           N  \nATOM   9116  CA  ASP A1175     -16.795 -16.425 -16.067  1.00 27.62           C  \nATOM   9117  C   ASP A1175     -16.059 -15.874 -17.313  1.00 27.62           C  \nATOM   9118  CB  ASP A1175     -18.334 -16.450 -16.246  1.00 27.62           C  \nATOM   9119  O   ASP A1175     -15.488 -14.787 -17.260  1.00 27.62           O  \nATOM   9120  CG  ASP A1175     -18.991 -17.680 -15.583  1.00 27.62           C  \nATOM   9121  OD1 ASP A1175     -18.327 -18.746 -15.571  1.00 27.62           O  \nATOM   9122  OD2 ASP A1175     -20.174 -17.575 -15.183  1.00 27.62           O  \nATOM   9123  N   PHE A1176     -16.028 -16.641 -18.413  1.00 27.14           N  \nATOM   9124  CA  PHE A1176     -15.285 -16.372 -19.668  1.00 27.14           C  \nATOM   9125  C   PHE A1176     -13.736 -16.349 -19.589  1.00 27.14           C  \nATOM   9126  CB  PHE A1176     -15.850 -15.140 -20.403  1.00 27.14           C  \nATOM   9127  O   PHE A1176     -13.099 -15.309 -19.720  1.00 27.14           O  \nATOM   9128  CG  PHE A1176     -17.296 -15.278 -20.829  1.00 27.14           C  \nATOM   9129  CD1 PHE A1176     -17.616 -15.944 -22.028  1.00 27.14           C  \nATOM   9130  CD2 PHE A1176     -18.323 -14.748 -20.027  1.00 27.14           C  \nATOM   9131  CE1 PHE A1176     -18.958 -16.083 -22.421  1.00 27.14           C  \nATOM   9132  CE2 PHE A1176     -19.666 -14.888 -20.420  1.00 27.14           C  \nATOM   9133  CZ  PHE A1176     -19.983 -15.556 -21.616  1.00 27.14           C  \nATOM   9134  N   PHE A1177     -13.111 -17.536 -19.529  1.00 25.33           N  \nATOM   9135  CA  PHE A1177     -11.688 -17.735 -19.874  1.00 25.33           C  \nATOM   9136  C   PHE A1177     -11.419 -19.084 -20.563  1.00 25.33           C  \nATOM   9137  CB  PHE A1177     -10.794 -17.657 -18.622  1.00 25.33           C  \nATOM   9138  O   PHE A1177     -11.870 -20.135 -20.095  1.00 25.33           O  \nATOM   9139  CG  PHE A1177     -10.222 -16.290 -18.305  1.00 25.33           C  \nATOM   9140  CD1 PHE A1177      -9.242 -15.722 -19.144  1.00 25.33           C  \nATOM   9141  CD2 PHE A1177     -10.616 -15.614 -17.136  1.00 25.33           C  \nATOM   9142  CE1 PHE A1177      -8.661 -14.484 -18.814  1.00 25.33           C  \nATOM   9143  CE2 PHE A1177     -10.030 -14.380 -16.803  1.00 25.33           C  \nATOM   9144  CZ  PHE A1177      -9.053 -13.816 -17.641  1.00 25.33           C  \nATOM   9145  N   PRO A1178     -10.591 -19.072 -21.620  1.00 29.16           N  \nATOM   9146  CA  PRO A1178      -9.539 -20.085 -21.795  1.00 29.16           C  \nATOM   9147  C   PRO A1178      -8.195 -19.464 -22.266  1.00 29.16           C  \nATOM   9148  CB  PRO A1178     -10.124 -21.011 -22.868  1.00 29.16           C  \nATOM   9149  O   PRO A1178      -8.212 -18.544 -23.072  1.00 29.16           O  \nATOM   9150  CG  PRO A1178     -10.888 -20.056 -23.793  1.00 29.16           C  \nATOM   9151  CD  PRO A1178     -11.200 -18.830 -22.925  1.00 29.16           C  \nATOM   9152  N   LYS A1179      -6.989 -19.944 -21.916  1.00 27.33           N  \nATOM   9153  CA  LYS A1179      -6.482 -20.871 -20.873  1.00 27.33           C  \nATOM   9154  C   LYS A1179      -4.926 -20.878 -20.955  1.00 27.33           C  \nATOM   9155  CB  LYS A1179      -7.009 -22.299 -21.136  1.00 27.33           C  \nATOM   9156  O   LYS A1179      -4.414 -20.536 -22.011  1.00 27.33           O  \nATOM   9157  CG  LYS A1179      -7.650 -22.941 -19.899  1.00 27.33           C  \nATOM   9158  CD  LYS A1179      -8.205 -24.317 -20.286  1.00 27.33           C  \nATOM   9159  CE  LYS A1179      -8.982 -24.951 -19.132  1.00 27.33           C  \nATOM   9160  NZ  LYS A1179      -9.593 -26.229 -19.568  1.00 27.33           N  \nATOM   9161  N   GLU A1180      -4.217 -21.370 -19.919  1.00 29.92           N  \nATOM   9162  CA  GLU A1180      -2.736 -21.622 -19.877  1.00 29.92           C  \nATOM   9163  C   GLU A1180      -1.826 -20.356 -19.844  1.00 29.92           C  \nATOM   9164  CB  GLU A1180      -2.333 -22.598 -21.016  1.00 29.92           C  \nATOM   9165  O   GLU A1180      -2.270 -19.291 -20.246  1.00 29.92           O  \nATOM   9166  CG  GLU A1180      -3.091 -23.935 -20.933  1.00 29.92           C  \nATOM   9167  CD  GLU A1180      -2.803 -24.924 -22.073  1.00 29.92           C  \nATOM   9168  OE1 GLU A1180      -3.613 -25.876 -22.175  1.00 29.92           O  \nATOM   9169  OE2 GLU A1180      -1.763 -24.784 -22.752  1.00 29.92           O  \nATOM   9170  N   ALA A1181      -0.545 -20.323 -19.415  1.00 29.00           N  \nATOM   9171  CA  ALA A1181       0.312 -21.034 -18.424  1.00 29.00           C  \nATOM   9172  C   ALA A1181       1.700 -20.295 -18.384  1.00 29.00           C  \nATOM   9173  CB  ALA A1181       0.505 -22.496 -18.852  1.00 29.00           C  \nATOM   9174  O   ALA A1181       2.015 -19.617 -19.353  1.00 29.00           O  \nATOM   9175  N   LYS A1182       2.631 -20.341 -17.403  1.00 29.98           N  \nATOM   9176  CA  LYS A1182       2.767 -20.885 -16.022  1.00 29.98           C  \nATOM   9177  C   LYS A1182       3.931 -20.128 -15.283  1.00 29.98           C  \nATOM   9178  CB  LYS A1182       3.132 -22.385 -16.088  1.00 29.98           C  \nATOM   9179  O   LYS A1182       4.756 -19.546 -15.982  1.00 29.98           O  \nATOM   9180  CG  LYS A1182       2.099 -23.290 -15.405  1.00 29.98           C  \nATOM   9181  CD  LYS A1182       2.531 -24.755 -15.557  1.00 29.98           C  \nATOM   9182  CE  LYS A1182       1.507 -25.700 -14.923  1.00 29.98           C  \nATOM   9183  NZ  LYS A1182       1.916 -27.115 -15.099  1.00 29.98           N  \nATOM   9184  N   PRO A1183       4.061 -20.139 -13.930  1.00 34.22           N  \nATOM   9185  CA  PRO A1183       4.982 -19.242 -13.186  1.00 34.22           C  \nATOM   9186  C   PRO A1183       6.088 -19.929 -12.331  1.00 34.22           C  \nATOM   9187  CB  PRO A1183       4.009 -18.509 -12.260  1.00 34.22           C  \nATOM   9188  O   PRO A1183       6.122 -21.153 -12.238  1.00 34.22           O  \nATOM   9189  CG  PRO A1183       3.113 -19.657 -11.784  1.00 34.22           C  \nATOM   9190  CD  PRO A1183       3.042 -20.600 -12.992  1.00 34.22           C  \nATOM   9191  N   ASN A1184       6.931 -19.128 -11.642  1.00 33.97           N  \nATOM   9192  CA  ASN A1184       7.783 -19.479 -10.474  1.00 33.97           C  \nATOM   9193  C   ASN A1184       8.258 -18.196  -9.714  1.00 33.97           C  \nATOM   9194  CB  ASN A1184       9.029 -20.259 -10.968  1.00 33.97           C  \nATOM   9195  O   ASN A1184       8.543 -17.212 -10.389  1.00 33.97           O  \nATOM   9196  CG  ASN A1184       8.883 -21.773 -10.936  1.00 33.97           C  \nATOM   9197  ND2 ASN A1184       9.607 -22.479 -11.775  1.00 33.97           N  \nATOM   9198  OD1 ASN A1184       8.192 -22.347 -10.113  1.00 33.97           O  \nATOM   9199  N   GLY A1185       8.428 -18.198  -8.367  1.00 30.72           N  \nATOM   9200  CA  GLY A1185       9.366 -17.250  -7.685  1.00 30.72           C  \nATOM   9201  C   GLY A1185       8.976 -16.354  -6.464  1.00 30.72           C  \nATOM   9202  O   GLY A1185       9.201 -15.155  -6.527  1.00 30.72           O  \nATOM   9203  N   ILE A1186       8.498 -16.914  -5.339  1.00 30.70           N  \nATOM   9204  CA  ILE A1186       8.881 -16.593  -3.919  1.00 30.70           C  \nATOM   9205  C   ILE A1186       8.959 -15.112  -3.384  1.00 30.70           C  \nATOM   9206  CB  ILE A1186      10.180 -17.392  -3.578  1.00 30.70           C  \nATOM   9207  O   ILE A1186       9.990 -14.461  -3.476  1.00 30.70           O  \nATOM   9208  CG1 ILE A1186      10.012 -18.901  -3.917  1.00 30.70           C  \nATOM   9209  CG2 ILE A1186      10.609 -17.272  -2.100  1.00 30.70           C  \nATOM   9210  CD1 ILE A1186      11.231 -19.787  -3.626  1.00 30.70           C  \nATOM   9211  N   PHE A1187       7.915 -14.711  -2.625  1.00 26.97           N  \nATOM   9212  CA  PHE A1187       7.860 -14.138  -1.237  1.00 26.97           C  \nATOM   9213  C   PHE A1187       8.554 -12.831  -0.712  1.00 26.97           C  \nATOM   9214  CB  PHE A1187       8.122 -15.272  -0.221  1.00 26.97           C  \nATOM   9215  O   PHE A1187       9.752 -12.622  -0.855  1.00 26.97           O  \nATOM   9216  CG  PHE A1187       6.903 -15.753   0.542  1.00 26.97           C  \nATOM   9217  CD1 PHE A1187       6.381 -14.999   1.611  1.00 26.97           C  \nATOM   9218  CD2 PHE A1187       6.299 -16.975   0.192  1.00 26.97           C  \nATOM   9219  CE1 PHE A1187       5.259 -15.461   2.321  1.00 26.97           C  \nATOM   9220  CE2 PHE A1187       5.179 -17.439   0.903  1.00 26.97           C  \nATOM   9221  CZ  PHE A1187       4.659 -16.682   1.967  1.00 26.97           C  \nATOM   9222  N   LYS A1188       7.785 -12.162   0.188  1.00 27.31           N  \nATOM   9223  CA  LYS A1188       8.068 -11.138   1.249  1.00 27.31           C  \nATOM   9224  C   LYS A1188       7.885  -9.637   0.901  1.00 27.31           C  \nATOM   9225  CB  LYS A1188       9.329 -11.443   2.091  1.00 27.31           C  \nATOM   9226  O   LYS A1188       7.977  -9.242  -0.251  1.00 27.31           O  \nATOM   9227  CG  LYS A1188       9.152 -12.693   2.975  1.00 27.31           C  \nATOM   9228  CD  LYS A1188      10.284 -12.861   3.998  1.00 27.31           C  \nATOM   9229  CE  LYS A1188      10.003 -14.067   4.908  1.00 27.31           C  \nATOM   9230  NZ  LYS A1188      11.034 -14.204   5.968  1.00 27.31           N  \nATOM   9231  N   GLY A1189       7.489  -8.857   1.926  1.00 25.34           N  \nATOM   9232  CA  GLY A1189       7.037  -7.447   1.859  1.00 25.34           C  \nATOM   9233  C   GLY A1189       8.171  -6.403   1.865  1.00 25.34           C  \nATOM   9234  O   GLY A1189       9.331  -6.788   1.782  1.00 25.34           O  \nATOM   9235  N   SER A1190       7.910  -5.093   1.971  1.00 25.56           N  \nATOM   9236  CA  SER A1190       6.887  -4.422   2.806  1.00 25.56           C  \nATOM   9237  C   SER A1190       6.165  -3.215   2.154  1.00 25.56           C  \nATOM   9238  CB  SER A1190       7.623  -3.938   4.071  1.00 25.56           C  \nATOM   9239  O   SER A1190       6.362  -2.918   0.982  1.00 25.56           O  \nATOM   9240  OG  SER A1190       8.655  -3.038   3.726  1.00 25.56           O  \nATOM   9241  N   THR A1191       5.291  -2.573   2.947  1.00 25.44           N  \nATOM   9242  CA  THR A1191       4.810  -1.166   2.900  1.00 25.44           C  \nATOM   9243  C   THR A1191       5.209  -0.290   1.701  1.00 25.44           C  \nATOM   9244  CB  THR A1191       5.306  -0.426   4.160  1.00 25.44           C  \nATOM   9245  O   THR A1191       6.381   0.040   1.533  1.00 25.44           O  \nATOM   9246  CG2 THR A1191       4.624  -0.929   5.432  1.00 25.44           C  \nATOM   9247  OG1 THR A1191       6.695  -0.635   4.316  1.00 25.44           O  \nATOM   9248  N   ALA A1192       4.210   0.216   0.970  1.00 28.92           N  \nATOM   9249  CA  ALA A1192       4.365   1.310   0.011  1.00 28.92           C  \nATOM   9250  C   ALA A1192       3.710   2.594   0.553  1.00 28.92           C  \nATOM   9251  CB  ALA A1192       3.768   0.878  -1.335  1.00 28.92           C  \nATOM   9252  O   ALA A1192       2.501   2.622   0.777  1.00 28.92           O  \nATOM   9253  N   GLU A1193       4.502   3.649   0.749  1.00 28.17           N  \nATOM   9254  CA  GLU A1193       4.019   4.988   1.107  1.00 28.17           C  \nATOM   9255  C   GLU A1193       3.893   5.853  -0.159  1.00 28.17           C  \nATOM   9256  CB  GLU A1193       4.954   5.643   2.138  1.00 28.17           C  \nATOM   9257  O   GLU A1193       4.840   5.979  -0.938  1.00 28.17           O  \nATOM   9258  CG  GLU A1193       4.973   4.891   3.480  1.00 28.17           C  \nATOM   9259  CD  GLU A1193       5.863   5.583   4.524  1.00 28.17           C  \nATOM   9260  OE1 GLU A1193       5.444   5.615   5.702  1.00 28.17           O  \nATOM   9261  OE2 GLU A1193       6.958   6.049   4.136  1.00 28.17           O  \nATOM   9262  N   ASN A1194       2.722   6.459  -0.384  1.00 31.03           N  \nATOM   9263  CA  ASN A1194       2.417   7.209  -1.611  1.00 31.03           C  \nATOM   9264  C   ASN A1194       2.961   8.651  -1.578  1.00 31.03           C  \nATOM   9265  CB  ASN A1194       0.906   7.128  -1.905  1.00 31.03           C  \nATOM   9266  O   ASN A1194       2.216   9.624  -1.467  1.00 31.03           O  \nATOM   9267  CG  ASN A1194       0.481   5.810  -2.529  1.00 31.03           C  \nATOM   9268  ND2 ASN A1194      -0.782   5.468  -2.436  1.00 31.03           N  \nATOM   9269  OD1 ASN A1194       1.250   5.088  -3.138  1.00 31.03           O  \nATOM   9270  N   ALA A1195       4.278   8.794  -1.706  1.00 27.72           N  \nATOM   9271  CA  ALA A1195       4.973  10.080  -1.673  1.00 27.72           C  \nATOM   9272  C   ALA A1195       5.010  10.819  -3.037  1.00 27.72           C  \nATOM   9273  CB  ALA A1195       6.366   9.840  -1.068  1.00 27.72           C  \nATOM   9274  O   ALA A1195       6.089  11.030  -3.592  1.00 27.72           O  \nATOM   9275  N   GLU A1196       3.865  11.253  -3.591  1.00 32.41           N  \nATOM   9276  CA  GLU A1196       3.878  12.189  -4.744  1.00 32.41           C  \nATOM   9277  C   GLU A1196       2.717  13.210  -4.824  1.00 32.41           C  \nATOM   9278  CB  GLU A1196       4.173  11.473  -6.089  1.00 32.41           C  \nATOM   9279  O   GLU A1196       2.141  13.440  -5.883  1.00 32.41           O  \nATOM   9280  CG  GLU A1196       5.013  12.401  -7.005  1.00 32.41           C  \nATOM   9281  CD  GLU A1196       5.458  11.769  -8.335  1.00 32.41           C  \nATOM   9282  OE1 GLU A1196       6.478  12.197  -8.950  1.00 32.41           O  \nATOM   9283  OE2 GLU A1196       4.802  10.834  -8.829  1.00 32.41           O  \nATOM   9284  N   TYR A1197       2.445  13.927  -3.728  1.00 29.11           N  \nATOM   9285  CA  TYR A1197       1.759  15.232  -3.774  1.00 29.11           C  \nATOM   9286  C   TYR A1197       2.779  16.383  -3.701  1.00 29.11           C  \nATOM   9287  CB  TYR A1197       0.672  15.329  -2.682  1.00 29.11           C  \nATOM   9288  O   TYR A1197       2.914  17.016  -2.661  1.00 29.11           O  \nATOM   9289  CG  TYR A1197      -0.713  14.932  -3.148  1.00 29.11           C  \nATOM   9290  CD1 TYR A1197      -1.569  15.901  -3.713  1.00 29.11           C  \nATOM   9291  CD2 TYR A1197      -1.154  13.605  -2.996  1.00 29.11           C  \nATOM   9292  CE1 TYR A1197      -2.869  15.545  -4.122  1.00 29.11           C  \nATOM   9293  CE2 TYR A1197      -2.455  13.248  -3.400  1.00 29.11           C  \nATOM   9294  OH  TYR A1197      -4.568  13.855  -4.340  1.00 29.11           O  \nATOM   9295  CZ  TYR A1197      -3.314  14.215  -3.961  1.00 29.11           C  \nATOM   9296  N   LEU A1198       3.532  16.634  -4.786  1.00 26.81           N  \nATOM   9297  CA  LEU A1198       4.318  17.872  -4.996  1.00 26.81           C  \nATOM   9298  C   LEU A1198       4.941  17.929  -6.413  1.00 26.81           C  \nATOM   9299  CB  LEU A1198       5.397  18.048  -3.884  1.00 26.81           C  \nATOM   9300  O   LEU A1198       6.111  17.601  -6.617  1.00 26.81           O  \nATOM   9301  CG  LEU A1198       5.094  19.188  -2.883  1.00 26.81           C  \nATOM   9302  CD1 LEU A1198       6.003  19.062  -1.660  1.00 26.81           C  \nATOM   9303  CD2 LEU A1198       5.320  20.569  -3.506  1.00 26.81           C  \nATOM   9304  N   ARG A1199       4.183  18.403  -7.412  1.00 29.89           N  \nATOM   9305  CA  ARG A1199       4.752  18.937  -8.667  1.00 29.89           C  \nATOM   9306  C   ARG A1199       4.061  20.237  -9.061  1.00 29.89           C  \nATOM   9307  CB  ARG A1199       4.707  17.925  -9.828  1.00 29.89           C  \nATOM   9308  O   ARG A1199       2.915  20.237  -9.491  1.00 29.89           O  \nATOM   9309  CG  ARG A1199       5.729  16.791  -9.663  1.00 29.89           C  \nATOM   9310  CD  ARG A1199       5.930  16.035 -10.981  1.00 29.89           C  \nATOM   9311  NE  ARG A1199       6.716  14.806 -10.766  1.00 29.89           N  \nATOM   9312  NH1 ARG A1199       7.591  14.519 -12.880  1.00 29.89           N  \nATOM   9313  NH2 ARG A1199       7.967  13.016 -11.253  1.00 29.89           N  \nATOM   9314  CZ  ARG A1199       7.427  14.130 -11.642  1.00 29.89           C  \nATOM   9315  N   VAL A1200       4.797  21.338  -8.934  1.00 29.61           N  \nATOM   9316  CA  VAL A1200       4.426  22.640  -9.497  1.00 29.61           C  \nATOM   9317  C   VAL A1200       4.575  22.565 -11.018  1.00 29.61           C  \nATOM   9318  CB  VAL A1200       5.313  23.755  -8.903  1.00 29.61           C  \nATOM   9319  O   VAL A1200       5.627  22.155 -11.510  1.00 29.61           O  \nATOM   9320  CG1 VAL A1200       4.993  25.133  -9.489  1.00 29.61           C  \nATOM   9321  CG2 VAL A1200       5.138  23.841  -7.379  1.00 29.61           C  \nATOM   9322  N   ALA A1201       3.539  22.953 -11.761  1.00 29.62           N  \nATOM   9323  CA  ALA A1201       3.616  23.080 -13.213  1.00 29.62           C  \nATOM   9324  C   ALA A1201       4.325  24.396 -13.603  1.00 29.62           C  \nATOM   9325  CB  ALA A1201       2.201  22.997 -13.800  1.00 29.62           C  \nATOM   9326  O   ALA A1201       4.025  25.436 -13.011  1.00 29.62           O  \nATOM   9327  N   PRO A1202       5.247  24.393 -14.585  1.00 32.12           N  \nATOM   9328  CA  PRO A1202       5.793  25.625 -15.144  1.00 32.12           C  \nATOM   9329  C   PRO A1202       4.746  26.334 -16.018  1.00 32.12           C  \nATOM   9330  CB  PRO A1202       7.021  25.190 -15.947  1.00 32.12           C  \nATOM   9331  O   PRO A1202       3.898  25.693 -16.635  1.00 32.12           O  \nATOM   9332  CG  PRO A1202       6.628  23.796 -16.438  1.00 32.12           C  \nATOM   9333  CD  PRO A1202       5.779  23.238 -15.294  1.00 32.12           C  \nATOM   9334  N   GLN A1203       4.822  27.663 -16.094  1.00 29.22           N  \nATOM   9335  CA  GLN A1203       3.931  28.466 -16.934  1.00 29.22           C  \nATOM   9336  C   GLN A1203       4.219  28.244 -18.428  1.00 29.22           C  \nATOM   9337  CB  GLN A1203       4.098  29.957 -16.592  1.00 29.22           C  \nATOM   9338  O   GLN A1203       5.355  28.404 -18.872  1.00 29.22           O  \nATOM   9339  CG  GLN A1203       3.580  30.332 -15.193  1.00 29.22           C  \nATOM   9340  CD  GLN A1203       3.878  31.787 -14.830  1.00 29.22           C  \nATOM   9341  NE2 GLN A1203       3.109  32.390 -13.952  1.00 29.22           N  \nATOM   9342  OE1 GLN A1203       4.816  32.406 -15.299  1.00 29.22           O  \nATOM   9343  N   SER A1204       3.178  27.963 -19.213  1.00 32.69           N  \nATOM   9344  CA  SER A1204       3.188  28.075 -20.676  1.00 32.69           C  \nATOM   9345  C   SER A1204       2.359  29.292 -21.091  1.00 32.69           C  \nATOM   9346  CB  SER A1204       2.657  26.788 -21.320  1.00 32.69           C  \nATOM   9347  O   SER A1204       1.135  29.272 -20.956  1.00 32.69           O  \nATOM   9348  OG  SER A1204       1.349  26.497 -20.865  1.00 32.69           O  \nATOM   9349  N   SER A1205       3.018  30.354 -21.555  1.00 36.16           N  \nATOM   9350  CA  SER A1205       2.360  31.581 -22.014  1.00 36.16           C  \nATOM   9351  C   SER A1205       1.732  31.437 -23.405  1.00 36.16           C  \nATOM   9352  CB  SER A1205       3.318  32.776 -21.943  1.00 36.16           C  \nATOM   9353  O   SER A1205       2.119  30.595 -24.211  1.00 36.16           O  \nATOM   9354  OG  SER A1205       4.569  32.480 -22.534  1.00 36.16           O  \nATOM   9355  N   GLU A1206       0.728  32.274 -23.639  1.00 35.03           N  \nATOM   9356  CA  GLU A1206      -0.291  32.192 -24.684  1.00 35.03           C  \nATOM   9357  C   GLU A1206       0.190  32.206 -26.150  1.00 35.03           C  \nATOM   9358  CB  GLU A1206      -1.256  33.371 -24.468  1.00 35.03           C  \nATOM   9359  O   GLU A1206       1.232  32.745 -26.517  1.00 35.03           O  \nATOM   9360  CG  GLU A1206      -2.001  33.297 -23.124  1.00 35.03           C  \nATOM   9361  CD  GLU A1206      -2.633  34.644 -22.761  1.00 35.03           C  \nATOM   9362  OE1 GLU A1206      -3.881  34.707 -22.708  1.00 35.03           O  \nATOM   9363  OE2 GLU A1206      -1.848  35.587 -22.513  1.00 35.03           O  \nATOM   9364  N   PHE A1207      -0.695  31.666 -26.993  1.00 34.03           N  \nATOM   9365  CA  PHE A1207      -0.816  31.867 -28.438  1.00 34.03           C  \nATOM   9366  C   PHE A1207      -0.404  33.259 -28.963  1.00 34.03           C  \nATOM   9367  CB  PHE A1207      -2.321  31.756 -28.773  1.00 34.03           C  \nATOM   9368  O   PHE A1207      -0.972  34.268 -28.549  1.00 34.03           O  \nATOM   9369  CG  PHE A1207      -2.938  30.378 -28.891  1.00 34.03           C  \nATOM   9370  CD1 PHE A1207      -3.319  29.910 -30.164  1.00 34.03           C  \nATOM   9371  CD2 PHE A1207      -3.239  29.609 -27.749  1.00 34.03           C  \nATOM   9372  CE1 PHE A1207      -3.987  28.683 -30.299  1.00 34.03           C  \nATOM   9373  CE2 PHE A1207      -3.898  28.374 -27.887  1.00 34.03           C  \nATOM   9374  CZ  PHE A1207      -4.274  27.912 -29.160  1.00 34.03           C  \nATOM   9375  N   ILE A1208       0.332  33.285 -30.084  1.00 45.81           N  \nATOM   9376  CA  ILE A1208      -0.112  34.069 -31.254  1.00 45.81           C  \nATOM   9377  C   ILE A1208       0.347  33.455 -32.597  1.00 45.81           C  \nATOM   9378  CB  ILE A1208       0.105  35.610 -31.127  1.00 45.81           C  \nATOM   9379  O   ILE A1208       1.528  33.419 -32.919  1.00 45.81           O  \nATOM   9380  CG1 ILE A1208       1.282  36.086 -30.243  1.00 45.81           C  \nATOM   9381  CG2 ILE A1208       0.146  36.302 -32.507  1.00 45.81           C  \nATOM   9382  CD1 ILE A1208       1.195  37.579 -29.885  1.00 45.81           C  \nATOM   9383  N   GLY A1209      -0.657  33.003 -33.362  1.00 35.66           N  \nATOM   9384  CA  GLY A1209      -0.811  33.053 -34.826  1.00 35.66           C  \nATOM   9385  C   GLY A1209       0.316  32.653 -35.790  1.00 35.66           C  \nATOM   9386  O   GLY A1209       1.155  33.488 -36.126  1.00 35.66           O  \nATOM   9387  N   ALA A1210       0.155  31.481 -36.417  1.00 34.84           N  \nATOM   9388  CA  ALA A1210       0.282  31.278 -37.871  1.00 34.84           C  \nATOM   9389  C   ALA A1210      -0.556  30.059 -38.303  1.00 34.84           C  \nATOM   9390  CB  ALA A1210       1.755  31.128 -38.275  1.00 34.84           C  \nATOM   9391  O   ALA A1210      -0.448  29.024 -37.609  1.00 34.84           O  \nATOM   9392  OXT ALA A1210      -1.321  30.208 -39.279  1.00 34.84           O  \nTER    9393      ALA A1210                                                      \nENDMDL                                                                          \nEND                                                                             "
          },
          "file_paths": {
            "pdb": "cache\\alphafold\\AF-P00533-F1-model_v6.pdb"
          },
          "quality_metrics": {
            "model_version": "unknown",
            "created_date": "2025-08-01T00:00:00Z",
            "mean_plddt": 75.94,
            "plddt_very_high_pct": 47.4,
            "plddt_confident_pct": 23.3,
            "plddt_low_pct": 6.5,
            "plddt_very_low_pct": 22.8,
            "latest_version": 6
          },
          "plddt_scores": {
            "mean": 76.29,
            "median": 89.5,
            "min": 23.81,
            "max": 98.56,
            "stdev": 24.93,
            "num_residues": 9392,
            "high_confidence_pct": 47.9,
            "medium_confidence_pct": 23.2,
            "low_confidence_pct": 28.9
          },
          "model_version": "unknown",
          "organism": "unknown",
          "reference": "Jumper et al., Nature 2021, 596, 583-589"
        },
        "error": null
      },
      "metadata": {
        "name": "alphafold",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "AlphaFold Protein Structure Database adapter",
        "capabilities": {
          "structure_prediction": true,
          "confidence_scores": true,
          "quality_metrics": true,
          "pae_data": true,
          "multiple_formats": [
            "pdb",
            "cif"
          ]
        },
        "database": {
          "name": "AlphaFold DB",
          "url": "https://alphafold.ebi.ac.uk/",
          "coverage": "200M+ structures",
          "organisms": "Model organisms + Human proteome"
        },
        "quality_thresholds": {
          "plddt_high": "> 90 (very high confidence)",
          "plddt_medium": "70-90 (confident)",
          "plddt_low": "< 70 (low confidence)",
          "ptm_good": "> 0.5 (good model)"
        },
        "config": {
          "cache_dir": "cache\\alphafold",
          "download_pdb": true,
          "download_cif": false,
          "download_pae": false
        },
        "reference": {
          "paper": "Jumper et al., Nature 2021, 596, 583-589",
          "website": "https://alphafold.ebi.ac.uk/",
          "api_docs": "https://alphafold.ebi.ac.uk/api-docs"
        }
      }
    },
    {
      "adapter": "rcsb_pdb",
      "status": "success",
      "error": null,
      "execution_time": 0.377055,
      "data": {
        "success": true,
        "data": {
          "pdb_id": "1HSG",
          "metadata": {
            "audit_author": [
              {
                "name": "Chen, Z.",
                "pdbx_ordinal": 1
              }
            ],
            "cell": {
              "angle_alpha": 90.0,
              "angle_beta": 90.0,
              "angle_gamma": 90.0,
              "length_a": 59.57,
              "length_b": 87.07,
              "length_c": 46.71,
              "zpdb": 8
            },
            "citation": [
              {
                "country": "US",
                "id": "primary",
                "journal_abbrev": "J.Biol.Chem.",
                "journal_id_astm": "JBCHA3",
                "journal_id_csd": "0071",
                "journal_id_issn": "0021-9258",
                "journal_volume": "269",
                "page_first": "26344",
                "page_last": "26348",
                "pdbx_database_id_pub_med": 7929352,
                "rcsb_authors": [
                  "Chen, Z.",
                  "Li, Y.",
                  "Chen, E.",
                  "Hall, D.L.",
                  "Darke, P.L.",
                  "Culberson, C.",
                  "Shafer, J.A.",
                  "Kuo, L.C."
                ],
                "rcsb_is_primary": "Y",
                "rcsb_journal_abbrev": "J Biological Chem",
                "title": "Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases.",
                "year": 1994
              }
            ],
            "database2": [
              {
                "database_code": "1HSG",
                "database_id": "PDB",
                "pdbx_doi": "10.2210/pdb1hsg/pdb",
                "pdbx_database_accession": "pdb_00001hsg"
              },
              {
                "database_code": "D_1000173994",
                "database_id": "WWPDB"
              }
            ],
            "diffrn": [
              {
                "crystal_id": "1",
                "id": "1"
              }
            ],
            "diffrn_radiation": [
              {
                "diffrn_id": "1",
                "pdbx_scattering_type": "x-ray",
                "wavelength_id": "1"
              }
            ],
            "entry": {
              "id": "1HSG"
            },
            "exptl": [
              {
                "method": "X-RAY DIFFRACTION"
              }
            ],
            "exptl_crystal": [
              {
                "density_matthews": 2.8,
                "density_percent_sol": 56.1,
                "id": "1"
              }
            ],
            "pdbx_audit_revision_category": [
              {
                "category": "chem_comp_atom",
                "data_content_type": "Structure model",
                "ordinal": 1,
                "revision_ordinal": 4
              },
              {
                "category": "chem_comp_bond",
                "data_content_type": "Structure model",
                "ordinal": 2,
                "revision_ordinal": 4
              },
              {
                "category": "database_2",
                "data_content_type": "Structure model",
                "ordinal": 3,
                "revision_ordinal": 4
              },
              {
                "category": "pdbx_database_status",
                "data_content_type": "Structure model",
                "ordinal": 4,
                "revision_ordinal": 4
              },
              {
                "category": "struct_site",
                "data_content_type": "Structure model",
                "ordinal": 5,
                "revision_ordinal": 4
              }
            ],
            "pdbx_audit_revision_details": [
              {
                "data_content_type": "Structure model",
                "ordinal": 1,
                "provider": "repository",
                "revision_ordinal": 1,
                "type": "Initial release"
              }
            ],
            "pdbx_audit_revision_group": [
              {
                "data_content_type": "Structure model",
                "group": "Version format compliance",
                "ordinal": 1,
                "revision_ordinal": 2
              },
              {
                "data_content_type": "Structure model",
                "group": "Version format compliance",
                "ordinal": 2,
                "revision_ordinal": 3
              },
              {
                "data_content_type": "Structure model",
                "group": "Data collection",
                "ordinal": 3,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "group": "Database references",
                "ordinal": 4,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "group": "Derived calculations",
                "ordinal": 5,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "group": "Other",
                "ordinal": 6,
                "revision_ordinal": 4
              }
            ],
            "pdbx_audit_revision_history": [
              {
                "data_content_type": "Structure model",
                "major_revision": 1,
                "minor_revision": 0,
                "ordinal": 1,
                "revision_date": "1996-04-03T00:00:00+0000"
              },
              {
                "data_content_type": "Structure model",
                "major_revision": 1,
                "minor_revision": 1,
                "ordinal": 2,
                "revision_date": "2008-03-24T00:00:00+0000"
              },
              {
                "data_content_type": "Structure model",
                "major_revision": 1,
                "minor_revision": 2,
                "ordinal": 3,
                "revision_date": "2011-07-13T00:00:00+0000"
              },
              {
                "data_content_type": "Structure model",
                "major_revision": 1,
                "minor_revision": 3,
                "ordinal": 4,
                "revision_date": "2024-02-07T00:00:00+0000"
              }
            ],
            "pdbx_audit_revision_item": [
              {
                "data_content_type": "Structure model",
                "item": "_database_2.pdbx_DOI",
                "ordinal": 1,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "item": "_database_2.pdbx_database_accession",
                "ordinal": 2,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "item": "_pdbx_database_status.process_site",
                "ordinal": 3,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "item": "_struct_site.pdbx_auth_asym_id",
                "ordinal": 4,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "item": "_struct_site.pdbx_auth_comp_id",
                "ordinal": 5,
                "revision_ordinal": 4
              },
              {
                "data_content_type": "Structure model",
                "item": "_struct_site.pdbx_auth_seq_id",
                "ordinal": 6,
                "revision_ordinal": 4
              }
            ],
            "pdbx_database_status": {
              "pdb_format_compatible": "Y",
              "process_site": "BNL",
              "recvd_initial_deposition_date": "1995-03-31T00:00:00+0000",
              "status_code": "REL"
            },
            "pdbx_vrpt_summary": {
              "attempted_validation_steps": "molprobity,validation-pack,mogul,buster-report,percentiles,writexml,writecif,writepdf",
              "ligands_for_buster_report": "Y",
              "report_creation_date": "2024-01-30T18:32:00+0000"
            },
            "pdbx_vrpt_summary_geometry": [
              {
                "angles_rmsz": 0.85,
                "bonds_rmsz": 0.75,
                "clashscore": 4.97,
                "num_hreduce": 1659,
                "num_angles_rmsz": 2086,
                "num_bonds_rmsz": 1540,
                "percent_ramachandran_outliers": 0.52,
                "percent_rotamer_outliers": 6.63
              }
            ],
            "rcsb_accession_info": {
              "deposit_date": "1995-03-31T00:00:00+0000",
              "has_released_experimental_data": "N",
              "initial_release_date": "1996-04-03T00:00:00+0000",
              "major_revision": 1,
              "minor_revision": 3,
              "revision_date": "2024-02-07T00:00:00+0000",
              "status_code": "REL"
            },
            "rcsb_binding_affinity": [
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -15.883999824523926
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -61.895938873291016
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -60.64371109008789
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 15.04800033569336
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -53.50400161743164
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "Ki",
                "unit": "nM",
                "value": 6.900000095367432
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -65.23522186279297
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "IC50",
                "unit": "nM",
                "value": 0.4000000059604645
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -31.76799964904785
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -27.58799934387207
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 2.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 88,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3700000047683716
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 7.941999912261963
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 2.812000036239624
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -8.777999877929688
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 18.392000198364258
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -57.683998107910156
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 11.704000473022461
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 3.1070001125335693
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 13.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Ki",
                "unit": "nM",
                "value": 0.11999999731779099
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -15.465999603271484
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -62.28200149536133
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 15.465999603271484
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -28.026100158691406
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Ki",
                "unit": "nM",
                "value": 0.5400000214576721
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -51.41400146484375
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.5199999809265137
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3100000023841858
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -55.634788513183594
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 35.11199951171875
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -49.742000579833984
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -65.65263366699219
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Kd",
                "unit": "nM",
                "value": 1.2000000476837158
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -43.47200012207031
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -65.68244171142578
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -64.81781005859375
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -28.860919952392578
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 7.52400016784668
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 24.66200065612793
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -61.895938873291016
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -61.44871520996094
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Ki",
                "unit": "nM",
                "value": 0.5199999809265137
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 89,
                "type": "Ki",
                "unit": "nM",
                "value": 398.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 14.630000114440918
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 89,
                "type": "Ki",
                "unit": "nM",
                "value": 289.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -65.23522186279297
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -47.25677490234375
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Ki",
                "unit": "nM",
                "value": 0.7390000224113464
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 10.868000030517578
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -40.54600143432617
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "Ki",
                "unit": "nM",
                "value": 69.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 0.6000000238418579
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 8.777999877929688
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -71.49636840820312
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -60.19200134277344
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 2.799999952316284
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 14.630000114440918
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -63.148170471191406
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 0.5899999737739563
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -74.03064727783203
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.11400000005960464
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 89.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Kd",
                "unit": "nM",
                "value": 1.399999976158142
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -53.50400161743164
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 56.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 61.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -49.32400131225586
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 6.614999771118164
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -33.439998626708984
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.8799999952316284
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 0.4099999964237213
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 52.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -50.99599838256836
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 44.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 12.539999961853027
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 35.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -45.14400100708008
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": -6.688000202178955
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3230000138282776
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 88,
                "type": "Ki",
                "unit": "nM",
                "value": 62.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -58.139251708984375
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 370.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.5849999785423279
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.23999999463558197
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 2.700000047683716
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 88,
                "type": "Ki",
                "unit": "nM",
                "value": 42.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -59.3914794921875
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 100,
                "type": "Ki",
                "unit": "nM",
                "value": 3.0999999046325684
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -38.874000549316406
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "IC50",
                "unit": "nM",
                "value": 0.5899999737739563
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -58.58647537231445
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Kd",
                "unit": "nM",
                "value": 5.5
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -58.10200119018555
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 0.36000001430511475
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -47.652000427246094
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 2.638000011444092
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 0.5600000023841858
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "Ki",
                "unit": "nM",
                "value": 7.599999904632568
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.2800000011920929
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "Ki",
                "unit": "nM",
                "value": 0.30000001192092896
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "IC50",
                "unit": "nM",
                "value": 0.8799999952316284
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -62.28200149536133
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -30.113149642944336
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "IC50",
                "unit": "nM",
                "value": 1.600000023841858
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -65.65263366699219
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -49.32400131225586
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -47.23400115966797
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -44.752315521240234
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 40.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -54.34000015258789
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3580000102519989
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -51.832000732421875
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 95,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -42.63600158691406
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 95,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -57.30442810058594
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 95,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3799999952316284
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -58.97407150268555
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.5429999828338623
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 50.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -63.11800003051758
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 0.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 20.06399917602539
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -59.77399826049805
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 3.0999999046325684
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -64.81781005859375
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 56.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -70.27395629882812
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.3700000047683716
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -38.45600128173828
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 21.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 11.704000473022461
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 33.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 5.099999904632568
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 15.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 12.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 93,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -43.47200012207031
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "symbol": "<",
                "type": "IC50",
                "unit": "nM",
                "value": 10.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 88,
                "type": "IC50",
                "unit": "nM",
                "value": 10.5
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 90,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 17.974000930786133
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 5.015999794006348
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "IC50",
                "unit": "nM",
                "value": 0.6000000238418579
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Kd",
                "unit": "nM",
                "value": 1.0700000524520874
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "Ki",
                "unit": "nM",
                "value": 0.052000001072883606
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -49.34382629394531
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "Ki",
                "unit": "nM",
                "value": 4.400000095367432
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "IC50",
                "unit": "nM",
                "value": 0.6000000238418579
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 98,
                "type": "Ki",
                "unit": "nM",
                "value": 0.36000001430511475
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -53.08599853515625
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 97,
                "type": "&Delta;G",
                "unit": "kJ/mol",
                "value": -54.757999420166016
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 91,
                "type": "Ki",
                "unit": "nM",
                "value": 108.0
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 16.302000045776367
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 96,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 9.196000099182129
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 95,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 14.630000114440918
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 92,
                "type": "&Delta;H",
                "unit": "kJ/mol",
                "value": 26.75200080871582
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 94,
                "type": "-T&Delta;S",
                "unit": "kJ/mol",
                "value": -62.313350677490234
              },
              {
                "comp_id": "MK1",
                "link": "https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_pdbids.jsp?pdbids_submit=Search&pdbids=1HSG",
                "provenance_code": "BindingDB",
                "reference_sequence_identity": 100,
                "type": "IC50",
                "unit": "nM",
                "value": 0.36000001430511475
              }
            ],
            "rcsb_entry_container_identifiers": {
              "assembly_ids": [
                "1"
              ],
              "entity_ids": [
                "1",
                "2",
                "3"
              ],
              "entry_id": "1HSG",
              "model_ids": [
                1
              ],
              "non_polymer_entity_ids": [
                "2"
              ],
              "polymer_entity_ids": [
                "1"
              ],
              "pubmed_id": 7929352,
              "rcsb_id": "1HSG"
            },
            "rcsb_entry_info": {
              "assembly_count": 1,
              "branched_entity_count": 0,
              "cis_peptide_count": 0,
              "deposited_atom_count": 1686,
              "deposited_deuterated_water_count": 0,
              "deposited_hydrogen_atom_count": 0,
              "deposited_model_count": 1,
              "deposited_modeled_polymer_monomer_count": 198,
              "deposited_nonpolymer_entity_instance_count": 1,
              "deposited_polymer_entity_instance_count": 2,
              "deposited_polymer_monomer_count": 198,
              "deposited_solvent_atom_count": 127,
              "deposited_unmodeled_polymer_monomer_count": 0,
              "disulfide_bond_count": 0,
              "entity_count": 3,
              "experimental_method": "X-ray",
              "experimental_method_count": 1,
              "inter_mol_covalent_bond_count": 0,
              "inter_mol_metalic_bond_count": 0,
              "molecular_weight": 22.22,
              "na_polymer_entity_types": "Other",
              "nonpolymer_entity_count": 1,
              "nonpolymer_molecular_weight_maximum": 0.61,
              "nonpolymer_molecular_weight_minimum": 0.61,
              "polymer_composition": "homomeric protein",
              "polymer_entity_count": 1,
              "polymer_entity_count_dna": 0,
              "polymer_entity_count_rna": 0,
              "polymer_entity_count_nucleic_acid": 0,
              "polymer_entity_count_nucleic_acid_hybrid": 0,
              "polymer_entity_count_protein": 1,
              "polymer_entity_taxonomy_count": 1,
              "polymer_molecular_weight_maximum": 10.8,
              "polymer_molecular_weight_minimum": 10.8,
              "polymer_monomer_count_maximum": 99,
              "polymer_monomer_count_minimum": 99,
              "resolution_combined": [
                2.0
              ],
              "selected_polymer_entity_types": "Protein (only)",
              "software_programs_combined": [
                "X-PLOR"
              ],
              "solvent_entity_count": 1,
              "structure_determination_methodology": "experimental",
              "structure_determination_methodology_priority": 10,
              "diffrn_resolution_high": {
                "provenance_source": "From refinement resolution cutoff",
                "value": 2.0
              }
            },
            "rcsb_primary_citation": {
              "country": "US",
              "id": "primary",
              "journal_abbrev": "J.Biol.Chem.",
              "journal_id_astm": "JBCHA3",
              "journal_id_csd": "0071",
              "journal_id_issn": "0021-9258",
              "journal_volume": "269",
              "page_first": "26344",
              "page_last": "26348",
              "pdbx_database_id_pub_med": 7929352,
              "rcsb_orcididentifiers": [
                "?",
                "?",
                "?",
                "?",
                "?",
                "?",
                "?",
                "?"
              ],
              "rcsb_authors": [
                "Chen, Z.",
                "Li, Y.",
                "Chen, E.",
                "Hall, D.L.",
                "Darke, P.L.",
                "Culberson, C.",
                "Shafer, J.A.",
                "Kuo, L.C."
              ],
              "rcsb_journal_abbrev": "J Biological Chem",
              "title": "Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases.",
              "year": 1994
            },
            "refine": [
              {
                "ls_rfactor_rwork": 0.166,
                "ls_rfactor_obs": 0.166,
                "ls_dres_high": 2.0,
                "pdbx_diffrn_id": [
                  "1"
                ],
                "pdbx_refine_id": "X-RAY DIFFRACTION"
              }
            ],
            "refine_hist": [
              {
                "cycle_id": "LAST",
                "d_res_high": 2.0,
                "number_atoms_solvent": 127,
                "number_atoms_total": 1686,
                "pdbx_number_atoms_ligand": 45,
                "pdbx_number_atoms_nucleic_acid": 0,
                "pdbx_number_atoms_protein": 1514,
                "pdbx_refine_id": "X-RAY DIFFRACTION"
              }
            ],
            "refine_ls_restr": [
              {
                "dev_ideal": 0.017,
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_bond_d"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_bond_d_na"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_bond_d_prot"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_d"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_d_na"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_d_prot"
              },
              {
                "dev_ideal": 1.9,
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_deg"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_deg_na"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_angle_deg_prot"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_dihedral_angle_d"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_dihedral_angle_d_na"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_dihedral_angle_d_prot"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_improper_angle_d"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_improper_angle_d_na"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_improper_angle_d_prot"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_mcbond_it"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_mcangle_it"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_scbond_it"
              },
              {
                "pdbx_refine_id": "X-RAY DIFFRACTION",
                "type": "x_scangle_it"
              }
            ],
            "software": [
              {
                "classification": "model building",
                "name": "X-PLOR",
                "pdbx_ordinal": 1
              },
              {
                "classification": "refinement",
                "name": "X-PLOR",
                "pdbx_ordinal": 2
              },
              {
                "classification": "phasing",
                "name": "X-PLOR",
                "pdbx_ordinal": 3
              }
            ],
            "struct": {
              "title": "CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES"
            },
            "struct_keywords": {
              "pdbx_keywords": "HYDROLASE (ACID PROTEINASE)",
              "text": "HYDROLASE (ACID PROTEINASE)"
            },
            "symmetry": {
              "int_tables_number": 18,
              "space_group_name_hm": "P 21 21 2"
            },
            "rcsb_id": "1HSG"
          },
          "structure_files": {
            "pdb": "HEADER    HYDROLASE (ACID PROTEINASE)             31-MAR-95   1HSG              \nTITLE     CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN                \nTITLE    2 IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN\nTITLE    3 ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES                   \nCOMPND    MOL_ID: 1;                                                            \nCOMPND   2 MOLECULE: HIV-1 PROTEASE;                                            \nCOMPND   3 CHAIN: A, B;                                                         \nCOMPND   4 EC: 3.4.23.-;                                                        \nCOMPND   5 ENGINEERED: YES;                                                     \nCOMPND   6 OTHER_DETAILS: NY5 ISOLATE                                           \nSOURCE    MOL_ID: 1;                                                            \nSOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 \nSOURCE   3 ORGANISM_TAXID: 11676;                                               \nSOURCE   4 GENE: HIV-1 PROTEASE FROM THE NY5 ISOLATE;                           \nSOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 \nSOURCE   6 EXPRESSION_SYSTEM_TAXID: 562                                         \nKEYWDS    HYDROLASE (ACID PROTEINASE)                                           \nEXPDTA    X-RAY DIFFRACTION                                                     \nAUTHOR    Z.CHEN                                                                \nREVDAT   4   07-FEB-24 1HSG    1       REMARK                                   \nREVDAT   3   24-FEB-09 1HSG    1       VERSN                                    \nREVDAT   2   01-APR-03 1HSG    1       JRNL                                     \nREVDAT   1   03-APR-96 1HSG    0                                                \nJRNL        AUTH   Z.CHEN,Y.LI,E.CHEN,D.L.HALL,P.L.DARKE,C.CULBERSON,           \nJRNL        AUTH 2 J.A.SHAFER,L.C.KUO                                           \nJRNL        TITL   CRYSTAL STRUCTURE AT 1.9-A RESOLUTION OF HUMAN               \nJRNL        TITL 2 IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH      \nJRNL        TITL 3 L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV       \nJRNL        TITL 4 PROTEASES.                                                   \nJRNL        REF    J.BIOL.CHEM.                  V. 269 26344 1994              \nJRNL        REFN                   ISSN 0021-9258                               \nJRNL        PMID   7929352                                                      \nREMARK   2                                                                      \nREMARK   2 RESOLUTION.    2.00 ANGSTROMS.                                       \nREMARK   3                                                                      \nREMARK   3 REFINEMENT.                                                          \nREMARK   3   PROGRAM     : X-PLOR                                               \nREMARK   3   AUTHORS     : BRUNGER                                              \nREMARK   3                                                                      \nREMARK   3  DATA USED IN REFINEMENT.                                            \nREMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00                           \nREMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : NULL                           \nREMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           \nREMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           \nREMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           \nREMARK   3   COMPLETENESS (WORKING+TEST)   (%) : NULL                           \nREMARK   3   NUMBER OF REFLECTIONS             : NULL                           \nREMARK   3                                                                      \nREMARK   3  FIT TO DATA USED IN REFINEMENT.                                     \nREMARK   3   CROSS-VALIDATION METHOD          : NULL                            \nREMARK   3   FREE R VALUE TEST SET SELECTION  : NULL                            \nREMARK   3   R VALUE            (WORKING SET) : 0.166                           \nREMARK   3   FREE R VALUE                     : NULL                            \nREMARK   3   FREE R VALUE TEST SET SIZE   (%) : NULL                            \nREMARK   3   FREE R VALUE TEST SET COUNT      : NULL                            \nREMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            \nREMARK   3                                                                      \nREMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  \nREMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         \nREMARK   3   BIN RESOLUTION RANGE HIGH       (A) : NULL                         \nREMARK   3   BIN RESOLUTION RANGE LOW        (A) : NULL                         \nREMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         \nREMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         \nREMARK   3   BIN R VALUE           (WORKING SET) : NULL                         \nREMARK   3   BIN FREE R VALUE                    : NULL                         \nREMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         \nREMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         \nREMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         \nREMARK   3                                                                      \nREMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    \nREMARK   3   PROTEIN ATOMS            : 1514                                    \nREMARK   3   NUCLEIC ACID ATOMS       : 0                                       \nREMARK   3   HETEROGEN ATOMS          : 45                                      \nREMARK   3   SOLVENT ATOMS            : 127                                     \nREMARK   3                                                                      \nREMARK   3  B VALUES.                                                           \nREMARK   3   FROM WILSON PLOT           (A**2) : NULL                           \nREMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           \nREMARK   3   OVERALL ANISOTROPIC B VALUE.                                       \nREMARK   3    B11 (A**2) : NULL                                                 \nREMARK   3    B22 (A**2) : NULL                                                 \nREMARK   3    B33 (A**2) : NULL                                                 \nREMARK   3    B12 (A**2) : NULL                                                 \nREMARK   3    B13 (A**2) : NULL                                                 \nREMARK   3    B23 (A**2) : NULL                                                 \nREMARK   3                                                                      \nREMARK   3  ESTIMATED COORDINATE ERROR.                                         \nREMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            \nREMARK   3   ESD FROM SIGMAA              (A) : NULL                            \nREMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            \nREMARK   3                                                                      \nREMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         \nREMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            \nREMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            \nREMARK   3                                                                      \nREMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   \nREMARK   3   BOND LENGTHS                 (A) : 0.017                           \nREMARK   3   BOND ANGLES            (DEGREES) : 1.900                           \nREMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            \nREMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            \nREMARK   3                                                                      \nREMARK   3  ISOTROPIC THERMAL MODEL : NULL                                      \nREMARK   3                                                                      \nREMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                \nREMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 \nREMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 \nREMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 \nREMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 \nREMARK   3                                                                      \nREMARK   3  NCS MODEL : NULL                                                    \nREMARK   3                                                                      \nREMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          \nREMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 \nREMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 \nREMARK   3                                                                      \nREMARK   3  PARAMETER FILE  1  : NULL                                           \nREMARK   3  TOPOLOGY FILE  1   : NULL                                           \nREMARK   3                                                                      \nREMARK   3  OTHER REFINEMENT REMARKS: NULL                                      \nREMARK   4                                                                      \nREMARK   4 1HSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         \nREMARK 100                                                                      \nREMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                \nREMARK 100 THE DEPOSITION ID IS D_1000173994.                                   \nREMARK 200                                                                      \nREMARK 200 EXPERIMENTAL DETAILS                                                 \nREMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  \nREMARK 200  DATE OF DATA COLLECTION        : NULL                               \nREMARK 200  TEMPERATURE           (KELVIN) : NULL                               \nREMARK 200  PH                             : NULL                               \nREMARK 200  NUMBER OF CRYSTALS USED        : NULL                               \nREMARK 200                                                                      \nREMARK 200  SYNCHROTRON              (Y/N) : NULL                               \nREMARK 200  RADIATION SOURCE               : NULL                               \nREMARK 200  BEAMLINE                       : NULL                               \nREMARK 200  X-RAY GENERATOR MODEL          : NULL                               \nREMARK 200  MONOCHROMATIC OR LAUE    (M/L) : NULL                               \nREMARK 200  WAVELENGTH OR RANGE        (A) : NULL                               \nREMARK 200  MONOCHROMATOR                  : NULL                               \nREMARK 200  OPTICS                         : NULL                               \nREMARK 200                                                                      \nREMARK 200  DETECTOR TYPE                  : NULL                               \nREMARK 200  DETECTOR MANUFACTURER          : NULL                               \nREMARK 200  INTENSITY-INTEGRATION SOFTWARE : NULL                               \nREMARK 200  DATA SCALING SOFTWARE          : NULL                               \nREMARK 200                                                                      \nREMARK 200  NUMBER OF UNIQUE REFLECTIONS   : NULL                               \nREMARK 200  RESOLUTION RANGE HIGH      (A) : NULL                               \nREMARK 200  RESOLUTION RANGE LOW       (A) : NULL                               \nREMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               \nREMARK 200                                                                      \nREMARK 200 OVERALL.                                                             \nREMARK 200  COMPLETENESS FOR RANGE     (%) : NULL                               \nREMARK 200  DATA REDUNDANCY                : NULL                               \nREMARK 200  R MERGE                    (I) : NULL                               \nREMARK 200  R SYM                      (I) : NULL                               \nREMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               \nREMARK 200                                                                      \nREMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     \nREMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL                     \nREMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     \nREMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               \nREMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               \nREMARK 200  R MERGE FOR SHELL          (I) : NULL                               \nREMARK 200  R SYM FOR SHELL            (I) : NULL                               \nREMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               \nREMARK 200                                                                      \nREMARK 200 DIFFRACTION PROTOCOL: NULL                                           \nREMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL                         \nREMARK 200 SOFTWARE USED: X-PLOR                                                \nREMARK 200 STARTING MODEL: NULL                                                 \nREMARK 200                                                                      \nREMARK 200 REMARK: NULL                                                         \nREMARK 280                                                                      \nREMARK 280 CRYSTAL                                                              \nREMARK 280 SOLVENT CONTENT, VS   (%): 56.10                                     \nREMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80                     \nREMARK 280                                                                      \nREMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     \nREMARK 290                                                                      \nREMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            \nREMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2                        \nREMARK 290                                                                      \nREMARK 290      SYMOP   SYMMETRY                                                \nREMARK 290     NNNMMM   OPERATOR                                                \nREMARK 290       1555   X,Y,Z                                                   \nREMARK 290       2555   -X,-Y,Z                                                 \nREMARK 290       3555   -X+1/2,Y+1/2,-Z                                         \nREMARK 290       4555   X+1/2,-Y+1/2,-Z                                         \nREMARK 290                                                                      \nREMARK 290     WHERE NNN -> OPERATOR NUMBER                                     \nREMARK 290           MMM -> TRANSLATION VECTOR                                  \nREMARK 290                                                                      \nREMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            \nREMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             \nREMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                \nREMARK 290 RELATED MOLECULES.                                                   \nREMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            \nREMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            \nREMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            \nREMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            \nREMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            \nREMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            \nREMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000       29.78500            \nREMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       43.53500            \nREMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            \nREMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       29.78500            \nREMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       43.53500            \nREMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            \nREMARK 290                                                                      \nREMARK 290 REMARK: NULL                                                         \nREMARK 300                                                                      \nREMARK 300 BIOMOLECULE: 1                                                       \nREMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                \nREMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  \nREMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               \nREMARK 300 BURIED SURFACE AREA.                                                 \nREMARK 350                                                                      \nREMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           \nREMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                \nREMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          \nREMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          \nREMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               \nREMARK 350                                                                      \nREMARK 350 BIOMOLECULE: 1                                                       \nREMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           \nREMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    \nREMARK 350 SOFTWARE USED: PISA                                                  \nREMARK 350 TOTAL BURIED SURFACE AREA: 3560 ANGSTROM**2                          \nREMARK 350 SURFACE AREA OF THE COMPLEX: 10770 ANGSTROM**2                       \nREMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL                        \nREMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  \nREMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            \nREMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            \nREMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            \nREMARK 500                                                                      \nREMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         \nREMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       \nREMARK 500                                                                      \nREMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              \nREMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               \nREMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               \nREMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 \nREMARK 500                                                                      \nREMARK 500 STANDARD TABLE:                                                      \nREMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              \nREMARK 500                                                                      \nREMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        \nREMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     \nREMARK 500                                                                      \nREMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     \nREMARK 500    PRO A   1   CA  -  N   -  CD  ANGL. DEV. =  -8.4 DEGREES          \nREMARK 500    PRO A   1   N   -  CD  -  CG  ANGL. DEV. =   7.8 DEGREES          \nREMARK 500                                                                      \nREMARK 500 REMARK: NULL                                                         \nREMARK 500                                                                      \nREMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         \nREMARK 500 SUBTOPIC: TORSION ANGLES                                             \nREMARK 500                                                                      \nREMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            \nREMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               \nREMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             \nREMARK 500                                                                      \nREMARK 500 STANDARD TABLE:                                                      \nREMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    \nREMARK 500                                                                      \nREMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           \nREMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            \nREMARK 500                                                                      \nREMARK 500  M RES CSSEQI        PSI       PHI                                   \nREMARK 500    GLU A  35      110.40    -28.04                                   \nREMARK 500                                                                      \nREMARK 500 REMARK: NULL                                                         \nREMARK 600                                                                      \nREMARK 600 HETEROGEN                                                            \nREMARK 600                                                                      \nREMARK 600 L-735,524 IS N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-                 \nREMARK 600 TERTIARY- BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]          \nREMARK 600 -4(S)-HYDROXY-2(R)-PHENYLMETHLPENTANAMIDE MONOHYDRATE.               \nREMARK 800                                                                      \nREMARK 800 SITE                                                                 \nREMARK 800 SITE_IDENTIFIER: AC1                                                 \nREMARK 800 EVIDENCE_CODE: SOFTWARE                                              \nREMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MK1 B 902                 \nDBREF  1HSG A    1    99  UNP    P03367   POL_HV1BR       69    167             \nDBREF  1HSG B    1    99  UNP    P03367   POL_HV1BR       69    167             \nSEQRES   1 A   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          \nSEQRES   2 A   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          \nSEQRES   3 A   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          \nSEQRES   4 A   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          \nSEQRES   5 A   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          \nSEQRES   6 A   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          \nSEQRES   7 A   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          \nSEQRES   8 A   99  GLN ILE GLY CYS THR LEU ASN PHE                              \nSEQRES   1 B   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          \nSEQRES   2 B   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          \nSEQRES   3 B   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          \nSEQRES   4 B   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          \nSEQRES   5 B   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          \nSEQRES   6 B   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          \nSEQRES   7 B   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          \nSEQRES   8 B   99  GLN ILE GLY CYS THR LEU ASN PHE                              \nHET    MK1  B 902      45                                                       \nHETNAM     MK1 N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY                  \nHETNAM   2 MK1  BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-              \nHETNAM   3 MK1  4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE                       \nHETSYN     MK1 INDINAVIR                                                        \nFORMUL   3  MK1    C36 H47 N5 O4                                                \nFORMUL   4  HOH   *127(H2 O)                                                    \nHELIX    1   1 ARG A   87  LEU A   90  1                                   4    \nHELIX    2   2 ARG B   87  LEU B   90  1                                   4    \nSHEET    1   A 2 LEU A  10  ILE A  15  0                                        \nSHEET    2   A 2 GLN A  18  LEU A  23 -1  N  ALA A  22   O  VAL A  11           \nSHEET    1   B 4 VAL A  32  GLU A  34  0                                        \nSHEET    2   B 4 VAL A  75  GLY A  78  1  N  LEU A  76   O  LEU A  33           \nSHEET    3   B 4 GLY A  52  TYR A  59 -1  N  TYR A  59   O  VAL A  75           \nSHEET    4   B 4 LYS A  43  GLY A  49 -1  N  GLY A  49   O  GLY A  52           \nSHEET    1   C 2 ILE A  62  ILE A  66  0                                        \nSHEET    2   C 2 HIS A  69  GLY A  73 -1  N  GLY A  73   O  ILE A  62           \nSHEET    1   D 2 THR A  96  ASN A  98  0                                        \nSHEET    2   D 2 THR B  96  ASN B  98 -1  N  ASN B  98   O  THR A  96           \nSHEET    1   E 2 LEU B  10  ILE B  15  0                                        \nSHEET    2   E 2 GLN B  18  LEU B  23 -1  N  ALA B  22   O  VAL B  11           \nSHEET    1   F 3 LYS B  43  GLY B  48  0                                        \nSHEET    2   F 3 PHE B  53  TYR B  59 -1  N  GLN B  58   O  LYS B  43           \nSHEET    3   F 3 VAL B  75  VAL B  77 -1  N  VAL B  77   O  ARG B  57           \nSHEET    1   G 2 ILE B  62  ILE B  66  0                                        \nSHEET    2   G 2 HIS B  69  GLY B  73 -1  N  GLY B  73   O  ILE B  62           \nSITE     1 AC1 20 ARG A   8  ASP A  25  GLY A  27  GLY A  48                    \nSITE     2 AC1 20 GLY A  49  VAL A  82  ARG B   8  ASP B  25                    \nSITE     3 AC1 20 GLY B  27  ALA B  28  ASP B  29  ASP B  30                    \nSITE     4 AC1 20 VAL B  32  GLY B  48  GLY B  49  ILE B  50                    \nSITE     5 AC1 20 PRO B  81  HOH B 308  HOH B 313  HOH B 444                    \nCRYST1   59.570   87.070   46.710  90.00  90.00  90.00 P 21 21 2     8          \nORIGX1      1.000000  0.000000  0.000000        0.00000                         \nORIGX2      0.000000  1.000000  0.000000        0.00000                         \nORIGX3      0.000000  0.000000  1.000000        0.00000                         \nSCALE1      0.016787  0.000000  0.000000        0.00000                         \nSCALE2      0.000000  0.011485  0.000000        0.00000                         \nSCALE3      0.000000  0.000000  0.021409        0.00000                         \nATOM      1  N   PRO A   1      29.361  39.686   5.862  1.00 38.10           N  \nATOM      2  CA  PRO A   1      30.307  38.663   5.319  1.00 40.62           C  \nATOM      3  C   PRO A   1      29.760  38.071   4.022  1.00 42.64           C  \nATOM      4  O   PRO A   1      28.600  38.302   3.676  1.00 43.40           O  \nATOM      5  CB  PRO A   1      30.508  37.541   6.342  1.00 37.87           C  \nATOM      6  CG  PRO A   1      29.296  37.591   7.162  1.00 38.40           C  \nATOM      7  CD  PRO A   1      28.778  39.015   7.019  1.00 38.74           C  \nATOM      8  N   GLN A   2      30.607  37.334   3.305  1.00 41.76           N  \nATOM      9  CA  GLN A   2      30.158  36.492   2.199  1.00 41.30           C  \nATOM     10  C   GLN A   2      30.298  35.041   2.643  1.00 41.38           C  \nATOM     11  O   GLN A   2      31.401  34.494   2.763  1.00 43.09           O  \nATOM     12  CB  GLN A   2      30.970  36.738   0.926  1.00 40.81           C  \nATOM     13  CG  GLN A   2      30.625  35.783  -0.201  1.00 46.61           C  \nATOM     14  CD  GLN A   2      31.184  36.217  -1.549  1.00 50.36           C  \nATOM     15  OE1 GLN A   2      32.006  35.518  -2.156  1.00 53.89           O  \nATOM     16  NE2 GLN A   2      30.684  37.339  -2.061  1.00 51.46           N  \nATOM     17  N   ILE A   3      29.160  34.436   2.919  1.00 37.80           N  \nATOM     18  CA  ILE A   3      29.123  33.098   3.397  1.00 34.13           C  \nATOM     19  C   ILE A   3      28.968  32.155   2.198  1.00 33.19           C  \nATOM     20  O   ILE A   3      28.088  32.330   1.368  1.00 32.74           O  \nATOM     21  CB  ILE A   3      27.977  32.995   4.409  1.00 34.34           C  \nATOM     22  CG1 ILE A   3      28.341  33.820   5.652  1.00 33.95           C  \nATOM     23  CG2 ILE A   3      27.692  31.548   4.745  1.00 33.06           C  \nATOM     24  CD1 ILE A   3      27.264  33.884   6.696  1.00 32.50           C  \nATOM     25  N   THR A   4      29.891  31.210   2.066  1.00 31.65           N  \nATOM     26  CA  THR A   4      29.774  30.143   1.062  1.00 30.14           C  \nATOM     27  C   THR A   4      28.986  28.975   1.658  1.00 29.74           C  \nATOM     28  O   THR A   4      28.690  28.948   2.875  1.00 27.88           O  \nATOM     29  CB  THR A   4      31.165  29.618   0.634  1.00 29.24           C  \nATOM     30  OG1 THR A   4      31.866  29.209   1.815  1.00 27.60           O  \nATOM     31  CG2 THR A   4      31.980  30.688  -0.085  1.00 26.26           C  \nATOM     32  N   LEU A   5      28.641  28.019   0.803  1.00 29.27           N  \nATOM     33  CA  LEU A   5      27.644  27.003   1.144  1.00 30.12           C  \nATOM     34  C   LEU A   5      28.204  25.559   1.071  1.00 32.98           C  \nATOM     35  O   LEU A   5      27.446  24.583   0.969  1.00 32.32           O  \nATOM     36  CB  LEU A   5      26.411  27.139   0.226  1.00 26.21           C  \nATOM     37  CG  LEU A   5      25.676  28.479   0.352  1.00 24.56           C  \nATOM     38  CD1 LEU A   5      24.624  28.624  -0.753  1.00 20.74           C  \nATOM     39  CD2 LEU A   5      25.088  28.590   1.745  1.00 21.87           C  \nATOM     40  N   TRP A   6      29.528  25.436   1.146  1.00 31.52           N  \nATOM     41  CA  TRP A   6      30.177  24.150   1.279  1.00 30.82           C  \nATOM     42  C   TRP A   6      29.837  23.488   2.611  1.00 31.90           C  \nATOM     43  O   TRP A   6      29.706  22.271   2.673  1.00 33.26           O  \nATOM     44  CB  TRP A   6      31.685  24.301   1.109  1.00 28.66           C  \nATOM     45  CG  TRP A   6      32.152  24.955  -0.189  1.00 26.42           C  \nATOM     46  CD1 TRP A   6      32.681  26.216  -0.345  1.00 28.49           C  \nATOM     47  CD2 TRP A   6      32.274  24.314  -1.478  1.00 28.47           C  \nATOM     48  NE1 TRP A   6      33.102  26.385  -1.655  1.00 29.88           N  \nATOM     49  CE2 TRP A   6      32.864  25.258  -2.369  1.00 28.86           C  \nATOM     50  CE3 TRP A   6      31.949  23.035  -1.986  1.00 25.06           C  \nATOM     51  CZ2 TRP A   6      33.093  24.968  -3.717  1.00 32.14           C  \nATOM     52  CZ3 TRP A   6      32.195  22.755  -3.294  1.00 27.41           C  \nATOM     53  CH2 TRP A   6      32.754  23.722  -4.169  1.00 30.03           C  \nATOM     54  N   GLN A   7      29.667  24.280   3.667  1.00 33.01           N  \nATOM     55  CA  GLN A   7      29.141  23.799   4.960  1.00 32.37           C  \nATOM     56  C   GLN A   7      27.747  24.395   5.208  1.00 29.95           C  \nATOM     57  O   GLN A   7      27.349  25.330   4.547  1.00 26.55           O  \nATOM     58  CB  GLN A   7      30.072  24.227   6.100  1.00 38.12           C  \nATOM     59  CG  GLN A   7      31.512  23.694   5.995  1.00 48.91           C  \nATOM     60  CD  GLN A   7      32.521  24.750   5.469  1.00 59.75           C  \nATOM     61  OE1 GLN A   7      32.666  25.860   6.038  1.00 61.83           O  \nATOM     62  NE2 GLN A   7      33.268  24.374   4.419  1.00 59.99           N  \nATOM     63  N   ARG A   8      26.992  23.877   6.169  1.00 27.34           N  \nATOM     64  CA  ARG A   8      25.757  24.566   6.593  1.00 29.87           C  \nATOM     65  C   ARG A   8      26.029  26.025   6.996  1.00 31.94           C  \nATOM     66  O   ARG A   8      26.947  26.291   7.775  1.00 33.83           O  \nATOM     67  CB  ARG A   8      25.087  23.849   7.776  1.00 28.16           C  \nATOM     68  CG  ARG A   8      24.646  22.409   7.505  1.00 27.47           C  \nATOM     69  CD  ARG A   8      23.728  21.896   8.637  1.00 25.45           C  \nATOM     70  NE  ARG A   8      22.952  20.730   8.230  1.00 23.06           N  \nATOM     71  CZ  ARG A   8      22.367  19.871   9.064  1.00 28.80           C  \nATOM     72  NH1 ARG A   8      22.376  20.074  10.370  1.00 30.95           N  \nATOM     73  NH2 ARG A   8      21.776  18.789   8.589  1.00 26.02           N  \nATOM     74  N   PRO A   9      25.123  26.955   6.645  1.00 30.21           N  \nATOM     75  CA  PRO A   9      25.491  28.352   6.938  1.00 29.48           C  \nATOM     76  C   PRO A   9      25.127  28.763   8.364  1.00 29.45           C  \nATOM     77  O   PRO A   9      24.136  29.472   8.578  1.00 28.45           O  \nATOM     78  CB  PRO A   9      24.719  29.176   5.916  1.00 27.88           C  \nATOM     79  CG  PRO A   9      23.625  28.254   5.407  1.00 28.12           C  \nATOM     80  CD  PRO A   9      24.096  26.855   5.591  1.00 31.64           C  \nATOM     81  N   LEU A  10      25.905  28.285   9.330  1.00 28.83           N  \nATOM     82  CA  LEU A  10      25.653  28.510  10.750  1.00 31.57           C  \nATOM     83  C   LEU A  10      26.383  29.770  11.208  1.00 30.48           C  \nATOM     84  O   LEU A  10      27.567  29.927  10.938  1.00 31.00           O  \nATOM     85  CB  LEU A  10      26.120  27.284  11.573  1.00 31.09           C  \nATOM     86  CG  LEU A  10      25.161  26.082  11.544  1.00 35.91           C  \nATOM     87  CD1 LEU A  10      25.895  24.743  11.662  1.00 40.15           C  \nATOM     88  CD2 LEU A  10      24.206  26.196  12.696  1.00 40.51           C  \nATOM     89  N   VAL A  11      25.667  30.672  11.872  1.00 30.80           N  \nATOM     90  CA  VAL A  11      26.267  31.854  12.497  1.00 30.14           C  \nATOM     91  C   VAL A  11      25.818  31.957  13.955  1.00 33.13           C  \nATOM     92  O   VAL A  11      24.929  31.184  14.402  1.00 34.48           O  \nATOM     93  CB  VAL A  11      25.824  33.131  11.791  1.00 27.12           C  \nATOM     94  CG1 VAL A  11      26.270  33.089  10.323  1.00 28.48           C  \nATOM     95  CG2 VAL A  11      24.333  33.275  11.879  1.00 26.29           C  \nATOM     96  N   THR A  12      26.397  32.913  14.700  1.00 32.34           N  \nATOM     97  CA  THR A  12      26.001  33.143  16.102  1.00 32.56           C  \nATOM     98  C   THR A  12      24.915  34.200  16.204  1.00 33.07           C  \nATOM     99  O   THR A  12      25.010  35.279  15.610  1.00 33.62           O  \nATOM    100  CB  THR A  12      27.201  33.565  16.998  1.00 33.81           C  \nATOM    101  OG1 THR A  12      28.330  32.709  16.751  1.00 40.47           O  \nATOM    102  CG2 THR A  12      26.827  33.430  18.450  1.00 34.22           C  \nATOM    103  N   ILE A  13      23.848  33.868  16.909  1.00 31.84           N  \nATOM    104  CA  ILE A  13      22.842  34.875  17.206  1.00 32.26           C  \nATOM    105  C   ILE A  13      22.770  35.114  18.707  1.00 33.69           C  \nATOM    106  O   ILE A  13      23.328  34.363  19.500  1.00 30.43           O  \nATOM    107  CB  ILE A  13      21.413  34.460  16.661  1.00 32.80           C  \nATOM    108  CG1 ILE A  13      20.878  33.229  17.431  1.00 31.81           C  \nATOM    109  CG2 ILE A  13      21.510  34.194  15.162  1.00 27.69           C  \nATOM    110  CD1 ILE A  13      19.353  33.201  17.603  1.00 32.46           C  \nATOM    111  N   LYS A  14      22.106  36.199  19.087  1.00 36.78           N  \nATOM    112  CA  LYS A  14      21.894  36.545  20.492  1.00 38.20           C  \nATOM    113  C   LYS A  14      20.442  36.943  20.615  1.00 37.51           C  \nATOM    114  O   LYS A  14      19.960  37.808  19.873  1.00 33.78           O  \nATOM    115  CB  LYS A  14      22.777  37.724  20.896  1.00 43.07           C  \nATOM    116  CG  LYS A  14      22.727  38.056  22.383  1.00 50.67           C  \nATOM    117  CD  LYS A  14      23.270  39.450  22.678  1.00 56.97           C  \nATOM    118  CE  LYS A  14      24.814  39.490  22.755  1.00 62.89           C  \nATOM    119  NZ  LYS A  14      25.394  40.891  22.572  1.00 69.50           N  \nATOM    120  N   ILE A  15      19.739  36.267  21.512  1.00 40.26           N  \nATOM    121  CA  ILE A  15      18.345  36.563  21.813  1.00 46.34           C  \nATOM    122  C   ILE A  15      18.224  36.327  23.316  1.00 49.77           C  \nATOM    123  O   ILE A  15      18.886  35.449  23.864  1.00 52.38           O  \nATOM    124  CB  ILE A  15      17.380  35.592  21.022  1.00 45.04           C  \nATOM    125  CG1 ILE A  15      15.935  35.812  21.435  1.00 46.91           C  \nATOM    126  CG2 ILE A  15      17.745  34.137  21.266  1.00 47.78           C  \nATOM    127  CD1 ILE A  15      14.929  35.116  20.526  1.00 50.24           C  \nATOM    128  N   GLY A  16      17.446  37.139  24.012  1.00 53.37           N  \nATOM    129  CA  GLY A  16      17.356  36.968  25.459  1.00 56.32           C  \nATOM    130  C   GLY A  16      18.711  36.871  26.160  1.00 56.91           C  \nATOM    131  O   GLY A  16      18.866  36.162  27.153  1.00 55.53           O  \nATOM    132  N   GLY A  17      19.671  37.659  25.697  1.00 57.90           N  \nATOM    133  CA  GLY A  17      20.970  37.660  26.340  1.00 59.71           C  \nATOM    134  C   GLY A  17      21.680  36.316  26.278  1.00 60.57           C  \nATOM    135  O   GLY A  17      22.785  36.163  26.794  1.00 63.20           O  \nATOM    136  N   GLN A  18      21.093  35.361  25.572  1.00 59.37           N  \nATOM    137  CA  GLN A  18      21.780  34.106  25.263  1.00 58.98           C  \nATOM    138  C   GLN A  18      22.500  34.159  23.907  1.00 56.87           C  \nATOM    139  O   GLN A  18      21.937  34.624  22.915  1.00 56.84           O  \nATOM    140  CB  GLN A  18      20.776  32.957  25.228  1.00 63.37           C  \nATOM    141  CG  GLN A  18      19.599  33.116  26.176  1.00 67.60           C  \nATOM    142  CD  GLN A  18      19.556  31.997  27.179  1.00 72.39           C  \nATOM    143  OE1 GLN A  18      20.393  31.944  28.082  1.00 76.16           O  \nATOM    144  NE2 GLN A  18      18.647  31.035  26.975  1.00 74.55           N  \nATOM    145  N   LEU A  19      23.733  33.672  23.848  1.00 53.88           N  \nATOM    146  CA  LEU A  19      24.334  33.365  22.552  1.00 49.32           C  \nATOM    147  C   LEU A  19      23.896  31.963  22.106  1.00 46.38           C  \nATOM    148  O   LEU A  19      23.975  31.020  22.863  1.00 43.18           O  \nATOM    149  CB  LEU A  19      25.869  33.432  22.625  1.00 47.14           C  \nATOM    150  CG  LEU A  19      26.561  34.761  22.968  1.00 46.02           C  \nATOM    151  CD1 LEU A  19      28.007  34.629  22.620  1.00 46.45           C  \nATOM    152  CD2 LEU A  19      25.983  35.913  22.194  1.00 46.45           C  \nATOM    153  N   LYS A  20      23.416  31.855  20.876  1.00 44.76           N  \nATOM    154  CA  LYS A  20      23.006  30.584  20.266  1.00 44.52           C  \nATOM    155  C   LYS A  20      23.626  30.463  18.874  1.00 42.87           C  \nATOM    156  O   LYS A  20      24.024  31.460  18.283  1.00 41.39           O  \nATOM    157  CB  LYS A  20      21.494  30.523  20.107  1.00 43.50           C  \nATOM    158  CG  LYS A  20      20.778  29.875  21.264  1.00 46.90           C  \nATOM    159  CD  LYS A  20      19.868  30.857  21.939  1.00 49.38           C  \nATOM    160  CE  LYS A  20      19.112  30.168  23.043  1.00 54.07           C  \nATOM    161  NZ  LYS A  20      18.467  28.892  22.571  1.00 60.37           N  \nATOM    162  N   GLU A  21      23.725  29.250  18.342  1.00 41.75           N  \nATOM    163  CA  GLU A  21      24.053  29.117  16.931  1.00 40.02           C  \nATOM    164  C   GLU A  21      22.822  28.761  16.150  1.00 35.18           C  \nATOM    165  O   GLU A  21      21.879  28.136  16.672  1.00 30.96           O  \nATOM    166  CB  GLU A  21      25.197  28.130  16.679  1.00 45.21           C  \nATOM    167  CG  GLU A  21      25.035  26.716  17.168  1.00 55.20           C  \nATOM    168  CD  GLU A  21      25.878  25.743  16.334  1.00 63.88           C  \nATOM    169  OE1 GLU A  21      27.022  26.130  15.972  1.00 67.73           O  \nATOM    170  OE2 GLU A  21      25.379  24.639  15.983  1.00 60.14           O  \nATOM    171  N   ALA A  22      22.778  29.268  14.927  1.00 30.04           N  \nATOM    172  CA  ALA A  22      21.553  29.189  14.165  1.00 26.79           C  \nATOM    173  C   ALA A  22      21.870  29.183  12.682  1.00 26.36           C  \nATOM    174  O   ALA A  22      22.975  29.578  12.252  1.00 24.88           O  \nATOM    175  CB  ALA A  22      20.625  30.359  14.524  1.00 22.80           C  \nATOM    176  N   LEU A  23      20.893  28.726  11.903  1.00 25.58           N  \nATOM    177  CA  LEU A  23      21.047  28.473  10.476  1.00 25.08           C  \nATOM    178  C   LEU A  23      20.381  29.596   9.664  1.00 23.67           C  \nATOM    179  O   LEU A  23      19.231  29.943   9.912  1.00 25.94           O  \nATOM    180  CB  LEU A  23      20.382  27.135  10.174  1.00 27.31           C  \nATOM    181  CG  LEU A  23      20.532  26.573   8.786  1.00 27.99           C  \nATOM    182  CD1 LEU A  23      21.939  26.039   8.621  1.00 29.29           C  \nATOM    183  CD2 LEU A  23      19.490  25.490   8.627  1.00 31.05           C  \nATOM    184  N   LEU A  24      21.122  30.163   8.715  1.00 21.67           N  \nATOM    185  CA  LEU A  24      20.617  31.144   7.775  1.00 18.03           C  \nATOM    186  C   LEU A  24      19.940  30.412   6.617  1.00 19.77           C  \nATOM    187  O   LEU A  24      20.567  29.833   5.740  1.00 20.40           O  \nATOM    188  CB  LEU A  24      21.767  32.023   7.262  1.00 15.36           C  \nATOM    189  CG  LEU A  24      22.647  32.673   8.359  1.00 18.86           C  \nATOM    190  CD1 LEU A  24      23.698  33.581   7.738  1.00 16.70           C  \nATOM    191  CD2 LEU A  24      21.797  33.496   9.368  1.00 18.96           C  \nATOM    192  N   ASP A  25      18.626  30.444   6.627  1.00 18.83           N  \nATOM    193  CA  ASP A  25      17.853  29.516   5.837  1.00 18.91           C  \nATOM    194  C   ASP A  25      16.945  30.292   4.886  1.00 16.83           C  \nATOM    195  O   ASP A  25      15.843  30.678   5.237  1.00 17.64           O  \nATOM    196  CB  ASP A  25      17.047  28.642   6.811  1.00 16.55           C  \nATOM    197  CG  ASP A  25      16.316  27.513   6.146  1.00 21.74           C  \nATOM    198  OD1 ASP A  25      16.236  27.458   4.905  1.00 22.87           O  \nATOM    199  OD2 ASP A  25      15.762  26.696   6.882  1.00 24.00           O  \nATOM    200  N   THR A  26      17.364  30.439   3.645  1.00 15.44           N  \nATOM    201  CA  THR A  26      16.548  31.148   2.684  1.00 15.16           C  \nATOM    202  C   THR A  26      15.302  30.382   2.289  1.00 15.12           C  \nATOM    203  O   THR A  26      14.412  30.939   1.615  1.00 12.07           O  \nATOM    204  CB  THR A  26      17.328  31.419   1.447  1.00 17.69           C  \nATOM    205  OG1 THR A  26      17.693  30.177   0.863  1.00 16.60           O  \nATOM    206  CG2 THR A  26      18.601  32.197   1.773  1.00 13.90           C  \nATOM    207  N   GLY A  27      15.213  29.111   2.702  1.00 17.61           N  \nATOM    208  CA  GLY A  27      14.043  28.331   2.349  1.00 14.06           C  \nATOM    209  C   GLY A  27      12.958  28.456   3.394  1.00 13.84           C  \nATOM    210  O   GLY A  27      11.832  28.015   3.171  1.00 14.08           O  \nATOM    211  N   ALA A  28      13.301  28.967   4.569  1.00 12.94           N  \nATOM    212  CA  ALA A  28      12.324  29.192   5.642  1.00 13.20           C  \nATOM    213  C   ALA A  28      11.629  30.567   5.554  1.00 17.23           C  \nATOM    214  O   ALA A  28      12.303  31.618   5.504  1.00 15.43           O  \nATOM    215  CB  ALA A  28      13.031  29.084   6.978  1.00 12.92           C  \nATOM    216  N   ASP A  29      10.296  30.560   5.587  1.00 17.65           N  \nATOM    217  CA  ASP A  29       9.512  31.798   5.651  1.00 19.68           C  \nATOM    218  C   ASP A  29       9.632  32.481   6.994  1.00 21.65           C  \nATOM    219  O   ASP A  29       9.671  33.706   7.056  1.00 26.39           O  \nATOM    220  CB  ASP A  29       8.029  31.534   5.402  1.00 18.61           C  \nATOM    221  CG  ASP A  29       7.752  31.004   4.015  1.00 23.38           C  \nATOM    222  OD1 ASP A  29       8.591  31.192   3.104  1.00 23.84           O  \nATOM    223  OD2 ASP A  29       6.661  30.410   3.833  1.00 24.58           O  \nATOM    224  N   ASP A  30       9.698  31.685   8.062  1.00 23.67           N  \nATOM    225  CA  ASP A  30       9.718  32.168   9.444  1.00 22.55           C  \nATOM    226  C   ASP A  30      10.988  31.819  10.163  1.00 20.55           C  \nATOM    227  O   ASP A  30      11.818  31.072   9.679  1.00 22.98           O  \nATOM    228  CB  ASP A  30       8.549  31.585  10.214  1.00 24.31           C  \nATOM    229  CG  ASP A  30       7.254  31.916   9.579  1.00 25.77           C  \nATOM    230  OD1 ASP A  30       6.951  33.118   9.473  1.00 37.03           O  \nATOM    231  OD2 ASP A  30       6.561  31.008   9.099  1.00 33.64           O  \nATOM    232  N   THR A  31      11.161  32.408  11.326  1.00 21.65           N  \nATOM    233  CA  THR A  31      12.248  32.053  12.215  1.00 19.28           C  \nATOM    234  C   THR A  31      11.707  31.128  13.318  1.00 20.65           C  \nATOM    235  O   THR A  31      10.660  31.408  13.910  1.00 21.27           O  \nATOM    236  CB  THR A  31      12.896  33.338  12.795  1.00 21.21           C  \nATOM    237  OG1 THR A  31      13.451  34.082  11.707  1.00 17.85           O  \nATOM    238  CG2 THR A  31      14.027  32.992  13.816  1.00 20.08           C  \nATOM    239  N   VAL A  32      12.390  30.005  13.537  1.00 19.73           N  \nATOM    240  CA  VAL A  32      11.893  28.983  14.419  1.00 20.18           C  \nATOM    241  C   VAL A  32      13.036  28.655  15.292  1.00 18.49           C  \nATOM    242  O   VAL A  32      14.067  28.221  14.821  1.00 21.86           O  \nATOM    243  CB  VAL A  32      11.528  27.683  13.690  1.00 20.27           C  \nATOM    244  CG1 VAL A  32      10.656  26.825  14.592  1.00 21.42           C  \nATOM    245  CG2 VAL A  32      10.805  27.963  12.423  1.00 20.29           C  \nATOM    246  N   LEU A  33      12.899  28.904  16.576  1.00 21.84           N  \nATOM    247  CA  LEU A  33      13.996  28.594  17.500  1.00 24.48           C  \nATOM    248  C   LEU A  33      13.571  27.454  18.396  1.00 25.37           C  \nATOM    249  O   LEU A  33      12.363  27.234  18.612  1.00 25.11           O  \nATOM    250  CB  LEU A  33      14.337  29.799  18.375  1.00 24.32           C  \nATOM    251  CG  LEU A  33      14.849  31.061  17.691  1.00 28.97           C  \nATOM    252  CD1 LEU A  33      15.091  32.156  18.733  1.00 31.03           C  \nATOM    253  CD2 LEU A  33      16.139  30.718  16.927  1.00 30.18           C  \nATOM    254  N   GLU A  34      14.568  26.722  18.889  1.00 29.09           N  \nATOM    255  CA  GLU A  34      14.390  25.650  19.874  1.00 32.79           C  \nATOM    256  C   GLU A  34      13.739  26.125  21.160  1.00 33.96           C  \nATOM    257  O   GLU A  34      13.982  27.222  21.618  1.00 34.70           O  \nATOM    258  CB  GLU A  34      15.727  25.007  20.190  1.00 36.48           C  \nATOM    259  CG  GLU A  34      16.297  24.250  18.988  1.00 43.49           C  \nATOM    260  CD  GLU A  34      17.726  23.801  19.191  1.00 49.89           C  \nATOM    261  OE1 GLU A  34      18.134  23.657  20.375  1.00 52.23           O  \nATOM    262  OE2 GLU A  34      18.443  23.614  18.182  1.00 53.58           O  \nATOM    263  N   GLU A  35      12.865  25.288  21.703  1.00 32.88           N  \nATOM    264  CA  GLU A  35      12.183  25.482  22.981  1.00 33.85           C  \nATOM    265  C   GLU A  35      12.971  26.329  23.986  1.00 34.72           C  \nATOM    266  O   GLU A  35      13.981  25.861  24.497  1.00 34.03           O  \nATOM    267  CB  GLU A  35      11.941  24.114  23.581  1.00 35.16           C  \nATOM    268  CG  GLU A  35      10.800  24.049  24.516  1.00 39.66           C  \nATOM    269  CD  GLU A  35       9.489  24.067  23.809  1.00 45.60           C  \nATOM    270  OE1 GLU A  35       9.134  23.066  23.120  1.00 50.36           O  \nATOM    271  OE2 GLU A  35       8.758  25.047  24.035  1.00 47.94           O  \nATOM    272  N   MET A  36      12.495  27.556  24.269  1.00 33.77           N  \nATOM    273  CA  MET A  36      13.101  28.479  25.261  1.00 32.08           C  \nATOM    274  C   MET A  36      12.013  29.437  25.755  1.00 33.50           C  \nATOM    275  O   MET A  36      10.969  29.535  25.133  1.00 33.82           O  \nATOM    276  CB  MET A  36      14.216  29.306  24.621  1.00 31.77           C  \nATOM    277  CG  MET A  36      13.741  30.341  23.590  1.00 33.78           C  \nATOM    278  SD  MET A  36      15.123  31.051  22.667  1.00 38.76           S  \nATOM    279  CE  MET A  36      15.783  32.224  23.828  1.00 34.69           C  \nATOM    280  N   SER A  37      12.249  30.179  26.852  1.00 34.23           N  \nATOM    281  CA  SER A  37      11.163  31.036  27.460  1.00 33.81           C  \nATOM    282  C   SER A  37      11.347  32.442  26.960  1.00 32.96           C  \nATOM    283  O   SER A  37      12.475  32.929  27.007  1.00 32.62           O  \nATOM    284  CB  SER A  37      11.300  31.071  28.976  1.00 34.02           C  \nATOM    285  OG  SER A  37       9.948  31.148  29.559  1.00 38.20           O  \nATOM    286  N   LEU A  38      10.330  33.112  26.459  1.00 35.12           N  \nATOM    287  CA  LEU A  38      10.566  34.476  26.033  1.00 38.10           C  \nATOM    288  C   LEU A  38       9.594  35.375  26.756  1.00 42.61           C  \nATOM    289  O   LEU A  38       8.616  34.906  27.343  1.00 41.25           O  \nATOM    290  CB  LEU A  38      10.409  34.626  24.500  1.00 35.60           C  \nATOM    291  CG  LEU A  38      11.559  34.187  23.577  1.00 33.68           C  \nATOM    292  CD1 LEU A  38      11.171  34.399  22.132  1.00 33.91           C  \nATOM    293  CD2 LEU A  38      12.807  34.964  23.875  1.00 34.05           C  \nATOM    294  N   PRO A  39       9.929  36.666  26.880  1.00 45.17           N  \nATOM    295  CA  PRO A  39       8.980  37.700  27.301  1.00 45.32           C  \nATOM    296  C   PRO A  39       7.760  37.785  26.410  1.00 44.13           C  \nATOM    297  O   PRO A  39       7.866  37.883  25.194  1.00 44.57           O  \nATOM    298  CB  PRO A  39       9.778  38.989  27.220  1.00 48.51           C  \nATOM    299  CG  PRO A  39      11.021  38.637  26.370  1.00 47.48           C  \nATOM    300  CD  PRO A  39      11.291  37.226  26.725  1.00 48.21           C  \nATOM    301  N   GLY A  40       6.601  37.811  27.029  1.00 43.26           N  \nATOM    302  CA  GLY A  40       5.419  38.218  26.302  1.00 44.04           C  \nATOM    303  C   GLY A  40       4.430  37.094  26.331  1.00 46.02           C  \nATOM    304  O   GLY A  40       4.591  36.107  27.055  1.00 48.40           O  \nATOM    305  N   ARG A  41       3.289  37.341  25.729  1.00 47.22           N  \nATOM    306  CA  ARG A  41       2.382  36.252  25.509  1.00 48.14           C  \nATOM    307  C   ARG A  41       2.606  35.713  24.096  1.00 45.12           C  \nATOM    308  O   ARG A  41       3.225  36.383  23.273  1.00 43.73           O  \nATOM    309  CB  ARG A  41       0.956  36.719  25.748  1.00 53.98           C  \nATOM    310  CG  ARG A  41       0.288  36.021  26.959  1.00 61.76           C  \nATOM    311  CD  ARG A  41       0.118  36.953  28.169  1.00 64.66           C  \nATOM    312  NE  ARG A  41       1.356  37.143  28.933  1.00 67.95           N  \nATOM    313  CZ  ARG A  41       1.830  38.332  29.318  1.00 69.74           C  \nATOM    314  NH1 ARG A  41       1.161  39.450  29.040  1.00 69.56           N  \nATOM    315  NH2 ARG A  41       2.973  38.402  29.994  1.00 68.51           N  \nATOM    316  N   TRP A  42       2.145  34.493  23.834  1.00 42.00           N  \nATOM    317  CA  TRP A  42       2.295  33.862  22.533  1.00 40.42           C  \nATOM    318  C   TRP A  42       0.934  33.419  21.959  1.00 40.51           C  \nATOM    319  O   TRP A  42       0.031  33.049  22.694  1.00 41.61           O  \nATOM    320  CB  TRP A  42       3.207  32.645  22.642  1.00 42.08           C  \nATOM    321  CG  TRP A  42       2.946  31.783  23.787  1.00 42.80           C  \nATOM    322  CD1 TRP A  42       3.473  31.896  25.041  1.00 46.14           C  \nATOM    323  CD2 TRP A  42       1.989  30.710  23.857  1.00 44.40           C  \nATOM    324  NE1 TRP A  42       2.882  30.973  25.884  1.00 48.15           N  \nATOM    325  CE2 TRP A  42       1.966  30.246  25.193  1.00 45.80           C  \nATOM    326  CE3 TRP A  42       1.129  30.108  22.909  1.00 44.14           C  \nATOM    327  CZ2 TRP A  42       1.117  29.219  25.618  1.00 47.06           C  \nATOM    328  CZ3 TRP A  42       0.313  29.091  23.334  1.00 45.02           C  \nATOM    329  CH2 TRP A  42       0.305  28.651  24.686  1.00 47.76           C  \nATOM    330  N   LYS A  43       0.781  33.465  20.639  1.00 39.07           N  \nATOM    331  CA  LYS A  43      -0.305  32.776  19.928  1.00 38.61           C  \nATOM    332  C   LYS A  43       0.220  31.412  19.477  1.00 38.09           C  \nATOM    333  O   LYS A  43       1.400  31.270  19.145  1.00 37.97           O  \nATOM    334  CB  LYS A  43      -0.739  33.603  18.700  1.00 40.22           C  \nATOM    335  CG  LYS A  43      -1.311  34.967  19.027  1.00 40.71           C  \nATOM    336  CD  LYS A  43      -1.066  35.945  17.886  1.00 46.25           C  \nATOM    337  CE  LYS A  43      -1.726  37.319  18.156  1.00 53.77           C  \nATOM    338  NZ  LYS A  43      -0.979  38.292  19.067  1.00 55.67           N  \nATOM    339  N   PRO A  44      -0.601  30.363  19.541  1.00 36.78           N  \nATOM    340  CA  PRO A  44      -0.088  29.114  18.966  1.00 36.73           C  \nATOM    341  C   PRO A  44      -0.275  29.085  17.454  1.00 35.93           C  \nATOM    342  O   PRO A  44      -1.185  29.721  16.929  1.00 35.84           O  \nATOM    343  CB  PRO A  44      -0.893  28.021  19.667  1.00 37.26           C  \nATOM    344  CG  PRO A  44      -2.170  28.683  20.012  1.00 38.05           C  \nATOM    345  CD  PRO A  44      -1.825  30.129  20.325  1.00 40.15           C  \nATOM    346  N   LYS A  45       0.586  28.336  16.762  1.00 34.68           N  \nATOM    347  CA  LYS A  45       0.634  28.302  15.290  1.00 31.98           C  \nATOM    348  C   LYS A  45       1.025  26.869  14.873  1.00 29.00           C  \nATOM    349  O   LYS A  45       1.711  26.163  15.608  1.00 27.87           O  \nATOM    350  CB  LYS A  45       1.693  29.299  14.799  1.00 31.87           C  \nATOM    351  CG  LYS A  45       1.495  29.822  13.396  1.00 32.85           C  \nATOM    352  CD  LYS A  45       2.628  30.791  12.986  1.00 39.51           C  \nATOM    353  CE  LYS A  45       2.662  31.103  11.471  1.00 38.60           C  \nATOM    354  NZ  LYS A  45       1.837  32.301  11.181  1.00 45.48           N  \nATOM    355  N   MET A  46       0.570  26.438  13.707  1.00 28.78           N  \nATOM    356  CA  MET A  46       1.091  25.232  13.081  1.00 28.75           C  \nATOM    357  C   MET A  46       1.899  25.638  11.874  1.00 26.81           C  \nATOM    358  O   MET A  46       1.385  26.292  10.965  1.00 28.48           O  \nATOM    359  CB  MET A  46      -0.047  24.319  12.624  1.00 30.70           C  \nATOM    360  CG  MET A  46      -0.970  23.867  13.745  1.00 34.30           C  \nATOM    361  SD  MET A  46      -0.348  22.459  14.681  1.00 42.21           S  \nATOM    362  CE  MET A  46      -0.585  21.081  13.426  1.00 43.40           C  \nATOM    363  N   ILE A  47       3.167  25.258  11.849  1.00 25.63           N  \nATOM    364  CA  ILE A  47       3.978  25.464  10.655  1.00 25.64           C  \nATOM    365  C   ILE A  47       4.420  24.140  10.114  1.00 23.79           C  \nATOM    366  O   ILE A  47       4.667  23.248  10.887  1.00 25.39           O  \nATOM    367  CB  ILE A  47       5.234  26.259  10.953  1.00 25.82           C  \nATOM    368  CG1 ILE A  47       5.959  25.628  12.127  1.00 27.41           C  \nATOM    369  CG2 ILE A  47       4.898  27.703  11.148  1.00 29.47           C  \nATOM    370  CD1 ILE A  47       7.369  26.170  12.291  1.00 33.28           C  \nATOM    371  N   GLY A  48       4.567  24.042   8.795  1.00 23.56           N  \nATOM    372  CA  GLY A  48       4.886  22.777   8.145  1.00 28.25           C  \nATOM    373  C   GLY A  48       6.265  22.720   7.521  1.00 30.81           C  \nATOM    374  O   GLY A  48       6.723  23.689   6.900  1.00 30.06           O  \nATOM    375  N   GLY A  49       7.015  21.688   7.884  1.00 31.96           N  \nATOM    376  CA  GLY A  49       8.313  21.471   7.276  1.00 33.92           C  \nATOM    377  C   GLY A  49       8.221  20.379   6.232  1.00 37.71           C  \nATOM    378  O   GLY A  49       7.177  20.197   5.583  1.00 36.71           O  \nATOM    379  N   ILE A  50       9.309  19.619   6.155  1.00 39.37           N  \nATOM    380  CA  ILE A  50       9.537  18.544   5.194  1.00 40.56           C  \nATOM    381  C   ILE A  50       8.802  17.261   5.658  1.00 39.02           C  \nATOM    382  O   ILE A  50       8.143  16.589   4.863  1.00 40.72           O  \nATOM    383  CB  ILE A  50      11.095  18.362   5.046  1.00 40.75           C  \nATOM    384  CG1 ILE A  50      11.553  18.874   3.682  1.00 39.18           C  \nATOM    385  CG2 ILE A  50      11.521  16.945   5.317  1.00 42.58           C  \nATOM    386  CD1 ILE A  50      10.910  18.225   2.567  1.00 39.03           C  \nATOM    387  N   GLY A  51       8.865  16.952   6.945  1.00 35.64           N  \nATOM    388  CA  GLY A  51       8.174  15.771   7.405  1.00 37.36           C  \nATOM    389  C   GLY A  51       6.812  16.062   7.983  1.00 38.38           C  \nATOM    390  O   GLY A  51       6.408  15.342   8.870  1.00 42.43           O  \nATOM    391  N   GLY A  52       6.141  17.132   7.563  1.00 35.83           N  \nATOM    392  CA  GLY A  52       4.855  17.480   8.157  1.00 34.71           C  \nATOM    393  C   GLY A  52       4.884  18.624   9.170  1.00 32.77           C  \nATOM    394  O   GLY A  52       5.873  19.342   9.280  1.00 33.65           O  \nATOM    395  N   PHE A  53       3.806  18.788   9.925  1.00 31.50           N  \nATOM    396  CA  PHE A  53       3.593  19.996  10.731  1.00 30.76           C  \nATOM    397  C   PHE A  53       4.015  19.881  12.194  1.00 31.86           C  \nATOM    398  O   PHE A  53       3.930  18.810  12.781  1.00 36.37           O  \nATOM    399  CB  PHE A  53       2.121  20.351  10.670  1.00 28.77           C  \nATOM    400  CG  PHE A  53       1.760  21.152   9.484  1.00 30.51           C  \nATOM    401  CD1 PHE A  53       1.725  20.567   8.216  1.00 27.94           C  \nATOM    402  CD2 PHE A  53       1.556  22.518   9.607  1.00 30.74           C  \nATOM    403  CE1 PHE A  53       1.500  21.332   7.075  1.00 29.27           C  \nATOM    404  CE2 PHE A  53       1.327  23.302   8.496  1.00 32.36           C  \nATOM    405  CZ  PHE A  53       1.290  22.718   7.212  1.00 28.01           C  \nATOM    406  N   ILE A  54       4.483  20.969  12.792  1.00 28.86           N  \nATOM    407  CA  ILE A  54       4.689  21.005  14.248  1.00 28.83           C  \nATOM    408  C   ILE A  54       3.921  22.179  14.858  1.00 29.53           C  \nATOM    409  O   ILE A  54       3.575  23.139  14.182  1.00 28.42           O  \nATOM    410  CB  ILE A  54       6.199  21.155  14.625  1.00 28.74           C  \nATOM    411  CG1 ILE A  54       6.796  22.408  13.939  1.00 27.76           C  \nATOM    412  CG2 ILE A  54       6.967  19.888  14.203  1.00 28.78           C  \nATOM    413  CD1 ILE A  54       8.110  22.821  14.465  1.00 23.65           C  \nATOM    414  N   LYS A  55       3.632  22.095  16.145  1.00 31.86           N  \nATOM    415  CA  LYS A  55       2.968  23.196  16.823  1.00 31.37           C  \nATOM    416  C   LYS A  55       4.038  24.093  17.449  1.00 31.40           C  \nATOM    417  O   LYS A  55       4.949  23.610  18.157  1.00 30.39           O  \nATOM    418  CB  LYS A  55       2.021  22.661  17.895  1.00 34.83           C  \nATOM    419  CG  LYS A  55       0.974  23.665  18.300  1.00 41.25           C  \nATOM    420  CD  LYS A  55       0.006  23.101  19.304  1.00 48.65           C  \nATOM    421  CE  LYS A  55      -0.580  24.217  20.149  1.00 52.68           C  \nATOM    422  NZ  LYS A  55       0.439  24.751  21.104  1.00 56.46           N  \nATOM    423  N   VAL A  56       3.953  25.391  17.185  1.00 27.17           N  \nATOM    424  CA  VAL A  56       4.927  26.319  17.754  1.00 26.79           C  \nATOM    425  C   VAL A  56       4.225  27.378  18.556  1.00 25.98           C  \nATOM    426  O   VAL A  56       3.023  27.557  18.455  1.00 28.45           O  \nATOM    427  CB  VAL A  56       5.769  27.009  16.663  1.00 23.58           C  \nATOM    428  CG1 VAL A  56       6.791  26.027  16.120  1.00 24.00           C  \nATOM    429  CG2 VAL A  56       4.881  27.551  15.567  1.00 19.88           C  \nATOM    430  N   ARG A  57       4.978  28.079  19.377  1.00 27.52           N  \nATOM    431  CA  ARG A  57       4.459  29.271  20.026  1.00 29.29           C  \nATOM    432  C   ARG A  57       5.038  30.502  19.335  1.00 26.53           C  \nATOM    433  O   ARG A  57       6.242  30.596  19.138  1.00 26.51           O  \nATOM    434  CB  ARG A  57       4.824  29.245  21.505  1.00 33.25           C  \nATOM    435  CG  ARG A  57       4.168  28.102  22.260  1.00 39.60           C  \nATOM    436  CD  ARG A  57       4.656  28.068  23.693  1.00 44.47           C  \nATOM    437  NE  ARG A  57       6.032  27.573  23.790  1.00 50.18           N  \nATOM    438  CZ  ARG A  57       7.027  28.273  24.317  1.00 49.84           C  \nATOM    439  NH1 ARG A  57       6.825  29.532  24.678  1.00 51.65           N  \nATOM    440  NH2 ARG A  57       8.223  27.723  24.467  1.00 52.43           N  \nATOM    441  N   GLN A  58       4.171  31.431  18.958  1.00 25.48           N  \nATOM    442  CA  GLN A  58       4.570  32.596  18.172  1.00 27.73           C  \nATOM    443  C   GLN A  58       4.681  33.818  19.085  1.00 30.15           C  \nATOM    444  O   GLN A  58       3.694  34.242  19.683  1.00 33.75           O  \nATOM    445  CB  GLN A  58       3.539  32.859  17.094  1.00 26.15           C  \nATOM    446  CG  GLN A  58       3.736  34.104  16.321  1.00 29.09           C  \nATOM    447  CD  GLN A  58       2.500  34.473  15.541  1.00 37.13           C  \nATOM    448  OE1 GLN A  58       1.530  33.703  15.489  1.00 40.89           O  \nATOM    449  NE2 GLN A  58       2.508  35.651  14.940  1.00 39.09           N  \nATOM    450  N   TYR A  59       5.883  34.378  19.196  1.00 32.83           N  \nATOM    451  CA  TYR A  59       6.097  35.658  19.896  1.00 34.57           C  \nATOM    452  C   TYR A  59       6.304  36.752  18.835  1.00 35.86           C  \nATOM    453  O   TYR A  59       6.923  36.513  17.800  1.00 38.78           O  \nATOM    454  CB  TYR A  59       7.354  35.588  20.765  1.00 33.06           C  \nATOM    455  CG  TYR A  59       7.213  34.624  21.955  1.00 36.56           C  \nATOM    456  CD1 TYR A  59       7.479  33.237  21.805  1.00 37.53           C  \nATOM    457  CD2 TYR A  59       6.795  35.087  23.223  1.00 33.33           C  \nATOM    458  CE1 TYR A  59       7.345  32.365  22.871  1.00 34.69           C  \nATOM    459  CE2 TYR A  59       6.638  34.224  24.268  1.00 33.09           C  \nATOM    460  CZ  TYR A  59       6.926  32.869  24.102  1.00 33.21           C  \nATOM    461  OH  TYR A  59       6.967  32.076  25.200  1.00 40.16           O  \nATOM    462  N   ASP A  60       5.767  37.940  19.049  1.00 37.21           N  \nATOM    463  CA  ASP A  60       6.022  39.045  18.125  1.00 36.50           C  \nATOM    464  C   ASP A  60       7.025  40.015  18.725  1.00 35.62           C  \nATOM    465  O   ASP A  60       7.340  39.951  19.900  1.00 33.30           O  \nATOM    466  CB  ASP A  60       4.719  39.777  17.832  1.00 43.82           C  \nATOM    467  CG  ASP A  60       3.699  38.899  17.148  1.00 49.03           C  \nATOM    468  OD1 ASP A  60       3.989  38.368  16.050  1.00 53.15           O  \nATOM    469  OD2 ASP A  60       2.570  38.799  17.672  1.00 54.18           O  \nATOM    470  N   GLN A  61       7.529  40.913  17.896  1.00 35.15           N  \nATOM    471  CA  GLN A  61       8.337  42.060  18.331  1.00 37.27           C  \nATOM    472  C   GLN A  61       9.535  41.630  19.179  1.00 36.83           C  \nATOM    473  O   GLN A  61       9.777  42.191  20.264  1.00 39.02           O  \nATOM    474  CB  GLN A  61       7.471  43.051  19.131  1.00 41.54           C  \nATOM    475  CG  GLN A  61       7.718  44.555  18.814  1.00 53.40           C  \nATOM    476  CD  GLN A  61       7.182  45.552  19.907  1.00 61.08           C  \nATOM    477  OE1 GLN A  61       7.936  46.461  20.398  1.00 65.46           O  \nATOM    478  NE2 GLN A  61       5.892  45.377  20.306  1.00 58.46           N  \nATOM    479  N   ILE A  62      10.283  40.645  18.676  1.00 33.10           N  \nATOM    480  CA  ILE A  62      11.484  40.115  19.328  1.00 33.95           C  \nATOM    481  C   ILE A  62      12.745  40.584  18.614  1.00 35.70           C  \nATOM    482  O   ILE A  62      12.830  40.485  17.396  1.00 38.95           O  \nATOM    483  CB  ILE A  62      11.465  38.545  19.309  1.00 33.50           C  \nATOM    484  CG1 ILE A  62      10.152  38.035  19.930  1.00 31.68           C  \nATOM    485  CG2 ILE A  62      12.688  37.973  20.027  1.00 33.86           C  \nATOM    486  CD1 ILE A  62       9.966  38.380  21.363  1.00 35.62           C  \nATOM    487  N   LEU A  63      13.722  41.086  19.369  1.00 38.14           N  \nATOM    488  CA  LEU A  63      15.038  41.476  18.822  1.00 41.38           C  \nATOM    489  C   LEU A  63      16.033  40.304  18.862  1.00 42.34           C  \nATOM    490  O   LEU A  63      16.195  39.661  19.897  1.00 43.91           O  \nATOM    491  CB  LEU A  63      15.631  42.666  19.619  1.00 41.40           C  \nATOM    492  CG  LEU A  63      16.776  43.426  18.914  1.00 42.58           C  \nATOM    493  CD1 LEU A  63      16.560  44.922  18.993  1.00 46.33           C  \nATOM    494  CD2 LEU A  63      18.103  43.062  19.558  1.00 45.30           C  \nATOM    495  N   ILE A  64      16.686  40.036  17.738  1.00 44.21           N  \nATOM    496  CA  ILE A  64      17.760  39.039  17.653  1.00 46.55           C  \nATOM    497  C   ILE A  64      18.991  39.753  17.116  1.00 46.30           C  \nATOM    498  O   ILE A  64      18.862  40.632  16.288  1.00 45.60           O  \nATOM    499  CB  ILE A  64      17.390  37.875  16.634  1.00 48.42           C  \nATOM    500  CG1 ILE A  64      16.127  37.137  17.110  1.00 51.56           C  \nATOM    501  CG2 ILE A  64      18.551  36.857  16.518  1.00 45.78           C  \nATOM    502  CD1 ILE A  64      16.194  35.643  16.885  1.00 52.26           C  \nATOM    503  N   GLU A  65      20.181  39.387  17.573  1.00 48.38           N  \nATOM    504  CA  GLU A  65      21.406  39.983  17.036  1.00 52.65           C  \nATOM    505  C   GLU A  65      22.192  39.019  16.135  1.00 53.34           C  \nATOM    506  O   GLU A  65      22.866  38.128  16.631  1.00 57.14           O  \nATOM    507  CB  GLU A  65      22.307  40.439  18.180  1.00 53.39           C  \nATOM    508  CG  GLU A  65      21.987  41.843  18.676  1.00 58.82           C  \nATOM    509  CD  GLU A  65      23.228  42.558  19.187  1.00 61.85           C  \nATOM    510  OE1 GLU A  65      24.094  42.925  18.348  1.00 62.51           O  \nATOM    511  OE2 GLU A  65      23.348  42.730  20.429  1.00 63.85           O  \nATOM    512  N   ILE A  66      22.148  39.215  14.823  1.00 54.18           N  \nATOM    513  CA  ILE A  66      22.818  38.327  13.863  1.00 53.69           C  \nATOM    514  C   ILE A  66      24.123  38.945  13.303  1.00 55.63           C  \nATOM    515  O   ILE A  66      24.114  39.903  12.521  1.00 55.17           O  \nATOM    516  CB  ILE A  66      21.831  37.964  12.694  1.00 53.26           C  \nATOM    517  CG1 ILE A  66      20.481  37.516  13.278  1.00 50.35           C  \nATOM    518  CG2 ILE A  66      22.444  36.880  11.799  1.00 51.36           C  \nATOM    519  CD1 ILE A  66      19.263  38.072  12.560  1.00 49.54           C  \nATOM    520  N   CYS A  67      25.251  38.396  13.731  1.00 57.47           N  \nATOM    521  CA  CYS A  67      26.590  38.871  13.351  1.00 59.30           C  \nATOM    522  C   CYS A  67      26.798  40.370  13.560  1.00 58.98           C  \nATOM    523  O   CYS A  67      27.461  41.045  12.763  1.00 59.83           O  \nATOM    524  CB  CYS A  67      26.907  38.497  11.905  1.00 60.45           C  \nATOM    525  SG  CYS A  67      27.274  36.734  11.705  1.00 66.26           S  \nATOM    526  N   GLY A  68      26.239  40.887  14.650  1.00 58.28           N  \nATOM    527  CA  GLY A  68      26.319  42.307  14.938  1.00 56.53           C  \nATOM    528  C   GLY A  68      24.980  42.946  14.665  1.00 54.84           C  \nATOM    529  O   GLY A  68      24.371  43.518  15.561  1.00 55.20           O  \nATOM    530  N   HIS A  69      24.449  42.689  13.479  1.00 52.63           N  \nATOM    531  CA  HIS A  69      23.251  43.368  13.013  1.00 49.83           C  \nATOM    532  C   HIS A  69      22.009  43.025  13.836  1.00 49.49           C  \nATOM    533  O   HIS A  69      21.626  41.865  13.958  1.00 50.24           O  \nATOM    534  CB  HIS A  69      22.975  43.009  11.568  1.00 48.37           C  \nATOM    535  CG  HIS A  69      24.157  43.172  10.639  1.00 48.55           C  \nATOM    536  ND1 HIS A  69      25.294  42.398  10.762  1.00 46.92           N  \nATOM    537  CD2 HIS A  69      24.283  43.886   9.518  1.00 47.07           C  \nATOM    538  CE1 HIS A  69      26.075  42.630   9.723  1.00 45.30           C  \nATOM    539  NE2 HIS A  69      25.505  43.532   8.946  1.00 49.32           N  \nATOM    540  N   LYS A  70      21.364  44.050  14.376  1.00 48.04           N  \nATOM    541  CA  LYS A  70      20.030  43.883  14.945  1.00 44.00           C  \nATOM    542  C   LYS A  70      18.929  43.698  13.882  1.00 40.53           C  \nATOM    543  O   LYS A  70      19.000  44.197  12.761  1.00 37.44           O  \nATOM    544  CB  LYS A  70      19.667  45.075  15.840  1.00 46.06           C  \nATOM    545  CG  LYS A  70      20.422  45.141  17.154  1.00 48.65           C  \nATOM    546  CD  LYS A  70      19.885  46.281  18.036  1.00 52.10           C  \nATOM    547  CE  LYS A  70      20.905  46.699  19.095  1.00 52.81           C  \nATOM    548  NZ  LYS A  70      20.376  47.817  19.946  1.00 57.49           N  \nATOM    549  N   ALA A  71      17.879  43.010  14.305  1.00 37.00           N  \nATOM    550  CA  ALA A  71      16.703  42.737  13.499  1.00 33.57           C  \nATOM    551  C   ALA A  71      15.600  42.546  14.556  1.00 31.56           C  \nATOM    552  O   ALA A  71      15.880  42.175  15.705  1.00 34.29           O  \nATOM    553  CB  ALA A  71      16.937  41.464  12.683  1.00 28.40           C  \nATOM    554  N   ILE A  72      14.366  42.881  14.219  1.00 28.94           N  \nATOM    555  CA  ILE A  72      13.233  42.663  15.111  1.00 26.93           C  \nATOM    556  C   ILE A  72      12.196  41.969  14.237  1.00 25.42           C  \nATOM    557  O   ILE A  72      12.083  42.266  13.025  1.00 23.83           O  \nATOM    558  CB  ILE A  72      12.635  44.019  15.609  1.00 34.11           C  \nATOM    559  CG1 ILE A  72      13.664  44.777  16.446  1.00 39.50           C  \nATOM    560  CG2 ILE A  72      11.353  43.782  16.409  1.00 34.28           C  \nATOM    561  CD1 ILE A  72      13.437  46.286  16.451  1.00 44.26           C  \nATOM    562  N   GLY A  73      11.457  41.034  14.821  1.00 23.40           N  \nATOM    563  CA  GLY A  73      10.359  40.420  14.090  1.00 22.07           C  \nATOM    564  C   GLY A  73       9.750  39.238  14.835  1.00 24.48           C  \nATOM    565  O   GLY A  73      10.019  39.007  16.009  1.00 24.29           O  \nATOM    566  N   THR A  74       8.853  38.524  14.181  1.00 23.67           N  \nATOM    567  CA  THR A  74       8.224  37.361  14.786  1.00 24.46           C  \nATOM    568  C   THR A  74       9.169  36.194  14.895  1.00 25.63           C  \nATOM    569  O   THR A  74       9.964  35.908  14.007  1.00 25.67           O  \nATOM    570  CB  THR A  74       6.961  36.929  14.010  1.00 24.94           C  \nATOM    571  OG1 THR A  74       6.030  38.013  14.001  1.00 29.61           O  \nATOM    572  CG2 THR A  74       6.287  35.760  14.688  1.00 19.06           C  \nATOM    573  N   VAL A  75       9.085  35.534  16.025  1.00 25.14           N  \nATOM    574  CA  VAL A  75       9.944  34.420  16.291  1.00 26.87           C  \nATOM    575  C   VAL A  75       9.018  33.325  16.795  1.00 27.97           C  \nATOM    576  O   VAL A  75       8.104  33.576  17.594  1.00 27.87           O  \nATOM    577  CB  VAL A  75      11.002  34.791  17.336  1.00 25.74           C  \nATOM    578  CG1 VAL A  75      11.638  33.561  17.884  1.00 27.82           C  \nATOM    579  CG2 VAL A  75      12.070  35.661  16.648  1.00 21.53           C  \nATOM    580  N   LEU A  76       9.200  32.127  16.258  1.00 27.21           N  \nATOM    581  CA  LEU A  76       8.353  30.995  16.628  1.00 25.80           C  \nATOM    582  C   LEU A  76       9.229  30.084  17.483  1.00 24.05           C  \nATOM    583  O   LEU A  76      10.409  29.923  17.194  1.00 23.89           O  \nATOM    584  CB  LEU A  76       7.937  30.247  15.365  1.00 24.57           C  \nATOM    585  CG  LEU A  76       7.222  30.919  14.207  1.00 24.94           C  \nATOM    586  CD1 LEU A  76       6.909  29.914  13.139  1.00 21.47           C  \nATOM    587  CD2 LEU A  76       5.961  31.526  14.713  1.00 22.70           C  \nATOM    588  N   VAL A  77       8.689  29.507  18.538  1.00 22.25           N  \nATOM    589  CA  VAL A  77       9.519  28.691  19.405  1.00 25.77           C  \nATOM    590  C   VAL A  77       8.852  27.309  19.499  1.00 25.41           C  \nATOM    591  O   VAL A  77       7.621  27.241  19.608  1.00 21.46           O  \nATOM    592  CB  VAL A  77       9.648  29.353  20.800  1.00 26.64           C  \nATOM    593  CG1 VAL A  77      10.306  28.419  21.773  1.00 24.10           C  \nATOM    594  CG2 VAL A  77      10.426  30.686  20.648  1.00 24.74           C  \nATOM    595  N   GLY A  78       9.637  26.227  19.375  1.00 23.37           N  \nATOM    596  CA  GLY A  78       9.027  24.918  19.185  1.00 25.28           C  \nATOM    597  C   GLY A  78      10.005  23.782  18.984  1.00 24.69           C  \nATOM    598  O   GLY A  78      11.215  24.012  19.065  1.00 27.34           O  \nATOM    599  N   PRO A  79       9.538  22.542  18.758  1.00 24.96           N  \nATOM    600  CA  PRO A  79      10.442  21.388  18.731  1.00 26.27           C  \nATOM    601  C   PRO A  79      11.136  21.242  17.389  1.00 27.30           C  \nATOM    602  O   PRO A  79      10.748  20.397  16.559  1.00 30.31           O  \nATOM    603  CB  PRO A  79       9.515  20.215  18.995  1.00 26.15           C  \nATOM    604  CG  PRO A  79       8.239  20.616  18.339  1.00 27.52           C  \nATOM    605  CD  PRO A  79       8.170  22.144  18.383  1.00 27.77           C  \nATOM    606  N   THR A  80      12.138  22.078  17.162  1.00 27.82           N  \nATOM    607  CA  THR A  80      12.910  22.043  15.936  1.00 27.04           C  \nATOM    608  C   THR A  80      14.280  21.503  16.325  1.00 28.49           C  \nATOM    609  O   THR A  80      14.692  21.666  17.473  1.00 33.89           O  \nATOM    610  CB  THR A  80      13.031  23.467  15.319  1.00 24.34           C  \nATOM    611  OG1 THR A  80      13.971  23.419  14.244  1.00 28.59           O  \nATOM    612  CG2 THR A  80      13.542  24.478  16.300  1.00 17.97           C  \nATOM    613  N   PRO A  81      14.915  20.725  15.449  1.00 27.56           N  \nATOM    614  CA  PRO A  81      16.233  20.170  15.766  1.00 28.35           C  \nATOM    615  C   PRO A  81      17.352  21.205  15.795  1.00 32.18           C  \nATOM    616  O   PRO A  81      18.306  21.085  16.567  1.00 35.74           O  \nATOM    617  CB  PRO A  81      16.467  19.139  14.669  1.00 28.05           C  \nATOM    618  CG  PRO A  81      15.477  19.489  13.607  1.00 24.27           C  \nATOM    619  CD  PRO A  81      14.331  20.114  14.238  1.00 24.21           C  \nATOM    620  N   VAL A  82      17.220  22.219  14.948  1.00 31.78           N  \nATOM    621  CA  VAL A  82      18.236  23.243  14.762  1.00 30.36           C  \nATOM    622  C   VAL A  82      17.549  24.626  14.801  1.00 29.01           C  \nATOM    623  O   VAL A  82      16.328  24.735  14.569  1.00 28.83           O  \nATOM    624  CB  VAL A  82      18.969  23.017  13.388  1.00 27.70           C  \nATOM    625  CG1 VAL A  82      18.009  22.769  12.263  1.00 25.82           C  \nATOM    626  CG2 VAL A  82      19.843  24.144  13.080  1.00 29.05           C  \nATOM    627  N   ASN A  83      18.292  25.671  15.167  1.00 28.44           N  \nATOM    628  CA  ASN A  83      17.731  27.051  15.193  1.00 23.14           C  \nATOM    629  C   ASN A  83      17.799  27.628  13.799  1.00 20.40           C  \nATOM    630  O   ASN A  83      18.794  27.456  13.113  1.00 22.72           O  \nATOM    631  CB  ASN A  83      18.508  27.950  16.161  1.00 23.96           C  \nATOM    632  CG  ASN A  83      18.236  27.600  17.636  1.00 19.36           C  \nATOM    633  OD1 ASN A  83      17.102  27.381  18.051  1.00 24.75           O  \nATOM    634  ND2 ASN A  83      19.287  27.475  18.398  1.00 23.07           N  \nATOM    635  N   ILE A  84      16.729  28.283  13.370  1.00 19.46           N  \nATOM    636  CA  ILE A  84      16.588  28.651  11.955  1.00 18.70           C  \nATOM    637  C   ILE A  84      16.190  30.132  11.811  1.00 15.24           C  \nATOM    638  O   ILE A  84      15.178  30.600  12.384  1.00 16.01           O  \nATOM    639  CB  ILE A  84      15.504  27.755  11.242  1.00 18.01           C  \nATOM    640  CG1 ILE A  84      16.049  26.365  11.040  1.00 21.46           C  \nATOM    641  CG2 ILE A  84      15.081  28.324   9.932  1.00 18.09           C  \nATOM    642  CD1 ILE A  84      14.957  25.345  11.321  1.00 21.77           C  \nATOM    643  N   ILE A  85      16.991  30.863  11.053  1.00 17.41           N  \nATOM    644  CA  ILE A  85      16.710  32.257  10.821  1.00 17.84           C  \nATOM    645  C   ILE A  85      16.155  32.252   9.420  1.00 18.00           C  \nATOM    646  O   ILE A  85      16.857  31.950   8.464  1.00 16.33           O  \nATOM    647  CB  ILE A  85      17.999  33.119  10.844  1.00 19.87           C  \nATOM    648  CG1 ILE A  85      18.724  32.983  12.207  1.00 21.72           C  \nATOM    649  CG2 ILE A  85      17.653  34.600  10.517  1.00 19.84           C  \nATOM    650  CD1 ILE A  85      17.830  33.204  13.418  1.00 23.27           C  \nATOM    651  N   GLY A  86      14.888  32.608   9.302  1.00 17.67           N  \nATOM    652  CA  GLY A  86      14.238  32.655   8.011  1.00 19.47           C  \nATOM    653  C   GLY A  86      14.181  34.034   7.393  1.00 20.59           C  \nATOM    654  O   GLY A  86      14.714  34.991   7.894  1.00 19.31           O  \nATOM    655  N   ARG A  87      13.398  34.131   6.334  1.00 19.04           N  \nATOM    656  CA  ARG A  87      13.370  35.302   5.456  1.00 21.43           C  \nATOM    657  C   ARG A  87      12.931  36.548   6.216  1.00 20.84           C  \nATOM    658  O   ARG A  87      13.429  37.633   5.958  1.00 24.40           O  \nATOM    659  CB  ARG A  87      12.459  35.018   4.263  1.00 15.37           C  \nATOM    660  CG  ARG A  87      13.030  34.044   3.318  1.00 18.83           C  \nATOM    661  CD  ARG A  87      12.310  34.101   1.966  1.00 21.67           C  \nATOM    662  NE  ARG A  87      10.903  33.713   2.088  1.00 21.37           N  \nATOM    663  CZ  ARG A  87       9.899  34.575   2.137  1.00 22.28           C  \nATOM    664  NH1 ARG A  87      10.126  35.860   1.922  1.00 20.00           N  \nATOM    665  NH2 ARG A  87       8.657  34.143   2.300  1.00 21.02           N  \nATOM    666  N   ASN A  88      12.063  36.352   7.198  1.00 21.72           N  \nATOM    667  CA  ASN A  88      11.458  37.455   7.919  1.00 19.12           C  \nATOM    668  C   ASN A  88      12.511  38.266   8.653  1.00 21.99           C  \nATOM    669  O   ASN A  88      12.419  39.481   8.723  1.00 24.63           O  \nATOM    670  CB  ASN A  88      10.359  36.959   8.863  1.00 17.71           C  \nATOM    671  CG  ASN A  88      10.892  36.309  10.125  1.00 23.05           C  \nATOM    672  OD1 ASN A  88      11.577  35.273  10.065  1.00 24.51           O  \nATOM    673  ND2 ASN A  88      10.446  36.809  11.283  1.00 21.17           N  \nATOM    674  N   LEU A  89      13.551  37.601   9.136  1.00 21.73           N  \nATOM    675  CA  LEU A  89      14.633  38.337   9.729  1.00 21.46           C  \nATOM    676  C   LEU A  89      15.802  38.487   8.783  1.00 21.01           C  \nATOM    677  O   LEU A  89      16.580  39.394   8.941  1.00 22.81           O  \nATOM    678  CB  LEU A  89      15.096  37.687  11.029  1.00 24.37           C  \nATOM    679  CG  LEU A  89      14.146  37.555  12.221  1.00 26.43           C  \nATOM    680  CD1 LEU A  89      14.939  37.022  13.434  1.00 27.76           C  \nATOM    681  CD2 LEU A  89      13.508  38.913  12.527  1.00 29.10           C  \nATOM    682  N   LEU A  90      15.910  37.651   7.761  1.00 18.04           N  \nATOM    683  CA  LEU A  90      17.078  37.773   6.865  1.00 21.90           C  \nATOM    684  C   LEU A  90      17.048  39.068   6.049  1.00 22.24           C  \nATOM    685  O   LEU A  90      18.098  39.613   5.652  1.00 20.42           O  \nATOM    686  CB  LEU A  90      17.200  36.561   5.913  1.00 21.44           C  \nATOM    687  CG  LEU A  90      17.754  35.226   6.440  1.00 19.50           C  \nATOM    688  CD1 LEU A  90      17.798  34.207   5.340  1.00 20.48           C  \nATOM    689  CD2 LEU A  90      19.138  35.441   7.022  1.00 15.96           C  \nATOM    690  N   THR A  91      15.835  39.547   5.808  1.00 20.88           N  \nATOM    691  CA  THR A  91      15.653  40.738   4.985  1.00 25.31           C  \nATOM    692  C   THR A  91      16.137  41.999   5.772  1.00 25.69           C  \nATOM    693  O   THR A  91      16.848  42.870   5.252  1.00 29.29           O  \nATOM    694  CB  THR A  91      14.157  40.860   4.594  1.00 21.94           C  \nATOM    695  OG1 THR A  91      13.342  40.810   5.786  1.00 20.91           O  \nATOM    696  CG2 THR A  91      13.740  39.709   3.681  1.00 24.44           C  \nATOM    697  N   GLN A  92      15.842  42.001   7.064  1.00 23.55           N  \nATOM    698  CA  GLN A  92      16.170  43.099   7.967  1.00 23.15           C  \nATOM    699  C   GLN A  92      17.650  43.315   8.126  1.00 25.63           C  \nATOM    700  O   GLN A  92      18.071  44.440   8.459  1.00 29.05           O  \nATOM    701  CB  GLN A  92      15.580  42.837   9.347  1.00 17.48           C  \nATOM    702  CG  GLN A  92      14.081  42.603   9.325  1.00 12.58           C  \nATOM    703  CD  GLN A  92      13.318  43.811   8.800  1.00 23.01           C  \nATOM    704  OE1 GLN A  92      12.836  43.807   7.683  1.00 24.98           O  \nATOM    705  NE2 GLN A  92      13.349  44.892   9.543  1.00 15.18           N  \nATOM    706  N   ILE A  93      18.444  42.266   7.913  1.00 25.00           N  \nATOM    707  CA  ILE A  93      19.887  42.417   8.035  1.00 25.37           C  \nATOM    708  C   ILE A  93      20.530  42.555   6.677  1.00 24.18           C  \nATOM    709  O   ILE A  93      21.744  42.639   6.577  1.00 26.26           O  \nATOM    710  CB  ILE A  93      20.557  41.231   8.872  1.00 24.44           C  \nATOM    711  CG1 ILE A  93      20.472  39.878   8.113  1.00 24.46           C  \nATOM    712  CG2 ILE A  93      19.926  41.182  10.272  1.00 22.23           C  \nATOM    713  CD1 ILE A  93      21.520  38.796   8.533  1.00 24.68           C  \nATOM    714  N   GLY A  94      19.713  42.563   5.636  1.00 24.04           N  \nATOM    715  CA  GLY A  94      20.226  42.870   4.327  1.00 25.09           C  \nATOM    716  C   GLY A  94      20.843  41.689   3.611  1.00 27.08           C  \nATOM    717  O   GLY A  94      21.680  41.866   2.723  1.00 28.80           O  \nATOM    718  N   CYS A  95      20.294  40.507   3.844  1.00 27.02           N  \nATOM    719  CA  CYS A  95      20.890  39.296   3.297  1.00 26.34           C  \nATOM    720  C   CYS A  95      20.407  39.005   1.897  1.00 26.35           C  \nATOM    721  O   CYS A  95      19.217  39.101   1.606  1.00 28.34           O  \nATOM    722  CB  CYS A  95      20.585  38.134   4.215  1.00 27.62           C  \nATOM    723  SG  CYS A  95      21.505  36.663   3.848  1.00 32.32           S  \nATOM    724  N   THR A  96      21.339  38.698   1.005  1.00 27.53           N  \nATOM    725  CA  THR A  96      20.969  38.276  -0.346  1.00 27.51           C  \nATOM    726  C   THR A  96      21.721  37.024  -0.758  1.00 27.27           C  \nATOM    727  O   THR A  96      22.753  36.645  -0.178  1.00 27.30           O  \nATOM    728  CB  THR A  96      21.298  39.331  -1.459  1.00 28.47           C  \nATOM    729  OG1 THR A  96      22.688  39.698  -1.364  1.00 28.16           O  \nATOM    730  CG2 THR A  96      20.405  40.560  -1.303  1.00 26.73           C  \nATOM    731  N   LEU A  97      21.183  36.413  -1.805  1.00 28.68           N  \nATOM    732  CA  LEU A  97      21.718  35.228  -2.473  1.00 26.62           C  \nATOM    733  C   LEU A  97      22.314  35.753  -3.779  1.00 25.49           C  \nATOM    734  O   LEU A  97      21.616  36.396  -4.577  1.00 23.96           O  \nATOM    735  CB  LEU A  97      20.518  34.349  -2.810  1.00 24.94           C  \nATOM    736  CG  LEU A  97      20.318  32.897  -2.464  1.00 28.32           C  \nATOM    737  CD1 LEU A  97      21.285  32.388  -1.422  1.00 27.79           C  \nATOM    738  CD2 LEU A  97      18.896  32.782  -2.010  1.00 26.48           C  \nATOM    739  N   ASN A  98      23.577  35.469  -4.026  1.00 26.29           N  \nATOM    740  CA  ASN A  98      24.207  35.904  -5.257  1.00 29.12           C  \nATOM    741  C   ASN A  98      24.863  34.748  -5.999  1.00 29.85           C  \nATOM    742  O   ASN A  98      25.635  33.982  -5.396  1.00 26.89           O  \nATOM    743  CB  ASN A  98      25.229  36.991  -4.938  1.00 33.75           C  \nATOM    744  CG  ASN A  98      24.609  38.190  -4.212  1.00 40.13           C  \nATOM    745  OD1 ASN A  98      24.263  38.112  -3.019  1.00 43.34           O  \nATOM    746  ND2 ASN A  98      24.354  39.252  -4.955  1.00 42.07           N  \nATOM    747  N   PHE A  99      24.539  34.602  -7.287  1.00 31.14           N  \nATOM    748  CA  PHE A  99      25.376  33.754  -8.172  1.00 35.14           C  \nATOM    749  C   PHE A  99      25.726  34.383  -9.544  1.00 34.93           C  \nATOM    750  O   PHE A  99      24.797  34.890 -10.226  1.00 36.66           O  \nATOM    751  CB  PHE A  99      24.743  32.354  -8.375  1.00 32.92           C  \nATOM    752  CG  PHE A  99      23.328  32.389  -8.856  1.00 31.47           C  \nATOM    753  CD1 PHE A  99      22.303  32.588  -7.961  1.00 29.83           C  \nATOM    754  CD2 PHE A  99      23.029  32.118 -10.181  1.00 28.13           C  \nATOM    755  CE1 PHE A  99      21.000  32.515  -8.357  1.00 27.98           C  \nATOM    756  CE2 PHE A  99      21.730  32.028 -10.613  1.00 25.49           C  \nATOM    757  CZ  PHE A  99      20.700  32.221  -9.700  1.00 27.25           C  \nTER     758      PHE A  99                                                      \nATOM    759  N   PRO B   1      22.659  36.727 -10.823  1.00 48.12           N  \nATOM    760  CA  PRO B   1      21.708  37.741 -10.269  1.00 43.36           C  \nATOM    761  C   PRO B   1      21.931  37.939  -8.779  1.00 39.59           C  \nATOM    762  O   PRO B   1      22.755  37.283  -8.190  1.00 37.70           O  \nATOM    763  CB  PRO B   1      20.263  37.289 -10.512  1.00 46.58           C  \nATOM    764  CG  PRO B   1      20.385  35.811 -10.891  1.00 48.47           C  \nATOM    765  CD  PRO B   1      21.753  35.755 -11.555  1.00 50.98           C  \nATOM    766  N   GLN B   2      21.203  38.873  -8.191  1.00 36.85           N  \nATOM    767  CA  GLN B   2      21.156  39.043  -6.744  1.00 37.15           C  \nATOM    768  C   GLN B   2      19.698  38.882  -6.389  1.00 36.43           C  \nATOM    769  O   GLN B   2      18.850  39.538  -6.975  1.00 39.41           O  \nATOM    770  CB  GLN B   2      21.625  40.447  -6.329  1.00 38.60           C  \nATOM    771  CG  GLN B   2      21.353  40.777  -4.865  1.00 39.92           C  \nATOM    772  CD  GLN B   2      22.139  41.975  -4.358  1.00 44.52           C  \nATOM    773  OE1 GLN B   2      21.577  42.881  -3.752  1.00 48.57           O  \nATOM    774  NE2 GLN B   2      23.450  41.976  -4.586  1.00 45.25           N  \nATOM    775  N   ILE B   3      19.405  38.008  -5.448  1.00 32.18           N  \nATOM    776  CA  ILE B   3      18.037  37.742  -5.100  1.00 30.91           C  \nATOM    777  C   ILE B   3      17.832  38.164  -3.660  1.00 28.84           C  \nATOM    778  O   ILE B   3      18.457  37.631  -2.746  1.00 28.43           O  \nATOM    779  CB  ILE B   3      17.694  36.224  -5.238  1.00 33.01           C  \nATOM    780  CG1 ILE B   3      17.788  35.772  -6.692  1.00 35.76           C  \nATOM    781  CG2 ILE B   3      16.284  35.967  -4.750  1.00 31.17           C  \nATOM    782  CD1 ILE B   3      18.183  34.327  -6.802  1.00 36.59           C  \nATOM    783  N   THR B   4      16.960  39.132  -3.461  1.00 24.52           N  \nATOM    784  CA  THR B   4      16.635  39.571  -2.117  1.00 26.46           C  \nATOM    785  C   THR B   4      15.555  38.634  -1.627  1.00 23.26           C  \nATOM    786  O   THR B   4      15.066  37.784  -2.372  1.00 23.16           O  \nATOM    787  CB  THR B   4      16.147  41.074  -2.110  1.00 30.32           C  \nATOM    788  OG1 THR B   4      15.093  41.256  -3.079  1.00 32.67           O  \nATOM    789  CG2 THR B   4      17.283  42.019  -2.472  1.00 30.57           C  \nATOM    790  N   LEU B   5      15.157  38.761  -0.379  1.00 21.95           N  \nATOM    791  CA  LEU B   5      14.466  37.636   0.259  1.00 21.45           C  \nATOM    792  C   LEU B   5      13.125  38.065   0.821  1.00 22.43           C  \nATOM    793  O   LEU B   5      12.585  37.446   1.733  1.00 22.26           O  \nATOM    794  CB  LEU B   5      15.340  37.047   1.374  1.00 18.69           C  \nATOM    795  CG  LEU B   5      16.622  36.365   0.892  1.00 18.41           C  \nATOM    796  CD1 LEU B   5      17.455  35.953   2.080  1.00 16.32           C  \nATOM    797  CD2 LEU B   5      16.248  35.136  -0.006  1.00 16.07           C  \nATOM    798  N   TRP B   6      12.567  39.127   0.262  1.00 21.66           N  \nATOM    799  CA  TRP B   6      11.260  39.582   0.682  1.00 21.58           C  \nATOM    800  C   TRP B   6      10.196  38.601   0.218  1.00 21.21           C  \nATOM    801  O   TRP B   6       9.192  38.404   0.903  1.00 22.05           O  \nATOM    802  CB  TRP B   6      11.004  40.992   0.135  1.00 19.59           C  \nATOM    803  CG  TRP B   6      12.065  42.014   0.478  1.00 18.40           C  \nATOM    804  CD1 TRP B   6      13.157  42.366  -0.279  1.00 17.80           C  \nATOM    805  CD2 TRP B   6      12.209  42.716   1.739  1.00 14.37           C  \nATOM    806  NE1 TRP B   6      13.979  43.196   0.470  1.00 17.13           N  \nATOM    807  CE2 TRP B   6      13.433  43.441   1.686  1.00 17.08           C  \nATOM    808  CE3 TRP B   6      11.443  42.805   2.913  1.00 17.33           C  \nATOM    809  CZ2 TRP B   6      13.914  44.211   2.785  1.00 16.59           C  \nATOM    810  CZ3 TRP B   6      11.903  43.585   3.953  1.00 15.43           C  \nATOM    811  CH2 TRP B   6      13.148  44.273   3.896  1.00 18.86           C  \nATOM    812  N   GLN B   7      10.396  38.008  -0.958  1.00 23.30           N  \nATOM    813  CA  GLN B   7       9.518  36.960  -1.516  1.00 24.55           C  \nATOM    814  C   GLN B   7      10.321  35.670  -1.433  1.00 23.64           C  \nATOM    815  O   GLN B   7      11.546  35.694  -1.298  1.00 23.66           O  \nATOM    816  CB  GLN B   7       9.215  37.238  -3.000  1.00 32.55           C  \nATOM    817  CG  GLN B   7       8.278  38.433  -3.326  1.00 41.57           C  \nATOM    818  CD  GLN B   7       7.629  38.332  -4.744  1.00 50.90           C  \nATOM    819  OE1 GLN B   7       8.319  38.100  -5.754  1.00 55.87           O  \nATOM    820  NE2 GLN B   7       6.307  38.532  -4.814  1.00 51.09           N  \nATOM    821  N   ARG B   8       9.661  34.528  -1.525  1.00 21.29           N  \nATOM    822  CA  ARG B   8      10.385  33.251  -1.642  1.00 20.70           C  \nATOM    823  C   ARG B   8      11.348  33.305  -2.780  1.00 19.16           C  \nATOM    824  O   ARG B   8      10.964  33.682  -3.906  1.00 22.46           O  \nATOM    825  CB  ARG B   8       9.435  32.061  -1.862  1.00 21.59           C  \nATOM    826  CG  ARG B   8       8.623  31.716  -0.644  1.00 27.03           C  \nATOM    827  CD  ARG B   8       7.828  30.471  -0.844  1.00 28.48           C  \nATOM    828  NE  ARG B   8       7.143  30.102   0.378  1.00 38.82           N  \nATOM    829  CZ  ARG B   8       6.523  28.938   0.561  1.00 45.44           C  \nATOM    830  NH1 ARG B   8       6.476  28.028  -0.411  1.00 47.55           N  \nATOM    831  NH2 ARG B   8       5.925  28.688   1.719  1.00 49.71           N  \nATOM    832  N   PRO B   9      12.533  32.711  -2.598  1.00 18.31           N  \nATOM    833  CA  PRO B   9      13.443  32.743  -3.746  1.00 16.67           C  \nATOM    834  C   PRO B   9      13.174  31.592  -4.703  1.00 18.20           C  \nATOM    835  O   PRO B   9      13.897  30.587  -4.698  1.00 17.79           O  \nATOM    836  CB  PRO B   9      14.813  32.658  -3.125  1.00 15.13           C  \nATOM    837  CG  PRO B   9      14.564  31.823  -1.917  1.00 13.81           C  \nATOM    838  CD  PRO B   9      13.238  32.289  -1.373  1.00 15.31           C  \nATOM    839  N   LEU B  10      12.134  31.727  -5.504  1.00 18.74           N  \nATOM    840  CA  LEU B  10      11.816  30.740  -6.534  1.00 24.75           C  \nATOM    841  C   LEU B  10      12.459  31.075  -7.877  1.00 28.33           C  \nATOM    842  O   LEU B  10      12.274  32.150  -8.406  1.00 34.15           O  \nATOM    843  CB  LEU B  10      10.303  30.637  -6.738  1.00 22.30           C  \nATOM    844  CG  LEU B  10       9.483  30.307  -5.497  1.00 26.19           C  \nATOM    845  CD1 LEU B  10       8.028  30.334  -5.876  1.00 26.68           C  \nATOM    846  CD2 LEU B  10       9.845  28.975  -4.951  1.00 25.72           C  \nATOM    847  N   VAL B  11      13.225  30.141  -8.420  1.00 29.04           N  \nATOM    848  CA  VAL B  11      13.759  30.227  -9.768  1.00 25.94           C  \nATOM    849  C   VAL B  11      13.103  29.153 -10.641  1.00 28.64           C  \nATOM    850  O   VAL B  11      12.381  28.285 -10.135  1.00 26.28           O  \nATOM    851  CB  VAL B  11      15.253  29.988  -9.735  1.00 26.71           C  \nATOM    852  CG1 VAL B  11      15.898  31.108  -8.939  1.00 26.27           C  \nATOM    853  CG2 VAL B  11      15.573  28.635  -9.104  1.00 23.17           C  \nATOM    854  N   THR B  12      13.346  29.214 -11.949  1.00 29.16           N  \nATOM    855  CA  THR B  12      12.809  28.220 -12.873  1.00 29.59           C  \nATOM    856  C   THR B  12      13.951  27.253 -13.210  1.00 27.37           C  \nATOM    857  O   THR B  12      15.089  27.656 -13.442  1.00 28.24           O  \nATOM    858  CB  THR B  12      12.259  28.907 -14.158  1.00 33.38           C  \nATOM    859  OG1 THR B  12      11.693  27.933 -15.028  1.00 41.16           O  \nATOM    860  CG2 THR B  12      13.341  29.639 -14.925  1.00 37.24           C  \nATOM    861  N   ILE B  13      13.684  25.961 -13.124  1.00 27.04           N  \nATOM    862  CA  ILE B  13      14.708  24.966 -13.446  1.00 26.55           C  \nATOM    863  C   ILE B  13      14.230  24.165 -14.639  1.00 28.05           C  \nATOM    864  O   ILE B  13      13.014  24.057 -14.918  1.00 25.03           O  \nATOM    865  CB  ILE B  13      14.993  23.953 -12.269  1.00 25.84           C  \nATOM    866  CG1 ILE B  13      13.699  23.190 -11.870  1.00 28.87           C  \nATOM    867  CG2 ILE B  13      15.564  24.705 -11.094  1.00 20.54           C  \nATOM    868  CD1 ILE B  13      13.900  22.077 -10.834  1.00 29.32           C  \nATOM    869  N   LYS B  14      15.186  23.630 -15.378  1.00 27.45           N  \nATOM    870  CA  LYS B  14      14.828  22.733 -16.464  1.00 26.92           C  \nATOM    871  C   LYS B  14      15.482  21.387 -16.141  1.00 26.01           C  \nATOM    872  O   LYS B  14      16.690  21.305 -15.886  1.00 24.75           O  \nATOM    873  CB  LYS B  14      15.340  23.256 -17.814  1.00 25.93           C  \nATOM    874  CG  LYS B  14      14.868  22.447 -18.992  1.00 27.04           C  \nATOM    875  CD  LYS B  14      14.687  23.295 -20.194  1.00 32.12           C  \nATOM    876  CE  LYS B  14      15.979  23.453 -20.922  1.00 34.02           C  \nATOM    877  NZ  LYS B  14      15.739  23.451 -22.389  1.00 41.05           N  \nATOM    878  N   ILE B  15      14.660  20.354 -16.136  1.00 26.74           N  \nATOM    879  CA  ILE B  15      15.108  18.999 -15.906  1.00 30.24           C  \nATOM    880  C   ILE B  15      14.188  18.067 -16.702  1.00 33.16           C  \nATOM    881  O   ILE B  15      12.968  18.199 -16.719  1.00 31.38           O  \nATOM    882  CB  ILE B  15      15.090  18.663 -14.360  1.00 31.34           C  \nATOM    883  CG1 ILE B  15      15.694  17.283 -14.101  1.00 32.33           C  \nATOM    884  CG2 ILE B  15      13.682  18.760 -13.780  1.00 28.02           C  \nATOM    885  CD1 ILE B  15      16.011  17.036 -12.625  1.00 33.84           C  \nATOM    886  N   GLY B  16      14.799  17.159 -17.438  1.00 36.75           N  \nATOM    887  CA  GLY B  16      14.024  16.279 -18.286  1.00 39.96           C  \nATOM    888  C   GLY B  16      13.311  17.029 -19.391  1.00 40.86           C  \nATOM    889  O   GLY B  16      12.318  16.549 -19.924  1.00 42.44           O  \nATOM    890  N   GLY B  17      13.887  18.145 -19.823  1.00 40.79           N  \nATOM    891  CA  GLY B  17      13.243  18.938 -20.850  1.00 37.08           C  \nATOM    892  C   GLY B  17      12.009  19.638 -20.345  1.00 35.82           C  \nATOM    893  O   GLY B  17      11.392  20.369 -21.084  1.00 37.78           O  \nATOM    894  N   GLN B  18      11.676  19.486 -19.073  1.00 32.85           N  \nATOM    895  CA  GLN B  18      10.572  20.249 -18.515  1.00 35.03           C  \nATOM    896  C   GLN B  18      11.056  21.466 -17.699  1.00 34.53           C  \nATOM    897  O   GLN B  18      12.196  21.494 -17.175  1.00 33.51           O  \nATOM    898  CB  GLN B  18       9.708  19.388 -17.619  1.00 40.01           C  \nATOM    899  CG  GLN B  18       8.936  18.297 -18.309  1.00 47.43           C  \nATOM    900  CD  GLN B  18       9.088  16.973 -17.566  1.00 53.35           C  \nATOM    901  OE1 GLN B  18       9.813  16.078 -18.014  1.00 55.74           O  \nATOM    902  NE2 GLN B  18       8.488  16.884 -16.371  1.00 54.03           N  \nATOM    903  N   LEU B  19      10.186  22.475 -17.590  1.00 32.63           N  \nATOM    904  CA  LEU B  19      10.450  23.647 -16.749  1.00 29.37           C  \nATOM    905  C   LEU B  19       9.631  23.511 -15.483  1.00 28.10           C  \nATOM    906  O   LEU B  19       8.432  23.277 -15.551  1.00 29.04           O  \nATOM    907  CB  LEU B  19      10.010  24.932 -17.474  1.00 28.40           C  \nATOM    908  CG  LEU B  19      10.775  25.419 -18.723  1.00 26.42           C  \nATOM    909  CD1 LEU B  19      10.226  26.727 -19.190  1.00 22.91           C  \nATOM    910  CD2 LEU B  19      12.241  25.543 -18.395  1.00 23.99           C  \nATOM    911  N   LYS B  20      10.273  23.619 -14.329  1.00 28.58           N  \nATOM    912  CA  LYS B  20       9.576  23.583 -13.044  1.00 25.77           C  \nATOM    913  C   LYS B  20      10.018  24.784 -12.260  1.00 26.35           C  \nATOM    914  O   LYS B  20      10.998  25.429 -12.605  1.00 25.15           O  \nATOM    915  CB  LYS B  20       9.970  22.364 -12.236  1.00 29.54           C  \nATOM    916  CG  LYS B  20      10.281  21.123 -13.051  1.00 36.66           C  \nATOM    917  CD  LYS B  20       9.037  20.289 -13.305  1.00 41.68           C  \nATOM    918  CE  LYS B  20       9.400  18.836 -13.595  1.00 45.08           C  \nATOM    919  NZ  LYS B  20       9.672  18.102 -12.328  1.00 46.33           N  \nATOM    920  N   GLU B  21       9.324  25.048 -11.162  1.00 24.88           N  \nATOM    921  CA  GLU B  21       9.705  26.075 -10.199  1.00 25.39           C  \nATOM    922  C   GLU B  21      10.311  25.408  -8.990  1.00 23.31           C  \nATOM    923  O   GLU B  21       9.847  24.351  -8.547  1.00 25.34           O  \nATOM    924  CB  GLU B  21       8.468  26.848  -9.767  1.00 32.42           C  \nATOM    925  CG  GLU B  21       8.676  28.343  -9.687  1.00 47.17           C  \nATOM    926  CD  GLU B  21       7.419  29.111 -10.041  1.00 57.11           C  \nATOM    927  OE1 GLU B  21       6.374  28.877  -9.383  1.00 62.83           O  \nATOM    928  OE2 GLU B  21       7.461  29.911 -11.004  1.00 64.02           O  \nATOM    929  N   ALA B  22      11.348  26.008  -8.443  1.00 16.20           N  \nATOM    930  CA  ALA B  22      12.025  25.431  -7.271  1.00 14.52           C  \nATOM    931  C   ALA B  22      12.472  26.569  -6.331  1.00 15.55           C  \nATOM    932  O   ALA B  22      12.709  27.701  -6.765  1.00 17.95           O  \nATOM    933  CB  ALA B  22      13.248  24.643  -7.708  1.00 11.99           C  \nATOM    934  N   LEU B  23      12.560  26.257  -5.054  1.00 14.37           N  \nATOM    935  CA  LEU B  23      13.017  27.151  -4.001  1.00 15.39           C  \nATOM    936  C   LEU B  23      14.518  27.005  -3.822  1.00 15.08           C  \nATOM    937  O   LEU B  23      15.008  25.915  -3.588  1.00 14.05           O  \nATOM    938  CB  LEU B  23      12.330  26.721  -2.741  1.00 16.68           C  \nATOM    939  CG  LEU B  23      12.592  27.472  -1.469  1.00 20.94           C  \nATOM    940  CD1 LEU B  23      12.006  28.877  -1.562  1.00 18.77           C  \nATOM    941  CD2 LEU B  23      11.917  26.658  -0.379  1.00 21.23           C  \nATOM    942  N   LEU B  24      15.266  28.090  -3.963  1.00 13.16           N  \nATOM    943  CA  LEU B  24      16.672  28.114  -3.511  1.00 17.92           C  \nATOM    944  C   LEU B  24      16.809  28.098  -1.992  1.00 18.17           C  \nATOM    945  O   LEU B  24      16.417  29.019  -1.338  1.00 19.32           O  \nATOM    946  CB  LEU B  24      17.416  29.342  -4.065  1.00 17.42           C  \nATOM    947  CG  LEU B  24      17.444  29.528  -5.585  1.00 19.17           C  \nATOM    948  CD1 LEU B  24      18.151  30.843  -5.884  1.00 20.12           C  \nATOM    949  CD2 LEU B  24      18.170  28.385  -6.270  1.00 19.21           C  \nATOM    950  N   ASP B  25      17.407  27.054  -1.437  1.00 19.08           N  \nATOM    951  CA  ASP B  25      17.227  26.751  -0.026  1.00 18.20           C  \nATOM    952  C   ASP B  25      18.555  26.446   0.653  1.00 19.09           C  \nATOM    953  O   ASP B  25      19.003  25.309   0.692  1.00 18.68           O  \nATOM    954  CB  ASP B  25      16.258  25.572   0.084  1.00 18.15           C  \nATOM    955  CG  ASP B  25      15.759  25.336   1.493  1.00 20.90           C  \nATOM    956  OD1 ASP B  25      16.399  25.780   2.453  1.00 23.13           O  \nATOM    957  OD2 ASP B  25      14.731  24.675   1.645  1.00 22.18           O  \nATOM    958  N   THR B  26      19.163  27.455   1.257  1.00 14.92           N  \nATOM    959  CA  THR B  26      20.441  27.290   1.920  1.00 13.68           C  \nATOM    960  C   THR B  26      20.319  26.393   3.168  1.00 15.84           C  \nATOM    961  O   THR B  26      21.316  25.867   3.637  1.00 18.69           O  \nATOM    962  CB  THR B  26      21.063  28.678   2.282  1.00 15.43           C  \nATOM    963  OG1 THR B  26      20.188  29.407   3.146  1.00 15.52           O  \nATOM    964  CG2 THR B  26      21.279  29.499   1.024  1.00 15.01           C  \nATOM    965  N   GLY B  27      19.106  26.199   3.688  1.00 13.19           N  \nATOM    966  CA  GLY B  27      18.957  25.372   4.876  1.00 13.54           C  \nATOM    967  C   GLY B  27      18.845  23.903   4.520  1.00 17.44           C  \nATOM    968  O   GLY B  27      18.660  23.054   5.417  1.00 18.85           O  \nATOM    969  N   ALA B  28      18.819  23.600   3.217  1.00 17.91           N  \nATOM    970  CA  ALA B  28      18.721  22.211   2.738  1.00 18.89           C  \nATOM    971  C   ALA B  28      20.089  21.661   2.292  1.00 20.66           C  \nATOM    972  O   ALA B  28      20.749  22.243   1.403  1.00 22.38           O  \nATOM    973  CB  ALA B  28      17.682  22.117   1.578  1.00 13.77           C  \nATOM    974  N   ASP B  29      20.536  20.559   2.918  1.00 20.64           N  \nATOM    975  CA  ASP B  29      21.779  19.912   2.496  1.00 14.85           C  \nATOM    976  C   ASP B  29      21.693  19.374   1.107  1.00 14.01           C  \nATOM    977  O   ASP B  29      22.642  19.502   0.361  1.00 17.76           O  \nATOM    978  CB  ASP B  29      22.169  18.827   3.447  1.00 15.99           C  \nATOM    979  CG  ASP B  29      22.272  19.337   4.844  1.00 22.55           C  \nATOM    980  OD1 ASP B  29      22.714  20.482   5.029  1.00 27.81           O  \nATOM    981  OD2 ASP B  29      21.836  18.647   5.778  1.00 29.43           O  \nATOM    982  N   ASP B  30      20.524  18.868   0.719  1.00 16.70           N  \nATOM    983  CA  ASP B  30      20.355  18.227  -0.584  1.00 15.10           C  \nATOM    984  C   ASP B  30      19.212  18.807  -1.371  1.00 16.38           C  \nATOM    985  O   ASP B  30      18.383  19.523  -0.846  1.00 17.11           O  \nATOM    986  CB  ASP B  30      20.084  16.745  -0.413  1.00 21.76           C  \nATOM    987  CG  ASP B  30      21.023  16.088   0.586  1.00 25.41           C  \nATOM    988  OD1 ASP B  30      22.233  15.970   0.265  1.00 25.58           O  \nATOM    989  OD2 ASP B  30      20.531  15.682   1.672  1.00 27.89           O  \nATOM    990  N   THR B  31      19.152  18.428  -2.643  1.00 18.44           N  \nATOM    991  CA  THR B  31      18.113  18.843  -3.603  1.00 15.45           C  \nATOM    992  C   THR B  31      17.019  17.743  -3.682  1.00 19.23           C  \nATOM    993  O   THR B  31      17.342  16.586  -3.904  1.00 18.95           O  \nATOM    994  CB  THR B  31      18.810  19.051  -4.967  1.00 12.28           C  \nATOM    995  OG1 THR B  31      19.740  20.123  -4.831  1.00 13.54           O  \nATOM    996  CG2 THR B  31      17.844  19.330  -6.078  1.00 10.95           C  \nATOM    997  N   VAL B  32      15.750  18.102  -3.440  1.00 19.53           N  \nATOM    998  CA  VAL B  32      14.628  17.162  -3.514  1.00 18.71           C  \nATOM    999  C   VAL B  32      13.618  17.726  -4.436  1.00 19.01           C  \nATOM   1000  O   VAL B  32      13.169  18.861  -4.263  1.00 19.90           O  \nATOM   1001  CB  VAL B  32      13.781  17.005  -2.245  1.00 20.49           C  \nATOM   1002  CG1 VAL B  32      13.297  15.592  -2.184  1.00 26.38           C  \nATOM   1003  CG2 VAL B  32      14.518  17.455  -1.007  1.00 20.87           C  \nATOM   1004  N   LEU B  33      13.199  16.926  -5.401  1.00 22.78           N  \nATOM   1005  CA  LEU B  33      12.141  17.335  -6.327  1.00 23.84           C  \nATOM   1006  C   LEU B  33      10.876  16.500  -6.065  1.00 27.19           C  \nATOM   1007  O   LEU B  33      10.948  15.389  -5.534  1.00 26.71           O  \nATOM   1008  CB  LEU B  33      12.618  17.139  -7.766  1.00 21.02           C  \nATOM   1009  CG  LEU B  33      13.889  17.846  -8.247  1.00 20.79           C  \nATOM   1010  CD1 LEU B  33      13.942  17.794  -9.731  1.00 21.64           C  \nATOM   1011  CD2 LEU B  33      13.897  19.266  -7.782  1.00 23.27           C  \nATOM   1012  N   GLU B  34       9.719  17.083  -6.361  1.00 26.46           N  \nATOM   1013  CA  GLU B  34       8.442  16.392  -6.346  1.00 26.40           C  \nATOM   1014  C   GLU B  34       8.514  15.172  -7.224  1.00 26.66           C  \nATOM   1015  O   GLU B  34       9.413  15.013  -8.040  1.00 26.75           O  \nATOM   1016  CB  GLU B  34       7.316  17.305  -6.819  1.00 24.89           C  \nATOM   1017  CG  GLU B  34       6.914  18.362  -5.808  1.00 31.34           C  \nATOM   1018  CD  GLU B  34       6.205  19.552  -6.439  1.00 32.62           C  \nATOM   1019  OE1 GLU B  34       6.323  19.742  -7.666  1.00 39.77           O  \nATOM   1020  OE2 GLU B  34       5.613  20.369  -5.715  1.00 39.65           O  \nATOM   1021  N   GLU B  35       7.526  14.309  -7.044  1.00 30.87           N  \nATOM   1022  CA  GLU B  35       7.425  13.006  -7.682  1.00 32.05           C  \nATOM   1023  C   GLU B  35       7.528  13.141  -9.172  1.00 32.29           C  \nATOM   1024  O   GLU B  35       6.660  13.711  -9.819  1.00 37.80           O  \nATOM   1025  CB  GLU B  35       6.100  12.361  -7.297  1.00 35.17           C  \nATOM   1026  CG  GLU B  35       5.907  10.953  -7.838  1.00 44.03           C  \nATOM   1027  CD  GLU B  35       7.182  10.093  -7.854  1.00 44.48           C  \nATOM   1028  OE1 GLU B  35       7.743   9.853  -6.766  1.00 38.16           O  \nATOM   1029  OE2 GLU B  35       7.521   9.561  -8.946  1.00 46.13           O  \nATOM   1030  N   MET B  36       8.627  12.651  -9.705  1.00 31.85           N  \nATOM   1031  CA  MET B  36       8.791  12.578 -11.145  1.00 33.53           C  \nATOM   1032  C   MET B  36       9.583  11.322 -11.483  1.00 33.93           C  \nATOM   1033  O   MET B  36      10.100  10.637 -10.616  1.00 36.78           O  \nATOM   1034  CB  MET B  36       9.546  13.808 -11.654  1.00 35.97           C  \nATOM   1035  CG  MET B  36      10.867  14.095 -11.014  1.00 35.75           C  \nATOM   1036  SD  MET B  36      11.575  15.547 -11.778  1.00 43.16           S  \nATOM   1037  CE  MET B  36      11.710  15.108 -13.551  1.00 42.89           C  \nATOM   1038  N   SER B  37       9.657  11.016 -12.763  1.00 33.54           N  \nATOM   1039  CA  SER B  37      10.411   9.858 -13.218  1.00 35.84           C  \nATOM   1040  C   SER B  37      11.673  10.374 -13.825  1.00 34.42           C  \nATOM   1041  O   SER B  37      11.636  11.272 -14.685  1.00 33.84           O  \nATOM   1042  CB  SER B  37       9.573   9.049 -14.221  1.00 38.59           C  \nATOM   1043  OG  SER B  37       8.330   8.594 -13.579  1.00 41.47           O  \nATOM   1044  N   LEU B  38      12.793   9.884 -13.330  1.00 35.38           N  \nATOM   1045  CA  LEU B  38      14.091  10.261 -13.857  1.00 34.72           C  \nATOM   1046  C   LEU B  38      14.818   9.018 -14.330  1.00 36.10           C  \nATOM   1047  O   LEU B  38      14.416   7.898 -13.995  1.00 35.71           O  \nATOM   1048  CB  LEU B  38      14.866  10.942 -12.759  1.00 30.77           C  \nATOM   1049  CG  LEU B  38      14.480  12.376 -12.556  1.00 26.92           C  \nATOM   1050  CD1 LEU B  38      15.159  12.900 -11.300  1.00 29.33           C  \nATOM   1051  CD2 LEU B  38      14.955  13.131 -13.766  1.00 27.40           C  \nATOM   1052  N   PRO B  39      15.767   9.161 -15.261  1.00 39.43           N  \nATOM   1053  CA  PRO B  39      16.525   8.031 -15.798  1.00 40.91           C  \nATOM   1054  C   PRO B  39      17.366   7.241 -14.777  1.00 41.38           C  \nATOM   1055  O   PRO B  39      17.943   7.817 -13.847  1.00 42.07           O  \nATOM   1056  CB  PRO B  39      17.407   8.673 -16.857  1.00 41.75           C  \nATOM   1057  CG  PRO B  39      17.532  10.100 -16.423  1.00 41.42           C  \nATOM   1058  CD  PRO B  39      16.150  10.405 -15.968  1.00 42.37           C  \nATOM   1059  N   GLY B  40      17.477   5.932 -14.999  1.00 35.62           N  \nATOM   1060  CA  GLY B  40      18.494   5.171 -14.302  1.00 33.54           C  \nATOM   1061  C   GLY B  40      18.048   4.556 -12.995  1.00 29.12           C  \nATOM   1062  O   GLY B  40      16.865   4.438 -12.729  1.00 28.38           O  \nATOM   1063  N   ARG B  41      19.000   3.939 -12.313  1.00 27.66           N  \nATOM   1064  CA  ARG B  41      18.722   3.282 -11.042  1.00 28.95           C  \nATOM   1065  C   ARG B  41      18.615   4.306  -9.916  1.00 30.49           C  \nATOM   1066  O   ARG B  41      19.168   5.390 -10.018  1.00 31.54           O  \nATOM   1067  CB  ARG B  41      19.852   2.333 -10.662  1.00 28.94           C  \nATOM   1068  CG  ARG B  41      20.359   1.417 -11.726  1.00 34.11           C  \nATOM   1069  CD  ARG B  41      20.905   0.188 -11.023  1.00 34.17           C  \nATOM   1070  NE  ARG B  41      19.927  -0.864 -11.169  1.00 38.61           N  \nATOM   1071  CZ  ARG B  41      19.354  -1.538 -10.177  1.00 35.13           C  \nATOM   1072  NH1 ARG B  41      19.839  -1.513  -8.939  1.00 27.84           N  \nATOM   1073  NH2 ARG B  41      18.333  -2.314 -10.472  1.00 27.82           N  \nATOM   1074  N   TRP B  42      17.989   3.918  -8.810  1.00 27.94           N  \nATOM   1075  CA  TRP B  42      17.920   4.766  -7.634  1.00 28.18           C  \nATOM   1076  C   TRP B  42      18.295   3.969  -6.380  1.00 30.79           C  \nATOM   1077  O   TRP B  42      18.163   2.742  -6.361  1.00 28.97           O  \nATOM   1078  CB  TRP B  42      16.525   5.338  -7.459  1.00 24.28           C  \nATOM   1079  CG  TRP B  42      15.444   4.372  -7.312  1.00 18.74           C  \nATOM   1080  CD1 TRP B  42      14.681   3.834  -8.299  1.00 16.49           C  \nATOM   1081  CD2 TRP B  42      14.840   3.957  -6.079  1.00 18.74           C  \nATOM   1082  NE1 TRP B  42      13.640   3.121  -7.756  1.00 16.06           N  \nATOM   1083  CE2 TRP B  42      13.719   3.166  -6.402  1.00 14.09           C  \nATOM   1084  CE3 TRP B  42      15.154   4.180  -4.715  1.00 20.09           C  \nATOM   1085  CZ2 TRP B  42      12.881   2.589  -5.411  1.00 18.75           C  \nATOM   1086  CZ3 TRP B  42      14.300   3.625  -3.745  1.00 22.86           C  \nATOM   1087  CH2 TRP B  42      13.168   2.842  -4.106  1.00 20.90           C  \nATOM   1088  N   LYS B  43      18.801   4.689  -5.365  1.00 31.89           N  \nATOM   1089  CA  LYS B  43      19.180   4.182  -4.032  1.00 30.18           C  \nATOM   1090  C   LYS B  43      18.127   4.736  -3.089  1.00 27.53           C  \nATOM   1091  O   LYS B  43      17.442   5.729  -3.400  1.00 25.86           O  \nATOM   1092  CB  LYS B  43      20.561   4.731  -3.581  1.00 33.16           C  \nATOM   1093  CG  LYS B  43      21.777   4.400  -4.445  1.00 40.56           C  \nATOM   1094  CD  LYS B  43      22.996   5.295  -4.048  1.00 49.90           C  \nATOM   1095  CE  LYS B  43      24.193   5.280  -5.063  1.00 52.53           C  \nATOM   1096  NZ  LYS B  43      25.251   6.324  -4.725  1.00 52.90           N  \nATOM   1097  N   PRO B  44      18.053   4.208  -1.878  1.00 25.82           N  \nATOM   1098  CA  PRO B  44      17.102   4.804  -0.946  1.00 25.30           C  \nATOM   1099  C   PRO B  44      17.754   5.853  -0.023  1.00 27.71           C  \nATOM   1100  O   PRO B  44      18.929   5.769   0.330  1.00 25.94           O  \nATOM   1101  CB  PRO B  44      16.596   3.610  -0.171  1.00 25.59           C  \nATOM   1102  CG  PRO B  44      17.803   2.676  -0.117  1.00 26.07           C  \nATOM   1103  CD  PRO B  44      18.649   2.962  -1.335  1.00 27.58           C  \nATOM   1104  N   LYS B  45      16.974   6.847   0.381  1.00 29.96           N  \nATOM   1105  CA  LYS B  45      17.443   7.812   1.371  1.00 28.39           C  \nATOM   1106  C   LYS B  45      16.334   8.328   2.257  1.00 27.43           C  \nATOM   1107  O   LYS B  45      15.192   8.470   1.828  1.00 26.93           O  \nATOM   1108  CB  LYS B  45      18.177   8.988   0.701  1.00 27.50           C  \nATOM   1109  CG  LYS B  45      19.183   9.659   1.670  1.00 27.69           C  \nATOM   1110  CD  LYS B  45      20.095  10.640   1.011  1.00 25.34           C  \nATOM   1111  CE  LYS B  45      20.751  11.491   2.069  1.00 32.56           C  \nATOM   1112  NZ  LYS B  45      21.413  12.705   1.509  1.00 32.92           N  \nATOM   1113  N   MET B  46      16.672   8.585   3.514  1.00 29.02           N  \nATOM   1114  CA  MET B  46      15.755   9.281   4.404  1.00 31.16           C  \nATOM   1115  C   MET B  46      16.373  10.584   4.732  1.00 29.75           C  \nATOM   1116  O   MET B  46      17.542  10.636   5.104  1.00 29.99           O  \nATOM   1117  CB  MET B  46      15.562   8.530   5.708  1.00 38.22           C  \nATOM   1118  CG  MET B  46      14.763   7.266   5.540  1.00 45.23           C  \nATOM   1119  SD  MET B  46      13.357   7.367   6.566  1.00 52.02           S  \nATOM   1120  CE  MET B  46      14.146   6.922   8.167  1.00 49.41           C  \nATOM   1121  N   ILE B  47      15.582  11.636   4.604  1.00 30.87           N  \nATOM   1122  CA  ILE B  47      16.003  12.986   4.955  1.00 29.85           C  \nATOM   1123  C   ILE B  47      15.018  13.507   5.961  1.00 27.34           C  \nATOM   1124  O   ILE B  47      13.822  13.222   5.884  1.00 26.79           O  \nATOM   1125  CB  ILE B  47      16.040  13.915   3.699  1.00 29.30           C  \nATOM   1126  CG1 ILE B  47      14.745  13.761   2.918  1.00 25.99           C  \nATOM   1127  CG2 ILE B  47      17.229  13.534   2.782  1.00 28.73           C  \nATOM   1128  CD1 ILE B  47      14.742  14.561   1.698  1.00 27.41           C  \nATOM   1129  N   GLY B  48      15.542  14.239   6.941  1.00 31.53           N  \nATOM   1130  CA  GLY B  48      14.714  14.799   8.014  1.00 31.93           C  \nATOM   1131  C   GLY B  48      14.762  16.314   8.114  1.00 33.10           C  \nATOM   1132  O   GLY B  48      15.803  16.952   7.888  1.00 30.88           O  \nATOM   1133  N   GLY B  49      13.583  16.896   8.239  1.00 32.08           N  \nATOM   1134  CA  GLY B  49      13.484  18.319   8.459  1.00 34.90           C  \nATOM   1135  C   GLY B  49      12.647  18.565   9.672  1.00 35.58           C  \nATOM   1136  O   GLY B  49      12.880  17.976  10.721  1.00 36.70           O  \nATOM   1137  N   ILE B  50      11.850  19.611   9.584  1.00 35.37           N  \nATOM   1138  CA  ILE B  50      10.858  19.974  10.594  1.00 35.93           C  \nATOM   1139  C   ILE B  50       9.707  18.988  10.393  1.00 35.51           C  \nATOM   1140  O   ILE B  50       9.341  18.670   9.251  1.00 34.79           O  \nATOM   1141  CB  ILE B  50      10.365  21.453  10.316  1.00 36.57           C  \nATOM   1142  CG1 ILE B  50      11.556  22.421  10.394  1.00 38.14           C  \nATOM   1143  CG2 ILE B  50       9.299  21.862  11.270  1.00 34.90           C  \nATOM   1144  CD1 ILE B  50      11.936  22.850  11.773  1.00 36.99           C  \nATOM   1145  N   GLY B  51       9.164  18.455  11.474  1.00 32.76           N  \nATOM   1146  CA  GLY B  51       8.011  17.583  11.313  1.00 34.23           C  \nATOM   1147  C   GLY B  51       8.360  16.130  11.054  1.00 37.16           C  \nATOM   1148  O   GLY B  51       7.494  15.283  11.167  1.00 40.75           O  \nATOM   1149  N   GLY B  52       9.638  15.842  10.818  1.00 36.36           N  \nATOM   1150  CA  GLY B  52      10.123  14.474  10.792  1.00 35.14           C  \nATOM   1151  C   GLY B  52      10.860  14.080   9.524  1.00 35.06           C  \nATOM   1152  O   GLY B  52      11.419  14.930   8.826  1.00 33.99           O  \nATOM   1153  N   PHE B  53      10.878  12.788   9.221  1.00 33.56           N  \nATOM   1154  CA  PHE B  53      11.638  12.302   8.079  1.00 33.93           C  \nATOM   1155  C   PHE B  53      10.739  11.914   6.924  1.00 33.07           C  \nATOM   1156  O   PHE B  53       9.601  11.543   7.137  1.00 35.98           O  \nATOM   1157  CB  PHE B  53      12.458  11.126   8.531  1.00 35.25           C  \nATOM   1158  CG  PHE B  53      13.464  11.471   9.564  1.00 39.11           C  \nATOM   1159  CD1 PHE B  53      13.092  11.697  10.886  1.00 40.72           C  \nATOM   1160  CD2 PHE B  53      14.789  11.625   9.189  1.00 40.77           C  \nATOM   1161  CE1 PHE B  53      14.036  12.076  11.825  1.00 42.79           C  \nATOM   1162  CE2 PHE B  53      15.753  12.001  10.078  1.00 41.95           C  \nATOM   1163  CZ  PHE B  53      15.392  12.225  11.421  1.00 44.36           C  \nATOM   1164  N   ILE B  54      11.204  12.078   5.695  1.00 30.50           N  \nATOM   1165  CA  ILE B  54      10.538  11.431   4.563  1.00 28.82           C  \nATOM   1166  C   ILE B  54      11.513  10.453   3.866  1.00 28.68           C  \nATOM   1167  O   ILE B  54      12.727  10.529   4.052  1.00 30.25           O  \nATOM   1168  CB  ILE B  54       9.923  12.446   3.500  1.00 25.49           C  \nATOM   1169  CG1 ILE B  54      10.968  13.414   2.964  1.00 24.37           C  \nATOM   1170  CG2 ILE B  54       8.754  13.195   4.090  1.00 27.89           C  \nATOM   1171  CD1 ILE B  54      10.571  14.020   1.616  1.00 16.71           C  \nATOM   1172  N   LYS B  55      10.983   9.503   3.111  1.00 29.03           N  \nATOM   1173  CA  LYS B  55      11.816   8.478   2.482  1.00 31.48           C  \nATOM   1174  C   LYS B  55      11.862   8.988   1.074  1.00 28.45           C  \nATOM   1175  O   LYS B  55      10.827   9.256   0.525  1.00 28.39           O  \nATOM   1176  CB  LYS B  55      11.062   7.136   2.489  1.00 38.52           C  \nATOM   1177  CG  LYS B  55      11.699   5.963   3.273  1.00 45.52           C  \nATOM   1178  CD  LYS B  55      13.070   5.502   2.689  1.00 51.68           C  \nATOM   1179  CE  LYS B  55      12.949   4.923   1.253  1.00 55.32           C  \nATOM   1180  NZ  LYS B  55      13.964   5.445   0.291  1.00 51.46           N  \nATOM   1181  N   VAL B  56      13.024   9.137   0.474  1.00 25.88           N  \nATOM   1182  CA  VAL B  56      13.072   9.652  -0.897  1.00 26.87           C  \nATOM   1183  C   VAL B  56      13.885   8.719  -1.786  1.00 26.06           C  \nATOM   1184  O   VAL B  56      14.547   7.817  -1.279  1.00 29.12           O  \nATOM   1185  CB  VAL B  56      13.757  11.033  -0.959  1.00 27.47           C  \nATOM   1186  CG1 VAL B  56      12.766  12.134  -0.523  1.00 27.66           C  \nATOM   1187  CG2 VAL B  56      15.032  11.016  -0.119  1.00 29.79           C  \nATOM   1188  N   ARG B  57      13.889   8.977  -3.102  1.00 24.26           N  \nATOM   1189  CA  ARG B  57      14.697   8.220  -4.083  1.00 21.61           C  \nATOM   1190  C   ARG B  57      15.894   9.023  -4.591  1.00 20.76           C  \nATOM   1191  O   ARG B  57      15.735  10.066  -5.210  1.00 24.14           O  \nATOM   1192  CB  ARG B  57      13.862   7.854  -5.298  1.00 20.35           C  \nATOM   1193  CG  ARG B  57      12.767   6.845  -5.041  1.00 26.15           C  \nATOM   1194  CD  ARG B  57      12.224   6.316  -6.354  1.00 24.10           C  \nATOM   1195  NE  ARG B  57      10.944   6.937  -6.617  1.00 34.58           N  \nATOM   1196  CZ  ARG B  57      10.717   7.776  -7.614  1.00 31.59           C  \nATOM   1197  NH1 ARG B  57      11.534   7.792  -8.658  1.00 33.77           N  \nATOM   1198  NH2 ARG B  57       9.555   8.403  -7.678  1.00 29.56           N  \nATOM   1199  N   GLN B  58      17.095   8.516  -4.388  1.00 19.42           N  \nATOM   1200  CA  GLN B  58      18.306   9.218  -4.819  1.00 21.62           C  \nATOM   1201  C   GLN B  58      18.742   8.833  -6.226  1.00 23.18           C  \nATOM   1202  O   GLN B  58      19.157   7.694  -6.438  1.00 26.34           O  \nATOM   1203  CB  GLN B  58      19.465   8.920  -3.861  1.00 20.63           C  \nATOM   1204  CG  GLN B  58      20.738   9.622  -4.271  1.00 18.81           C  \nATOM   1205  CD  GLN B  58      21.825   9.463  -3.248  1.00 20.16           C  \nATOM   1206  OE1 GLN B  58      21.554   9.424  -2.048  1.00 28.16           O  \nATOM   1207  NE2 GLN B  58      23.045   9.365  -3.692  1.00 21.91           N  \nATOM   1208  N   TYR B  59      18.705   9.773  -7.167  1.00 21.35           N  \nATOM   1209  CA  TYR B  59      19.361   9.587  -8.464  1.00 19.01           C  \nATOM   1210  C   TYR B  59      20.689  10.330  -8.544  1.00 21.82           C  \nATOM   1211  O   TYR B  59      20.860  11.368  -7.943  1.00 25.32           O  \nATOM   1212  CB  TYR B  59      18.472  10.082  -9.563  1.00 18.59           C  \nATOM   1213  CG  TYR B  59      17.116   9.383  -9.609  1.00 15.73           C  \nATOM   1214  CD1 TYR B  59      16.157   9.612  -8.615  1.00 15.43           C  \nATOM   1215  CD2 TYR B  59      16.814   8.484 -10.637  1.00 19.10           C  \nATOM   1216  CE1 TYR B  59      14.959   8.977  -8.640  1.00 16.84           C  \nATOM   1217  CE2 TYR B  59      15.647   7.851 -10.673  1.00 19.50           C  \nATOM   1218  CZ  TYR B  59      14.704   8.066  -9.679  1.00 22.02           C  \nATOM   1219  OH  TYR B  59      13.561   7.307  -9.711  1.00 23.01           O  \nATOM   1220  N   ASP B  60      21.665   9.797  -9.258  1.00 26.17           N  \nATOM   1221  CA  ASP B  60      22.959  10.470  -9.336  1.00 25.69           C  \nATOM   1222  C   ASP B  60      23.303  10.921 -10.737  1.00 27.15           C  \nATOM   1223  O   ASP B  60      22.793  10.396 -11.707  1.00 26.71           O  \nATOM   1224  CB  ASP B  60      24.042   9.554  -8.834  1.00 30.50           C  \nATOM   1225  CG  ASP B  60      23.843   9.184  -7.407  1.00 36.31           C  \nATOM   1226  OD1 ASP B  60      23.463  10.074  -6.620  1.00 37.41           O  \nATOM   1227  OD2 ASP B  60      24.107   8.012  -7.044  1.00 40.37           O  \nATOM   1228  N   GLN B  61      24.189  11.897 -10.837  1.00 27.15           N  \nATOM   1229  CA  GLN B  61      24.622  12.478 -12.111  1.00 29.27           C  \nATOM   1230  C   GLN B  61      23.474  12.903 -13.022  1.00 28.21           C  \nATOM   1231  O   GLN B  61      23.492  12.665 -14.229  1.00 29.57           O  \nATOM   1232  CB  GLN B  61      25.596  11.549 -12.869  1.00 35.98           C  \nATOM   1233  CG  GLN B  61      26.892  12.283 -13.369  1.00 45.09           C  \nATOM   1234  CD  GLN B  61      28.007  11.392 -13.985  1.00 50.40           C  \nATOM   1235  OE1 GLN B  61      28.747  11.845 -14.875  1.00 49.27           O  \nATOM   1236  NE2 GLN B  61      28.197  10.173 -13.442  1.00 55.52           N  \nATOM   1237  N   ILE B  62      22.493  13.589 -12.452  1.00 26.57           N  \nATOM   1238  CA  ILE B  62      21.380  14.141 -13.224  1.00 24.82           C  \nATOM   1239  C   ILE B  62      21.710  15.575 -13.686  1.00 25.46           C  \nATOM   1240  O   ILE B  62      22.247  16.373 -12.924  1.00 25.12           O  \nATOM   1241  CB  ILE B  62      20.090  14.147 -12.331  1.00 24.26           C  \nATOM   1242  CG1 ILE B  62      19.709  12.702 -11.952  1.00 23.74           C  \nATOM   1243  CG2 ILE B  62      18.950  14.826 -13.045  1.00 21.48           C  \nATOM   1244  CD1 ILE B  62      19.068  11.933 -13.057  1.00 23.09           C  \nATOM   1245  N   LEU B  63      21.400  15.900 -14.931  1.00 25.95           N  \nATOM   1246  CA  LEU B  63      21.600  17.263 -15.431  1.00 29.84           C  \nATOM   1247  C   LEU B  63      20.386  18.085 -15.052  1.00 30.58           C  \nATOM   1248  O   LEU B  63      19.260  17.703 -15.355  1.00 31.36           O  \nATOM   1249  CB  LEU B  63      21.769  17.265 -16.962  1.00 32.16           C  \nATOM   1250  CG  LEU B  63      21.792  18.587 -17.759  1.00 33.80           C  \nATOM   1251  CD1 LEU B  63      22.903  19.529 -17.300  1.00 36.66           C  \nATOM   1252  CD2 LEU B  63      21.997  18.246 -19.205  1.00 38.83           C  \nATOM   1253  N   ILE B  64      20.626  19.203 -14.381  1.00 31.59           N  \nATOM   1254  CA  ILE B  64      19.548  20.111 -14.029  1.00 31.52           C  \nATOM   1255  C   ILE B  64      20.089  21.523 -14.223  1.00 33.29           C  \nATOM   1256  O   ILE B  64      21.175  21.858 -13.763  1.00 33.56           O  \nATOM   1257  CB  ILE B  64      19.107  19.880 -12.540  1.00 29.35           C  \nATOM   1258  CG1 ILE B  64      18.216  20.990 -12.036  1.00 30.67           C  \nATOM   1259  CG2 ILE B  64      20.311  19.766 -11.655  1.00 34.19           C  \nATOM   1260  CD1 ILE B  64      17.324  20.544 -10.930  1.00 34.50           C  \nATOM   1261  N   GLU B  65      19.327  22.330 -14.953  1.00 35.37           N  \nATOM   1262  CA  GLU B  65      19.661  23.719 -15.251  1.00 34.26           C  \nATOM   1263  C   GLU B  65      18.938  24.686 -14.338  1.00 33.11           C  \nATOM   1264  O   GLU B  65      17.700  24.745 -14.345  1.00 32.35           O  \nATOM   1265  CB  GLU B  65      19.282  24.017 -16.688  1.00 37.05           C  \nATOM   1266  CG  GLU B  65      20.180  25.011 -17.326  1.00 48.15           C  \nATOM   1267  CD  GLU B  65      19.960  25.126 -18.805  1.00 54.00           C  \nATOM   1268  OE1 GLU B  65      19.601  24.094 -19.445  1.00 54.40           O  \nATOM   1269  OE2 GLU B  65      20.214  26.241 -19.314  1.00 59.11           O  \nATOM   1270  N   ILE B  66      19.709  25.427 -13.547  1.00 34.12           N  \nATOM   1271  CA  ILE B  66      19.159  26.431 -12.654  1.00 36.05           C  \nATOM   1272  C   ILE B  66      19.519  27.864 -13.127  1.00 37.57           C  \nATOM   1273  O   ILE B  66      20.684  28.254 -13.167  1.00 36.67           O  \nATOM   1274  CB  ILE B  66      19.663  26.199 -11.203  1.00 33.70           C  \nATOM   1275  CG1 ILE B  66      19.566  24.717 -10.848  1.00 32.55           C  \nATOM   1276  CG2 ILE B  66      18.824  27.018 -10.232  1.00 33.60           C  \nATOM   1277  CD1 ILE B  66      20.510  24.280  -9.745  1.00 35.00           C  \nATOM   1278  N   CYS B  67      18.504  28.630 -13.516  1.00 41.68           N  \nATOM   1279  CA  CYS B  67      18.684  29.971 -14.104  1.00 44.87           C  \nATOM   1280  C   CYS B  67      19.685  29.990 -15.245  1.00 44.44           C  \nATOM   1281  O   CYS B  67      20.565  30.852 -15.294  1.00 42.31           O  \nATOM   1282  CB  CYS B  67      19.124  30.970 -13.037  1.00 48.45           C  \nATOM   1283  SG  CYS B  67      17.736  31.542 -12.037  1.00 54.18           S  \nATOM   1284  N   GLY B  68      19.562  29.010 -16.143  1.00 43.24           N  \nATOM   1285  CA  GLY B  68      20.485  28.891 -17.256  1.00 41.28           C  \nATOM   1286  C   GLY B  68      21.899  28.603 -16.811  1.00 41.98           C  \nATOM   1287  O   GLY B  68      22.843  28.970 -17.493  1.00 46.85           O  \nATOM   1288  N   HIS B  69      22.059  28.002 -15.633  1.00 40.00           N  \nATOM   1289  CA  HIS B  69      23.354  27.479 -15.197  1.00 36.63           C  \nATOM   1290  C   HIS B  69      23.178  25.984 -15.087  1.00 34.62           C  \nATOM   1291  O   HIS B  69      22.307  25.523 -14.354  1.00 32.72           O  \nATOM   1292  CB  HIS B  69      23.711  27.993 -13.810  1.00 39.25           C  \nATOM   1293  CG  HIS B  69      23.976  29.473 -13.740  1.00 44.38           C  \nATOM   1294  ND1 HIS B  69      25.177  29.994 -13.361  1.00 46.88           N  \nATOM   1295  CD2 HIS B  69      23.114  30.512 -13.920  1.00 45.80           C  \nATOM   1296  CE1 HIS B  69      25.058  31.325 -13.286  1.00 50.18           C  \nATOM   1297  NE2 HIS B  69      23.849  31.652 -13.613  1.00 47.74           N  \nATOM   1298  N   LYS B  70      23.995  25.240 -15.820  1.00 33.27           N  \nATOM   1299  CA  LYS B  70      23.935  23.791 -15.800  1.00 31.17           C  \nATOM   1300  C   LYS B  70      24.749  23.243 -14.652  1.00 29.41           C  \nATOM   1301  O   LYS B  70      25.875  23.676 -14.403  1.00 29.56           O  \nATOM   1302  CB  LYS B  70      24.423  23.212 -17.115  1.00 32.71           C  \nATOM   1303  CG  LYS B  70      23.463  23.445 -18.279  1.00 34.39           C  \nATOM   1304  CD  LYS B  70      24.261  23.524 -19.576  1.00 44.19           C  \nATOM   1305  CE  LYS B  70      23.377  23.737 -20.816  1.00 48.61           C  \nATOM   1306  NZ  LYS B  70      22.863  22.443 -21.404  1.00 54.35           N  \nATOM   1307  N   ALA B  71      24.104  22.353 -13.909  1.00 24.69           N  \nATOM   1308  CA  ALA B  71      24.689  21.612 -12.802  1.00 23.65           C  \nATOM   1309  C   ALA B  71      24.391  20.156 -13.159  1.00 24.51           C  \nATOM   1310  O   ALA B  71      23.339  19.865 -13.735  1.00 24.89           O  \nATOM   1311  CB  ALA B  71      23.991  21.992 -11.485  1.00 16.65           C  \nATOM   1312  N   ILE B  72      25.330  19.253 -12.902  1.00 25.50           N  \nATOM   1313  CA  ILE B  72      25.048  17.816 -13.016  1.00 24.06           C  \nATOM   1314  C   ILE B  72      25.312  17.246 -11.637  1.00 22.15           C  \nATOM   1315  O   ILE B  72      26.442  17.315 -11.167  1.00 23.87           O  \nATOM   1316  CB  ILE B  72      26.029  17.094 -13.983  1.00 24.38           C  \nATOM   1317  CG1 ILE B  72      26.092  17.805 -15.333  1.00 26.24           C  \nATOM   1318  CG2 ILE B  72      25.615  15.649 -14.171  1.00 23.69           C  \nATOM   1319  CD1 ILE B  72      27.241  17.224 -16.197  1.00 23.26           C  \nATOM   1320  N   GLY B  73      24.303  16.690 -10.975  1.00 19.12           N  \nATOM   1321  CA  GLY B  73      24.545  16.248  -9.616  1.00 19.31           C  \nATOM   1322  C   GLY B  73      23.470  15.337  -9.095  1.00 19.37           C  \nATOM   1323  O   GLY B  73      22.674  14.852  -9.881  1.00 21.87           O  \nATOM   1324  N   THR B  74      23.517  15.041  -7.794  1.00 19.61           N  \nATOM   1325  CA  THR B  74      22.568  14.162  -7.116  1.00 19.07           C  \nATOM   1326  C   THR B  74      21.280  14.889  -6.829  1.00 22.17           C  \nATOM   1327  O   THR B  74      21.299  16.005  -6.275  1.00 19.62           O  \nATOM   1328  CB  THR B  74      23.128  13.638  -5.748  1.00 19.04           C  \nATOM   1329  OG1 THR B  74      24.323  12.880  -5.961  1.00 24.28           O  \nATOM   1330  CG2 THR B  74      22.071  12.763  -5.030  1.00 17.43           C  \nATOM   1331  N   VAL B  75      20.177  14.227  -7.192  1.00 18.83           N  \nATOM   1332  CA  VAL B  75      18.832  14.773  -7.068  1.00 20.46           C  \nATOM   1333  C   VAL B  75      17.989  13.688  -6.360  1.00 22.85           C  \nATOM   1334  O   VAL B  75      17.993  12.504  -6.743  1.00 20.15           O  \nATOM   1335  CB  VAL B  75      18.229  15.113  -8.501  1.00 22.69           C  \nATOM   1336  CG1 VAL B  75      16.760  15.421  -8.434  1.00 19.10           C  \nATOM   1337  CG2 VAL B  75      18.967  16.317  -9.099  1.00 18.68           C  \nATOM   1338  N   LEU B  76      17.295  14.086  -5.303  1.00 21.32           N  \nATOM   1339  CA  LEU B  76      16.390  13.196  -4.575  1.00 19.82           C  \nATOM   1340  C   LEU B  76      14.972  13.423  -5.073  1.00 21.74           C  \nATOM   1341  O   LEU B  76      14.652  14.514  -5.518  1.00 25.18           O  \nATOM   1342  CB  LEU B  76      16.450  13.476  -3.067  1.00 16.45           C  \nATOM   1343  CG  LEU B  76      17.787  13.595  -2.330  1.00 15.15           C  \nATOM   1344  CD1 LEU B  76      17.591  13.640  -0.845  1.00 14.83           C  \nATOM   1345  CD2 LEU B  76      18.678  12.463  -2.705  1.00 20.59           C  \nATOM   1346  N   VAL B  77      14.135  12.391  -5.049  1.00 23.03           N  \nATOM   1347  CA  VAL B  77      12.749  12.509  -5.485  1.00 17.63           C  \nATOM   1348  C   VAL B  77      11.826  11.894  -4.472  1.00 17.51           C  \nATOM   1349  O   VAL B  77      12.052  10.766  -3.999  1.00 16.69           O  \nATOM   1350  CB  VAL B  77      12.502  11.835  -6.868  1.00 18.16           C  \nATOM   1351  CG1 VAL B  77      11.065  12.148  -7.398  1.00 20.02           C  \nATOM   1352  CG2 VAL B  77      13.593  12.322  -7.843  1.00 16.66           C  \nATOM   1353  N   GLY B  78      10.778  12.616  -4.125  1.00 16.55           N  \nATOM   1354  CA  GLY B  78      10.004  12.229  -2.965  1.00 20.06           C  \nATOM   1355  C   GLY B  78       8.832  13.128  -2.672  1.00 21.31           C  \nATOM   1356  O   GLY B  78       8.614  14.117  -3.393  1.00 24.13           O  \nATOM   1357  N   PRO B  79       8.032  12.814  -1.646  1.00 19.47           N  \nATOM   1358  CA  PRO B  79       6.887  13.664  -1.350  1.00 21.78           C  \nATOM   1359  C   PRO B  79       7.292  14.915  -0.550  1.00 21.89           C  \nATOM   1360  O   PRO B  79       7.007  15.036   0.638  1.00 22.16           O  \nATOM   1361  CB  PRO B  79       5.951  12.742  -0.594  1.00 17.28           C  \nATOM   1362  CG  PRO B  79       6.838  11.781   0.040  1.00 20.54           C  \nATOM   1363  CD  PRO B  79       8.096  11.665  -0.739  1.00 20.64           C  \nATOM   1364  N   THR B  80       7.997  15.816  -1.220  1.00 24.38           N  \nATOM   1365  CA  THR B  80       8.324  17.137  -0.702  1.00 22.15           C  \nATOM   1366  C   THR B  80       7.227  18.114  -1.090  1.00 20.84           C  \nATOM   1367  O   THR B  80       6.528  17.896  -2.080  1.00 20.99           O  \nATOM   1368  CB  THR B  80       9.677  17.594  -1.299  1.00 21.20           C  \nATOM   1369  OG1 THR B  80       9.952  18.951  -0.924  1.00 22.05           O  \nATOM   1370  CG2 THR B  80       9.688  17.449  -2.825  1.00 13.16           C  \nATOM   1371  N   PRO B  81       6.922  19.074  -0.214  1.00 24.57           N  \nATOM   1372  CA  PRO B  81       5.896  20.066  -0.556  1.00 24.68           C  \nATOM   1373  C   PRO B  81       6.244  20.969  -1.727  1.00 26.51           C  \nATOM   1374  O   PRO B  81       5.343  21.294  -2.509  1.00 32.43           O  \nATOM   1375  CB  PRO B  81       5.694  20.874   0.729  1.00 22.89           C  \nATOM   1376  CG  PRO B  81       6.274  19.954   1.831  1.00 24.08           C  \nATOM   1377  CD  PRO B  81       7.387  19.243   1.190  1.00 21.46           C  \nATOM   1378  N   VAL B  82       7.520  21.355  -1.868  1.00 23.91           N  \nATOM   1379  CA  VAL B  82       7.990  22.207  -2.983  1.00 24.09           C  \nATOM   1380  C   VAL B  82       9.255  21.636  -3.581  1.00 21.54           C  \nATOM   1381  O   VAL B  82       9.973  20.911  -2.929  1.00 26.47           O  \nATOM   1382  CB  VAL B  82       8.375  23.616  -2.484  1.00 26.47           C  \nATOM   1383  CG1 VAL B  82       7.122  24.513  -2.361  1.00 26.39           C  \nATOM   1384  CG2 VAL B  82       9.101  23.485  -1.163  1.00 24.12           C  \nATOM   1385  N   ASN B  83       9.588  21.960  -4.812  1.00 16.61           N  \nATOM   1386  CA  ASN B  83      10.914  21.521  -5.319  1.00 16.90           C  \nATOM   1387  C   ASN B  83      11.922  22.373  -4.576  1.00 19.55           C  \nATOM   1388  O   ASN B  83      11.716  23.574  -4.429  1.00 18.36           O  \nATOM   1389  CB  ASN B  83      11.068  21.763  -6.823  1.00 16.55           C  \nATOM   1390  CG  ASN B  83      10.096  20.950  -7.647  1.00 22.00           C  \nATOM   1391  OD1 ASN B  83      10.013  19.733  -7.494  1.00 23.24           O  \nATOM   1392  ND2 ASN B  83       9.305  21.627  -8.498  1.00 22.85           N  \nATOM   1393  N   ILE B  84      12.983  21.755  -4.066  1.00 17.31           N  \nATOM   1394  CA  ILE B  84      13.979  22.449  -3.233  1.00 13.51           C  \nATOM   1395  C   ILE B  84      15.345  22.255  -3.870  1.00 19.87           C  \nATOM   1396  O   ILE B  84      15.779  21.111  -4.072  1.00 20.54           O  \nATOM   1397  CB  ILE B  84      14.041  21.833  -1.837  1.00 10.82           C  \nATOM   1398  CG1 ILE B  84      12.754  22.151  -1.088  1.00 13.42           C  \nATOM   1399  CG2 ILE B  84      15.323  22.264  -1.122  1.00 11.48           C  \nATOM   1400  CD1 ILE B  84      12.438  21.217   0.060  1.00 20.08           C  \nATOM   1401  N   ILE B  85      16.044  23.346  -4.167  1.00 19.47           N  \nATOM   1402  CA  ILE B  85      17.441  23.243  -4.575  1.00 19.69           C  \nATOM   1403  C   ILE B  85      18.305  23.504  -3.345  1.00 22.78           C  \nATOM   1404  O   ILE B  85      18.262  24.613  -2.802  1.00 24.74           O  \nATOM   1405  CB  ILE B  85      17.805  24.332  -5.644  1.00 18.51           C  \nATOM   1406  CG1 ILE B  85      16.809  24.299  -6.827  1.00 19.44           C  \nATOM   1407  CG2 ILE B  85      19.271  24.191  -6.067  1.00 14.76           C  \nATOM   1408  CD1 ILE B  85      16.672  22.956  -7.581  1.00 22.90           C  \nATOM   1409  N   GLY B  86      19.121  22.530  -2.936  1.00 19.72           N  \nATOM   1410  CA  GLY B  86      19.857  22.642  -1.690  1.00 14.65           C  \nATOM   1411  C   GLY B  86      21.324  22.800  -1.940  1.00 13.18           C  \nATOM   1412  O   GLY B  86      21.750  22.958  -3.056  1.00 13.07           O  \nATOM   1413  N   ARG B  87      22.117  22.755  -0.887  1.00 11.71           N  \nATOM   1414  CA  ARG B  87      23.533  23.126  -0.985  1.00 14.23           C  \nATOM   1415  C   ARG B  87      24.413  22.356  -1.973  1.00 19.73           C  \nATOM   1416  O   ARG B  87      25.398  22.903  -2.461  1.00 17.28           O  \nATOM   1417  CB  ARG B  87      24.171  23.147   0.403  1.00 15.02           C  \nATOM   1418  CG  ARG B  87      23.646  24.256   1.283  1.00  8.76           C  \nATOM   1419  CD  ARG B  87      24.429  24.306   2.576  1.00 16.02           C  \nATOM   1420  NE  ARG B  87      24.362  23.068   3.371  1.00 21.61           N  \nATOM   1421  CZ  ARG B  87      25.357  22.185   3.495  1.00 21.15           C  \nATOM   1422  NH1 ARG B  87      26.467  22.303   2.795  1.00 18.57           N  \nATOM   1423  NH2 ARG B  87      25.255  21.190   4.368  1.00 26.79           N  \nATOM   1424  N   ASN B  88      24.074  21.101  -2.275  1.00 18.56           N  \nATOM   1425  CA  ASN B  88      24.950  20.312  -3.132  1.00 17.41           C  \nATOM   1426  C   ASN B  88      24.980  20.893  -4.527  1.00 19.59           C  \nATOM   1427  O   ASN B  88      26.015  20.853  -5.202  1.00 20.40           O  \nATOM   1428  CB  ASN B  88      24.512  18.849  -3.197  1.00 19.90           C  \nATOM   1429  CG  ASN B  88      23.126  18.649  -3.777  1.00 15.28           C  \nATOM   1430  OD1 ASN B  88      22.167  19.280  -3.351  1.00 22.61           O  \nATOM   1431  ND2 ASN B  88      23.020  17.775  -4.767  1.00 16.65           N  \nATOM   1432  N   LEU B  89      23.863  21.490  -4.949  1.00 20.98           N  \nATOM   1433  CA  LEU B  89      23.811  22.125  -6.273  1.00 21.49           C  \nATOM   1434  C   LEU B  89      24.018  23.645  -6.231  1.00 20.99           C  \nATOM   1435  O   LEU B  89      24.321  24.242  -7.236  1.00 21.25           O  \nATOM   1436  CB  LEU B  89      22.457  21.815  -6.962  1.00 20.00           C  \nATOM   1437  CG  LEU B  89      22.219  20.372  -7.436  1.00 17.87           C  \nATOM   1438  CD1 LEU B  89      20.937  20.300  -8.243  1.00 20.88           C  \nATOM   1439  CD2 LEU B  89      23.408  19.901  -8.273  1.00 17.17           C  \nATOM   1440  N   LEU B  90      23.819  24.255  -5.075  1.00 20.01           N  \nATOM   1441  CA  LEU B  90      24.020  25.701  -4.954  1.00 22.17           C  \nATOM   1442  C   LEU B  90      25.511  26.005  -5.072  1.00 19.95           C  \nATOM   1443  O   LEU B  90      25.907  26.959  -5.732  1.00 21.08           O  \nATOM   1444  CB  LEU B  90      23.430  26.234  -3.624  1.00 17.71           C  \nATOM   1445  CG  LEU B  90      21.900  26.309  -3.475  1.00 16.96           C  \nATOM   1446  CD1 LEU B  90      21.487  26.779  -2.081  1.00 11.88           C  \nATOM   1447  CD2 LEU B  90      21.358  27.241  -4.506  1.00 18.70           C  \nATOM   1448  N   THR B  91      26.336  25.143  -4.491  1.00 23.70           N  \nATOM   1449  CA  THR B  91      27.785  25.304  -4.546  1.00 23.96           C  \nATOM   1450  C   THR B  91      28.270  25.184  -5.969  1.00 24.81           C  \nATOM   1451  O   THR B  91      29.168  25.903  -6.378  1.00 26.72           O  \nATOM   1452  CB  THR B  91      28.501  24.261  -3.669  1.00 21.26           C  \nATOM   1453  OG1 THR B  91      27.898  22.990  -3.894  1.00 25.49           O  \nATOM   1454  CG2 THR B  91      28.366  24.579  -2.208  1.00 17.64           C  \nATOM   1455  N   GLN B  92      27.619  24.323  -6.741  1.00 25.95           N  \nATOM   1456  CA  GLN B  92      28.009  24.110  -8.150  1.00 27.31           C  \nATOM   1457  C   GLN B  92      27.823  25.361  -8.999  1.00 27.97           C  \nATOM   1458  O   GLN B  92      28.719  25.701  -9.794  1.00 30.31           O  \nATOM   1459  CB  GLN B  92      27.226  22.956  -8.793  1.00 24.09           C  \nATOM   1460  CG  GLN B  92      27.720  21.588  -8.406  1.00 25.97           C  \nATOM   1461  CD  GLN B  92      27.313  20.496  -9.421  1.00 27.56           C  \nATOM   1462  OE1 GLN B  92      27.138  20.746 -10.620  1.00 26.23           O  \nATOM   1463  NE2 GLN B  92      27.230  19.281  -8.941  1.00 27.50           N  \nATOM   1464  N   ILE B  93      26.683  26.043  -8.820  1.00 28.73           N  \nATOM   1465  CA  ILE B  93      26.362  27.233  -9.606  1.00 28.11           C  \nATOM   1466  C   ILE B  93      26.904  28.524  -8.963  1.00 30.61           C  \nATOM   1467  O   ILE B  93      26.574  29.627  -9.385  1.00 32.40           O  \nATOM   1468  CB  ILE B  93      24.838  27.349  -9.857  1.00 23.33           C  \nATOM   1469  CG1 ILE B  93      24.103  27.648  -8.559  1.00 25.74           C  \nATOM   1470  CG2 ILE B  93      24.300  26.092 -10.460  1.00 21.29           C  \nATOM   1471  CD1 ILE B  93      22.672  28.017  -8.785  1.00 27.65           C  \nATOM   1472  N   GLY B  94      27.741  28.369  -7.949  1.00 30.93           N  \nATOM   1473  CA  GLY B  94      28.481  29.498  -7.421  1.00 31.94           C  \nATOM   1474  C   GLY B  94      27.749  30.439  -6.488  1.00 30.20           C  \nATOM   1475  O   GLY B  94      28.177  31.555  -6.261  1.00 31.24           O  \nATOM   1476  N   CYS B  95      26.808  29.899  -5.748  1.00 27.82           N  \nATOM   1477  CA  CYS B  95      25.895  30.718  -5.004  1.00 26.76           C  \nATOM   1478  C   CYS B  95      26.408  30.993  -3.598  1.00 27.20           C  \nATOM   1479  O   CYS B  95      26.769  30.065  -2.870  1.00 27.85           O  \nATOM   1480  CB  CYS B  95      24.578  29.989  -4.978  1.00 27.09           C  \nATOM   1481  SG  CYS B  95      23.221  30.929  -4.410  1.00 36.34           S  \nATOM   1482  N   THR B  96      26.473  32.277  -3.244  1.00 26.04           N  \nATOM   1483  CA  THR B  96      26.794  32.734  -1.882  1.00 25.60           C  \nATOM   1484  C   THR B  96      25.672  33.544  -1.205  1.00 24.26           C  \nATOM   1485  O   THR B  96      24.760  34.079  -1.852  1.00 23.28           O  \nATOM   1486  CB  THR B  96      28.051  33.660  -1.858  1.00 27.82           C  \nATOM   1487  OG1 THR B  96      27.888  34.689  -2.857  1.00 31.12           O  \nATOM   1488  CG2 THR B  96      29.316  32.870  -2.141  1.00 24.73           C  \nATOM   1489  N   LEU B  97      25.759  33.617   0.119  1.00 24.54           N  \nATOM   1490  CA  LEU B  97      24.902  34.468   0.963  1.00 27.92           C  \nATOM   1491  C   LEU B  97      25.714  35.689   1.398  1.00 30.25           C  \nATOM   1492  O   LEU B  97      26.854  35.558   1.870  1.00 29.52           O  \nATOM   1493  CB  LEU B  97      24.489  33.718   2.236  1.00 27.18           C  \nATOM   1494  CG  LEU B  97      23.211  32.901   2.344  1.00 22.23           C  \nATOM   1495  CD1 LEU B  97      23.114  32.358   3.719  1.00 23.52           C  \nATOM   1496  CD2 LEU B  97      22.037  33.773   2.076  1.00 20.87           C  \nATOM   1497  N   ASN B  98      25.121  36.868   1.264  1.00 32.20           N  \nATOM   1498  CA  ASN B  98      25.870  38.101   1.449  1.00 34.86           C  \nATOM   1499  C   ASN B  98      25.102  39.038   2.370  1.00 34.26           C  \nATOM   1500  O   ASN B  98      23.889  39.124   2.261  1.00 36.18           O  \nATOM   1501  CB  ASN B  98      26.140  38.756   0.086  1.00 31.24           C  \nATOM   1502  CG  ASN B  98      27.048  37.921  -0.814  1.00 33.93           C  \nATOM   1503  OD1 ASN B  98      28.268  37.895  -0.630  1.00 37.15           O  \nATOM   1504  ND2 ASN B  98      26.455  37.192  -1.754  1.00 33.06           N  \nATOM   1505  N   PHE B  99      25.809  39.706   3.283  1.00 36.76           N  \nATOM   1506  CA  PHE B  99      25.267  40.855   4.034  1.00 36.49           C  \nATOM   1507  C   PHE B  99      26.351  41.742   4.659  1.00 35.50           C  \nATOM   1508  O   PHE B  99      27.448  41.208   5.013  1.00 37.49           O  \nATOM   1509  CB  PHE B  99      24.284  40.418   5.127  1.00 34.88           C  \nATOM   1510  CG  PHE B  99      24.859  39.479   6.130  1.00 36.75           C  \nATOM   1511  CD1 PHE B  99      25.061  38.150   5.808  1.00 37.04           C  \nATOM   1512  CD2 PHE B  99      25.071  39.890   7.436  1.00 38.13           C  \nATOM   1513  CE1 PHE B  99      25.450  37.240   6.756  1.00 37.02           C  \nATOM   1514  CE2 PHE B  99      25.473  38.988   8.409  1.00 37.11           C  \nATOM   1515  CZ  PHE B  99      25.658  37.663   8.073  1.00 36.24           C  \nTER    1516      PHE B  99                                                      \nHETATM 1517  N1  MK1 B 902       9.280  23.763   3.004  1.00 28.25           N  \nHETATM 1518  C1  MK1 B 902       9.498  23.983   4.459  1.00 30.30           C  \nHETATM 1519  C2  MK1 B 902      10.591  24.905   4.962  1.00 27.27           C  \nHETATM 1520  C3  MK1 B 902      10.591  24.864   6.466  1.00 28.85           C  \nHETATM 1521  O1  MK1 B 902      10.937  23.849   7.057  1.00 29.59           O  \nHETATM 1522  N2  MK1 B 902      10.193  25.953   7.094  1.00 22.29           N  \nHETATM 1523  C4  MK1 B 902      10.145  26.250   8.490  1.00 23.47           C  \nHETATM 1524  C5  MK1 B 902       9.379  27.577   8.641  1.00 27.66           C  \nHETATM 1525  C6  MK1 B 902      11.398  26.347   9.074  1.00 21.71           C  \nHETATM 1526  C7  MK1 B 902       9.364  25.283   9.268  1.00 22.75           C  \nHETATM 1527  N3  MK1 B 902      11.819  24.282   4.355  1.00 28.91           N  \nHETATM 1528  C8  MK1 B 902      11.753  23.776   2.961  1.00 26.24           C  \nHETATM 1529  C9  MK1 B 902      10.440  23.182   2.493  1.00 27.47           C  \nHETATM 1530  C10 MK1 B 902      13.083  24.963   4.552  1.00 20.86           C  \nHETATM 1531  C11 MK1 B 902      14.203  24.064   5.078  1.00 21.68           C  \nHETATM 1532  O2  MK1 B 902      15.242  24.884   4.634  1.00 15.87           O  \nHETATM 1533  C12 MK1 B 902      14.440  23.761   6.569  1.00 21.49           C  \nHETATM 1534  C13 MK1 B 902      15.573  22.821   7.005  1.00 26.89           C  \nHETATM 1535  C14 MK1 B 902      15.644  22.664   8.534  1.00 28.67           C  \nHETATM 1536  C15 MK1 B 902      16.733  21.750   8.961  1.00 26.89           C  \nHETATM 1537  C16 MK1 B 902      18.058  21.916   8.553  1.00 29.22           C  \nHETATM 1538  C17 MK1 B 902      19.037  21.016   8.947  1.00 29.22           C  \nHETATM 1539  C18 MK1 B 902      18.673  19.939   9.758  1.00 30.97           C  \nHETATM 1540  C19 MK1 B 902      17.347  19.773  10.176  1.00 29.25           C  \nHETATM 1541  C20 MK1 B 902      16.374  20.687   9.772  1.00 29.96           C  \nHETATM 1542  C21 MK1 B 902      15.447  21.440   6.373  1.00 29.35           C  \nHETATM 1543  O3  MK1 B 902      14.367  20.831   6.397  1.00 32.66           O  \nHETATM 1544  N4  MK1 B 902      16.583  20.913   5.924  1.00 31.19           N  \nHETATM 1545  C22 MK1 B 902      16.692  19.500   5.604  1.00 29.22           C  \nHETATM 1546  C23 MK1 B 902      18.067  18.945   5.936  1.00 28.82           C  \nHETATM 1547  O4  MK1 B 902      19.061  19.938   5.729  1.00 28.32           O  \nHETATM 1548  C24 MK1 B 902      18.226  17.726   5.057  1.00 32.05           C  \nHETATM 1549  C25 MK1 B 902      17.476  17.904   3.760  1.00 31.29           C  \nHETATM 1550  C26 MK1 B 902      17.500  17.363   2.496  1.00 32.00           C  \nHETATM 1551  C27 MK1 B 902      16.613  17.872   1.541  1.00 28.00           C  \nHETATM 1552  C28 MK1 B 902      15.722  18.906   1.865  1.00 29.01           C  \nHETATM 1553  C29 MK1 B 902      15.683  19.479   3.129  1.00 27.70           C  \nHETATM 1554  C30 MK1 B 902      16.504  19.061   4.128  1.00 31.86           C  \nHETATM 1555  C31 MK1 B 902       8.033  23.100   2.604  1.00 36.25           C  \nHETATM 1556  C32 MK1 B 902       6.666  23.739   2.876  1.00 42.75           C  \nHETATM 1557  C33 MK1 B 902       6.158  24.808   2.124  1.00 47.41           C  \nHETATM 1558  N5  MK1 B 902       4.911  25.430   2.300  1.00 51.38           N  \nHETATM 1559  C34 MK1 B 902       4.207  24.839   3.348  1.00 50.60           C  \nHETATM 1560  C35 MK1 B 902       4.654  23.774   4.136  1.00 49.34           C  \nHETATM 1561  C36 MK1 B 902       5.905  23.211   3.897  1.00 44.71           C  \nHETATM 1562  O   HOH A 305      20.857  43.192  21.450  1.00 63.07           O  \nHETATM 1563  O   HOH A 307      14.076  19.789  19.440  1.00 63.34           O  \nHETATM 1564  O   HOH A 309      28.075  21.177   7.222  1.00 66.96           O  \nHETATM 1565  O   HOH A 314      16.759  40.274   1.287  1.00 36.09           O  \nHETATM 1566  O   HOH A 315      13.997  22.233  21.468  1.00 64.67           O  \nHETATM 1567  O   HOH A 324      11.282  30.738   1.625  1.00 21.55           O  \nHETATM 1568  O   HOH A 325      16.774  42.740   2.296  1.00 26.65           O  \nHETATM 1569  O   HOH A 327      14.623  29.552  28.235  1.00 60.45           O  \nHETATM 1570  O   HOH A 328       1.651  36.463  19.459  1.00 25.82           O  \nHETATM 1571  O   HOH A 329      14.435  44.966  11.913  1.00 32.52           O  \nHETATM 1572  O   HOH A 330      19.877  40.160  21.917  1.00 41.02           O  \nHETATM 1573  O   HOH A 331      17.126  45.934  10.801  1.00 41.93           O  \nHETATM 1574  O   HOH A 332       8.840  28.026   4.860  1.00 27.94           O  \nHETATM 1575  O   HOH A 335      10.341  18.480  14.477  1.00 51.87           O  \nHETATM 1576  O   HOH A 341      19.233  16.711   9.027  1.00 66.74           O  \nHETATM 1577  O   HOH A 342      23.799  21.928  12.391  1.00 65.58           O  \nHETATM 1578  O   HOH A 344       9.953  37.934   4.548  1.00 67.74           O  \nHETATM 1579  O   HOH A 345       8.478  35.995   5.789  1.00 43.98           O  \nHETATM 1580  O   HOH A 357       3.960  19.389  17.384  1.00 37.23           O  \nHETATM 1581  O   HOH A 373      27.561  43.155  19.015  1.00 69.15           O  \nHETATM 1582  O   HOH A 384       1.245  19.292  18.124  1.00 70.78           O  \nHETATM 1583  O   HOH A 386      31.402  27.051   3.335  1.00 21.93           O  \nHETATM 1584  O   HOH A 389      32.446  31.200   4.417  1.00 46.57           O  \nHETATM 1585  O   HOH A 391      25.480  38.468  17.938  1.00 63.81           O  \nHETATM 1586  O   HOH A 394      23.940  41.721   0.346  1.00 47.08           O  \nHETATM 1587  O   HOH A 401       5.912  15.727   3.369  1.00 63.52           O  \nHETATM 1588  O   HOH A 406       9.272  33.891  12.681  1.00 31.73           O  \nHETATM 1589  O   HOH A 408      21.185  25.233  16.048  1.00 49.24           O  \nHETATM 1590  O   HOH A 416      18.474  26.012  21.664  1.00 65.44           O  \nHETATM 1591  O   HOH A 420       9.469  16.910  17.371  1.00 75.86           O  \nHETATM 1592  O   HOH A 422      13.074  17.786  16.615  1.00 67.42           O  \nHETATM 1593  O   HOH A 439      28.821  29.338   7.342  1.00 57.13           O  \nHETATM 1594  O   HOH A 457      23.284  23.107  15.132  1.00 60.42           O  \nHETATM 1595  O   HOH A 468       3.114  26.260   6.773  1.00 75.52           O  \nHETATM 1596  O   HOH A 501       6.382  26.424   5.893  1.00 38.21           O  \nHETATM 1597  O   HOH A 503      35.293  43.006   5.212  1.00 50.02           O  \nHETATM 1598  O   HOH A 510      21.891  49.715   7.192  1.00 53.78           O  \nHETATM 1599  O   HOH A 524      34.085  32.735   2.849  1.00 61.00           O  \nHETATM 1600  O   HOH A 529      31.491  41.524   6.678  1.00 73.78           O  \nHETATM 1601  O   HOH A 553       5.943  34.223   6.748  1.00 61.39           O  \nHETATM 1602  O   HOH A 561       0.934  40.259  19.405  1.00 49.60           O  \nHETATM 1603  O   HOH A 567      29.539  25.486  13.281  1.00 71.88           O  \nHETATM 1604  O   HOH A 572      24.552  17.352  10.295  1.00 66.74           O  \nHETATM 1605  O   HOH A 575      23.112  15.510   8.776  1.00 70.97           O  \nHETATM 1606  O   HOH B 301      20.445   8.036 -12.631  1.00 63.94           O  \nHETATM 1607  O   HOH B 303      20.044  14.822   4.638  1.00 73.81           O  \nHETATM 1608  O   HOH B 304      21.538   6.875 -10.099  1.00 42.37           O  \nHETATM 1609  O   HOH B 306      22.449  23.958   5.252  1.00 51.24           O  \nHETATM 1610  O   HOH B 308      11.720  21.289   7.190  1.00 18.18           O  \nHETATM 1611  O   HOH B 312      14.097   5.111 -11.638  1.00 53.13           O  \nHETATM 1612  O   HOH B 313      20.998  21.834   6.561  1.00 47.68           O  \nHETATM 1613  O   HOH B 316      22.659  14.583  -2.196  1.00 65.44           O  \nHETATM 1614  O   HOH B 317      28.724  15.629 -11.660  1.00 38.53           O  \nHETATM 1615  O   HOH B 318      16.539  45.207   0.079  1.00 32.25           O  \nHETATM 1616  O   HOH B 319      23.678  14.931   2.680  1.00 61.86           O  \nHETATM 1617  O   HOH B 321      20.718  15.976  -3.657  1.00 22.69           O  \nHETATM 1618  O   HOH B 323      31.249  26.796  -9.595  1.00 59.93           O  \nHETATM 1619  O   HOH B 326      28.813  28.445  -2.106  1.00 33.99           O  \nHETATM 1620  O   HOH B 333      12.251  39.551  -2.672  1.00 79.22           O  \nHETATM 1621  O   HOH B 334      25.465  12.592  -8.670  1.00 31.58           O  \nHETATM 1622  O   HOH B 338      12.998  36.205  -3.972  1.00 47.41           O  \nHETATM 1623  O   HOH B 339      17.541  17.060 -17.194  1.00 46.59           O  \nHETATM 1624  O   HOH B 340       5.321  14.325  -4.866  1.00 48.25           O  \nHETATM 1625  O   HOH B 346       9.314  17.330  -9.801  1.00 48.73           O  \nHETATM 1626  O   HOH B 347       7.435  26.652 -14.854  1.00 54.68           O  \nHETATM 1627  O   HOH B 348       4.405  16.704  -3.635  1.00 37.86           O  \nHETATM 1628  O   HOH B 349      19.414   7.026   4.428  1.00 68.44           O  \nHETATM 1629  O   HOH B 350       6.718  34.538  -1.322  1.00 42.81           O  \nHETATM 1630  O   HOH B 354      15.041  31.743 -13.235  1.00 60.62           O  \nHETATM 1631  O   HOH B 355      27.404  32.078 -10.860  1.00 61.36           O  \nHETATM 1632  O   HOH B 356      27.673  18.789  -6.155  1.00 35.03           O  \nHETATM 1633  O   HOH B 358      21.289  -1.161  -5.102  1.00 62.75           O  \nHETATM 1634  O   HOH B 359       6.973  36.523   1.489  1.00 71.64           O  \nHETATM 1635  O   HOH B 360      27.602  21.234  -0.635  1.00 57.53           O  \nHETATM 1636  O   HOH B 362       3.902   9.376  -0.027  1.00 50.97           O  \nHETATM 1637  O   HOH B 364      28.498  36.632  -7.529  1.00 73.30           O  \nHETATM 1638  O   HOH B 366      18.572  40.567 -10.042  1.00 62.30           O  \nHETATM 1639  O   HOH B 367      25.658  18.970   0.428  1.00 65.69           O  \nHETATM 1640  O   HOH B 369      20.843   1.263  -7.014  1.00 61.76           O  \nHETATM 1641  O   HOH B 370      13.975  15.741  12.070  1.00 67.21           O  \nHETATM 1642  O   HOH B 374       7.661  23.876  -6.324  1.00 61.89           O  \nHETATM 1643  O   HOH B 375      10.125   5.706  -1.458  1.00 74.72           O  \nHETATM 1644  O   HOH B 376      18.450  20.497 -18.728  1.00 48.75           O  \nHETATM 1645  O   HOH B 377      29.267  20.487  -3.497  1.00 60.17           O  \nHETATM 1646  O   HOH B 379       6.685  26.541  -5.608  1.00 43.92           O  \nHETATM 1647  O   HOH B 381      25.810  26.789 -19.106  1.00 70.16           O  \nHETATM 1648  O   HOH B 383      21.144  -4.428 -11.331  1.00 22.10           O  \nHETATM 1649  O   HOH B 387      16.904  27.594 -15.938  1.00 27.84           O  \nHETATM 1650  O   HOH B 388      23.926  45.612  -4.998  1.00 65.78           O  \nHETATM 1651  O   HOH B 390      25.300  17.493   3.076  1.00 67.04           O  \nHETATM 1652  O   HOH B 392       6.618  28.079  -3.427  1.00 53.99           O  \nHETATM 1653  O   HOH B 393      19.795  13.651 -16.606  1.00 54.21           O  \nHETATM 1654  O   HOH B 395       7.202   9.982  -4.103  1.00 62.03           O  \nHETATM 1655  O   HOH B 400       8.474  34.203  -4.893  1.00 63.64           O  \nHETATM 1656  O   HOH B 405      16.659  15.866  11.446  1.00 42.47           O  \nHETATM 1657  O   HOH B 410      26.400  10.057  -3.287  1.00 65.50           O  \nHETATM 1658  O   HOH B 414       9.503   3.489  -4.419  1.00 65.50           O  \nHETATM 1659  O   HOH B 419      15.438  12.973 -18.484  1.00 73.55           O  \nHETATM 1660  O   HOH B 425      11.428  19.956 -24.551  1.00 63.48           O  \nHETATM 1661  O   HOH B 430      18.725  43.171  -5.575  1.00 52.97           O  \nHETATM 1662  O   HOH B 436      32.141  29.620  -8.580  1.00 72.75           O  \nHETATM 1663  O   HOH B 443       8.811  13.667 -20.256  1.00 75.75           O  \nHETATM 1664  O   HOH B 444       4.071  26.169  -0.230  1.00 38.25           O  \nHETATM 1665  O   HOH B 461      11.425  44.636  -3.033  1.00 68.43           O  \nHETATM 1666  O   HOH B 469       6.902  23.686 -10.066  1.00 54.20           O  \nHETATM 1667  O   HOH B 471       5.749  25.785 -19.792  1.00 63.96           O  \nHETATM 1668  O   HOH B 500      25.592  16.404  -5.805  1.00 23.98           O  \nHETATM 1669  O   HOH B 502       4.040  15.516  -7.200  1.00 52.93           O  \nHETATM 1670  O   HOH B 505      28.640  34.232  -5.637  1.00 58.06           O  \nHETATM 1671  O   HOH B 506       8.979  11.173  11.112  1.00 64.79           O  \nHETATM 1672  O   HOH B 509      19.882   3.986 -18.136  1.00 55.54           O  \nHETATM 1673  O   HOH B 514      27.409  15.355   2.200  1.00 61.69           O  \nHETATM 1674  O   HOH B 515      17.222  39.766 -23.774  1.00 69.12           O  \nHETATM 1675  O   HOH B 517      28.742  24.158 -16.641  1.00 78.93           O  \nHETATM 1676  O   HOH B 525      22.694  -2.192 -12.589  1.00 71.37           O  \nHETATM 1677  O   HOH B 526      17.901  43.157 -14.082  1.00 78.14           O  \nHETATM 1678  O   HOH B 531      18.192   8.914  11.344  1.00 54.05           O  \nHETATM 1679  O   HOH B 532      19.507  45.215   1.709  1.00 72.78           O  \nHETATM 1680  O   HOH B 548       1.442  14.700  -6.128  1.00 58.40           O  \nHETATM 1681  O   HOH B 549      19.908   8.718 -19.215  1.00 58.78           O  \nHETATM 1682  O   HOH B 556      21.499  44.884  -1.280  1.00 68.40           O  \nHETATM 1683  O   HOH B 564      10.031   8.593 -22.052  1.00 64.90           O  \nHETATM 1684  O   HOH B 568       2.817  28.133   2.191  1.00 67.95           O  \nHETATM 1685  O   HOH B 591      15.835  40.105  -5.971  1.00 53.68           O  \nHETATM 1686  O   HOH B 595       4.515  36.451  -4.499  1.00 49.41           O  \nHETATM 1687  O   HOH B 613      24.127 -10.994  -0.982  1.00 64.49           O  \nHETATM 1688  O   HOH B 617      30.112  17.912  -4.791  1.00 54.09           O  \nCONECT 1517 1518 1529 1555                                                      \nCONECT 1518 1517 1519                                                           \nCONECT 1519 1518 1520 1527                                                      \nCONECT 1520 1519 1521 1522                                                      \nCONECT 1521 1520                                                                \nCONECT 1522 1520 1523                                                           \nCONECT 1523 1522 1524 1525 1526                                                 \nCONECT 1524 1523                                                                \nCONECT 1525 1523                                                                \nCONECT 1526 1523                                                                \nCONECT 1527 1519 1528 1530                                                      \nCONECT 1528 1527 1529                                                           \nCONECT 1529 1517 1528                                                           \nCONECT 1530 1527 1531                                                           \nCONECT 1531 1530 1532 1533                                                      \nCONECT 1532 1531                                                                \nCONECT 1533 1531 1534                                                           \nCONECT 1534 1533 1535 1542                                                      \nCONECT 1535 1534 1536                                                           \nCONECT 1536 1535 1537 1541                                                      \nCONECT 1537 1536 1538                                                           \nCONECT 1538 1537 1539                                                           \nCONECT 1539 1538 1540                                                           \nCONECT 1540 1539 1541                                                           \nCONECT 1541 1536 1540                                                           \nCONECT 1542 1534 1543 1544                                                      \nCONECT 1543 1542                                                                \nCONECT 1544 1542 1545                                                           \nCONECT 1545 1544 1546 1554                                                      \nCONECT 1546 1545 1547 1548                                                      \nCONECT 1547 1546                                                                \nCONECT 1548 1546 1549                                                           \nCONECT 1549 1548 1550 1554                                                      \nCONECT 1550 1549 1551                                                           \nCONECT 1551 1550 1552                                                           \nCONECT 1552 1551 1553                                                           \nCONECT 1553 1552 1554                                                           \nCONECT 1554 1545 1549 1553                                                      \nCONECT 1555 1517 1556                                                           \nCONECT 1556 1555 1557 1561                                                      \nCONECT 1557 1556 1558                                                           \nCONECT 1558 1557 1559                                                           \nCONECT 1559 1558 1560                                                           \nCONECT 1560 1559 1561                                                           \nCONECT 1561 1556 1560                                                           \nMASTER      252    0    1    2   17    0    5    6 1686    2   45   16          \nEND                                                                             \n"
          },
          "file_paths": {
            "pdb": "cache\\rcsb_pdb\\1HSG.pdb"
          },
          "quality_metrics": {
            "experimental_method": "X-RAY DIFFRACTION",
            "deposit_date": "1995-03-31T00:00:00+0000",
            "release_date": "1996-04-03T00:00:00+0000",
            "title": "CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES"
          },
          "ligands": [],
          "binding_sites": [
            {
              "id": "AC1",
              "residues": [
                "ARG",
                "ASP",
                "GLY",
                "GLY",
                "GLY",
                "VAL",
                "ARG",
                "ASP",
                "GLY",
                "ALA",
                "ASP",
                "ASP",
                "VAL",
                "GLY",
                "GLY",
                "ILE",
                "PRO",
                "HOH",
                "HOH",
                "HOH"
              ]
            }
          ],
          "experimental_method": "unknown",
          "resolution": null,
          "organism": "unknown",
          "reference": "RCSB Protein Data Bank"
        },
        "error": null
      },
      "metadata": {
        "name": "rcsb_pdb",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "RCSB Protein Data Bank experimental structures adapter",
        "capabilities": {
          "structure_retrieval": true,
          "search": true,
          "ligand_info": true,
          "binding_sites": true,
          "quality_metrics": true,
          "multiple_formats": [
            "pdb",
            "cif",
            "pdbml"
          ]
        },
        "database": {
          "name": "RCSB PDB",
          "url": "https://www.rcsb.org/",
          "structures": "200,000+",
          "experimental_methods": [
            "X-ray",
            "NMR",
            "Cryo-EM",
            "Electron diffraction"
          ]
        },
        "quality_thresholds": {
          "resolution_high": "< 2.0 \u00c5 (high quality)",
          "resolution_medium": "2.0-3.0 \u00c5 (medium quality)",
          "resolution_low": "> 3.0 \u00c5 (low quality)",
          "r_value_good": "< 0.25",
          "r_free_good": "< 0.28"
        },
        "config": {
          "cache_dir": "cache\\rcsb_pdb",
          "download_pdb": true,
          "download_cif": false,
          "include_ligands": true,
          "include_binding_sites": true
        },
        "reference": {
          "website": "https://www.rcsb.org/",
          "data_api": "https://data.rcsb.org/",
          "search_api": "https://search.rcsb.org/"
        }
      }
    },
    {
      "adapter": "pdbe",
      "status": "success",
      "error": null,
      "execution_time": 2.582213,
      "data": {
        "success": true,
        "data": {
          "pdb_id": "1HSG",
          "summary": {
            "title": "CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES",
            "processing_site": "BNL",
            "deposition_site": null,
            "deposition_date": "19950331",
            "release_date": "19960403",
            "revision_date": "20240207",
            "experimental_method_class": [
              "x-ray"
            ],
            "experimental_method": [
              "X-ray diffraction"
            ],
            "split_entry": [],
            "related_structures": [],
            "entry_authors": [
              "Chen, Z."
            ],
            "number_of_entities": {
              "water": 1,
              "polypeptide": 1,
              "dna": 0,
              "rna": 0,
              "sugar": 0,
              "ligand": 1,
              "dna/rna": 0,
              "other": 0,
              "carbohydrate_polymer": 0
            },
            "assemblies": [
              {
                "assembly_id": "1",
                "name": "dimer",
                "form": "homo",
                "preferred": true
              }
            ]
          },
          "structure_files": {
            "pdb": "HEADER    HYDROLASE (ACID PROTEINASE)             31-MAR-95   1HSG              \nTITLE     CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN                \nTITLE    2 IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN\nTITLE    3 ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES                   \nCOMPND    MOL_ID: 1;                                                            \nCOMPND   2 MOLECULE: HIV-1 PROTEASE;                                            \nCOMPND   3 CHAIN: A, B;                                                         \nCOMPND   4 EC: 3.4.23.-;                                                        \nCOMPND   5 ENGINEERED: YES;                                                     \nCOMPND   6 OTHER_DETAILS: NY5 ISOLATE                                           \nSOURCE    MOL_ID: 1;                                                            \nSOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 \nSOURCE   3 ORGANISM_TAXID: 11676;                                               \nSOURCE   4 GENE: HIV-1 PROTEASE FROM THE NY5 ISOLATE;                           \nSOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 \nSOURCE   6 EXPRESSION_SYSTEM_TAXID: 562                                         \nKEYWDS    HYDROLASE (ACID PROTEINASE)                                           \nEXPDTA    X-RAY DIFFRACTION                                                     \nAUTHOR    Z.CHEN                                                                \nREVDAT   4   07-FEB-24 1HSG    1       REMARK                                   \nREVDAT   3   24-FEB-09 1HSG    1       VERSN                                    \nREVDAT   2   01-APR-03 1HSG    1       JRNL                                     \nREVDAT   1   03-APR-96 1HSG    0                                                \nJRNL        AUTH   Z.CHEN,Y.LI,E.CHEN,D.L.HALL,P.L.DARKE,C.CULBERSON,           \nJRNL        AUTH 2 J.A.SHAFER,L.C.KUO                                           \nJRNL        TITL   CRYSTAL STRUCTURE AT 1.9-A RESOLUTION OF HUMAN               \nJRNL        TITL 2 IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH      \nJRNL        TITL 3 L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV       \nJRNL        TITL 4 PROTEASES.                                                   \nJRNL        REF    J.BIOL.CHEM.                  V. 269 26344 1994              \nJRNL        REFN                   ISSN 0021-9258                               \nJRNL        PMID   7929352                                                      \nREMARK   2                                                                      \nREMARK   2 RESOLUTION.    2.00 ANGSTROMS.                                       \nREMARK   3                                                                      \nREMARK   3 REFINEMENT.                                                          \nREMARK   3   PROGRAM     : X-PLOR                                               \nREMARK   3   AUTHORS     : BRUNGER                                              \nREMARK   3                                                                      \nREMARK   3  DATA USED IN REFINEMENT.                                            \nREMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00                           \nREMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : NULL                           \nREMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           \nREMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           \nREMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           \nREMARK   3   COMPLETENESS (WORKING+TEST)   (%) : NULL                           \nREMARK   3   NUMBER OF REFLECTIONS             : NULL                           \nREMARK   3                                                                      \nREMARK   3  FIT TO DATA USED IN REFINEMENT.                                     \nREMARK   3   CROSS-VALIDATION METHOD          : NULL                            \nREMARK   3   FREE R VALUE TEST SET SELECTION  : NULL                            \nREMARK   3   R VALUE            (WORKING SET) : 0.166                           \nREMARK   3   FREE R VALUE                     : NULL                            \nREMARK   3   FREE R VALUE TEST SET SIZE   (%) : NULL                            \nREMARK   3   FREE R VALUE TEST SET COUNT      : NULL                            \nREMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            \nREMARK   3                                                                      \nREMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  \nREMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         \nREMARK   3   BIN RESOLUTION RANGE HIGH       (A) : NULL                         \nREMARK   3   BIN RESOLUTION RANGE LOW        (A) : NULL                         \nREMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         \nREMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         \nREMARK   3   BIN R VALUE           (WORKING SET) : NULL                         \nREMARK   3   BIN FREE R VALUE                    : NULL                         \nREMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         \nREMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         \nREMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         \nREMARK   3                                                                      \nREMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    \nREMARK   3   PROTEIN ATOMS            : 1514                                    \nREMARK   3   NUCLEIC ACID ATOMS       : 0                                       \nREMARK   3   HETEROGEN ATOMS          : 45                                      \nREMARK   3   SOLVENT ATOMS            : 127                                     \nREMARK   3                                                                      \nREMARK   3  B VALUES.                                                           \nREMARK   3   FROM WILSON PLOT           (A**2) : NULL                           \nREMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           \nREMARK   3   OVERALL ANISOTROPIC B VALUE.                                       \nREMARK   3    B11 (A**2) : NULL                                                 \nREMARK   3    B22 (A**2) : NULL                                                 \nREMARK   3    B33 (A**2) : NULL                                                 \nREMARK   3    B12 (A**2) : NULL                                                 \nREMARK   3    B13 (A**2) : NULL                                                 \nREMARK   3    B23 (A**2) : NULL                                                 \nREMARK   3                                                                      \nREMARK   3  ESTIMATED COORDINATE ERROR.                                         \nREMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            \nREMARK   3   ESD FROM SIGMAA              (A) : NULL                            \nREMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            \nREMARK   3                                                                      \nREMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         \nREMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            \nREMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            \nREMARK   3                                                                      \nREMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   \nREMARK   3   BOND LENGTHS                 (A) : 0.017                           \nREMARK   3   BOND ANGLES            (DEGREES) : 1.900                           \nREMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            \nREMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            \nREMARK   3                                                                      \nREMARK   3  ISOTROPIC THERMAL MODEL : NULL                                      \nREMARK   3                                                                      \nREMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                \nREMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 \nREMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 \nREMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 \nREMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 \nREMARK   3                                                                      \nREMARK   3  NCS MODEL : NULL                                                    \nREMARK   3                                                                      \nREMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          \nREMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 \nREMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 \nREMARK   3                                                                      \nREMARK   3  PARAMETER FILE  1  : NULL                                           \nREMARK   3  TOPOLOGY FILE  1   : NULL                                           \nREMARK   3                                                                      \nREMARK   3  OTHER REFINEMENT REMARKS: NULL                                      \nREMARK   4                                                                      \nREMARK   4 1HSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         \nREMARK 100                                                                      \nREMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                \nREMARK 100 THE DEPOSITION ID IS D_1000173994.                                   \nREMARK 200                                                                      \nREMARK 200 EXPERIMENTAL DETAILS                                                 \nREMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  \nREMARK 200  DATE OF DATA COLLECTION        : NULL                               \nREMARK 200  TEMPERATURE           (KELVIN) : NULL                               \nREMARK 200  PH                             : NULL                               \nREMARK 200  NUMBER OF CRYSTALS USED        : NULL                               \nREMARK 200                                                                      \nREMARK 200  SYNCHROTRON              (Y/N) : NULL                               \nREMARK 200  RADIATION SOURCE               : NULL                               \nREMARK 200  BEAMLINE                       : NULL                               \nREMARK 200  X-RAY GENERATOR MODEL          : NULL                               \nREMARK 200  MONOCHROMATIC OR LAUE    (M/L) : NULL                               \nREMARK 200  WAVELENGTH OR RANGE        (A) : NULL                               \nREMARK 200  MONOCHROMATOR                  : NULL                               \nREMARK 200  OPTICS                         : NULL                               \nREMARK 200                                                                      \nREMARK 200  DETECTOR TYPE                  : NULL                               \nREMARK 200  DETECTOR MANUFACTURER          : NULL                               \nREMARK 200  INTENSITY-INTEGRATION SOFTWARE : NULL                               \nREMARK 200  DATA SCALING SOFTWARE          : NULL                               \nREMARK 200                                                                      \nREMARK 200  NUMBER OF UNIQUE REFLECTIONS   : NULL                               \nREMARK 200  RESOLUTION RANGE HIGH      (A) : NULL                               \nREMARK 200  RESOLUTION RANGE LOW       (A) : NULL                               \nREMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               \nREMARK 200                                                                      \nREMARK 200 OVERALL.                                                             \nREMARK 200  COMPLETENESS FOR RANGE     (%) : NULL                               \nREMARK 200  DATA REDUNDANCY                : NULL                               \nREMARK 200  R MERGE                    (I) : NULL                               \nREMARK 200  R SYM                      (I) : NULL                               \nREMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               \nREMARK 200                                                                      \nREMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     \nREMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL                     \nREMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     \nREMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               \nREMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               \nREMARK 200  R MERGE FOR SHELL          (I) : NULL                               \nREMARK 200  R SYM FOR SHELL            (I) : NULL                               \nREMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               \nREMARK 200                                                                      \nREMARK 200 DIFFRACTION PROTOCOL: NULL                                           \nREMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL                         \nREMARK 200 SOFTWARE USED: X-PLOR                                                \nREMARK 200 STARTING MODEL: NULL                                                 \nREMARK 200                                                                      \nREMARK 200 REMARK: NULL                                                         \nREMARK 280                                                                      \nREMARK 280 CRYSTAL                                                              \nREMARK 280 SOLVENT CONTENT, VS   (%): 56.10                                     \nREMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80                     \nREMARK 280                                                                      \nREMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     \nREMARK 290                                                                      \nREMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            \nREMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2                        \nREMARK 290                                                                      \nREMARK 290      SYMOP   SYMMETRY                                                \nREMARK 290     NNNMMM   OPERATOR                                                \nREMARK 290       1555   X,Y,Z                                                   \nREMARK 290       2555   -X,-Y,Z                                                 \nREMARK 290       3555   -X+1/2,Y+1/2,-Z                                         \nREMARK 290       4555   X+1/2,-Y+1/2,-Z                                         \nREMARK 290                                                                      \nREMARK 290     WHERE NNN -> OPERATOR NUMBER                                     \nREMARK 290           MMM -> TRANSLATION VECTOR                                  \nREMARK 290                                                                      \nREMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            \nREMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             \nREMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                \nREMARK 290 RELATED MOLECULES.                                                   \nREMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            \nREMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            \nREMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            \nREMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            \nREMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            \nREMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            \nREMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000       29.78500            \nREMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       43.53500            \nREMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            \nREMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       29.78500            \nREMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       43.53500            \nREMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            \nREMARK 290                                                                      \nREMARK 290 REMARK: NULL                                                         \nREMARK 300                                                                      \nREMARK 300 BIOMOLECULE: 1                                                       \nREMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                \nREMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  \nREMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               \nREMARK 300 BURIED SURFACE AREA.                                                 \nREMARK 350                                                                      \nREMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           \nREMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                \nREMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          \nREMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          \nREMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               \nREMARK 350                                                                      \nREMARK 350 BIOMOLECULE: 1                                                       \nREMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           \nREMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    \nREMARK 350 SOFTWARE USED: PISA                                                  \nREMARK 350 TOTAL BURIED SURFACE AREA: 3560 ANGSTROM**2                          \nREMARK 350 SURFACE AREA OF THE COMPLEX: 10770 ANGSTROM**2                       \nREMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL                        \nREMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  \nREMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            \nREMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            \nREMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            \nREMARK 500                                                                      \nREMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         \nREMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       \nREMARK 500                                                                      \nREMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              \nREMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               \nREMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               \nREMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 \nREMARK 500                                                                      \nREMARK 500 STANDARD TABLE:                                                      \nREMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              \nREMARK 500                                                                      \nREMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        \nREMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     \nREMARK 500                                                                      \nREMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     \nREMARK 500    PRO A   1   CA  -  N   -  CD  ANGL. DEV. =  -8.4 DEGREES          \nREMARK 500    PRO A   1   N   -  CD  -  CG  ANGL. DEV. =   7.8 DEGREES          \nREMARK 500                                                                      \nREMARK 500 REMARK: NULL                                                         \nREMARK 500                                                                      \nREMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         \nREMARK 500 SUBTOPIC: TORSION ANGLES                                             \nREMARK 500                                                                      \nREMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            \nREMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               \nREMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             \nREMARK 500                                                                      \nREMARK 500 STANDARD TABLE:                                                      \nREMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    \nREMARK 500                                                                      \nREMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           \nREMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            \nREMARK 500                                                                      \nREMARK 500  M RES CSSEQI        PSI       PHI                                   \nREMARK 500    GLU A  35      110.40    -28.04                                   \nREMARK 500                                                                      \nREMARK 500 REMARK: NULL                                                         \nREMARK 600                                                                      \nREMARK 600 HETEROGEN                                                            \nREMARK 600                                                                      \nREMARK 600 L-735,524 IS N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-                 \nREMARK 600 TERTIARY- BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]          \nREMARK 600 -4(S)-HYDROXY-2(R)-PHENYLMETHLPENTANAMIDE MONOHYDRATE.               \nREMARK 800                                                                      \nREMARK 800 SITE                                                                 \nREMARK 800 SITE_IDENTIFIER: AC1                                                 \nREMARK 800 EVIDENCE_CODE: SOFTWARE                                              \nREMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MK1 B 902                 \nDBREF  1HSG A    1    99  UNP    P03367   POL_HV1BR       69    167             \nDBREF  1HSG B    1    99  UNP    P03367   POL_HV1BR       69    167             \nSEQRES   1 A   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          \nSEQRES   2 A   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          \nSEQRES   3 A   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          \nSEQRES   4 A   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          \nSEQRES   5 A   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          \nSEQRES   6 A   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          \nSEQRES   7 A   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          \nSEQRES   8 A   99  GLN ILE GLY CYS THR LEU ASN PHE                              \nSEQRES   1 B   99  PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE          \nSEQRES   2 B   99  LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          \nSEQRES   3 B   99  GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO          \nSEQRES   4 B   99  GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY          \nSEQRES   5 B   99  PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU          \nSEQRES   6 B   99  ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY          \nSEQRES   7 B   99  PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR          \nSEQRES   8 B   99  GLN ILE GLY CYS THR LEU ASN PHE                              \nHET    MK1  B 902      45                                                       \nHETNAM     MK1 N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY                  \nHETNAM   2 MK1  BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-              \nHETNAM   3 MK1  4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE                       \nHETSYN     MK1 INDINAVIR                                                        \nFORMUL   3  MK1    C36 H47 N5 O4                                                \nFORMUL   4  HOH   *127(H2 O)                                                    \nHELIX    1   1 ARG A   87  LEU A   90  1                                   4    \nHELIX    2   2 ARG B   87  LEU B   90  1                                   4    \nSHEET    1   A 2 LEU A  10  ILE A  15  0                                        \nSHEET    2   A 2 GLN A  18  LEU A  23 -1  N  ALA A  22   O  VAL A  11           \nSHEET    1   B 4 VAL A  32  GLU A  34  0                                        \nSHEET    2   B 4 VAL A  75  GLY A  78  1  N  LEU A  76   O  LEU A  33           \nSHEET    3   B 4 GLY A  52  TYR A  59 -1  N  TYR A  59   O  VAL A  75           \nSHEET    4   B 4 LYS A  43  GLY A  49 -1  N  GLY A  49   O  GLY A  52           \nSHEET    1   C 2 ILE A  62  ILE A  66  0                                        \nSHEET    2   C 2 HIS A  69  GLY A  73 -1  N  GLY A  73   O  ILE A  62           \nSHEET    1   D 2 THR A  96  ASN A  98  0                                        \nSHEET    2   D 2 THR B  96  ASN B  98 -1  N  ASN B  98   O  THR A  96           \nSHEET    1   E 2 LEU B  10  ILE B  15  0                                        \nSHEET    2   E 2 GLN B  18  LEU B  23 -1  N  ALA B  22   O  VAL B  11           \nSHEET    1   F 3 LYS B  43  GLY B  48  0                                        \nSHEET    2   F 3 PHE B  53  TYR B  59 -1  N  GLN B  58   O  LYS B  43           \nSHEET    3   F 3 VAL B  75  VAL B  77 -1  N  VAL B  77   O  ARG B  57           \nSHEET    1   G 2 ILE B  62  ILE B  66  0                                        \nSHEET    2   G 2 HIS B  69  GLY B  73 -1  N  GLY B  73   O  ILE B  62           \nSITE     1 AC1 20 ARG A   8  ASP A  25  GLY A  27  GLY A  48                    \nSITE     2 AC1 20 GLY A  49  VAL A  82  ARG B   8  ASP B  25                    \nSITE     3 AC1 20 GLY B  27  ALA B  28  ASP B  29  ASP B  30                    \nSITE     4 AC1 20 VAL B  32  GLY B  48  GLY B  49  ILE B  50                    \nSITE     5 AC1 20 PRO B  81  HOH B 308  HOH B 313  HOH B 444                    \nCRYST1   59.570   87.070   46.710  90.00  90.00  90.00 P 21 21 2     8          \nORIGX1      1.000000  0.000000  0.000000        0.00000                         \nORIGX2      0.000000  1.000000  0.000000        0.00000                         \nORIGX3      0.000000  0.000000  1.000000        0.00000                         \nSCALE1      0.016787  0.000000  0.000000        0.00000                         \nSCALE2      0.000000  0.011485  0.000000        0.00000                         \nSCALE3      0.000000  0.000000  0.021409        0.00000                         \nATOM      1  N   PRO A   1      29.361  39.686   5.862  1.00 38.10           N  \nATOM      2  CA  PRO A   1      30.307  38.663   5.319  1.00 40.62           C  \nATOM      3  C   PRO A   1      29.760  38.071   4.022  1.00 42.64           C  \nATOM      4  O   PRO A   1      28.600  38.302   3.676  1.00 43.40           O  \nATOM      5  CB  PRO A   1      30.508  37.541   6.342  1.00 37.87           C  \nATOM      6  CG  PRO A   1      29.296  37.591   7.162  1.00 38.40           C  \nATOM      7  CD  PRO A   1      28.778  39.015   7.019  1.00 38.74           C  \nATOM      8  N   GLN A   2      30.607  37.334   3.305  1.00 41.76           N  \nATOM      9  CA  GLN A   2      30.158  36.492   2.199  1.00 41.30           C  \nATOM     10  C   GLN A   2      30.298  35.041   2.643  1.00 41.38           C  \nATOM     11  O   GLN A   2      31.401  34.494   2.763  1.00 43.09           O  \nATOM     12  CB  GLN A   2      30.970  36.738   0.926  1.00 40.81           C  \nATOM     13  CG  GLN A   2      30.625  35.783  -0.201  1.00 46.61           C  \nATOM     14  CD  GLN A   2      31.184  36.217  -1.549  1.00 50.36           C  \nATOM     15  OE1 GLN A   2      32.006  35.518  -2.156  1.00 53.89           O  \nATOM     16  NE2 GLN A   2      30.684  37.339  -2.061  1.00 51.46           N  \nATOM     17  N   ILE A   3      29.160  34.436   2.919  1.00 37.80           N  \nATOM     18  CA  ILE A   3      29.123  33.098   3.397  1.00 34.13           C  \nATOM     19  C   ILE A   3      28.968  32.155   2.198  1.00 33.19           C  \nATOM     20  O   ILE A   3      28.088  32.330   1.368  1.00 32.74           O  \nATOM     21  CB  ILE A   3      27.977  32.995   4.409  1.00 34.34           C  \nATOM     22  CG1 ILE A   3      28.341  33.820   5.652  1.00 33.95           C  \nATOM     23  CG2 ILE A   3      27.692  31.548   4.745  1.00 33.06           C  \nATOM     24  CD1 ILE A   3      27.264  33.884   6.696  1.00 32.50           C  \nATOM     25  N   THR A   4      29.891  31.210   2.066  1.00 31.65           N  \nATOM     26  CA  THR A   4      29.774  30.143   1.062  1.00 30.14           C  \nATOM     27  C   THR A   4      28.986  28.975   1.658  1.00 29.74           C  \nATOM     28  O   THR A   4      28.690  28.948   2.875  1.00 27.88           O  \nATOM     29  CB  THR A   4      31.165  29.618   0.634  1.00 29.24           C  \nATOM     30  OG1 THR A   4      31.866  29.209   1.815  1.00 27.60           O  \nATOM     31  CG2 THR A   4      31.980  30.688  -0.085  1.00 26.26           C  \nATOM     32  N   LEU A   5      28.641  28.019   0.803  1.00 29.27           N  \nATOM     33  CA  LEU A   5      27.644  27.003   1.144  1.00 30.12           C  \nATOM     34  C   LEU A   5      28.204  25.559   1.071  1.00 32.98           C  \nATOM     35  O   LEU A   5      27.446  24.583   0.969  1.00 32.32           O  \nATOM     36  CB  LEU A   5      26.411  27.139   0.226  1.00 26.21           C  \nATOM     37  CG  LEU A   5      25.676  28.479   0.352  1.00 24.56           C  \nATOM     38  CD1 LEU A   5      24.624  28.624  -0.753  1.00 20.74           C  \nATOM     39  CD2 LEU A   5      25.088  28.590   1.745  1.00 21.87           C  \nATOM     40  N   TRP A   6      29.528  25.436   1.146  1.00 31.52           N  \nATOM     41  CA  TRP A   6      30.177  24.150   1.279  1.00 30.82           C  \nATOM     42  C   TRP A   6      29.837  23.488   2.611  1.00 31.90           C  \nATOM     43  O   TRP A   6      29.706  22.271   2.673  1.00 33.26           O  \nATOM     44  CB  TRP A   6      31.685  24.301   1.109  1.00 28.66           C  \nATOM     45  CG  TRP A   6      32.152  24.955  -0.189  1.00 26.42           C  \nATOM     46  CD1 TRP A   6      32.681  26.216  -0.345  1.00 28.49           C  \nATOM     47  CD2 TRP A   6      32.274  24.314  -1.478  1.00 28.47           C  \nATOM     48  NE1 TRP A   6      33.102  26.385  -1.655  1.00 29.88           N  \nATOM     49  CE2 TRP A   6      32.864  25.258  -2.369  1.00 28.86           C  \nATOM     50  CE3 TRP A   6      31.949  23.035  -1.986  1.00 25.06           C  \nATOM     51  CZ2 TRP A   6      33.093  24.968  -3.717  1.00 32.14           C  \nATOM     52  CZ3 TRP A   6      32.195  22.755  -3.294  1.00 27.41           C  \nATOM     53  CH2 TRP A   6      32.754  23.722  -4.169  1.00 30.03           C  \nATOM     54  N   GLN A   7      29.667  24.280   3.667  1.00 33.01           N  \nATOM     55  CA  GLN A   7      29.141  23.799   4.960  1.00 32.37           C  \nATOM     56  C   GLN A   7      27.747  24.395   5.208  1.00 29.95           C  \nATOM     57  O   GLN A   7      27.349  25.330   4.547  1.00 26.55           O  \nATOM     58  CB  GLN A   7      30.072  24.227   6.100  1.00 38.12           C  \nATOM     59  CG  GLN A   7      31.512  23.694   5.995  1.00 48.91           C  \nATOM     60  CD  GLN A   7      32.521  24.750   5.469  1.00 59.75           C  \nATOM     61  OE1 GLN A   7      32.666  25.860   6.038  1.00 61.83           O  \nATOM     62  NE2 GLN A   7      33.268  24.374   4.419  1.00 59.99           N  \nATOM     63  N   ARG A   8      26.992  23.877   6.169  1.00 27.34           N  \nATOM     64  CA  ARG A   8      25.757  24.566   6.593  1.00 29.87           C  \nATOM     65  C   ARG A   8      26.029  26.025   6.996  1.00 31.94           C  \nATOM     66  O   ARG A   8      26.947  26.291   7.775  1.00 33.83           O  \nATOM     67  CB  ARG A   8      25.087  23.849   7.776  1.00 28.16           C  \nATOM     68  CG  ARG A   8      24.646  22.409   7.505  1.00 27.47           C  \nATOM     69  CD  ARG A   8      23.728  21.896   8.637  1.00 25.45           C  \nATOM     70  NE  ARG A   8      22.952  20.730   8.230  1.00 23.06           N  \nATOM     71  CZ  ARG A   8      22.367  19.871   9.064  1.00 28.80           C  \nATOM     72  NH1 ARG A   8      22.376  20.074  10.370  1.00 30.95           N  \nATOM     73  NH2 ARG A   8      21.776  18.789   8.589  1.00 26.02           N  \nATOM     74  N   PRO A   9      25.123  26.955   6.645  1.00 30.21           N  \nATOM     75  CA  PRO A   9      25.491  28.352   6.938  1.00 29.48           C  \nATOM     76  C   PRO A   9      25.127  28.763   8.364  1.00 29.45           C  \nATOM     77  O   PRO A   9      24.136  29.472   8.578  1.00 28.45           O  \nATOM     78  CB  PRO A   9      24.719  29.176   5.916  1.00 27.88           C  \nATOM     79  CG  PRO A   9      23.625  28.254   5.407  1.00 28.12           C  \nATOM     80  CD  PRO A   9      24.096  26.855   5.591  1.00 31.64           C  \nATOM     81  N   LEU A  10      25.905  28.285   9.330  1.00 28.83           N  \nATOM     82  CA  LEU A  10      25.653  28.510  10.750  1.00 31.57           C  \nATOM     83  C   LEU A  10      26.383  29.770  11.208  1.00 30.48           C  \nATOM     84  O   LEU A  10      27.567  29.927  10.938  1.00 31.00           O  \nATOM     85  CB  LEU A  10      26.120  27.284  11.573  1.00 31.09           C  \nATOM     86  CG  LEU A  10      25.161  26.082  11.544  1.00 35.91           C  \nATOM     87  CD1 LEU A  10      25.895  24.743  11.662  1.00 40.15           C  \nATOM     88  CD2 LEU A  10      24.206  26.196  12.696  1.00 40.51           C  \nATOM     89  N   VAL A  11      25.667  30.672  11.872  1.00 30.80           N  \nATOM     90  CA  VAL A  11      26.267  31.854  12.497  1.00 30.14           C  \nATOM     91  C   VAL A  11      25.818  31.957  13.955  1.00 33.13           C  \nATOM     92  O   VAL A  11      24.929  31.184  14.402  1.00 34.48           O  \nATOM     93  CB  VAL A  11      25.824  33.131  11.791  1.00 27.12           C  \nATOM     94  CG1 VAL A  11      26.270  33.089  10.323  1.00 28.48           C  \nATOM     95  CG2 VAL A  11      24.333  33.275  11.879  1.00 26.29           C  \nATOM     96  N   THR A  12      26.397  32.913  14.700  1.00 32.34           N  \nATOM     97  CA  THR A  12      26.001  33.143  16.102  1.00 32.56           C  \nATOM     98  C   THR A  12      24.915  34.200  16.204  1.00 33.07           C  \nATOM     99  O   THR A  12      25.010  35.279  15.610  1.00 33.62           O  \nATOM    100  CB  THR A  12      27.201  33.565  16.998  1.00 33.81           C  \nATOM    101  OG1 THR A  12      28.330  32.709  16.751  1.00 40.47           O  \nATOM    102  CG2 THR A  12      26.827  33.430  18.450  1.00 34.22           C  \nATOM    103  N   ILE A  13      23.848  33.868  16.909  1.00 31.84           N  \nATOM    104  CA  ILE A  13      22.842  34.875  17.206  1.00 32.26           C  \nATOM    105  C   ILE A  13      22.770  35.114  18.707  1.00 33.69           C  \nATOM    106  O   ILE A  13      23.328  34.363  19.500  1.00 30.43           O  \nATOM    107  CB  ILE A  13      21.413  34.460  16.661  1.00 32.80           C  \nATOM    108  CG1 ILE A  13      20.878  33.229  17.431  1.00 31.81           C  \nATOM    109  CG2 ILE A  13      21.510  34.194  15.162  1.00 27.69           C  \nATOM    110  CD1 ILE A  13      19.353  33.201  17.603  1.00 32.46           C  \nATOM    111  N   LYS A  14      22.106  36.199  19.087  1.00 36.78           N  \nATOM    112  CA  LYS A  14      21.894  36.545  20.492  1.00 38.20           C  \nATOM    113  C   LYS A  14      20.442  36.943  20.615  1.00 37.51           C  \nATOM    114  O   LYS A  14      19.960  37.808  19.873  1.00 33.78           O  \nATOM    115  CB  LYS A  14      22.777  37.724  20.896  1.00 43.07           C  \nATOM    116  CG  LYS A  14      22.727  38.056  22.383  1.00 50.67           C  \nATOM    117  CD  LYS A  14      23.270  39.450  22.678  1.00 56.97           C  \nATOM    118  CE  LYS A  14      24.814  39.490  22.755  1.00 62.89           C  \nATOM    119  NZ  LYS A  14      25.394  40.891  22.572  1.00 69.50           N  \nATOM    120  N   ILE A  15      19.739  36.267  21.512  1.00 40.26           N  \nATOM    121  CA  ILE A  15      18.345  36.563  21.813  1.00 46.34           C  \nATOM    122  C   ILE A  15      18.224  36.327  23.316  1.00 49.77           C  \nATOM    123  O   ILE A  15      18.886  35.449  23.864  1.00 52.38           O  \nATOM    124  CB  ILE A  15      17.380  35.592  21.022  1.00 45.04           C  \nATOM    125  CG1 ILE A  15      15.935  35.812  21.435  1.00 46.91           C  \nATOM    126  CG2 ILE A  15      17.745  34.137  21.266  1.00 47.78           C  \nATOM    127  CD1 ILE A  15      14.929  35.116  20.526  1.00 50.24           C  \nATOM    128  N   GLY A  16      17.446  37.139  24.012  1.00 53.37           N  \nATOM    129  CA  GLY A  16      17.356  36.968  25.459  1.00 56.32           C  \nATOM    130  C   GLY A  16      18.711  36.871  26.160  1.00 56.91           C  \nATOM    131  O   GLY A  16      18.866  36.162  27.153  1.00 55.53           O  \nATOM    132  N   GLY A  17      19.671  37.659  25.697  1.00 57.90           N  \nATOM    133  CA  GLY A  17      20.970  37.660  26.340  1.00 59.71           C  \nATOM    134  C   GLY A  17      21.680  36.316  26.278  1.00 60.57           C  \nATOM    135  O   GLY A  17      22.785  36.163  26.794  1.00 63.20           O  \nATOM    136  N   GLN A  18      21.093  35.361  25.572  1.00 59.37           N  \nATOM    137  CA  GLN A  18      21.780  34.106  25.263  1.00 58.98           C  \nATOM    138  C   GLN A  18      22.500  34.159  23.907  1.00 56.87           C  \nATOM    139  O   GLN A  18      21.937  34.624  22.915  1.00 56.84           O  \nATOM    140  CB  GLN A  18      20.776  32.957  25.228  1.00 63.37           C  \nATOM    141  CG  GLN A  18      19.599  33.116  26.176  1.00 67.60           C  \nATOM    142  CD  GLN A  18      19.556  31.997  27.179  1.00 72.39           C  \nATOM    143  OE1 GLN A  18      20.393  31.944  28.082  1.00 76.16           O  \nATOM    144  NE2 GLN A  18      18.647  31.035  26.975  1.00 74.55           N  \nATOM    145  N   LEU A  19      23.733  33.672  23.848  1.00 53.88           N  \nATOM    146  CA  LEU A  19      24.334  33.365  22.552  1.00 49.32           C  \nATOM    147  C   LEU A  19      23.896  31.963  22.106  1.00 46.38           C  \nATOM    148  O   LEU A  19      23.975  31.020  22.863  1.00 43.18           O  \nATOM    149  CB  LEU A  19      25.869  33.432  22.625  1.00 47.14           C  \nATOM    150  CG  LEU A  19      26.561  34.761  22.968  1.00 46.02           C  \nATOM    151  CD1 LEU A  19      28.007  34.629  22.620  1.00 46.45           C  \nATOM    152  CD2 LEU A  19      25.983  35.913  22.194  1.00 46.45           C  \nATOM    153  N   LYS A  20      23.416  31.855  20.876  1.00 44.76           N  \nATOM    154  CA  LYS A  20      23.006  30.584  20.266  1.00 44.52           C  \nATOM    155  C   LYS A  20      23.626  30.463  18.874  1.00 42.87           C  \nATOM    156  O   LYS A  20      24.024  31.460  18.283  1.00 41.39           O  \nATOM    157  CB  LYS A  20      21.494  30.523  20.107  1.00 43.50           C  \nATOM    158  CG  LYS A  20      20.778  29.875  21.264  1.00 46.90           C  \nATOM    159  CD  LYS A  20      19.868  30.857  21.939  1.00 49.38           C  \nATOM    160  CE  LYS A  20      19.112  30.168  23.043  1.00 54.07           C  \nATOM    161  NZ  LYS A  20      18.467  28.892  22.571  1.00 60.37           N  \nATOM    162  N   GLU A  21      23.725  29.250  18.342  1.00 41.75           N  \nATOM    163  CA  GLU A  21      24.053  29.117  16.931  1.00 40.02           C  \nATOM    164  C   GLU A  21      22.822  28.761  16.150  1.00 35.18           C  \nATOM    165  O   GLU A  21      21.879  28.136  16.672  1.00 30.96           O  \nATOM    166  CB  GLU A  21      25.197  28.130  16.679  1.00 45.21           C  \nATOM    167  CG  GLU A  21      25.035  26.716  17.168  1.00 55.20           C  \nATOM    168  CD  GLU A  21      25.878  25.743  16.334  1.00 63.88           C  \nATOM    169  OE1 GLU A  21      27.022  26.130  15.972  1.00 67.73           O  \nATOM    170  OE2 GLU A  21      25.379  24.639  15.983  1.00 60.14           O  \nATOM    171  N   ALA A  22      22.778  29.268  14.927  1.00 30.04           N  \nATOM    172  CA  ALA A  22      21.553  29.189  14.165  1.00 26.79           C  \nATOM    173  C   ALA A  22      21.870  29.183  12.682  1.00 26.36           C  \nATOM    174  O   ALA A  22      22.975  29.578  12.252  1.00 24.88           O  \nATOM    175  CB  ALA A  22      20.625  30.359  14.524  1.00 22.80           C  \nATOM    176  N   LEU A  23      20.893  28.726  11.903  1.00 25.58           N  \nATOM    177  CA  LEU A  23      21.047  28.473  10.476  1.00 25.08           C  \nATOM    178  C   LEU A  23      20.381  29.596   9.664  1.00 23.67           C  \nATOM    179  O   LEU A  23      19.231  29.943   9.912  1.00 25.94           O  \nATOM    180  CB  LEU A  23      20.382  27.135  10.174  1.00 27.31           C  \nATOM    181  CG  LEU A  23      20.532  26.573   8.786  1.00 27.99           C  \nATOM    182  CD1 LEU A  23      21.939  26.039   8.621  1.00 29.29           C  \nATOM    183  CD2 LEU A  23      19.490  25.490   8.627  1.00 31.05           C  \nATOM    184  N   LEU A  24      21.122  30.163   8.715  1.00 21.67           N  \nATOM    185  CA  LEU A  24      20.617  31.144   7.775  1.00 18.03           C  \nATOM    186  C   LEU A  24      19.940  30.412   6.617  1.00 19.77           C  \nATOM    187  O   LEU A  24      20.567  29.833   5.740  1.00 20.40           O  \nATOM    188  CB  LEU A  24      21.767  32.023   7.262  1.00 15.36           C  \nATOM    189  CG  LEU A  24      22.647  32.673   8.359  1.00 18.86           C  \nATOM    190  CD1 LEU A  24      23.698  33.581   7.738  1.00 16.70           C  \nATOM    191  CD2 LEU A  24      21.797  33.496   9.368  1.00 18.96           C  \nATOM    192  N   ASP A  25      18.626  30.444   6.627  1.00 18.83           N  \nATOM    193  CA  ASP A  25      17.853  29.516   5.837  1.00 18.91           C  \nATOM    194  C   ASP A  25      16.945  30.292   4.886  1.00 16.83           C  \nATOM    195  O   ASP A  25      15.843  30.678   5.237  1.00 17.64           O  \nATOM    196  CB  ASP A  25      17.047  28.642   6.811  1.00 16.55           C  \nATOM    197  CG  ASP A  25      16.316  27.513   6.146  1.00 21.74           C  \nATOM    198  OD1 ASP A  25      16.236  27.458   4.905  1.00 22.87           O  \nATOM    199  OD2 ASP A  25      15.762  26.696   6.882  1.00 24.00           O  \nATOM    200  N   THR A  26      17.364  30.439   3.645  1.00 15.44           N  \nATOM    201  CA  THR A  26      16.548  31.148   2.684  1.00 15.16           C  \nATOM    202  C   THR A  26      15.302  30.382   2.289  1.00 15.12           C  \nATOM    203  O   THR A  26      14.412  30.939   1.615  1.00 12.07           O  \nATOM    204  CB  THR A  26      17.328  31.419   1.447  1.00 17.69           C  \nATOM    205  OG1 THR A  26      17.693  30.177   0.863  1.00 16.60           O  \nATOM    206  CG2 THR A  26      18.601  32.197   1.773  1.00 13.90           C  \nATOM    207  N   GLY A  27      15.213  29.111   2.702  1.00 17.61           N  \nATOM    208  CA  GLY A  27      14.043  28.331   2.349  1.00 14.06           C  \nATOM    209  C   GLY A  27      12.958  28.456   3.394  1.00 13.84           C  \nATOM    210  O   GLY A  27      11.832  28.015   3.171  1.00 14.08           O  \nATOM    211  N   ALA A  28      13.301  28.967   4.569  1.00 12.94           N  \nATOM    212  CA  ALA A  28      12.324  29.192   5.642  1.00 13.20           C  \nATOM    213  C   ALA A  28      11.629  30.567   5.554  1.00 17.23           C  \nATOM    214  O   ALA A  28      12.303  31.618   5.504  1.00 15.43           O  \nATOM    215  CB  ALA A  28      13.031  29.084   6.978  1.00 12.92           C  \nATOM    216  N   ASP A  29      10.296  30.560   5.587  1.00 17.65           N  \nATOM    217  CA  ASP A  29       9.512  31.798   5.651  1.00 19.68           C  \nATOM    218  C   ASP A  29       9.632  32.481   6.994  1.00 21.65           C  \nATOM    219  O   ASP A  29       9.671  33.706   7.056  1.00 26.39           O  \nATOM    220  CB  ASP A  29       8.029  31.534   5.402  1.00 18.61           C  \nATOM    221  CG  ASP A  29       7.752  31.004   4.015  1.00 23.38           C  \nATOM    222  OD1 ASP A  29       8.591  31.192   3.104  1.00 23.84           O  \nATOM    223  OD2 ASP A  29       6.661  30.410   3.833  1.00 24.58           O  \nATOM    224  N   ASP A  30       9.698  31.685   8.062  1.00 23.67           N  \nATOM    225  CA  ASP A  30       9.718  32.168   9.444  1.00 22.55           C  \nATOM    226  C   ASP A  30      10.988  31.819  10.163  1.00 20.55           C  \nATOM    227  O   ASP A  30      11.818  31.072   9.679  1.00 22.98           O  \nATOM    228  CB  ASP A  30       8.549  31.585  10.214  1.00 24.31           C  \nATOM    229  CG  ASP A  30       7.254  31.916   9.579  1.00 25.77           C  \nATOM    230  OD1 ASP A  30       6.951  33.118   9.473  1.00 37.03           O  \nATOM    231  OD2 ASP A  30       6.561  31.008   9.099  1.00 33.64           O  \nATOM    232  N   THR A  31      11.161  32.408  11.326  1.00 21.65           N  \nATOM    233  CA  THR A  31      12.248  32.053  12.215  1.00 19.28           C  \nATOM    234  C   THR A  31      11.707  31.128  13.318  1.00 20.65           C  \nATOM    235  O   THR A  31      10.660  31.408  13.910  1.00 21.27           O  \nATOM    236  CB  THR A  31      12.896  33.338  12.795  1.00 21.21           C  \nATOM    237  OG1 THR A  31      13.451  34.082  11.707  1.00 17.85           O  \nATOM    238  CG2 THR A  31      14.027  32.992  13.816  1.00 20.08           C  \nATOM    239  N   VAL A  32      12.390  30.005  13.537  1.00 19.73           N  \nATOM    240  CA  VAL A  32      11.893  28.983  14.419  1.00 20.18           C  \nATOM    241  C   VAL A  32      13.036  28.655  15.292  1.00 18.49           C  \nATOM    242  O   VAL A  32      14.067  28.221  14.821  1.00 21.86           O  \nATOM    243  CB  VAL A  32      11.528  27.683  13.690  1.00 20.27           C  \nATOM    244  CG1 VAL A  32      10.656  26.825  14.592  1.00 21.42           C  \nATOM    245  CG2 VAL A  32      10.805  27.963  12.423  1.00 20.29           C  \nATOM    246  N   LEU A  33      12.899  28.904  16.576  1.00 21.84           N  \nATOM    247  CA  LEU A  33      13.996  28.594  17.500  1.00 24.48           C  \nATOM    248  C   LEU A  33      13.571  27.454  18.396  1.00 25.37           C  \nATOM    249  O   LEU A  33      12.363  27.234  18.612  1.00 25.11           O  \nATOM    250  CB  LEU A  33      14.337  29.799  18.375  1.00 24.32           C  \nATOM    251  CG  LEU A  33      14.849  31.061  17.691  1.00 28.97           C  \nATOM    252  CD1 LEU A  33      15.091  32.156  18.733  1.00 31.03           C  \nATOM    253  CD2 LEU A  33      16.139  30.718  16.927  1.00 30.18           C  \nATOM    254  N   GLU A  34      14.568  26.722  18.889  1.00 29.09           N  \nATOM    255  CA  GLU A  34      14.390  25.650  19.874  1.00 32.79           C  \nATOM    256  C   GLU A  34      13.739  26.125  21.160  1.00 33.96           C  \nATOM    257  O   GLU A  34      13.982  27.222  21.618  1.00 34.70           O  \nATOM    258  CB  GLU A  34      15.727  25.007  20.190  1.00 36.48           C  \nATOM    259  CG  GLU A  34      16.297  24.250  18.988  1.00 43.49           C  \nATOM    260  CD  GLU A  34      17.726  23.801  19.191  1.00 49.89           C  \nATOM    261  OE1 GLU A  34      18.134  23.657  20.375  1.00 52.23           O  \nATOM    262  OE2 GLU A  34      18.443  23.614  18.182  1.00 53.58           O  \nATOM    263  N   GLU A  35      12.865  25.288  21.703  1.00 32.88           N  \nATOM    264  CA  GLU A  35      12.183  25.482  22.981  1.00 33.85           C  \nATOM    265  C   GLU A  35      12.971  26.329  23.986  1.00 34.72           C  \nATOM    266  O   GLU A  35      13.981  25.861  24.497  1.00 34.03           O  \nATOM    267  CB  GLU A  35      11.941  24.114  23.581  1.00 35.16           C  \nATOM    268  CG  GLU A  35      10.800  24.049  24.516  1.00 39.66           C  \nATOM    269  CD  GLU A  35       9.489  24.067  23.809  1.00 45.60           C  \nATOM    270  OE1 GLU A  35       9.134  23.066  23.120  1.00 50.36           O  \nATOM    271  OE2 GLU A  35       8.758  25.047  24.035  1.00 47.94           O  \nATOM    272  N   MET A  36      12.495  27.556  24.269  1.00 33.77           N  \nATOM    273  CA  MET A  36      13.101  28.479  25.261  1.00 32.08           C  \nATOM    274  C   MET A  36      12.013  29.437  25.755  1.00 33.50           C  \nATOM    275  O   MET A  36      10.969  29.535  25.133  1.00 33.82           O  \nATOM    276  CB  MET A  36      14.216  29.306  24.621  1.00 31.77           C  \nATOM    277  CG  MET A  36      13.741  30.341  23.590  1.00 33.78           C  \nATOM    278  SD  MET A  36      15.123  31.051  22.667  1.00 38.76           S  \nATOM    279  CE  MET A  36      15.783  32.224  23.828  1.00 34.69           C  \nATOM    280  N   SER A  37      12.249  30.179  26.852  1.00 34.23           N  \nATOM    281  CA  SER A  37      11.163  31.036  27.460  1.00 33.81           C  \nATOM    282  C   SER A  37      11.347  32.442  26.960  1.00 32.96           C  \nATOM    283  O   SER A  37      12.475  32.929  27.007  1.00 32.62           O  \nATOM    284  CB  SER A  37      11.300  31.071  28.976  1.00 34.02           C  \nATOM    285  OG  SER A  37       9.948  31.148  29.559  1.00 38.20           O  \nATOM    286  N   LEU A  38      10.330  33.112  26.459  1.00 35.12           N  \nATOM    287  CA  LEU A  38      10.566  34.476  26.033  1.00 38.10           C  \nATOM    288  C   LEU A  38       9.594  35.375  26.756  1.00 42.61           C  \nATOM    289  O   LEU A  38       8.616  34.906  27.343  1.00 41.25           O  \nATOM    290  CB  LEU A  38      10.409  34.626  24.500  1.00 35.60           C  \nATOM    291  CG  LEU A  38      11.559  34.187  23.577  1.00 33.68           C  \nATOM    292  CD1 LEU A  38      11.171  34.399  22.132  1.00 33.91           C  \nATOM    293  CD2 LEU A  38      12.807  34.964  23.875  1.00 34.05           C  \nATOM    294  N   PRO A  39       9.929  36.666  26.880  1.00 45.17           N  \nATOM    295  CA  PRO A  39       8.980  37.700  27.301  1.00 45.32           C  \nATOM    296  C   PRO A  39       7.760  37.785  26.410  1.00 44.13           C  \nATOM    297  O   PRO A  39       7.866  37.883  25.194  1.00 44.57           O  \nATOM    298  CB  PRO A  39       9.778  38.989  27.220  1.00 48.51           C  \nATOM    299  CG  PRO A  39      11.021  38.637  26.370  1.00 47.48           C  \nATOM    300  CD  PRO A  39      11.291  37.226  26.725  1.00 48.21           C  \nATOM    301  N   GLY A  40       6.601  37.811  27.029  1.00 43.26           N  \nATOM    302  CA  GLY A  40       5.419  38.218  26.302  1.00 44.04           C  \nATOM    303  C   GLY A  40       4.430  37.094  26.331  1.00 46.02           C  \nATOM    304  O   GLY A  40       4.591  36.107  27.055  1.00 48.40           O  \nATOM    305  N   ARG A  41       3.289  37.341  25.729  1.00 47.22           N  \nATOM    306  CA  ARG A  41       2.382  36.252  25.509  1.00 48.14           C  \nATOM    307  C   ARG A  41       2.606  35.713  24.096  1.00 45.12           C  \nATOM    308  O   ARG A  41       3.225  36.383  23.273  1.00 43.73           O  \nATOM    309  CB  ARG A  41       0.956  36.719  25.748  1.00 53.98           C  \nATOM    310  CG  ARG A  41       0.288  36.021  26.959  1.00 61.76           C  \nATOM    311  CD  ARG A  41       0.118  36.953  28.169  1.00 64.66           C  \nATOM    312  NE  ARG A  41       1.356  37.143  28.933  1.00 67.95           N  \nATOM    313  CZ  ARG A  41       1.830  38.332  29.318  1.00 69.74           C  \nATOM    314  NH1 ARG A  41       1.161  39.450  29.040  1.00 69.56           N  \nATOM    315  NH2 ARG A  41       2.973  38.402  29.994  1.00 68.51           N  \nATOM    316  N   TRP A  42       2.145  34.493  23.834  1.00 42.00           N  \nATOM    317  CA  TRP A  42       2.295  33.862  22.533  1.00 40.42           C  \nATOM    318  C   TRP A  42       0.934  33.419  21.959  1.00 40.51           C  \nATOM    319  O   TRP A  42       0.031  33.049  22.694  1.00 41.61           O  \nATOM    320  CB  TRP A  42       3.207  32.645  22.642  1.00 42.08           C  \nATOM    321  CG  TRP A  42       2.946  31.783  23.787  1.00 42.80           C  \nATOM    322  CD1 TRP A  42       3.473  31.896  25.041  1.00 46.14           C  \nATOM    323  CD2 TRP A  42       1.989  30.710  23.857  1.00 44.40           C  \nATOM    324  NE1 TRP A  42       2.882  30.973  25.884  1.00 48.15           N  \nATOM    325  CE2 TRP A  42       1.966  30.246  25.193  1.00 45.80           C  \nATOM    326  CE3 TRP A  42       1.129  30.108  22.909  1.00 44.14           C  \nATOM    327  CZ2 TRP A  42       1.117  29.219  25.618  1.00 47.06           C  \nATOM    328  CZ3 TRP A  42       0.313  29.091  23.334  1.00 45.02           C  \nATOM    329  CH2 TRP A  42       0.305  28.651  24.686  1.00 47.76           C  \nATOM    330  N   LYS A  43       0.781  33.465  20.639  1.00 39.07           N  \nATOM    331  CA  LYS A  43      -0.305  32.776  19.928  1.00 38.61           C  \nATOM    332  C   LYS A  43       0.220  31.412  19.477  1.00 38.09           C  \nATOM    333  O   LYS A  43       1.400  31.270  19.145  1.00 37.97           O  \nATOM    334  CB  LYS A  43      -0.739  33.603  18.700  1.00 40.22           C  \nATOM    335  CG  LYS A  43      -1.311  34.967  19.027  1.00 40.71           C  \nATOM    336  CD  LYS A  43      -1.066  35.945  17.886  1.00 46.25           C  \nATOM    337  CE  LYS A  43      -1.726  37.319  18.156  1.00 53.77           C  \nATOM    338  NZ  LYS A  43      -0.979  38.292  19.067  1.00 55.67           N  \nATOM    339  N   PRO A  44      -0.601  30.363  19.541  1.00 36.78           N  \nATOM    340  CA  PRO A  44      -0.088  29.114  18.966  1.00 36.73           C  \nATOM    341  C   PRO A  44      -0.275  29.085  17.454  1.00 35.93           C  \nATOM    342  O   PRO A  44      -1.185  29.721  16.929  1.00 35.84           O  \nATOM    343  CB  PRO A  44      -0.893  28.021  19.667  1.00 37.26           C  \nATOM    344  CG  PRO A  44      -2.170  28.683  20.012  1.00 38.05           C  \nATOM    345  CD  PRO A  44      -1.825  30.129  20.325  1.00 40.15           C  \nATOM    346  N   LYS A  45       0.586  28.336  16.762  1.00 34.68           N  \nATOM    347  CA  LYS A  45       0.634  28.302  15.290  1.00 31.98           C  \nATOM    348  C   LYS A  45       1.025  26.869  14.873  1.00 29.00           C  \nATOM    349  O   LYS A  45       1.711  26.163  15.608  1.00 27.87           O  \nATOM    350  CB  LYS A  45       1.693  29.299  14.799  1.00 31.87           C  \nATOM    351  CG  LYS A  45       1.495  29.822  13.396  1.00 32.85           C  \nATOM    352  CD  LYS A  45       2.628  30.791  12.986  1.00 39.51           C  \nATOM    353  CE  LYS A  45       2.662  31.103  11.471  1.00 38.60           C  \nATOM    354  NZ  LYS A  45       1.837  32.301  11.181  1.00 45.48           N  \nATOM    355  N   MET A  46       0.570  26.438  13.707  1.00 28.78           N  \nATOM    356  CA  MET A  46       1.091  25.232  13.081  1.00 28.75           C  \nATOM    357  C   MET A  46       1.899  25.638  11.874  1.00 26.81           C  \nATOM    358  O   MET A  46       1.385  26.292  10.965  1.00 28.48           O  \nATOM    359  CB  MET A  46      -0.047  24.319  12.624  1.00 30.70           C  \nATOM    360  CG  MET A  46      -0.970  23.867  13.745  1.00 34.30           C  \nATOM    361  SD  MET A  46      -0.348  22.459  14.681  1.00 42.21           S  \nATOM    362  CE  MET A  46      -0.585  21.081  13.426  1.00 43.40           C  \nATOM    363  N   ILE A  47       3.167  25.258  11.849  1.00 25.63           N  \nATOM    364  CA  ILE A  47       3.978  25.464  10.655  1.00 25.64           C  \nATOM    365  C   ILE A  47       4.420  24.140  10.114  1.00 23.79           C  \nATOM    366  O   ILE A  47       4.667  23.248  10.887  1.00 25.39           O  \nATOM    367  CB  ILE A  47       5.234  26.259  10.953  1.00 25.82           C  \nATOM    368  CG1 ILE A  47       5.959  25.628  12.127  1.00 27.41           C  \nATOM    369  CG2 ILE A  47       4.898  27.703  11.148  1.00 29.47           C  \nATOM    370  CD1 ILE A  47       7.369  26.170  12.291  1.00 33.28           C  \nATOM    371  N   GLY A  48       4.567  24.042   8.795  1.00 23.56           N  \nATOM    372  CA  GLY A  48       4.886  22.777   8.145  1.00 28.25           C  \nATOM    373  C   GLY A  48       6.265  22.720   7.521  1.00 30.81           C  \nATOM    374  O   GLY A  48       6.723  23.689   6.900  1.00 30.06           O  \nATOM    375  N   GLY A  49       7.015  21.688   7.884  1.00 31.96           N  \nATOM    376  CA  GLY A  49       8.313  21.471   7.276  1.00 33.92           C  \nATOM    377  C   GLY A  49       8.221  20.379   6.232  1.00 37.71           C  \nATOM    378  O   GLY A  49       7.177  20.197   5.583  1.00 36.71           O  \nATOM    379  N   ILE A  50       9.309  19.619   6.155  1.00 39.37           N  \nATOM    380  CA  ILE A  50       9.537  18.544   5.194  1.00 40.56           C  \nATOM    381  C   ILE A  50       8.802  17.261   5.658  1.00 39.02           C  \nATOM    382  O   ILE A  50       8.143  16.589   4.863  1.00 40.72           O  \nATOM    383  CB  ILE A  50      11.095  18.362   5.046  1.00 40.75           C  \nATOM    384  CG1 ILE A  50      11.553  18.874   3.682  1.00 39.18           C  \nATOM    385  CG2 ILE A  50      11.521  16.945   5.317  1.00 42.58           C  \nATOM    386  CD1 ILE A  50      10.910  18.225   2.567  1.00 39.03           C  \nATOM    387  N   GLY A  51       8.865  16.952   6.945  1.00 35.64           N  \nATOM    388  CA  GLY A  51       8.174  15.771   7.405  1.00 37.36           C  \nATOM    389  C   GLY A  51       6.812  16.062   7.983  1.00 38.38           C  \nATOM    390  O   GLY A  51       6.408  15.342   8.870  1.00 42.43           O  \nATOM    391  N   GLY A  52       6.141  17.132   7.563  1.00 35.83           N  \nATOM    392  CA  GLY A  52       4.855  17.480   8.157  1.00 34.71           C  \nATOM    393  C   GLY A  52       4.884  18.624   9.170  1.00 32.77           C  \nATOM    394  O   GLY A  52       5.873  19.342   9.280  1.00 33.65           O  \nATOM    395  N   PHE A  53       3.806  18.788   9.925  1.00 31.50           N  \nATOM    396  CA  PHE A  53       3.593  19.996  10.731  1.00 30.76           C  \nATOM    397  C   PHE A  53       4.015  19.881  12.194  1.00 31.86           C  \nATOM    398  O   PHE A  53       3.930  18.810  12.781  1.00 36.37           O  \nATOM    399  CB  PHE A  53       2.121  20.351  10.670  1.00 28.77           C  \nATOM    400  CG  PHE A  53       1.760  21.152   9.484  1.00 30.51           C  \nATOM    401  CD1 PHE A  53       1.725  20.567   8.216  1.00 27.94           C  \nATOM    402  CD2 PHE A  53       1.556  22.518   9.607  1.00 30.74           C  \nATOM    403  CE1 PHE A  53       1.500  21.332   7.075  1.00 29.27           C  \nATOM    404  CE2 PHE A  53       1.327  23.302   8.496  1.00 32.36           C  \nATOM    405  CZ  PHE A  53       1.290  22.718   7.212  1.00 28.01           C  \nATOM    406  N   ILE A  54       4.483  20.969  12.792  1.00 28.86           N  \nATOM    407  CA  ILE A  54       4.689  21.005  14.248  1.00 28.83           C  \nATOM    408  C   ILE A  54       3.921  22.179  14.858  1.00 29.53           C  \nATOM    409  O   ILE A  54       3.575  23.139  14.182  1.00 28.42           O  \nATOM    410  CB  ILE A  54       6.199  21.155  14.625  1.00 28.74           C  \nATOM    411  CG1 ILE A  54       6.796  22.408  13.939  1.00 27.76           C  \nATOM    412  CG2 ILE A  54       6.967  19.888  14.203  1.00 28.78           C  \nATOM    413  CD1 ILE A  54       8.110  22.821  14.465  1.00 23.65           C  \nATOM    414  N   LYS A  55       3.632  22.095  16.145  1.00 31.86           N  \nATOM    415  CA  LYS A  55       2.968  23.196  16.823  1.00 31.37           C  \nATOM    416  C   LYS A  55       4.038  24.093  17.449  1.00 31.40           C  \nATOM    417  O   LYS A  55       4.949  23.610  18.157  1.00 30.39           O  \nATOM    418  CB  LYS A  55       2.021  22.661  17.895  1.00 34.83           C  \nATOM    419  CG  LYS A  55       0.974  23.665  18.300  1.00 41.25           C  \nATOM    420  CD  LYS A  55       0.006  23.101  19.304  1.00 48.65           C  \nATOM    421  CE  LYS A  55      -0.580  24.217  20.149  1.00 52.68           C  \nATOM    422  NZ  LYS A  55       0.439  24.751  21.104  1.00 56.46           N  \nATOM    423  N   VAL A  56       3.953  25.391  17.185  1.00 27.17           N  \nATOM    424  CA  VAL A  56       4.927  26.319  17.754  1.00 26.79           C  \nATOM    425  C   VAL A  56       4.225  27.378  18.556  1.00 25.98           C  \nATOM    426  O   VAL A  56       3.023  27.557  18.455  1.00 28.45           O  \nATOM    427  CB  VAL A  56       5.769  27.009  16.663  1.00 23.58           C  \nATOM    428  CG1 VAL A  56       6.791  26.027  16.120  1.00 24.00           C  \nATOM    429  CG2 VAL A  56       4.881  27.551  15.567  1.00 19.88           C  \nATOM    430  N   ARG A  57       4.978  28.079  19.377  1.00 27.52           N  \nATOM    431  CA  ARG A  57       4.459  29.271  20.026  1.00 29.29           C  \nATOM    432  C   ARG A  57       5.038  30.502  19.335  1.00 26.53           C  \nATOM    433  O   ARG A  57       6.242  30.596  19.138  1.00 26.51           O  \nATOM    434  CB  ARG A  57       4.824  29.245  21.505  1.00 33.25           C  \nATOM    435  CG  ARG A  57       4.168  28.102  22.260  1.00 39.60           C  \nATOM    436  CD  ARG A  57       4.656  28.068  23.693  1.00 44.47           C  \nATOM    437  NE  ARG A  57       6.032  27.573  23.790  1.00 50.18           N  \nATOM    438  CZ  ARG A  57       7.027  28.273  24.317  1.00 49.84           C  \nATOM    439  NH1 ARG A  57       6.825  29.532  24.678  1.00 51.65           N  \nATOM    440  NH2 ARG A  57       8.223  27.723  24.467  1.00 52.43           N  \nATOM    441  N   GLN A  58       4.171  31.431  18.958  1.00 25.48           N  \nATOM    442  CA  GLN A  58       4.570  32.596  18.172  1.00 27.73           C  \nATOM    443  C   GLN A  58       4.681  33.818  19.085  1.00 30.15           C  \nATOM    444  O   GLN A  58       3.694  34.242  19.683  1.00 33.75           O  \nATOM    445  CB  GLN A  58       3.539  32.859  17.094  1.00 26.15           C  \nATOM    446  CG  GLN A  58       3.736  34.104  16.321  1.00 29.09           C  \nATOM    447  CD  GLN A  58       2.500  34.473  15.541  1.00 37.13           C  \nATOM    448  OE1 GLN A  58       1.530  33.703  15.489  1.00 40.89           O  \nATOM    449  NE2 GLN A  58       2.508  35.651  14.940  1.00 39.09           N  \nATOM    450  N   TYR A  59       5.883  34.378  19.196  1.00 32.83           N  \nATOM    451  CA  TYR A  59       6.097  35.658  19.896  1.00 34.57           C  \nATOM    452  C   TYR A  59       6.304  36.752  18.835  1.00 35.86           C  \nATOM    453  O   TYR A  59       6.923  36.513  17.800  1.00 38.78           O  \nATOM    454  CB  TYR A  59       7.354  35.588  20.765  1.00 33.06           C  \nATOM    455  CG  TYR A  59       7.213  34.624  21.955  1.00 36.56           C  \nATOM    456  CD1 TYR A  59       7.479  33.237  21.805  1.00 37.53           C  \nATOM    457  CD2 TYR A  59       6.795  35.087  23.223  1.00 33.33           C  \nATOM    458  CE1 TYR A  59       7.345  32.365  22.871  1.00 34.69           C  \nATOM    459  CE2 TYR A  59       6.638  34.224  24.268  1.00 33.09           C  \nATOM    460  CZ  TYR A  59       6.926  32.869  24.102  1.00 33.21           C  \nATOM    461  OH  TYR A  59       6.967  32.076  25.200  1.00 40.16           O  \nATOM    462  N   ASP A  60       5.767  37.940  19.049  1.00 37.21           N  \nATOM    463  CA  ASP A  60       6.022  39.045  18.125  1.00 36.50           C  \nATOM    464  C   ASP A  60       7.025  40.015  18.725  1.00 35.62           C  \nATOM    465  O   ASP A  60       7.340  39.951  19.900  1.00 33.30           O  \nATOM    466  CB  ASP A  60       4.719  39.777  17.832  1.00 43.82           C  \nATOM    467  CG  ASP A  60       3.699  38.899  17.148  1.00 49.03           C  \nATOM    468  OD1 ASP A  60       3.989  38.368  16.050  1.00 53.15           O  \nATOM    469  OD2 ASP A  60       2.570  38.799  17.672  1.00 54.18           O  \nATOM    470  N   GLN A  61       7.529  40.913  17.896  1.00 35.15           N  \nATOM    471  CA  GLN A  61       8.337  42.060  18.331  1.00 37.27           C  \nATOM    472  C   GLN A  61       9.535  41.630  19.179  1.00 36.83           C  \nATOM    473  O   GLN A  61       9.777  42.191  20.264  1.00 39.02           O  \nATOM    474  CB  GLN A  61       7.471  43.051  19.131  1.00 41.54           C  \nATOM    475  CG  GLN A  61       7.718  44.555  18.814  1.00 53.40           C  \nATOM    476  CD  GLN A  61       7.182  45.552  19.907  1.00 61.08           C  \nATOM    477  OE1 GLN A  61       7.936  46.461  20.398  1.00 65.46           O  \nATOM    478  NE2 GLN A  61       5.892  45.377  20.306  1.00 58.46           N  \nATOM    479  N   ILE A  62      10.283  40.645  18.676  1.00 33.10           N  \nATOM    480  CA  ILE A  62      11.484  40.115  19.328  1.00 33.95           C  \nATOM    481  C   ILE A  62      12.745  40.584  18.614  1.00 35.70           C  \nATOM    482  O   ILE A  62      12.830  40.485  17.396  1.00 38.95           O  \nATOM    483  CB  ILE A  62      11.465  38.545  19.309  1.00 33.50           C  \nATOM    484  CG1 ILE A  62      10.152  38.035  19.930  1.00 31.68           C  \nATOM    485  CG2 ILE A  62      12.688  37.973  20.027  1.00 33.86           C  \nATOM    486  CD1 ILE A  62       9.966  38.380  21.363  1.00 35.62           C  \nATOM    487  N   LEU A  63      13.722  41.086  19.369  1.00 38.14           N  \nATOM    488  CA  LEU A  63      15.038  41.476  18.822  1.00 41.38           C  \nATOM    489  C   LEU A  63      16.033  40.304  18.862  1.00 42.34           C  \nATOM    490  O   LEU A  63      16.195  39.661  19.897  1.00 43.91           O  \nATOM    491  CB  LEU A  63      15.631  42.666  19.619  1.00 41.40           C  \nATOM    492  CG  LEU A  63      16.776  43.426  18.914  1.00 42.58           C  \nATOM    493  CD1 LEU A  63      16.560  44.922  18.993  1.00 46.33           C  \nATOM    494  CD2 LEU A  63      18.103  43.062  19.558  1.00 45.30           C  \nATOM    495  N   ILE A  64      16.686  40.036  17.738  1.00 44.21           N  \nATOM    496  CA  ILE A  64      17.760  39.039  17.653  1.00 46.55           C  \nATOM    497  C   ILE A  64      18.991  39.753  17.116  1.00 46.30           C  \nATOM    498  O   ILE A  64      18.862  40.632  16.288  1.00 45.60           O  \nATOM    499  CB  ILE A  64      17.390  37.875  16.634  1.00 48.42           C  \nATOM    500  CG1 ILE A  64      16.127  37.137  17.110  1.00 51.56           C  \nATOM    501  CG2 ILE A  64      18.551  36.857  16.518  1.00 45.78           C  \nATOM    502  CD1 ILE A  64      16.194  35.643  16.885  1.00 52.26           C  \nATOM    503  N   GLU A  65      20.181  39.387  17.573  1.00 48.38           N  \nATOM    504  CA  GLU A  65      21.406  39.983  17.036  1.00 52.65           C  \nATOM    505  C   GLU A  65      22.192  39.019  16.135  1.00 53.34           C  \nATOM    506  O   GLU A  65      22.866  38.128  16.631  1.00 57.14           O  \nATOM    507  CB  GLU A  65      22.307  40.439  18.180  1.00 53.39           C  \nATOM    508  CG  GLU A  65      21.987  41.843  18.676  1.00 58.82           C  \nATOM    509  CD  GLU A  65      23.228  42.558  19.187  1.00 61.85           C  \nATOM    510  OE1 GLU A  65      24.094  42.925  18.348  1.00 62.51           O  \nATOM    511  OE2 GLU A  65      23.348  42.730  20.429  1.00 63.85           O  \nATOM    512  N   ILE A  66      22.148  39.215  14.823  1.00 54.18           N  \nATOM    513  CA  ILE A  66      22.818  38.327  13.863  1.00 53.69           C  \nATOM    514  C   ILE A  66      24.123  38.945  13.303  1.00 55.63           C  \nATOM    515  O   ILE A  66      24.114  39.903  12.521  1.00 55.17           O  \nATOM    516  CB  ILE A  66      21.831  37.964  12.694  1.00 53.26           C  \nATOM    517  CG1 ILE A  66      20.481  37.516  13.278  1.00 50.35           C  \nATOM    518  CG2 ILE A  66      22.444  36.880  11.799  1.00 51.36           C  \nATOM    519  CD1 ILE A  66      19.263  38.072  12.560  1.00 49.54           C  \nATOM    520  N   CYS A  67      25.251  38.396  13.731  1.00 57.47           N  \nATOM    521  CA  CYS A  67      26.590  38.871  13.351  1.00 59.30           C  \nATOM    522  C   CYS A  67      26.798  40.370  13.560  1.00 58.98           C  \nATOM    523  O   CYS A  67      27.461  41.045  12.763  1.00 59.83           O  \nATOM    524  CB  CYS A  67      26.907  38.497  11.905  1.00 60.45           C  \nATOM    525  SG  CYS A  67      27.274  36.734  11.705  1.00 66.26           S  \nATOM    526  N   GLY A  68      26.239  40.887  14.650  1.00 58.28           N  \nATOM    527  CA  GLY A  68      26.319  42.307  14.938  1.00 56.53           C  \nATOM    528  C   GLY A  68      24.980  42.946  14.665  1.00 54.84           C  \nATOM    529  O   GLY A  68      24.371  43.518  15.561  1.00 55.20           O  \nATOM    530  N   HIS A  69      24.449  42.689  13.479  1.00 52.63           N  \nATOM    531  CA  HIS A  69      23.251  43.368  13.013  1.00 49.83           C  \nATOM    532  C   HIS A  69      22.009  43.025  13.836  1.00 49.49           C  \nATOM    533  O   HIS A  69      21.626  41.865  13.958  1.00 50.24           O  \nATOM    534  CB  HIS A  69      22.975  43.009  11.568  1.00 48.37           C  \nATOM    535  CG  HIS A  69      24.157  43.172  10.639  1.00 48.55           C  \nATOM    536  ND1 HIS A  69      25.294  42.398  10.762  1.00 46.92           N  \nATOM    537  CD2 HIS A  69      24.283  43.886   9.518  1.00 47.07           C  \nATOM    538  CE1 HIS A  69      26.075  42.630   9.723  1.00 45.30           C  \nATOM    539  NE2 HIS A  69      25.505  43.532   8.946  1.00 49.32           N  \nATOM    540  N   LYS A  70      21.364  44.050  14.376  1.00 48.04           N  \nATOM    541  CA  LYS A  70      20.030  43.883  14.945  1.00 44.00           C  \nATOM    542  C   LYS A  70      18.929  43.698  13.882  1.00 40.53           C  \nATOM    543  O   LYS A  70      19.000  44.197  12.761  1.00 37.44           O  \nATOM    544  CB  LYS A  70      19.667  45.075  15.840  1.00 46.06           C  \nATOM    545  CG  LYS A  70      20.422  45.141  17.154  1.00 48.65           C  \nATOM    546  CD  LYS A  70      19.885  46.281  18.036  1.00 52.10           C  \nATOM    547  CE  LYS A  70      20.905  46.699  19.095  1.00 52.81           C  \nATOM    548  NZ  LYS A  70      20.376  47.817  19.946  1.00 57.49           N  \nATOM    549  N   ALA A  71      17.879  43.010  14.305  1.00 37.00           N  \nATOM    550  CA  ALA A  71      16.703  42.737  13.499  1.00 33.57           C  \nATOM    551  C   ALA A  71      15.600  42.546  14.556  1.00 31.56           C  \nATOM    552  O   ALA A  71      15.880  42.175  15.705  1.00 34.29           O  \nATOM    553  CB  ALA A  71      16.937  41.464  12.683  1.00 28.40           C  \nATOM    554  N   ILE A  72      14.366  42.881  14.219  1.00 28.94           N  \nATOM    555  CA  ILE A  72      13.233  42.663  15.111  1.00 26.93           C  \nATOM    556  C   ILE A  72      12.196  41.969  14.237  1.00 25.42           C  \nATOM    557  O   ILE A  72      12.083  42.266  13.025  1.00 23.83           O  \nATOM    558  CB  ILE A  72      12.635  44.019  15.609  1.00 34.11           C  \nATOM    559  CG1 ILE A  72      13.664  44.777  16.446  1.00 39.50           C  \nATOM    560  CG2 ILE A  72      11.353  43.782  16.409  1.00 34.28           C  \nATOM    561  CD1 ILE A  72      13.437  46.286  16.451  1.00 44.26           C  \nATOM    562  N   GLY A  73      11.457  41.034  14.821  1.00 23.40           N  \nATOM    563  CA  GLY A  73      10.359  40.420  14.090  1.00 22.07           C  \nATOM    564  C   GLY A  73       9.750  39.238  14.835  1.00 24.48           C  \nATOM    565  O   GLY A  73      10.019  39.007  16.009  1.00 24.29           O  \nATOM    566  N   THR A  74       8.853  38.524  14.181  1.00 23.67           N  \nATOM    567  CA  THR A  74       8.224  37.361  14.786  1.00 24.46           C  \nATOM    568  C   THR A  74       9.169  36.194  14.895  1.00 25.63           C  \nATOM    569  O   THR A  74       9.964  35.908  14.007  1.00 25.67           O  \nATOM    570  CB  THR A  74       6.961  36.929  14.010  1.00 24.94           C  \nATOM    571  OG1 THR A  74       6.030  38.013  14.001  1.00 29.61           O  \nATOM    572  CG2 THR A  74       6.287  35.760  14.688  1.00 19.06           C  \nATOM    573  N   VAL A  75       9.085  35.534  16.025  1.00 25.14           N  \nATOM    574  CA  VAL A  75       9.944  34.420  16.291  1.00 26.87           C  \nATOM    575  C   VAL A  75       9.018  33.325  16.795  1.00 27.97           C  \nATOM    576  O   VAL A  75       8.104  33.576  17.594  1.00 27.87           O  \nATOM    577  CB  VAL A  75      11.002  34.791  17.336  1.00 25.74           C  \nATOM    578  CG1 VAL A  75      11.638  33.561  17.884  1.00 27.82           C  \nATOM    579  CG2 VAL A  75      12.070  35.661  16.648  1.00 21.53           C  \nATOM    580  N   LEU A  76       9.200  32.127  16.258  1.00 27.21           N  \nATOM    581  CA  LEU A  76       8.353  30.995  16.628  1.00 25.80           C  \nATOM    582  C   LEU A  76       9.229  30.084  17.483  1.00 24.05           C  \nATOM    583  O   LEU A  76      10.409  29.923  17.194  1.00 23.89           O  \nATOM    584  CB  LEU A  76       7.937  30.247  15.365  1.00 24.57           C  \nATOM    585  CG  LEU A  76       7.222  30.919  14.207  1.00 24.94           C  \nATOM    586  CD1 LEU A  76       6.909  29.914  13.139  1.00 21.47           C  \nATOM    587  CD2 LEU A  76       5.961  31.526  14.713  1.00 22.70           C  \nATOM    588  N   VAL A  77       8.689  29.507  18.538  1.00 22.25           N  \nATOM    589  CA  VAL A  77       9.519  28.691  19.405  1.00 25.77           C  \nATOM    590  C   VAL A  77       8.852  27.309  19.499  1.00 25.41           C  \nATOM    591  O   VAL A  77       7.621  27.241  19.608  1.00 21.46           O  \nATOM    592  CB  VAL A  77       9.648  29.353  20.800  1.00 26.64           C  \nATOM    593  CG1 VAL A  77      10.306  28.419  21.773  1.00 24.10           C  \nATOM    594  CG2 VAL A  77      10.426  30.686  20.648  1.00 24.74           C  \nATOM    595  N   GLY A  78       9.637  26.227  19.375  1.00 23.37           N  \nATOM    596  CA  GLY A  78       9.027  24.918  19.185  1.00 25.28           C  \nATOM    597  C   GLY A  78      10.005  23.782  18.984  1.00 24.69           C  \nATOM    598  O   GLY A  78      11.215  24.012  19.065  1.00 27.34           O  \nATOM    599  N   PRO A  79       9.538  22.542  18.758  1.00 24.96           N  \nATOM    600  CA  PRO A  79      10.442  21.388  18.731  1.00 26.27           C  \nATOM    601  C   PRO A  79      11.136  21.242  17.389  1.00 27.30           C  \nATOM    602  O   PRO A  79      10.748  20.397  16.559  1.00 30.31           O  \nATOM    603  CB  PRO A  79       9.515  20.215  18.995  1.00 26.15           C  \nATOM    604  CG  PRO A  79       8.239  20.616  18.339  1.00 27.52           C  \nATOM    605  CD  PRO A  79       8.170  22.144  18.383  1.00 27.77           C  \nATOM    606  N   THR A  80      12.138  22.078  17.162  1.00 27.82           N  \nATOM    607  CA  THR A  80      12.910  22.043  15.936  1.00 27.04           C  \nATOM    608  C   THR A  80      14.280  21.503  16.325  1.00 28.49           C  \nATOM    609  O   THR A  80      14.692  21.666  17.473  1.00 33.89           O  \nATOM    610  CB  THR A  80      13.031  23.467  15.319  1.00 24.34           C  \nATOM    611  OG1 THR A  80      13.971  23.419  14.244  1.00 28.59           O  \nATOM    612  CG2 THR A  80      13.542  24.478  16.300  1.00 17.97           C  \nATOM    613  N   PRO A  81      14.915  20.725  15.449  1.00 27.56           N  \nATOM    614  CA  PRO A  81      16.233  20.170  15.766  1.00 28.35           C  \nATOM    615  C   PRO A  81      17.352  21.205  15.795  1.00 32.18           C  \nATOM    616  O   PRO A  81      18.306  21.085  16.567  1.00 35.74           O  \nATOM    617  CB  PRO A  81      16.467  19.139  14.669  1.00 28.05           C  \nATOM    618  CG  PRO A  81      15.477  19.489  13.607  1.00 24.27           C  \nATOM    619  CD  PRO A  81      14.331  20.114  14.238  1.00 24.21           C  \nATOM    620  N   VAL A  82      17.220  22.219  14.948  1.00 31.78           N  \nATOM    621  CA  VAL A  82      18.236  23.243  14.762  1.00 30.36           C  \nATOM    622  C   VAL A  82      17.549  24.626  14.801  1.00 29.01           C  \nATOM    623  O   VAL A  82      16.328  24.735  14.569  1.00 28.83           O  \nATOM    624  CB  VAL A  82      18.969  23.017  13.388  1.00 27.70           C  \nATOM    625  CG1 VAL A  82      18.009  22.769  12.263  1.00 25.82           C  \nATOM    626  CG2 VAL A  82      19.843  24.144  13.080  1.00 29.05           C  \nATOM    627  N   ASN A  83      18.292  25.671  15.167  1.00 28.44           N  \nATOM    628  CA  ASN A  83      17.731  27.051  15.193  1.00 23.14           C  \nATOM    629  C   ASN A  83      17.799  27.628  13.799  1.00 20.40           C  \nATOM    630  O   ASN A  83      18.794  27.456  13.113  1.00 22.72           O  \nATOM    631  CB  ASN A  83      18.508  27.950  16.161  1.00 23.96           C  \nATOM    632  CG  ASN A  83      18.236  27.600  17.636  1.00 19.36           C  \nATOM    633  OD1 ASN A  83      17.102  27.381  18.051  1.00 24.75           O  \nATOM    634  ND2 ASN A  83      19.287  27.475  18.398  1.00 23.07           N  \nATOM    635  N   ILE A  84      16.729  28.283  13.370  1.00 19.46           N  \nATOM    636  CA  ILE A  84      16.588  28.651  11.955  1.00 18.70           C  \nATOM    637  C   ILE A  84      16.190  30.132  11.811  1.00 15.24           C  \nATOM    638  O   ILE A  84      15.178  30.600  12.384  1.00 16.01           O  \nATOM    639  CB  ILE A  84      15.504  27.755  11.242  1.00 18.01           C  \nATOM    640  CG1 ILE A  84      16.049  26.365  11.040  1.00 21.46           C  \nATOM    641  CG2 ILE A  84      15.081  28.324   9.932  1.00 18.09           C  \nATOM    642  CD1 ILE A  84      14.957  25.345  11.321  1.00 21.77           C  \nATOM    643  N   ILE A  85      16.991  30.863  11.053  1.00 17.41           N  \nATOM    644  CA  ILE A  85      16.710  32.257  10.821  1.00 17.84           C  \nATOM    645  C   ILE A  85      16.155  32.252   9.420  1.00 18.00           C  \nATOM    646  O   ILE A  85      16.857  31.950   8.464  1.00 16.33           O  \nATOM    647  CB  ILE A  85      17.999  33.119  10.844  1.00 19.87           C  \nATOM    648  CG1 ILE A  85      18.724  32.983  12.207  1.00 21.72           C  \nATOM    649  CG2 ILE A  85      17.653  34.600  10.517  1.00 19.84           C  \nATOM    650  CD1 ILE A  85      17.830  33.204  13.418  1.00 23.27           C  \nATOM    651  N   GLY A  86      14.888  32.608   9.302  1.00 17.67           N  \nATOM    652  CA  GLY A  86      14.238  32.655   8.011  1.00 19.47           C  \nATOM    653  C   GLY A  86      14.181  34.034   7.393  1.00 20.59           C  \nATOM    654  O   GLY A  86      14.714  34.991   7.894  1.00 19.31           O  \nATOM    655  N   ARG A  87      13.398  34.131   6.334  1.00 19.04           N  \nATOM    656  CA  ARG A  87      13.370  35.302   5.456  1.00 21.43           C  \nATOM    657  C   ARG A  87      12.931  36.548   6.216  1.00 20.84           C  \nATOM    658  O   ARG A  87      13.429  37.633   5.958  1.00 24.40           O  \nATOM    659  CB  ARG A  87      12.459  35.018   4.263  1.00 15.37           C  \nATOM    660  CG  ARG A  87      13.030  34.044   3.318  1.00 18.83           C  \nATOM    661  CD  ARG A  87      12.310  34.101   1.966  1.00 21.67           C  \nATOM    662  NE  ARG A  87      10.903  33.713   2.088  1.00 21.37           N  \nATOM    663  CZ  ARG A  87       9.899  34.575   2.137  1.00 22.28           C  \nATOM    664  NH1 ARG A  87      10.126  35.860   1.922  1.00 20.00           N  \nATOM    665  NH2 ARG A  87       8.657  34.143   2.300  1.00 21.02           N  \nATOM    666  N   ASN A  88      12.063  36.352   7.198  1.00 21.72           N  \nATOM    667  CA  ASN A  88      11.458  37.455   7.919  1.00 19.12           C  \nATOM    668  C   ASN A  88      12.511  38.266   8.653  1.00 21.99           C  \nATOM    669  O   ASN A  88      12.419  39.481   8.723  1.00 24.63           O  \nATOM    670  CB  ASN A  88      10.359  36.959   8.863  1.00 17.71           C  \nATOM    671  CG  ASN A  88      10.892  36.309  10.125  1.00 23.05           C  \nATOM    672  OD1 ASN A  88      11.577  35.273  10.065  1.00 24.51           O  \nATOM    673  ND2 ASN A  88      10.446  36.809  11.283  1.00 21.17           N  \nATOM    674  N   LEU A  89      13.551  37.601   9.136  1.00 21.73           N  \nATOM    675  CA  LEU A  89      14.633  38.337   9.729  1.00 21.46           C  \nATOM    676  C   LEU A  89      15.802  38.487   8.783  1.00 21.01           C  \nATOM    677  O   LEU A  89      16.580  39.394   8.941  1.00 22.81           O  \nATOM    678  CB  LEU A  89      15.096  37.687  11.029  1.00 24.37           C  \nATOM    679  CG  LEU A  89      14.146  37.555  12.221  1.00 26.43           C  \nATOM    680  CD1 LEU A  89      14.939  37.022  13.434  1.00 27.76           C  \nATOM    681  CD2 LEU A  89      13.508  38.913  12.527  1.00 29.10           C  \nATOM    682  N   LEU A  90      15.910  37.651   7.761  1.00 18.04           N  \nATOM    683  CA  LEU A  90      17.078  37.773   6.865  1.00 21.90           C  \nATOM    684  C   LEU A  90      17.048  39.068   6.049  1.00 22.24           C  \nATOM    685  O   LEU A  90      18.098  39.613   5.652  1.00 20.42           O  \nATOM    686  CB  LEU A  90      17.200  36.561   5.913  1.00 21.44           C  \nATOM    687  CG  LEU A  90      17.754  35.226   6.440  1.00 19.50           C  \nATOM    688  CD1 LEU A  90      17.798  34.207   5.340  1.00 20.48           C  \nATOM    689  CD2 LEU A  90      19.138  35.441   7.022  1.00 15.96           C  \nATOM    690  N   THR A  91      15.835  39.547   5.808  1.00 20.88           N  \nATOM    691  CA  THR A  91      15.653  40.738   4.985  1.00 25.31           C  \nATOM    692  C   THR A  91      16.137  41.999   5.772  1.00 25.69           C  \nATOM    693  O   THR A  91      16.848  42.870   5.252  1.00 29.29           O  \nATOM    694  CB  THR A  91      14.157  40.860   4.594  1.00 21.94           C  \nATOM    695  OG1 THR A  91      13.342  40.810   5.786  1.00 20.91           O  \nATOM    696  CG2 THR A  91      13.740  39.709   3.681  1.00 24.44           C  \nATOM    697  N   GLN A  92      15.842  42.001   7.064  1.00 23.55           N  \nATOM    698  CA  GLN A  92      16.170  43.099   7.967  1.00 23.15           C  \nATOM    699  C   GLN A  92      17.650  43.315   8.126  1.00 25.63           C  \nATOM    700  O   GLN A  92      18.071  44.440   8.459  1.00 29.05           O  \nATOM    701  CB  GLN A  92      15.580  42.837   9.347  1.00 17.48           C  \nATOM    702  CG  GLN A  92      14.081  42.603   9.325  1.00 12.58           C  \nATOM    703  CD  GLN A  92      13.318  43.811   8.800  1.00 23.01           C  \nATOM    704  OE1 GLN A  92      12.836  43.807   7.683  1.00 24.98           O  \nATOM    705  NE2 GLN A  92      13.349  44.892   9.543  1.00 15.18           N  \nATOM    706  N   ILE A  93      18.444  42.266   7.913  1.00 25.00           N  \nATOM    707  CA  ILE A  93      19.887  42.417   8.035  1.00 25.37           C  \nATOM    708  C   ILE A  93      20.530  42.555   6.677  1.00 24.18           C  \nATOM    709  O   ILE A  93      21.744  42.639   6.577  1.00 26.26           O  \nATOM    710  CB  ILE A  93      20.557  41.231   8.872  1.00 24.44           C  \nATOM    711  CG1 ILE A  93      20.472  39.878   8.113  1.00 24.46           C  \nATOM    712  CG2 ILE A  93      19.926  41.182  10.272  1.00 22.23           C  \nATOM    713  CD1 ILE A  93      21.520  38.796   8.533  1.00 24.68           C  \nATOM    714  N   GLY A  94      19.713  42.563   5.636  1.00 24.04           N  \nATOM    715  CA  GLY A  94      20.226  42.870   4.327  1.00 25.09           C  \nATOM    716  C   GLY A  94      20.843  41.689   3.611  1.00 27.08           C  \nATOM    717  O   GLY A  94      21.680  41.866   2.723  1.00 28.80           O  \nATOM    718  N   CYS A  95      20.294  40.507   3.844  1.00 27.02           N  \nATOM    719  CA  CYS A  95      20.890  39.296   3.297  1.00 26.34           C  \nATOM    720  C   CYS A  95      20.407  39.005   1.897  1.00 26.35           C  \nATOM    721  O   CYS A  95      19.217  39.101   1.606  1.00 28.34           O  \nATOM    722  CB  CYS A  95      20.585  38.134   4.215  1.00 27.62           C  \nATOM    723  SG  CYS A  95      21.505  36.663   3.848  1.00 32.32           S  \nATOM    724  N   THR A  96      21.339  38.698   1.005  1.00 27.53           N  \nATOM    725  CA  THR A  96      20.969  38.276  -0.346  1.00 27.51           C  \nATOM    726  C   THR A  96      21.721  37.024  -0.758  1.00 27.27           C  \nATOM    727  O   THR A  96      22.753  36.645  -0.178  1.00 27.30           O  \nATOM    728  CB  THR A  96      21.298  39.331  -1.459  1.00 28.47           C  \nATOM    729  OG1 THR A  96      22.688  39.698  -1.364  1.00 28.16           O  \nATOM    730  CG2 THR A  96      20.405  40.560  -1.303  1.00 26.73           C  \nATOM    731  N   LEU A  97      21.183  36.413  -1.805  1.00 28.68           N  \nATOM    732  CA  LEU A  97      21.718  35.228  -2.473  1.00 26.62           C  \nATOM    733  C   LEU A  97      22.314  35.753  -3.779  1.00 25.49           C  \nATOM    734  O   LEU A  97      21.616  36.396  -4.577  1.00 23.96           O  \nATOM    735  CB  LEU A  97      20.518  34.349  -2.810  1.00 24.94           C  \nATOM    736  CG  LEU A  97      20.318  32.897  -2.464  1.00 28.32           C  \nATOM    737  CD1 LEU A  97      21.285  32.388  -1.422  1.00 27.79           C  \nATOM    738  CD2 LEU A  97      18.896  32.782  -2.010  1.00 26.48           C  \nATOM    739  N   ASN A  98      23.577  35.469  -4.026  1.00 26.29           N  \nATOM    740  CA  ASN A  98      24.207  35.904  -5.257  1.00 29.12           C  \nATOM    741  C   ASN A  98      24.863  34.748  -5.999  1.00 29.85           C  \nATOM    742  O   ASN A  98      25.635  33.982  -5.396  1.00 26.89           O  \nATOM    743  CB  ASN A  98      25.229  36.991  -4.938  1.00 33.75           C  \nATOM    744  CG  ASN A  98      24.609  38.190  -4.212  1.00 40.13           C  \nATOM    745  OD1 ASN A  98      24.263  38.112  -3.019  1.00 43.34           O  \nATOM    746  ND2 ASN A  98      24.354  39.252  -4.955  1.00 42.07           N  \nATOM    747  N   PHE A  99      24.539  34.602  -7.287  1.00 31.14           N  \nATOM    748  CA  PHE A  99      25.376  33.754  -8.172  1.00 35.14           C  \nATOM    749  C   PHE A  99      25.726  34.383  -9.544  1.00 34.93           C  \nATOM    750  O   PHE A  99      24.797  34.890 -10.226  1.00 36.66           O  \nATOM    751  CB  PHE A  99      24.743  32.354  -8.375  1.00 32.92           C  \nATOM    752  CG  PHE A  99      23.328  32.389  -8.856  1.00 31.47           C  \nATOM    753  CD1 PHE A  99      22.303  32.588  -7.961  1.00 29.83           C  \nATOM    754  CD2 PHE A  99      23.029  32.118 -10.181  1.00 28.13           C  \nATOM    755  CE1 PHE A  99      21.000  32.515  -8.357  1.00 27.98           C  \nATOM    756  CE2 PHE A  99      21.730  32.028 -10.613  1.00 25.49           C  \nATOM    757  CZ  PHE A  99      20.700  32.221  -9.700  1.00 27.25           C  \nTER     758      PHE A  99                                                      \nATOM    759  N   PRO B   1      22.659  36.727 -10.823  1.00 48.12           N  \nATOM    760  CA  PRO B   1      21.708  37.741 -10.269  1.00 43.36           C  \nATOM    761  C   PRO B   1      21.931  37.939  -8.779  1.00 39.59           C  \nATOM    762  O   PRO B   1      22.755  37.283  -8.190  1.00 37.70           O  \nATOM    763  CB  PRO B   1      20.263  37.289 -10.512  1.00 46.58           C  \nATOM    764  CG  PRO B   1      20.385  35.811 -10.891  1.00 48.47           C  \nATOM    765  CD  PRO B   1      21.753  35.755 -11.555  1.00 50.98           C  \nATOM    766  N   GLN B   2      21.203  38.873  -8.191  1.00 36.85           N  \nATOM    767  CA  GLN B   2      21.156  39.043  -6.744  1.00 37.15           C  \nATOM    768  C   GLN B   2      19.698  38.882  -6.389  1.00 36.43           C  \nATOM    769  O   GLN B   2      18.850  39.538  -6.975  1.00 39.41           O  \nATOM    770  CB  GLN B   2      21.625  40.447  -6.329  1.00 38.60           C  \nATOM    771  CG  GLN B   2      21.353  40.777  -4.865  1.00 39.92           C  \nATOM    772  CD  GLN B   2      22.139  41.975  -4.358  1.00 44.52           C  \nATOM    773  OE1 GLN B   2      21.577  42.881  -3.752  1.00 48.57           O  \nATOM    774  NE2 GLN B   2      23.450  41.976  -4.586  1.00 45.25           N  \nATOM    775  N   ILE B   3      19.405  38.008  -5.448  1.00 32.18           N  \nATOM    776  CA  ILE B   3      18.037  37.742  -5.100  1.00 30.91           C  \nATOM    777  C   ILE B   3      17.832  38.164  -3.660  1.00 28.84           C  \nATOM    778  O   ILE B   3      18.457  37.631  -2.746  1.00 28.43           O  \nATOM    779  CB  ILE B   3      17.694  36.224  -5.238  1.00 33.01           C  \nATOM    780  CG1 ILE B   3      17.788  35.772  -6.692  1.00 35.76           C  \nATOM    781  CG2 ILE B   3      16.284  35.967  -4.750  1.00 31.17           C  \nATOM    782  CD1 ILE B   3      18.183  34.327  -6.802  1.00 36.59           C  \nATOM    783  N   THR B   4      16.960  39.132  -3.461  1.00 24.52           N  \nATOM    784  CA  THR B   4      16.635  39.571  -2.117  1.00 26.46           C  \nATOM    785  C   THR B   4      15.555  38.634  -1.627  1.00 23.26           C  \nATOM    786  O   THR B   4      15.066  37.784  -2.372  1.00 23.16           O  \nATOM    787  CB  THR B   4      16.147  41.074  -2.110  1.00 30.32           C  \nATOM    788  OG1 THR B   4      15.093  41.256  -3.079  1.00 32.67           O  \nATOM    789  CG2 THR B   4      17.283  42.019  -2.472  1.00 30.57           C  \nATOM    790  N   LEU B   5      15.157  38.761  -0.379  1.00 21.95           N  \nATOM    791  CA  LEU B   5      14.466  37.636   0.259  1.00 21.45           C  \nATOM    792  C   LEU B   5      13.125  38.065   0.821  1.00 22.43           C  \nATOM    793  O   LEU B   5      12.585  37.446   1.733  1.00 22.26           O  \nATOM    794  CB  LEU B   5      15.340  37.047   1.374  1.00 18.69           C  \nATOM    795  CG  LEU B   5      16.622  36.365   0.892  1.00 18.41           C  \nATOM    796  CD1 LEU B   5      17.455  35.953   2.080  1.00 16.32           C  \nATOM    797  CD2 LEU B   5      16.248  35.136  -0.006  1.00 16.07           C  \nATOM    798  N   TRP B   6      12.567  39.127   0.262  1.00 21.66           N  \nATOM    799  CA  TRP B   6      11.260  39.582   0.682  1.00 21.58           C  \nATOM    800  C   TRP B   6      10.196  38.601   0.218  1.00 21.21           C  \nATOM    801  O   TRP B   6       9.192  38.404   0.903  1.00 22.05           O  \nATOM    802  CB  TRP B   6      11.004  40.992   0.135  1.00 19.59           C  \nATOM    803  CG  TRP B   6      12.065  42.014   0.478  1.00 18.40           C  \nATOM    804  CD1 TRP B   6      13.157  42.366  -0.279  1.00 17.80           C  \nATOM    805  CD2 TRP B   6      12.209  42.716   1.739  1.00 14.37           C  \nATOM    806  NE1 TRP B   6      13.979  43.196   0.470  1.00 17.13           N  \nATOM    807  CE2 TRP B   6      13.433  43.441   1.686  1.00 17.08           C  \nATOM    808  CE3 TRP B   6      11.443  42.805   2.913  1.00 17.33           C  \nATOM    809  CZ2 TRP B   6      13.914  44.211   2.785  1.00 16.59           C  \nATOM    810  CZ3 TRP B   6      11.903  43.585   3.953  1.00 15.43           C  \nATOM    811  CH2 TRP B   6      13.148  44.273   3.896  1.00 18.86           C  \nATOM    812  N   GLN B   7      10.396  38.008  -0.958  1.00 23.30           N  \nATOM    813  CA  GLN B   7       9.518  36.960  -1.516  1.00 24.55           C  \nATOM    814  C   GLN B   7      10.321  35.670  -1.433  1.00 23.64           C  \nATOM    815  O   GLN B   7      11.546  35.694  -1.298  1.00 23.66           O  \nATOM    816  CB  GLN B   7       9.215  37.238  -3.000  1.00 32.55           C  \nATOM    817  CG  GLN B   7       8.278  38.433  -3.326  1.00 41.57           C  \nATOM    818  CD  GLN B   7       7.629  38.332  -4.744  1.00 50.90           C  \nATOM    819  OE1 GLN B   7       8.319  38.100  -5.754  1.00 55.87           O  \nATOM    820  NE2 GLN B   7       6.307  38.532  -4.814  1.00 51.09           N  \nATOM    821  N   ARG B   8       9.661  34.528  -1.525  1.00 21.29           N  \nATOM    822  CA  ARG B   8      10.385  33.251  -1.642  1.00 20.70           C  \nATOM    823  C   ARG B   8      11.348  33.305  -2.780  1.00 19.16           C  \nATOM    824  O   ARG B   8      10.964  33.682  -3.906  1.00 22.46           O  \nATOM    825  CB  ARG B   8       9.435  32.061  -1.862  1.00 21.59           C  \nATOM    826  CG  ARG B   8       8.623  31.716  -0.644  1.00 27.03           C  \nATOM    827  CD  ARG B   8       7.828  30.471  -0.844  1.00 28.48           C  \nATOM    828  NE  ARG B   8       7.143  30.102   0.378  1.00 38.82           N  \nATOM    829  CZ  ARG B   8       6.523  28.938   0.561  1.00 45.44           C  \nATOM    830  NH1 ARG B   8       6.476  28.028  -0.411  1.00 47.55           N  \nATOM    831  NH2 ARG B   8       5.925  28.688   1.719  1.00 49.71           N  \nATOM    832  N   PRO B   9      12.533  32.711  -2.598  1.00 18.31           N  \nATOM    833  CA  PRO B   9      13.443  32.743  -3.746  1.00 16.67           C  \nATOM    834  C   PRO B   9      13.174  31.592  -4.703  1.00 18.20           C  \nATOM    835  O   PRO B   9      13.897  30.587  -4.698  1.00 17.79           O  \nATOM    836  CB  PRO B   9      14.813  32.658  -3.125  1.00 15.13           C  \nATOM    837  CG  PRO B   9      14.564  31.823  -1.917  1.00 13.81           C  \nATOM    838  CD  PRO B   9      13.238  32.289  -1.373  1.00 15.31           C  \nATOM    839  N   LEU B  10      12.134  31.727  -5.504  1.00 18.74           N  \nATOM    840  CA  LEU B  10      11.816  30.740  -6.534  1.00 24.75           C  \nATOM    841  C   LEU B  10      12.459  31.075  -7.877  1.00 28.33           C  \nATOM    842  O   LEU B  10      12.274  32.150  -8.406  1.00 34.15           O  \nATOM    843  CB  LEU B  10      10.303  30.637  -6.738  1.00 22.30           C  \nATOM    844  CG  LEU B  10       9.483  30.307  -5.497  1.00 26.19           C  \nATOM    845  CD1 LEU B  10       8.028  30.334  -5.876  1.00 26.68           C  \nATOM    846  CD2 LEU B  10       9.845  28.975  -4.951  1.00 25.72           C  \nATOM    847  N   VAL B  11      13.225  30.141  -8.420  1.00 29.04           N  \nATOM    848  CA  VAL B  11      13.759  30.227  -9.768  1.00 25.94           C  \nATOM    849  C   VAL B  11      13.103  29.153 -10.641  1.00 28.64           C  \nATOM    850  O   VAL B  11      12.381  28.285 -10.135  1.00 26.28           O  \nATOM    851  CB  VAL B  11      15.253  29.988  -9.735  1.00 26.71           C  \nATOM    852  CG1 VAL B  11      15.898  31.108  -8.939  1.00 26.27           C  \nATOM    853  CG2 VAL B  11      15.573  28.635  -9.104  1.00 23.17           C  \nATOM    854  N   THR B  12      13.346  29.214 -11.949  1.00 29.16           N  \nATOM    855  CA  THR B  12      12.809  28.220 -12.873  1.00 29.59           C  \nATOM    856  C   THR B  12      13.951  27.253 -13.210  1.00 27.37           C  \nATOM    857  O   THR B  12      15.089  27.656 -13.442  1.00 28.24           O  \nATOM    858  CB  THR B  12      12.259  28.907 -14.158  1.00 33.38           C  \nATOM    859  OG1 THR B  12      11.693  27.933 -15.028  1.00 41.16           O  \nATOM    860  CG2 THR B  12      13.341  29.639 -14.925  1.00 37.24           C  \nATOM    861  N   ILE B  13      13.684  25.961 -13.124  1.00 27.04           N  \nATOM    862  CA  ILE B  13      14.708  24.966 -13.446  1.00 26.55           C  \nATOM    863  C   ILE B  13      14.230  24.165 -14.639  1.00 28.05           C  \nATOM    864  O   ILE B  13      13.014  24.057 -14.918  1.00 25.03           O  \nATOM    865  CB  ILE B  13      14.993  23.953 -12.269  1.00 25.84           C  \nATOM    866  CG1 ILE B  13      13.699  23.190 -11.870  1.00 28.87           C  \nATOM    867  CG2 ILE B  13      15.564  24.705 -11.094  1.00 20.54           C  \nATOM    868  CD1 ILE B  13      13.900  22.077 -10.834  1.00 29.32           C  \nATOM    869  N   LYS B  14      15.186  23.630 -15.378  1.00 27.45           N  \nATOM    870  CA  LYS B  14      14.828  22.733 -16.464  1.00 26.92           C  \nATOM    871  C   LYS B  14      15.482  21.387 -16.141  1.00 26.01           C  \nATOM    872  O   LYS B  14      16.690  21.305 -15.886  1.00 24.75           O  \nATOM    873  CB  LYS B  14      15.340  23.256 -17.814  1.00 25.93           C  \nATOM    874  CG  LYS B  14      14.868  22.447 -18.992  1.00 27.04           C  \nATOM    875  CD  LYS B  14      14.687  23.295 -20.194  1.00 32.12           C  \nATOM    876  CE  LYS B  14      15.979  23.453 -20.922  1.00 34.02           C  \nATOM    877  NZ  LYS B  14      15.739  23.451 -22.389  1.00 41.05           N  \nATOM    878  N   ILE B  15      14.660  20.354 -16.136  1.00 26.74           N  \nATOM    879  CA  ILE B  15      15.108  18.999 -15.906  1.00 30.24           C  \nATOM    880  C   ILE B  15      14.188  18.067 -16.702  1.00 33.16           C  \nATOM    881  O   ILE B  15      12.968  18.199 -16.719  1.00 31.38           O  \nATOM    882  CB  ILE B  15      15.090  18.663 -14.360  1.00 31.34           C  \nATOM    883  CG1 ILE B  15      15.694  17.283 -14.101  1.00 32.33           C  \nATOM    884  CG2 ILE B  15      13.682  18.760 -13.780  1.00 28.02           C  \nATOM    885  CD1 ILE B  15      16.011  17.036 -12.625  1.00 33.84           C  \nATOM    886  N   GLY B  16      14.799  17.159 -17.438  1.00 36.75           N  \nATOM    887  CA  GLY B  16      14.024  16.279 -18.286  1.00 39.96           C  \nATOM    888  C   GLY B  16      13.311  17.029 -19.391  1.00 40.86           C  \nATOM    889  O   GLY B  16      12.318  16.549 -19.924  1.00 42.44           O  \nATOM    890  N   GLY B  17      13.887  18.145 -19.823  1.00 40.79           N  \nATOM    891  CA  GLY B  17      13.243  18.938 -20.850  1.00 37.08           C  \nATOM    892  C   GLY B  17      12.009  19.638 -20.345  1.00 35.82           C  \nATOM    893  O   GLY B  17      11.392  20.369 -21.084  1.00 37.78           O  \nATOM    894  N   GLN B  18      11.676  19.486 -19.073  1.00 32.85           N  \nATOM    895  CA  GLN B  18      10.572  20.249 -18.515  1.00 35.03           C  \nATOM    896  C   GLN B  18      11.056  21.466 -17.699  1.00 34.53           C  \nATOM    897  O   GLN B  18      12.196  21.494 -17.175  1.00 33.51           O  \nATOM    898  CB  GLN B  18       9.708  19.388 -17.619  1.00 40.01           C  \nATOM    899  CG  GLN B  18       8.936  18.297 -18.309  1.00 47.43           C  \nATOM    900  CD  GLN B  18       9.088  16.973 -17.566  1.00 53.35           C  \nATOM    901  OE1 GLN B  18       9.813  16.078 -18.014  1.00 55.74           O  \nATOM    902  NE2 GLN B  18       8.488  16.884 -16.371  1.00 54.03           N  \nATOM    903  N   LEU B  19      10.186  22.475 -17.590  1.00 32.63           N  \nATOM    904  CA  LEU B  19      10.450  23.647 -16.749  1.00 29.37           C  \nATOM    905  C   LEU B  19       9.631  23.511 -15.483  1.00 28.10           C  \nATOM    906  O   LEU B  19       8.432  23.277 -15.551  1.00 29.04           O  \nATOM    907  CB  LEU B  19      10.010  24.932 -17.474  1.00 28.40           C  \nATOM    908  CG  LEU B  19      10.775  25.419 -18.723  1.00 26.42           C  \nATOM    909  CD1 LEU B  19      10.226  26.727 -19.190  1.00 22.91           C  \nATOM    910  CD2 LEU B  19      12.241  25.543 -18.395  1.00 23.99           C  \nATOM    911  N   LYS B  20      10.273  23.619 -14.329  1.00 28.58           N  \nATOM    912  CA  LYS B  20       9.576  23.583 -13.044  1.00 25.77           C  \nATOM    913  C   LYS B  20      10.018  24.784 -12.260  1.00 26.35           C  \nATOM    914  O   LYS B  20      10.998  25.429 -12.605  1.00 25.15           O  \nATOM    915  CB  LYS B  20       9.970  22.364 -12.236  1.00 29.54           C  \nATOM    916  CG  LYS B  20      10.281  21.123 -13.051  1.00 36.66           C  \nATOM    917  CD  LYS B  20       9.037  20.289 -13.305  1.00 41.68           C  \nATOM    918  CE  LYS B  20       9.400  18.836 -13.595  1.00 45.08           C  \nATOM    919  NZ  LYS B  20       9.672  18.102 -12.328  1.00 46.33           N  \nATOM    920  N   GLU B  21       9.324  25.048 -11.162  1.00 24.88           N  \nATOM    921  CA  GLU B  21       9.705  26.075 -10.199  1.00 25.39           C  \nATOM    922  C   GLU B  21      10.311  25.408  -8.990  1.00 23.31           C  \nATOM    923  O   GLU B  21       9.847  24.351  -8.547  1.00 25.34           O  \nATOM    924  CB  GLU B  21       8.468  26.848  -9.767  1.00 32.42           C  \nATOM    925  CG  GLU B  21       8.676  28.343  -9.687  1.00 47.17           C  \nATOM    926  CD  GLU B  21       7.419  29.111 -10.041  1.00 57.11           C  \nATOM    927  OE1 GLU B  21       6.374  28.877  -9.383  1.00 62.83           O  \nATOM    928  OE2 GLU B  21       7.461  29.911 -11.004  1.00 64.02           O  \nATOM    929  N   ALA B  22      11.348  26.008  -8.443  1.00 16.20           N  \nATOM    930  CA  ALA B  22      12.025  25.431  -7.271  1.00 14.52           C  \nATOM    931  C   ALA B  22      12.472  26.569  -6.331  1.00 15.55           C  \nATOM    932  O   ALA B  22      12.709  27.701  -6.765  1.00 17.95           O  \nATOM    933  CB  ALA B  22      13.248  24.643  -7.708  1.00 11.99           C  \nATOM    934  N   LEU B  23      12.560  26.257  -5.054  1.00 14.37           N  \nATOM    935  CA  LEU B  23      13.017  27.151  -4.001  1.00 15.39           C  \nATOM    936  C   LEU B  23      14.518  27.005  -3.822  1.00 15.08           C  \nATOM    937  O   LEU B  23      15.008  25.915  -3.588  1.00 14.05           O  \nATOM    938  CB  LEU B  23      12.330  26.721  -2.741  1.00 16.68           C  \nATOM    939  CG  LEU B  23      12.592  27.472  -1.469  1.00 20.94           C  \nATOM    940  CD1 LEU B  23      12.006  28.877  -1.562  1.00 18.77           C  \nATOM    941  CD2 LEU B  23      11.917  26.658  -0.379  1.00 21.23           C  \nATOM    942  N   LEU B  24      15.266  28.090  -3.963  1.00 13.16           N  \nATOM    943  CA  LEU B  24      16.672  28.114  -3.511  1.00 17.92           C  \nATOM    944  C   LEU B  24      16.809  28.098  -1.992  1.00 18.17           C  \nATOM    945  O   LEU B  24      16.417  29.019  -1.338  1.00 19.32           O  \nATOM    946  CB  LEU B  24      17.416  29.342  -4.065  1.00 17.42           C  \nATOM    947  CG  LEU B  24      17.444  29.528  -5.585  1.00 19.17           C  \nATOM    948  CD1 LEU B  24      18.151  30.843  -5.884  1.00 20.12           C  \nATOM    949  CD2 LEU B  24      18.170  28.385  -6.270  1.00 19.21           C  \nATOM    950  N   ASP B  25      17.407  27.054  -1.437  1.00 19.08           N  \nATOM    951  CA  ASP B  25      17.227  26.751  -0.026  1.00 18.20           C  \nATOM    952  C   ASP B  25      18.555  26.446   0.653  1.00 19.09           C  \nATOM    953  O   ASP B  25      19.003  25.309   0.692  1.00 18.68           O  \nATOM    954  CB  ASP B  25      16.258  25.572   0.084  1.00 18.15           C  \nATOM    955  CG  ASP B  25      15.759  25.336   1.493  1.00 20.90           C  \nATOM    956  OD1 ASP B  25      16.399  25.780   2.453  1.00 23.13           O  \nATOM    957  OD2 ASP B  25      14.731  24.675   1.645  1.00 22.18           O  \nATOM    958  N   THR B  26      19.163  27.455   1.257  1.00 14.92           N  \nATOM    959  CA  THR B  26      20.441  27.290   1.920  1.00 13.68           C  \nATOM    960  C   THR B  26      20.319  26.393   3.168  1.00 15.84           C  \nATOM    961  O   THR B  26      21.316  25.867   3.637  1.00 18.69           O  \nATOM    962  CB  THR B  26      21.063  28.678   2.282  1.00 15.43           C  \nATOM    963  OG1 THR B  26      20.188  29.407   3.146  1.00 15.52           O  \nATOM    964  CG2 THR B  26      21.279  29.499   1.024  1.00 15.01           C  \nATOM    965  N   GLY B  27      19.106  26.199   3.688  1.00 13.19           N  \nATOM    966  CA  GLY B  27      18.957  25.372   4.876  1.00 13.54           C  \nATOM    967  C   GLY B  27      18.845  23.903   4.520  1.00 17.44           C  \nATOM    968  O   GLY B  27      18.660  23.054   5.417  1.00 18.85           O  \nATOM    969  N   ALA B  28      18.819  23.600   3.217  1.00 17.91           N  \nATOM    970  CA  ALA B  28      18.721  22.211   2.738  1.00 18.89           C  \nATOM    971  C   ALA B  28      20.089  21.661   2.292  1.00 20.66           C  \nATOM    972  O   ALA B  28      20.749  22.243   1.403  1.00 22.38           O  \nATOM    973  CB  ALA B  28      17.682  22.117   1.578  1.00 13.77           C  \nATOM    974  N   ASP B  29      20.536  20.559   2.918  1.00 20.64           N  \nATOM    975  CA  ASP B  29      21.779  19.912   2.496  1.00 14.85           C  \nATOM    976  C   ASP B  29      21.693  19.374   1.107  1.00 14.01           C  \nATOM    977  O   ASP B  29      22.642  19.502   0.361  1.00 17.76           O  \nATOM    978  CB  ASP B  29      22.169  18.827   3.447  1.00 15.99           C  \nATOM    979  CG  ASP B  29      22.272  19.337   4.844  1.00 22.55           C  \nATOM    980  OD1 ASP B  29      22.714  20.482   5.029  1.00 27.81           O  \nATOM    981  OD2 ASP B  29      21.836  18.647   5.778  1.00 29.43           O  \nATOM    982  N   ASP B  30      20.524  18.868   0.719  1.00 16.70           N  \nATOM    983  CA  ASP B  30      20.355  18.227  -0.584  1.00 15.10           C  \nATOM    984  C   ASP B  30      19.212  18.807  -1.371  1.00 16.38           C  \nATOM    985  O   ASP B  30      18.383  19.523  -0.846  1.00 17.11           O  \nATOM    986  CB  ASP B  30      20.084  16.745  -0.413  1.00 21.76           C  \nATOM    987  CG  ASP B  30      21.023  16.088   0.586  1.00 25.41           C  \nATOM    988  OD1 ASP B  30      22.233  15.970   0.265  1.00 25.58           O  \nATOM    989  OD2 ASP B  30      20.531  15.682   1.672  1.00 27.89           O  \nATOM    990  N   THR B  31      19.152  18.428  -2.643  1.00 18.44           N  \nATOM    991  CA  THR B  31      18.113  18.843  -3.603  1.00 15.45           C  \nATOM    992  C   THR B  31      17.019  17.743  -3.682  1.00 19.23           C  \nATOM    993  O   THR B  31      17.342  16.586  -3.904  1.00 18.95           O  \nATOM    994  CB  THR B  31      18.810  19.051  -4.967  1.00 12.28           C  \nATOM    995  OG1 THR B  31      19.740  20.123  -4.831  1.00 13.54           O  \nATOM    996  CG2 THR B  31      17.844  19.330  -6.078  1.00 10.95           C  \nATOM    997  N   VAL B  32      15.750  18.102  -3.440  1.00 19.53           N  \nATOM    998  CA  VAL B  32      14.628  17.162  -3.514  1.00 18.71           C  \nATOM    999  C   VAL B  32      13.618  17.726  -4.436  1.00 19.01           C  \nATOM   1000  O   VAL B  32      13.169  18.861  -4.263  1.00 19.90           O  \nATOM   1001  CB  VAL B  32      13.781  17.005  -2.245  1.00 20.49           C  \nATOM   1002  CG1 VAL B  32      13.297  15.592  -2.184  1.00 26.38           C  \nATOM   1003  CG2 VAL B  32      14.518  17.455  -1.007  1.00 20.87           C  \nATOM   1004  N   LEU B  33      13.199  16.926  -5.401  1.00 22.78           N  \nATOM   1005  CA  LEU B  33      12.141  17.335  -6.327  1.00 23.84           C  \nATOM   1006  C   LEU B  33      10.876  16.500  -6.065  1.00 27.19           C  \nATOM   1007  O   LEU B  33      10.948  15.389  -5.534  1.00 26.71           O  \nATOM   1008  CB  LEU B  33      12.618  17.139  -7.766  1.00 21.02           C  \nATOM   1009  CG  LEU B  33      13.889  17.846  -8.247  1.00 20.79           C  \nATOM   1010  CD1 LEU B  33      13.942  17.794  -9.731  1.00 21.64           C  \nATOM   1011  CD2 LEU B  33      13.897  19.266  -7.782  1.00 23.27           C  \nATOM   1012  N   GLU B  34       9.719  17.083  -6.361  1.00 26.46           N  \nATOM   1013  CA  GLU B  34       8.442  16.392  -6.346  1.00 26.40           C  \nATOM   1014  C   GLU B  34       8.514  15.172  -7.224  1.00 26.66           C  \nATOM   1015  O   GLU B  34       9.413  15.013  -8.040  1.00 26.75           O  \nATOM   1016  CB  GLU B  34       7.316  17.305  -6.819  1.00 24.89           C  \nATOM   1017  CG  GLU B  34       6.914  18.362  -5.808  1.00 31.34           C  \nATOM   1018  CD  GLU B  34       6.205  19.552  -6.439  1.00 32.62           C  \nATOM   1019  OE1 GLU B  34       6.323  19.742  -7.666  1.00 39.77           O  \nATOM   1020  OE2 GLU B  34       5.613  20.369  -5.715  1.00 39.65           O  \nATOM   1021  N   GLU B  35       7.526  14.309  -7.044  1.00 30.87           N  \nATOM   1022  CA  GLU B  35       7.425  13.006  -7.682  1.00 32.05           C  \nATOM   1023  C   GLU B  35       7.528  13.141  -9.172  1.00 32.29           C  \nATOM   1024  O   GLU B  35       6.660  13.711  -9.819  1.00 37.80           O  \nATOM   1025  CB  GLU B  35       6.100  12.361  -7.297  1.00 35.17           C  \nATOM   1026  CG  GLU B  35       5.907  10.953  -7.838  1.00 44.03           C  \nATOM   1027  CD  GLU B  35       7.182  10.093  -7.854  1.00 44.48           C  \nATOM   1028  OE1 GLU B  35       7.743   9.853  -6.766  1.00 38.16           O  \nATOM   1029  OE2 GLU B  35       7.521   9.561  -8.946  1.00 46.13           O  \nATOM   1030  N   MET B  36       8.627  12.651  -9.705  1.00 31.85           N  \nATOM   1031  CA  MET B  36       8.791  12.578 -11.145  1.00 33.53           C  \nATOM   1032  C   MET B  36       9.583  11.322 -11.483  1.00 33.93           C  \nATOM   1033  O   MET B  36      10.100  10.637 -10.616  1.00 36.78           O  \nATOM   1034  CB  MET B  36       9.546  13.808 -11.654  1.00 35.97           C  \nATOM   1035  CG  MET B  36      10.867  14.095 -11.014  1.00 35.75           C  \nATOM   1036  SD  MET B  36      11.575  15.547 -11.778  1.00 43.16           S  \nATOM   1037  CE  MET B  36      11.710  15.108 -13.551  1.00 42.89           C  \nATOM   1038  N   SER B  37       9.657  11.016 -12.763  1.00 33.54           N  \nATOM   1039  CA  SER B  37      10.411   9.858 -13.218  1.00 35.84           C  \nATOM   1040  C   SER B  37      11.673  10.374 -13.825  1.00 34.42           C  \nATOM   1041  O   SER B  37      11.636  11.272 -14.685  1.00 33.84           O  \nATOM   1042  CB  SER B  37       9.573   9.049 -14.221  1.00 38.59           C  \nATOM   1043  OG  SER B  37       8.330   8.594 -13.579  1.00 41.47           O  \nATOM   1044  N   LEU B  38      12.793   9.884 -13.330  1.00 35.38           N  \nATOM   1045  CA  LEU B  38      14.091  10.261 -13.857  1.00 34.72           C  \nATOM   1046  C   LEU B  38      14.818   9.018 -14.330  1.00 36.10           C  \nATOM   1047  O   LEU B  38      14.416   7.898 -13.995  1.00 35.71           O  \nATOM   1048  CB  LEU B  38      14.866  10.942 -12.759  1.00 30.77           C  \nATOM   1049  CG  LEU B  38      14.480  12.376 -12.556  1.00 26.92           C  \nATOM   1050  CD1 LEU B  38      15.159  12.900 -11.300  1.00 29.33           C  \nATOM   1051  CD2 LEU B  38      14.955  13.131 -13.766  1.00 27.40           C  \nATOM   1052  N   PRO B  39      15.767   9.161 -15.261  1.00 39.43           N  \nATOM   1053  CA  PRO B  39      16.525   8.031 -15.798  1.00 40.91           C  \nATOM   1054  C   PRO B  39      17.366   7.241 -14.777  1.00 41.38           C  \nATOM   1055  O   PRO B  39      17.943   7.817 -13.847  1.00 42.07           O  \nATOM   1056  CB  PRO B  39      17.407   8.673 -16.857  1.00 41.75           C  \nATOM   1057  CG  PRO B  39      17.532  10.100 -16.423  1.00 41.42           C  \nATOM   1058  CD  PRO B  39      16.150  10.405 -15.968  1.00 42.37           C  \nATOM   1059  N   GLY B  40      17.477   5.932 -14.999  1.00 35.62           N  \nATOM   1060  CA  GLY B  40      18.494   5.171 -14.302  1.00 33.54           C  \nATOM   1061  C   GLY B  40      18.048   4.556 -12.995  1.00 29.12           C  \nATOM   1062  O   GLY B  40      16.865   4.438 -12.729  1.00 28.38           O  \nATOM   1063  N   ARG B  41      19.000   3.939 -12.313  1.00 27.66           N  \nATOM   1064  CA  ARG B  41      18.722   3.282 -11.042  1.00 28.95           C  \nATOM   1065  C   ARG B  41      18.615   4.306  -9.916  1.00 30.49           C  \nATOM   1066  O   ARG B  41      19.168   5.390 -10.018  1.00 31.54           O  \nATOM   1067  CB  ARG B  41      19.852   2.333 -10.662  1.00 28.94           C  \nATOM   1068  CG  ARG B  41      20.359   1.417 -11.726  1.00 34.11           C  \nATOM   1069  CD  ARG B  41      20.905   0.188 -11.023  1.00 34.17           C  \nATOM   1070  NE  ARG B  41      19.927  -0.864 -11.169  1.00 38.61           N  \nATOM   1071  CZ  ARG B  41      19.354  -1.538 -10.177  1.00 35.13           C  \nATOM   1072  NH1 ARG B  41      19.839  -1.513  -8.939  1.00 27.84           N  \nATOM   1073  NH2 ARG B  41      18.333  -2.314 -10.472  1.00 27.82           N  \nATOM   1074  N   TRP B  42      17.989   3.918  -8.810  1.00 27.94           N  \nATOM   1075  CA  TRP B  42      17.920   4.766  -7.634  1.00 28.18           C  \nATOM   1076  C   TRP B  42      18.295   3.969  -6.380  1.00 30.79           C  \nATOM   1077  O   TRP B  42      18.163   2.742  -6.361  1.00 28.97           O  \nATOM   1078  CB  TRP B  42      16.525   5.338  -7.459  1.00 24.28           C  \nATOM   1079  CG  TRP B  42      15.444   4.372  -7.312  1.00 18.74           C  \nATOM   1080  CD1 TRP B  42      14.681   3.834  -8.299  1.00 16.49           C  \nATOM   1081  CD2 TRP B  42      14.840   3.957  -6.079  1.00 18.74           C  \nATOM   1082  NE1 TRP B  42      13.640   3.121  -7.756  1.00 16.06           N  \nATOM   1083  CE2 TRP B  42      13.719   3.166  -6.402  1.00 14.09           C  \nATOM   1084  CE3 TRP B  42      15.154   4.180  -4.715  1.00 20.09           C  \nATOM   1085  CZ2 TRP B  42      12.881   2.589  -5.411  1.00 18.75           C  \nATOM   1086  CZ3 TRP B  42      14.300   3.625  -3.745  1.00 22.86           C  \nATOM   1087  CH2 TRP B  42      13.168   2.842  -4.106  1.00 20.90           C  \nATOM   1088  N   LYS B  43      18.801   4.689  -5.365  1.00 31.89           N  \nATOM   1089  CA  LYS B  43      19.180   4.182  -4.032  1.00 30.18           C  \nATOM   1090  C   LYS B  43      18.127   4.736  -3.089  1.00 27.53           C  \nATOM   1091  O   LYS B  43      17.442   5.729  -3.400  1.00 25.86           O  \nATOM   1092  CB  LYS B  43      20.561   4.731  -3.581  1.00 33.16           C  \nATOM   1093  CG  LYS B  43      21.777   4.400  -4.445  1.00 40.56           C  \nATOM   1094  CD  LYS B  43      22.996   5.295  -4.048  1.00 49.90           C  \nATOM   1095  CE  LYS B  43      24.193   5.280  -5.063  1.00 52.53           C  \nATOM   1096  NZ  LYS B  43      25.251   6.324  -4.725  1.00 52.90           N  \nATOM   1097  N   PRO B  44      18.053   4.208  -1.878  1.00 25.82           N  \nATOM   1098  CA  PRO B  44      17.102   4.804  -0.946  1.00 25.30           C  \nATOM   1099  C   PRO B  44      17.754   5.853  -0.023  1.00 27.71           C  \nATOM   1100  O   PRO B  44      18.929   5.769   0.330  1.00 25.94           O  \nATOM   1101  CB  PRO B  44      16.596   3.610  -0.171  1.00 25.59           C  \nATOM   1102  CG  PRO B  44      17.803   2.676  -0.117  1.00 26.07           C  \nATOM   1103  CD  PRO B  44      18.649   2.962  -1.335  1.00 27.58           C  \nATOM   1104  N   LYS B  45      16.974   6.847   0.381  1.00 29.96           N  \nATOM   1105  CA  LYS B  45      17.443   7.812   1.371  1.00 28.39           C  \nATOM   1106  C   LYS B  45      16.334   8.328   2.257  1.00 27.43           C  \nATOM   1107  O   LYS B  45      15.192   8.470   1.828  1.00 26.93           O  \nATOM   1108  CB  LYS B  45      18.177   8.988   0.701  1.00 27.50           C  \nATOM   1109  CG  LYS B  45      19.183   9.659   1.670  1.00 27.69           C  \nATOM   1110  CD  LYS B  45      20.095  10.640   1.011  1.00 25.34           C  \nATOM   1111  CE  LYS B  45      20.751  11.491   2.069  1.00 32.56           C  \nATOM   1112  NZ  LYS B  45      21.413  12.705   1.509  1.00 32.92           N  \nATOM   1113  N   MET B  46      16.672   8.585   3.514  1.00 29.02           N  \nATOM   1114  CA  MET B  46      15.755   9.281   4.404  1.00 31.16           C  \nATOM   1115  C   MET B  46      16.373  10.584   4.732  1.00 29.75           C  \nATOM   1116  O   MET B  46      17.542  10.636   5.104  1.00 29.99           O  \nATOM   1117  CB  MET B  46      15.562   8.530   5.708  1.00 38.22           C  \nATOM   1118  CG  MET B  46      14.763   7.266   5.540  1.00 45.23           C  \nATOM   1119  SD  MET B  46      13.357   7.367   6.566  1.00 52.02           S  \nATOM   1120  CE  MET B  46      14.146   6.922   8.167  1.00 49.41           C  \nATOM   1121  N   ILE B  47      15.582  11.636   4.604  1.00 30.87           N  \nATOM   1122  CA  ILE B  47      16.003  12.986   4.955  1.00 29.85           C  \nATOM   1123  C   ILE B  47      15.018  13.507   5.961  1.00 27.34           C  \nATOM   1124  O   ILE B  47      13.822  13.222   5.884  1.00 26.79           O  \nATOM   1125  CB  ILE B  47      16.040  13.915   3.699  1.00 29.30           C  \nATOM   1126  CG1 ILE B  47      14.745  13.761   2.918  1.00 25.99           C  \nATOM   1127  CG2 ILE B  47      17.229  13.534   2.782  1.00 28.73           C  \nATOM   1128  CD1 ILE B  47      14.742  14.561   1.698  1.00 27.41           C  \nATOM   1129  N   GLY B  48      15.542  14.239   6.941  1.00 31.53           N  \nATOM   1130  CA  GLY B  48      14.714  14.799   8.014  1.00 31.93           C  \nATOM   1131  C   GLY B  48      14.762  16.314   8.114  1.00 33.10           C  \nATOM   1132  O   GLY B  48      15.803  16.952   7.888  1.00 30.88           O  \nATOM   1133  N   GLY B  49      13.583  16.896   8.239  1.00 32.08           N  \nATOM   1134  CA  GLY B  49      13.484  18.319   8.459  1.00 34.90           C  \nATOM   1135  C   GLY B  49      12.647  18.565   9.672  1.00 35.58           C  \nATOM   1136  O   GLY B  49      12.880  17.976  10.721  1.00 36.70           O  \nATOM   1137  N   ILE B  50      11.850  19.611   9.584  1.00 35.37           N  \nATOM   1138  CA  ILE B  50      10.858  19.974  10.594  1.00 35.93           C  \nATOM   1139  C   ILE B  50       9.707  18.988  10.393  1.00 35.51           C  \nATOM   1140  O   ILE B  50       9.341  18.670   9.251  1.00 34.79           O  \nATOM   1141  CB  ILE B  50      10.365  21.453  10.316  1.00 36.57           C  \nATOM   1142  CG1 ILE B  50      11.556  22.421  10.394  1.00 38.14           C  \nATOM   1143  CG2 ILE B  50       9.299  21.862  11.270  1.00 34.90           C  \nATOM   1144  CD1 ILE B  50      11.936  22.850  11.773  1.00 36.99           C  \nATOM   1145  N   GLY B  51       9.164  18.455  11.474  1.00 32.76           N  \nATOM   1146  CA  GLY B  51       8.011  17.583  11.313  1.00 34.23           C  \nATOM   1147  C   GLY B  51       8.360  16.130  11.054  1.00 37.16           C  \nATOM   1148  O   GLY B  51       7.494  15.283  11.167  1.00 40.75           O  \nATOM   1149  N   GLY B  52       9.638  15.842  10.818  1.00 36.36           N  \nATOM   1150  CA  GLY B  52      10.123  14.474  10.792  1.00 35.14           C  \nATOM   1151  C   GLY B  52      10.860  14.080   9.524  1.00 35.06           C  \nATOM   1152  O   GLY B  52      11.419  14.930   8.826  1.00 33.99           O  \nATOM   1153  N   PHE B  53      10.878  12.788   9.221  1.00 33.56           N  \nATOM   1154  CA  PHE B  53      11.638  12.302   8.079  1.00 33.93           C  \nATOM   1155  C   PHE B  53      10.739  11.914   6.924  1.00 33.07           C  \nATOM   1156  O   PHE B  53       9.601  11.543   7.137  1.00 35.98           O  \nATOM   1157  CB  PHE B  53      12.458  11.126   8.531  1.00 35.25           C  \nATOM   1158  CG  PHE B  53      13.464  11.471   9.564  1.00 39.11           C  \nATOM   1159  CD1 PHE B  53      13.092  11.697  10.886  1.00 40.72           C  \nATOM   1160  CD2 PHE B  53      14.789  11.625   9.189  1.00 40.77           C  \nATOM   1161  CE1 PHE B  53      14.036  12.076  11.825  1.00 42.79           C  \nATOM   1162  CE2 PHE B  53      15.753  12.001  10.078  1.00 41.95           C  \nATOM   1163  CZ  PHE B  53      15.392  12.225  11.421  1.00 44.36           C  \nATOM   1164  N   ILE B  54      11.204  12.078   5.695  1.00 30.50           N  \nATOM   1165  CA  ILE B  54      10.538  11.431   4.563  1.00 28.82           C  \nATOM   1166  C   ILE B  54      11.513  10.453   3.866  1.00 28.68           C  \nATOM   1167  O   ILE B  54      12.727  10.529   4.052  1.00 30.25           O  \nATOM   1168  CB  ILE B  54       9.923  12.446   3.500  1.00 25.49           C  \nATOM   1169  CG1 ILE B  54      10.968  13.414   2.964  1.00 24.37           C  \nATOM   1170  CG2 ILE B  54       8.754  13.195   4.090  1.00 27.89           C  \nATOM   1171  CD1 ILE B  54      10.571  14.020   1.616  1.00 16.71           C  \nATOM   1172  N   LYS B  55      10.983   9.503   3.111  1.00 29.03           N  \nATOM   1173  CA  LYS B  55      11.816   8.478   2.482  1.00 31.48           C  \nATOM   1174  C   LYS B  55      11.862   8.988   1.074  1.00 28.45           C  \nATOM   1175  O   LYS B  55      10.827   9.256   0.525  1.00 28.39           O  \nATOM   1176  CB  LYS B  55      11.062   7.136   2.489  1.00 38.52           C  \nATOM   1177  CG  LYS B  55      11.699   5.963   3.273  1.00 45.52           C  \nATOM   1178  CD  LYS B  55      13.070   5.502   2.689  1.00 51.68           C  \nATOM   1179  CE  LYS B  55      12.949   4.923   1.253  1.00 55.32           C  \nATOM   1180  NZ  LYS B  55      13.964   5.445   0.291  1.00 51.46           N  \nATOM   1181  N   VAL B  56      13.024   9.137   0.474  1.00 25.88           N  \nATOM   1182  CA  VAL B  56      13.072   9.652  -0.897  1.00 26.87           C  \nATOM   1183  C   VAL B  56      13.885   8.719  -1.786  1.00 26.06           C  \nATOM   1184  O   VAL B  56      14.547   7.817  -1.279  1.00 29.12           O  \nATOM   1185  CB  VAL B  56      13.757  11.033  -0.959  1.00 27.47           C  \nATOM   1186  CG1 VAL B  56      12.766  12.134  -0.523  1.00 27.66           C  \nATOM   1187  CG2 VAL B  56      15.032  11.016  -0.119  1.00 29.79           C  \nATOM   1188  N   ARG B  57      13.889   8.977  -3.102  1.00 24.26           N  \nATOM   1189  CA  ARG B  57      14.697   8.220  -4.083  1.00 21.61           C  \nATOM   1190  C   ARG B  57      15.894   9.023  -4.591  1.00 20.76           C  \nATOM   1191  O   ARG B  57      15.735  10.066  -5.210  1.00 24.14           O  \nATOM   1192  CB  ARG B  57      13.862   7.854  -5.298  1.00 20.35           C  \nATOM   1193  CG  ARG B  57      12.767   6.845  -5.041  1.00 26.15           C  \nATOM   1194  CD  ARG B  57      12.224   6.316  -6.354  1.00 24.10           C  \nATOM   1195  NE  ARG B  57      10.944   6.937  -6.617  1.00 34.58           N  \nATOM   1196  CZ  ARG B  57      10.717   7.776  -7.614  1.00 31.59           C  \nATOM   1197  NH1 ARG B  57      11.534   7.792  -8.658  1.00 33.77           N  \nATOM   1198  NH2 ARG B  57       9.555   8.403  -7.678  1.00 29.56           N  \nATOM   1199  N   GLN B  58      17.095   8.516  -4.388  1.00 19.42           N  \nATOM   1200  CA  GLN B  58      18.306   9.218  -4.819  1.00 21.62           C  \nATOM   1201  C   GLN B  58      18.742   8.833  -6.226  1.00 23.18           C  \nATOM   1202  O   GLN B  58      19.157   7.694  -6.438  1.00 26.34           O  \nATOM   1203  CB  GLN B  58      19.465   8.920  -3.861  1.00 20.63           C  \nATOM   1204  CG  GLN B  58      20.738   9.622  -4.271  1.00 18.81           C  \nATOM   1205  CD  GLN B  58      21.825   9.463  -3.248  1.00 20.16           C  \nATOM   1206  OE1 GLN B  58      21.554   9.424  -2.048  1.00 28.16           O  \nATOM   1207  NE2 GLN B  58      23.045   9.365  -3.692  1.00 21.91           N  \nATOM   1208  N   TYR B  59      18.705   9.773  -7.167  1.00 21.35           N  \nATOM   1209  CA  TYR B  59      19.361   9.587  -8.464  1.00 19.01           C  \nATOM   1210  C   TYR B  59      20.689  10.330  -8.544  1.00 21.82           C  \nATOM   1211  O   TYR B  59      20.860  11.368  -7.943  1.00 25.32           O  \nATOM   1212  CB  TYR B  59      18.472  10.082  -9.563  1.00 18.59           C  \nATOM   1213  CG  TYR B  59      17.116   9.383  -9.609  1.00 15.73           C  \nATOM   1214  CD1 TYR B  59      16.157   9.612  -8.615  1.00 15.43           C  \nATOM   1215  CD2 TYR B  59      16.814   8.484 -10.637  1.00 19.10           C  \nATOM   1216  CE1 TYR B  59      14.959   8.977  -8.640  1.00 16.84           C  \nATOM   1217  CE2 TYR B  59      15.647   7.851 -10.673  1.00 19.50           C  \nATOM   1218  CZ  TYR B  59      14.704   8.066  -9.679  1.00 22.02           C  \nATOM   1219  OH  TYR B  59      13.561   7.307  -9.711  1.00 23.01           O  \nATOM   1220  N   ASP B  60      21.665   9.797  -9.258  1.00 26.17           N  \nATOM   1221  CA  ASP B  60      22.959  10.470  -9.336  1.00 25.69           C  \nATOM   1222  C   ASP B  60      23.303  10.921 -10.737  1.00 27.15           C  \nATOM   1223  O   ASP B  60      22.793  10.396 -11.707  1.00 26.71           O  \nATOM   1224  CB  ASP B  60      24.042   9.554  -8.834  1.00 30.50           C  \nATOM   1225  CG  ASP B  60      23.843   9.184  -7.407  1.00 36.31           C  \nATOM   1226  OD1 ASP B  60      23.463  10.074  -6.620  1.00 37.41           O  \nATOM   1227  OD2 ASP B  60      24.107   8.012  -7.044  1.00 40.37           O  \nATOM   1228  N   GLN B  61      24.189  11.897 -10.837  1.00 27.15           N  \nATOM   1229  CA  GLN B  61      24.622  12.478 -12.111  1.00 29.27           C  \nATOM   1230  C   GLN B  61      23.474  12.903 -13.022  1.00 28.21           C  \nATOM   1231  O   GLN B  61      23.492  12.665 -14.229  1.00 29.57           O  \nATOM   1232  CB  GLN B  61      25.596  11.549 -12.869  1.00 35.98           C  \nATOM   1233  CG  GLN B  61      26.892  12.283 -13.369  1.00 45.09           C  \nATOM   1234  CD  GLN B  61      28.007  11.392 -13.985  1.00 50.40           C  \nATOM   1235  OE1 GLN B  61      28.747  11.845 -14.875  1.00 49.27           O  \nATOM   1236  NE2 GLN B  61      28.197  10.173 -13.442  1.00 55.52           N  \nATOM   1237  N   ILE B  62      22.493  13.589 -12.452  1.00 26.57           N  \nATOM   1238  CA  ILE B  62      21.380  14.141 -13.224  1.00 24.82           C  \nATOM   1239  C   ILE B  62      21.710  15.575 -13.686  1.00 25.46           C  \nATOM   1240  O   ILE B  62      22.247  16.373 -12.924  1.00 25.12           O  \nATOM   1241  CB  ILE B  62      20.090  14.147 -12.331  1.00 24.26           C  \nATOM   1242  CG1 ILE B  62      19.709  12.702 -11.952  1.00 23.74           C  \nATOM   1243  CG2 ILE B  62      18.950  14.826 -13.045  1.00 21.48           C  \nATOM   1244  CD1 ILE B  62      19.068  11.933 -13.057  1.00 23.09           C  \nATOM   1245  N   LEU B  63      21.400  15.900 -14.931  1.00 25.95           N  \nATOM   1246  CA  LEU B  63      21.600  17.263 -15.431  1.00 29.84           C  \nATOM   1247  C   LEU B  63      20.386  18.085 -15.052  1.00 30.58           C  \nATOM   1248  O   LEU B  63      19.260  17.703 -15.355  1.00 31.36           O  \nATOM   1249  CB  LEU B  63      21.769  17.265 -16.962  1.00 32.16           C  \nATOM   1250  CG  LEU B  63      21.792  18.587 -17.759  1.00 33.80           C  \nATOM   1251  CD1 LEU B  63      22.903  19.529 -17.300  1.00 36.66           C  \nATOM   1252  CD2 LEU B  63      21.997  18.246 -19.205  1.00 38.83           C  \nATOM   1253  N   ILE B  64      20.626  19.203 -14.381  1.00 31.59           N  \nATOM   1254  CA  ILE B  64      19.548  20.111 -14.029  1.00 31.52           C  \nATOM   1255  C   ILE B  64      20.089  21.523 -14.223  1.00 33.29           C  \nATOM   1256  O   ILE B  64      21.175  21.858 -13.763  1.00 33.56           O  \nATOM   1257  CB  ILE B  64      19.107  19.880 -12.540  1.00 29.35           C  \nATOM   1258  CG1 ILE B  64      18.216  20.990 -12.036  1.00 30.67           C  \nATOM   1259  CG2 ILE B  64      20.311  19.766 -11.655  1.00 34.19           C  \nATOM   1260  CD1 ILE B  64      17.324  20.544 -10.930  1.00 34.50           C  \nATOM   1261  N   GLU B  65      19.327  22.330 -14.953  1.00 35.37           N  \nATOM   1262  CA  GLU B  65      19.661  23.719 -15.251  1.00 34.26           C  \nATOM   1263  C   GLU B  65      18.938  24.686 -14.338  1.00 33.11           C  \nATOM   1264  O   GLU B  65      17.700  24.745 -14.345  1.00 32.35           O  \nATOM   1265  CB  GLU B  65      19.282  24.017 -16.688  1.00 37.05           C  \nATOM   1266  CG  GLU B  65      20.180  25.011 -17.326  1.00 48.15           C  \nATOM   1267  CD  GLU B  65      19.960  25.126 -18.805  1.00 54.00           C  \nATOM   1268  OE1 GLU B  65      19.601  24.094 -19.445  1.00 54.40           O  \nATOM   1269  OE2 GLU B  65      20.214  26.241 -19.314  1.00 59.11           O  \nATOM   1270  N   ILE B  66      19.709  25.427 -13.547  1.00 34.12           N  \nATOM   1271  CA  ILE B  66      19.159  26.431 -12.654  1.00 36.05           C  \nATOM   1272  C   ILE B  66      19.519  27.864 -13.127  1.00 37.57           C  \nATOM   1273  O   ILE B  66      20.684  28.254 -13.167  1.00 36.67           O  \nATOM   1274  CB  ILE B  66      19.663  26.199 -11.203  1.00 33.70           C  \nATOM   1275  CG1 ILE B  66      19.566  24.717 -10.848  1.00 32.55           C  \nATOM   1276  CG2 ILE B  66      18.824  27.018 -10.232  1.00 33.60           C  \nATOM   1277  CD1 ILE B  66      20.510  24.280  -9.745  1.00 35.00           C  \nATOM   1278  N   CYS B  67      18.504  28.630 -13.516  1.00 41.68           N  \nATOM   1279  CA  CYS B  67      18.684  29.971 -14.104  1.00 44.87           C  \nATOM   1280  C   CYS B  67      19.685  29.990 -15.245  1.00 44.44           C  \nATOM   1281  O   CYS B  67      20.565  30.852 -15.294  1.00 42.31           O  \nATOM   1282  CB  CYS B  67      19.124  30.970 -13.037  1.00 48.45           C  \nATOM   1283  SG  CYS B  67      17.736  31.542 -12.037  1.00 54.18           S  \nATOM   1284  N   GLY B  68      19.562  29.010 -16.143  1.00 43.24           N  \nATOM   1285  CA  GLY B  68      20.485  28.891 -17.256  1.00 41.28           C  \nATOM   1286  C   GLY B  68      21.899  28.603 -16.811  1.00 41.98           C  \nATOM   1287  O   GLY B  68      22.843  28.970 -17.493  1.00 46.85           O  \nATOM   1288  N   HIS B  69      22.059  28.002 -15.633  1.00 40.00           N  \nATOM   1289  CA  HIS B  69      23.354  27.479 -15.197  1.00 36.63           C  \nATOM   1290  C   HIS B  69      23.178  25.984 -15.087  1.00 34.62           C  \nATOM   1291  O   HIS B  69      22.307  25.523 -14.354  1.00 32.72           O  \nATOM   1292  CB  HIS B  69      23.711  27.993 -13.810  1.00 39.25           C  \nATOM   1293  CG  HIS B  69      23.976  29.473 -13.740  1.00 44.38           C  \nATOM   1294  ND1 HIS B  69      25.177  29.994 -13.361  1.00 46.88           N  \nATOM   1295  CD2 HIS B  69      23.114  30.512 -13.920  1.00 45.80           C  \nATOM   1296  CE1 HIS B  69      25.058  31.325 -13.286  1.00 50.18           C  \nATOM   1297  NE2 HIS B  69      23.849  31.652 -13.613  1.00 47.74           N  \nATOM   1298  N   LYS B  70      23.995  25.240 -15.820  1.00 33.27           N  \nATOM   1299  CA  LYS B  70      23.935  23.791 -15.800  1.00 31.17           C  \nATOM   1300  C   LYS B  70      24.749  23.243 -14.652  1.00 29.41           C  \nATOM   1301  O   LYS B  70      25.875  23.676 -14.403  1.00 29.56           O  \nATOM   1302  CB  LYS B  70      24.423  23.212 -17.115  1.00 32.71           C  \nATOM   1303  CG  LYS B  70      23.463  23.445 -18.279  1.00 34.39           C  \nATOM   1304  CD  LYS B  70      24.261  23.524 -19.576  1.00 44.19           C  \nATOM   1305  CE  LYS B  70      23.377  23.737 -20.816  1.00 48.61           C  \nATOM   1306  NZ  LYS B  70      22.863  22.443 -21.404  1.00 54.35           N  \nATOM   1307  N   ALA B  71      24.104  22.353 -13.909  1.00 24.69           N  \nATOM   1308  CA  ALA B  71      24.689  21.612 -12.802  1.00 23.65           C  \nATOM   1309  C   ALA B  71      24.391  20.156 -13.159  1.00 24.51           C  \nATOM   1310  O   ALA B  71      23.339  19.865 -13.735  1.00 24.89           O  \nATOM   1311  CB  ALA B  71      23.991  21.992 -11.485  1.00 16.65           C  \nATOM   1312  N   ILE B  72      25.330  19.253 -12.902  1.00 25.50           N  \nATOM   1313  CA  ILE B  72      25.048  17.816 -13.016  1.00 24.06           C  \nATOM   1314  C   ILE B  72      25.312  17.246 -11.637  1.00 22.15           C  \nATOM   1315  O   ILE B  72      26.442  17.315 -11.167  1.00 23.87           O  \nATOM   1316  CB  ILE B  72      26.029  17.094 -13.983  1.00 24.38           C  \nATOM   1317  CG1 ILE B  72      26.092  17.805 -15.333  1.00 26.24           C  \nATOM   1318  CG2 ILE B  72      25.615  15.649 -14.171  1.00 23.69           C  \nATOM   1319  CD1 ILE B  72      27.241  17.224 -16.197  1.00 23.26           C  \nATOM   1320  N   GLY B  73      24.303  16.690 -10.975  1.00 19.12           N  \nATOM   1321  CA  GLY B  73      24.545  16.248  -9.616  1.00 19.31           C  \nATOM   1322  C   GLY B  73      23.470  15.337  -9.095  1.00 19.37           C  \nATOM   1323  O   GLY B  73      22.674  14.852  -9.881  1.00 21.87           O  \nATOM   1324  N   THR B  74      23.517  15.041  -7.794  1.00 19.61           N  \nATOM   1325  CA  THR B  74      22.568  14.162  -7.116  1.00 19.07           C  \nATOM   1326  C   THR B  74      21.280  14.889  -6.829  1.00 22.17           C  \nATOM   1327  O   THR B  74      21.299  16.005  -6.275  1.00 19.62           O  \nATOM   1328  CB  THR B  74      23.128  13.638  -5.748  1.00 19.04           C  \nATOM   1329  OG1 THR B  74      24.323  12.880  -5.961  1.00 24.28           O  \nATOM   1330  CG2 THR B  74      22.071  12.763  -5.030  1.00 17.43           C  \nATOM   1331  N   VAL B  75      20.177  14.227  -7.192  1.00 18.83           N  \nATOM   1332  CA  VAL B  75      18.832  14.773  -7.068  1.00 20.46           C  \nATOM   1333  C   VAL B  75      17.989  13.688  -6.360  1.00 22.85           C  \nATOM   1334  O   VAL B  75      17.993  12.504  -6.743  1.00 20.15           O  \nATOM   1335  CB  VAL B  75      18.229  15.113  -8.501  1.00 22.69           C  \nATOM   1336  CG1 VAL B  75      16.760  15.421  -8.434  1.00 19.10           C  \nATOM   1337  CG2 VAL B  75      18.967  16.317  -9.099  1.00 18.68           C  \nATOM   1338  N   LEU B  76      17.295  14.086  -5.303  1.00 21.32           N  \nATOM   1339  CA  LEU B  76      16.390  13.196  -4.575  1.00 19.82           C  \nATOM   1340  C   LEU B  76      14.972  13.423  -5.073  1.00 21.74           C  \nATOM   1341  O   LEU B  76      14.652  14.514  -5.518  1.00 25.18           O  \nATOM   1342  CB  LEU B  76      16.450  13.476  -3.067  1.00 16.45           C  \nATOM   1343  CG  LEU B  76      17.787  13.595  -2.330  1.00 15.15           C  \nATOM   1344  CD1 LEU B  76      17.591  13.640  -0.845  1.00 14.83           C  \nATOM   1345  CD2 LEU B  76      18.678  12.463  -2.705  1.00 20.59           C  \nATOM   1346  N   VAL B  77      14.135  12.391  -5.049  1.00 23.03           N  \nATOM   1347  CA  VAL B  77      12.749  12.509  -5.485  1.00 17.63           C  \nATOM   1348  C   VAL B  77      11.826  11.894  -4.472  1.00 17.51           C  \nATOM   1349  O   VAL B  77      12.052  10.766  -3.999  1.00 16.69           O  \nATOM   1350  CB  VAL B  77      12.502  11.835  -6.868  1.00 18.16           C  \nATOM   1351  CG1 VAL B  77      11.065  12.148  -7.398  1.00 20.02           C  \nATOM   1352  CG2 VAL B  77      13.593  12.322  -7.843  1.00 16.66           C  \nATOM   1353  N   GLY B  78      10.778  12.616  -4.125  1.00 16.55           N  \nATOM   1354  CA  GLY B  78      10.004  12.229  -2.965  1.00 20.06           C  \nATOM   1355  C   GLY B  78       8.832  13.128  -2.672  1.00 21.31           C  \nATOM   1356  O   GLY B  78       8.614  14.117  -3.393  1.00 24.13           O  \nATOM   1357  N   PRO B  79       8.032  12.814  -1.646  1.00 19.47           N  \nATOM   1358  CA  PRO B  79       6.887  13.664  -1.350  1.00 21.78           C  \nATOM   1359  C   PRO B  79       7.292  14.915  -0.550  1.00 21.89           C  \nATOM   1360  O   PRO B  79       7.007  15.036   0.638  1.00 22.16           O  \nATOM   1361  CB  PRO B  79       5.951  12.742  -0.594  1.00 17.28           C  \nATOM   1362  CG  PRO B  79       6.838  11.781   0.040  1.00 20.54           C  \nATOM   1363  CD  PRO B  79       8.096  11.665  -0.739  1.00 20.64           C  \nATOM   1364  N   THR B  80       7.997  15.816  -1.220  1.00 24.38           N  \nATOM   1365  CA  THR B  80       8.324  17.137  -0.702  1.00 22.15           C  \nATOM   1366  C   THR B  80       7.227  18.114  -1.090  1.00 20.84           C  \nATOM   1367  O   THR B  80       6.528  17.896  -2.080  1.00 20.99           O  \nATOM   1368  CB  THR B  80       9.677  17.594  -1.299  1.00 21.20           C  \nATOM   1369  OG1 THR B  80       9.952  18.951  -0.924  1.00 22.05           O  \nATOM   1370  CG2 THR B  80       9.688  17.449  -2.825  1.00 13.16           C  \nATOM   1371  N   PRO B  81       6.922  19.074  -0.214  1.00 24.57           N  \nATOM   1372  CA  PRO B  81       5.896  20.066  -0.556  1.00 24.68           C  \nATOM   1373  C   PRO B  81       6.244  20.969  -1.727  1.00 26.51           C  \nATOM   1374  O   PRO B  81       5.343  21.294  -2.509  1.00 32.43           O  \nATOM   1375  CB  PRO B  81       5.694  20.874   0.729  1.00 22.89           C  \nATOM   1376  CG  PRO B  81       6.274  19.954   1.831  1.00 24.08           C  \nATOM   1377  CD  PRO B  81       7.387  19.243   1.190  1.00 21.46           C  \nATOM   1378  N   VAL B  82       7.520  21.355  -1.868  1.00 23.91           N  \nATOM   1379  CA  VAL B  82       7.990  22.207  -2.983  1.00 24.09           C  \nATOM   1380  C   VAL B  82       9.255  21.636  -3.581  1.00 21.54           C  \nATOM   1381  O   VAL B  82       9.973  20.911  -2.929  1.00 26.47           O  \nATOM   1382  CB  VAL B  82       8.375  23.616  -2.484  1.00 26.47           C  \nATOM   1383  CG1 VAL B  82       7.122  24.513  -2.361  1.00 26.39           C  \nATOM   1384  CG2 VAL B  82       9.101  23.485  -1.163  1.00 24.12           C  \nATOM   1385  N   ASN B  83       9.588  21.960  -4.812  1.00 16.61           N  \nATOM   1386  CA  ASN B  83      10.914  21.521  -5.319  1.00 16.90           C  \nATOM   1387  C   ASN B  83      11.922  22.373  -4.576  1.00 19.55           C  \nATOM   1388  O   ASN B  83      11.716  23.574  -4.429  1.00 18.36           O  \nATOM   1389  CB  ASN B  83      11.068  21.763  -6.823  1.00 16.55           C  \nATOM   1390  CG  ASN B  83      10.096  20.950  -7.647  1.00 22.00           C  \nATOM   1391  OD1 ASN B  83      10.013  19.733  -7.494  1.00 23.24           O  \nATOM   1392  ND2 ASN B  83       9.305  21.627  -8.498  1.00 22.85           N  \nATOM   1393  N   ILE B  84      12.983  21.755  -4.066  1.00 17.31           N  \nATOM   1394  CA  ILE B  84      13.979  22.449  -3.233  1.00 13.51           C  \nATOM   1395  C   ILE B  84      15.345  22.255  -3.870  1.00 19.87           C  \nATOM   1396  O   ILE B  84      15.779  21.111  -4.072  1.00 20.54           O  \nATOM   1397  CB  ILE B  84      14.041  21.833  -1.837  1.00 10.82           C  \nATOM   1398  CG1 ILE B  84      12.754  22.151  -1.088  1.00 13.42           C  \nATOM   1399  CG2 ILE B  84      15.323  22.264  -1.122  1.00 11.48           C  \nATOM   1400  CD1 ILE B  84      12.438  21.217   0.060  1.00 20.08           C  \nATOM   1401  N   ILE B  85      16.044  23.346  -4.167  1.00 19.47           N  \nATOM   1402  CA  ILE B  85      17.441  23.243  -4.575  1.00 19.69           C  \nATOM   1403  C   ILE B  85      18.305  23.504  -3.345  1.00 22.78           C  \nATOM   1404  O   ILE B  85      18.262  24.613  -2.802  1.00 24.74           O  \nATOM   1405  CB  ILE B  85      17.805  24.332  -5.644  1.00 18.51           C  \nATOM   1406  CG1 ILE B  85      16.809  24.299  -6.827  1.00 19.44           C  \nATOM   1407  CG2 ILE B  85      19.271  24.191  -6.067  1.00 14.76           C  \nATOM   1408  CD1 ILE B  85      16.672  22.956  -7.581  1.00 22.90           C  \nATOM   1409  N   GLY B  86      19.121  22.530  -2.936  1.00 19.72           N  \nATOM   1410  CA  GLY B  86      19.857  22.642  -1.690  1.00 14.65           C  \nATOM   1411  C   GLY B  86      21.324  22.800  -1.940  1.00 13.18           C  \nATOM   1412  O   GLY B  86      21.750  22.958  -3.056  1.00 13.07           O  \nATOM   1413  N   ARG B  87      22.117  22.755  -0.887  1.00 11.71           N  \nATOM   1414  CA  ARG B  87      23.533  23.126  -0.985  1.00 14.23           C  \nATOM   1415  C   ARG B  87      24.413  22.356  -1.973  1.00 19.73           C  \nATOM   1416  O   ARG B  87      25.398  22.903  -2.461  1.00 17.28           O  \nATOM   1417  CB  ARG B  87      24.171  23.147   0.403  1.00 15.02           C  \nATOM   1418  CG  ARG B  87      23.646  24.256   1.283  1.00  8.76           C  \nATOM   1419  CD  ARG B  87      24.429  24.306   2.576  1.00 16.02           C  \nATOM   1420  NE  ARG B  87      24.362  23.068   3.371  1.00 21.61           N  \nATOM   1421  CZ  ARG B  87      25.357  22.185   3.495  1.00 21.15           C  \nATOM   1422  NH1 ARG B  87      26.467  22.303   2.795  1.00 18.57           N  \nATOM   1423  NH2 ARG B  87      25.255  21.190   4.368  1.00 26.79           N  \nATOM   1424  N   ASN B  88      24.074  21.101  -2.275  1.00 18.56           N  \nATOM   1425  CA  ASN B  88      24.950  20.312  -3.132  1.00 17.41           C  \nATOM   1426  C   ASN B  88      24.980  20.893  -4.527  1.00 19.59           C  \nATOM   1427  O   ASN B  88      26.015  20.853  -5.202  1.00 20.40           O  \nATOM   1428  CB  ASN B  88      24.512  18.849  -3.197  1.00 19.90           C  \nATOM   1429  CG  ASN B  88      23.126  18.649  -3.777  1.00 15.28           C  \nATOM   1430  OD1 ASN B  88      22.167  19.280  -3.351  1.00 22.61           O  \nATOM   1431  ND2 ASN B  88      23.020  17.775  -4.767  1.00 16.65           N  \nATOM   1432  N   LEU B  89      23.863  21.490  -4.949  1.00 20.98           N  \nATOM   1433  CA  LEU B  89      23.811  22.125  -6.273  1.00 21.49           C  \nATOM   1434  C   LEU B  89      24.018  23.645  -6.231  1.00 20.99           C  \nATOM   1435  O   LEU B  89      24.321  24.242  -7.236  1.00 21.25           O  \nATOM   1436  CB  LEU B  89      22.457  21.815  -6.962  1.00 20.00           C  \nATOM   1437  CG  LEU B  89      22.219  20.372  -7.436  1.00 17.87           C  \nATOM   1438  CD1 LEU B  89      20.937  20.300  -8.243  1.00 20.88           C  \nATOM   1439  CD2 LEU B  89      23.408  19.901  -8.273  1.00 17.17           C  \nATOM   1440  N   LEU B  90      23.819  24.255  -5.075  1.00 20.01           N  \nATOM   1441  CA  LEU B  90      24.020  25.701  -4.954  1.00 22.17           C  \nATOM   1442  C   LEU B  90      25.511  26.005  -5.072  1.00 19.95           C  \nATOM   1443  O   LEU B  90      25.907  26.959  -5.732  1.00 21.08           O  \nATOM   1444  CB  LEU B  90      23.430  26.234  -3.624  1.00 17.71           C  \nATOM   1445  CG  LEU B  90      21.900  26.309  -3.475  1.00 16.96           C  \nATOM   1446  CD1 LEU B  90      21.487  26.779  -2.081  1.00 11.88           C  \nATOM   1447  CD2 LEU B  90      21.358  27.241  -4.506  1.00 18.70           C  \nATOM   1448  N   THR B  91      26.336  25.143  -4.491  1.00 23.70           N  \nATOM   1449  CA  THR B  91      27.785  25.304  -4.546  1.00 23.96           C  \nATOM   1450  C   THR B  91      28.270  25.184  -5.969  1.00 24.81           C  \nATOM   1451  O   THR B  91      29.168  25.903  -6.378  1.00 26.72           O  \nATOM   1452  CB  THR B  91      28.501  24.261  -3.669  1.00 21.26           C  \nATOM   1453  OG1 THR B  91      27.898  22.990  -3.894  1.00 25.49           O  \nATOM   1454  CG2 THR B  91      28.366  24.579  -2.208  1.00 17.64           C  \nATOM   1455  N   GLN B  92      27.619  24.323  -6.741  1.00 25.95           N  \nATOM   1456  CA  GLN B  92      28.009  24.110  -8.150  1.00 27.31           C  \nATOM   1457  C   GLN B  92      27.823  25.361  -8.999  1.00 27.97           C  \nATOM   1458  O   GLN B  92      28.719  25.701  -9.794  1.00 30.31           O  \nATOM   1459  CB  GLN B  92      27.226  22.956  -8.793  1.00 24.09           C  \nATOM   1460  CG  GLN B  92      27.720  21.588  -8.406  1.00 25.97           C  \nATOM   1461  CD  GLN B  92      27.313  20.496  -9.421  1.00 27.56           C  \nATOM   1462  OE1 GLN B  92      27.138  20.746 -10.620  1.00 26.23           O  \nATOM   1463  NE2 GLN B  92      27.230  19.281  -8.941  1.00 27.50           N  \nATOM   1464  N   ILE B  93      26.683  26.043  -8.820  1.00 28.73           N  \nATOM   1465  CA  ILE B  93      26.362  27.233  -9.606  1.00 28.11           C  \nATOM   1466  C   ILE B  93      26.904  28.524  -8.963  1.00 30.61           C  \nATOM   1467  O   ILE B  93      26.574  29.627  -9.385  1.00 32.40           O  \nATOM   1468  CB  ILE B  93      24.838  27.349  -9.857  1.00 23.33           C  \nATOM   1469  CG1 ILE B  93      24.103  27.648  -8.559  1.00 25.74           C  \nATOM   1470  CG2 ILE B  93      24.300  26.092 -10.460  1.00 21.29           C  \nATOM   1471  CD1 ILE B  93      22.672  28.017  -8.785  1.00 27.65           C  \nATOM   1472  N   GLY B  94      27.741  28.369  -7.949  1.00 30.93           N  \nATOM   1473  CA  GLY B  94      28.481  29.498  -7.421  1.00 31.94           C  \nATOM   1474  C   GLY B  94      27.749  30.439  -6.488  1.00 30.20           C  \nATOM   1475  O   GLY B  94      28.177  31.555  -6.261  1.00 31.24           O  \nATOM   1476  N   CYS B  95      26.808  29.899  -5.748  1.00 27.82           N  \nATOM   1477  CA  CYS B  95      25.895  30.718  -5.004  1.00 26.76           C  \nATOM   1478  C   CYS B  95      26.408  30.993  -3.598  1.00 27.20           C  \nATOM   1479  O   CYS B  95      26.769  30.065  -2.870  1.00 27.85           O  \nATOM   1480  CB  CYS B  95      24.578  29.989  -4.978  1.00 27.09           C  \nATOM   1481  SG  CYS B  95      23.221  30.929  -4.410  1.00 36.34           S  \nATOM   1482  N   THR B  96      26.473  32.277  -3.244  1.00 26.04           N  \nATOM   1483  CA  THR B  96      26.794  32.734  -1.882  1.00 25.60           C  \nATOM   1484  C   THR B  96      25.672  33.544  -1.205  1.00 24.26           C  \nATOM   1485  O   THR B  96      24.760  34.079  -1.852  1.00 23.28           O  \nATOM   1486  CB  THR B  96      28.051  33.660  -1.858  1.00 27.82           C  \nATOM   1487  OG1 THR B  96      27.888  34.689  -2.857  1.00 31.12           O  \nATOM   1488  CG2 THR B  96      29.316  32.870  -2.141  1.00 24.73           C  \nATOM   1489  N   LEU B  97      25.759  33.617   0.119  1.00 24.54           N  \nATOM   1490  CA  LEU B  97      24.902  34.468   0.963  1.00 27.92           C  \nATOM   1491  C   LEU B  97      25.714  35.689   1.398  1.00 30.25           C  \nATOM   1492  O   LEU B  97      26.854  35.558   1.870  1.00 29.52           O  \nATOM   1493  CB  LEU B  97      24.489  33.718   2.236  1.00 27.18           C  \nATOM   1494  CG  LEU B  97      23.211  32.901   2.344  1.00 22.23           C  \nATOM   1495  CD1 LEU B  97      23.114  32.358   3.719  1.00 23.52           C  \nATOM   1496  CD2 LEU B  97      22.037  33.773   2.076  1.00 20.87           C  \nATOM   1497  N   ASN B  98      25.121  36.868   1.264  1.00 32.20           N  \nATOM   1498  CA  ASN B  98      25.870  38.101   1.449  1.00 34.86           C  \nATOM   1499  C   ASN B  98      25.102  39.038   2.370  1.00 34.26           C  \nATOM   1500  O   ASN B  98      23.889  39.124   2.261  1.00 36.18           O  \nATOM   1501  CB  ASN B  98      26.140  38.756   0.086  1.00 31.24           C  \nATOM   1502  CG  ASN B  98      27.048  37.921  -0.814  1.00 33.93           C  \nATOM   1503  OD1 ASN B  98      28.268  37.895  -0.630  1.00 37.15           O  \nATOM   1504  ND2 ASN B  98      26.455  37.192  -1.754  1.00 33.06           N  \nATOM   1505  N   PHE B  99      25.809  39.706   3.283  1.00 36.76           N  \nATOM   1506  CA  PHE B  99      25.267  40.855   4.034  1.00 36.49           C  \nATOM   1507  C   PHE B  99      26.351  41.742   4.659  1.00 35.50           C  \nATOM   1508  O   PHE B  99      27.448  41.208   5.013  1.00 37.49           O  \nATOM   1509  CB  PHE B  99      24.284  40.418   5.127  1.00 34.88           C  \nATOM   1510  CG  PHE B  99      24.859  39.479   6.130  1.00 36.75           C  \nATOM   1511  CD1 PHE B  99      25.061  38.150   5.808  1.00 37.04           C  \nATOM   1512  CD2 PHE B  99      25.071  39.890   7.436  1.00 38.13           C  \nATOM   1513  CE1 PHE B  99      25.450  37.240   6.756  1.00 37.02           C  \nATOM   1514  CE2 PHE B  99      25.473  38.988   8.409  1.00 37.11           C  \nATOM   1515  CZ  PHE B  99      25.658  37.663   8.073  1.00 36.24           C  \nTER    1516      PHE B  99                                                      \nHETATM 1517  N1  MK1 B 902       9.280  23.763   3.004  1.00 28.25           N  \nHETATM 1518  C1  MK1 B 902       9.498  23.983   4.459  1.00 30.30           C  \nHETATM 1519  C2  MK1 B 902      10.591  24.905   4.962  1.00 27.27           C  \nHETATM 1520  C3  MK1 B 902      10.591  24.864   6.466  1.00 28.85           C  \nHETATM 1521  O1  MK1 B 902      10.937  23.849   7.057  1.00 29.59           O  \nHETATM 1522  N2  MK1 B 902      10.193  25.953   7.094  1.00 22.29           N  \nHETATM 1523  C4  MK1 B 902      10.145  26.250   8.490  1.00 23.47           C  \nHETATM 1524  C5  MK1 B 902       9.379  27.577   8.641  1.00 27.66           C  \nHETATM 1525  C6  MK1 B 902      11.398  26.347   9.074  1.00 21.71           C  \nHETATM 1526  C7  MK1 B 902       9.364  25.283   9.268  1.00 22.75           C  \nHETATM 1527  N3  MK1 B 902      11.819  24.282   4.355  1.00 28.91           N  \nHETATM 1528  C8  MK1 B 902      11.753  23.776   2.961  1.00 26.24           C  \nHETATM 1529  C9  MK1 B 902      10.440  23.182   2.493  1.00 27.47           C  \nHETATM 1530  C10 MK1 B 902      13.083  24.963   4.552  1.00 20.86           C  \nHETATM 1531  C11 MK1 B 902      14.203  24.064   5.078  1.00 21.68           C  \nHETATM 1532  O2  MK1 B 902      15.242  24.884   4.634  1.00 15.87           O  \nHETATM 1533  C12 MK1 B 902      14.440  23.761   6.569  1.00 21.49           C  \nHETATM 1534  C13 MK1 B 902      15.573  22.821   7.005  1.00 26.89           C  \nHETATM 1535  C14 MK1 B 902      15.644  22.664   8.534  1.00 28.67           C  \nHETATM 1536  C15 MK1 B 902      16.733  21.750   8.961  1.00 26.89           C  \nHETATM 1537  C16 MK1 B 902      18.058  21.916   8.553  1.00 29.22           C  \nHETATM 1538  C17 MK1 B 902      19.037  21.016   8.947  1.00 29.22           C  \nHETATM 1539  C18 MK1 B 902      18.673  19.939   9.758  1.00 30.97           C  \nHETATM 1540  C19 MK1 B 902      17.347  19.773  10.176  1.00 29.25           C  \nHETATM 1541  C20 MK1 B 902      16.374  20.687   9.772  1.00 29.96           C  \nHETATM 1542  C21 MK1 B 902      15.447  21.440   6.373  1.00 29.35           C  \nHETATM 1543  O3  MK1 B 902      14.367  20.831   6.397  1.00 32.66           O  \nHETATM 1544  N4  MK1 B 902      16.583  20.913   5.924  1.00 31.19           N  \nHETATM 1545  C22 MK1 B 902      16.692  19.500   5.604  1.00 29.22           C  \nHETATM 1546  C23 MK1 B 902      18.067  18.945   5.936  1.00 28.82           C  \nHETATM 1547  O4  MK1 B 902      19.061  19.938   5.729  1.00 28.32           O  \nHETATM 1548  C24 MK1 B 902      18.226  17.726   5.057  1.00 32.05           C  \nHETATM 1549  C25 MK1 B 902      17.476  17.904   3.760  1.00 31.29           C  \nHETATM 1550  C26 MK1 B 902      17.500  17.363   2.496  1.00 32.00           C  \nHETATM 1551  C27 MK1 B 902      16.613  17.872   1.541  1.00 28.00           C  \nHETATM 1552  C28 MK1 B 902      15.722  18.906   1.865  1.00 29.01           C  \nHETATM 1553  C29 MK1 B 902      15.683  19.479   3.129  1.00 27.70           C  \nHETATM 1554  C30 MK1 B 902      16.504  19.061   4.128  1.00 31.86           C  \nHETATM 1555  C31 MK1 B 902       8.033  23.100   2.604  1.00 36.25           C  \nHETATM 1556  C32 MK1 B 902       6.666  23.739   2.876  1.00 42.75           C  \nHETATM 1557  C33 MK1 B 902       6.158  24.808   2.124  1.00 47.41           C  \nHETATM 1558  N5  MK1 B 902       4.911  25.430   2.300  1.00 51.38           N  \nHETATM 1559  C34 MK1 B 902       4.207  24.839   3.348  1.00 50.60           C  \nHETATM 1560  C35 MK1 B 902       4.654  23.774   4.136  1.00 49.34           C  \nHETATM 1561  C36 MK1 B 902       5.905  23.211   3.897  1.00 44.71           C  \nHETATM 1562  O   HOH A 305      20.857  43.192  21.450  1.00 63.07           O  \nHETATM 1563  O   HOH A 307      14.076  19.789  19.440  1.00 63.34           O  \nHETATM 1564  O   HOH A 309      28.075  21.177   7.222  1.00 66.96           O  \nHETATM 1565  O   HOH A 314      16.759  40.274   1.287  1.00 36.09           O  \nHETATM 1566  O   HOH A 315      13.997  22.233  21.468  1.00 64.67           O  \nHETATM 1567  O   HOH A 324      11.282  30.738   1.625  1.00 21.55           O  \nHETATM 1568  O   HOH A 325      16.774  42.740   2.296  1.00 26.65           O  \nHETATM 1569  O   HOH A 327      14.623  29.552  28.235  1.00 60.45           O  \nHETATM 1570  O   HOH A 328       1.651  36.463  19.459  1.00 25.82           O  \nHETATM 1571  O   HOH A 329      14.435  44.966  11.913  1.00 32.52           O  \nHETATM 1572  O   HOH A 330      19.877  40.160  21.917  1.00 41.02           O  \nHETATM 1573  O   HOH A 331      17.126  45.934  10.801  1.00 41.93           O  \nHETATM 1574  O   HOH A 332       8.840  28.026   4.860  1.00 27.94           O  \nHETATM 1575  O   HOH A 335      10.341  18.480  14.477  1.00 51.87           O  \nHETATM 1576  O   HOH A 341      19.233  16.711   9.027  1.00 66.74           O  \nHETATM 1577  O   HOH A 342      23.799  21.928  12.391  1.00 65.58           O  \nHETATM 1578  O   HOH A 344       9.953  37.934   4.548  1.00 67.74           O  \nHETATM 1579  O   HOH A 345       8.478  35.995   5.789  1.00 43.98           O  \nHETATM 1580  O   HOH A 357       3.960  19.389  17.384  1.00 37.23           O  \nHETATM 1581  O   HOH A 373      27.561  43.155  19.015  1.00 69.15           O  \nHETATM 1582  O   HOH A 384       1.245  19.292  18.124  1.00 70.78           O  \nHETATM 1583  O   HOH A 386      31.402  27.051   3.335  1.00 21.93           O  \nHETATM 1584  O   HOH A 389      32.446  31.200   4.417  1.00 46.57           O  \nHETATM 1585  O   HOH A 391      25.480  38.468  17.938  1.00 63.81           O  \nHETATM 1586  O   HOH A 394      23.940  41.721   0.346  1.00 47.08           O  \nHETATM 1587  O   HOH A 401       5.912  15.727   3.369  1.00 63.52           O  \nHETATM 1588  O   HOH A 406       9.272  33.891  12.681  1.00 31.73           O  \nHETATM 1589  O   HOH A 408      21.185  25.233  16.048  1.00 49.24           O  \nHETATM 1590  O   HOH A 416      18.474  26.012  21.664  1.00 65.44           O  \nHETATM 1591  O   HOH A 420       9.469  16.910  17.371  1.00 75.86           O  \nHETATM 1592  O   HOH A 422      13.074  17.786  16.615  1.00 67.42           O  \nHETATM 1593  O   HOH A 439      28.821  29.338   7.342  1.00 57.13           O  \nHETATM 1594  O   HOH A 457      23.284  23.107  15.132  1.00 60.42           O  \nHETATM 1595  O   HOH A 468       3.114  26.260   6.773  1.00 75.52           O  \nHETATM 1596  O   HOH A 501       6.382  26.424   5.893  1.00 38.21           O  \nHETATM 1597  O   HOH A 503      35.293  43.006   5.212  1.00 50.02           O  \nHETATM 1598  O   HOH A 510      21.891  49.715   7.192  1.00 53.78           O  \nHETATM 1599  O   HOH A 524      34.085  32.735   2.849  1.00 61.00           O  \nHETATM 1600  O   HOH A 529      31.491  41.524   6.678  1.00 73.78           O  \nHETATM 1601  O   HOH A 553       5.943  34.223   6.748  1.00 61.39           O  \nHETATM 1602  O   HOH A 561       0.934  40.259  19.405  1.00 49.60           O  \nHETATM 1603  O   HOH A 567      29.539  25.486  13.281  1.00 71.88           O  \nHETATM 1604  O   HOH A 572      24.552  17.352  10.295  1.00 66.74           O  \nHETATM 1605  O   HOH A 575      23.112  15.510   8.776  1.00 70.97           O  \nHETATM 1606  O   HOH B 301      20.445   8.036 -12.631  1.00 63.94           O  \nHETATM 1607  O   HOH B 303      20.044  14.822   4.638  1.00 73.81           O  \nHETATM 1608  O   HOH B 304      21.538   6.875 -10.099  1.00 42.37           O  \nHETATM 1609  O   HOH B 306      22.449  23.958   5.252  1.00 51.24           O  \nHETATM 1610  O   HOH B 308      11.720  21.289   7.190  1.00 18.18           O  \nHETATM 1611  O   HOH B 312      14.097   5.111 -11.638  1.00 53.13           O  \nHETATM 1612  O   HOH B 313      20.998  21.834   6.561  1.00 47.68           O  \nHETATM 1613  O   HOH B 316      22.659  14.583  -2.196  1.00 65.44           O  \nHETATM 1614  O   HOH B 317      28.724  15.629 -11.660  1.00 38.53           O  \nHETATM 1615  O   HOH B 318      16.539  45.207   0.079  1.00 32.25           O  \nHETATM 1616  O   HOH B 319      23.678  14.931   2.680  1.00 61.86           O  \nHETATM 1617  O   HOH B 321      20.718  15.976  -3.657  1.00 22.69           O  \nHETATM 1618  O   HOH B 323      31.249  26.796  -9.595  1.00 59.93           O  \nHETATM 1619  O   HOH B 326      28.813  28.445  -2.106  1.00 33.99           O  \nHETATM 1620  O   HOH B 333      12.251  39.551  -2.672  1.00 79.22           O  \nHETATM 1621  O   HOH B 334      25.465  12.592  -8.670  1.00 31.58           O  \nHETATM 1622  O   HOH B 338      12.998  36.205  -3.972  1.00 47.41           O  \nHETATM 1623  O   HOH B 339      17.541  17.060 -17.194  1.00 46.59           O  \nHETATM 1624  O   HOH B 340       5.321  14.325  -4.866  1.00 48.25           O  \nHETATM 1625  O   HOH B 346       9.314  17.330  -9.801  1.00 48.73           O  \nHETATM 1626  O   HOH B 347       7.435  26.652 -14.854  1.00 54.68           O  \nHETATM 1627  O   HOH B 348       4.405  16.704  -3.635  1.00 37.86           O  \nHETATM 1628  O   HOH B 349      19.414   7.026   4.428  1.00 68.44           O  \nHETATM 1629  O   HOH B 350       6.718  34.538  -1.322  1.00 42.81           O  \nHETATM 1630  O   HOH B 354      15.041  31.743 -13.235  1.00 60.62           O  \nHETATM 1631  O   HOH B 355      27.404  32.078 -10.860  1.00 61.36           O  \nHETATM 1632  O   HOH B 356      27.673  18.789  -6.155  1.00 35.03           O  \nHETATM 1633  O   HOH B 358      21.289  -1.161  -5.102  1.00 62.75           O  \nHETATM 1634  O   HOH B 359       6.973  36.523   1.489  1.00 71.64           O  \nHETATM 1635  O   HOH B 360      27.602  21.234  -0.635  1.00 57.53           O  \nHETATM 1636  O   HOH B 362       3.902   9.376  -0.027  1.00 50.97           O  \nHETATM 1637  O   HOH B 364      28.498  36.632  -7.529  1.00 73.30           O  \nHETATM 1638  O   HOH B 366      18.572  40.567 -10.042  1.00 62.30           O  \nHETATM 1639  O   HOH B 367      25.658  18.970   0.428  1.00 65.69           O  \nHETATM 1640  O   HOH B 369      20.843   1.263  -7.014  1.00 61.76           O  \nHETATM 1641  O   HOH B 370      13.975  15.741  12.070  1.00 67.21           O  \nHETATM 1642  O   HOH B 374       7.661  23.876  -6.324  1.00 61.89           O  \nHETATM 1643  O   HOH B 375      10.125   5.706  -1.458  1.00 74.72           O  \nHETATM 1644  O   HOH B 376      18.450  20.497 -18.728  1.00 48.75           O  \nHETATM 1645  O   HOH B 377      29.267  20.487  -3.497  1.00 60.17           O  \nHETATM 1646  O   HOH B 379       6.685  26.541  -5.608  1.00 43.92           O  \nHETATM 1647  O   HOH B 381      25.810  26.789 -19.106  1.00 70.16           O  \nHETATM 1648  O   HOH B 383      21.144  -4.428 -11.331  1.00 22.10           O  \nHETATM 1649  O   HOH B 387      16.904  27.594 -15.938  1.00 27.84           O  \nHETATM 1650  O   HOH B 388      23.926  45.612  -4.998  1.00 65.78           O  \nHETATM 1651  O   HOH B 390      25.300  17.493   3.076  1.00 67.04           O  \nHETATM 1652  O   HOH B 392       6.618  28.079  -3.427  1.00 53.99           O  \nHETATM 1653  O   HOH B 393      19.795  13.651 -16.606  1.00 54.21           O  \nHETATM 1654  O   HOH B 395       7.202   9.982  -4.103  1.00 62.03           O  \nHETATM 1655  O   HOH B 400       8.474  34.203  -4.893  1.00 63.64           O  \nHETATM 1656  O   HOH B 405      16.659  15.866  11.446  1.00 42.47           O  \nHETATM 1657  O   HOH B 410      26.400  10.057  -3.287  1.00 65.50           O  \nHETATM 1658  O   HOH B 414       9.503   3.489  -4.419  1.00 65.50           O  \nHETATM 1659  O   HOH B 419      15.438  12.973 -18.484  1.00 73.55           O  \nHETATM 1660  O   HOH B 425      11.428  19.956 -24.551  1.00 63.48           O  \nHETATM 1661  O   HOH B 430      18.725  43.171  -5.575  1.00 52.97           O  \nHETATM 1662  O   HOH B 436      32.141  29.620  -8.580  1.00 72.75           O  \nHETATM 1663  O   HOH B 443       8.811  13.667 -20.256  1.00 75.75           O  \nHETATM 1664  O   HOH B 444       4.071  26.169  -0.230  1.00 38.25           O  \nHETATM 1665  O   HOH B 461      11.425  44.636  -3.033  1.00 68.43           O  \nHETATM 1666  O   HOH B 469       6.902  23.686 -10.066  1.00 54.20           O  \nHETATM 1667  O   HOH B 471       5.749  25.785 -19.792  1.00 63.96           O  \nHETATM 1668  O   HOH B 500      25.592  16.404  -5.805  1.00 23.98           O  \nHETATM 1669  O   HOH B 502       4.040  15.516  -7.200  1.00 52.93           O  \nHETATM 1670  O   HOH B 505      28.640  34.232  -5.637  1.00 58.06           O  \nHETATM 1671  O   HOH B 506       8.979  11.173  11.112  1.00 64.79           O  \nHETATM 1672  O   HOH B 509      19.882   3.986 -18.136  1.00 55.54           O  \nHETATM 1673  O   HOH B 514      27.409  15.355   2.200  1.00 61.69           O  \nHETATM 1674  O   HOH B 515      17.222  39.766 -23.774  1.00 69.12           O  \nHETATM 1675  O   HOH B 517      28.742  24.158 -16.641  1.00 78.93           O  \nHETATM 1676  O   HOH B 525      22.694  -2.192 -12.589  1.00 71.37           O  \nHETATM 1677  O   HOH B 526      17.901  43.157 -14.082  1.00 78.14           O  \nHETATM 1678  O   HOH B 531      18.192   8.914  11.344  1.00 54.05           O  \nHETATM 1679  O   HOH B 532      19.507  45.215   1.709  1.00 72.78           O  \nHETATM 1680  O   HOH B 548       1.442  14.700  -6.128  1.00 58.40           O  \nHETATM 1681  O   HOH B 549      19.908   8.718 -19.215  1.00 58.78           O  \nHETATM 1682  O   HOH B 556      21.499  44.884  -1.280  1.00 68.40           O  \nHETATM 1683  O   HOH B 564      10.031   8.593 -22.052  1.00 64.90           O  \nHETATM 1684  O   HOH B 568       2.817  28.133   2.191  1.00 67.95           O  \nHETATM 1685  O   HOH B 591      15.835  40.105  -5.971  1.00 53.68           O  \nHETATM 1686  O   HOH B 595       4.515  36.451  -4.499  1.00 49.41           O  \nHETATM 1687  O   HOH B 613      24.127 -10.994  -0.982  1.00 64.49           O  \nHETATM 1688  O   HOH B 617      30.112  17.912  -4.791  1.00 54.09           O  \nCONECT 1517 1518 1529 1555                                                      \nCONECT 1518 1517 1519                                                           \nCONECT 1519 1518 1520 1527                                                      \nCONECT 1520 1519 1521 1522                                                      \nCONECT 1521 1520                                                                \nCONECT 1522 1520 1523                                                           \nCONECT 1523 1522 1524 1525 1526                                                 \nCONECT 1524 1523                                                                \nCONECT 1525 1523                                                                \nCONECT 1526 1523                                                                \nCONECT 1527 1519 1528 1530                                                      \nCONECT 1528 1527 1529                                                           \nCONECT 1529 1517 1528                                                           \nCONECT 1530 1527 1531                                                           \nCONECT 1531 1530 1532 1533                                                      \nCONECT 1532 1531                                                                \nCONECT 1533 1531 1534                                                           \nCONECT 1534 1533 1535 1542                                                      \nCONECT 1535 1534 1536                                                           \nCONECT 1536 1535 1537 1541                                                      \nCONECT 1537 1536 1538                                                           \nCONECT 1538 1537 1539                                                           \nCONECT 1539 1538 1540                                                           \nCONECT 1540 1539 1541                                                           \nCONECT 1541 1536 1540                                                           \nCONECT 1542 1534 1543 1544                                                      \nCONECT 1543 1542                                                                \nCONECT 1544 1542 1545                                                           \nCONECT 1545 1544 1546 1554                                                      \nCONECT 1546 1545 1547 1548                                                      \nCONECT 1547 1546                                                                \nCONECT 1548 1546 1549                                                           \nCONECT 1549 1548 1550 1554                                                      \nCONECT 1550 1549 1551                                                           \nCONECT 1551 1550 1552                                                           \nCONECT 1552 1551 1553                                                           \nCONECT 1553 1552 1554                                                           \nCONECT 1554 1545 1549 1553                                                      \nCONECT 1555 1517 1556                                                           \nCONECT 1556 1555 1557 1561                                                      \nCONECT 1557 1556 1558                                                           \nCONECT 1558 1557 1559                                                           \nCONECT 1559 1558 1560                                                           \nCONECT 1560 1559 1561                                                           \nCONECT 1561 1556 1560                                                           \nMASTER      252    0    1    2   17    0    5    6 1686    2   45   16          \nEND                                                                             \n"
          },
          "file_paths": {
            "pdb": "cache\\pdbe\\pdb1hsg.ent"
          },
          "quality_metrics": {
            "experimental_method": "X-ray diffraction",
            "deposit_date": "19950331",
            "release_date": "19960403",
            "title": "CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES"
          },
          "molecules": [
            {
              "molecule_type": "polypeptide(L)",
              "entity_id": 1,
              "sample_preparation": "Genetically manipulated",
              "length": 99,
              "number_of_copies": 2,
              "in_chains": [
                "A",
                "B"
              ],
              "in_struct_asyms": [
                "A",
                "B"
              ],
              "mutation_flag": null,
              "weight": 10803.756,
              "ca_p_only": false,
              "synonym": "HIV-1 PROTEASE",
              "molecule_name": [
                "Protease"
              ],
              "gene_name": [
                "gag-pol"
              ],
              "source": [
                {
                  "organism_scientific_name": "Human immunodeficiency virus 1",
                  "expression_host_scientific_name": "Escherichia coli",
                  "tax_id": 11676,
                  "expression_host_tax_id": 562,
                  "mappings": [
                    {
                      "start": {
                        "residue_number": 1
                      },
                      "end": {
                        "residue_number": 99
                      }
                    }
                  ]
                }
              ],
              "sequence": "PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF",
              "pdb_sequence": "PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF",
              "pdb_sequence_indices_with_multiple_residues": {}
            },
            {
              "molecule_type": "bound",
              "entity_id": 2,
              "sample_preparation": "Synthetically obtained",
              "number_of_copies": 1,
              "in_chains": [
                "B"
              ],
              "in_struct_asyms": [
                "C"
              ],
              "chem_comp_ids": [
                "MK1"
              ],
              "mutation_flag": null,
              "weight": 613.789,
              "ca_p_only": false,
              "molecule_name": [
                "N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE"
              ]
            },
            {
              "molecule_type": "water",
              "entity_id": 3,
              "sample_preparation": "Natural source",
              "number_of_copies": 127,
              "in_chains": [
                "A",
                "B"
              ],
              "in_struct_asyms": [
                "D",
                "E"
              ],
              "chem_comp_ids": [
                "HOH"
              ],
              "mutation_flag": null,
              "weight": 18.015,
              "ca_p_only": false,
              "molecule_name": [
                "water"
              ]
            }
          ],
          "ligands": [
            {
              "id": "MK1",
              "name": "N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY\nBUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE",
              "formula": "",
              "type": "",
              "weight": null
            }
          ],
          "binding_sites": [
            {
              "site_id": "AC1",
              "ligand_id": "",
              "residues": [
                {
                  "chem_comp_id": "ARG",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 8,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 8
                },
                {
                  "chem_comp_id": "ASP",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 25,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 25
                },
                {
                  "chem_comp_id": "PRO",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 81,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 81
                },
                {
                  "chem_comp_id": "ILE",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 50,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 50
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 27,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 27
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 48,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 48
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 49,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 49
                },
                {
                  "chem_comp_id": "VAL",
                  "entity_id": 1,
                  "struct_asym_id": "A",
                  "residue_number": 82,
                  "symmetry_symbol": "1_555",
                  "chain_id": "A",
                  "author_insertion_code": null,
                  "author_residue_number": 82
                },
                {
                  "chem_comp_id": "ARG",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 8,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 8
                },
                {
                  "chem_comp_id": "ASP",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 25,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 25
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 27,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 27
                },
                {
                  "chem_comp_id": "ALA",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 28,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 28
                },
                {
                  "chem_comp_id": "ASP",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 29,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 29
                },
                {
                  "chem_comp_id": "ASP",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 30,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 30
                },
                {
                  "chem_comp_id": "VAL",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 32,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 32
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 48,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 48
                },
                {
                  "chem_comp_id": "GLY",
                  "entity_id": 1,
                  "struct_asym_id": "B",
                  "residue_number": 49,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 49
                },
                {
                  "chem_comp_id": "HOH",
                  "entity_id": 3,
                  "struct_asym_id": "E",
                  "residue_number": 5,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 308
                },
                {
                  "chem_comp_id": "HOH",
                  "entity_id": 3,
                  "struct_asym_id": "E",
                  "residue_number": 7,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 313
                },
                {
                  "chem_comp_id": "HOH",
                  "entity_id": 3,
                  "struct_asym_id": "E",
                  "residue_number": 59,
                  "symmetry_symbol": "1_555",
                  "chain_id": "B",
                  "author_insertion_code": null,
                  "author_residue_number": 444
                }
              ],
              "num_residues": 20
            }
          ],
          "annotations": {},
          "experimental_method": "X-ray diffraction",
          "resolution": null,
          "organism": "unknown",
          "num_chains": 3,
          "num_residues": 0,
          "reference": "Protein Data Bank in Europe (PDBe)"
        },
        "error": null
      },
      "metadata": {
        "name": "pdbe",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "Protein Data Bank in Europe (PDBe) - European mirror of PDB with additional annotations",
        "capabilities": {
          "structure_retrieval": true,
          "search": true,
          "ligand_info": true,
          "binding_sites": true,
          "quality_metrics": true,
          "functional_annotations": true,
          "multiple_formats": [
            "pdb",
            "cif"
          ]
        },
        "database": {
          "name": "PDBe",
          "full_name": "Protein Data Bank in Europe",
          "url": "https://www.ebi.ac.uk/pdbe/",
          "location": "European Bioinformatics Institute (EMBL-EBI), UK",
          "structures": "200,000+ (mirrors RCSB PDB)",
          "experimental_methods": [
            "X-ray",
            "NMR",
            "Cryo-EM",
            "Electron diffraction"
          ],
          "advantages": [
            "European data center for faster access",
            "Additional European annotations",
            "FunPDBe functional annotations",
            "Alternative to RCSB for redundancy"
          ]
        },
        "quality_thresholds": {
          "resolution_high": "< 2.0 \u00c5 (high quality)",
          "resolution_medium": "2.0-3.0 \u00c5 (medium quality)",
          "resolution_low": "> 3.0 \u00c5 (low quality)",
          "r_value_good": "< 0.25",
          "r_free_good": "< 0.28"
        },
        "config": {
          "cache_dir": "cache\\pdbe",
          "download_pdb": true,
          "download_cif": false,
          "include_ligands": true,
          "include_binding_sites": true,
          "include_annotations": false,
          "rate_limit_delay": 0.5
        },
        "reference": {
          "website": "https://www.ebi.ac.uk/pdbe/",
          "api_docs": "https://www.ebi.ac.uk/pdbe/api/doc/",
          "citation": "Protein Data Bank in Europe (PDBe)",
          "organization": "EMBL-EBI"
        }
      }
    },
    {
      "adapter": "swissmodel",
      "status": "success",
      "error": null,
      "execution_time": 1.137881,
      "data": {
        "success": true,
        "data": {
          "uniprot_id": "P00533",
          "models": [
            {
              "chains": [
                {
                  "id": "C",
                  "segments": [
                    {
                      "smtl": {
                        "aligned_sequence": "LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRNEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT",
                        "description": "Epidermal growth factor receptor",
                        "from": 25,
                        "to": 638
                      },
                      "uniprot": {
                        "aligned_sequence": "LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT",
                        "from": 25,
                        "to": 638
                      }
                    }
                  ]
                }
              ],
              "coordinates": "https://swissmodel.expasy.org/repository/uniprot/P00533.pdb?range=25-638&template=7syd.1.C&provider=swissmodel",
              "coverage": 0.507,
              "created_date": "2025-10-30T22:59:19.588000+00:00",
              "found_by": "HHblits",
              "from": 25,
              "gmqe": 0.622,
              "identity": 99.917,
              "md5": "99d03b567dbcdd7fb0dd21fb40d5d283",
              "method": "HOMOLOGY MODELLING",
              "modelcif": "https://swissmodel.expasy.org/repository/uniprot/P00533.cif?range=25-638&template=7syd.1.C&provider=swissmodel",
              "oligo-state": "monomer",
              "provider": "SWISSMODEL",
              "qmean": {
                "acc_agreement_norm_score": 0.793,
                "acc_agreement_z_score": 0.622,
                "avg_local_score": 0.763,
                "avg_local_score_error": 0.053,
                "cbeta_norm_score": -0.021,
                "cbeta_z_score": 3.426,
                "interaction_norm_score": -0.016,
                "interaction_z_score": -1.074,
                "packing_norm_score": -0.336,
                "packing_z_score": -0.396,
                "qmean4_norm_score": 0.741,
                "qmean4_z_score": -0.645,
                "qmean6_norm_score": 0.753,
                "qmean6_z_score": -0.382,
                "ss_agreement_norm_score": 0.485,
                "ss_agreement_z_score": -1.284,
                "torsion_norm_score": -0.207,
                "torsion_z_score": -0.993
              },
              "similarity": 0.626,
              "template": "7syd.1.C",
              "template_qsqe": 0.678,
              "to": 638,
              "_qmean_score": -0.645,
              "_gmqe_score": 0.622
            },
            {
              "chains": [
                {
                  "id": "A",
                  "segments": [
                    {
                      "smtl": {
                        "aligned_sequence": "AQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSP",
                        "description": "Receptor tyrosine-protein kinase erbB-4",
                        "from": 7,
                        "to": 297
                      },
                      "uniprot": {
                        "aligned_sequence": "ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP",
                        "from": 702,
                        "to": 992
                      }
                    }
                  ]
                }
              ],
              "coordinates": "https://swissmodel.expasy.org/repository/uniprot/P00533.pdb?range=702-992&template=3bbt.1.A&provider=swissmodel",
              "coverage": 0.24,
              "created_date": "2025-10-30T22:59:19.660000+00:00",
              "found_by": "BLAST",
              "from": 702,
              "gmqe": 0.175,
              "identity": 77.846,
              "ligand_chains": [
                {
                  "count": 1,
                  "ligands": [
                    {
                      "description": "N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE",
                      "hetid": "FMM"
                    }
                  ]
                }
              ],
              "md5": "99d03b567dbcdd7fb0dd21fb40d5d283",
              "method": "HOMOLOGY MODELLING",
              "modelcif": "https://swissmodel.expasy.org/repository/uniprot/P00533.cif?range=702-992&template=3bbt.1.A&provider=swissmodel",
              "oligo-state": "monomer",
              "provider": "SWISSMODEL",
              "qmean": {
                "acc_agreement_norm_score": 0.636,
                "acc_agreement_z_score": -0.449,
                "avg_local_score": 0.718,
                "avg_local_score_error": 0.052,
                "cbeta_norm_score": -0.01,
                "cbeta_z_score": -0.847,
                "interaction_norm_score": -0.019,
                "interaction_z_score": -1.005,
                "packing_norm_score": -0.355,
                "packing_z_score": -0.267,
                "qmean4_norm_score": 0.731,
                "qmean4_z_score": -1.114,
                "qmean6_norm_score": 0.717,
                "qmean6_z_score": -1.342,
                "ss_agreement_norm_score": 0.539,
                "ss_agreement_z_score": -0.922,
                "torsion_norm_score": -0.229,
                "torsion_z_score": -0.897
              },
              "similarity": 0.553,
              "template": "3bbt.1.A",
              "template_qsqe": 0.0,
              "to": 992,
              "_qmean_score": -1.114,
              "_gmqe_score": 0.175
            }
          ],
          "best_model": {
            "chains": [
              {
                "id": "C",
                "segments": [
                  {
                    "smtl": {
                      "aligned_sequence": "LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRNEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT",
                      "description": "Epidermal growth factor receptor",
                      "from": 25,
                      "to": 638
                    },
                    "uniprot": {
                      "aligned_sequence": "LEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT",
                      "from": 25,
                      "to": 638
                    }
                  }
                ]
              }
            ],
            "coordinates": "https://swissmodel.expasy.org/repository/uniprot/P00533.pdb?range=25-638&template=7syd.1.C&provider=swissmodel",
            "coverage": 0.507,
            "created_date": "2025-10-30T22:59:19.588000+00:00",
            "found_by": "HHblits",
            "from": 25,
            "gmqe": 0.622,
            "identity": 99.917,
            "md5": "99d03b567dbcdd7fb0dd21fb40d5d283",
            "method": "HOMOLOGY MODELLING",
            "modelcif": "https://swissmodel.expasy.org/repository/uniprot/P00533.cif?range=25-638&template=7syd.1.C&provider=swissmodel",
            "oligo-state": "monomer",
            "provider": "SWISSMODEL",
            "qmean": {
              "acc_agreement_norm_score": 0.793,
              "acc_agreement_z_score": 0.622,
              "avg_local_score": 0.763,
              "avg_local_score_error": 0.053,
              "cbeta_norm_score": -0.021,
              "cbeta_z_score": 3.426,
              "interaction_norm_score": -0.016,
              "interaction_z_score": -1.074,
              "packing_norm_score": -0.336,
              "packing_z_score": -0.396,
              "qmean4_norm_score": 0.741,
              "qmean4_z_score": -0.645,
              "qmean6_norm_score": 0.753,
              "qmean6_z_score": -0.382,
              "ss_agreement_norm_score": 0.485,
              "ss_agreement_z_score": -1.284,
              "torsion_norm_score": -0.207,
              "torsion_z_score": -0.993
            },
            "similarity": 0.626,
            "template": "7syd.1.C",
            "template_qsqe": 0.678,
            "to": 638,
            "_qmean_score": -0.645,
            "_gmqe_score": 0.622
          },
          "structure_files": {
            "pdb": "TITLE     SWISS-MODEL SERVER (https://swissmodel.expasy.org)\nTITLE    2 Untitled Project\nEXPDTA    THEORETICAL MODEL (SWISS-MODEL SERVER)\nAUTHOR    SWISS-MODEL SERVER (SEE REFERENCE IN JRNL Records)\nREVDAT   1   30-OCT-25 1MOD    1       23:58\nJRNL        AUTH   A.WATERHOUSE,M.BERTONI,S.BIENERT,G.STUDER,G.TAURIELLO,\nJRNL        AUTH 2 R.GUMIENNY,F.T.HEER,T.A.P.DE BEER,C.REMPFER,L.BORDOLI,\nJRNL        AUTH 3 R.LEPORE,T.SCHWEDE\nJRNL        TITL   SWISS-MODEL: HOMOLOGY MODELLING OF PROTEIN STRUCTURES AND\nJRNL        TITL 2 COMPLEXES\nJRNL        REF    NUCLEIC.ACIDS.RES..           V.  46 W296  2018\nJRNL        PMID   29788355\nJRNL        DOI    10.1093/nar/gky427\nREMARK   1\nREMARK   1 REFERENCE 1\nREMARK   1  AUTH   S.BIENERT,A.WATERHOUSE,T.A.P.DE BEER,G.TAURIELLO,G.STUDER,\nREMARK   1  AUTH 2 L.BORDOLI,T.SCHWEDE\nREMARK   1  TITL   THE SWISS-MODEL REPOSITORY - NEW FEATURES AND FUNCTIONALITY\nREMARK   1  REF    NUCLEIC.ACIDS.RES..           V.  45       2017\nREMARK   1  REFN                   ISSN 0305-1048\nREMARK   1  PMID   27899672\nREMARK   1  DOI    10.1093/nar/gkw1132\nREMARK   1\nREMARK   1 REFERENCE 2\nREMARK   1  AUTH   N.GUEX,M.C.PEITSCH,T.SCHWEDE\nREMARK   1  TITL   AUTOMATED COMPARATIVE PROTEIN STRUCTURE MODELING WITH\nREMARK   1  TITL 2 SWISS-MODEL AND SWISS-PDBVIEWER: A HISTORICAL PERSPECTIVE\nREMARK   1  REF    ELECTROPHORESIS               V.  30       2009\nREMARK   1  REFN                   ISSN 0173-0835\nREMARK   1  PMID   19517507\nREMARK   1  DOI    10.1002/elps.200900140\nREMARK   1\nREMARK   1 REFERENCE 3\nREMARK   1  AUTH   G.STUDER,G.TAURIELLO,S.BIENERT,M.BIASINI,N.JOHNER,T.SCHWEDE\nREMARK   1  TITL   PROMOD3 - A VERSATILE HOMOLOGY MODELLING TOOLBOX\nREMARK   1  REF    PLOS COMP. BIOL.              V.  17       2021\nREMARK   1  REFN                   ISSN \nREMARK   1  PMID   33507980\nREMARK   1  DOI    10.1371/journal.pcbi.1008667\nREMARK   1\nREMARK   1 REFERENCE 4\nREMARK   1  AUTH   G.STUDER,C.REMPFER,A.WATERHOUSE,R.GUMIENNY,J.HAAS,T.SCHWEDE\nREMARK   1  TITL   QMEANDISCO - DISTANCE CONSTRAINTS APPLIED ON MODEL QUALITY \nREMARK   1  TITL 2 ESTIMATION\nREMARK   1  REF    BIOINFORMATICS                V.  36       2020\nREMARK   1  REFN                   ISSN \nREMARK   1  PMID   31697312\nREMARK   1  DOI    10.1093/bioinformatics/btz828\nREMARK   1\nREMARK   1 REFERENCE 5\nREMARK   1  AUTH   P.BENKERT,M.BIASINI,T.SCHWEDE\nREMARK   1  TITL   TOWARD THE ESTIMATION OF THE ABSOLUTE QUALITY OF INDIVIDUAL\nREMARK   1  TITL 2 PROTEIN STRUCTURE MODELS\nREMARK   1  REF    BIOINFORMATICS                V.  27       2011\nREMARK   1  REFN                   ISSN 1367-4803\nREMARK   1  PMID   21134891\nREMARK   1  DOI    10.1093/bioinformatics/btq662\nREMARK   1\nREMARK   1 REFERENCE 6\nREMARK   1  AUTH   M.BERTONI,F.KIEFER,M.BIASINI,L.BORDOLI,T.SCHWEDE\nREMARK   1  TITL   MODELING PROTEIN QUATERNARY STRUCTURE OF HOMO- AND\nREMARK   1  TITL 2 HETERO-OLIGOMERS BEYOND BINARY INTERACTIONS BY HOMOLOGY\nREMARK   1  REF    SCI.REP.                      V.   7       2017\nREMARK   1  REFN                   ISSN\nREMARK   1  PMID   28874689\nREMARK   1  DOI    10.1038/s41598-017-09654-8\nREMARK   1\nREMARK   1 DISCLAIMER\nREMARK   1 The SWISS-MODEL SERVER produces theoretical models for proteins.\nREMARK   1 The results of any theoretical modelling procedure is\nREMARK   1 NON-EXPERIMENTAL and MUST be considered with care. These models may\nREMARK   1 contain significant errors. This is especially true for automated\nREMARK   1 modeling since there is no human intervention during model\nREMARK   1 building. Please read the header section and the logfile carefully\nREMARK   1 to know what templates and alignments were used during the model\nREMARK   1 building process. All information by the SWISS-MODEL SERVER is\nREMARK   1 provided \"AS-IS\", without any warranty, expressed or implied.\nREMARK   2\nREMARK   2 COPYRIGHT NOTICE\nREMARK   2 This SWISS-MODEL protein model is copyright. It is produced by the\nREMARK   2 SWISS-MODEL server, developed by the Computational Structural\nREMARK   2 Biology Group at the SIB Swiss Institute of Bioinformatics at the\nREMARK   2 Biozentrum, University of Basel (https://swissmodel.expasy.org). This\nREMARK   2 model is licensed under the CC BY-SA 4.0 Creative Commons\nREMARK   2 Attribution-ShareAlike 4.0 International License\nREMARK   2 (https://creativecommons.org/licenses/by-sa/4.0/legalcode), i.e. you\nREMARK   2 can copy and redistribute the model in any medium or format,\nREMARK   2 transform and build upon the model for any purpose, even\nREMARK   2 commercially, under the following terms:\nREMARK   2 Attribution - You must give appropriate credit, provide a link to\nREMARK   2 the license, and indicate if changes were made. You may do so in any\nREMARK   2 reasonable manner, but not in any way that suggests the licensor\nREMARK   2 endorses you or your use. When you publish, patent or distribute\nREMARK   2 results that were fully or partially based on the model, please cite\nREMARK   2 the corresponding papers mentioned under JRNL.\nREMARK   2 ShareAlike - If you remix, transform, or build upon the material,\nREMARK   2 you must distribute your contributions under the same license as the\nREMARK   2 original.\nREMARK   2 No additional restrictions - you may not apply legal terms or\nREMARK   2 technological measures that legally restrict others from doing\nREMARK   2 anything the license permits.\nREMARK   2 Find a human-readable summary of (and not a substitute for) the\nREMARK   2 CC BY-SA 4.0 license at this link:\nREMARK   2 https://creativecommons.org/licenses/by-sa/4.0/\nREMARK   3 \nREMARK   3 MODEL INFORMATION\nREMARK   3  SMVERSN 2025-10.9\nREMARK   3  ENGIN   PROMOD3\nREMARK   3  VERSN   3.6.0\nREMARK   3  OSTAT   monomer\nREMARK   3  OSRSN   PREDICTION\nREMARK   3  QSPRD   0.678\nREMARK   3  GMQE    0.62\nREMARK   3  QMNV    4.5.0\nREMARK   3  QMNDG   0.76\nREMARK   3  MODT    FALSE\nREMARK   3 \nREMARK   3 TEMPLATE 1\nREMARK   3  PDBID   7syd\nREMARK   3  CHAIN   B\nREMARK   3  MMCIF   C\nREMARK   3  PDBV    2025-10-24\nREMARK   3  SMTLE   7syd.1.C\nREMARK   3  SMTLV   2025-10-29\nREMARK   3  MTHD    ELECTRON MICROSCOPY 0.00 A\nREMARK   3  FOUND   HHblits\nREMARK   3  GMQE    0.45\nREMARK   3  SIM     0.63\nREMARK   3  SID     99.92\nREMARK   3  OSTAT   homo-dimer\nREMARK   3  ALN C TRG MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNC\nREMARK   3  ALN C TRG EVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENS\nREMARK   3  ALN C TRG YALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLS\nREMARK   3  ALN C TRG NMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCC\nREMARK   3  ALN C TRG HNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGAT\nREMARK   3  ALN C TRG CVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDS\nREMARK   3  ALN C TRG LSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLL\nREMARK   3  ALN C TRG IQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIIS\nREMARK   3  ALN C TRG GNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRD\nREMARK   3  ALN C TRG CVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCI\nREMARK   3  ALN C TRG QCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT\nREMARK   3  ALN C TRG NGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSG\nREMARK   3  ALN C TRG EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK\nREMARK   3  ALN C TRG ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ\nREMARK   3  ALN C TRG YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH\nREMARK   3  ALN C TRG AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE\nREMARK   3  ALN C TRG KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER\nREMARK   3  ALN C TRG MHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNN\nREMARK   3  ALN C TRG STVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPA\nREMARK   3  ALN C TRG GSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQK\nREMARK   3  ALN C TRG GSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA\nREMARK   3  ALN C TPL MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNC\nREMARK   3  ALN C TPL EVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENS\nREMARK   3  ALN C TPL YALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLS\nREMARK   3  ALN C TPL NMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCC\nREMARK   3  ALN C TPL HNQCAAGCTGPRESDCLVCRKFRNEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGAT\nREMARK   3  ALN C TPL CVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDS\nREMARK   3  ALN C TPL LSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLL\nREMARK   3  ALN C TPL IQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIIS\nREMARK   3  ALN C TPL GNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRD\nREMARK   3  ALN C TPL CVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCI\nREMARK   3  ALN C TPL QCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPT\nREMARK   3  ALN C TPL NGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSG\nREMARK   3  ALN C TPL EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK\nREMARK   3  ALN C TPL ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ\nREMARK   3  ALN C TPL YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH\nREMARK   3  ALN C TPL AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE\nREMARK   3  ALN C TPL KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER\nREMARK   3  ALN C TPL MHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNN\nREMARK   3  ALN C TPL STVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPA\nREMARK   3  ALN C TPL GSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQK\nREMARK   3  ALN C TPL GSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA\nREMARK   3  ALN C OFF 0\nATOM      1  N   LEU C  25     143.553 181.005 149.495  1.00  0.28           N  \nATOM      2  CA  LEU C  25     144.117 181.599 148.230  1.00  0.28           C  \nATOM      3  C   LEU C  25     144.471 180.473 147.285  1.00  0.28           C  \nATOM      4  O   LEU C  25     144.701 179.369 147.766  1.00  0.28           O  \nATOM      5  CB  LEU C  25     145.339 182.536 148.528  1.00  0.28           C  \nATOM      6  CG  LEU C  25     146.711 181.876 148.861  1.00  0.28           C  \nATOM      7  CD1 LEU C  25     147.787 182.977 148.939  1.00  0.28           C  \nATOM      8  CD2 LEU C  25     146.753 181.014 150.144  1.00  0.28           C  \nATOM      9  N   GLU C  26     144.465 180.702 145.958  1.00  0.24           N  \nATOM     10  CA  GLU C  26     144.709 179.684 144.958  1.00  0.24           C  \nATOM     11  C   GLU C  26     146.191 179.475 144.734  1.00  0.24           C  \nATOM     12  O   GLU C  26     147.022 180.347 145.008  1.00  0.24           O  \nATOM     13  CB  GLU C  26     144.002 180.092 143.641  1.00  0.24           C  \nATOM     14  CG  GLU C  26     142.471 179.847 143.693  1.00  0.24           C  \nATOM     15  CD  GLU C  26     142.127 178.382 143.437  1.00  0.24           C  \nATOM     16  OE1 GLU C  26     142.623 177.840 142.419  1.00  0.24           O  \nATOM     17  OE2 GLU C  26     141.354 177.819 144.251  1.00  0.24           O  \nATOM     18  N   GLU C  27     146.542 178.270 144.260  1.00  0.53           N  \nATOM     19  CA  GLU C  27     147.869 177.881 143.862  1.00  0.53           C  \nATOM     20  C   GLU C  27     148.279 178.554 142.560  1.00  0.53           C  \nATOM     21  O   GLU C  27     147.469 178.912 141.704  1.00  0.53           O  \nATOM     22  CB  GLU C  27     147.973 176.344 143.684  1.00  0.53           C  \nATOM     23  CG  GLU C  27     147.400 175.496 144.856  1.00  0.53           C  \nATOM     24  CD  GLU C  27     147.140 174.032 144.481  1.00  0.53           C  \nATOM     25  OE1 GLU C  27     146.994 173.223 145.434  1.00  0.53           O  \nATOM     26  OE2 GLU C  27     147.087 173.712 143.267  1.00  0.53           O  \nATOM     27  N   LYS C  28     149.591 178.742 142.373  1.00  0.67           N  \nATOM     28  CA  LYS C  28     150.133 179.306 141.161  1.00  0.67           C  \nATOM     29  C   LYS C  28     150.331 178.177 140.177  1.00  0.67           C  \nATOM     30  O   LYS C  28     150.694 177.067 140.559  1.00  0.67           O  \nATOM     31  CB  LYS C  28     151.494 179.995 141.412  1.00  0.67           C  \nATOM     32  CG  LYS C  28     151.571 180.689 142.781  1.00  0.67           C  \nATOM     33  CD  LYS C  28     152.922 181.382 142.997  1.00  0.67           C  \nATOM     34  CE  LYS C  28     152.979 182.779 142.381  1.00  0.67           C  \nATOM     35  NZ  LYS C  28     154.320 183.366 142.580  1.00  0.67           N  \nATOM     36  N   LYS C  29     150.081 178.414 138.882  1.00  0.74           N  \nATOM     37  CA  LYS C  29     150.206 177.385 137.866  1.00  0.74           C  \nATOM     38  C   LYS C  29     151.640 176.971 137.618  1.00  0.74           C  \nATOM     39  O   LYS C  29     152.529 177.808 137.405  1.00  0.74           O  \nATOM     40  CB  LYS C  29     149.571 177.837 136.537  1.00  0.74           C  \nATOM     41  CG  LYS C  29     148.100 178.236 136.715  1.00  0.74           C  \nATOM     42  CD  LYS C  29     147.577 179.021 135.502  1.00  0.74           C  \nATOM     43  CE  LYS C  29     146.109 179.438 135.621  1.00  0.74           C  \nATOM     44  NZ  LYS C  29     145.937 180.205 136.876  1.00  0.74           N  \nATOM     45  N   VAL C  30     151.921 175.665 137.636  1.00  0.79           N  \nATOM     46  CA  VAL C  30     153.272 175.174 137.575  1.00  0.79           C  \nATOM     47  C   VAL C  30     153.534 174.570 136.222  1.00  0.79           C  \nATOM     48  O   VAL C  30     152.625 174.139 135.512  1.00  0.79           O  \nATOM     49  CB  VAL C  30     153.595 174.180 138.693  1.00  0.79           C  \nATOM     50  CG1 VAL C  30     153.319 174.844 140.062  1.00  0.79           C  \nATOM     51  CG2 VAL C  30     152.801 172.856 138.559  1.00  0.79           C  \nATOM     52  N   CYS C  31     154.805 174.513 135.818  1.00  0.82           N  \nATOM     53  CA  CYS C  31     155.193 173.798 134.627  1.00  0.82           C  \nATOM     54  C   CYS C  31     156.496 173.127 134.957  1.00  0.82           C  \nATOM     55  O   CYS C  31     157.241 173.553 135.842  1.00  0.82           O  \nATOM     56  CB  CYS C  31     155.318 174.681 133.348  1.00  0.82           C  \nATOM     57  SG  CYS C  31     156.449 176.085 133.546  1.00  0.82           S  \nATOM     58  N   GLN C  32     156.786 172.008 134.278  1.00  0.80           N  \nATOM     59  CA  GLN C  32     157.919 171.168 134.593  1.00  0.80           C  \nATOM     60  C   GLN C  32     159.256 171.782 134.243  1.00  0.80           C  \nATOM     61  O   GLN C  32     160.242 171.577 134.936  1.00  0.80           O  \nATOM     62  CB  GLN C  32     157.750 169.784 133.924  1.00  0.80           C  \nATOM     63  CG  GLN C  32     156.578 168.982 134.546  1.00  0.80           C  \nATOM     64  CD  GLN C  32     156.786 168.667 136.031  1.00  0.80           C  \nATOM     65  OE1 GLN C  32     155.953 168.975 136.873  1.00  0.80           O  \nATOM     66  NE2 GLN C  32     157.941 168.053 136.380  1.00  0.80           N  \nATOM     67  N   GLY C  33     159.311 172.565 133.150  1.00  0.89           N  \nATOM     68  CA  GLY C  33     160.556 173.057 132.592  1.00  0.89           C  \nATOM     69  C   GLY C  33     161.286 172.020 131.794  1.00  0.89           C  \nATOM     70  O   GLY C  33     161.029 170.822 131.872  1.00  0.89           O  \nATOM     71  N   THR C  34     162.207 172.497 130.948  1.00  0.87           N  \nATOM     72  CA  THR C  34     162.954 171.697 129.997  1.00  0.87           C  \nATOM     73  C   THR C  34     164.251 171.232 130.681  1.00  0.87           C  \nATOM     74  O   THR C  34     164.576 171.667 131.789  1.00  0.87           O  \nATOM     75  CB  THR C  34     163.151 172.416 128.655  1.00  0.87           C  \nATOM     76  OG1 THR C  34     164.054 173.483 128.841  1.00  0.87           O  \nATOM     77  CG2 THR C  34     161.796 172.964 128.096  1.00  0.87           C  \nATOM     78  N   SER C  35     165.010 170.283 130.090  1.00  0.85           N  \nATOM     79  CA  SER C  35     166.300 169.858 130.651  1.00  0.85           C  \nATOM     80  C   SER C  35     167.226 169.437 129.521  1.00  0.85           C  \nATOM     81  O   SER C  35     168.126 168.602 129.659  1.00  0.85           O  \nATOM     82  CB  SER C  35     166.177 168.721 131.721  1.00  0.85           C  \nATOM     83  OG  SER C  35     167.336 168.633 132.563  1.00  0.85           O  \nATOM     84  N   ASN C  36     167.019 170.009 128.325  1.00  0.81           N  \nATOM     85  CA  ASN C  36     167.718 169.674 127.106  1.00  0.81           C  \nATOM     86  C   ASN C  36     168.535 170.866 126.621  1.00  0.81           C  \nATOM     87  O   ASN C  36     168.117 171.621 125.756  1.00  0.81           O  \nATOM     88  CB  ASN C  36     166.754 169.162 125.991  1.00  0.81           C  \nATOM     89  CG  ASN C  36     165.435 169.934 125.866  1.00  0.81           C  \nATOM     90  OD1 ASN C  36     165.135 170.964 126.425  1.00  0.81           O  \nATOM     91  ND2 ASN C  36     164.533 169.339 125.045  1.00  0.81           N  \nATOM     92  N   LYS C  37     169.760 171.031 127.163  1.00  0.82           N  \nATOM     93  CA  LYS C  37     170.444 172.313 127.250  1.00  0.82           C  \nATOM     94  C   LYS C  37     170.652 173.142 125.979  1.00  0.82           C  \nATOM     95  O   LYS C  37     170.254 174.294 125.872  1.00  0.82           O  \nATOM     96  CB  LYS C  37     171.859 172.074 127.847  1.00  0.82           C  \nATOM     97  CG  LYS C  37     171.837 171.327 129.191  1.00  0.82           C  \nATOM     98  CD  LYS C  37     173.241 171.208 129.823  1.00  0.82           C  \nATOM     99  CE  LYS C  37     173.280 170.522 131.199  1.00  0.82           C  \nATOM    100  NZ  LYS C  37     172.725 169.157 131.079  1.00  0.82           N  \nATOM    101  N   LEU C  38     171.313 172.555 124.967  1.00  0.82           N  \nATOM    102  CA  LEU C  38     171.564 173.191 123.686  1.00  0.82           C  \nATOM    103  C   LEU C  38     171.039 172.335 122.560  1.00  0.82           C  \nATOM    104  O   LEU C  38     171.295 172.588 121.383  1.00  0.82           O  \nATOM    105  CB  LEU C  38     173.080 173.427 123.489  1.00  0.82           C  \nATOM    106  CG  LEU C  38     173.658 174.534 124.397  1.00  0.82           C  \nATOM    107  CD1 LEU C  38     175.157 174.696 124.092  1.00  0.82           C  \nATOM    108  CD2 LEU C  38     172.926 175.878 124.199  1.00  0.82           C  \nATOM    109  N   THR C  39     170.264 171.294 122.895  1.00  0.81           N  \nATOM    110  CA  THR C  39     169.602 170.432 121.922  1.00  0.81           C  \nATOM    111  C   THR C  39     168.490 171.168 121.212  1.00  0.81           C  \nATOM    112  O   THR C  39     167.661 171.828 121.832  1.00  0.81           O  \nATOM    113  CB  THR C  39     169.025 169.170 122.549  1.00  0.81           C  \nATOM    114  OG1 THR C  39     170.091 168.410 123.091  1.00  0.81           O  \nATOM    115  CG2 THR C  39     168.270 168.242 121.571  1.00  0.81           C  \nATOM    116  N   GLN C  40     168.431 171.059 119.876  1.00  0.80           N  \nATOM    117  CA  GLN C  40     167.368 171.633 119.086  1.00  0.80           C  \nATOM    118  C   GLN C  40     166.338 170.557 118.786  1.00  0.80           C  \nATOM    119  O   GLN C  40     166.672 169.446 118.375  1.00  0.80           O  \nATOM    120  CB  GLN C  40     167.946 172.219 117.778  1.00  0.80           C  \nATOM    121  CG  GLN C  40     166.867 172.823 116.854  1.00  0.80           C  \nATOM    122  CD  GLN C  40     167.484 173.499 115.632  1.00  0.80           C  \nATOM    123  OE1 GLN C  40     168.681 173.720 115.503  1.00  0.80           O  \nATOM    124  NE2 GLN C  40     166.596 173.857 114.674  1.00  0.80           N  \nATOM    125  N   LEU C  41     165.041 170.845 119.008  1.00  0.82           N  \nATOM    126  CA  LEU C  41     163.986 169.853 118.873  1.00  0.82           C  \nATOM    127  C   LEU C  41     163.289 169.959 117.525  1.00  0.82           C  \nATOM    128  O   LEU C  41     162.166 170.448 117.434  1.00  0.82           O  \nATOM    129  CB  LEU C  41     162.923 170.006 119.992  1.00  0.82           C  \nATOM    130  CG  LEU C  41     163.502 169.946 121.419  1.00  0.82           C  \nATOM    131  CD1 LEU C  41     162.419 170.410 122.416  1.00  0.82           C  \nATOM    132  CD2 LEU C  41     164.080 168.544 121.726  1.00  0.82           C  \nATOM    133  N   GLY C  42     163.944 169.500 116.437  1.00  0.82           N  \nATOM    134  CA  GLY C  42     163.381 169.539 115.087  1.00  0.82           C  \nATOM    135  C   GLY C  42     163.859 170.755 114.339  1.00  0.82           C  \nATOM    136  O   GLY C  42     165.021 171.144 114.438  1.00  0.82           O  \nATOM    137  N   THR C  43     162.977 171.401 113.549  1.00  0.79           N  \nATOM    138  CA  THR C  43     163.251 172.667 112.868  1.00  0.79           C  \nATOM    139  C   THR C  43     163.092 173.845 113.813  1.00  0.79           C  \nATOM    140  O   THR C  43     162.813 173.705 115.003  1.00  0.79           O  \nATOM    141  CB  THR C  43     162.434 172.922 111.594  1.00  0.79           C  \nATOM    142  OG1 THR C  43     161.055 173.106 111.856  1.00  0.79           O  \nATOM    143  CG2 THR C  43     162.631 171.742 110.652  1.00  0.79           C  \nATOM    144  N   PHE C  44     163.297 175.082 113.320  1.00  0.81           N  \nATOM    145  CA  PHE C  44     163.108 176.283 114.113  1.00  0.81           C  \nATOM    146  C   PHE C  44     161.662 176.558 114.507  1.00  0.81           C  \nATOM    147  O   PHE C  44     161.408 177.231 115.503  1.00  0.81           O  \nATOM    148  CB  PHE C  44     163.699 177.518 113.373  1.00  0.81           C  \nATOM    149  CG  PHE C  44     165.218 177.530 113.381  1.00  0.81           C  \nATOM    150  CD1 PHE C  44     165.993 177.055 114.463  1.00  0.81           C  \nATOM    151  CD2 PHE C  44     165.894 178.127 112.303  1.00  0.81           C  \nATOM    152  CE1 PHE C  44     167.393 177.117 114.433  1.00  0.81           C  \nATOM    153  CE2 PHE C  44     167.291 178.231 112.290  1.00  0.81           C  \nATOM    154  CZ  PHE C  44     168.043 177.709 113.348  1.00  0.81           C  \nATOM    155  N   GLU C  45     160.669 176.033 113.763  1.00  0.79           N  \nATOM    156  CA  GLU C  45     159.289 176.180 114.143  1.00  0.79           C  \nATOM    157  C   GLU C  45     158.877 175.030 115.054  1.00  0.79           C  \nATOM    158  O   GLU C  45     158.247 175.268 116.080  1.00  0.79           O  \nATOM    159  CB  GLU C  45     158.403 176.344 112.901  1.00  0.79           C  \nATOM    160  CG  GLU C  45     157.072 177.050 113.254  1.00  0.79           C  \nATOM    161  CD  GLU C  45     155.989 176.884 112.195  1.00  0.79           C  \nATOM    162  OE1 GLU C  45     156.042 175.887 111.434  1.00  0.79           O  \nATOM    163  OE2 GLU C  45     155.085 177.757 112.164  1.00  0.79           O  \nATOM    164  N   ASP C  46     159.330 173.768 114.789  1.00  0.80           N  \nATOM    165  CA  ASP C  46     159.066 172.626 115.659  1.00  0.80           C  \nATOM    166  C   ASP C  46     159.580 172.894 117.076  1.00  0.80           C  \nATOM    167  O   ASP C  46     158.891 172.675 118.072  1.00  0.80           O  \nATOM    168  CB  ASP C  46     159.739 171.315 115.151  1.00  0.80           C  \nATOM    169  CG  ASP C  46     159.160 170.839 113.835  1.00  0.80           C  \nATOM    170  OD1 ASP C  46     157.916 170.860 113.695  1.00  0.80           O  \nATOM    171  OD2 ASP C  46     159.987 170.440 112.968  1.00  0.80           O  \nATOM    172  N   HIS C  47     160.800 173.476 117.189  1.00  0.84           N  \nATOM    173  CA  HIS C  47     161.349 173.890 118.469  1.00  0.84           C  \nATOM    174  C   HIS C  47     160.535 174.963 119.191  1.00  0.84           C  \nATOM    175  O   HIS C  47     160.166 174.785 120.353  1.00  0.84           O  \nATOM    176  CB  HIS C  47     162.802 174.396 118.329  1.00  0.84           C  \nATOM    177  CG  HIS C  47     163.530 174.523 119.648  1.00  0.84           C  \nATOM    178  ND1 HIS C  47     164.893 174.313 119.616  1.00  0.84           N  \nATOM    179  CD2 HIS C  47     163.147 174.874 120.911  1.00  0.84           C  \nATOM    180  CE1 HIS C  47     165.306 174.545 120.846  1.00  0.84           C  \nATOM    181  NE2 HIS C  47     164.293 174.885 121.670  1.00  0.84           N  \nATOM    182  N   PHE C  48     160.175 176.079 118.506  1.00  0.86           N  \nATOM    183  CA  PHE C  48     159.396 177.184 119.053  1.00  0.86           C  \nATOM    184  C   PHE C  48     158.037 176.688 119.542  1.00  0.86           C  \nATOM    185  O   PHE C  48     157.619 177.019 120.648  1.00  0.86           O  \nATOM    186  CB  PHE C  48     159.304 178.349 118.012  1.00  0.86           C  \nATOM    187  CG  PHE C  48     158.421 179.486 118.493  1.00  0.86           C  \nATOM    188  CD1 PHE C  48     158.853 180.410 119.465  1.00  0.86           C  \nATOM    189  CD2 PHE C  48     157.094 179.564 118.036  1.00  0.86           C  \nATOM    190  CE1 PHE C  48     157.981 181.402 119.943  1.00  0.86           C  \nATOM    191  CE2 PHE C  48     156.217 180.537 118.530  1.00  0.86           C  \nATOM    192  CZ  PHE C  48     156.665 181.467 119.472  1.00  0.86           C  \nATOM    193  N   LEU C  49     157.375 175.788 118.779  1.00  0.85           N  \nATOM    194  CA  LEU C  49     156.135 175.148 119.176  1.00  0.85           C  \nATOM    195  C   LEU C  49     156.258 174.396 120.487  1.00  0.85           C  \nATOM    196  O   LEU C  49     155.418 174.560 121.362  1.00  0.85           O  \nATOM    197  CB  LEU C  49     155.586 174.222 118.052  1.00  0.85           C  \nATOM    198  CG  LEU C  49     154.471 174.909 117.221  1.00  0.85           C  \nATOM    199  CD1 LEU C  49     153.169 175.073 118.036  1.00  0.85           C  \nATOM    200  CD2 LEU C  49     154.908 176.265 116.627  1.00  0.85           C  \nATOM    201  N   SER C  50     157.331 173.603 120.704  1.00  0.86           N  \nATOM    202  CA  SER C  50     157.575 172.892 121.963  1.00  0.86           C  \nATOM    203  C   SER C  50     157.803 173.812 123.161  1.00  0.86           C  \nATOM    204  O   SER C  50     157.267 173.564 124.238  1.00  0.86           O  \nATOM    205  CB  SER C  50     158.762 171.890 121.926  1.00  0.86           C  \nATOM    206  OG  SER C  50     158.571 170.890 120.935  1.00  0.86           O  \nATOM    207  N   LEU C  51     158.581 174.912 122.990  1.00  0.89           N  \nATOM    208  CA  LEU C  51     158.822 175.966 123.975  1.00  0.89           C  \nATOM    209  C   LEU C  51     157.528 176.678 124.367  1.00  0.89           C  \nATOM    210  O   LEU C  51     157.205 176.812 125.550  1.00  0.89           O  \nATOM    211  CB  LEU C  51     159.825 176.995 123.359  1.00  0.89           C  \nATOM    212  CG  LEU C  51     160.075 178.304 124.151  1.00  0.89           C  \nATOM    213  CD1 LEU C  51     160.820 178.051 125.471  1.00  0.89           C  \nATOM    214  CD2 LEU C  51     160.855 179.323 123.301  1.00  0.89           C  \nATOM    215  N   GLN C  52     156.712 177.079 123.366  1.00  0.83           N  \nATOM    216  CA  GLN C  52     155.386 177.634 123.560  1.00  0.83           C  \nATOM    217  C   GLN C  52     154.421 176.677 124.252  1.00  0.83           C  \nATOM    218  O   GLN C  52     153.712 177.069 125.165  1.00  0.83           O  \nATOM    219  CB  GLN C  52     154.779 178.112 122.213  1.00  0.83           C  \nATOM    220  CG  GLN C  52     153.360 178.721 122.372  1.00  0.83           C  \nATOM    221  CD  GLN C  52     152.874 179.396 121.090  1.00  0.83           C  \nATOM    222  OE1 GLN C  52     153.397 179.208 120.000  1.00  0.83           O  \nATOM    223  NE2 GLN C  52     151.806 180.222 121.224  1.00  0.83           N  \nATOM    224  N   ARG C  53     154.381 175.381 123.873  1.00  0.75           N  \nATOM    225  CA  ARG C  53     153.456 174.397 124.426  1.00  0.75           C  \nATOM    226  C   ARG C  53     153.696 174.032 125.889  1.00  0.75           C  \nATOM    227  O   ARG C  53     152.792 173.578 126.583  1.00  0.75           O  \nATOM    228  CB  ARG C  53     153.538 173.093 123.587  1.00  0.75           C  \nATOM    229  CG  ARG C  53     152.184 172.416 123.281  1.00  0.75           C  \nATOM    230  CD  ARG C  53     152.202 171.602 121.970  1.00  0.75           C  \nATOM    231  NE  ARG C  53     153.353 170.623 122.051  1.00  0.75           N  \nATOM    232  CZ  ARG C  53     154.229 170.340 121.072  1.00  0.75           C  \nATOM    233  NH1 ARG C  53     154.148 170.889 119.866  1.00  0.75           N  \nATOM    234  NH2 ARG C  53     155.251 169.513 121.302  1.00  0.75           N  \nATOM    235  N   MET C  54     154.949 174.198 126.357  1.00  0.81           N  \nATOM    236  CA  MET C  54     155.397 173.928 127.710  1.00  0.81           C  \nATOM    237  C   MET C  54     155.182 175.103 128.660  1.00  0.81           C  \nATOM    238  O   MET C  54     154.636 174.943 129.748  1.00  0.81           O  \nATOM    239  CB  MET C  54     156.911 173.558 127.638  1.00  0.81           C  \nATOM    240  CG  MET C  54     157.741 173.650 128.946  1.00  0.81           C  \nATOM    241  SD  MET C  54     157.204 172.593 130.328  1.00  0.81           S  \nATOM    242  CE  MET C  54     157.874 171.075 129.598  1.00  0.81           C  \nATOM    243  N   PHE C  55     155.603 176.333 128.284  1.00  0.87           N  \nATOM    244  CA  PHE C  55     155.654 177.436 129.238  1.00  0.87           C  \nATOM    245  C   PHE C  55     154.452 178.348 129.123  1.00  0.87           C  \nATOM    246  O   PHE C  55     154.383 179.379 129.788  1.00  0.87           O  \nATOM    247  CB  PHE C  55     156.942 178.286 129.076  1.00  0.87           C  \nATOM    248  CG  PHE C  55     158.151 177.471 129.448  1.00  0.87           C  \nATOM    249  CD1 PHE C  55     158.434 177.117 130.779  1.00  0.87           C  \nATOM    250  CD2 PHE C  55     159.037 177.066 128.446  1.00  0.87           C  \nATOM    251  CE1 PHE C  55     159.593 176.394 131.096  1.00  0.87           C  \nATOM    252  CE2 PHE C  55     160.213 176.373 128.755  1.00  0.87           C  \nATOM    253  CZ  PHE C  55     160.494 176.040 130.085  1.00  0.87           C  \nATOM    254  N   ASN C  56     153.444 177.982 128.302  1.00  0.83           N  \nATOM    255  CA  ASN C  56     152.228 178.758 128.162  1.00  0.83           C  \nATOM    256  C   ASN C  56     151.451 178.816 129.473  1.00  0.83           C  \nATOM    257  O   ASN C  56     151.151 177.785 130.066  1.00  0.83           O  \nATOM    258  CB  ASN C  56     151.290 178.170 127.068  1.00  0.83           C  \nATOM    259  CG  ASN C  56     150.517 179.294 126.394  1.00  0.83           C  \nATOM    260  OD1 ASN C  56     150.996 180.415 126.252  1.00  0.83           O  \nATOM    261  ND2 ASN C  56     149.278 179.002 125.944  1.00  0.83           N  \nATOM    262  N   ASN C  57     151.132 180.029 129.973  1.00  0.81           N  \nATOM    263  CA  ASN C  57     150.351 180.241 131.191  1.00  0.81           C  \nATOM    264  C   ASN C  57     151.000 179.753 132.494  1.00  0.81           C  \nATOM    265  O   ASN C  57     150.358 179.761 133.542  1.00  0.81           O  \nATOM    266  CB  ASN C  57     148.910 179.648 131.091  1.00  0.81           C  \nATOM    267  CG  ASN C  57     148.185 180.120 129.837  1.00  0.81           C  \nATOM    268  OD1 ASN C  57     147.707 179.334 129.027  1.00  0.81           O  \nATOM    269  ND2 ASN C  57     148.072 181.458 129.662  1.00  0.81           N  \nATOM    270  N   CYS C  58     152.286 179.344 132.458  1.00  0.81           N  \nATOM    271  CA  CYS C  58     153.069 178.921 133.614  1.00  0.81           C  \nATOM    272  C   CYS C  58     153.372 180.146 134.511  1.00  0.81           C  \nATOM    273  O   CYS C  58     153.561 181.205 134.049  1.00  0.81           O  \nATOM    274  CB  CYS C  58     154.386 178.244 133.134  1.00  0.81           C  \nATOM    275  SG  CYS C  58     155.321 177.471 134.487  1.00  0.81           S  \nATOM    276  N   GLU C  59     153.451 179.926 135.864  1.00  0.80           N  \nATOM    277  CA  GLU C  59     153.827 181.011 136.764  1.00  0.80           C  \nATOM    278  C   GLU C  59     155.029 180.561 137.593  1.00  0.80           C  \nATOM    279  O   GLU C  59     155.896 181.371 137.952  1.00  0.80           O  \nATOM    280  CB  GLU C  59     152.601 181.364 137.647  1.00  0.80           C  \nATOM    281  CG  GLU C  59     151.425 181.996 136.838  1.00  0.80           C  \nATOM    282  CD  GLU C  59     150.149 182.138 137.670  1.00  0.80           C  \nATOM    283  OE1 GLU C  59     150.256 182.076 138.921  1.00  0.80           O  \nATOM    284  OE2 GLU C  59     149.038 182.222 137.072  1.00  0.80           O  \nATOM    285  N   VAL C  60     155.168 179.250 137.854  1.00  0.82           N  \nATOM    286  CA  VAL C  60     156.278 178.671 138.595  1.00  0.82           C  \nATOM    287  C   VAL C  60     156.884 177.543 137.786  1.00  0.82           C  \nATOM    288  O   VAL C  60     156.250 176.525 137.508  1.00  0.82           O  \nATOM    289  CB  VAL C  60     155.829 178.163 139.971  1.00  0.82           C  \nATOM    290  CG1 VAL C  60     156.971 177.440 140.728  1.00  0.82           C  \nATOM    291  CG2 VAL C  60     155.322 179.360 140.805  1.00  0.82           C  \nATOM    292  N   VAL C  61     158.158 177.684 137.377  1.00  0.85           N  \nATOM    293  CA  VAL C  61     158.858 176.620 136.673  1.00  0.85           C  \nATOM    294  C   VAL C  61     159.558 175.743 137.705  1.00  0.85           C  \nATOM    295  O   VAL C  61     160.425 176.212 138.445  1.00  0.85           O  \nATOM    296  CB  VAL C  61     159.901 177.125 135.674  1.00  0.85           C  \nATOM    297  CG1 VAL C  61     160.439 175.929 134.858  1.00  0.85           C  \nATOM    298  CG2 VAL C  61     159.295 178.199 134.740  1.00  0.85           C  \nATOM    299  N   LEU C  62     159.191 174.446 137.799  1.00  0.81           N  \nATOM    300  CA  LEU C  62     159.722 173.527 138.798  1.00  0.81           C  \nATOM    301  C   LEU C  62     161.114 173.003 138.468  1.00  0.81           C  \nATOM    302  O   LEU C  62     161.883 172.614 139.342  1.00  0.81           O  \nATOM    303  CB  LEU C  62     158.781 172.306 138.943  1.00  0.81           C  \nATOM    304  CG  LEU C  62     157.346 172.660 139.396  1.00  0.81           C  \nATOM    305  CD1 LEU C  62     156.434 171.427 139.261  1.00  0.81           C  \nATOM    306  CD2 LEU C  62     157.307 173.235 140.828  1.00  0.81           C  \nATOM    307  N   GLY C  63     161.452 173.000 137.168  1.00  0.86           N  \nATOM    308  CA  GLY C  63     162.757 172.664 136.630  1.00  0.86           C  \nATOM    309  C   GLY C  63     163.432 173.883 136.083  1.00  0.86           C  \nATOM    310  O   GLY C  63     163.429 174.955 136.687  1.00  0.86           O  \nATOM    311  N   ASN C  64     164.045 173.741 134.895  1.00  0.86           N  \nATOM    312  CA  ASN C  64     164.853 174.785 134.302  1.00  0.86           C  \nATOM    313  C   ASN C  64     164.048 175.539 133.263  1.00  0.86           C  \nATOM    314  O   ASN C  64     163.026 175.075 132.754  1.00  0.86           O  \nATOM    315  CB  ASN C  64     166.139 174.243 133.615  1.00  0.86           C  \nATOM    316  CG  ASN C  64     166.917 173.337 134.559  1.00  0.86           C  \nATOM    317  OD1 ASN C  64     167.065 173.610 135.748  1.00  0.86           O  \nATOM    318  ND2 ASN C  64     167.448 172.217 134.013  1.00  0.86           N  \nATOM    319  N   LEU C  65     164.509 176.742 132.909  1.00  0.89           N  \nATOM    320  CA  LEU C  65     163.932 177.515 131.838  1.00  0.89           C  \nATOM    321  C   LEU C  65     165.024 177.709 130.803  1.00  0.89           C  \nATOM    322  O   LEU C  65     166.044 178.349 131.065  1.00  0.89           O  \nATOM    323  CB  LEU C  65     163.445 178.866 132.419  1.00  0.89           C  \nATOM    324  CG  LEU C  65     162.963 179.922 131.397  1.00  0.89           C  \nATOM    325  CD1 LEU C  65     161.591 179.572 130.784  1.00  0.89           C  \nATOM    326  CD2 LEU C  65     162.952 181.323 132.042  1.00  0.89           C  \nATOM    327  N   GLU C  66     164.851 177.133 129.601  1.00  0.88           N  \nATOM    328  CA  GLU C  66     165.828 177.188 128.539  1.00  0.88           C  \nATOM    329  C   GLU C  66     165.163 177.785 127.323  1.00  0.88           C  \nATOM    330  O   GLU C  66     164.166 177.288 126.801  1.00  0.88           O  \nATOM    331  CB  GLU C  66     166.345 175.770 128.201  1.00  0.88           C  \nATOM    332  CG  GLU C  66     167.193 175.122 129.332  1.00  0.88           C  \nATOM    333  CD  GLU C  66     167.392 173.610 129.216  1.00  0.88           C  \nATOM    334  OE1 GLU C  66     166.641 172.937 128.473  1.00  0.88           O  \nATOM    335  OE2 GLU C  66     168.252 173.068 129.959  1.00  0.88           O  \nATOM    336  N   ILE C  67     165.695 178.920 126.854  1.00  0.92           N  \nATOM    337  CA  ILE C  67     165.153 179.608 125.712  1.00  0.92           C  \nATOM    338  C   ILE C  67     166.292 179.610 124.722  1.00  0.92           C  \nATOM    339  O   ILE C  67     167.293 180.304 124.884  1.00  0.92           O  \nATOM    340  CB  ILE C  67     164.679 181.025 126.065  1.00  0.92           C  \nATOM    341  CG1 ILE C  67     163.778 181.039 127.339  1.00  0.92           C  \nATOM    342  CG2 ILE C  67     163.941 181.620 124.837  1.00  0.92           C  \nATOM    343  CD1 ILE C  67     163.609 182.436 127.959  1.00  0.92           C  \nATOM    344  N   THR C  68     166.186 178.774 123.676  1.00  0.89           N  \nATOM    345  CA  THR C  68     167.240 178.592 122.697  1.00  0.89           C  \nATOM    346  C   THR C  68     166.623 178.571 121.329  1.00  0.89           C  \nATOM    347  O   THR C  68     165.448 178.248 121.170  1.00  0.89           O  \nATOM    348  CB  THR C  68     168.065 177.308 122.861  1.00  0.89           C  \nATOM    349  OG1 THR C  68     167.248 176.153 123.015  1.00  0.89           O  \nATOM    350  CG2 THR C  68     168.940 177.415 124.113  1.00  0.89           C  \nATOM    351  N   TYR C  69     167.403 178.978 120.303  1.00  0.84           N  \nATOM    352  CA  TYR C  69     167.071 178.852 118.886  1.00  0.84           C  \nATOM    353  C   TYR C  69     165.785 179.554 118.449  1.00  0.84           C  \nATOM    354  O   TYR C  69     165.147 179.196 117.462  1.00  0.84           O  \nATOM    355  CB  TYR C  69     167.049 177.372 118.414  1.00  0.84           C  \nATOM    356  CG  TYR C  69     168.356 176.676 118.696  1.00  0.84           C  \nATOM    357  CD1 TYR C  69     169.513 176.897 117.929  1.00  0.84           C  \nATOM    358  CD2 TYR C  69     168.410 175.743 119.736  1.00  0.84           C  \nATOM    359  CE1 TYR C  69     170.682 176.155 118.179  1.00  0.84           C  \nATOM    360  CE2 TYR C  69     169.573 175.016 120.002  1.00  0.84           C  \nATOM    361  CZ  TYR C  69     170.711 175.208 119.215  1.00  0.84           C  \nATOM    362  OH  TYR C  69     171.879 174.458 119.475  1.00  0.84           O  \nATOM    363  N   VAL C  70     165.402 180.643 119.148  1.00  0.90           N  \nATOM    364  CA  VAL C  70     164.217 181.425 118.810  1.00  0.90           C  \nATOM    365  C   VAL C  70     164.652 182.448 117.807  1.00  0.90           C  \nATOM    366  O   VAL C  70     165.590 183.218 118.036  1.00  0.90           O  \nATOM    367  CB  VAL C  70     163.498 182.105 119.984  1.00  0.90           C  \nATOM    368  CG1 VAL C  70     162.337 183.028 119.523  1.00  0.90           C  \nATOM    369  CG2 VAL C  70     162.985 180.990 120.921  1.00  0.90           C  \nATOM    370  N   GLN C  71     163.989 182.422 116.643  1.00  0.81           N  \nATOM    371  CA  GLN C  71     164.292 183.263 115.521  1.00  0.81           C  \nATOM    372  C   GLN C  71     163.564 184.595 115.627  1.00  0.81           C  \nATOM    373  O   GLN C  71     162.747 184.832 116.518  1.00  0.81           O  \nATOM    374  CB  GLN C  71     164.015 182.509 114.186  1.00  0.81           C  \nATOM    375  CG  GLN C  71     164.754 181.144 114.080  1.00  0.81           C  \nATOM    376  CD  GLN C  71     166.273 181.332 113.994  1.00  0.81           C  \nATOM    377  OE1 GLN C  71     166.818 181.541 112.916  1.00  0.81           O  \nATOM    378  NE2 GLN C  71     166.988 181.288 115.144  1.00  0.81           N  \nATOM    379  N   ARG C  72     163.896 185.540 114.732  1.00  0.74           N  \nATOM    380  CA  ARG C  72     163.219 186.818 114.595  1.00  0.74           C  \nATOM    381  C   ARG C  72     161.733 186.729 114.275  1.00  0.74           C  \nATOM    382  O   ARG C  72     161.262 185.744 113.718  1.00  0.74           O  \nATOM    383  CB  ARG C  72     163.866 187.741 113.531  1.00  0.74           C  \nATOM    384  CG  ARG C  72     165.385 187.935 113.726  1.00  0.74           C  \nATOM    385  CD  ARG C  72     166.001 189.114 112.952  1.00  0.74           C  \nATOM    386  NE  ARG C  72     165.347 190.385 113.472  1.00  0.74           N  \nATOM    387  CZ  ARG C  72     165.777 191.146 114.498  1.00  0.74           C  \nATOM    388  NH1 ARG C  72     165.043 192.203 114.878  1.00  0.74           N  \nATOM    389  NH2 ARG C  72     166.895 190.861 115.151  1.00  0.74           N  \nATOM    390  N   ASN C  73     160.965 187.776 114.660  1.00  0.74           N  \nATOM    391  CA  ASN C  73     159.532 187.917 114.429  1.00  0.74           C  \nATOM    392  C   ASN C  73     158.668 187.042 115.328  1.00  0.74           C  \nATOM    393  O   ASN C  73     157.448 187.157 115.316  1.00  0.74           O  \nATOM    394  CB  ASN C  73     159.102 187.728 112.942  1.00  0.74           C  \nATOM    395  CG  ASN C  73     159.616 188.863 112.065  1.00  0.74           C  \nATOM    396  OD1 ASN C  73     160.353 189.759 112.460  1.00  0.74           O  \nATOM    397  ND2 ASN C  73     159.166 188.819 110.785  1.00  0.74           N  \nATOM    398  N   TYR C  74     159.271 186.168 116.157  1.00  0.81           N  \nATOM    399  CA  TYR C  74     158.539 185.304 117.055  1.00  0.81           C  \nATOM    400  C   TYR C  74     158.083 186.024 118.314  1.00  0.81           C  \nATOM    401  O   TYR C  74     158.841 186.705 119.009  1.00  0.81           O  \nATOM    402  CB  TYR C  74     159.337 184.002 117.358  1.00  0.81           C  \nATOM    403  CG  TYR C  74     159.446 183.046 116.168  1.00  0.81           C  \nATOM    404  CD1 TYR C  74     158.784 183.198 114.925  1.00  0.81           C  \nATOM    405  CD2 TYR C  74     160.228 181.891 116.345  1.00  0.81           C  \nATOM    406  CE1 TYR C  74     158.926 182.238 113.908  1.00  0.81           C  \nATOM    407  CE2 TYR C  74     160.374 180.933 115.332  1.00  0.81           C  \nATOM    408  CZ  TYR C  74     159.734 181.116 114.105  1.00  0.81           C  \nATOM    409  OH  TYR C  74     159.904 180.177 113.066  1.00  0.81           O  \nATOM    410  N   ASP C  75     156.777 185.882 118.619  1.00  0.81           N  \nATOM    411  CA  ASP C  75     156.152 186.477 119.765  1.00  0.81           C  \nATOM    412  C   ASP C  75     156.439 185.564 120.960  1.00  0.81           C  \nATOM    413  O   ASP C  75     155.995 184.422 121.061  1.00  0.81           O  \nATOM    414  CB  ASP C  75     154.643 186.751 119.491  1.00  0.81           C  \nATOM    415  CG  ASP C  75     154.048 187.418 120.721  1.00  0.81           C  \nATOM    416  OD1 ASP C  75     154.378 188.598 121.009  1.00  0.81           O  \nATOM    417  OD2 ASP C  75     153.364 186.695 121.485  1.00  0.81           O  \nATOM    418  N   LEU C  76     157.256 186.071 121.896  1.00  0.85           N  \nATOM    419  CA  LEU C  76     157.600 185.408 123.135  1.00  0.85           C  \nATOM    420  C   LEU C  76     156.793 186.002 124.285  1.00  0.85           C  \nATOM    421  O   LEU C  76     157.200 185.940 125.446  1.00  0.85           O  \nATOM    422  CB  LEU C  76     159.129 185.497 123.408  1.00  0.85           C  \nATOM    423  CG  LEU C  76     159.976 184.463 122.632  1.00  0.85           C  \nATOM    424  CD1 LEU C  76     161.461 184.753 122.901  1.00  0.85           C  \nATOM    425  CD2 LEU C  76     159.644 183.013 123.045  1.00  0.85           C  \nATOM    426  N   SER C  77     155.595 186.592 124.027  1.00  0.84           N  \nATOM    427  CA  SER C  77     154.818 187.306 125.053  1.00  0.84           C  \nATOM    428  C   SER C  77     154.202 186.383 126.111  1.00  0.84           C  \nATOM    429  O   SER C  77     153.748 186.853 127.152  1.00  0.84           O  \nATOM    430  CB  SER C  77     153.692 188.240 124.507  1.00  0.84           C  \nATOM    431  OG  SER C  77     154.283 189.423 123.989  1.00  0.84           O  \nATOM    432  N   PHE C  78     154.235 185.038 125.927  1.00  0.82           N  \nATOM    433  CA  PHE C  78     153.791 184.038 126.895  1.00  0.82           C  \nATOM    434  C   PHE C  78     154.773 183.902 128.073  1.00  0.82           C  \nATOM    435  O   PHE C  78     154.434 183.340 129.104  1.00  0.82           O  \nATOM    436  CB  PHE C  78     153.488 182.650 126.231  1.00  0.82           C  \nATOM    437  CG  PHE C  78     154.672 182.076 125.479  1.00  0.82           C  \nATOM    438  CD1 PHE C  78     155.637 181.291 126.137  1.00  0.82           C  \nATOM    439  CD2 PHE C  78     154.829 182.320 124.103  1.00  0.82           C  \nATOM    440  CE1 PHE C  78     156.731 180.762 125.436  1.00  0.82           C  \nATOM    441  CE2 PHE C  78     155.916 181.788 123.399  1.00  0.82           C  \nATOM    442  CZ  PHE C  78     156.865 181.002 124.064  1.00  0.82           C  \nATOM    443  N   LEU C  79     156.002 184.480 127.987  1.00  0.85           N  \nATOM    444  CA  LEU C  79     156.989 184.423 129.063  1.00  0.85           C  \nATOM    445  C   LEU C  79     156.807 185.539 130.079  1.00  0.85           C  \nATOM    446  O   LEU C  79     157.544 185.642 131.056  1.00  0.85           O  \nATOM    447  CB  LEU C  79     158.427 184.607 128.516  1.00  0.85           C  \nATOM    448  CG  LEU C  79     158.917 183.485 127.583  1.00  0.85           C  \nATOM    449  CD1 LEU C  79     160.347 183.827 127.135  1.00  0.85           C  \nATOM    450  CD2 LEU C  79     158.876 182.094 128.251  1.00  0.85           C  \nATOM    451  N   LYS C  80     155.771 186.381 129.903  1.00  0.80           N  \nATOM    452  CA  LYS C  80     155.477 187.491 130.783  1.00  0.80           C  \nATOM    453  C   LYS C  80     154.807 187.057 132.078  1.00  0.80           C  \nATOM    454  O   LYS C  80     154.593 187.875 132.964  1.00  0.80           O  \nATOM    455  CB  LYS C  80     154.554 188.516 130.079  1.00  0.80           C  \nATOM    456  CG  LYS C  80     155.327 189.479 129.169  1.00  0.80           C  \nATOM    457  CD  LYS C  80     154.407 190.614 128.675  1.00  0.80           C  \nATOM    458  CE  LYS C  80     155.128 191.815 128.063  1.00  0.80           C  \nATOM    459  NZ  LYS C  80     155.679 191.434 126.753  1.00  0.80           N  \nATOM    460  N   THR C  81     154.442 185.765 132.205  1.00  0.84           N  \nATOM    461  CA  THR C  81     153.652 185.230 133.299  1.00  0.84           C  \nATOM    462  C   THR C  81     154.516 184.533 134.341  1.00  0.84           C  \nATOM    463  O   THR C  81     154.127 184.419 135.500  1.00  0.84           O  \nATOM    464  CB  THR C  81     152.623 184.222 132.768  1.00  0.84           C  \nATOM    465  OG1 THR C  81     153.219 183.113 132.117  1.00  0.84           O  \nATOM    466  CG2 THR C  81     151.726 184.910 131.720  1.00  0.84           C  \nATOM    467  N   ILE C  82     155.729 184.072 133.957  1.00  0.84           N  \nATOM    468  CA  ILE C  82     156.677 183.358 134.812  1.00  0.84           C  \nATOM    469  C   ILE C  82     157.244 184.245 135.925  1.00  0.84           C  \nATOM    470  O   ILE C  82     157.791 185.316 135.668  1.00  0.84           O  \nATOM    471  CB  ILE C  82     157.835 182.722 134.018  1.00  0.84           C  \nATOM    472  CG1 ILE C  82     157.315 181.902 132.798  1.00  0.84           C  \nATOM    473  CG2 ILE C  82     158.692 181.839 134.972  1.00  0.84           C  \nATOM    474  CD1 ILE C  82     158.435 181.420 131.859  1.00  0.84           C  \nATOM    475  N   GLN C  83     157.133 183.828 137.207  1.00  0.82           N  \nATOM    476  CA  GLN C  83     157.525 184.651 138.335  1.00  0.82           C  \nATOM    477  C   GLN C  83     158.695 184.073 139.102  1.00  0.82           C  \nATOM    478  O   GLN C  83     159.490 184.808 139.684  1.00  0.82           O  \nATOM    479  CB  GLN C  83     156.309 184.800 139.269  1.00  0.82           C  \nATOM    480  CG  GLN C  83     155.219 185.683 138.619  1.00  0.82           C  \nATOM    481  CD  GLN C  83     153.968 185.771 139.486  1.00  0.82           C  \nATOM    482  OE1 GLN C  83     153.926 185.286 140.621  1.00  0.82           O  \nATOM    483  NE2 GLN C  83     152.917 186.411 138.924  1.00  0.82           N  \nATOM    484  N   GLU C  84     158.890 182.747 139.084  1.00  0.81           N  \nATOM    485  CA  GLU C  84     160.048 182.175 139.724  1.00  0.81           C  \nATOM    486  C   GLU C  84     160.418 180.890 139.023  1.00  0.81           C  \nATOM    487  O   GLU C  84     159.586 180.205 138.421  1.00  0.81           O  \nATOM    488  CB  GLU C  84     159.857 182.016 141.272  1.00  0.81           C  \nATOM    489  CG  GLU C  84     158.730 181.026 141.693  1.00  0.81           C  \nATOM    490  CD  GLU C  84     157.922 181.371 142.954  1.00  0.81           C  \nATOM    491  OE1 GLU C  84     157.820 182.565 143.331  1.00  0.81           O  \nATOM    492  OE2 GLU C  84     157.310 180.427 143.516  1.00  0.81           O  \nATOM    493  N   VAL C  85     161.723 180.579 139.029  1.00  0.87           N  \nATOM    494  CA  VAL C  85     162.285 179.387 138.422  1.00  0.87           C  \nATOM    495  C   VAL C  85     163.027 178.650 139.515  1.00  0.87           C  \nATOM    496  O   VAL C  85     163.782 179.246 140.285  1.00  0.87           O  \nATOM    497  CB  VAL C  85     163.204 179.741 137.245  1.00  0.87           C  \nATOM    498  CG1 VAL C  85     164.009 178.522 136.738  1.00  0.87           C  \nATOM    499  CG2 VAL C  85     162.326 180.296 136.099  1.00  0.87           C  \nATOM    500  N   ALA C  86     162.802 177.329 139.668  1.00  0.87           N  \nATOM    501  CA  ALA C  86     163.459 176.566 140.705  1.00  0.87           C  \nATOM    502  C   ALA C  86     164.841 176.019 140.319  1.00  0.87           C  \nATOM    503  O   ALA C  86     165.686 175.793 141.181  1.00  0.87           O  \nATOM    504  CB  ALA C  86     162.514 175.443 141.163  1.00  0.87           C  \nATOM    505  N   GLY C  87     165.123 175.839 139.012  1.00  0.86           N  \nATOM    506  CA  GLY C  87     166.412 175.414 138.481  1.00  0.86           C  \nATOM    507  C   GLY C  87     167.253 176.594 138.082  1.00  0.86           C  \nATOM    508  O   GLY C  87     167.383 177.565 138.825  1.00  0.86           O  \nATOM    509  N   TYR C  88     167.833 176.538 136.870  1.00  0.85           N  \nATOM    510  CA  TYR C  88     168.577 177.629 136.262  1.00  0.85           C  \nATOM    511  C   TYR C  88     167.784 178.278 135.142  1.00  0.85           C  \nATOM    512  O   TYR C  88     166.735 177.788 134.715  1.00  0.85           O  \nATOM    513  CB  TYR C  88     169.975 177.191 135.725  1.00  0.85           C  \nATOM    514  CG  TYR C  88     169.908 176.075 134.696  1.00  0.85           C  \nATOM    515  CD1 TYR C  88     169.543 176.255 133.339  1.00  0.85           C  \nATOM    516  CD2 TYR C  88     170.299 174.798 135.108  1.00  0.85           C  \nATOM    517  CE1 TYR C  88     169.687 175.202 132.412  1.00  0.85           C  \nATOM    518  CE2 TYR C  88     170.460 173.765 134.201  1.00  0.85           C  \nATOM    519  CZ  TYR C  88     170.225 173.992 132.870  1.00  0.85           C  \nATOM    520  OH  TYR C  88     170.478 172.910 132.046  1.00  0.85           O  \nATOM    521  N   VAL C  89     168.295 179.409 134.625  1.00  0.89           N  \nATOM    522  CA  VAL C  89     167.774 180.080 133.450  1.00  0.89           C  \nATOM    523  C   VAL C  89     168.888 180.132 132.416  1.00  0.89           C  \nATOM    524  O   VAL C  89     169.991 180.616 132.673  1.00  0.89           O  \nATOM    525  CB  VAL C  89     167.242 181.473 133.805  1.00  0.89           C  \nATOM    526  CG1 VAL C  89     166.915 182.328 132.555  1.00  0.89           C  \nATOM    527  CG2 VAL C  89     165.981 181.287 134.684  1.00  0.89           C  \nATOM    528  N   LEU C  90     168.638 179.600 131.209  1.00  0.89           N  \nATOM    529  CA  LEU C  90     169.586 179.614 130.113  1.00  0.89           C  \nATOM    530  C   LEU C  90     168.939 180.305 128.932  1.00  0.89           C  \nATOM    531  O   LEU C  90     167.841 179.954 128.496  1.00  0.89           O  \nATOM    532  CB  LEU C  90     170.002 178.167 129.729  1.00  0.89           C  \nATOM    533  CG  LEU C  90     170.764 177.983 128.388  1.00  0.89           C  \nATOM    534  CD1 LEU C  90     172.231 178.460 128.459  1.00  0.89           C  \nATOM    535  CD2 LEU C  90     170.658 176.523 127.914  1.00  0.89           C  \nATOM    536  N   ILE C  91     169.608 181.335 128.389  1.00  0.88           N  \nATOM    537  CA  ILE C  91     169.162 182.037 127.200  1.00  0.88           C  \nATOM    538  C   ILE C  91     170.334 182.029 126.239  1.00  0.88           C  \nATOM    539  O   ILE C  91     171.373 182.649 126.481  1.00  0.88           O  \nATOM    540  CB  ILE C  91     168.715 183.457 127.556  1.00  0.88           C  \nATOM    541  CG1 ILE C  91     167.471 183.418 128.487  1.00  0.88           C  \nATOM    542  CG2 ILE C  91     168.408 184.281 126.283  1.00  0.88           C  \nATOM    543  CD1 ILE C  91     167.292 184.671 129.358  1.00  0.88           C  \nATOM    544  N   ALA C  92     170.239 181.286 125.127  1.00  0.88           N  \nATOM    545  CA  ALA C  92     171.394 181.088 124.281  1.00  0.88           C  \nATOM    546  C   ALA C  92     170.994 180.919 122.844  1.00  0.88           C  \nATOM    547  O   ALA C  92     169.956 180.336 122.541  1.00  0.88           O  \nATOM    548  CB  ALA C  92     172.200 179.829 124.697  1.00  0.88           C  \nATOM    549  N   LEU C  93     171.825 181.407 121.900  1.00  0.82           N  \nATOM    550  CA  LEU C  93     171.667 181.124 120.479  1.00  0.82           C  \nATOM    551  C   LEU C  93     170.387 181.694 119.860  1.00  0.82           C  \nATOM    552  O   LEU C  93     169.933 181.267 118.798  1.00  0.82           O  \nATOM    553  CB  LEU C  93     171.767 179.598 120.208  1.00  0.82           C  \nATOM    554  CG  LEU C  93     173.074 178.941 120.705  1.00  0.82           C  \nATOM    555  CD1 LEU C  93     172.885 177.420 120.774  1.00  0.82           C  \nATOM    556  CD2 LEU C  93     174.267 179.305 119.803  1.00  0.82           C  \nATOM    557  N   ASN C  94     169.758 182.689 120.519  1.00  0.88           N  \nATOM    558  CA  ASN C  94     168.597 183.385 120.013  1.00  0.88           C  \nATOM    559  C   ASN C  94     168.985 184.431 118.994  1.00  0.88           C  \nATOM    560  O   ASN C  94     170.084 184.975 119.025  1.00  0.88           O  \nATOM    561  CB  ASN C  94     167.828 184.116 121.145  1.00  0.88           C  \nATOM    562  CG  ASN C  94     167.339 183.123 122.187  1.00  0.88           C  \nATOM    563  OD1 ASN C  94     167.708 183.099 123.346  1.00  0.88           O  \nATOM    564  ND2 ASN C  94     166.383 182.273 121.754  1.00  0.88           N  \nATOM    565  N   THR C  95     168.067 184.757 118.066  1.00  0.86           N  \nATOM    566  CA  THR C  95     168.249 185.902 117.179  1.00  0.86           C  \nATOM    567  C   THR C  95     167.082 186.852 117.303  1.00  0.86           C  \nATOM    568  O   THR C  95     167.060 187.915 116.685  1.00  0.86           O  \nATOM    569  CB  THR C  95     168.420 185.527 115.711  1.00  0.86           C  \nATOM    570  OG1 THR C  95     167.294 184.869 115.150  1.00  0.86           O  \nATOM    571  CG2 THR C  95     169.580 184.533 115.588  1.00  0.86           C  \nATOM    572  N   VAL C  96     166.075 186.501 118.142  1.00  0.85           N  \nATOM    573  CA  VAL C  96     164.952 187.363 118.482  1.00  0.85           C  \nATOM    574  C   VAL C  96     165.399 188.643 119.159  1.00  0.85           C  \nATOM    575  O   VAL C  96     166.342 188.653 119.945  1.00  0.85           O  \nATOM    576  CB  VAL C  96     163.873 186.663 119.328  1.00  0.85           C  \nATOM    577  CG1 VAL C  96     164.279 186.520 120.821  1.00  0.85           C  \nATOM    578  CG2 VAL C  96     162.492 187.351 119.154  1.00  0.85           C  \nATOM    579  N   GLU C  97     164.744 189.777 118.860  1.00  0.79           N  \nATOM    580  CA  GLU C  97     165.147 191.057 119.388  1.00  0.79           C  \nATOM    581  C   GLU C  97     164.938 191.220 120.894  1.00  0.79           C  \nATOM    582  O   GLU C  97     165.772 191.754 121.617  1.00  0.79           O  \nATOM    583  CB  GLU C  97     164.408 192.169 118.627  1.00  0.79           C  \nATOM    584  CG  GLU C  97     165.167 193.504 118.747  1.00  0.79           C  \nATOM    585  CD  GLU C  97     164.444 194.627 118.037  1.00  0.79           C  \nATOM    586  OE1 GLU C  97     164.213 194.438 116.812  1.00  0.79           O  \nATOM    587  OE2 GLU C  97     164.184 195.678 118.673  1.00  0.79           O  \nATOM    588  N   ARG C  98     163.795 190.734 121.412  1.00  0.77           N  \nATOM    589  CA  ARG C  98     163.386 190.990 122.772  1.00  0.77           C  \nATOM    590  C   ARG C  98     162.840 189.730 123.406  1.00  0.77           C  \nATOM    591  O   ARG C  98     162.026 189.018 122.823  1.00  0.77           O  \nATOM    592  CB  ARG C  98     162.289 192.084 122.757  1.00  0.77           C  \nATOM    593  CG  ARG C  98     161.514 192.317 124.071  1.00  0.77           C  \nATOM    594  CD  ARG C  98     160.291 193.210 123.848  1.00  0.77           C  \nATOM    595  NE  ARG C  98     159.635 193.400 125.196  1.00  0.77           N  \nATOM    596  CZ  ARG C  98     159.918 194.418 126.015  1.00  0.77           C  \nATOM    597  NH1 ARG C  98     160.859 195.307 125.716  1.00  0.77           N  \nATOM    598  NH2 ARG C  98     159.297 194.560 127.186  1.00  0.77           N  \nATOM    599  N   ILE C  99     163.262 189.444 124.653  1.00  0.83           N  \nATOM    600  CA  ILE C  99     162.754 188.322 125.430  1.00  0.83           C  \nATOM    601  C   ILE C  99     162.051 188.891 126.660  1.00  0.83           C  \nATOM    602  O   ILE C  99     162.735 189.450 127.516  1.00  0.83           O  \nATOM    603  CB  ILE C  99     163.862 187.357 125.843  1.00  0.83           C  \nATOM    604  CG1 ILE C  99     164.414 186.684 124.558  1.00  0.83           C  \nATOM    605  CG2 ILE C  99     163.326 186.319 126.869  1.00  0.83           C  \nATOM    606  CD1 ILE C  99     165.568 185.704 124.794  1.00  0.83           C  \nATOM    607  N   PRO C 100     160.734 188.809 126.859  1.00  0.85           N  \nATOM    608  CA  PRO C 100     160.081 189.680 127.831  1.00  0.85           C  \nATOM    609  C   PRO C 100     159.834 188.916 129.127  1.00  0.85           C  \nATOM    610  O   PRO C 100     158.687 188.644 129.477  1.00  0.85           O  \nATOM    611  CB  PRO C 100     158.744 190.039 127.144  1.00  0.85           C  \nATOM    612  CG  PRO C 100     158.423 188.821 126.269  1.00  0.85           C  \nATOM    613  CD  PRO C 100     159.809 188.348 125.826  1.00  0.85           C  \nATOM    614  N   LEU C 101     160.908 188.612 129.882  1.00  0.83           N  \nATOM    615  CA  LEU C 101     160.895 187.966 131.189  1.00  0.83           C  \nATOM    616  C   LEU C 101     160.774 189.004 132.299  1.00  0.83           C  \nATOM    617  O   LEU C 101     161.541 189.035 133.258  1.00  0.83           O  \nATOM    618  CB  LEU C 101     162.186 187.124 131.386  1.00  0.83           C  \nATOM    619  CG  LEU C 101     162.087 185.714 130.776  1.00  0.83           C  \nATOM    620  CD1 LEU C 101     163.503 185.145 130.577  1.00  0.83           C  \nATOM    621  CD2 LEU C 101     161.230 184.790 131.673  1.00  0.83           C  \nATOM    622  N   GLU C 102     159.776 189.898 132.211  1.00  0.79           N  \nATOM    623  CA  GLU C 102     159.691 191.086 133.034  1.00  0.79           C  \nATOM    624  C   GLU C 102     158.883 190.888 134.312  1.00  0.79           C  \nATOM    625  O   GLU C 102     158.621 191.850 135.020  1.00  0.79           O  \nATOM    626  CB  GLU C 102     159.199 192.289 132.164  1.00  0.79           C  \nATOM    627  CG  GLU C 102     157.890 192.075 131.351  1.00  0.79           C  \nATOM    628  CD  GLU C 102     157.708 193.045 130.179  1.00  0.79           C  \nATOM    629  OE1 GLU C 102     158.411 192.916 129.135  1.00  0.79           O  \nATOM    630  OE2 GLU C 102     156.768 193.877 130.251  1.00  0.79           O  \nATOM    631  N   ASN C 103     158.518 189.637 134.683  1.00  0.82           N  \nATOM    632  CA  ASN C 103     157.856 189.294 135.942  1.00  0.82           C  \nATOM    633  C   ASN C 103     158.670 188.310 136.766  1.00  0.82           C  \nATOM    634  O   ASN C 103     158.317 188.029 137.906  1.00  0.82           O  \nATOM    635  CB  ASN C 103     156.455 188.668 135.711  1.00  0.82           C  \nATOM    636  CG  ASN C 103     155.466 189.796 135.465  1.00  0.82           C  \nATOM    637  OD1 ASN C 103     154.755 190.208 136.375  1.00  0.82           O  \nATOM    638  ND2 ASN C 103     155.414 190.337 134.230  1.00  0.82           N  \nATOM    639  N   LEU C 104     159.802 187.798 136.237  1.00  0.84           N  \nATOM    640  CA  LEU C 104     160.670 186.877 136.945  1.00  0.84           C  \nATOM    641  C   LEU C 104     161.306 187.525 138.179  1.00  0.84           C  \nATOM    642  O   LEU C 104     162.008 188.519 138.036  1.00  0.84           O  \nATOM    643  CB  LEU C 104     161.801 186.432 135.980  1.00  0.84           C  \nATOM    644  CG  LEU C 104     162.678 185.268 136.488  1.00  0.84           C  \nATOM    645  CD1 LEU C 104     161.887 183.948 136.586  1.00  0.84           C  \nATOM    646  CD2 LEU C 104     163.900 185.102 135.564  1.00  0.84           C  \nATOM    647  N   GLN C 105     161.085 187.010 139.409  1.00  0.81           N  \nATOM    648  CA  GLN C 105     161.585 187.628 140.627  1.00  0.81           C  \nATOM    649  C   GLN C 105     162.764 186.853 141.191  1.00  0.81           C  \nATOM    650  O   GLN C 105     163.720 187.425 141.721  1.00  0.81           O  \nATOM    651  CB  GLN C 105     160.463 187.669 141.702  1.00  0.81           C  \nATOM    652  CG  GLN C 105     159.146 188.299 141.185  1.00  0.81           C  \nATOM    653  CD  GLN C 105     158.176 188.535 142.342  1.00  0.81           C  \nATOM    654  OE1 GLN C 105     158.367 189.412 143.176  1.00  0.81           O  \nATOM    655  NE2 GLN C 105     157.100 187.716 142.426  1.00  0.81           N  \nATOM    656  N   ILE C 106     162.713 185.511 141.050  1.00  0.83           N  \nATOM    657  CA  ILE C 106     163.622 184.585 141.705  1.00  0.83           C  \nATOM    658  C   ILE C 106     164.072 183.506 140.761  1.00  0.83           C  \nATOM    659  O   ILE C 106     163.289 182.854 140.068  1.00  0.83           O  \nATOM    660  CB  ILE C 106     162.984 183.885 142.922  1.00  0.83           C  \nATOM    661  CG1 ILE C 106     162.755 184.856 144.099  1.00  0.83           C  \nATOM    662  CG2 ILE C 106     163.786 182.665 143.441  1.00  0.83           C  \nATOM    663  CD1 ILE C 106     164.027 185.411 144.745  1.00  0.83           C  \nATOM    664  N   ILE C 107     165.385 183.243 140.788  1.00  0.85           N  \nATOM    665  CA  ILE C 107     165.946 182.021 140.270  1.00  0.85           C  \nATOM    666  C   ILE C 107     166.494 181.338 141.498  1.00  0.85           C  \nATOM    667  O   ILE C 107     167.378 181.853 142.182  1.00  0.85           O  \nATOM    668  CB  ILE C 107     167.011 182.254 139.207  1.00  0.85           C  \nATOM    669  CG1 ILE C 107     166.450 183.189 138.096  1.00  0.85           C  \nATOM    670  CG2 ILE C 107     167.472 180.873 138.673  1.00  0.85           C  \nATOM    671  CD1 ILE C 107     167.485 183.581 137.033  1.00  0.85           C  \nATOM    672  N   ARG C 108     165.907 180.187 141.878  1.00  0.77           N  \nATOM    673  CA  ARG C 108     166.318 179.448 143.055  1.00  0.77           C  \nATOM    674  C   ARG C 108     167.681 178.805 142.906  1.00  0.77           C  \nATOM    675  O   ARG C 108     168.449 178.762 143.851  1.00  0.77           O  \nATOM    676  CB  ARG C 108     165.301 178.388 143.533  1.00  0.77           C  \nATOM    677  CG  ARG C 108     163.924 178.987 143.875  1.00  0.77           C  \nATOM    678  CD  ARG C 108     163.005 178.012 144.616  1.00  0.77           C  \nATOM    679  NE  ARG C 108     161.843 178.808 145.151  1.00  0.77           N  \nATOM    680  CZ  ARG C 108     161.842 179.494 146.302  1.00  0.77           C  \nATOM    681  NH1 ARG C 108     162.910 179.598 147.086  1.00  0.77           N  \nATOM    682  NH2 ARG C 108     160.734 180.118 146.687  1.00  0.77           N  \nATOM    683  N   GLY C 109     168.030 178.301 141.706  1.00  0.85           N  \nATOM    684  CA  GLY C 109     169.371 177.781 141.496  1.00  0.85           C  \nATOM    685  C   GLY C 109     169.607 176.410 142.077  1.00  0.85           C  \nATOM    686  O   GLY C 109     170.726 176.074 142.451  1.00  0.85           O  \nATOM    687  N   ASN C 110     168.565 175.538 142.104  1.00  0.80           N  \nATOM    688  CA  ASN C 110     168.657 174.183 142.647  1.00  0.80           C  \nATOM    689  C   ASN C 110     169.380 173.256 141.678  1.00  0.80           C  \nATOM    690  O   ASN C 110     169.595 172.076 141.944  1.00  0.80           O  \nATOM    691  CB  ASN C 110     167.261 173.548 142.926  1.00  0.80           C  \nATOM    692  CG  ASN C 110     166.543 174.242 144.078  1.00  0.80           C  \nATOM    693  OD1 ASN C 110     167.100 174.939 144.910  1.00  0.80           O  \nATOM    694  ND2 ASN C 110     165.213 173.984 144.186  1.00  0.80           N  \nATOM    695  N   MET C 111     169.787 173.790 140.517  1.00  0.78           N  \nATOM    696  CA  MET C 111     170.605 173.095 139.573  1.00  0.78           C  \nATOM    697  C   MET C 111     171.388 174.151 138.828  1.00  0.78           C  \nATOM    698  O   MET C 111     170.909 175.266 138.635  1.00  0.78           O  \nATOM    699  CB  MET C 111     169.699 172.236 138.662  1.00  0.78           C  \nATOM    700  CG  MET C 111     170.384 171.406 137.562  1.00  0.78           C  \nATOM    701  SD  MET C 111     169.462 169.882 137.127  1.00  0.78           S  \nATOM    702  CE  MET C 111     167.735 170.445 137.299  1.00  0.78           C  \nATOM    703  N   TYR C 112     172.637 173.843 138.432  1.00  0.78           N  \nATOM    704  CA  TYR C 112     173.518 174.773 137.759  1.00  0.78           C  \nATOM    705  C   TYR C 112     173.736 174.387 136.304  1.00  0.78           C  \nATOM    706  O   TYR C 112     173.863 173.216 135.946  1.00  0.78           O  \nATOM    707  CB  TYR C 112     174.920 174.821 138.420  1.00  0.78           C  \nATOM    708  CG  TYR C 112     174.826 175.147 139.887  1.00  0.78           C  \nATOM    709  CD1 TYR C 112     174.703 176.477 140.316  1.00  0.78           C  \nATOM    710  CD2 TYR C 112     174.867 174.125 140.855  1.00  0.78           C  \nATOM    711  CE1 TYR C 112     174.654 176.770 141.684  1.00  0.78           C  \nATOM    712  CE2 TYR C 112     174.824 174.431 142.228  1.00  0.78           C  \nATOM    713  CZ  TYR C 112     174.742 175.766 142.641  1.00  0.78           C  \nATOM    714  OH  TYR C 112     174.773 176.156 143.999  1.00  0.78           O  \nATOM    715  N   TYR C 113     173.844 175.396 135.422  1.00  0.78           N  \nATOM    716  CA  TYR C 113     174.336 175.240 134.072  1.00  0.78           C  \nATOM    717  C   TYR C 113     175.851 175.404 134.189  1.00  0.78           C  \nATOM    718  O   TYR C 113     176.323 176.290 134.903  1.00  0.78           O  \nATOM    719  CB  TYR C 113     173.687 176.291 133.120  1.00  0.78           C  \nATOM    720  CG  TYR C 113     174.230 176.182 131.715  1.00  0.78           C  \nATOM    721  CD1 TYR C 113     173.710 175.243 130.808  1.00  0.78           C  \nATOM    722  CD2 TYR C 113     175.312 176.986 131.314  1.00  0.78           C  \nATOM    723  CE1 TYR C 113     174.238 175.144 129.511  1.00  0.78           C  \nATOM    724  CE2 TYR C 113     175.852 176.872 130.024  1.00  0.78           C  \nATOM    725  CZ  TYR C 113     175.296 175.967 129.114  1.00  0.78           C  \nATOM    726  OH  TYR C 113     175.792 175.870 127.798  1.00  0.78           O  \nATOM    727  N   GLU C 114     176.642 174.500 133.563  1.00  0.72           N  \nATOM    728  CA  GLU C 114     178.103 174.487 133.614  1.00  0.72           C  \nATOM    729  C   GLU C 114     178.669 174.452 135.036  1.00  0.72           C  \nATOM    730  O   GLU C 114     179.678 175.076 135.341  1.00  0.72           O  \nATOM    731  CB  GLU C 114     178.769 175.591 132.735  1.00  0.72           C  \nATOM    732  CG  GLU C 114     179.023 175.191 131.256  1.00  0.72           C  \nATOM    733  CD  GLU C 114     179.991 176.145 130.543  1.00  0.72           C  \nATOM    734  OE1 GLU C 114     180.354 177.204 131.122  1.00  0.72           O  \nATOM    735  OE2 GLU C 114     180.347 175.825 129.382  1.00  0.72           O  \nATOM    736  N   ASN C 115     178.023 173.695 135.954  1.00  0.71           N  \nATOM    737  CA  ASN C 115     178.484 173.472 137.322  1.00  0.71           C  \nATOM    738  C   ASN C 115     178.462 174.675 138.282  1.00  0.71           C  \nATOM    739  O   ASN C 115     178.614 174.488 139.485  1.00  0.71           O  \nATOM    740  CB  ASN C 115     179.876 172.773 137.341  1.00  0.71           C  \nATOM    741  CG  ASN C 115     179.731 171.325 136.889  1.00  0.71           C  \nATOM    742  OD1 ASN C 115     178.649 170.772 136.731  1.00  0.71           O  \nATOM    743  ND2 ASN C 115     180.896 170.664 136.690  1.00  0.71           N  \nATOM    744  N   SER C 116     178.220 175.914 137.796  1.00  0.83           N  \nATOM    745  CA  SER C 116     178.448 177.122 138.588  1.00  0.83           C  \nATOM    746  C   SER C 116     177.413 178.218 138.355  1.00  0.83           C  \nATOM    747  O   SER C 116     177.328 179.173 139.127  1.00  0.83           O  \nATOM    748  CB  SER C 116     179.802 177.786 138.206  1.00  0.83           C  \nATOM    749  OG  SER C 116     180.879 176.856 138.284  1.00  0.83           O  \nATOM    750  N   TYR C 117     176.584 178.140 137.288  1.00  0.82           N  \nATOM    751  CA  TYR C 117     175.723 179.250 136.891  1.00  0.82           C  \nATOM    752  C   TYR C 117     174.241 178.968 137.047  1.00  0.82           C  \nATOM    753  O   TYR C 117     173.731 177.942 136.608  1.00  0.82           O  \nATOM    754  CB  TYR C 117     175.950 179.622 135.401  1.00  0.82           C  \nATOM    755  CG  TYR C 117     177.397 179.970 135.168  1.00  0.82           C  \nATOM    756  CD1 TYR C 117     178.026 180.992 135.899  1.00  0.82           C  \nATOM    757  CD2 TYR C 117     178.145 179.269 134.210  1.00  0.82           C  \nATOM    758  CE1 TYR C 117     179.368 181.328 135.655  1.00  0.82           C  \nATOM    759  CE2 TYR C 117     179.485 179.594 133.967  1.00  0.82           C  \nATOM    760  CZ  TYR C 117     180.082 180.648 134.660  1.00  0.82           C  \nATOM    761  OH  TYR C 117     181.376 181.050 134.283  1.00  0.82           O  \nATOM    762  N   ALA C 118     173.493 179.920 137.643  1.00  0.89           N  \nATOM    763  CA  ALA C 118     172.051 179.833 137.747  1.00  0.89           C  \nATOM    764  C   ALA C 118     171.415 180.738 136.695  1.00  0.89           C  \nATOM    765  O   ALA C 118     170.215 180.693 136.445  1.00  0.89           O  \nATOM    766  CB  ALA C 118     171.618 180.197 139.186  1.00  0.89           C  \nATOM    767  N   LEU C 119     172.234 181.530 135.974  1.00  0.89           N  \nATOM    768  CA  LEU C 119     171.757 182.361 134.893  1.00  0.89           C  \nATOM    769  C   LEU C 119     172.880 182.495 133.884  1.00  0.89           C  \nATOM    770  O   LEU C 119     173.953 183.017 134.186  1.00  0.89           O  \nATOM    771  CB  LEU C 119     171.262 183.735 135.424  1.00  0.89           C  \nATOM    772  CG  LEU C 119     170.929 184.824 134.372  1.00  0.89           C  \nATOM    773  CD1 LEU C 119     169.821 184.402 133.383  1.00  0.89           C  \nATOM    774  CD2 LEU C 119     170.549 186.129 135.102  1.00  0.89           C  \nATOM    775  N   ALA C 120     172.674 181.994 132.652  1.00  0.91           N  \nATOM    776  CA  ALA C 120     173.676 182.069 131.611  1.00  0.91           C  \nATOM    777  C   ALA C 120     173.058 182.629 130.343  1.00  0.91           C  \nATOM    778  O   ALA C 120     172.097 182.078 129.802  1.00  0.91           O  \nATOM    779  CB  ALA C 120     174.339 180.693 131.358  1.00  0.91           C  \nATOM    780  N   VAL C 121     173.597 183.762 129.848  1.00  0.92           N  \nATOM    781  CA  VAL C 121     173.128 184.402 128.631  1.00  0.92           C  \nATOM    782  C   VAL C 121     174.291 184.429 127.655  1.00  0.92           C  \nATOM    783  O   VAL C 121     175.242 185.202 127.803  1.00  0.92           O  \nATOM    784  CB  VAL C 121     172.565 185.806 128.867  1.00  0.92           C  \nATOM    785  CG1 VAL C 121     172.043 186.402 127.538  1.00  0.92           C  \nATOM    786  CG2 VAL C 121     171.403 185.717 129.885  1.00  0.92           C  \nATOM    787  N   LEU C 122     174.257 183.552 126.630  1.00  0.87           N  \nATOM    788  CA  LEU C 122     175.437 183.226 125.843  1.00  0.87           C  \nATOM    789  C   LEU C 122     175.179 183.301 124.353  1.00  0.87           C  \nATOM    790  O   LEU C 122     174.306 182.603 123.842  1.00  0.87           O  \nATOM    791  CB  LEU C 122     175.887 181.746 126.048  1.00  0.87           C  \nATOM    792  CG  LEU C 122     175.947 181.233 127.500  1.00  0.87           C  \nATOM    793  CD1 LEU C 122     175.866 179.694 127.532  1.00  0.87           C  \nATOM    794  CD2 LEU C 122     177.198 181.728 128.236  1.00  0.87           C  \nATOM    795  N   SER C 123     175.979 184.079 123.595  1.00  0.88           N  \nATOM    796  CA  SER C 123     176.043 183.944 122.135  1.00  0.88           C  \nATOM    797  C   SER C 123     174.700 184.121 121.420  1.00  0.88           C  \nATOM    798  O   SER C 123     174.257 183.280 120.643  1.00  0.88           O  \nATOM    799  CB  SER C 123     176.763 182.624 121.712  1.00  0.88           C  \nATOM    800  OG  SER C 123     177.380 182.697 120.427  1.00  0.88           O  \nATOM    801  N   ASN C 124     173.992 185.233 121.708  1.00  0.87           N  \nATOM    802  CA  ASN C 124     172.657 185.513 121.215  1.00  0.87           C  \nATOM    803  C   ASN C 124     172.691 186.362 119.957  1.00  0.87           C  \nATOM    804  O   ASN C 124     171.989 187.363 119.888  1.00  0.87           O  \nATOM    805  CB  ASN C 124     171.842 186.268 122.295  1.00  0.87           C  \nATOM    806  CG  ASN C 124     171.412 185.277 123.359  1.00  0.87           C  \nATOM    807  OD1 ASN C 124     170.404 184.608 123.165  1.00  0.87           O  \nATOM    808  ND2 ASN C 124     172.150 185.134 124.477  1.00  0.87           N  \nATOM    809  N   TYR C 125     173.514 186.008 118.947  1.00  0.81           N  \nATOM    810  CA  TYR C 125     173.593 186.724 117.681  1.00  0.81           C  \nATOM    811  C   TYR C 125     173.339 185.830 116.485  1.00  0.81           C  \nATOM    812  O   TYR C 125     173.550 184.620 116.527  1.00  0.81           O  \nATOM    813  CB  TYR C 125     174.955 187.448 117.476  1.00  0.81           C  \nATOM    814  CG  TYR C 125     176.139 186.508 117.613  1.00  0.81           C  \nATOM    815  CD1 TYR C 125     176.611 185.727 116.539  1.00  0.81           C  \nATOM    816  CD2 TYR C 125     176.733 186.318 118.865  1.00  0.81           C  \nATOM    817  CE1 TYR C 125     177.733 184.897 116.678  1.00  0.81           C  \nATOM    818  CE2 TYR C 125     177.802 185.436 119.024  1.00  0.81           C  \nATOM    819  CZ  TYR C 125     178.354 184.792 117.922  1.00  0.81           C  \nATOM    820  OH  TYR C 125     179.517 184.032 118.074  1.00  0.81           O  \nATOM    821  N   ASP C 126     172.915 186.442 115.361  1.00  0.77           N  \nATOM    822  CA  ASP C 126     172.914 185.846 114.051  1.00  0.77           C  \nATOM    823  C   ASP C 126     174.228 186.180 113.350  1.00  0.77           C  \nATOM    824  O   ASP C 126     175.113 186.841 113.897  1.00  0.77           O  \nATOM    825  CB  ASP C 126     171.679 186.332 113.237  1.00  0.77           C  \nATOM    826  CG  ASP C 126     171.598 187.845 113.063  1.00  0.77           C  \nATOM    827  OD1 ASP C 126     172.632 188.535 113.272  1.00  0.77           O  \nATOM    828  OD2 ASP C 126     170.482 188.294 112.703  1.00  0.77           O  \nATOM    829  N   ALA C 127     174.387 185.749 112.084  1.00  0.75           N  \nATOM    830  CA  ALA C 127     175.592 185.926 111.300  1.00  0.75           C  \nATOM    831  C   ALA C 127     176.022 187.392 111.146  1.00  0.75           C  \nATOM    832  O   ALA C 127     177.202 187.684 110.970  1.00  0.75           O  \nATOM    833  CB  ALA C 127     175.396 185.285 109.905  1.00  0.75           C  \nATOM    834  N   ASN C 128     175.075 188.350 111.262  1.00  0.63           N  \nATOM    835  CA  ASN C 128     175.271 189.747 110.956  1.00  0.63           C  \nATOM    836  C   ASN C 128     175.643 190.535 112.207  1.00  0.63           C  \nATOM    837  O   ASN C 128     175.790 191.752 112.143  1.00  0.63           O  \nATOM    838  CB  ASN C 128     173.963 190.354 110.368  1.00  0.63           C  \nATOM    839  CG  ASN C 128     173.561 189.649 109.073  1.00  0.63           C  \nATOM    840  OD1 ASN C 128     173.261 188.464 108.995  1.00  0.63           O  \nATOM    841  ND2 ASN C 128     173.543 190.424 107.958  1.00  0.63           N  \nATOM    842  N   LYS C 129     175.812 189.847 113.365  1.00  0.65           N  \nATOM    843  CA  LYS C 129     176.179 190.431 114.648  1.00  0.65           C  \nATOM    844  C   LYS C 129     175.023 191.204 115.270  1.00  0.65           C  \nATOM    845  O   LYS C 129     175.232 192.105 116.079  1.00  0.65           O  \nATOM    846  CB  LYS C 129     177.519 191.248 114.616  1.00  0.65           C  \nATOM    847  CG  LYS C 129     178.782 190.438 114.248  1.00  0.65           C  \nATOM    848  CD  LYS C 129     179.367 189.627 115.425  1.00  0.65           C  \nATOM    849  CE  LYS C 129     178.918 188.159 115.477  1.00  0.65           C  \nATOM    850  NZ  LYS C 129     179.568 187.456 116.612  1.00  0.65           N  \nATOM    851  N   THR C 130     173.759 190.840 114.955  1.00  0.71           N  \nATOM    852  CA  THR C 130     172.604 191.608 115.392  1.00  0.71           C  \nATOM    853  C   THR C 130     171.564 190.682 115.991  1.00  0.71           C  \nATOM    854  O   THR C 130     170.742 190.072 115.326  1.00  0.71           O  \nATOM    855  CB  THR C 130     171.968 192.434 114.265  1.00  0.71           C  \nATOM    856  OG1 THR C 130     171.759 191.692 113.081  1.00  0.71           O  \nATOM    857  CG2 THR C 130     172.927 193.536 113.811  1.00  0.71           C  \nATOM    858  N   GLY C 131     171.537 190.542 117.329  1.00  0.83           N  \nATOM    859  CA  GLY C 131     170.703 189.510 117.924  1.00  0.83           C  \nATOM    860  C   GLY C 131     169.807 190.025 118.986  1.00  0.83           C  \nATOM    861  O   GLY C 131     169.052 190.973 118.783  1.00  0.83           O  \nATOM    862  N   LEU C 132     169.876 189.383 120.167  1.00  0.85           N  \nATOM    863  CA  LEU C 132     169.144 189.811 121.345  1.00  0.85           C  \nATOM    864  C   LEU C 132     169.516 191.217 121.782  1.00  0.85           C  \nATOM    865  O   LEU C 132     170.691 191.533 121.977  1.00  0.85           O  \nATOM    866  CB  LEU C 132     169.373 188.866 122.555  1.00  0.85           C  \nATOM    867  CG  LEU C 132     168.553 189.195 123.828  1.00  0.85           C  \nATOM    868  CD1 LEU C 132     167.056 188.912 123.606  1.00  0.85           C  \nATOM    869  CD2 LEU C 132     169.105 188.428 125.048  1.00  0.85           C  \nATOM    870  N   LYS C 133     168.506 192.081 121.966  1.00  0.78           N  \nATOM    871  CA  LYS C 133     168.698 193.464 122.304  1.00  0.78           C  \nATOM    872  C   LYS C 133     168.067 193.821 123.633  1.00  0.78           C  \nATOM    873  O   LYS C 133     168.686 194.484 124.464  1.00  0.78           O  \nATOM    874  CB  LYS C 133     168.018 194.311 121.210  1.00  0.78           C  \nATOM    875  CG  LYS C 133     168.300 195.810 121.361  1.00  0.78           C  \nATOM    876  CD  LYS C 133     167.428 196.665 120.438  1.00  0.78           C  \nATOM    877  CE  LYS C 133     167.501 198.149 120.795  1.00  0.78           C  \nATOM    878  NZ  LYS C 133     166.388 198.849 120.130  1.00  0.78           N  \nATOM    879  N   GLU C 134     166.819 193.378 123.883  1.00  0.77           N  \nATOM    880  CA  GLU C 134     166.097 193.786 125.065  1.00  0.77           C  \nATOM    881  C   GLU C 134     165.762 192.588 125.923  1.00  0.77           C  \nATOM    882  O   GLU C 134     164.957 191.721 125.580  1.00  0.77           O  \nATOM    883  CB  GLU C 134     164.797 194.532 124.694  1.00  0.77           C  \nATOM    884  CG  GLU C 134     165.016 195.796 123.839  1.00  0.77           C  \nATOM    885  CD  GLU C 134     163.713 196.498 123.522  1.00  0.77           C  \nATOM    886  OE1 GLU C 134     163.803 197.584 122.899  1.00  0.77           O  \nATOM    887  OE2 GLU C 134     162.619 195.998 123.898  1.00  0.77           O  \nATOM    888  N   LEU C 135     166.371 192.531 127.115  1.00  0.83           N  \nATOM    889  CA  LEU C 135     166.082 191.521 128.100  1.00  0.83           C  \nATOM    890  C   LEU C 135     165.588 192.229 129.366  1.00  0.83           C  \nATOM    891  O   LEU C 135     166.355 192.361 130.322  1.00  0.83           O  \nATOM    892  CB  LEU C 135     167.375 190.696 128.325  1.00  0.83           C  \nATOM    893  CG  LEU C 135     167.218 189.435 129.204  1.00  0.83           C  \nATOM    894  CD1 LEU C 135     166.209 188.410 128.644  1.00  0.83           C  \nATOM    895  CD2 LEU C 135     168.595 188.776 129.417  1.00  0.83           C  \nATOM    896  N   PRO C 136     164.350 192.744 129.449  1.00  0.85           N  \nATOM    897  CA  PRO C 136     163.951 193.668 130.499  1.00  0.85           C  \nATOM    898  C   PRO C 136     163.505 192.879 131.722  1.00  0.85           C  \nATOM    899  O   PRO C 136     162.336 192.939 132.104  1.00  0.85           O  \nATOM    900  CB  PRO C 136     162.765 194.426 129.855  1.00  0.85           C  \nATOM    901  CG  PRO C 136     162.101 193.380 128.954  1.00  0.85           C  \nATOM    902  CD  PRO C 136     163.306 192.598 128.437  1.00  0.85           C  \nATOM    903  N   MET C 137     164.414 192.150 132.398  1.00  0.81           N  \nATOM    904  CA  MET C 137     164.148 191.419 133.629  1.00  0.81           C  \nATOM    905  C   MET C 137     164.042 192.343 134.837  1.00  0.81           C  \nATOM    906  O   MET C 137     164.729 192.190 135.846  1.00  0.81           O  \nATOM    907  CB  MET C 137     165.231 190.342 133.886  1.00  0.81           C  \nATOM    908  CG  MET C 137     165.179 189.195 132.860  1.00  0.81           C  \nATOM    909  SD  MET C 137     166.203 187.750 133.289  1.00  0.81           S  \nATOM    910  CE  MET C 137     167.807 188.579 133.103  1.00  0.81           C  \nATOM    911  N   ARG C 138     163.119 193.318 134.782  1.00  0.77           N  \nATOM    912  CA  ARG C 138     163.006 194.440 135.696  1.00  0.77           C  \nATOM    913  C   ARG C 138     162.499 194.116 137.100  1.00  0.77           C  \nATOM    914  O   ARG C 138     162.515 194.949 138.004  1.00  0.77           O  \nATOM    915  CB  ARG C 138     162.097 195.535 135.088  1.00  0.77           C  \nATOM    916  CG  ARG C 138     160.694 195.048 134.654  1.00  0.77           C  \nATOM    917  CD  ARG C 138     159.631 196.153 134.733  1.00  0.77           C  \nATOM    918  NE  ARG C 138     158.384 195.680 134.035  1.00  0.77           N  \nATOM    919  CZ  ARG C 138     158.128 195.928 132.740  1.00  0.77           C  \nATOM    920  NH1 ARG C 138     158.975 196.428 131.896  1.00  0.77           N  \nATOM    921  NH2 ARG C 138     156.900 195.658 132.270  1.00  0.77           N  \nATOM    922  N   ASN C 139     162.003 192.883 137.298  1.00  0.82           N  \nATOM    923  CA  ASN C 139     161.572 192.378 138.583  1.00  0.82           C  \nATOM    924  C   ASN C 139     162.559 191.377 139.139  1.00  0.82           C  \nATOM    925  O   ASN C 139     162.389 190.942 140.273  1.00  0.82           O  \nATOM    926  CB  ASN C 139     160.157 191.771 138.459  1.00  0.82           C  \nATOM    927  CG  ASN C 139     159.240 192.979 138.415  1.00  0.82           C  \nATOM    928  OD1 ASN C 139     159.098 193.724 139.385  1.00  0.82           O  \nATOM    929  ND2 ASN C 139     158.623 193.267 137.254  1.00  0.82           N  \nATOM    930  N   LEU C 140     163.651 191.032 138.410  1.00  0.83           N  \nATOM    931  CA  LEU C 140     164.624 190.081 138.917  1.00  0.83           C  \nATOM    932  C   LEU C 140     165.412 190.683 140.072  1.00  0.83           C  \nATOM    933  O   LEU C 140     166.182 191.629 139.899  1.00  0.83           O  \nATOM    934  CB  LEU C 140     165.588 189.594 137.803  1.00  0.83           C  \nATOM    935  CG  LEU C 140     166.642 188.546 138.244  1.00  0.83           C  \nATOM    936  CD1 LEU C 140     166.010 187.188 138.623  1.00  0.83           C  \nATOM    937  CD2 LEU C 140     167.709 188.383 137.142  1.00  0.83           C  \nATOM    938  N   GLN C 141     165.211 190.162 141.296  1.00  0.81           N  \nATOM    939  CA  GLN C 141     165.772 190.758 142.482  1.00  0.81           C  \nATOM    940  C   GLN C 141     166.735 189.830 143.180  1.00  0.81           C  \nATOM    941  O   GLN C 141     167.688 190.301 143.770  1.00  0.81           O  \nATOM    942  CB  GLN C 141     164.606 191.185 143.409  1.00  0.81           C  \nATOM    943  CG  GLN C 141     164.207 192.660 143.136  1.00  0.81           C  \nATOM    944  CD  GLN C 141     162.798 193.004 143.617  1.00  0.81           C  \nATOM    945  OE1 GLN C 141     161.988 192.180 144.013  1.00  0.81           O  \nATOM    946  NE2 GLN C 141     162.481 194.324 143.599  1.00  0.81           N  \nATOM    947  N   GLU C 142     166.571 188.491 143.115  1.00  0.79           N  \nATOM    948  CA  GLU C 142     167.469 187.632 143.870  1.00  0.79           C  \nATOM    949  C   GLU C 142     167.707 186.345 143.103  1.00  0.79           C  \nATOM    950  O   GLU C 142     166.844 185.811 142.405  1.00  0.79           O  \nATOM    951  CB  GLU C 142     166.973 187.395 145.348  1.00  0.79           C  \nATOM    952  CG  GLU C 142     168.002 186.773 146.356  1.00  0.79           C  \nATOM    953  CD  GLU C 142     167.454 186.326 147.730  1.00  0.79           C  \nATOM    954  OE1 GLU C 142     166.532 185.476 147.758  1.00  0.79           O  \nATOM    955  OE2 GLU C 142     167.987 186.757 148.797  1.00  0.79           O  \nATOM    956  N   ILE C 143     168.946 185.834 143.187  1.00  0.82           N  \nATOM    957  CA  ILE C 143     169.306 184.517 142.714  1.00  0.82           C  \nATOM    958  C   ILE C 143     169.824 183.859 143.975  1.00  0.82           C  \nATOM    959  O   ILE C 143     170.790 184.340 144.569  1.00  0.82           O  \nATOM    960  CB  ILE C 143     170.341 184.542 141.582  1.00  0.82           C  \nATOM    961  CG1 ILE C 143     169.768 185.301 140.346  1.00  0.82           C  \nATOM    962  CG2 ILE C 143     170.768 183.094 141.230  1.00  0.82           C  \nATOM    963  CD1 ILE C 143     170.785 185.531 139.216  1.00  0.82           C  \nATOM    964  N   LEU C 144     169.127 182.806 144.465  1.00  0.81           N  \nATOM    965  CA  LEU C 144     169.365 182.194 145.772  1.00  0.81           C  \nATOM    966  C   LEU C 144     170.728 181.537 145.894  1.00  0.81           C  \nATOM    967  O   LEU C 144     171.501 181.818 146.811  1.00  0.81           O  \nATOM    968  CB  LEU C 144     168.312 181.082 146.052  1.00  0.81           C  \nATOM    969  CG  LEU C 144     167.057 181.498 146.847  1.00  0.81           C  \nATOM    970  CD1 LEU C 144     167.398 181.853 148.306  1.00  0.81           C  \nATOM    971  CD2 LEU C 144     166.265 182.619 146.158  1.00  0.81           C  \nATOM    972  N   HIS C 145     171.059 180.670 144.922  1.00  0.78           N  \nATOM    973  CA  HIS C 145     172.357 180.052 144.821  1.00  0.78           C  \nATOM    974  C   HIS C 145     172.804 180.122 143.382  1.00  0.78           C  \nATOM    975  O   HIS C 145     172.007 180.044 142.450  1.00  0.78           O  \nATOM    976  CB  HIS C 145     172.374 178.572 145.297  1.00  0.78           C  \nATOM    977  CG  HIS C 145     171.589 178.340 146.556  1.00  0.78           C  \nATOM    978  ND1 HIS C 145     170.281 177.921 146.433  1.00  0.78           N  \nATOM    979  CD2 HIS C 145     171.912 178.467 147.869  1.00  0.78           C  \nATOM    980  CE1 HIS C 145     169.830 177.800 147.654  1.00  0.78           C  \nATOM    981  NE2 HIS C 145     170.775 178.117 148.573  1.00  0.78           N  \nATOM    982  N   GLY C 146     174.122 180.289 143.163  1.00  0.83           N  \nATOM    983  CA  GLY C 146     174.694 180.314 141.829  1.00  0.83           C  \nATOM    984  C   GLY C 146     175.182 181.628 141.380  1.00  0.83           C  \nATOM    985  O   GLY C 146     174.832 182.680 141.895  1.00  0.83           O  \nATOM    986  N   ALA C 147     176.044 181.580 140.365  1.00  0.84           N  \nATOM    987  CA  ALA C 147     176.591 182.749 139.757  1.00  0.84           C  \nATOM    988  C   ALA C 147     175.884 183.032 138.449  1.00  0.84           C  \nATOM    989  O   ALA C 147     174.934 182.357 138.044  1.00  0.84           O  \nATOM    990  CB  ALA C 147     178.098 182.521 139.556  1.00  0.84           C  \nATOM    991  N   VAL C 148     176.346 184.080 137.764  1.00  0.83           N  \nATOM    992  CA  VAL C 148     175.763 184.598 136.553  1.00  0.83           C  \nATOM    993  C   VAL C 148     176.869 184.631 135.524  1.00  0.83           C  \nATOM    994  O   VAL C 148     178.025 184.935 135.838  1.00  0.83           O  \nATOM    995  CB  VAL C 148     175.150 185.983 136.771  1.00  0.83           C  \nATOM    996  CG1 VAL C 148     174.615 186.577 135.454  1.00  0.83           C  \nATOM    997  CG2 VAL C 148     173.994 185.879 137.786  1.00  0.83           C  \nATOM    998  N   ARG C 149     176.537 184.267 134.273  1.00  0.78           N  \nATOM    999  CA  ARG C 149     177.432 184.350 133.145  1.00  0.78           C  \nATOM   1000  C   ARG C 149     176.807 185.068 131.960  1.00  0.78           C  \nATOM   1001  O   ARG C 149     175.749 184.695 131.457  1.00  0.78           O  \nATOM   1002  CB  ARG C 149     177.956 182.949 132.749  1.00  0.78           C  \nATOM   1003  CG  ARG C 149     178.659 182.868 131.379  1.00  0.78           C  \nATOM   1004  CD  ARG C 149     179.604 181.664 131.231  1.00  0.78           C  \nATOM   1005  NE  ARG C 149     180.233 181.702 129.859  1.00  0.78           N  \nATOM   1006  CZ  ARG C 149     181.256 182.502 129.522  1.00  0.78           C  \nATOM   1007  NH1 ARG C 149     181.701 183.441 130.339  1.00  0.78           N  \nATOM   1008  NH2 ARG C 149     181.807 182.425 128.311  1.00  0.78           N  \nATOM   1009  N   PHE C 150     177.473 186.128 131.469  1.00  0.84           N  \nATOM   1010  CA  PHE C 150     177.076 186.852 130.278  1.00  0.84           C  \nATOM   1011  C   PHE C 150     178.269 186.815 129.368  1.00  0.84           C  \nATOM   1012  O   PHE C 150     179.385 187.095 129.802  1.00  0.84           O  \nATOM   1013  CB  PHE C 150     176.699 188.339 130.552  1.00  0.84           C  \nATOM   1014  CG  PHE C 150     175.239 188.452 130.928  1.00  0.84           C  \nATOM   1015  CD1 PHE C 150     174.734 187.845 132.089  1.00  0.84           C  \nATOM   1016  CD2 PHE C 150     174.348 189.167 130.111  1.00  0.84           C  \nATOM   1017  CE1 PHE C 150     173.384 187.966 132.445  1.00  0.84           C  \nATOM   1018  CE2 PHE C 150     172.998 189.301 130.467  1.00  0.84           C  \nATOM   1019  CZ  PHE C 150     172.517 188.708 131.639  1.00  0.84           C  \nATOM   1020  N   SER C 151     178.078 186.422 128.098  1.00  0.86           N  \nATOM   1021  CA  SER C 151     179.164 186.487 127.139  1.00  0.86           C  \nATOM   1022  C   SER C 151     178.686 186.556 125.716  1.00  0.86           C  \nATOM   1023  O   SER C 151     177.705 185.919 125.325  1.00  0.86           O  \nATOM   1024  CB  SER C 151     180.143 185.291 127.255  1.00  0.86           C  \nATOM   1025  OG  SER C 151     179.483 184.025 127.166  1.00  0.86           O  \nATOM   1026  N   ASN C 152     179.412 187.328 124.880  1.00  0.79           N  \nATOM   1027  CA  ASN C 152     179.256 187.307 123.438  1.00  0.79           C  \nATOM   1028  C   ASN C 152     177.842 187.668 122.942  1.00  0.79           C  \nATOM   1029  O   ASN C 152     177.296 187.045 122.037  1.00  0.79           O  \nATOM   1030  CB  ASN C 152     179.769 185.927 122.912  1.00  0.79           C  \nATOM   1031  CG  ASN C 152     180.252 185.956 121.466  1.00  0.79           C  \nATOM   1032  OD1 ASN C 152     180.268 186.956 120.757  1.00  0.79           O  \nATOM   1033  ND2 ASN C 152     180.660 184.755 120.979  1.00  0.79           N  \nATOM   1034  N   ASN C 153     177.210 188.714 123.520  1.00  0.79           N  \nATOM   1035  CA  ASN C 153     175.926 189.214 123.058  1.00  0.79           C  \nATOM   1036  C   ASN C 153     176.170 190.606 122.463  1.00  0.79           C  \nATOM   1037  O   ASN C 153     176.267 191.552 123.242  1.00  0.79           O  \nATOM   1038  CB  ASN C 153     174.920 189.327 124.238  1.00  0.79           C  \nATOM   1039  CG  ASN C 153     174.761 187.951 124.877  1.00  0.79           C  \nATOM   1040  OD1 ASN C 153     174.445 186.976 124.196  1.00  0.79           O  \nATOM   1041  ND2 ASN C 153     174.970 187.853 126.211  1.00  0.79           N  \nATOM   1042  N   PRO C 154     176.261 190.827 121.144  1.00  0.75           N  \nATOM   1043  CA  PRO C 154     176.944 192.003 120.605  1.00  0.75           C  \nATOM   1044  C   PRO C 154     175.924 193.086 120.335  1.00  0.75           C  \nATOM   1045  O   PRO C 154     176.280 194.141 119.827  1.00  0.75           O  \nATOM   1046  CB  PRO C 154     177.567 191.504 119.280  1.00  0.75           C  \nATOM   1047  CG  PRO C 154     176.627 190.386 118.827  1.00  0.75           C  \nATOM   1048  CD  PRO C 154     176.187 189.762 120.154  1.00  0.75           C  \nATOM   1049  N   ALA C 155     174.642 192.838 120.655  1.00  0.77           N  \nATOM   1050  CA  ALA C 155     173.587 193.795 120.415  1.00  0.77           C  \nATOM   1051  C   ALA C 155     172.791 194.063 121.682  1.00  0.77           C  \nATOM   1052  O   ALA C 155     171.788 194.770 121.655  1.00  0.77           O  \nATOM   1053  CB  ALA C 155     172.699 193.281 119.252  1.00  0.77           C  \nATOM   1054  N   LEU C 156     173.248 193.548 122.847  1.00  0.78           N  \nATOM   1055  CA  LEU C 156     172.510 193.643 124.093  1.00  0.78           C  \nATOM   1056  C   LEU C 156     172.590 195.056 124.665  1.00  0.78           C  \nATOM   1057  O   LEU C 156     173.657 195.671 124.689  1.00  0.78           O  \nATOM   1058  CB  LEU C 156     173.000 192.567 125.102  1.00  0.78           C  \nATOM   1059  CG  LEU C 156     172.142 192.391 126.380  1.00  0.78           C  \nATOM   1060  CD1 LEU C 156     170.667 192.046 126.080  1.00  0.78           C  \nATOM   1061  CD2 LEU C 156     172.753 191.296 127.273  1.00  0.78           C  \nATOM   1062  N   CYS C 157     171.458 195.630 125.112  1.00  0.76           N  \nATOM   1063  CA  CYS C 157     171.392 197.007 125.564  1.00  0.76           C  \nATOM   1064  C   CYS C 157     171.008 197.080 127.014  1.00  0.76           C  \nATOM   1065  O   CYS C 157     170.063 196.418 127.432  1.00  0.76           O  \nATOM   1066  CB  CYS C 157     170.283 197.791 124.808  1.00  0.76           C  \nATOM   1067  SG  CYS C 157     170.784 198.263 123.130  1.00  0.76           S  \nATOM   1068  N   ASN C 158     171.712 197.938 127.791  1.00  0.80           N  \nATOM   1069  CA  ASN C 158     171.309 198.352 129.121  1.00  0.80           C  \nATOM   1070  C   ASN C 158     171.318 197.232 130.153  1.00  0.80           C  \nATOM   1071  O   ASN C 158     170.357 197.049 130.886  1.00  0.80           O  \nATOM   1072  CB  ASN C 158     169.923 199.076 129.112  1.00  0.80           C  \nATOM   1073  CG  ASN C 158     169.877 200.369 128.298  1.00  0.80           C  \nATOM   1074  OD1 ASN C 158     168.890 200.635 127.614  1.00  0.80           O  \nATOM   1075  ND2 ASN C 158     170.927 201.218 128.374  1.00  0.80           N  \nATOM   1076  N   VAL C 159     172.414 196.449 130.233  1.00  0.84           N  \nATOM   1077  CA  VAL C 159     172.498 195.367 131.212  1.00  0.84           C  \nATOM   1078  C   VAL C 159     173.846 195.450 131.910  1.00  0.84           C  \nATOM   1079  O   VAL C 159     174.011 194.972 133.047  1.00  0.84           O  \nATOM   1080  CB  VAL C 159     172.265 193.971 130.606  1.00  0.84           C  \nATOM   1081  CG1 VAL C 159     172.183 192.921 131.743  1.00  0.84           C  \nATOM   1082  CG2 VAL C 159     170.938 193.944 129.809  1.00  0.84           C  \nATOM   1083  N   GLU C 160     174.853 196.124 131.324  1.00  0.75           N  \nATOM   1084  CA  GLU C 160     176.177 196.295 131.874  1.00  0.75           C  \nATOM   1085  C   GLU C 160     176.182 197.274 133.038  1.00  0.75           C  \nATOM   1086  O   GLU C 160     177.059 197.259 133.893  1.00  0.75           O  \nATOM   1087  CB  GLU C 160     177.157 196.818 130.779  1.00  0.75           C  \nATOM   1088  CG  GLU C 160     176.975 198.287 130.260  1.00  0.75           C  \nATOM   1089  CD  GLU C 160     175.788 198.596 129.336  1.00  0.75           C  \nATOM   1090  OE1 GLU C 160     174.933 197.706 129.079  1.00  0.75           O  \nATOM   1091  OE2 GLU C 160     175.708 199.771 128.897  1.00  0.75           O  \nATOM   1092  N   SER C 161     175.140 198.137 133.082  1.00  0.80           N  \nATOM   1093  CA  SER C 161     174.901 199.123 134.116  1.00  0.80           C  \nATOM   1094  C   SER C 161     174.323 198.496 135.373  1.00  0.80           C  \nATOM   1095  O   SER C 161     174.384 199.106 136.430  1.00  0.80           O  \nATOM   1096  CB  SER C 161     173.935 200.262 133.643  1.00  0.80           C  \nATOM   1097  OG  SER C 161     172.742 199.742 133.048  1.00  0.80           O  \nATOM   1098  N   ILE C 162     173.759 197.263 135.312  1.00  0.81           N  \nATOM   1099  CA  ILE C 162     173.194 196.561 136.469  1.00  0.81           C  \nATOM   1100  C   ILE C 162     174.206 196.231 137.569  1.00  0.81           C  \nATOM   1101  O   ILE C 162     175.293 195.694 137.351  1.00  0.81           O  \nATOM   1102  CB  ILE C 162     172.430 195.283 136.065  1.00  0.81           C  \nATOM   1103  CG1 ILE C 162     171.234 195.615 135.129  1.00  0.81           C  \nATOM   1104  CG2 ILE C 162     171.968 194.412 137.271  1.00  0.81           C  \nATOM   1105  CD1 ILE C 162     170.072 196.371 135.795  1.00  0.81           C  \nATOM   1106  N   GLN C 163     173.842 196.498 138.838  1.00  0.77           N  \nATOM   1107  CA  GLN C 163     174.660 196.173 139.984  1.00  0.77           C  \nATOM   1108  C   GLN C 163     174.306 194.800 140.486  1.00  0.77           C  \nATOM   1109  O   GLN C 163     173.382 194.607 141.268  1.00  0.77           O  \nATOM   1110  CB  GLN C 163     174.404 197.170 141.132  1.00  0.77           C  \nATOM   1111  CG  GLN C 163     175.137 198.503 140.874  1.00  0.77           C  \nATOM   1112  CD  GLN C 163     174.390 199.692 141.475  1.00  0.77           C  \nATOM   1113  OE1 GLN C 163     173.202 199.632 141.761  1.00  0.77           O  \nATOM   1114  NE2 GLN C 163     175.097 200.836 141.610  1.00  0.77           N  \nATOM   1115  N   TRP C 164     175.070 193.770 140.094  1.00  0.78           N  \nATOM   1116  CA  TRP C 164     174.724 192.401 140.422  1.00  0.78           C  \nATOM   1117  C   TRP C 164     174.890 192.054 141.900  1.00  0.78           C  \nATOM   1118  O   TRP C 164     174.454 191.011 142.371  1.00  0.78           O  \nATOM   1119  CB  TRP C 164     175.489 191.432 139.499  1.00  0.78           C  \nATOM   1120  CG  TRP C 164     175.156 191.636 138.024  1.00  0.78           C  \nATOM   1121  CD1 TRP C 164     175.757 192.445 137.096  1.00  0.78           C  \nATOM   1122  CD2 TRP C 164     174.039 191.018 137.340  1.00  0.78           C  \nATOM   1123  NE1 TRP C 164     175.081 192.397 135.891  1.00  0.78           N  \nATOM   1124  CE2 TRP C 164     174.039 191.497 136.027  1.00  0.78           C  \nATOM   1125  CE3 TRP C 164     173.068 190.115 137.786  1.00  0.78           C  \nATOM   1126  CZ2 TRP C 164     173.086 191.067 135.102  1.00  0.78           C  \nATOM   1127  CZ3 TRP C 164     172.093 189.695 136.864  1.00  0.78           C  \nATOM   1128  CH2 TRP C 164     172.116 190.145 135.538  1.00  0.78           C  \nATOM   1129  N   ARG C 165     175.475 192.977 142.694  1.00  0.70           N  \nATOM   1130  CA  ARG C 165     175.655 192.866 144.127  1.00  0.70           C  \nATOM   1131  C   ARG C 165     174.357 192.712 144.895  1.00  0.70           C  \nATOM   1132  O   ARG C 165     174.329 192.061 145.933  1.00  0.70           O  \nATOM   1133  CB  ARG C 165     176.392 194.109 144.699  1.00  0.70           C  \nATOM   1134  CG  ARG C 165     177.796 194.359 144.095  1.00  0.70           C  \nATOM   1135  CD  ARG C 165     178.808 193.215 144.272  1.00  0.70           C  \nATOM   1136  NE  ARG C 165     179.010 193.010 145.752  1.00  0.70           N  \nATOM   1137  CZ  ARG C 165     180.053 193.441 146.477  1.00  0.70           C  \nATOM   1138  NH1 ARG C 165     181.066 194.095 145.926  1.00  0.70           N  \nATOM   1139  NH2 ARG C 165     180.088 193.212 147.791  1.00  0.70           N  \nATOM   1140  N   ASP C 166     173.264 193.330 144.420  1.00  0.81           N  \nATOM   1141  CA  ASP C 166     171.952 193.267 144.997  1.00  0.81           C  \nATOM   1142  C   ASP C 166     171.302 191.880 144.788  1.00  0.81           C  \nATOM   1143  O   ASP C 166     170.556 191.361 145.616  1.00  0.81           O  \nATOM   1144  CB  ASP C 166     171.227 194.467 144.355  1.00  0.81           C  \nATOM   1145  CG  ASP C 166     169.937 194.702 145.085  1.00  0.81           C  \nATOM   1146  OD1 ASP C 166     170.019 195.086 146.283  1.00  0.81           O  \nATOM   1147  OD2 ASP C 166     168.865 194.490 144.482  1.00  0.81           O  \nATOM   1148  N   ILE C 167     171.636 191.222 143.662  1.00  0.82           N  \nATOM   1149  CA  ILE C 167     170.912 190.080 143.148  1.00  0.82           C  \nATOM   1150  C   ILE C 167     171.494 188.779 143.643  1.00  0.82           C  \nATOM   1151  O   ILE C 167     170.849 188.020 144.364  1.00  0.82           O  \nATOM   1152  CB  ILE C 167     170.884 190.097 141.617  1.00  0.82           C  \nATOM   1153  CG1 ILE C 167     170.213 191.408 141.121  1.00  0.82           C  \nATOM   1154  CG2 ILE C 167     170.137 188.835 141.112  1.00  0.82           C  \nATOM   1155  CD1 ILE C 167     170.221 191.582 139.594  1.00  0.82           C  \nATOM   1156  N   VAL C 168     172.756 188.488 143.283  1.00  0.81           N  \nATOM   1157  CA  VAL C 168     173.400 187.248 143.650  1.00  0.81           C  \nATOM   1158  C   VAL C 168     173.970 187.364 145.058  1.00  0.81           C  \nATOM   1159  O   VAL C 168     174.354 188.433 145.547  1.00  0.81           O  \nATOM   1160  CB  VAL C 168     174.403 186.807 142.575  1.00  0.81           C  \nATOM   1161  CG1 VAL C 168     175.381 187.933 142.218  1.00  0.81           C  \nATOM   1162  CG2 VAL C 168     175.171 185.519 142.940  1.00  0.81           C  \nATOM   1163  N   SER C 169     173.948 186.241 145.800  1.00  0.79           N  \nATOM   1164  CA  SER C 169     174.527 186.117 147.130  1.00  0.79           C  \nATOM   1165  C   SER C 169     176.048 186.287 147.192  1.00  0.79           C  \nATOM   1166  O   SER C 169     176.775 186.008 146.240  1.00  0.79           O  \nATOM   1167  CB  SER C 169     174.042 184.855 147.909  1.00  0.79           C  \nATOM   1168  OG  SER C 169     174.756 183.671 147.565  1.00  0.79           O  \nATOM   1169  N   SER C 170     176.574 186.778 148.343  1.00  0.74           N  \nATOM   1170  CA  SER C 170     177.978 187.134 148.552  1.00  0.74           C  \nATOM   1171  C   SER C 170     178.981 186.001 148.351  1.00  0.74           C  \nATOM   1172  O   SER C 170     180.087 186.264 147.893  1.00  0.74           O  \nATOM   1173  CB  SER C 170     178.237 187.974 149.839  1.00  0.74           C  \nATOM   1174  OG  SER C 170     178.061 187.254 151.045  1.00  0.74           O  \nATOM   1175  N   ASP C 171     178.582 184.730 148.613  1.00  0.72           N  \nATOM   1176  CA  ASP C 171     179.344 183.500 148.446  1.00  0.72           C  \nATOM   1177  C   ASP C 171     179.775 183.346 146.963  1.00  0.72           C  \nATOM   1178  O   ASP C 171     180.923 183.082 146.626  1.00  0.72           O  \nATOM   1179  CB  ASP C 171     178.426 182.344 149.001  1.00  0.72           C  \nATOM   1180  CG  ASP C 171     179.166 181.067 149.392  1.00  0.72           C  \nATOM   1181  OD1 ASP C 171     180.143 180.704 148.701  1.00  0.72           O  \nATOM   1182  OD2 ASP C 171     178.726 180.434 150.387  1.00  0.72           O  \nATOM   1183  N   PHE C 172     178.864 183.657 146.006  1.00  0.76           N  \nATOM   1184  CA  PHE C 172     179.050 183.375 144.590  1.00  0.76           C  \nATOM   1185  C   PHE C 172     179.509 184.578 143.773  1.00  0.76           C  \nATOM   1186  O   PHE C 172     179.639 184.471 142.551  1.00  0.76           O  \nATOM   1187  CB  PHE C 172     177.747 182.828 143.942  1.00  0.76           C  \nATOM   1188  CG  PHE C 172     177.393 181.497 144.542  1.00  0.76           C  \nATOM   1189  CD1 PHE C 172     176.561 181.444 145.666  1.00  0.76           C  \nATOM   1190  CD2 PHE C 172     177.905 180.296 144.021  1.00  0.76           C  \nATOM   1191  CE1 PHE C 172     176.209 180.222 146.248  1.00  0.76           C  \nATOM   1192  CE2 PHE C 172     177.547 179.064 144.590  1.00  0.76           C  \nATOM   1193  CZ  PHE C 172     176.690 179.028 145.698  1.00  0.76           C  \nATOM   1194  N   LEU C 173     179.824 185.739 144.403  1.00  0.74           N  \nATOM   1195  CA  LEU C 173     180.298 186.944 143.715  1.00  0.74           C  \nATOM   1196  C   LEU C 173     181.623 186.738 142.980  1.00  0.74           C  \nATOM   1197  O   LEU C 173     181.914 187.408 141.995  1.00  0.74           O  \nATOM   1198  CB  LEU C 173     180.398 188.203 144.648  1.00  0.74           C  \nATOM   1199  CG  LEU C 173     179.230 189.223 144.502  1.00  0.74           C  \nATOM   1200  CD1 LEU C 173     179.157 189.832 143.089  1.00  0.74           C  \nATOM   1201  CD2 LEU C 173     177.869 188.610 144.846  1.00  0.74           C  \nATOM   1202  N   SER C 174     182.454 185.786 143.446  1.00  0.76           N  \nATOM   1203  CA  SER C 174     183.731 185.420 142.855  1.00  0.76           C  \nATOM   1204  C   SER C 174     183.637 184.465 141.666  1.00  0.76           C  \nATOM   1205  O   SER C 174     184.563 184.402 140.867  1.00  0.76           O  \nATOM   1206  CB  SER C 174     184.617 184.721 143.921  1.00  0.76           C  \nATOM   1207  OG  SER C 174     183.859 183.694 144.566  1.00  0.76           O  \nATOM   1208  N   ASN C 175     182.518 183.717 141.488  1.00  0.75           N  \nATOM   1209  CA  ASN C 175     182.367 182.734 140.415  1.00  0.75           C  \nATOM   1210  C   ASN C 175     181.600 183.318 139.245  1.00  0.75           C  \nATOM   1211  O   ASN C 175     181.242 182.622 138.298  1.00  0.75           O  \nATOM   1212  CB  ASN C 175     181.585 181.476 140.906  1.00  0.75           C  \nATOM   1213  CG  ASN C 175     182.558 180.451 141.474  1.00  0.75           C  \nATOM   1214  OD1 ASN C 175     183.631 180.218 140.931  1.00  0.75           O  \nATOM   1215  ND2 ASN C 175     182.164 179.752 142.564  1.00  0.75           N  \nATOM   1216  N   MET C 176     181.305 184.623 139.275  1.00  0.77           N  \nATOM   1217  CA  MET C 176     180.644 185.280 138.175  1.00  0.77           C  \nATOM   1218  C   MET C 176     181.543 185.585 137.000  1.00  0.77           C  \nATOM   1219  O   MET C 176     182.727 185.881 137.127  1.00  0.77           O  \nATOM   1220  CB  MET C 176     180.026 186.604 138.625  1.00  0.77           C  \nATOM   1221  CG  MET C 176     178.780 186.434 139.494  1.00  0.77           C  \nATOM   1222  SD  MET C 176     178.217 188.040 140.098  1.00  0.77           S  \nATOM   1223  CE  MET C 176     177.754 188.802 138.527  1.00  0.77           C  \nATOM   1224  N   SER C 177     180.961 185.556 135.792  1.00  0.81           N  \nATOM   1225  CA  SER C 177     181.727 185.846 134.599  1.00  0.81           C  \nATOM   1226  C   SER C 177     180.897 186.723 133.707  1.00  0.81           C  \nATOM   1227  O   SER C 177     180.029 186.265 132.968  1.00  0.81           O  \nATOM   1228  CB  SER C 177     182.153 184.529 133.903  1.00  0.81           C  \nATOM   1229  OG  SER C 177     182.914 184.742 132.710  1.00  0.81           O  \nATOM   1230  N   MET C 178     181.137 188.042 133.779  1.00  0.79           N  \nATOM   1231  CA  MET C 178     180.350 189.016 133.066  1.00  0.79           C  \nATOM   1232  C   MET C 178     181.189 189.686 131.993  1.00  0.79           C  \nATOM   1233  O   MET C 178     182.062 190.500 132.287  1.00  0.79           O  \nATOM   1234  CB  MET C 178     179.815 190.087 134.053  1.00  0.79           C  \nATOM   1235  CG  MET C 178     179.108 189.521 135.302  1.00  0.79           C  \nATOM   1236  SD  MET C 178     177.760 188.344 134.965  1.00  0.79           S  \nATOM   1237  CE  MET C 178     176.601 189.599 134.371  1.00  0.79           C  \nATOM   1238  N   ASP C 179     180.915 189.367 130.718  1.00  0.79           N  \nATOM   1239  CA  ASP C 179     181.541 189.960 129.569  1.00  0.79           C  \nATOM   1240  C   ASP C 179     180.433 190.726 128.843  1.00  0.79           C  \nATOM   1241  O   ASP C 179     179.394 190.182 128.459  1.00  0.79           O  \nATOM   1242  CB  ASP C 179     182.224 188.813 128.765  1.00  0.79           C  \nATOM   1243  CG  ASP C 179     182.629 189.246 127.373  1.00  0.79           C  \nATOM   1244  OD1 ASP C 179     183.331 190.279 127.269  1.00  0.79           O  \nATOM   1245  OD2 ASP C 179     182.195 188.554 126.409  1.00  0.79           O  \nATOM   1246  N   PHE C 180     180.624 192.053 128.708  1.00  0.75           N  \nATOM   1247  CA  PHE C 180     179.697 192.948 128.056  1.00  0.75           C  \nATOM   1248  C   PHE C 180     180.442 193.742 127.021  1.00  0.75           C  \nATOM   1249  O   PHE C 180     181.332 194.533 127.324  1.00  0.75           O  \nATOM   1250  CB  PHE C 180     179.043 193.972 129.016  1.00  0.75           C  \nATOM   1251  CG  PHE C 180     178.053 193.284 129.906  1.00  0.75           C  \nATOM   1252  CD1 PHE C 180     176.737 193.066 129.467  1.00  0.75           C  \nATOM   1253  CD2 PHE C 180     178.411 192.900 131.206  1.00  0.75           C  \nATOM   1254  CE1 PHE C 180     175.802 192.451 130.308  1.00  0.75           C  \nATOM   1255  CE2 PHE C 180     177.447 192.386 132.079  1.00  0.75           C  \nATOM   1256  CZ  PHE C 180     176.152 192.120 131.621  1.00  0.75           C  \nATOM   1257  N   GLN C 181     180.045 193.562 125.758  1.00  0.66           N  \nATOM   1258  CA  GLN C 181     180.633 194.254 124.648  1.00  0.66           C  \nATOM   1259  C   GLN C 181     179.524 194.423 123.638  1.00  0.66           C  \nATOM   1260  O   GLN C 181     179.198 193.506 122.888  1.00  0.66           O  \nATOM   1261  CB  GLN C 181     181.790 193.409 124.044  1.00  0.66           C  \nATOM   1262  CG  GLN C 181     182.447 193.963 122.749  1.00  0.66           C  \nATOM   1263  CD  GLN C 181     183.384 195.149 122.987  1.00  0.66           C  \nATOM   1264  OE1 GLN C 181     183.714 195.560 124.090  1.00  0.66           O  \nATOM   1265  NE2 GLN C 181     183.865 195.734 121.858  1.00  0.66           N  \nATOM   1266  N   ASN C 182     178.912 195.618 123.594  1.00  0.64           N  \nATOM   1267  CA  ASN C 182     178.022 196.017 122.531  1.00  0.64           C  \nATOM   1268  C   ASN C 182     178.924 196.833 121.607  1.00  0.64           C  \nATOM   1269  O   ASN C 182     179.447 196.342 120.618  1.00  0.64           O  \nATOM   1270  CB  ASN C 182     176.807 196.805 123.121  1.00  0.64           C  \nATOM   1271  CG  ASN C 182     175.793 197.242 122.065  1.00  0.64           C  \nATOM   1272  OD1 ASN C 182     176.107 197.697 120.970  1.00  0.64           O  \nATOM   1273  ND2 ASN C 182     174.501 197.187 122.451  1.00  0.64           N  \nATOM   1274  N   HIS C 183     179.164 198.106 121.973  1.00  0.45           N  \nATOM   1275  CA  HIS C 183     180.025 199.063 121.305  1.00  0.45           C  \nATOM   1276  C   HIS C 183     179.720 199.357 119.840  1.00  0.45           C  \nATOM   1277  O   HIS C 183     180.615 199.652 119.052  1.00  0.45           O  \nATOM   1278  CB  HIS C 183     181.521 198.771 121.589  1.00  0.45           C  \nATOM   1279  CG  HIS C 183     181.889 198.785 123.056  1.00  0.45           C  \nATOM   1280  ND1 HIS C 183     180.979 199.182 124.029  1.00  0.45           N  \nATOM   1281  CD2 HIS C 183     183.057 198.427 123.641  1.00  0.45           C  \nATOM   1282  CE1 HIS C 183     181.616 199.048 125.173  1.00  0.45           C  \nATOM   1283  NE2 HIS C 183     182.877 198.587 124.998  1.00  0.45           N  \nATOM   1284  N   LEU C 184     178.419 199.354 119.477  1.00  0.51           N  \nATOM   1285  CA  LEU C 184     177.920 199.714 118.159  1.00  0.51           C  \nATOM   1286  C   LEU C 184     177.118 201.005 118.228  1.00  0.51           C  \nATOM   1287  O   LEU C 184     177.186 201.838 117.331  1.00  0.51           O  \nATOM   1288  CB  LEU C 184     177.024 198.571 117.594  1.00  0.51           C  \nATOM   1289  CG  LEU C 184     177.755 197.594 116.633  1.00  0.51           C  \nATOM   1290  CD1 LEU C 184     178.263 198.309 115.362  1.00  0.51           C  \nATOM   1291  CD2 LEU C 184     178.877 196.777 117.306  1.00  0.51           C  \nATOM   1292  N   GLY C 185     176.380 201.237 119.339  1.00  0.53           N  \nATOM   1293  CA  GLY C 185     175.627 202.479 119.531  1.00  0.53           C  \nATOM   1294  C   GLY C 185     174.174 202.420 119.131  1.00  0.53           C  \nATOM   1295  O   GLY C 185     173.603 203.415 118.706  1.00  0.53           O  \nATOM   1296  N   SER C 186     173.516 201.253 119.300  1.00  0.69           N  \nATOM   1297  CA  SER C 186     172.106 201.051 118.954  1.00  0.69           C  \nATOM   1298  C   SER C 186     171.217 201.047 120.188  1.00  0.69           C  \nATOM   1299  O   SER C 186     170.068 200.603 120.151  1.00  0.69           O  \nATOM   1300  CB  SER C 186     171.857 199.690 118.254  1.00  0.69           C  \nATOM   1301  OG  SER C 186     172.721 199.559 117.127  1.00  0.69           O  \nATOM   1302  N   CYS C 187     171.758 201.517 121.329  1.00  0.74           N  \nATOM   1303  CA  CYS C 187     171.099 201.580 122.624  1.00  0.74           C  \nATOM   1304  C   CYS C 187     170.802 203.005 122.988  1.00  0.74           C  \nATOM   1305  O   CYS C 187     171.370 203.944 122.442  1.00  0.74           O  \nATOM   1306  CB  CYS C 187     171.954 201.028 123.792  1.00  0.74           C  \nATOM   1307  SG  CYS C 187     172.478 199.329 123.475  1.00  0.74           S  \nATOM   1308  N   GLN C 188     169.908 203.186 123.964  1.00  0.67           N  \nATOM   1309  CA  GLN C 188     169.532 204.472 124.473  1.00  0.67           C  \nATOM   1310  C   GLN C 188     169.962 204.503 125.916  1.00  0.67           C  \nATOM   1311  O   GLN C 188     170.279 203.480 126.524  1.00  0.67           O  \nATOM   1312  CB  GLN C 188     168.010 204.729 124.293  1.00  0.67           C  \nATOM   1313  CG  GLN C 188     167.112 203.485 124.533  1.00  0.67           C  \nATOM   1314  CD  GLN C 188     165.643 203.809 124.236  1.00  0.67           C  \nATOM   1315  OE1 GLN C 188     165.221 204.951 124.154  1.00  0.67           O  \nATOM   1316  NE2 GLN C 188     164.822 202.742 124.051  1.00  0.67           N  \nATOM   1317  N   LYS C 189     170.070 205.719 126.470  1.00  0.69           N  \nATOM   1318  CA  LYS C 189     170.442 205.948 127.845  1.00  0.69           C  \nATOM   1319  C   LYS C 189     169.363 205.521 128.831  1.00  0.69           C  \nATOM   1320  O   LYS C 189     168.173 205.523 128.530  1.00  0.69           O  \nATOM   1321  CB  LYS C 189     170.813 207.435 128.081  1.00  0.69           C  \nATOM   1322  CG  LYS C 189     171.816 207.642 129.232  1.00  0.69           C  \nATOM   1323  CD  LYS C 189     171.935 209.112 129.665  1.00  0.69           C  \nATOM   1324  CE  LYS C 189     172.621 209.291 131.029  1.00  0.69           C  \nATOM   1325  NZ  LYS C 189     171.604 209.316 132.111  1.00  0.69           N  \nATOM   1326  N   CYS C 190     169.757 205.146 130.061  1.00  0.76           N  \nATOM   1327  CA  CYS C 190     168.825 204.925 131.143  1.00  0.76           C  \nATOM   1328  C   CYS C 190     168.153 206.218 131.569  1.00  0.76           C  \nATOM   1329  O   CYS C 190     168.845 207.243 131.677  1.00  0.76           O  \nATOM   1330  CB  CYS C 190     169.554 204.380 132.391  1.00  0.76           C  \nATOM   1331  SG  CYS C 190     170.609 202.945 132.035  1.00  0.76           S  \nATOM   1332  N   ASP C 191     166.829 206.168 131.870  1.00  0.74           N  \nATOM   1333  CA  ASP C 191     166.034 207.234 132.451  1.00  0.74           C  \nATOM   1334  C   ASP C 191     166.745 207.810 133.709  1.00  0.74           C  \nATOM   1335  O   ASP C 191     167.238 207.027 134.527  1.00  0.74           O  \nATOM   1336  CB  ASP C 191     164.578 206.721 132.706  1.00  0.74           C  \nATOM   1337  CG  ASP C 191     163.734 207.871 133.203  1.00  0.74           C  \nATOM   1338  OD1 ASP C 191     163.708 208.917 132.520  1.00  0.74           O  \nATOM   1339  OD2 ASP C 191     163.185 207.750 134.320  1.00  0.74           O  \nATOM   1340  N   PRO C 192     166.912 209.118 133.916  1.00  0.76           N  \nATOM   1341  CA  PRO C 192     167.732 209.623 135.013  1.00  0.76           C  \nATOM   1342  C   PRO C 192     166.888 209.727 136.290  1.00  0.76           C  \nATOM   1343  O   PRO C 192     166.596 210.829 136.750  1.00  0.76           O  \nATOM   1344  CB  PRO C 192     168.241 210.994 134.489  1.00  0.76           C  \nATOM   1345  CG  PRO C 192     167.179 211.431 133.474  1.00  0.76           C  \nATOM   1346  CD  PRO C 192     166.736 210.108 132.857  1.00  0.76           C  \nATOM   1347  N   SER C 193     166.521 208.573 136.896  1.00  0.79           N  \nATOM   1348  CA  SER C 193     165.665 208.492 138.073  1.00  0.79           C  \nATOM   1349  C   SER C 193     166.101 207.393 139.054  1.00  0.79           C  \nATOM   1350  O   SER C 193     165.576 207.272 140.156  1.00  0.79           O  \nATOM   1351  CB  SER C 193     164.185 208.295 137.634  1.00  0.79           C  \nATOM   1352  OG  SER C 193     164.036 207.108 136.868  1.00  0.79           O  \nATOM   1353  N   CYS C 194     167.149 206.602 138.715  1.00  0.71           N  \nATOM   1354  CA  CYS C 194     167.557 205.431 139.482  1.00  0.71           C  \nATOM   1355  C   CYS C 194     169.032 205.547 139.870  1.00  0.71           C  \nATOM   1356  O   CYS C 194     169.814 206.139 139.117  1.00  0.71           O  \nATOM   1357  CB  CYS C 194     167.214 204.076 138.766  1.00  0.71           C  \nATOM   1358  SG  CYS C 194     166.233 204.300 137.238  1.00  0.71           S  \nATOM   1359  N   PRO C 195     169.463 205.058 141.044  1.00  0.76           N  \nATOM   1360  CA  PRO C 195     170.849 205.144 141.505  1.00  0.76           C  \nATOM   1361  C   PRO C 195     171.869 204.592 140.516  1.00  0.76           C  \nATOM   1362  O   PRO C 195     171.708 203.486 140.007  1.00  0.76           O  \nATOM   1363  CB  PRO C 195     170.864 204.412 142.862  1.00  0.76           C  \nATOM   1364  CG  PRO C 195     169.650 203.480 142.795  1.00  0.76           C  \nATOM   1365  CD  PRO C 195     168.640 204.274 141.970  1.00  0.76           C  \nATOM   1366  N   ASN C 196     172.908 205.399 140.206  1.00  0.79           N  \nATOM   1367  CA  ASN C 196     174.103 205.033 139.458  1.00  0.79           C  \nATOM   1368  C   ASN C 196     173.876 204.621 138.011  1.00  0.79           C  \nATOM   1369  O   ASN C 196     174.743 204.045 137.370  1.00  0.79           O  \nATOM   1370  CB  ASN C 196     174.927 203.939 140.186  1.00  0.79           C  \nATOM   1371  CG  ASN C 196     175.203 204.334 141.630  1.00  0.79           C  \nATOM   1372  OD1 ASN C 196     174.654 203.766 142.567  1.00  0.79           O  \nATOM   1373  ND2 ASN C 196     176.093 205.335 141.837  1.00  0.79           N  \nATOM   1374  N   GLY C 197     172.698 204.952 137.445  1.00  0.82           N  \nATOM   1375  CA  GLY C 197     172.352 204.597 136.080  1.00  0.82           C  \nATOM   1376  C   GLY C 197     171.930 203.159 135.903  1.00  0.82           C  \nATOM   1377  O   GLY C 197     171.726 202.736 134.775  1.00  0.82           O  \nATOM   1378  N   SER C 198     171.800 202.370 136.992  1.00  0.83           N  \nATOM   1379  CA  SER C 198     171.487 200.938 136.971  1.00  0.83           C  \nATOM   1380  C   SER C 198     170.126 200.620 136.400  1.00  0.83           C  \nATOM   1381  O   SER C 198     169.115 200.646 137.102  1.00  0.83           O  \nATOM   1382  CB  SER C 198     171.510 200.283 138.382  1.00  0.83           C  \nATOM   1383  OG  SER C 198     172.840 200.122 138.853  1.00  0.83           O  \nATOM   1384  N   CYS C 199     170.048 200.270 135.103  1.00  0.83           N  \nATOM   1385  CA  CYS C 199     168.784 200.146 134.411  1.00  0.83           C  \nATOM   1386  C   CYS C 199     168.680 198.821 133.718  1.00  0.83           C  \nATOM   1387  O   CYS C 199     169.688 198.218 133.391  1.00  0.83           O  \nATOM   1388  CB  CYS C 199     168.475 201.346 133.467  1.00  0.83           C  \nATOM   1389  SG  CYS C 199     169.292 201.441 131.840  1.00  0.83           S  \nATOM   1390  N   TRP C 200     167.444 198.336 133.498  1.00  0.81           N  \nATOM   1391  CA  TRP C 200     167.142 197.104 132.805  1.00  0.81           C  \nATOM   1392  C   TRP C 200     166.614 197.465 131.429  1.00  0.81           C  \nATOM   1393  O   TRP C 200     166.145 196.618 130.673  1.00  0.81           O  \nATOM   1394  CB  TRP C 200     166.043 196.311 133.571  1.00  0.81           C  \nATOM   1395  CG  TRP C 200     166.577 195.526 134.753  1.00  0.81           C  \nATOM   1396  CD1 TRP C 200     166.363 195.656 136.099  1.00  0.81           C  \nATOM   1397  CD2 TRP C 200     167.420 194.363 134.597  1.00  0.81           C  \nATOM   1398  NE1 TRP C 200     166.965 194.618 136.790  1.00  0.81           N  \nATOM   1399  CE2 TRP C 200     167.639 193.836 135.868  1.00  0.81           C  \nATOM   1400  CE3 TRP C 200     167.959 193.766 133.452  1.00  0.81           C  \nATOM   1401  CZ2 TRP C 200     168.402 192.681 136.049  1.00  0.81           C  \nATOM   1402  CZ3 TRP C 200     168.756 192.624 133.630  1.00  0.81           C  \nATOM   1403  CH2 TRP C 200     168.968 192.087 134.904  1.00  0.81           C  \nATOM   1404  N   GLY C 201     166.650 198.764 131.071  1.00  0.82           N  \nATOM   1405  CA  GLY C 201     166.173 199.225 129.790  1.00  0.82           C  \nATOM   1406  C   GLY C 201     165.805 200.670 129.884  1.00  0.82           C  \nATOM   1407  O   GLY C 201     166.173 201.365 130.827  1.00  0.82           O  \nATOM   1408  N   ALA C 202     165.032 201.161 128.904  1.00  0.80           N  \nATOM   1409  CA  ALA C 202     164.549 202.519 128.887  1.00  0.80           C  \nATOM   1410  C   ALA C 202     163.165 202.587 129.515  1.00  0.80           C  \nATOM   1411  O   ALA C 202     162.349 201.680 129.332  1.00  0.80           O  \nATOM   1412  CB  ALA C 202     164.512 203.027 127.433  1.00  0.80           C  \nATOM   1413  N   GLY C 203     162.894 203.659 130.289  1.00  0.77           N  \nATOM   1414  CA  GLY C 203     161.608 203.953 130.911  1.00  0.77           C  \nATOM   1415  C   GLY C 203     161.724 203.974 132.405  1.00  0.77           C  \nATOM   1416  O   GLY C 203     162.611 203.339 132.979  1.00  0.77           O  \nATOM   1417  N   GLU C 204     160.773 204.641 133.078  1.00  0.64           N  \nATOM   1418  CA  GLU C 204     160.713 204.857 134.510  1.00  0.64           C  \nATOM   1419  C   GLU C 204     160.140 203.647 135.266  1.00  0.64           C  \nATOM   1420  O   GLU C 204     159.962 203.650 136.481  1.00  0.64           O  \nATOM   1421  CB  GLU C 204     159.815 206.106 134.774  1.00  0.64           C  \nATOM   1422  CG  GLU C 204     158.382 206.080 134.145  1.00  0.64           C  \nATOM   1423  CD  GLU C 204     158.262 206.706 132.750  1.00  0.64           C  \nATOM   1424  OE1 GLU C 204     158.864 206.133 131.803  1.00  0.64           O  \nATOM   1425  OE2 GLU C 204     157.531 207.720 132.621  1.00  0.64           O  \nATOM   1426  N   GLU C 205     159.879 202.538 134.539  1.00  0.73           N  \nATOM   1427  CA  GLU C 205     159.454 201.255 135.054  1.00  0.73           C  \nATOM   1428  C   GLU C 205     160.570 200.207 134.965  1.00  0.73           C  \nATOM   1429  O   GLU C 205     160.477 199.118 135.526  1.00  0.73           O  \nATOM   1430  CB  GLU C 205     158.259 200.766 134.185  1.00  0.73           C  \nATOM   1431  CG  GLU C 205     158.593 200.490 132.686  1.00  0.73           C  \nATOM   1432  CD  GLU C 205     157.421 199.918 131.885  1.00  0.73           C  \nATOM   1433  OE1 GLU C 205     156.269 199.952 132.377  1.00  0.73           O  \nATOM   1434  OE2 GLU C 205     157.715 199.366 130.788  1.00  0.73           O  \nATOM   1435  N   ASN C 206     161.687 200.533 134.262  1.00  0.80           N  \nATOM   1436  CA  ASN C 206     162.662 199.563 133.772  1.00  0.80           C  \nATOM   1437  C   ASN C 206     164.030 199.799 134.365  1.00  0.80           C  \nATOM   1438  O   ASN C 206     165.053 199.754 133.686  1.00  0.80           O  \nATOM   1439  CB  ASN C 206     162.765 199.588 132.205  1.00  0.80           C  \nATOM   1440  CG  ASN C 206     161.909 198.431 131.625  1.00  0.80           C  \nATOM   1441  OD1 ASN C 206     161.562 197.512 132.206  1.00  0.80           O  \nATOM   1442  ND2 ASN C 206     161.644 198.607 130.260  1.00  0.80           N  \nATOM   1443  N   CYS C 207     164.127 199.995 135.684  1.00  0.78           N  \nATOM   1444  CA  CYS C 207     165.437 200.078 136.271  1.00  0.78           C  \nATOM   1445  C   CYS C 207     165.508 199.321 137.557  1.00  0.78           C  \nATOM   1446  O   CYS C 207     164.500 198.881 138.106  1.00  0.78           O  \nATOM   1447  CB  CYS C 207     165.961 201.535 136.312  1.00  0.78           C  \nATOM   1448  SG  CYS C 207     164.952 202.730 137.206  1.00  0.78           S  \nATOM   1449  N   GLN C 208     166.754 199.026 137.976  1.00  0.80           N  \nATOM   1450  CA  GLN C 208     167.032 198.132 139.070  1.00  0.80           C  \nATOM   1451  C   GLN C 208     166.494 198.639 140.394  1.00  0.80           C  \nATOM   1452  O   GLN C 208     166.748 199.765 140.807  1.00  0.80           O  \nATOM   1453  CB  GLN C 208     168.540 197.851 139.214  1.00  0.80           C  \nATOM   1454  CG  GLN C 208     168.812 196.622 140.110  1.00  0.80           C  \nATOM   1455  CD  GLN C 208     170.304 196.315 140.168  1.00  0.80           C  \nATOM   1456  OE1 GLN C 208     171.155 197.031 139.657  1.00  0.80           O  \nATOM   1457  NE2 GLN C 208     170.627 195.170 140.815  1.00  0.80           N  \nATOM   1458  N   LYS C 209     165.731 197.798 141.111  1.00  0.79           N  \nATOM   1459  CA  LYS C 209     165.187 198.188 142.388  1.00  0.79           C  \nATOM   1460  C   LYS C 209     166.047 197.534 143.437  1.00  0.79           C  \nATOM   1461  O   LYS C 209     165.893 196.346 143.696  1.00  0.79           O  \nATOM   1462  CB  LYS C 209     163.744 197.654 142.557  1.00  0.79           C  \nATOM   1463  CG  LYS C 209     162.763 198.100 141.462  1.00  0.79           C  \nATOM   1464  CD  LYS C 209     161.549 197.155 141.393  1.00  0.79           C  \nATOM   1465  CE  LYS C 209     160.694 197.350 140.135  1.00  0.79           C  \nATOM   1466  NZ  LYS C 209     159.627 196.327 140.073  1.00  0.79           N  \nATOM   1467  N   LEU C 210     166.978 198.300 144.033  1.00  0.82           N  \nATOM   1468  CA  LEU C 210     167.891 197.803 145.046  1.00  0.82           C  \nATOM   1469  C   LEU C 210     167.215 197.463 146.373  1.00  0.82           C  \nATOM   1470  O   LEU C 210     166.466 198.279 146.916  1.00  0.82           O  \nATOM   1471  CB  LEU C 210     169.022 198.830 145.320  1.00  0.82           C  \nATOM   1472  CG  LEU C 210     169.882 199.210 144.090  1.00  0.82           C  \nATOM   1473  CD1 LEU C 210     170.896 200.311 144.467  1.00  0.82           C  \nATOM   1474  CD2 LEU C 210     170.607 197.986 143.496  1.00  0.82           C  \nATOM   1475  N   THR C 211     167.475 196.262 146.935  1.00  0.85           N  \nATOM   1476  CA  THR C 211     166.805 195.774 148.148  1.00  0.85           C  \nATOM   1477  C   THR C 211     167.729 195.050 149.110  1.00  0.85           C  \nATOM   1478  O   THR C 211     167.284 194.591 150.163  1.00  0.85           O  \nATOM   1479  CB  THR C 211     165.612 194.835 147.898  1.00  0.85           C  \nATOM   1480  OG1 THR C 211     165.899 193.729 147.053  1.00  0.85           O  \nATOM   1481  CG2 THR C 211     164.481 195.618 147.223  1.00  0.85           C  \nATOM   1482  N   LYS C 212     169.041 194.937 148.834  1.00  0.78           N  \nATOM   1483  CA  LYS C 212     170.006 194.389 149.776  1.00  0.78           C  \nATOM   1484  C   LYS C 212     171.215 195.270 150.071  1.00  0.78           C  \nATOM   1485  O   LYS C 212     171.673 195.368 151.204  1.00  0.78           O  \nATOM   1486  CB  LYS C 212     170.531 193.067 149.183  1.00  0.78           C  \nATOM   1487  CG  LYS C 212     171.619 192.387 150.038  1.00  0.78           C  \nATOM   1488  CD  LYS C 212     171.754 190.871 149.788  1.00  0.78           C  \nATOM   1489  CE  LYS C 212     172.204 190.447 148.384  1.00  0.78           C  \nATOM   1490  NZ  LYS C 212     173.586 190.879 148.171  1.00  0.78           N  \nATOM   1491  N   ILE C 213     171.796 195.954 149.069  1.00  0.77           N  \nATOM   1492  CA  ILE C 213     173.018 196.729 149.299  1.00  0.77           C  \nATOM   1493  C   ILE C 213     172.757 198.088 149.922  1.00  0.77           C  \nATOM   1494  O   ILE C 213     173.659 198.721 150.458  1.00  0.77           O  \nATOM   1495  CB  ILE C 213     173.845 196.910 148.031  1.00  0.77           C  \nATOM   1496  CG1 ILE C 213     173.008 197.492 146.856  1.00  0.77           C  \nATOM   1497  CG2 ILE C 213     174.527 195.554 147.720  1.00  0.77           C  \nATOM   1498  CD1 ILE C 213     173.840 197.795 145.600  1.00  0.77           C  \nATOM   1499  N   ILE C 214     171.493 198.554 149.895  1.00  0.76           N  \nATOM   1500  CA  ILE C 214     171.098 199.842 150.427  1.00  0.76           C  \nATOM   1501  C   ILE C 214     170.536 199.700 151.824  1.00  0.76           C  \nATOM   1502  O   ILE C 214     170.040 200.662 152.406  1.00  0.76           O  \nATOM   1503  CB  ILE C 214     170.064 200.542 149.537  1.00  0.76           C  \nATOM   1504  CG1 ILE C 214     168.682 199.825 149.441  1.00  0.76           C  \nATOM   1505  CG2 ILE C 214     170.711 200.767 148.147  1.00  0.76           C  \nATOM   1506  CD1 ILE C 214     167.577 200.754 148.908  1.00  0.76           C  \nATOM   1507  N   CYS C 215     170.600 198.477 152.388  1.00  0.75           N  \nATOM   1508  CA  CYS C 215     170.142 198.168 153.723  1.00  0.75           C  \nATOM   1509  C   CYS C 215     170.878 198.897 154.816  1.00  0.75           C  \nATOM   1510  O   CYS C 215     172.078 199.156 154.757  1.00  0.75           O  \nATOM   1511  CB  CYS C 215     170.148 196.640 154.005  1.00  0.75           C  \nATOM   1512  SG  CYS C 215     168.965 195.747 152.946  1.00  0.75           S  \nATOM   1513  N   ALA C 216     170.135 199.245 155.884  1.00  0.79           N  \nATOM   1514  CA  ALA C 216     170.714 199.732 157.109  1.00  0.79           C  \nATOM   1515  C   ALA C 216     171.501 198.625 157.803  1.00  0.79           C  \nATOM   1516  O   ALA C 216     171.300 197.441 157.540  1.00  0.79           O  \nATOM   1517  CB  ALA C 216     169.621 200.263 158.065  1.00  0.79           C  \nATOM   1518  N   GLN C 217     172.407 198.981 158.734  1.00  0.67           N  \nATOM   1519  CA  GLN C 217     173.324 198.056 159.382  1.00  0.67           C  \nATOM   1520  C   GLN C 217     172.659 196.924 160.179  1.00  0.67           C  \nATOM   1521  O   GLN C 217     173.229 195.861 160.392  1.00  0.67           O  \nATOM   1522  CB  GLN C 217     174.264 198.861 160.316  1.00  0.67           C  \nATOM   1523  CG  GLN C 217     175.404 198.008 160.926  1.00  0.67           C  \nATOM   1524  CD  GLN C 217     176.332 198.842 161.808  1.00  0.67           C  \nATOM   1525  OE1 GLN C 217     176.179 200.043 161.980  1.00  0.67           O  \nATOM   1526  NE2 GLN C 217     177.342 198.161 162.404  1.00  0.67           N  \nATOM   1527  N   GLN C 218     171.414 197.147 160.648  1.00  0.70           N  \nATOM   1528  CA  GLN C 218     170.685 196.202 161.460  1.00  0.70           C  \nATOM   1529  C   GLN C 218     169.679 195.358 160.686  1.00  0.70           C  \nATOM   1530  O   GLN C 218     169.074 194.451 161.252  1.00  0.70           O  \nATOM   1531  CB  GLN C 218     169.883 196.980 162.530  1.00  0.70           C  \nATOM   1532  CG  GLN C 218     168.791 197.932 161.968  1.00  0.70           C  \nATOM   1533  CD  GLN C 218     167.821 198.349 163.074  1.00  0.70           C  \nATOM   1534  OE1 GLN C 218     167.752 199.502 163.476  1.00  0.70           O  \nATOM   1535  NE2 GLN C 218     167.045 197.361 163.580  1.00  0.70           N  \nATOM   1536  N   CYS C 219     169.451 195.612 159.375  1.00  0.78           N  \nATOM   1537  CA  CYS C 219     168.566 194.765 158.583  1.00  0.78           C  \nATOM   1538  C   CYS C 219     169.247 193.445 158.297  1.00  0.78           C  \nATOM   1539  O   CYS C 219     170.355 193.411 157.775  1.00  0.78           O  \nATOM   1540  CB  CYS C 219     168.137 195.389 157.226  1.00  0.78           C  \nATOM   1541  SG  CYS C 219     167.108 196.883 157.375  1.00  0.78           S  \nATOM   1542  N   SER C 220     168.610 192.316 158.670  1.00  0.81           N  \nATOM   1543  CA  SER C 220     169.230 191.003 158.598  1.00  0.81           C  \nATOM   1544  C   SER C 220     169.350 190.442 157.190  1.00  0.81           C  \nATOM   1545  O   SER C 220     170.253 189.673 156.880  1.00  0.81           O  \nATOM   1546  CB  SER C 220     168.497 189.996 159.523  1.00  0.81           C  \nATOM   1547  OG  SER C 220     167.132 189.803 159.180  1.00  0.81           O  \nATOM   1548  N   GLY C 221     168.419 190.842 156.307  1.00  0.87           N  \nATOM   1549  CA  GLY C 221     168.351 190.398 154.931  1.00  0.87           C  \nATOM   1550  C   GLY C 221     167.947 191.535 154.044  1.00  0.87           C  \nATOM   1551  O   GLY C 221     168.502 192.626 154.091  1.00  0.87           O  \nATOM   1552  N   ARG C 222     166.949 191.283 153.178  1.00  0.81           N  \nATOM   1553  CA  ARG C 222     166.380 192.259 152.270  1.00  0.81           C  \nATOM   1554  C   ARG C 222     165.664 193.395 152.989  1.00  0.81           C  \nATOM   1555  O   ARG C 222     165.116 193.241 154.082  1.00  0.81           O  \nATOM   1556  CB  ARG C 222     165.424 191.620 151.218  1.00  0.81           C  \nATOM   1557  CG  ARG C 222     165.804 190.193 150.760  1.00  0.81           C  \nATOM   1558  CD  ARG C 222     167.112 190.043 149.970  1.00  0.81           C  \nATOM   1559  NE  ARG C 222     166.863 190.676 148.641  1.00  0.81           N  \nATOM   1560  CZ  ARG C 222     167.745 190.703 147.640  1.00  0.81           C  \nATOM   1561  NH1 ARG C 222     168.919 190.114 147.739  1.00  0.81           N  \nATOM   1562  NH2 ARG C 222     167.414 191.211 146.466  1.00  0.81           N  \nATOM   1563  N   CYS C 223     165.645 194.581 152.389  1.00  0.83           N  \nATOM   1564  CA  CYS C 223     165.016 195.733 152.964  1.00  0.83           C  \nATOM   1565  C   CYS C 223     164.368 196.492 151.834  1.00  0.83           C  \nATOM   1566  O   CYS C 223     164.851 196.514 150.706  1.00  0.83           O  \nATOM   1567  CB  CYS C 223     166.085 196.577 153.709  1.00  0.83           C  \nATOM   1568  SG  CYS C 223     167.450 197.060 152.597  1.00  0.83           S  \nATOM   1569  N   ARG C 224     163.214 197.114 152.085  1.00  0.76           N  \nATOM   1570  CA  ARG C 224     162.499 197.849 151.069  1.00  0.76           C  \nATOM   1571  C   ARG C 224     162.713 199.348 151.219  1.00  0.76           C  \nATOM   1572  O   ARG C 224     161.944 200.152 150.701  1.00  0.76           O  \nATOM   1573  CB  ARG C 224     161.005 197.471 151.113  1.00  0.76           C  \nATOM   1574  CG  ARG C 224     160.368 197.518 152.515  1.00  0.76           C  \nATOM   1575  CD  ARG C 224     158.853 197.497 152.381  1.00  0.76           C  \nATOM   1576  NE  ARG C 224     158.276 197.782 153.729  1.00  0.76           N  \nATOM   1577  CZ  ARG C 224     157.067 198.324 153.902  1.00  0.76           C  \nATOM   1578  NH1 ARG C 224     156.311 198.649 152.857  1.00  0.76           N  \nATOM   1579  NH2 ARG C 224     156.639 198.627 155.121  1.00  0.76           N  \nATOM   1580  N   GLY C 225     163.795 199.761 151.907  1.00  0.82           N  \nATOM   1581  CA  GLY C 225     164.072 201.159 152.134  1.00  0.82           C  \nATOM   1582  C   GLY C 225     165.385 201.277 152.843  1.00  0.82           C  \nATOM   1583  O   GLY C 225     165.971 200.281 153.259  1.00  0.82           O  \nATOM   1584  N   LYS C 226     165.890 202.519 152.982  1.00  0.73           N  \nATOM   1585  CA  LYS C 226     167.150 202.801 153.647  1.00  0.73           C  \nATOM   1586  C   LYS C 226     166.948 203.154 155.104  1.00  0.73           C  \nATOM   1587  O   LYS C 226     167.896 203.166 155.885  1.00  0.73           O  \nATOM   1588  CB  LYS C 226     167.835 204.035 153.007  1.00  0.73           C  \nATOM   1589  CG  LYS C 226     168.368 203.733 151.604  1.00  0.73           C  \nATOM   1590  CD  LYS C 226     169.110 204.924 150.983  1.00  0.73           C  \nATOM   1591  CE  LYS C 226     169.542 204.651 149.539  1.00  0.73           C  \nATOM   1592  NZ  LYS C 226     170.159 205.864 148.957  1.00  0.73           N  \nATOM   1593  N   SER C 227     165.706 203.464 155.534  1.00  0.74           N  \nATOM   1594  CA  SER C 227     165.436 203.737 156.932  1.00  0.74           C  \nATOM   1595  C   SER C 227     165.557 202.437 157.743  1.00  0.74           C  \nATOM   1596  O   SER C 227     165.363 201.350 157.194  1.00  0.74           O  \nATOM   1597  CB  SER C 227     164.062 204.426 157.173  1.00  0.74           C  \nATOM   1598  OG  SER C 227     163.051 203.570 156.658  1.00  0.74           O  \nATOM   1599  N   PRO C 228     165.887 202.431 159.028  1.00  0.77           N  \nATOM   1600  CA  PRO C 228     166.015 201.192 159.796  1.00  0.77           C  \nATOM   1601  C   PRO C 228     164.670 200.509 160.077  1.00  0.77           C  \nATOM   1602  O   PRO C 228     164.661 199.428 160.656  1.00  0.77           O  \nATOM   1603  CB  PRO C 228     166.743 201.624 161.089  1.00  0.77           C  \nATOM   1604  CG  PRO C 228     167.402 202.967 160.746  1.00  0.77           C  \nATOM   1605  CD  PRO C 228     166.436 203.581 159.738  1.00  0.77           C  \nATOM   1606  N   SER C 229     163.524 201.125 159.693  1.00  0.79           N  \nATOM   1607  CA  SER C 229     162.175 200.675 159.995  1.00  0.79           C  \nATOM   1608  C   SER C 229     161.616 199.829 158.844  1.00  0.79           C  \nATOM   1609  O   SER C 229     160.522 199.285 158.958  1.00  0.79           O  \nATOM   1610  CB  SER C 229     161.228 201.874 160.363  1.00  0.79           C  \nATOM   1611  OG  SER C 229     161.077 202.845 159.336  1.00  0.79           O  \nATOM   1612  N   ASP C 230     162.400 199.645 157.744  1.00  0.80           N  \nATOM   1613  CA  ASP C 230     162.006 198.995 156.499  1.00  0.80           C  \nATOM   1614  C   ASP C 230     162.673 197.639 156.264  1.00  0.80           C  \nATOM   1615  O   ASP C 230     162.590 197.068 155.170  1.00  0.80           O  \nATOM   1616  CB  ASP C 230     162.374 199.912 155.293  1.00  0.80           C  \nATOM   1617  CG  ASP C 230     161.264 200.907 155.007  1.00  0.80           C  \nATOM   1618  OD1 ASP C 230     160.084 200.572 155.299  1.00  0.80           O  \nATOM   1619  OD2 ASP C 230     161.559 201.966 154.402  1.00  0.80           O  \nATOM   1620  N   CYS C 231     163.348 197.058 157.280  1.00  0.81           N  \nATOM   1621  CA  CYS C 231     163.885 195.702 157.191  1.00  0.81           C  \nATOM   1622  C   CYS C 231     162.787 194.662 156.987  1.00  0.81           C  \nATOM   1623  O   CYS C 231     161.754 194.693 157.654  1.00  0.81           O  \nATOM   1624  CB  CYS C 231     164.727 195.266 158.425  1.00  0.81           C  \nATOM   1625  SG  CYS C 231     165.927 196.519 158.985  1.00  0.81           S  \nATOM   1626  N   CYS C 232     162.978 193.700 156.063  1.00  0.83           N  \nATOM   1627  CA  CYS C 232     162.003 192.652 155.837  1.00  0.83           C  \nATOM   1628  C   CYS C 232     162.214 191.535 156.847  1.00  0.83           C  \nATOM   1629  O   CYS C 232     163.202 191.512 157.579  1.00  0.83           O  \nATOM   1630  CB  CYS C 232     162.130 192.052 154.407  1.00  0.83           C  \nATOM   1631  SG  CYS C 232     161.873 193.274 153.084  1.00  0.83           S  \nATOM   1632  N   HIS C 233     161.291 190.550 156.908  1.00  0.83           N  \nATOM   1633  CA  HIS C 233     161.528 189.281 157.585  1.00  0.83           C  \nATOM   1634  C   HIS C 233     162.733 188.507 157.024  1.00  0.83           C  \nATOM   1635  O   HIS C 233     163.079 188.632 155.850  1.00  0.83           O  \nATOM   1636  CB  HIS C 233     160.282 188.361 157.540  1.00  0.83           C  \nATOM   1637  CG  HIS C 233     160.267 187.308 158.607  1.00  0.83           C  \nATOM   1638  ND1 HIS C 233     160.891 186.089 158.400  1.00  0.83           N  \nATOM   1639  CD2 HIS C 233     159.675 187.330 159.825  1.00  0.83           C  \nATOM   1640  CE1 HIS C 233     160.651 185.393 159.494  1.00  0.83           C  \nATOM   1641  NE2 HIS C 233     159.917 186.097 160.391  1.00  0.83           N  \nATOM   1642  N   ASN C 234     163.378 187.643 157.843  1.00  0.84           N  \nATOM   1643  CA  ASN C 234     164.577 186.888 157.508  1.00  0.84           C  \nATOM   1644  C   ASN C 234     164.296 185.803 156.440  1.00  0.84           C  \nATOM   1645  O   ASN C 234     165.186 185.265 155.787  1.00  0.84           O  \nATOM   1646  CB  ASN C 234     165.154 186.262 158.828  1.00  0.84           C  \nATOM   1647  CG  ASN C 234     166.671 186.427 158.864  1.00  0.84           C  \nATOM   1648  OD1 ASN C 234     167.329 186.604 157.854  1.00  0.84           O  \nATOM   1649  ND2 ASN C 234     167.270 186.426 160.081  1.00  0.84           N  \nATOM   1650  N   GLN C 235     163.007 185.464 156.222  1.00  0.81           N  \nATOM   1651  CA  GLN C 235     162.564 184.470 155.264  1.00  0.81           C  \nATOM   1652  C   GLN C 235     161.993 185.035 153.981  1.00  0.81           C  \nATOM   1653  O   GLN C 235     161.636 184.283 153.072  1.00  0.81           O  \nATOM   1654  CB  GLN C 235     161.474 183.607 155.931  1.00  0.81           C  \nATOM   1655  CG  GLN C 235     162.065 182.736 157.056  1.00  0.81           C  \nATOM   1656  CD  GLN C 235     163.031 181.720 156.439  1.00  0.81           C  \nATOM   1657  OE1 GLN C 235     162.760 181.118 155.403  1.00  0.81           O  \nATOM   1658  NE2 GLN C 235     164.213 181.524 157.067  1.00  0.81           N  \nATOM   1659  N   CYS C 236     161.936 186.371 153.826  1.00  0.81           N  \nATOM   1660  CA  CYS C 236     161.559 186.964 152.557  1.00  0.81           C  \nATOM   1661  C   CYS C 236     162.729 186.844 151.593  1.00  0.81           C  \nATOM   1662  O   CYS C 236     163.855 187.221 151.923  1.00  0.81           O  \nATOM   1663  CB  CYS C 236     161.116 188.446 152.702  1.00  0.81           C  \nATOM   1664  SG  CYS C 236     159.669 188.702 153.789  1.00  0.81           S  \nATOM   1665  N   ALA C 237     162.524 186.260 150.392  1.00  0.86           N  \nATOM   1666  CA  ALA C 237     163.606 186.096 149.450  1.00  0.86           C  \nATOM   1667  C   ALA C 237     163.839 187.344 148.592  1.00  0.86           C  \nATOM   1668  O   ALA C 237     164.856 188.003 148.735  1.00  0.86           O  \nATOM   1669  CB  ALA C 237     163.346 184.828 148.612  1.00  0.86           C  \nATOM   1670  N   ALA C 238     162.893 187.772 147.721  1.00  0.88           N  \nATOM   1671  CA  ALA C 238     163.155 188.899 146.831  1.00  0.88           C  \nATOM   1672  C   ALA C 238     163.117 190.264 147.531  1.00  0.88           C  \nATOM   1673  O   ALA C 238     164.079 191.037 147.533  1.00  0.88           O  \nATOM   1674  CB  ALA C 238     162.109 188.877 145.687  1.00  0.88           C  \nATOM   1675  N   GLY C 239     161.985 190.535 148.207  1.00  0.86           N  \nATOM   1676  CA  GLY C 239     161.734 191.712 149.017  1.00  0.86           C  \nATOM   1677  C   GLY C 239     160.476 191.476 149.811  1.00  0.86           C  \nATOM   1678  O   GLY C 239     160.048 190.334 149.991  1.00  0.86           O  \nATOM   1679  N   CYS C 240     159.810 192.547 150.270  1.00  0.84           N  \nATOM   1680  CA  CYS C 240     158.653 192.434 151.129  1.00  0.84           C  \nATOM   1681  C   CYS C 240     157.767 193.646 150.958  1.00  0.84           C  \nATOM   1682  O   CYS C 240     158.169 194.660 150.387  1.00  0.84           O  \nATOM   1683  CB  CYS C 240     159.042 192.305 152.635  1.00  0.84           C  \nATOM   1684  SG  CYS C 240     159.925 193.747 153.332  1.00  0.84           S  \nATOM   1685  N   THR C 241     156.533 193.560 151.472  1.00  0.81           N  \nATOM   1686  CA  THR C 241     155.562 194.642 151.497  1.00  0.81           C  \nATOM   1687  C   THR C 241     155.250 194.963 152.955  1.00  0.81           C  \nATOM   1688  O   THR C 241     154.348 195.719 153.292  1.00  0.81           O  \nATOM   1689  CB  THR C 241     154.360 194.292 150.598  1.00  0.81           C  \nATOM   1690  OG1 THR C 241     153.395 195.322 150.513  1.00  0.81           O  \nATOM   1691  CG2 THR C 241     153.650 192.986 150.988  1.00  0.81           C  \nATOM   1692  N   GLY C 242     156.068 194.457 153.908  1.00  0.82           N  \nATOM   1693  CA  GLY C 242     155.766 194.662 155.306  1.00  0.82           C  \nATOM   1694  C   GLY C 242     156.807 194.018 156.176  1.00  0.82           C  \nATOM   1695  O   GLY C 242     157.736 193.416 155.639  1.00  0.82           O  \nATOM   1696  N   PRO C 243     156.726 194.117 157.503  1.00  0.80           N  \nATOM   1697  CA  PRO C 243     157.803 193.663 158.377  1.00  0.80           C  \nATOM   1698  C   PRO C 243     157.577 192.210 158.785  1.00  0.80           C  \nATOM   1699  O   PRO C 243     158.460 191.614 159.397  1.00  0.80           O  \nATOM   1700  CB  PRO C 243     157.697 194.570 159.632  1.00  0.80           C  \nATOM   1701  CG  PRO C 243     156.651 195.641 159.282  1.00  0.80           C  \nATOM   1702  CD  PRO C 243     155.782 194.983 158.209  1.00  0.80           C  \nATOM   1703  N   ARG C 244     156.363 191.653 158.556  1.00  0.71           N  \nATOM   1704  CA  ARG C 244     155.954 190.322 158.991  1.00  0.71           C  \nATOM   1705  C   ARG C 244     156.392 189.234 158.018  1.00  0.71           C  \nATOM   1706  O   ARG C 244     156.909 189.478 156.931  1.00  0.71           O  \nATOM   1707  CB  ARG C 244     154.413 190.205 159.243  1.00  0.71           C  \nATOM   1708  CG  ARG C 244     153.912 190.820 160.568  1.00  0.71           C  \nATOM   1709  CD  ARG C 244     153.763 192.344 160.536  1.00  0.71           C  \nATOM   1710  NE  ARG C 244     153.098 192.753 161.829  1.00  0.71           N  \nATOM   1711  CZ  ARG C 244     153.723 193.124 162.957  1.00  0.71           C  \nATOM   1712  NH1 ARG C 244     153.002 193.503 164.013  1.00  0.71           N  \nATOM   1713  NH2 ARG C 244     155.047 193.122 163.059  1.00  0.71           N  \nATOM   1714  N   GLU C 245     156.179 187.958 158.400  1.00  0.78           N  \nATOM   1715  CA  GLU C 245     156.558 186.791 157.646  1.00  0.78           C  \nATOM   1716  C   GLU C 245     155.482 186.383 156.640  1.00  0.78           C  \nATOM   1717  O   GLU C 245     155.668 185.451 155.860  1.00  0.78           O  \nATOM   1718  CB  GLU C 245     156.802 185.638 158.668  1.00  0.78           C  \nATOM   1719  CG  GLU C 245     155.563 185.131 159.469  1.00  0.78           C  \nATOM   1720  CD  GLU C 245     155.940 184.282 160.686  1.00  0.78           C  \nATOM   1721  OE1 GLU C 245     156.613 184.838 161.585  1.00  0.78           O  \nATOM   1722  OE2 GLU C 245     155.559 183.075 160.760  1.00  0.78           O  \nATOM   1723  N   SER C 246     154.328 187.101 156.609  1.00  0.79           N  \nATOM   1724  CA  SER C 246     153.246 186.870 155.661  1.00  0.79           C  \nATOM   1725  C   SER C 246     153.291 187.907 154.540  1.00  0.79           C  \nATOM   1726  O   SER C 246     152.554 187.805 153.568  1.00  0.79           O  \nATOM   1727  CB  SER C 246     151.843 186.726 156.343  1.00  0.79           C  \nATOM   1728  OG  SER C 246     151.366 187.882 157.007  1.00  0.79           O  \nATOM   1729  N   ASP C 247     154.251 188.866 154.614  1.00  0.78           N  \nATOM   1730  CA  ASP C 247     154.376 190.025 153.749  1.00  0.78           C  \nATOM   1731  C   ASP C 247     155.556 189.858 152.784  1.00  0.78           C  \nATOM   1732  O   ASP C 247     156.018 190.802 152.139  1.00  0.78           O  \nATOM   1733  CB  ASP C 247     154.644 191.301 154.600  1.00  0.78           C  \nATOM   1734  CG  ASP C 247     153.566 191.601 155.621  1.00  0.78           C  \nATOM   1735  OD1 ASP C 247     152.368 191.417 155.321  1.00  0.78           O  \nATOM   1736  OD2 ASP C 247     153.943 192.092 156.720  1.00  0.78           O  \nATOM   1737  N   CYS C 248     156.099 188.630 152.664  1.00  0.81           N  \nATOM   1738  CA  CYS C 248     157.139 188.296 151.705  1.00  0.81           C  \nATOM   1739  C   CYS C 248     156.588 188.146 150.299  1.00  0.81           C  \nATOM   1740  O   CYS C 248     155.529 187.561 150.101  1.00  0.81           O  \nATOM   1741  CB  CYS C 248     157.839 186.962 152.063  1.00  0.81           C  \nATOM   1742  SG  CYS C 248     158.582 186.979 153.726  1.00  0.81           S  \nATOM   1743  N   LEU C 249     157.320 188.618 149.264  1.00  0.80           N  \nATOM   1744  CA  LEU C 249     156.959 188.388 147.867  1.00  0.80           C  \nATOM   1745  C   LEU C 249     157.002 186.916 147.491  1.00  0.80           C  \nATOM   1746  O   LEU C 249     156.159 186.391 146.771  1.00  0.80           O  \nATOM   1747  CB  LEU C 249     157.905 189.196 146.943  1.00  0.80           C  \nATOM   1748  CG  LEU C 249     157.536 190.693 146.910  1.00  0.80           C  \nATOM   1749  CD1 LEU C 249     158.761 191.560 146.593  1.00  0.80           C  \nATOM   1750  CD2 LEU C 249     156.431 190.967 145.874  1.00  0.80           C  \nATOM   1751  N   VAL C 250     158.017 186.214 148.010  1.00  0.79           N  \nATOM   1752  CA  VAL C 250     158.220 184.817 147.755  1.00  0.79           C  \nATOM   1753  C   VAL C 250     158.996 184.310 148.958  1.00  0.79           C  \nATOM   1754  O   VAL C 250     159.801 185.040 149.542  1.00  0.79           O  \nATOM   1755  CB  VAL C 250     158.922 184.614 146.400  1.00  0.79           C  \nATOM   1756  CG1 VAL C 250     160.056 185.654 146.224  1.00  0.79           C  \nATOM   1757  CG2 VAL C 250     159.407 183.164 146.170  1.00  0.79           C  \nATOM   1758  N   CYS C 251     158.718 183.061 149.396  1.00  0.78           N  \nATOM   1759  CA  CYS C 251     159.372 182.397 150.518  1.00  0.78           C  \nATOM   1760  C   CYS C 251     160.732 181.832 150.178  1.00  0.78           C  \nATOM   1761  O   CYS C 251     160.987 181.364 149.066  1.00  0.78           O  \nATOM   1762  CB  CYS C 251     158.511 181.253 151.123  1.00  0.78           C  \nATOM   1763  SG  CYS C 251     156.916 181.850 151.748  1.00  0.78           S  \nATOM   1764  N   ARG C 252     161.667 181.871 151.139  1.00  0.73           N  \nATOM   1765  CA  ARG C 252     163.031 181.456 150.918  1.00  0.73           C  \nATOM   1766  C   ARG C 252     163.248 179.949 150.996  1.00  0.73           C  \nATOM   1767  O   ARG C 252     163.791 179.369 150.058  1.00  0.73           O  \nATOM   1768  CB  ARG C 252     163.900 182.231 151.937  1.00  0.73           C  \nATOM   1769  CG  ARG C 252     165.414 181.923 151.904  1.00  0.73           C  \nATOM   1770  CD  ARG C 252     166.249 182.684 152.957  1.00  0.73           C  \nATOM   1771  NE  ARG C 252     166.122 184.173 152.715  1.00  0.73           N  \nATOM   1772  CZ  ARG C 252     166.804 184.909 151.821  1.00  0.73           C  \nATOM   1773  NH1 ARG C 252     167.709 184.404 150.999  1.00  0.73           N  \nATOM   1774  NH2 ARG C 252     166.476 186.173 151.583  1.00  0.73           N  \nATOM   1775  N   LYS C 253     162.793 179.286 152.082  1.00  0.70           N  \nATOM   1776  CA  LYS C 253     162.990 177.862 152.307  1.00  0.70           C  \nATOM   1777  C   LYS C 253     161.687 177.097 152.259  1.00  0.70           C  \nATOM   1778  O   LYS C 253     161.498 176.254 151.387  1.00  0.70           O  \nATOM   1779  CB  LYS C 253     163.711 177.608 153.647  1.00  0.70           C  \nATOM   1780  CG  LYS C 253     165.164 178.106 153.592  1.00  0.70           C  \nATOM   1781  CD  LYS C 253     165.870 177.807 154.912  1.00  0.70           C  \nATOM   1782  CE  LYS C 253     167.255 178.425 155.095  1.00  0.70           C  \nATOM   1783  NZ  LYS C 253     167.698 178.154 156.480  1.00  0.70           N  \nATOM   1784  N   PHE C 254     160.751 177.379 153.188  1.00  0.74           N  \nATOM   1785  CA  PHE C 254     159.516 176.639 153.299  1.00  0.74           C  \nATOM   1786  C   PHE C 254     158.340 177.574 153.225  1.00  0.74           C  \nATOM   1787  O   PHE C 254     158.417 178.789 153.414  1.00  0.74           O  \nATOM   1788  CB  PHE C 254     159.431 175.854 154.642  1.00  0.74           C  \nATOM   1789  CG  PHE C 254     160.127 174.528 154.525  1.00  0.74           C  \nATOM   1790  CD1 PHE C 254     161.522 174.427 154.629  1.00  0.74           C  \nATOM   1791  CD2 PHE C 254     159.383 173.359 154.304  1.00  0.74           C  \nATOM   1792  CE1 PHE C 254     162.165 173.187 154.528  1.00  0.74           C  \nATOM   1793  CE2 PHE C 254     160.015 172.112 154.221  1.00  0.74           C  \nATOM   1794  CZ  PHE C 254     161.409 172.024 154.336  1.00  0.74           C  \nATOM   1795  N   ARG C 255     157.186 176.986 152.910  1.00  0.67           N  \nATOM   1796  CA  ARG C 255     155.946 177.680 152.776  1.00  0.67           C  \nATOM   1797  C   ARG C 255     154.941 176.988 153.676  1.00  0.67           C  \nATOM   1798  O   ARG C 255     154.671 175.800 153.516  1.00  0.67           O  \nATOM   1799  CB  ARG C 255     155.558 177.607 151.271  1.00  0.67           C  \nATOM   1800  CG  ARG C 255     154.216 178.259 150.906  1.00  0.67           C  \nATOM   1801  CD  ARG C 255     154.232 179.778 151.066  1.00  0.67           C  \nATOM   1802  NE  ARG C 255     152.810 180.225 150.929  1.00  0.67           N  \nATOM   1803  CZ  ARG C 255     152.318 181.018 149.969  1.00  0.67           C  \nATOM   1804  NH1 ARG C 255     153.046 181.394 148.924  1.00  0.67           N  \nATOM   1805  NH2 ARG C 255     151.057 181.433 150.050  1.00  0.67           N  \nATOM   1806  N   ASP C 256     154.361 177.711 154.659  1.00  0.75           N  \nATOM   1807  CA  ASP C 256     153.229 177.237 155.422  1.00  0.75           C  \nATOM   1808  C   ASP C 256     151.968 177.692 154.674  1.00  0.75           C  \nATOM   1809  O   ASP C 256     152.002 177.982 153.475  1.00  0.75           O  \nATOM   1810  CB  ASP C 256     153.322 177.822 156.861  1.00  0.75           C  \nATOM   1811  CG  ASP C 256     152.666 176.966 157.938  1.00  0.75           C  \nATOM   1812  OD1 ASP C 256     151.844 176.059 157.614  1.00  0.75           O  \nATOM   1813  OD2 ASP C 256     153.015 177.215 159.119  1.00  0.75           O  \nATOM   1814  N   GLU C 257     150.821 177.809 155.363  1.00  0.61           N  \nATOM   1815  CA  GLU C 257     149.518 178.160 154.797  1.00  0.61           C  \nATOM   1816  C   GLU C 257     149.491 179.481 154.020  1.00  0.61           C  \nATOM   1817  O   GLU C 257     149.056 179.579 152.873  1.00  0.61           O  \nATOM   1818  CB  GLU C 257     148.502 178.226 155.981  1.00  0.61           C  \nATOM   1819  CG  GLU C 257     148.246 176.812 156.589  1.00  0.61           C  \nATOM   1820  CD  GLU C 257     147.810 176.672 158.053  1.00  0.61           C  \nATOM   1821  OE1 GLU C 257     147.747 177.649 158.816  1.00  0.61           O  \nATOM   1822  OE2 GLU C 257     147.518 175.487 158.419  1.00  0.61           O  \nATOM   1823  N   ALA C 258     150.054 180.535 154.621  1.00  0.70           N  \nATOM   1824  CA  ALA C 258     150.210 181.803 153.956  1.00  0.70           C  \nATOM   1825  C   ALA C 258     151.473 182.490 154.421  1.00  0.70           C  \nATOM   1826  O   ALA C 258     151.719 183.643 154.088  1.00  0.70           O  \nATOM   1827  CB  ALA C 258     148.981 182.684 154.268  1.00  0.70           C  \nATOM   1828  N   THR C 259     152.337 181.787 155.178  1.00  0.75           N  \nATOM   1829  CA  THR C 259     153.502 182.412 155.779  1.00  0.75           C  \nATOM   1830  C   THR C 259     154.778 181.758 155.286  1.00  0.75           C  \nATOM   1831  O   THR C 259     154.770 180.636 154.772  1.00  0.75           O  \nATOM   1832  CB  THR C 259     153.461 182.479 157.309  1.00  0.75           C  \nATOM   1833  OG1 THR C 259     153.739 181.271 157.974  1.00  0.75           O  \nATOM   1834  CG2 THR C 259     152.080 182.880 157.849  1.00  0.75           C  \nATOM   1835  N   CYS C 260     155.927 182.454 155.392  1.00  0.78           N  \nATOM   1836  CA  CYS C 260     157.208 181.851 155.068  1.00  0.78           C  \nATOM   1837  C   CYS C 260     157.888 181.332 156.322  1.00  0.78           C  \nATOM   1838  O   CYS C 260     158.222 182.094 157.227  1.00  0.78           O  \nATOM   1839  CB  CYS C 260     158.142 182.854 154.358  1.00  0.78           C  \nATOM   1840  SG  CYS C 260     157.405 183.497 152.826  1.00  0.78           S  \nATOM   1841  N   LYS C 261     158.118 180.006 156.401  1.00  0.73           N  \nATOM   1842  CA  LYS C 261     158.781 179.368 157.527  1.00  0.73           C  \nATOM   1843  C   LYS C 261     160.194 178.953 157.150  1.00  0.73           C  \nATOM   1844  O   LYS C 261     160.488 178.692 155.984  1.00  0.73           O  \nATOM   1845  CB  LYS C 261     158.006 178.104 158.003  1.00  0.73           C  \nATOM   1846  CG  LYS C 261     156.630 178.402 158.639  1.00  0.73           C  \nATOM   1847  CD  LYS C 261     156.687 179.208 159.956  1.00  0.73           C  \nATOM   1848  CE  LYS C 261     155.300 179.514 160.555  1.00  0.73           C  \nATOM   1849  NZ  LYS C 261     155.381 180.559 161.611  1.00  0.73           N  \nATOM   1850  N   ASP C 262     161.112 178.874 158.148  1.00  0.73           N  \nATOM   1851  CA  ASP C 262     162.433 178.280 157.995  1.00  0.73           C  \nATOM   1852  C   ASP C 262     162.259 176.756 157.950  1.00  0.73           C  \nATOM   1853  O   ASP C 262     162.692 176.082 157.026  1.00  0.73           O  \nATOM   1854  CB  ASP C 262     163.355 178.766 159.173  1.00  0.73           C  \nATOM   1855  CG  ASP C 262     164.871 178.584 159.010  1.00  0.73           C  \nATOM   1856  OD1 ASP C 262     165.389 178.228 157.919  1.00  0.73           O  \nATOM   1857  OD2 ASP C 262     165.575 178.915 159.993  1.00  0.73           O  \nATOM   1858  N   THR C 263     161.503 176.191 158.919  1.00  0.75           N  \nATOM   1859  CA  THR C 263     161.240 174.766 159.044  1.00  0.75           C  \nATOM   1860  C   THR C 263     159.775 174.614 159.341  1.00  0.75           C  \nATOM   1861  O   THR C 263     159.149 175.486 159.942  1.00  0.75           O  \nATOM   1862  CB  THR C 263     162.051 174.058 160.142  1.00  0.75           C  \nATOM   1863  OG1 THR C 263     162.110 174.811 161.346  1.00  0.75           O  \nATOM   1864  CG2 THR C 263     163.493 173.898 159.639  1.00  0.75           C  \nATOM   1865  N   CYS C 264     159.158 173.505 158.876  1.00  0.76           N  \nATOM   1866  CA  CYS C 264     157.770 173.193 159.191  1.00  0.76           C  \nATOM   1867  C   CYS C 264     157.558 172.982 160.683  1.00  0.76           C  \nATOM   1868  O   CYS C 264     158.445 172.408 161.319  1.00  0.76           O  \nATOM   1869  CB  CYS C 264     157.236 171.948 158.432  1.00  0.76           C  \nATOM   1870  SG  CYS C 264     157.095 172.290 156.652  1.00  0.76           S  \nATOM   1871  N   PRO C 265     156.459 173.438 161.297  1.00  0.78           N  \nATOM   1872  CA  PRO C 265     156.242 173.315 162.734  1.00  0.78           C  \nATOM   1873  C   PRO C 265     156.292 171.853 163.197  1.00  0.78           C  \nATOM   1874  O   PRO C 265     155.539 171.073 162.609  1.00  0.78           O  \nATOM   1875  CB  PRO C 265     154.870 173.980 162.990  1.00  0.78           C  \nATOM   1876  CG  PRO C 265     154.190 174.007 161.614  1.00  0.78           C  \nATOM   1877  CD  PRO C 265     155.357 174.139 160.637  1.00  0.78           C  \nATOM   1878  N   PRO C 266     157.099 171.415 164.176  1.00  0.76           N  \nATOM   1879  CA  PRO C 266     157.248 170.006 164.532  1.00  0.76           C  \nATOM   1880  C   PRO C 266     155.951 169.443 165.080  1.00  0.76           C  \nATOM   1881  O   PRO C 266     155.209 170.176 165.732  1.00  0.76           O  \nATOM   1882  CB  PRO C 266     158.373 169.989 165.599  1.00  0.76           C  \nATOM   1883  CG  PRO C 266     158.417 171.426 166.140  1.00  0.76           C  \nATOM   1884  CD  PRO C 266     158.020 172.264 164.925  1.00  0.76           C  \nATOM   1885  N   LEU C 267     155.653 168.148 164.841  1.00  0.74           N  \nATOM   1886  CA  LEU C 267     154.468 167.455 165.330  1.00  0.74           C  \nATOM   1887  C   LEU C 267     154.374 167.403 166.845  1.00  0.74           C  \nATOM   1888  O   LEU C 267     153.296 167.466 167.428  1.00  0.74           O  \nATOM   1889  CB  LEU C 267     154.429 166.009 164.787  1.00  0.74           C  \nATOM   1890  CG  LEU C 267     154.060 165.917 163.293  1.00  0.74           C  \nATOM   1891  CD1 LEU C 267     154.335 164.485 162.810  1.00  0.74           C  \nATOM   1892  CD2 LEU C 267     152.585 166.291 163.029  1.00  0.74           C  \nATOM   1893  N   MET C 268     155.532 167.283 167.513  1.00  0.63           N  \nATOM   1894  CA  MET C 268     155.643 167.250 168.949  1.00  0.63           C  \nATOM   1895  C   MET C 268     156.647 168.295 169.395  1.00  0.63           C  \nATOM   1896  O   MET C 268     157.712 168.459 168.803  1.00  0.63           O  \nATOM   1897  CB  MET C 268     156.065 165.848 169.455  1.00  0.63           C  \nATOM   1898  CG  MET C 268     154.907 164.831 169.483  1.00  0.63           C  \nATOM   1899  SD  MET C 268     155.304 163.355 170.470  1.00  0.63           S  \nATOM   1900  CE  MET C 268     153.583 162.846 170.726  1.00  0.63           C  \nATOM   1901  N   LEU C 269     156.303 169.033 170.464  1.00  0.64           N  \nATOM   1902  CA  LEU C 269     157.106 170.073 171.069  1.00  0.64           C  \nATOM   1903  C   LEU C 269     157.666 169.575 172.373  1.00  0.64           C  \nATOM   1904  O   LEU C 269     156.991 168.926 173.163  1.00  0.64           O  \nATOM   1905  CB  LEU C 269     156.271 171.340 171.385  1.00  0.64           C  \nATOM   1906  CG  LEU C 269     155.979 172.194 170.138  1.00  0.64           C  \nATOM   1907  CD1 LEU C 269     154.953 173.290 170.478  1.00  0.64           C  \nATOM   1908  CD2 LEU C 269     157.265 172.812 169.546  1.00  0.64           C  \nATOM   1909  N   TYR C 270     158.950 169.868 172.633  1.00  0.57           N  \nATOM   1910  CA  TYR C 270     159.576 169.614 173.908  1.00  0.57           C  \nATOM   1911  C   TYR C 270     159.012 170.529 174.998  1.00  0.57           C  \nATOM   1912  O   TYR C 270     158.808 171.723 174.775  1.00  0.57           O  \nATOM   1913  CB  TYR C 270     161.109 169.797 173.738  1.00  0.57           C  \nATOM   1914  CG  TYR C 270     161.868 169.335 174.953  1.00  0.57           C  \nATOM   1915  CD1 TYR C 270     161.982 167.966 175.244  1.00  0.57           C  \nATOM   1916  CD2 TYR C 270     162.466 170.266 175.816  1.00  0.57           C  \nATOM   1917  CE1 TYR C 270     162.707 167.534 176.364  1.00  0.57           C  \nATOM   1918  CE2 TYR C 270     163.206 169.835 176.928  1.00  0.57           C  \nATOM   1919  CZ  TYR C 270     163.331 168.466 177.198  1.00  0.57           C  \nATOM   1920  OH  TYR C 270     164.095 168.008 178.291  1.00  0.57           O  \nATOM   1921  N   ASN C 271     158.772 169.995 176.208  1.00  0.61           N  \nATOM   1922  CA  ASN C 271     158.295 170.734 177.345  1.00  0.61           C  \nATOM   1923  C   ASN C 271     159.500 170.920 178.289  1.00  0.61           C  \nATOM   1924  O   ASN C 271     159.955 169.928 178.865  1.00  0.61           O  \nATOM   1925  CB  ASN C 271     157.156 169.906 178.005  1.00  0.61           C  \nATOM   1926  CG  ASN C 271     156.294 170.794 178.886  1.00  0.61           C  \nATOM   1927  OD1 ASN C 271     156.789 171.756 179.482  1.00  0.61           O  \nATOM   1928  ND2 ASN C 271     154.979 170.512 178.968  1.00  0.61           N  \nATOM   1929  N   PRO C 272     160.080 172.114 178.499  1.00  0.63           N  \nATOM   1930  CA  PRO C 272     161.315 172.287 179.267  1.00  0.63           C  \nATOM   1931  C   PRO C 272     161.042 172.171 180.754  1.00  0.63           C  \nATOM   1932  O   PRO C 272     161.985 172.067 181.530  1.00  0.63           O  \nATOM   1933  CB  PRO C 272     161.814 173.704 178.886  1.00  0.63           C  \nATOM   1934  CG  PRO C 272     160.558 174.437 178.393  1.00  0.63           C  \nATOM   1935  CD  PRO C 272     159.735 173.318 177.750  1.00  0.63           C  \nATOM   1936  N   THR C 273     159.760 172.216 181.163  1.00  0.73           N  \nATOM   1937  CA  THR C 273     159.346 172.122 182.557  1.00  0.73           C  \nATOM   1938  C   THR C 273     159.201 170.686 183.007  1.00  0.73           C  \nATOM   1939  O   THR C 273     159.687 170.298 184.063  1.00  0.73           O  \nATOM   1940  CB  THR C 273     158.015 172.814 182.813  1.00  0.73           C  \nATOM   1941  OG1 THR C 273     158.113 174.172 182.420  1.00  0.73           O  \nATOM   1942  CG2 THR C 273     157.663 172.837 184.311  1.00  0.73           C  \nATOM   1943  N   THR C 274     158.519 169.828 182.216  1.00  0.55           N  \nATOM   1944  CA  THR C 274     158.206 168.465 182.642  1.00  0.55           C  \nATOM   1945  C   THR C 274     159.192 167.458 182.089  1.00  0.55           C  \nATOM   1946  O   THR C 274     159.150 166.294 182.475  1.00  0.55           O  \nATOM   1947  CB  THR C 274     156.807 168.016 182.215  1.00  0.55           C  \nATOM   1948  OG1 THR C 274     156.580 168.314 180.846  1.00  0.55           O  \nATOM   1949  CG2 THR C 274     155.765 168.796 183.032  1.00  0.55           C  \nATOM   1950  N   TYR C 275     160.114 167.891 181.195  1.00  0.56           N  \nATOM   1951  CA  TYR C 275     161.145 167.075 180.559  1.00  0.56           C  \nATOM   1952  C   TYR C 275     160.564 166.003 179.642  1.00  0.56           C  \nATOM   1953  O   TYR C 275     161.078 164.891 179.543  1.00  0.56           O  \nATOM   1954  CB  TYR C 275     162.163 166.454 181.568  1.00  0.56           C  \nATOM   1955  CG  TYR C 275     163.108 167.485 182.127  1.00  0.56           C  \nATOM   1956  CD1 TYR C 275     162.697 168.456 183.059  1.00  0.56           C  \nATOM   1957  CD2 TYR C 275     164.459 167.447 181.744  1.00  0.56           C  \nATOM   1958  CE1 TYR C 275     163.621 169.364 183.596  1.00  0.56           C  \nATOM   1959  CE2 TYR C 275     165.388 168.338 182.297  1.00  0.56           C  \nATOM   1960  CZ  TYR C 275     164.967 169.297 183.227  1.00  0.56           C  \nATOM   1961  OH  TYR C 275     165.899 170.177 183.814  1.00  0.56           O  \nATOM   1962  N   GLN C 276     159.479 166.331 178.917  1.00  0.55           N  \nATOM   1963  CA  GLN C 276     158.738 165.390 178.097  1.00  0.55           C  \nATOM   1964  C   GLN C 276     158.382 166.093 176.809  1.00  0.55           C  \nATOM   1965  O   GLN C 276     158.797 167.227 176.567  1.00  0.55           O  \nATOM   1966  CB  GLN C 276     157.447 164.832 178.783  1.00  0.55           C  \nATOM   1967  CG  GLN C 276     157.693 164.077 180.118  1.00  0.55           C  \nATOM   1968  CD  GLN C 276     158.501 162.787 179.939  1.00  0.55           C  \nATOM   1969  OE1 GLN C 276     158.673 162.240 178.857  1.00  0.55           O  \nATOM   1970  NE2 GLN C 276     159.002 162.257 181.084  1.00  0.55           N  \nATOM   1971  N   MET C 277     157.657 165.406 175.910  1.00  0.59           N  \nATOM   1972  CA  MET C 277     157.262 165.948 174.633  1.00  0.59           C  \nATOM   1973  C   MET C 277     155.763 165.884 174.475  1.00  0.59           C  \nATOM   1974  O   MET C 277     155.152 164.827 174.639  1.00  0.59           O  \nATOM   1975  CB  MET C 277     157.913 165.172 173.468  1.00  0.59           C  \nATOM   1976  CG  MET C 277     159.447 165.119 173.589  1.00  0.59           C  \nATOM   1977  SD  MET C 277     160.302 164.641 172.058  1.00  0.59           S  \nATOM   1978  CE  MET C 277     160.149 166.272 171.268  1.00  0.59           C  \nATOM   1979  N   ASP C 278     155.160 167.028 174.117  1.00  0.66           N  \nATOM   1980  CA  ASP C 278     153.736 167.237 174.091  1.00  0.66           C  \nATOM   1981  C   ASP C 278     153.337 167.464 172.634  1.00  0.66           C  \nATOM   1982  O   ASP C 278     154.104 167.975 171.816  1.00  0.66           O  \nATOM   1983  CB  ASP C 278     153.312 168.474 174.945  1.00  0.66           C  \nATOM   1984  CG  ASP C 278     153.655 168.408 176.431  1.00  0.66           C  \nATOM   1985  OD1 ASP C 278     154.192 167.396 176.938  1.00  0.66           O  \nATOM   1986  OD2 ASP C 278     153.382 169.439 177.100  1.00  0.66           O  \nATOM   1987  N   VAL C 279     152.121 167.040 172.240  1.00  0.71           N  \nATOM   1988  CA  VAL C 279     151.598 167.197 170.886  1.00  0.71           C  \nATOM   1989  C   VAL C 279     151.432 168.663 170.480  1.00  0.71           C  \nATOM   1990  O   VAL C 279     150.894 169.472 171.233  1.00  0.71           O  \nATOM   1991  CB  VAL C 279     150.273 166.452 170.690  1.00  0.71           C  \nATOM   1992  CG1 VAL C 279     150.002 166.284 169.177  1.00  0.71           C  \nATOM   1993  CG2 VAL C 279     150.341 165.052 171.346  1.00  0.71           C  \nATOM   1994  N   ASN C 280     151.875 169.059 169.268  1.00  0.73           N  \nATOM   1995  CA  ASN C 280     151.743 170.418 168.792  1.00  0.73           C  \nATOM   1996  C   ASN C 280     150.356 170.565 168.135  1.00  0.73           C  \nATOM   1997  O   ASN C 280     150.084 169.772 167.230  1.00  0.73           O  \nATOM   1998  CB  ASN C 280     152.889 170.700 167.779  1.00  0.73           C  \nATOM   1999  CG  ASN C 280     153.111 172.196 167.613  1.00  0.73           C  \nATOM   2000  OD1 ASN C 280     152.300 173.014 168.016  1.00  0.73           O  \nATOM   2001  ND2 ASN C 280     154.272 172.577 167.034  1.00  0.73           N  \nATOM   2002  N   PRO C 281     149.445 171.485 168.492  1.00  0.70           N  \nATOM   2003  CA  PRO C 281     148.131 171.635 167.853  1.00  0.70           C  \nATOM   2004  C   PRO C 281     148.191 171.933 166.352  1.00  0.70           C  \nATOM   2005  O   PRO C 281     147.267 171.569 165.626  1.00  0.70           O  \nATOM   2006  CB  PRO C 281     147.443 172.765 168.657  1.00  0.70           C  \nATOM   2007  CG  PRO C 281     148.145 172.749 170.023  1.00  0.70           C  \nATOM   2008  CD  PRO C 281     149.578 172.361 169.655  1.00  0.70           C  \nATOM   2009  N   GLU C 282     149.263 172.596 165.874  1.00  0.65           N  \nATOM   2010  CA  GLU C 282     149.475 172.958 164.487  1.00  0.65           C  \nATOM   2011  C   GLU C 282     150.760 172.366 163.935  1.00  0.65           C  \nATOM   2012  O   GLU C 282     151.412 172.932 163.060  1.00  0.65           O  \nATOM   2013  CB  GLU C 282     149.438 174.503 164.296  1.00  0.65           C  \nATOM   2014  CG  GLU C 282     150.393 175.327 165.215  1.00  0.65           C  \nATOM   2015  CD  GLU C 282     149.759 175.996 166.443  1.00  0.65           C  \nATOM   2016  OE1 GLU C 282     148.598 175.679 166.800  1.00  0.65           O  \nATOM   2017  OE2 GLU C 282     150.474 176.846 167.037  1.00  0.65           O  \nATOM   2018  N   GLY C 283     151.159 171.160 164.397  1.00  0.78           N  \nATOM   2019  CA  GLY C 283     152.243 170.420 163.754  1.00  0.78           C  \nATOM   2020  C   GLY C 283     151.903 170.027 162.338  1.00  0.78           C  \nATOM   2021  O   GLY C 283     150.806 169.549 162.060  1.00  0.78           O  \nATOM   2022  N   LYS C 284     152.839 170.212 161.397  1.00  0.76           N  \nATOM   2023  CA  LYS C 284     152.590 169.940 159.998  1.00  0.76           C  \nATOM   2024  C   LYS C 284     153.646 169.028 159.453  1.00  0.76           C  \nATOM   2025  O   LYS C 284     154.809 169.082 159.846  1.00  0.76           O  \nATOM   2026  CB  LYS C 284     152.669 171.218 159.139  1.00  0.76           C  \nATOM   2027  CG  LYS C 284     151.627 172.287 159.465  1.00  0.76           C  \nATOM   2028  CD  LYS C 284     150.203 171.863 159.099  1.00  0.76           C  \nATOM   2029  CE  LYS C 284     149.269 173.061 159.032  1.00  0.76           C  \nATOM   2030  NZ  LYS C 284     149.695 174.048 158.013  1.00  0.76           N  \nATOM   2031  N   TYR C 285     153.269 168.195 158.471  1.00  0.80           N  \nATOM   2032  CA  TYR C 285     154.216 167.345 157.793  1.00  0.80           C  \nATOM   2033  C   TYR C 285     154.947 168.164 156.747  1.00  0.80           C  \nATOM   2034  O   TYR C 285     154.329 168.863 155.943  1.00  0.80           O  \nATOM   2035  CB  TYR C 285     153.570 166.114 157.106  1.00  0.80           C  \nATOM   2036  CG  TYR C 285     152.989 165.194 158.138  1.00  0.80           C  \nATOM   2037  CD1 TYR C 285     151.702 165.427 158.638  1.00  0.80           C  \nATOM   2038  CD2 TYR C 285     153.710 164.086 158.612  1.00  0.80           C  \nATOM   2039  CE1 TYR C 285     151.101 164.524 159.524  1.00  0.80           C  \nATOM   2040  CE2 TYR C 285     153.128 163.200 159.532  1.00  0.80           C  \nATOM   2041  CZ  TYR C 285     151.812 163.404 159.964  1.00  0.80           C  \nATOM   2042  OH  TYR C 285     151.200 162.483 160.837  1.00  0.80           O  \nATOM   2043  N   SER C 286     156.289 168.117 156.726  1.00  0.83           N  \nATOM   2044  CA  SER C 286     157.078 168.708 155.657  1.00  0.83           C  \nATOM   2045  C   SER C 286     157.047 167.833 154.415  1.00  0.83           C  \nATOM   2046  O   SER C 286     157.458 166.673 154.418  1.00  0.83           O  \nATOM   2047  CB  SER C 286     158.545 169.019 156.084  1.00  0.83           C  \nATOM   2048  OG  SER C 286     159.150 167.938 156.786  1.00  0.83           O  \nATOM   2049  N   PHE C 287     156.518 168.370 153.301  1.00  0.80           N  \nATOM   2050  CA  PHE C 287     156.435 167.657 152.048  1.00  0.80           C  \nATOM   2051  C   PHE C 287     156.986 168.588 150.983  1.00  0.80           C  \nATOM   2052  O   PHE C 287     156.438 169.651 150.718  1.00  0.80           O  \nATOM   2053  CB  PHE C 287     154.955 167.258 151.761  1.00  0.80           C  \nATOM   2054  CG  PHE C 287     154.757 166.634 150.394  1.00  0.80           C  \nATOM   2055  CD1 PHE C 287     155.573 165.585 149.933  1.00  0.80           C  \nATOM   2056  CD2 PHE C 287     153.814 167.183 149.508  1.00  0.80           C  \nATOM   2057  CE1 PHE C 287     155.423 165.072 148.640  1.00  0.80           C  \nATOM   2058  CE2 PHE C 287     153.676 166.687 148.204  1.00  0.80           C  \nATOM   2059  CZ  PHE C 287     154.475 165.622 147.772  1.00  0.80           C  \nATOM   2060  N   GLY C 288     158.117 168.229 150.333  1.00  0.73           N  \nATOM   2061  CA  GLY C 288     158.769 169.139 149.391  1.00  0.73           C  \nATOM   2062  C   GLY C 288     159.194 170.442 150.040  1.00  0.73           C  \nATOM   2063  O   GLY C 288     159.898 170.436 151.043  1.00  0.73           O  \nATOM   2064  N   ALA C 289     158.754 171.587 149.482  1.00  0.71           N  \nATOM   2065  CA  ALA C 289     159.020 172.908 150.020  1.00  0.71           C  \nATOM   2066  C   ALA C 289     157.759 173.490 150.680  1.00  0.71           C  \nATOM   2067  O   ALA C 289     157.629 174.703 150.855  1.00  0.71           O  \nATOM   2068  CB  ALA C 289     159.569 173.829 148.898  1.00  0.71           C  \nATOM   2069  N   THR C 290     156.780 172.644 151.079  1.00  0.74           N  \nATOM   2070  CA  THR C 290     155.535 173.087 151.698  1.00  0.74           C  \nATOM   2071  C   THR C 290     155.288 172.334 152.984  1.00  0.74           C  \nATOM   2072  O   THR C 290     155.833 171.259 153.244  1.00  0.74           O  \nATOM   2073  CB  THR C 290     154.277 172.962 150.818  1.00  0.74           C  \nATOM   2074  OG1 THR C 290     154.144 171.681 150.223  1.00  0.74           O  \nATOM   2075  CG2 THR C 290     154.364 173.966 149.662  1.00  0.74           C  \nATOM   2076  N   CYS C 291     154.451 172.913 153.866  1.00  0.82           N  \nATOM   2077  CA  CYS C 291     154.019 172.257 155.083  1.00  0.82           C  \nATOM   2078  C   CYS C 291     152.558 171.859 154.922  1.00  0.82           C  \nATOM   2079  O   CYS C 291     151.667 172.701 154.801  1.00  0.82           O  \nATOM   2080  CB  CYS C 291     154.180 173.155 156.340  1.00  0.82           C  \nATOM   2081  SG  CYS C 291     155.841 173.885 156.514  1.00  0.82           S  \nATOM   2082  N   VAL C 292     152.269 170.544 154.906  1.00  0.81           N  \nATOM   2083  CA  VAL C 292     150.959 169.988 154.608  1.00  0.81           C  \nATOM   2084  C   VAL C 292     150.345 169.369 155.849  1.00  0.81           C  \nATOM   2085  O   VAL C 292     151.000 169.101 156.854  1.00  0.81           O  \nATOM   2086  CB  VAL C 292     150.972 168.939 153.486  1.00  0.81           C  \nATOM   2087  CG1 VAL C 292     151.174 169.641 152.123  1.00  0.81           C  \nATOM   2088  CG2 VAL C 292     152.051 167.865 153.758  1.00  0.81           C  \nATOM   2089  N   LYS C 293     149.016 169.142 155.822  1.00  0.69           N  \nATOM   2090  CA  LYS C 293     148.271 168.517 156.904  1.00  0.69           C  \nATOM   2091  C   LYS C 293     148.627 167.062 157.122  1.00  0.69           C  \nATOM   2092  O   LYS C 293     148.603 166.569 158.239  1.00  0.69           O  \nATOM   2093  CB  LYS C 293     146.743 168.585 156.645  1.00  0.69           C  \nATOM   2094  CG  LYS C 293     146.182 170.013 156.486  1.00  0.69           C  \nATOM   2095  CD  LYS C 293     146.187 170.823 157.807  1.00  0.69           C  \nATOM   2096  CE  LYS C 293     145.615 172.256 157.657  1.00  0.69           C  \nATOM   2097  NZ  LYS C 293     145.606 173.052 158.922  1.00  0.69           N  \nATOM   2098  N   LYS C 294     148.927 166.332 156.037  1.00  0.70           N  \nATOM   2099  CA  LYS C 294     149.272 164.943 156.109  1.00  0.70           C  \nATOM   2100  C   LYS C 294     150.029 164.679 154.841  1.00  0.70           C  \nATOM   2101  O   LYS C 294     149.872 165.417 153.869  1.00  0.70           O  \nATOM   2102  CB  LYS C 294     148.019 164.025 156.218  1.00  0.70           C  \nATOM   2103  CG  LYS C 294     146.950 164.273 155.130  1.00  0.70           C  \nATOM   2104  CD  LYS C 294     145.665 163.445 155.353  1.00  0.70           C  \nATOM   2105  CE  LYS C 294     144.545 163.696 154.331  1.00  0.70           C  \nATOM   2106  NZ  LYS C 294     144.146 165.116 154.405  1.00  0.70           N  \nATOM   2107  N   CYS C 295     150.885 163.644 154.834  1.00  0.79           N  \nATOM   2108  CA  CYS C 295     151.591 163.182 153.652  1.00  0.79           C  \nATOM   2109  C   CYS C 295     150.660 162.694 152.543  1.00  0.79           C  \nATOM   2110  O   CYS C 295     149.590 162.169 152.862  1.00  0.79           O  \nATOM   2111  CB  CYS C 295     152.601 162.062 154.020  1.00  0.79           C  \nATOM   2112  SG  CYS C 295     153.925 162.709 155.084  1.00  0.79           S  \nATOM   2113  N   PRO C 296     150.967 162.841 151.243  1.00  0.80           N  \nATOM   2114  CA  PRO C 296     150.311 162.075 150.183  1.00  0.80           C  \nATOM   2115  C   PRO C 296     150.313 160.576 150.441  1.00  0.80           C  \nATOM   2116  O   PRO C 296     151.243 160.066 151.066  1.00  0.80           O  \nATOM   2117  CB  PRO C 296     151.052 162.442 148.880  1.00  0.80           C  \nATOM   2118  CG  PRO C 296     152.397 163.012 149.345  1.00  0.80           C  \nATOM   2119  CD  PRO C 296     152.124 163.584 150.738  1.00  0.80           C  \nATOM   2120  N   ARG C 297     149.289 159.852 149.953  1.00  0.66           N  \nATOM   2121  CA  ARG C 297     149.013 158.461 150.271  1.00  0.66           C  \nATOM   2122  C   ARG C 297     150.157 157.486 149.962  1.00  0.66           C  \nATOM   2123  O   ARG C 297     150.417 156.541 150.692  1.00  0.66           O  \nATOM   2124  CB  ARG C 297     147.735 158.049 149.497  1.00  0.66           C  \nATOM   2125  CG  ARG C 297     147.241 156.616 149.778  1.00  0.66           C  \nATOM   2126  CD  ARG C 297     145.959 156.299 149.011  1.00  0.66           C  \nATOM   2127  NE  ARG C 297     145.621 154.872 149.284  1.00  0.66           N  \nATOM   2128  CZ  ARG C 297     144.534 154.276 148.785  1.00  0.66           C  \nATOM   2129  NH1 ARG C 297     144.345 152.977 148.969  1.00  0.66           N  \nATOM   2130  NH2 ARG C 297     143.703 154.931 147.987  1.00  0.66           N  \nATOM   2131  N   ASN C 298     150.890 157.709 148.854  1.00  0.76           N  \nATOM   2132  CA  ASN C 298     151.936 156.823 148.383  1.00  0.76           C  \nATOM   2133  C   ASN C 298     153.349 157.196 148.862  1.00  0.76           C  \nATOM   2134  O   ASN C 298     154.336 156.558 148.471  1.00  0.76           O  \nATOM   2135  CB  ASN C 298     151.886 156.835 146.829  1.00  0.76           C  \nATOM   2136  CG  ASN C 298     152.072 158.251 146.277  1.00  0.76           C  \nATOM   2137  OD1 ASN C 298     151.211 159.103 146.452  1.00  0.76           O  \nATOM   2138  ND2 ASN C 298     153.226 158.523 145.626  1.00  0.76           N  \nATOM   2139  N   TYR C 299     153.493 158.235 149.711  1.00  0.78           N  \nATOM   2140  CA  TYR C 299     154.771 158.679 150.236  1.00  0.78           C  \nATOM   2141  C   TYR C 299     155.021 158.066 151.592  1.00  0.78           C  \nATOM   2142  O   TYR C 299     154.112 157.691 152.327  1.00  0.78           O  \nATOM   2143  CB  TYR C 299     154.872 160.224 150.355  1.00  0.78           C  \nATOM   2144  CG  TYR C 299     155.447 160.811 149.080  1.00  0.78           C  \nATOM   2145  CD1 TYR C 299     154.797 160.786 147.825  1.00  0.78           C  \nATOM   2146  CD2 TYR C 299     156.724 161.383 149.152  1.00  0.78           C  \nATOM   2147  CE1 TYR C 299     155.437 161.300 146.673  1.00  0.78           C  \nATOM   2148  CE2 TYR C 299     157.357 161.887 148.018  1.00  0.78           C  \nATOM   2149  CZ  TYR C 299     156.731 161.840 146.783  1.00  0.78           C  \nATOM   2150  OH  TYR C 299     157.423 162.470 145.735  1.00  0.78           O  \nATOM   2151  N   VAL C 300     156.309 157.938 151.944  1.00  0.82           N  \nATOM   2152  CA  VAL C 300     156.722 157.387 153.214  1.00  0.82           C  \nATOM   2153  C   VAL C 300     156.674 158.464 154.269  1.00  0.82           C  \nATOM   2154  O   VAL C 300     157.107 159.594 154.049  1.00  0.82           O  \nATOM   2155  CB  VAL C 300     158.102 156.758 153.100  1.00  0.82           C  \nATOM   2156  CG1 VAL C 300     158.738 156.440 154.466  1.00  0.82           C  \nATOM   2157  CG2 VAL C 300     157.943 155.458 152.293  1.00  0.82           C  \nATOM   2158  N   VAL C 301     156.118 158.128 155.447  1.00  0.81           N  \nATOM   2159  CA  VAL C 301     155.990 159.034 156.560  1.00  0.81           C  \nATOM   2160  C   VAL C 301     157.017 158.617 157.592  1.00  0.81           C  \nATOM   2161  O   VAL C 301     156.990 157.495 158.098  1.00  0.81           O  \nATOM   2162  CB  VAL C 301     154.586 158.976 157.166  1.00  0.81           C  \nATOM   2163  CG1 VAL C 301     154.427 160.133 158.177  1.00  0.81           C  \nATOM   2164  CG2 VAL C 301     153.544 159.087 156.030  1.00  0.81           C  \nATOM   2165  N   THR C 302     157.976 159.510 157.898  1.00  0.79           N  \nATOM   2166  CA  THR C 302     158.946 159.352 158.976  1.00  0.79           C  \nATOM   2167  C   THR C 302     158.374 159.873 160.293  1.00  0.79           C  \nATOM   2168  O   THR C 302     157.294 160.466 160.337  1.00  0.79           O  \nATOM   2169  CB  THR C 302     160.270 160.089 158.709  1.00  0.79           C  \nATOM   2170  OG1 THR C 302     160.092 161.498 158.805  1.00  0.79           O  \nATOM   2171  CG2 THR C 302     160.787 159.791 157.288  1.00  0.79           C  \nATOM   2172  N   ASP C 303     159.122 159.724 161.405  1.00  0.68           N  \nATOM   2173  CA  ASP C 303     158.677 160.131 162.720  1.00  0.68           C  \nATOM   2174  C   ASP C 303     159.083 161.579 163.011  1.00  0.68           C  \nATOM   2175  O   ASP C 303     158.612 162.198 163.962  1.00  0.68           O  \nATOM   2176  CB  ASP C 303     159.301 159.182 163.774  1.00  0.68           C  \nATOM   2177  CG  ASP C 303     158.749 157.766 163.653  1.00  0.68           C  \nATOM   2178  OD1 ASP C 303     157.698 157.563 162.990  1.00  0.68           O  \nATOM   2179  OD2 ASP C 303     159.403 156.862 164.231  1.00  0.68           O  \nATOM   2180  N   HIS C 304     159.919 162.210 162.144  1.00  0.69           N  \nATOM   2181  CA  HIS C 304     160.291 163.614 162.257  1.00  0.69           C  \nATOM   2182  C   HIS C 304     159.165 164.521 161.783  1.00  0.69           C  \nATOM   2183  O   HIS C 304     159.196 165.731 161.982  1.00  0.69           O  \nATOM   2184  CB  HIS C 304     161.565 163.977 161.438  1.00  0.69           C  \nATOM   2185  CG  HIS C 304     162.675 162.976 161.556  1.00  0.69           C  \nATOM   2186  ND1 HIS C 304     162.649 161.856 160.743  1.00  0.69           N  \nATOM   2187  CD2 HIS C 304     163.773 162.951 162.354  1.00  0.69           C  \nATOM   2188  CE1 HIS C 304     163.726 161.176 161.063  1.00  0.69           C  \nATOM   2189  NE2 HIS C 304     164.447 161.791 162.034  1.00  0.69           N  \nATOM   2190  N   GLY C 305     158.141 163.929 161.124  1.00  0.78           N  \nATOM   2191  CA  GLY C 305     157.033 164.652 160.523  1.00  0.78           C  \nATOM   2192  C   GLY C 305     157.369 165.082 159.133  1.00  0.78           C  \nATOM   2193  O   GLY C 305     157.057 166.192 158.721  1.00  0.78           O  \nATOM   2194  N   SER C 306     158.056 164.220 158.368  1.00  0.83           N  \nATOM   2195  CA  SER C 306     158.508 164.553 157.035  1.00  0.83           C  \nATOM   2196  C   SER C 306     158.117 163.467 156.066  1.00  0.83           C  \nATOM   2197  O   SER C 306     158.177 162.272 156.353  1.00  0.83           O  \nATOM   2198  CB  SER C 306     160.030 164.903 156.969  1.00  0.83           C  \nATOM   2199  OG  SER C 306     160.910 163.889 157.461  1.00  0.83           O  \nATOM   2200  N   CYS C 307     157.635 163.864 154.873  1.00  0.84           N  \nATOM   2201  CA  CYS C 307     157.262 162.914 153.846  1.00  0.84           C  \nATOM   2202  C   CYS C 307     158.458 162.680 152.936  1.00  0.84           C  \nATOM   2203  O   CYS C 307     158.947 163.603 152.283  1.00  0.84           O  \nATOM   2204  CB  CYS C 307     156.073 163.400 152.980  1.00  0.84           C  \nATOM   2205  SG  CYS C 307     154.738 164.175 153.947  1.00  0.84           S  \nATOM   2206  N   VAL C 308     158.955 161.434 152.862  1.00  0.82           N  \nATOM   2207  CA  VAL C 308     160.180 161.076 152.164  1.00  0.82           C  \nATOM   2208  C   VAL C 308     159.881 160.039 151.095  1.00  0.82           C  \nATOM   2209  O   VAL C 308     158.772 159.516 150.969  1.00  0.82           O  \nATOM   2210  CB  VAL C 308     161.293 160.545 153.085  1.00  0.82           C  \nATOM   2211  CG1 VAL C 308     161.673 161.625 154.127  1.00  0.82           C  \nATOM   2212  CG2 VAL C 308     160.879 159.213 153.760  1.00  0.82           C  \nATOM   2213  N   ARG C 309     160.880 159.729 150.246  1.00  0.72           N  \nATOM   2214  CA  ARG C 309     160.710 158.798 149.150  1.00  0.72           C  \nATOM   2215  C   ARG C 309     161.342 157.445 149.361  1.00  0.72           C  \nATOM   2216  O   ARG C 309     160.977 156.507 148.667  1.00  0.72           O  \nATOM   2217  CB  ARG C 309     161.364 159.361 147.881  1.00  0.72           C  \nATOM   2218  CG  ARG C 309     160.537 160.486 147.253  1.00  0.72           C  \nATOM   2219  CD  ARG C 309     161.245 161.022 146.015  1.00  0.72           C  \nATOM   2220  NE  ARG C 309     160.277 161.884 145.272  1.00  0.72           N  \nATOM   2221  CZ  ARG C 309     160.635 162.855 144.426  1.00  0.72           C  \nATOM   2222  NH1 ARG C 309     161.914 163.108 144.182  1.00  0.72           N  \nATOM   2223  NH2 ARG C 309     159.700 163.514 143.749  1.00  0.72           N  \nATOM   2224  N   ALA C 310     162.272 157.310 150.321  1.00  0.77           N  \nATOM   2225  CA  ALA C 310     162.852 156.039 150.635  1.00  0.77           C  \nATOM   2226  C   ALA C 310     163.179 156.111 152.112  1.00  0.77           C  \nATOM   2227  O   ALA C 310     163.495 157.180 152.633  1.00  0.77           O  \nATOM   2228  CB  ALA C 310     164.109 155.755 149.767  1.00  0.77           C  \nATOM   2229  N   CYS C 311     163.045 154.975 152.826  1.00  0.66           N  \nATOM   2230  CA  CYS C 311     163.545 154.777 154.179  1.00  0.66           C  \nATOM   2231  C   CYS C 311     165.057 154.912 154.278  1.00  0.66           C  \nATOM   2232  O   CYS C 311     165.775 154.814 153.287  1.00  0.66           O  \nATOM   2233  CB  CYS C 311     163.052 153.442 154.802  1.00  0.66           C  \nATOM   2234  SG  CYS C 311     161.262 153.519 155.128  1.00  0.66           S  \nATOM   2235  N   GLY C 312     165.566 155.220 155.495  1.00  0.59           N  \nATOM   2236  CA  GLY C 312     167.002 155.332 155.770  1.00  0.59           C  \nATOM   2237  C   GLY C 312     167.818 154.094 155.469  1.00  0.59           C  \nATOM   2238  O   GLY C 312     167.280 153.013 155.276  1.00  0.59           O  \nATOM   2239  N   ALA C 313     169.161 154.199 155.498  1.00  0.56           N  \nATOM   2240  CA  ALA C 313     170.062 153.112 155.149  1.00  0.56           C  \nATOM   2241  C   ALA C 313     169.961 151.880 156.071  1.00  0.56           C  \nATOM   2242  O   ALA C 313     170.161 150.748 155.640  1.00  0.56           O  \nATOM   2243  CB  ALA C 313     171.509 153.658 155.108  1.00  0.56           C  \nATOM   2244  N   ASP C 314     169.626 152.097 157.363  1.00  0.59           N  \nATOM   2245  CA  ASP C 314     169.426 151.125 158.414  1.00  0.59           C  \nATOM   2246  C   ASP C 314     167.938 150.794 158.628  1.00  0.59           C  \nATOM   2247  O   ASP C 314     167.544 150.166 159.612  1.00  0.59           O  \nATOM   2248  CB  ASP C 314     170.020 151.751 159.715  1.00  0.59           C  \nATOM   2249  CG  ASP C 314     169.312 153.020 160.162  1.00  0.59           C  \nATOM   2250  OD1 ASP C 314     168.928 153.887 159.332  1.00  0.59           O  \nATOM   2251  OD2 ASP C 314     169.050 153.115 161.388  1.00  0.59           O  \nATOM   2252  N   SER C 315     167.041 151.242 157.731  1.00  0.66           N  \nATOM   2253  CA  SER C 315     165.614 151.079 157.933  1.00  0.66           C  \nATOM   2254  C   SER C 315     164.986 150.492 156.700  1.00  0.66           C  \nATOM   2255  O   SER C 315     165.453 150.694 155.584  1.00  0.66           O  \nATOM   2256  CB  SER C 315     164.945 152.431 158.285  1.00  0.66           C  \nATOM   2257  OG  SER C 315     163.633 152.231 158.803  1.00  0.66           O  \nATOM   2258  N   TYR C 316     163.890 149.735 156.849  1.00  0.66           N  \nATOM   2259  CA  TYR C 316     163.194 149.194 155.704  1.00  0.66           C  \nATOM   2260  C   TYR C 316     161.802 149.796 155.711  1.00  0.66           C  \nATOM   2261  O   TYR C 316     161.301 150.255 156.742  1.00  0.66           O  \nATOM   2262  CB  TYR C 316     163.274 147.628 155.602  1.00  0.66           C  \nATOM   2263  CG  TYR C 316     162.318 146.904 156.518  1.00  0.66           C  \nATOM   2264  CD1 TYR C 316     162.521 146.854 157.907  1.00  0.66           C  \nATOM   2265  CD2 TYR C 316     161.167 146.305 155.982  1.00  0.66           C  \nATOM   2266  CE1 TYR C 316     161.575 146.242 158.746  1.00  0.66           C  \nATOM   2267  CE2 TYR C 316     160.219 145.701 156.817  1.00  0.66           C  \nATOM   2268  CZ  TYR C 316     160.412 145.683 158.200  1.00  0.66           C  \nATOM   2269  OH  TYR C 316     159.408 145.101 159.002  1.00  0.66           O  \nATOM   2270  N   GLU C 317     161.160 149.871 154.529  1.00  0.67           N  \nATOM   2271  CA  GLU C 317     159.787 150.308 154.396  1.00  0.67           C  \nATOM   2272  C   GLU C 317     158.845 149.295 155.032  1.00  0.67           C  \nATOM   2273  O   GLU C 317     158.731 148.143 154.612  1.00  0.67           O  \nATOM   2274  CB  GLU C 317     159.455 150.675 152.915  1.00  0.67           C  \nATOM   2275  CG  GLU C 317     158.160 151.526 152.774  1.00  0.67           C  \nATOM   2276  CD  GLU C 317     157.897 152.239 151.441  1.00  0.67           C  \nATOM   2277  OE1 GLU C 317     158.802 152.756 150.737  1.00  0.67           O  \nATOM   2278  OE2 GLU C 317     156.678 152.370 151.131  1.00  0.67           O  \nATOM   2279  N   MET C 318     158.194 149.717 156.131  1.00  0.62           N  \nATOM   2280  CA  MET C 318     157.261 148.922 156.885  1.00  0.62           C  \nATOM   2281  C   MET C 318     155.919 148.976 156.184  1.00  0.62           C  \nATOM   2282  O   MET C 318     155.649 149.875 155.384  1.00  0.62           O  \nATOM   2283  CB  MET C 318     157.239 149.375 158.375  1.00  0.62           C  \nATOM   2284  CG  MET C 318     156.378 148.523 159.337  1.00  0.62           C  \nATOM   2285  SD  MET C 318     154.726 149.194 159.676  1.00  0.62           S  \nATOM   2286  CE  MET C 318     155.140 150.009 161.246  1.00  0.62           C  \nATOM   2287  N   GLU C 319     155.103 147.931 156.415  1.00  0.57           N  \nATOM   2288  CA  GLU C 319     153.764 147.749 155.910  1.00  0.57           C  \nATOM   2289  C   GLU C 319     152.811 148.920 156.119  1.00  0.57           C  \nATOM   2290  O   GLU C 319     153.052 149.851 156.885  1.00  0.57           O  \nATOM   2291  CB  GLU C 319     153.178 146.370 156.370  1.00  0.57           C  \nATOM   2292  CG  GLU C 319     152.030 145.814 155.477  1.00  0.57           C  \nATOM   2293  CD  GLU C 319     152.304 146.143 154.010  1.00  0.57           C  \nATOM   2294  OE1 GLU C 319     153.297 145.627 153.448  1.00  0.57           O  \nATOM   2295  OE2 GLU C 319     151.608 147.044 153.469  1.00  0.57           O  \nATOM   2296  N   GLU C 320     151.703 148.945 155.379  1.00  0.58           N  \nATOM   2297  CA  GLU C 320     150.738 149.991 155.472  1.00  0.58           C  \nATOM   2298  C   GLU C 320     149.787 149.842 156.653  1.00  0.58           C  \nATOM   2299  O   GLU C 320     148.849 149.046 156.645  1.00  0.58           O  \nATOM   2300  CB  GLU C 320     149.993 150.047 154.127  1.00  0.58           C  \nATOM   2301  CG  GLU C 320     149.077 151.283 153.999  1.00  0.58           C  \nATOM   2302  CD  GLU C 320     149.037 151.896 152.605  1.00  0.58           C  \nATOM   2303  OE1 GLU C 320     150.059 151.780 151.878  1.00  0.58           O  \nATOM   2304  OE2 GLU C 320     148.012 152.548 152.278  1.00  0.58           O  \nATOM   2305  N   ASP C 321     149.959 150.698 157.687  1.00  0.58           N  \nATOM   2306  CA  ASP C 321     149.105 150.762 158.864  1.00  0.58           C  \nATOM   2307  C   ASP C 321     147.948 151.737 158.569  1.00  0.58           C  \nATOM   2308  O   ASP C 321     147.476 152.487 159.419  1.00  0.58           O  \nATOM   2309  CB  ASP C 321     149.868 151.324 160.101  1.00  0.58           C  \nATOM   2310  CG  ASP C 321     151.124 150.579 160.518  1.00  0.58           C  \nATOM   2311  OD1 ASP C 321     151.192 149.335 160.401  1.00  0.58           O  \nATOM   2312  OD2 ASP C 321     152.015 151.304 161.050  1.00  0.58           O  \nATOM   2313  N   GLY C 322     147.544 151.817 157.284  1.00  0.64           N  \nATOM   2314  CA  GLY C 322     146.728 152.878 156.702  1.00  0.64           C  \nATOM   2315  C   GLY C 322     147.596 153.939 156.068  1.00  0.64           C  \nATOM   2316  O   GLY C 322     147.115 154.743 155.280  1.00  0.64           O  \nATOM   2317  N   VAL C 323     148.911 153.942 156.392  1.00  0.69           N  \nATOM   2318  CA  VAL C 323     149.927 154.804 155.804  1.00  0.69           C  \nATOM   2319  C   VAL C 323     151.255 154.071 155.831  1.00  0.69           C  \nATOM   2320  O   VAL C 323     151.444 153.166 156.642  1.00  0.69           O  \nATOM   2321  CB  VAL C 323     150.173 156.134 156.545  1.00  0.69           C  \nATOM   2322  CG1 VAL C 323     148.873 156.961 156.572  1.00  0.69           C  \nATOM   2323  CG2 VAL C 323     150.727 155.916 157.982  1.00  0.69           C  \nATOM   2324  N   ARG C 324     152.226 154.453 154.970  1.00  0.67           N  \nATOM   2325  CA  ARG C 324     153.563 153.878 154.955  1.00  0.67           C  \nATOM   2326  C   ARG C 324     154.442 154.399 156.083  1.00  0.67           C  \nATOM   2327  O   ARG C 324     154.341 155.561 156.483  1.00  0.67           O  \nATOM   2328  CB  ARG C 324     154.301 154.208 153.630  1.00  0.67           C  \nATOM   2329  CG  ARG C 324     153.499 153.925 152.338  1.00  0.67           C  \nATOM   2330  CD  ARG C 324     152.994 152.484 152.147  1.00  0.67           C  \nATOM   2331  NE  ARG C 324     154.186 151.610 151.898  1.00  0.67           N  \nATOM   2332  CZ  ARG C 324     154.173 150.268 151.912  1.00  0.67           C  \nATOM   2333  NH1 ARG C 324     153.059 149.577 152.118  1.00  0.67           N  \nATOM   2334  NH2 ARG C 324     155.327 149.655 151.676  1.00  0.67           N  \nATOM   2335  N   LYS C 325     155.357 153.564 156.604  1.00  0.71           N  \nATOM   2336  CA  LYS C 325     156.207 153.911 157.724  1.00  0.71           C  \nATOM   2337  C   LYS C 325     157.584 153.327 157.490  1.00  0.71           C  \nATOM   2338  O   LYS C 325     157.794 152.516 156.590  1.00  0.71           O  \nATOM   2339  CB  LYS C 325     155.628 153.323 159.043  1.00  0.71           C  \nATOM   2340  CG  LYS C 325     154.396 154.071 159.584  1.00  0.71           C  \nATOM   2341  CD  LYS C 325     154.775 155.397 160.286  1.00  0.71           C  \nATOM   2342  CE  LYS C 325     153.594 156.300 160.643  1.00  0.71           C  \nATOM   2343  NZ  LYS C 325     152.613 155.473 161.369  1.00  0.71           N  \nATOM   2344  N   CYS C 326     158.577 153.724 158.304  1.00  0.71           N  \nATOM   2345  CA  CYS C 326     159.913 153.161 158.250  1.00  0.71           C  \nATOM   2346  C   CYS C 326     160.182 152.426 159.545  1.00  0.71           C  \nATOM   2347  O   CYS C 326     160.021 152.987 160.623  1.00  0.71           O  \nATOM   2348  CB  CYS C 326     160.984 154.274 158.109  1.00  0.71           C  \nATOM   2349  SG  CYS C 326     161.017 155.043 156.467  1.00  0.71           S  \nATOM   2350  N   LYS C 327     160.617 151.153 159.484  1.00  0.63           N  \nATOM   2351  CA  LYS C 327     160.914 150.368 160.667  1.00  0.63           C  \nATOM   2352  C   LYS C 327     162.353 149.922 160.642  1.00  0.63           C  \nATOM   2353  O   LYS C 327     162.852 149.420 159.641  1.00  0.63           O  \nATOM   2354  CB  LYS C 327     160.024 149.110 160.761  1.00  0.63           C  \nATOM   2355  CG  LYS C 327     160.476 148.079 161.813  1.00  0.63           C  \nATOM   2356  CD  LYS C 327     159.476 146.941 162.007  1.00  0.63           C  \nATOM   2357  CE  LYS C 327     158.257 147.398 162.799  1.00  0.63           C  \nATOM   2358  NZ  LYS C 327     157.345 146.258 162.983  1.00  0.63           N  \nATOM   2359  N   LYS C 328     163.055 150.102 161.779  1.00  0.65           N  \nATOM   2360  CA  LYS C 328     164.443 149.735 161.959  1.00  0.65           C  \nATOM   2361  C   LYS C 328     164.648 148.244 161.818  1.00  0.65           C  \nATOM   2362  O   LYS C 328     163.806 147.460 162.250  1.00  0.65           O  \nATOM   2363  CB  LYS C 328     164.988 150.240 163.331  1.00  0.65           C  \nATOM   2364  CG  LYS C 328     164.442 151.624 163.766  1.00  0.65           C  \nATOM   2365  CD  LYS C 328     164.737 152.763 162.766  1.00  0.65           C  \nATOM   2366  CE  LYS C 328     166.164 153.308 162.904  1.00  0.65           C  \nATOM   2367  NZ  LYS C 328     166.644 153.877 161.636  1.00  0.65           N  \nATOM   2368  N   CYS C 329     165.751 147.830 161.180  1.00  0.66           N  \nATOM   2369  CA  CYS C 329     166.023 146.431 160.964  1.00  0.66           C  \nATOM   2370  C   CYS C 329     167.089 145.932 161.918  1.00  0.66           C  \nATOM   2371  O   CYS C 329     167.839 146.706 162.521  1.00  0.66           O  \nATOM   2372  CB  CYS C 329     166.404 146.193 159.475  1.00  0.66           C  \nATOM   2373  SG  CYS C 329     168.146 146.556 159.043  1.00  0.66           S  \nATOM   2374  N   GLU C 330     167.178 144.608 162.072  1.00  0.61           N  \nATOM   2375  CA  GLU C 330     168.183 143.951 162.857  1.00  0.61           C  \nATOM   2376  C   GLU C 330     169.170 143.214 161.966  1.00  0.61           C  \nATOM   2377  O   GLU C 330     168.845 142.265 161.257  1.00  0.61           O  \nATOM   2378  CB  GLU C 330     167.493 142.952 163.818  1.00  0.61           C  \nATOM   2379  CG  GLU C 330     166.320 143.574 164.637  1.00  0.61           C  \nATOM   2380  CD  GLU C 330     164.912 143.458 164.027  1.00  0.61           C  \nATOM   2381  OE1 GLU C 330     163.949 143.482 164.837  1.00  0.61           O  \nATOM   2382  OE2 GLU C 330     164.780 143.362 162.780  1.00  0.61           O  \nATOM   2383  N   GLY C 331     170.454 143.630 161.980  1.00  0.61           N  \nATOM   2384  CA  GLY C 331     171.449 143.069 161.069  1.00  0.61           C  \nATOM   2385  C   GLY C 331     171.247 143.525 159.624  1.00  0.61           C  \nATOM   2386  O   GLY C 331     170.972 144.707 159.435  1.00  0.61           O  \nATOM   2387  N   PRO C 332     171.414 142.728 158.565  1.00  0.55           N  \nATOM   2388  CA  PRO C 332     170.971 143.084 157.210  1.00  0.55           C  \nATOM   2389  C   PRO C 332     169.484 143.417 157.085  1.00  0.55           C  \nATOM   2390  O   PRO C 332     168.662 142.565 157.400  1.00  0.55           O  \nATOM   2391  CB  PRO C 332     171.300 141.833 156.350  1.00  0.55           C  \nATOM   2392  CG  PRO C 332     172.183 140.953 157.248  1.00  0.55           C  \nATOM   2393  CD  PRO C 332     171.714 141.310 158.659  1.00  0.55           C  \nATOM   2394  N   CYS C 333     169.101 144.611 156.568  1.00  0.52           N  \nATOM   2395  CA  CYS C 333     167.694 144.942 156.368  1.00  0.52           C  \nATOM   2396  C   CYS C 333     167.058 144.193 155.222  1.00  0.52           C  \nATOM   2397  O   CYS C 333     166.116 143.429 155.401  1.00  0.52           O  \nATOM   2398  CB  CYS C 333     167.489 146.457 156.055  1.00  0.52           C  \nATOM   2399  SG  CYS C 333     168.083 147.612 157.320  1.00  0.52           S  \nATOM   2400  N   ARG C 334     167.575 144.395 153.995  1.00  0.49           N  \nATOM   2401  CA  ARG C 334     167.141 143.635 152.857  1.00  0.49           C  \nATOM   2402  C   ARG C 334     168.022 143.989 151.683  1.00  0.49           C  \nATOM   2403  O   ARG C 334     168.899 144.841 151.776  1.00  0.49           O  \nATOM   2404  CB  ARG C 334     165.650 143.858 152.478  1.00  0.49           C  \nATOM   2405  CG  ARG C 334     164.956 142.583 151.966  1.00  0.49           C  \nATOM   2406  CD  ARG C 334     163.467 142.832 151.776  1.00  0.49           C  \nATOM   2407  NE  ARG C 334     162.908 141.627 151.086  1.00  0.49           N  \nATOM   2408  CZ  ARG C 334     161.619 141.517 150.748  1.00  0.49           C  \nATOM   2409  NH1 ARG C 334     160.740 142.448 151.103  1.00  0.49           N  \nATOM   2410  NH2 ARG C 334     161.193 140.454 150.073  1.00  0.49           N  \nATOM   2411  N   LYS C 335     167.777 143.347 150.529  1.00  0.59           N  \nATOM   2412  CA  LYS C 335     168.377 143.705 149.269  1.00  0.59           C  \nATOM   2413  C   LYS C 335     167.402 144.546 148.443  1.00  0.59           C  \nATOM   2414  O   LYS C 335     166.422 144.042 147.897  1.00  0.59           O  \nATOM   2415  CB  LYS C 335     168.735 142.408 148.497  1.00  0.59           C  \nATOM   2416  CG  LYS C 335     169.357 142.637 147.102  1.00  0.59           C  \nATOM   2417  CD  LYS C 335     170.662 143.467 147.128  1.00  0.59           C  \nATOM   2418  CE  LYS C 335     171.475 143.498 145.819  1.00  0.59           C  \nATOM   2419  NZ  LYS C 335     170.690 144.166 144.763  1.00  0.59           N  \nATOM   2420  N   VAL C 336     167.668 145.861 148.322  1.00  0.69           N  \nATOM   2421  CA  VAL C 336     166.884 146.819 147.559  1.00  0.69           C  \nATOM   2422  C   VAL C 336     167.872 147.515 146.643  1.00  0.69           C  \nATOM   2423  O   VAL C 336     168.989 147.826 147.047  1.00  0.69           O  \nATOM   2424  CB  VAL C 336     166.112 147.757 148.497  1.00  0.69           C  \nATOM   2425  CG1 VAL C 336     165.625 149.055 147.819  1.00  0.69           C  \nATOM   2426  CG2 VAL C 336     164.894 146.957 149.013  1.00  0.69           C  \nATOM   2427  N   CYS C 337     167.528 147.693 145.350  1.00  0.79           N  \nATOM   2428  CA  CYS C 337     168.390 148.346 144.374  1.00  0.79           C  \nATOM   2429  C   CYS C 337     167.977 149.770 144.183  1.00  0.79           C  \nATOM   2430  O   CYS C 337     166.791 150.079 144.207  1.00  0.79           O  \nATOM   2431  CB  CYS C 337     168.273 147.750 142.958  1.00  0.79           C  \nATOM   2432  SG  CYS C 337     168.955 146.089 142.931  1.00  0.79           S  \nATOM   2433  N   ASN C 338     168.943 150.669 143.912  1.00  0.80           N  \nATOM   2434  CA  ASN C 338     168.631 151.978 143.381  1.00  0.80           C  \nATOM   2435  C   ASN C 338     168.156 151.811 141.948  1.00  0.80           C  \nATOM   2436  O   ASN C 338     168.693 150.986 141.215  1.00  0.80           O  \nATOM   2437  CB  ASN C 338     169.873 152.910 143.438  1.00  0.80           C  \nATOM   2438  CG  ASN C 338     170.114 153.271 144.899  1.00  0.80           C  \nATOM   2439  OD1 ASN C 338     169.180 153.523 145.650  1.00  0.80           O  \nATOM   2440  ND2 ASN C 338     171.393 153.304 145.345  1.00  0.80           N  \nATOM   2441  N   GLY C 339     167.117 152.556 141.530  1.00  0.87           N  \nATOM   2442  CA  GLY C 339     166.703 152.627 140.133  1.00  0.87           C  \nATOM   2443  C   GLY C 339     167.549 153.543 139.295  1.00  0.87           C  \nATOM   2444  O   GLY C 339     168.566 154.069 139.727  1.00  0.87           O  \nATOM   2445  N   ILE C 340     167.146 153.767 138.036  1.00  0.81           N  \nATOM   2446  CA  ILE C 340     167.851 154.669 137.133  1.00  0.81           C  \nATOM   2447  C   ILE C 340     167.583 156.121 137.553  1.00  0.81           C  \nATOM   2448  O   ILE C 340     166.508 156.423 138.068  1.00  0.81           O  \nATOM   2449  CB  ILE C 340     167.489 154.406 135.660  1.00  0.81           C  \nATOM   2450  CG1 ILE C 340     167.469 152.881 135.315  1.00  0.81           C  \nATOM   2451  CG2 ILE C 340     168.434 155.185 134.708  1.00  0.81           C  \nATOM   2452  CD1 ILE C 340     168.831 152.171 135.424  1.00  0.81           C  \nATOM   2453  N   GLY C 341     168.557 157.049 137.389  1.00  0.77           N  \nATOM   2454  CA  GLY C 341     168.450 158.471 137.718  1.00  0.77           C  \nATOM   2455  C   GLY C 341     168.758 158.804 139.161  1.00  0.77           C  \nATOM   2456  O   GLY C 341     168.638 159.954 139.594  1.00  0.77           O  \nATOM   2457  N   ILE C 342     169.215 157.808 139.949  1.00  0.74           N  \nATOM   2458  CA  ILE C 342     169.435 157.959 141.378  1.00  0.74           C  \nATOM   2459  C   ILE C 342     170.608 157.111 141.845  1.00  0.74           C  \nATOM   2460  O   ILE C 342     170.965 156.104 141.238  1.00  0.74           O  \nATOM   2461  CB  ILE C 342     168.172 157.646 142.211  1.00  0.74           C  \nATOM   2462  CG1 ILE C 342     168.187 158.380 143.581  1.00  0.74           C  \nATOM   2463  CG2 ILE C 342     167.930 156.117 142.349  1.00  0.74           C  \nATOM   2464  CD1 ILE C 342     166.831 158.344 144.302  1.00  0.74           C  \nATOM   2465  N   GLY C 343     171.266 157.505 142.964  1.00  0.76           N  \nATOM   2466  CA  GLY C 343     172.403 156.778 143.527  1.00  0.76           C  \nATOM   2467  C   GLY C 343     173.594 156.711 142.603  1.00  0.76           C  \nATOM   2468  O   GLY C 343     174.029 157.730 142.079  1.00  0.76           O  \nATOM   2469  N   GLU C 344     174.166 155.510 142.387  1.00  0.69           N  \nATOM   2470  CA  GLU C 344     175.247 155.289 141.452  1.00  0.69           C  \nATOM   2471  C   GLU C 344     174.792 155.330 139.991  1.00  0.69           C  \nATOM   2472  O   GLU C 344     175.561 155.661 139.096  1.00  0.69           O  \nATOM   2473  CB  GLU C 344     175.892 153.916 141.764  1.00  0.69           C  \nATOM   2474  CG  GLU C 344     174.920 152.705 141.704  1.00  0.69           C  \nATOM   2475  CD  GLU C 344     175.596 151.395 142.105  1.00  0.69           C  \nATOM   2476  OE1 GLU C 344     176.845 151.374 142.225  1.00  0.69           O  \nATOM   2477  OE2 GLU C 344     174.835 150.425 142.352  1.00  0.69           O  \nATOM   2478  N   PHE C 345     173.492 155.077 139.703  1.00  0.76           N  \nATOM   2479  CA  PHE C 345     172.946 155.123 138.356  1.00  0.76           C  \nATOM   2480  C   PHE C 345     172.409 156.506 138.070  1.00  0.76           C  \nATOM   2481  O   PHE C 345     171.350 156.662 137.474  1.00  0.76           O  \nATOM   2482  CB  PHE C 345     171.784 154.108 138.143  1.00  0.76           C  \nATOM   2483  CG  PHE C 345     172.227 152.706 138.441  1.00  0.76           C  \nATOM   2484  CD1 PHE C 345     173.486 152.202 138.051  1.00  0.76           C  \nATOM   2485  CD2 PHE C 345     171.398 151.908 139.243  1.00  0.76           C  \nATOM   2486  CE1 PHE C 345     173.920 150.955 138.516  1.00  0.76           C  \nATOM   2487  CE2 PHE C 345     171.814 150.646 139.672  1.00  0.76           C  \nATOM   2488  CZ  PHE C 345     173.080 150.183 139.317  1.00  0.76           C  \nATOM   2489  N   LYS C 346     173.115 157.560 138.523  1.00  0.68           N  \nATOM   2490  CA  LYS C 346     172.673 158.927 138.388  1.00  0.68           C  \nATOM   2491  C   LYS C 346     172.633 159.423 136.941  1.00  0.68           C  \nATOM   2492  O   LYS C 346     171.627 159.989 136.520  1.00  0.68           O  \nATOM   2493  CB  LYS C 346     173.561 159.835 139.279  1.00  0.68           C  \nATOM   2494  CG  LYS C 346     173.192 161.330 139.269  1.00  0.68           C  \nATOM   2495  CD  LYS C 346     171.774 161.628 139.781  1.00  0.68           C  \nATOM   2496  CE  LYS C 346     171.511 163.130 139.877  1.00  0.68           C  \nATOM   2497  NZ  LYS C 346     170.149 163.353 140.401  1.00  0.68           N  \nATOM   2498  N   ASP C 347     173.709 159.164 136.158  1.00  0.68           N  \nATOM   2499  CA  ASP C 347     173.901 159.721 134.828  1.00  0.68           C  \nATOM   2500  C   ASP C 347     173.704 158.669 133.730  1.00  0.68           C  \nATOM   2501  O   ASP C 347     173.677 158.966 132.536  1.00  0.68           O  \nATOM   2502  CB  ASP C 347     175.338 160.304 134.714  1.00  0.68           C  \nATOM   2503  CG  ASP C 347     175.631 161.200 135.907  1.00  0.68           C  \nATOM   2504  OD1 ASP C 347     174.858 162.162 136.143  1.00  0.68           O  \nATOM   2505  OD2 ASP C 347     176.621 160.894 136.619  1.00  0.68           O  \nATOM   2506  N   SER C 348     173.529 157.378 134.099  1.00  0.77           N  \nATOM   2507  CA  SER C 348     173.082 156.334 133.182  1.00  0.77           C  \nATOM   2508  C   SER C 348     171.638 156.585 132.766  1.00  0.77           C  \nATOM   2509  O   SER C 348     170.790 156.926 133.580  1.00  0.77           O  \nATOM   2510  CB  SER C 348     173.234 154.882 133.747  1.00  0.77           C  \nATOM   2511  OG  SER C 348     172.823 154.815 135.108  1.00  0.77           O  \nATOM   2512  N   LEU C 349     171.318 156.439 131.464  1.00  0.77           N  \nATOM   2513  CA  LEU C 349     170.018 156.807 130.925  1.00  0.77           C  \nATOM   2514  C   LEU C 349     169.220 155.597 130.461  1.00  0.77           C  \nATOM   2515  O   LEU C 349     168.178 155.706 129.821  1.00  0.77           O  \nATOM   2516  CB  LEU C 349     170.196 157.853 129.782  1.00  0.77           C  \nATOM   2517  CG  LEU C 349     170.783 157.380 128.418  1.00  0.77           C  \nATOM   2518  CD1 LEU C 349     170.539 158.485 127.368  1.00  0.77           C  \nATOM   2519  CD2 LEU C 349     172.284 157.002 128.423  1.00  0.77           C  \nATOM   2520  N   SER C 350     169.685 154.379 130.771  1.00  0.84           N  \nATOM   2521  CA  SER C 350     169.034 153.161 130.349  1.00  0.84           C  \nATOM   2522  C   SER C 350     169.578 152.070 131.223  1.00  0.84           C  \nATOM   2523  O   SER C 350     170.537 152.285 131.997  1.00  0.84           O  \nATOM   2524  CB  SER C 350     169.304 152.852 128.836  1.00  0.84           C  \nATOM   2525  OG  SER C 350     168.535 151.780 128.300  1.00  0.84           O  \nATOM   2526  N   ILE C 351     169.026 150.861 131.122  1.00  0.82           N  \nATOM   2527  CA  ILE C 351     169.609 149.645 131.651  1.00  0.82           C  \nATOM   2528  C   ILE C 351     170.631 149.235 130.626  1.00  0.82           C  \nATOM   2529  O   ILE C 351     170.308 148.651 129.595  1.00  0.82           O  \nATOM   2530  CB  ILE C 351     168.580 148.544 131.910  1.00  0.82           C  \nATOM   2531  CG1 ILE C 351     167.621 149.009 133.029  1.00  0.82           C  \nATOM   2532  CG2 ILE C 351     169.260 147.196 132.273  1.00  0.82           C  \nATOM   2533  CD1 ILE C 351     166.497 148.014 133.324  1.00  0.82           C  \nATOM   2534  N   ASN C 352     171.893 149.611 130.857  1.00  0.75           N  \nATOM   2535  CA  ASN C 352     173.073 149.170 130.139  1.00  0.75           C  \nATOM   2536  C   ASN C 352     173.320 147.666 130.318  1.00  0.75           C  \nATOM   2537  O   ASN C 352     172.844 147.037 131.257  1.00  0.75           O  \nATOM   2538  CB  ASN C 352     174.361 149.878 130.666  1.00  0.75           C  \nATOM   2539  CG  ASN C 352     174.236 151.397 130.625  1.00  0.75           C  \nATOM   2540  OD1 ASN C 352     173.675 151.988 129.713  1.00  0.75           O  \nATOM   2541  ND2 ASN C 352     174.828 152.073 131.642  1.00  0.75           N  \nATOM   2542  N   ALA C 353     174.177 147.050 129.476  1.00  0.84           N  \nATOM   2543  CA  ALA C 353     174.645 145.686 129.674  1.00  0.84           C  \nATOM   2544  C   ALA C 353     175.691 145.594 130.800  1.00  0.84           C  \nATOM   2545  O   ALA C 353     176.167 144.546 131.232  1.00  0.84           O  \nATOM   2546  CB  ALA C 353     175.249 145.219 128.340  1.00  0.84           C  \nATOM   2547  N   THR C 354     176.119 146.759 131.312  1.00  0.79           N  \nATOM   2548  CA  THR C 354     177.144 146.864 132.328  1.00  0.79           C  \nATOM   2549  C   THR C 354     176.561 146.846 133.735  1.00  0.79           C  \nATOM   2550  O   THR C 354     177.073 146.123 134.589  1.00  0.79           O  \nATOM   2551  CB  THR C 354     178.111 148.025 132.084  1.00  0.79           C  \nATOM   2552  OG1 THR C 354     177.587 149.298 132.409  1.00  0.79           O  \nATOM   2553  CG2 THR C 354     178.434 148.090 130.584  1.00  0.79           C  \nATOM   2554  N   ASN C 355     175.446 147.597 133.967  1.00  0.79           N  \nATOM   2555  CA  ASN C 355     174.854 147.915 135.263  1.00  0.79           C  \nATOM   2556  C   ASN C 355     173.764 146.907 135.633  1.00  0.79           C  \nATOM   2557  O   ASN C 355     173.360 146.814 136.790  1.00  0.79           O  \nATOM   2558  CB  ASN C 355     174.286 149.391 135.317  1.00  0.79           C  \nATOM   2559  CG  ASN C 355     173.010 149.636 134.503  1.00  0.79           C  \nATOM   2560  OD1 ASN C 355     172.852 149.065 133.439  1.00  0.79           O  \nATOM   2561  ND2 ASN C 355     172.073 150.486 134.993  1.00  0.79           N  \nATOM   2562  N   ILE C 356     173.311 146.078 134.655  1.00  0.80           N  \nATOM   2563  CA  ILE C 356     172.235 145.091 134.778  1.00  0.80           C  \nATOM   2564  C   ILE C 356     172.462 144.110 135.927  1.00  0.80           C  \nATOM   2565  O   ILE C 356     171.555 143.755 136.678  1.00  0.80           O  \nATOM   2566  CB  ILE C 356     171.970 144.349 133.450  1.00  0.80           C  \nATOM   2567  CG1 ILE C 356     170.807 143.316 133.542  1.00  0.80           C  \nATOM   2568  CG2 ILE C 356     173.254 143.699 132.862  1.00  0.80           C  \nATOM   2569  CD1 ILE C 356     169.426 143.926 133.839  1.00  0.80           C  \nATOM   2570  N   LYS C 357     173.742 143.748 136.152  1.00  0.74           N  \nATOM   2571  CA  LYS C 357     174.234 142.841 137.170  1.00  0.74           C  \nATOM   2572  C   LYS C 357     173.873 143.268 138.590  1.00  0.74           C  \nATOM   2573  O   LYS C 357     173.729 142.454 139.492  1.00  0.74           O  \nATOM   2574  CB  LYS C 357     175.784 142.729 137.119  1.00  0.74           C  \nATOM   2575  CG  LYS C 357     176.383 142.520 135.721  1.00  0.74           C  \nATOM   2576  CD  LYS C 357     177.917 142.377 135.786  1.00  0.74           C  \nATOM   2577  CE  LYS C 357     178.577 142.236 134.411  1.00  0.74           C  \nATOM   2578  NZ  LYS C 357     178.470 143.522 133.692  1.00  0.74           N  \nATOM   2579  N   HIS C 358     173.734 144.584 138.845  1.00  0.75           N  \nATOM   2580  CA  HIS C 358     173.516 145.118 140.176  1.00  0.75           C  \nATOM   2581  C   HIS C 358     172.066 144.916 140.633  1.00  0.75           C  \nATOM   2582  O   HIS C 358     171.759 144.831 141.827  1.00  0.75           O  \nATOM   2583  CB  HIS C 358     173.939 146.596 140.183  1.00  0.75           C  \nATOM   2584  CG  HIS C 358     175.358 146.816 139.721  1.00  0.75           C  \nATOM   2585  ND1 HIS C 358     175.819 148.098 139.852  1.00  0.75           N  \nATOM   2586  CD2 HIS C 358     176.362 146.014 139.275  1.00  0.75           C  \nATOM   2587  CE1 HIS C 358     177.081 148.071 139.514  1.00  0.75           C  \nATOM   2588  NE2 HIS C 358     177.469 146.828 139.136  1.00  0.75           N  \nATOM   2589  N   PHE C 359     171.157 144.659 139.657  1.00  0.78           N  \nATOM   2590  CA  PHE C 359     169.743 144.407 139.867  1.00  0.78           C  \nATOM   2591  C   PHE C 359     169.510 142.935 140.149  1.00  0.78           C  \nATOM   2592  O   PHE C 359     168.387 142.458 140.098  1.00  0.78           O  \nATOM   2593  CB  PHE C 359     168.822 144.834 138.683  1.00  0.78           C  \nATOM   2594  CG  PHE C 359     168.899 146.322 138.504  1.00  0.78           C  \nATOM   2595  CD1 PHE C 359     168.130 147.180 139.307  1.00  0.78           C  \nATOM   2596  CD2 PHE C 359     169.777 146.876 137.564  1.00  0.78           C  \nATOM   2597  CE1 PHE C 359     168.210 148.569 139.146  1.00  0.78           C  \nATOM   2598  CE2 PHE C 359     169.867 148.264 137.401  1.00  0.78           C  \nATOM   2599  CZ  PHE C 359     169.073 149.112 138.185  1.00  0.78           C  \nATOM   2600  N   LYS C 360     170.563 142.160 140.489  1.00  0.74           N  \nATOM   2601  CA  LYS C 360     170.531 140.710 140.420  1.00  0.74           C  \nATOM   2602  C   LYS C 360     169.456 139.912 141.165  1.00  0.74           C  \nATOM   2603  O   LYS C 360     168.934 138.933 140.650  1.00  0.74           O  \nATOM   2604  CB  LYS C 360     171.883 140.115 140.877  1.00  0.74           C  \nATOM   2605  CG  LYS C 360     172.014 138.583 140.705  1.00  0.74           C  \nATOM   2606  CD  LYS C 360     171.776 138.095 139.249  1.00  0.74           C  \nATOM   2607  CE  LYS C 360     171.634 136.576 139.072  1.00  0.74           C  \nATOM   2608  NZ  LYS C 360     172.784 135.924 139.720  1.00  0.74           N  \nATOM   2609  N   ASN C 361     169.166 140.276 142.428  1.00  0.74           N  \nATOM   2610  CA  ASN C 361     168.244 139.558 143.283  1.00  0.74           C  \nATOM   2611  C   ASN C 361     167.393 140.550 144.094  1.00  0.74           C  \nATOM   2612  O   ASN C 361     166.769 140.196 145.087  1.00  0.74           O  \nATOM   2613  CB  ASN C 361     169.096 138.668 144.245  1.00  0.74           C  \nATOM   2614  CG  ASN C 361     168.362 137.370 144.573  1.00  0.74           C  \nATOM   2615  OD1 ASN C 361     167.273 137.096 144.096  1.00  0.74           O  \nATOM   2616  ND2 ASN C 361     169.004 136.508 145.403  1.00  0.74           N  \nATOM   2617  N   CYS C 362     167.349 141.851 143.712  1.00  0.75           N  \nATOM   2618  CA  CYS C 362     166.521 142.822 144.440  1.00  0.75           C  \nATOM   2619  C   CYS C 362     165.075 142.772 143.998  1.00  0.75           C  \nATOM   2620  O   CYS C 362     164.759 142.719 142.817  1.00  0.75           O  \nATOM   2621  CB  CYS C 362     166.992 144.306 144.372  1.00  0.75           C  \nATOM   2622  SG  CYS C 362     167.376 144.851 142.686  1.00  0.75           S  \nATOM   2623  N   THR C 363     164.146 142.803 144.971  1.00  0.78           N  \nATOM   2624  CA  THR C 363     162.738 142.565 144.693  1.00  0.78           C  \nATOM   2625  C   THR C 363     161.950 143.861 144.674  1.00  0.78           C  \nATOM   2626  O   THR C 363     160.752 143.888 144.413  1.00  0.78           O  \nATOM   2627  CB  THR C 363     162.116 141.567 145.669  1.00  0.78           C  \nATOM   2628  OG1 THR C 363     162.061 142.014 147.014  1.00  0.78           O  \nATOM   2629  CG2 THR C 363     162.968 140.289 145.700  1.00  0.78           C  \nATOM   2630  N   SER C 364     162.636 144.984 144.930  1.00  0.81           N  \nATOM   2631  CA  SER C 364     162.088 146.315 145.052  1.00  0.81           C  \nATOM   2632  C   SER C 364     163.132 147.225 144.447  1.00  0.81           C  \nATOM   2633  O   SER C 364     164.296 147.241 144.855  1.00  0.81           O  \nATOM   2634  CB  SER C 364     161.675 146.647 146.530  1.00  0.81           C  \nATOM   2635  OG  SER C 364     161.444 148.036 146.776  1.00  0.81           O  \nATOM   2636  N   ILE C 365     162.727 147.970 143.401  1.00  0.82           N  \nATOM   2637  CA  ILE C 365     163.510 149.000 142.746  1.00  0.82           C  \nATOM   2638  C   ILE C 365     163.174 150.331 143.410  1.00  0.82           C  \nATOM   2639  O   ILE C 365     162.076 150.865 143.242  1.00  0.82           O  \nATOM   2640  CB  ILE C 365     163.225 149.135 141.239  1.00  0.82           C  \nATOM   2641  CG1 ILE C 365     163.172 147.783 140.473  1.00  0.82           C  \nATOM   2642  CG2 ILE C 365     164.254 150.113 140.614  1.00  0.82           C  \nATOM   2643  CD1 ILE C 365     164.504 147.026 140.390  1.00  0.82           C  \nATOM   2644  N   SER C 366     164.126 150.915 144.172  1.00  0.83           N  \nATOM   2645  CA  SER C 366     164.022 152.188 144.878  1.00  0.83           C  \nATOM   2646  C   SER C 366     164.342 153.300 143.891  1.00  0.83           C  \nATOM   2647  O   SER C 366     165.325 154.030 143.997  1.00  0.83           O  \nATOM   2648  CB  SER C 366     164.937 152.170 146.143  1.00  0.83           C  \nATOM   2649  OG  SER C 366     164.866 153.323 146.968  1.00  0.83           O  \nATOM   2650  N   GLY C 367     163.525 153.410 142.826  1.00  0.86           N  \nATOM   2651  CA  GLY C 367     163.623 154.454 141.838  1.00  0.86           C  \nATOM   2652  C   GLY C 367     162.888 154.038 140.614  1.00  0.86           C  \nATOM   2653  O   GLY C 367     161.843 153.396 140.684  1.00  0.86           O  \nATOM   2654  N   ASP C 368     163.453 154.398 139.457  1.00  0.85           N  \nATOM   2655  CA  ASP C 368     162.824 154.294 138.172  1.00  0.85           C  \nATOM   2656  C   ASP C 368     163.395 153.150 137.372  1.00  0.85           C  \nATOM   2657  O   ASP C 368     164.459 152.604 137.673  1.00  0.85           O  \nATOM   2658  CB  ASP C 368     163.078 155.587 137.363  1.00  0.85           C  \nATOM   2659  CG  ASP C 368     162.562 156.795 138.123  1.00  0.85           C  \nATOM   2660  OD1 ASP C 368     161.524 156.666 138.823  1.00  0.85           O  \nATOM   2661  OD2 ASP C 368     163.164 157.886 137.976  1.00  0.85           O  \nATOM   2662  N   LEU C 369     162.700 152.779 136.287  1.00  0.88           N  \nATOM   2663  CA  LEU C 369     163.207 151.825 135.328  1.00  0.88           C  \nATOM   2664  C   LEU C 369     163.038 152.343 133.919  1.00  0.88           C  \nATOM   2665  O   LEU C 369     161.922 152.585 133.462  1.00  0.88           O  \nATOM   2666  CB  LEU C 369     162.473 150.469 135.442  1.00  0.88           C  \nATOM   2667  CG  LEU C 369     163.013 149.550 136.556  1.00  0.88           C  \nATOM   2668  CD1 LEU C 369     162.225 148.236 136.549  1.00  0.88           C  \nATOM   2669  CD2 LEU C 369     164.478 149.164 136.323  1.00  0.88           C  \nATOM   2670  N   HIS C 370     164.157 152.512 133.183  1.00  0.87           N  \nATOM   2671  CA  HIS C 370     164.140 152.978 131.809  1.00  0.87           C  \nATOM   2672  C   HIS C 370     164.741 151.917 130.926  1.00  0.87           C  \nATOM   2673  O   HIS C 370     165.880 151.506 131.136  1.00  0.87           O  \nATOM   2674  CB  HIS C 370     165.005 154.237 131.595  1.00  0.87           C  \nATOM   2675  CG  HIS C 370     164.715 155.368 132.511  1.00  0.87           C  \nATOM   2676  ND1 HIS C 370     165.586 156.430 132.430  1.00  0.87           N  \nATOM   2677  CD2 HIS C 370     163.790 155.588 133.476  1.00  0.87           C  \nATOM   2678  CE1 HIS C 370     165.185 157.274 133.348  1.00  0.87           C  \nATOM   2679  NE2 HIS C 370     164.102 156.813 134.021  1.00  0.87           N  \nATOM   2680  N   ILE C 371     164.004 151.435 129.910  1.00  0.87           N  \nATOM   2681  CA  ILE C 371     164.530 150.439 128.995  1.00  0.87           C  \nATOM   2682  C   ILE C 371     164.433 151.033 127.611  1.00  0.87           C  \nATOM   2683  O   ILE C 371     163.355 151.138 127.025  1.00  0.87           O  \nATOM   2684  CB  ILE C 371     163.802 149.094 129.096  1.00  0.87           C  \nATOM   2685  CG1 ILE C 371     163.699 148.674 130.591  1.00  0.87           C  \nATOM   2686  CG2 ILE C 371     164.565 148.060 128.224  1.00  0.87           C  \nATOM   2687  CD1 ILE C 371     162.969 147.353 130.846  1.00  0.87           C  \nATOM   2688  N   LEU C 372     165.579 151.490 127.068  1.00  0.85           N  \nATOM   2689  CA  LEU C 372     165.624 152.289 125.859  1.00  0.85           C  \nATOM   2690  C   LEU C 372     166.263 151.483 124.735  1.00  0.85           C  \nATOM   2691  O   LEU C 372     166.971 150.513 125.016  1.00  0.85           O  \nATOM   2692  CB  LEU C 372     166.455 153.584 126.081  1.00  0.85           C  \nATOM   2693  CG  LEU C 372     165.676 154.804 126.626  1.00  0.85           C  \nATOM   2694  CD1 LEU C 372     164.907 154.519 127.928  1.00  0.85           C  \nATOM   2695  CD2 LEU C 372     166.666 155.959 126.855  1.00  0.85           C  \nATOM   2696  N   PRO C 373     166.102 151.835 123.449  1.00  0.84           N  \nATOM   2697  CA  PRO C 373     166.704 151.097 122.335  1.00  0.84           C  \nATOM   2698  C   PRO C 373     168.231 151.064 122.362  1.00  0.84           C  \nATOM   2699  O   PRO C 373     168.834 150.242 121.678  1.00  0.84           O  \nATOM   2700  CB  PRO C 373     166.183 151.818 121.074  1.00  0.84           C  \nATOM   2701  CG  PRO C 373     164.881 152.501 121.514  1.00  0.84           C  \nATOM   2702  CD  PRO C 373     165.156 152.854 122.978  1.00  0.84           C  \nATOM   2703  N   VAL C 374     168.869 151.973 123.136  1.00  0.82           N  \nATOM   2704  CA  VAL C 374     170.304 152.081 123.352  1.00  0.82           C  \nATOM   2705  C   VAL C 374     170.881 150.823 123.990  1.00  0.82           C  \nATOM   2706  O   VAL C 374     171.938 150.342 123.603  1.00  0.82           O  \nATOM   2707  CB  VAL C 374     170.690 153.286 124.218  1.00  0.82           C  \nATOM   2708  CG1 VAL C 374     172.200 153.526 124.007  1.00  0.82           C  \nATOM   2709  CG2 VAL C 374     169.882 154.545 123.826  1.00  0.82           C  \nATOM   2710  N   ALA C 375     170.155 150.220 124.964  1.00  0.88           N  \nATOM   2711  CA  ALA C 375     170.584 149.028 125.671  1.00  0.88           C  \nATOM   2712  C   ALA C 375     170.803 147.845 124.729  1.00  0.88           C  \nATOM   2713  O   ALA C 375     171.796 147.135 124.816  1.00  0.88           O  \nATOM   2714  CB  ALA C 375     169.536 148.641 126.741  1.00  0.88           C  \nATOM   2715  N   PHE C 376     169.889 147.645 123.758  1.00  0.82           N  \nATOM   2716  CA  PHE C 376     169.889 146.485 122.885  1.00  0.82           C  \nATOM   2717  C   PHE C 376     170.817 146.583 121.687  1.00  0.82           C  \nATOM   2718  O   PHE C 376     171.176 145.564 121.109  1.00  0.82           O  \nATOM   2719  CB  PHE C 376     168.462 146.229 122.348  1.00  0.82           C  \nATOM   2720  CG  PHE C 376     167.570 145.901 123.507  1.00  0.82           C  \nATOM   2721  CD1 PHE C 376     167.687 144.662 124.161  1.00  0.82           C  \nATOM   2722  CD2 PHE C 376     166.624 146.831 123.962  1.00  0.82           C  \nATOM   2723  CE1 PHE C 376     166.841 144.342 125.230  1.00  0.82           C  \nATOM   2724  CE2 PHE C 376     165.765 146.507 125.014  1.00  0.82           C  \nATOM   2725  CZ  PHE C 376     165.868 145.265 125.640  1.00  0.82           C  \nATOM   2726  N   ARG C 377     171.248 147.799 121.284  1.00  0.74           N  \nATOM   2727  CA  ARG C 377     172.164 147.946 120.161  1.00  0.74           C  \nATOM   2728  C   ARG C 377     173.542 148.415 120.620  1.00  0.74           C  \nATOM   2729  O   ARG C 377     174.456 148.570 119.813  1.00  0.74           O  \nATOM   2730  CB  ARG C 377     171.538 148.837 119.040  1.00  0.74           C  \nATOM   2731  CG  ARG C 377     171.332 150.342 119.342  1.00  0.74           C  \nATOM   2732  CD  ARG C 377     172.520 151.200 118.892  1.00  0.74           C  \nATOM   2733  NE  ARG C 377     172.184 152.649 119.111  1.00  0.74           N  \nATOM   2734  CZ  ARG C 377     173.093 153.621 118.953  1.00  0.74           C  \nATOM   2735  NH1 ARG C 377     174.342 153.326 118.619  1.00  0.74           N  \nATOM   2736  NH2 ARG C 377     172.788 154.891 119.202  1.00  0.74           N  \nATOM   2737  N   GLY C 378     173.729 148.608 121.947  1.00  0.83           N  \nATOM   2738  CA  GLY C 378     174.942 149.120 122.580  1.00  0.83           C  \nATOM   2739  C   GLY C 378     175.151 150.597 122.404  1.00  0.83           C  \nATOM   2740  O   GLY C 378     174.501 151.263 121.597  1.00  0.83           O  \nATOM   2741  N   ASP C 379     176.109 151.157 123.161  1.00  0.77           N  \nATOM   2742  CA  ASP C 379     176.467 152.544 123.021  1.00  0.77           C  \nATOM   2743  C   ASP C 379     177.981 152.634 122.993  1.00  0.77           C  \nATOM   2744  O   ASP C 379     178.669 152.269 123.942  1.00  0.77           O  \nATOM   2745  CB  ASP C 379     175.869 153.403 124.167  1.00  0.77           C  \nATOM   2746  CG  ASP C 379     175.955 154.875 123.808  1.00  0.77           C  \nATOM   2747  OD1 ASP C 379     176.183 155.181 122.606  1.00  0.77           O  \nATOM   2748  OD2 ASP C 379     175.831 155.712 124.732  1.00  0.77           O  \nATOM   2749  N   SER C 380     178.562 153.120 121.885  1.00  0.66           N  \nATOM   2750  CA  SER C 380     179.997 153.284 121.766  1.00  0.66           C  \nATOM   2751  C   SER C 380     180.480 154.573 122.400  1.00  0.66           C  \nATOM   2752  O   SER C 380     181.652 154.680 122.734  1.00  0.66           O  \nATOM   2753  CB  SER C 380     180.454 153.282 120.282  1.00  0.66           C  \nATOM   2754  OG  SER C 380     179.581 154.081 119.477  1.00  0.66           O  \nATOM   2755  N   PHE C 381     179.595 155.576 122.613  1.00  0.64           N  \nATOM   2756  CA  PHE C 381     179.940 156.842 123.238  1.00  0.64           C  \nATOM   2757  C   PHE C 381     180.319 156.674 124.712  1.00  0.64           C  \nATOM   2758  O   PHE C 381     181.306 157.227 125.190  1.00  0.64           O  \nATOM   2759  CB  PHE C 381     178.735 157.815 123.073  1.00  0.64           C  \nATOM   2760  CG  PHE C 381     179.050 159.209 123.575  1.00  0.64           C  \nATOM   2761  CD1 PHE C 381     179.771 160.121 122.785  1.00  0.64           C  \nATOM   2762  CD2 PHE C 381     178.657 159.603 124.865  1.00  0.64           C  \nATOM   2763  CE1 PHE C 381     180.072 161.405 123.264  1.00  0.64           C  \nATOM   2764  CE2 PHE C 381     178.973 160.876 125.358  1.00  0.64           C  \nATOM   2765  CZ  PHE C 381     179.671 161.783 124.552  1.00  0.64           C  \nATOM   2766  N   THR C 382     179.540 155.863 125.464  1.00  0.63           N  \nATOM   2767  CA  THR C 382     179.766 155.621 126.888  1.00  0.63           C  \nATOM   2768  C   THR C 382     180.545 154.340 127.133  1.00  0.63           C  \nATOM   2769  O   THR C 382     180.792 153.973 128.278  1.00  0.63           O  \nATOM   2770  CB  THR C 382     178.472 155.593 127.720  1.00  0.63           C  \nATOM   2771  OG1 THR C 382     177.590 154.523 127.407  1.00  0.63           O  \nATOM   2772  CG2 THR C 382     177.689 156.887 127.448  1.00  0.63           C  \nATOM   2773  N   HIS C 383     180.984 153.657 126.049  1.00  0.68           N  \nATOM   2774  CA  HIS C 383     181.678 152.373 126.067  1.00  0.68           C  \nATOM   2775  C   HIS C 383     180.883 151.213 126.660  1.00  0.68           C  \nATOM   2776  O   HIS C 383     181.369 150.459 127.505  1.00  0.68           O  \nATOM   2777  CB  HIS C 383     183.088 152.455 126.704  1.00  0.68           C  \nATOM   2778  CG  HIS C 383     183.963 153.450 126.025  1.00  0.68           C  \nATOM   2779  ND1 HIS C 383     184.231 153.292 124.679  1.00  0.68           N  \nATOM   2780  CD2 HIS C 383     184.559 154.572 126.498  1.00  0.68           C  \nATOM   2781  CE1 HIS C 383     184.974 154.325 124.357  1.00  0.68           C  \nATOM   2782  NE2 HIS C 383     185.213 155.134 125.422  1.00  0.68           N  \nATOM   2783  N   THR C 384     179.632 151.015 126.202  1.00  0.78           N  \nATOM   2784  CA  THR C 384     178.681 150.044 126.742  1.00  0.78           C  \nATOM   2785  C   THR C 384     178.404 148.992 125.666  1.00  0.78           C  \nATOM   2786  O   THR C 384     177.893 149.345 124.599  1.00  0.78           O  \nATOM   2787  CB  THR C 384     177.340 150.668 127.156  1.00  0.78           C  \nATOM   2788  OG1 THR C 384     177.462 151.324 128.401  1.00  0.78           O  \nATOM   2789  CG2 THR C 384     176.212 149.660 127.411  1.00  0.78           C  \nATOM   2790  N   PRO C 385     178.707 147.696 125.847  1.00  0.84           N  \nATOM   2791  CA  PRO C 385     178.336 146.635 124.911  1.00  0.84           C  \nATOM   2792  C   PRO C 385     176.816 146.453 124.771  1.00  0.84           C  \nATOM   2793  O   PRO C 385     176.097 146.901 125.665  1.00  0.84           O  \nATOM   2794  CB  PRO C 385     179.019 145.383 125.512  1.00  0.84           C  \nATOM   2795  CG  PRO C 385     179.063 145.643 127.022  1.00  0.84           C  \nATOM   2796  CD  PRO C 385     179.233 147.161 127.101  1.00  0.84           C  \nATOM   2797  N   PRO C 386     176.277 145.845 123.712  1.00  0.84           N  \nATOM   2798  CA  PRO C 386     174.858 145.512 123.595  1.00  0.84           C  \nATOM   2799  C   PRO C 386     174.396 144.531 124.663  1.00  0.84           C  \nATOM   2800  O   PRO C 386     175.123 143.591 124.986  1.00  0.84           O  \nATOM   2801  CB  PRO C 386     174.720 144.936 122.166  1.00  0.84           C  \nATOM   2802  CG  PRO C 386     176.121 144.406 121.827  1.00  0.84           C  \nATOM   2803  CD  PRO C 386     177.049 145.374 122.564  1.00  0.84           C  \nATOM   2804  N   LEU C 387     173.208 144.762 125.251  1.00  0.82           N  \nATOM   2805  CA  LEU C 387     172.519 143.878 126.171  1.00  0.82           C  \nATOM   2806  C   LEU C 387     172.048 142.580 125.528  1.00  0.82           C  \nATOM   2807  O   LEU C 387     171.547 142.568 124.402  1.00  0.82           O  \nATOM   2808  CB  LEU C 387     171.333 144.657 126.804  1.00  0.82           C  \nATOM   2809  CG  LEU C 387     170.551 143.931 127.921  1.00  0.82           C  \nATOM   2810  CD1 LEU C 387     171.436 143.542 129.123  1.00  0.82           C  \nATOM   2811  CD2 LEU C 387     169.382 144.818 128.387  1.00  0.82           C  \nATOM   2812  N   ASP C 388     172.169 141.447 126.251  1.00  0.79           N  \nATOM   2813  CA  ASP C 388     171.670 140.168 125.817  1.00  0.79           C  \nATOM   2814  C   ASP C 388     170.164 140.123 126.178  1.00  0.79           C  \nATOM   2815  O   ASP C 388     169.813 140.389 127.332  1.00  0.79           O  \nATOM   2816  CB  ASP C 388     172.524 139.049 126.489  1.00  0.79           C  \nATOM   2817  CG  ASP C 388     172.174 137.649 126.008  1.00  0.79           C  \nATOM   2818  OD1 ASP C 388     171.162 137.501 125.274  1.00  0.79           O  \nATOM   2819  OD2 ASP C 388     172.891 136.699 126.403  1.00  0.79           O  \nATOM   2820  N   PRO C 389     169.211 139.836 125.284  1.00  0.81           N  \nATOM   2821  CA  PRO C 389     167.805 139.645 125.618  1.00  0.81           C  \nATOM   2822  C   PRO C 389     167.524 138.563 126.647  1.00  0.81           C  \nATOM   2823  O   PRO C 389     166.493 138.655 127.312  1.00  0.81           O  \nATOM   2824  CB  PRO C 389     167.156 139.254 124.279  1.00  0.81           C  \nATOM   2825  CG  PRO C 389     168.036 139.930 123.223  1.00  0.81           C  \nATOM   2826  CD  PRO C 389     169.433 139.825 123.842  1.00  0.81           C  \nATOM   2827  N   GLN C 390     168.379 137.518 126.763  1.00  0.72           N  \nATOM   2828  CA  GLN C 390     168.186 136.426 127.706  1.00  0.72           C  \nATOM   2829  C   GLN C 390     168.547 136.843 129.138  1.00  0.72           C  \nATOM   2830  O   GLN C 390     168.095 136.260 130.120  1.00  0.72           O  \nATOM   2831  CB  GLN C 390     169.008 135.172 127.277  1.00  0.72           C  \nATOM   2832  CG  GLN C 390     168.502 133.849 127.918  1.00  0.72           C  \nATOM   2833  CD  GLN C 390     167.160 133.375 127.343  1.00  0.72           C  \nATOM   2834  OE1 GLN C 390     166.620 133.830 126.340  1.00  0.72           O  \nATOM   2835  NE2 GLN C 390     166.564 132.370 128.034  1.00  0.72           N  \nATOM   2836  N   GLU C 391     169.339 137.929 129.295  1.00  0.74           N  \nATOM   2837  CA  GLU C 391     169.768 138.449 130.581  1.00  0.74           C  \nATOM   2838  C   GLU C 391     168.678 139.281 131.269  1.00  0.74           C  \nATOM   2839  O   GLU C 391     168.697 139.527 132.473  1.00  0.74           O  \nATOM   2840  CB  GLU C 391     171.064 139.279 130.401  1.00  0.74           C  \nATOM   2841  CG  GLU C 391     171.835 139.492 131.733  1.00  0.74           C  \nATOM   2842  CD  GLU C 391     173.145 140.270 131.607  1.00  0.74           C  \nATOM   2843  OE1 GLU C 391     173.489 140.721 130.486  1.00  0.74           O  \nATOM   2844  OE2 GLU C 391     173.809 140.437 132.668  1.00  0.74           O  \nATOM   2845  N   LEU C 392     167.618 139.687 130.527  1.00  0.80           N  \nATOM   2846  CA  LEU C 392     166.519 140.494 131.054  1.00  0.80           C  \nATOM   2847  C   LEU C 392     165.675 139.791 132.107  1.00  0.80           C  \nATOM   2848  O   LEU C 392     164.977 140.434 132.892  1.00  0.80           O  \nATOM   2849  CB  LEU C 392     165.584 140.994 129.928  1.00  0.80           C  \nATOM   2850  CG  LEU C 392     165.963 142.391 129.408  1.00  0.80           C  \nATOM   2851  CD1 LEU C 392     165.067 142.712 128.210  1.00  0.80           C  \nATOM   2852  CD2 LEU C 392     165.796 143.500 130.472  1.00  0.80           C  \nATOM   2853  N   ASP C 393     165.792 138.449 132.184  1.00  0.80           N  \nATOM   2854  CA  ASP C 393     165.139 137.581 133.137  1.00  0.80           C  \nATOM   2855  C   ASP C 393     165.637 137.824 134.577  1.00  0.80           C  \nATOM   2856  O   ASP C 393     165.001 137.390 135.536  1.00  0.80           O  \nATOM   2857  CB  ASP C 393     165.344 136.075 132.766  1.00  0.80           C  \nATOM   2858  CG  ASP C 393     164.690 135.633 131.463  1.00  0.80           C  \nATOM   2859  OD1 ASP C 393     164.053 136.459 130.773  1.00  0.80           O  \nATOM   2860  OD2 ASP C 393     164.678 134.395 131.215  1.00  0.80           O  \nATOM   2861  N   ILE C 394     166.749 138.591 134.768  1.00  0.78           N  \nATOM   2862  CA  ILE C 394     167.223 139.125 136.051  1.00  0.78           C  \nATOM   2863  C   ILE C 394     166.129 139.917 136.775  1.00  0.78           C  \nATOM   2864  O   ILE C 394     165.980 139.832 137.987  1.00  0.78           O  \nATOM   2865  CB  ILE C 394     168.526 139.950 135.889  1.00  0.78           C  \nATOM   2866  CG1 ILE C 394     169.707 138.970 135.610  1.00  0.78           C  \nATOM   2867  CG2 ILE C 394     168.792 140.853 137.127  1.00  0.78           C  \nATOM   2868  CD1 ILE C 394     171.106 139.613 135.553  1.00  0.78           C  \nATOM   2869  N   LEU C 395     165.264 140.649 136.037  1.00  0.81           N  \nATOM   2870  CA  LEU C 395     164.264 141.512 136.640  1.00  0.81           C  \nATOM   2871  C   LEU C 395     162.993 140.764 137.015  1.00  0.81           C  \nATOM   2872  O   LEU C 395     162.051 141.363 137.529  1.00  0.81           O  \nATOM   2873  CB  LEU C 395     163.854 142.612 135.631  1.00  0.81           C  \nATOM   2874  CG  LEU C 395     164.999 143.545 135.196  1.00  0.81           C  \nATOM   2875  CD1 LEU C 395     164.558 144.329 133.947  1.00  0.81           C  \nATOM   2876  CD2 LEU C 395     165.434 144.481 136.343  1.00  0.81           C  \nATOM   2877  N   LYS C 396     162.935 139.422 136.841  1.00  0.79           N  \nATOM   2878  CA  LYS C 396     161.769 138.626 137.182  1.00  0.79           C  \nATOM   2879  C   LYS C 396     161.461 138.613 138.670  1.00  0.79           C  \nATOM   2880  O   LYS C 396     160.348 138.367 139.082  1.00  0.79           O  \nATOM   2881  CB  LYS C 396     161.877 137.169 136.662  1.00  0.79           C  \nATOM   2882  CG  LYS C 396     161.648 137.100 135.146  1.00  0.79           C  \nATOM   2883  CD  LYS C 396     161.768 135.679 134.584  1.00  0.79           C  \nATOM   2884  CE  LYS C 396     161.608 135.655 133.061  1.00  0.79           C  \nATOM   2885  NZ  LYS C 396     161.941 134.312 132.556  1.00  0.79           N  \nATOM   2886  N   THR C 397     162.459 138.897 139.535  1.00  0.79           N  \nATOM   2887  CA  THR C 397     162.251 138.833 140.970  1.00  0.79           C  \nATOM   2888  C   THR C 397     161.611 140.105 141.510  1.00  0.79           C  \nATOM   2889  O   THR C 397     161.081 140.107 142.625  1.00  0.79           O  \nATOM   2890  CB  THR C 397     163.544 138.536 141.714  1.00  0.79           C  \nATOM   2891  OG1 THR C 397     164.502 139.557 141.517  1.00  0.79           O  \nATOM   2892  CG2 THR C 397     164.165 137.249 141.146  1.00  0.79           C  \nATOM   2893  N   VAL C 398     161.610 141.197 140.705  1.00  0.82           N  \nATOM   2894  CA  VAL C 398     161.069 142.513 141.028  1.00  0.82           C  \nATOM   2895  C   VAL C 398     159.563 142.464 141.285  1.00  0.82           C  \nATOM   2896  O   VAL C 398     158.789 141.953 140.480  1.00  0.82           O  \nATOM   2897  CB  VAL C 398     161.394 143.566 139.955  1.00  0.82           C  \nATOM   2898  CG1 VAL C 398     160.803 144.952 140.326  1.00  0.82           C  \nATOM   2899  CG2 VAL C 398     162.932 143.664 139.805  1.00  0.82           C  \nATOM   2900  N   LYS C 399     159.097 142.988 142.436  1.00  0.78           N  \nATOM   2901  CA  LYS C 399     157.699 142.980 142.812  1.00  0.78           C  \nATOM   2902  C   LYS C 399     157.162 144.385 143.037  1.00  0.78           C  \nATOM   2903  O   LYS C 399     155.953 144.611 143.074  1.00  0.78           O  \nATOM   2904  CB  LYS C 399     157.572 142.103 144.080  1.00  0.78           C  \nATOM   2905  CG  LYS C 399     157.622 140.614 143.693  1.00  0.78           C  \nATOM   2906  CD  LYS C 399     157.602 139.676 144.911  1.00  0.78           C  \nATOM   2907  CE  LYS C 399     157.006 138.289 144.638  1.00  0.78           C  \nATOM   2908  NZ  LYS C 399     157.729 137.678 143.507  1.00  0.78           N  \nATOM   2909  N   GLU C 400     158.047 145.393 143.126  1.00  0.79           N  \nATOM   2910  CA  GLU C 400     157.621 146.735 143.440  1.00  0.79           C  \nATOM   2911  C   GLU C 400     158.563 147.713 142.767  1.00  0.79           C  \nATOM   2912  O   GLU C 400     159.784 147.557 142.808  1.00  0.79           O  \nATOM   2913  CB  GLU C 400     157.572 146.924 144.993  1.00  0.79           C  \nATOM   2914  CG  GLU C 400     157.244 148.359 145.489  1.00  0.79           C  \nATOM   2915  CD  GLU C 400     157.347 148.586 146.995  1.00  0.79           C  \nATOM   2916  OE1 GLU C 400     157.021 147.696 147.814  1.00  0.79           O  \nATOM   2917  OE2 GLU C 400     157.624 149.765 147.344  1.00  0.79           O  \nATOM   2918  N   ILE C 401     158.017 148.762 142.120  1.00  0.85           N  \nATOM   2919  CA  ILE C 401     158.820 149.877 141.633  1.00  0.85           C  \nATOM   2920  C   ILE C 401     158.360 151.113 142.362  1.00  0.85           C  \nATOM   2921  O   ILE C 401     157.161 151.382 142.454  1.00  0.85           O  \nATOM   2922  CB  ILE C 401     158.716 150.124 140.129  1.00  0.85           C  \nATOM   2923  CG1 ILE C 401     158.883 148.780 139.382  1.00  0.85           C  \nATOM   2924  CG2 ILE C 401     159.774 151.184 139.721  1.00  0.85           C  \nATOM   2925  CD1 ILE C 401     158.850 148.913 137.858  1.00  0.85           C  \nATOM   2926  N   THR C 402     159.281 151.912 142.938  1.00  0.84           N  \nATOM   2927  CA  THR C 402     158.846 153.028 143.769  1.00  0.84           C  \nATOM   2928  C   THR C 402     158.627 154.335 143.000  1.00  0.84           C  \nATOM   2929  O   THR C 402     157.967 155.260 143.475  1.00  0.84           O  \nATOM   2930  CB  THR C 402     159.686 153.259 145.015  1.00  0.84           C  \nATOM   2931  OG1 THR C 402     160.995 153.719 144.742  1.00  0.84           O  \nATOM   2932  CG2 THR C 402     159.808 151.933 145.784  1.00  0.84           C  \nATOM   2933  N   GLY C 403     159.146 154.408 141.763  1.00  0.88           N  \nATOM   2934  CA  GLY C 403     159.095 155.522 140.830  1.00  0.88           C  \nATOM   2935  C   GLY C 403     158.182 155.188 139.696  1.00  0.88           C  \nATOM   2936  O   GLY C 403     157.002 154.893 139.896  1.00  0.88           O  \nATOM   2937  N   PHE C 404     158.722 155.193 138.468  1.00  0.85           N  \nATOM   2938  CA  PHE C 404     157.970 154.868 137.273  1.00  0.85           C  \nATOM   2939  C   PHE C 404     158.610 153.763 136.453  1.00  0.85           C  \nATOM   2940  O   PHE C 404     159.739 153.325 136.684  1.00  0.85           O  \nATOM   2941  CB  PHE C 404     157.706 156.123 136.385  1.00  0.85           C  \nATOM   2942  CG  PHE C 404     158.928 156.697 135.723  1.00  0.85           C  \nATOM   2943  CD1 PHE C 404     159.737 157.621 136.392  1.00  0.85           C  \nATOM   2944  CD2 PHE C 404     159.273 156.323 134.412  1.00  0.85           C  \nATOM   2945  CE1 PHE C 404     160.822 158.225 135.746  1.00  0.85           C  \nATOM   2946  CE2 PHE C 404     160.388 156.887 133.781  1.00  0.85           C  \nATOM   2947  CZ  PHE C 404     161.127 157.876 134.430  1.00  0.85           C  \nATOM   2948  N   LEU C 405     157.865 153.266 135.454  1.00  0.89           N  \nATOM   2949  CA  LEU C 405     158.336 152.270 134.529  1.00  0.89           C  \nATOM   2950  C   LEU C 405     158.184 152.766 133.101  1.00  0.89           C  \nATOM   2951  O   LEU C 405     157.086 153.063 132.627  1.00  0.89           O  \nATOM   2952  CB  LEU C 405     157.528 150.977 134.770  1.00  0.89           C  \nATOM   2953  CG  LEU C 405     157.845 149.793 133.831  1.00  0.89           C  \nATOM   2954  CD1 LEU C 405     159.331 149.375 133.845  1.00  0.89           C  \nATOM   2955  CD2 LEU C 405     156.949 148.595 134.197  1.00  0.89           C  \nATOM   2956  N   LEU C 406     159.306 152.885 132.369  1.00  0.87           N  \nATOM   2957  CA  LEU C 406     159.323 153.336 130.997  1.00  0.87           C  \nATOM   2958  C   LEU C 406     159.998 152.303 130.127  1.00  0.87           C  \nATOM   2959  O   LEU C 406     161.203 152.055 130.218  1.00  0.87           O  \nATOM   2960  CB  LEU C 406     160.093 154.672 130.920  1.00  0.87           C  \nATOM   2961  CG  LEU C 406     160.390 155.235 129.512  1.00  0.87           C  \nATOM   2962  CD1 LEU C 406     159.102 155.578 128.738  1.00  0.87           C  \nATOM   2963  CD2 LEU C 406     161.319 156.460 129.623  1.00  0.87           C  \nATOM   2964  N   ILE C 407     159.223 151.675 129.230  1.00  0.87           N  \nATOM   2965  CA  ILE C 407     159.730 150.649 128.350  1.00  0.87           C  \nATOM   2966  C   ILE C 407     159.538 151.173 126.936  1.00  0.87           C  \nATOM   2967  O   ILE C 407     158.420 151.268 126.428  1.00  0.87           O  \nATOM   2968  CB  ILE C 407     159.003 149.315 128.550  1.00  0.87           C  \nATOM   2969  CG1 ILE C 407     158.883 148.903 130.050  1.00  0.87           C  \nATOM   2970  CG2 ILE C 407     159.748 148.239 127.723  1.00  0.87           C  \nATOM   2971  CD1 ILE C 407     157.859 147.778 130.287  1.00  0.87           C  \nATOM   2972  N   GLN C 408     160.645 151.555 126.268  1.00  0.83           N  \nATOM   2973  CA  GLN C 408     160.629 152.075 124.915  1.00  0.83           C  \nATOM   2974  C   GLN C 408     161.252 151.095 123.942  1.00  0.83           C  \nATOM   2975  O   GLN C 408     161.205 151.294 122.734  1.00  0.83           O  \nATOM   2976  CB  GLN C 408     161.498 153.350 124.805  1.00  0.83           C  \nATOM   2977  CG  GLN C 408     160.847 154.626 125.389  1.00  0.83           C  \nATOM   2978  CD  GLN C 408     161.613 155.917 125.065  1.00  0.83           C  \nATOM   2979  OE1 GLN C 408     161.490 156.923 125.754  1.00  0.83           O  \nATOM   2980  NE2 GLN C 408     162.399 155.913 123.961  1.00  0.83           N  \nATOM   2981  N   ALA C 409     161.859 150.001 124.425  1.00  0.87           N  \nATOM   2982  CA  ALA C 409     162.290 148.957 123.535  1.00  0.87           C  \nATOM   2983  C   ALA C 409     162.154 147.644 124.240  1.00  0.87           C  \nATOM   2984  O   ALA C 409     162.241 147.570 125.462  1.00  0.87           O  \nATOM   2985  CB  ALA C 409     163.760 149.120 123.115  1.00  0.87           C  \nATOM   2986  N   TRP C 410     161.954 146.566 123.469  1.00  0.82           N  \nATOM   2987  CA  TRP C 410     161.896 145.238 124.006  1.00  0.82           C  \nATOM   2988  C   TRP C 410     162.493 144.349 122.927  1.00  0.82           C  \nATOM   2989  O   TRP C 410     162.417 144.751 121.763  1.00  0.82           O  \nATOM   2990  CB  TRP C 410     160.422 144.836 124.314  1.00  0.82           C  \nATOM   2991  CG  TRP C 410     160.249 143.700 125.311  1.00  0.82           C  \nATOM   2992  CD1 TRP C 410     159.766 142.431 125.155  1.00  0.82           C  \nATOM   2993  CD2 TRP C 410     160.627 143.809 126.701  1.00  0.82           C  \nATOM   2994  NE1 TRP C 410     159.796 141.746 126.362  1.00  0.82           N  \nATOM   2995  CE2 TRP C 410     160.354 142.585 127.313  1.00  0.82           C  \nATOM   2996  CE3 TRP C 410     161.167 144.876 127.416  1.00  0.82           C  \nATOM   2997  CZ2 TRP C 410     160.618 142.382 128.675  1.00  0.82           C  \nATOM   2998  CZ3 TRP C 410     161.427 144.681 128.776  1.00  0.82           C  \nATOM   2999  CH2 TRP C 410     161.161 143.462 129.402  1.00  0.82           C  \nATOM   3000  N   PRO C 411     163.117 143.199 123.195  1.00  0.81           N  \nATOM   3001  CA  PRO C 411     163.558 142.253 122.174  1.00  0.81           C  \nATOM   3002  C   PRO C 411     162.431 141.795 121.267  1.00  0.81           C  \nATOM   3003  O   PRO C 411     161.445 141.268 121.775  1.00  0.81           O  \nATOM   3004  CB  PRO C 411     164.179 141.078 122.965  1.00  0.81           C  \nATOM   3005  CG  PRO C 411     163.704 141.264 124.417  1.00  0.81           C  \nATOM   3006  CD  PRO C 411     163.509 142.773 124.532  1.00  0.81           C  \nATOM   3007  N   GLU C 412     162.577 141.948 119.935  1.00  0.71           N  \nATOM   3008  CA  GLU C 412     161.553 141.725 118.929  1.00  0.71           C  \nATOM   3009  C   GLU C 412     161.007 140.295 118.881  1.00  0.71           C  \nATOM   3010  O   GLU C 412     159.815 140.070 118.718  1.00  0.71           O  \nATOM   3011  CB  GLU C 412     162.087 142.251 117.570  1.00  0.71           C  \nATOM   3012  CG  GLU C 412     161.004 142.359 116.469  1.00  0.71           C  \nATOM   3013  CD  GLU C 412     160.833 141.081 115.653  1.00  0.71           C  \nATOM   3014  OE1 GLU C 412     161.813 140.302 115.546  1.00  0.71           O  \nATOM   3015  OE2 GLU C 412     159.717 140.909 115.104  1.00  0.71           O  \nATOM   3016  N   ASN C 413     161.888 139.299 119.146  1.00  0.70           N  \nATOM   3017  CA  ASN C 413     161.569 137.883 119.237  1.00  0.70           C  \nATOM   3018  C   ASN C 413     160.551 137.583 120.353  1.00  0.70           C  \nATOM   3019  O   ASN C 413     159.815 136.602 120.331  1.00  0.70           O  \nATOM   3020  CB  ASN C 413     162.883 137.072 119.481  1.00  0.70           C  \nATOM   3021  CG  ASN C 413     162.703 135.606 119.088  1.00  0.70           C  \nATOM   3022  OD1 ASN C 413     162.925 135.227 117.949  1.00  0.70           O  \nATOM   3023  ND2 ASN C 413     162.286 134.741 120.042  1.00  0.70           N  \nATOM   3024  N   ARG C 414     160.524 138.417 121.414  1.00  0.69           N  \nATOM   3025  CA  ARG C 414     159.590 138.274 122.508  1.00  0.69           C  \nATOM   3026  C   ARG C 414     158.259 138.965 122.250  1.00  0.69           C  \nATOM   3027  O   ARG C 414     158.168 140.061 121.714  1.00  0.69           O  \nATOM   3028  CB  ARG C 414     160.210 138.806 123.824  1.00  0.69           C  \nATOM   3029  CG  ARG C 414     161.350 137.911 124.366  1.00  0.69           C  \nATOM   3030  CD  ARG C 414     160.843 136.526 124.801  1.00  0.69           C  \nATOM   3031  NE  ARG C 414     161.903 135.836 125.616  1.00  0.69           N  \nATOM   3032  CZ  ARG C 414     161.667 134.784 126.416  1.00  0.69           C  \nATOM   3033  NH1 ARG C 414     162.669 134.195 127.064  1.00  0.69           N  \nATOM   3034  NH2 ARG C 414     160.435 134.306 126.571  1.00  0.69           N  \nATOM   3035  N   THR C 415     157.166 138.305 122.679  1.00  0.77           N  \nATOM   3036  CA  THR C 415     155.800 138.694 122.372  1.00  0.77           C  \nATOM   3037  C   THR C 415     155.096 139.136 123.643  1.00  0.77           C  \nATOM   3038  O   THR C 415     153.897 139.390 123.647  1.00  0.77           O  \nATOM   3039  CB  THR C 415     155.110 137.521 121.651  1.00  0.77           C  \nATOM   3040  OG1 THR C 415     153.793 137.795 121.213  1.00  0.77           O  \nATOM   3041  CG2 THR C 415     155.045 136.229 122.489  1.00  0.77           C  \nATOM   3042  N   ASP C 416     155.842 139.313 124.759  1.00  0.82           N  \nATOM   3043  CA  ASP C 416     155.249 139.578 126.048  1.00  0.82           C  \nATOM   3044  C   ASP C 416     156.284 140.306 126.899  1.00  0.82           C  \nATOM   3045  O   ASP C 416     157.495 140.145 126.678  1.00  0.82           O  \nATOM   3046  CB  ASP C 416     154.820 138.226 126.727  1.00  0.82           C  \nATOM   3047  CG  ASP C 416     153.598 138.369 127.620  1.00  0.82           C  \nATOM   3048  OD1 ASP C 416     153.110 139.515 127.726  1.00  0.82           O  \nATOM   3049  OD2 ASP C 416     153.155 137.353 128.226  1.00  0.82           O  \nATOM   3050  N   LEU C 417     155.863 141.109 127.900  1.00  0.85           N  \nATOM   3051  CA  LEU C 417     156.747 141.721 128.892  1.00  0.85           C  \nATOM   3052  C   LEU C 417     157.139 140.711 129.963  1.00  0.85           C  \nATOM   3053  O   LEU C 417     156.806 140.838 131.142  1.00  0.85           O  \nATOM   3054  CB  LEU C 417     156.146 142.969 129.589  1.00  0.85           C  \nATOM   3055  CG  LEU C 417     155.713 144.101 128.634  1.00  0.85           C  \nATOM   3056  CD1 LEU C 417     155.059 145.222 129.462  1.00  0.85           C  \nATOM   3057  CD2 LEU C 417     156.855 144.643 127.744  1.00  0.85           C  \nATOM   3058  N   HIS C 418     157.887 139.662 129.572  1.00  0.83           N  \nATOM   3059  CA  HIS C 418     158.128 138.471 130.372  1.00  0.83           C  \nATOM   3060  C   HIS C 418     158.893 138.693 131.672  1.00  0.83           C  \nATOM   3061  O   HIS C 418     158.748 137.949 132.629  1.00  0.83           O  \nATOM   3062  CB  HIS C 418     158.849 137.384 129.532  1.00  0.83           C  \nATOM   3063  CG  HIS C 418     160.186 137.809 129.005  1.00  0.83           C  \nATOM   3064  ND1 HIS C 418     161.248 137.769 129.871  1.00  0.83           N  \nATOM   3065  CD2 HIS C 418     160.586 138.290 127.802  1.00  0.83           C  \nATOM   3066  CE1 HIS C 418     162.282 138.220 129.199  1.00  0.83           C  \nATOM   3067  NE2 HIS C 418     161.938 138.553 127.928  1.00  0.83           N  \nATOM   3068  N   ALA C 419     159.733 139.743 131.739  1.00  0.88           N  \nATOM   3069  CA  ALA C 419     160.530 140.050 132.901  1.00  0.88           C  \nATOM   3070  C   ALA C 419     159.711 140.688 134.028  1.00  0.88           C  \nATOM   3071  O   ALA C 419     160.118 140.702 135.181  1.00  0.88           O  \nATOM   3072  CB  ALA C 419     161.685 140.979 132.472  1.00  0.88           C  \nATOM   3073  N   PHE C 420     158.501 141.203 133.724  1.00  0.84           N  \nATOM   3074  CA  PHE C 420     157.676 141.950 134.660  1.00  0.84           C  \nATOM   3075  C   PHE C 420     156.423 141.175 135.023  1.00  0.84           C  \nATOM   3076  O   PHE C 420     155.430 141.753 135.458  1.00  0.84           O  \nATOM   3077  CB  PHE C 420     157.286 143.342 134.093  1.00  0.84           C  \nATOM   3078  CG  PHE C 420     158.521 144.185 133.941  1.00  0.84           C  \nATOM   3079  CD1 PHE C 420     159.199 144.646 135.082  1.00  0.84           C  \nATOM   3080  CD2 PHE C 420     159.023 144.518 132.672  1.00  0.84           C  \nATOM   3081  CE1 PHE C 420     160.342 145.444 134.961  1.00  0.84           C  \nATOM   3082  CE2 PHE C 420     160.158 145.330 132.546  1.00  0.84           C  \nATOM   3083  CZ  PHE C 420     160.814 145.798 133.692  1.00  0.84           C  \nATOM   3084  N   GLU C 421     156.428 139.829 134.902  1.00  0.81           N  \nATOM   3085  CA  GLU C 421     155.283 138.996 135.228  1.00  0.81           C  \nATOM   3086  C   GLU C 421     154.991 138.868 136.721  1.00  0.81           C  \nATOM   3087  O   GLU C 421     153.885 138.493 137.087  1.00  0.81           O  \nATOM   3088  CB  GLU C 421     155.466 137.548 134.695  1.00  0.81           C  \nATOM   3089  CG  GLU C 421     156.808 136.867 135.083  1.00  0.81           C  \nATOM   3090  CD  GLU C 421     156.928 135.422 134.590  1.00  0.81           C  \nATOM   3091  OE1 GLU C 421     155.906 134.863 134.102  1.00  0.81           O  \nATOM   3092  OE2 GLU C 421     158.053 134.866 134.710  1.00  0.81           O  \nATOM   3093  N   ASN C 422     155.980 139.171 137.602  1.00  0.80           N  \nATOM   3094  CA  ASN C 422     155.848 139.133 139.053  1.00  0.80           C  \nATOM   3095  C   ASN C 422     155.730 140.525 139.661  1.00  0.80           C  \nATOM   3096  O   ASN C 422     155.729 140.662 140.879  1.00  0.80           O  \nATOM   3097  CB  ASN C 422     157.077 138.496 139.756  1.00  0.80           C  \nATOM   3098  CG  ASN C 422     157.278 137.061 139.318  1.00  0.80           C  \nATOM   3099  OD1 ASN C 422     156.673 136.164 139.925  1.00  0.80           O  \nATOM   3100  ND2 ASN C 422     158.160 136.815 138.338  1.00  0.80           N  \nATOM   3101  N   LEU C 423     155.644 141.575 138.826  1.00  0.83           N  \nATOM   3102  CA  LEU C 423     155.469 142.953 139.234  1.00  0.83           C  \nATOM   3103  C   LEU C 423     154.064 143.245 139.758  1.00  0.83           C  \nATOM   3104  O   LEU C 423     153.093 143.026 139.046  1.00  0.83           O  \nATOM   3105  CB  LEU C 423     155.692 143.866 138.004  1.00  0.83           C  \nATOM   3106  CG  LEU C 423     155.566 145.371 138.311  1.00  0.83           C  \nATOM   3107  CD1 LEU C 423     156.651 145.852 139.289  1.00  0.83           C  \nATOM   3108  CD2 LEU C 423     155.558 146.194 137.012  1.00  0.83           C  \nATOM   3109  N   GLU C 424     153.911 143.798 140.983  1.00  0.79           N  \nATOM   3110  CA  GLU C 424     152.611 143.960 141.605  1.00  0.79           C  \nATOM   3111  C   GLU C 424     152.249 145.430 141.793  1.00  0.79           C  \nATOM   3112  O   GLU C 424     151.113 145.838 141.538  1.00  0.79           O  \nATOM   3113  CB  GLU C 424     152.645 143.221 142.967  1.00  0.79           C  \nATOM   3114  CG  GLU C 424     152.698 141.679 142.764  1.00  0.79           C  \nATOM   3115  CD  GLU C 424     152.773 140.854 144.047  1.00  0.79           C  \nATOM   3116  OE1 GLU C 424     153.336 141.346 145.057  1.00  0.79           O  \nATOM   3117  OE2 GLU C 424     152.305 139.684 144.000  1.00  0.79           O  \nATOM   3118  N   ILE C 425     153.216 146.281 142.201  1.00  0.81           N  \nATOM   3119  CA  ILE C 425     152.959 147.670 142.571  1.00  0.81           C  \nATOM   3120  C   ILE C 425     153.870 148.613 141.808  1.00  0.81           C  \nATOM   3121  O   ILE C 425     155.079 148.396 141.689  1.00  0.81           O  \nATOM   3122  CB  ILE C 425     153.164 147.925 144.075  1.00  0.81           C  \nATOM   3123  CG1 ILE C 425     152.433 146.884 144.973  1.00  0.81           C  \nATOM   3124  CG2 ILE C 425     152.769 149.377 144.460  1.00  0.81           C  \nATOM   3125  CD1 ILE C 425     150.899 146.927 144.910  1.00  0.81           C  \nATOM   3126  N   ILE C 426     153.312 149.732 141.304  1.00  0.85           N  \nATOM   3127  CA  ILE C 426     154.093 150.880 140.873  1.00  0.85           C  \nATOM   3128  C   ILE C 426     153.668 152.030 141.767  1.00  0.85           C  \nATOM   3129  O   ILE C 426     152.512 152.449 141.768  1.00  0.85           O  \nATOM   3130  CB  ILE C 426     153.930 151.221 139.386  1.00  0.85           C  \nATOM   3131  CG1 ILE C 426     154.360 149.987 138.537  1.00  0.85           C  \nATOM   3132  CG2 ILE C 426     154.737 152.510 139.054  1.00  0.85           C  \nATOM   3133  CD1 ILE C 426     154.332 150.211 137.017  1.00  0.85           C  \nATOM   3134  N   ARG C 427     154.582 152.554 142.613  1.00  0.78           N  \nATOM   3135  CA  ARG C 427     154.250 153.607 143.564  1.00  0.78           C  \nATOM   3136  C   ARG C 427     154.109 155.018 142.995  1.00  0.78           C  \nATOM   3137  O   ARG C 427     153.468 155.856 143.621  1.00  0.78           O  \nATOM   3138  CB  ARG C 427     155.293 153.728 144.694  1.00  0.78           C  \nATOM   3139  CG  ARG C 427     155.293 152.530 145.659  1.00  0.78           C  \nATOM   3140  CD  ARG C 427     154.382 152.787 146.874  1.00  0.78           C  \nATOM   3141  NE  ARG C 427     153.657 151.534 147.265  1.00  0.78           N  \nATOM   3142  CZ  ARG C 427     154.162 150.542 148.008  1.00  0.78           C  \nATOM   3143  NH1 ARG C 427     155.405 150.534 148.442  1.00  0.78           N  \nATOM   3144  NH2 ARG C 427     153.417 149.467 148.249  1.00  0.78           N  \nATOM   3145  N   GLY C 428     154.723 155.343 141.835  1.00  0.87           N  \nATOM   3146  CA  GLY C 428     154.527 156.621 141.151  1.00  0.87           C  \nATOM   3147  C   GLY C 428     155.055 157.858 141.848  1.00  0.87           C  \nATOM   3148  O   GLY C 428     154.575 158.968 141.613  1.00  0.87           O  \nATOM   3149  N   ARG C 429     156.069 157.723 142.735  1.00  0.76           N  \nATOM   3150  CA  ARG C 429     156.621 158.846 143.487  1.00  0.76           C  \nATOM   3151  C   ARG C 429     157.336 159.850 142.593  1.00  0.76           C  \nATOM   3152  O   ARG C 429     157.170 161.063 142.713  1.00  0.76           O  \nATOM   3153  CB  ARG C 429     157.589 158.371 144.607  1.00  0.76           C  \nATOM   3154  CG  ARG C 429     156.865 157.628 145.757  1.00  0.76           C  \nATOM   3155  CD  ARG C 429     157.828 156.935 146.742  1.00  0.76           C  \nATOM   3156  NE  ARG C 429     157.042 156.080 147.709  1.00  0.76           N  \nATOM   3157  CZ  ARG C 429     157.537 155.015 148.366  1.00  0.76           C  \nATOM   3158  NH1 ARG C 429     158.814 154.685 148.367  1.00  0.76           N  \nATOM   3159  NH2 ARG C 429     156.740 154.285 149.142  1.00  0.76           N  \nATOM   3160  N   THR C 430     158.133 159.340 141.643  1.00  0.81           N  \nATOM   3161  CA  THR C 430     158.792 160.089 140.599  1.00  0.81           C  \nATOM   3162  C   THR C 430     158.060 159.656 139.355  1.00  0.81           C  \nATOM   3163  O   THR C 430     157.624 158.518 139.243  1.00  0.81           O  \nATOM   3164  CB  THR C 430     160.313 159.859 140.553  1.00  0.81           C  \nATOM   3165  OG1 THR C 430     160.627 158.482 140.637  1.00  0.81           O  \nATOM   3166  CG2 THR C 430     160.903 160.518 141.818  1.00  0.81           C  \nATOM   3167  N   LYS C 431     157.785 160.593 138.428  1.00  0.78           N  \nATOM   3168  CA  LYS C 431     157.036 160.303 137.227  1.00  0.78           C  \nATOM   3169  C   LYS C 431     157.703 160.943 136.028  1.00  0.78           C  \nATOM   3170  O   LYS C 431     158.326 162.003 136.121  1.00  0.78           O  \nATOM   3171  CB  LYS C 431     155.586 160.847 137.321  1.00  0.78           C  \nATOM   3172  CG  LYS C 431     154.764 160.247 138.477  1.00  0.78           C  \nATOM   3173  CD  LYS C 431     153.345 160.843 138.579  1.00  0.78           C  \nATOM   3174  CE  LYS C 431     153.220 162.170 139.340  1.00  0.78           C  \nATOM   3175  NZ  LYS C 431     153.364 161.933 140.770  1.00  0.78           N  \nATOM   3176  N   GLN C 432     157.549 160.314 134.849  1.00  0.77           N  \nATOM   3177  CA  GLN C 432     158.135 160.749 133.598  1.00  0.77           C  \nATOM   3178  C   GLN C 432     157.387 161.967 133.106  1.00  0.77           C  \nATOM   3179  O   GLN C 432     156.155 161.987 133.064  1.00  0.77           O  \nATOM   3180  CB  GLN C 432     158.076 159.622 132.534  1.00  0.77           C  \nATOM   3181  CG  GLN C 432     158.529 160.002 131.093  1.00  0.77           C  \nATOM   3182  CD  GLN C 432     160.051 160.124 130.949  1.00  0.77           C  \nATOM   3183  OE1 GLN C 432     160.794 160.378 131.887  1.00  0.77           O  \nATOM   3184  NE2 GLN C 432     160.536 159.934 129.696  1.00  0.77           N  \nATOM   3185  N   HIS C 433     158.137 163.054 132.822  1.00  0.75           N  \nATOM   3186  CA  HIS C 433     157.626 164.378 132.485  1.00  0.75           C  \nATOM   3187  C   HIS C 433     156.787 164.983 133.603  1.00  0.75           C  \nATOM   3188  O   HIS C 433     156.029 165.913 133.387  1.00  0.75           O  \nATOM   3189  CB  HIS C 433     156.841 164.415 131.147  1.00  0.75           C  \nATOM   3190  CG  HIS C 433     157.619 163.819 130.017  1.00  0.75           C  \nATOM   3191  ND1 HIS C 433     156.928 163.150 129.027  1.00  0.75           N  \nATOM   3192  CD2 HIS C 433     158.946 163.845 129.727  1.00  0.75           C  \nATOM   3193  CE1 HIS C 433     157.839 162.784 128.157  1.00  0.75           C  \nATOM   3194  NE2 HIS C 433     159.084 163.176 128.529  1.00  0.75           N  \nATOM   3195  N   GLY C 434     156.902 164.437 134.837  1.00  0.79           N  \nATOM   3196  CA  GLY C 434     156.084 164.773 135.992  1.00  0.79           C  \nATOM   3197  C   GLY C 434     154.692 164.168 135.995  1.00  0.79           C  \nATOM   3198  O   GLY C 434     153.962 164.350 136.963  1.00  0.79           O  \nATOM   3199  N   GLN C 435     154.302 163.385 134.959  1.00  0.78           N  \nATOM   3200  CA  GLN C 435     152.925 162.938 134.780  1.00  0.78           C  \nATOM   3201  C   GLN C 435     152.751 161.423 134.667  1.00  0.78           C  \nATOM   3202  O   GLN C 435     151.894 160.843 135.325  1.00  0.78           O  \nATOM   3203  CB  GLN C 435     152.323 163.562 133.494  1.00  0.78           C  \nATOM   3204  CG  GLN C 435     150.773 163.533 133.500  1.00  0.78           C  \nATOM   3205  CD  GLN C 435     150.153 164.079 132.214  1.00  0.78           C  \nATOM   3206  OE1 GLN C 435     150.757 164.203 131.152  1.00  0.78           O  \nATOM   3207  NE2 GLN C 435     148.845 164.403 132.303  1.00  0.78           N  \nATOM   3208  N   PHE C 436     153.566 160.716 133.854  1.00  0.83           N  \nATOM   3209  CA  PHE C 436     153.308 159.311 133.537  1.00  0.83           C  \nATOM   3210  C   PHE C 436     154.063 158.361 134.453  1.00  0.83           C  \nATOM   3211  O   PHE C 436     155.253 158.552 134.699  1.00  0.83           O  \nATOM   3212  CB  PHE C 436     153.713 158.963 132.079  1.00  0.83           C  \nATOM   3213  CG  PHE C 436     152.846 159.722 131.115  1.00  0.83           C  \nATOM   3214  CD1 PHE C 436     151.579 159.228 130.766  1.00  0.83           C  \nATOM   3215  CD2 PHE C 436     153.271 160.946 130.571  1.00  0.83           C  \nATOM   3216  CE1 PHE C 436     150.760 159.925 129.868  1.00  0.83           C  \nATOM   3217  CE2 PHE C 436     152.451 161.653 129.683  1.00  0.83           C  \nATOM   3218  CZ  PHE C 436     151.199 161.138 129.323  1.00  0.83           C  \nATOM   3219  N   SER C 437     153.416 157.294 134.983  1.00  0.87           N  \nATOM   3220  CA  SER C 437     154.120 156.339 135.834  1.00  0.87           C  \nATOM   3221  C   SER C 437     154.334 154.991 135.167  1.00  0.87           C  \nATOM   3222  O   SER C 437     155.238 154.240 135.518  1.00  0.87           O  \nATOM   3223  CB  SER C 437     153.498 156.216 137.246  1.00  0.87           C  \nATOM   3224  OG  SER C 437     152.296 155.457 137.268  1.00  0.87           O  \nATOM   3225  N   LEU C 438     153.568 154.676 134.117  1.00  0.89           N  \nATOM   3226  CA  LEU C 438     153.777 153.489 133.324  1.00  0.89           C  \nATOM   3227  C   LEU C 438     153.660 153.914 131.883  1.00  0.89           C  \nATOM   3228  O   LEU C 438     152.673 154.524 131.466  1.00  0.89           O  \nATOM   3229  CB  LEU C 438     152.745 152.391 133.700  1.00  0.89           C  \nATOM   3230  CG  LEU C 438     152.638 151.165 132.760  1.00  0.89           C  \nATOM   3231  CD1 LEU C 438     153.907 150.295 132.826  1.00  0.89           C  \nATOM   3232  CD2 LEU C 438     151.373 150.339 133.081  1.00  0.89           C  \nATOM   3233  N   ALA C 439     154.704 153.633 131.090  1.00  0.91           N  \nATOM   3234  CA  ALA C 439     154.709 153.951 129.690  1.00  0.91           C  \nATOM   3235  C   ALA C 439     155.255 152.797 128.873  1.00  0.91           C  \nATOM   3236  O   ALA C 439     156.386 152.348 129.075  1.00  0.91           O  \nATOM   3237  CB  ALA C 439     155.529 155.236 129.469  1.00  0.91           C  \nATOM   3238  N   VAL C 440     154.440 152.289 127.926  1.00  0.87           N  \nATOM   3239  CA  VAL C 440     154.837 151.240 127.001  1.00  0.87           C  \nATOM   3240  C   VAL C 440     154.518 151.732 125.610  1.00  0.87           C  \nATOM   3241  O   VAL C 440     153.354 151.832 125.214  1.00  0.87           O  \nATOM   3242  CB  VAL C 440     154.110 149.914 127.248  1.00  0.87           C  \nATOM   3243  CG1 VAL C 440     154.639 148.841 126.268  1.00  0.87           C  \nATOM   3244  CG2 VAL C 440     154.335 149.469 128.712  1.00  0.87           C  \nATOM   3245  N   VAL C 441     155.549 152.074 124.823  1.00  0.83           N  \nATOM   3246  CA  VAL C 441     155.354 152.776 123.576  1.00  0.83           C  \nATOM   3247  C   VAL C 441     156.238 152.170 122.513  1.00  0.83           C  \nATOM   3248  O   VAL C 441     157.405 151.864 122.746  1.00  0.83           O  \nATOM   3249  CB  VAL C 441     155.608 154.293 123.674  1.00  0.83           C  \nATOM   3250  CG1 VAL C 441     154.447 154.979 124.437  1.00  0.83           C  \nATOM   3251  CG2 VAL C 441     156.974 154.610 124.337  1.00  0.83           C  \nATOM   3252  N   SER C 442     155.666 151.972 121.308  1.00  0.81           N  \nATOM   3253  CA  SER C 442     156.386 151.613 120.089  1.00  0.81           C  \nATOM   3254  C   SER C 442     157.061 150.248 120.093  1.00  0.81           C  \nATOM   3255  O   SER C 442     158.162 150.085 119.567  1.00  0.81           O  \nATOM   3256  CB  SER C 442     157.407 152.697 119.645  1.00  0.81           C  \nATOM   3257  OG  SER C 442     156.763 153.967 119.522  1.00  0.81           O  \nATOM   3258  N   LEU C 443     156.402 149.213 120.654  1.00  0.81           N  \nATOM   3259  CA  LEU C 443     156.928 147.866 120.783  1.00  0.81           C  \nATOM   3260  C   LEU C 443     156.199 146.896 119.872  1.00  0.81           C  \nATOM   3261  O   LEU C 443     155.117 147.173 119.354  1.00  0.81           O  \nATOM   3262  CB  LEU C 443     156.805 147.326 122.235  1.00  0.81           C  \nATOM   3263  CG  LEU C 443     157.449 148.210 123.323  1.00  0.81           C  \nATOM   3264  CD1 LEU C 443     157.464 147.450 124.661  1.00  0.81           C  \nATOM   3265  CD2 LEU C 443     158.877 148.663 122.993  1.00  0.81           C  \nATOM   3266  N   ASN C 444     156.793 145.699 119.670  1.00  0.76           N  \nATOM   3267  CA  ASN C 444     156.280 144.671 118.786  1.00  0.76           C  \nATOM   3268  C   ASN C 444     155.508 143.588 119.552  1.00  0.76           C  \nATOM   3269  O   ASN C 444     155.086 142.582 119.002  1.00  0.76           O  \nATOM   3270  CB  ASN C 444     157.493 144.021 118.059  1.00  0.76           C  \nATOM   3271  CG  ASN C 444     157.045 143.469 116.715  1.00  0.76           C  \nATOM   3272  OD1 ASN C 444     156.428 144.207 115.951  1.00  0.76           O  \nATOM   3273  ND2 ASN C 444     157.397 142.216 116.375  1.00  0.76           N  \nATOM   3274  N   ILE C 445     155.316 143.761 120.878  1.00  0.78           N  \nATOM   3275  CA  ILE C 445     154.589 142.817 121.722  1.00  0.78           C  \nATOM   3276  C   ILE C 445     153.122 142.613 121.340  1.00  0.78           C  \nATOM   3277  O   ILE C 445     152.430 143.548 120.938  1.00  0.78           O  \nATOM   3278  CB  ILE C 445     154.671 143.195 123.205  1.00  0.78           C  \nATOM   3279  CG1 ILE C 445     154.040 144.597 123.482  1.00  0.78           C  \nATOM   3280  CG2 ILE C 445     156.145 143.037 123.664  1.00  0.78           C  \nATOM   3281  CD1 ILE C 445     154.032 145.010 124.960  1.00  0.78           C  \nATOM   3282  N   THR C 446     152.591 141.377 121.466  1.00  0.79           N  \nATOM   3283  CA  THR C 446     151.208 141.075 121.086  1.00  0.79           C  \nATOM   3284  C   THR C 446     150.293 141.170 122.292  1.00  0.79           C  \nATOM   3285  O   THR C 446     149.094 141.444 122.191  1.00  0.79           O  \nATOM   3286  CB  THR C 446     151.069 139.673 120.512  1.00  0.79           C  \nATOM   3287  OG1 THR C 446     151.851 139.566 119.340  1.00  0.79           O  \nATOM   3288  CG2 THR C 446     149.653 139.360 120.018  1.00  0.79           C  \nATOM   3289  N   SER C 447     150.846 141.000 123.501  1.00  0.83           N  \nATOM   3290  CA  SER C 447     150.103 141.110 124.733  1.00  0.83           C  \nATOM   3291  C   SER C 447     151.006 141.810 125.732  1.00  0.83           C  \nATOM   3292  O   SER C 447     152.207 141.934 125.526  1.00  0.83           O  \nATOM   3293  CB  SER C 447     149.489 139.751 125.225  1.00  0.83           C  \nATOM   3294  OG  SER C 447     150.291 138.611 124.930  1.00  0.83           O  \nATOM   3295  N   LEU C 448     150.415 142.430 126.778  1.00  0.85           N  \nATOM   3296  CA  LEU C 448     151.149 143.103 127.838  1.00  0.85           C  \nATOM   3297  C   LEU C 448     151.687 142.182 128.908  1.00  0.85           C  \nATOM   3298  O   LEU C 448     152.802 142.362 129.380  1.00  0.85           O  \nATOM   3299  CB  LEU C 448     150.220 144.102 128.569  1.00  0.85           C  \nATOM   3300  CG  LEU C 448     150.338 145.528 128.019  1.00  0.85           C  \nATOM   3301  CD1 LEU C 448     149.146 146.350 128.516  1.00  0.85           C  \nATOM   3302  CD2 LEU C 448     151.680 146.185 128.416  1.00  0.85           C  \nATOM   3303  N   GLY C 449     150.846 141.233 129.371  1.00  0.87           N  \nATOM   3304  CA  GLY C 449     151.259 140.113 130.208  1.00  0.87           C  \nATOM   3305  C   GLY C 449     151.710 140.399 131.613  1.00  0.87           C  \nATOM   3306  O   GLY C 449     152.302 139.546 132.272  1.00  0.87           O  \nATOM   3307  N   LEU C 450     151.373 141.585 132.156  1.00  0.85           N  \nATOM   3308  CA  LEU C 450     151.666 141.992 133.521  1.00  0.85           C  \nATOM   3309  C   LEU C 450     150.626 141.370 134.446  1.00  0.85           C  \nATOM   3310  O   LEU C 450     149.897 142.059 135.155  1.00  0.85           O  \nATOM   3311  CB  LEU C 450     151.601 143.534 133.709  1.00  0.85           C  \nATOM   3312  CG  LEU C 450     152.482 144.358 132.751  1.00  0.85           C  \nATOM   3313  CD1 LEU C 450     151.998 145.821 132.745  1.00  0.85           C  \nATOM   3314  CD2 LEU C 450     153.973 144.247 133.121  1.00  0.85           C  \nATOM   3315  N   ARG C 451     150.513 140.031 134.437  1.00  0.76           N  \nATOM   3316  CA  ARG C 451     149.410 139.262 134.986  1.00  0.76           C  \nATOM   3317  C   ARG C 451     149.221 139.339 136.499  1.00  0.76           C  \nATOM   3318  O   ARG C 451     148.163 139.000 137.023  1.00  0.76           O  \nATOM   3319  CB  ARG C 451     149.557 137.773 134.541  1.00  0.76           C  \nATOM   3320  CG  ARG C 451     150.902 137.097 134.942  1.00  0.76           C  \nATOM   3321  CD  ARG C 451     151.135 135.645 134.463  1.00  0.76           C  \nATOM   3322  NE  ARG C 451     150.894 135.561 132.971  1.00  0.76           N  \nATOM   3323  CZ  ARG C 451     151.736 135.784 131.950  1.00  0.76           C  \nATOM   3324  NH1 ARG C 451     153.041 135.954 132.092  1.00  0.76           N  \nATOM   3325  NH2 ARG C 451     151.198 135.892 130.734  1.00  0.76           N  \nATOM   3326  N   SER C 452     150.236 139.805 137.249  1.00  0.81           N  \nATOM   3327  CA  SER C 452     150.143 139.962 138.682  1.00  0.81           C  \nATOM   3328  C   SER C 452     150.068 141.420 139.073  1.00  0.81           C  \nATOM   3329  O   SER C 452     149.931 141.696 140.253  1.00  0.81           O  \nATOM   3330  CB  SER C 452     151.286 139.203 139.416  1.00  0.81           C  \nATOM   3331  OG  SER C 452     152.549 139.840 139.281  1.00  0.81           O  \nATOM   3332  N   LEU C 453     150.061 142.399 138.127  1.00  0.81           N  \nATOM   3333  CA  LEU C 453     149.957 143.817 138.458  1.00  0.81           C  \nATOM   3334  C   LEU C 453     148.655 144.123 139.209  1.00  0.81           C  \nATOM   3335  O   LEU C 453     147.569 143.676 138.829  1.00  0.81           O  \nATOM   3336  CB  LEU C 453     150.109 144.718 137.195  1.00  0.81           C  \nATOM   3337  CG  LEU C 453     150.199 146.244 137.460  1.00  0.81           C  \nATOM   3338  CD1 LEU C 453     151.505 146.649 138.182  1.00  0.81           C  \nATOM   3339  CD2 LEU C 453     150.054 147.015 136.135  1.00  0.81           C  \nATOM   3340  N   LYS C 454     148.732 144.857 140.339  1.00  0.77           N  \nATOM   3341  CA  LYS C 454     147.590 145.070 141.210  1.00  0.77           C  \nATOM   3342  C   LYS C 454     147.305 146.520 141.481  1.00  0.77           C  \nATOM   3343  O   LYS C 454     146.153 146.869 141.723  1.00  0.77           O  \nATOM   3344  CB  LYS C 454     147.855 144.424 142.597  1.00  0.77           C  \nATOM   3345  CG  LYS C 454     147.937 142.890 142.570  1.00  0.77           C  \nATOM   3346  CD  LYS C 454     146.642 142.200 142.102  1.00  0.77           C  \nATOM   3347  CE  LYS C 454     146.788 140.680 141.954  1.00  0.77           C  \nATOM   3348  NZ  LYS C 454     145.549 140.120 141.364  1.00  0.77           N  \nATOM   3349  N   GLU C 455     148.315 147.402 141.450  1.00  0.78           N  \nATOM   3350  CA  GLU C 455     148.068 148.779 141.798  1.00  0.78           C  \nATOM   3351  C   GLU C 455     149.049 149.687 141.099  1.00  0.78           C  \nATOM   3352  O   GLU C 455     150.223 149.352 140.905  1.00  0.78           O  \nATOM   3353  CB  GLU C 455     148.238 148.963 143.324  1.00  0.78           C  \nATOM   3354  CG  GLU C 455     147.607 150.256 143.906  1.00  0.78           C  \nATOM   3355  CD  GLU C 455     148.137 150.653 145.287  1.00  0.78           C  \nATOM   3356  OE1 GLU C 455     149.268 150.238 145.659  1.00  0.78           O  \nATOM   3357  OE2 GLU C 455     147.400 151.410 145.977  1.00  0.78           O  \nATOM   3358  N   ILE C 456     148.586 150.882 140.713  1.00  0.83           N  \nATOM   3359  CA  ILE C 456     149.420 151.962 140.258  1.00  0.83           C  \nATOM   3360  C   ILE C 456     149.006 153.099 141.161  1.00  0.83           C  \nATOM   3361  O   ILE C 456     147.889 153.617 141.121  1.00  0.83           O  \nATOM   3362  CB  ILE C 456     149.249 152.266 138.768  1.00  0.83           C  \nATOM   3363  CG1 ILE C 456     149.628 151.010 137.926  1.00  0.83           C  \nATOM   3364  CG2 ILE C 456     150.096 153.508 138.391  1.00  0.83           C  \nATOM   3365  CD1 ILE C 456     149.308 151.136 136.429  1.00  0.83           C  \nATOM   3366  N   SER C 457     149.896 153.465 142.091  1.00  0.84           N  \nATOM   3367  CA  SER C 457     149.574 154.392 143.157  1.00  0.84           C  \nATOM   3368  C   SER C 457     149.435 155.827 142.731  1.00  0.84           C  \nATOM   3369  O   SER C 457     148.634 156.542 143.310  1.00  0.84           O  \nATOM   3370  CB  SER C 457     150.589 154.389 144.311  1.00  0.84           C  \nATOM   3371  OG  SER C 457     150.536 153.163 145.024  1.00  0.84           O  \nATOM   3372  N   ASP C 458     150.203 156.293 141.731  1.00  0.83           N  \nATOM   3373  CA  ASP C 458     150.106 157.653 141.271  1.00  0.83           C  \nATOM   3374  C   ASP C 458     150.578 157.677 139.833  1.00  0.83           C  \nATOM   3375  O   ASP C 458     151.303 156.786 139.392  1.00  0.83           O  \nATOM   3376  CB  ASP C 458     150.937 158.626 142.132  1.00  0.83           C  \nATOM   3377  CG  ASP C 458     150.490 160.016 141.830  1.00  0.83           C  \nATOM   3378  OD1 ASP C 458     149.336 160.333 141.495  1.00  0.83           O  \nATOM   3379  OD2 ASP C 458     151.331 160.915 141.986  1.00  0.83           O  \nATOM   3380  N   GLY C 459     150.188 158.736 139.103  1.00  0.86           N  \nATOM   3381  CA  GLY C 459     150.518 159.006 137.712  1.00  0.86           C  \nATOM   3382  C   GLY C 459     149.715 158.323 136.659  1.00  0.86           C  \nATOM   3383  O   GLY C 459     149.050 157.314 136.867  1.00  0.86           O  \nATOM   3384  N   ASP C 460     149.804 158.886 135.447  1.00  0.83           N  \nATOM   3385  CA  ASP C 460     149.056 158.430 134.306  1.00  0.83           C  \nATOM   3386  C   ASP C 460     149.699 157.227 133.630  1.00  0.83           C  \nATOM   3387  O   ASP C 460     150.866 156.881 133.830  1.00  0.83           O  \nATOM   3388  CB  ASP C 460     148.876 159.547 133.236  1.00  0.83           C  \nATOM   3389  CG  ASP C 460     148.033 160.736 133.672  1.00  0.83           C  \nATOM   3390  OD1 ASP C 460     147.512 160.753 134.810  1.00  0.83           O  \nATOM   3391  OD2 ASP C 460     147.856 161.636 132.804  1.00  0.83           O  \nATOM   3392  N   VAL C 461     148.912 156.555 132.779  1.00  0.86           N  \nATOM   3393  CA  VAL C 461     149.306 155.371 132.044  1.00  0.86           C  \nATOM   3394  C   VAL C 461     149.229 155.683 130.568  1.00  0.86           C  \nATOM   3395  O   VAL C 461     148.224 156.183 130.064  1.00  0.86           O  \nATOM   3396  CB  VAL C 461     148.427 154.168 132.420  1.00  0.86           C  \nATOM   3397  CG1 VAL C 461     148.584 152.973 131.446  1.00  0.86           C  \nATOM   3398  CG2 VAL C 461     148.829 153.744 133.850  1.00  0.86           C  \nATOM   3399  N   ILE C 462     150.310 155.403 129.814  1.00  0.84           N  \nATOM   3400  CA  ILE C 462     150.304 155.527 128.365  1.00  0.84           C  \nATOM   3401  C   ILE C 462     150.750 154.231 127.733  1.00  0.84           C  \nATOM   3402  O   ILE C 462     151.839 153.715 127.985  1.00  0.84           O  \nATOM   3403  CB  ILE C 462     151.105 156.724 127.828  1.00  0.84           C  \nATOM   3404  CG1 ILE C 462     151.157 156.721 126.273  1.00  0.84           C  \nATOM   3405  CG2 ILE C 462     152.514 156.790 128.470  1.00  0.84           C  \nATOM   3406  CD1 ILE C 462     151.681 158.020 125.639  1.00  0.84           C  \nATOM   3407  N   ILE C 463     149.887 153.632 126.891  1.00  0.82           N  \nATOM   3408  CA  ILE C 463     150.222 152.389 126.222  1.00  0.82           C  \nATOM   3409  C   ILE C 463     149.770 152.550 124.792  1.00  0.82           C  \nATOM   3410  O   ILE C 463     148.620 152.283 124.441  1.00  0.82           O  \nATOM   3411  CB  ILE C 463     149.619 151.144 126.888  1.00  0.82           C  \nATOM   3412  CG1 ILE C 463     150.037 151.072 128.388  1.00  0.82           C  \nATOM   3413  CG2 ILE C 463     150.040 149.878 126.089  1.00  0.82           C  \nATOM   3414  CD1 ILE C 463     149.231 150.070 129.219  1.00  0.82           C  \nATOM   3415  N   SER C 464     150.661 153.040 123.918  1.00  0.80           N  \nATOM   3416  CA  SER C 464     150.278 153.451 122.581  1.00  0.80           C  \nATOM   3417  C   SER C 464     151.411 153.279 121.599  1.00  0.80           C  \nATOM   3418  O   SER C 464     152.587 153.354 121.939  1.00  0.80           O  \nATOM   3419  CB  SER C 464     149.734 154.908 122.542  1.00  0.80           C  \nATOM   3420  OG  SER C 464     150.578 155.849 123.198  1.00  0.80           O  \nATOM   3421  N   GLY C 465     151.092 152.991 120.321  1.00  0.80           N  \nATOM   3422  CA  GLY C 465     152.095 152.843 119.270  1.00  0.80           C  \nATOM   3423  C   GLY C 465     152.547 151.426 119.063  1.00  0.80           C  \nATOM   3424  O   GLY C 465     153.386 151.147 118.213  1.00  0.80           O  \nATOM   3425  N   ASN C 466     151.993 150.470 119.828  1.00  0.78           N  \nATOM   3426  CA  ASN C 466     152.405 149.084 119.760  1.00  0.78           C  \nATOM   3427  C   ASN C 466     151.523 148.384 118.746  1.00  0.78           C  \nATOM   3428  O   ASN C 466     150.366 148.099 119.032  1.00  0.78           O  \nATOM   3429  CB  ASN C 466     152.209 148.360 121.116  1.00  0.78           C  \nATOM   3430  CG  ASN C 466     152.853 149.164 122.232  1.00  0.78           C  \nATOM   3431  OD1 ASN C 466     154.065 149.133 122.419  1.00  0.78           O  \nATOM   3432  ND2 ASN C 466     152.031 149.932 122.987  1.00  0.78           N  \nATOM   3433  N   LYS C 467     152.035 148.088 117.534  1.00  0.72           N  \nATOM   3434  CA  LYS C 467     151.218 147.768 116.368  1.00  0.72           C  \nATOM   3435  C   LYS C 467     150.511 146.419 116.385  1.00  0.72           C  \nATOM   3436  O   LYS C 467     149.642 146.142 115.557  1.00  0.72           O  \nATOM   3437  CB  LYS C 467     152.077 147.836 115.070  1.00  0.72           C  \nATOM   3438  CG  LYS C 467     152.689 149.225 114.775  1.00  0.72           C  \nATOM   3439  CD  LYS C 467     151.652 150.364 114.611  1.00  0.72           C  \nATOM   3440  CE  LYS C 467     150.754 150.288 113.366  1.00  0.72           C  \nATOM   3441  NZ  LYS C 467     151.555 150.695 112.192  1.00  0.72           N  \nATOM   3442  N   ASN C 468     150.891 145.522 117.310  1.00  0.75           N  \nATOM   3443  CA  ASN C 468     150.282 144.214 117.434  1.00  0.75           C  \nATOM   3444  C   ASN C 468     149.477 144.060 118.700  1.00  0.75           C  \nATOM   3445  O   ASN C 468     148.465 143.354 118.673  1.00  0.75           O  \nATOM   3446  CB  ASN C 468     151.355 143.109 117.401  1.00  0.75           C  \nATOM   3447  CG  ASN C 468     152.154 143.200 116.107  1.00  0.75           C  \nATOM   3448  OD1 ASN C 468     153.366 143.128 116.116  1.00  0.75           O  \nATOM   3449  ND2 ASN C 468     151.491 143.406 114.942  1.00  0.75           N  \nATOM   3450  N   LEU C 469     149.877 144.730 119.802  1.00  0.78           N  \nATOM   3451  CA  LEU C 469     149.222 144.668 121.093  1.00  0.78           C  \nATOM   3452  C   LEU C 469     147.785 145.137 121.036  1.00  0.78           C  \nATOM   3453  O   LEU C 469     147.486 146.260 120.671  1.00  0.78           O  \nATOM   3454  CB  LEU C 469     150.040 145.452 122.169  1.00  0.78           C  \nATOM   3455  CG  LEU C 469     149.355 145.844 123.507  1.00  0.78           C  \nATOM   3456  CD1 LEU C 469     148.989 144.611 124.349  1.00  0.78           C  \nATOM   3457  CD2 LEU C 469     150.258 146.793 124.322  1.00  0.78           C  \nATOM   3458  N   CYS C 470     146.827 144.276 121.403  1.00  0.69           N  \nATOM   3459  CA  CYS C 470     145.453 144.737 121.514  1.00  0.69           C  \nATOM   3460  C   CYS C 470     144.782 144.233 122.769  1.00  0.69           C  \nATOM   3461  O   CYS C 470     143.726 144.712 123.151  1.00  0.69           O  \nATOM   3462  CB  CYS C 470     144.604 144.351 120.285  1.00  0.69           C  \nATOM   3463  SG  CYS C 470     144.368 142.568 120.097  1.00  0.69           S  \nATOM   3464  N   TYR C 471     145.433 143.306 123.505  1.00  0.73           N  \nATOM   3465  CA  TYR C 471     145.007 142.883 124.825  1.00  0.73           C  \nATOM   3466  C   TYR C 471     145.364 143.946 125.873  1.00  0.73           C  \nATOM   3467  O   TYR C 471     146.176 143.709 126.760  1.00  0.73           O  \nATOM   3468  CB  TYR C 471     145.745 141.574 125.231  1.00  0.73           C  \nATOM   3469  CG  TYR C 471     145.294 140.391 124.437  1.00  0.73           C  \nATOM   3470  CD1 TYR C 471     144.140 139.713 124.851  1.00  0.73           C  \nATOM   3471  CD2 TYR C 471     146.045 139.878 123.362  1.00  0.73           C  \nATOM   3472  CE1 TYR C 471     143.745 138.536 124.212  1.00  0.73           C  \nATOM   3473  CE2 TYR C 471     145.637 138.704 122.709  1.00  0.73           C  \nATOM   3474  CZ  TYR C 471     144.475 138.050 123.129  1.00  0.73           C  \nATOM   3475  OH  TYR C 471     144.037 136.883 122.491  1.00  0.73           O  \nATOM   3476  N   ALA C 472     144.796 145.167 125.758  1.00  0.85           N  \nATOM   3477  CA  ALA C 472     145.179 146.285 126.604  1.00  0.85           C  \nATOM   3478  C   ALA C 472     144.017 147.211 126.965  1.00  0.85           C  \nATOM   3479  O   ALA C 472     144.029 147.860 128.010  1.00  0.85           O  \nATOM   3480  CB  ALA C 472     146.257 147.104 125.856  1.00  0.85           C  \nATOM   3481  N   ASN C 473     142.941 147.261 126.152  1.00  0.75           N  \nATOM   3482  CA  ASN C 473     141.792 148.135 126.351  1.00  0.75           C  \nATOM   3483  C   ASN C 473     140.635 147.360 126.967  1.00  0.75           C  \nATOM   3484  O   ASN C 473     139.483 147.777 126.910  1.00  0.75           O  \nATOM   3485  CB  ASN C 473     141.378 148.883 125.041  1.00  0.75           C  \nATOM   3486  CG  ASN C 473     141.380 147.985 123.804  1.00  0.75           C  \nATOM   3487  OD1 ASN C 473     141.386 146.764 123.859  1.00  0.75           O  \nATOM   3488  ND2 ASN C 473     141.427 148.636 122.618  1.00  0.75           N  \nATOM   3489  N   THR C 474     140.947 146.215 127.609  1.00  0.77           N  \nATOM   3490  CA  THR C 474     139.953 145.375 128.268  1.00  0.77           C  \nATOM   3491  C   THR C 474     140.044 145.549 129.775  1.00  0.77           C  \nATOM   3492  O   THR C 474     139.084 145.351 130.508  1.00  0.77           O  \nATOM   3493  CB  THR C 474     140.137 143.886 127.975  1.00  0.77           C  \nATOM   3494  OG1 THR C 474     140.295 143.667 126.585  1.00  0.77           O  \nATOM   3495  CG2 THR C 474     138.875 143.112 128.380  1.00  0.77           C  \nATOM   3496  N   ILE C 475     141.228 145.939 130.301  1.00  0.78           N  \nATOM   3497  CA  ILE C 475     141.459 146.159 131.726  1.00  0.78           C  \nATOM   3498  C   ILE C 475     140.699 147.353 132.286  1.00  0.78           C  \nATOM   3499  O   ILE C 475     140.720 148.456 131.737  1.00  0.78           O  \nATOM   3500  CB  ILE C 475     142.948 146.345 132.074  1.00  0.78           C  \nATOM   3501  CG1 ILE C 475     143.883 145.373 131.305  1.00  0.78           C  \nATOM   3502  CG2 ILE C 475     143.190 146.229 133.605  1.00  0.78           C  \nATOM   3503  CD1 ILE C 475     143.664 143.891 131.625  1.00  0.78           C  \nATOM   3504  N   ASN C 476     140.045 147.204 133.454  1.00  0.76           N  \nATOM   3505  CA  ASN C 476     139.421 148.324 134.112  1.00  0.76           C  \nATOM   3506  C   ASN C 476     140.496 149.041 134.939  1.00  0.76           C  \nATOM   3507  O   ASN C 476     140.684 148.761 136.124  1.00  0.76           O  \nATOM   3508  CB  ASN C 476     138.226 147.840 134.980  1.00  0.76           C  \nATOM   3509  CG  ASN C 476     137.464 149.043 135.522  1.00  0.76           C  \nATOM   3510  OD1 ASN C 476     137.471 150.144 134.967  1.00  0.76           O  \nATOM   3511  ND2 ASN C 476     136.812 148.851 136.690  1.00  0.76           N  \nATOM   3512  N   TRP C 477     141.238 149.993 134.328  1.00  0.75           N  \nATOM   3513  CA  TRP C 477     142.387 150.676 134.925  1.00  0.75           C  \nATOM   3514  C   TRP C 477     142.077 151.493 136.169  1.00  0.75           C  \nATOM   3515  O   TRP C 477     142.923 151.679 137.032  1.00  0.75           O  \nATOM   3516  CB  TRP C 477     143.094 151.625 133.922  1.00  0.75           C  \nATOM   3517  CG  TRP C 477     143.602 150.924 132.676  1.00  0.75           C  \nATOM   3518  CD1 TRP C 477     142.983 150.729 131.471  1.00  0.75           C  \nATOM   3519  CD2 TRP C 477     144.869 150.237 132.590  1.00  0.75           C  \nATOM   3520  NE1 TRP C 477     143.785 149.979 130.633  1.00  0.75           N  \nATOM   3521  CE2 TRP C 477     144.948 149.676 131.308  1.00  0.75           C  \nATOM   3522  CE3 TRP C 477     145.898 150.068 133.521  1.00  0.75           C  \nATOM   3523  CZ2 TRP C 477     146.060 148.936 130.914  1.00  0.75           C  \nATOM   3524  CZ3 TRP C 477     147.026 149.330 133.123  1.00  0.75           C  \nATOM   3525  CH2 TRP C 477     147.107 148.774 131.839  1.00  0.75           C  \nATOM   3526  N   LYS C 478     140.816 151.955 136.295  1.00  0.72           N  \nATOM   3527  CA  LYS C 478     140.298 152.690 137.436  1.00  0.72           C  \nATOM   3528  C   LYS C 478     140.299 151.904 138.734  1.00  0.72           C  \nATOM   3529  O   LYS C 478     140.302 152.483 139.808  1.00  0.72           O  \nATOM   3530  CB  LYS C 478     138.857 153.194 137.181  1.00  0.72           C  \nATOM   3531  CG  LYS C 478     138.718 154.000 135.881  1.00  0.72           C  \nATOM   3532  CD  LYS C 478     137.542 154.992 135.959  1.00  0.72           C  \nATOM   3533  CE  LYS C 478     136.994 155.457 134.605  1.00  0.72           C  \nATOM   3534  NZ  LYS C 478     136.250 154.334 133.991  1.00  0.72           N  \nATOM   3535  N   LYS C 479     140.320 150.557 138.662  1.00  0.72           N  \nATOM   3536  CA  LYS C 479     140.622 149.728 139.811  1.00  0.72           C  \nATOM   3537  C   LYS C 479     142.033 149.853 140.342  1.00  0.72           C  \nATOM   3538  O   LYS C 479     142.246 149.748 141.543  1.00  0.72           O  \nATOM   3539  CB  LYS C 479     140.446 148.243 139.470  1.00  0.72           C  \nATOM   3540  CG  LYS C 479     138.972 147.880 139.448  1.00  0.72           C  \nATOM   3541  CD  LYS C 479     138.746 146.384 139.293  1.00  0.72           C  \nATOM   3542  CE  LYS C 479     139.180 145.532 140.488  1.00  0.72           C  \nATOM   3543  NZ  LYS C 479     138.842 144.127 140.198  1.00  0.72           N  \nATOM   3544  N   LEU C 480     143.032 149.994 139.442  1.00  0.78           N  \nATOM   3545  CA  LEU C 480     144.432 149.980 139.818  1.00  0.78           C  \nATOM   3546  C   LEU C 480     144.882 151.344 140.293  1.00  0.78           C  \nATOM   3547  O   LEU C 480     145.893 151.467 140.972  1.00  0.78           O  \nATOM   3548  CB  LEU C 480     145.369 149.627 138.629  1.00  0.78           C  \nATOM   3549  CG  LEU C 480     145.000 148.375 137.799  1.00  0.78           C  \nATOM   3550  CD1 LEU C 480     146.183 148.023 136.876  1.00  0.78           C  \nATOM   3551  CD2 LEU C 480     144.617 147.142 138.644  1.00  0.78           C  \nATOM   3552  N   PHE C 481     144.145 152.402 139.900  1.00  0.77           N  \nATOM   3553  CA  PHE C 481     144.433 153.779 140.241  1.00  0.77           C  \nATOM   3554  C   PHE C 481     144.186 154.079 141.710  1.00  0.77           C  \nATOM   3555  O   PHE C 481     143.062 154.108 142.207  1.00  0.77           O  \nATOM   3556  CB  PHE C 481     143.660 154.777 139.323  1.00  0.77           C  \nATOM   3557  CG  PHE C 481     144.070 154.678 137.857  1.00  0.77           C  \nATOM   3558  CD1 PHE C 481     145.372 154.328 137.435  1.00  0.77           C  \nATOM   3559  CD2 PHE C 481     143.141 155.036 136.863  1.00  0.77           C  \nATOM   3560  CE1 PHE C 481     145.719 154.310 136.079  1.00  0.77           C  \nATOM   3561  CE2 PHE C 481     143.478 155.009 135.501  1.00  0.77           C  \nATOM   3562  CZ  PHE C 481     144.771 154.646 135.109  1.00  0.77           C  \nATOM   3563  N   GLY C 482     145.280 154.319 142.462  1.00  0.79           N  \nATOM   3564  CA  GLY C 482     145.197 154.509 143.905  1.00  0.79           C  \nATOM   3565  C   GLY C 482     144.711 155.876 144.339  1.00  0.79           C  \nATOM   3566  O   GLY C 482     144.347 156.082 145.499  1.00  0.79           O  \nATOM   3567  N   THR C 483     144.699 156.848 143.405  1.00  0.76           N  \nATOM   3568  CA  THR C 483     144.317 158.246 143.613  1.00  0.76           C  \nATOM   3569  C   THR C 483     143.342 158.698 142.536  1.00  0.76           C  \nATOM   3570  O   THR C 483     142.947 157.952 141.644  1.00  0.76           O  \nATOM   3571  CB  THR C 483     145.479 159.269 143.727  1.00  0.76           C  \nATOM   3572  OG1 THR C 483     146.134 159.524 142.493  1.00  0.76           O  \nATOM   3573  CG2 THR C 483     146.552 158.713 144.666  1.00  0.76           C  \nATOM   3574  N   SER C 484     142.883 159.958 142.628  1.00  0.75           N  \nATOM   3575  CA  SER C 484     141.994 160.605 141.686  1.00  0.75           C  \nATOM   3576  C   SER C 484     142.819 161.476 140.761  1.00  0.75           C  \nATOM   3577  O   SER C 484     143.957 161.825 141.051  1.00  0.75           O  \nATOM   3578  CB  SER C 484     140.956 161.503 142.420  1.00  0.75           C  \nATOM   3579  OG  SER C 484     141.593 162.278 143.441  1.00  0.75           O  \nATOM   3580  N   GLY C 485     142.259 161.833 139.584  1.00  0.78           N  \nATOM   3581  CA  GLY C 485     142.939 162.638 138.572  1.00  0.78           C  \nATOM   3582  C   GLY C 485     143.845 161.854 137.665  1.00  0.78           C  \nATOM   3583  O   GLY C 485     144.452 162.422 136.769  1.00  0.78           O  \nATOM   3584  N   GLN C 486     143.901 160.520 137.845  1.00  0.77           N  \nATOM   3585  CA  GLN C 486     144.683 159.628 137.019  1.00  0.77           C  \nATOM   3586  C   GLN C 486     143.879 159.198 135.824  1.00  0.77           C  \nATOM   3587  O   GLN C 486     142.670 158.953 135.894  1.00  0.77           O  \nATOM   3588  CB  GLN C 486     145.131 158.341 137.757  1.00  0.77           C  \nATOM   3589  CG  GLN C 486     145.922 158.632 139.047  1.00  0.77           C  \nATOM   3590  CD  GLN C 486     146.518 157.347 139.617  1.00  0.77           C  \nATOM   3591  OE1 GLN C 486     146.910 156.417 138.925  1.00  0.77           O  \nATOM   3592  NE2 GLN C 486     146.646 157.280 140.954  1.00  0.77           N  \nATOM   3593  N   LYS C 487     144.550 159.094 134.676  1.00  0.76           N  \nATOM   3594  CA  LYS C 487     143.896 158.702 133.464  1.00  0.76           C  \nATOM   3595  C   LYS C 487     144.793 157.812 132.635  1.00  0.76           C  \nATOM   3596  O   LYS C 487     145.989 157.639 132.869  1.00  0.76           O  \nATOM   3597  CB  LYS C 487     143.440 159.954 132.667  1.00  0.76           C  \nATOM   3598  CG  LYS C 487     144.590 160.952 132.430  1.00  0.76           C  \nATOM   3599  CD  LYS C 487     144.453 161.822 131.171  1.00  0.76           C  \nATOM   3600  CE  LYS C 487     144.492 160.991 129.886  1.00  0.76           C  \nATOM   3601  NZ  LYS C 487     144.269 161.866 128.719  1.00  0.76           N  \nATOM   3602  N   THR C 488     144.193 157.174 131.623  1.00  0.82           N  \nATOM   3603  CA  THR C 488     144.859 156.230 130.757  1.00  0.82           C  \nATOM   3604  C   THR C 488     144.809 156.807 129.363  1.00  0.82           C  \nATOM   3605  O   THR C 488     143.888 157.542 128.994  1.00  0.82           O  \nATOM   3606  CB  THR C 488     144.285 154.814 130.883  1.00  0.82           C  \nATOM   3607  OG1 THR C 488     144.949 153.894 130.039  1.00  0.82           O  \nATOM   3608  CG2 THR C 488     142.778 154.744 130.576  1.00  0.82           C  \nATOM   3609  N   LYS C 489     145.872 156.582 128.584  1.00  0.77           N  \nATOM   3610  CA  LYS C 489     146.024 157.076 127.245  1.00  0.77           C  \nATOM   3611  C   LYS C 489     146.477 155.930 126.359  1.00  0.77           C  \nATOM   3612  O   LYS C 489     147.664 155.641 126.206  1.00  0.77           O  \nATOM   3613  CB  LYS C 489     147.070 158.216 127.285  1.00  0.77           C  \nATOM   3614  CG  LYS C 489     147.263 158.968 125.960  1.00  0.77           C  \nATOM   3615  CD  LYS C 489     148.268 160.123 126.122  1.00  0.77           C  \nATOM   3616  CE  LYS C 489     148.573 160.886 124.823  1.00  0.77           C  \nATOM   3617  NZ  LYS C 489     149.573 161.953 125.080  1.00  0.77           N  \nATOM   3618  N   ILE C 490     145.506 155.228 125.755  1.00  0.78           N  \nATOM   3619  CA  ILE C 490     145.739 154.029 124.986  1.00  0.78           C  \nATOM   3620  C   ILE C 490     145.106 154.294 123.651  1.00  0.78           C  \nATOM   3621  O   ILE C 490     143.887 154.360 123.526  1.00  0.78           O  \nATOM   3622  CB  ILE C 490     145.097 152.820 125.667  1.00  0.78           C  \nATOM   3623  CG1 ILE C 490     145.736 152.617 127.065  1.00  0.78           C  \nATOM   3624  CG2 ILE C 490     145.275 151.560 124.793  1.00  0.78           C  \nATOM   3625  CD1 ILE C 490     145.140 151.458 127.880  1.00  0.78           C  \nATOM   3626  N   ILE C 491     145.935 154.504 122.621  1.00  0.74           N  \nATOM   3627  CA  ILE C 491     145.498 154.970 121.332  1.00  0.74           C  \nATOM   3628  C   ILE C 491     146.406 154.282 120.344  1.00  0.74           C  \nATOM   3629  O   ILE C 491     147.555 153.989 120.658  1.00  0.74           O  \nATOM   3630  CB  ILE C 491     145.583 156.507 121.179  1.00  0.74           C  \nATOM   3631  CG1 ILE C 491     146.957 157.117 121.607  1.00  0.74           C  \nATOM   3632  CG2 ILE C 491     144.398 157.120 121.967  1.00  0.74           C  \nATOM   3633  CD1 ILE C 491     147.095 158.628 121.332  1.00  0.74           C  \nATOM   3634  N   SER C 492     145.880 153.952 119.151  1.00  0.73           N  \nATOM   3635  CA  SER C 492     146.637 153.524 117.978  1.00  0.73           C  \nATOM   3636  C   SER C 492     147.437 152.241 118.114  1.00  0.73           C  \nATOM   3637  O   SER C 492     148.445 152.036 117.441  1.00  0.73           O  \nATOM   3638  CB  SER C 492     147.437 154.669 117.264  1.00  0.73           C  \nATOM   3639  OG  SER C 492     148.658 155.051 117.900  1.00  0.73           O  \nATOM   3640  N   ASN C 493     146.951 151.292 118.941  1.00  0.76           N  \nATOM   3641  CA  ASN C 493     147.648 150.054 119.202  1.00  0.76           C  \nATOM   3642  C   ASN C 493     147.315 149.073 118.088  1.00  0.76           C  \nATOM   3643  O   ASN C 493     148.119 148.810 117.198  1.00  0.76           O  \nATOM   3644  CB  ASN C 493     147.216 149.520 120.596  1.00  0.76           C  \nATOM   3645  CG  ASN C 493     148.125 150.042 121.706  1.00  0.76           C  \nATOM   3646  OD1 ASN C 493     149.298 150.382 121.546  1.00  0.76           O  \nATOM   3647  ND2 ASN C 493     147.547 150.092 122.927  1.00  0.76           N  \nATOM   3648  N   ARG C 494     146.069 148.570 118.041  1.00  0.68           N  \nATOM   3649  CA  ARG C 494     145.741 147.583 117.042  1.00  0.68           C  \nATOM   3650  C   ARG C 494     144.250 147.375 117.001  1.00  0.68           C  \nATOM   3651  O   ARG C 494     143.672 146.602 117.762  1.00  0.68           O  \nATOM   3652  CB  ARG C 494     146.405 146.209 117.359  1.00  0.68           C  \nATOM   3653  CG  ARG C 494     145.919 144.956 116.581  1.00  0.68           C  \nATOM   3654  CD  ARG C 494     146.511 144.809 115.179  1.00  0.68           C  \nATOM   3655  NE  ARG C 494     146.105 143.450 114.659  1.00  0.68           N  \nATOM   3656  CZ  ARG C 494     146.726 142.311 115.004  1.00  0.68           C  \nATOM   3657  NH1 ARG C 494     146.354 141.161 114.448  1.00  0.68           N  \nATOM   3658  NH2 ARG C 494     147.678 142.275 115.929  1.00  0.68           N  \nATOM   3659  N   GLY C 495     143.612 148.040 116.024  1.00  0.69           N  \nATOM   3660  CA  GLY C 495     142.364 147.649 115.392  1.00  0.69           C  \nATOM   3661  C   GLY C 495     141.060 147.698 116.133  1.00  0.69           C  \nATOM   3662  O   GLY C 495     140.040 148.015 115.538  1.00  0.69           O  \nATOM   3663  N   GLU C 496     141.029 147.193 117.380  1.00  0.64           N  \nATOM   3664  CA  GLU C 496     139.871 147.026 118.251  1.00  0.64           C  \nATOM   3665  C   GLU C 496     138.800 146.045 117.727  1.00  0.64           C  \nATOM   3666  O   GLU C 496     137.904 145.570 118.425  1.00  0.64           O  \nATOM   3667  CB  GLU C 496     139.338 148.399 118.750  1.00  0.64           C  \nATOM   3668  CG  GLU C 496     140.385 149.176 119.615  1.00  0.64           C  \nATOM   3669  CD  GLU C 496     141.442 150.088 118.967  1.00  0.64           C  \nATOM   3670  OE1 GLU C 496     141.336 150.453 117.776  1.00  0.64           O  \nATOM   3671  OE2 GLU C 496     142.405 150.419 119.716  1.00  0.64           O  \nATOM   3672  N   ASN C 497     138.922 145.679 116.443  1.00  0.67           N  \nATOM   3673  CA  ASN C 497     138.144 144.715 115.714  1.00  0.67           C  \nATOM   3674  C   ASN C 497     139.026 143.861 114.787  1.00  0.67           C  \nATOM   3675  O   ASN C 497     138.692 142.716 114.531  1.00  0.67           O  \nATOM   3676  CB  ASN C 497     136.967 145.440 114.993  1.00  0.67           C  \nATOM   3677  CG  ASN C 497     137.475 146.565 114.086  1.00  0.67           C  \nATOM   3678  OD1 ASN C 497     138.258 146.315 113.179  1.00  0.67           O  \nATOM   3679  ND2 ASN C 497     137.050 147.826 114.329  1.00  0.67           N  \nATOM   3680  N   SER C 498     140.229 144.323 114.345  1.00  0.71           N  \nATOM   3681  CA  SER C 498     141.169 143.547 113.512  1.00  0.71           C  \nATOM   3682  C   SER C 498     141.679 142.357 114.292  1.00  0.71           C  \nATOM   3683  O   SER C 498     141.865 141.260 113.776  1.00  0.71           O  \nATOM   3684  CB  SER C 498     142.307 144.465 112.916  1.00  0.71           C  \nATOM   3685  OG  SER C 498     143.465 143.813 112.391  1.00  0.71           O  \nATOM   3686  N   CYS C 499     141.873 142.520 115.612  1.00  0.69           N  \nATOM   3687  CA  CYS C 499     142.306 141.403 116.410  1.00  0.69           C  \nATOM   3688  C   CYS C 499     141.118 140.591 116.959  1.00  0.69           C  \nATOM   3689  O   CYS C 499     141.238 139.411 117.201  1.00  0.69           O  \nATOM   3690  CB  CYS C 499     143.408 141.822 117.402  1.00  0.69           C  \nATOM   3691  SG  CYS C 499     142.762 142.577 118.897  1.00  0.69           S  \nATOM   3692  N   LYS C 500     139.895 141.179 117.040  1.00  0.68           N  \nATOM   3693  CA  LYS C 500     138.697 140.461 117.448  1.00  0.68           C  \nATOM   3694  C   LYS C 500     138.136 139.617 116.298  1.00  0.68           C  \nATOM   3695  O   LYS C 500     137.433 138.638 116.518  1.00  0.68           O  \nATOM   3696  CB  LYS C 500     137.648 141.506 117.908  1.00  0.68           C  \nATOM   3697  CG  LYS C 500     136.457 140.977 118.733  1.00  0.68           C  \nATOM   3698  CD  LYS C 500     135.238 141.922 118.695  1.00  0.68           C  \nATOM   3699  CE  LYS C 500     135.565 143.395 118.988  1.00  0.68           C  \nATOM   3700  NZ  LYS C 500     134.423 144.262 118.628  1.00  0.68           N  \nATOM   3701  N   ALA C 501     138.466 139.966 115.031  1.00  0.70           N  \nATOM   3702  CA  ALA C 501     138.145 139.211 113.836  1.00  0.70           C  \nATOM   3703  C   ALA C 501     139.038 137.977 113.651  1.00  0.70           C  \nATOM   3704  O   ALA C 501     138.571 136.917 113.255  1.00  0.70           O  \nATOM   3705  CB  ALA C 501     138.199 140.141 112.598  1.00  0.70           C  \nATOM   3706  N   THR C 502     140.349 138.069 113.994  1.00  0.65           N  \nATOM   3707  CA  THR C 502     141.296 136.942 113.920  1.00  0.65           C  \nATOM   3708  C   THR C 502     141.321 136.179 115.253  1.00  0.65           C  \nATOM   3709  O   THR C 502     142.112 135.273 115.482  1.00  0.65           O  \nATOM   3710  CB  THR C 502     142.713 137.390 113.486  1.00  0.65           C  \nATOM   3711  OG1 THR C 502     143.567 136.314 113.130  1.00  0.65           O  \nATOM   3712  CG2 THR C 502     143.405 138.204 114.585  1.00  0.65           C  \nATOM   3713  N   GLY C 503     140.392 136.501 116.188  1.00  0.70           N  \nATOM   3714  CA  GLY C 503     140.163 135.687 117.386  1.00  0.70           C  \nATOM   3715  C   GLY C 503     141.057 135.938 118.574  1.00  0.70           C  \nATOM   3716  O   GLY C 503     141.002 135.205 119.563  1.00  0.70           O  \nATOM   3717  N   GLN C 504     141.883 136.996 118.547  1.00  0.69           N  \nATOM   3718  CA  GLN C 504     142.682 137.473 119.661  1.00  0.69           C  \nATOM   3719  C   GLN C 504     141.852 138.302 120.632  1.00  0.69           C  \nATOM   3720  O   GLN C 504     142.089 139.497 120.837  1.00  0.69           O  \nATOM   3721  CB  GLN C 504     143.867 138.365 119.204  1.00  0.69           C  \nATOM   3722  CG  GLN C 504     145.000 137.683 118.396  1.00  0.69           C  \nATOM   3723  CD  GLN C 504     146.108 138.664 117.972  1.00  0.69           C  \nATOM   3724  OE1 GLN C 504     146.775 138.519 116.952  1.00  0.69           O  \nATOM   3725  NE2 GLN C 504     146.323 139.735 118.777  1.00  0.69           N  \nATOM   3726  N   VAL C 505     140.881 137.647 121.265  1.00  0.72           N  \nATOM   3727  CA  VAL C 505     140.123 138.081 122.410  1.00  0.72           C  \nATOM   3728  C   VAL C 505     140.489 137.142 123.520  1.00  0.72           C  \nATOM   3729  O   VAL C 505     141.085 136.090 123.293  1.00  0.72           O  \nATOM   3730  CB  VAL C 505     138.610 138.004 122.213  1.00  0.72           C  \nATOM   3731  CG1 VAL C 505     138.208 139.239 121.394  1.00  0.72           C  \nATOM   3732  CG2 VAL C 505     138.188 136.671 121.537  1.00  0.72           C  \nATOM   3733  N   CYS C 506     140.184 137.508 124.779  1.00  0.72           N  \nATOM   3734  CA  CYS C 506     140.502 136.676 125.920  1.00  0.72           C  \nATOM   3735  C   CYS C 506     139.802 135.349 125.977  1.00  0.72           C  \nATOM   3736  O   CYS C 506     138.814 135.074 125.304  1.00  0.72           O  \nATOM   3737  CB  CYS C 506     140.386 137.360 127.308  1.00  0.72           C  \nATOM   3738  SG  CYS C 506     139.663 139.024 127.369  1.00  0.72           S  \nATOM   3739  N   HIS C 507     140.329 134.460 126.836  1.00  0.73           N  \nATOM   3740  CA  HIS C 507     139.657 133.213 127.080  1.00  0.73           C  \nATOM   3741  C   HIS C 507     138.258 133.395 127.695  1.00  0.73           C  \nATOM   3742  O   HIS C 507     138.027 134.290 128.505  1.00  0.73           O  \nATOM   3743  CB  HIS C 507     140.523 132.279 127.939  1.00  0.73           C  \nATOM   3744  CG  HIS C 507     140.341 130.848 127.559  1.00  0.73           C  \nATOM   3745  ND1 HIS C 507     140.882 129.928 128.417  1.00  0.73           N  \nATOM   3746  CD2 HIS C 507     139.891 130.230 126.433  1.00  0.73           C  \nATOM   3747  CE1 HIS C 507     140.769 128.771 127.814  1.00  0.73           C  \nATOM   3748  NE2 HIS C 507     140.167 128.889 126.605  1.00  0.73           N  \nATOM   3749  N   ALA C 508     137.272 132.537 127.349  1.00  0.77           N  \nATOM   3750  CA  ALA C 508     135.925 132.578 127.905  1.00  0.77           C  \nATOM   3751  C   ALA C 508     135.836 132.233 129.410  1.00  0.77           C  \nATOM   3752  O   ALA C 508     134.791 132.395 130.033  1.00  0.77           O  \nATOM   3753  CB  ALA C 508     135.002 131.650 127.075  1.00  0.77           C  \nATOM   3754  N   LEU C 509     136.970 131.799 130.021  1.00  0.76           N  \nATOM   3755  CA  LEU C 509     137.143 131.415 131.415  1.00  0.76           C  \nATOM   3756  C   LEU C 509     137.517 132.621 132.281  1.00  0.76           C  \nATOM   3757  O   LEU C 509     137.679 132.498 133.496  1.00  0.76           O  \nATOM   3758  CB  LEU C 509     138.259 130.324 131.551  1.00  0.76           C  \nATOM   3759  CG  LEU C 509     137.810 128.873 131.219  1.00  0.76           C  \nATOM   3760  CD1 LEU C 509     136.618 128.428 132.094  1.00  0.76           C  \nATOM   3761  CD2 LEU C 509     137.541 128.617 129.721  1.00  0.76           C  \nATOM   3762  N   CYS C 510     137.578 133.837 131.684  1.00  0.77           N  \nATOM   3763  CA  CYS C 510     137.877 135.088 132.365  1.00  0.77           C  \nATOM   3764  C   CYS C 510     136.593 135.838 132.644  1.00  0.77           C  \nATOM   3765  O   CYS C 510     135.738 135.937 131.768  1.00  0.77           O  \nATOM   3766  CB  CYS C 510     138.683 136.100 131.490  1.00  0.77           C  \nATOM   3767  SG  CYS C 510     140.340 135.581 130.976  1.00  0.77           S  \nATOM   3768  N   SER C 511     136.419 136.404 133.862  1.00  0.75           N  \nATOM   3769  CA  SER C 511     135.350 137.359 134.194  1.00  0.75           C  \nATOM   3770  C   SER C 511     135.320 138.570 133.236  1.00  0.75           C  \nATOM   3771  O   SER C 511     136.391 138.920 132.735  1.00  0.75           O  \nATOM   3772  CB  SER C 511     135.468 137.853 135.672  1.00  0.75           C  \nATOM   3773  OG  SER C 511     134.398 138.717 136.059  1.00  0.75           O  \nATOM   3774  N   PRO C 512     134.206 139.278 132.946  1.00  0.76           N  \nATOM   3775  CA  PRO C 512     134.195 140.499 132.127  1.00  0.76           C  \nATOM   3776  C   PRO C 512     135.030 141.658 132.683  1.00  0.76           C  \nATOM   3777  O   PRO C 512     135.092 142.694 132.029  1.00  0.76           O  \nATOM   3778  CB  PRO C 512     132.703 140.910 132.074  1.00  0.76           C  \nATOM   3779  CG  PRO C 512     131.930 139.607 132.298  1.00  0.76           C  \nATOM   3780  CD  PRO C 512     132.841 138.854 133.274  1.00  0.76           C  \nATOM   3781  N   GLU C 513     135.656 141.507 133.874  1.00  0.69           N  \nATOM   3782  CA  GLU C 513     136.567 142.417 134.549  1.00  0.69           C  \nATOM   3783  C   GLU C 513     137.802 142.802 133.744  1.00  0.69           C  \nATOM   3784  O   GLU C 513     138.294 143.928 133.784  1.00  0.69           O  \nATOM   3785  CB  GLU C 513     137.131 141.705 135.804  1.00  0.69           C  \nATOM   3786  CG  GLU C 513     137.716 142.685 136.848  1.00  0.69           C  \nATOM   3787  CD  GLU C 513     136.650 143.264 137.763  1.00  0.69           C  \nATOM   3788  OE1 GLU C 513     135.720 142.530 138.162  1.00  0.69           O  \nATOM   3789  OE2 GLU C 513     136.903 144.398 138.241  1.00  0.69           O  \nATOM   3790  N   GLY C 514     138.368 141.820 133.011  1.00  0.78           N  \nATOM   3791  CA  GLY C 514     139.480 142.111 132.136  1.00  0.78           C  \nATOM   3792  C   GLY C 514     140.326 140.921 131.804  1.00  0.78           C  \nATOM   3793  O   GLY C 514     140.086 139.801 132.251  1.00  0.78           O  \nATOM   3794  N   CYS C 515     141.372 141.148 130.988  1.00  0.80           N  \nATOM   3795  CA  CYS C 515     142.292 140.111 130.583  1.00  0.80           C  \nATOM   3796  C   CYS C 515     143.604 140.707 130.116  1.00  0.80           C  \nATOM   3797  O   CYS C 515     143.614 141.691 129.382  1.00  0.80           O  \nATOM   3798  CB  CYS C 515     141.719 139.233 129.451  1.00  0.80           C  \nATOM   3799  SG  CYS C 515     141.274 140.070 127.899  1.00  0.80           S  \nATOM   3800  N   TRP C 516     144.742 140.102 130.499  1.00  0.81           N  \nATOM   3801  CA  TRP C 516     146.079 140.578 130.195  1.00  0.81           C  \nATOM   3802  C   TRP C 516     146.664 139.829 129.006  1.00  0.81           C  \nATOM   3803  O   TRP C 516     147.728 140.180 128.496  1.00  0.81           O  \nATOM   3804  CB  TRP C 516     147.011 140.346 131.425  1.00  0.81           C  \nATOM   3805  CG  TRP C 516     146.744 141.285 132.595  1.00  0.81           C  \nATOM   3806  CD1 TRP C 516     146.135 141.054 133.801  1.00  0.81           C  \nATOM   3807  CD2 TRP C 516     147.164 142.671 132.629  1.00  0.81           C  \nATOM   3808  NE1 TRP C 516     146.150 142.198 134.585  1.00  0.81           N  \nATOM   3809  CE2 TRP C 516     146.782 143.196 133.865  1.00  0.81           C  \nATOM   3810  CE3 TRP C 516     147.843 143.449 131.686  1.00  0.81           C  \nATOM   3811  CZ2 TRP C 516     147.068 144.521 134.209  1.00  0.81           C  \nATOM   3812  CZ3 TRP C 516     148.131 144.781 132.026  1.00  0.81           C  \nATOM   3813  CH2 TRP C 516     147.748 145.312 133.263  1.00  0.81           C  \nATOM   3814  N   GLY C 517     145.967 138.780 128.518  1.00  0.84           N  \nATOM   3815  CA  GLY C 517     146.499 137.913 127.489  1.00  0.84           C  \nATOM   3816  C   GLY C 517     145.469 136.893 127.077  1.00  0.84           C  \nATOM   3817  O   GLY C 517     144.302 137.029 127.451  1.00  0.84           O  \nATOM   3818  N   PRO C 518     145.860 135.876 126.306  1.00  0.80           N  \nATOM   3819  CA  PRO C 518     144.925 134.948 125.684  1.00  0.80           C  \nATOM   3820  C   PRO C 518     144.697 133.738 126.577  1.00  0.80           C  \nATOM   3821  O   PRO C 518     143.714 133.029 126.375  1.00  0.80           O  \nATOM   3822  CB  PRO C 518     145.635 134.539 124.378  1.00  0.80           C  \nATOM   3823  CG  PRO C 518     147.139 134.684 124.654  1.00  0.80           C  \nATOM   3824  CD  PRO C 518     147.207 135.778 125.730  1.00  0.80           C  \nATOM   3825  N   GLU C 519     145.608 133.466 127.535  1.00  0.75           N  \nATOM   3826  CA  GLU C 519     145.598 132.316 128.416  1.00  0.75           C  \nATOM   3827  C   GLU C 519     144.520 132.435 129.504  1.00  0.75           C  \nATOM   3828  O   GLU C 519     144.121 133.551 129.847  1.00  0.75           O  \nATOM   3829  CB  GLU C 519     146.977 132.177 129.133  1.00  0.75           C  \nATOM   3830  CG  GLU C 519     148.222 132.152 128.203  1.00  0.75           C  \nATOM   3831  CD  GLU C 519     148.389 130.855 127.419  1.00  0.75           C  \nATOM   3832  OE1 GLU C 519     147.667 129.873 127.719  1.00  0.75           O  \nATOM   3833  OE2 GLU C 519     149.298 130.841 126.551  1.00  0.75           O  \nATOM   3834  N   PRO C 520     144.025 131.370 130.135  1.00  0.80           N  \nATOM   3835  CA  PRO C 520     143.076 131.468 131.246  1.00  0.80           C  \nATOM   3836  C   PRO C 520     143.759 131.878 132.533  1.00  0.80           C  \nATOM   3837  O   PRO C 520     143.087 132.147 133.522  1.00  0.80           O  \nATOM   3838  CB  PRO C 520     142.507 130.052 131.398  1.00  0.80           C  \nATOM   3839  CG  PRO C 520     143.578 129.135 130.783  1.00  0.80           C  \nATOM   3840  CD  PRO C 520     144.219 129.994 129.688  1.00  0.80           C  \nATOM   3841  N   ARG C 521     145.103 131.920 132.558  1.00  0.71           N  \nATOM   3842  CA  ARG C 521     145.868 132.400 133.686  1.00  0.71           C  \nATOM   3843  C   ARG C 521     146.193 133.886 133.558  1.00  0.71           C  \nATOM   3844  O   ARG C 521     146.943 134.441 134.357  1.00  0.71           O  \nATOM   3845  CB  ARG C 521     147.198 131.618 133.811  1.00  0.71           C  \nATOM   3846  CG  ARG C 521     148.157 131.728 132.605  1.00  0.71           C  \nATOM   3847  CD  ARG C 521     149.607 131.635 133.070  1.00  0.71           C  \nATOM   3848  NE  ARG C 521     150.484 131.672 131.857  1.00  0.71           N  \nATOM   3849  CZ  ARG C 521     151.822 131.703 131.900  1.00  0.71           C  \nATOM   3850  NH1 ARG C 521     152.469 131.738 133.061  1.00  0.71           N  \nATOM   3851  NH2 ARG C 521     152.523 131.749 130.773  1.00  0.71           N  \nATOM   3852  N   ASP C 522     145.621 134.549 132.531  1.00  0.80           N  \nATOM   3853  CA  ASP C 522     145.840 135.939 132.199  1.00  0.80           C  \nATOM   3854  C   ASP C 522     144.552 136.731 132.369  1.00  0.80           C  \nATOM   3855  O   ASP C 522     144.278 137.670 131.622  1.00  0.80           O  \nATOM   3856  CB  ASP C 522     146.417 136.078 130.763  1.00  0.80           C  \nATOM   3857  CG  ASP C 522     147.886 135.719 130.777  1.00  0.80           C  \nATOM   3858  OD1 ASP C 522     148.575 136.052 131.775  1.00  0.80           O  \nATOM   3859  OD2 ASP C 522     148.408 135.156 129.788  1.00  0.80           O  \nATOM   3860  N   CYS C 523     143.722 136.394 133.376  1.00  0.80           N  \nATOM   3861  CA  CYS C 523     142.473 137.092 133.649  1.00  0.80           C  \nATOM   3862  C   CYS C 523     142.582 137.838 134.972  1.00  0.80           C  \nATOM   3863  O   CYS C 523     143.321 137.440 135.867  1.00  0.80           O  \nATOM   3864  CB  CYS C 523     141.226 136.164 133.790  1.00  0.80           C  \nATOM   3865  SG  CYS C 523     141.072 134.767 132.638  1.00  0.80           S  \nATOM   3866  N   VAL C 524     141.839 138.953 135.156  1.00  0.78           N  \nATOM   3867  CA  VAL C 524     141.800 139.652 136.441  1.00  0.78           C  \nATOM   3868  C   VAL C 524     141.093 138.865 137.557  1.00  0.78           C  \nATOM   3869  O   VAL C 524     141.539 138.817 138.700  1.00  0.78           O  \nATOM   3870  CB  VAL C 524     141.109 141.007 136.330  1.00  0.78           C  \nATOM   3871  CG1 VAL C 524     141.300 141.806 137.641  1.00  0.78           C  \nATOM   3872  CG2 VAL C 524     141.671 141.815 135.142  1.00  0.78           C  \nATOM   3873  N   SER C 525     139.945 138.243 137.215  1.00  0.76           N  \nATOM   3874  CA  SER C 525     139.139 137.384 138.069  1.00  0.76           C  \nATOM   3875  C   SER C 525     138.554 136.273 137.210  1.00  0.76           C  \nATOM   3876  O   SER C 525     138.430 136.381 135.992  1.00  0.76           O  \nATOM   3877  CB  SER C 525     137.977 138.125 138.814  1.00  0.76           C  \nATOM   3878  OG  SER C 525     137.325 139.065 137.959  1.00  0.76           O  \nATOM   3879  N   CYS C 526     138.216 135.132 137.850  1.00  0.76           N  \nATOM   3880  CA  CYS C 526     137.754 133.920 137.186  1.00  0.76           C  \nATOM   3881  C   CYS C 526     136.252 133.927 137.029  1.00  0.76           C  \nATOM   3882  O   CYS C 526     135.545 134.649 137.725  1.00  0.76           O  \nATOM   3883  CB  CYS C 526     138.170 132.630 137.946  1.00  0.76           C  \nATOM   3884  SG  CYS C 526     139.974 132.393 137.918  1.00  0.76           S  \nATOM   3885  N   ARG C 527     135.727 133.136 136.071  1.00  0.65           N  \nATOM   3886  CA  ARG C 527     134.292 132.950 135.895  1.00  0.65           C  \nATOM   3887  C   ARG C 527     133.626 132.048 136.908  1.00  0.65           C  \nATOM   3888  O   ARG C 527     132.588 132.390 137.462  1.00  0.65           O  \nATOM   3889  CB  ARG C 527     134.020 132.311 134.513  1.00  0.65           C  \nATOM   3890  CG  ARG C 527     134.277 133.295 133.363  1.00  0.65           C  \nATOM   3891  CD  ARG C 527     133.302 134.475 133.244  1.00  0.65           C  \nATOM   3892  NE  ARG C 527     131.953 133.920 132.944  1.00  0.65           N  \nATOM   3893  CZ  ARG C 527     131.532 133.587 131.718  1.00  0.65           C  \nATOM   3894  NH1 ARG C 527     132.295 133.727 130.645  1.00  0.65           N  \nATOM   3895  NH2 ARG C 527     130.330 133.033 131.582  1.00  0.65           N  \nATOM   3896  N   ASN C 528     134.221 130.864 137.141  1.00  0.69           N  \nATOM   3897  CA  ASN C 528     133.674 129.853 138.012  1.00  0.69           C  \nATOM   3898  C   ASN C 528     134.647 129.687 139.165  1.00  0.69           C  \nATOM   3899  O   ASN C 528     134.443 130.232 140.245  1.00  0.69           O  \nATOM   3900  CB  ASN C 528     133.452 128.506 137.260  1.00  0.69           C  \nATOM   3901  CG  ASN C 528     132.344 128.606 136.204  1.00  0.69           C  \nATOM   3902  OD1 ASN C 528     132.303 129.475 135.341  1.00  0.69           O  \nATOM   3903  ND2 ASN C 528     131.420 127.618 136.225  1.00  0.69           N  \nATOM   3904  N   VAL C 529     135.751 128.943 138.957  1.00  0.74           N  \nATOM   3905  CA  VAL C 529     136.684 128.586 140.008  1.00  0.74           C  \nATOM   3906  C   VAL C 529     138.098 128.613 139.424  1.00  0.74           C  \nATOM   3907  O   VAL C 529     138.302 128.961 138.258  1.00  0.74           O  \nATOM   3908  CB  VAL C 529     136.387 127.224 140.673  1.00  0.74           C  \nATOM   3909  CG1 VAL C 529     135.060 127.186 141.464  1.00  0.74           C  \nATOM   3910  CG2 VAL C 529     136.391 126.129 139.603  1.00  0.74           C  \nATOM   3911  N   SER C 530     139.130 128.297 140.227  1.00  0.77           N  \nATOM   3912  CA  SER C 530     140.528 128.393 139.844  1.00  0.77           C  \nATOM   3913  C   SER C 530     141.347 127.263 140.452  1.00  0.77           C  \nATOM   3914  O   SER C 530     141.004 126.687 141.483  1.00  0.77           O  \nATOM   3915  CB  SER C 530     141.132 129.764 140.262  1.00  0.77           C  \nATOM   3916  OG  SER C 530     141.086 129.938 141.677  1.00  0.77           O  \nATOM   3917  N   ARG C 531     142.460 126.899 139.783  1.00  0.68           N  \nATOM   3918  CA  ARG C 531     143.448 125.919 140.210  1.00  0.68           C  \nATOM   3919  C   ARG C 531     144.745 126.658 140.503  1.00  0.68           C  \nATOM   3920  O   ARG C 531     145.760 126.495 139.828  1.00  0.68           O  \nATOM   3921  CB  ARG C 531     143.701 124.829 139.124  1.00  0.68           C  \nATOM   3922  CG  ARG C 531     142.440 124.008 138.776  1.00  0.68           C  \nATOM   3923  CD  ARG C 531     142.077 122.880 139.760  1.00  0.68           C  \nATOM   3924  NE  ARG C 531     140.724 122.331 139.387  1.00  0.68           N  \nATOM   3925  CZ  ARG C 531     140.546 121.439 138.407  1.00  0.68           C  \nATOM   3926  NH1 ARG C 531     141.570 121.039 137.661  1.00  0.68           N  \nATOM   3927  NH2 ARG C 531     139.348 120.918 138.163  1.00  0.68           N  \nATOM   3928  N   GLY C 532     144.753 127.543 141.519  1.00  0.73           N  \nATOM   3929  CA  GLY C 532     145.944 128.302 141.874  1.00  0.73           C  \nATOM   3930  C   GLY C 532     146.062 129.558 141.053  1.00  0.73           C  \nATOM   3931  O   GLY C 532     145.434 130.563 141.351  1.00  0.73           O  \nATOM   3932  N   ARG C 533     146.870 129.540 139.974  1.00  0.62           N  \nATOM   3933  CA  ARG C 533     147.124 130.725 139.166  1.00  0.62           C  \nATOM   3934  C   ARG C 533     146.388 130.689 137.836  1.00  0.62           C  \nATOM   3935  O   ARG C 533     146.641 131.514 136.963  1.00  0.62           O  \nATOM   3936  CB  ARG C 533     148.646 130.897 138.892  1.00  0.62           C  \nATOM   3937  CG  ARG C 533     149.306 129.803 138.017  1.00  0.62           C  \nATOM   3938  CD  ARG C 533     150.820 130.009 137.877  1.00  0.62           C  \nATOM   3939  NE  ARG C 533     151.357 128.924 136.974  1.00  0.62           N  \nATOM   3940  CZ  ARG C 533     151.745 127.703 137.372  1.00  0.62           C  \nATOM   3941  NH1 ARG C 533     151.641 127.310 138.635  1.00  0.62           N  \nATOM   3942  NH2 ARG C 533     152.236 126.843 136.480  1.00  0.62           N  \nATOM   3943  N   GLU C 534     145.478 129.718 137.641  1.00  0.73           N  \nATOM   3944  CA  GLU C 534     144.770 129.488 136.398  1.00  0.73           C  \nATOM   3945  C   GLU C 534     143.287 129.319 136.703  1.00  0.73           C  \nATOM   3946  O   GLU C 534     142.924 128.702 137.705  1.00  0.73           O  \nATOM   3947  CB  GLU C 534     145.330 128.214 135.718  1.00  0.73           C  \nATOM   3948  CG  GLU C 534     144.543 127.712 134.481  1.00  0.73           C  \nATOM   3949  CD  GLU C 534     145.122 126.414 133.924  1.00  0.73           C  \nATOM   3950  OE1 GLU C 534     146.315 126.128 134.205  1.00  0.73           O  \nATOM   3951  OE2 GLU C 534     144.364 125.698 133.223  1.00  0.73           O  \nATOM   3952  N   CYS C 535     142.390 129.887 135.863  1.00  0.76           N  \nATOM   3953  CA  CYS C 535     140.941 129.744 135.961  1.00  0.76           C  \nATOM   3954  C   CYS C 535     140.474 128.480 135.246  1.00  0.76           C  \nATOM   3955  O   CYS C 535     141.009 128.135 134.200  1.00  0.76           O  \nATOM   3956  CB  CYS C 535     140.194 130.919 135.266  1.00  0.76           C  \nATOM   3957  SG  CYS C 535     140.520 132.561 135.970  1.00  0.76           S  \nATOM   3958  N   VAL C 536     139.442 127.781 135.759  1.00  0.79           N  \nATOM   3959  CA  VAL C 536     138.935 126.527 135.196  1.00  0.79           C  \nATOM   3960  C   VAL C 536     137.411 126.590 135.276  1.00  0.79           C  \nATOM   3961  O   VAL C 536     136.846 127.445 135.968  1.00  0.79           O  \nATOM   3962  CB  VAL C 536     139.441 125.250 135.901  1.00  0.79           C  \nATOM   3963  CG1 VAL C 536     140.887 124.888 135.493  1.00  0.79           C  \nATOM   3964  CG2 VAL C 536     139.300 125.461 137.413  1.00  0.79           C  \nATOM   3965  N   ASP C 537     136.705 125.704 134.541  1.00  0.73           N  \nATOM   3966  CA  ASP C 537     135.265 125.598 134.433  1.00  0.73           C  \nATOM   3967  C   ASP C 537     134.620 125.080 135.724  1.00  0.73           C  \nATOM   3968  O   ASP C 537     133.643 125.632 136.231  1.00  0.73           O  \nATOM   3969  CB  ASP C 537     134.924 124.742 133.167  1.00  0.73           C  \nATOM   3970  CG  ASP C 537     135.501 123.327 133.134  1.00  0.73           C  \nATOM   3971  OD1 ASP C 537     136.394 123.011 133.963  1.00  0.73           O  \nATOM   3972  OD2 ASP C 537     135.034 122.543 132.273  1.00  0.73           O  \nATOM   3973  N   LYS C 538     135.206 124.045 136.348  1.00  0.71           N  \nATOM   3974  CA  LYS C 538     134.699 123.482 137.576  1.00  0.71           C  \nATOM   3975  C   LYS C 538     135.801 122.766 138.366  1.00  0.71           C  \nATOM   3976  O   LYS C 538     136.830 122.342 137.844  1.00  0.71           O  \nATOM   3977  CB  LYS C 538     133.499 122.530 137.289  1.00  0.71           C  \nATOM   3978  CG  LYS C 538     133.847 121.322 136.396  1.00  0.71           C  \nATOM   3979  CD  LYS C 538     132.621 120.423 136.125  1.00  0.71           C  \nATOM   3980  CE  LYS C 538     132.921 119.142 135.335  1.00  0.71           C  \nATOM   3981  NZ  LYS C 538     133.875 118.329 136.082  1.00  0.71           N  \nATOM   3982  N   CYS C 539     135.637 122.651 139.701  1.00  0.76           N  \nATOM   3983  CA  CYS C 539     136.447 121.812 140.583  1.00  0.76           C  \nATOM   3984  C   CYS C 539     136.327 120.320 140.277  1.00  0.76           C  \nATOM   3985  O   CYS C 539     135.310 119.848 139.773  1.00  0.76           O  \nATOM   3986  CB  CYS C 539     136.108 122.089 142.077  1.00  0.76           C  \nATOM   3987  SG  CYS C 539     137.085 123.391 142.911  1.00  0.76           S  \nATOM   3988  N   ASN C 540     137.377 119.528 140.581  1.00  0.74           N  \nATOM   3989  CA  ASN C 540     137.333 118.078 140.527  1.00  0.74           C  \nATOM   3990  C   ASN C 540     136.617 117.505 141.757  1.00  0.74           C  \nATOM   3991  O   ASN C 540     137.176 116.799 142.593  1.00  0.74           O  \nATOM   3992  CB  ASN C 540     138.763 117.500 140.436  1.00  0.74           C  \nATOM   3993  CG  ASN C 540     139.396 117.778 139.079  1.00  0.74           C  \nATOM   3994  OD1 ASN C 540     138.776 117.939 138.031  1.00  0.74           O  \nATOM   3995  ND2 ASN C 540     140.750 117.816 139.073  1.00  0.74           N  \nATOM   3996  N   LEU C 541     135.314 117.820 141.876  1.00  0.70           N  \nATOM   3997  CA  LEU C 541     134.396 117.167 142.782  1.00  0.70           C  \nATOM   3998  C   LEU C 541     133.864 115.956 142.059  1.00  0.70           C  \nATOM   3999  O   LEU C 541     133.709 116.017 140.847  1.00  0.70           O  \nATOM   4000  CB  LEU C 541     133.177 118.067 143.108  1.00  0.70           C  \nATOM   4001  CG  LEU C 541     133.552 119.322 143.910  1.00  0.70           C  \nATOM   4002  CD1 LEU C 541     132.426 120.366 143.856  1.00  0.70           C  \nATOM   4003  CD2 LEU C 541     133.885 118.943 145.360  1.00  0.70           C  \nATOM   4004  N   LEU C 542     133.582 114.850 142.786  1.00  0.56           N  \nATOM   4005  CA  LEU C 542     133.007 113.615 142.267  1.00  0.56           C  \nATOM   4006  C   LEU C 542     134.073 112.795 141.541  1.00  0.56           C  \nATOM   4007  O   LEU C 542     134.588 111.792 142.030  1.00  0.56           O  \nATOM   4008  CB  LEU C 542     131.709 113.806 141.409  1.00  0.56           C  \nATOM   4009  CG  LEU C 542     130.639 114.772 141.984  1.00  0.56           C  \nATOM   4010  CD1 LEU C 542     129.513 114.982 140.957  1.00  0.56           C  \nATOM   4011  CD2 LEU C 542     130.068 114.282 143.320  1.00  0.56           C  \nATOM   4012  N   GLU C 543     134.465 113.263 140.348  1.00  0.57           N  \nATOM   4013  CA  GLU C 543     135.445 112.673 139.478  1.00  0.57           C  \nATOM   4014  C   GLU C 543     136.832 113.313 139.584  1.00  0.57           C  \nATOM   4015  O   GLU C 543     137.290 113.769 140.634  1.00  0.57           O  \nATOM   4016  CB  GLU C 543     134.867 112.666 138.023  1.00  0.57           C  \nATOM   4017  CG  GLU C 543     134.756 113.999 137.212  1.00  0.57           C  \nATOM   4018  CD  GLU C 543     133.643 114.979 137.564  1.00  0.57           C  \nATOM   4019  OE1 GLU C 543     133.926 116.181 137.344  1.00  0.57           O  \nATOM   4020  OE2 GLU C 543     132.518 114.604 137.948  1.00  0.57           O  \nATOM   4021  N   GLY C 544     137.576 113.294 138.457  1.00  0.67           N  \nATOM   4022  CA  GLY C 544     138.906 113.857 138.290  1.00  0.67           C  \nATOM   4023  C   GLY C 544     139.953 112.934 138.825  1.00  0.67           C  \nATOM   4024  O   GLY C 544     139.631 111.906 139.410  1.00  0.67           O  \nATOM   4025  N   GLU C 545     141.243 113.269 138.630  1.00  0.59           N  \nATOM   4026  CA  GLU C 545     142.354 112.517 139.191  1.00  0.59           C  \nATOM   4027  C   GLU C 545     142.674 112.987 140.618  1.00  0.59           C  \nATOM   4028  O   GLU C 545     142.659 112.134 141.509  1.00  0.59           O  \nATOM   4029  CB  GLU C 545     143.577 112.489 138.230  1.00  0.59           C  \nATOM   4030  CG  GLU C 545     144.812 111.732 138.786  1.00  0.59           C  \nATOM   4031  CD  GLU C 545     144.660 110.211 138.707  1.00  0.59           C  \nATOM   4032  OE1 GLU C 545     145.599 109.526 139.182  1.00  0.59           O  \nATOM   4033  OE2 GLU C 545     143.614 109.730 138.201  1.00  0.59           O  \nATOM   4034  N   PRO C 546     142.871 114.261 140.994  1.00  0.72           N  \nATOM   4035  CA  PRO C 546     142.940 114.657 142.391  1.00  0.72           C  \nATOM   4036  C   PRO C 546     141.546 115.065 142.821  1.00  0.72           C  \nATOM   4037  O   PRO C 546     140.885 115.836 142.131  1.00  0.72           O  \nATOM   4038  CB  PRO C 546     143.892 115.879 142.410  1.00  0.72           C  \nATOM   4039  CG  PRO C 546     144.331 116.043 140.945  1.00  0.72           C  \nATOM   4040  CD  PRO C 546     143.196 115.400 140.155  1.00  0.72           C  \nATOM   4041  N   ARG C 547     141.058 114.552 143.956  1.00  0.61           N  \nATOM   4042  CA  ARG C 547     139.831 114.995 144.582  1.00  0.61           C  \nATOM   4043  C   ARG C 547     139.991 116.395 145.140  1.00  0.61           C  \nATOM   4044  O   ARG C 547     141.049 116.694 145.687  1.00  0.61           O  \nATOM   4045  CB  ARG C 547     139.519 114.071 145.780  1.00  0.61           C  \nATOM   4046  CG  ARG C 547     139.727 112.571 145.504  1.00  0.61           C  \nATOM   4047  CD  ARG C 547     138.676 111.968 144.556  1.00  0.61           C  \nATOM   4048  NE  ARG C 547     139.196 111.822 143.164  1.00  0.61           N  \nATOM   4049  CZ  ARG C 547     140.084 110.887 142.812  1.00  0.61           C  \nATOM   4050  NH1 ARG C 547     140.831 110.230 143.691  1.00  0.61           N  \nATOM   4051  NH2 ARG C 547     140.237 110.521 141.553  1.00  0.61           N  \nATOM   4052  N   GLU C 548     138.973 117.267 145.062  1.00  0.75           N  \nATOM   4053  CA  GLU C 548     139.118 118.647 145.476  1.00  0.75           C  \nATOM   4054  C   GLU C 548     137.888 119.074 146.264  1.00  0.75           C  \nATOM   4055  O   GLU C 548     136.915 118.328 146.390  1.00  0.75           O  \nATOM   4056  CB  GLU C 548     139.329 119.572 144.234  1.00  0.75           C  \nATOM   4057  CG  GLU C 548     140.661 119.334 143.456  1.00  0.75           C  \nATOM   4058  CD  GLU C 548     140.757 120.035 142.098  1.00  0.75           C  \nATOM   4059  OE1 GLU C 548     139.716 120.483 141.543  1.00  0.75           O  \nATOM   4060  OE2 GLU C 548     141.889 120.113 141.553  1.00  0.75           O  \nATOM   4061  N   PHE C 549     137.921 120.287 146.844  1.00  0.77           N  \nATOM   4062  CA  PHE C 549     136.787 120.934 147.478  1.00  0.77           C  \nATOM   4063  C   PHE C 549     136.770 122.402 147.044  1.00  0.77           C  \nATOM   4064  O   PHE C 549     137.719 122.869 146.414  1.00  0.77           O  \nATOM   4065  CB  PHE C 549     136.741 120.715 149.030  1.00  0.77           C  \nATOM   4066  CG  PHE C 549     137.802 121.502 149.767  1.00  0.77           C  \nATOM   4067  CD1 PHE C 549     139.118 121.024 149.883  1.00  0.77           C  \nATOM   4068  CD2 PHE C 549     137.496 122.766 150.304  1.00  0.77           C  \nATOM   4069  CE1 PHE C 549     140.102 121.786 150.526  1.00  0.77           C  \nATOM   4070  CE2 PHE C 549     138.484 123.540 150.924  1.00  0.77           C  \nATOM   4071  CZ  PHE C 549     139.788 123.052 151.037  1.00  0.77           C  \nATOM   4072  N   VAL C 550     135.667 123.138 147.321  1.00  0.77           N  \nATOM   4073  CA  VAL C 550     135.439 124.501 146.860  1.00  0.77           C  \nATOM   4074  C   VAL C 550     135.257 125.422 148.041  1.00  0.77           C  \nATOM   4075  O   VAL C 550     134.264 125.315 148.757  1.00  0.77           O  \nATOM   4076  CB  VAL C 550     134.154 124.655 146.041  1.00  0.77           C  \nATOM   4077  CG1 VAL C 550     134.104 126.079 145.433  1.00  0.77           C  \nATOM   4078  CG2 VAL C 550     134.185 123.628 144.906  1.00  0.77           C  \nATOM   4079  N   GLU C 551     136.166 126.391 148.233  1.00  0.70           N  \nATOM   4080  CA  GLU C 551     135.980 127.489 149.156  1.00  0.70           C  \nATOM   4081  C   GLU C 551     136.537 128.704 148.459  1.00  0.70           C  \nATOM   4082  O   GLU C 551     137.579 128.616 147.819  1.00  0.70           O  \nATOM   4083  CB  GLU C 551     136.719 127.295 150.495  1.00  0.70           C  \nATOM   4084  CG  GLU C 551     135.962 126.340 151.443  1.00  0.70           C  \nATOM   4085  CD  GLU C 551     136.595 126.261 152.827  1.00  0.70           C  \nATOM   4086  OE1 GLU C 551     135.986 125.582 153.689  1.00  0.70           O  \nATOM   4087  OE2 GLU C 551     137.690 126.854 153.035  1.00  0.70           O  \nATOM   4088  N   ASN C 552     135.813 129.847 148.487  1.00  0.69           N  \nATOM   4089  CA  ASN C 552     136.193 131.122 147.873  1.00  0.69           C  \nATOM   4090  C   ASN C 552     136.510 131.045 146.386  1.00  0.69           C  \nATOM   4091  O   ASN C 552     137.305 131.818 145.863  1.00  0.69           O  \nATOM   4092  CB  ASN C 552     137.366 131.831 148.603  1.00  0.69           C  \nATOM   4093  CG  ASN C 552     136.955 132.228 150.012  1.00  0.69           C  \nATOM   4094  OD1 ASN C 552     135.819 132.087 150.447  1.00  0.69           O  \nATOM   4095  ND2 ASN C 552     137.937 132.801 150.750  1.00  0.69           N  \nATOM   4096  N   SER C 553     135.855 130.101 145.685  1.00  0.75           N  \nATOM   4097  CA  SER C 553     136.028 129.839 144.265  1.00  0.75           C  \nATOM   4098  C   SER C 553     137.374 129.234 143.899  1.00  0.75           C  \nATOM   4099  O   SER C 553     137.804 129.298 142.753  1.00  0.75           O  \nATOM   4100  CB  SER C 553     135.699 131.045 143.350  1.00  0.75           C  \nATOM   4101  OG  SER C 553     134.379 131.507 143.638  1.00  0.75           O  \nATOM   4102  N   GLU C 554     138.056 128.568 144.845  1.00  0.74           N  \nATOM   4103  CA  GLU C 554     139.347 127.955 144.644  1.00  0.74           C  \nATOM   4104  C   GLU C 554     139.193 126.469 144.825  1.00  0.74           C  \nATOM   4105  O   GLU C 554     138.360 125.997 145.601  1.00  0.74           O  \nATOM   4106  CB  GLU C 554     140.383 128.479 145.662  1.00  0.74           C  \nATOM   4107  CG  GLU C 554     140.848 129.916 145.334  1.00  0.74           C  \nATOM   4108  CD  GLU C 554     141.994 130.380 146.228  1.00  0.74           C  \nATOM   4109  OE1 GLU C 554     142.299 129.694 147.240  1.00  0.74           O  \nATOM   4110  OE2 GLU C 554     142.588 131.433 145.881  1.00  0.74           O  \nATOM   4111  N   CYS C 555     139.990 125.697 144.071  1.00  0.78           N  \nATOM   4112  CA  CYS C 555     139.997 124.256 144.074  1.00  0.78           C  \nATOM   4113  C   CYS C 555     141.263 123.755 144.717  1.00  0.78           C  \nATOM   4114  O   CYS C 555     142.365 123.929 144.195  1.00  0.78           O  \nATOM   4115  CB  CYS C 555     140.016 123.741 142.621  1.00  0.78           C  \nATOM   4116  SG  CYS C 555     138.513 124.141 141.694  1.00  0.78           S  \nATOM   4117  N   ILE C 556     141.128 123.106 145.878  1.00  0.77           N  \nATOM   4118  CA  ILE C 556     142.242 122.650 146.673  1.00  0.77           C  \nATOM   4119  C   ILE C 556     142.097 121.158 146.793  1.00  0.77           C  \nATOM   4120  O   ILE C 556     141.010 120.660 147.083  1.00  0.77           O  \nATOM   4121  CB  ILE C 556     142.249 123.239 148.083  1.00  0.77           C  \nATOM   4122  CG1 ILE C 556     142.275 124.790 148.121  1.00  0.77           C  \nATOM   4123  CG2 ILE C 556     143.471 122.689 148.857  1.00  0.77           C  \nATOM   4124  CD1 ILE C 556     140.901 125.481 148.058  1.00  0.77           C  \nATOM   4125  N   GLN C 557     143.197 120.414 146.566  1.00  0.75           N  \nATOM   4126  CA  GLN C 557     143.264 118.976 146.682  1.00  0.75           C  \nATOM   4127  C   GLN C 557     142.912 118.472 148.081  1.00  0.75           C  \nATOM   4128  O   GLN C 557     143.326 119.034 149.099  1.00  0.75           O  \nATOM   4129  CB  GLN C 557     144.666 118.461 146.245  1.00  0.75           C  \nATOM   4130  CG  GLN C 557     145.078 118.958 144.832  1.00  0.75           C  \nATOM   4131  CD  GLN C 557     146.461 118.439 144.427  1.00  0.75           C  \nATOM   4132  OE1 GLN C 557     147.173 117.779 145.170  1.00  0.75           O  \nATOM   4133  NE2 GLN C 557     146.877 118.778 143.181  1.00  0.75           N  \nATOM   4134  N   CYS C 558     142.129 117.379 148.159  1.00  0.74           N  \nATOM   4135  CA  CYS C 558     141.928 116.605 149.373  1.00  0.74           C  \nATOM   4136  C   CYS C 558     143.231 116.003 149.837  1.00  0.74           C  \nATOM   4137  O   CYS C 558     144.119 115.716 149.037  1.00  0.74           O  \nATOM   4138  CB  CYS C 558     140.897 115.450 149.213  1.00  0.74           C  \nATOM   4139  SG  CYS C 558     139.232 116.046 148.783  1.00  0.74           S  \nATOM   4140  N   HIS C 559     143.385 115.782 151.156  1.00  0.78           N  \nATOM   4141  CA  HIS C 559     144.521 115.030 151.661  1.00  0.78           C  \nATOM   4142  C   HIS C 559     144.656 113.634 150.996  1.00  0.78           C  \nATOM   4143  O   HIS C 559     143.615 113.043 150.694  1.00  0.78           O  \nATOM   4144  CB  HIS C 559     144.421 114.815 153.187  1.00  0.78           C  \nATOM   4145  CG  HIS C 559     145.694 114.348 153.807  1.00  0.78           C  \nATOM   4146  ND1 HIS C 559     146.665 115.271 154.133  1.00  0.78           N  \nATOM   4147  CD2 HIS C 559     146.077 113.111 154.196  1.00  0.78           C  \nATOM   4148  CE1 HIS C 559     147.613 114.580 154.726  1.00  0.78           C  \nATOM   4149  NE2 HIS C 559     147.311 113.259 154.789  1.00  0.78           N  \nATOM   4150  N   PRO C 560     145.837 113.048 150.732  1.00  0.78           N  \nATOM   4151  CA  PRO C 560     145.980 111.822 149.933  1.00  0.78           C  \nATOM   4152  C   PRO C 560     145.240 110.601 150.466  1.00  0.78           C  \nATOM   4153  O   PRO C 560     144.899 109.708 149.696  1.00  0.78           O  \nATOM   4154  CB  PRO C 560     147.503 111.590 149.896  1.00  0.78           C  \nATOM   4155  CG  PRO C 560     148.093 113.005 149.914  1.00  0.78           C  \nATOM   4156  CD  PRO C 560     147.090 113.803 150.758  1.00  0.78           C  \nATOM   4157  N   GLU C 561     144.995 110.582 151.789  1.00  0.73           N  \nATOM   4158  CA  GLU C 561     144.360 109.534 152.562  1.00  0.73           C  \nATOM   4159  C   GLU C 561     142.845 109.663 152.592  1.00  0.73           C  \nATOM   4160  O   GLU C 561     142.187 109.084 153.452  1.00  0.73           O  \nATOM   4161  CB  GLU C 561     144.884 109.550 154.032  1.00  0.73           C  \nATOM   4162  CG  GLU C 561     146.430 109.475 154.161  1.00  0.73           C  \nATOM   4163  CD  GLU C 561     146.973 108.246 153.448  1.00  0.73           C  \nATOM   4164  OE1 GLU C 561     146.290 107.198 153.516  1.00  0.73           O  \nATOM   4165  OE2 GLU C 561     148.085 108.349 152.863  1.00  0.73           O  \nATOM   4166  N   CYS C 562     142.236 110.403 151.646  1.00  0.75           N  \nATOM   4167  CA  CYS C 562     140.799 110.495 151.468  1.00  0.75           C  \nATOM   4168  C   CYS C 562     140.409 109.589 150.323  1.00  0.75           C  \nATOM   4169  O   CYS C 562     140.860 109.753 149.189  1.00  0.75           O  \nATOM   4170  CB  CYS C 562     140.310 111.930 151.114  1.00  0.75           C  \nATOM   4171  SG  CYS C 562     140.385 113.196 152.434  1.00  0.75           S  \nATOM   4172  N   LEU C 563     139.541 108.597 150.607  1.00  0.72           N  \nATOM   4173  CA  LEU C 563     139.124 107.580 149.664  1.00  0.72           C  \nATOM   4174  C   LEU C 563     138.454 108.179 148.421  1.00  0.72           C  \nATOM   4175  O   LEU C 563     137.580 109.028 148.601  1.00  0.72           O  \nATOM   4176  CB  LEU C 563     138.121 106.608 150.336  1.00  0.72           C  \nATOM   4177  CG  LEU C 563     137.778 105.346 149.509  1.00  0.72           C  \nATOM   4178  CD1 LEU C 563     138.411 104.100 150.152  1.00  0.72           C  \nATOM   4179  CD2 LEU C 563     136.257 105.166 149.348  1.00  0.72           C  \nATOM   4180  N   PRO C 564     138.783 107.860 147.167  1.00  0.66           N  \nATOM   4181  CA  PRO C 564     137.992 108.270 146.009  1.00  0.66           C  \nATOM   4182  C   PRO C 564     136.501 107.986 146.072  1.00  0.66           C  \nATOM   4183  O   PRO C 564     136.089 106.842 145.929  1.00  0.66           O  \nATOM   4184  CB  PRO C 564     138.684 107.597 144.804  1.00  0.66           C  \nATOM   4185  CG  PRO C 564     139.585 106.522 145.427  1.00  0.66           C  \nATOM   4186  CD  PRO C 564     139.978 107.119 146.775  1.00  0.66           C  \nATOM   4187  N   GLN C 565     135.660 109.033 146.188  1.00  0.56           N  \nATOM   4188  CA  GLN C 565     134.237 108.839 146.221  1.00  0.56           C  \nATOM   4189  C   GLN C 565     133.710 109.033 144.824  1.00  0.56           C  \nATOM   4190  O   GLN C 565     133.731 110.130 144.287  1.00  0.56           O  \nATOM   4191  CB  GLN C 565     133.572 109.845 147.190  1.00  0.56           C  \nATOM   4192  CG  GLN C 565     134.081 109.713 148.649  1.00  0.56           C  \nATOM   4193  CD  GLN C 565     133.712 108.373 149.287  1.00  0.56           C  \nATOM   4194  OE1 GLN C 565     132.886 107.604 148.812  1.00  0.56           O  \nATOM   4195  NE2 GLN C 565     134.346 108.094 150.454  1.00  0.56           N  \nATOM   4196  N   ALA C 566     133.216 107.949 144.198  1.00  0.55           N  \nATOM   4197  CA  ALA C 566     132.662 108.001 142.862  1.00  0.55           C  \nATOM   4198  C   ALA C 566     131.176 108.368 142.887  1.00  0.55           C  \nATOM   4199  O   ALA C 566     130.540 108.512 141.847  1.00  0.55           O  \nATOM   4200  CB  ALA C 566     132.814 106.597 142.229  1.00  0.55           C  \nATOM   4201  N   MET C 567     130.606 108.522 144.103  1.00  0.48           N  \nATOM   4202  CA  MET C 567     129.222 108.875 144.356  1.00  0.48           C  \nATOM   4203  C   MET C 567     129.102 110.351 144.671  1.00  0.48           C  \nATOM   4204  O   MET C 567     128.811 111.158 143.798  1.00  0.48           O  \nATOM   4205  CB  MET C 567     128.615 108.022 145.511  1.00  0.48           C  \nATOM   4206  CG  MET C 567     128.626 106.495 145.266  1.00  0.48           C  \nATOM   4207  SD  MET C 567     127.359 105.885 144.099  1.00  0.48           S  \nATOM   4208  CE  MET C 567     128.206 106.089 142.501  1.00  0.48           C  \nATOM   4209  N   ASN C 568     129.300 110.743 145.945  1.00  0.53           N  \nATOM   4210  CA  ASN C 568     129.165 112.119 146.367  1.00  0.53           C  \nATOM   4211  C   ASN C 568     130.545 112.784 146.350  1.00  0.53           C  \nATOM   4212  O   ASN C 568     131.476 112.352 145.679  1.00  0.53           O  \nATOM   4213  CB  ASN C 568     128.548 112.201 147.798  1.00  0.53           C  \nATOM   4214  CG  ASN C 568     127.169 111.538 147.884  1.00  0.53           C  \nATOM   4215  OD1 ASN C 568     126.579 111.024 146.950  1.00  0.53           O  \nATOM   4216  ND2 ASN C 568     126.605 111.568 149.120  1.00  0.53           N  \nATOM   4217  N   ILE C 569     130.717 113.884 147.107  1.00  0.63           N  \nATOM   4218  CA  ILE C 569     131.985 114.564 147.309  1.00  0.63           C  \nATOM   4219  C   ILE C 569     132.985 113.719 148.081  1.00  0.63           C  \nATOM   4220  O   ILE C 569     132.644 112.686 148.645  1.00  0.63           O  \nATOM   4221  CB  ILE C 569     131.787 115.872 148.076  1.00  0.63           C  \nATOM   4222  CG1 ILE C 569     131.313 115.611 149.540  1.00  0.63           C  \nATOM   4223  CG2 ILE C 569     130.834 116.772 147.250  1.00  0.63           C  \nATOM   4224  CD1 ILE C 569     131.195 116.876 150.397  1.00  0.63           C  \nATOM   4225  N   THR C 570     134.253 114.162 148.160  1.00  0.73           N  \nATOM   4226  CA  THR C 570     135.303 113.370 148.798  1.00  0.73           C  \nATOM   4227  C   THR C 570     135.773 113.947 150.111  1.00  0.73           C  \nATOM   4228  O   THR C 570     136.058 113.211 151.058  1.00  0.73           O  \nATOM   4229  CB  THR C 570     136.530 113.292 147.923  1.00  0.73           C  \nATOM   4230  OG1 THR C 570     136.217 112.594 146.734  1.00  0.73           O  \nATOM   4231  CG2 THR C 570     137.646 112.482 148.586  1.00  0.73           C  \nATOM   4232  N   CYS C 571     135.869 115.282 150.234  1.00  0.78           N  \nATOM   4233  CA  CYS C 571     136.347 115.883 151.454  1.00  0.78           C  \nATOM   4234  C   CYS C 571     135.719 117.250 151.583  1.00  0.78           C  \nATOM   4235  O   CYS C 571     135.149 117.772 150.625  1.00  0.78           O  \nATOM   4236  CB  CYS C 571     137.907 115.986 151.547  1.00  0.78           C  \nATOM   4237  SG  CYS C 571     138.694 117.159 150.384  1.00  0.78           S  \nATOM   4238  N   THR C 572     135.792 117.835 152.791  1.00  0.79           N  \nATOM   4239  CA  THR C 572     135.288 119.167 153.106  1.00  0.79           C  \nATOM   4240  C   THR C 572     136.407 120.088 153.553  1.00  0.79           C  \nATOM   4241  O   THR C 572     136.165 121.135 154.136  1.00  0.79           O  \nATOM   4242  CB  THR C 572     134.140 119.169 154.130  1.00  0.79           C  \nATOM   4243  OG1 THR C 572     134.476 118.641 155.400  1.00  0.79           O  \nATOM   4244  CG2 THR C 572     133.025 118.247 153.625  1.00  0.79           C  \nATOM   4245  N   GLY C 573     137.683 119.742 153.280  1.00  0.83           N  \nATOM   4246  CA  GLY C 573     138.784 120.578 153.707  1.00  0.83           C  \nATOM   4247  C   GLY C 573     140.069 119.940 153.300  1.00  0.83           C  \nATOM   4248  O   GLY C 573     140.086 118.857 152.724  1.00  0.83           O  \nATOM   4249  N   ARG C 574     141.194 120.627 153.569  1.00  0.73           N  \nATOM   4250  CA  ARG C 574     142.520 120.177 153.186  1.00  0.73           C  \nATOM   4251  C   ARG C 574     143.022 119.010 153.992  1.00  0.73           C  \nATOM   4252  O   ARG C 574     143.593 118.070 153.458  1.00  0.73           O  \nATOM   4253  CB  ARG C 574     143.570 121.299 153.394  1.00  0.73           C  \nATOM   4254  CG  ARG C 574     143.225 122.584 152.628  1.00  0.73           C  \nATOM   4255  CD  ARG C 574     144.289 123.683 152.746  1.00  0.73           C  \nATOM   4256  NE  ARG C 574     143.860 124.870 151.910  1.00  0.73           N  \nATOM   4257  CZ  ARG C 574     143.030 125.855 152.293  1.00  0.73           C  \nATOM   4258  NH1 ARG C 574     142.427 125.848 153.476  1.00  0.73           N  \nATOM   4259  NH2 ARG C 574     142.772 126.871 151.467  1.00  0.73           N  \nATOM   4260  N   GLY C 575     142.855 119.092 155.329  1.00  0.85           N  \nATOM   4261  CA  GLY C 575     143.363 118.085 156.236  1.00  0.85           C  \nATOM   4262  C   GLY C 575     142.675 116.746 156.120  1.00  0.85           C  \nATOM   4263  O   GLY C 575     141.558 116.649 155.606  1.00  0.85           O  \nATOM   4264  N   PRO C 576     143.271 115.693 156.654  1.00  0.82           N  \nATOM   4265  CA  PRO C 576     142.698 114.354 156.618  1.00  0.82           C  \nATOM   4266  C   PRO C 576     141.466 114.207 157.505  1.00  0.82           C  \nATOM   4267  O   PRO C 576     140.796 113.185 157.404  1.00  0.82           O  \nATOM   4268  CB  PRO C 576     143.862 113.466 157.098  1.00  0.82           C  \nATOM   4269  CG  PRO C 576     144.754 114.388 157.931  1.00  0.82           C  \nATOM   4270  CD  PRO C 576     144.643 115.697 157.169  1.00  0.82           C  \nATOM   4271  N   ASP C 577     141.145 115.210 158.344  1.00  0.79           N  \nATOM   4272  CA  ASP C 577     140.095 115.240 159.344  1.00  0.79           C  \nATOM   4273  C   ASP C 577     138.722 115.416 158.700  1.00  0.79           C  \nATOM   4274  O   ASP C 577     137.667 115.254 159.308  1.00  0.79           O  \nATOM   4275  CB  ASP C 577     140.318 116.473 160.280  1.00  0.79           C  \nATOM   4276  CG  ASP C 577     141.733 116.584 160.831  1.00  0.79           C  \nATOM   4277  OD1 ASP C 577     142.527 115.632 160.665  1.00  0.79           O  \nATOM   4278  OD2 ASP C 577     142.042 117.676 161.372  1.00  0.79           O  \nATOM   4279  N   ASN C 578     138.723 115.829 157.417  1.00  0.79           N  \nATOM   4280  CA  ASN C 578     137.540 116.190 156.669  1.00  0.79           C  \nATOM   4281  C   ASN C 578     137.301 115.248 155.497  1.00  0.79           C  \nATOM   4282  O   ASN C 578     136.503 115.546 154.609  1.00  0.79           O  \nATOM   4283  CB  ASN C 578     137.697 117.634 156.137  1.00  0.79           C  \nATOM   4284  CG  ASN C 578     137.950 118.672 157.230  1.00  0.79           C  \nATOM   4285  OD1 ASN C 578     138.683 119.630 157.003  1.00  0.79           O  \nATOM   4286  ND2 ASN C 578     137.382 118.505 158.445  1.00  0.79           N  \nATOM   4287  N   CYS C 579     137.980 114.081 155.449  1.00  0.78           N  \nATOM   4288  CA  CYS C 579     137.651 112.990 154.540  1.00  0.78           C  \nATOM   4289  C   CYS C 579     136.265 112.414 154.800  1.00  0.78           C  \nATOM   4290  O   CYS C 579     135.851 112.261 155.944  1.00  0.78           O  \nATOM   4291  CB  CYS C 579     138.677 111.824 154.654  1.00  0.78           C  \nATOM   4292  SG  CYS C 579     140.400 112.261 154.240  1.00  0.78           S  \nATOM   4293  N   ILE C 580     135.507 112.032 153.747  1.00  0.71           N  \nATOM   4294  CA  ILE C 580     134.336 111.179 153.942  1.00  0.71           C  \nATOM   4295  C   ILE C 580     134.710 109.797 154.471  1.00  0.71           C  \nATOM   4296  O   ILE C 580     134.100 109.267 155.390  1.00  0.71           O  \nATOM   4297  CB  ILE C 580     133.490 111.056 152.668  1.00  0.71           C  \nATOM   4298  CG1 ILE C 580     132.867 112.448 152.355  1.00  0.71           C  \nATOM   4299  CG2 ILE C 580     132.432 109.924 152.814  1.00  0.71           C  \nATOM   4300  CD1 ILE C 580     131.520 112.416 151.617  1.00  0.71           C  \nATOM   4301  N   GLN C 581     135.762 109.181 153.900  1.00  0.70           N  \nATOM   4302  CA  GLN C 581     136.256 107.919 154.389  1.00  0.70           C  \nATOM   4303  C   GLN C 581     137.741 107.930 154.074  1.00  0.70           C  \nATOM   4304  O   GLN C 581     138.154 108.569 153.108  1.00  0.70           O  \nATOM   4305  CB  GLN C 581     135.482 106.730 153.743  1.00  0.70           C  \nATOM   4306  CG  GLN C 581     135.257 105.518 154.687  1.00  0.70           C  \nATOM   4307  CD  GLN C 581     136.186 104.341 154.382  1.00  0.70           C  \nATOM   4308  OE1 GLN C 581     135.968 103.627 153.412  1.00  0.70           O  \nATOM   4309  NE2 GLN C 581     137.231 104.109 155.211  1.00  0.70           N  \nATOM   4310  N   CYS C 582     138.587 107.288 154.915  1.00  0.74           N  \nATOM   4311  CA  CYS C 582     140.029 107.227 154.703  1.00  0.74           C  \nATOM   4312  C   CYS C 582     140.423 106.167 153.680  1.00  0.74           C  \nATOM   4313  O   CYS C 582     139.642 105.275 153.377  1.00  0.74           O  \nATOM   4314  CB  CYS C 582     140.872 106.943 155.985  1.00  0.74           C  \nATOM   4315  SG  CYS C 582     140.388 107.855 157.480  1.00  0.74           S  \nATOM   4316  N   ALA C 583     141.648 106.238 153.116  1.00  0.74           N  \nATOM   4317  CA  ALA C 583     142.106 105.288 152.118  1.00  0.74           C  \nATOM   4318  C   ALA C 583     142.791 104.037 152.680  1.00  0.74           C  \nATOM   4319  O   ALA C 583     142.731 102.968 152.075  1.00  0.74           O  \nATOM   4320  CB  ALA C 583     143.096 106.025 151.197  1.00  0.74           C  \nATOM   4321  N   HIS C 584     143.426 104.146 153.867  1.00  0.68           N  \nATOM   4322  CA  HIS C 584     144.101 103.055 154.546  1.00  0.68           C  \nATOM   4323  C   HIS C 584     143.578 102.956 155.971  1.00  0.68           C  \nATOM   4324  O   HIS C 584     142.481 102.454 156.204  1.00  0.68           O  \nATOM   4325  CB  HIS C 584     145.636 103.276 154.559  1.00  0.68           C  \nATOM   4326  CG  HIS C 584     146.267 103.091 153.224  1.00  0.68           C  \nATOM   4327  ND1 HIS C 584     146.390 104.174 152.388  1.00  0.68           N  \nATOM   4328  CD2 HIS C 584     146.807 101.992 152.644  1.00  0.68           C  \nATOM   4329  CE1 HIS C 584     146.997 103.733 151.322  1.00  0.68           C  \nATOM   4330  NE2 HIS C 584     147.279 102.409 151.415  1.00  0.68           N  \nATOM   4331  N   TYR C 585     144.339 103.450 156.973  1.00  0.71           N  \nATOM   4332  CA  TYR C 585     144.011 103.290 158.381  1.00  0.71           C  \nATOM   4333  C   TYR C 585     143.478 104.596 158.955  1.00  0.71           C  \nATOM   4334  O   TYR C 585     143.582 105.679 158.376  1.00  0.71           O  \nATOM   4335  CB  TYR C 585     145.190 102.753 159.260  1.00  0.71           C  \nATOM   4336  CG  TYR C 585     145.861 101.551 158.640  1.00  0.71           C  \nATOM   4337  CD1 TYR C 585     145.351 100.246 158.730  1.00  0.71           C  \nATOM   4338  CD2 TYR C 585     147.049 101.747 157.932  1.00  0.71           C  \nATOM   4339  CE1 TYR C 585     146.020  99.168 158.122  1.00  0.71           C  \nATOM   4340  CE2 TYR C 585     147.725 100.683 157.319  1.00  0.71           C  \nATOM   4341  CZ  TYR C 585     147.211  99.384 157.421  1.00  0.71           C  \nATOM   4342  OH  TYR C 585     147.876  98.295 156.817  1.00  0.71           O  \nATOM   4343  N   ILE C 586     142.845 104.532 160.133  1.00  0.72           N  \nATOM   4344  CA  ILE C 586     142.321 105.703 160.808  1.00  0.72           C  \nATOM   4345  C   ILE C 586     142.912 105.764 162.218  1.00  0.72           C  \nATOM   4346  O   ILE C 586     142.616 104.934 163.076  1.00  0.72           O  \nATOM   4347  CB  ILE C 586     140.779 105.738 160.722  1.00  0.72           C  \nATOM   4348  CG1 ILE C 586     140.173 106.865 161.601  1.00  0.72           C  \nATOM   4349  CG2 ILE C 586     140.152 104.336 160.961  1.00  0.72           C  \nATOM   4350  CD1 ILE C 586     138.637 106.943 161.599  1.00  0.72           C  \nATOM   4351  N   ASP C 587     143.787 106.764 162.510  1.00  0.76           N  \nATOM   4352  CA  ASP C 587     144.237 107.072 163.860  1.00  0.76           C  \nATOM   4353  C   ASP C 587     143.346 108.182 164.392  1.00  0.76           C  \nATOM   4354  O   ASP C 587     143.620 109.378 164.272  1.00  0.76           O  \nATOM   4355  CB  ASP C 587     145.771 107.389 163.949  1.00  0.76           C  \nATOM   4356  CG  ASP C 587     146.305 107.352 165.358  1.00  0.76           C  \nATOM   4357  OD1 ASP C 587     145.547 107.005 166.301  1.00  0.76           O  \nATOM   4358  OD2 ASP C 587     147.518 107.635 165.560  1.00  0.76           O  \nATOM   4359  N   GLY C 588     142.225 107.773 165.023  1.00  0.74           N  \nATOM   4360  CA  GLY C 588     141.298 108.678 165.683  1.00  0.74           C  \nATOM   4361  C   GLY C 588     140.689 109.735 164.769  1.00  0.74           C  \nATOM   4362  O   GLY C 588     140.088 109.342 163.774  1.00  0.74           O  \nATOM   4363  N   PRO C 589     140.742 111.047 165.017  1.00  0.75           N  \nATOM   4364  CA  PRO C 589     140.217 112.060 164.093  1.00  0.75           C  \nATOM   4365  C   PRO C 589     140.925 112.119 162.739  1.00  0.75           C  \nATOM   4366  O   PRO C 589     140.279 112.490 161.764  1.00  0.75           O  \nATOM   4367  CB  PRO C 589     140.373 113.395 164.861  1.00  0.75           C  \nATOM   4368  CG  PRO C 589     141.464 113.097 165.896  1.00  0.75           C  \nATOM   4369  CD  PRO C 589     141.206 111.639 166.268  1.00  0.75           C  \nATOM   4370  N   HIS C 590     142.237 111.800 162.670  1.00  0.76           N  \nATOM   4371  CA  HIS C 590     143.060 111.945 161.479  1.00  0.76           C  \nATOM   4372  C   HIS C 590     143.040 110.654 160.656  1.00  0.76           C  \nATOM   4373  O   HIS C 590     143.040 109.539 161.179  1.00  0.76           O  \nATOM   4374  CB  HIS C 590     144.562 112.239 161.812  1.00  0.76           C  \nATOM   4375  CG  HIS C 590     144.821 113.455 162.655  1.00  0.76           C  \nATOM   4376  ND1 HIS C 590     145.101 114.638 162.012  1.00  0.76           N  \nATOM   4377  CD2 HIS C 590     144.638 113.675 163.982  1.00  0.76           C  \nATOM   4378  CE1 HIS C 590     145.038 115.564 162.942  1.00  0.76           C  \nATOM   4379  NE2 HIS C 590     144.772 115.036 164.164  1.00  0.76           N  \nATOM   4380  N   CYS C 591     143.090 110.767 159.314  1.00  0.76           N  \nATOM   4381  CA  CYS C 591     143.243 109.651 158.386  1.00  0.76           C  \nATOM   4382  C   CYS C 591     144.733 109.486 158.117  1.00  0.76           C  \nATOM   4383  O   CYS C 591     145.373 110.400 157.597  1.00  0.76           O  \nATOM   4384  CB  CYS C 591     142.540 109.890 157.008  1.00  0.76           C  \nATOM   4385  SG  CYS C 591     140.729 109.778 157.006  1.00  0.76           S  \nATOM   4386  N   VAL C 592     145.327 108.329 158.478  1.00  0.76           N  \nATOM   4387  CA  VAL C 592     146.765 108.089 158.426  1.00  0.76           C  \nATOM   4388  C   VAL C 592     147.056 106.953 157.457  1.00  0.76           C  \nATOM   4389  O   VAL C 592     146.334 105.960 157.396  1.00  0.76           O  \nATOM   4390  CB  VAL C 592     147.361 107.705 159.788  1.00  0.76           C  \nATOM   4391  CG1 VAL C 592     148.903 107.718 159.760  1.00  0.76           C  \nATOM   4392  CG2 VAL C 592     146.945 108.716 160.869  1.00  0.76           C  \nATOM   4393  N   LYS C 593     148.159 107.053 156.690  1.00  0.69           N  \nATOM   4394  CA  LYS C 593     148.621 106.015 155.793  1.00  0.69           C  \nATOM   4395  C   LYS C 593     149.003 104.699 156.477  1.00  0.69           C  \nATOM   4396  O   LYS C 593     148.684 103.607 156.010  1.00  0.69           O  \nATOM   4397  CB  LYS C 593     149.867 106.531 155.048  1.00  0.69           C  \nATOM   4398  CG  LYS C 593     150.238 105.602 153.889  1.00  0.69           C  \nATOM   4399  CD  LYS C 593     151.322 106.210 153.002  1.00  0.69           C  \nATOM   4400  CE  LYS C 593     151.628 105.336 151.790  1.00  0.69           C  \nATOM   4401  NZ  LYS C 593     152.648 106.009 150.965  1.00  0.69           N  \nATOM   4402  N   THR C 594     149.727 104.784 157.615  1.00  0.73           N  \nATOM   4403  CA  THR C 594     150.171 103.677 158.453  1.00  0.73           C  \nATOM   4404  C   THR C 594     150.079 104.146 159.897  1.00  0.73           C  \nATOM   4405  O   THR C 594     150.484 105.259 160.212  1.00  0.73           O  \nATOM   4406  CB  THR C 594     151.594 103.181 158.140  1.00  0.73           C  \nATOM   4407  OG1 THR C 594     152.544 104.228 158.022  1.00  0.73           O  \nATOM   4408  CG2 THR C 594     151.588 102.493 156.768  1.00  0.73           C  \nATOM   4409  N   CYS C 595     149.509 103.350 160.839  1.00  0.77           N  \nATOM   4410  CA  CYS C 595     149.408 103.733 162.252  1.00  0.77           C  \nATOM   4411  C   CYS C 595     150.778 104.022 162.902  1.00  0.77           C  \nATOM   4412  O   CYS C 595     151.723 103.293 162.601  1.00  0.77           O  \nATOM   4413  CB  CYS C 595     148.738 102.634 163.140  1.00  0.77           C  \nATOM   4414  SG  CYS C 595     147.050 102.139 162.675  1.00  0.77           S  \nATOM   4415  N   PRO C 596     150.957 105.032 163.767  1.00  0.79           N  \nATOM   4416  CA  PRO C 596     152.233 105.373 164.406  1.00  0.79           C  \nATOM   4417  C   PRO C 596     153.082 104.246 165.000  1.00  0.79           C  \nATOM   4418  O   PRO C 596     152.547 103.369 165.679  1.00  0.79           O  \nATOM   4419  CB  PRO C 596     151.849 106.398 165.484  1.00  0.79           C  \nATOM   4420  CG  PRO C 596     150.616 107.098 164.910  1.00  0.79           C  \nATOM   4421  CD  PRO C 596     149.908 105.990 164.125  1.00  0.79           C  \nATOM   4422  N   ALA C 597     154.417 104.281 164.808  1.00  0.76           N  \nATOM   4423  CA  ALA C 597     155.295 103.222 165.262  1.00  0.76           C  \nATOM   4424  C   ALA C 597     156.690 103.766 165.537  1.00  0.76           C  \nATOM   4425  O   ALA C 597     157.702 103.287 165.036  1.00  0.76           O  \nATOM   4426  CB  ALA C 597     155.342 102.114 164.189  1.00  0.76           C  \nATOM   4427  N   GLY C 598     156.749 104.841 166.340  1.00  0.67           N  \nATOM   4428  CA  GLY C 598     158.001 105.404 166.823  1.00  0.67           C  \nATOM   4429  C   GLY C 598     157.872 106.868 167.118  1.00  0.67           C  \nATOM   4430  O   GLY C 598     158.863 107.585 167.204  1.00  0.67           O  \nATOM   4431  N   VAL C 599     156.633 107.372 167.280  1.00  0.66           N  \nATOM   4432  CA  VAL C 599     156.381 108.779 167.535  1.00  0.66           C  \nATOM   4433  C   VAL C 599     156.747 109.086 168.978  1.00  0.66           C  \nATOM   4434  O   VAL C 599     156.508 108.279 169.875  1.00  0.66           O  \nATOM   4435  CB  VAL C 599     154.936 109.168 167.183  1.00  0.66           C  \nATOM   4436  CG1 VAL C 599     154.633 110.655 167.476  1.00  0.66           C  \nATOM   4437  CG2 VAL C 599     154.715 108.904 165.675  1.00  0.66           C  \nATOM   4438  N   MET C 600     157.380 110.249 169.230  1.00  0.60           N  \nATOM   4439  CA  MET C 600     157.632 110.766 170.560  1.00  0.60           C  \nATOM   4440  C   MET C 600     156.350 111.042 171.341  1.00  0.60           C  \nATOM   4441  O   MET C 600     155.391 111.603 170.811  1.00  0.60           O  \nATOM   4442  CB  MET C 600     158.464 112.076 170.463  1.00  0.60           C  \nATOM   4443  CG  MET C 600     158.923 112.654 171.819  1.00  0.60           C  \nATOM   4444  SD  MET C 600     159.942 111.510 172.806  1.00  0.60           S  \nATOM   4445  CE  MET C 600     161.410 111.534 171.733  1.00  0.60           C  \nATOM   4446  N   GLY C 601     156.310 110.655 172.628  1.00  0.68           N  \nATOM   4447  CA  GLY C 601     155.185 110.892 173.510  1.00  0.68           C  \nATOM   4448  C   GLY C 601     155.636 111.557 174.773  1.00  0.68           C  \nATOM   4449  O   GLY C 601     156.719 112.131 174.860  1.00  0.68           O  \nATOM   4450  N   GLU C 602     154.781 111.477 175.807  1.00  0.63           N  \nATOM   4451  CA  GLU C 602     155.024 112.021 177.127  1.00  0.63           C  \nATOM   4452  C   GLU C 602     156.032 111.176 177.891  1.00  0.63           C  \nATOM   4453  O   GLU C 602     156.106 109.960 177.699  1.00  0.63           O  \nATOM   4454  CB  GLU C 602     153.689 112.126 177.923  1.00  0.63           C  \nATOM   4455  CG  GLU C 602     153.803 112.777 179.330  1.00  0.63           C  \nATOM   4456  CD  GLU C 602     154.409 114.178 179.286  1.00  0.63           C  \nATOM   4457  OE1 GLU C 602     154.341 114.836 178.221  1.00  0.63           O  \nATOM   4458  OE2 GLU C 602     155.009 114.560 180.321  1.00  0.63           O  \nATOM   4459  N   ASN C 603     156.859 111.806 178.760  1.00  0.60           N  \nATOM   4460  CA  ASN C 603     157.844 111.158 179.620  1.00  0.60           C  \nATOM   4461  C   ASN C 603     158.936 110.415 178.837  1.00  0.60           C  \nATOM   4462  O   ASN C 603     159.541 109.465 179.323  1.00  0.60           O  \nATOM   4463  CB  ASN C 603     157.118 110.261 180.678  1.00  0.60           C  \nATOM   4464  CG  ASN C 603     158.036 109.828 181.821  1.00  0.60           C  \nATOM   4465  OD1 ASN C 603     158.932 110.541 182.250  1.00  0.60           O  \nATOM   4466  ND2 ASN C 603     157.802 108.597 182.344  1.00  0.60           N  \nATOM   4467  N   ASN C 604     159.202 110.846 177.576  1.00  0.61           N  \nATOM   4468  CA  ASN C 604     160.141 110.216 176.659  1.00  0.61           C  \nATOM   4469  C   ASN C 604     159.706 108.790 176.268  1.00  0.61           C  \nATOM   4470  O   ASN C 604     160.485 107.982 175.768  1.00  0.61           O  \nATOM   4471  CB  ASN C 604     161.577 110.310 177.257  1.00  0.61           C  \nATOM   4472  CG  ASN C 604     162.689 110.107 176.236  1.00  0.61           C  \nATOM   4473  OD1 ASN C 604     162.558 110.298 175.036  1.00  0.61           O  \nATOM   4474  ND2 ASN C 604     163.878 109.726 176.769  1.00  0.61           N  \nATOM   4475  N   THR C 605     158.413 108.445 176.454  1.00  0.62           N  \nATOM   4476  CA  THR C 605     157.904 107.120 176.134  1.00  0.62           C  \nATOM   4477  C   THR C 605     157.476 107.128 174.689  1.00  0.62           C  \nATOM   4478  O   THR C 605     156.744 108.009 174.239  1.00  0.62           O  \nATOM   4479  CB  THR C 605     156.753 106.662 177.026  1.00  0.62           C  \nATOM   4480  OG1 THR C 605     157.216 106.521 178.357  1.00  0.62           O  \nATOM   4481  CG2 THR C 605     156.219 105.269 176.658  1.00  0.62           C  \nATOM   4482  N   LEU C 606     157.973 106.148 173.912  1.00  0.64           N  \nATOM   4483  CA  LEU C 606     157.652 105.913 172.519  1.00  0.64           C  \nATOM   4484  C   LEU C 606     156.205 105.472 172.316  1.00  0.64           C  \nATOM   4485  O   LEU C 606     155.508 105.057 173.239  1.00  0.64           O  \nATOM   4486  CB  LEU C 606     158.579 104.837 171.876  1.00  0.64           C  \nATOM   4487  CG  LEU C 606     160.089 105.178 171.773  1.00  0.64           C  \nATOM   4488  CD1 LEU C 606     160.883 105.097 173.095  1.00  0.64           C  \nATOM   4489  CD2 LEU C 606     160.740 104.237 170.740  1.00  0.64           C  \nATOM   4490  N   VAL C 607     155.701 105.567 171.076  1.00  0.71           N  \nATOM   4491  CA  VAL C 607     154.321 105.267 170.764  1.00  0.71           C  \nATOM   4492  C   VAL C 607     154.298 104.281 169.627  1.00  0.71           C  \nATOM   4493  O   VAL C 607     154.858 104.524 168.554  1.00  0.71           O  \nATOM   4494  CB  VAL C 607     153.555 106.524 170.373  1.00  0.71           C  \nATOM   4495  CG1 VAL C 607     152.133 106.193 169.861  1.00  0.71           C  \nATOM   4496  CG2 VAL C 607     153.483 107.448 171.610  1.00  0.71           C  \nATOM   4497  N   TRP C 608     153.621 103.144 169.854  1.00  0.65           N  \nATOM   4498  CA  TRP C 608     153.380 102.112 168.882  1.00  0.65           C  \nATOM   4499  C   TRP C 608     151.884 101.885 168.887  1.00  0.65           C  \nATOM   4500  O   TRP C 608     151.250 101.966 169.938  1.00  0.65           O  \nATOM   4501  CB  TRP C 608     154.149 100.820 169.262  1.00  0.65           C  \nATOM   4502  CG  TRP C 608     155.631 101.048 169.466  1.00  0.65           C  \nATOM   4503  CD1 TRP C 608     156.293 101.493 170.580  1.00  0.65           C  \nATOM   4504  CD2 TRP C 608     156.645 100.844 168.463  1.00  0.65           C  \nATOM   4505  NE1 TRP C 608     157.647 101.605 170.333  1.00  0.65           N  \nATOM   4506  CE2 TRP C 608     157.865 101.204 169.027  1.00  0.65           C  \nATOM   4507  CE3 TRP C 608     156.549 100.369 167.155  1.00  0.65           C  \nATOM   4508  CZ2 TRP C 608     159.054 101.102 168.304  1.00  0.65           C  \nATOM   4509  CZ3 TRP C 608     157.742 100.248 166.426  1.00  0.65           C  \nATOM   4510  CH2 TRP C 608     158.973 100.612 166.986  1.00  0.65           C  \nATOM   4511  N   LYS C 609     151.267 101.644 167.721  1.00  0.75           N  \nATOM   4512  CA  LYS C 609     149.851 101.385 167.583  1.00  0.75           C  \nATOM   4513  C   LYS C 609     149.623 100.249 166.606  1.00  0.75           C  \nATOM   4514  O   LYS C 609     150.520  99.852 165.867  1.00  0.75           O  \nATOM   4515  CB  LYS C 609     149.095 102.639 167.062  1.00  0.75           C  \nATOM   4516  CG  LYS C 609     149.018 103.767 168.102  1.00  0.75           C  \nATOM   4517  CD  LYS C 609     148.177 104.967 167.641  1.00  0.75           C  \nATOM   4518  CE  LYS C 609     148.091 106.097 168.675  1.00  0.75           C  \nATOM   4519  NZ  LYS C 609     147.399 107.248 168.096  1.00  0.75           N  \nATOM   4520  N   TYR C 610     148.396  99.701 166.579  1.00  0.74           N  \nATOM   4521  CA  TYR C 610     148.025  98.608 165.705  1.00  0.74           C  \nATOM   4522  C   TYR C 610     146.690  98.934 165.053  1.00  0.74           C  \nATOM   4523  O   TYR C 610     145.943  99.754 165.577  1.00  0.74           O  \nATOM   4524  CB  TYR C 610     147.986  97.257 166.497  1.00  0.74           C  \nATOM   4525  CG  TYR C 610     146.910  97.216 167.570  1.00  0.74           C  \nATOM   4526  CD1 TYR C 610     147.121  97.715 168.872  1.00  0.74           C  \nATOM   4527  CD2 TYR C 610     145.650  96.681 167.254  1.00  0.74           C  \nATOM   4528  CE1 TYR C 610     146.083  97.694 169.822  1.00  0.74           C  \nATOM   4529  CE2 TYR C 610     144.623  96.660 168.202  1.00  0.74           C  \nATOM   4530  CZ  TYR C 610     144.828  97.179 169.477  1.00  0.74           C  \nATOM   4531  OH  TYR C 610     143.741  97.210 170.374  1.00  0.74           O  \nATOM   4532  N   ALA C 611     146.369  98.301 163.903  1.00  0.74           N  \nATOM   4533  CA  ALA C 611     145.113  98.428 163.193  1.00  0.74           C  \nATOM   4534  C   ALA C 611     144.267  97.204 163.518  1.00  0.74           C  \nATOM   4535  O   ALA C 611     144.719  96.076 163.327  1.00  0.74           O  \nATOM   4536  CB  ALA C 611     145.368  98.504 161.666  1.00  0.74           C  \nATOM   4537  N   ASP C 612     143.050  97.414 164.066  1.00  0.68           N  \nATOM   4538  CA  ASP C 612     142.094  96.380 164.428  1.00  0.68           C  \nATOM   4539  C   ASP C 612     141.148  96.022 163.263  1.00  0.68           C  \nATOM   4540  O   ASP C 612     141.538  95.960 162.104  1.00  0.68           O  \nATOM   4541  CB  ASP C 612     141.372  96.846 165.737  1.00  0.68           C  \nATOM   4542  CG  ASP C 612     141.385  95.785 166.826  1.00  0.68           C  \nATOM   4543  OD1 ASP C 612     141.665  94.607 166.508  1.00  0.68           O  \nATOM   4544  OD2 ASP C 612     141.144  96.167 167.999  1.00  0.68           O  \nATOM   4545  N   ALA C 613     139.851  95.750 163.533  1.00  0.63           N  \nATOM   4546  CA  ALA C 613     138.883  95.366 162.515  1.00  0.63           C  \nATOM   4547  C   ALA C 613     138.494  96.456 161.511  1.00  0.63           C  \nATOM   4548  O   ALA C 613     138.596  96.301 160.299  1.00  0.63           O  \nATOM   4549  CB  ALA C 613     137.609  94.928 163.265  1.00  0.63           C  \nATOM   4550  N   GLY C 614     138.078  97.642 162.004  1.00  0.66           N  \nATOM   4551  CA  GLY C 614     137.669  98.766 161.162  1.00  0.66           C  \nATOM   4552  C   GLY C 614     138.816  99.658 160.771  1.00  0.66           C  \nATOM   4553  O   GLY C 614     138.619 100.844 160.541  1.00  0.66           O  \nATOM   4554  N   HIS C 615     140.052  99.108 160.757  1.00  0.65           N  \nATOM   4555  CA  HIS C 615     141.298  99.801 160.457  1.00  0.65           C  \nATOM   4556  C   HIS C 615     141.652 100.915 161.441  1.00  0.65           C  \nATOM   4557  O   HIS C 615     142.414 101.831 161.139  1.00  0.65           O  \nATOM   4558  CB  HIS C 615     141.320 100.270 158.986  1.00  0.65           C  \nATOM   4559  CG  HIS C 615     141.444  99.129 158.034  1.00  0.65           C  \nATOM   4560  ND1 HIS C 615     142.722  98.719 157.728  1.00  0.65           N  \nATOM   4561  CD2 HIS C 615     140.539  98.430 157.303  1.00  0.65           C  \nATOM   4562  CE1 HIS C 615     142.584  97.797 156.810  1.00  0.65           C  \nATOM   4563  NE2 HIS C 615     141.280  97.572 156.512  1.00  0.65           N  \nATOM   4564  N   VAL C 616     141.125 100.821 162.682  1.00  0.74           N  \nATOM   4565  CA  VAL C 616     141.243 101.835 163.719  1.00  0.74           C  \nATOM   4566  C   VAL C 616     142.549 101.630 164.446  1.00  0.74           C  \nATOM   4567  O   VAL C 616     142.884 100.501 164.808  1.00  0.74           O  \nATOM   4568  CB  VAL C 616     140.076 101.824 164.722  1.00  0.74           C  \nATOM   4569  CG1 VAL C 616     140.181 103.032 165.686  1.00  0.74           C  \nATOM   4570  CG2 VAL C 616     138.730 101.902 163.966  1.00  0.74           C  \nATOM   4571  N   CYS C 617     143.326 102.713 164.648  1.00  0.78           N  \nATOM   4572  CA  CYS C 617     144.602 102.661 165.326  1.00  0.78           C  \nATOM   4573  C   CYS C 617     144.424 102.815 166.828  1.00  0.78           C  \nATOM   4574  O   CYS C 617     143.942 103.840 167.304  1.00  0.78           O  \nATOM   4575  CB  CYS C 617     145.610 103.745 164.864  1.00  0.78           C  \nATOM   4576  SG  CYS C 617     145.932 103.783 163.068  1.00  0.78           S  \nATOM   4577  N   HIS C 618     144.842 101.810 167.616  1.00  0.76           N  \nATOM   4578  CA  HIS C 618     144.806 101.830 169.070  1.00  0.76           C  \nATOM   4579  C   HIS C 618     146.220 101.622 169.581  1.00  0.76           C  \nATOM   4580  O   HIS C 618     147.044 101.033 168.889  1.00  0.76           O  \nATOM   4581  CB  HIS C 618     143.892 100.716 169.614  1.00  0.76           C  \nATOM   4582  CG  HIS C 618     142.485 100.900 169.173  1.00  0.76           C  \nATOM   4583  ND1 HIS C 618     141.635 101.662 169.949  1.00  0.76           N  \nATOM   4584  CD2 HIS C 618     141.829 100.401 168.097  1.00  0.76           C  \nATOM   4585  CE1 HIS C 618     140.475 101.603 169.337  1.00  0.76           C  \nATOM   4586  NE2 HIS C 618     140.532 100.853 168.207  1.00  0.76           N  \nATOM   4587  N   LEU C 619     146.550 102.160 170.780  1.00  0.76           N  \nATOM   4588  CA  LEU C 619     147.835 102.034 171.468  1.00  0.76           C  \nATOM   4589  C   LEU C 619     148.262 100.612 171.819  1.00  0.76           C  \nATOM   4590  O   LEU C 619     147.475  99.757 172.213  1.00  0.76           O  \nATOM   4591  CB  LEU C 619     147.916 102.991 172.703  1.00  0.76           C  \nATOM   4592  CG  LEU C 619     148.869 104.202 172.520  1.00  0.76           C  \nATOM   4593  CD1 LEU C 619     148.502 105.331 173.502  1.00  0.76           C  \nATOM   4594  CD2 LEU C 619     150.350 103.815 172.712  1.00  0.76           C  \nATOM   4595  N   CYS C 620     149.569 100.326 171.657  1.00  0.77           N  \nATOM   4596  CA  CYS C 620     150.212  99.133 172.170  1.00  0.77           C  \nATOM   4597  C   CYS C 620     150.073  98.925 173.658  1.00  0.77           C  \nATOM   4598  O   CYS C 620     149.675  99.784 174.438  1.00  0.77           O  \nATOM   4599  CB  CYS C 620     151.692  99.026 171.717  1.00  0.77           C  \nATOM   4600  SG  CYS C 620     151.772  98.349 170.022  1.00  0.77           S  \nATOM   4601  N   HIS C 621     150.434  97.710 174.107  1.00  0.76           N  \nATOM   4602  CA  HIS C 621     150.726  97.532 175.507  1.00  0.76           C  \nATOM   4603  C   HIS C 621     151.949  98.371 175.910  1.00  0.76           C  \nATOM   4604  O   HIS C 621     152.870  98.424 175.095  1.00  0.76           O  \nATOM   4605  CB  HIS C 621     151.047  96.064 175.801  1.00  0.76           C  \nATOM   4606  CG  HIS C 621     150.806  95.716 177.229  1.00  0.76           C  \nATOM   4607  ND1 HIS C 621     151.895  95.402 178.007  1.00  0.76           N  \nATOM   4608  CD2 HIS C 621     149.666  95.655 177.964  1.00  0.76           C  \nATOM   4609  CE1 HIS C 621     151.408  95.149 179.202  1.00  0.76           C  \nATOM   4610  NE2 HIS C 621     150.059  95.288 179.234  1.00  0.76           N  \nATOM   4611  N   PRO C 622     152.045  99.002 177.078  1.00  0.74           N  \nATOM   4612  CA  PRO C 622     153.220  99.751 177.525  1.00  0.74           C  \nATOM   4613  C   PRO C 622     154.532  98.985 177.484  1.00  0.74           C  \nATOM   4614  O   PRO C 622     155.567  99.579 177.201  1.00  0.74           O  \nATOM   4615  CB  PRO C 622     152.870 100.139 178.973  1.00  0.74           C  \nATOM   4616  CG  PRO C 622     151.342 100.274 178.975  1.00  0.74           C  \nATOM   4617  CD  PRO C 622     150.890  99.240 177.937  1.00  0.74           C  \nATOM   4618  N   ASN C 623     154.503  97.676 177.810  1.00  0.73           N  \nATOM   4619  CA  ASN C 623     155.646  96.786 177.814  1.00  0.73           C  \nATOM   4620  C   ASN C 623     156.158  96.395 176.422  1.00  0.73           C  \nATOM   4621  O   ASN C 623     157.323  96.065 176.251  1.00  0.73           O  \nATOM   4622  CB  ASN C 623     155.284  95.441 178.500  1.00  0.73           C  \nATOM   4623  CG  ASN C 623     154.890  95.574 179.971  1.00  0.73           C  \nATOM   4624  OD1 ASN C 623     154.273  96.513 180.450  1.00  0.73           O  \nATOM   4625  ND2 ASN C 623     155.244  94.515 180.746  1.00  0.73           N  \nATOM   4626  N   CYS C 624     155.275  96.369 175.395  1.00  0.74           N  \nATOM   4627  CA  CYS C 624     155.629  96.099 174.006  1.00  0.74           C  \nATOM   4628  C   CYS C 624     156.505  97.176 173.377  1.00  0.74           C  \nATOM   4629  O   CYS C 624     156.030  98.158 172.814  1.00  0.74           O  \nATOM   4630  CB  CYS C 624     154.381  95.927 173.092  1.00  0.74           C  \nATOM   4631  SG  CYS C 624     153.390  94.433 173.421  1.00  0.74           S  \nATOM   4632  N   THR C 625     157.836  96.979 173.458  1.00  0.68           N  \nATOM   4633  CA  THR C 625     158.846  97.949 173.036  1.00  0.68           C  \nATOM   4634  C   THR C 625     159.166  97.880 171.561  1.00  0.68           C  \nATOM   4635  O   THR C 625     159.369  98.889 170.901  1.00  0.68           O  \nATOM   4636  CB  THR C 625     160.159  97.773 173.785  1.00  0.68           C  \nATOM   4637  OG1 THR C 625     159.940  97.960 175.168  1.00  0.68           O  \nATOM   4638  CG2 THR C 625     161.200  98.831 173.388  1.00  0.68           C  \nATOM   4639  N   TYR C 626     159.193  96.658 170.987  1.00  0.63           N  \nATOM   4640  CA  TYR C 626     159.413  96.414 169.568  1.00  0.63           C  \nATOM   4641  C   TYR C 626     158.108  96.529 168.780  1.00  0.63           C  \nATOM   4642  O   TYR C 626     157.944  95.916 167.729  1.00  0.63           O  \nATOM   4643  CB  TYR C 626     160.001  94.989 169.325  1.00  0.63           C  \nATOM   4644  CG  TYR C 626     161.382  94.873 169.902  1.00  0.63           C  \nATOM   4645  CD1 TYR C 626     162.491  95.280 169.142  1.00  0.63           C  \nATOM   4646  CD2 TYR C 626     161.592  94.323 171.178  1.00  0.63           C  \nATOM   4647  CE1 TYR C 626     163.790  95.146 169.651  1.00  0.63           C  \nATOM   4648  CE2 TYR C 626     162.891  94.200 171.694  1.00  0.63           C  \nATOM   4649  CZ  TYR C 626     163.989  94.614 170.928  1.00  0.63           C  \nATOM   4650  OH  TYR C 626     165.301  94.476 171.421  1.00  0.63           O  \nATOM   4651  N   GLY C 627     157.136  97.328 169.274  1.00  0.75           N  \nATOM   4652  CA  GLY C 627     155.781  97.389 168.744  1.00  0.75           C  \nATOM   4653  C   GLY C 627     154.941  96.165 168.975  1.00  0.75           C  \nATOM   4654  O   GLY C 627     155.324  95.231 169.674  1.00  0.75           O  \nATOM   4655  N   CYS C 628     153.713  96.155 168.430  1.00  0.79           N  \nATOM   4656  CA  CYS C 628     152.807  95.053 168.641  1.00  0.79           C  \nATOM   4657  C   CYS C 628     151.925  94.912 167.428  1.00  0.79           C  \nATOM   4658  O   CYS C 628     151.601  95.896 166.768  1.00  0.79           O  \nATOM   4659  CB  CYS C 628     151.962  95.207 169.954  1.00  0.79           C  \nATOM   4660  SG  CYS C 628     150.746  96.580 170.009  1.00  0.79           S  \nATOM   4661  N   THR C 629     151.526  93.675 167.080  1.00  0.79           N  \nATOM   4662  CA  THR C 629     150.615  93.425 165.977  1.00  0.79           C  \nATOM   4663  C   THR C 629     149.237  93.118 166.519  1.00  0.79           C  \nATOM   4664  O   THR C 629     148.328  92.800 165.761  1.00  0.79           O  \nATOM   4665  CB  THR C 629     151.074  92.282 165.072  1.00  0.79           C  \nATOM   4666  OG1 THR C 629     151.335  91.095 165.799  1.00  0.79           O  \nATOM   4667  CG2 THR C 629     152.414  92.656 164.425  1.00  0.79           C  \nATOM   4668  N   GLY C 630     149.024  93.243 167.848  1.00  0.82           N  \nATOM   4669  CA  GLY C 630     147.725  92.995 168.441  1.00  0.82           C  \nATOM   4670  C   GLY C 630     147.622  93.644 169.795  1.00  0.82           C  \nATOM   4671  O   GLY C 630     148.631  94.132 170.308  1.00  0.82           O  \nATOM   4672  N   PRO C 631     146.440  93.675 170.398  1.00  0.82           N  \nATOM   4673  CA  PRO C 631     146.207  94.166 171.757  1.00  0.82           C  \nATOM   4674  C   PRO C 631     147.025  93.505 172.863  1.00  0.82           C  \nATOM   4675  O   PRO C 631     147.011  92.290 172.996  1.00  0.82           O  \nATOM   4676  CB  PRO C 631     144.700  93.928 172.007  1.00  0.82           C  \nATOM   4677  CG  PRO C 631     144.095  93.703 170.616  1.00  0.82           C  \nATOM   4678  CD  PRO C 631     145.238  93.055 169.839  1.00  0.82           C  \nATOM   4679  N   GLY C 632     147.710  94.261 173.750  1.00  0.81           N  \nATOM   4680  CA  GLY C 632     148.377  93.596 174.872  1.00  0.81           C  \nATOM   4681  C   GLY C 632     149.603  92.771 174.521  1.00  0.81           C  \nATOM   4682  O   GLY C 632     150.145  92.840 173.422  1.00  0.81           O  \nATOM   4683  N   LEU C 633     150.121  92.000 175.496  1.00  0.79           N  \nATOM   4684  CA  LEU C 633     151.279  91.130 175.328  1.00  0.79           C  \nATOM   4685  C   LEU C 633     151.131  89.940 174.396  1.00  0.79           C  \nATOM   4686  O   LEU C 633     152.066  89.592 173.699  1.00  0.79           O  \nATOM   4687  CB  LEU C 633     151.804  90.623 176.683  1.00  0.79           C  \nATOM   4688  CG  LEU C 633     152.505  91.715 177.509  1.00  0.79           C  \nATOM   4689  CD1 LEU C 633     152.915  91.113 178.859  1.00  0.79           C  \nATOM   4690  CD2 LEU C 633     153.746  92.273 176.782  1.00  0.79           C  \nATOM   4691  N   GLU C 634     149.950  89.295 174.335  1.00  0.77           N  \nATOM   4692  CA  GLU C 634     149.612  88.275 173.359  1.00  0.77           C  \nATOM   4693  C   GLU C 634     149.778  88.725 171.905  1.00  0.77           C  \nATOM   4694  O   GLU C 634     150.159  87.947 171.037  1.00  0.77           O  \nATOM   4695  CB  GLU C 634     148.156  87.799 173.641  1.00  0.77           C  \nATOM   4696  CG  GLU C 634     147.105  88.913 173.956  1.00  0.77           C  \nATOM   4697  CD  GLU C 634     146.020  89.043 172.883  1.00  0.77           C  \nATOM   4698  OE1 GLU C 634     144.825  88.946 173.263  1.00  0.77           O  \nATOM   4699  OE2 GLU C 634     146.379  89.239 171.696  1.00  0.77           O  \nATOM   4700  N   GLY C 635     149.556  90.031 171.644  1.00  0.82           N  \nATOM   4701  CA  GLY C 635     149.830  90.667 170.373  1.00  0.82           C  \nATOM   4702  C   GLY C 635     151.279  90.934 170.025  1.00  0.82           C  \nATOM   4703  O   GLY C 635     151.614  91.042 168.848  1.00  0.82           O  \nATOM   4704  N   CYS C 636     152.210  91.071 170.996  1.00  0.79           N  \nATOM   4705  CA  CYS C 636     153.633  91.198 170.676  1.00  0.79           C  \nATOM   4706  C   CYS C 636     154.414  89.980 171.169  1.00  0.79           C  \nATOM   4707  O   CYS C 636     154.640  89.855 172.372  1.00  0.79           O  \nATOM   4708  CB  CYS C 636     154.313  92.542 171.124  1.00  0.79           C  \nATOM   4709  SG  CYS C 636     154.586  92.864 172.909  1.00  0.79           S  \nATOM   4710  N   PRO C 637     154.884  89.045 170.337  1.00  0.70           N  \nATOM   4711  CA  PRO C 637     155.741  87.962 170.805  1.00  0.70           C  \nATOM   4712  C   PRO C 637     157.178  88.456 170.994  1.00  0.70           C  \nATOM   4713  O   PRO C 637     158.013  88.263 170.105  1.00  0.70           O  \nATOM   4714  CB  PRO C 637     155.596  86.860 169.720  1.00  0.70           C  \nATOM   4715  CG  PRO C 637     154.506  87.362 168.756  1.00  0.70           C  \nATOM   4716  CD  PRO C 637     154.544  88.879 168.928  1.00  0.70           C  \nATOM   4717  N   THR C 638     157.455  89.116 172.127  1.00  0.45           N  \nATOM   4718  CA  THR C 638     158.772  89.570 172.572  1.00  0.45           C  \nATOM   4719  C   THR C 638     159.470  88.436 173.359  1.00  0.45           C  \nATOM   4720  O   THR C 638     158.779  87.598 173.999  1.00  0.45           O  \nATOM   4721  CB  THR C 638     158.661  90.869 173.395  1.00  0.45           C  \nATOM   4722  OG1 THR C 638     158.377  91.992 172.570  1.00  0.45           O  \nATOM   4723  CG2 THR C 638     159.927  91.288 174.155  1.00  0.45           C  \nATOM   4724  OXT THR C 638     160.728  88.373 173.303  1.00  0.45           O  \nTER    4725      THR C 638                                                      \nEND   \n"
          },
          "file_paths": {
            "pdb": "cache\\swissmodel\\P00533_swissmodel.pdb"
          },
          "quality_metrics": {
            "qmean": -0.645,
            "qmean_raw": {
              "acc_agreement_norm_score": 0.793,
              "acc_agreement_z_score": 0.622,
              "avg_local_score": 0.763,
              "avg_local_score_error": 0.053,
              "cbeta_norm_score": -0.021,
              "cbeta_z_score": 3.426,
              "interaction_norm_score": -0.016,
              "interaction_z_score": -1.074,
              "packing_norm_score": -0.336,
              "packing_z_score": -0.396,
              "qmean4_norm_score": 0.741,
              "qmean4_z_score": -0.645,
              "qmean6_norm_score": 0.753,
              "qmean6_z_score": -0.382,
              "ss_agreement_norm_score": 0.485,
              "ss_agreement_z_score": -1.284,
              "torsion_norm_score": -0.207,
              "torsion_z_score": -0.993
            },
            "gmqe": 0.622,
            "sequence_identity": 99.917,
            "sequence_similarity": 0.626,
            "coverage": 0.507,
            "oligo_state": "monomer",
            "method": "HOMOLOGY MODELLING",
            "model_range": {
              "start": 25,
              "end": 638,
              "length": 614
            },
            "quality_assessment": [
              "Very high quality (QMEAN)",
              "Medium reliability (GMQE)"
            ]
          },
          "template_info": "7syd.1.C",
          "model_count": 2,
          "reference": "Waterhouse et al., Nucleic Acids Res. 2018, 46, D296-D303"
        },
        "error": null
      },
      "metadata": {
        "name": "swissmodel",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "SWISS-MODEL homology modeling repository adapter",
        "capabilities": {
          "homology_models": true,
          "quality_assessment": true,
          "template_info": true,
          "sequence_coverage": true,
          "quality_filtering": true
        },
        "database": {
          "name": "SWISS-MODEL Repository",
          "url": "https://swissmodel.expasy.org/repository",
          "coverage": "800,000+ models covering UniProtKB",
          "update_frequency": "Quarterly"
        },
        "quality_metrics": {
          "qmean": {
            "range": "-4 to 0",
            "interpretation": "Higher is better",
            "high_quality": "> -1.5",
            "medium_quality": "-2.5 to -1.5",
            "low_quality": "< -2.5"
          },
          "gmqe": {
            "range": "0 to 1",
            "interpretation": "Higher is better",
            "high_reliability": "> 0.7",
            "medium_reliability": "0.4 to 0.7",
            "low_reliability": "< 0.4"
          }
        },
        "config": {
          "cache_dir": "cache\\swissmodel",
          "download_pdb": true,
          "min_qmean": -4.0,
          "min_gmqe": 0.0
        },
        "reference": {
          "paper": "Waterhouse et al., Nucleic Acids Res. 2018, 46, D296-D303",
          "website": "https://swissmodel.expasy.org/",
          "documentation": "https://swissmodel.expasy.org/docs/repository_help"
        },
        "use_cases": [
          "Get homology models when experimental structures unavailable",
          "Quality assessment of protein structure models",
          "Template-based modeling feasibility analysis",
          "Comparative modeling for drug discovery"
        ]
      }
    },
    {
      "adapter": "pdb_redo",
      "status": "success",
      "error": null,
      "execution_time": 1.55999,
      "data": {
        "success": true,
        "data": {
          "pdb_id": "1HSG",
          "structure_files": {},
          "file_paths": {},
          "quality_metrics": {},
          "validation_report": null,
          "improvements": {},
          "refinement_version": "unknown",
          "reference": "Joosten et al., IUCrJ 2014, 1, 213-220"
        },
        "error": null
      },
      "metadata": {
        "name": "pdb_redo",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "PDB-REDO re-refined protein structures adapter",
        "capabilities": {
          "re_refined_structures": true,
          "quality_improvement": true,
          "validation_reports": true,
          "structure_factors": true,
          "multiple_formats": [
            "pdb",
            "cif",
            "mtz"
          ]
        },
        "database": {
          "name": "PDB-REDO",
          "url": "https://pdb-redo.eu/",
          "coverage": "180,000+ re-refined structures",
          "update_frequency": "Weekly"
        },
        "improvements": {
          "r_factors": "Typically 2-5% improvement",
          "geometry": "Better bond lengths and angles",
          "density_fit": "Improved fit to electron density",
          "outliers": "Reduced Ramachandran and rotamer outliers"
        },
        "config": {
          "cache_dir": "cache\\pdb_redo",
          "download_pdb": true,
          "download_cif": false,
          "download_mtz": false,
          "include_validation": true
        },
        "reference": {
          "paper": "Joosten et al., IUCrJ 2014, 1, 213-220",
          "website": "https://pdb-redo.eu/",
          "documentation": "https://pdb-redo.eu/about"
        }
      }
    },
    {
      "adapter": "sabdab",
      "status": "success",
      "error": null,
      "execution_time": 1.269445,
      "data": {
        "success": false,
        "data": {},
        "error": "SAbDab API returned status 500"
      },
      "metadata": {
        "name": "sabdab",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "Structural Antibody Database (SAbDab) adapter for antibody structures",
        "capabilities": {
          "pdb_lookup": true,
          "antigen_search": true,
          "cdr_sequences": true,
          "antibody_classification": true,
          "quality_filtering": true
        },
        "database": {
          "name": "SAbDab",
          "maintainer": "Oxford Protein Informatics Group",
          "url": "http://opig.stats.ox.ac.uk/webapps/newsabdab/sabdab/",
          "update_frequency": "Weekly",
          "coverage": "All antibody structures in PDB"
        },
        "antibody_types": [
          "IgG",
          "IgA",
          "IgM",
          "IgE",
          "IgD",
          "Fab",
          "scFv",
          "VHH",
          "Nanobody"
        ],
        "quality_filters": {
          "resolution": "< 3.0 \u00c5 recommended",
          "rfactor": "< 0.3 recommended",
          "methods": [
            "X-ray",
            "EM",
            "NMR"
          ]
        },
        "config": {
          "cache_dir": "cache\\sabdab",
          "timeout": 60,
          "max_results": 100,
          "rate_limit_delay": 0.5
        },
        "reference": {
          "paper": "Dunbar et al. (2014) Nucleic Acids Research",
          "doi": "10.1093/nar/gkt1043",
          "url": "http://opig.stats.ox.ac.uk/webapps/newsabdab/sabdab/about/"
        }
      }
    },
    {
      "adapter": "immunebuilder",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "Invalid input. Provide 'heavy_chain' sequence at minimum."
      },
      "metadata": {
        "name": "immunebuilder",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "ImmuneBuilder adapter for fast antibody structure prediction from sequence",
        "capabilities": {
          "structure_prediction": true,
          "antibody_types": [
            "fab",
            "scfv",
            "vhh",
            "full_antibody"
          ],
          "confidence_scores": true,
          "batch_prediction": true,
          "fast_prediction": true
        },
        "method": {
          "name": "ImmuneBuilder (ABodyBuilder2)",
          "type": "Deep Learning",
          "training_data": "SAbDab database",
          "speed": "~1-5 seconds per structure",
          "accuracy": "Comparable to AlphaFold for antibody variable domains"
        },
        "antibody_types": {
          "fab": "Fab fragment (heavy + light chain variable domains)",
          "scfv": "Single-chain variable fragment",
          "vhh": "VHH nanobody (heavy chain only)",
          "full": "Full antibody (if constant domains included)"
        },
        "config": {
          "output_dir": "output\\immunebuilder",
          "num_models": 1,
          "save_structures": true,
          "use_gpu": true
        },
        "requirements": {
          "package": "immunebuilder",
          "install": "pip install immunebuilder",
          "dependencies": [
            "biopython",
            "torch",
            "numpy"
          ]
        },
        "reference": {
          "paper": "Abanades et al., Communications Biology (2023)",
          "doi": "10.1038/s42003-023-04927-7",
          "github": "https://github.com/oxpig/ImmuneBuilder",
          "group": "Oxford Protein Informatics Group (OPIG)"
        },
        "use_cases": [
          "Antibody structure prediction",
          "Therapeutic antibody design",
          "Nanobody engineering",
          "CDR loop modeling",
          "High-throughput screening",
          "Structure-based antibody optimization"
        ]
      }
    },
    {
      "adapter": "vina_docking",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Invalid SMILES string or could not parse with RDKit"
      },
      "metadata": {
        "name": "vina_docking",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Molecular docking using AutoDock Vina",
        "requirements": [
          "AutoDock Vina binary",
          "RDKit (pip install rdkit)",
          "Receptor PDBQT file"
        ],
        "config": {
          "receptor_path": null,
          "docking_box_center": [
            null,
            null,
            null
          ],
          "docking_box_size": [
            25,
            25,
            25
          ],
          "exhaustiveness": 8,
          "num_modes": 9,
          "vina_binary": "vina"
        },
        "scoring": {
          "raw_unit": "kcal/mol",
          "raw_range": "typically -12 to -4",
          "normalized_range": "0 to 1 (higher is better)",
          "normalization_function": "vina_affinity_to01()"
        }
      }
    },
    {
      "adapter": "gnina",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Invalid SMILES string or could not parse with RDKit"
      },
      "metadata": {
        "name": "gnina",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "CNN-enhanced molecular docking using GNINA",
        "features": [
          "CNN-based scoring",
          "Vina-compatible docking",
          "Multiple scoring functions",
          "Fast and accurate"
        ],
        "requirements": [
          "GNINA binary",
          "RDKit (pip install rdkit)",
          "Receptor PDBQT file",
          "GPU recommended for CNN scoring"
        ],
        "config": {
          "receptor_path": null,
          "docking_box_center": [
            null,
            null,
            null
          ],
          "docking_box_size": [
            25,
            25,
            25
          ],
          "exhaustiveness": 8,
          "num_modes": 9,
          "gnina_binary": "gnina",
          "cnn_scoring": "default"
        },
        "scoring": {
          "vina_score": "kcal/mol (Vina scoring function)",
          "cnn_affinity": "kcal/mol (CNN prediction)",
          "cnn_score": "CNN pose score",
          "binding_score": "Normalized 0-1 (higher is better)",
          "normalization_function": "vina_affinity_to01()"
        }
      }
    },
    {
      "adapter": "diffdock",
      "status": "success",
      "error": null,
      "execution_time": 0.002003,
      "data": {
        "success": false,
        "data": null,
        "error": "No protein_path or protein_data provided. Pass in input_data dict, kwarg, or protein_data."
      },
      "metadata": {
        "name": "diffdock",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Diffusion-based molecular docking using DiffDock",
        "features": [
          "Blind docking (no binding site required)",
          "Multiple pose predictions",
          "Confidence scores",
          "State-of-the-art accuracy"
        ],
        "requirements": [
          "DiffDock installation",
          "RDKit (pip install rdkit)",
          "GPU recommended"
        ],
        "config": {
          "diffdock_path": null,
          "inference_steps": 20,
          "samples_per_complex": 40,
          "use_gpu": true
        },
        "input": {
          "protein": "PDB file path",
          "ligand": "SMILES string"
        },
        "output": {
          "confidence": "DiffDock confidence score (higher = better)",
          "binding_score": "Normalized score 0-1 (higher = better)",
          "estimated_affinity": "Estimated kcal/mol (more negative = better)",
          "poses": "List of docked poses with SDF files"
        }
      }
    },
    {
      "adapter": "bindingdb",
      "status": "success",
      "error": null,
      "execution_time": 0.246279,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "target": null,
          "entries": [
            {
              "type": "Ki",
              "value": 5.2,
              "unit": "nM",
              "value_nm": 5.2,
              "pvalue": 8.28,
              "target": "Example Kinase",
              "target_type": "protein",
              "organism": "Homo sapiens",
              "assay_description": "Radioligand binding assay",
              "pH": 7.4,
              "temperature": "25\u00b0C",
              "reference": "PMID:12345678",
              "year": 2023
            },
            {
              "type": "IC50",
              "value": 12.5,
              "unit": "nM",
              "value_nm": 12.5,
              "pvalue": 7.9,
              "target": "Example Kinase",
              "target_type": "protein",
              "organism": "Homo sapiens",
              "assay_description": "Cell-based proliferation assay",
              "reference": "PMID:12345679",
              "year": 2023
            },
            {
              "type": "Kd",
              "value": 3.8,
              "unit": "nM",
              "value_nm": 3.8,
              "pvalue": 8.42,
              "target": "Example Kinase",
              "target_type": "protein",
              "organism": "Homo sapiens",
              "assay_description": "Surface plasmon resonance",
              "temperature": "25\u00b0C",
              "reference": "PMID:12345680",
              "year": 2022
            }
          ],
          "count": 3,
          "statistics": null,
          "source": "BindingDB",
          "note": "This is example data. Full implementation requires SOAP API integration."
        },
        "error": null
      },
      "metadata": {
        "name": "bindingdb",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "Query experimental binding affinity data from BindingDB",
        "features": [
          "Experimental Ki, Kd, IC50, EC50 values",
          "Target protein information",
          "Assay conditions and references",
          "Literature citations"
        ],
        "data_types": {
          "Ki": "Inhibition constant (equilibrium dissociation)",
          "Kd": "Dissociation constant",
          "IC50": "Half-maximal inhibitory concentration",
          "EC50": "Half-maximal effective concentration"
        },
        "config": {
          "timeout": 30,
          "max_results": 100,
          "min_affinity": null
        },
        "input": {
          "smiles": "Compound SMILES structure",
          "inchi": "Compound InChI",
          "target": "Protein target name",
          "name": "Compound name"
        },
        "output": {
          "entries": "List of experimental measurements",
          "statistics": "Aggregated statistics (mean, min, max)",
          "references": "Literature citations"
        },
        "notes": [
          "Requires SOAP API integration for full functionality",
          "Currently returns example data structure",
          "Production version needs zeep library or TSV parsing"
        ]
      }
    },
    {
      "adapter": "openmm",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "Invalid SMILES string"
      },
      "metadata": {
        "name": "openmm",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Molecular dynamics simulation and energy minimization using OpenMM",
        "capabilities": {
          "energy_minimization": true,
          "molecular_dynamics": true,
          "property_calculation": true,
          "conformer_generation": true,
          "stability_assessment": true,
          "gpu_acceleration": true
        },
        "config": {
          "force_field": "gaff",
          "minimize_steps": 1000,
          "run_md": false,
          "md_steps": 10000,
          "md_temperature": 300.0,
          "platform": "auto"
        },
        "reference": {
          "paper": "Eastman et al., PLoS Comput. Biol. 2017, 13(7), e1005659",
          "website": "http://openmm.org/",
          "documentation": "http://docs.openmm.org/"
        },
        "computational_cost": {
          "minimization": "1-10 seconds per molecule (CPU)",
          "md_simulation": "10-60 seconds for 10-100 ps (CPU)",
          "gpu_speedup": "5-50x faster with CUDA/OpenCL"
        }
      }
    },
    {
      "adapter": "gmx_mmpbsa",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Invalid input data. See logs for details."
      },
      "metadata": {
        "name": "gmx_mmpbsa",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Calculate binding free energies using MM/PBSA and MM/GBSA methods",
        "capabilities": {
          "mm_pbsa": true,
          "mm_gbsa": true,
          "energy_decomposition": true,
          "per_residue_decomposition": true,
          "trajectory_analysis": true
        },
        "requirements": [
          "gmx_MMPBSA (pip install gmx_MMPBSA)",
          "AmberTools (conda install -c conda-forge ambertools)",
          "GROMACS (optional, for preprocessing)",
          "Topology file (.prmtop, .gro, etc.)",
          "Trajectory file (.xtc, .trr, etc.)",
          "Index file (.ndx)"
        ],
        "config": {
          "method": "pb",
          "startframe": 1,
          "endframe": -1,
          "interval": 1,
          "decomp": false,
          "saltcon": 0.15,
          "temperature": 298.15
        },
        "reference": {
          "paper": "Valdes-Tresanco et al., J. Chem. Theory Comput. 2021, 17(10), 6281-6291",
          "github": "https://github.com/Valdes-Tresanco-MS/gmx_MMPBSA",
          "documentation": "https://valdes-tresanco-ms.github.io/gmx_MMPBSA/"
        },
        "input_format": {
          "topology_file": "Path to topology file",
          "trajectory_file": "Path to MD trajectory file",
          "index_file": "Path to GROMACS index file",
          "receptor_group": "Receptor group name from index",
          "ligand_group": "Ligand group name from index"
        },
        "output_format": {
          "binding_free_energy": "kcal/mol (lower is better)",
          "delta_h": "Enthalpy change (kcal/mol)",
          "delta_s": "Entropy change (-T*\u0394S, kcal/mol)",
          "components": {
            "van_der_waals": "Van der Waals energy",
            "electrostatic": "Electrostatic energy",
            "polar_solvation": "Polar solvation energy",
            "sasa": "Non-polar solvation (SASA)"
          }
        },
        "computational_cost": {
          "typical_runtime": "1-30 minutes depending on trajectory length",
          "memory_usage": "1-4 GB",
          "parallelization": "Limited (mainly single-threaded)"
        }
      }
    },
    {
      "adapter": "molscrub",
      "status": "success",
      "error": null,
      "execution_time": 0.056678,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "conformers": [
            {
              "conformer_id": 6,
              "energy": 18.90976897766099,
              "structure": "HETATM    1  C1  UNL     1       3.243  -0.945  -0.693  1.00  0.00           C  \nHETATM    2  C2  UNL     1       1.953  -0.183  -0.735  1.00  0.00           C  \nHETATM    3  O1  UNL     1       1.528   0.406  -1.720  1.00  0.00           O  \nHETATM    4  O2  UNL     1       1.355  -0.243   0.520  1.00  0.00           O  \nHETATM    5  C3  UNL     1       0.098   0.368   0.545  1.00  0.00           C  \nHETATM    6  C4  UNL     1       0.039   1.665   1.065  1.00  0.00           C  \nHETATM    7  C5  UNL     1      -1.188   2.320   1.145  1.00  0.00           C  \nHETATM    8  C6  UNL     1      -2.350   1.678   0.719  1.00  0.00           C  \nHETATM    9  C7  UNL     1      -2.290   0.373   0.217  1.00  0.00           C  \nHETATM   10  C8  UNL     1      -1.063  -0.302   0.130  1.00  0.00           C  \nHETATM   11  C9  UNL     1      -0.995  -1.698  -0.375  1.00  0.00           C  \nHETATM   12  O3  UNL     1      -0.013  -2.415  -0.424  1.00  0.00           O  \nHETATM   13  O4  UNL     1      -2.189  -2.151  -0.804  1.00  0.00           O  \nHETATM   14  H1  UNL     1       3.937  -0.462  -0.001  1.00  0.00           H  \nHETATM   15  H2  UNL     1       3.691  -0.953  -1.692  1.00  0.00           H  \nHETATM   16  H3  UNL     1       3.055  -1.979  -0.392  1.00  0.00           H  \nHETATM   17  H4  UNL     1       0.944   2.164   1.398  1.00  0.00           H  \nHETATM   18  H5  UNL     1      -1.240   3.333   1.538  1.00  0.00           H  \nHETATM   19  H6  UNL     1      -3.308   2.191   0.779  1.00  0.00           H  \nHETATM   20  H7  UNL     1      -3.212  -0.108  -0.102  1.00  0.00           H  \nHETATM   21  H8  UNL     1      -1.995  -3.058  -1.118  1.00  0.00           H  \nCONECT    1    2   14   15   16\nCONECT    2    3    3    4\nCONECT    4    5\nCONECT    5    6    6   10\nCONECT    6    7   17\nCONECT    7    8    8   18\nCONECT    8    9   19\nCONECT    9   10   10   20\nCONECT   10   11\nCONECT   11   12   12   13\nCONECT   13   21\nEND\n",
              "rmsd_to_lowest": 0.0
            },
            {
              "conformer_id": 7,
              "energy": 18.909768979377404,
              "structure": "HETATM    1  C1  UNL     1       3.251  -1.004  -0.562  1.00  0.00           C  \nHETATM    2  C2  UNL     1       2.006  -0.582   0.158  1.00  0.00           C  \nHETATM    3  O1  UNL     1       1.706  -0.938   1.291  1.00  0.00           O  \nHETATM    4  O2  UNL     1       1.285   0.283  -0.658  1.00  0.00           O  \nHETATM    5  C3  UNL     1       0.060   0.655  -0.098  1.00  0.00           C  \nHETATM    6  C4  UNL     1       0.007   1.905   0.526  1.00  0.00           C  \nHETATM    7  C5  UNL     1      -1.192   2.349   1.081  1.00  0.00           C  \nHETATM    8  C6  UNL     1      -2.334   1.552   1.000  1.00  0.00           C  \nHETATM    9  C7  UNL     1      -2.282   0.310   0.359  1.00  0.00           C  \nHETATM   10  C8  UNL     1      -1.082  -0.152  -0.206  1.00  0.00           C  \nHETATM   11  C9  UNL     1      -1.027  -1.458  -0.914  1.00  0.00           C  \nHETATM   12  O3  UNL     1      -0.077  -1.930  -1.511  1.00  0.00           O  \nHETATM   13  O4  UNL     1      -2.192  -2.131  -0.848  1.00  0.00           O  \nHETATM   14  H1  UNL     1       3.894  -0.137  -0.730  1.00  0.00           H  \nHETATM   15  H2  UNL     1       3.794  -1.731   0.050  1.00  0.00           H  \nHETATM   16  H3  UNL     1       2.989  -1.480  -1.510  1.00  0.00           H  \nHETATM   17  H4  UNL     1       0.896   2.526   0.588  1.00  0.00           H  \nHETATM   18  H5  UNL     1      -1.237   3.315   1.577  1.00  0.00           H  \nHETATM   19  H6  UNL     1      -3.269   1.897   1.435  1.00  0.00           H  \nHETATM   20  H7  UNL     1      -3.188  -0.289   0.303  1.00  0.00           H  \nHETATM   21  H8  UNL     1      -2.008  -2.963  -1.333  1.00  0.00           H  \nCONECT    1    2   14   15   16\nCONECT    2    3    3    4\nCONECT    4    5\nCONECT    5    6    6   10\nCONECT    6    7   17\nCONECT    7    8    8   18\nCONECT    8    9   19\nCONECT    9   10   10   20\nCONECT   10   11\nCONECT   11   12   12   13\nCONECT   13   21\nEND\n",
              "rmsd_to_lowest": 0.9816778433107902
            },
            {
              "conformer_id": 4,
              "energy": 20.833145171839277,
              "structure": "HETATM    1  C1  UNL     1       3.149  -1.039  -0.651  1.00  0.00           C  \nHETATM    2  C2  UNL     1       1.925  -0.611   0.102  1.00  0.00           C  \nHETATM    3  O1  UNL     1       1.678  -0.931   1.257  1.00  0.00           O  \nHETATM    4  O2  UNL     1       1.156   0.203  -0.721  1.00  0.00           O  \nHETATM    5  C3  UNL     1      -0.032   0.613  -0.111  1.00  0.00           C  \nHETATM    6  C4  UNL     1      -0.027   1.896   0.451  1.00  0.00           C  \nHETATM    7  C5  UNL     1      -1.177   2.391   1.063  1.00  0.00           C  \nHETATM    8  C6  UNL     1      -2.332   1.613   1.105  1.00  0.00           C  \nHETATM    9  C7  UNL     1      -2.340   0.340   0.526  1.00  0.00           C  \nHETATM   10  C8  UNL     1      -1.192  -0.174  -0.099  1.00  0.00           C  \nHETATM   11  C9  UNL     1      -1.315  -1.523  -0.706  1.00  0.00           C  \nHETATM   12  O3  UNL     1      -2.289  -2.250  -0.607  1.00  0.00           O  \nHETATM   13  O4  UNL     1      -0.258  -1.911  -1.440  1.00  0.00           O  \nHETATM   14  H1  UNL     1       2.859  -1.582  -1.554  1.00  0.00           H  \nHETATM   15  H2  UNL     1       3.746  -1.706  -0.022  1.00  0.00           H  \nHETATM   16  H3  UNL     1       3.753  -0.164  -0.905  1.00  0.00           H  \nHETATM   17  H4  UNL     1       0.874   2.503   0.420  1.00  0.00           H  \nHETATM   18  H5  UNL     1      -1.171   3.383   1.510  1.00  0.00           H  \nHETATM   19  H6  UNL     1      -3.229   1.996   1.585  1.00  0.00           H  \nHETATM   20  H7  UNL     1      -3.254  -0.250   0.564  1.00  0.00           H  \nHETATM   21  H8  UNL     1      -0.525  -2.797  -1.764  1.00  0.00           H  \nCONECT    1    2   14   15   16\nCONECT    2    3    3    4\nCONECT    4    5\nCONECT    5    6    6   10\nCONECT    6    7   17\nCONECT    7    8    8   18\nCONECT    8    9   19\nCONECT    9   10   10   20\nCONECT   10   11\nCONECT   11   12   12   13\nCONECT   13   21\nEND\n",
              "rmsd_to_lowest": 1.2333772194015589
            },
            {
              "conformer_id": 5,
              "energy": 20.83314517588801,
              "structure": "HETATM    1  C1  UNL     1       3.144  -1.010  -0.720  1.00  0.00           C  \nHETATM    2  C2  UNL     1       1.861  -0.235  -0.757  1.00  0.00           C  \nHETATM    3  O1  UNL     1       1.453   0.379  -1.734  1.00  0.00           O  \nHETATM    4  O2  UNL     1       1.246  -0.326   0.486  1.00  0.00           O  \nHETATM    5  C3  UNL     1       0.016   0.334   0.527  1.00  0.00           C  \nHETATM    6  C4  UNL     1       0.022   1.616   1.088  1.00  0.00           C  \nHETATM    7  C5  UNL     1      -1.167   2.338   1.185  1.00  0.00           C  \nHETATM    8  C6  UNL     1      -2.359   1.777   0.733  1.00  0.00           C  \nHETATM    9  C7  UNL     1      -2.365   0.488   0.190  1.00  0.00           C  \nHETATM   10  C8  UNL     1      -1.178  -0.256   0.089  1.00  0.00           C  \nHETATM   11  C9  UNL     1      -1.298  -1.624  -0.476  1.00  0.00           C  \nHETATM   12  O3  UNL     1      -2.315  -2.098  -0.951  1.00  0.00           O  \nHETATM   13  O4  UNL     1      -0.180  -2.366  -0.400  1.00  0.00           O  \nHETATM   14  H1  UNL     1       3.619  -0.971  -1.704  1.00  0.00           H  \nHETATM   15  H2  UNL     1       3.822  -0.568   0.015  1.00  0.00           H  \nHETATM   16  H3  UNL     1       2.939  -2.056  -0.476  1.00  0.00           H  \nHETATM   17  H4  UNL     1       0.951   2.056   1.440  1.00  0.00           H  \nHETATM   18  H5  UNL     1      -1.163   3.339   1.610  1.00  0.00           H  \nHETATM   19  H6  UNL     1      -3.287   2.339   0.804  1.00  0.00           H  \nHETATM   20  H7  UNL     1      -3.308   0.064  -0.152  1.00  0.00           H  \nHETATM   21  H8  UNL     1      -0.453  -3.220  -0.798  1.00  0.00           H  \nCONECT    1    2   14   15   16\nCONECT    2    3    3    4\nCONECT    4    5\nCONECT    5    6    6   10\nCONECT    6    7   17\nCONECT    7    8    8   18\nCONECT    8    9   19\nCONECT    9   10   10   20\nCONECT   10   11\nCONECT   11   12   12   13\nCONECT   13   21\nEND\n",
              "rmsd_to_lowest": 0.7807148386909979
            }
          ],
          "num_generated": 10,
          "num_filtered": 4,
          "lowest_energy": 18.90976897766099,
          "output_format": "pdb",
          "properties": {
            "molecular_weight": 180.15900000000005,
            "num_atoms": 21,
            "num_heavy_atoms": 13,
            "num_rotatable_bonds": 3
          },
          "warnings": [
            "Only 4 unique conformers found (requested 10)"
          ]
        },
        "error": null
      },
      "metadata": {
        "name": "molscrub",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Conformer generation and molecular cleaning using RDKit",
        "requirements": [
          "RDKit (pip install rdkit)"
        ],
        "features": [
          "3D conformer generation (ETKDG algorithm)",
          "Molecular cleaning and standardization",
          "Energy optimization (MMFF94 or UFF)",
          "RMSD-based filtering",
          "Multiple output formats (PDB, MOL2, SDF)"
        ],
        "config": {
          "num_conformers": 10,
          "energy_window": 10.0,
          "rms_threshold": 0.5,
          "optimize": true,
          "output_format": "pdb",
          "use_mmff": true,
          "max_iterations": 200,
          "random_seed": 42
        },
        "supported_formats": [
          "pdb",
          "mol2",
          "sdf",
          "mol"
        ],
        "use_cases": [
          "Pre-docking ligand preparation",
          "MD simulation setup",
          "Virtual screening library preparation",
          "Conformer ensemble generation"
        ]
      }
    },
    {
      "adapter": "admet_ai",
      "status": "success",
      "error": null,
      "execution_time": 0.00996,
      "data": {
        "success": false,
        "data": {},
        "error": "ADMET-AI library not installed. Install with: pip install admet-ai"
      },
      "metadata": {
        "name": "admet_ai",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "ADMET property predictions using ADMET-AI",
        "properties": {
          "total_properties": 49,
          "categories": [
            "Absorption",
            "Distribution",
            "Metabolism",
            "Excretion",
            "Toxicity",
            "Physicochemical"
          ],
          "model": "Chemprop-RDKit",
          "reference": "https://github.com/swansonk14/admet_ai"
        },
        "config": {
          "properties_filter": "all"
        }
      }
    },
    {
      "adapter": "rdkit_local",
      "status": "skipped",
      "error": "No test configuration defined"
    },
    {
      "adapter": "pkcsm",
      "status": "success",
      "error": null,
      "execution_time": 10.96558,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "predictions": {
            "absorption": {
              "water_solubility": -3.45,
              "caco2_permeability": 1.23,
              "intestinal_absorption_human": 95.2,
              "skin_permeability": -2.7,
              "pgp_substrate": false,
              "pgp_inhibitor": true
            },
            "distribution": {
              "vdss_human": 0.82,
              "fraction_unbound_human": 0.15,
              "bbb_permeability": -1.2,
              "cns_permeability": -2.5
            },
            "metabolism": {
              "cyp2d6_substrate": false,
              "cyp3a4_substrate": true,
              "cyp1a2_inhibitor": false,
              "cyp2c19_inhibitor": false,
              "cyp2c9_inhibitor": false,
              "cyp2d6_inhibitor": false,
              "cyp3a4_inhibitor": true
            },
            "excretion": {
              "total_clearance": 0.65,
              "renal_oct2_substrate": false
            },
            "toxicity": {
              "ames_toxicity": false,
              "max_tolerated_dose_human": 0.42,
              "herg_i_inhibitor": false,
              "herg_ii_inhibitor": false,
              "oral_rat_acute_toxicity_ld50": 2.35,
              "oral_rat_chronic_toxicity_loael": 1.85,
              "hepatotoxicity": false,
              "skin_sensitization": false,
              "t_pyriformis_toxicity": 0.28
            }
          },
          "property_count": 28,
          "categories": [
            "absorption",
            "distribution",
            "metabolism",
            "excretion",
            "toxicity"
          ],
          "model": "pkCSM",
          "reference": "Pires et al. (2015) J. Med. Chem.",
          "note": "Predictions obtained from pkCSM web service"
        },
        "error": null
      },
      "metadata": {
        "name": "pkcsm",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "ADMET property predictions using pkCSM web service",
        "properties": {
          "total_categories": 5,
          "categories": {
            "Absorption": [
              "water_solubility",
              "caco2_permeability",
              "intestinal_absorption_human",
              "skin_permeability",
              "pgp_substrate",
              "pgp_inhibitor"
            ],
            "Distribution": [
              "vdss_human",
              "fraction_unbound_human",
              "bbb_permeability",
              "cns_permeability"
            ],
            "Metabolism": [
              "cyp2d6_substrate",
              "cyp3a4_substrate",
              "cyp1a2_inhibitor",
              "cyp2c19_inhibitor",
              "cyp2c9_inhibitor",
              "cyp2d6_inhibitor",
              "cyp3a4_inhibitor"
            ],
            "Excretion": [
              "total_clearance",
              "renal_oct2_substrate"
            ],
            "Toxicity": [
              "ames_toxicity",
              "max_tolerated_dose_human",
              "herg_i_inhibitor",
              "herg_ii_inhibitor",
              "oral_rat_acute_toxicity_ld50",
              "oral_rat_chronic_toxicity_loael",
              "hepatotoxicity",
              "skin_sensitization",
              "t_pyriformis_toxicity"
            ]
          },
          "model": "Graph-based signatures",
          "reference": "https://biosig.lab.uq.edu.au/pkcsm/"
        },
        "config": {
          "timeout": 120,
          "retry_attempts": 3,
          "retry_delay": 5
        },
        "notes": [
          "Uses web scraping (no official REST API available)",
          "Free service but may have rate limits",
          "Predictions typically take 30-60 seconds",
          "Service availability depends on pkCSM server status"
        ],
        "citation": "Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of medicinal chemistry, 58(9), 4066-4072."
      }
    },
    {
      "adapter": "swisstarget",
      "status": "success",
      "error": null,
      "execution_time": 6.087435,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "organism": "Homo sapiens",
          "targets": [
            {
              "target_name": "Cyclooxygenase-2 (COX-2)",
              "uniprot_id": "P35354",
              "target_class": "Enzyme",
              "target_family": "Oxidoreductase",
              "probability": 0.95,
              "known_actives": 1523,
              "organism": "Homo sapiens",
              "chembl_id": "CHEMBL230",
              "pathway": "Arachidonic acid metabolism"
            },
            {
              "target_name": "Cyclooxygenase-1 (COX-1)",
              "uniprot_id": "P23219",
              "target_class": "Enzyme",
              "target_family": "Oxidoreductase",
              "probability": 0.87,
              "known_actives": 987,
              "organism": "Homo sapiens",
              "chembl_id": "CHEMBL221",
              "pathway": "Arachidonic acid metabolism"
            },
            {
              "target_name": "Cannabinoid receptor 1",
              "uniprot_id": "P21554",
              "target_class": "GPCR",
              "target_family": "Class A (Rhodopsin-like)",
              "probability": 0.72,
              "known_actives": 2341,
              "organism": "Homo sapiens",
              "chembl_id": "CHEMBL218",
              "pathway": "Endocannabinoid signaling"
            },
            {
              "target_name": "Prostaglandin E synthase",
              "uniprot_id": "O14684",
              "target_class": "Enzyme",
              "target_family": "Transferase",
              "probability": 0.68,
              "known_actives": 234,
              "organism": "Homo sapiens",
              "chembl_id": "CHEMBL4462",
              "pathway": "Arachidonic acid metabolism"
            },
            {
              "target_name": "Peroxisome proliferator-activated receptor gamma",
              "uniprot_id": "P37231",
              "target_class": "Nuclear Receptor",
              "target_family": "NR1C subfamily",
              "probability": 0.54,
              "known_actives": 1876,
              "organism": "Homo sapiens",
              "chembl_id": "CHEMBL235",
              "pathway": "Lipid metabolism"
            }
          ],
          "statistics": {
            "total_targets": 5,
            "max_probability": 0.95,
            "mean_probability": 0.752,
            "high_confidence": 3,
            "medium_confidence": 2,
            "low_confidence": 0
          },
          "target_classes": {
            "Enzyme": [
              "Cyclooxygenase-2 (COX-2)",
              "Cyclooxygenase-1 (COX-1)",
              "Prostaglandin E synthase"
            ],
            "GPCR": [
              "Cannabinoid receptor 1"
            ],
            "Nuclear Receptor": [
              "Peroxisome proliferator-activated receptor gamma"
            ]
          },
          "source": "SwissTargetPrediction",
          "note": "This is example data. Full implementation requires web scraping or official API."
        },
        "error": null
      },
      "metadata": {
        "name": "swisstarget",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "Predict protein targets for small molecules using SwissTargetPrediction",
        "features": [
          "Target prediction by 2D/3D similarity",
          "Probability scores",
          "Multiple organisms",
          "Target classification",
          "Pathway information"
        ],
        "use_cases": [
          "Reverse pharmacology",
          "Off-target prediction",
          "Drug repurposing",
          "Polypharmacology analysis"
        ],
        "organisms": [
          "Homo sapiens",
          "Mus musculus",
          "Rattus norvegicus",
          "Bos taurus",
          "Canis familiaris"
        ],
        "target_classes": [
          "Enzyme",
          "GPCR",
          "Kinase",
          "Nuclear Receptor",
          "Ion Channel",
          "Transporter"
        ],
        "config": {
          "timeout": 60,
          "organism": "Homo sapiens",
          "min_probability": 0.0,
          "max_targets": 15
        },
        "input": {
          "smiles": "Compound SMILES structure"
        },
        "output": {
          "targets": "List of predicted targets with probabilities",
          "statistics": "Prediction statistics and confidence distribution",
          "target_classes": "Targets grouped by class"
        },
        "notes": [
          "Requires web scraping or official API for full functionality",
          "Currently returns example data structure",
          "Production version needs HTML parsing or API integration"
        ]
      }
    },
    {
      "adapter": "targetnet",
      "status": "success",
      "error": null,
      "execution_time": 0.002506,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "primary_targets": [],
          "off_targets": [
            {
              "target_id": "CHEMBL4005",
              "confidence": 0.55,
              "target_name": "Cytochrome P450 3A4",
              "uniprot_id": "P08684",
              "target_type": "Enzyme",
              "disease_areas": [
                "Drug Metabolism"
              ]
            }
          ],
          "all_predictions": [
            {
              "target_id": "CHEMBL4005",
              "confidence": 0.55,
              "target_name": "Cytochrome P450 3A4",
              "uniprot_id": "P08684",
              "target_type": "Enzyme",
              "disease_areas": [
                "Drug Metabolism"
              ]
            }
          ],
          "polypharmacology": {
            "is_polypharmacological": false,
            "target_count": 1,
            "target_type_distribution": {
              "Enzyme": 1
            },
            "target_diversity": 1.0,
            "disease_areas": [
              "Drug Metabolism"
            ],
            "selectivity_score": 0.9
          },
          "statistics": {
            "total_targets": 1,
            "primary_targets": 0,
            "off_targets": 1,
            "mean_confidence": 0.55
          },
          "parameters": {
            "confidence_threshold": 0.5,
            "max_targets": 10
          }
        },
        "error": null
      },
      "metadata": {
        "name": "targetnet",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "TargetNet - Protein target prediction",
        "capabilities": [
          "Predict protein targets",
          "Off-target analysis",
          "Multi-target profiling",
          "Polypharmacology analysis",
          "Target-based drug repurposing"
        ],
        "target_database_size": 10,
        "config": {
          "confidence_threshold": 0.5,
          "max_targets": 10,
          "use_local": true
        }
      }
    },
    {
      "adapter": "olorenchemengine",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": true,
        "data": {
          "predictions": [
            {
              "smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "properties": {
                "solubility": {
                  "value": -3.378,
                  "unit": "log(mol/L)",
                  "uncertainty": 0.495,
                  "confidence": 0.505
                },
                "logp": {
                  "value": 4.935,
                  "unit": "unitless",
                  "uncertainty": 0.344,
                  "confidence": 0.656
                },
                "permeability": {
                  "value": 1.283,
                  "unit": "log(cm/s)",
                  "uncertainty": 0.407,
                  "confidence": 0.593
                },
                "caco2": {
                  "value": -4.088,
                  "unit": "log(cm/s)",
                  "uncertainty": 0.336,
                  "confidence": 0.664
                },
                "bioavailability": {
                  "value": 0.786,
                  "unit": "probability",
                  "uncertainty": 0.13,
                  "confidence": 0.87
                },
                "herg": {
                  "value": 2.412,
                  "unit": "pIC50",
                  "uncertainty": 0.358,
                  "confidence": 0.642
                }
              }
            }
          ],
          "num_molecules": 1,
          "properties_predicted": [
            "solubility",
            "logp",
            "permeability",
            "caco2",
            "bioavailability",
            "herg"
          ],
          "model_used": "default",
          "uncertainty_included": true,
          "metadata": {
            "model_version": "Oloren ChemEngine v1.0",
            "architecture": "default",
            "batch_size": 32
          }
        },
        "error": null
      },
      "metadata": {
        "name": "olorenchemengine",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "Advanced molecular property prediction with uncertainty quantification",
        "capabilities": {
          "supported_properties": [
            "solubility",
            "logp",
            "permeability",
            "clearance",
            "half_life",
            "herg",
            "ames",
            "caco2",
            "bioavailability",
            "bbb_permeability"
          ],
          "property_categories": [
            "excretion",
            "metabolism",
            "toxicity",
            "physicochemical",
            "distribution",
            "absorption"
          ],
          "model_architectures": [
            "default",
            "gcn",
            "attentivefp",
            "mpnn"
          ],
          "uncertainty_quantification": true,
          "batch_predictions": true,
          "transfer_learning": true
        },
        "reference": "https://github.com/Oloren-AI/olorenchemengine",
        "config": {
          "default_properties": "common_admet",
          "model_type": "default",
          "include_uncertainty": true,
          "batch_size": 32
        }
      }
    },
    {
      "adapter": "comptox",
      "status": "success",
      "error": null,
      "execution_time": 3.185588,
      "data": {
        "success": false,
        "data": null,
        "error": "Failed to find chemical in CompTox: CC(=O)Oc1ccccc1C(=O)O"
      },
      "metadata": {
        "name": "comptox",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.1,
          "timeout": 45,
          "max_retries": 3
        }
      }
    },
    {
      "adapter": "tox21",
      "status": "success",
      "error": null,
      "execution_time": 9.75573,
      "data": {
        "success": true,
        "data": {
          "compound": {
            "cid": 2244,
            "query": "CC(=O)Oc1ccccc1C(=O)O",
            "query_type": "smiles"
          },
          "toxicity_results": [],
          "summary": {
            "total_assays": 0,
            "active_assays": 0,
            "inactive_assays": 0,
            "toxicity_flags": [],
            "overall_risk": "unknown"
          },
          "warnings": []
        },
        "error": null
      },
      "metadata": {
        "name": "tox21",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "NIH Tox21 toxicity screening data via PubChem BioAssay",
        "data_source": "Tox21 (NIH/EPA/FDA collaboration)",
        "coverage": {
          "compounds": "12,000+",
          "assays": "50+",
          "categories": [
            "nuclear_receptor",
            "stress_response"
          ]
        },
        "assays": {
          "total": 12,
          "nuclear_receptor": 7,
          "stress_response": 5,
          "available": [
            "NR-AR",
            "NR-ER",
            "NR-ER-LBD",
            "NR-AR-LBD",
            "NR-AhR",
            "NR-Aromatase",
            "NR-PPAR-gamma",
            "SR-ARE",
            "SR-ATAD5",
            "SR-HSE",
            "SR-MMP",
            "SR-p53"
          ]
        },
        "endpoints": [
          "endocrine_disruption",
          "metabolic_activation",
          "metabolic_disruption",
          "oxidative_stress",
          "genotoxicity",
          "stress_response",
          "mitochondrial_toxicity",
          "dna_damage"
        ],
        "config": {
          "rate_limit_delay": 0.3,
          "timeout": 45,
          "max_retries": 3
        },
        "references": [
          "https://tripod.nih.gov/tox21/",
          "https://pubchem.ncbi.nlm.nih.gov/",
          "Huang et al. (2018) Nucleic Acids Res. doi:10.1093/nar/gky1033"
        ],
        "citation": "Huang, R., et al. (2018). The NCATS Tox21 Program: Enabling technologies for high-throughput screening and data integration. Frontiers in Public Health, 6, 190."
      }
    },
    {
      "adapter": "xtb",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "xtb-python not installed. Install with: conda install -c conda-forge xtb-python"
      },
      "metadata": {
        "name": "xtb",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Fast semiempirical quantum chemistry calculations using xTB",
        "methods": [
          "GFN2-xTB",
          "GFN1-xTB",
          "GFN0-xTB"
        ],
        "capabilities": [
          "Geometry optimization",
          "Energy calculations",
          "HOMO/LUMO analysis",
          "Molecular properties",
          "Solvent models (GBSA)"
        ],
        "typical_runtime": "1-10 seconds per molecule",
        "reference": "https://github.com/grimme-lab/xtb",
        "citation": "Grimme, S. et al. J. Chem. Theory Comput. 2017, 13, 1989-2009",
        "config": {
          "method": "GFN2-xTB",
          "optimize": true,
          "charge": 0,
          "uhf": 0,
          "solvent": null,
          "accuracy": 1.0
        }
      }
    },
    {
      "adapter": "aizynthfinder",
      "status": "success",
      "error": null,
      "execution_time": 0.001506,
      "data": {
        "success": true,
        "data": {
          "smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "routes_found": 0,
          "routes": [],
          "best_route": null,
          "synthesis_score": 0.0,
          "n_steps": null,
          "feasibility": "none"
        },
        "error": null
      },
      "metadata": {
        "name": "aizynthfinder",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Retrosynthesis route planning using AiZynthFinder",
        "capabilities": {
          "multi_route_discovery": true,
          "synthesis_step_counting": true,
          "feasibility_scoring": true,
          "reaction_templates": true
        },
        "config": {
          "max_routes": 5,
          "timeout": 120,
          "expansion_time": 60,
          "stock": "zinc"
        },
        "reference": {
          "paper": "Genheden et al., J. Chem. Inf. Model. 2020, 60, 12, 5910-5919",
          "github": "https://github.com/MolecularAI/aizynthfinder"
        }
      }
    },
    {
      "adapter": "llm_retrosynthesis",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "No API key configured for claude"
      },
      "metadata": {
        "name": "llm_retrosynthesis",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "provider": "claude",
        "model": "claude-3-5-sonnet-20241022",
        "description": "LLM-based retrosynthesis using Claude or GPT-4",
        "capabilities": [
          "retrosynthesis",
          "route_generation",
          "synthesis_planning"
        ]
      }
    },
    {
      "adapter": "reinvent",
      "status": "success",
      "error": null,
      "execution_time": 0.119018,
      "data": {
        "success": true,
        "data": {
          "molecules": [
            {
              "smiles": "O=COc1ccccc1C(=O)O",
              "score": 0.6778778103745307,
              "properties": {
                "molecular_weight": 166.13199999999995,
                "logp": 0.9199999999999999,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 3,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.6778778103745307,
                "num_atoms": 12
              },
              "is_original": false
            },
            {
              "smiles": "CCC(=O)Oc1ccccc1C(=O)O",
              "score": 0.5871542670914858,
              "properties": {
                "molecular_weight": 194.18599999999998,
                "logp": 1.7002,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 3,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5871542670914858,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cccc(C)c1C(=O)O",
              "score": 0.5735408372550064,
              "properties": {
                "molecular_weight": 194.18599999999998,
                "logp": 1.6185200000000002,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5735408372550064,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1c(C)cccc1C(=O)O",
              "score": 0.5735408372550064,
              "properties": {
                "molecular_weight": 194.18599999999998,
                "logp": 1.6185200000000002,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5735408372550064,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccc(C)cc1C(=O)O",
              "score": 0.5735408372550064,
              "properties": {
                "molecular_weight": 194.18599999999998,
                "logp": 1.6185200000000002,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5735408372550064,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cc(C)ccc1C(=O)O",
              "score": 0.5735408372550064,
              "properties": {
                "molecular_weight": 194.18599999999998,
                "logp": 1.6185200000000002,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5735408372550064,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "score": 0.5501217966938848,
              "properties": {
                "molecular_weight": 180.15899999999996,
                "logp": 1.3101,
                "tpsa": 63.60000000000001,
                "hbd": 1,
                "hba": 3,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5501217966938848,
                "num_atoms": 13
              },
              "is_original": true
            },
            {
              "smiles": "CC(=O)Oc1ccc(O)cc1C(=O)O",
              "score": 0.5444495427307616,
              "properties": {
                "molecular_weight": 196.158,
                "logp": 1.0157,
                "tpsa": 83.83,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5444495427307616,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cccc(O)c1C(=O)O",
              "score": 0.5444495427307616,
              "properties": {
                "molecular_weight": 196.158,
                "logp": 1.0157,
                "tpsa": 83.83,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5444495427307616,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cc(O)ccc1C(=O)O",
              "score": 0.5444495427307616,
              "properties": {
                "molecular_weight": 196.158,
                "logp": 1.0157,
                "tpsa": 83.83,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5444495427307616,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1c(O)cccc1C(=O)O",
              "score": 0.5444495427307616,
              "properties": {
                "molecular_weight": 196.158,
                "logp": 1.0157,
                "tpsa": 83.83,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5444495427307616,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "O=C(CO)Oc1ccccc1C(=O)O",
              "score": 0.5355445692257615,
              "properties": {
                "molecular_weight": 196.158,
                "logp": 0.28250000000000014,
                "tpsa": 83.83,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 3,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5355445692257615,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "NCC(=O)Oc1ccccc1C(=O)O",
              "score": 0.5325856512170263,
              "properties": {
                "molecular_weight": 195.17399999999998,
                "logp": 0.24889999999999984,
                "tpsa": 89.62000000000002,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 3,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5325856512170263,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "COC(=O)c1ccccc1OC(C)=O",
              "score": 0.5270970873600443,
              "properties": {
                "molecular_weight": 194.18599999999995,
                "logp": 1.3984999999999999,
                "tpsa": 52.6,
                "hbd": 0,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.5270970873600443,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "O=C(CS)Oc1ccccc1C(=O)O",
              "score": 0.4489706580628645,
              "properties": {
                "molecular_weight": 212.226,
                "logp": 1.2200000000000002,
                "tpsa": 63.60000000000001,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 3,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.4489706580628645,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1c(S)cccc1C(=O)O",
              "score": 0.4437452093337356,
              "properties": {
                "molecular_weight": 212.22600000000003,
                "logp": 1.5988000000000002,
                "tpsa": 63.60000000000001,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.4437452093337356,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cc(S)ccc1C(=O)O",
              "score": 0.44374520933373557,
              "properties": {
                "molecular_weight": 212.226,
                "logp": 1.5988000000000002,
                "tpsa": 63.60000000000001,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.44374520933373557,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccc(S)cc1C(=O)O",
              "score": 0.44374520933373557,
              "properties": {
                "molecular_weight": 212.226,
                "logp": 1.5988000000000002,
                "tpsa": 63.60000000000001,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.44374520933373557,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cccc(S)c1C(=O)O",
              "score": 0.4437452093337355,
              "properties": {
                "molecular_weight": 212.22599999999997,
                "logp": 1.5988000000000002,
                "tpsa": 63.60000000000001,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.4437452093337355,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccccc1C(=O)ON",
              "score": 0.42534304646131604,
              "properties": {
                "molecular_weight": 195.17399999999995,
                "logp": 0.6424000000000001,
                "tpsa": 78.62,
                "hbd": 1,
                "hba": 5,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.42534304646131604,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cc(N)ccc1C(=O)O",
              "score": 0.41525786096833234,
              "properties": {
                "molecular_weight": 195.174,
                "logp": 0.8923000000000001,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.41525786096833234,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccc(N)cc1C(=O)O",
              "score": 0.41525786096833234,
              "properties": {
                "molecular_weight": 195.174,
                "logp": 0.8923000000000001,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.41525786096833234,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1c(N)cccc1C(=O)O",
              "score": 0.41525786096833234,
              "properties": {
                "molecular_weight": 195.174,
                "logp": 0.8923000000000001,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.41525786096833234,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1cccc(N)c1C(=O)O",
              "score": 0.4152578609683323,
              "properties": {
                "molecular_weight": 195.17399999999995,
                "logp": 0.8923000000000001,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 4,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.4152578609683323,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccccc1C(=O)OS",
              "score": 0.3500436137350726,
              "properties": {
                "molecular_weight": 212.22599999999997,
                "logp": 1.6135,
                "tpsa": 52.60000000000001,
                "hbd": 1,
                "hba": 5,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.3500436137350726,
                "num_atoms": 14
              },
              "is_original": false
            },
            {
              "smiles": "CC(=O)Oc1ccccc1C(=O)OO",
              "score": 0.3331808966992133,
              "properties": {
                "molecular_weight": 196.15799999999996,
                "logp": 1.2417,
                "tpsa": 72.83000000000001,
                "hbd": 1,
                "hba": 5,
                "rotatable_bonds": 2,
                "num_rings": 1,
                "aromatic_rings": 1,
                "qed": 0.3331808966992133,
                "num_atoms": 14
              },
              "is_original": false
            }
          ],
          "original_smiles": "CC(=O)Oc1ccccc1C(=O)O",
          "target_properties": {},
          "model": "REINVENT-Optimization",
          "statistics": {
            "total_molecules": 26,
            "valid_molecules": 26,
            "valid_ratio": 1.0,
            "mean_score": 0.4952266614643286,
            "max_score": 0.6778778103745307,
            "min_score": 0.3331808966992133,
            "std_score": 0.08171908821886305
          }
        },
        "error": null
      },
      "metadata": {
        "name": "reinvent",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "REINVENT reinforcement learning-based molecular design",
        "capabilities": [
          "Generate novel molecules",
          "Optimize existing molecules",
          "Scaffold decoration",
          "Multi-objective optimization",
          "Property-guided design"
        ],
        "modes": [
          "generate",
          "optimize",
          "decorate"
        ],
        "reference": "https://github.com/MolecularAI/REINVENT4",
        "config": {}
      }
    },
    {
      "adapter": "molgan",
      "status": "success",
      "error": null,
      "execution_time": 0.148795,
      "data": {
        "success": true,
        "data": {
          "molecules": [
            {
              "smiles": "CN.Cl.FC(F)F.c1ccc2ccccc2c1",
              "qed": 0.7650629295486164,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 265.706,
                "logp": 4.0150000000000015,
                "tpsa": 26.02,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.7650629295486164,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.9216876431828721
            },
            {
              "smiles": "CN.Cl.FC(F)F.c1ccsc1",
              "qed": 0.7164119782202342,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 221.675,
                "logp": 2.923300000000001,
                "tpsa": 26.02,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.7164119782202343,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.9054706594067449
            },
            {
              "smiles": "FC(F)F.NC=O.c1ccc2ccccc2c1",
              "qed": 0.7095965273867599,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 243.22800000000004,
                "logp": 3.1198000000000015,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.7095965273867602,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.9031988424622535
            },
            {
              "smiles": "CN.CO.FC(F)F.c1ccccc1",
              "qed": 0.689486917762958,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 211.22700000000003,
                "logp": 2.0484999999999998,
                "tpsa": 46.25,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6894869177629582,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8964956392543194
            },
            {
              "smiles": "CO.Cl.c1ccc2ccccc2c1",
              "qed": 0.6872345794759762,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 196.677,
                "logp": 2.8701000000000016,
                "tpsa": 20.23,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6872345794759762,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8957448598253254
            },
            {
              "smiles": "CN.CO.FC(F)F.c1ccncc1",
              "qed": 0.6837709884629221,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 212.21500000000003,
                "logp": 1.4434999999999998,
                "tpsa": 59.14,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6837709884629221,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8945903294876407
            },
            {
              "smiles": "CN.FC(F)F.NC=O.c1ccsc1",
              "qed": 0.6645483602335573,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 230.25500000000005,
                "logp": 1.603,
                "tpsa": 69.11,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6645483602335576,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8881827867445192
            },
            {
              "smiles": "CO.FC(F)F.c1ccsc1",
              "qed": 0.6597072193955369,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 186.198,
                "logp": 2.535100000000001,
                "tpsa": 20.23,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.659707219395537,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8865690731318456
            },
            {
              "smiles": "C1CCNCC1.CO.Cl.FC(F)F",
              "qed": 0.6582617331027036,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 223.66599999999997,
                "logp": 1.9687000000000008,
                "tpsa": 32.26,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6582617331027036,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8860872443675678
            },
            {
              "smiles": "Cl.Cl.O=CO.c1ccccc1",
              "qed": 0.6471658557068731,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 197.06100000000004,
                "logp": 2.231,
                "tpsa": 37.3,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6471658557068731,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8823886185689577
            },
            {
              "smiles": "N[SH](=O)=O.c1ccc2ccccc2c1",
              "qed": 0.6425944265556873,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 209.27,
                "logp": 1.3113000000000001,
                "tpsa": 60.160000000000004,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6425944265556873,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8808648088518959
            },
            {
              "smiles": "FC(F)F.N[SH](=O)=O.c1ccoc1",
              "qed": 0.6372785884103768,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 219.18400000000003,
                "logp": 0.9296,
                "tpsa": 73.30000000000001,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6372785884103769,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8790928628034589
            },
            {
              "smiles": "C1CCCCC1.FC(F)F.NC=O.NC=O",
              "qed": 0.6355023208253444,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 244.25699999999998,
                "logp": 1.7221,
                "tpsa": 86.18,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6355023208253444,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8785007736084481
            },
            {
              "smiles": "CN.CN.CN.c1ccc2ccccc2c1",
              "qed": 0.6315294575498372,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 221.348,
                "logp": 1.5645000000000013,
                "tpsa": 78.06,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6315294575498374,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8771764858499459
            },
            {
              "smiles": "C1CCOCC1.CO.FC(F)F",
              "qed": 0.6293973694602935,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 188.18899999999996,
                "logp": 1.9738999999999998,
                "tpsa": 29.46,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6293973694602933,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8764657898200978
            },
            {
              "smiles": "C1CCOCC1.FC(F)F.NC=O.O=CO",
              "qed": 0.6285253637251434,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 247.213,
                "logp": 1.1677,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6285253637251434,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8761751212417145
            },
            {
              "smiles": "CN.c1ccc2ccccc2c1",
              "qed": 0.6273003686562862,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 159.232,
                "logp": 2.4147000000000007,
                "tpsa": 26.02,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6273003686562864,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8757667895520954
            },
            {
              "smiles": "CO.c1ccc2ccccc2c1",
              "qed": 0.6272448764509475,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 160.21599999999998,
                "logp": 2.4483000000000006,
                "tpsa": 20.23,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6272448764509475,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8757482921503158
            },
            {
              "smiles": "C1CCCCC1.CN.FC(F)F",
              "qed": 0.6162151920343975,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 185.233,
                "logp": 3.094000000000001,
                "tpsa": 26.02,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6162151920343975,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8720717306781326
            },
            {
              "smiles": "C1CCCCC1.Cl.Cl.O=CO",
              "qed": 0.6143040561252191,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 203.10900000000004,
                "logp": 2.8850000000000016,
                "tpsa": 37.3,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6143040561252191,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.871434685375073
            },
            {
              "smiles": "CO.CO.O=CO.c1ccc2ccccc2c1",
              "qed": 0.6110247462372009,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 238.28300000000002,
                "logp": 1.7575999999999998,
                "tpsa": 77.76,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.6110247462372009,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.870341582079067
            },
            {
              "smiles": "CN.FC(F)F.c1cc[nH]c1",
              "qed": 0.6086112603801158,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 168.162,
                "logp": 1.7681,
                "tpsa": 41.81,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6086112603801158,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8695370867933719
            },
            {
              "smiles": "NC=O.c1ccc2ccccc2c1",
              "qed": 0.6076937380886809,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 173.21499999999997,
                "logp": 1.9412999999999998,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.607693738088681,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8692312460295604
            },
            {
              "smiles": "CN.FC(F)F.N[SH](=O)=O.c1ccccc1",
              "qed": 0.6059678045904606,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 260.281,
                "logp": 0.9115000000000002,
                "tpsa": 86.18,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.6059678045904606,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8686559348634869
            },
            {
              "smiles": "C1CCOC1.CN.FC(F)F",
              "qed": 0.6028010189218549,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 173.178,
                "logp": 1.5502,
                "tpsa": 35.25,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.602801018921855,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8676003396406183
            },
            {
              "smiles": "C1CCNCC1.CN.FC(F)F",
              "qed": 0.6015140338704565,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 186.221,
                "logp": 1.5132999999999999,
                "tpsa": 38.05,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.6015140338704565,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8671713446234856
            },
            {
              "smiles": "FC(F)F.c1ccc2ccccc2c1",
              "qed": 0.5993517668605982,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 198.187,
                "logp": 4.018300000000002,
                "tpsa": 0.0,
                "hbd": 0,
                "hba": 0,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.5993517668605983,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8664505889535329
            },
            {
              "smiles": "Cl.O=CO.c1ccsc1",
              "qed": 0.5978893467163363,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 166.62899999999996,
                "logp": 1.8706999999999998,
                "tpsa": 37.3,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5978893467163363,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8659631155721121
            },
            {
              "smiles": "CN.Cl.O=CO.c1ccoc1",
              "qed": 0.5852847824750533,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 181.61899999999997,
                "logp": 0.9770999999999999,
                "tpsa": 76.46000000000001,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5852847824750533,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8617615941583511
            },
            {
              "smiles": "CN.Cl.O=CO.c1ccoc1",
              "qed": 0.5852847824750533,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 181.61899999999997,
                "logp": 0.9770999999999999,
                "tpsa": 76.46000000000001,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5852847824750533,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8617615941583511
            },
            {
              "smiles": "C1CCCCC1.CO.FC(F)F.N[SH](=O)=O",
              "qed": 0.5830949875122969,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 267.313,
                "logp": 1.5990999999999997,
                "tpsa": 80.39,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5830949875122969,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8610316625040989
            },
            {
              "smiles": "C1CCCCC1.CO.Cl.NC=O",
              "qed": 0.5781181761299206,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 197.706,
                "logp": 1.4724,
                "tpsa": 63.32,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5781181761299206,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8593727253766401
            },
            {
              "smiles": "FC(F)F.FC(F)F.NC=O.c1ccncc1",
              "qed": 0.5779276934533735,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 264.16900000000004,
                "logp": 2.5401000000000007,
                "tpsa": 55.980000000000004,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5779276934533736,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.8593092311511246
            },
            {
              "smiles": "Cl.c1ccc2ccccc2c1",
              "qed": 0.5608811166638357,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 164.635,
                "logp": 3.2616000000000014,
                "tpsa": 0.0,
                "hbd": 0,
                "hba": 0,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.5608811166638357,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8536270388879452
            },
            {
              "smiles": "Cl.c1ccc2ccccc2c1",
              "qed": 0.5608811166638357,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 164.635,
                "logp": 3.2616000000000014,
                "tpsa": 0.0,
                "hbd": 0,
                "hba": 0,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.5608811166638357,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8536270388879452
            },
            {
              "smiles": "CO.O=CO.c1ccsc1",
              "qed": 0.5606234215282392,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 162.20999999999998,
                "logp": 1.0574,
                "tpsa": 57.53,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5606234215282392,
                "num_atoms": 10,
                "num_heavy_atoms": 10
              },
              "validity_score": 0.853541140509413
            },
            {
              "smiles": "CN.FC(F)F.NC=O.c1cc[nH]c1",
              "qed": 0.558410831613131,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 213.20300000000006,
                "logp": 0.8695999999999997,
                "tpsa": 84.9,
                "hbd": 3,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.558410831613131,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8528036105377104
            },
            {
              "smiles": "FC(F)F.c1ccncc1",
              "qed": 0.5509074086331638,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 149.115,
                "logp": 2.2600999999999996,
                "tpsa": 12.89,
                "hbd": 0,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5509074086331639,
                "num_atoms": 10,
                "num_heavy_atoms": 10
              },
              "validity_score": 0.8503024695443879
            },
            {
              "smiles": "CN.Cl.c1cc[nH]c1",
              "qed": 0.5466064789730368,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 134.60999999999999,
                "logp": 1.0113999999999999,
                "tpsa": 41.81,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5466064789730367,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8488688263243457
            },
            {
              "smiles": "CN.O=CO.O=CO.c1ccsc1",
              "qed": 0.5441769057036253,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 207.251,
                "logp": 0.7246000000000005,
                "tpsa": 100.62000000000002,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5441769057036253,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8480589685678751
            },
            {
              "smiles": "Cl.O=CO.c1cc[nH]c1",
              "qed": 0.5438161445259353,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 149.57699999999997,
                "logp": 1.1372999999999998,
                "tpsa": 53.089999999999996,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5438161445259352,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8479387148419785
            },
            {
              "smiles": "C1CCCCC1.Cl.FC(F)F",
              "qed": 0.5428920029325559,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 190.636,
                "logp": 3.940900000000002,
                "tpsa": 0.0,
                "hbd": 0,
                "hba": 0,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5428920029325559,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8476306676441853
            },
            {
              "smiles": "O=CO.c1ccsc1",
              "qed": 0.539507757654421,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 130.168,
                "logp": 1.4489,
                "tpsa": 37.3,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.539507757654421,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.846502585884807
            },
            {
              "smiles": "CN.c1ccccc1",
              "qed": 0.5329766339620635,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 109.17199999999998,
                "logp": 1.2615,
                "tpsa": 26.02,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5329766339620634,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8443255446540211
            },
            {
              "smiles": "O=CO.c1ccccc1",
              "qed": 0.5304138968302117,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 124.13899999999997,
                "logp": 1.3874,
                "tpsa": 37.3,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5304138968302117,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8434712989434039
            },
            {
              "smiles": "C1CCOC1.Cl.O=CO",
              "qed": 0.5281419985217201,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 154.59300000000002,
                "logp": 0.9194,
                "tpsa": 46.53,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5281419985217201,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.84271399950724
            },
            {
              "smiles": "C1CCNCC1.FC(F)F.FC(F)F.O=CO",
              "qed": 0.5258630491555718,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 271.20099999999996,
                "logp": 2.8177000000000003,
                "tpsa": 49.33,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5258630491555718,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.8419543497185239
            },
            {
              "smiles": "C1CCOCC1.CO.CO",
              "qed": 0.5253735911371086,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 150.218,
                "logp": 0.4039,
                "tpsa": 49.69,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5253735911371086,
                "num_atoms": 10,
                "num_heavy_atoms": 10
              },
              "validity_score": 0.8417911970457029
            },
            {
              "smiles": "C1CCOCC1.Cl.Cl",
              "qed": 0.5249823706791767,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 159.056,
                "logp": 2.030500000000001,
                "tpsa": 9.23,
                "hbd": 0,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5249823706791767,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8416607902263923
            },
            {
              "smiles": "CN.c1ccoc1",
              "qed": 0.523448663366531,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 99.133,
                "logp": 0.8545,
                "tpsa": 39.16,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.523448663366531,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8411495544555102
            },
            {
              "smiles": "CN.c1ccoc1",
              "qed": 0.523448663366531,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 99.133,
                "logp": 0.8545,
                "tpsa": 39.16,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.523448663366531,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8411495544555102
            },
            {
              "smiles": "O=CO.c1ccncc1",
              "qed": 0.5211210653846723,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 125.12699999999998,
                "logp": 0.7824,
                "tpsa": 50.19,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5211210653846724,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8403736884615575
            },
            {
              "smiles": "NC=O.c1ccsc1",
              "qed": 0.5183356083287826,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 129.184,
                "logp": 0.8495999999999999,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5183356083287826,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8394452027762608
            },
            {
              "smiles": "Cl.c1cc[nH]c1",
              "qed": 0.5115167576286248,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 103.552,
                "logp": 1.4364999999999999,
                "tpsa": 15.79,
                "hbd": 1,
                "hba": 0,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5115167576286248,
                "num_atoms": 6,
                "num_heavy_atoms": 6
              },
              "validity_score": 0.837172252542875
            },
            {
              "smiles": "C1CCOC1.Cl.NC=O",
              "qed": 0.5099598186602019,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 153.609,
                "logp": 0.3201,
                "tpsa": 52.32,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5099598186602019,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8366532728867341
            },
            {
              "smiles": "C1CCOCC1.NC=O.O=CO",
              "qed": 0.5090332861412664,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 177.20000000000002,
                "logp": -0.01080000000000042,
                "tpsa": 89.62,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5090332861412664,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8363444287137555
            },
            {
              "smiles": "NC=O.c1ccccc1",
              "qed": 0.5090072711200299,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 123.15499999999996,
                "logp": 0.7880999999999999,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5090072711200299,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.83633575704001
            },
            {
              "smiles": "C1CCNCC1.Cl",
              "qed": 0.5077353121066428,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 121.611,
                "logp": 1.1817,
                "tpsa": 12.03,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.5077353121066428,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8359117707022143
            },
            {
              "smiles": "CO.N[SH](=O)=O.c1ccsc1",
              "qed": 0.5050060379604423,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 197.281,
                "logp": -0.17190000000000005,
                "tpsa": 80.39,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5050060379604423,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8350020126534807
            },
            {
              "smiles": "C1CCOC1.FC(F)F",
              "qed": 0.502081956428008,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 142.12,
                "logp": 1.9753,
                "tpsa": 9.23,
                "hbd": 0,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.502081956428008,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.834027318809336
            },
            {
              "smiles": "NC=O.c1ccncc1",
              "qed": 0.5015083347595439,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 124.14299999999997,
                "logp": 0.18309999999999982,
                "tpsa": 55.980000000000004,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.5015083347595439,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8338361115865146
            },
            {
              "smiles": "C1CCCCC1.NC=O",
              "qed": 0.49400959932831784,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 129.203,
                "logp": 1.4421,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.49400959932831784,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8313365331094392
            },
            {
              "smiles": "C1CCCCC1.NC=O",
              "qed": 0.49400959932831784,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 129.203,
                "logp": 1.4421,
                "tpsa": 43.09,
                "hbd": 1,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.49400959932831784,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8313365331094392
            },
            {
              "smiles": "C1CCCCC1.CN.N[SH](=O)=O",
              "qed": 0.48971609292221535,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 196.316,
                "logp": 0.3870000000000005,
                "tpsa": 86.18,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.48971609292221535,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.8299053643074051
            },
            {
              "smiles": "CN.c1cc[nH]c1",
              "qed": 0.4896238336861349,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 98.149,
                "logp": 0.5895999999999999,
                "tpsa": 41.81,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4896238336861349,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8298746112287118
            },
            {
              "smiles": "CN.c1cc[nH]c1",
              "qed": 0.4896238336861349,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 98.149,
                "logp": 0.5895999999999999,
                "tpsa": 41.81,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4896238336861349,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8298746112287118
            },
            {
              "smiles": "C1CCOCC1.CO.NC=O",
              "qed": 0.48956213296027373,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 163.21699999999998,
                "logp": -0.10310000000000008,
                "tpsa": 72.55000000000001,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.48956213296027373,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8298540443200912
            },
            {
              "smiles": "O=CO.c1cc[nH]c1",
              "qed": 0.48676316022379335,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 113.11599999999999,
                "logp": 0.7155,
                "tpsa": 53.089999999999996,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.48676316022379335,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8289210534079311
            },
            {
              "smiles": "CN.NC=O.O=CO.c1ccoc1",
              "qed": 0.48307987736738495,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 190.199,
                "logp": -0.34319999999999906,
                "tpsa": 119.55000000000001,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.483079877367385,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.827693292455795
            },
            {
              "smiles": "C1CCOC1.CO",
              "qed": 0.48189116718531866,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 104.14899999999999,
                "logp": 0.40530000000000005,
                "tpsa": 29.46,
                "hbd": 1,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.48189116718531866,
                "num_atoms": 7,
                "num_heavy_atoms": 7
              },
              "validity_score": 0.8272970557284395
            },
            {
              "smiles": "C1CCNCC1.CO",
              "qed": 0.4801570177200409,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 117.192,
                "logp": 0.3683999999999999,
                "tpsa": 32.26,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4801570177200409,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8267190059066802
            },
            {
              "smiles": "C1CCNCC1.CN",
              "qed": 0.4785613463856993,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 116.20800000000001,
                "logp": 0.3347999999999999,
                "tpsa": 38.05,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4785613463856993,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8261871154618997
            },
            {
              "smiles": "C1CCOC1.CN.O=CO",
              "qed": 0.4780174635676557,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 149.19000000000003,
                "logp": 0.07250000000000001,
                "tpsa": 72.55,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4780174635676558,
                "num_atoms": 10,
                "num_heavy_atoms": 10
              },
              "validity_score": 0.8260058211892186
            },
            {
              "smiles": "FC(F)F.NC=O.N[SH](=O)=O.c1ccsc1",
              "qed": 0.4759230196317666,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 280.293,
                "logp": 0.4996000000000001,
                "tpsa": 103.25,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4759230196317666,
                "num_atoms": 16,
                "num_heavy_atoms": 16
              },
              "validity_score": 0.8253076732105887
            },
            {
              "smiles": "C1CCNCC1.O=CO",
              "qed": 0.46945368112354124,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 131.175,
                "logp": 0.4606999999999999,
                "tpsa": 49.33,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.46945368112354124,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8231512270411804
            },
            {
              "smiles": "CN.CO.c1cc[nH]c1",
              "qed": 0.46945197127896887,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 130.191,
                "logp": 0.19809999999999933,
                "tpsa": 62.04,
                "hbd": 3,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.46945197127896887,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8231506570929895
            },
            {
              "smiles": "NC=O.c1cc[nH]c1",
              "qed": 0.45983306465666385,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 112.13199999999998,
                "logp": 0.11619999999999969,
                "tpsa": 58.88,
                "hbd": 2,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4598330646566638,
                "num_atoms": 8,
                "num_heavy_atoms": 8
              },
              "validity_score": 0.8199443548855546
            },
            {
              "smiles": "C1CCOC1.Cl",
              "qed": 0.4535036993490143,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 108.568,
                "logp": 1.2186,
                "tpsa": 9.23,
                "hbd": 0,
                "hba": 1,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4535036993490143,
                "num_atoms": 6,
                "num_heavy_atoms": 6
              },
              "validity_score": 0.8178345664496715
            },
            {
              "smiles": "C1CCOC1.N[SH](=O)=O",
              "qed": 0.45061760690414926,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 153.203,
                "logp": -0.7316999999999999,
                "tpsa": 69.39,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.45061760690414926,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8168725356347165
            },
            {
              "smiles": "C1CCOC1.N[SH](=O)=O",
              "qed": 0.45061760690414926,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 153.203,
                "logp": -0.7316999999999999,
                "tpsa": 69.39,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.45061760690414926,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8168725356347165
            },
            {
              "smiles": "C1CCOC1.N[SH](=O)=O",
              "qed": 0.45061760690414926,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 153.203,
                "logp": -0.7316999999999999,
                "tpsa": 69.39,
                "hbd": 2,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.45061760690414926,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8168725356347165
            },
            {
              "smiles": "FC(F)F.NC=O.N[SH](=O)=O.c1ccncc1",
              "qed": 0.4500254810768508,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 275.252,
                "logp": -0.1669000000000005,
                "tpsa": 116.14,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4500254810768508,
                "num_atoms": 17,
                "num_heavy_atoms": 17
              },
              "validity_score": 0.8166751603589503
            },
            {
              "smiles": "C1CCNCC1.NC=O",
              "qed": 0.4483817893226269,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 130.191,
                "logp": -0.13859999999999972,
                "tpsa": 55.12,
                "hbd": 2,
                "hba": 2,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4483817893226269,
                "num_atoms": 9,
                "num_heavy_atoms": 9
              },
              "validity_score": 0.8161272631075424
            },
            {
              "smiles": "C1CCOC1.CO.NC=O.O=CO",
              "qed": 0.43852005559621665,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 195.215,
                "logp": -0.7923999999999982,
                "tpsa": 109.85000000000001,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4385200555962167,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.8128400185320723
            },
            {
              "smiles": "Cl.N[SH](=O)=O.O=CO.c1ccncc1",
              "qed": 0.42644106740635623,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 242.68400000000003,
                "logp": -0.3243000000000007,
                "tpsa": 110.35000000000001,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.42644106740635623,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.808813689135452
            },
            {
              "smiles": "C1CCNCC1.CN.NC=O",
              "qed": 0.41635284566846337,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 161.249,
                "logp": -0.5636999999999983,
                "tpsa": 81.13999999999999,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4163528456684634,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8054509485561545
            },
            {
              "smiles": "C1CCOC1.CN.N[SH](=O)=O",
              "qed": 0.4138807818308737,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 184.26100000000002,
                "logp": -1.156799999999999,
                "tpsa": 95.41,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4138807818308737,
                "num_atoms": 11,
                "num_heavy_atoms": 11
              },
              "validity_score": 0.8046269272769578
            },
            {
              "smiles": "C1CCNCC1.N[SH](=O)=O",
              "qed": 0.4138008380495354,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 166.246,
                "logp": -0.7685999999999995,
                "tpsa": 72.19,
                "hbd": 3,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4138008380495354,
                "num_atoms": 10,
                "num_heavy_atoms": 10
              },
              "validity_score": 0.8046002793498451
            },
            {
              "smiles": "C1CCNCC1.CO.O=CO.O=CO",
              "qed": 0.4104686235952081,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 209.24200000000002,
                "logp": -0.2299999999999987,
                "tpsa": 106.86,
                "hbd": 4,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.4104686235952081,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8034895411984028
            },
            {
              "smiles": "CN.CO.N[SH](=O)=O.c1ccoc1",
              "qed": 0.40831629084805887,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 212.27100000000004,
                "logp": -1.065499999999999,
                "tpsa": 119.55,
                "hbd": 4,
                "hba": 5,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.40831629084805904,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.802772096949353
            },
            {
              "smiles": "CN.CN.N[SH](=O)=O.c1ccncc1",
              "qed": 0.40606904107882663,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 222.31400000000005,
                "logp": -1.2970999999999984,
                "tpsa": 125.08999999999999,
                "hbd": 4,
                "hba": 5,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.40606904107882674,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8020230136929424
            },
            {
              "smiles": "Cl.NC=O.N[SH](=O)=O.c1ccncc1",
              "qed": 0.4021573189681577,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 241.70000000000005,
                "logp": -0.9235999999999995,
                "tpsa": 116.14,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.4021573189681578,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.8007191063227191
            },
            {
              "smiles": "C1CCNCC1.CN.CO.O=CO",
              "qed": 0.39508611389950893,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 194.27500000000003,
                "logp": -0.3558999999999984,
                "tpsa": 95.58,
                "hbd": 4,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.395086113899509,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.798362037966503
            },
            {
              "smiles": "CO.NC=O.NC=O.c1cc[nH]c1",
              "qed": 0.38423873050837815,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 189.21500000000003,
                "logp": -1.1738000000000002,
                "tpsa": 122.19999999999999,
                "hbd": 4,
                "hba": 3,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.3842387305083781,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.7947462435027927
            },
            {
              "smiles": "N[SH](=O)=O.O=CO.c1ccncc1",
              "qed": 0.3819990913632116,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 206.223,
                "logp": -0.7460999999999995,
                "tpsa": 110.35000000000001,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.38199909136321164,
                "num_atoms": 13,
                "num_heavy_atoms": 13
              },
              "validity_score": 0.7939996971210705
            },
            {
              "smiles": "N[SH](=O)=O.O=CO.c1ccoc1",
              "qed": 0.37975671526849836,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 195.196,
                "logp": -0.5480999999999998,
                "tpsa": 110.60000000000001,
                "hbd": 3,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.3797567152684984,
                "num_atoms": 12,
                "num_heavy_atoms": 12
              },
              "validity_score": 0.7932522384228328
            },
            {
              "smiles": "CO.NC=O.N[SH](=O)=O.c1ccccc1",
              "qed": 0.3358295433455279,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 236.29300000000003,
                "logp": -1.131899999999999,
                "tpsa": 123.47999999999999,
                "hbd": 4,
                "hba": 4,
                "rotatable_bonds": 0,
                "aromatic_rings": 1,
                "qed": 0.33582954334552795,
                "num_atoms": 15,
                "num_heavy_atoms": 15
              },
              "validity_score": 0.7786098477818427
            },
            {
              "smiles": "N[SH](=O)=O.N[SH](=O)=O.O=CO.c1ccc2ccccc2c1",
              "qed": 0.3216620687597495,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 336.3910000000001,
                "logp": -0.5163999999999984,
                "tpsa": 157.61999999999998,
                "hbd": 5,
                "hba": 5,
                "rotatable_bonds": 0,
                "aromatic_rings": 2,
                "qed": 0.3216620687597495,
                "num_atoms": 21,
                "num_heavy_atoms": 21
              },
              "validity_score": 0.7738873562532499
            },
            {
              "smiles": "C1CCOCC1.CO.N[SH](=O)=O.O=CO",
              "qed": 0.31898938312898845,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 245.297,
                "logp": -1.0322999999999982,
                "tpsa": 126.92,
                "hbd": 4,
                "hba": 5,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.31898938312898845,
                "num_atoms": 15,
                "num_heavy_atoms": 15
              },
              "validity_score": 0.7729964610429961
            },
            {
              "smiles": "C1CCNCC1.N[SH](=O)=O.N[SH](=O)=O",
              "qed": 0.3071276182864386,
              "source": "RDKit-Fallback",
              "valid": true,
              "properties": {
                "molecular_weight": 247.342,
                "logp": -2.2970999999999986,
                "tpsa": 132.35,
                "hbd": 5,
                "hba": 5,
                "rotatable_bonds": 0,
                "aromatic_rings": 0,
                "qed": 0.3071276182864386,
                "num_atoms": 14,
                "num_heavy_atoms": 14
              },
              "validity_score": 0.7690425394288128
            }
          ],
          "statistics": {
            "total_generated": 100,
            "valid_molecules": 100,
            "validity_ratio": 1.0,
            "unique_molecules": 93,
            "uniqueness_ratio": 0.93,
            "novelty_estimate": 0.95,
            "mean_qed": 0.5270849752634514,
            "target_count": 100,
            "success_rate": 1.0
          },
          "parameters": {
            "num_molecules": 100,
            "temperature": 0.8,
            "target_properties": {}
          },
          "model": "RDKit-Fallback"
        },
        "error": null
      },
      "metadata": {
        "name": "molgan",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "MolGAN - GAN-based molecular generation",
        "capabilities": [
          "Generate novel molecules",
          "Property-guided generation",
          "Drug-likeness optimization",
          "Molecular graph generation"
        ],
        "reference": "https://arxiv.org/abs/1805.11973",
        "config": {
          "temperature": 0.8,
          "max_atoms": 38,
          "use_local": true
        }
      }
    },
    {
      "adapter": "denovo",
      "status": "success",
      "error": null,
      "execution_time": 0.014541,
      "data": {
        "success": true,
        "data": {
          "molecules": [
            {
              "smiles": "Clc1ccccc1",
              "original_scaffold": "c1ccccc1",
              "seed_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "source": "rnn_scaffold_hop"
            },
            {
              "smiles": "Fc1ccccc1",
              "original_scaffold": "c1ccccc1",
              "seed_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "source": "rnn_scaffold_hop"
            },
            {
              "smiles": "Nc1ccccc1",
              "original_scaffold": "c1ccccc1",
              "seed_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "source": "rnn_scaffold_hop"
            },
            {
              "smiles": "Oc1ccccc1",
              "original_scaffold": "c1ccccc1",
              "seed_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "source": "rnn_scaffold_hop"
            },
            {
              "smiles": "Cc1ccccc1",
              "original_scaffold": "c1ccccc1",
              "seed_smiles": "CC(=O)Oc1ccccc1C(=O)O",
              "source": "rnn_scaffold_hop"
            }
          ],
          "metrics": {
            "validity": 1.0,
            "uniqueness": 1.0,
            "novelty": 0.9,
            "diversity": 0.625,
            "total_generated": 5,
            "target_count": 100
          },
          "parameters": {
            "mode": "scaffold_hop",
            "model_type": "rnn",
            "num_molecules": 100,
            "target_profile": {},
            "constraints": {},
            "objectives": [
              "qed"
            ]
          },
          "model_info": {
            "type": "rnn",
            "version": "1.0.0",
            "fallback_used": true
          }
        },
        "error": null
      },
      "metadata": {
        "name": "denovo",
        "type": "ml",
        "version": "1.0.0",
        "enabled": true,
        "description": "General de novo drug design framework",
        "supported_models": [
          "RNN",
          "VAE",
          "Transformer",
          "Fragment"
        ],
        "capabilities": [
          "De novo molecule generation",
          "Scaffold hopping",
          "Property optimization",
          "Multi-objective design",
          "Diversity control"
        ],
        "config": {
          "model_type": "rnn",
          "optimize_properties": true,
          "use_pretrained": true
        }
      }
    },
    {
      "adapter": "ord",
      "status": "success",
      "error": null,
      "execution_time": 0.54856,
      "data": {
        "success": false,
        "data": {},
        "error": "Failed to query ORD database"
      },
      "metadata": {
        "name": "ord",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "description": "Open Reaction Database for forward synthesis planning",
        "capabilities": {
          "search_by_product": true,
          "search_by_reactant": true,
          "search_by_reagent": true,
          "reaction_conditions": true,
          "yield_data": true,
          "batch_queries": true,
          "literature_references": true
        },
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 30,
          "max_results": 50,
          "min_yield": 0.0
        },
        "reference": {
          "website": "https://open-reaction-database.org/",
          "github": "https://github.com/open-reaction-database/ord-schema",
          "paper": "Kearnes et al., J. Am. Chem. Soc. 2021, 143, 45, 18820-18826"
        }
      }
    },
    {
      "adapter": "clinicaltrials",
      "status": "success",
      "error": null,
      "execution_time": 1.483415,
      "data": {
        "success": true,
        "data": {
          "studies": [
            {
              "nct_id": "NCT05709509",
              "title": "Effect of Colchicine on MMP-9, NOX2, and TGF-\u03b21 in Myocardial Infarct",
              "status": "UNKNOWN",
              "phase": [
                "PHASE4"
              ],
              "enrollment": null,
              "start_date": "2022-06-01",
              "completion_date": "2023-05-01",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Colchicine",
                  "description": "Colchicine: A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. commonly used as anti-inflammatory drugs."
                },
                {
                  "type": "PROCEDURE",
                  "name": "Percutaneous Coronary Intervention",
                  "description": "Percutaneous Coronary Intervention: a family of minimally invasive procedures used to open clogged coronary arteries (those that deliver blood to the heart)"
                },
                {
                  "type": "OTHER",
                  "name": "Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.",
                  "description": "The subjects just received optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate."
                }
              ],
              "conditions": [
                "ST Elevation Myocardial Infarction",
                "Colchicine",
                "Cardiac Remodeling, Ventricular"
              ],
              "primary_outcomes": [
                {
                  "measure": "The change between 24 hours MMP-9 to day 5",
                  "description": "Matrix metallopeptidase 9 (MMP-9), also known as 92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B (GELB), is a matrixin, a class of enzymes that belong to the zinc-metalloproteinases family involved in the degradation of the extracellular matrix.",
                  "timeFrame": "24 Hours, Day 5"
                },
                {
                  "measure": "The change between 24 hours NOX2 to day 5",
                  "description": "NADPH oxidase 2 (Nox2), also known as cytochrome b(558) subunit beta or Cytochrome b-245 heavy chain, is a protein that in humans is encoded by the NOX2 gene (also called CYBB gene). The protein is a superoxide generating enzyme which forms reactive oxygen species (ROS).",
                  "timeFrame": "24 Hours, Day 5"
                },
                {
                  "measure": "The change between 24 hours TGF-\u03b21 to day 5",
                  "description": "Transforming growth factor \u03b21 (TGFB1) is a multifunctional secreted protein that generally regulates immune function,544 as well as cell survival and migration, through the Sma- and Mad-related proteins (SMAD) signaling pathway.",
                  "timeFrame": "24 Hours, Day 5"
                },
                {
                  "measure": "Left ventricular end-diastolic volume (LVEDV)",
                  "description": "The volume of blood in the left ventricle at the end of ventricular filling is called the end-diastolic volume (EDV), which is about 120 mL in the adult human.",
                  "timeFrame": "Month 1"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT03532698",
              "title": "Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)",
              "status": "UNKNOWN",
              "phase": [],
              "enrollment": null,
              "start_date": "2020-08-01",
              "completion_date": "2022-12-31",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "Aspirin, also known as acetylsalicylic acid (ASA), is a very safe medication used to treat pain, fever, or inflammation."
                },
                {
                  "type": "DRUG",
                  "name": "Osimertinib",
                  "description": "Osimertinib, also known as azd9291, is a 3rd-generation EGFR-TKI used to treat NSCLC patients with resistance to 1st generation EGFR-TKI due to T790M mutation. It has been approved in clinical applications by the FDA in 2015."
                }
              ],
              "conditions": [
                "Non-Small Cell Lung Cancer Stage IIIB",
                "Non-small Cell Lung Cancer Stage IV",
                "EGFR T790M"
              ],
              "primary_outcomes": [
                {
                  "measure": "Objective Response Rate(ORR) according to resist 1.1",
                  "description": "To evaluate the response to therapy and Objective Response Rate of the combination of Osimertinib and Aspirin in patients who has metastatic pulmonary adenocarcinoma disease progression to 3st generation EGFR-TKI Osimertinib.",
                  "timeFrame": "2years"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT06486792",
              "title": "Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation",
              "status": "NOT_YET_RECRUITING",
              "phase": [
                "PHASE4"
              ],
              "enrollment": null,
              "start_date": "2024-09-01",
              "completion_date": "2028-03-01",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Apixaban",
                  "description": "Patients who have had an ischemic stroke will receive either an anticoagulant or aspirin according to their randomization arm."
                },
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "Aspirin is used as the standard of care"
                }
              ],
              "conditions": [
                "Stroke",
                "Ischemic Stroke",
                "Cerebral Infarction",
                "Atrial Fibrillation"
              ],
              "primary_outcomes": [
                {
                  "measure": "Occurrence of fatal or nonfatal ischemic stroke, or peripheral emboli (even if asymptomatic) [peripheral emboli: emboli in arm or leg, new renal, splenic, hepatic, mesenteric infarction]",
                  "description": "Evaluate two commonly used antithrombotic treatment strategies in patients with recent ischemic stroke and at high risk of atrial fibrillation.",
                  "timeFrame": "During the 12 month follow-up"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01968798",
              "title": "ASPREE Cancer Endpoints Study",
              "status": "UNKNOWN",
              "phase": [
                "PHASE4"
              ],
              "enrollment": null,
              "start_date": "2013-09",
              "completion_date": "2024-04",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "100mg enteric-coated aspirin, taken daily"
                },
                {
                  "type": "DRUG",
                  "name": "Placebo",
                  "description": "100mg enteric-coated placebo, taken daily"
                }
              ],
              "conditions": [
                "Cancer"
              ],
              "primary_outcomes": [
                {
                  "measure": "To examine the effect of daily low-dose aspirin (100 mg) compared to placebo, on specific DNA biomarkers and selected specific incident and recurrent cancer and metastases.",
                  "description": "The ASPREE Cancer Endpoint Study (ACES) will allow for the examination of the effect of daily low-dose aspirin (100 mg) compared to placebo, on specific DNA biomarkers and selected specific incident and recurrent cancer and metastases. The establishment of this ACES biobank will allow for the exploration of DNA-related molecular mechanisms of aspirin's protective effect against cancer, cancer associated mortality and metastases, using blood or saliva DNA specimens, urine, and tumor tissue.",
                  "timeFrame": "every 6 months"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT06478537",
              "title": "TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination",
              "status": "RECRUITING",
              "phase": [
                "PHASE2"
              ],
              "enrollment": null,
              "start_date": "2024-06-20",
              "completion_date": "2027-06-20",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Hetrombopag Olamine",
                  "description": "Treatment period: 24-week Hetrombopag (2.5mg/d\\~7.5mg/d) treatment.\n\n* Two consecutive visits with PLT\\>600 \u00d7 10\\^9/L: daily dose reduction of 2.5mg; If the lowest dose has been used, extend the dosing interval.\n* Two consecutive visits with PLT\\<300 \u00d7 10\\^9/L: increase the daily dose by 2.5mg until the maximum dose is reached.\n* Two consecutive visits with PLT\\<50 \u00d7 10\\^9/L: increase the daily dose by 2.5mg until the maximum dose is reached; If PLT is still\\<50 \u00d7 10\\^9/L with7.5mg/d \u00d7 28d, the patient will be withdrawn.\n\nDrug discontinuation period\uff1a8-week Hetrombopag (2.5mg/d\\~7.5mg/d) reduction. Hetrombopag reduces by 2.5mg every 2 weeks, and after reducing to the minimum dose of 2.5mg/d x 2 weeks, it is changed to 2.5mg once every other day (Qod) treatment, with a maximum reduction time of 8 weeks. If the PLT during two consecutive visits is less than 30 \u00d7 10\\^9/L, the patient will be withdrawn."
                },
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "Aspirin 100mg, qd"
                }
              ],
              "conditions": [
                "Immune Thrombocytopenia"
              ],
              "primary_outcomes": [
                {
                  "measure": "Sustained response off treatment (SROT)",
                  "description": "The percentage of participants with successful discontinuation of TPO-RAs after tapering and discontinuation",
                  "timeFrame": "3 year"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01740921",
              "title": "GLP-1 and Microvascular Function in Type 2 Diabetes",
              "status": "COMPLETED",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2011-01",
              "completion_date": "2016-02",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Liraglutide",
                  "description": "Administered once daily"
                },
                {
                  "type": "OTHER",
                  "name": "diet",
                  "description": "reduction of caloric intake to promote weight loss"
                },
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "300mg of Aspirin per day"
                }
              ],
              "conditions": [
                "Type 2 Diabetes"
              ],
              "primary_outcomes": [
                {
                  "measure": "change of baseline skin maximum hyperaemia at 4 months",
                  "description": "laser doppler fluximetry",
                  "timeFrame": "baseline and 4 months"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01061034",
              "title": "Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers",
              "status": "COMPLETED",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2007-03",
              "completion_date": "2007-06",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "aspirin and omeprazole",
                  "description": "aspirin 100 mg, once daily aspirin 100 mg and omeprazole 20 mg both once daily."
                }
              ],
              "conditions": [
                "Aspirin Blood Level",
                "Proton Pump Inhiditor Treatment"
              ],
              "primary_outcomes": [
                {
                  "measure": "Aspirin Level in Blood (Area Under the Curve)",
                  "description": "Aspirins pharmacokinetics: aspirin blood level determined by use of high performance liquid chromatography (HPLC) at baseline, 1, 2,4,6,10 and 24 hours after administration of aspirin on day 7 and on day 21.\n\nThe area unther the time vs. concentration curve of the reccurent measurments(AUC) reflects bioavailability of aspirin.",
                  "timeFrame": "on day 7,on day 21"
                }
              ],
              "has_results": true,
              "outcome_measures": [
                {
                  "type": "PRIMARY",
                  "title": "Aspirin Level in Blood (Area Under the Curve)",
                  "description": "Aspirins pharmacokinetics: aspirin blood level determined by use of high performance liquid chromatography (HPLC) at baseline, 1, 2,4,6,10 and 24 hours after administration of aspirin on day 7 and on day 21.\n\nThe area unther the time vs. concentration curve of the reccurent measurments(AUC) reflects bioavailability of aspirin.",
                  "populationDescription": "9 volunteers completed the study, one volunteer was excluded from pharmacokinetics, because serum salicylic acid concentration was not at the baseline (non-detectable) in the 0-hour sample.",
                  "reportingStatus": "POSTED",
                  "anticipatedPostingDate": "2007-04",
                  "paramType": "MEAN",
                  "dispersionType": "Standard Deviation",
                  "unitOfMeasure": "mg*hour/mL",
                  "timeFrame": "on day 7,on day 21",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Aspirin Then Aspirin Plus Omeprazole",
                      "description": "7 days of Aspirin (100mg) alone, followed by 14 days of Aspirin and Omeprazole (20mg BID for 3 days and then 20mg once daily"
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "8"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "title": "aspirin area under the curve on day 7",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "49.4",
                              "spread": "13.5"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "aspirin area under the curve on day 21",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "50.7",
                              "spread": "15.3"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "1 hour after admission day 7 (aspirin alone)",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "8.7",
                              "spread": "4"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "1 hour after admission day 21 (aspirin+omeprazole)",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "6.5",
                              "spread": "4.1"
                            }
                          ]
                        }
                      ]
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Platelet Function Tests",
                  "description": "Platelet function tests were determined by optical whole blood aggregometry in response to arachidonic acid and adenosine diphosphate.\n\nthe results reflects the percent of active platelets.",
                  "reportingStatus": "POSTED",
                  "anticipatedPostingDate": "2007-01",
                  "paramType": "MEAN",
                  "dispersionType": "Standard Deviation",
                  "unitOfMeasure": "percent",
                  "timeFrame": "on day 0 as a baseline and on day 7 and 21 of the study.",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Aspirin Then Aspirin Plus Omeprazole",
                      "description": "7 days of Aspirin (100mg) alone, followed by 14 days of Aspirin and Omeprazole (20mg BID for 3 days and then 20mg once daily"
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "9"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "title": "day 0",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "80",
                              "spread": "4.18"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "day 7",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "8.55",
                              "spread": "2.45"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "day 21",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "8.77",
                              "spread": "2.38"
                            }
                          ]
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "nct_id": "NCT00563875",
              "title": "Laboratory Aspirin Resistance in Diabetics and Non-Diabetics",
              "status": "COMPLETED",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2007-11",
              "completion_date": "2008-06",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "acetylsalicylic acid",
                  "description": "75 mg/d for 7 days (healthy volunteers) and continued treatment with 75 mg/d in patients taking daily aspirin."
                }
              ],
              "conditions": [
                "Drug Resistance"
              ],
              "primary_outcomes": [
                {
                  "measure": "Platelet aggregation",
                  "description": null,
                  "timeFrame": "(at least) one hour after aspirin ingestion"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT06952712",
              "title": "Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women",
              "status": "NOT_YET_RECRUITING",
              "phase": [
                "PHASE3"
              ],
              "enrollment": null,
              "start_date": "2025-05-07",
              "completion_date": "2028-05-06",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin 100mg",
                  "description": "Aspirin 100mg qn was started from 12-16 weeks of gestation and discontinued from 36+0-36+6 weeks of gestation"
                },
                {
                  "type": "DRUG",
                  "name": "Aspirin 150mg",
                  "description": "Aspirin 150mg qn was started from 12-16 weeks of gestation and discontinued from 36+0-36+6 weeks of gestation"
                }
              ],
              "conditions": [
                "Preeclampsia"
              ],
              "primary_outcomes": [
                {
                  "measure": "The incidence of preeclampsia",
                  "description": "Hypertension and proteinuria or other organ dysfunction occur after 20 weeks of gestation",
                  "timeFrame": "Within one week of delivery"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01033526",
              "title": "Symptomatic Treatment of Common Cold Symptoms",
              "status": "COMPLETED",
              "phase": [
                "PHASE4"
              ],
              "enrollment": null,
              "start_date": "2005-10",
              "completion_date": "2007-06",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin (Acetylsalicylic acid, BAYE4465)",
                  "description": "1-2 tablets Acetylsalicylic Acid 400 mg (in combination with Ascorbic Acid 240 mg) as needed every 4-6 hours over a maximum of 5 days"
                },
                {
                  "type": "DRUG",
                  "name": "Placebo",
                  "description": "1-2 tablets matching Placebo as needed every 4-6 hours over a maximum of 5 days"
                }
              ],
              "conditions": [
                "Common Cold"
              ],
              "primary_outcomes": [
                {
                  "measure": "Change in Cold Symptoms (patient Wisconsin Upper Respiratory Symptom Survey (WURSS domain 2 score) from baseline",
                  "description": null,
                  "timeFrame": "2 hours following intake of the first study medication dose"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT02313909",
              "title": "Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)",
              "status": "TERMINATED",
              "phase": [
                "PHASE3"
              ],
              "enrollment": null,
              "start_date": "2014-12-23",
              "completion_date": "2018-02-15",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Rivaroxaban (Xarelto, BAY59-7939)",
                  "description": "15 mg, once daily, orally, tablet"
                },
                {
                  "type": "DRUG",
                  "name": "Acetylsalicylic acid (Aspirin, BAY1019036)",
                  "description": "100 mg, once daily, orally, tablet"
                },
                {
                  "type": "OTHER",
                  "name": "Rivaroxaban-Placebo",
                  "description": "Matching placebo, once daily, orally, tablet"
                },
                {
                  "type": "OTHER",
                  "name": "Aspirin-Placebo",
                  "description": "Matching placebo, once daily, orally, tablet"
                }
              ],
              "conditions": [
                "Stroke"
              ],
              "primary_outcomes": [
                {
                  "measure": "Incidence Rate of the Composite Efficacy Outcome (Adjudicated)",
                  "description": "Components of composite efficacy outcome (adjudicated) includes stroke (ischemic, hemorrhagic, and undefined stroke, TIA with positive neuroimaging) and systemic embolism. Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred.",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)"
                },
                {
                  "measure": "Incidence Rate of a Major Bleeding Event According to the International Society on Thrombosis and Haemostasis (ISTH) Criteria (Adjudicated)",
                  "description": "Major bleeding event (as per ISTH), defined as bleeding event that met at least one of following: fatal bleeding; symptomatic bleeding in a critical area or organ (intraarticular, intramuscular with compartment syndrome, intraocular, intraspinal, pericardial, or retroperitoneal); symptomatic intracranial haemorrhage; clinically overt bleeding associated with a recent decrease in the hemoglobin level of greater than or equal to (\\>=) 2 grams per decilitre (g/dL) (20 grams per liter \\[g/L\\]; 1.24 millimoles per liter \\[mmol/L\\]) compared to the most recent hemoglobin value available before the event; clinically overt bleeding leading to transfusion of 2 or more units of packed red blood cells or whole blood. The results were based on classification of events that have been positively adjudicated as major bleeding events. Incidence rate estimated as number of subjects with incident events divided by cumulative at-risk time, where subject is no longer at risk once an incident event occurred.",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)"
                }
              ],
              "has_results": true,
              "outcome_measures": [
                {
                  "type": "PRIMARY",
                  "title": "Incidence Rate of the Composite Efficacy Outcome (Adjudicated)",
                  "description": "Components of composite efficacy outcome (adjudicated) includes stroke (ischemic, hemorrhagic, and undefined stroke, TIA with positive neuroimaging) and systemic embolism. Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "5.14",
                              "lowerLimit": "4.40",
                              "upperLimit": "5.97"
                            },
                            {
                              "groupId": "OG001",
                              "value": "4.78",
                              "lowerLimit": "4.07",
                              "upperLimit": "5.58"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis: Stroke + Systemic embolism: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.51884",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.07",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.87",
                      "ciUpperLimit": "1.33"
                    }
                  ]
                },
                {
                  "type": "PRIMARY",
                  "title": "Incidence Rate of a Major Bleeding Event According to the International Society on Thrombosis and Haemostasis (ISTH) Criteria (Adjudicated)",
                  "description": "Major bleeding event (as per ISTH), defined as bleeding event that met at least one of following: fatal bleeding; symptomatic bleeding in a critical area or organ (intraarticular, intramuscular with compartment syndrome, intraocular, intraspinal, pericardial, or retroperitoneal); symptomatic intracranial haemorrhage; clinically overt bleeding associated with a recent decrease in the hemoglobin level of greater than or equal to (\\>=) 2 grams per decilitre (g/dL) (20 grams per liter \\[g/L\\]; 1.24 millimoles per liter \\[mmol/L\\]) compared to the most recent hemoglobin value available before the event; clinically overt bleeding leading to transfusion of 2 or more units of packed red blood cells or whole blood. The results were based on classification of events that have been positively adjudicated as major bleeding events. Incidence rate estimated as number of subjects with incident events divided by cumulative at-risk time, where subject is no longer at risk once an incident event occurred.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "1.82",
                              "lowerLimit": "1.39",
                              "upperLimit": "2.33"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.67",
                              "lowerLimit": "0.42",
                              "upperLimit": "1.00"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis: ISTH major bleeding events: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.00002",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "2.72",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "1.68",
                      "ciUpperLimit": "4.39"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of Any of the Following: Cardiovascular Death, Recurrent Stroke, Systemic Embolism and Myocardial Infarction",
                  "description": "Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred. Cardiovascular death includes death due to hemorrhage and death with undetermined/unknown cause. Systemic embolism is defined as abrupt vascular insufficiency associated with clinical or radiological evidence of arterial occlusion in the absence of other likely mechanisms. The diagnosis of myocardial infarction requires the combination of: 1)evidence of myocardial necrosis (either changes in cardiac biomarkers or post-mortem pathological findings); and 2)supporting information derived from the clinical presentation, electrocardiographic changes, or the results of myocardial or coronary artery imaging.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "6.20",
                              "lowerLimit": "5.38",
                              "upperLimit": "7.10"
                            },
                            {
                              "groupId": "OG001",
                              "value": "5.85",
                              "lowerLimit": "5.05",
                              "upperLimit": "6.73"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Confidence intervals were calculated, if at least 1 event in each treatment arm existed. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.56922",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.06",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.87",
                      "ciUpperLimit": "1.29"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of All-Cause Mortality",
                  "description": "All-cause mortality includes all deaths of participants due to any cause.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "1.88",
                              "lowerLimit": "1.45",
                              "upperLimit": "2.40"
                            },
                            {
                              "groupId": "OG001",
                              "value": "1.50",
                              "lowerLimit": "1.12",
                              "upperLimit": "1.97"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Confidence intervals were calculated, if at least 1 event in each treatment arm existed. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.22078",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.26",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.87",
                      "ciUpperLimit": "1.81"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of the Following: Stroke, Ischemic Stroke, Disabling Stroke, Cardiovascular (CV) Death, Myocardial Infarction",
                  "description": "Disabling stroke is defined as stroke with modified Rankin score (mRS) greater than or equal to (\\>=) 4 as assessed by investigator. mRS spans 0-6, running from perfect health to death. A score of 0-3 indicates functional status ranging from no symptoms to \"moderate disability\" (defined in the mRS as requiring some help, but able to walk without assistance); mRS 4-6 indicates functional status ranging from \"moderately severe disability\" (unable to walk or to attend to own bodily needs without assistance)through to death. CV death includes death due to hemorrhage and death with undetermined/unknown cause. Diagnosis of myocardial infarction requires combination of: 1) evidence of myocardial necrosis either changes in cardiac biomarkers or post-mortem pathological findings); 2) supporting information derived from clinical presentation, electrocardiographic changes, or results of myocardial or coronary artery imaging.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "title": "Stroke",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "5.11",
                              "lowerLimit": "4.37",
                              "upperLimit": "5.93"
                            },
                            {
                              "groupId": "OG001",
                              "value": "4.71",
                              "lowerLimit": "4.01",
                              "upperLimit": "5.51"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "Ischemic stroke",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "4.71",
                              "lowerLimit": "4.01",
                              "upperLimit": "5.51"
                            },
                            {
                              "groupId": "OG001",
                              "value": "4.56",
                              "lowerLimit": "3.87",
                              "upperLimit": "5.34"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "Disabling stroke",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "1.20",
                              "lowerLimit": "0.86",
                              "upperLimit": "1.62"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.84",
                              "lowerLimit": "0.56",
                              "upperLimit": "1.21"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "CV death(includes death due to hemorrhage)",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "0.99",
                              "lowerLimit": "0.68",
                              "upperLimit": "1.38"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.66",
                              "lowerLimit": "0.42",
                              "upperLimit": "1.00"
                            }
                          ]
                        }
                      ]
                    },
                    {
                      "title": "Myocardial infarction",
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "0.49",
                              "lowerLimit": "0.29",
                              "upperLimit": "0.79"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.67",
                              "lowerLimit": "0.42",
                              "upperLimit": "1.00"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 1: Stroke: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.47970",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.08",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.87",
                      "ciUpperLimit": "1.34"
                    },
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 2: Ischemic stroke: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.78738",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.03",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.83",
                      "ciUpperLimit": "1.29"
                    },
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 3: Disabling stroke: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.14822",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.42",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.88",
                      "ciUpperLimit": "2.28"
                    },
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 4:CV death: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.14051",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.48",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.87",
                      "ciUpperLimit": "2.52"
                    },
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 5: Myocardial infarction: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.34284",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "0.74",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "0.39",
                      "ciUpperLimit": "1.38"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of Life-Threatening Bleeding Events",
                  "description": "Life-threatening bleeding was defined as a subset of major bleeding that met at least one of the following criteria: 1) fatal bleeding; 2) symptomatic intracranial haemorrhage; 3) reduction in hemoglobin of at least 5 g/dl (50 g/l; 3.10 mmol/L); 4) transfusion of at least 4 units of packed red cells or whole blood; 5) associated with hypotension requiring the use of intravenous inotropic agents; 6) necessitated surgical intervention. Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "1.02",
                              "lowerLimit": "0.71",
                              "upperLimit": "1.42"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.43",
                              "lowerLimit": "0.24",
                              "upperLimit": "0.72"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.00443",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "2.34",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "1.28",
                      "ciUpperLimit": "4.29"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of Clinically Relevant Non-Major Bleeding Events",
                  "description": "Non-major clinically relevant bleeding was defined as non-major overt bleeding but required medical attention (example: hospitalization, medical treatment for bleeding), and/or was associated with the study drug interruption of more than 14 days. The results were based on the outcome events at or after randomization until the efficacy cut-off date. Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "3.52",
                              "lowerLimit": "2.91",
                              "upperLimit": "4.21"
                            },
                            {
                              "groupId": "OG001",
                              "value": "2.32",
                              "lowerLimit": "1.84",
                              "upperLimit": "2.90"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.00451",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "1.51",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "1.13",
                      "ciUpperLimit": "2.00"
                    }
                  ]
                },
                {
                  "type": "SECONDARY",
                  "title": "Incidence Rate of Intracranial Hemorrhage",
                  "description": "Intracranial hemorrhage included all bleeding events that occurred in intracerebral, sub arachnoidal as well as subdural or epidural sites. The below table displays results for all randomized participants and the outcomes at or after randomization until the efficacy cut-off date. Incidence rate estimated as number of participants with incident events divided by cumulative at-risk time, where participant is no longer at risk once an incident event occurred.",
                  "populationDescription": "Intention-to-treat analysis set included all randomized participants. Participants who were evaluable for this measure at given time period for the arm were included in the category.",
                  "reportingStatus": "POSTED",
                  "paramType": "NUMBER",
                  "dispersionType": "95% Confidence Interval",
                  "unitOfMeasure": "event/100 participant-years",
                  "timeFrame": "From randomization until the efficacy cut-off date (median 326 days)",
                  "groups": [
                    {
                      "id": "OG000",
                      "title": "Rivaroxaban 15 mg OD",
                      "description": "Subjects received rivaroxaban 15 mg immediate-release film-coated tablet and matching placebo of acetylsalicylic acid orally once daily (OD)."
                    },
                    {
                      "id": "OG001",
                      "title": "Acetylsalicylic Acid 100 mg OD",
                      "description": "Subjects received acetylsalicylic acid 100 mg enteric-coated tablet and matching placebo of rivaroxaban orally once daily (OD)."
                    }
                  ],
                  "denoms": [
                    {
                      "units": "Participants",
                      "counts": [
                        {
                          "groupId": "OG000",
                          "value": "3609"
                        },
                        {
                          "groupId": "OG001",
                          "value": "3604"
                        }
                      ]
                    }
                  ],
                  "classes": [
                    {
                      "categories": [
                        {
                          "measurements": [
                            {
                              "groupId": "OG000",
                              "value": "0.70",
                              "lowerLimit": "0.45",
                              "upperLimit": "1.04"
                            },
                            {
                              "groupId": "OG001",
                              "value": "0.35",
                              "lowerLimit": "0.18",
                              "upperLimit": "0.61"
                            }
                          ]
                        }
                      ]
                    }
                  ],
                  "analyses": [
                    {
                      "groupIds": [
                        "OG000",
                        "OG001"
                      ],
                      "groupDescription": "Statistical analysis 1: Risk reduction was estimated with the stratified Cox proportional hazards model. Hazard ratios (95% confidence interval) as compared to acetylsalicylic acid arm were reported. Rivaroxaban treatment was compared with the Acetylsalicylic acid control group using a stratified log-rank test. P-values (two-sided) as compared to acetylsalicylic acid arm were based on the log-rank test.",
                      "nonInferiorityType": "SUPERIORITY",
                      "pValue": "0.04409",
                      "statisticalMethod": "Log Rank",
                      "paramType": "Hazard Ratio (HR)",
                      "paramValue": "2.01",
                      "ciPctValue": "95",
                      "ciNumSides": "TWO_SIDED",
                      "ciLowerLimit": "1.00",
                      "ciUpperLimit": "4.02"
                    }
                  ]
                }
              ]
            },
            {
              "nct_id": "NCT03176498",
              "title": "Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife\u00ae-CI) for Cerebral Infarction Patients in Convalescent Period.",
              "status": "SUSPENDED",
              "phase": [
                "PHASE1",
                "PHASE2"
              ],
              "enrollment": null,
              "start_date": "2025-12-31",
              "completion_date": "2026-12-31",
              "interventions": [
                {
                  "type": "BIOLOGICAL",
                  "name": "Allogeneic umbilical cord mesenchymal stem cell",
                  "description": "Experimental group receive Allogeneic umbilical cord mesenchymal stem cell\uff0ci.v (SCLnow 19#)"
                },
                {
                  "type": "DRUG",
                  "name": "Aspirin Enteric-coated Tablets & Atorvastatin Calcium",
                  "description": "Aspirin Enteric-coated Tablets, 0.1g/d by mouth; Atorvastatin Calcium, 20mg/d by mouth."
                }
              ],
              "conditions": [
                "Cerebral Infarction"
              ],
              "primary_outcomes": [
                {
                  "measure": "Motor function analysis",
                  "description": "Based on Activity of Daily Living Scale (ADL) to analysis efficacy of cell treatment.The score of patient with upper limb \\>60, and total score \\>90 is considered good recovery.",
                  "timeFrame": "6 months"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01072604",
              "title": "Pharmacokinetic Study Comparing Aspirin and Aspirin Granules",
              "status": "COMPLETED",
              "phase": [
                "PHASE1"
              ],
              "enrollment": null,
              "start_date": "2009-07",
              "completion_date": "2009-08",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Acetylsalicylic acid (Aspirin, BAY1019036)",
                  "description": "One oral dose of new formula Aspirin Prototype 1 under fasting conditions"
                },
                {
                  "type": "DRUG",
                  "name": "Acetylsalicylic acid (Aspirin, BAY1019036)",
                  "description": "One oral dose of new formula Aspirin Prototype 2 under fasting conditions"
                },
                {
                  "type": "DRUG",
                  "name": "Acetylsalicylic acid (Aspirin, BAYE4465)",
                  "description": "One oral dose of Aspirin Plain Tablet under fasting conditions"
                },
                {
                  "type": "DRUG",
                  "name": "Acetylsalicylic acid (Aspirin, BAYE4465)",
                  "description": "One oral dose of Aspirin Dry Granules under fasting conditions"
                }
              ],
              "conditions": [
                "Pharmacokinetics"
              ],
              "primary_outcomes": [
                {
                  "measure": "Bioequivalence of new formula aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects",
                  "description": null,
                  "timeFrame": "24 hours"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT06866964",
              "title": "A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy",
              "status": "RECRUITING",
              "phase": [
                "PHASE2"
              ],
              "enrollment": null,
              "start_date": "2025-08-28",
              "completion_date": "2031-01",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Low-dose ASA",
                  "description": "81 mg by mouth daily for 26 weeks"
                }
              ],
              "conditions": [
                "Germ Cell Tumor",
                "Testicular Cancer"
              ],
              "primary_outcomes": [
                {
                  "measure": "Venous thromboembolism (VTE)-free",
                  "description": "A binary variable indicating whether the participant had zero VTE events within 26 weeks of initiation of standard chemotherapy. VTE events include objectively confirmed symptomatic or asymptomatic proximal deep-vein thrombosis in a lower limb, symptomatic deep-vein thrombosis in an upper limb or distal deep-vein thrombosis in a lower limb, symptomatic or incidental pulmonary embolism, symptomatic or incidental central catheter related thrombosis, or death from venous thromboembolism.",
                  "timeFrame": "26 weeks after initiation of standard chemotherapy"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01321255",
              "title": "Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.",
              "status": "COMPLETED",
              "phase": [
                "PHASE3"
              ],
              "enrollment": null,
              "start_date": "2012-01",
              "completion_date": "2014-06",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "FDC",
                  "description": "FDC includes a combination of 100 mg aspirin, 40 mg simvastatin, and 2.5;5;10 mg Ramipril"
                },
                {
                  "type": "DRUG",
                  "name": "Separately drugs, simvastatin, aspirin and ramipril",
                  "description": "Aspirin 100 mg once a day Ramipril 2.5; 5; 10 mg once a day Simvastatin 40 mg once a day"
                }
              ],
              "conditions": [
                "Myocardial Infarction"
              ],
              "primary_outcomes": [
                {
                  "measure": "Proportion of patients receiving AAS, an ACE inhibitor and a statin among those without contraindications to any of these drugs Adherence to treatment measured by: Morinsky-Green test and Pill accountability.",
                  "description": "Phase 1",
                  "timeFrame": "18 months"
                },
                {
                  "measure": "Adherence to treatment measured by the Morisky-Green questionnaire",
                  "description": "Phase 1:\n\nAdherence to treatment measured by the Morisky-Green questionnaire. According to this, patients will be classified as \"Good adherents\" when the total score ranges between 16 and 20 and as \"Poor adherents\" if the total score is \\<16 points",
                  "timeFrame": "18 months"
                },
                {
                  "measure": "Treatment adherence measured by: Morisky-Green test: (Good adherence score 16-20) at 1 and 9 months.",
                  "description": "Phase 2",
                  "timeFrame": "18 months"
                },
                {
                  "measure": "Treatment adherence measured by: Pill counts at 1-4-9 months. (Good adherence 80-110% PC)",
                  "description": "Phase 2",
                  "timeFrame": "18 months"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT04645004",
              "title": "Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy",
              "status": "COMPLETED",
              "phase": [
                "PHASE1",
                "PHASE2"
              ],
              "enrollment": null,
              "start_date": "2020-12-29",
              "completion_date": "2024-03-15",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin 81Mg Non-enteric coated Tab",
                  "description": "one tab daily"
                }
              ],
              "conditions": [
                "Preeclampsia"
              ],
              "primary_outcomes": [
                {
                  "measure": "salicylic acid level",
                  "description": "time/concentration profile",
                  "timeFrame": "24 hour"
                },
                {
                  "measure": "serum thromboxane",
                  "description": "ELISA based quantification of serum thromboxane B2",
                  "timeFrame": "4 week post initiation"
                },
                {
                  "measure": "PFA-100",
                  "description": "PFA-100 epi closure time (Siemens)",
                  "timeFrame": "4 week post initiation"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT02261025",
              "title": "The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis",
              "status": "COMPLETED",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2008-01",
              "completion_date": "2014-09",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "acetylsalicylic acid",
                  "description": "75-100mg,per day"
                }
              ],
              "conditions": [
                "Hemodialysis"
              ],
              "primary_outcomes": [
                {
                  "measure": "survival rate",
                  "description": null,
                  "timeFrame": "5 years"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT01257893",
              "title": "Aspirin Resistance in Women With Migraine",
              "status": "WITHDRAWN",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2010-11",
              "completion_date": "2012-08",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin (acetylsalicylic acid)",
                  "description": "Aspirin one 81 mg capsule per day for 10-14 consecutive days"
                },
                {
                  "type": "DRUG",
                  "name": "Placebo",
                  "description": "1 placebo capsule identical in appearance and excipient to aspirin capsule per day for 10-14 consecutive days"
                }
              ],
              "conditions": [
                "Episodic Migraine",
                "Chronic Migraine"
              ],
              "primary_outcomes": [
                {
                  "measure": "Aspirin Reaction Units (ARU)",
                  "description": "Measurement of ARU, indicative of platelet inhibition, using the VerifyNow Aspirin Assay (Accumetrics, San Diego, CA)",
                  "timeFrame": "10-14 days"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT02831218",
              "title": "Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation",
              "status": "TERMINATED",
              "phase": [
                "NA"
              ],
              "enrollment": null,
              "start_date": "2016-12",
              "completion_date": "2017-09",
              "interventions": [
                {
                  "type": "PROCEDURE",
                  "name": "QCA and Aspirin",
                  "description": "QCA(quantitative coronary angiography) guided BVS implantation and all patients are treated with dual antiplatelet therapy (aspirin 100mg/day and clopidogrel 75mg per day\\[or ticagrelor 90mg po bid\\]) for 12 months after BVS implantation, and randomized to either aspirin alone (aspirin 100mg/day) or clopidogrel alone (clopidogrel 75mg /day) for the next 4 years."
                },
                {
                  "type": "PROCEDURE",
                  "name": "QCA and Clopidogrel",
                  "description": "QCA(quantitative coronary angiography) guided BVS implantation and all patients are treated with dual antiplatelet therapy (aspirin 100mg/day and clopidogrel 75mg per day\\[or ticagrelor 90mg po bid\\]) for 12 months after BVS implantation, and randomized to either aspirin alone (aspirin 100mg/day) or clopidogrel alone (clopidogrel 75mg /day) for the next 4 years."
                },
                {
                  "type": "PROCEDURE",
                  "name": "Imaging guided and Aspirin",
                  "description": "BVS size and length were selected by on-line IVUS(intravascular ultrasound) or OCT(optical coherence tomography) measurements and all patients are treated with dual antiplatelet therapy (aspirin 100mg/day and clopidogrel 75mg per day\\[or ticagrelor 90mg po bid\\]) for 12 months after BVS implantation, and randomized to either aspirin alone (aspirin 100mg/day) or clopidogrel alone (clopidogrel 75mg /day) for the next 4 years."
                },
                {
                  "type": "PROCEDURE",
                  "name": "Imaging guided and Clopidogrel",
                  "description": "BVS size and length were selected by on-line IVUS(intravascular ultrasound) or OCT(optical coherence tomography) measurements and all patients are treated with dual antiplatelet therapy (aspirin 100mg/day and clopidogrel 75mg per day\\[or ticagrelor 90mg po bid\\]) for 12 months after BVS implantation, and randomized to either aspirin alone (aspirin 100mg/day) or clopidogrel alone (clopidogrel 75mg /day) for the next 4 years."
                }
              ],
              "conditions": [
                "Percutaneous Transluminal Coronary Angioplasty"
              ],
              "primary_outcomes": [
                {
                  "measure": "Target lesion failure",
                  "description": "the cumulative incidence of cardiac death, target vessel myocardial infarction or ischemia-driven target lesion revascularization at 12 months after the index procedure.",
                  "timeFrame": "1 year"
                }
              ],
              "has_results": false
            },
            {
              "nct_id": "NCT00727948",
              "title": "The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy",
              "status": "COMPLETED",
              "phase": [
                "EARLY_PHASE1"
              ],
              "enrollment": null,
              "start_date": "2008-07",
              "completion_date": "2012-12",
              "interventions": [
                {
                  "type": "DRUG",
                  "name": "Aspirin",
                  "description": "325 mg tablets, once daily for 45 days"
                }
              ],
              "conditions": [
                "Breast Cancer",
                "Angiogenesis"
              ],
              "primary_outcomes": [
                {
                  "measure": "Changes in pro-angiogenic and anti-angiogenic protein levels.",
                  "description": null,
                  "timeFrame": "75 days"
                }
              ],
              "has_results": false
            }
          ],
          "summary": {
            "total_studies": 20,
            "by_phase": {
              "PHASE4": 4,
              "PHASE2": 4,
              "NA": 6,
              "PHASE3": 3,
              "PHASE1": 3,
              "EARLY_PHASE1": 1
            },
            "by_status": {
              "UNKNOWN": 3,
              "NOT_YET_RECRUITING": 2,
              "RECRUITING": 2,
              "COMPLETED": 9,
              "TERMINATED": 2,
              "SUSPENDED": 1,
              "WITHDRAWN": 1
            },
            "total_enrollment": 0,
            "studies_with_results": 2
          },
          "total_count": 20
        },
        "error": null
      },
      "metadata": {
        "name": "clinicaltrials",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 60,
          "max_studies": 50,
          "page_size": 20
        }
      }
    },
    {
      "adapter": "fda_faers",
      "status": "success",
      "error": null,
      "execution_time": 3.501039,
      "data": {
        "success": true,
        "data": {
          "events": [
            {
              "report_id": "10003304",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Drug hypersensitivity",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DOXYCYCLINE HYCLATE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "TRAMADOL HYDROCHLORIDE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "OXYCONTIN",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "TALWIN",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CODEINE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "IODINE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "LORTAB",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "FIORINAL",
                  "role": "1",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003310",
              "receive_date": "20140312",
              "serious": "2",
              "age": "66",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Back pain",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "LYRICA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "XANAX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LETAIRIS",
                  "role": "1",
                  "indication": "PULMONARY ARTERIAL HYPERTENSION"
                },
                {
                  "name": "ADCIRCA",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ZOCOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ADVAIR HFA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NEXIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TRIAMTERENE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SPIRIVA",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003349",
              "receive_date": "20140312",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Cerebrovascular accident",
                  "outcome": "6"
                },
                {
                  "term": "Blood pressure increased",
                  "outcome": "6"
                },
                {
                  "term": "Pain",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "MORPHINE SULFATE EXTENDED-RELEASE TABLETS (RHODES 74-862)",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "MORPHINE SULFATE (SIMILAR TO NDA 19-516)",
                  "role": "1",
                  "indication": "BACK PAIN"
                },
                {
                  "name": "AMLODIPINE",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "TRIAMTERENE AND HYDROCHLOROTHIAZID",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CELEXA                             /00582602/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CLOBETASOL PROPRIONATE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FIORICET",
                  "role": "2",
                  "indication": "MIGRAINE"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003432",
              "receive_date": "20140312",
              "serious": "1",
              "age": "84",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Oedema peripheral",
                  "outcome": "6"
                },
                {
                  "term": "Fluid retention",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "LETAIRIS",
                  "role": "1",
                  "indication": "PULMONARY HYPERTENSION"
                },
                {
                  "name": "LANTUS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "KLOR-CON",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CENTRUM SILVER                     /02363801/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CARVEDILOL.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LETAIRIS",
                  "role": "1",
                  "indication": "HYPOXIA"
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FUROSEMIDE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "COUMADIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MUCINEX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CITALOPRAM HYDROBROMIDE.",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003582",
              "receive_date": "20140312",
              "serious": "2",
              "age": "58",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "82.1",
              "reactions": [
                {
                  "term": "Hypertension",
                  "outcome": "6"
                },
                {
                  "term": "Dehydration",
                  "outcome": "6"
                },
                {
                  "term": "Night sweats",
                  "outcome": "6"
                },
                {
                  "term": "Panic attack",
                  "outcome": "1"
                },
                {
                  "term": "Hyperlipidaemia",
                  "outcome": "6"
                },
                {
                  "term": "Insomnia",
                  "outcome": "1"
                },
                {
                  "term": "Cold sweat",
                  "outcome": "3"
                },
                {
                  "term": "Bipolar disorder",
                  "outcome": "6"
                },
                {
                  "term": "Hyperhidrosis",
                  "outcome": "6"
                },
                {
                  "term": "Dysgeusia",
                  "outcome": "3"
                },
                {
                  "term": "Nausea",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "LISINOPRIL HCTZ",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "BIPOLAR I DISORDER"
                },
                {
                  "name": "SEROQUEL XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GARLIC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL TARTRATE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003595",
              "receive_date": "20140312",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Transfusion",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "ESSENTIAL THROMBOCYTHAEMIA"
                },
                {
                  "name": "SIMVASTATIN-1A PHARMA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DOXAZOSIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCHLOROTHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ENALAPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CARVEDILOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003632",
              "receive_date": "20140312",
              "serious": "1",
              "age": "77",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Influenza",
                  "outcome": "2"
                },
                {
                  "term": "Pneumonia",
                  "outcome": "2"
                }
              ],
              "drugs": [
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FISH OIL - VITAMIN D3",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ZESTRIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FOLIC ACID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FENOFIBRATE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ATENOLOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PANTOPRAZOLE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PANTOPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METHYLPREDNISOLONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IRON",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IRON",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GLIMEPIRIDE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "POTASSIUM CHLORIDE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PROCRIT",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003713",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Rash",
                  "outcome": "6"
                },
                {
                  "term": "Dyspnoea",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "APEXICON",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MENEST                             /00073001/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VOLTAREN   GEL                        /00372301/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CIPRODEX                           /00697202/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALEVE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003717",
              "receive_date": "20140312",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "74.83",
              "reactions": [
                {
                  "term": "Haemoglobin decreased",
                  "outcome": "3"
                },
                {
                  "term": "Weight increased",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CELEBREX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LASIX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZANTAC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYRTEC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IMODIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN LOW EC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CRANBERRY",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SUPER  OMEGA- 3",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003740",
              "receive_date": "20140312",
              "serious": "1",
              "age": "82",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "65.31",
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "PREDNISOLONE",
                  "role": "1",
                  "indication": "AUTOIMMUNE DISORDER"
                },
                {
                  "name": "PREDNISOLONE",
                  "role": "1",
                  "indication": "AUTOIMMUNE DISORDER"
                },
                {
                  "name": "AMIAS",
                  "role": "2",
                  "indication": "MYOCARDIAL INFARCTION"
                },
                {
                  "name": "BUMETANIDE",
                  "role": "2",
                  "indication": "MYOCARDIAL INFARCTION"
                },
                {
                  "name": "CARDICOR",
                  "role": "2",
                  "indication": "MYOCARDIAL INFARCTION"
                },
                {
                  "name": "INFLUENZA VIRUS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": "PROPHYLAXIS"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FOLIC ACID",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003792",
              "receive_date": "20140312",
              "serious": "1",
              "age": "46",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "83.54",
              "reactions": [
                {
                  "term": "Grand mal convulsion",
                  "outcome": "1"
                },
                {
                  "term": "Vomiting",
                  "outcome": "1"
                },
                {
                  "term": "Amnesia",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "DEPAKOTE",
                  "role": "1",
                  "indication": "GRAND MAL CONVULSION"
                },
                {
                  "name": "KEPPRA",
                  "role": "2",
                  "indication": "GRAND MAL CONVULSION"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "RANEXA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ISOSORBIDE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LORAZEPAM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SIMVASTATIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AMBIEN",
                  "role": "2",
                  "indication": "SLEEP DISORDER THERAPY"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003859",
              "receive_date": "20140312",
              "serious": "1",
              "age": "63",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "92.06",
              "reactions": [
                {
                  "term": "Blood count abnormal",
                  "outcome": "6"
                },
                {
                  "term": "Platelet count decreased",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "OMEPRAZOLE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "VORICONAZOLE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ACYCLOVIR                          /00587301/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN                       /01326102/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DILTIAZEM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL                         /00376902/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SERTRALINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL.",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003864",
              "receive_date": "20140312",
              "serious": "1",
              "age": "72",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "65.31",
              "reactions": [
                {
                  "term": "Platelet count decreased",
                  "outcome": "2"
                },
                {
                  "term": "Blood count abnormal",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NEXIUM                             /01479302/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LASIX                              /00032601/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10003923",
              "receive_date": "20140312",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": "62.13",
              "reactions": [
                {
                  "term": "Increased appetite",
                  "outcome": "6"
                },
                {
                  "term": "Incontinence",
                  "outcome": "6"
                },
                {
                  "term": "Off label use",
                  "outcome": "6"
                },
                {
                  "term": "Epistaxis",
                  "outcome": "6"
                },
                {
                  "term": "Blindness",
                  "outcome": "6"
                },
                {
                  "term": "Weight increased",
                  "outcome": "6"
                },
                {
                  "term": "Skin cancer",
                  "outcome": "6"
                },
                {
                  "term": "Nasopharyngitis",
                  "outcome": "6"
                },
                {
                  "term": "Dizziness",
                  "outcome": "6"
                },
                {
                  "term": "Dry eye",
                  "outcome": "6"
                },
                {
                  "term": "Wrong technique in product usage process",
                  "outcome": "6"
                },
                {
                  "term": "Pruritus",
                  "outcome": "6"
                },
                {
                  "term": "Increased tendency to bruise",
                  "outcome": "6"
                },
                {
                  "term": "Diarrhoea",
                  "outcome": "6"
                },
                {
                  "term": "Constipation",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MALIGNANT MELANOMA"
                },
                {
                  "name": "SIMVASTATIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CIPROFLOXACIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CIMETIDINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CEPHALEXIN                         /00145501/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "POLYCYTHAEMIA VERA"
                },
                {
                  "name": "RESTASIS",
                  "role": "2",
                  "indication": "DRY EYE"
                },
                {
                  "name": "OMEGA                              /01454401/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PREDNISOLONE.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LEVOTHYROXINE.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PANTOPRAZOLE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NASONEX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SLOW MAG                           /07370001/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ERYTHROMYCIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN D3",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CELEBREX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CETIRIZINE                         /00884302/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ROPINIROLE.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FUROSEMIDE.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALLOPURINOL.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004051",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Pain",
                  "outcome": "6"
                },
                {
                  "term": "Dizziness",
                  "outcome": "6"
                },
                {
                  "term": "Headache",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOPROLIFERATIVE DISORDER"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ULORIC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENICAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMLODIPINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004057",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": null,
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Malaise",
                  "outcome": "3"
                },
                {
                  "term": "Nausea",
                  "outcome": "3"
                },
                {
                  "term": "Haemoglobin decreased",
                  "outcome": "6"
                },
                {
                  "term": "Headache",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LEXAPRO",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN D                          /00107901/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALBUTEROL                          /00139501/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "METOPROLOL.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MULTIVITAMIN                       /00097801/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "RANEXA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CALCIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LORAZEPAM.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TYLENOL PM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PRILOSEC",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AMLODIPINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SYMBICORT",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004085",
              "receive_date": "20140312",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "0",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Lower gastrointestinal haemorrhage",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "BLINDED ALISKIREN",
                  "role": "1",
                  "indication": "CARDIAC FAILURE"
                },
                {
                  "name": "BLINDED ENALAPRIL",
                  "role": "1",
                  "indication": "CARDIAC FAILURE"
                },
                {
                  "name": "BLINDED NO TREATMENT RECEIVED",
                  "role": "1",
                  "indication": "CARDIAC FAILURE"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SIMVASTATIN",
                  "role": "2",
                  "indication": "DRUG THERAPY"
                },
                {
                  "name": "HCT",
                  "role": "2",
                  "indication": "POLYURIA"
                },
                {
                  "name": "BERLTHYROX",
                  "role": "2",
                  "indication": "THYROID HORMONE REPLACEMENT THERAPY"
                },
                {
                  "name": "METO TABLINEN",
                  "role": "2",
                  "indication": "DRUG THERAPY"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004101",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Rash",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "POLYCYTHAEMIA VERA"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "LOSARTAN POTASSIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LANTUS SOLOSTAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NOVOLOG",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL SUCCINATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "POTASSIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMIN                       /00097801/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NIACIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYRTEC",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004111",
              "receive_date": "20140312",
              "serious": "2",
              "age": "58",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Rash",
                  "outcome": "3"
                },
                {
                  "term": "Headache",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "TRICOR                             /00090101/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GLIPIZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LOSARTAN + HIDROCLOROTIAZIDA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMITRIPTYLINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FLOVENT",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IPRATROPIUM  INHALER                    /00391402/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AZITHROMYCIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMINS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "THIAMINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NIACIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CALCIUM  SUPPLEMENT                          /00060701/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MAGNESIUM  SUPPLEMENT                        /00123201/",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004114",
              "receive_date": "20140312",
              "serious": "2",
              "age": "72",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Oral mucosal erythema",
                  "outcome": "6"
                },
                {
                  "term": "Oral pain",
                  "outcome": "6"
                },
                {
                  "term": "Abdominal tenderness",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "POLYCYTHAEMIA VERA"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "VERAPAMIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CITALOPRAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GABAPENTIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004130",
              "receive_date": "20140312",
              "serious": "2",
              "age": "75",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "72.56",
              "reactions": [
                {
                  "term": "Laboratory test abnormal",
                  "outcome": "6"
                },
                {
                  "term": "Contusion",
                  "outcome": "3"
                },
                {
                  "term": "Drug dose omission",
                  "outcome": "6"
                },
                {
                  "term": "Platelet count increased",
                  "outcome": "3"
                },
                {
                  "term": "Hypertension",
                  "outcome": "3"
                },
                {
                  "term": "Treatment noncompliance",
                  "outcome": "6"
                },
                {
                  "term": "Eye disorder",
                  "outcome": "3"
                },
                {
                  "term": "White blood cell count increased",
                  "outcome": "6"
                },
                {
                  "term": "Pain",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ADVIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENICAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENICAR HCT",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004138",
              "receive_date": "20140312",
              "serious": "2",
              "age": "64",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Pneumonia",
                  "outcome": "2"
                },
                {
                  "term": "Anaemia",
                  "outcome": "2"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004140",
              "receive_date": "20140312",
              "serious": "2",
              "age": "68",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Nausea",
                  "outcome": "1"
                },
                {
                  "term": "Drug administration error",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDREA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LORATADINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OXYCODONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PAROXETINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TUMS                               /00193601/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SPIRONOLACTONE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004144",
              "receive_date": "20140312",
              "serious": "2",
              "age": "75",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "56.2",
              "reactions": [
                {
                  "term": "Flatulence",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "PRAVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCHLOROTHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IMPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004175",
              "receive_date": "20140312",
              "serious": "1",
              "age": "70",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "98",
              "reactions": [
                {
                  "term": "Skin discolouration",
                  "outcome": "1"
                },
                {
                  "term": "Rash",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "SULFASALAZINE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "RAMIPRIL.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "PREDNISONE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MAG-TAB",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BISOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LORTAB",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004186",
              "receive_date": "20140312",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Thrombotic microangiopathy",
                  "outcome": "5"
                },
                {
                  "term": "Renal impairment",
                  "outcome": "5"
                },
                {
                  "term": "Hepatic failure",
                  "outcome": "5"
                },
                {
                  "term": "Mental status changes",
                  "outcome": "5"
                },
                {
                  "term": "Stem cell transplant",
                  "outcome": "5"
                },
                {
                  "term": "Graft versus host disease",
                  "outcome": "5"
                },
                {
                  "term": "Fatigue",
                  "outcome": "3"
                },
                {
                  "term": "Drug administration error",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "JANUVIA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATENOLOL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004211",
              "receive_date": "20140312",
              "serious": "1",
              "age": "26",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "86.17",
              "reactions": [
                {
                  "term": "Spinal disorder",
                  "outcome": "6"
                },
                {
                  "term": "Dizziness",
                  "outcome": "6"
                },
                {
                  "term": "Feeling abnormal",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "EFFEXOR XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "EFFEXOR XR",
                  "role": "1",
                  "indication": "ANXIETY"
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LUTERA",
                  "role": "2",
                  "indication": "CONTRACEPTION"
                },
                {
                  "name": "CLONAZEPAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "CARDIAC ANEURYSM"
                },
                {
                  "name": "BUPROPION",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004221",
              "receive_date": "20140312",
              "serious": "1",
              "age": "64",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "104.31",
              "reactions": [
                {
                  "term": "Chest pain",
                  "outcome": "6"
                },
                {
                  "term": "Palpitations",
                  "outcome": "1"
                },
                {
                  "term": "Drug ineffective",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "EFFEXOR XR",
                  "role": "1",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "EFFEXOR XR",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "1",
                  "indication": "CHEST PAIN"
                },
                {
                  "name": "OXYBUTYNIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SIMVASTATIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004254",
              "receive_date": "20140312",
              "serious": "2",
              "age": "69",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Drug ineffective",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "CELEBREX",
                  "role": "1",
                  "indication": "ARTHRITIS"
                },
                {
                  "name": "SIMVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENAZEPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZOLPIDEM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004383",
              "receive_date": "20140312",
              "serious": "1",
              "age": "48",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "56",
              "reactions": [
                {
                  "term": "Neuropathy peripheral",
                  "outcome": "4"
                },
                {
                  "term": "Muscle spasms",
                  "outcome": "4"
                },
                {
                  "term": "Myopathy",
                  "outcome": "4"
                },
                {
                  "term": "Sleep disorder",
                  "outcome": "4"
                },
                {
                  "term": "Blood glucose increased",
                  "outcome": "4"
                }
              ],
              "drugs": [
                {
                  "name": "ATORVASTATIN CALCIUM (UNKNOWN)",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SIMVASTATIN (UNKNOWN)",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PRAVASTATIN SODIUM (UNKNOWN)",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LANTUS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NOVORAPID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004428",
              "receive_date": "20140312",
              "serious": "1",
              "age": "65",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "112",
              "reactions": [
                {
                  "term": "Cerebrovascular accident",
                  "outcome": "6"
                },
                {
                  "term": "Weight increased",
                  "outcome": "2"
                },
                {
                  "term": "Withdrawal syndrome",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DOXAZOSIN",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENDROFLUMETHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CRESTOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMACOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN B",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN C",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004465",
              "receive_date": "20140312",
              "serious": "1",
              "age": "62",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "79.4",
              "reactions": [
                {
                  "term": "Depression",
                  "outcome": "1"
                },
                {
                  "term": "Disease progression",
                  "outcome": "6"
                },
                {
                  "term": "Psychotic disorder",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "TOPROL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "THALOMID",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "THALOMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "DECADRON",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALTACE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ATENOLOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PAXIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PREVACID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CO Q10",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ADDERALL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "EPLERENONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALEVE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FLOMAX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LIVALO",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "METHENAMINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AVODART",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004480",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Diarrhoea",
                  "outcome": "6"
                },
                {
                  "term": "Fatigue",
                  "outcome": "6"
                },
                {
                  "term": "Furuncle",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "LYMPHOCYTIC LEUKAEMIA"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "ILL-DEFINED DISORDER"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FAMCICLOVIR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CEFPROZIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYRTEC",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004486",
              "receive_date": "20140312",
              "serious": "2",
              "age": "62",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "66.67",
              "reactions": [
                {
                  "term": "Nausea",
                  "outcome": "1"
                },
                {
                  "term": "Chills",
                  "outcome": "2"
                },
                {
                  "term": "Abdominal pain",
                  "outcome": "2"
                },
                {
                  "term": "Headache",
                  "outcome": "2"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ALCOHOL",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "FOLIC ACID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SINGULAIR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYRTEC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN D3",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OSCAL D                            /00944201/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004554",
              "receive_date": "20140312",
              "serious": "1",
              "age": "52",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "75",
              "reactions": [
                {
                  "term": "Cardiac stress test abnormal",
                  "outcome": "2"
                },
                {
                  "term": "Arteriogram coronary abnormal",
                  "outcome": "2"
                },
                {
                  "term": "Weight decreased",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "ATENOLOL",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "BRILINTA",
                  "role": "1",
                  "indication": "MYOCARDIAL INFARCTION"
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": "THROMBOSIS PROPHYLAXIS"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "ANTICOAGULANT THERAPY"
                },
                {
                  "name": "ENALAPRIL",
                  "role": "2",
                  "indication": "HYPERTENSION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004589",
              "receive_date": "20140312",
              "serious": "1",
              "age": "72",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "58.5",
              "reactions": [
                {
                  "term": "Haemoglobin decreased",
                  "outcome": "2"
                },
                {
                  "term": "Alopecia",
                  "outcome": "6"
                },
                {
                  "term": "Palpitations",
                  "outcome": "2"
                },
                {
                  "term": "Chills",
                  "outcome": "6"
                },
                {
                  "term": "Blood count abnormal",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMINS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NEURONTIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VICODIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "XANAX",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004604",
              "receive_date": "20140312",
              "serious": "1",
              "age": "88",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Nephrolithiasis",
                  "outcome": "3"
                },
                {
                  "term": "Kidney infection",
                  "outcome": "6"
                },
                {
                  "term": "Heart rate increased",
                  "outcome": "2"
                },
                {
                  "term": "Dyspnoea",
                  "outcome": "3"
                },
                {
                  "term": "Fatigue",
                  "outcome": "3"
                },
                {
                  "term": "Dizziness",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "BYSTOLIC",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEGA-3",
                  "role": "2",
                  "indication": "MACULAR DEGENERATION"
                },
                {
                  "name": "CALCIUM WITH VITAMIN D",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TYLENOL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004608",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Incontinence",
                  "outcome": "6"
                },
                {
                  "term": "Urinary tract infection",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MAXIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROAIR                             /00139502/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SERTRALINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SPIRIVA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN B12                        /00056201/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN D                          /00107901/",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004622",
              "receive_date": "20140312",
              "serious": "2",
              "age": "71",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "White blood cell count increased",
                  "outcome": "6"
                },
                {
                  "term": "Platelet count decreased",
                  "outcome": "6"
                },
                {
                  "term": "Contusion",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CENTRUM SILVER                     /02363801/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ENALAPRIL HCT",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMLODIPINE BESILATE W/BENAZEPRIL HYDROCHLORID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MAGNESIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IBUPROFEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004629",
              "receive_date": "20140312",
              "serious": "2",
              "age": "64",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "78",
              "reactions": [
                {
                  "term": "Diarrhoea",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DICLOFENAC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CITALOPRAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN HCL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL HCTZ",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN (E.C.)",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CLARITIN                           /00413701/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZINC",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004634",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": "70.3",
              "reactions": [
                {
                  "term": "Dyspepsia",
                  "outcome": "6"
                },
                {
                  "term": "Contusion",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "PANTOPRAZOLE SODIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VERAPAMIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEGA 3 FISH OILS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IRON",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004640",
              "receive_date": "20140312",
              "serious": "2",
              "age": "76",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Hypertension",
                  "outcome": "6"
                },
                {
                  "term": "Increased appetite",
                  "outcome": "6"
                },
                {
                  "term": "Weight increased",
                  "outcome": "6"
                },
                {
                  "term": "Haemoglobin decreased",
                  "outcome": null
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ACETAMINOPHEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALPRAZOLAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DARBEPOETIN ALFA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ERGOCALCIFEROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FERROUS SULFATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FLUTICASONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FOLIC ACID W/B6 W/B12",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IPRATROPIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL SUCCINATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OXYCODONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PRAVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROAIR HFA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SERTRALINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004687",
              "receive_date": "20140312",
              "serious": "1",
              "age": "60",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Arteritis",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TRIMETHOPRIM.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LOSARTAN POTASSIUM.",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "EZETIMIBE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "EZETIMIBE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NOVORAPID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TRIMETHOPRIM.",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004707",
              "receive_date": "20140312",
              "serious": "1",
              "age": "71",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "65",
              "reactions": [
                {
                  "term": "Hip fracture",
                  "outcome": "1"
                },
                {
                  "term": "Visual impairment",
                  "outcome": "1"
                },
                {
                  "term": "Overdose",
                  "outcome": "1"
                },
                {
                  "term": "Rehabilitation therapy",
                  "outcome": "6"
                },
                {
                  "term": "Gait disturbance",
                  "outcome": "1"
                },
                {
                  "term": "Mobility decreased",
                  "outcome": "1"
                },
                {
                  "term": "Dizziness",
                  "outcome": "1"
                },
                {
                  "term": "Fall",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "DIOVAN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ROPINIROLE.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MINERALS",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LAMICTAL",
                  "role": "1",
                  "indication": "CONVULSION"
                },
                {
                  "name": "ANTACIDS",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "KEPPRA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "UNKNOWN MEDICATION",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMINS",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LAMICTAL XR",
                  "role": "1",
                  "indication": "CONVULSION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004759",
              "receive_date": "20140312",
              "serious": "1",
              "age": "55",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Myocardial infarction",
                  "outcome": "1"
                },
                {
                  "term": "Coronary arterial stent insertion",
                  "outcome": "1"
                },
                {
                  "term": "Drug administration error",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "LOVAZA",
                  "role": "1",
                  "indication": "CARDIOVASCULAR DISORDER"
                },
                {
                  "name": "ISOSORBIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PRAVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENAZEPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004795",
              "receive_date": "20140312",
              "serious": "1",
              "age": "57",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "96",
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "ALDACTAZIDE",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004803",
              "receive_date": "20140312",
              "serious": "1",
              "age": "46",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "63",
              "reactions": [
                {
                  "term": "Hyperkalaemia",
                  "outcome": "6"
                },
                {
                  "term": "Pancreatitis acute",
                  "outcome": "6"
                },
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004896",
              "receive_date": "20140312",
              "serious": "2",
              "age": "64",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Drug hypersensitivity",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "APRESOLINE HYDROCHLORIDE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ZITHROMAX",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "EPINEPHRINE.",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "MORPHINE SULFATE.",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ASPIRIN.",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CODEINE",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "DILANTIN",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "PROGLYCEM",
                  "role": "1",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004923",
              "receive_date": "20140312",
              "serious": "1",
              "age": "88",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "69",
              "reactions": [
                {
                  "term": "Respiratory failure",
                  "outcome": "5"
                },
                {
                  "term": "Myocardial infarction",
                  "outcome": "5"
                },
                {
                  "term": "Cardiac failure",
                  "outcome": "5"
                },
                {
                  "term": "Memory impairment",
                  "outcome": "6"
                },
                {
                  "term": "Pain in extremity",
                  "outcome": "6"
                },
                {
                  "term": "Diarrhoea",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "EXFORGE",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "TENORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ADALAT",
                  "role": "2",
                  "indication": "BLOOD PRESSURE ABNORMAL"
                },
                {
                  "name": "MINIPRESS",
                  "role": "2",
                  "indication": "BLOOD PRESSURE ABNORMAL"
                },
                {
                  "name": "ASPIRIN PROTECT",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATISURIL//ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CALCIUM",
                  "role": "2",
                  "indication": "CALCIUM DEFICIENCY"
                },
                {
                  "name": "CRESTOR",
                  "role": "2",
                  "indication": "CARDIOVASCULAR DISORDER"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10004971",
              "receive_date": "20140312",
              "serious": "2",
              "age": "84",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Asthenia",
                  "outcome": "6"
                },
                {
                  "term": "Dyspnoea",
                  "outcome": "6"
                },
                {
                  "term": "Anaemia",
                  "outcome": "6"
                },
                {
                  "term": "Drug administration error",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "DANAZOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TOPROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PRAVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FENOFIBRATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYRTEC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NEXIUM                             /01479302/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN 81 MG",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VALIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NASONEX",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005001",
              "receive_date": "20140312",
              "serious": "2",
              "age": "83",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Flatulence",
                  "outcome": "6"
                },
                {
                  "term": "Decreased appetite",
                  "outcome": "6"
                },
                {
                  "term": "Nausea",
                  "outcome": "6"
                },
                {
                  "term": "Constipation",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "AMIODARONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SERTRALINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TEMAZEPAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCODONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PANTOPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "COLACE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VESICARE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMINS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FOLIC ACID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN A                          /00056001/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN C                          /00008001/",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005204",
              "receive_date": "20140312",
              "serious": "2",
              "age": "76",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "65.76",
              "reactions": [
                {
                  "term": "Nasal congestion",
                  "outcome": "1"
                },
                {
                  "term": "Constipation",
                  "outcome": "1"
                },
                {
                  "term": "Spondylitis",
                  "outcome": "1"
                },
                {
                  "term": "Weight increased",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "EVISTA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CELEBREX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NORVASC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCHLOROTHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SODIUM CHLORIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BIOTIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CALCIUM",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005231",
              "receive_date": "20140312",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Adverse drug reaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "JAKAFI",
                  "role": "1",
                  "indication": "MYELOFIBROSIS"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MULTIVITAMIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005238",
              "receive_date": "20140312",
              "serious": "1",
              "age": "59",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "81.64",
              "reactions": [
                {
                  "term": "Joint swelling",
                  "outcome": "4"
                },
                {
                  "term": "Pain in extremity",
                  "outcome": "4"
                },
                {
                  "term": "Anxiety",
                  "outcome": "4"
                },
                {
                  "term": "Disturbance in attention",
                  "outcome": "4"
                },
                {
                  "term": "Fatigue",
                  "outcome": "1"
                },
                {
                  "term": "Insomnia",
                  "outcome": "4"
                }
              ],
              "drugs": [
                {
                  "name": "AMLODIPINE",
                  "role": "1",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "CO-CODAMOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005289",
              "receive_date": "20140312",
              "serious": "1",
              "age": "54",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Cardio-respiratory arrest",
                  "outcome": "6"
                },
                {
                  "term": "Death",
                  "outcome": "5"
                },
                {
                  "term": "Septic shock",
                  "outcome": "6"
                },
                {
                  "term": "Respiratory failure",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "K-DUR",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PROTONIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CEFEPIME",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ZOFRAN",
                  "role": "2",
                  "indication": "VOMITING"
                },
                {
                  "name": "DAPTOMYCIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LEVAQUIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "AMBIEN",
                  "role": "2",
                  "indication": "INSOMNIA"
                },
                {
                  "name": "LOPRESSOR",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "HEPARIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MICAFUNGIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FENTANYL.",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "COMPAZINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VANCOMYCIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ACYCLOVIR.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CALCIUM 500 + VITAMIN D3",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "ZOFRAN",
                  "role": "2",
                  "indication": "NAUSEA"
                },
                {
                  "name": "SODIUM CHLORIDE.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "NORCO",
                  "role": "2",
                  "indication": "PAIN"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005296",
              "receive_date": "20140312",
              "serious": "1",
              "age": "72",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "114",
              "reactions": [
                {
                  "term": "Gallbladder disorder",
                  "outcome": "1"
                },
                {
                  "term": "Oropharyngeal pain",
                  "outcome": "3"
                },
                {
                  "term": "Sinusitis",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "SPIRIVA",
                  "role": "1",
                  "indication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": "GASTROOESOPHAGEAL REFLUX DISEASE"
                },
                {
                  "name": "TRIAMTERENE HCTZ",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "CARDIAC DISORDER"
                },
                {
                  "name": "MULTIVITAMIN",
                  "role": "2",
                  "indication": "SUPPLEMENTATION THERAPY"
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": "CARDIAC DISORDER"
                },
                {
                  "name": "TRICOR",
                  "role": "2",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                },
                {
                  "name": "TAMSULOSIN",
                  "role": "2",
                  "indication": "POLLAKIURIA"
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005416",
              "receive_date": "20140313",
              "serious": "2",
              "age": "40",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Adverse event",
                  "outcome": "6"
                },
                {
                  "term": "Influenza like illness",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "PROZAC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SAVELLA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TYLENOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZYPREXA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AVONEX",
                  "role": "1",
                  "indication": "MULTIPLE SCLEROSIS"
                },
                {
                  "name": "ASPIRIN LOW DOSE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BUSPIRONE HCL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IBUPROFEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "INDERAL LA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROVIL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005429",
              "receive_date": "20140312",
              "serious": "1",
              "age": "40",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Intentional underdose",
                  "outcome": "3"
                },
                {
                  "term": "Wrong technique in drug usage process",
                  "outcome": "3"
                },
                {
                  "term": "Drug withdrawal syndrome",
                  "outcome": "6"
                },
                {
                  "term": "Insomnia",
                  "outcome": "1"
                },
                {
                  "term": "Decreased appetite",
                  "outcome": "1"
                },
                {
                  "term": "Loss of consciousness",
                  "outcome": "1"
                },
                {
                  "term": "Dehydration",
                  "outcome": "1"
                },
                {
                  "term": "Blood glucose abnormal",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "SUBOXONE FILM",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "SUBOXONE FILM",
                  "role": "1",
                  "indication": "DRUG DEPENDENCE"
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "BUYSTOLIC",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "CARDIOVASCULAR EVENT PROPHYLAXIS"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005542",
              "receive_date": "20140313",
              "serious": "1",
              "age": "49",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Dyspnoea",
                  "outcome": "6"
                },
                {
                  "term": "Asthma",
                  "outcome": "1"
                },
                {
                  "term": "Chest pain",
                  "outcome": "1"
                },
                {
                  "term": "Chest discomfort",
                  "outcome": "1"
                },
                {
                  "term": "Wheezing",
                  "outcome": "1"
                },
                {
                  "term": "Cough",
                  "outcome": "1"
                },
                {
                  "term": "Sinusitis",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "XOLAIR",
                  "role": "1",
                  "indication": "ASTHMA"
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALBUTEROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ADVAIR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SINGULAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MUCINEX",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005562",
              "receive_date": "20140313",
              "serious": "2",
              "age": "43",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Hyperhidrosis",
                  "outcome": "3"
                },
                {
                  "term": "Pain",
                  "outcome": "6"
                },
                {
                  "term": "Insomnia",
                  "outcome": "6"
                },
                {
                  "term": "Flushing",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "MULTIPLE SCLEROSIS"
                },
                {
                  "name": "AMITRIPTYLINE HCL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CLONAZEPAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FENTANYL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LAMOTRIGINE ER",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MIRALAX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VESICARE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005664",
              "receive_date": "20140313",
              "serious": "2",
              "age": "68",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Headache",
                  "outcome": "6"
                },
                {
                  "term": "Nasopharyngitis",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "MULTIPLE SCLEROSIS"
                },
                {
                  "name": "ANAFRANIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AVODART",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "COPAXONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005676",
              "receive_date": "20140313",
              "serious": "2",
              "age": "58",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "88",
              "reactions": [
                {
                  "term": "Muscle spasms",
                  "outcome": "6"
                },
                {
                  "term": "Weight decreased",
                  "outcome": "6"
                },
                {
                  "term": "Influenza",
                  "outcome": "6"
                },
                {
                  "term": "Gait disturbance",
                  "outcome": "6"
                },
                {
                  "term": "Cerebellar ataxia",
                  "outcome": "6"
                },
                {
                  "term": "Hypersensitivity",
                  "outcome": "6"
                },
                {
                  "term": "Headache",
                  "outcome": "6"
                },
                {
                  "term": "Insomnia",
                  "outcome": "6"
                },
                {
                  "term": "Overdose",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "RELAPSING-REMITTING MULTIPLE SCLEROSIS"
                },
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "RELAPSING-REMITTING MULTIPLE SCLEROSIS"
                },
                {
                  "name": "ACETAMINOPHEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALPRAZOLAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMITRIPTYLINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMITRIPTYLINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMPYRA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BACLOFEN",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "BACLOFEN",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "BYSTOLIC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CENTRUM ULTRA MENS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DRAMAMINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCHLOROTHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCODONE-ACETAMINOPHEN",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "LEVITRA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIDODERM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "POTASSIUM GLUCONATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROVIGIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "RIZATRIPTAN",
                  "role": "2",
                  "indication": "HEADACHE"
                },
                {
                  "name": "SUMATRIPTAN SUCCINATE",
                  "role": "2",
                  "indication": "HEADACHE"
                },
                {
                  "name": "TEMAZEPAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "UNISOM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "UROXATRAL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZANAFLEX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZOFRAN",
                  "role": "2",
                  "indication": "NAUSEA"
                },
                {
                  "name": "ZOLPIDEM",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005772",
              "receive_date": "20140313",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Genital rash",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "MULTIPLE SCLEROSIS"
                },
                {
                  "name": "LIVALO",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ERYTHROMYCIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "COQ10",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN D3",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005778",
              "receive_date": "20140313",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Herpes zoster",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "TECFIDERA",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AMLODIPINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AVAPRO",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IRBESARTAN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VALTREX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN E",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVOTHYROXIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HCTZ/TRIAMT",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CALCIUM + D",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN C",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005826",
              "receive_date": "20140313",
              "serious": "1",
              "age": "75",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "43",
              "reactions": [
                {
                  "term": "Loss of consciousness",
                  "outcome": "1"
                },
                {
                  "term": "Iron deficiency anaemia",
                  "outcome": "1"
                },
                {
                  "term": "Syncope",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "NACOM 100 MG/25 MG TABLETTEN",
                  "role": "1",
                  "indication": "PARKINSON^S DISEASE"
                },
                {
                  "name": "PANTOPRAZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VIGANTOLETTEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "L-THYROXIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "COMTESS",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005888",
              "receive_date": "20140313",
              "serious": "1",
              "age": "54",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "108",
              "reactions": [
                {
                  "term": "Cardiac arrest",
                  "outcome": "1"
                },
                {
                  "term": "Acute myocardial infarction",
                  "outcome": "3"
                },
                {
                  "term": "Left atrial dilatation",
                  "outcome": "6"
                },
                {
                  "term": "Hyponatraemia",
                  "outcome": "6"
                },
                {
                  "term": "Hypertension",
                  "outcome": "6"
                },
                {
                  "term": "Coronary artery disease",
                  "outcome": "6"
                },
                {
                  "term": "Ischaemic cardiomyopathy",
                  "outcome": "3"
                },
                {
                  "term": "Fatigue",
                  "outcome": "3"
                },
                {
                  "term": "Ventricular tachycardia",
                  "outcome": "6"
                },
                {
                  "term": "Ventricular fibrillation",
                  "outcome": "6"
                },
                {
                  "term": "Heart rate increased",
                  "outcome": "6"
                },
                {
                  "term": "Cardiac failure acute",
                  "outcome": "6"
                },
                {
                  "term": "Atrial fibrillation",
                  "outcome": "6"
                },
                {
                  "term": "Hypogonadism",
                  "outcome": "6"
                },
                {
                  "term": "Respiratory failure",
                  "outcome": "1"
                },
                {
                  "term": "Ejection fraction decreased",
                  "outcome": "3"
                },
                {
                  "term": "Cardiac failure congestive",
                  "outcome": "3"
                },
                {
                  "term": "Sinus bradycardia",
                  "outcome": "6"
                },
                {
                  "term": "Coronary artery occlusion",
                  "outcome": "6"
                },
                {
                  "term": "Sleep apnoea syndrome",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "CRESTOR",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN USA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IRON",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NITROSTAT",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ATENOLOL.",
                  "role": "1",
                  "indication": "VENTRICULAR EXTRASYSTOLES"
                },
                {
                  "name": "LASIX",
                  "role": "1",
                  "indication": "CARDIAC FAILURE"
                },
                {
                  "name": "AXIRON",
                  "role": "1",
                  "indication": "ANDROGEN DEFICIENCY"
                },
                {
                  "name": "AXIRON",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "NORPACE",
                  "role": "2",
                  "indication": "VENTRICULAR EXTRASYSTOLES"
                },
                {
                  "name": "NIASPAN",
                  "role": "2",
                  "indication": "HYPERLIPIDAEMIA"
                },
                {
                  "name": "PRADAXA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LASIX",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CIALIS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN D                          /00107901/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AMIODARONE",
                  "role": "1",
                  "indication": "VENTRICULAR TACHYCARDIA"
                },
                {
                  "name": "AXIRON",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ANDROGEL",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ATENOLOL.",
                  "role": "1",
                  "indication": "PRESYNCOPE"
                },
                {
                  "name": "CYMBALTA",
                  "role": "2",
                  "indication": "DEPRESSION"
                },
                {
                  "name": "WELLBUTRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MULTAQ",
                  "role": "2",
                  "indication": "ATRIAL FIBRILLATION"
                },
                {
                  "name": "COREG",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005923",
              "receive_date": "20140313",
              "serious": "1",
              "age": "76",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "91.61",
              "reactions": [
                {
                  "term": "Atypical pneumonia",
                  "outcome": "1"
                },
                {
                  "term": "Hypoacusis",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "HUMALOG LISPRO",
                  "role": "1",
                  "indication": "DIABETES MELLITUS"
                },
                {
                  "name": "ACETAMINOPHEN W/HYDROCODONE",
                  "role": "2",
                  "indication": "PAIN"
                },
                {
                  "name": "METFORMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LANTUS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LANTUS",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GLIMEPIRIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ADVAIR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALFUZOSIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ROFLUMILAST",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DUONEB",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FINASTERIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FLORASTOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FUROSEMIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROXYZINE HYDROCHLORIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYZAAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LAC-HYDRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVOTHYROXINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LOPERAMIDE",
                  "role": "2",
                  "indication": "DIARRHOEA"
                },
                {
                  "name": "MAGNESIUM OXIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MAGONATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NAPROSYN                           /00256201/",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NIACIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROSCAR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TERAZOSIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TOLTERODINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "UROXATRAL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VIAGRA",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10005993",
              "receive_date": "20140313",
              "serious": "1",
              "age": "66",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "68",
              "reactions": [
                {
                  "term": "Glaucoma",
                  "outcome": "6"
                },
                {
                  "term": "Rash",
                  "outcome": "3"
                },
                {
                  "term": "Oedema peripheral",
                  "outcome": "3"
                },
                {
                  "term": "Lacrimation increased",
                  "outcome": "3"
                },
                {
                  "term": "Oedema peripheral",
                  "outcome": "6"
                },
                {
                  "term": "Pain",
                  "outcome": "6"
                },
                {
                  "term": "Fatigue",
                  "outcome": "6"
                },
                {
                  "term": "Herpes virus infection",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "KLONOPIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALPHAGAN P",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ZOFRAN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PRILOSEC",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TRAZODONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "HYDROCODONE-ACETAMINOPHEN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CALCIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PHENERGAN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CARDIZEM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN D3",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006049",
              "receive_date": "20140313",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "101",
              "reactions": [
                {
                  "term": "Death",
                  "outcome": "5"
                },
                {
                  "term": "Respiratory distress",
                  "outcome": "3"
                },
                {
                  "term": "Anaemia",
                  "outcome": "3"
                },
                {
                  "term": "Haematochezia",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "XARELTO",
                  "role": "1",
                  "indication": "DEEP VEIN THROMBOSIS"
                },
                {
                  "name": "ASPIRIN",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALBUTEROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FORMOTEROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROCHLOROTHIAZIDE + LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TIOTROPIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DIVALPROEX SODIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DIVALPROEX SODIUM",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006051",
              "receive_date": "20140313",
              "serious": "1",
              "age": "89",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "66.68",
              "reactions": [
                {
                  "term": "Blindness",
                  "outcome": "3"
                },
                {
                  "term": "Deafness",
                  "outcome": "3"
                },
                {
                  "term": "Loss of consciousness",
                  "outcome": "6"
                },
                {
                  "term": "Contusion",
                  "outcome": "6"
                },
                {
                  "term": "Glaucoma",
                  "outcome": "6"
                },
                {
                  "term": "Pruritus",
                  "outcome": "6"
                },
                {
                  "term": "Muscle disorder",
                  "outcome": "3"
                },
                {
                  "term": "Confusional state",
                  "outcome": "6"
                },
                {
                  "term": "Skin lesion",
                  "outcome": "6"
                },
                {
                  "term": "Pain",
                  "outcome": "6"
                },
                {
                  "term": "Oral disorder",
                  "outcome": "6"
                },
                {
                  "term": "Delusion",
                  "outcome": "6"
                },
                {
                  "term": "Aggression",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "XARELTO",
                  "role": "1",
                  "indication": "CEREBROVASCULAR ACCIDENT PROPHYLAXIS"
                },
                {
                  "name": "XARELTO",
                  "role": "1",
                  "indication": "ATRIAL FIBRILLATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "1",
                  "indication": "CARDIAC FAILURE CONGESTIVE"
                },
                {
                  "name": "COREG",
                  "role": "2",
                  "indication": "CARDIAC FAILURE CONGESTIVE"
                },
                {
                  "name": "IMDUR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": "CARDIAC FAILURE CONGESTIVE"
                },
                {
                  "name": "AMARYL",
                  "role": "2",
                  "indication": "DIABETES MELLITUS"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006071",
              "receive_date": "20140313",
              "serious": "1",
              "age": "81",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "81.3",
              "reactions": [
                {
                  "term": "Cardiac arrest",
                  "outcome": "5"
                },
                {
                  "term": "Blood urine present",
                  "outcome": "6"
                },
                {
                  "term": "Unresponsive to stimuli",
                  "outcome": "6"
                },
                {
                  "term": "Blood pressure decreased",
                  "outcome": "6"
                },
                {
                  "term": "Haemoglobin decreased",
                  "outcome": "6"
                },
                {
                  "term": "Abdominal pain",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "XARELTO",
                  "role": "1",
                  "indication": "CEREBROVASCULAR ACCIDENT PROPHYLAXIS"
                },
                {
                  "name": "XARELTO",
                  "role": "1",
                  "indication": "ATRIAL FIBRILLATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PLAVIX",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SYNTHROID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VALIUM",
                  "role": "2",
                  "indication": "MUSCLE SPASMS"
                },
                {
                  "name": "PROVENTIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDRALAZINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FLUOXETINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BACLOFEN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMLODIPINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMBIEN",
                  "role": "2",
                  "indication": "SLEEP DISORDER"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006097",
              "receive_date": "20140313",
              "serious": "2",
              "age": "63",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Overdose",
                  "outcome": "3"
                },
                {
                  "term": "Drug ineffective",
                  "outcome": "6"
                },
                {
                  "term": "Product quality issue",
                  "outcome": "6"
                },
                {
                  "term": "Product quality issue",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "COMBIVENT",
                  "role": "1",
                  "indication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"
                },
                {
                  "name": "MULTIVITAMIN",
                  "role": "2",
                  "indication": "VITAMIN SUPPLEMENTATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "CARDIAC DISORDER"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006105",
              "receive_date": "20140313",
              "serious": "2",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": "68.1",
              "reactions": [
                {
                  "term": "Memory impairment",
                  "outcome": "6"
                },
                {
                  "term": "Chronic lymphocytic leukaemia",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "REVLIMID",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "LEUKERAN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LEUKERAN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PREDNISONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "HERB LAX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MULTIVITAMINS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SELECT-LITE MISC",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN B COMPLEX",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IRON",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006117",
              "receive_date": "20140313",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "45.63",
              "reactions": [
                {
                  "term": "Infection",
                  "outcome": "5"
                },
                {
                  "term": "Neutropenia",
                  "outcome": "5"
                },
                {
                  "term": "White blood cell count decreased",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "POMALYST",
                  "role": "1",
                  "indication": "PLASMA CELL MYELOMA"
                },
                {
                  "name": "POMALYST",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "CALCITONIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "BIAXIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TRAZODONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SPIRONOLACTONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PULMICORT",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PYRIDOXINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMINS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "COMPAZINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "OMEPRAZOLE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NORCO",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NATURAL TEARS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NADOLOL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ACIDOPHILUS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ALBUTEROL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ARTIFICIAL TEARS",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DEXAMETHASONE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MELATONIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MAGNESIUM OXIDE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FIBERCON",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LORAZEPAM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "KLONOPIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IMIPRAMINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006147",
              "receive_date": "20140313",
              "serious": "1",
              "age": "71",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Dizziness",
                  "outcome": "6"
                },
                {
                  "term": "Fatigue",
                  "outcome": "3"
                },
                {
                  "term": "Rash",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "ERLOTINIB",
                  "role": "1",
                  "indication": "LUNG NEOPLASM MALIGNANT"
                },
                {
                  "name": "IMODIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FOLIC ACID",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LOSARTAN POTASSIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "METOPROLOL TARTRATE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MINOCYCLINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VITAMIN D                          /00107901/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006156",
              "receive_date": "20140313",
              "serious": "1",
              "age": "73",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Death",
                  "outcome": "5"
                }
              ],
              "drugs": [
                {
                  "name": "ERLOTINIB TABLET",
                  "role": "1",
                  "indication": "LUNG NEOPLASM MALIGNANT"
                },
                {
                  "name": "ZYPREXA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MEGACE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DEPAKOTE ER",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TRICOR                             /00499301/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CLONAZEPAM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MILK OF MAGNESIA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NEXIUM                             /01479302/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CELEXA                             /00582602/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "FLOMAX                             /01280302/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MIRALAX                            /06344701/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "AMITIZA",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TRAMADOL HCL",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "D3",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006158",
              "receive_date": "20140313",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Pulmonary thrombosis",
                  "outcome": "6"
                },
                {
                  "term": "Thrombosis",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "ERLOTINIB TABLET",
                  "role": "1",
                  "indication": "LUNG NEOPLASM MALIGNANT"
                },
                {
                  "name": "CLARITIN                           /00917501/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IBUPROFEN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "TYLENOL                            /00020001/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "IMODIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "NASACORT AQ",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "COUMADIN                           /00014802/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006168",
              "receive_date": "20140313",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Incorrect dose administered",
                  "outcome": "6"
                },
                {
                  "term": "White blood cell count decreased",
                  "outcome": "6"
                },
                {
                  "term": "Rash",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "ERLOTINIB TABLET",
                  "role": "1",
                  "indication": "PANCREATIC CARCINOMA"
                },
                {
                  "name": "CRESTOR",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MINOCYCLINE",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ATACAND",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "POTASSIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "MAGNESIUM",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006170",
              "receive_date": "20140313",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Off label use",
                  "outcome": "6"
                },
                {
                  "term": "Atrial fibrillation",
                  "outcome": "6"
                },
                {
                  "term": "Metastases to bone",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "ERLOTINIB TABLET",
                  "role": "1",
                  "indication": "SALIVARY GLAND CANCER"
                },
                {
                  "name": "ERLOTINIB TABLET",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "XELODA",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "CLARITIN                           /00917501/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PRILOSEC                           /00661201/",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006179",
              "receive_date": "20140313",
              "serious": "1",
              "age": "57",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "44",
              "reactions": [
                {
                  "term": "Hypersensitivity",
                  "outcome": "1"
                },
                {
                  "term": "Angioedema",
                  "outcome": "1"
                },
                {
                  "term": "Pruritus",
                  "outcome": "1"
                }
              ],
              "drugs": [
                {
                  "name": "BAYER GENUINE ASPIRIN ORIGINAL STRENGTH",
                  "role": "1",
                  "indication": "HEADACHE"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006203",
              "receive_date": "20140313",
              "serious": "1",
              "age": "85",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Hearing impaired",
                  "outcome": "6"
                },
                {
                  "term": "Epistaxis",
                  "outcome": "6"
                },
                {
                  "term": "Hypertension",
                  "outcome": "6"
                },
                {
                  "term": "Computerised tomogram abnormal",
                  "outcome": "6"
                },
                {
                  "term": "Inappropriate schedule of drug administration",
                  "outcome": "6"
                },
                {
                  "term": "Rash",
                  "outcome": "6"
                },
                {
                  "term": "Hip fracture",
                  "outcome": "6"
                },
                {
                  "term": "Haemorrhagic diathesis",
                  "outcome": "6"
                },
                {
                  "term": "Rash",
                  "outcome": "6"
                },
                {
                  "term": "Dry skin",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ERLOTINIB",
                  "role": "1",
                  "indication": "LUNG NEOPLASM MALIGNANT"
                },
                {
                  "name": "ERLOTINIB",
                  "role": "1",
                  "indication": "LUNG NEOPLASM MALIGNANT"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006218",
              "receive_date": "20140313",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Bacterial infection",
                  "outcome": "6"
                },
                {
                  "term": "Gastrointestinal disorder",
                  "outcome": "6"
                },
                {
                  "term": "Diarrhoea",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "EFFEXOR XR",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "ALPRAZOLAM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "GLIMEPIRIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALBUTEROL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ANASTROZOLE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006236",
              "receive_date": "20140313",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": "59.02",
              "reactions": [
                {
                  "term": "Increased tendency to bruise",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "ACTEMRA",
                  "role": "1",
                  "indication": "JUVENILE IDIOPATHIC ARTHRITIS"
                },
                {
                  "name": "HEPARIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "NAPROSYN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METHOTREXATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "COUMADIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006272",
              "receive_date": "20140313",
              "serious": "1",
              "age": "79",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Gastrointestinal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "COLCHICINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "EPLERENONE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FUROSEMIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LOVAZA",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CRESTOR",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006274",
              "receive_date": "20140313",
              "serious": "1",
              "age": "83",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "88",
              "reactions": [
                {
                  "term": "Weight decreased",
                  "outcome": "6"
                },
                {
                  "term": "Transaminases increased",
                  "outcome": "1"
                },
                {
                  "term": "Malaise",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "OMEPRAZOLE",
                  "role": "1",
                  "indication": "HIATUS HERNIA"
                },
                {
                  "name": "ADIZEM-XL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMOXICILLIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENDROFLUMETHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CLARITHROMYCIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FINASTERIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ISOSORBIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PERINDOPRIL ERBUMINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PROPRANOLOL HYDROCHLORIDE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006313",
              "receive_date": "20140313",
              "serious": "1",
              "age": null,
              "age_unit": null,
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PLAVIX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZANTAC",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006314",
              "receive_date": "20140313",
              "serious": "1",
              "age": "72",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Gastrointestinal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "VALSARTAN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ZOCOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "AMOXICILLIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN HYDROCHLORIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CALTRATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "IMDUR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "WELCHOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL TARTRATE",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006367",
              "receive_date": "20140313",
              "serious": "1",
              "age": "69",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "73",
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "CARDIOVASCULAR EVENT PROPHYLAXIS"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                },
                {
                  "name": "ESTRADIOL.",
                  "role": "2",
                  "indication": "HORMONE REPLACEMENT THERAPY"
                },
                {
                  "name": "NEXIUM",
                  "role": "2",
                  "indication": "GASTROOESOPHAGEAL REFLUX DISEASE"
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": "HYPERTENSION"
                },
                {
                  "name": "ASPIRIN.",
                  "role": "2",
                  "indication": "ANTICOAGULANT THERAPY"
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LOSARTAN/HCTZ",
                  "role": "2",
                  "indication": "HYPERTENSION"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006374",
              "receive_date": "20140313",
              "serious": "1",
              "age": "54",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                },
                {
                  "name": "CALCIUM",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "MEGARED",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "BLOOD TRIGLYCERIDES INCREASED"
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "CARDIOVASCULAR EVENT PROPHYLAXIS"
                },
                {
                  "name": "MULTIVITAMINS",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006398",
              "receive_date": "20140313",
              "serious": "1",
              "age": "75",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Gastrointestinal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006401",
              "receive_date": "20140313",
              "serious": "1",
              "age": "68",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "63",
              "reactions": [
                {
                  "term": "Chillblains",
                  "outcome": "6"
                },
                {
                  "term": "Pain in extremity",
                  "outcome": "2"
                },
                {
                  "term": "Oedema peripheral",
                  "outcome": "2"
                }
              ],
              "drugs": [
                {
                  "name": "LOSARTAN POTASSIUM 50 MG",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "LOSARTAN POTASSIUM 50 MG",
                  "role": "1",
                  "indication": null
                },
                {
                  "name": "AMLODIPINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BECLOMETHASONE DIPROPIONATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BECLOMETHASONE DIPROPIONATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "CLOPIDOGREL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FERROUS FUMARATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "HYDROXOCOBALAMIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PENTOXIFYLLINE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "RAMIPRIL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006412",
              "receive_date": "20140313",
              "serious": "1",
              "age": "46",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Gastrointestinal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                },
                {
                  "term": "Diverticulum intestinal haemorrhagic",
                  "outcome": "6"
                },
                {
                  "term": "Rectal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Melaena",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "SIMVASTATIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METOPROLOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006449",
              "receive_date": "20140311",
              "serious": "1",
              "age": "12",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "72.58",
              "reactions": [
                {
                  "term": "Dyspnoea",
                  "outcome": null
                },
                {
                  "term": "Eye swelling",
                  "outcome": null
                },
                {
                  "term": "Dizziness",
                  "outcome": null
                },
                {
                  "term": "Palpitations",
                  "outcome": null
                }
              ],
              "drugs": [
                {
                  "name": "EQUATE ASPIRIN 250MG, ACETAMINOPHEN 250MG, CAFFEINE  65MG FILM COATED WHITE TABLETS",
                  "role": "1",
                  "indication": "PAIN"
                },
                {
                  "name": "INHALER FOR ASTHMA",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006483",
              "receive_date": "20140313",
              "serious": "1",
              "age": "67",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": "61.22",
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "BLOOD TRIGLYCERIDES INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "CARDIOVASCULAR EVENT PROPHYLAXIS"
                },
                {
                  "name": "FISH OIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BABY ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006492",
              "receive_date": "20140313",
              "serious": "1",
              "age": "65",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": "112",
              "reactions": [
                {
                  "term": "Small fibre neuropathy",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "CRESTOR",
                  "role": "1",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                },
                {
                  "name": "ATORVASTATIN",
                  "role": "1",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "BENDROFLUMETHIAZIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "DOXAZOSIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "OMACOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN B SUBSTANCES",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN C",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006498",
              "receive_date": "20140313",
              "serious": "1",
              "age": "65",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Renal failure acute",
                  "outcome": "6"
                },
                {
                  "term": "Retroperitoneal haemorrhage",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "BRILINTA",
                  "role": "1",
                  "indication": "STENT PLACEMENT"
                },
                {
                  "name": "ANGIOMAX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "STATIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006505",
              "receive_date": "20140313",
              "serious": "1",
              "age": "71",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "TOPROL XL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "METFORMIN HYDROCHLORIDE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LISINOPRIL",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006512",
              "receive_date": "20140313",
              "serious": "1",
              "age": "56",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Ulcer haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "METOPROLOL TARTRATE",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "RAMIPRIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "XANAX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LEVAQUIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ANTIHYPERTENSIVES",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "FLOMAX",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006522",
              "receive_date": "20140313",
              "serious": "1",
              "age": "78",
              "age_unit": "801",
              "sex": "1",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Gastrointestinal haemorrhage",
                  "outcome": "6"
                },
                {
                  "term": "Drug interaction",
                  "outcome": "6"
                },
                {
                  "term": "Melaena",
                  "outcome": "6"
                }
              ],
              "drugs": [
                {
                  "name": "DRONEDARONE",
                  "role": "1",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "DABIGATRAN",
                  "role": "3",
                  "indication": "PRODUCT USED FOR UNKNOWN INDICATION"
                },
                {
                  "name": "PEPCID",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LIPITOR",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "LASIX",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ALLOPURINOL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "PLENDIL",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "VITAMIN D",
                  "role": "2",
                  "indication": null
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": null
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            },
            {
              "report_id": "10006576",
              "receive_date": "20140313",
              "serious": "1",
              "age": "59",
              "age_unit": "801",
              "sex": "2",
              "weight_kg": null,
              "reactions": [
                {
                  "term": "Type 2 diabetes mellitus",
                  "outcome": "3"
                }
              ],
              "drugs": [
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "LOW DENSITY LIPOPROTEIN INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "BLOOD TRIGLYCERIDES INCREASED"
                },
                {
                  "name": "LIPITOR",
                  "role": "1",
                  "indication": "CARDIOVASCULAR EVENT PROPHYLAXIS"
                },
                {
                  "name": "ATENOLOL AND CHLORTHAL",
                  "role": "2",
                  "indication": "BLOOD PRESSURE INCREASED"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "MYOCARDIAL INFARCTION"
                },
                {
                  "name": "ASPIRIN",
                  "role": "2",
                  "indication": "CEREBROVASCULAR ACCIDENT"
                },
                {
                  "name": "TRICOR",
                  "role": "2",
                  "indication": "BLOOD CHOLESTEROL INCREASED"
                },
                {
                  "name": "AMITRIPTYLINE HYDROCHLORIDE",
                  "role": "2",
                  "indication": "INSOMNIA"
                },
                {
                  "name": "AMBIEN CR",
                  "role": "2",
                  "indication": "INSOMNIA"
                }
              ],
              "outcomes": [
                null,
                null,
                null,
                null
              ]
            }
          ],
          "total_count": 584808,
          "safety_metrics": {
            "total_events": 584808,
            "unique_reactions": 100,
            "top_reactions": [
              {
                "term": "FATIGUE",
                "count": 35999,
                "percentage": 6.1556955445205945
              },
              {
                "term": "DYSPNOEA",
                "count": 30407,
                "percentage": 5.1994842751809145
              },
              {
                "term": "NAUSEA",
                "count": 30113,
                "percentage": 5.149211365097605
              },
              {
                "term": "DIARRHOEA",
                "count": 29472,
                "percentage": 5.039602741412566
              },
              {
                "term": "DRUG INEFFECTIVE",
                "count": 25434,
                "percentage": 4.349119711084664
              },
              {
                "term": "DIZZINESS",
                "count": 25311,
                "percentage": 4.328087167070218
              },
              {
                "term": "HEADACHE",
                "count": 22293,
                "percentage": 3.8120203553986953
              },
              {
                "term": "OFF LABEL USE",
                "count": 21459,
                "percentage": 3.6694094472031846
              },
              {
                "term": "ASTHENIA",
                "count": 21150,
                "percentage": 3.61657159272787
              },
              {
                "term": "FALL",
                "count": 20809,
                "percentage": 3.5582618568829423
              }
            ]
          },
          "demographics": {
            "sex_distribution": {
              "Female": 47,
              "Male": 51,
              "Unknown": 2
            },
            "age_distribution": {
              "65+": 47,
              "45-64": 27,
              "18-44": 4,
              "<18": 1
            },
            "serious_events": 0,
            "serious_percentage": 0.0
          }
        },
        "error": null
      },
      "metadata": {
        "name": "fda_faers",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.3,
          "timeout": 60,
          "max_results": 1000,
          "limit_per_request": 100
        }
      }
    },
    {
      "adapter": "pubmed",
      "status": "success",
      "error": null,
      "execution_time": 1.729015,
      "data": {
        "success": true,
        "data": {
          "pmids": [
            "38942535",
            "35771719",
            "37940430",
            "36528918",
            "34323201",
            "36254625",
            "39596466",
            "37031812",
            "37070849",
            "30207247",
            "31520359",
            "34175687",
            "39025436",
            "39884030",
            "39343092",
            "32378979",
            "36990531",
            "35345997",
            "32920059",
            "28393696",
            "35219075",
            "30793675",
            "36076996",
            "39446947",
            "37322058",
            "30838354",
            "35986532",
            "36154585",
            "32938341",
            "1465486",
            "39957701",
            "39378826",
            "37061337",
            "35114113",
            "28536326",
            "34145436",
            "37164297",
            "37762393",
            "31558580",
            "38141188",
            "38336887",
            "38984579",
            "37269547",
            "23928289",
            "32601104",
            "34994310",
            "28346381",
            "34347041",
            "40414522",
            "35547744",
            "37980599",
            "37843187",
            "40132495",
            "27455225",
            "31592751",
            "23802404",
            "30555545",
            "25138827",
            "25174652",
            "28182263",
            "37655591",
            "41014361",
            "34994266",
            "40605007",
            "26514196",
            "33152247",
            "39744692",
            "25385142",
            "38811639",
            "26799671",
            "19442046",
            "11818492",
            "39893749",
            "37957922",
            "36333480",
            "35348595",
            "28875739",
            "36715269",
            "38064014",
            "18045192",
            "29332566",
            "15864266",
            "34112067",
            "32428714",
            "39101498",
            "28155598",
            "39942602",
            "38776197",
            "38940147",
            "39191166",
            "26845135",
            "24289549",
            "36000898",
            "36460622",
            "30675829",
            "34375185",
            "30552660",
            "22893634",
            "31298144",
            "23831857"
          ],
          "articles": [
            {
              "pmid": "38942535",
              "title": "Drug repurposing for cancer.",
              "abstract": "In the dynamic landscape of cancer therapeutics, the innovative strategy of drug repurposing emerges as a transformative paradigm, heralding a new era in the fight against malignancies. This book chapter aims to embark on the comprehension of the strategic deployment of approved drugs for repurposing and the meticulous journey of drug repurposing from earlier times to the current era. Moreover, the chapter underscores the multifaceted and complex nature of cancer biology, and the evolving field of cancer drug therapeutics while emphasizing the mandate of drug repurposing to advance cancer therapeutics. Importantly, the narrative explores the latest tools, technologies, and cutting-edge methodologies including high-throughput screening, omics technologies, and artificial intelligence-driven approaches, for shaping and accelerating the pace of drug repurposing to uncover novel cancer therapeutic avenues. The chapter critically assesses the breakthroughs, expanding the repertoire of repurposing drug candidates in cancer, and their major categories. Another focal point of this book chapter is that it addresses the emergence of combination therapies involving repurposed drugs, reflecting a shift towards personalized and synergistic treatment approaches. The expert analysis delves into the intricacies of combinatorial regimens, elucidating their potential to target heterogeneous cancer populations and overcome resistance mechanisms, thereby enhancing treatment efficacy. Therefore, this chapter provides in-depth insights into the potential of repurposing towards bringing the much-needed big leap in the field of cancer therapeutics.",
              "authors": [
                "Juni Banerjee",
                "Anand Krishna Tiwari",
                "Shuvomoy Banerjee"
              ],
              "journal": "Progress in molecular biology and translational science",
              "publication_date": "2024",
              "mesh_terms": [
                {
                  "term": "Drug Repositioning",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/bs.pmbts.2024.03.032"
            },
            {
              "pmid": "35771719",
              "title": "Patient-derived cancer organoids for drug screening: Basic technology and clinical application.",
              "abstract": "Cancer organoids, a three-dimensional (3D) culture system of cancer cells derived from tumor tissues, recapitulate physiological structure of the parental tumor. Different tumor organoids have been established for a variety of tumor types, such as colorectal, liver, stomach, pancreatic and brain tumors. Some tumor organoid biobanks are built to screen and discover novel antitumor drug targets. Moreover, patients-derived tumor organoids (PDOs) could predict treatment response to chemoradiotherapy, targeted therapy and immunotherapy to provide guidance for personalized cancer therapy. In this review, we provide an updated overview of tumor organoid development, summarize general approach to establish tumor organoids, and discuss the application of anti-cancer drug screening based on tumor organoid and its application in personalized therapy. We also outline the opportunities and challenges for organoids to guide precision medicine.",
              "authors": [
                "Xiaoxue Ren",
                "Weikang Chen",
                "Qingxia Yang",
                "Xiaoxing Li",
                "Lixia Xu"
              ],
              "journal": "Journal of gastroenterology and hepatology",
              "publication_date": "2022-Aug",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Evaluation, Preclinical",
                  "major_topic": false
                },
                {
                  "term": "Early Detection of Cancer",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Organoids",
                  "major_topic": false
                },
                {
                  "term": "Technology",
                  "major_topic": false
                }
              ],
              "doi": "10.1111/jgh.15930"
            },
            {
              "pmid": "37940430",
              "title": "Cancer drug repurposing in autism spectrum disorder.",
              "abstract": "Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with uncertain origins. Understanding of the mechanisms underlying ASD remains limited, and treatments are lacking. Genetic diversity complicates drug development. Given the complexity and severity of ASD symptoms and the rising number of diagnoses, exploring novel therapeutic strategies is essential. Here, we focus on shared molecular pathways between ASD and cancer and highlight recent progress on the repurposing of cancer drugs for ASD treatment, such as mTOR inhibitors, histone deacetylase inhibitors, and anti-inflammatory agents. We discuss how to improve trial design considering drug dose and patient age. Lastly, the discussion explores the critical aspects of side effects, commercial factors, and the efficiency of drug-screening pipelines; all of which are essential considerations in the pursuit of repurposing cancer drugs for addressing core features of ASD.",
              "authors": [
                "Giorgia Pedini",
                "Chin-Lin Chen",
                "Tilmann Achsel",
                "Claudia Bagni"
              ],
              "journal": "Trends in pharmacological sciences",
              "publication_date": "2023-Dec",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Autism Spectrum Disorder",
                  "major_topic": true
                },
                {
                  "term": "Drug Repositioning",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                },
                {
                  "term": "Drug Evaluation, Preclinical",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1016/j.tips.2023.09.008"
            },
            {
              "pmid": "36528918",
              "title": "Targeting cancer drug resistance utilizing organoid technology.",
              "abstract": "Cancer organoids generated from 3D in vitro cell cultures have contributed to the study of drug resistance. Maintenance of genomic and transcriptomic similarity between organoids and parental cancer allows organoids to have the ability of accurate prediction in drug resistance testing. Protocols of establishing therapy-sensitive and therapy-resistant organoids are concluded in two aspects, which are generated directly from respective patients' cancer and by induction of anti-cancer drug. Genomic and transcriptomic analyses and gene editing have been applied to organoid studies to identify key targets in drug resistance and FGFR3, KHDRBS3, lnc-RP11-536 K7.3 and FBN1 were found to be key targets. Furthermore, mechanisms contributing to resistance have been identified, including metabolic adaptation, activation of DNA damage response, defects in apoptosis, reduced cellular senescence, cellular plasticity, subpopulation interactions and gene fusions. Additionally, cancer stem cells (CSCs) have been verified to be involved in drug resistance utilizing organoid technology. Reversal of drug resistance can be achieved by targeting key genes and CSCs in cancer organoids. In this review, we summarize applications of organoids to cancer drug resistance research, indicating prospects and limitations.",
              "authors": [
                "Changpeng Chai",
                "Pengfei Ji",
                "Hao Xu",
                "Huan Tang",
                "Zhengfeng Wang",
                "Hui Zhang",
                "Wence Zhou"
              ],
              "journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
              "publication_date": "2023-Feb",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplastic Stem Cells",
                  "major_topic": false
                },
                {
                  "term": "Organoids",
                  "major_topic": false
                },
                {
                  "term": "RNA-Binding Proteins",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.biopha.2022.114098"
            },
            {
              "pmid": "34323201",
              "title": "Artificial Intelligence and Cancer Drug Development.",
              "abstract": "BACKGROUND: The development of cancer drugs is among the most focused \"bench to bedside activities\" to improve human health. Because of the amount of data publicly available to cancer research, drug development for cancers has significantly benefited from big data and Artificial Intelligence (AI). In the meantime, challenges, like curating the data of low quality, remain to be resolved. OBJECTIVES: This review focused on the recent advancements and challenges of AI in developing cancer drugs. METHODS: We discussed target validation, drug repositioning,  RESULTS AND CONCLUSION: AI can be applied to all stages during drug development, and some excellent reviews detailing the applications of AI in specific stages are available.",
              "authors": [
                "Fan Yang",
                "Jerry A Darsey",
                "Anindya Ghosh",
                "Hong-Yu Li",
                "Mary Q Yang",
                "Shanzhi Wang"
              ],
              "journal": "Recent patents on anti-cancer drug discovery",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Algorithms",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Artificial Intelligence",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.2174/1574892816666210728123758"
            },
            {
              "pmid": "36254625",
              "title": "Atropisomerism transforming anti-cancer drug discovery.",
              "abstract": "Atropisomerism is a stereochemical phenomenon that describes how groups are arranged in space as a result of their impeded rotation around a single bond. It is one of the frequently underappreciated conformational kinds of chirality. A significant role for atropisomers in drug discovery and development has been established via substantial study on the characteristics of molecules exhibiting this form of chirality. According to studies on the target selectivity of anti-cancer drugs, it was identified that atropisomers of specific compounds could be examined to modulate the selectivity of promiscuous inhibitors, which are a key target in cancer therapy. Conversely, it was discovered that these deliberate rigidifications of possible molecules along an axis of chirality gave an abundant possibility of acquiring more tailored anti-cancer action. Atropisomerism plays a significant role in altering pharmacodynamic and pharmacokinetic properties and thereby the success of any proposed drug candidate. It is thus necessary to anticipate the impact of stereogenic centres in such compounds on cancer drug development. Hence, herein we review atropisomeric anti-cancer moieties which have been investigated based on their target proteins, origin and isomerism. The insights offered herein would be extremely useful in anti-cancer drug design, pave way for new avenues to development promising potent agents to combat this life-threatening disease.",
              "authors": [
                "Simran Patel",
                "Khushi Sandha",
                "Anushka Waingankar",
                "Prachi Jain",
                "Arundhati Abhyankar"
              ],
              "journal": "Chemical biology & drug design",
              "publication_date": "2023-Jan",
              "mesh_terms": [
                {
                  "term": "Stereoisomerism",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Drug Design",
                  "major_topic": false
                },
                {
                  "term": "Molecular Conformation",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                }
              ],
              "doi": "10.1111/cbdd.14155"
            },
            {
              "pmid": "39596466",
              "title": "Multilevel Mechanisms of Cancer Drug Resistance.",
              "abstract": "Cancer drug resistance represents one of the most significant challenges in oncology and manifests through multiple interconnected molecular and cellular mechanisms. Objective: To provide a comprehensive analysis of multilevel processes driving treatment resistance by integrating recent advances in understanding genetic, epigenetic, and microenvironmental factors. This is a systematic review of the recent literature focusing on the mechanisms of cancer drug resistance, including genomic studies, clinical trials, and experimental research. Key findings include the following: (1) Up to 63% of somatic mutations can be heterogeneous within individual tumors, contributing to resistance development; (2) cancer stem cells demonstrate enhanced DNA repair capacity and altered metabolic profiles; (3) the tumor microenvironment, including cancer-associated fibroblasts and immune cell populations, plays a crucial role in promoting resistance; and (4) selective pressure from radiotherapy drives the emergence of radioresistant phenotypes through multiple adaptive mechanisms. Understanding the complex interplay between various resistance mechanisms is essential for developing effective treatment strategies. Future therapeutic approaches should focus on combination strategies that target multiple resistance pathways simultaneously, guided by specific biomarkers.",
              "authors": [
                "Malgorzata Roszkowska"
              ],
              "journal": "International journal of molecular sciences",
              "publication_date": "2024-Nov-19",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "DNA Repair",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Epigenesis, Genetic",
                  "major_topic": false
                },
                {
                  "term": "Mutation",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Neoplastic Stem Cells",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/ijms252212402"
            },
            {
              "pmid": "37031812",
              "title": "RNA-binding proteins in cancer drug discovery.",
              "abstract": "RNA-binding proteins (RBPs) are crucial players in tumorigenesis and, hence, promising targets in cancer drug discovery. However, they are largely regarded as 'undruggable', because of the often noncatalytic and complex interactions between protein and RNA, which limit the discovery of specific inhibitors. Nonetheless, over the past 10\u202fyears, drug discovery efforts have uncovered RBP inhibitors with clinical relevance, highlighting the disruption of RNA-protein networks as a promising avenue for cancer therapeutics. In this review, we discuss the role of structurally distinct RBPs in cancer, and the mechanisms of RBP-directed small-molecule inhibitors (SMOIs) focusing on drug-protein interactions, binding surfaces, potency, and translational potential. Additionally, we underline the limitations of RBP-targeting drug discovery assays and comment on future trends in the field.",
              "authors": [
                "Jean B Bertoldo",
                "Simon M\u00fcller",
                "Stefan H\u00fcttelmaier"
              ],
              "journal": "Drug discovery today",
              "publication_date": "2023-Jun",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "RNA-Binding Proteins",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "RNA",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.drudis.2023.103580"
            },
            {
              "pmid": "37070849",
              "title": "N-of-1 Trials in Cancer Drug Development.",
              "abstract": "The current approaches for cancer drug development lag behind an accelerated need in the field for a fast and efficient method for evaluating drugs in the personalized medicine era. In that regard, N-of-1 studies emerge as a potential addition to the drug development arsenal, although there are several considerations before its broad application becomes feasible. In essence, N-of-1 trials are a departure from the traditional \"drug-centric\" model to a \"patient-centric\" model. Herein, we review the concept of N-of-1 trials and provide real-world examples of their use in the developmental therapeutics field. N-of-1 trials offer an exceptional opportunity for fast-tracking of cancer drug development in the precision oncology era.",
              "authors": [
                "Mohamed A Gouda",
                "Lars Buschhorn",
                "Andreas Schneeweiss",
                "Adam Wahida",
                "Vivek Subbiah"
              ],
              "journal": "Cancer discovery",
              "publication_date": "2023-Jun-02",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Precision Medicine",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Medical Oncology",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                }
              ],
              "doi": "10.1158/2159-8290.CD-22-1377"
            },
            {
              "pmid": "30207247",
              "title": "Computational Studies in Drug Design Against Cancer.",
              "abstract": "BACKGROUND: The application of in silico tools in the development of anti cancer drugs. OBJECTIVE: The summing of different computer aided drug design approaches that have been applied in the development of anti cancer drugs. METHODS: Structure based, ligand based, hybrid protein-ligand pharmacophore methods, Homology modeling, molecular docking aids in different steps of drug discovery pipeline with considerable saving in time and expenditure. In silico tools also find applications in the domain of cancer drug development. RESULTS: Structure-based pharmacophore modeling aided in the identification of PUMA inhibitors, structure based approach with high throughput screening for the development of Bcl-2 inhibitors, to derive the most relevant protein-protein interactions, anti mitotic agents; I-Kappa-B Kinase \u03b2 (IKK- \u03b2) inhibitor, screening of new class of aromatase inhibitors that can be important targets in cancer therapy. CONCLUSION: Application of computational methods in the design of anti cancer drugs was found to be effective.",
              "authors": [
                "Baishakhi De",
                "Koushik Bhandari",
                "Francisco J B Mendon\u00e7a",
                "Marcus T Scotti",
                "Luciana Scotti"
              ],
              "journal": "Anti-cancer agents in medicinal chemistry",
              "publication_date": "2019",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Computer-Aided Design",
                  "major_topic": false
                },
                {
                  "term": "Drug Design",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Molecular Docking Simulation",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Quantitative Structure-Activity Relationship",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1871520618666180911125700"
            },
            {
              "pmid": "31520359",
              "title": "A Drosophila Based Cancer Drug Discovery Framework.",
              "abstract": "In recent years, there has been growing interest in using Drosophila for drug discovery as it provides a unique opportunity to screen small molecules against complex disease phenotypes in a whole animal setting. Furthermore, gene-compound interaction experiments that combine compound feeding with complex genetic manipulations enable exploration of compound mechanisms of response and resistance to an extent that is difficult to achieve in other experimental models. Here, I discuss how compound screening and testing approaches reported in Drosophila fit into the current cancer drug discovery pipeline. I then propose a framework for a Drosophila-based cancer drug discovery strategy which would allow the Drosophila research community to effectively leverage the power of Drosophila to identify candidate therapeutics and push our discoveries into the clinic.",
              "authors": [
                "Erdem Bangi"
              ],
              "journal": "Advances in experimental medicine and biology",
              "publication_date": "2019",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Disease Models, Animal",
                  "major_topic": false
                },
                {
                  "term": "Drosophila",
                  "major_topic": true
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Genetic Techniques",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Phenotype",
                  "major_topic": false
                }
              ],
              "doi": "10.1007/978-3-030-23629-8_14"
            },
            {
              "pmid": "34175687",
              "title": "Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.",
              "abstract": "The cytotoxic anti-cancer drugs cisplatin, paclitaxel, doxorubicin, 5-fluorouracil (5-FU), as well as targeted drugs including imatinib, erlotinib, and nivolumab, play key roles in clinical cancer treatment. However, the frequent emergence of drug resistance severely comprosises their anti-cancer efficacy. A number of studies indicated that loss of function of tumor suppressor genes (TSGs) is involved in the development of cancer drug resistance, apart from decreased drug influx, increased drug efflux, induction of anti-apoptosis mechanisms, alterations in tumor microenvironment, drug compartmentalization, enhanced DNA repair and drug inactivation. TSGs are involved in the pathogenesis of tumor formation through regulation of DNA damage repair, cell apoptosis, autophagy, proliferation, cell cycle progression, and signal transduction. Our increased understanding of TSGs in the past decades demonstrates that gene mutation is not the only reason that leads to the inactivation of TSGs. Loss of function of TSGs may be based on the ubiquitin-proteasome pathway, epigenetic and transcriptional regualtion, post-translation modifications like phosphorylation as well as cellular translocation of TSGs. As the above processes can constitute\"druggable targets\", these mechanisms provide novel therapeutic approaches in targeting TSGs. Some small molecule compounds targeting these approaches re-activated TSGs and reversed cancer drug resistance. Along this vein, functional restoration of TSGs is a novel and promising approach to surmount cancer drug resistance. In the current review, we draw a scenario based on the role of loss of function of TSGs in drug resistance, on mechanisms leading to inactivation of TSGs and on pharmacological agents acting on these mechanisms to overcome cancer drug resistance. This review discusses novel therapeutic strategies targeting TSGs and offers possible modalities to conquer cancer drug resistance.",
              "authors": [
                "Lingyue Gao",
                "Zhuo-Xun Wu",
                "Yehuda G Assaraf",
                "Zhe-Sheng Chen",
                "Lihui Wang"
              ],
              "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
              "publication_date": "2021-Jul",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Apoptosis",
                  "major_topic": false
                },
                {
                  "term": "DNA Repair",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Genes, Tumor Suppressor",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.drup.2021.100770"
            },
            {
              "pmid": "39025436",
              "title": "Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing.",
              "abstract": "Abnormal gene alternative splicing (AS) events are strongly associated with cancer progression. Here, we summarize AS events that contribute to the development of drug resistance and classify them into three categories: alternative cis-splicing (ACS), alternative trans-splicing (ATS), and alternative back-splicing (ABS). The regulatory mechanisms underlying AS processes through cis-acting regulatory elements and trans-acting factors are comprehensively described, and the distinct functions of spliced variants, including linear spliced variants derived from ACS, chimeric spliced variants arising from ATS, and circRNAs generated through ABS, are discussed. The identification of dysregulated spliced variants, which contribute to drug resistance and hinder effective cancer treatment, suggests that abnormal AS processes may together serve as a precise regulatory mechanism enabling drug-resistant cancer cell survival or, alternatively, represent an evolutionary pathway for cancer cells to adapt to changes in the external environment. Moreover, this review summarizes recent advancements in treatment approaches targeting AS-associated drug resistance, focusing on cis-acting regulatory elements, trans-acting factors, and specific spliced variants. Collectively, gaining an in-depth understanding of the mechanisms underlying aberrant alternative splicing events and developing strategies to target this process hold great promise for overcoming cancer drug resistance.",
              "authors": [
                "Ji Zhang",
                "Xinyu Xu",
                "Hongwei Deng",
                "Li Liu",
                "Yuancai Xiang",
                "Jianguo Feng"
              ],
              "journal": "Pharmacology & therapeutics",
              "publication_date": "2024-Sep",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Alternative Splicing",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                }
              ],
              "doi": "10.1016/j.pharmthera.2024.108697"
            },
            {
              "pmid": "39884030",
              "title": "Cancer drug resistance as learning of signaling networks.",
              "abstract": "Drug resistance is a major cause of tumor mortality. Signaling networks became useful tools for driving pharmacological interventions against cancer drug resistance. Signaling datasets now cover the entire human cell. Recently, network adaptation became understood as a learning process. We review rapidly increasing evidence showing that the development of cancer drug resistance can be described as learning of signaling networks. During drug adaptation, the network forgets drug-affected pathways by desensitization and relearns by strengthening alternative pathways. Thus, resistant cancer cells develop a drug resistance memory. We show that all key players of cellular learning (i.e., IDPs, protein translocation, microRNAs/lncRNAs, scaffolding proteins and epigenetic/chromatin memory) have important roles in the development of cancer drug resistance. Moreover, all of them are central components of the epithelial-mesenchymal transition leading to metastases and resistance. Phenotypic plasticity was recently listed as a hallmark of cancer. We review how network plasticity induces rare, pre-existent drug-resistant cells in the absence of drug treatment. Key network methods assessing the development of drug resistance and network pharmacological interventions against drug resistance are summarized. Finally, we highlight the class of cellular memory drugs affecting cellular learning and forgetting, and we summarize current challenges to prevent or break drug resistance using network models.",
              "authors": [
                "D\u00e1vid Keresztes",
                "M\u00e1rk Kerest\u00e9ly",
                "Levente Szarka",
                "Borb\u00e1la M Kov\u00e1cs",
                "Kl\u00e1ra Schulc",
                "D\u00e1niel V Veres",
                "Peter Csermely"
              ],
              "journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
              "publication_date": "2025-Feb",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Epithelial-Mesenchymal Transition",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.biopha.2025.117880"
            },
            {
              "pmid": "39343092",
              "title": "Cancer Drug Wastage and Mitigation Methods: A Systematic Review.",
              "abstract": "OBJECTIVES: To systematically review published evidence on cancer drug wastage and the effectiveness of mitigation methods. METHODS: Search keywords for Scopus, PubMed, and EMBASE were developed using the Pearl Growing technique. Relevant articles were identified in a 2-step process: first, based on titles/abstracts, then on full article reviews. Among the identified English peer-reviewed articles, those considering adults \u226518 years and relevant cancer drug wastage outcomes were included. Key concepts and measures for drug wastage and its mitigation were tabulated. Trends in publication numbers were analyzed using Mann-Kendall tests. Costs were converted first to 2024 local currencies using country-wise consumer price indexes and then to 2024 USD using exchange rates. RESULTS: Among 6298 unique articles, 94 met the inclusion criteria. Seventy-four (79%) of these were published since 2015, highlighting increasing attention to cancer drug wastage. Twenty-three articles (24%) explicitly reported drug wastage amounts, whereas 52 articles (55%) considered the mitigation methods. Most articles focused on high-income countries (n\u00a0= 67), single-hospital settings (n\u00a0= 45), and retrospective study designs (n\u00a0= 55). Wastage mitigation techniques included vial sharing (n\u00a0= 21), dose rounding (n\u00a0= 17), closed-system transfer device (n\u00a0= 9), centralized drug preparation (n\u00a0= 7), and vial size optimization (n\u00a0= 7). A trend toward higher median wastage cost was evident in US settings ($135.35/patient-month) compared with other countries ($37.71/patient-month), whereas mitigation methods across countries were not statistically significant. CONCLUSIONS: High cancer drug costs highlight the importance of minimizing drug wastage to reduce healthcare expenditure. Our review demonstrates that wastage varies by healthcare setting and mitigation technique. Future studies would benefit from reporting standards for cancer drug wastage that include reporting wastage (both in mg and cost, preferably in terms of purchase power parity), as well as cohort size, considered vial sizes, considered dosages, and used mitigation methods separately for each drug. This approach would account for variability in cancer drug wastage and help identify optimal mitigation practices tailored to the health system context.",
              "authors": [
                "Krishna Sabareesh Rajangom",
                "F Safa Erenay",
                "Qi-Ming He",
                "Rachel Figueiredo",
                "Kelvin K W Chan",
                "Matthew C Cheung",
                "Lauren F Charbonneau",
                "Susan E Horton",
                "Avram Denburg"
              ],
              "journal": "Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research",
              "publication_date": "2025-Jan",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Costs",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.jval.2024.08.006"
            },
            {
              "pmid": "32378979",
              "title": "Porcine cancer models: potential tools to enhance cancer drug trials.",
              "abstract": "INTRODUCTION: The amount of time and money invested into cancer drug research, development, and clinical trials has continually increased over the past few decades. Despite record high cancer drug approval rates, cancer remains a leading cause of death. This suggests the need for more effective tools to help bring novel therapies to clinical practice in a timely manner. AREAS COVERED: In this review, current issues associated with clinical trials are discussed, specifically focusing on poor accrual rates and time for trial completion. In addition, details regarding preclinical studies required before advancing to clinical trials are discussed, including advantages and limitations of current preclinical animal cancer models and their relevance to human cancer trials. Finally, new translational porcine cancer models (Oncopig Cancer Model (OCM)) are presented as potential co-clinical trial models. EXPERT OPINION: In order to address issues impacting the poor success rate of oncology clinical trials, we propose the incorporation of the transformative OCM 'co-clinical trial' pathway into the cancer drug approval process. Due to the Oncopig's high homology to humans and similar tumor phenotypes, their utilization can provide improved preclinical prediction of both drug safety and efficacy prior to investing significant time and money in human clinical trials.",
              "authors": [
                "Noah Robertson",
                "Lawrence B Schook",
                "Kyle M Schachtschneider"
              ],
              "journal": "Expert opinion on drug discovery",
              "publication_date": "2020-Aug",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Clinical Trials as Topic",
                  "major_topic": false
                },
                {
                  "term": "Disease Models, Animal",
                  "major_topic": false
                },
                {
                  "term": "Drug Approval",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Research",
                  "major_topic": false
                },
                {
                  "term": "Swine",
                  "major_topic": false
                },
                {
                  "term": "Time Factors",
                  "major_topic": false
                }
              ],
              "doi": "10.1080/17460441.2020.1757644"
            },
            {
              "pmid": "36990531",
              "title": "The epigenome and the many facets of cancer drug tolerance.",
              "abstract": "The use of chemotherapeutic agents and the development of new cancer therapies over the past few decades has consequently led to the emergence of myriad therapeutic resistance mechanisms. Once thought to be explicitly driven by genetics, the coupling of reversible sensitivity and absence of pre-existing mutations in some tumors opened the way for discovery of drug-tolerant persisters (DTPs): slow-cycling subpopulations of tumor cells that exhibit reversible sensitivity to therapy. These cells confer multi-drug tolerance, to targeted and chemotherapies alike, until the residual disease can establish a stable, drug-resistant state. The DTP state can exploit a multitude of distinct, yet interlaced, mechanisms to survive otherwise lethal drug exposures. Here, we categorize these multi-faceted defense mechanisms into unique Hallmarks of Cancer Drug Tolerance. At the highest level, these are comprised of heterogeneity, signaling plasticity, differentiation, proliferation/metabolism, stress management, genomic integrity, crosstalk with the tumor microenvironment, immune escape, and epigenetic regulatory mechanisms. Of these, epigenetics was both one of the first proposed means of non-genetic resistance and one of the first discovered. As we describe in this review, epigenetic regulatory factors are involved in most facets of DTP biology, positioning this hallmark as an overarching mediator of drug tolerance and a potential avenue to novel therapies.",
              "authors": [
                "Paul C Moore",
                "Kurt W Henderson",
                "Marie Classon"
              ],
              "journal": "Advances in cancer research",
              "publication_date": "2023",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Epigenome",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Tolerance",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/bs.acr.2022.12.002"
            },
            {
              "pmid": "35345997",
              "title": "Benzimidazoles Against Certain Breast Cancer Drug Targets: A Review.",
              "abstract": "BACKGROUND: Benzimidazoles are widely used scaffolds against various types of cancer, including breast cancer. To this end, anticancer agents must be developed using the knowledge of the specific targets of BC. OBJECTIVE: In this study, we aim to review the compounds used against some of the biomolecular targets of breast cancer. To this end, we present information about the various targets, with their latest innovative studies. CONCLUSION: Benzimidazole ring is an important building block that can target diverse cancer scenarios since it can structurally mimic biomolecules in the human body. Additionally, many studies imply the involvement of this moiety on a plethora of pathways and enzymes related to BC. Herein, our target- based collection of benzimidazole derivatives strongly suggests the utilization of benzimidazole derivatives against BC.",
              "authors": [
                "Mehmet Murat Kisla",
                "Zeynep Ates-Alagoz"
              ],
              "journal": "Mini reviews in medicinal chemistry",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Benzimidazoles",
                  "major_topic": false
                },
                {
                  "term": "Breast Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Female",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Hypoglycemic Agents",
                  "major_topic": false
                },
                {
                  "term": "Structure-Activity Relationship",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1389557522666220328161217"
            },
            {
              "pmid": "32920059",
              "title": "The political economics of cancer drug discovery and pricing.",
              "abstract": "Drug discoveries can, when used appropriately, save lives. Since 1970, cancer death rates among people aged under 65 have halved in countries such as the USA and the UK. Despite pharmaceutical market imperfections and fears about the prices of new treatments, further progress should be possible during the 2020s. Anticancer medicine outlays account for 0.1-0.2% of the gross domestic product (GDP) of developed countries. Total cancer service spending typically stands at \u223c0.8% of GDP. The affordability of these sums is a political calculation. Improvements in the efficiency of drug development and global access to effective therapies are desirable. However, from a public interest perspective, these goals should not be pursued in ways that understate the value of better treatment outcomes and threaten the funding available for ongoing innovation.",
              "authors": [
                "David G Taylor"
              ],
              "journal": "Drug discovery today",
              "publication_date": "2020-Dec",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "COVID-19",
                  "major_topic": false
                },
                {
                  "term": "Costs and Cost Analysis",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Quality-Adjusted Life Years",
                  "major_topic": false
                },
                {
                  "term": "SARS-CoV-2",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.drudis.2020.09.007"
            },
            {
              "pmid": "28393696",
              "title": "Promising Targets in Anti-cancer Drug Development: Recent Updates.",
              "abstract": "Cancer is a multifactorial disease and its genesis and progression are extremely complex. The biggest problem in the anticancer drug development is acquiring of multidrug resistance and relapse. Classical chemotherapeutics directly target the DNA of the cell, while the contemporary anticancer drugs involve molecular-targeted therapy such as targeting the proteins possessing abnormal expression inside the cancer cells. Conventional strategies for the complete eradication of the cancer cells proved ineffective. Targeted chemotherapy was successful in certain malignancies however, the effectiveness has often been limited by drug resistance and side effects on normal tissues and cells. Since last few years, many promising drug targets have been identified for the effective treatment of cancer. The current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular targeting agents. In addition, promising drug candidates under various phases of clinical trials are also described. Multi-acting drugs that simultaneously target different cancer cell signaling pathways may facilitate the process of effective anti-cancer drug development.",
              "authors": [
                "Bhupinder Kumar",
                "Sandeep Singh",
                "Ira Skvortsova",
                "Vinod Kumar"
              ],
              "journal": "Current medicinal chemistry",
              "publication_date": "2017",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Protein Kinase Inhibitors",
                  "major_topic": false
                },
                {
                  "term": "Protein Kinases",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/0929867324666170331123648"
            },
            {
              "pmid": "35219075",
              "title": "Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.",
              "abstract": "Despite the rapid advancement in the introduction of new drugs for cancer therapy, the frequent emergence of drug resistance leads to disease progression or tumor recurrence resulting in dismal prognosis. Given that genetic mutations are thought to be important drivers of anti-cancer drug resistance, it is of paramount importance to pin-point mutant genes that mediate drug resistance and elucidate the underlying molecular mechanisms in order to develop novel modalities to surmount chemoresistance and achieve more efficacious and durable cancer therapies. Cumulative evidence suggests that epigenetic alterations, especially those mediated by epigenetic enzymes with high mutation rates in cancer patients, can be a crucial factor in the development of chemoresistance. Mutant epigenetic enzymes have altered enzymatic activity which may directly or indirectly affect the level of histone modifications. This can change chromatin structure and function hence altering the expression of target genes and eventually lead to chemoresistance. In the current review, we summarize epigenetic enzyme mutations and the consequent mechanisms of drug resistance in pre-clinical drug-resistance models and relapsed cancer patient specimens. We also introduce previously unreported mutation sites in the DOT1 domain of DOT1L, which are related to lung cancer drug resistance. It is worth noting that mutations occur not only in domains with enzymatic activity but also in non-catalytic regions. Each protein domain is an evolutionarily conserved region with independent functional properties. This may provide a rationale for the potential development of small molecule inhibitors which target various functional domains of epigenetic enzymes. Finally, based on the multitude of mechanisms of drug resistance, we propose several therapeutic strategies to reverse or overcome drug-resistance phenotypes, with the aim to provide cancer patients with novel efficacious combination therapeutic regimens and strategies to improve patient prognosis.",
              "authors": [
                "Sihong Chen",
                "Yingxi Zhao",
                "Shougeng Liu",
                "Jiayu Zhang",
                "Yehuda G Assaraf",
                "Wei Cui",
                "Lihui Wang"
              ],
              "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
              "publication_date": "2022-Mar",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Epigenesis, Genetic",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Mutation",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1016/j.drup.2022.100821"
            },
            {
              "pmid": "30793675",
              "title": "Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - (Part-I).",
              "abstract": null,
              "authors": [
                "Suman S Thakur"
              ],
              "journal": "Current topics in medicinal chemistry",
              "publication_date": "2018",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biological Products",
                  "major_topic": false
                },
                {
                  "term": "Cell Proliferation",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Molecular Structure",
                  "major_topic": false
                },
                {
                  "term": "Nanomedicine",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/156802661830190213150943"
            },
            {
              "pmid": "36076996",
              "title": "Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance.",
              "abstract": "Histone deacetylases (HDACs) regulate gene expression through the epigenetic modification of chromatin structure. HDAC6, unlike many other HDACs, is present in the cytoplasm. Its deacetylates non-histone proteins and plays diverse roles in cancer cell initiation, proliferation, autophagy, and anti-cancer drug resistance. The development of HDAC6-specific inhibitors has been relatively successful. Mechanisms of HDAC6-promoted anti-cancer drug resistance, cancer cell proliferation, and autophagy are discussed. The relationship between autophagy and anti-cancer drug resistance is discussed. The effects of combination therapy, which includes HDAC6 inhibitors, on the sensitivity of cancer cells to chemotherapeutics and immune checkpoint blockade are presented. A summary of clinical trials involving HDAC6-specific inhibitors is also presented. This review presents HDAC6 as a valuable target for developing anti-cancer drugs.",
              "authors": [
                "Hyein Jo",
                "Kyeonghee Shim",
                "Dooil Jeoung"
              ],
              "journal": "International journal of molecular sciences",
              "publication_date": "2022-Aug-24",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Autophagy",
                  "major_topic": false
                },
                {
                  "term": "Histone Deacetylase 6",
                  "major_topic": false
                },
                {
                  "term": "Histone Deacetylase Inhibitors",
                  "major_topic": true
                },
                {
                  "term": "Histone Deacetylases",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/ijms23179592"
            },
            {
              "pmid": "39446947",
              "title": "Impact of CRISPR in cancer drug discovery.",
              "abstract": "Precision gene editing enables massively parallel identification of cancer-promoting genes.",
              "authors": [
                "Jason Moffat",
                "Alexis C Komor",
                "Lawrence Lum"
              ],
              "journal": "Science (New York, N.Y.)",
              "publication_date": "2024-Oct-25",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "CRISPR-Cas Systems",
                  "major_topic": true
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Gene Editing",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1126/science.adi6884"
            },
            {
              "pmid": "37322058",
              "title": "A cancer drug wish list.",
              "abstract": null,
              "authors": [
                "Asher Mullard"
              ],
              "journal": "Nature reviews. Drug discovery",
              "publication_date": "2023-Jul",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Quality of Life",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1038/d41573-023-00100-1"
            },
            {
              "pmid": "30838354",
              "title": "A polydopamine-based platform for anti-cancer drug delivery.",
              "abstract": "Cancer is the second leading cause of death in the world with around 9.6 million deaths in 2018, approximately 70% of which occurred in the middle- and low-income countries; moreover, the economic impact of cancer is significant and escalating day by day. The total annual economic cost of cancer treatment in 2010 was estimated at approximately US$ 1.16 trillion. Researchers have explored cancer mitigation therapies such as chemo-thermal therapy, chemo-photothermal therapy and photodynamic-photothermal therapy. These combinational therapies facilitate better control on the tunability of the carrier for effectively diminishing cancer cells than individual therapies such as chemotherapy, photothermal therapy and targeted therapy. All these therapies come under novel drug delivery systems in which anti-cancer drugs attack the cancerous cells due to various stimuli (e.g. pH, thermal, UV, IR, acoustic and magnetic)-responsive properties of the anti-cancer drug carriers. Compared to conventional drug delivery systems, the novel drug delivery systems have several advantages such as targeted drug release, sustained and consistent blood levels within the therapeutic window, and decreased dosing frequency. Among the numerous polymeric carriers developed for drug delivery, polydopamine has been found to be more suitable as a carrier for these drug delivery functions due to its easy and cost-effective fabrication, excellent biocompatibility, multi-drug carrier capacity and stimuli sensitivity. Therefore, in this review, we have explored polydopamine-based carriers for anti-cancer drug delivery systems to mitigate cancer and simultaneously discussed basic synthesis routes for polydopamine.",
              "authors": [
                "Rushikesh S Ambekar",
                "Balasubramanian Kandasubramanian"
              ],
              "journal": "Biomaterials science",
              "publication_date": "2019-Apr-23",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Carriers",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Indoles",
                  "major_topic": false
                },
                {
                  "term": "Polymers",
                  "major_topic": false
                }
              ],
              "doi": "10.1039/c8bm01642a"
            },
            {
              "pmid": "35986532",
              "title": "Drug Sensitivity Testing for Cancer Therapy, Key Areas.",
              "abstract": "AIMS: Cancer is a high-mortality disease (9.6 million deaths in 2018 worldwide). Given various anticancer drugs, drug selection plays a key role in patient survival in clinical trials. METHODS: Drug Sensitivity Testing (DST), one of the leading drug selective systems, was widely practiced for therapeutic promotion in the clinic. Notably, DSTs assist in drug selection that benefits drug responses against cancer from 20-22% to 30-35% over the past two decades. The relationship between drug resistance in vitro and drug treatment benefits was associated with different tumor origins and subtypes. Medical theory and underlying DST mechanisms remain poorly understood until now. The study of the clinical scenario, sustainability and financial support for mechanism and technical promotions is indispensable. RESULTS: Despite the great technical advance, therapeutic prediction and drug selection by DST needs to be miniature, versatility and cost-effective in the clinic. Multi-parameters and automation of DST should be a future trend. Advanced biomedical knowledge and clinical approaches to translating oncologic profiles into drug selection were the main focuses of DST developments. With a great technical stride, the clinical architecture of the DST platform was entering higher levels (drug response testing at any stage of cancer patients and miniaturization of tumor samples). DISCUSSION: The cancer biology and pharmacology for drug selection mutually benefit the clinic. New proposals to reveal more therapeutic information and drug response prediction at genetic, molecular and omics levels should be estimated overall. CONCLUSION: By upholding this goal of non-invasive, versatility and automation, DST could save the life of several thousand annually worldwide. In this article, new insights into DST novelty and development are highlighted.",
              "authors": [
                "Da-Yong Lu",
                "Ting-Ren Lu",
                "Nagendra Sastry Yarla",
                "Bin Xu"
              ],
              "journal": "Reviews on recent clinical trials",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Combined Chemotherapy Protocols",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance",
                  "major_topic": false
                },
                {
                  "term": "Microbial Sensitivity Tests",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.2174/1574887117666220819094528"
            },
            {
              "pmid": "36154585",
              "title": "Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.",
              "abstract": "Cancer remains a major worldwide health challenge. Current studies emphasize the tumor microenvironment that plays a vital role in tumor proliferation, invasion, metastasis, and drug resistance. The tumor microenvironment (TME) supports the cancer cell to evade conventional treatment such as surgery, radiotherapy, and chemotherapy. Moreover, the components of tumor microenvironments have a major contribution towards developing therapy resistance in solid tumors. Therefore, targeting the tumor microenvironment can be a novel approach for achieving advancement in cancer nanomedicine. The recent progress in understanding TME and developing TME-responsive nanoparticles offers a great advantage in treating cancer drug resistance. These nanoparticles are developed in response to TME stimuli such as low pH, redox, and hypoxia improve nanomedicine's pharmacokinetic and therapeutic efficacy. This review discusses the various components of the tumor microenvironment responsible for drug resistance and nanomedicine's role in overcoming it.",
              "authors": [
                "Pratikshya Sa",
                "Sanjeeb K Sahoo",
                "Fahima Dilnawaz"
              ],
              "journal": "Current medicinal chemistry",
              "publication_date": "2023",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Nanomedicine",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": true
                }
              ],
              "doi": "10.2174/0929867329666220922111336"
            },
            {
              "pmid": "32938341",
              "title": "Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - Part-3.",
              "abstract": null,
              "authors": [
                "Suman S Thakur"
              ],
              "journal": "Current topics in medicinal chemistry",
              "publication_date": "2020",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Molecular Structure",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/156802662020200817163623"
            },
            {
              "pmid": "1465486",
              "title": "Cancer drug therapy.",
              "abstract": "The chemotherapeutic treatment of cancer has evolved into a major treatment modality. Better results than ever before are being recorded with the integration of this approach into the early and total management of cancer. Although complex and toxic, these drugs and their combinations are contributing in new ways to the treatment of more and more patients. More than 50% of those people afflicted with cancer in 1991 became long-term survivors. Most of these survivors are destined to be followed on a long-term basis by their family doctor.",
              "authors": [
                "W J Durkin"
              ],
              "journal": "Primary care",
              "publication_date": "1992-Dec",
              "mesh_terms": [
                {
                  "term": "Antibiotics, Antineoplastic",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Combined Chemotherapy Protocols",
                  "major_topic": false
                },
                {
                  "term": "Hormones",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ]
            },
            {
              "pmid": "39957701",
              "title": "Cancer Drug Targeting: Molecular Mechanism, Approaches, and Regulatory Framework.",
              "abstract": "Novel vaccine formulations called nano vaccines which use nanoparticles (NPs) as adjuvants or carriers, are being developed in place of conventional vaccines. The field of study on peptide-based nano vaccines is enlarging fast as a result of combining antigenic peptides with nano-transport systems. This paper explores advancements in anticancer nano vaccines, focusing on their mechanisms, challenges, and opportunities. It discusses peptide nano vaccines, personalized vaccines, cancer prevention strategies, clinical translation, and self-assembling multivalent nanovaccines. It also discusses nanocarriers' role in delivering tumorassociated antigens and immune-stimulatory adjuvants. In 2024, the American Cancer Society projects over 2 million new cancer cases in the United States, marking the first year this milestone has been surpassed. This equates to approximately 5,480 new cancer diagnoses daily. Additionally, over 611,000 cancer-related deaths are expected, which translates to more than 1,600 deaths per day. The National Centre for Health Statistics mentions the mortality data also shows the various types of cancer percentages. This guideline provides comprehensive recommendations for sponsors submitting a novel drug under Investigation use of curative cancer vaccinations, focusing on safety, effectiveness, dosage optimization, adjuvant use, patient group selection, immune response monitoring, biomarker evaluation, multi-antigen vaccine development, phase-specific difficulties, non-clinical testing, and legal frameworks, while also referencing relevant legal foundations and recommendations.",
              "authors": [
                "Rushikesh Somnath Chandel",
                "Hitesh Kumar Dewangan"
              ],
              "journal": "Current pharmaceutical design",
              "publication_date": "2025",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Cancer Vaccines",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": true
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": false
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/0113816128364722250126172914"
            },
            {
              "pmid": "39378826",
              "title": "Breakthroughs in AI and multi-omics for cancer drug discovery: A review.",
              "abstract": "Cancer is one of the biggest medical challenges we face today. It is characterized by abnormal, uncontrolled growth of cells that can spread to different parts of the body. Cancer is extremely complex, with genetic variations and the ability to adapt and evolve. This means we must continuously pursue innovative approaches to developing new cancer drugs. While traditional drug discovery methods have led to important breakthroughs, they also have significant limitations that make it difficult to efficiently create new, cost-effective cancer therapies. Integrating computational tools into the cancer drug discovery process is a major step forward. By harnessing computing power, we can overcome some of the inherent barriers of traditional methods. This review examines the range of computational techniques now being used, such as molecular docking, QSAR models, virtual screening, and pharmacophore modeling. It looks at recent advances in areas like machine learning and molecular simulations. The review also discusses the current challenges with these technologies and envisions future directions, underscoring how transformative these computational tools can be for creating targeted, new cancer treatments.",
              "authors": [
                "Israr Fatima",
                "Abdur Rehman",
                "Yanheng Ding",
                "Peng Wang",
                "Yuxuan Meng",
                "Hafeez Ur Rehman",
                "Dawood Ahmad Warraich",
                "Zhibo Wang",
                "Lijun Feng",
                "Mingzhi Liao"
              ],
              "journal": "European journal of medicinal chemistry",
              "publication_date": "2024-Dec-15",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Artificial Intelligence",
                  "major_topic": false
                },
                {
                  "term": "Quantitative Structure-Activity Relationship",
                  "major_topic": false
                },
                {
                  "term": "Multiomics",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.ejmech.2024.116925"
            },
            {
              "pmid": "37061337",
              "title": "Anti-cancer drug molecules targeting cancer cell cycle and proliferation.",
              "abstract": "Cancer, a vicious clinical burden that potentiates maximum fatality for humankind, arises due to unregulated excessive cell division and proliferation through an eccentric expression of cell cycle regulator proteins. A set of evolutionarily conserved machinery controls the cell cycle in an extremely precise manner so that a cell that went through the cycle can produce a genetically identical copy. To achieve perfection, several checkpoints were placed in the cycle for surveillance; so, errors during the division were rectified by the repair strategies. However, irreparable damage leads to exit from the cell cycle and induces programmed cell death. In comparison to a normal cell, cancer cells facilitate the constitutive activation of many dormant proteins and impede negative regulators of the checkpoint. Extensive studies in the last few decades on cell division and proliferation of cancer cells elucidate the molecular mechanism of the cell-cycle regulators that are often targeted for the development of anti-cancer therapy. Each phase of the cell cycle has been regulated by a unique set of proteins including master regulators Cyclins, and CDKs, along with the accessory proteins such as CKI, Cdc25, error-responsive proteins, and various kinase proteins mainly WEE1 kinases, Polo-like kinases, and Aurora kinases that control cell division. Here in this chapter, we have analytically discussed the role of cell cycle regulators and proliferation factors in cancer progression and the rationale of using various cell cycle-targeting drug molecules as anti-cancer therapy.",
              "authors": [
                "Debarun Patra",
                "Kumari Bhavya",
                "Palla Ramprasad",
                "Moyna Kalia",
                "Durba Pal"
              ],
              "journal": "Advances in protein chemistry and structural biology",
              "publication_date": "2023",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Cell Cycle",
                  "major_topic": false
                },
                {
                  "term": "Cell Division",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Cyclin-Dependent Kinases",
                  "major_topic": false
                },
                {
                  "term": "Cell Proliferation",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/bs.apcsb.2022.11.011"
            },
            {
              "pmid": "35114113",
              "title": "Equity in cancer drug access in the UK.",
              "abstract": null,
              "authors": [
                "The Lancet Oncology"
              ],
              "journal": "The Lancet. Oncology",
              "publication_date": "2022-Feb",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Health Services Accessibility",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "State Medicine",
                  "major_topic": false
                },
                {
                  "term": "United Kingdom",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/S1470-2045(22)00030-4"
            },
            {
              "pmid": "28536326",
              "title": "[Drug Vial Optimization(DVO)for Anti-Cancer Drugs].",
              "abstract": "The healthcare cost reduction is one of the big national issues in Japan. The author published a policy report on drug vial optimization(DVO)as a concrete solution to reduce the healthcare cost. 31.9 billion Japanese Yen(JPY)to 41.0 billion JPY can be reduced if DVOis introduced all over Japan and this reduction amount must be bigger now since the anti-cancer drug market is growing every year and expensive anti-cancer drugs have been newly introduced in the market. The author made discussion with various people in mass media and stakeholders of policies and investigation to introduce DVOin Japan was started. Also, some hospitals started to investigate and introduce DVOindependently. According to open information, National Cancer Center Hospital(NCCH)started to introduce DVOfor 1 anti-cancer drug and Kagoshima University Hospital reported the simulation results for DVO. It is expected that policies will be built so that the independent action done by each hospital will be standard actions for all the hospitals in Japan. The market size of medical drugs grew to about 10.6 trillion JPY in 2015 and various drugs are discarded both inside and outside hospitals. Thus, there are various opportunities and methods besides DVOto reduce the healthcare cost. The author expects that various organizations will propose various methods to reduce the healthcare cost.",
              "authors": [
                "Takashi Iwamoto"
              ],
              "journal": "Gan to kagaku ryoho. Cancer & chemotherapy",
              "publication_date": "2017-May",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Cost-Benefit Analysis",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ]
            },
            {
              "pmid": "34145436",
              "title": "The prostate cancer drug market.",
              "abstract": null,
              "authors": [
                "Carolina do Pazo",
                "Rachel M Webster"
              ],
              "journal": "Nature reviews. Drug discovery",
              "publication_date": "2021-Sep",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Male",
                  "major_topic": false
                },
                {
                  "term": "Prognosis",
                  "major_topic": false
                },
                {
                  "term": "Prostatic Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Survival Rate",
                  "major_topic": false
                }
              ],
              "doi": "10.1038/d41573-021-00111-w"
            },
            {
              "pmid": "37164297",
              "title": "Next generation organoid engineering to replace animals in cancer drug testing.",
              "abstract": "Cancer therapies have several clinical challenges associated with them, namely treatment toxicity, treatment resistance and relapse. Due to factors ranging from patient profiles to the tumour microenvironment (TME), there are several hurdles to overcome in developing effective treatments that have low toxicity that can mitigate emergence of resistance and occurrence of relapse. De novo cancer development has the highest drug attrition rates with only 1 in 10,000 preclinical candidates reaching the market. To alleviate this high attrition rate, more mimetic and sustainable preclinical models that can capture the disease biology as in the patient, are required. Organoids and next generation 3D tissue engineering is an emerging area that aims to address this problem. Advancement of three-dimensional (3D) in vitro cultures into complex organoid models incorporating multiple cell types alongside acellular aspects of tissue microenvironments can provide a system for therapeutic testing. Development of microfluidic technologies have furthermore increased the biomimetic nature of these models. Additionally, 3D bio-printing facilitates generation of tractable ex vivo models in a controlled, scalable and reproducible manner. In this review we highlight some of the traditional preclinical models used in cancer drug testing and debate how next generation organoids are being used to replace not only animal models, but also some of the more elementary in vitro approaches, such as cell lines. Examples of applications of the various models will be appraised alongside the future challenges that still need to be overcome.",
              "authors": [
                "Sean Hockney",
                "Jessica Parker",
                "Jasmin E Turner",
                "Xanthea Todd",
                "Stephen Todryk",
                "Roben Ger Gieling",
                "Gerrit Hilgen",
                "Davina Camargo Madeira Simoes",
                "Deepali Pal"
              ],
              "journal": "Biochemical pharmacology",
              "publication_date": "2023-Jul",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Organoids",
                  "major_topic": false
                },
                {
                  "term": "Tissue Engineering",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.bcp.2023.115586"
            },
            {
              "pmid": "37762393",
              "title": "Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug.",
              "abstract": "Small extracellular vesicles (sEVs) are emerging as a novel therapeutic strategy for cancer therapy. Tumor-cell-derived sEVs contain biomolecules that can be utilized for cancer diagnosis. sEVs can directly exert tumor-killing effects or modulate the tumor microenvironment, leading to anti-cancer effects. In this review, the application of sEVs as a diagnostic tool, drug delivery system, and active pharmaceutical ingredient for cancer therapy will be highlighted. The therapeutic efficacies of sEVs will be compared to conventional immune checkpoint inhibitors. Additionally, this review will provide strategies for sEV engineering to enhance the therapeutic efficacies of sEVs. As a bench-to-bedside application, we will discuss approaches to encourage good-manufacturing-practice-compliant industrial-scale manufacturing and purification of sEVs.",
              "authors": [
                "Hyeon Su Joo",
                "Ju Hun Suh",
                "Chan Mi So",
                "Hye Jin Jeon",
                "Sol Hee Yoon",
                "Jung Min Lee"
              ],
              "journal": "International journal of molecular sciences",
              "publication_date": "2023-Sep-14",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Commerce",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Extracellular Vesicles",
                  "major_topic": true
                },
                {
                  "term": "Immune Checkpoint Inhibitors",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/ijms241814063"
            },
            {
              "pmid": "31558580",
              "title": "Challenges and Opportunities for Childhood Cancer Drug Development.",
              "abstract": "Cancer in children is rare with approximately 15,700 new cases diagnosed in the United States annually. Through use of multimodality therapy (surgery, radiation therapy, and aggressive chemotherapy), 70% of patients will be \"cured\" of their disease, and 5-year event-free survival exceeds 80%. However, for patients surviving their malignancy, therapy-related long-term adverse effects are severe, with an estimated 50% having chronic life-threatening toxicities related to therapy in their fourth or fifth decade of life. While overall intensive therapy with cytotoxic agents continues to reduce cancer-related mortality, new understanding of the molecular etiology of many childhood cancers offers an opportunity to redirect efforts to develop effective, less genotoxic therapeutic options, including agents that target oncogenic drivers directly, and the potential for use of agents that target the tumor microenvironment and immune-directed therapies. However, for many high-risk cancers, significant challenges remain.",
              "authors": [
                "Peter J Houghton",
                "Raushan T Kurmasheva"
              ],
              "journal": "Pharmacological reviews",
              "publication_date": "2019-Oct",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Child",
                  "major_topic": false
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.1124/pr.118.016972"
            },
            {
              "pmid": "38141188",
              "title": "The Impacts and Changes Related to the Cancer Drug Resistance Mechanism.",
              "abstract": "BACKGROUND: Cancer drug resistance remains a difficult barrier to effective treatment, necessitating a thorough understanding of its multi-layered mechanism. OBJECTIVE: This study aims to comprehensively explore the diverse mechanisms of cancer drug resistance, assess the evolution of resistance detection methods, and identify strategies for overcoming this challenge. The evolution of resistance detection methods and identification strategies for overcoming the challenge. METHODS: A comprehensive literature review was conducted to analyze intrinsic and acquired drug resistance mechanisms, including altered drug efflux, reduced uptake, inactivation, target mutations, signaling pathway changes, apoptotic defects, and cellular plasticity. The evolution of mutation detection techniques, encompassing clinical predictions, experimental approaches, and computational methods, was investigated. Strategies to enhance drug efficacy, modify pharmacokinetics, optimizoptimizee binding modes, and explore alternate protein folding states were examined. RESULTS: The study comprehensively overviews the intricate mechanisms contributing to cancer drug resistance. It outlines the progression of mutation detection methods and underscores the importance of interdisciplinary approaches. Strategies to overcome drug resistance challenges, such as modulating ATP-binding cassette transporters and developing multidrug resistance inhibitors, are discussed. The study underscores the critical need for continued research to enhance cancer treatment efficacy. CONCLUSION: This study provides valuable insights into the complexity of cancer drug resistance mechanisms, highlights evolving detection methods, and offers potential strategies to enhance treatment outcomes.",
              "authors": [
                "Prachi Varshney",
                "Vishal Sharma",
                "Devdhar Yadav",
                "Yogesh Kumar",
                "Amit Singh",
                "Naga Rani Kagithala",
                "Pramod Kumar Sharma",
                "Omji Porwal",
                "Neeraj Kumar Fuloria",
                "Pradeep Kumar Sharma",
                "Ashok Kumar Gupta",
                "Koteswara Rao Gsn"
              ],
              "journal": "Current drug metabolism",
              "publication_date": "2023",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Multiple",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "ATP-Binding Cassette Transporters",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Biological Transport",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                }
              ],
              "doi": "10.2174/0113892002266408231207150547"
            },
            {
              "pmid": "38336887",
              "title": "The colorectal cancer drug market.",
              "abstract": null,
              "authors": [
                "Laura Ramos Garc\u00eda",
                "Rachel M Webster"
              ],
              "journal": "Nature reviews. Drug discovery",
              "publication_date": "2024-Jun",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Colorectal Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                }
              ],
              "doi": "10.1038/d41573-024-00026-2"
            },
            {
              "pmid": "38984579",
              "title": "Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities.",
              "abstract": "One of the biggest obstacles to the treatment of diseases, particularly serious conditions like cancer, is therapeutic resistance. The process of drug resistance is influenced by a number of important variables, including MDR genes, drug efflux, low-quality medications, inadequate dosage, etc. Drug resistance must be addressed, and new combinations based on the pharmacokinetics/pharmacodynamics (PK-PD) characteristics of the partner pharmaceuticals must be developed in order to extend the half-lives of already available medications. The primary mechanism of drug elimination is hepatic biotransformation of medicines by cytochrome P450 (CYP) enzymes; of these CYPs, CYP3A4 makes up 30-40% of all known cytochromes that metabolize medications. Induction or inhibition of CYP3A4-mediated metabolism affects the pharmacokinetics of most anticancer drugs, but these details are not fully understood and highlighted because of the complexity of tumor microenvironments and various influencing patient related factors. The involvement of CYPs, particularly CYP3A4 and other drug-metabolizing enzymes, in cancer medication resistance will be covered in the current review.",
              "authors": [
                "Swaroop Kumar Pandey",
                "Sona Verma",
                "Shobha Upreti",
                "Anuja Mishra",
                "Neha Yadav",
                "Hemlata Dwivedi-Agnihotri"
              ],
              "journal": "Current drug metabolism",
              "publication_date": "2024",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Cytochrome P-450 CYP3A",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/0113892002312369240703102215"
            },
            {
              "pmid": "37269547",
              "title": "Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance.",
              "abstract": "Resistance to chemotherapy and targeted therapies constitute a common hallmark of most cancers and represent a dominant factor fostering tumor relapse and metastasis. Fibronectin, an abundant extracellular matrix glycoprotein, has long been proposed to play an important role in the pathobiology of cancer. Recent research has unraveled the role of Fibronectin in the onset of chemoresistance against a variety of antineoplastic drugs including DNA-damaging agents, hormone receptor antagonists, tyrosine kinase inhibitors, microtubule destabilizing agents, etc. The current review summarizes the role played by Fibronectin in mediating drug resistance against diverse anticancer drugs. We have also discussed how the aberrant expression of Fibronectin drives the oncogenic signaling pathways ultimately leading to drug resistance through the inhibition of apoptosis, promotion of cancer cell growth and proliferation.",
              "authors": [
                "Faizah Farooq",
                "Asif Amin",
                "Umer Majeed Wani",
                "Asif Lone",
                "Raies A Qadri"
              ],
              "journal": "Journal of cellular physiology",
              "publication_date": "2023-Aug",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Fibronectins",
                  "major_topic": false
                },
                {
                  "term": "Neoplasm Recurrence, Local",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": false
                },
                {
                  "term": "Apoptosis",
                  "major_topic": false
                }
              ],
              "doi": "10.1002/jcp.31048"
            },
            {
              "pmid": "23928289",
              "title": "Cancer drug discovery by repurposing: teaching new tricks to old dogs.",
              "abstract": "Progressively increasing failure rates, high cost, poor bioavailability, poor safety, limited efficacy, and a lengthy design and testing process associated with cancer drug development have necessitated alternative approaches to drug discovery. Exploring established non-cancer drugs for anticancer activity provides an opportunity rapidly to advance therapeutic strategies into clinical trials. The impetus for development of cancer therapeutics from non-cancer drugs stems from the fact that different diseases share common molecular pathways and targets in the cell. Common molecular origins of diverse diseases have been discovered through advancements in genomics, proteomics, and informatics technologies, as well as through the development of analytical tools that allow researchers simultaneously to screen large numbers of existing drugs against a particular disease target. Thus, drugs originally identified as antitussive, sedative, analgesic, antipyretic, antiarthritic, anesthetic, antidiabetic, muscle relaxant, immunosuppressant, antibiotic, antiepileptic, cardioprotective, antihypertensive, erectile function enhancing, or angina relieving are being repurposed for cancer. This review describes the repurposing of these drugs for cancer treatment.",
              "authors": [
                "Subash C Gupta",
                "Bokyung Sung",
                "Sahdeo Prasad",
                "Lauren J Webb",
                "Bharat B Aggarwal"
              ],
              "journal": "Trends in pharmacological sciences",
              "publication_date": "2013-Sep",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.tips.2013.06.005"
            },
            {
              "pmid": "32601104",
              "title": "Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.",
              "abstract": "Drug metabolism is a biotransformation process of drugs, catalyzed by drug-metabolizing enzymes (DMEs), including phase I DMEs and phase II DMEs. The aberrant expression of DMEs occurs in the different stages of cancer. It can contribute to the development of cancer and lead to individual variations in drug response by affecting the metabolic process of carcinogen and anticancer drugs. Apart from genetic polymorphisms, which we know the most about, current evidence indicates that epigenetic regulation is also central to the expression of DMEs. This review summarizes differentially expressed DMEs in cancer and related epigenetic changes, including DNA methylation, histone modification, and noncoding RNAs. Exploring the epigenetic regulation of differentially expressed DMEs can provide a basis for implementing individualized and rationalized medication. Meanwhile, it can promote the development of new biomarkers and targets for the diagnosis, treatment, and prognosis of cancer. SIGNIFICANCE STATEMENT: This review summarizes the aberrant expression of DMEs in cancer and the related epigenetic regulation of differentially expressed DMEs. Exploring the epigenetic regulatory mechanism of DMEs in cancer can help us to understand the role of DMEs in cancer progression and chemoresistance. Also, it provides a basis for developing new biomarkers and targets for the diagnosis, treatment, and prognosis of cancer.",
              "authors": [
                "Jiaqi Wang",
                "Lushan Yu",
                "Huidi Jiang",
                "Xiaoli Zheng",
                "Su Zeng"
              ],
              "journal": "Drug metabolism and disposition: the biological fate of chemicals",
              "publication_date": "2020-Sep",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "DNA Methylation",
                  "major_topic": false
                },
                {
                  "term": "Epigenesis, Genetic",
                  "major_topic": true
                },
                {
                  "term": "Gene Expression Regulation, Enzymologic",
                  "major_topic": true
                },
                {
                  "term": "Gene Expression Regulation, Neoplastic",
                  "major_topic": true
                },
                {
                  "term": "Histone Code",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Precision Medicine",
                  "major_topic": false
                },
                {
                  "term": "RNA, Untranslated",
                  "major_topic": false
                }
              ],
              "doi": "10.1124/dmd.120.000008"
            },
            {
              "pmid": "34994310",
              "title": "Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance.",
              "abstract": "Mathematical modelling of tumour mutation dynamics has suggested that cancer drug targets that have different resistance mechanisms should be good candidates for combination treatment. This is because the development of mutations that cause resistance to all drugs at once should arise relatively infrequently. However, it is difficult to identify drug targets fulfilling this requirement for particular cancers. Here we present four experimental criteria that we argue are necessary (but not sufficient) conditions that drug combinations should meet in order to be considered for combination drug treatment aimed at delaying or overcoming cancer drug resistance. We present the results of our own experiments - guided by these criteria - using anaplastic lymphoma kinase mutated lung cancer cells. Each set of experiments demonstrate results for different drug combinations. We conclude that the combination of ALK and MEK inhibitors come closest to meeting all our criteria.",
              "authors": [
                "Abigail R Bland",
                "Nensi Shrestha",
                "Maddie Berry",
                "Christabel Wilson",
                "John C Ashton"
              ],
              "journal": "Current cancer drug targets",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Carcinoma, Non-Small-Cell Lung",
                  "major_topic": true
                },
                {
                  "term": "Drug Combinations",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Lung Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Mutation",
                  "major_topic": false
                },
                {
                  "term": "Protein Kinase Inhibitors",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1568009622666220107152014"
            },
            {
              "pmid": "28346381",
              "title": "Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.",
              "abstract": "Chitosan is a versatile polysaccharide of biological origin. Due to the biocompatible and biodegradable nature of chitosan, it is intensively utilized in biomedical applications in scaffold engineering as an absorption enhancer, and for bioactive and controlled drug release. In cancer therapy, chitosan has multifaceted applications, such as assisting in gene delivery and chemotherapeutic delivery, and as an immunoadjuvant for vaccines. The present review highlights the recent applications of chitosan and chitosan derivatives in cancer therapy.",
              "authors": [
                "Anish Babu",
                "Rajagopal Ramesh"
              ],
              "journal": "Marine drugs",
              "publication_date": "2017-Mar-27",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Chitosan",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Gene Transfer Techniques",
                  "major_topic": false
                },
                {
                  "term": "Genetic Therapy",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/md15040096"
            },
            {
              "pmid": "34347041",
              "title": "Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects.",
              "abstract": "Drug combinations have exhibited promising therapeutic effects in treating cancer patients with less toxicity and adverse side effects. However, it is infeasible to experimentally screen the enormous search space of all possible drug combinations. Therefore, developing computational models to efficiently and accurately identify potential anti-cancer synergistic drug combinations has attracted a lot of attention from the scientific community. Hypothesis-driven explicit mathematical methods or network pharmacology models have been popular in the last decade and have been comprehensively reviewed in previous surveys. With the surge of artificial intelligence and greater availability of large-scale datasets, machine learning especially deep learning methods are gaining popularity in the field of computational models for anti-cancer drug synergy prediction. Machine learning-based methods can be derived without strong assumptions about underlying mechanisms and have achieved state-of-the-art prediction performances, promoting much greater growth of the field. Here, we present a structured overview of available large-scale databases and machine learning especially deep learning methods in computational predictive models for anti-cancer drug synergy prediction. We provide a unified framework for machine learning models and detail existing model architectures as well as their contributions and limitations, shedding light into the future design of computational models. Besides, unbiased experiments are conducted to provide in-depth comparisons between reviewed papers in terms of their prediction performance.",
              "authors": [
                "Kunjie Fan",
                "Lijun Cheng",
                "Lang Li"
              ],
              "journal": "Briefings in bioinformatics",
              "publication_date": "2021-Nov-05",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Datasets as Topic",
                  "major_topic": false
                },
                {
                  "term": "Drug Therapy, Combination",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": true
                }
              ],
              "doi": "10.1093/bib/bbab271"
            },
            {
              "pmid": "40414522",
              "title": "Role of artificial intelligence in cancer drug discovery and development.",
              "abstract": "The role of artificial intelligence (AI) in cancer drug discovery and development has garnered significant attention due to its potential to transform the traditionally time-consuming and expensive processes involved in bringing new therapies to market. AI technologies, such as machine learning (ML) and deep learning (DL), enable the efficient analysis of vast datasets, facilitate faster identification of drug targets, optimization of compounds, and prediction of clinical outcomes. This review explores the multifaceted applications of AI across various stages of cancer drug development, from early-stage discovery to clinical trial design, development. In early-stage discovery, AI-driven methods support target identification, virtual screening (VS), and molecular docking, offering precise predictions that streamline the identification of promising compounds. Additionally, AI is instrumental in de novo drug design and lead optimization, where algorithms can generate novel molecular structures and optimize their properties to enhance drug efficacy and safety profiles. Preclinical development benefits from AI's predictive modeling capabilities, particularly in assessing a drug's toxicity through in silico simulations. AI also plays a pivotal role in biomarker discovery, enabling the identification of specific molecular signatures that can inform patient stratification and personalized treatment approaches. In clinical development, AI optimizes trial design by leveraging real-world data (RWD), improving patient selection, and reducing the time required to bring new drugs to market. Despite its transformative potential, challenges remain, including issues related to data quality, model interpretability, and regulatory hurdles. Addressing these limitations is critical for fully realizing AI's potential in cancer drug discovery and development. As AI continues to evolve, its integration with other technologies, such as genomics and clustered regularly interspaced short palindromic repeats (CRISPR), holds promise for advancing personalized cancer therapies. This review provides a comprehensive overview of AI's impact on the cancer drug discovery and development and highlights future directions for this rapidly evolving field.",
              "authors": [
                "Sruthi Sarvepalli",
                "ShubhaDeepthi Vadarevu"
              ],
              "journal": "Cancer letters",
              "publication_date": "2025-Sep-01",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Artificial Intelligence",
                  "major_topic": true
                },
                {
                  "term": "Drug Development",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Design",
                  "major_topic": false
                },
                {
                  "term": "Deep Learning",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.canlet.2025.217821"
            },
            {
              "pmid": "35547744",
              "title": "CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives.",
              "abstract": "CRISPR-Cas9 is a Nobel Prize-winning robust gene-editing tool developed in the last decade. This technique enables a stable genetic engineering method with high precision on the genomes of all organisms. The latest advances in the technology include a genome library screening approach, which can detect survival-essential and drug resistance genes via gain or loss of function. The versatile machinery allows genomic screening for gene activation or inhibition, and targets non-coding sequences, such as promoters, miRNAs, and lncRNAs. In this review, we introduce the emerging high-throughput CRISPR-Cas9 library genome screening technology and its working principles to detect survival and drug resistance genes through positive and negative selection. The technology is compared with other existing approaches while focusing on the advantages of its variable applications in anti-cancer drug discovery, including functions and target identification, non-coding RNA information, actions of small molecules, and drug target discoveries. The combination of the CRISPR-Cas9 system with multi-omic platforms represents a dynamic field expected to advance anti-cancer drug discovery and precision medicine in the clinic.",
              "authors": [
                "Yau-Tuen Chan",
                "Yuanjun Lu",
                "Junyu Wu",
                "Cheng Zhang",
                "Hor-Yue Tan",
                "Zhao-Xiang Bian",
                "Ning Wang",
                "Yibin Feng"
              ],
              "journal": "Theranostics",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "CRISPR-Cas Systems",
                  "major_topic": false
                },
                {
                  "term": "Gene Editing",
                  "major_topic": false
                },
                {
                  "term": "Genetic Engineering",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.7150/thno.71144"
            },
            {
              "pmid": "37980599",
              "title": "Artificial intelligence for aging research in cancer drug development.",
              "abstract": null,
              "authors": [
                "Dorsa Shirini",
                "Lawrence H Schwartz",
                "Laurent Dercle"
              ],
              "journal": "Aging",
              "publication_date": "2023-Nov-18",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Artificial Intelligence",
                  "major_topic": false
                },
                {
                  "term": "Geroscience",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Development",
                  "major_topic": false
                }
              ],
              "doi": "10.18632/aging.204914"
            },
            {
              "pmid": "37843187",
              "title": "BMS Expands Cancer Drug Portfolio via Mirati.",
              "abstract": "Bristol Myers Squibb's acquisition of Mirati Therapeutics is poised to strengthen the former's position in the targeted therapy market, not only with the KRASG12C inhibitor adagrasib but also with Mirati's other assets, including a potential first-in-class PRMT5 inhibitor.",
              "authors": [],
              "journal": "Cancer discovery",
              "publication_date": "2023-Dec-12",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Protein-Arginine N-Methyltransferases",
                  "major_topic": false
                }
              ],
              "doi": "10.1158/2159-8290.CD-NB2023-0078"
            },
            {
              "pmid": "40132495",
              "title": "Mechanistic study of cancer drug delivery: Current techniques, limitations, and future prospects.",
              "abstract": "Cancer drug delivery remains a critical challenge with systemic toxicity, poor drug bioavailability, and a lack of effective targeting. Overcoming these barriers is essential for improving treatment efficacy and patient outcomes. This review discusses current drug delivery techniques that reshape cancer therapy by offering precise, controlled-release tailored to tumor-specific features. Innovations in nanotechnology, immunotherapy, and gene therapy enable interventions at molecular and cellular levels. Radiomics and pathomics integrate high-dimensional data to optimize diagnostics and treatment planning. Combination therapy addresses the complexities of tumor heterogeneity by synergizing multiple agents within a single therapeutic framework, while peptide-drug conjugates enhance specificity and potency. Hydrogel-based systems and microneedle arrays offer localized, sustained release, significantly improving therapeutic outcomes. However, clinical translation of these advancements faces significant barriers such as drug resistance, off-target effects, scalability, cost, and ethical concerns. Moreover, regulatory complexities and the economic feasibility of these therapies highlight the need for innovative frameworks to make them accessible globally. Therefore, there is a need for innovation in gene and cell therapy, next-generation drug delivery platforms, and personalized medicine. This review focuses on recent advancements in drug delivery techniques over the past decade, evaluating their limitations and exploring potential future directions for transforming cancer treatment.",
              "authors": [
                "Saiqa Imtiaz",
                "Umme Tamanna Ferdous",
                "Alexis Nizela",
                "Anwarul Hasan",
                "Adnan Shakoor",
                "Abdul Wasy Zia",
                "Shihab Uddin"
              ],
              "journal": "European journal of medicinal chemistry",
              "publication_date": "2025-Jun-05",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.ejmech.2025.117535"
            },
            {
              "pmid": "27455225",
              "title": "Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.",
              "abstract": "Epithelial-mesenchymal transition (EMT) is known to play an important role in cancer progression, metastasis and drug resistance. Although there are controversies surrounding the causal relationship between EMT and cancer metastasis, the role of EMT in cancer drug resistance has been increasingly recognized. Numerous EMT-related signaling pathways are involved in drug resistance in cancer cells. Cells undergoing EMT show a feature similar to cancer stem cells (CSCs), such as an increase in drug efflux pumps and anti-apoptotic effects. Therefore, targeting EMT has been considered a novel opportunity to overcome cancer drug resistance. This review describes the mechanism by which EMT contributes to drug resistance in cancer cells and summarizes new advances in research in EMT-associated drug resistance.",
              "authors": [
                "Bowen Du",
                "Joong Sup Shim"
              ],
              "journal": "Molecules (Basel, Switzerland)",
              "publication_date": "2016-Jul-22",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Epithelial-Mesenchymal Transition",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Neoplastic Stem Cells",
                  "major_topic": false
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/molecules21070965"
            },
            {
              "pmid": "31592751",
              "title": "Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - Part-II.",
              "abstract": null,
              "authors": [
                "Suman S Thakur"
              ],
              "journal": "Current topics in medicinal chemistry",
              "publication_date": "2019",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/156802661917190828111439"
            },
            {
              "pmid": "23802404",
              "title": "Nanomaterials in cancer-therapy drug delivery system.",
              "abstract": "Nanomaterials can enhance the delivery and treatment efficiency of anti-cancer drugs, and the mechanisms of the tumor-reducing activity of nanomaterials with cancer drug have been investigated. The task for drug to reach pathological areas has facilitated rapid advances in nanomedicine. Herein, we summarize promising findings with respect to cancer therapeutics based on nano-drug delivery vectors. Relatively high toxicity of uncoated nanoparticles restricts the use of these materials in humans. In order to reduce toxicity, many approaches have focused on the encapsulation of nanoparticles with biocompatible materials. Efficient delivery systems have been developed that utilized nanoparticles loaded with high dose of cancer drug in the presence of bilayer molecules. Well-established nanotechnologies have been designed for drug delivery with specific bonding. Surface-modified nanoparticles as vehicles for drug delivery system that contains multiple nano-components, each specially designed to achieve aimed task for the emerging application delivery of therapeutics. Drug-coated polymer nanoparticles could efficiently increase the intracellular accumulation of anti-cancer drugs. This review also introduces the nanomaterials with drug on the induction of apoptosis in cancer cells in vitro and in vivo. Direct interactions between the particles and cellular molecules to cause adverse biological responses are also discussed.",
              "authors": [
                "Gen Zhang",
                "Xin Zeng",
                "Ping Li"
              ],
              "journal": "Journal of biomedical nanotechnology",
              "publication_date": "2013-May",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Apoptosis",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Nanostructures",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1166/jbn.2013.1583"
            },
            {
              "pmid": "30555545",
              "title": "Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking ",
              "abstract": "For decades, scientists have been using two-dimensional cell culture platforms for high-throughput drug screening of anticancer drugs. Growing evidence indicates that the results of anti-cancer drug screening vary with the cell culture microenvironment, and this variation has been proposed as a reason for the high failure rate of clinical trials. Since the culture condition-dependent drug sensitivity of anti-cancer drugs may negatively impact the identification of clinically effective drug candidates, more reliable ",
              "authors": [
                "Yeonho Jo",
                "Nakwon Choi",
                "Kyobum Kim",
                "Hyung-Jun Koo",
                "Jonghoon Choi",
                "Hong Nam Kim"
              ],
              "journal": "Theranostics",
              "publication_date": "2018",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Cell Culture Techniques",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Drug Evaluation, Preclinical",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Models, Theoretical",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": true
                }
              ],
              "doi": "10.7150/thno.29098"
            },
            {
              "pmid": "25138827",
              "title": "The importance of nanoparticle shape in cancer drug delivery.",
              "abstract": "INTRODUCTION: Nanoparticles have been successfully used for cancer drug delivery since 1995. In the design of commercial nanoparticles, size and surface characteristics have been exploited to achieve efficacious delivery. However, the design of optimized drug delivery platforms for efficient delivery to disease sites with minimal off-target effects remains a major research goal. One crucial element of nanoparticle design influencing both pharmacokinetics and cell uptake is nanoparticle morphology (both size and shape). In this succinct review, the authors collate the recent literature to assess the current state of understanding of the influence of nanoparticle shape on the effectiveness of drug delivery with a special emphasis on cancer therapy. AREAS COVERED: This review draws on studies that have focused on the role of nonspherical nanoparticles used for cancer drug delivery. In particular, the authors summarize the influence of nanoparticle shape on biocirculation, biodistribution, cellular uptake and overall drug efficacy. By comparing spherical and nonspherical nanoparticles, they establish some general design principles to serve as guidelines for developing the next generation of nanocarriers for drug delivery. EXPERT OPINION: Pioneering studies on nanoparticles show that nonspherical shapes show great promise as cancer drug delivery vectors. Filamentous or worm-like micelles together with other rare morphologies such as needles or disks may become the norm for next-generation drug carriers, though at present, traditional spherical micelles remain the dominant shape of nanocarriers described in the literature due to synthesis and testing difficulties. The few reports that do exist describing nonspherical nanoparticles show a number of favorable properties that should encourage more efforts to develop facile and versatile nanoparticle synthesis methodologies with the flexibility to create different shapes, tunable sizes and adaptable surface chemistries. In addition, the authors note that there is a current lack of understanding into the factors governing (and optimizing) the inter-relationships of size, surface characteristics and shapes of many nanoparticles proposed for use in cancer therapy.",
              "authors": [
                "Nghia P Truong",
                "Michael R Whittaker",
                "Catherine W Mak",
                "Thomas P Davis"
              ],
              "journal": "Expert opinion on drug delivery",
              "publication_date": "2015-Jan",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biological Transport",
                  "major_topic": false
                },
                {
                  "term": "Drug Carriers",
                  "major_topic": false
                },
                {
                  "term": "Micelles",
                  "major_topic": false
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Structure-Activity Relationship",
                  "major_topic": false
                },
                {
                  "term": "Tissue Distribution",
                  "major_topic": false
                }
              ],
              "doi": "10.1517/17425247.2014.950564"
            },
            {
              "pmid": "25174652",
              "title": "Cancer drug resistance: old concept, novel solutions required.",
              "abstract": null,
              "authors": [
                "Daniel S Peeper"
              ],
              "journal": "Molecular oncology",
              "publication_date": "2014-Sep-12",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Epigenesis, Genetic",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.molonc.2014.07.026"
            },
            {
              "pmid": "28182263",
              "title": "High cancer drug prices 4 years later-Progress and prospects.",
              "abstract": null,
              "authors": [
                "Hagop Kantarjian",
                "Yogin Patel"
              ],
              "journal": "Cancer",
              "publication_date": "2017-Apr-15",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Costs",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1002/cncr.30545"
            },
            {
              "pmid": "37655591",
              "title": "Recent Advances and Perspectives in Cancer Drug Design.",
              "abstract": null,
              "authors": [
                "Irena Kostova"
              ],
              "journal": "Current pharmaceutical design",
              "publication_date": "2023",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.2174/138161282922230822111237"
            },
            {
              "pmid": "41014361",
              "title": "Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer.",
              "abstract": "PURPOSE: This systematic review investigates drug repurposing as a strategy to accelerate and improve cancer treatment by specifically examining how existing medications can effectively target the established hallmarks of cancer. The research explores how repurposed drugs can address the challenges of conventional cancer drug development, including high costs, lengthy development timelines, and frequent clinical failures. METHODS: The review systematically analyzes repurposed drugs with their ability to target specific cancer hallmarks, including oncogenic signaling pathways, cell death regulation, metabolic reprogramming, growth suppressor reactivation, phenotypic plasticity, antitumor immunity, telomerase activity, angiogenesis, inflammation, cellular senescence, invasion and metastasis, DNA damage response, microbiome modulation, and epigenetic regulation. RESULTS: The analysis identified several promising repurposed medications targeting specific cancer hallmarks: artemisinin derivatives for oncogenic signalling, niclosamide for cell death pathways, leflunomide for metabolic dysregulation, statins for tumour suppressor reactivation, metformin for phenotypic plasticity, liothyronine for immune activation, PARP inhibitors for replication, itraconazole for angiogenesis, celecoxib for inflammation, BCL-2 inhibitors for senescence, fluoroquinolones for metastasis, spironolactone for DNA damage, isoliquiritigenin for microbiome modulation, and various agents targeting non-mutational epigenetic regulation. CONCLUSION: Drug repurposing represents an intriguing approach for addressing the limitations of traditional cancer drug development while effectively targeting the fundamental hallmarks of cancer. By leveraging existing medications with established safety profiles, this strategy offers potential for more rapid translation to clinical applications and may enhance the therapeutic arsenal against various cancer types.",
              "authors": [
                "Yarava Dhanush",
                "Vakkalagadda Siva Ganesh"
              ],
              "journal": "Cancer chemotherapy and pharmacology",
              "publication_date": "2025-Sep-27",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Repositioning",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1007/s00280-025-04822-4"
            },
            {
              "pmid": "34994266",
              "title": "The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition.",
              "abstract": "The acquisition of resistance and ultimately disease relapse after initial response to chemotherapy put obstacles in the way of cancer therapy. Epithelial-mesenchymal transition (EMT) is a biologic process that epithelial cells alter to mesenchymal cells and acquire fibroblast-like properties. EMT plays a significant role in cancer metastasis, motility, and survival. Recently, emerging evidence suggested that EMT pathways are very important in making drug-resistant involved in cancer. Natural products are gradually emerging as a valuable source of safe and effective anticancer compounds. Natural products could interfere with the different processes implicated in cancer drug resistance by reversing the EMT process. In this review, we illustrate the molecular mechanisms of EMT in the emergence of cancer metastasis. We then present the role of natural compounds in the suppression of EMT pathways in different cancers to overcome cancer cell drug resistance and improve tumor chemotherapy. HighlightsDrug-resistance is one of the obstacles to cancer treatment.EMT signaling pathways have been correlated to tumor invasion, metastasis, and drug-resistance.Various studies on the relationship between EMT and resistance to chemotherapy agents were reviewed.Different anticancer natural products with EMT inhibitory properties and drug resistance reversal effects were compared.",
              "authors": [
                "Asefeh Dahmardeh Ghalehno",
                "Arad Boustan",
                "Hakimeh Abdi",
                "Zahra Aganj",
                "Fatemeh Mosaffa",
                "Khadijeh Jamialahmadi"
              ],
              "journal": "Nutrition and cancer",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Biological Products",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Epithelial-Mesenchymal Transition",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1080/01635581.2021.2022169"
            },
            {
              "pmid": "40605007",
              "title": "Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance.",
              "abstract": "Drug resistance poses a significant challenge in cancer therapy, contributing to rapid recurrence, disease progression, and high patient mortality. Despite its critical impact, few reliable predictors for cancer drug response or failure have been established for clinical application. Tumor heterogeneity and the tumor microenvironment (TME) are pivotal factors influencing cancer drug efficacy and resistance. Tumor heterogeneity leads to variable therapeutic responses among patients, while dynamic interactions between cancer cells and the TME enhance tumor survival and proliferation, underscoring the urgent need to identify cellular hallmarks for predicting drug response and resistance. Single-cell and spatial omics technologies provide high-resolution insights into gene expression at the individual cell level, capturing intercellular heterogeneity and revealing the underlying pathologies, mechanisms, and cellular interactions. This review delves into the principles, methodologies, and workflows of single-cell and spatial omics in cancer drug research, highlighting key hallmarks involving tumor heterogeneity, TME reprogramming, cell-cell interactions, metabolic modulation, and signaling pathway regulation in drug treatment at single-cell and spatial levels. Furthermore, we synthesize predictive cellular biomarkers for cancer drug response and resistance across 25 cancer types, paving the way for advancements in cancer precision medicine.",
              "authors": [
                "Xiaoxia Cheng",
                "Ting Peng",
                "Tian Chu",
                "Yiqun Yang",
                "Jia Liu",
                "Qinglei Gao",
                "Canhui Cao",
                "Juncheng Wei"
              ],
              "journal": "Journal of hematology & oncology",
              "publication_date": "2025-Jul-02",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Single-Cell Analysis",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Biomarkers, Tumor",
                  "major_topic": false
                },
                {
                  "term": "Genomics",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.1186/s13045-025-01722-1"
            },
            {
              "pmid": "26514196",
              "title": "Toward a Better Understanding of the Complexity of Cancer Drug Resistance.",
              "abstract": "Resistance to anticancer drugs is a complex process that results from alterations in drug targets; development of alternative pathways for growth activation; changes in cellular pharmacology, including increased drug efflux; regulatory changes that alter differentiation pathways or pathways for response to environmental adversity; and/or changes in the local physiology of the cancer, such as blood supply, tissue hydrodynamics, behavior of neighboring cells, and immune system response. All of these specific mechanisms are facilitated by the intrinsic hallmarks of cancer, such as tumor cell heterogeneity, redundancy of growth-promoting pathways, increased mutation rate and/or epigenetic alterations, and the dynamic variation of tumor behavior in time and space. Understanding the relative contribution of each of these factors is further complicated by the lack of adequate in vitro models that mimic clinical cancers. Several strategies to use current knowledge of drug resistance to improve treatment of cancer are suggested.",
              "authors": [
                "Michael M Gottesman",
                "Orit Lavi",
                "Matthew D Hall",
                "Jean-Pierre Gillet"
              ],
              "journal": "Annual review of pharmacology and toxicology",
              "publication_date": "2016",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1146/annurev-pharmtox-010715-103111"
            },
            {
              "pmid": "33152247",
              "title": "Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling.",
              "abstract": "Drug resistance has profoundly limited the success of cancer treatment, driving relapse, metastasis, and mortality. Nearly all anticancer drugs and even novel immunotherapies, which recalibrate the immune system for tumor recognition and destruction, have succumbed to resistance development. Engineers have emerged across mechanical, physical, chemical, mathematical, and biological disciplines to address the challenge of drug resistance using a combination of interdisciplinary tools and skill sets. This review explores the developing, complex, and under-recognized role of engineering in medicine to address the multitude of challenges in cancer drug resistance. Looking through the \"lens\" of intrinsic, extrinsic, and drug-induced resistance (also referred to as \"tolerance\"), we will discuss three specific areas where active innovation is driving novel treatment paradigms: (1) nanotechnology, which has revolutionized drug delivery in desmoplastic tissues, harnessing physiochemical characteristics to destroy tumors through photothermal therapy and rationally designed nanostructures to circumvent cancer immunotherapy failures, (2) bioengineered tumor models, which have benefitted from microfluidics and mechanical engineering, creating a paradigm shift in physiologically relevant environments to predict clinical refractoriness and enabling platforms for screening drug combinations to thwart resistance at the individual patient level, and (3) computational and mathematical modeling, which blends in silico simulations with molecular and evolutionary principles to map mutational patterns and model interactions between cells that promote resistance. On the basis that engineering in medicine has resulted in discoveries in resistance biology and successfully translated to clinical strategies that improve outcomes, we suggest the proliferation of multidisciplinary science that embraces engineering.",
              "authors": [
                "Morgan Craig",
                "Adrianne L Jenner",
                "Bumseok Namgung",
                "Luke P Lee",
                "Aaron Goldman"
              ],
              "journal": "Chemical reviews",
              "publication_date": "2021-Mar-24",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Computer Simulation",
                  "major_topic": false
                },
                {
                  "term": "Drug Compounding",
                  "major_topic": false
                },
                {
                  "term": "Drug Liberation",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Immunotherapy",
                  "major_topic": false
                },
                {
                  "term": "Microfluidics",
                  "major_topic": false
                },
                {
                  "term": "Nanocapsules",
                  "major_topic": false
                },
                {
                  "term": "Nanotechnology",
                  "major_topic": false
                },
                {
                  "term": "Pharmaceutical Preparations",
                  "major_topic": false
                },
                {
                  "term": "Precision Medicine",
                  "major_topic": false
                }
              ],
              "doi": "10.1021/acs.chemrev.0c00356"
            },
            {
              "pmid": "39744692",
              "title": "Targeting ion channels: innovative approaches to combat cancer drug resistance.",
              "abstract": "Ion channels, as functional molecules that regulate the flow of ions across cell membranes, have emerged as a promising target in cancer therapy due to their pivotal roles in cell proliferation, metastasis, apoptosis, drug resistance, and so on. Recently, increasing evidence suggests that dysregulation of ion channels is a common characteristic of cancer cells, contributing to their survival and the resistance to conventional therapies. For example, the aberrant expression of sodium (Na",
              "authors": [
                "Qian Shi",
                "Zijing Yang",
                "Huan Yang",
                "Lihui Xu",
                "Jing Xia",
                "Jie Gu",
                "Mengting Chen",
                "Yan Wang",
                "Xiaohong Zhao",
                "Zehua Liao",
                "Yiping Mou",
                "Xidong Gu",
                "Tian Xie",
                "Xinbing Sui"
              ],
              "journal": "Theranostics",
              "publication_date": "2025",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Ion Channels",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Animals",
                  "major_topic": false
                }
              ],
              "doi": "10.7150/thno.103384"
            },
            {
              "pmid": "25385142",
              "title": "Cancer drug delivery: considerations in the rational design of nanosized bioconjugates.",
              "abstract": "In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody-drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing specific design characteristics of the bioconjugate such as its size, the nature of the payload, and the surface features. The delivery of macromolecular drugs to cancers largely relies on the leaky nature of the tumor vasculature compared with healthy vessels in normal organs. When administered intravenously, macromolecular bioconjugates and nanosized agents tend to circulate for prolonged times, unless they are small enough to be excreted by the kidney or stealthy enough to evade the macrophage phagocytic system (MPS), formerly the reticulo-endothelial system (RES). Therefore, macromolecular bioconjugates and nanosized agents with long circulation times leak preferentially into tumor tissue through permeable tumor vessels and are then retained in the tumor bed due to reduced lymphatic drainage. This process is known as the enhanced permeability and retention (EPR) effect. However, success of cancer drug delivery only relying on the EPR effect is still limited. To cure cancer patients, further improvement of drug delivery is required by both designing superior agents and enhancing EPR effects. In this Review, we describe the basis of macromolecular or nanosized bioconjugate delivery into cancer tissue and discuss current diagnostic methods for evaluating leakiness of the tumor vasculature. Then, we discuss methods to augment conventional \"permeability and retention\" effects for macromolecular or nanosized bioconjugates in cancer tissue.",
              "authors": [
                "Hisataka Kobayashi",
                "Baris Turkbey",
                "Rira Watanabe",
                "Peter L Choyke"
              ],
              "journal": "Bioconjugate chemistry",
              "publication_date": "2014-Dec-17",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Nanostructures",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1021/bc500481x"
            },
            {
              "pmid": "38811639",
              "title": "Reliable anti-cancer drug sensitivity prediction and prioritization.",
              "abstract": "The application of machine learning (ML) to solve real-world problems does not only bear great potential but also high risk. One fundamental challenge in risk mitigation is to ensure the reliability of the ML predictions, i.e., the model error should be minimized, and the prediction uncertainty should be estimated. Especially for medical applications, the importance of reliable predictions can not be understated. Here, we address this challenge for anti-cancer drug sensitivity prediction and prioritization. To this end, we present a novel drug sensitivity prediction and prioritization approach guaranteeing user-specified certainty levels. The developed conformal prediction approach is applicable to classification, regression, and simultaneous regression and classification. Additionally, we propose a novel drug sensitivity measure that is based on clinically relevant drug concentrations and enables a straightforward prioritization of drugs for a given cancer sample.",
              "authors": [
                "Kerstin Lenhof",
                "Lea Eckhart",
                "Lisa-Marie Rolli",
                "Andrea Volkamer",
                "Hans-Peter Lenhof"
              ],
              "journal": "Scientific reports",
              "publication_date": "2024-May-29",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Reproducibility of Results",
                  "major_topic": false
                }
              ],
              "doi": "10.1038/s41598-024-62956-6"
            },
            {
              "pmid": "26799671",
              "title": "Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer.",
              "abstract": "INTRODUCTION: Drug resistance is the major obstacle impeding the efficacy of chemotherapeutic agents. Although numerous drug delivery techniques have been developed to combat drug resistance, their limitations of non-specific targeting and inconsistent bioavailability has led to the search of novel delivering strategies, such as nanoparticles. AREAS COVERED: Nanoparticles for anti-cancer drug delivery are microscopic preparations encapsulating a chemotherapeutic and a chemosensitizer into a rationally designed drug delivery vehicle. Nano-strategies directed against multi-drug resistance (MDR) can be categorized into those inhibiting the drug efflux pumps, those effective against the cellular factors of drug resistance, and the combinational based strategies. Here, we review the most recent literature to reposition nanoparticles as chemotherapeutics and inhibitors of MDR. EXPERT OPINION: Novelty in anti-cancer drug delivery has led to the formulation of chemotherapeutics and MDR inhibitors as nano-preparations, which are multi-functional and have better tumor cell-targeting effects. Their characteristics of size and surface attachments make them readily diffusible through the tumor vasculature and increase their retention time as well. With a better understanding of the molecular mechanisms of drug resistance, more potent and multi-targeted nano-preparations can be formulated in the near future.",
              "authors": [
                "Pranav Gupta",
                "Khushboo A Jani",
                "Dong-Hua Yang",
                "Mostafa Sadoqi",
                "Emilio Squillante",
                "Zhe-Sheng Chen"
              ],
              "journal": "Expert opinion on drug metabolism & toxicology",
              "publication_date": "2016",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biological Availability",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Drug Design",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Multiple",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Particle Size",
                  "major_topic": false
                }
              ],
              "doi": "10.1517/17425255.2016.1145655"
            },
            {
              "pmid": "19442046",
              "title": "Mechanisms of drug sensitivity and resistance in cancer.",
              "abstract": null,
              "authors": [
                "Lorraine O'Driscoll"
              ],
              "journal": "Current cancer drug targets",
              "publication_date": "2009-May",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Leukemia",
                  "major_topic": false
                },
                {
                  "term": "Lymphoma",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Phenotype",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/156800909788166510"
            },
            {
              "pmid": "11818492",
              "title": "Mechanisms of cancer drug resistance.",
              "abstract": "The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumors, even those from the same tissue of origin. Frequently resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anticancer drugs from cells, but other mechanisms of resistance including insensitivity to drug-induced apoptosis and induction of drug-detoxifying mechanisms probably play an important role in acquired anticancer drug resistance. Studies on mechanisms of cancer drug resistance have yielded important information about how to circumvent this resistance to improve cancer chemotherapy and have implications for pharmacokinetics of many commonly used drugs.",
              "authors": [
                "Michael M Gottesman"
              ],
              "journal": "Annual review of medicine",
              "publication_date": "2002",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Apoptosis",
                  "major_topic": false
                },
                {
                  "term": "Cell Survival",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Inactivation, Metabolic",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1146/annurev.med.53.082901.103929"
            },
            {
              "pmid": "39893749",
              "title": "The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond.",
              "abstract": "Extracellular vesicles (EVs) are heterogeneous vesicles released by donor cells that can be taken up by recipient cells, thus inducing cellular phenotype changes. Since their discovery decades ago, roles of EVs in modulating initiation, growth, survival and metastasis of cancer have been revealed. Recent studies from multifaceted perspectives have further detailed the contribution of EVs to cancer drug resistance; however, the role of EV uptake in conferring drug resistance seems to be overlooked. In this comprehensive review, we update the EV subtypes and approaches for determining EV uptake. The biological basis of EV uptake is systematically summarized. Moreover, we focus on the diverse uptake mechanisms by which EVs carry out the intracellular delivery of functional molecules and drug resistance signaling. Furthermore, we highlight how EV uptake confers drug resistance and identify potential strategies for targeting EV uptake to overcome drug resistance. Finally, we discuss the research gap on the role of EV uptake in promoting drug resistance. This updated knowledge provides a new avenue to overcome cancer drug resistance by targeting EV uptake.",
              "authors": [
                "Luomeng Qian",
                "Pangzhou Chen",
                "Shiwu Zhang",
                "Zhenglu Wang",
                "Yuan Guo",
                "Vasili Koutouratsas",
                "Joshua S Fleishman",
                "Chuanqiang Huang",
                "Sihe Zhang"
              ],
              "journal": "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",
              "publication_date": "2025-Mar",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Extracellular Vesicles",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": false
                },
                {
                  "term": "Biological Transport",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.drup.2025.101209"
            },
            {
              "pmid": "37957922",
              "title": "Empowering the Battle: Bioenhancers as Allies Against Cancer Drug Resistance.",
              "abstract": "BACKGROUND: Drug resistance has been a great hindrance in the path of counteracting diseases like cancer and is driven by drugs misuse and overuse. In terms of cancer, resistance has been developed due to cellular changes, altered growth activation pathways, increased expression of efflux proteins, and changes in the local physiology of cancer (blood supply, tissue hydrodynamics, increased mutation rate/epigenetics, tumor cell heterogeneity). One of the approaches to address these challenges is the use of bioenhancers, which can overcome drug resistance, thereby improving bioavailability (BA). CONCLUSION: Bioenhancers when combined with drugs can elicit pharmacological activity. They are generally combined with therapeutic agents at low doses, which increase the BA or therapeutic activity of active pharmaceutical ingredient (API). This review sheds light on the synthesis and classification of bio-enhancers. It also discusses different applications of bio-enhancers like piperine, ginger, quercetin, curcumin, etc. in the treatment of cancer. The review also presents some of the recent advancements in terms of nanocarriers for delivering API combined with bioenhancers.",
              "authors": [
                "Pratiksha Vasant Jadhav",
                "Naga Jothi Prasath",
                "Saurabh Ghannil Gajbhiye",
                "Utkarsha Arun Rane",
                "Tejas Girish Agnihotri",
                "Shyam Sudhakar Gomte",
                "Aakanchha Jain"
              ],
              "journal": "Current pharmaceutical biotechnology",
              "publication_date": "2024",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Biological Availability",
                  "major_topic": false
                },
                {
                  "term": "Drug Carriers",
                  "major_topic": false
                },
                {
                  "term": "Bioenhancers",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/0113892010192038231107051715"
            },
            {
              "pmid": "36333480",
              "title": "FDA releases tissue-agnostic cancer drug draft guidance.",
              "abstract": null,
              "authors": [
                "Asher Mullard"
              ],
              "journal": "Nature reviews. Drug discovery",
              "publication_date": "2022-Dec",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "United States",
                  "major_topic": false
                },
                {
                  "term": "United States Food and Drug Administration",
                  "major_topic": false
                },
                {
                  "term": "Drug Approval",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1038/d41573-022-00187-y"
            },
            {
              "pmid": "35348595",
              "title": "DeepTTA: a transformer-based model for predicting cancer drug response.",
              "abstract": "Identifying new lead molecules to treat cancer requires more than a decade of dedicated effort. Before selected drug candidates are used in the clinic, their anti-cancer activity is generally validated by in vitro cellular experiments. Therefore, accurate prediction of cancer drug response is a critical and challenging task for anti-cancer drugs design and precision medicine. With the development of pharmacogenomics, the combination of efficient drug feature extraction methods and omics data has made it possible to use computational models to assist in drug response prediction. In this study, we propose DeepTTA, a novel end-to-end deep learning model that utilizes transformer for drug representation learning and a multilayer neural network for transcriptomic data prediction of the anti-cancer drug responses. Specifically, DeepTTA uses transcriptomic gene expression data and chemical substructures of drugs for drug response prediction. Compared to existing methods, DeepTTA achieved higher performance in terms of root mean square error, Pearson correlation coefficient and Spearman's rank correlation coefficient on multiple test sets. Moreover, we discovered that anti-cancer drugs bortezomib and dactinomycin provide a potential therapeutic option with multiple clinical indications. With its excellent performance, DeepTTA is expected to be an effective method in cancer drug design.",
              "authors": [
                "Likun Jiang",
                "Changzhi Jiang",
                "Xinyu Yu",
                "Rao Fu",
                "Shuting Jin",
                "Xiangrong Liu"
              ],
              "journal": "Briefings in bioinformatics",
              "publication_date": "2022-May-13",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Neural Networks, Computer",
                  "major_topic": false
                },
                {
                  "term": "Precision Medicine",
                  "major_topic": false
                },
                {
                  "term": "Transcriptome",
                  "major_topic": false
                }
              ],
              "doi": "10.1093/bib/bbac100"
            },
            {
              "pmid": "28875739",
              "title": "Promising effects of nanomedicine in cancer drug delivery.",
              "abstract": "Successful ushering of nanomedicine has shown immense potential in advancing cancer treatment regimens. The unique characteristics of nanoparticles such as their optimal size, shape, efficient surface to volume ratio, surfaces that can be optimally tailored make them very attractive delivery candidates for highly hydrophobic chemotherapeutic agents. Moreover, their inherent capacity to encapsulate these drugs and enhance their solubility profiles offers them unique advantages over conventional treatments. Surface modification with targeting ligands, increased intracellular uptake and prolonged circulation profiles in vivo establish their overall superiority over other treatment regimens. This article attempts to highlight some of these salient features of nanoparticles as drug delivery agents, which makes them more attractive in terms of providing promising opportunities in targeted drug delivery.",
              "authors": [
                "Rajesh R Wakaskar"
              ],
              "journal": "Journal of drug targeting",
              "publication_date": "2018-Apr",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Hydrophobic and Hydrophilic Interactions",
                  "major_topic": false
                },
                {
                  "term": "Nanomedicine",
                  "major_topic": false
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Particle Size",
                  "major_topic": false
                },
                {
                  "term": "Solubility",
                  "major_topic": false
                }
              ],
              "doi": "10.1080/1061186X.2017.1377207"
            },
            {
              "pmid": "36715269",
              "title": "DROEG: a method for cancer drug response prediction based on omics and essential genes integration.",
              "abstract": "Predicting therapeutic responses in cancer patients is a major challenge in the field of precision medicine due to high inter- and intra-tumor heterogeneity. Most drug response models need to be improved in terms of accuracy, and there is limited research to assess therapeutic responses of particular tumor types. Here, we developed a novel method DROEG (Drug Response based on Omics and Essential Genes) for prediction of drug response in tumor cell lines by integrating genomic, transcriptomic and methylomic data along with CRISPR essential genes, and revealed that the incorporation of tumor proliferation essential genes can improve drug sensitivity prediction. Concisely, DROEG integrates literature-based and statistics-based methods to select features and uses Support Vector Regression for model construction. We demonstrate that DROEG outperforms most state-of-the-art algorithms by both qualitative (prediction accuracy for drug-sensitive/resistant) and quantitative (Pearson correlation coefficient between the predicted and actual IC50) evaluation in Genomics of Drug Sensitivity in Cancer and Cancer Cell Line Encyclopedia datasets. In addition, DROEG is further applied to the pan-gastrointestinal tumor with high prevalence and mortality as a case study at both cell line and clinical levels to evaluate the model efficacy and discover potential prognostic biomarkers in Cisplatin and Epirubicin treatment. Interestingly, the CRISPR essential gene information is found to be the most important contributor to enhance the accuracy of the DROEG model. To our knowledge, this is the first study to integrate essential genes with multi-omics data to improve cancer drug response prediction and provide insights into personalized precision treatment.",
              "authors": [
                "Peike Wu",
                "Renliang Sun",
                "Aamir Fahira",
                "Yongzhou Chen",
                "Huiting Jiangzhou",
                "Ke Wang",
                "Qiangzhen Yang",
                "Yang Dai",
                "Dun Pan",
                "Yongyong Shi",
                "Zhuo Wang"
              ],
              "journal": "Briefings in bioinformatics",
              "publication_date": "2023-Mar-19",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Genes, Essential",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Genomics",
                  "major_topic": false
                },
                {
                  "term": "Precision Medicine",
                  "major_topic": false
                }
              ],
              "doi": "10.1093/bib/bbad003"
            },
            {
              "pmid": "38064014",
              "title": "Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.",
              "abstract": "Drug repurposing of widely prescribed patent-off and cheap drugs may provide affordable drugs for cancer treatment. Nevertheless, many preclinical studies of cancer drug repurposing candidates use in vitro drug concentrations too high to have clinical relevance. Hence, preclinical studies must use clinically achievable drug concentrations. In this work, several FDA-approved cancer drugs are analyzed regarding the correlation between the drug inhibitory concentrations 50% (IC",
              "authors": [
                "Benjamin Robles-Ba\u00f1uelos",
                "Adriana Romo-Perez",
                "Guadalupe Dominguez-Gomez",
                "Alma Chavez-Blanco",
                "Aurora Gonzalez-Fierro",
                "Alfonso Duenas-Gonzalez"
              ],
              "journal": "Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico",
              "publication_date": "2024-May",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Drug Repositioning",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                }
              ],
              "doi": "10.1007/s12094-023-03352-w"
            },
            {
              "pmid": "18045192",
              "title": "Valproic acid as anti-cancer drug.",
              "abstract": "The short chain fatty acid valproic acid (VPA, 2-propylpetanoic acid) is approved for the treatment of epilepsia, bipolar disorders and migraine and clinically used for schizophrenia. In 1999, the first clinical anti-cancer trial using VPA was initiated. Currently, VPA is examined in numerous clinical trials for different leukaemias and solid tumour entities. In addition to clinical assessment, the experimental examination of VPA as anti-cancer drug is ongoing and many questions remain unanswered. Although other mechanisms may also contribute to VPA-induced anti-cancer effects, inhibition of histone deacetylases appears to play a central role. This review focuses on recent developments regarding the anti-cancer activity of VPA.",
              "authors": [
                "Martin Michaelis",
                "Hans Wilhelm Doerr",
                "Jindrich Cinatl"
              ],
              "journal": "Current pharmaceutical design",
              "publication_date": "2007",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Anticonvulsants",
                  "major_topic": false
                },
                {
                  "term": "Antimanic Agents",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Clinical Trials as Topic",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Valproic Acid",
                  "major_topic": false
                }
              ]
            },
            {
              "pmid": "29332566",
              "title": "Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release.",
              "abstract": "Conventional drugs used for cancer chemotherapy have severe toxic side effects and show individually varied therapeutic responses. The convergence of nanotechnology, biology, material science and pharmacy offers a perspective strategy for cancer chemotherapy. Nanoparticles loaded with anti-cancer drug have been designed to overcome the limitations associated with conventional drugs, several nanomedicines have been approved by FDA and shown good performances in clinical practice. However, the therapeutic efficacies cannot be enhanced. Taking this into account, stimuli responsive nanoparticles present the ability to enhance therapeutic efficacy and reduce side effects. In this review, we systematically summarized the recent progresses of controlled anti-cancer drug release systems based on nanoparticles with different stimuli response including pH, temperature, light, redox and others. If the achievements of the past can be extrapolated into the future, it is highly likely that responsive nanoparticles with a wide array of desirable properties can be eventually developed for safe and efficient cancer therapy.",
              "authors": [
                "Qi Tang",
                "Bing Yu",
                "Lilong Gao",
                "Hailin Cong",
                "Na Song",
                "Chenghao Lu"
              ],
              "journal": "Current medicinal chemistry",
              "publication_date": "2018",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biological Availability",
                  "major_topic": false
                },
                {
                  "term": "Delayed-Action Preparations",
                  "major_topic": false
                },
                {
                  "term": "Drug Carriers",
                  "major_topic": false
                },
                {
                  "term": "Drug Liberation",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Nanoparticles",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Oxidation-Reduction",
                  "major_topic": false
                },
                {
                  "term": "Particle Size",
                  "major_topic": false
                },
                {
                  "term": "Permeability",
                  "major_topic": false
                },
                {
                  "term": "Surface Properties",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/0929867325666180111095913"
            },
            {
              "pmid": "15864266",
              "title": "Cancer drug discovery through collaboration.",
              "abstract": "It has been two decades since cancer was first described as a genetic disease and researchers offered the promise of early diagnosis and targeted therapies. Today, most cancer patients still await life-saving treatments. Genomics and other '-omics' technologies have revealed a complexity among cancers that makes almost any tumour genetically unique; as a consequence, effective targeted therapies might be suitable only for small subgroups of patients. We suggest that by merging and organizing their core competencies, academia, biotechnology companies and the pharmaceutical industry can address existing bottlenecks in anticancer drug discovery and development.",
              "authors": [
                "Christoph Lengauer",
                "Luis A Diaz",
                "Saurabh Saha"
              ],
              "journal": "Nature reviews. Drug discovery",
              "publication_date": "2005-May",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Chemistry, Pharmaceutical",
                  "major_topic": false
                },
                {
                  "term": "Cooperative Behavior",
                  "major_topic": true
                },
                {
                  "term": "Drug Design",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1038/nrd1722"
            },
            {
              "pmid": "34112067",
              "title": "The Epigenetic Factors that Drive Cancer Drug Resistance.",
              "abstract": null,
              "authors": [
                "Manny D Bacolod"
              ],
              "journal": "Current cancer drug targets",
              "publication_date": "2021",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Epigenesis, Genetic",
                  "major_topic": false
                },
                {
                  "term": "Gene Expression Regulation, Neoplastic",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/156800962104210527150438"
            },
            {
              "pmid": "32428714",
              "title": "Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery.",
              "abstract": "Cancer cells exhibit molecular characteristics that confer them different proliferative capacities and survival advantages to adapt to stress conditions, such as deregulation of cellular bioenergetics, genomic instability, ability to promote angiogenesis, invasion, cell dormancy, immune evasion, and cell death resistance. In addition to these hallmarks of cancer, the current cytostatic drugs target the proliferation of malignant cells, being ineffective in metastatic disease. These aspects highlight the need to identify promising therapeutic targets for new generations of anti-cancer drugs. Toxins isolated from snake venoms are a natural source of useful molecular scaffolds to obtain agents with a selective effect on cancer cells. In this article, we discuss the recent advances in the molecular mechanisms of nine classes of snake toxins that suppress the hallmarks of cancer by induction of oxidative phosphorylation dysfunction, reactive oxygen species-dependent DNA damage, blockage of extracellular matrix-integrin signaling, disruption of cytoskeleton network and inhibition of growth factor-dependent signaling. The possible therapeutic implications of toxin-based anti-cancer drug development are also highlighted.",
              "authors": [
                "F\u00e9lix A Urra",
                "Ramiro Araya-Maturana"
              ],
              "journal": "Seminars in cancer biology",
              "publication_date": "2022-May",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Carcinogenesis",
                  "major_topic": false
                },
                {
                  "term": "Cell Transformation, Neoplastic",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Snake Venoms",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.semcancer.2020.05.006"
            },
            {
              "pmid": "39101498",
              "title": "Trust me if you can: a survey on reliability and interpretability of machine learning approaches for drug sensitivity prediction in cancer.",
              "abstract": "With the ever-increasing number of artificial intelligence (AI) systems, mitigating risks associated with their use has become one of the most urgent scientific and societal issues. To this end, the European Union passed the EU AI Act, proposing solution strategies that can be summarized under the umbrella term trustworthiness. In anti-cancer drug sensitivity prediction, machine learning (ML) methods are developed for application in medical decision support systems, which require an extraordinary level of trustworthiness. This review offers an overview of the ML landscape of methods for anti-cancer drug sensitivity prediction, including a brief introduction to the four major ML realms (supervised, unsupervised, semi-supervised, and reinforcement learning). In particular, we address the question to what extent trustworthiness-related properties, more specifically, interpretability and reliability, have been incorporated into anti-cancer drug sensitivity prediction methods over the previous decade. In total, we analyzed 36 papers with approaches for anti-cancer drug sensitivity prediction. Our results indicate that the need for reliability has hardly been addressed so far. Interpretability, on the other hand, has often been considered for model development. However, the concept is rather used intuitively, lacking clear definitions. Thus, we propose an easily extensible taxonomy for interpretability, unifying all prevalent connotations explicitly or implicitly used within the field.",
              "authors": [
                "Kerstin Lenhof",
                "Lea Eckhart",
                "Lisa-Marie Rolli",
                "Hans-Peter Lenhof"
              ],
              "journal": "Briefings in bioinformatics",
              "publication_date": "2024-Jul-25",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Reproducibility of Results",
                  "major_topic": false
                },
                {
                  "term": "Surveys and Questionnaires",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                }
              ],
              "doi": "10.1093/bib/bbae379"
            },
            {
              "pmid": "28155598",
              "title": "Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.",
              "abstract": "BACKGROUND: Tumour microenvironment is recognized as a major determinant of intrinsic resistance to anticancer therapies. In solid tumour types, such as breast cancer, lung cancer and pancreatic cancer, stromal components provide a fibrotic niche, which promotes stemness, EMT, chemo- and radioresistance of tumour. However, this microenvironment is not recapitulated in the conventional cell monoculture or xenografts, hence these in vitro and in vivo preclinical models are unlikely to be predictive of clinical response; which might attribute to the poor predictively of these preclinical drug-screening models. CONCLUSION: In this review, we summarized recently developed co-culture platforms in various tumour types that incorporate different stromal cell types and/or extracellular matrix (ECM), in the context of investigating potential mechanisms of stroma-mediated chemoresistance and evaluating novel agents and combinations. Some of these platforms will have great utility in the assessment of novel drug combinations and mechanistic understanding of the tumor-stroma interactions.",
              "authors": [
                "Ruiling Xu",
                "Frances M Richards"
              ],
              "journal": "Combinatorial chemistry & high throughput screening",
              "publication_date": "2017",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Coculture Techniques",
                  "major_topic": true
                },
                {
                  "term": "Drug Evaluation, Preclinical",
                  "major_topic": false
                },
                {
                  "term": "Extracellular Matrix",
                  "major_topic": false
                },
                {
                  "term": "Genetic Engineering",
                  "major_topic": false
                },
                {
                  "term": "High-Throughput Screening Assays",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Models, Biological",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1386207320666170202093538"
            },
            {
              "pmid": "39942602",
              "title": "Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.",
              "abstract": "Extracellular vesicles (EVs) are key mediators in the communication between cancer cells and their microenvironment, significantly influencing drug resistance. This review provides a comprehensive analysis of the roles of EVs in promoting drug resistance through mechanisms such as drug efflux, apoptosis resistance, autophagy imbalance, and tumor microenvironment modulation. Despite extensive research, details of EVs biogenesis, cargo selection, and specific pathways in EVs-mediated drug resistance are not fully understood. This review critically examines recent advancements, highlighting key studies that elucidate the molecular mechanisms of EVs functions. Additionally, innovative therapeutic strategies targeting EVs are explored, including inhibiting EVs biogenesis, engineering EVs for drug delivery, and identifying resistance-inhibiting molecules within EVs. By integrating insights from primary research and proposing new directions for future studies, this review aims to advance the understanding of EVs in cancer biology and foster effective interventions to mitigate drug resistance in cancer therapy.",
              "authors": [
                "Haodong Zhang",
                "Bohan Wu",
                "Yanheng Wang",
                "Huamao Du",
                "Liaoqiong Fang"
              ],
              "journal": "Molecules (Basel, Switzerland)",
              "publication_date": "2025-Jan-23",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Extracellular Vesicles",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Tumor Microenvironment",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Autophagy",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                }
              ],
              "doi": "10.3390/molecules30030498"
            },
            {
              "pmid": "38776197",
              "title": "RedCDR: Dual Relation Distillation for Cancer Drug Response Prediction.",
              "abstract": "Based on multi-omics data and drug information, predicting the response of cancer cell lines to drugs is a crucial area of research in modern oncology, as it can promote the development of personalized treatments. Despite the promising performance achieved by existing models, most of them overlook the variations among different omics and lack effective integration of multi-omics data. Moreover, the explicit modeling of cell line/drug attribute and cell line-drug association has not been thoroughly investigated in existing approaches. To address these issues, we propose RedCDR, a dual relation distillation model for cancer drug response (CDR) prediction. Specifically, a parallel dual-branch architecture is designed to enable both the independent learning and interactive fusion feasible for cell line/drug attribute and cell line-drug association information. To facilitate the adaptive interacting integration of multi-omics data, the proposed multi-omics encoder introduces the multiple similarity relations between cell lines and takes the importance of different omics data into account. To accomplish knowledge transfer from the two independent attribute and association branches to their fusion, a dual relation distillation mechanism consisting of representation distillation and prediction distillation is presented. Experiments conducted on the GDSC and CCLE datasets show that RedCDR outperforms previous state-of-the-art approaches in CDR prediction.",
              "authors": [
                "Muhao Xu",
                "Zhenfeng Zhu",
                "Yawei Zhao",
                "Kunlun He",
                "Qinghua Huang",
                "Yao Zhao"
              ],
              "journal": "IEEE/ACM transactions on computational biology and bioinformatics",
              "publication_date": "2024",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Computational Biology",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Cell Line, Tumor",
                  "major_topic": false
                },
                {
                  "term": "Algorithms",
                  "major_topic": false
                },
                {
                  "term": "Machine Learning",
                  "major_topic": false
                }
              ],
              "doi": "10.1109/TCBB.2024.3404262"
            },
            {
              "pmid": "38940147",
              "title": "Representing mutations for predicting cancer drug response.",
              "abstract": "MOTIVATION: Predicting cancer drug response requires a comprehensive assessment of many mutations present across a tumor genome. While current drug response models generally use a binary mutated/unmutated indicator for each gene, not all mutations in a gene are equivalent. RESULTS: Here, we construct and evaluate a series of predictive models based on leading methods for quantitative mutation scoring. Such methods include VEST4 and CADD, which score the impact of a mutation on gene function, and CHASMplus, which scores the likelihood a mutation drives cancer. The resulting predictive models capture cellular responses to dabrafenib, which targets BRAF-V600 mutations, whereas models based on binary mutation status do not. Performance improvements generalize to other drugs, extending genetic indications for PIK3CA, ERBB2, EGFR, PARP1, and ABL1 inhibitors. Introducing quantitative mutation features in drug response models increases performance and mechanistic understanding. AVAILABILITY AND IMPLEMENTATION: Code and example datasets are available at https://github.com/pgwall/qms.",
              "authors": [
                "Patrick Wall",
                "Trey Ideker"
              ],
              "journal": "Bioinformatics (Oxford, England)",
              "publication_date": "2024-Jun-28",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Mutation",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Imidazoles",
                  "major_topic": false
                },
                {
                  "term": "Oximes",
                  "major_topic": false
                },
                {
                  "term": "Computational Biology",
                  "major_topic": false
                }
              ],
              "doi": "10.1093/bioinformatics/btae209"
            },
            {
              "pmid": "39191166",
              "title": "DRN-CDR: A cancer drug response prediction model using multi-omics and drug features.",
              "abstract": "Cancer drug response (CDR) prediction is an important area of research that aims to personalize cancer therapy, optimizing treatment plans for maximum effectiveness while minimizing potential negative effects. Despite the advancements in Deep learning techniques, the effective integration of multi-omics data for drug response prediction remains challenging. In this paper, a regression method using Deep ResNet for CDR (DRN-CDR) prediction is proposed. We aim to explore the potential of considering sole cancer genes in drug response prediction. Here the multi-omics data such as gene expressions, mutation data, and methylation data along with the molecular structural information of drugs were integrated to predict the IC50 values of drugs. Drug features are extracted by employing a Uniform Graph Convolution Network, while Cell line features are extracted using a combination of Convolutional Neural Network and Fully Connected Networks. These features are then concatenated and fed into a deep ResNet for the prediction of IC50 values between Drug - Cell line pairs. The proposed method yielded higher Pearson's correlation coefficient (r",
              "authors": [
                "K R Saranya",
                "E R Vimina"
              ],
              "journal": "Computational biology and chemistry",
              "publication_date": "2024-Oct",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Cell Line, Tumor",
                  "major_topic": false
                },
                {
                  "term": "Neural Networks, Computer",
                  "major_topic": false
                },
                {
                  "term": "Deep Learning",
                  "major_topic": false
                },
                {
                  "term": "Drug Screening Assays, Antitumor",
                  "major_topic": false
                },
                {
                  "term": "Multiomics",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.compbiolchem.2024.108175"
            },
            {
              "pmid": "26845135",
              "title": "Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge.",
              "abstract": "Development of resistance in cancer cells results in a high failure rate in cancer chemotherapy in the clinic. Therefore, investigating the mechanisms by which cancer cells acquire the capability to avoid cell death upon exposure to antineoplastic agents is of great significance in cancer research. In this review article, we will provide an overview of the mechanisms and molecular machinery of drug resistance in cancer cells which include but may not be limited to altered membrane transport and drug metabolizing enzymes, genetic response, enhanced DNA repair and alternation in the target molecules. A special focus will be on describing the strategies and the rationale for exploitation of peroxisome proliferator-activated receptors for overcoming the observed resistance in cancer cells.",
              "authors": [
                "Bahman Yousefi",
                "Nosratollah Zarghami",
                "Nasser Samadi",
                "Maryam Majidinia"
              ],
              "journal": "Anti-cancer agents in medicinal chemistry",
              "publication_date": "2016",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Ligands",
                  "major_topic": false
                },
                {
                  "term": "Molecular Structure",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Peroxisome Proliferator-Activated Receptors",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1871520616666160204112941"
            },
            {
              "pmid": "24289549",
              "title": "Biotransformation, a promising technology for anti-cancer drug development.",
              "abstract": "With the high morbidity and mortality caused by cancer, finding new and more effective anti-cancer drugs is very urgent. In current research, biotransformation plays a vital role in the research and development of cancer drugs and has obtained some achievements. In this review, we have summarized four applications as follows: to exploit novel anti-cancer drugs, to improve existing anti-cancer drugs, to broaden limited anti-cancer drug resources and to investigate correlative mechanisms. Three different groups of important anti-cancer compounds were assessed to clarify the current practical applications of biotransformation in the development of anti-cancer drugs.",
              "authors": [
                "Fei Gao",
                "Jin-Ming Zhang",
                "Zhan-Guo Wang",
                "Wei Peng",
                "Hui-Ling Hu",
                "Chao-Mei Fu"
              ],
              "journal": "Asian Pacific journal of cancer prevention : APJCP",
              "publication_date": "2013",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biotransformation",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.7314/apjcp.2013.14.10.5599"
            },
            {
              "pmid": "36000898",
              "title": "Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.",
              "abstract": "MOTIVATION: Drug combinations have exhibited promise in treating cancers with less toxicity and fewer adverse reactions. However, in vitro screening of synergistic drug combinations is time-consuming and labor-intensive because of the combinatorial explosion. Although a number of computational methods have been developed for predicting synergistic drug combinations, the multi-way relations between drug combinations and cell lines existing in drug synergy data have not been well exploited. RESULTS: We propose a multi-way relation-enhanced hypergraph representation learning method to predict anti-cancer drug synergy, named HypergraphSynergy. HypergraphSynergy formulates synergistic drug combinations over cancer cell lines as a hypergraph, in which drugs and cell lines are represented by nodes and synergistic drug-drug-cell line triplets are represented by hyperedges, and leverages the biochemical features of drugs and cell lines as node attributes. Then, a hypergraph neural network is designed to learn the embeddings of drugs and cell lines from the hypergraph and predict drug synergy. Moreover, the auxiliary task of reconstructing the similarity networks of drugs and cell lines is considered to enhance the generalization ability of the model. In the computational experiments, HypergraphSynergy outperforms other state-of-the-art synergy prediction methods on two benchmark datasets for both classification and regression tasks and is applicable to unseen drug combinations or cell lines. The studies revealed that the hypergraph formulation allows us to capture and explain complex multi-way relations of drug combinations and cell lines, and also provides a flexible framework to make the best use of diverse information. AVAILABILITY AND IMPLEMENTATION: The source data and codes of HypergraphSynergy can be freely downloaded from https://github.com/liuxuan666/HypergraphSynergy. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",
              "authors": [
                "Xuan Liu",
                "Congzhi Song",
                "Shichao Liu",
                "Menglu Li",
                "Xionghui Zhou",
                "Wen Zhang"
              ],
              "journal": "Bioinformatics (Oxford, England)",
              "publication_date": "2022-Oct-14",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Computational Biology",
                  "major_topic": false
                },
                {
                  "term": "Drug Combinations",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                }
              ],
              "doi": "10.1093/bioinformatics/btac579"
            },
            {
              "pmid": "36460622",
              "title": "GADRP: graph convolutional networks and autoencoders for cancer drug response prediction.",
              "abstract": "Drug response prediction in cancer cell lines is of great significance in personalized medicine. In this study, we propose GADRP, a cancer drug response prediction model based on graph convolutional networks (GCNs) and autoencoders (AEs). We first use a stacked deep AE to extract low-dimensional representations from cell line features, and then construct a sparse drug cell line pair (DCP) network incorporating drug, cell line, and DCP similarity information. Later, initial residual and layer attention-based GCN (ILGCN) that can alleviate over-smoothing problem is utilized to learn DCP features. And finally, fully connected network is employed to make prediction. Benchmarking results demonstrate that GADRP can significantly improve prediction performance on all metrics compared with baselines on five datasets. Particularly, experiments of predictions of unknown DCP responses, drug-cancer tissue associations\uff0c and drug-pathway associations illustrate the predictive power of GADRP. All results highlight the effectiveness of GADRP in predicting drug responses, and its potential value in guiding anti-cancer drug selection.",
              "authors": [
                "Hong Wang",
                "Chong Dai",
                "Yuqi Wen",
                "Xiaoqi Wang",
                "Wenjuan Liu",
                "Song He",
                "Xiaochen Bo",
                "Shaoliang Peng"
              ],
              "journal": "Briefings in bioinformatics",
              "publication_date": "2023-Jan-19",
              "mesh_terms": [
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Benchmarking",
                  "major_topic": false
                },
                {
                  "term": "Cell Line",
                  "major_topic": false
                },
                {
                  "term": "Learning",
                  "major_topic": false
                }
              ],
              "doi": "10.1093/bib/bbac501"
            },
            {
              "pmid": "30675829",
              "title": "Computational Perspective on the Current State of the Methods and New Challenges in Cancer Drug Discovery.",
              "abstract": null,
              "authors": [
                "Dong-Qing Wei",
                "Gurudeeban Selvaraj",
                "Aman Chandra Kaushik"
              ],
              "journal": "Current pharmaceutical design",
              "publication_date": "2018",
              "mesh_terms": [
                {
                  "term": "Algorithms",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Computer-Aided Design",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Models, Molecular",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/138161282432190109105339"
            },
            {
              "pmid": "34375185",
              "title": "Role of Protein Tyrosine Phosphatase in Regulation of Cell Signaling Cascades Affecting Tumor Cell Growth: A Future Perspective as Anti-Cancer Drug Target.",
              "abstract": "Protein Tyrosine Phosphatase (PTP) superfamily is a key enzyme involved in the regulation of growth-related cell signaling cascades, such as the RAS/MAPK pathway, that directly affect cancer cell growth and metastasis. Several studies have indicated that the drug resistance observed in several late-stage tumors might also be affected by the levels of PTP in the cell. Hence, these phosphatases have been in the limelight for the past few decades as potential drug targets and several promising drug candidates have been developed, even though none of these drugs have reached the market yet. In this review, we explore the potential of PTP as a viable anti-cancer drug target by studying PTPs, their regulation of several key cancer cell signaling pathways, and how their levels affect various types of cancer. Furthermore, we present the current scenario of PTP as a molecular target and the various challenges faced in the development of PTP-targeting anti-cancer drugs.",
              "authors": [
                "Archanalakshmi Kambaru",
                "Nidhee Chaudhary"
              ],
              "journal": "Current pharmaceutical biotechnology",
              "publication_date": "2022",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": true
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": true
                },
                {
                  "term": "Protein Tyrosine Phosphatases",
                  "major_topic": false
                },
                {
                  "term": "Signal Transduction",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/1389201022666210810094739"
            },
            {
              "pmid": "30552660",
              "title": "Cancer Drug Toxicity: Moving from Patient to Survivor.",
              "abstract": "Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and personalized treatment modalities have contributed to this increased survivorship. Additionally, earlier diagnosis and detection of cancer, greater access to preventive screenings, and greater focus on cancer pharmaceutical safety have all been contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.",
              "authors": [
                "Megan Slocum",
                "Sophie F Garcia",
                "June M McKoy"
              ],
              "journal": "Cancer treatment and research",
              "publication_date": "2019",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Cancer Survivors",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                },
                {
                  "term": "Patient Safety",
                  "major_topic": false
                },
                {
                  "term": "Treatment Outcome",
                  "major_topic": false
                }
              ],
              "doi": "10.1007/978-3-319-43896-2_8"
            },
            {
              "pmid": "22893634",
              "title": "Implication of cancer stem cells in cancer drug development and drug delivery.",
              "abstract": "Conventional therapy against cancer by chemotherapy and radiation therapy has proven successful at decreasing bulk tumor size when cancer is diagnosed early enough. These therapeutic approaches, however, often result in recurrence years later. A number of studies have begun to identify a subpopulation of tumor-initiating cells that may be critical to early tumorigenesis and subsequent recurrence. These cells have been termed cancer stem cells (CSCs) and have been demonstrated to have properties of self-renewal, differentiation into other tumor cell types, and enhanced drug resistance. Given the growing body of evidence that CSCs play a key role in tumor biology in many cancer types, it is important to take into account the properties of these cells when developing novel cancer drugs and designing enhanced methods of drug delivery. This review covers some of the mechanisms by which CSCs escape conventional therapy as well as the potential approaches to targeting CSCs that may be used during cancer drug development.",
              "authors": [
                "Edward Kai-Hua Chow"
              ],
              "journal": "Journal of laboratory automation",
              "publication_date": "2013-Feb",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Delivery Systems",
                  "major_topic": true
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Drug Resistance, Neoplasm",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Neoplastic Stem Cells",
                  "major_topic": false
                }
              ],
              "doi": "10.1177/2211068212454739"
            },
            {
              "pmid": "31298144",
              "title": "Multiple Perspectives in Anti-cancer Drug Discovery: From old Targets and Natural Products to Innovative Computational Approaches.",
              "abstract": null,
              "authors": [
                "Alejandro Speck-Planche"
              ],
              "journal": "Anti-cancer agents in medicinal chemistry",
              "publication_date": "2019",
              "mesh_terms": [
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Biological Products",
                  "major_topic": false
                },
                {
                  "term": "Cell Proliferation",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": true
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Monte Carlo Method",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.2174/187152061902190418105054"
            },
            {
              "pmid": "23831857",
              "title": "Mathematical modeling in cancer drug discovery.",
              "abstract": "Mathematical models have the potential to help discover new therapeutic targets and treatment strategies. In this review, we discuss how the latest developments in mathematical modeling can provide useful context for the rational design, validation and prioritization of novel cancer drug targets and their combinations. We give special attention to two modeling approaches: network-based modeling and multiscale modeling, because they have begun to show promise in facilitating the process of effective cancer drug discovery. Both modeling approaches are integrated with a variety of experimental methods to ensure proper parameterization and to maximize their predictive value. We also discuss several challenges faced in modeling-based drug discovery.",
              "authors": [
                "Zhihui Wang",
                "Thomas S Deisboeck"
              ],
              "journal": "Drug discovery today",
              "publication_date": "2014-Feb",
              "mesh_terms": [
                {
                  "term": "Animals",
                  "major_topic": false
                },
                {
                  "term": "Antineoplastic Agents",
                  "major_topic": false
                },
                {
                  "term": "Drug Design",
                  "major_topic": false
                },
                {
                  "term": "Drug Discovery",
                  "major_topic": false
                },
                {
                  "term": "Humans",
                  "major_topic": false
                },
                {
                  "term": "Models, Theoretical",
                  "major_topic": true
                },
                {
                  "term": "Molecular Targeted Therapy",
                  "major_topic": false
                },
                {
                  "term": "Neoplasms",
                  "major_topic": false
                }
              ],
              "doi": "10.1016/j.drudis.2013.06.015"
            }
          ],
          "summary": {
            "total_articles": 100,
            "articles_with_abstracts": 84,
            "common_mesh_terms": [
              {
                "term": "Antineoplastic Agents",
                "count": 100
              },
              {
                "term": "Humans",
                "count": 94
              },
              {
                "term": "Neoplasms",
                "count": 87
              },
              {
                "term": "Animals",
                "count": 38
              },
              {
                "term": "Drug Resistance, Neoplasm",
                "count": 30
              },
              {
                "term": "Drug Discovery",
                "count": 20
              },
              {
                "term": "Drug Delivery Systems",
                "count": 13
              },
              {
                "term": "Tumor Microenvironment",
                "count": 11
              },
              {
                "term": "Drug Development",
                "count": 8
              },
              {
                "term": "Machine Learning",
                "count": 6
              }
            ],
            "top_journals": [
              {
                "journal": "Nature reviews. Drug discovery",
                "count": 5
              },
              {
                "journal": "Briefings in bioinformatics",
                "count": 5
              },
              {
                "journal": "Current pharmaceutical design",
                "count": 4
              },
              {
                "journal": "International journal of molecular sciences",
                "count": 3
              },
              {
                "journal": "Drug discovery today",
                "count": 3
              }
            ],
            "date_range": {
              "earliest": "1992-Dec",
              "latest": "2025-Sep-27"
            }
          },
          "query": "cancer drug"
        },
        "error": null
      },
      "metadata": {
        "name": "pubmed",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.34,
          "timeout": 30,
          "max_results": 100,
          "email": "pharmforge@example.com",
          "api_key": null
        }
      }
    },
    {
      "adapter": "europepmc",
      "status": "success",
      "error": null,
      "execution_time": 0.677906,
      "data": {
        "success": true,
        "data": {
          "articles": [],
          "summary": {
            "total_articles": 0,
            "open_access_count": 0,
            "with_fulltext_count": 0,
            "common_chemicals": [],
            "top_journals": [],
            "date_range": null
          },
          "query": "aspirin",
          "hit_count": 0,
          "total_returned": 0
        },
        "error": null
      },
      "metadata": {
        "name": "europepmc",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.2,
          "timeout": 30,
          "max_results": 100,
          "email": "pharmforge@example.com"
        }
      }
    },
    {
      "adapter": "google_patents",
      "status": "success",
      "error": null,
      "execution_time": 1.256526,
      "data": {
        "success": true,
        "data": {
          "patents": [],
          "summary": {
            "total_patents": 0,
            "assignees": [],
            "cpc_codes": [],
            "date_range": null,
            "chemical_entities": []
          },
          "query": "aspirin",
          "search_params": {
            "keywords": "aspirin",
            "cpc_codes": null,
            "assignee": null,
            "inventor": null,
            "date_after": null,
            "date_before": null
          }
        },
        "error": null
      },
      "metadata": {
        "name": "google_patents",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 30,
          "max_results": 50,
          "api_key": null
        }
      }
    },
    {
      "adapter": "lens",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Lens.org API token required. Get one at https://www.lens.org/lens/user/subscriptions#scholar"
      },
      "metadata": {
        "name": "lens",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 30,
          "max_results": 100,
          "api_token": null
        }
      }
    },
    {
      "adapter": "geo",
      "status": "success",
      "error": null,
      "execution_time": 0.922294,
      "data": {
        "success": true,
        "data": {
          "query": "GSE1000",
          "query_type": "accession",
          "accession_type": "GSE",
          "dataset": {
            "uid": "200001000",
            "database": "gds",
            "accession": "GSE1000",
            "title": "Osteosarcoma TE85 cell tissue culture study",
            "summary": "Amino acid conjugated surfaces and controls at 6 and 32 hours Keywords: other",
            "gpl": "96",
            "gse": "1000",
            "taxon": "Homo sapiens",
            "entrytype": "GSE",
            "gdstype": "Expression profiling by array",
            "ptechtype": "",
            "valtype": "",
            "n_samples": 10,
            "pubmedids": [],
            "projects": [],
            "ftplink": "ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE1nnn/GSE1000/",
            "download_urls": {
              "soft": "https://ftp.ncbi.nlm.nih.gov/geo/series/GSE1nnn/GSE1000/soft/GSE1000_family.soft.gz",
              "matrix": "https://ftp.ncbi.nlm.nih.gov/geo/series/GSE1nnn/GSE1000/matrix/GSE1000_series_matrix.txt.gz",
              "supplementary": "https://ftp.ncbi.nlm.nih.gov/geo/series/GSE1nnn/GSE1000/suppl/"
            }
          }
        },
        "error": null
      },
      "metadata": {
        "name": "geo",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.34,
          "timeout": 30,
          "max_results": 100,
          "email": "pharmforge@example.com",
          "api_key": null
        }
      }
    },
    {
      "adapter": "gtex",
      "status": "success",
      "error": null,
      "execution_time": 0.724699,
      "data": {
        "success": true,
        "data": {
          "gene_symbol": "EGFR",
          "query_type": "expression",
          "dataset": "gtex_v8",
          "tissues": [],
          "median_expression": {},
          "max_expression_tissue": null,
          "max_expression_value": null,
          "num_tissues_expressed": 0
        },
        "error": null
      },
      "metadata": {
        "name": "gtex",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.2,
          "timeout": 60,
          "max_tissues": 100
        }
      }
    },
    {
      "adapter": "reactome",
      "status": "success",
      "error": null,
      "execution_time": 0.803913,
      "data": {
        "success": true,
        "data": {
          "pathways": [
            {
              "pathway_id": null,
              "name": null,
              "species": null,
              "type": null
            }
          ],
          "total_found": 1
        },
        "error": null
      },
      "metadata": {
        "name": "reactome",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.5,
          "timeout": 60,
          "species": "Homo sapiens"
        }
      }
    },
    {
      "adapter": "kegg",
      "status": "success",
      "error": null,
      "execution_time": 1.747931,
      "data": {
        "success": true,
        "data": {
          "query": "EGFR",
          "results": [],
          "count": 0
        },
        "error": null
      },
      "metadata": {
        "name": "kegg",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.3,
          "timeout": 30,
          "default_organism": "hsa",
          "max_entries": 10
        }
      }
    },
    {
      "adapter": "brenda",
      "status": "success",
      "error": null,
      "execution_time": 1.025951,
      "data": {
        "success": true,
        "data": {
          "enzyme": {
            "ec_number": "1.1.1.1",
            "systematic_name": "Alcohol:NAD+ oxidoreductase",
            "common_name": "Alcohol dehydrogenase",
            "reaction": "Alcohol + NAD+ = Aldehyde + NADH + H+",
            "substrates": [
              "Ethanol",
              "Methanol",
              "Propanol"
            ],
            "products": [
              "Acetaldehyde",
              "Formaldehyde",
              "Propionaldehyde"
            ],
            "cofactors": [
              "NAD+",
              "Zn2+"
            ]
          },
          "kinetics": [
            {
              "parameter": "km",
              "value": 0.5,
              "unit": "mM",
              "substrate": "Ethanol",
              "organism": "Homo sapiens",
              "conditions": {
                "pH": 7.4,
                "temperature": 37
              },
              "reference": "PMID:12345678"
            },
            {
              "parameter": "km",
              "value": 1.2,
              "unit": "mM",
              "substrate": "Methanol",
              "organism": "Homo sapiens",
              "conditions": {
                "pH": 7.4,
                "temperature": 37
              },
              "reference": "PMID:23456789"
            },
            {
              "parameter": "kcat",
              "value": 150.0,
              "unit": "1/s",
              "substrate": "Ethanol",
              "organism": "Homo sapiens",
              "conditions": {
                "pH": 7.4,
                "temperature": 37
              },
              "reference": "PMID:12345678"
            }
          ],
          "inhibitors": [
            {
              "compound": "Disulfiram",
              "ki_value": 10.0,
              "unit": "nM",
              "inhibition_type": "competitive",
              "organism": "Homo sapiens",
              "reference": "PMID:34567890"
            },
            {
              "compound": "4-Methylpyrazole",
              "ki_value": 250.0,
              "unit": "nM",
              "inhibition_type": "competitive",
              "organism": "Homo sapiens",
              "reference": "PMID:45678901"
            }
          ],
          "num_kinetic_records": 3,
          "num_inhibitor_records": 2,
          "warnings": []
        },
        "error": null
      },
      "metadata": {
        "name": "brenda",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 90,
          "max_results": 50,
          "use_rest": true
        }
      }
    },
    {
      "adapter": "hmdb",
      "status": "success",
      "error": null,
      "execution_time": 10.362618,
      "data": {
        "success": true,
        "data": {
          "query": "glucose",
          "search_type": "name",
          "num_results": 20,
          "num_fetched": 5,
          "all_hmdb_ids": [
            "HMDB0003369",
            "HMDB0001054",
            "HMDB0011742",
            "HMDB0302910",
            "HMDB0012300",
            "HMDB0001401",
            "HMDB0302470",
            "HMDB0302089",
            "HMDB0006701",
            "HMDB0006603",
            "HMDB0001328",
            "HMDB0304344",
            "HMDB0006557",
            "HMDB0000122",
            "HMDB0003345",
            "HMDB0062805",
            "HMDB0301708",
            "HMDB0246614",
            "HMDB0000286",
            "HMDB0242534"
          ],
          "metabolites": [
            {
              "hmdb_id": null,
              "name": null,
              "systematic_name": null,
              "chemical_formula": null,
              "average_molecular_weight": null,
              "monoisotopic_molecular_weight": null,
              "iupac_name": null,
              "smiles": null,
              "inchi": null,
              "inchikey": null,
              "state": null,
              "description": null,
              "synonyms": [],
              "biofluid_locations": [],
              "tissue_locations": [],
              "concentrations": {},
              "diseases": [],
              "pathways": [],
              "proteins": [],
              "ontology": {
                "description": null,
                "origins": [],
                "biofunctions": [],
                "applications": []
              },
              "external_ids": {
                "pubchem_compound_id": null,
                "chemspider_id": null,
                "kegg_id": null,
                "chebi_id": null,
                "drugbank_id": null,
                "foodb_id": null
              }
            },
            {
              "hmdb_id": null,
              "name": null,
              "systematic_name": null,
              "chemical_formula": null,
              "average_molecular_weight": null,
              "monoisotopic_molecular_weight": null,
              "iupac_name": null,
              "smiles": null,
              "inchi": null,
              "inchikey": null,
              "state": null,
              "description": null,
              "synonyms": [],
              "biofluid_locations": [],
              "tissue_locations": [],
              "concentrations": {},
              "diseases": [],
              "pathways": [],
              "proteins": [],
              "ontology": {
                "description": null,
                "origins": [],
                "biofunctions": [],
                "applications": []
              },
              "external_ids": {
                "pubchem_compound_id": null,
                "chemspider_id": null,
                "kegg_id": null,
                "chebi_id": null,
                "drugbank_id": null,
                "foodb_id": null
              }
            },
            {
              "hmdb_id": null,
              "name": null,
              "systematic_name": null,
              "chemical_formula": null,
              "average_molecular_weight": null,
              "monoisotopic_molecular_weight": null,
              "iupac_name": null,
              "smiles": null,
              "inchi": null,
              "inchikey": null,
              "state": null,
              "description": null,
              "synonyms": [],
              "biofluid_locations": [],
              "tissue_locations": [],
              "concentrations": {},
              "diseases": [],
              "pathways": [],
              "proteins": [],
              "ontology": {
                "description": null,
                "origins": [],
                "biofunctions": [],
                "applications": []
              },
              "external_ids": {
                "pubchem_compound_id": null,
                "chemspider_id": null,
                "kegg_id": null,
                "chebi_id": null,
                "drugbank_id": null,
                "foodb_id": null
              }
            },
            {
              "hmdb_id": null,
              "name": null,
              "systematic_name": null,
              "chemical_formula": null,
              "average_molecular_weight": null,
              "monoisotopic_molecular_weight": null,
              "iupac_name": null,
              "smiles": null,
              "inchi": null,
              "inchikey": null,
              "state": null,
              "description": null,
              "synonyms": [],
              "biofluid_locations": [],
              "tissue_locations": [],
              "concentrations": {},
              "diseases": [],
              "pathways": [],
              "proteins": [],
              "ontology": {
                "description": null,
                "origins": [],
                "biofunctions": [],
                "applications": []
              },
              "external_ids": {
                "pubchem_compound_id": null,
                "chemspider_id": null,
                "kegg_id": null,
                "chebi_id": null,
                "drugbank_id": null,
                "foodb_id": null
              }
            },
            {
              "hmdb_id": null,
              "name": null,
              "systematic_name": null,
              "chemical_formula": null,
              "average_molecular_weight": null,
              "monoisotopic_molecular_weight": null,
              "iupac_name": null,
              "smiles": null,
              "inchi": null,
              "inchikey": null,
              "state": null,
              "description": null,
              "synonyms": [],
              "biofluid_locations": [],
              "tissue_locations": [],
              "concentrations": {},
              "diseases": [],
              "pathways": [],
              "proteins": [],
              "ontology": {
                "description": null,
                "origins": [],
                "biofunctions": [],
                "applications": []
              },
              "external_ids": {
                "pubchem_compound_id": null,
                "chemspider_id": null,
                "kegg_id": null,
                "chebi_id": null,
                "drugbank_id": null,
                "foodb_id": null
              }
            }
          ],
          "warning": "Only fetched details for first 5 results"
        },
        "error": null
      },
      "metadata": {
        "name": "hmdb",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 1.0,
          "timeout": 60,
          "max_results": 20,
          "default_biofluids": [
            "blood",
            "urine",
            "cerebrospinal_fluid"
          ]
        }
      }
    },
    {
      "adapter": "rnacentral",
      "status": "success",
      "error": null,
      "execution_time": 0.898405,
      "data": {
        "success": true,
        "data": {
          "rnacentral_id": "URS0000000001",
          "sequence": "AUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAGCGGUAGAGAGAAGCUUGCUUCUCUUGAGAGCGGCGGACGGGUGAGUAAUGCCUAGGAAUCUGCCUGGUAGUGGGGGAUAACGCUCGGAAACGGACGCUAAUACCGCAUACGUCCUACGGGAGAAAGCAGGGGACCUUCGGGCCUUGCGCUAUCAGAUGAGC",
          "length": 200,
          "rna_type": "rRNA",
          "description": "rRNA from 1 species",
          "species": [],
          "url": "http://rnacentral.org/api/v1/rna/URS0000000001",
          "raw_data": {
            "url": "http://rnacentral.org/api/v1/rna/URS0000000001",
            "rnacentral_id": "URS0000000001",
            "md5": "6bba097c8c39ed9a0fdf02273ee1c79a",
            "sequence": "AUUGAACGCUGGCGGCAGGCCUAACACAUGCAAGUCGAGCGGUAGAGAGAAGCUUGCUUCUCUUGAGAGCGGCGGACGGGUGAGUAAUGCCUAGGAAUCUGCCUGGUAGUGGGGGAUAACGCUCGGAAACGGACGCUAAUACCGCAUACGUCCUACGGGAGAAAGCAGGGGACCUUCGGGCCUUGCGCUAUCAGAUGAGC",
            "length": 200,
            "xrefs": "http://rnacentral.org/api/v1/rna/URS0000000001/xrefs",
            "publications": "http://rnacentral.org/api/v1/rna/URS0000000001/publications",
            "is_active": true,
            "description": "rRNA from 1 species",
            "rna_type": "rRNA",
            "count_distinct_organisms": 1,
            "distinct_databases": [
              "ENA"
            ]
          }
        },
        "error": null
      },
      "metadata": {
        "name": "rnacentral",
        "type": "api",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "rate_limit_delay": 0.3,
          "timeout": 60,
          "max_results": 100
        }
      }
    },
    {
      "adapter": "mordred",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Mordred is not installed. Install with: pip install mordred"
      },
      "metadata": {
        "name": "mordred",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 30,
          "ignore_3d": true
        }
      }
    },
    {
      "adapter": "molvs",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "MolVS is not installed. Install with: pip install molvs"
      },
      "metadata": {
        "name": "molvs",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 10,
          "include_validation": true,
          "include_tautomers": true
        }
      }
    },
    {
      "adapter": "deepchem",
      "status": "success",
      "error": null,
      "execution_time": 0.001504,
      "data": {
        "success": false,
        "data": null,
        "error": "DeepChem is not installed. Install with: pip install deepchem"
      },
      "metadata": {
        "name": "deepchem",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 60,
          "default_featurizer": "morgan",
          "default_radius": 2,
          "default_size": 2048,
          "max_atoms": 100
        }
      }
    },
    {
      "adapter": "scikit_mol",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "scikit-mol is not installed. Install with: pip install scikit-mol"
      },
      "metadata": {
        "name": "scikit_mol",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 30,
          "default_fingerprint": "morgan",
          "default_radius": 2,
          "default_nbits": 2048
        }
      }
    },
    {
      "adapter": "chemprop",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Chemprop is not installed. Install with: pip install chemprop"
      },
      "metadata": {
        "name": "chemprop",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 30,
          "max_atom_features": 133,
          "max_bond_features": 14
        }
      }
    },
    {
      "adapter": "mdanalysis",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "MDAnalysis is not installed. Install with: pip install MDAnalysis"
      },
      "metadata": {
        "name": "mdanalysis",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Molecular dynamics trajectory analysis using MDAnalysis",
        "capabilities": {
          "rmsd_calculation": true,
          "rmsf_calculation": true,
          "radius_of_gyration": true,
          "hydrogen_bond_analysis": false,
          "multiple_formats": true,
          "alignment": true
        },
        "supported_formats": {
          "topology": [
            "PDB",
            "PSF",
            "GRO",
            "TPR",
            "PRMTOP",
            "TOP"
          ],
          "trajectory": [
            "DCD",
            "XTC",
            "TRR",
            "NetCDF",
            "H5MD",
            "LAMMPS",
            "CRD"
          ]
        },
        "config": {
          "selection": "protein and name CA",
          "compute_rmsd": true,
          "compute_rmsf": true,
          "compute_rg": true,
          "compute_hbonds": false,
          "align_trajectory": true,
          "step": 1
        },
        "references": [
          {
            "paper": "Michaud-Agrawal et al., J. Comput. Chem. 2011, 32, 2319-2327",
            "doi": "10.1002/jcc.21787"
          },
          {
            "paper": "Gowers et al., Proc. of the 15th Python in Science Conf. 2016, 98-105",
            "doi": "10.25080/Majora-629e541a-00e"
          }
        ],
        "website": "https://www.mdanalysis.org/",
        "documentation": "https://docs.mdanalysis.org/",
        "computational_cost": {
          "rmsd": "Fast - linear with trajectory length",
          "rmsf": "Fast - linear with trajectory length",
          "radius_of_gyration": "Fast - linear with trajectory length",
          "hydrogen_bonds": "Moderate - depends on system size and trajectory length"
        }
      }
    },
    {
      "adapter": "openbabel",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "OpenBabel is not installed. Install with: pip install openbabel-wheel"
      },
      "metadata": {
        "name": "openbabel",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 30,
          "force_field": "mmff94",
          "gen_3d": true,
          "add_hydrogens": true,
          "optimize_steps": 500
        }
      }
    },
    {
      "adapter": "meeko",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Meeko is not installed. Install with: pip install meeko"
      },
      "metadata": {
        "name": "meeko",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Ligand preparation for AutoDock Vina/GPU using Meeko",
        "requirements": [
          "Meeko (pip install meeko)",
          "RDKit (pip install rdkit)"
        ],
        "features": [
          "SMILES to PDBQT conversion",
          "Macrocycle flexibility support",
          "Multiple conformer generation",
          "Hydrated docking preparation",
          "Flexible amide bonds",
          "Custom bond rigidification"
        ],
        "config": {
          "rigid_macrocycles": false,
          "keep_nonpolar_hydrogens": false,
          "hydrate": false,
          "flexible_amides": false,
          "min_ring_size": 7,
          "num_conformers": 1,
          "double_bond_penalty": 50.0
        },
        "outputs": {
          "pdbqt_string": "PDBQT formatted ligand (string)",
          "pdbqt_file": "Optional temporary file path",
          "num_torsions": "Number of rotatable bonds",
          "macrocycles": "Detected macrocycle information",
          "conformers": "List of prepared conformer data"
        },
        "integration": {
          "vina_adapter": "Compatible with VinaAdapter for docking workflows",
          "format": "PDBQT format ready for AutoDock Vina/GPU"
        }
      }
    },
    {
      "adapter": "torchdrug",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "TorchDrug is not installed. Install with: pip install torchdrug"
      },
      "metadata": {
        "name": "torchdrug",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 60,
          "default_model": "gin",
          "default_hidden_dims": [
            256,
            256,
            256
          ],
          "embedding_dim": 256,
          "batch_size": 32,
          "device": "cpu"
        }
      }
    },
    {
      "adapter": "dgllifesci",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "DGL-LifeSci is not installed. Install with: pip install dgllife"
      },
      "metadata": {
        "name": "dgllifesci",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 60,
          "default_featurizer": "canonical",
          "default_model": null,
          "device": "cpu",
          "batch_size": 32
        }
      }
    },
    {
      "adapter": "molfeat",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "MolFeat is not installed. Install with: pip install molfeat"
      },
      "metadata": {
        "name": "molfeat",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 120,
          "default_featurizer": "morgan",
          "default_radius": 2,
          "default_nbits": 2048,
          "batch_size": 32
        }
      }
    },
    {
      "adapter": "chemplot",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "ChemPlot is not installed. Install with: pip install chemplot"
      },
      "metadata": {
        "name": "chemplot",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 120,
          "default_method": "pca",
          "supported_methods": [
            "pca",
            "tsne",
            "umap"
          ]
        }
      }
    },
    {
      "adapter": "optuna",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Optuna is not installed. Install with: pip install optuna"
      },
      "metadata": {
        "name": "optuna",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 3600,
          "default_n_trials": 100,
          "default_sampler": "TPE"
        }
      }
    },
    {
      "adapter": "prolif",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": {},
        "error": "ProLIF is not installed. Install with: pip install prolif"
      },
      "metadata": {
        "name": "prolif",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "description": "Protein-ligand interaction fingerprint analysis using ProLIF",
        "capabilities": {
          "hydrogen_bonds": true,
          "hydrophobic_contacts": true,
          "pi_stacking": true,
          "pi_cation": true,
          "salt_bridges": true,
          "halogen_bonds": true,
          "metal_coordination": true,
          "trajectory_support": true,
          "residue_level_analysis": true,
          "frequency_calculation": true
        },
        "supported_interactions": [
          "HBDonor",
          "HBAcceptor",
          "PiStacking",
          "PiCation",
          "CationPi",
          "Hydrophobic",
          "Anionic",
          "Cationic",
          "XBDonor",
          "XBAcceptor",
          "MetalDonor",
          "MetalAcceptor"
        ],
        "supported_input_formats": {
          "separate_files": "protein_file and ligand_file paths",
          "complex_file": "single PDB/MOL2 file with ligand_selection",
          "mdanalysis_universe": "MDAnalysis Universe object with ligand_selection"
        },
        "config": {
          "protein_selection": "protein",
          "ligand_selection": "resname LIG",
          "interactions": null,
          "compute_frequency": true
        },
        "requirements": [
          "ProLIF (pip install prolif)",
          "MDAnalysis (pip install MDAnalysis)",
          "Pandas (pip install pandas, optional)"
        ],
        "references": [
          {
            "paper": "ProLIF: Protein-Ligand Interaction Fingerprints",
            "url": "https://prolif.readthedocs.io/"
          }
        ],
        "computational_cost": {
          "single_frame": "Fast - seconds for typical protein-ligand complex",
          "trajectory": "Moderate - linear with number of frames"
        }
      }
    },
    {
      "adapter": "datamol",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Datamol is not installed. Install with: pip install datamol"
      },
      "metadata": {
        "name": "datamol",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 120,
          "default_operation": "standardize",
          "supported_operations": [
            "standardize",
            "to_smiles",
            "conformers",
            "cluster",
            "diversity"
          ]
        }
      }
    },
    {
      "adapter": "py3dmol",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "py3Dmol is not installed. Install with: pip install py3Dmol"
      },
      "metadata": {
        "name": "py3dmol",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 30,
          "default_style": "stick",
          "default_width": 400,
          "default_height": 400,
          "supported_styles": [
            "stick",
            "sphere",
            "cartoon",
            "surface",
            "line",
            "cross"
          ],
          "supported_formats": [
            "pdb",
            "mol2",
            "sdf",
            "smiles"
          ]
        }
      }
    },
    {
      "adapter": "pymol",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "PyMOL is not installed. Install with: pip install pymol-open-source"
      },
      "metadata": {
        "name": "pymol",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 60,
          "default_style": "sticks",
          "default_color_scheme": "by_element",
          "default_background": "white",
          "default_width": 800,
          "default_height": 600,
          "default_ray_trace": true,
          "temp_dir": null,
          "cleanup_temp_files": true
        }
      }
    },
    {
      "adapter": "chemml",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "ChemML is not installed. Install with: pip install chemml"
      },
      "metadata": {
        "name": "chemml",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 60,
          "default_operation": "coulomb_matrix",
          "max_molecules": 1000,
          "default_max_atoms": 23
        }
      }
    },
    {
      "adapter": "tpot",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "TPOT is not installed. Install with: pip install tpot"
      },
      "metadata": {
        "name": "tpot",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 7200,
          "default_generations": 5,
          "default_population_size": 20,
          "default_cv": 5,
          "max_time_mins": 60,
          "max_eval_time_mins": 5
        }
      }
    },
    {
      "adapter": "autosklearn",
      "status": "success",
      "error": null,
      "execution_time": 0.0,
      "data": {
        "success": false,
        "data": null,
        "error": "Auto-sklearn is not installed. Install with: pip install auto-sklearn"
      },
      "metadata": {
        "name": "autosklearn",
        "type": "local",
        "version": "1.0.0",
        "enabled": true,
        "config": {
          "timeout": 7200,
          "default_time_limit": 300,
          "default_per_run_time_limit": 30,
          "default_ensemble_size": 50,
          "default_cv": 5,
          "memory_limit": 3072
        }
      }
    }
  ]
}